PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pierman, B; Toussaint, F; Bertin, A; Levy, D; Smargiasso, N; De Pauw, E; Boutry, M				Pierman, Baptiste; Toussaint, Frederic; Bertin, Aurelie; Levy, Daniel; Smargiasso, Nicolas; De Pauw, Edwin; Boutry, Marc			Activity of the purified plant ABC transporter NtPDR1 is stimulated by diterpenes and sesquiterpenes involved in constitutive and induced defenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; glycosylation; liposome; membrane reconstitution; plant defense; protein purification; single particle analysis; BY-2 cells; Nicotiana tabacum; terpenes	ATP-BINDING CASSETTE; DRUG-RESISTANCE TRANSPORTER; LIPID TRANSFER PROTEIN; NICOTIANA-TABACUM; H+-ATPASE; TOBACCO; EXPRESSION; SECRETION; MULTIDRUG; RECONSTITUTION	Within the plant ATP-binding cassette transporter family, pleiotropic drug resistance (PDR) transporters play essential functions, such as in hormone transport or defense against biotic and abiotic stresses. NtPDR1 from Nicotiana tabacum has been shown to be involved in the constitutive defense against pathogens through the secretion of toxic cyclic diterpenes, such as the antimicrobial substrates cembrene and sclareol from the leaf hairs (trichomes). However, direct evidence of an interaction between NtPDR1 and terpenes is lacking. Here, we stably expressed NtPDR1 in N. tabacum BY-2 suspension cells. NtPDR1 was purified as an active monomer glycosylated at a single site in the third external loop. NtPDR1 reconstitution in proteoliposomes stimulated its basal ATPase activity from 21 to 38 nmol of P(i<bold>)mg(</bold>-1<bold>)min(</bold>-1), and ATPase activity was further stimulated by the NtPDR1 substrates cembrene and sclareol, providing direct evidence of an interaction between NtPDR1 and its two substrates. Interestingly, NtPDR1 was also stimulated by capsidiol, a sesquiterpene produced by N. tabacum upon pathogen attack. We also monitored the transcriptional activity from the NtPDR1 promoter in situ with a reporter gene and found that, although NtPDR1 expression was limited to trichomes under normal conditions, addition of methyl jasmonate, a biotic stress hormone, induced expression in all leaf tissues. This finding indicated that NtPDR1 is involved not only in constitutive but also in induced plant defenses. In conclusion, we provide direct evidence of an interaction between the NtPDR1 transporter and its substrates and that NtPDR1 transports compounds involved in both constitutive (diterpenes) and induced (sesquiterpenes) plant defenses.	[Pierman, Baptiste; Toussaint, Frederic; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Bertin, Aurelie; Levy, Daniel] Univ Pierre & Marie Curie Paris 06, Lab Phys Chim Curie, Inst Curie, Paris Sci & Lettres Res Univ,CNRS,UMR168, F-75005 Paris, France; [Bertin, Aurelie; Levy, Daniel] Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, F-75005 Paris, France; [Smargiasso, Nicolas; De Pauw, Edwin] Univ Liege, Mol Syst Res Unit, Mass Spectrometry Lab, B-4000 Liege, Belgium	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; University of Liege	Boutry, M (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	marc.boutry@uclouvain.be		Bertin, Aurelie/0000-0002-3400-6887; levy, daniel/0000-0002-8949-4072; Toussaint, Frederic/0000-0002-4869-4350	French National Research Agency through the "Investments for the Future" [ANR-10-INSB-04]; Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France); Belgian Fund for Scientific Research; Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services)	French National Research Agency through the "Investments for the Future"(French National Research Agency (ANR)); Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services)	This work was supported by grants from the French National Research Agency through the "Investments for the Future" (France-BioImaging, Grant ANR-10-INSB-04), the Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France), the Belgian Fund for Scientific Research, and the Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services). The authors declare that they have no conflicts of interest with the contents of this article.	Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Biala W, 2017, J EXP BOT, V68, P3231, DOI 10.1093/jxb/erx059; Bienert MD, 2012, PLANT J, V72, P745, DOI 10.1111/j.1365-313X.2012.05108.x; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURDEN RS, 1975, PHYTOCHEMISTRY, V14, P221, DOI 10.1016/0031-9422(75)85043-6; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Champagne A, 2016, BBA-PROTEINS PROTEOM, V1864, P1039, DOI 10.1016/j.bbapap.2016.02.010; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Choi YE, 2012, PLANT J, V70, P480, DOI 10.1111/j.1365-313X.2011.04886.x; Crouzet J, 2006, FEBS LETT, V580, P1123, DOI 10.1016/j.febslet.2005.12.043; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Demessie Z, 2017, PHYTOCHEMISTRY, V140, P118, DOI 10.1016/j.phytochem.2017.04.019; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fu XQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00723; Furt F, 2011, PLANT CELL MONOGR, V19, P3, DOI 10.1007/978-3-642-13431-9_1; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kubes M, 2012, PLANT J, V69, P640, DOI 10.1111/j.1365-313X.2011.04818.x; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maldonado-Bonilla LD, 2008, EUR J PLANT PATHOL, V121, P439, DOI 10.1007/s10658-007-9262-1; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miah MF, 2016, BIOCHEM BIOPH RES CO, V469, P954, DOI 10.1016/j.bbrc.2015.12.095; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Navarre C, 2017, TRANSGENIC RES, V26, P375, DOI 10.1007/s11248-017-0013-6; Nocarova E, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-44; Pernstich C, 2014, PROTEIN EXPRES PURIF, V101, P68, DOI 10.1016/j.pep.2014.05.011; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sasabe M, 2002, FEBS LETT, V518, P164, DOI 10.1016/S0014-5793(02)02697-2; Sasse J, 2016, PLANT CELL ENVIRON, V39, P2725, DOI 10.1111/pce.12828; Shibata Y, 2016, PLANT CELL, V28, P1163, DOI 10.1105/tpc.15.00721; Shoji T, 2014, INT REV CEL MOL BIO, V309, P303, DOI 10.1016/B978-0-12-800255-1.00006-5; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153; Toussaint F, 2017, BIOCHEM J, V474, P1689, DOI 10.1042/BCJ20170108; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wang B, 2016, METAB ENG, V38, P159, DOI 10.1016/j.ymben.2016.07.004; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Yu F, 2013, P NATL ACAD SCI USA, V110, P15830, DOI 10.1073/pnas.1307504110	75	27	29	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19491	19502		10.1074/jbc.M117.811935	http://dx.doi.org/10.1074/jbc.M117.811935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972149	hybrid, Green Published			2022-12-28	WOS:000416226700028
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			The periplasmic transaminase PtaA of Pseudomonas fluorescens converts the glutamic acid residue at the pyoverdine fluorophore to -ketoglutaric acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; iron; Pseudomonas; pyridoxal phosphate; siderophore; periplasmic tailoring; pyoverdines; transaminase	POLYACRYLAMIDE-GELS; WEB SERVER; ELECTROPHORETIC TRANSFER; ESCHERICHIA-COLI; SIDEROPHORES; PROTEIN; AERUGINOSA; BIOSYNTHESIS; SECRETION; NITROCELLULOSE	The periplasmic conversion of ferribactin to pyoverdine is essential for siderophore biogenesis in fluorescent pseudomonads, such as pathogenic Pseudomonas aeruginosa or plant growth-promoting Pseudomonas fluorescens. The non-ribosomal peptide ferribactin undergoes cyclizations and oxidations that result in the fluorophore, and a strictly conserved fluorophore-bound glutamic acid residue is converted to a range of variants, including succinamide, succinic acid, and -ketoglutaric acid residues. We recently discovered that the pyridoxal phosphate-containing enzyme PvdN is responsible for the generation of the succinamide, which can be hydrolyzed to succinic acid. Based on this, a distinct unknown enzyme was postulated to be responsible for the conversion of the glutamic acid to -ketoglutaric acid. Here we report the identification and characterization of this enzyme in P. fluorescens strain A506. In silico analyses indicated a periplasmic transaminase in fluorescent pseudomonads and other proteobacteria that we termed PtaA for periplasmic transaminase A. An in-frame-deleted ptaA mutant selectively lacked the -ketoglutaric acid form of pyoverdine, and recombinant PtaA complemented this phenotype. The ptaA/pvdN double mutant produced exclusively the glutamic acid form of pyoverdine. PtaA is homodimeric and contains a pyridoxal phosphate cofactor. Mutation of the active-site lysine abolished PtaA activity and affected folding as well as Tat-dependent transport of the enzyme. In pseudomonads, the occurrence of ptaA correlates with the occurrence of -ketoglutaric acid forms of pyoverdines. As this enzyme is not restricted to pyoverdine-producing bacteria, its catalysis of periplasmic transaminations is most likely a general tool for specific biosynthetic pathways.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Science Foundation (Deutsche Forschungsgemeinschaft) [GRK1798, BR 2285/7-1]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (Deutsche Forschungsgemeinschaft) GRK1798 "Signaling at the Plant-Soil Interface" and Project BR 2285/7-1. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRISKOT G, 1986, Z NATURFORSCH C, V41, P497; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Calhoun DH, 2001, GENOME BIOL, V2; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GEISEN K, 1992, MONATSH CHEM, V123, P151, DOI 10.1007/BF01045308; Gulick AM, 2017, NAT PROD REP, V34, P981, DOI 10.1039/c7np00029d; GWOSE I, 1992, Z NATURFORSCH C, V47, P487; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; HOHLNEICHER U, 1992, Z NATURFORSCH B, V47, P1633, DOI 10.1515/znb-1992-1119; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KOEDAM N, 1994, BIOMETALS, V7, P287; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz C, 2000, Z NATURFORSCH C, V55, P146; Meyer JM, 2008, BIOMETALS, V21, P259, DOI 10.1007/s10534-007-9115-6; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POPPE K, 1987, TETRAHEDRON, V43, P2261, DOI 10.1016/S0040-4020(01)86810-1; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; SCHAFER H, 1991, Z NATURFORSCH C, V46, P398; Schalk IJ, 2017, J MED CHEM, V60, P4573, DOI 10.1021/acs.jmedchem.7b00554; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schons V, 2005, BIOCHEMISTRY-US, V44, P14069, DOI 10.1021/bi051155s; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6446, DOI 10.1021/bi00525a025; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wilson MJ, 2001, J BACTERIOL, V183, P2151, DOI 10.1128/JB.183.6.2151-2155.2001; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; YANG CC, 1984, BIOCHEMISTRY-US, V23, P3534, DOI 10.1021/bi00310a023; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	58	8	8	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18660	18671		10.1074/jbc.M117.812545	http://dx.doi.org/10.1074/jbc.M117.812545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28912270	Green Published, hybrid			2022-12-28	WOS:000414958100022
J	Bruno, J; Pozzi, N; Oliva, J; Edwards, JC				Bruno, Jonathan; Pozzi, Nicola; Oliva, Jonathan; Edwards, John C.			Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; membrane transporter reconstitution; nephrology; phospholipid vesicle; potassium channel; ApoL1; apolipoprotein L1	APOL1 RISK VARIANTS; TRYPANOSOME LYTIC FACTOR; LIPID-BINDING PROTEIN; AUTOPHAGIC CELL-DEATH; KIDNEY-DISEASE; COLICIN IA; CHANNEL; EXPRESSION; MEMBRANES; INSERTION	Apolipoprotein L1 (ApoL1) is a human serum protein conferring resistance to African trypanosomes, and certain ApoL1 variants increase susceptibility to some progressive kidney diseases. ApoL1 has been hypothesized to function like a pore-forming colicin and has been reported to have permeability effects on both intracellular and plasma membranes. Here, to gain insight into how ApoL1 may function in vivo, we used vesicle-based ion permeability, direct membrane association, and intrinsic fluorescence to study the activities of purified recombinant ApoL1. We found that ApoL1 confers chloride-selective permeability to preformed phospholipid vesicles and that this selectivity is strongly pH-sensitive, with maximal activity at pH 5 and little activity above pH 7. When ApoL1 and lipid were allowed to interact at low pH and were then brought to neutral pH, chloride permeability was suppressed, and potassium permeability was activated. Both chloride and potassium permeability linearly correlated with the mass of ApoL1 in the reaction mixture, and both exhibited lipid selectivity, requiring the presence of negatively charged lipids for activity. Potassium, but not chloride, permease activity required the presence of calcium ions in both the association and activation steps. Direct assessment of ApoL1-lipid associations confirmed that ApoL1 stably associates with phospholipid vesicles, requiring low pH and the presence of negatively charged phospholipids for maximal binding. Intrinsic fluorescence of ApoL1 supported the presence of a significant structural transition when ApoL1 is mixed with lipids at low pH. This pH-switchable ion-selective permeability may explain the different effects of ApoL1 reported in intracellular and plasma membrane environments.	[Bruno, Jonathan; Edwards, John C.] St Louis Univ, Dept Internal Med, St Louis, MO 63110 USA; [Pozzi, Nicola; Oliva, Jonathan] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University	Edwards, JC (corresponding author), St Louis Univ, Dept Internal Med, Renal Div, 3635 Vista Ave, St Louis, MO 63110 USA.	edwardjc@slu.edu	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020; Bruno, Jonathan/HII-3034-2022	Pozzi, Nicola/0000-0003-2309-7100; 	National Institutes of Health [RO1 HL092131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant RO1 HL092131 (to J. C. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bermejo IL, 2013, BIOPHYS J, V105, P1432, DOI 10.1016/j.bpj.2013.08.012; Bruggeman LA, 2017, J AM SOC NEPHROL, V28, P1008, DOI 10.1681/ASN.2016111262; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; ElEtri M, 1996, AM J PHYSIOL-LUNG C, V270, pL386, DOI 10.1152/ajplung.1996.270.3.L386; Fu YL, 2017, J AM SOC NEPHROL, V28, P1106, DOI 10.1681/ASN.2016050550; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Kaul P, 1996, PROTEIN SCI, V5, P687; Kienker PK, 2008, J GEN PHYSIOL, V132, P693, DOI 10.1085/jgp.200810042; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117, DOI 10.1681/ASN.2016050546; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Pays E, 2008, MICROBES INFECT, V10, P985, DOI 10.1016/j.micinf.2008.07.020; Pays E, 2014, NAT REV MICROBIOL, V12, P575, DOI 10.1038/nrmicro3298; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Zhaorigetu S, 2008, AUTOPHAGY, V4, P1079, DOI 10.4161/auto.7066	30	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18344	18353		10.1074/jbc.M117.813444	http://dx.doi.org/10.1074/jbc.M117.813444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28918394	Green Published, hybrid			2022-12-28	WOS:000414458200030
J	Suzuki, T; Yamamoto, M				Suzuki, Takafumi; Yamamoto, Masayuki			Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						animal model; antioxidant; gene regulation; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); stress response; Keap1; anti-inflammation	TRANSCRIPTION FACTOR NRF2; PROTEIN-PROTEIN INTERACTION; ANTIOXIDANT RESPONSE ELEMENT; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; INTERACTION INHIBITORS; INFLAMMATORY RESPONSE; SUBSTRATE ADAPTER; CYSTEINE RESIDUES; PHASE-2 RESPONSE	Transcription factor Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses. Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses the induction of pro-inflammatory cytokine genes. Keap1 (Kelch-like ECH-associated protein 1) is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase. Keap1 regulates the activity of Nrf2 and acts as a sensor for oxidative and electrophilic stresses. In this review, we discuss the molecular mechanisms by which the Keap1-Nrf2 system senses and regulates the cellular response to environmental stresses. In particular, we focus on the multiple stress-sensing mechanisms of Keap1 and novel regulatory functions of Nrf2.	[Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan	Tohoku University	Yamamoto, M (corresponding author), Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	masiyamamoto@med.tohoku.ac.jp	Suzuki, Takafumi/ABC-6582-2020; Yamamoto, Masayuki/A-4873-2010	Suzuki, Takafumi/0000-0002-3425-8208; Yamamoto, Masayuki/0000-0002-9073-9436	MEXT/JSPS KAKENHI [26111002, 17K15590, 26111010]; AMED-P-CREATE; Naito Foundation; Takeda Science Foundation; Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-P-CREATE; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by MEXT/JSPS KAKENHI Grants 26111002 (to M. Y.) and 17K15590 and 26111010 (to T. S.), AMED-P-CREATE (to M. Y.), the Naito Foundation (to M. Y.), the Takeda Science Foundation (to M. Y.), and the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED) (to M. Y.). This is the third article in the Thematic Minireview series "Redox metabolism and signaling." The authors declare that they have no conflicts of interest with the contents of this article.	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Bertrand HC, 2015, J MED CHEM, V58, P7186, DOI 10.1021/acs.jmedchem.5b00602; Burness CB, 2014, CNS DRUGS, V28, P373, DOI 10.1007/s40263-014-0155-5; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; COUTUREHAWS L, 1991, TOXICOL APPL PHARM, V107, P413, DOI 10.1016/0041-008X(91)90305-X; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Erttmann SF, 2011, FREE RADICAL BIO MED, V51, P626, DOI 10.1016/j.freeradbiomed.2011.05.022; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Higashi C, 2017, EUR J PHARMACOL, V802, P76, DOI 10.1016/j.ejphar.2017.02.044; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Iso T, 2016, MOL CELL BIOL, V36, P3100, DOI 10.1128/MCB.00389-16; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jiang ZY, 2016, J MED CHEM, V59, P10837, DOI 10.1021/acs.jmedchem.6b00586; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Keleku-Lukwete N, 2015, P NATL ACAD SCI USA, V112, P12169, DOI 10.1073/pnas.1509158112; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/529219; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26585; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyazaki Y, 2014, NEPHROL DIAL TRANSPL, V29, P783, DOI 10.1093/ndt/gfu002; Murakami S, 2014, GENES CELLS, V19, P239, DOI 10.1111/gtc.12126; Nezu M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam5711; Nezu M, 2017, KIDNEY INT, V91, P387, DOI 10.1016/j.kint.2016.08.023; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nishimura N, 2008, TOXICOL APPL PHARM, V231, P374, DOI 10.1016/j.taap.2008.05.012; Noel S, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0310-y; Ohkoshi A, 2013, CANCER PREV RES, V6, P149, DOI 10.1158/1940-6207.CAPR-12-0401-T; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Otsuki A, 2016, FREE RADICAL BIO MED, V91, P45, DOI 10.1016/j.freeradbiomed.2015.12.005; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Saito R, 2016, MOL CELL BIOL, V36, P271, DOI 10.1128/MCB.00868-15; Satoh H, 2016, CANCER RES, V76, P3088, DOI 10.1158/0008-5472.CAN-15-1584; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Small E, 2010, BIOCHEM BIOPH RES CO, V400, P471, DOI 10.1016/j.bbrc.2010.08.062; Street JM, 2011, J PHYSIOL-LONDON, V589, P6119, DOI 10.1113/jphysiol.2011.220277; Suzuki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14577; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yasuda D, 2016, BIOORG MED CHEM LETT, V26, P5956, DOI 10.1016/j.bmcl.2016.10.083; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	85	222	231	14	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16817	16824		10.1074/jbc.R117.800169	http://dx.doi.org/10.1074/jbc.R117.800169			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842501	Green Published, hybrid			2022-12-28	WOS:000413140600004
J	Baranovskiy, AG; Gu, JY; Babayeva, ND; Kurinov, I; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Gu, Jianyou; Babayeva, Nigar D.; Kurinov, Igor; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal structure of the human Pol is an element of B-subunit in complex with the C-terminal domain of the catalytic subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-EPSILON; CYCLE-DEPENDENT PHOSPHORYLATION; IRON-SULFUR CLUSTER; NONCATALYTIC SUBUNIT; ALPHA; REPLICATION; PRIMASE; DPB2; ARCHITECTURE; ORIGIN	The eukaryotic B-family DNA polymerases include four members: Pol alpha, Pol delta, Pol epsilon, and Pol zeta, which share common architectural features, such as the exonuclease/polymerase and C-terminal domains (CTDs) of catalytic subunitsboundto indispensable B-subunits, which serve as scaffolds that mediate interactions with other components of the replication machinery. Crystal structures for the B-subunits of Pol alpha and Pol delta / Pol zeta have been reported: the former within the primosome and separately with CTD and the latter with the N-terminal domain of the C-subunit. Here we present the crystal structure of the human Pol epsilon B-subunit (p59) in complex with CTD of the catalytic subunit (p261C). The structure revealed a well defined electron density for p261C and the phosphodiesterase and oligonucleotide/ oligosaccharide-binding domains of p59. However, electron density was missing for the p59 N-terminal domain and for the linker connecting it to the phosphodiesterase domain. Similar to Pol alpha, p261(C) of Pol epsilon contains a three-helix bundle in the middle and zinc-binding modules on each side. Intersubunit interactions involving 11 hydrogen bonds and numerous hydrophobic contacts account for stable complex formation with a buried surface area of 3094 A(2). Comparative structural analysis of p59-p261C with the corresponding Pol alpha complex revealed significant differences between the B-subunits and CTDs, as well as their interaction interfaces. The B-subunit of Pol delta / Pol zeta also substantially differs from B-subunits of either Pol alpha or Pol epsilon. This work provides a structural basis to explain biochemical and genetic data on the importance of B-subunit integrity in replisome function in vivo.	[Baranovskiy, Andrey G.; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Genet & Anat, Omaha, NE 68198 USA; [Kurinov, Igor] Cornell Univ, Northeastern Collaborat Access Team, Adv Photon Source, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Gu, Jianyou] Zhejiang Prov Hosp Tradit Chinese Med, Hangzhou 310006, Zhejiang, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Zhejiang Chinese Medical University	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796	NCI NIH HHS [P30 CA036727] Funding Source: Medline; NCRR NIH HHS [S10 RR029205] Funding Source: Medline; NIGMS NIH HHS [P41 GM103403, R01 GM101167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020062; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; DeLano W.L, PYMOL MOL GRAPHICS S; Dmowski M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006572; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Dua R, 2002, J BIOL CHEM, V277, P7889, DOI 10.1074/jbc.M108546200; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garbacz M, 2015, DNA REPAIR, V29, P23, DOI 10.1016/j.dnarep.2015.02.007; Garcia JS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-82; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Isoz I, 2012, NUCLEIC ACIDS RES, V40, P11545, DOI 10.1093/nar/gks880; Jain R, 2014, J MOL BIOL, V426, P301, DOI 10.1016/j.jmb.2013.10.015; Jaszczur M, 2008, GENETICS, V178, P633, DOI 10.1534/genetics.107.082818; Jaszczur M, 2009, MUTAT RES-FUND MOL M, V669, P27, DOI 10.1016/j.mrfmmm.2009.04.012; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kesti T, 2004, J BIOL CHEM, V279, P14245, DOI 10.1074/jbc.M313289200; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kraszewska J, 2012, MUTAT RES-FUND MOL M, V737, P34, DOI 10.1016/j.mrfmmm.2012.06.002; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Li Y, 2000, J BIOL CHEM, V275, P31554; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Tsubotao T, 2006, J BIOL CHEM, V281, P32898, DOI 10.1074/jbc.M606637200; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Zahurancik WJ, 2015, DNA REPAIR, V29, P16, DOI 10.1016/j.dnarep.2015.01.008; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655; Zhou JC, 2017, P NATL ACAD SCI USA, V114, P4141, DOI 10.1073/pnas.1700530114; Zhou JQ, 1997, NUCLEIC ACIDS RES, V25, P1094, DOI 10.1093/nar/25.6.1094	57	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15717	15730		10.1074/jbc.M117.792705	http://dx.doi.org/10.1074/jbc.M117.792705			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28747437	Green Published, hybrid			2022-12-28	WOS:000411512200012
J	Zhang, JC; Qu, PX; Zhou, C; Liu, X; Ma, XN; Wang, MY; Wang, YS; Su, JM; Liu, J; Zhang, Y				Zhang, Jingcheng; Qu, Pengxiang; Zhou, Chuan; Liu, Xin; Ma, Xiaonan; Wang, Mengyun; Wang, Yongsheng; Su, Jianmin; Liu, Jun; Zhang, Yong			MicroRNA-125b is a key epigenetic regulatory factor that promotes nuclear transfer reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; EMBRYONIC-DEVELOPMENT; CLONED EMBRYOS; BOVINE EMBRYOS; HETEROCHROMATIN; METHYLATION; IMPROVES; SUV39H1; DIFFERENTIATION; TRANSCRIPTION	Somatic cell nuclear transfer (SCNT)-mediated reprogramming is a rapid, efficient, and sophisticated process that reprograms differentiated somatic cells to a pluripotent state. However, many factors in this elaborate reprogramming process remain largely unknown. Here, we report that the microRNA (miR) miR-125b is an important component of SCNT-mediated reprogramming. Luciferase reporter assay, quantitative PCR, and Western blotting demonstrated that miR-125b directly binds the 3'-untranslated region of SUV39H1, encoding the histone- lysine N-methyltransferase SUV39H1, to down-regulate histone H3 lysine-9 tri-methylation (H3K9me3) in SCNT embryos. Furthermore, the miR-125b/SUV39H1 interaction induced loss of SUV39H1-mediated H3K9me3, caused heterochromatin relaxation, and promoted the development of SCNT embryos. Transcriptome analyses of SCNT blastomeres indicated that HNF1 homeobox B (HNF1B), a gene encoding a transcription factor downstream of and controlled by the miR-125b/SUV39H1 axis, is important for conferring developmental competence on preimplantation embryos. We conclude that miR-125b promotes SCNT-mediated nuclear reprogramming by targeting SUV39H1 to decrease the deposition of repressive H3K9me3 modifications.	[Zhang, Jingcheng; Qu, Pengxiang; Zhou, Chuan; Liu, Xin; Ma, Xiaonan; Wang, Mengyun; Wang, Yongsheng; Su, Jianmin; Liu, Jun; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wang, YS; Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	Wangyongsheng01@nwsuaf.edu.cn; zhy1956@263.net			National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Natural Science Foundation of China [31472094, 31772603]; National Major Project for Production of Transgenic Breeding [2016ZX08007003]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding	This work was supported by the National High Technology Research and Development Program of China (863 Program) (2011AA100303), a grant from the National Natural Science Foundation of China (31472094 and 31772603), and the National Major Project for Production of Transgenic Breeding (2016ZX08007003). The authors declare that they have no conflicts of interest with the contents of this article.	Antony J, 2013, MOL CELL BIOL, V33, P974, DOI 10.1128/MCB.01014-12; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brero A, 2009, CLONING STEM CELLS, V11, P319, DOI 10.1089/clo.2008.0083; Chang CC, 2010, CELL REPROGRAM, V12, P43, DOI 10.1089/cell.2009.0043; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Denicol AC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01266; Djeghloul D, 2016, STEM CELL REP, V6, P970, DOI 10.1016/j.stemcr.2016.05.007; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Hashem N., 2017, REPROD FERT DEVELOP, V29, P179; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Kallingappa PK, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.137109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KH, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160181; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2017, CHRONOBIOL INT, V20, P1; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Loi P, 2016, TRENDS BIOTECHNOL, V34, P791, DOI 10.1016/j.tibtech.2016.03.008; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Mondou E, 2012, MOL HUM REPROD, V18, P425, DOI 10.1093/molehr/gas015; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poleshko A, 2014, NUCLEUS-PHILA, V5, P32, DOI 10.4161/nucl.28167; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Teperek M, 2016, GENOME RES, V26, P1034, DOI 10.1101/gr.201541.115; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xiong XR, 2014, ZYGOTE, V22, P1, DOI 10.1017/S0967199412000184; Yang QY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501482; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	42	29	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15916	15926		10.1074/jbc.M117.796771	http://dx.doi.org/10.1074/jbc.M117.796771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794155	Green Published, hybrid			2022-12-28	WOS:000411512200028
J	Ebert, M; Schweyen, P; Broring, M; Laass, S; Hartig, E; Jahn, D				Ebert, Matthias; Schweyen, Peter; Broering, Martin; Laass, Sebastian; Haertig, Elisabeth; Jahn, Dieter			Heme and nitric oxide binding by the transcriptional regulator DnrF from the marine bacterium Dinoroseobacter shibae increases napD promoter affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATE RESPIRATION REGULATOR; GENE-EXPRESSION; PARACOCCUS-DENITRIFICANS; METABOLIC ADAPTATION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; FNR; ACTIVATION; PROTEINS; OXYGEN	Under oxygen-limiting conditions, the marine bacterium Dinoroseobacter shibae DFL12(T) generates energy via denitrification, a respiratory process in which nitric oxide (NO) is an intermediate. Accumulation of NO may cause cytotoxic effects. The response to this nitrosative (NO-triggered) stress is controlled by the Crp/Fnr-type transcriptional regulator DnrF. We analyzed the response to NO and the mechanism of NO sensing by the DnrF regulator. Using reporter gene fusions and transcriptomics, here we report that DnrF selectively repressed nitrate reductase (nap) genes, preventing further NO formation. In addition, DnrF induced the expression of the NO reductase genes (norCB), which promote NO consumption. We used UV-visible and EPR spectroscopy to characterize heme binding to DnrF and subsequent NO coordination. DnrF detects NO via its bound heme cofactor. We found that the dimeric DnrF bound one molecule of heme per subunit. Purified recombinant apo-DnrF bound its target promoter sequences (napD, nosR2, norC, hemA, and dnrE) in electromobility shift assays, and we identified a specific palindromic DNA-binding site 5'-TTGATN4ATCAA-3' in these target sequences via mutagenesis studies. Most importantly, successive addition of heme as well as heme and NO to purified recombinant apo-DnrF protein increased affinity of the holo-DnrF for its specific binding motif in the napD promoter. On the basis of these results, we propose a model for the DnrF-mediated NO stress response of this marine bacterium.	[Ebert, Matthias; Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany; [Schweyen, Peter; Broering, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Inorgan & Analyt Chem, Hagenring 30, D-38106 Braunschweig, Germany; [Laass, Sebastian] Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Goethe University Frankfurt; Braunschweig University of Technology	Hartig, E (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	e.haertig@tu-bs.de	Schweyen, Peter/AAP-5374-2020	Jahn, Dieter/0000-0002-4064-9205; Schweyen, Peter/0000-0003-3222-0502	Deutsche Forschungsgemeinschaft [TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (TRR 51). The authors declare that they have no conflicts of interest with the contents of this article.	Aono S, 2012, ANTIOXID REDOX SIGN, V16, P678, DOI 10.1089/ars.2011.4248; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Arai H, 2003, MICROBIOL-SGM, V149, P29, DOI 10.1099/mic.0.25936-0; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Cutruzzola F, 2014, BIOMETALS, V27, P763, DOI 10.1007/s10534-014-9770-3; Ebert M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00642; Ebert M, 2013, J BACTERIOL, V195, P4769, DOI 10.1128/JB.00860-13; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleischhacker AS, 2011, CURR OPIN CHEM BIOL, V15, P335, DOI 10.1016/j.cbpa.2011.01.006; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Giardina G, 2011, BIOCHEM SOC T, V39, P294, DOI 10.1042/BST0390294; Giardina G, 2009, PROTEINS, V77, P174, DOI 10.1002/prot.22428; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; GREEN J, 1993, FEMS MICROBIOL LETT, V113, P219, DOI 10.1111/j.1574-6968.1993.tb06517.x; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Hartig E, 2012, ADV MICROB PHYSIOL, V61, P195, DOI 10.1016/B978-0-12-394423-8.00005-6; Karnaukhova E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00465; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Laass S, 2014, J BIOL CHEM, V289, P13219, DOI 10.1074/jbc.M113.545004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YY, 2006, MICROBIOL-SGM, V152, P1461, DOI 10.1099/mic.0.28796-0; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Lobato L, 2014, J BIOL CHEM, V289, P26514, DOI 10.1074/jbc.M114.571398; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; Righetti P. G., 1990, IMMOBILIZED PH GRADI; Rinaldo S, 2012, ANTIOXID REDOX SIGN, V17, P1178, DOI 10.1089/ars.2011.4226; Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Tosques IE, 1996, J BACTERIOL, V178, P4958, DOI 10.1128/jb.178.16.4958-4964.1996; TRAGESER M, 1989, MOL MICROBIOL, V3, P593, DOI 10.1111/j.1365-2958.1989.tb00206.x; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Van Spanning RJM, 1999, J BACTERIOL, V181, P4129, DOI 10.1128/JB.181.13.4129-4132.1999; VANSPANNING RJM, 1995, FEBS LETT, V360, P151, DOI 10.1016/0014-5793(95)00091-M; Vollack KU, 2001, J BACTERIOL, V183, P2516, DOI 10.1128/JB.183.8.2516-2526.2001; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	52	8	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15468	15480		10.1074/jbc.M117.798728	http://dx.doi.org/10.1074/jbc.M117.798728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765283	Green Published, hybrid			2022-12-28	WOS:000410809800026
J	Wiechmann, S; Gartner, A; Kniss, A; Stengl, A; Behrends, C; Rogov, VV; Rodriguez, MS; Dotsch, V; Muller, S; Ernst, A				Wiechmann, Svenja; Gaertner, Anne; Kniss, Andreas; Stengl, Andreas; Behrends, Christian; Rogov, Vladimir V.; Rodriguez, Manuel S.; Doetsch, Volker; Mueller, Stefan; Ernst, Andreas			Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; STRUCTURAL BASIS; PML DEGRADATION; CONJUGATION; BINDING; SYSTEM; RNF4; IDENTIFICATION; PROTEINS; REVEALS	Posttranslational modifications by small ubiquitin-like modifiers (SUMOs) regulate many cellular processes, including genome integrity, gene expression, and ribosome biogenesis. The E2-conjugating enzyme Ubc9 catalyzes the conjugation of SUMOs to epsilon-amino groups of lysine residues in target proteins. Attachment of SUMO moieties to internal lysines in Ubc9 itself can further lead to the formation of polymeric SUMO chains. Mono-and poly-SUMOylations of target proteins provide docking sites for distinct adapter and effector proteins important for regulating discrete SUMO-regulated pathways. However, molecular tools to dissect pathways depending on either mono-or poly-SUMOylation are largely missing. Using a protein-engineering approach, we generated high-affinity SUMO2 variants by phage display that bind the back side binding site of Ubc9 and function as SUMO-based Ubc9 inhibitors (SUBINs). Importantly, we found that distinct SUBINs primarily inhibit poly-SUMO chain formation, whereas mono-SUMOylation was not impaired. Proof-of-principle experiments demonstrated that in a cellular context, SUBINs largely prevent heat shock-triggered polySUMOylation. Moreover, SUBINs abrogated arsenic-induced degradation of promyelocytic leukemia protein. We propose that the availability of the new chain-selective SUMO inhibitors reported here will enable a thorough investigation of poly-SUMO-mediated cellular processes, such as DNA damage responses and cell cycle progression.	[Wiechmann, Svenja; Gaertner, Anne; Stengl, Andreas; Behrends, Christian; Mueller, Stefan; Ernst, Andreas] Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Kniss, Andreas; Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Kniss, Andreas; Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Ernst, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Rodriguez, Manuel S.] Inst Technol Avancees Sci Vivant UPS, 1 Pl Pierre Potier Oncopole Entree B,BP 50624, F-31106 Toulouse 1, France; [Rodriguez, Manuel S.] IPBS CNRS, 1 Pl Pierre Potier Oncopole Entree B,BP 50624, F-31106 Toulouse 1, France; [Stengl, Andreas] Ludwig Maximilian Univ Munich, Dept Biol 2, Grosshaderner Str 2, D-82152 Martinsried, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Fraunhofer Gesellschaft; Centre National de la Recherche Scientifique (CNRS); University of Munich	Muller, S; Ernst, A (corresponding author), Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Ernst, A (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ste.mueller@em.uni-frankfurt.de; a.ernst@em.uni-frankfurt.de	Stengl, Andreas/ABD-2251-2021; Ernst, Andreas/M-3013-2019; RODRIGUEZ, Manuel S./D-5439-2018; Behrends, Christian/AAX-4201-2021	Stengl, Andreas/0000-0002-8802-3260; Behrends, Christian/0000-0002-9184-7607; Muller, Stefan/0000-0002-8792-7700	LOEWE Ub-Net; Cluster of Excellence "Macromolecular Complexes" [DFG EXC115]; Collaborative Research Center [SFB 1177]	LOEWE Ub-Net; Cluster of Excellence "Macromolecular Complexes"; Collaborative Research Center	This work was supported by LOEWE Ub-Net, Cluster of Excellence "Macromolecular Complexes" (DFG EXC115), and the Collaborative Research Center SFB 1177. The authors declare that they have no conflicts of interest with the contents of this article.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Da Silva-Ferrada E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01690; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P743; Gorelik M, 2016, P NATL ACAD SCI USA, V113, P3527, DOI 10.1073/pnas.1519389113; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Leung I, 2016, P NATL ACAD SCI USA, V113, P8705, DOI 10.1073/pnas.1524648113; Liu Q, 1999, J BIOMOL NMR, V13, P89, DOI 10.1023/A:1008364314328; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Manczyk N, 2017, PROTEIN SCI, V26, P1060, DOI 10.1002/pro.3155; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Nie MH, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010014; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sambrook D. W. R., 2001, MOL CLONING LAB MANU, P1366; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Sun MGF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600692; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yu B, 2015, P NATL ACAD SCI USA, V112, pE1724, DOI 10.1073/pnas.1415569112; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	49	19	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15340	15351		10.1074/jbc.M117.794255	http://dx.doi.org/10.1074/jbc.M117.794255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28784659	hybrid, Green Published			2022-12-28	WOS:000410809800016
J	Zhao, ZY; Tang, KW; Muylaert, I; Sarnuelsson, T; Elias, P				Zhao, Zhiyuan; Tang, Ka-Wei; Muylaert, Isabella; Sarnuelsson, Tore; Elias, Per			CDK9 and SPT5 proteins are specifically required for expression of herpes simplex virus 1 replication-dependent late genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; TERMINAL DOMAIN; MACROMOLECULAR-SYNTHESIS; GAMMA-2 GENES; TRANSCRIPTION; TYPE-1; ELONGATION; PROMOTER; ICP27	DNA replication greatly enhances expression of the herpes simplex virus 1 (HSV-1) gamma 2 late genes by still unknown mechanisms. Here, we demonstrate that 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), an inhibitor of CDK9, suppresses expression of gamma 2 late genes with an IC50 of 5 mu M, which is at least 10 times lower than the IC50 value required for inhibition of expression of early genes. The effect of DRB could not be explained by inhibition of DNA replication per se or loading of RNA polymerase II to late promoters and subsequent reduction of transcription. Instead, DRB reduces accumulation of gamma 2 late mRNA in the cytoplasm. In addition, we show that siRNA-mediated knockdown of the transcription factor SPT5, but not NELF-E, also gives rise to a specific inhibition of HSV-1 late gene expression. Finally, addition of DRB reduces co-immunoprecipitation of ICP27 using an anti-SPT5 antibody. Our results suggest that efficient expression of replication-dependent gamma 2 late genes is, at least in part, regulated by CDK9 dependent co-and/or post-transcriptional events involving SPT5 and ICP27.	[Zhao, Zhiyuan; Tang, Ka-Wei; Muylaert, Isabella; Sarnuelsson, Tore; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Inst Biomed, Box 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Inst Biomed, Box 440, SE-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se	Zhao, Zhiyuan/Q-9330-2018	Zhao, Zhiyuan/0000-0002-6962-1791; Tang, Ka-Wei/0000-0003-1189-5092	Swedish Cancer Society [16 0400]	Swedish Cancer Society(Swedish Cancer Society)	This work was supported by Grant 16 0400 from the Swedish Cancer Society (to P.E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrisch RG, 2016, J VIROL, V90, P2503, DOI 10.1128/JVI.02665-15; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Alfonso-Dunn R, 2017, CELL HOST MICROBE, V21, P507, DOI 10.1016/j.chom.2017.03.007; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; COEN DM, 1986, SCIENCE, V234, P53, DOI 10.1126/science.3018926; COOK WJ, 1995, J VIROL, V69, P7291, DOI 10.1128/JVI.69.11.7291-7294.1995; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; Dembowski JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006166; Dembowski JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004939; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; GUZOWSKI JF, 1994, J VIROL, V68, P7774, DOI 10.1128/JVI.68.12.7774-7789.1994; GUZOWSKI JF, 1993, J VIROL, V67, P5098, DOI 10.1128/JVI.67.9.5098-5108.1993; HOMA FL, 1986, MOL CELL BIOL, V6, P3652, DOI 10.1128/MCB.6.11.3652; HOMA FL, 1988, GENE DEV, V2, P40, DOI 10.1101/gad.2.1.40; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Jean S, 2001, VIROLOGY, V283, P273, DOI 10.1006/viro.2001.0902; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; KIBLER PK, 1991, J VIROL, V65, P6749, DOI 10.1128/JVI.65.12.6749-6760.1991; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MAVROMARANAZOS P, 1987, VIROLOGY, V161, P593, DOI 10.1016/0042-6822(87)90156-5; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; MCKNIGHT SL, 1984, CELL, V37, P253, DOI 10.1016/0092-8674(84)90321-0; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; Muylaert I, 2012, J BIOL CHEM, V287, P33142, DOI 10.1074/jbc.M112.356782; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pande NT, 1998, VIROLOGY, V246, P145, DOI 10.1006/viro.1998.9189; PEDERSON NE, 1992, J VIROL, V66, P6226, DOI 10.1128/JVI.66.10.6226-6232.1992; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; Sandri-Goldin RM, 2011, FUTURE MICROBIOL, V6, P1261, DOI [10.2217/FMB.11.119, 10.2217/fmb.11.119]; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Sedlackova L, 2010, J VIROL, V84, P2707, DOI 10.1128/JVI.02005-09; Smith RWP, 2017, P NATL ACAD SCI USA, V114, P6310, DOI 10.1073/pnas.1610417114; Smith RWP, 2005, BIOCHEM SOC T, V33, P499, DOI 10.1042/BST0330499; Sonawane YA, 2016, J MED CHEM, V59, P8667, DOI 10.1021/acs.jmedchem.6b00150; Weir JP, 2001, GENE, V271, P117, DOI 10.1016/S0378-1119(01)00512-1; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	57	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15489	15500		10.1074/jbc.M117.806000	http://dx.doi.org/10.1074/jbc.M117.806000			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28743741	Green Published, hybrid			2022-12-28	WOS:000410809800028
J	Nomura, W; Maeta, K; Inoue, Y				Nomura, Wataru; Maeta, Kazuhiro; Inoue, Yoshiharu			Phosphatidylinositol 3,5-bisphosphate is involved in methylglyoxal-induced activation of the Mpk1 mitogen-activated protein kinase cascade in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR PROTEIN; GLYOXALASE-I; YEAST; STRESS; MEMBRANE; CELL; COMPLEX; MORPHOLOGY; PATHWAY; ENDOCYTOSIS	Methylglyoxal (MG) is a natural metabolite derived from glycolysis, and this 2-oxoaldehyde has been implicated in some diseases including diabetes. However, the physiological significance of MG for cellular functions is yet to be fully elucidated. We previously reported that MG activates the Mpk1 (MAPK) cascade in the yeast Saccharomyces cerevisiae. To gain further insights into the cellular functions and responses to MG, we herein screened yeast-deletion mutant collections for susceptibility to MG. We found that mutants defective in the synthesis of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) are more susceptible to MG. PtdIns(3,5)P-2 levels increased following MG treatment, and vacuolar morphology concomitantly changed to a single swollen shape. MG activated the Pkc1-Mpk1 MAPK cascade in which a small GTPase Rho1 plays a crucial role, and the MG-induced phosphorylation of Mpk1 was impaired in mutants defective in the PtdIns(3,5)P-2 biosynthetic pathway. Of note, heat shock-induced stress also provoked Mpk1 phosphorylation in a Rho1-dependent manner; however, PtdIns(3,5)P-2 was dispensable for the heat shock-stimulated activation of this signaling pathway. Our results suggest that PtdIns(3,5)P-2 is specifically involved in the MG-induced activation of the Mpk1 MAPK cascade and in the cellular adaptation to MG-induced stress.	[Nomura, Wataru; Maeta, Kazuhiro; Inoue, Yoshiharu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Mol Microbiol, Uji, Kyoto 6110011, Japan; [Nomura, Wataru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan; [Maeta, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Neurotherapeut, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Inoue, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Mol Microbiol, Uji, Kyoto 6110011, Japan.	y_inoue@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26560397]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Challenging Exploratory Research (to W.N.) from Japan Society for the Promotion of Science (JSPS) Grant 26560397. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2005, J NEUROCHEM, V92, P255, DOI 10.1111/j.1471-4159.2004.02864.x; Angeloni Cristina, 2014, Biomed Res Int, V2014, P238485, DOI 10.1155/2014/238485; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Desfougeres Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29045; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Dove SK, 2007, BIOCHEM SOC SYMP, V74, P129, DOI 10.1042/BSS2007c12; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hama H, 2000, METHODS, V20, P465, DOI 10.1006/meth.2000.0959; Hatakeyama R, 2017, J CELL SCI, V130, P1169, DOI 10.1242/jcs.198382; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Inoue Y, 2011, SEMIN CELL DEV BIOL, V22, P278, DOI 10.1016/j.semcdb.2011.02.002; Jin N, 2016, BIOCHEM SOC T, V44, P177, DOI 10.1042/BST20150174; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753-8764.2004; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Meaden PG, 1999, YEAST, V15, P1211, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1211::AID-YEA448>3.0.CO;2-H; Nomura W, 2017, CELL SIGNAL, V31, P146, DOI 10.1016/j.cellsig.2017.01.002; Nomura W, 2015, MOL CELL BIOL, V35, P1269, DOI 10.1128/MCB.01118-14; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P238, DOI 10.1021/bi00829a034; SILVEIRA LA, 1990, J CELL BIOL, V111, P1437, DOI 10.1083/jcb.111.4.1437; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takatsume Y, 2006, J BIOL CHEM, V281, P9086, DOI 10.1074/jbc.M511037200; THORNALLEY PJ, 1989, DIABETES RES CLIN PR, V7, P115, DOI 10.1016/0168-8227(89)90101-0; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yoshida A, 2012, J BIOL CHEM, V287, P701, DOI 10.1074/jbc.M111.322222; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209	64	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15039	15048		10.1074/jbc.M117.791590	http://dx.doi.org/10.1074/jbc.M117.791590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28743744	Green Published, hybrid			2022-12-28	WOS:000409902100026
J	Essalmani, R; Susan-Resiga, D; Guillemot, J; Kim, W; Sachan, V; Awan, Z; Chamberland, A; Asselin, MC; Ly, K; Desjardins, R; Day, R; Prat, A; Seidah, NG				Essalmani, Rachid; Susan-Resiga, Delia; Guillemot, Johann; Kim, Woojin; Sachan, Vatsal; Awan, Zuhier; Chamberland, Ann; Asselin, Marie-Claude; Ly, Kevin; Desjardins, Roxanne; Day, Robert; Prat, Annik; Seidah, Nabil G.			Thrombin activation of protein C requires prior processing by a liver proprotein convertase (vol 292, pg 10564, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Awan, Zuhier] King Abdulaziz Univ, Clin Biochem Dept, Jeddah 21589, Saudi Arabia	King Abdulaziz University			Guillemot, Johann/O-1066-2013; Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018	Guillemot, Johann/0000-0002-5902-9188; Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277				Essalmani R, 2017, J BIOL CHEM, V292, P10564, DOI 10.1074/jbc.M116.770040	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13565	13565		10.1074/jbc.A116.77040	http://dx.doi.org/10.1074/jbc.A116.77040			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28821605	Green Published, hybrid			2022-12-28	WOS:000407942400005
J	Boselli, M; Lee, BH; Robert, J; Prado, MA; Min, SW; Cheng, CL; Silva, MC; Seong, C; Elsasser, S; Hatle, KM; Gahman, TC; Gygi, SP; Haggarty, SJ; Gan, L; King, RW; Finley, D				Boselli, Monica; Lee, Byung-Hoon; Robert, Jessica; Prado, Miguel A.; Min, Sang-Won; Cheng, Chialin; Silva, M. Catarina; Seong, Changhyun; Elsasser, Suzanne; Hatle, Ketki M.; Gahman, Timothy C.; Gygi, Steven P.; Haggarty, Stephen J.; Gan, Li; King, Randall W.; Finley, Daniel			An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegenerative disease; proteasome; small molecule; tauopathy; ubiquitin; IU1; IU1-47	UBIQUITIN-SPECIFIC PROTEASE; SMALL-MOLECULE INHIBITOR; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; 26S PROTEASOME; MEDIATED NEURODEGENERATION; TRANSGENIC MICE; ATAXIA MICE; DEGRADATION; AUTOPHAGY	The ubiquitin-proteasome system (UPS) is responsible for most selective protein degradation in eukaryotes and regulates numerous cellular processes, including cell cycle control and protein quality control. A component of this system, the deubiquitinating enzyme USP14, associates with the proteasome where it can rescue substrates from degradation by removal of the ubiquitin tag. We previously found that a small-molecule inhibitor of USP14, known as IU1, can increase the rate of degradation of a subset of proteasome substrates. We report here the synthesis and characterization of 87 variants of IU1, which resulted in the identification of a 10-fold more potent USP14 inhibitor that retains specificity for USP14. The capacity of this compound, IU1-47, to enhance protein degradation in cells was tested using as a reporter the microtubule-associated protein tau, which has been implicated in many neurodegenerative diseases. Using primary neuronal cultures, IU1-47 was found to accelerate the rate of degradation of wild-type tau, the pathological tau mutants P301L and P301S, and the A152T tau variant. We also report that a specific residue in tau, lysine 174, is critical for the IU1-47-mediated tau degradation by the proteasome. Finally, we show that IU1-47 stimulates autophagic flux in primary neurons. In summary, these findings provide a powerful research tool for investigating the complex biology of USP14.	[Boselli, Monica; Lee, Byung-Hoon; Robert, Jessica; Prado, Miguel A.; Seong, Changhyun; Elsasser, Suzanne; Hatle, Ketki M.; Gygi, Steven P.; King, Randall W.; Finley, Daniel] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Lee, Byung-Hoon] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Daegu 42988, South Korea; [Min, Sang-Won; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Neurol, San Francisco, CA 94158 USA; [Cheng, Chialin; Silva, M. Catarina; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Genom Med,Dept Neurol, Boston, MA 02114 USA; [Seong, Changhyun] Regeneron Pharmaceut, Tarrytown, NY 10591 USA; [Gahman, Timothy C.] Ludwig Inst Canc Res, Small Mol Discovery Program, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard Medical School; Massachusetts General Hospital; Regeneron; Ludwig Institute for Cancer Research	King, RW; Finley, D (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu; daniel_finley@hms.harvard.edu	Prado, Miguel A/P-3922-2017	Prado, Miguel A/0000-0002-4914-1619; Lee, Byung-Hoon/0000-0002-7101-0471; Gan, Li/0000-0003-4600-275X	Tau Consortium; National Institutes of Health [R01 GM095526, GM043601, R01 GM66492, R01 AG054214]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and Information Communication and Technology (ICT) [2017R1A2B4006671]; Daegu Gyeongbuk Institute of Science and Technology start-up fund; High Risk High Return, Ministry of Science, ICT, and Future Planning [2017010074, 2017010133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095526, R01GM043601, R37GM043601, R01GM067945, R01GM066492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054214] Funding Source: NIH RePORTER	Tau Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and Information Communication and Technology (ICT); Daegu Gyeongbuk Institute of Science and Technology start-up fund; High Risk High Return, Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Tau Consortium (to D. F. and S. J. H.); by National Institutes of Health Grants R01 GM095526 and GM043601 (to D. F.), R01 GM66492 (to R. W. K.), and R01 AG054214 (to L. G.); and by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science and Information Communication and Technology (ICT) Grant 2017R1A2B4006671, a Daegu Gyeongbuk Institute of Science and Technology start-up fund, and High Risk High Return, Ministry of Science, ICT, and Future Planning Grants 2017010074 and 2017010133 (to B.-H. L.). Patents 8933087 and 9201073 are held on IU1, IU1-47, and USP14 inhibition. A patent application on this work has been filed by Harvard University on behalf of the authors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Damme M, 2015, ACTA NEUROPATHOL, V129, P337, DOI 10.1007/s00401-014-1361-4; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harrill JA, 2015, IN VITRO CELL DEV-AN, V51, P612, DOI 10.1007/s11626-015-9873-3; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Homma T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11028; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hua YN, 2015, BBA-MOL BASIS DIS, V1852, P195, DOI 10.1016/j.bbadis.2014.04.032; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; Kim HT, 2017, J BIOL CHEM, V292, P9830, DOI 10.1074/jbc.M116.763128; King RW, 2014, NAT CHEM BIOL, V10, P870, DOI 10.1038/nchembio.1671; Kiprowska MJ, 2017, BBA-MOL BASIS DIS, V1863, P1157, DOI 10.1016/j.bbadis.2017.03.017; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liao YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.477; Lim KH, 2013, CURR PHARM DESIGN, V19, P4039, DOI 10.2174/1381612811319220013; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Lopez A, 2017, BRAIN, V140, P1128, DOI 10.1093/brain/awx005; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marshall AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084042; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; McKinnon C, 2016, ACTA NEUROPATHOL, V131, P411, DOI 10.1007/s00401-015-1508-y; Min JW, 2017, J NEUROCHEM, V140, P826, DOI 10.1111/jnc.13941; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009; Nakashima A, 2016, BIOCHEM BIOPH RES CO, V472, P598, DOI 10.1016/j.bbrc.2016.03.022; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Pir GJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0096-1; Ponnappan S, 2013, MECH AGEING DEV, V134, P53, DOI 10.1016/j.mad.2012.12.007; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sareen-Khanna K, 2016, AM J PHYSIOL-RENAL, V311, pF1035, DOI 10.1152/ajprenal.00252.2016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva MC, 2016, STEM CELL REP, V7, P325, DOI 10.1016/j.stemcr.2016.08.001; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Vaden JH, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-3; Vale C, 2010, CELL MOL NEUROBIOL, V30, P577, DOI 10.1007/s10571-009-9482-3; Walters BJ, 2014, J PHYSIOL-LONDON, V592, P571, DOI 10.1113/jphysiol.2013.266015; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xu DC, 2016, GENE DEV, V30, P1718, DOI 10.1101/gad.285122.116; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x; Young ZT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024612; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876; Zhu Y, 2017, ONCOTARGET, V8, P48725, DOI 10.18632/oncotarget.10706	89	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19209	19225		10.1074/jbc.M117.815126	http://dx.doi.org/10.1074/jbc.M117.815126			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972160	hybrid, Green Published			2022-12-28	WOS:000416226700006
J	Thom, SR; Bhopale, VM; Yu, K; Huang, WL; Kane, MA; Margolis, DJ				Thom, Stephen R.; Bhopale, Veena M.; Yu, Kevin; Huang, Weiliang; Kane, Maureen A.; Margolis, David J.			Neutrophil microparticle production and inflammasome activation by hyperglycemia due to cytoskeletal instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; inflammasome; interleukin 1 (IL-1); nitric oxide; nitrosylation; NLRP3	NITRIC-OXIDE SYNTHASE; TYPE-2 DIABETES-MELLITUS; FOCAL ADHESION KINASE; BETA(2) INTEGRIN INHIBITION; ACTIN S-NITROSYLATION; OXIDATIVE STRESS; NLRP3 INFLAMMASOME; VASCULAR INJURIES; ENDOTHELIAL-CELLS; SIGNALING PATHWAY	Microparticles are lipid bilayer-enclosed vesicles produced by cells under oxidative stress. MP production is elevated in patients with diabetes, but the underlying cellular mechanisms are poorly understood. We hypothesized that raising glucose above the physiological level of 5.5 mm would stimulate leukocytes to produce MPs and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) inflammasome. We found that when incubated in buffer with up to 20 mm glucose, human and murine neutrophils, but not monocytes, generate progressively more MPs with high interleukin (IL)-1 content. Enhanced MP production required generation of reactive chemical species by mitochondria, NADPH oxidase, and type 2 nitric-oxide synthase (NOS-2) and resulted in S-nitrosylation of actin. Depleting cells of capon (C-terminal PDZ ligand of neuronal nitric-oxide synthase protein), apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC), or pro-IL-1 prevented the hyperglycemia-induced enhancement of reactive species production, MP generation, and IL-1 synthesis. Additional components required for these responses included inositol 1,3,5-triphosphate receptors, PKC, and enhancement of filamentous-actin turnover. Numerous proteins become localized to short filamentous actin in response to S-nitrosylation, including vasodilator-stimulated phosphoprotein, focal adhesion kinase, the membrane phospholipid translocation enzymes flippase and floppase, capon, NLRP3, and ASC. We conclude that an interdependent oxidative stress response to hyperglycemia perturbs neutrophil cytoskeletal stability leading to MP production and IL-1 synthesis.	[Thom, Stephen R.; Bhopale, Veena M.; Yu, Kevin] Univ Maryland, Sch Med, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-013, Baltimore, MD 21201 USA; [Huang, Weiliang; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Margolis, David J.] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Margolis, David J.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Thom, SR (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-013, Baltimore, MD 21201 USA.	sthom@em.umaryland.edu			National Institutes of Health from NIDDK [R01-DK094260]; Office of Naval Research [N00014-16-1-2868]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094260] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Office of Naval Research(Office of Naval Research); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK094260 from NIDDK (to S. R. T. and D. J. M.), Office of Naval Research Grant N00014-16-1-2868 (to S. R. T.), and University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center Grant SOP1841-IQB2014 (to W. H. and M. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Alexandru N, 2016, BIOCHEM BIOPH RES CO, V472, P1, DOI 10.1016/j.bbrc.2016.02.038; Andreasen CH, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-118; Armstrong DG, 2013, DIABETES CARE, V36, P1815, DOI 10.2337/dc12-2285; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Bearer EL, 2000, CELL MOTIL CYTOSKEL, V47, P351, DOI 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8; Becker ML, 2008, PHARMACOGENET GENOM, V18, P591, DOI 10.1097/FPC.0b013e328300e8c5; Bei JJ, 2016, THROMB HAEMOSTASIS, V115, P632, DOI 10.1160/TH15-04-0322; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhopale VM, 2015, J BIOL CHEM, V290, P17474, DOI 10.1074/jbc.M115.651620; Bhullar J, 2016, FREE RADICAL BIO MED, V101, P154, DOI 10.1016/j.freeradbiomed.2016.10.010; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butin-Israeli V, 2016, FASEB J, V30, P4007, DOI 10.1096/fj.201600734R; Buzzo CD, 2017, SCI REP-UK, V7, DOI 10.1038/srep41686; Campello E, 2018, CYTOM PART B-CLIN CY, V94, P334, DOI 10.1002/cyto.b.21507; Carrel D, 2015, BIOL PSYCHIAT, V77, P969, DOI 10.1016/j.biopsych.2014.10.016; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; Chen W, 2017, INFLAMM RES, V66, P157, DOI 10.1007/s00011-016-1002-6; Chen Y, 2016, J MOL MED, V94, P1335, DOI 10.1007/s00109-016-1481-5; Chiva-Blanch G, 2017, INT J CARDIOL, V227, P876, DOI 10.1016/j.ijcard.2016.11.302; Chu AY, 2010, DIABETOLOGIA, V53, P510, DOI 10.1007/s00125-009-1608-0; Clattenburg L, 2015, MOL CELL BIOL, V35, P2265, DOI 10.1128/MCB.00062-15; Courtney MJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00252; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Elliott EI, 2016, IMMUNITY, V44, P713, DOI 10.1016/j.immuni.2016.03.015; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Joosten LAB, 2013, SEMIN IMMUNOL, V25, P416, DOI 10.1016/j.smim.2013.10.018; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; LAL AA, 1984, J BIOL CHEM, V259, P8794; Li SY, 2016, CELL PHYSIOL BIOCHEM, V39, P2439, DOI 10.1159/000452512; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Margolis DJ, 2017, WOUND REPAIR REGEN, V25, P733, DOI 10.1111/wrr.12564; Margolis DJ, 2013, WOUND REPAIR REGEN, V21, P17, DOI 10.1111/j.1524-475X.2012.00866.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Niu CG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004099; Ogata N, 2006, DIABETES RES CLIN PR, V73, P241, DOI 10.1016/j.diabres.2006.01.014; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pitanga TN, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-21; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Qiao C, 2015, J CELL PHYSIOL, V230, P1054, DOI 10.1002/jcp.24833; Qin W, 2010, ACTA PHARMACOL SIN, V31, P450, DOI 10.1038/aps.2010.25; Qiu YY, 2016, PHARMACOL RES, V114, P251, DOI 10.1016/j.phrs.2016.11.004; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Schmidt RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045186; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Sugiyama K, 2016, INT HEART J, V57, P341, DOI 10.1536/ihj.15-471; Tan KT, 2005, DIABETIC MED, V22, P1657, DOI 10.1111/j.1464-5491.2005.01707.x; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2017, FREE RADICAL BIO MED, V106, P406, DOI 10.1016/j.freeradbiomed.2017.03.005; Thom SR, 2014, J BIOL CHEM, V289, P18831, DOI 10.1074/jbc.M113.543702; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wang J, 2016, BRAIN RES BULL, V125, P99, DOI 10.1016/j.brainresbull.2016.05.014; Wang T, 2014, PHARMACOTHERAPY, V34, P131, DOI 10.1002/phar.1379; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Williamson JC, 2016, PROTEOMICS, V16, P907, DOI 10.1002/pmic.201400545; Yang M, 2012, J APPL PHYSIOL, V112, P204, DOI 10.1152/japplphysiol.00953.2011; Zhang Y, 2011, AM J RHINOL ALLERGY, V25, pE49, DOI 10.2500/ajra.2011.25.3588; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	84	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18312	18324		10.1074/jbc.M117.802629	http://dx.doi.org/10.1074/jbc.M117.802629			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28972154	hybrid, Green Published			2022-12-28	WOS:000414458200028
J	Wahedi, M; Wortham, AM; Kleven, MD; Zhao, NN; Jue, S; Enns, CA; Zhang, AS				Wahedi, Mastura; Wortham, Aaron M.; Kleven, Mark D.; Zhao, Ningning; Jue, Shall; Enns, Caroline A.; Zhang, An-Sheng			Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); iron; liver; receptor; signaling; HFE; hemojuvelin; hepcidin; matriptase-2; transferrin receptor-2	MESSENGER-RNA EXPRESSION; IRON-DEFICIENCY ANEMIA; JUVENILE HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR-2; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN-LEVELS; MICE LACKING; HEMOJUVELIN; TMPRSS6	Systemic iron homeostasis is maintained by regulation of iron absorption in the duodenum, iron recycling from erythrocytes, and iron mobilization from the liver and is controlled by the hepatic hormone hepcidin. Hepcidin expression is induced via the bone morphogenetic protein (BMP) signaling pathway that preferentially uses two type I (ALK2 and ALK3) and two type II (ActRIIA and BMPR2) BMP receptors. Hemojuvelin (HJV), HFE, and transferrin receptor-2 (TfR2) facilitate this process presumably by forming a plasma membrane complex with BMP receptors. Matriptase-2 (MT2) is a protease and key suppressor of hepatic hepcidin expression and cleaves HJV. Previous studies have therefore suggested that MT2 exerts its inhibitory effect by inactivating HJV. Here, we report that MT2 suppresses hepcidin expression independently of HJV. In Hjv(-/-) mice, increased expression of exogenous MT2 in the liver significantly reduced hepcidin expression similarly as observed in wild-type mice. Exogenous MT2 could fully correct abnormally high hepcidin expression and iron deficiency in MT2(-/-) mice. In contrast to MT2, increased Hjv expression caused no significant changes in wild-type mice, suggesting that Hjv is not a limiting factor for hepcidin expression. Further studies revealed that MT2 cleaves ALK2, ALK3, ActRIIA, Bmpr2, Hfe, and, to a lesser extent, Hjv and Tfr2. MT2-mediated Tfr2 cleavage was also observed in HepG2 cells endogenously expressing MT2 and TfR2. Moreover, iron-loaded transferrin blocked MT2-mediated Tfr2 cleavage, providing further insights into the mechanism of Tfr2's regulation by transferrin. Together, these observations indicate that MT2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.	[Wahedi, Mastura; Wortham, Aaron M.; Kleven, Mark D.; Jue, Shall; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Zhao, Ningning] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	Oregon Health & Science University; University of Arizona	Zhang, AS (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu		Kleven, Mark/0000-0003-1204-6658	National Institutes of Health [R01DK102791, R01DK072166, R00DK104066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R01DK102791, R00DK104066, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK102791 (to A. S. Z.), R01DK072166 (to C. A. E.), and R00DK104066 (to N. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2011, BLOOD, V117, P4590, DOI 10.1182/blood-2010-10-315507; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530; Gurieva I, 2017, BLOOD CELL MOL DIS, V64, P1, DOI 10.1016/j.bcmd.2017.02.007; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kent P, 2015, J MOL MED, V93, P489, DOI 10.1007/s00109-015-1253-7; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee P, 2012, BLOOD CELL MOL DIS, V48, P173, DOI 10.1016/j.bcmd.2011.12.005; Lefebvre T, 2015, CLIN CHEM LAB MED, V53, P1557, DOI 10.1515/cclm-2014-1093; Lenoir A, 2011, BLOOD, V117, P647, DOI 10.1182/blood-2010-07-295147; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nai A, 2010, BLOOD, V116, P851, DOI 10.1182/blood-2010-04-278655; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pagani A, 2017, BLOOD, V129, P3392, DOI 10.1182/blood-2017-03-773481; Pagani A, 2015, HAEMATOLOGICA, V100, P461, DOI 10.3324/haematol.2014.118521; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Rausa M, 2015, J CELL MOL MED, V19, P879, DOI 10.1111/jcmm.12462; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang CY, 2017, BLOOD, V130, P73, DOI 10.1182/blood-2016-12-759423; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao NN, 2016, J BIOL CHEM, V291, P12322, DOI 10.1074/jbc.M116.721191; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	62	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18354	18371		10.1074/jbc.M117.801795	http://dx.doi.org/10.1074/jbc.M117.801795			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924039	Green Published, hybrid			2022-12-28	WOS:000414458200031
J	Wu, BX; Li, AQ; Lei, LM; Kaneko, S; Wallace, C; Li, X; Li, ZH				Wu, Bill X.; Li, Anqi; Lei, Liming; Kaneko, Satoshi; Wallace, Caroline; Li, Xue; Li, Zihai			Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) 3 and is essential for mouse palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell signaling; development; embryo; TGF; GARP; palatogenesis	MEDIAL EDGE EPITHELIUM; CLEFT-PALATE; T-CELLS; KNOCKOUT MICE; SURFACE EXPRESSION; ACTIVE TGF-BETA-1; IN-VITRO; BETA; FUSION; FACTOR-BETA-3	Glycoprotein A repetitions predominant (GARP) (encoded by the Lrrc32 gene) plays important roles in cell-surface docking and activation of TGF. However, GARP's role in organ development in mammalian systems is unclear. To determine the function of GARP in vivo, we generated a GARP KO mouse model. Unexpectedly, the GARP KO mice died within 24 h after birth and exhibited defective palatogenesis without apparent abnormalities in other major organs. Furthermore, we observed decreased apoptosis and SMAD2 phosphorylation in the medial edge epithelial cells of the palatal shelf of GARP KO embryos at embryonic day 14.5 (E14.5), indicating a defect in the TGF signaling pathway in the GARP-null developing palates. Of note, the failure to develop the secondary palate and concurrent reduction of SMAD phosphorylation without other defects in GARP KO mice phenocopied TGF3 KO mice, although GARP has not been suggested previously to interact with TGF3. We found that GARP and TGF3 co-localize in medial edge epithelial cells at E14.5. In vitro studies confirmed that GARP and TGF3 directly interact and that GARP is indispensable for the surface expression of membrane-associated latent TGF3. Our findings indicate that GARP is essential for normal morphogenesis of the palate and demonstrate that GARP plays a crucial role in regulating TGF3 signaling during embryogenesis. In conclusion, we have uncovered a novel function of GARP in positively regulating TGF3 activation and function.	[Wu, Bill X.; Li, Anqi; Wallace, Caroline; Li, Zihai] Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Harvard Med Sch, Boston, MA 02115 USA; [Li, Zihai] Zhengzhou Univ, Sch Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China	Medical University of South Carolina; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Zhengzhou University	Li, ZH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu		Wallace, Caroline/0000-0001-8960-756X	NHLBI, National Institutes of Health [R01HL136921]; National Institutes of Health [R01DK110477]; NCI, National Institutes of Health [P01CA186866 02]; NIAID, National Institutes of Health [R01AI070603]; NATIONAL CANCER INSTITUTE [P01CA186866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110477] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NHLBI, National Institutes of Health Grant R01HL136921 and National Institutes of Health Grant R01DK110477 (to X. L.) and NCI, National Institutes of Health Grant P01CA186866 02 and NIAID, National Institutes of Health Grant R01AI070603 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrio MC, 2014, CELLS TISSUES ORGANS, V199, P201, DOI 10.1159/000362227; Carrillo-Galvez AB, 2015, STEM CELLS, V33, P183, DOI 10.1002/stem.1821; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Cui XM, 2005, DEV BIOL, V278, P193, DOI 10.1016/j.ydbio.2004.10.023; Cui XM, 2003, DEV DYNAM, V227, P387, DOI 10.1002/dvdy.10326; Dedobbeleer O, 2017, J IMMUNOL, V199, P391, DOI 10.4049/jimmunol.1601882; Edwards JP, 2016, EUR J IMMUNOL, V46, P1480, DOI 10.1002/eji.201546204; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Hahn SA, 2016, ONCOTARGET, V7, P42996, DOI 10.18632/oncotarget.9598; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Kaartinen V, 1997, DEV DYNAM, V209, P255, DOI 10.1002/(SICI)1097-0177(199707)209:3<255::AID-AJA1>3.0.CO;2-H; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Y, 2015, J IMMUNOL, V195, P2648, DOI 10.4049/jimmunol.1500139; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Metelli A, 2016, CANCER RES, V76, P7106, DOI 10.1158/0008-5472.CAN-16-1456; Murillo J, 2009, DIFFERENTIATION, V77, P209, DOI 10.1016/j.diff.2008.10.004; Nacinovich Renata, 2014, BMC Res Notes, V7, P248, DOI 10.1186/1756-0500-7-248; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Rachidi S, 2015, J HEPATOL, V62, P879, DOI 10.1016/j.jhep.2014.11.010; Roubin R, 1996, INT J DEV BIOL, V40, P545; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shevach EM, 2017, EXPERT OPIN THER TAR, V21, P191, DOI 10.1080/14728222.2017.1275568; Stockis J, 2017, MOL BIOSYST, V13, P1925, DOI 10.1039/c7mb00251c; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Vermeersch E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173329; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wincent J, 2010, EUR J MED GENET, V53, P50, DOI 10.1016/j.ejmg.2009.10.003; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang LT, 2007, DEV BIOL, V312, P384, DOI 10.1016/j.ydbio.2007.09.034; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014	42	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18091	18097		10.1074/jbc.M117.797613	http://dx.doi.org/10.1074/jbc.M117.797613			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912269	Green Published, hybrid			2022-12-28	WOS:000414458200009
J	Li, YQ; Zhang, LJ; Hu, YQ; Chen, M; Han, F; Qin, Y; Chen, M; Cui, XH; Duo, SG; Tang, FC; Gao, F				Li, Yaqiong; Zhang, Lianjun; Hu, Yuqiong; Chen, Min; Han, Feng; Qin, Yan; Chen, Min; Cui, Xiuhong; Duo, Shuguang; Tang, Fuchou; Gao, Fei			beta-Catenin directs the transformation of testis Sertoli cells to ovarian granulosa-like cells by inducing Foxl2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADAL DEVELOPMENT; SIGNALING PATHWAY; SEX-REVERSAL; DIFFERENTIATION; MOUSE; MICE; TRANSCRIPTION; ACTIVATION; GENE; SRY	Sertoli and granulosa cells are two major types of somatic cells in male and female gonads, respectively. Previous studies have shown that Sertoli and granulosa cells are derived from common progenitor cells and that differentiation of these two cell types is regulated by sex differentiation genes. The signaling pathway including the adhesion and transcription factor Ctnnb1 (cadherin-associated protein, beta 1, also known as beta-catenin) regulates differentiation of granulosa cells in the absence of the transcription factor Sry, and overactivation of beta-catenin in the presence of Sry leads to granulosa prior to sex determination. Surprisingly, our previous study found that beta-catenin overactivation in Sertoli cells after sex determination can also cause disruption of the testicular cord and aberrant testis development. However, the underlying molecular mechanism was unclear. In this study, we found that constitutive activation of Ctnnb1 in Sertoli cells led to ectopic expression of the granulosa cell-specific marker FOXL2in testes. Co-staining experiments revealed that FOXL2-positive cells were derived from Sertoli cells, and Sertoli cells were transformed into granulosa-like cells after Ctnnb1 overactivation. Further studies demonstrated that CTNNB1 induced Foxl2 expression by directly binding to transcription factor Tcf/Lef-binding sites in the FOXL2 promoter region. We also found that direct overexpression of Foxl2 decreased the expression of Sertoli cell-specific genes in primary Sertoli cells. Taken together, these results demonstrate that repression of beta-catenin (CTNNB1) signaling is required for lineage maintenance of Sertoli cells. Our study provides a new mechanism for Sertoli cell lineage maintenance during gonad development.	[Li, Yaqiong; Zhang, Lianjun; Chen, Min; Han, Feng; Qin, Yan; Chen, Min; Cui, Xiuhong; Duo, Shuguang; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Li, Yaqiong; Zhang, Lianjun; Han, Feng; Qin, Yan; Chen, Min; Gao, Fei] Univ Chinese Acad Sci, Beijing 101408, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Gao, F (corresponding author), Univ Chinese Acad Sci, Beijing 101408, Peoples R China.	gaof@ioz.ac.cn		Han, Feng/0000-0002-0274-9272	National Key R&D program of China [2016YFA0500901]; National Natural Science Funds for Distinguished Young Scholar [81525011]; National Natural Science Foundation of China [31471348, 31601193, 31671496]	National Key R&D program of China; National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D program of China Grant 2016YFA0500901, National Natural Science Funds for Distinguished Young Scholar Grant 81525011, and National Natural Science Foundation of China Grants 31471348, 31601193, and 31671496. The authors declare that they have no conflicts of interest with the contents of this article.	BAR A, 1978, J NUTR, V108, P1322, DOI 10.1093/jn/108.8.1322; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Clark PE, 2011, AM J PATHOL, V179, P3045, DOI 10.1016/j.ajpath.2011.08.006; Dang YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0991-3; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 2001, J EXP ZOOL, V290, P463, DOI 10.1002/jez.1089; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Li XX, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109405; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Pan B, 2011, MOL HUM REPROD, V17, P550, DOI 10.1093/molehr/gar017; Richards JS, 2012, ONCOGENE, V31, P1504, DOI 10.1038/onc.2011.341; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076642; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20	35	22	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17577	17586		10.1074/jbc.M117.811349	http://dx.doi.org/10.1074/jbc.M117.811349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900034	Green Published, hybrid			2022-12-28	WOS:000414013000001
J	Kaczmarczyk, A; Allahverdi, A; Brouwer, TB; Nordenskiold, L; Dekker, NH; van Noort, J				Kaczmarczyk, Artur; Allahverdi, Abdollah; Brouwer, Thomas B.; Nordenskiold, Lars; Dekker, Nynke H.; van Noort, John			Single-molecule force spectroscopy on histone H4 tail-cross-linked chromatin reveals fiber folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SEQUENCE; IN-VIVO; TRANSCRIPTION; NUCLEOSOMES; COMPACTION; OCTAMER; EM	The eukaryotic genome is highly compacted into a protein-DNA-complex called chromatin. The cell controls access of transcriptional regulators to chromosomal DNA via several mechanisms that act on chromatin-associated proteins and provide a rich spectrum of epigenetic regulation. Elucidating the mechanisms that fold chromatin fibers into higher-order structures is therefore key to understanding the epigenetic regulation of DNA accessibility. Here, using histone H4-V21C and histone H2A-E64C mutations, we employed single-molecule force spectroscopy to measure the unfolding of individual chromatin fibers that are reversibly cross-linked through the histone H4 tail. Fibers with covalently linked nucleosomes featured the same folding characteristics as fibers containing wild-type histones but exhibited increased stability against stretching forces. By stabilizing the secondary structure of chromatin, we confirmed a nucleosome repeat length (NRL)-dependent folding. Consistent with previous crystallographic and cryo-EM studies, the obtained force-extension curves on arrays with 167-bp NRLs best supported an underlying structure consisting of zig-zag, two-start fibers. For arrays with 197-bp NRLs, we previously inferred solenoidal folding, which was further corroborated by force-extension curves of the cross-linked fibers. The different unfolding pathways exhibited by these two types of arrays and reported here extend our understanding of chromatin structure and its potential roles in gene regulation. Importantly, these findings imply that chromatin compaction by nucleosome stacking protects nucleosomal DNA from external forces up to 4 piconewtons.	[Kaczmarczyk, Artur; Brouwer, Thomas B.; van Noort, John] Leiden Univ, Huygens Kamerlingh Onnes Lab, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands; [Dekker, Nynke H.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands; [Allahverdi, Abdollah; Nordenskiold, Lars] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Allahverdi, Abdollah] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, POB 14115-175, Tehran, Iran	Leiden University; Leiden University - Excl LUMC; Delft University of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tarbiat Modares University	van Noort, J (corresponding author), Leiden Univ, Huygens Kamerlingh Onnes Lab, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands.	noort@physics.leidenuniv.nl	van Noort, John/B-1242-2008; Allahverdi, Abdollah/AAE-1244-2022; NORDENSKIÖLD, LARS/ABD-4725-2020	van Noort, John/0000-0002-9094-5598; NORDENSKIÖLD, LARS/0000-0002-3681-209X; Kaczmarczyk, Artur/0000-0002-2100-2780	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project [680-47-616]; Singapore Ministry of Education Academic Research Fund through Tier 3 Grant [MOE2012-T3-1001]; Singapore Agency for Science Technology and Research through Biomedical Research Council Grant [10/1/22/19/666]	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project; Singapore Ministry of Education Academic Research Fund through Tier 3 Grant(Ministry of Education, Singapore); Singapore Agency for Science Technology and Research through Biomedical Research Council Grant	This work was supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, by NWO-VICI Research Program Project 680-47-616; the Singapore Ministry of Education Academic Research Fund through Tier 3 Grant MOE2012-T3-1001; and the Singapore Agency for Science Technology and Research through Biomedical Research Council Grant 10/1/22/19/666. The authors declare that they have no conflicts of interest with the contents of this article.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bednar J, 1999, MOL CELL, V4, P377, DOI 10.1016/S1097-2765(00)80339-1; Chen QM, 2017, J MOL BIOL, V429, P2075, DOI 10.1016/j.jmb.2017.03.016; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Flaus A, 2011, FRONT LIFE SCI, V5, P5, DOI 10.1080/21553769.2012.702667; Gilbert Nick, 2005, Briefings in Functional Genomics & Proteomics, V4, P129, DOI 10.1093/bfgp/4.2.129; Grigoryev SA, 2012, NUCLEUS-PHILA, V3, P493, DOI 10.4161/nucl.22168; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Kruithof M, 2008, BIOPHYS J, V94, P2343, DOI 10.1529/biophysj.107.121673; Langowski J, 2006, COMPUTATIONAL STUDIE, P605; Li W, 2016, MOL CELL, V64, P120, DOI 10.1016/j.molcel.2016.08.024; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maeshima K, 2016, CURR OPIN GENET DEV, V37, P36, DOI 10.1016/j.gde.2015.11.006; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Meng H, 2015, NUCLEIC ACIDS RES, V43, P3578, DOI 10.1093/nar/gkv215; Nikitina T., 2017, BIORXIV, DOI [10.1101/104083, DOI 10.1101/104083]; Norouzi D, 2015, AIMS BIOPHYS, V2, P613, DOI 10.3934/biophy.2015.4.613; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Tompitak M, 2017, BIOPHYS J, V112, P505, DOI 10.1016/j.bpj.2016.12.041; Victor JM, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-21; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	37	25	25	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17506	17513		10.1074/jbc.M117.791830	http://dx.doi.org/10.1074/jbc.M117.791830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855255	Green Published, hybrid			2022-12-28	WOS:000414009300030
J	Kedage, V; Strittmatter, BG; Dausinas, PB; Hollenhorst, PC				Kedage, Vivekananda; Strittmatter, Brady G.; Dausinas, Paige B.; Hollenhorst, Peter C.			Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER PROGRESSION; REGULATORY NETWORK; ANDROGEN RECEPTOR; ETS; FUSION; TMPRSS2-ERG; EXPRESSION; SPECIFICITY; INHIBITION; INVASION	In similar to 50% of prostate cancers, chromosomal rearrangements cause the fusion of the promoter and 5'-UTR of the androgenregulated TMPRSS2 (transmembrane protease, serine 2) gene to the open reading frame of ERG, encoding an ETS family transcription factor. This fusion results in expression of full-length or N-terminally truncated ERG protein in prostate epithelia. ERG is not expressed in normal prostate epithelia, but when expressed, it promotes tumorigenesis via altered gene expression, stimulating epithelial-mesenchymal transition, cellular migration/invasion, and transformation. However, limited knowledge about the molecular mechanisms of ERG function in prostate cells has hampered efforts to therapeutically target ERG. ERK-mediated phosphorylation of ERG is required for ERG functions in prostate cells, but the reason for this requirement is unknown. Here, we report a mechanism whereby ERK-mediated phosphorylation of ERG at one serine residue causes a conformational change that allows ERK phosphorylation at a second serine residue, Ser-96. We found that the Ser-96 phosphorylation resulted in dissociation of EZH2 and SUZ12, components of polycomb repressive complex 2 (PRC2), transcriptional activation of ERG target genes, and increased cell migration. Conversely, loss of ERG phosphorylation at Ser-96 resulted in recruitment of EZH2 across the ERG-cistrome and a genome-wide loss of ERG-mediated transcriptional activation and cell migration. In conclusion, our findings have identified critical molecular mechanisms involving ERK-mediated ERG activation that could be exploited for therapeutic intervention in ERG-positive prostate cancers.	[Kedage, Vivekananda; Strittmatter, Brady G.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Dausinas, Paige B.; Hollenhorst, Peter C.] Indiana Univ, Dept Med Sci, Bloomington, IN 47405 USA; [Kedage, Vivekananda] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Roche Holding; Genentech	Hollenhorst, PC (corresponding author), Indiana Univ, Dept Med Sci, Bloomington, IN 47405 USA.	pchollen@indiana.edu		Strittmatter, Brady/0000-0001-6989-0038	American Cancer Society [RSG-13-215-01-DMC]; Indiana University; Indiana University Simon Cancer Center [P30CA82709]; Indiana University [T32 GM109825]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM109825] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Indiana University; Indiana University Simon Cancer Center; Indiana University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Research Scholar Award RSG-13-215-01-DMC, by the Indiana University Vice Provost for Research through the Faculty Research Support Program, and by Indiana University Simon Cancer Center P30 Support Grant P30CA82709 (to P. C. H.). This work was also supported by the Indiana University Graduate Training Program in Quantitative and Chemical Biology under Award T32 GM109825 (to B. G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blee AM, 2016, ONCOTARGET, V7, P38319, DOI 10.18632/oncotarget.9513; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Ducret C, 1999, MOL CELL BIOL, V19, P7076; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hagen RM, 2014, AM J CLIN PATHOL, V142, P533, DOI 10.1309/AJCPH88QHXARISUP; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hu Y, 2008, CLIN CANCER RES, V14, P4719, DOI 10.1158/1078-0432.CCR-08-0531; Huang Y, 2016, LEUKEMIA, V30, P1552, DOI 10.1038/leu.2016.55; Kedage V, 2016, CELL REP, V17, P1289, DOI 10.1016/j.celrep.2016.10.001; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; Selvaraj N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-61; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	36	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17225	17235		10.1074/jbc.M117.796458	http://dx.doi.org/10.1074/jbc.M117.796458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28887309	hybrid, Green Published			2022-12-28	WOS:000414009300007
J	Bove-Fenderson, E; Urano, R; Straub, JE; Harris, DA				Bove-Fenderson, Erin; Urano, Ryo; Straub, John E.; Harris, David A.			Cellular prion protein targets amyloid-beta fibril ends via its C-terminal domain to prevent elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); neurodegeneration; prion; protein aggregation	GLUTAMATE-RECEPTOR 5; A-BETA; MICROSCOPIC MECHANISMS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; LAG PHASE; OLIGOMERS; IMPAIRMENT; TOXICITY; OCCURS	Oligomeric forms of the amyloid- (A) peptide are thought to represent the primary synaptotoxic species underlying the neurodegenerative changes seen in Alzheimer's disease. It has been proposed that the cellular prion protein (PrPC) functions as a cell-surface receptor, which binds to A oligomers and transduces their toxic effects. However, the molecular details of the PrPC-A interaction remain uncertain. Here, we investigated the effect of PrPC on polymerization of A under rigorously controlled conditions in which A converts from a monomeric to a fibrillar state via a series of kinetically defined steps. We demonstrated that PrPC specifically inhibited elongation of A fibrils, most likely by binding to the ends of growing fibrils. Surprisingly, this inhibitory effect required the globular C-terminal domain of PrPC, which has not been previously implicated in interactions with A. Our results suggest that PrPC recognizes structural features common to both A oligomers and fibril ends and that this interaction could contribute to the neurotoxic effect of A aggregates. Additionally, our results identify the C terminus of PrPC as a new and potentially more druggable molecular target for treating Alzheimer's disease.	[Bove-Fenderson, Erin; Harris, David A.] Boston Univ, Dept Biochem, Sch Med, K225,72 E Concord St, Boston, MA 02118 USA; [Urano, Ryo; Straub, John E.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University; Boston University	Harris, DA (corresponding author), Boston Univ, Dept Biochem, Sch Med, K225,72 E Concord St, Boston, MA 02118 USA.	daharris@bu.edu	URANO, Ryo/AAG-8623-2020	URANO, Ryo/0000-0003-1417-5074; Harris, David/0000-0002-6985-5790	National Institutes of Health (NIH) [R01 NS065244]; National Science Foundation [CHE-1362524]; NIH [R01 GM107703]; National Research Service Award Fellowship [5F31NS090747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, F31NS090747] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) Grant R01 NS065244 (to D. A. H.), National Science Foundation Grant CHE-1362524 and NIH Grant R01 GM107703 (to J. E. S.), and National Research Service Award Fellowship 5F31NS090747 (to E. B-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Biasini E, 2012, FUTURE MED CHEM, V4, P1655, DOI [10.4155/FMC.12.114, 10.4155/fmc.12.114]; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608918; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Haas LT, 2016, J BIOL CHEM, V291, P17112, DOI 10.1074/jbc.M116.720664; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Halfmann R., 2008, J VIS EXP, V10; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slapsak U, 2016, J BIOL CHEM, V291, P21857, DOI 10.1074/jbc.M116.743435; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473; Xu LQ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0410	49	23	23	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16858	16871		10.1074/jbc.M117.789990	http://dx.doi.org/10.1074/jbc.M117.789990			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842494	Green Published, hybrid			2022-12-28	WOS:000413140600008
J	Wu, XS; Huang, YH; Kaas, Q; Harvey, PJ; Wang, CK; Tae, HS; Adams, DJ; Craik, DJ				Wu, Xiaosa; Huang, Yen-Hua; Kaas, Quentin; Harvey, Peta J.; Wang, Conan K.; Tae, Han-Shen; Adams, David J.; Craik, David J.			Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; nicotinic acetylcholine receptors (nAChR); peptide chemical synthesis; peptide conformation; protein folding; conotoxin; cyclization; oxidative folding; stability	NICOTINIC ACETYLCHOLINE-RECEPTORS; CHAIN DES-(B30) INSULIN; ALPHA-O-CONOTOXIN; NEUROPATHIC PAIN; CHEMICAL-SYNTHESIS; CALCIUM-CHANNELS; GABA(B) RECEPTOR; CYCLIC-PEPTIDES; SENSORY NEURONS; STABILITY	Conotoxin GeXIVA inhibits the 910 nicotinic acetylcholine receptor (nAChR) and is analgesic in animal models of pain. -Conotoxins have four cysteines that can have three possible disulfide connectivities: globular (Cys(I)-Cys(III) and Cys(II)-Cys(IV)), ribbon (Cys(I)-Cys(IV) and Cys(II)-Cys(III)), or bead (Cys(I)-Cys(II) and Cys(III)-Cys(IV)). Native -conotoxins preferably adopt the globular connectivity, and previous studies of -conotoxins have focused on the globular isomers as the ribbon and bead isomers typically have lower potency at nAChRs than the globular form. A recent report showed that the bead and ribbon isomers of GeXIVA are more potent than the globular isomer, with low nanomolar half-maximal inhibitory concentrations (IC50). Despite this high potency, the therapeutic potential of GeXIVA is limited, because like most peptides, it is susceptible to proteolytic degradation and is challenging to synthesize in high yield. Here we used backbone cyclization as a strategy to improve the folding yield as well as increase the serum stability of ribbon GeXIVA while preserving activity at the 910 nAChR. Specifically, cyclization of ribbon GeXIVA with a two-residue linker maintained the biological activity at the human 910 nAChR and improved stability in human serum. Short linkers led to selective formation of the ribbon disulfide isomer without requiring orthogonal protection. Overall, this study highlights the value of backbone cyclization in directing folding, improving yields, and stabilizing conotoxins with therapeutic potential.	[Wu, Xiaosa; Huang, Yen-Hua; Kaas, Quentin; Harvey, Peta J.; Wang, Conan K.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tae, Han-Shen; Adams, David J.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia	University of Queensland; University of Wollongong	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Adams, David John/K-3578-2019; Wang, Conan K/D-1481-2010; Tae, Han-Shen/AAA-1904-2020; Wu, Xiaosa/ABD-1866-2020; Craik, David/B-1695-2010; Huang, Yen-Hua/J-9056-2014; harvey, peta/D-2048-2017; Kaas, Quentin/J-8727-2014; Wu, Xiaosa/C-8000-2017	Adams, David John/0000-0002-7030-2288; Wang, Conan K/0000-0002-7973-7632; Tae, Han-Shen/0000-0001-8961-7194; Craik, David/0000-0003-0007-6796; Huang, Yen-Hua/0000-0001-6937-2660; harvey, peta/0000-0003-4735-6242; Kaas, Quentin/0000-0001-9988-6152; Wu, Xiaosa/0000-0002-1733-9639	Australian Research Council [DP150103990];  [FL150100146]	Australian Research Council(Australian Research Council); 	This work was supported by Australian Research Council Grant DP150103990. The authors declare that they have no conflicts of interest with the contents of this article.; Australian Research Council Australian Laureate Fellow supported by Grant FL150100146. To whom correspondence should be addressed. Tel.: 61-7-33462019; Fax: 61-7-33462101; E-mail: d.craik@imb.uq.edu.au.	Akcan M, 2015, RSC DRUG DISCOV, V42, P275; Akcan M, 2011, J MED CHEM, V54, P782, DOI 10.1021/jm101018r; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2011, ANTIOXID REDOX SIGN, V14, P65, DOI 10.1089/ars.2010.3458; Armishaw CJ, 2010, BIOPOLYMERS, V94, P307, DOI 10.1002/bip.21360; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Carstens BB, 2016, BIOPOLYMERS, V106, P864, DOI 10.1002/bip.22848; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheneval O, 2014, J ORG CHEM, V79, P5538, DOI 10.1021/jo500699m; Clark RJ, 2012, TOXICON, V59, P446, DOI 10.1016/j.toxicon.2010.12.003; Clark RJ, 2012, METHOD ENZYMOL, V503, P57, DOI 10.1016/B978-0-12-396962-0.00003-3; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Conibear AC, 2014, ANGEW CHEM INT EDIT, V53, P10612, DOI 10.1002/anie.201402167; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Cruccu G, 2007, CURR OPIN NEUROL, V20, P531; Dekan Z, 2012, ORG BIOMOL CHEM, V10, P5791, DOI 10.1039/c2ob25133g; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gyanda R, 2013, J PEPT SCI, V19, P16, DOI 10.1002/psc.2467; Halai R, 2011, J MED CHEM, V54, P6984, DOI 10.1021/jm201060r; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hemu X, 2013, BIOPOLYMERS, V100, P492, DOI 10.1002/bip.22308; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P2403, DOI 10.1517/13543784.9.10.2403; Jensen JE, 2012, MAR DRUGS, V10, P1511, DOI 10.3390/md10071511; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Kwon S, 2016, BIOTECHNOL BIOENG, V113, P2202, DOI 10.1002/bit.25993; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li XD, 2016, PROG NEURO-PSYCHOPH, V66, P112, DOI 10.1016/j.pnpbp.2015.12.005; Lovelace ES, 2006, J MED CHEM, V49, P6561, DOI 10.1021/jm060299h; Lovelace ES, 2011, ANTIOXID REDOX SIGN, V14, P87, DOI 10.1089/ars.2009.3068; Luo SL, 2015, P NATL ACAD SCI USA, V112, pE4026, DOI 10.1073/pnas.1503617112; Luo SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054648; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Mohammadi SA, 2015, TOXINS, V7, P3916, DOI 10.3390/toxins7103916; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STATES DJ, 1984, J MOL BIOL, V174, P411, DOI 10.1016/0022-2836(84)90345-0; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Verdes A, 2016, INTEGR COMP BIOL, V56, pE230; Wang CK, 2015, J PHYS CHEM B, V119, P15821, DOI 10.1021/acs.jpcb.5b11085; Wang T, 2016, CURR TOP MED CHEM, V16, P901, DOI [10.2174/1568026615666150825142002, 10.2174/1568026615666150701114831]; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P1483, DOI 10.1021/bi011893q; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Wu XS, 2016, EUR J ORG CHEM, V2016, P3462, DOI 10.1002/ejoc.201600402; Wu XS, 2013, MAR DRUGS, V11, P3537, DOI 10.3390/md11093537; Xu SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14261; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Zaykov AN, 2014, ACS CHEM BIOL, V9, P683, DOI 10.1021/cb400792s	76	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17101	17112		10.1074/jbc.M117.808386	http://dx.doi.org/10.1074/jbc.M117.808386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28851841	Green Published, hybrid			2022-12-28	WOS:000413140600029
J	Yao, PB; Sun, HS; Xu, C; Chen, TQ; Zou, B; Jiang, P; Du, WJ				Yao, Pengbo; Sun, Huishan; Xu, Chang; Chen, Taiqi; Zou, Bing; Jiang, Peng; Du, Wenjing			Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; metabolism; pentose phosphate pathway (PPP); protein cross-linking; protein-protein interaction; 6PGD; NADPH; conformational simulation; malic enzyme	6-PHOSPHOGLUCONATE DEHYDROGENASE; TUMOR-GROWTH; CELL-PROLIFERATION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; 6-AMINONICOTINAMIDE; INHIBITION; P53	Recent studies have revealed that the oxidative pentose phosphate pathway (PPP), malic enzyme (ME), and folate metabolism are the three major routes for generating cellular NADPH, a key cofactor involved in redox control and reductive biosynthesis. Many tumor cells exhibit altered NADPH metabolism to fuel their rapid proliferation. However, little is known about how NADPH metabolism is coordinated in tumor cells. Here we report that ME1 increases the PPP flux by forming physiological complexes with 6-phosphogluconate dehydrogenase (6PGD). We found that ME1 and 6PGD form a hetero-oligomer that increases the capability of 6PGD to bind its substrate 6-phosphogluconate. Through activating 6PGD, ME1 enhances NADPH generation, PPP flux, and tumor cell growth. Interestingly, although ME1 could bind either the dimer-defect mutant 6PGD (K294R) or the NADP(+)-binding defect 6PGD mutants, only 6PGD (K294R) activity was induced by ME1. Thus, ME1/6PGD hetero-complexes may mimic the active oligomer form of 6PGD. Together, these findings uncover a direct cross-talk mechanism between ME1 and PPP, may reveal an alternative model for signaling transduction via protein conformational simulation, and pave the way for better understanding how metabolic pathways are coordinated in cancer.	[Yao, Pengbo; Xu, Chang; Chen, Taiqi; Zou, Bing; Jiang, Peng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Huishan; Du, Wenjing] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Sun, Huishan; Du, Wenjing] Chinese Acad Med Sci, Sch Basic Med, Beijing 100005, Peoples R China; [Sun, Huishan; Du, Wenjing] Peking Union Med Coll, Beijing 100005, Peoples R China	Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jiang, P (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Du, WJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China.	pengjiang@tsinghua.edu.cn; wenjingdu@ibms.pumc.edu.cn		Jiang, Peng/0000-0002-4218-0092	1000 Talents Program for Young Scholars; Tsinghua-Peking Center for Life Sciences; National Natural Science Foundation of China [31571470, 81672766]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-4-002]; State Key Laboratory Special Fund [2060204]; Peking Union College "Union Youth Fund" [3332016045]	1000 Talents Program for Young Scholars; Tsinghua-Peking Center for Life Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS); State Key Laboratory Special Fund; Peking Union College "Union Youth Fund"	This work was supported by the 1000 Talents Program for Young Scholars, the Tsinghua-Peking Center for Life Sciences, and National Natural Science Foundation of China (31571470; to P. J.) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-4-002), National Natural Science Foundation of China (81672766), State Key Laboratory Special Fund (2060204), Peking Union College "Union Youth Fund" (3332016045), and the 1000 Talents Program for Young Scholars (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg J, 2006, BIOCHEMISTRY-US, P577; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JY, 2014, BBA-PROTEINS PROTEOM, V1844, P1773, DOI 10.1016/j.bbapap.2014.06.019; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; KOHLER E, 1970, FEBS LETT, V6, P225, DOI 10.1016/0014-5793(70)80063-1; LANGE K, 1970, N-S ARCH PHARMAKOL, V267, P177, DOI 10.1007/BF00999399; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Shan CL, 2014, MOL CELL, V55, P552, DOI 10.1016/j.molcel.2014.06.020; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609	16	21	24	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17113	17120		10.1074/jbc.M117.810309	http://dx.doi.org/10.1074/jbc.M117.810309			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848047	hybrid, Green Published			2022-12-28	WOS:000413140600030
J	Kawas, RF; Anderson, RL; Ingle, SRB; Song, YH; Sran, AS; Rodriguez, HM				Kawas, Raja F.; Anderson, Robert L.; Ingle, Sadie R. Bartholomew; Song, Yonghong; Sran, Arvinder S.; Rodriguez, Hector M.			A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC SUBAORTIC STENOSIS; RABBIT SKELETAL-MUSCLE; PHOSPHATE RELEASE; CARDIOMYOPATHY; ATPASE; SUBFRAGMENTS; TROPOMYOSIN; MYOFIBRILS; MECHANISM; MOTORS	Mavacamten, formerly known as MYK-461 is a recently discovered novel small-molecule modulator of cardiac myosin that targets the underlying sarcomere hypercontractility of hypertrophic cardiomyopathy, one of the most prevalent heritable cardiovascular disorders. Studies on isolated cells and muscle fibers as well as intact animals have shown that mavacamten inhibits sarcomere force production, thereby reducing cardiac contractility. Initial mechanistic studies have suggested that mavacamten primarily reduces the steady-state ATPase activity by inhibiting the rate of phosphate release of beta-cardiac myosin-S1, but the molecular mechanism of action of mavacamten has not been described. Here we used steady-state and presteady-state kinetic analyses to investigate the mechanism of action of mavacamten. Transient kinetic analyses revealed that mavacamten modulates multiple steps of the myosin chemomechanical cycle. In addition to decreasing the rate-limiting step of the cycle (phosphate release), mavacamten reduced the number of myosin-S1 heads that can interact with the actin thin filament during transition from the weakly to the strongly bound state without affecting the intrinsic rate. Mavacamten also decreased the rate of myosin binding to actin in the ADP-bound state and the ADP-release rate from myosin-S1 alone. We, therefore, conclude that mavacamten acts on multiple stages of the myosin chemomechanical cycle. Although the primary mechanism of mavacamten-mediated inhibition of cardiac myosin is the decrease of phosphate release from beta-cardiac myosin-S1, a secondary mechanism decreases the number of actin-binding heads transitioning from the weakly to the strongly bound state, which occurs before phosphate release and may provide an additional method to modulate myosin function.	[Kawas, Raja F.; Anderson, Robert L.; Ingle, Sadie R. Bartholomew; Song, Yonghong; Sran, Arvinder S.; Rodriguez, Hector M.] MyoKardia Inc, 333 Allerton Ave, San Francisco, CA 94080 USA		Ingle, SRB (corresponding author), MyoKardia Inc, 333 Allerton Ave, San Francisco, CA 94080 USA.	sringle@myokardia.com						BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brizendine RK, 2015, P NATL ACAD SCI USA, V112, P11235, DOI 10.1073/pnas.1510241112; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Iorga B, 2004, J MUSCLE RES CELL M, V25, P367, DOI 10.1007/s10974-004-0812-2; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lionne C, 2002, BIOCHEMISTRY-US, V41, P13297, DOI 10.1021/bi0260278; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Patel BG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00336; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Ramaraj R, 2008, CARDIOL REV, V16, P172, DOI 10.1097/CRD.0b013e318178e525; Sato MK, 2012, BIOPHYS J, V103, P711, DOI 10.1016/j.bpj.2012.07.014; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEWART S, 1968, CIRCULATION, V37, P8, DOI 10.1161/01.CIR.37.1.8; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; WILSON WS, 1967, AM HEART J, V73, P4, DOI 10.1016/0002-8703(67)90303-1	26	73	76	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16571	16577		10.1074/jbc.M117.776815	http://dx.doi.org/10.1074/jbc.M117.776815			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28808052	Green Published, hybrid			2022-12-28	WOS:000412414800018
J	Burr, R; Ribbens, D; Raychaudhuri, S; Stewart, EV; Ho, J; Espenshade, PJ				Burr, Risa; Ribbens, Diedre; Raychaudhuri, Sumana; Stewart, Emerson V.; Ho, Jason; Espenshade, Peter J.			Dsc E3 ligase localization to the Golgi requires the ATPase Cdc48 and cofactor Ufd1 for activation of sterol regulatory element-binding protein in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL QUALITY-CONTROL; VALOSIN-CONTAINING PROTEIN; HMG-COA REDUCTASE; AAA-ATPASE; SREBP CLEAVAGE; MEMBRANE-PROTEINS; VCP MUTATIONS; SCHIZOSACCHAROMYCES-POMBE; UBIQUITIN; COMPLEX	Sterol regulatory element-binding proteins (SREBPs) in the fission yeast Schizosaccharomyces pombe regulate lipid homeostasis and the hypoxic response under conditions of low sterol or oxygen availability. SREBPs are cleaved in the Golgi through the combined action of the Dsc E3 ligase complex, the rhomboid protease Rbd2, and the essential ATPases associated with diverse cellular activities (AAA(+)) ATPase Cdc48. The soluble SREBP N-terminal transcription factor domain is then released into the cytosol to enter the nucleus and regulate gene expression. Previously, we reported that Cdc48 binding to Rbd2 is required for Rbd2-mediated SREBP cleavage. Here, using affinity chromatography and mass spectrometry experiments, we identified Cdc48-binding proteins in S. pombe, generating a list of many previously unknown potential Cdc48-binding partners. We show that the established Cdc48 cofactor Ufd1 is required for SREBP cleavage but does not interact with the Cdc48-Rbd2 complex. Cdc48-Ufd1 is instead required at a step prior to Rbd2 function, during Golgi localization of the Dsc E3 ligase complex. Together, these findings demonstrate that two distinct Cdc48 complexes, Cdc48-Ufd1 and Cdc48-Rbd2, are required for SREBP activation and low-oxygen adaptation in S. pombe.	[Burr, Risa; Ribbens, Diedre; Raychaudhuri, Sumana; Stewart, Emerson V.; Ho, Jason; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Burr, Risa/AGK-7711-2022	Burr, Risa/0000-0001-6851-2932; Espenshade, Peter/0000-0002-6433-0178	National Institutes of Health [HL077588, GM007445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL077588 (to P. J. E.) and GM007445 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Bat-Ochir C, 2016, MOL MICROBIOL, V100, P635, DOI 10.1111/mmi.13341; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Burr R, 2017, J BIOL CHEM, V292, P5311, DOI 10.1074/jbc.M117.778209; Burr R, 2016, J BIOL CHEM, V291, P12171, DOI 10.1074/jbc.M116.723650; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Cheung R, 2013, J BIOL CHEM, V288, P20351, DOI 10.1074/jbc.M113.482224; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Erzurumlu Y, 2013, INT J BIOCHEM CELL B, V45, P773, DOI 10.1016/j.biocel.2013.01.006; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kimura Y, 2013, GENES CELLS, V18, P1131, DOI 10.1111/gtc.12103; Kwon EJG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003104; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Li M, 2015, J CELL BIOL, V211, P639, DOI 10.1083/jcb.201505062; Marinova IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117779; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Nishikori S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201400; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Raychaudhuri S, 2015, J BIOL CHEM, V290, P14430, DOI 10.1074/jbc.M114.630863; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112	50	5	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16333	16350		10.1074/jbc.M117.802025	http://dx.doi.org/10.1074/jbc.M117.802025			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821619	Green Published, hybrid			2022-12-28	WOS:000412109400031
J	Glover, K; Li, Y; Mukhopadhyay, S; Leuthner, Z; Chakravarthy, S; Colbert, CL; Sinha, SC				Glover, Karen; Li, Yue; Mukhopadhyay, Shreya; Leuthner, Zoe; Chakravarthy, Srinivas; Colbert, Christopher L.; Sinha, Sangita C.			Structural transitions in conserved, ordered Beclin 1 domains essential to regulating autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PROTEIN SECONDARY STRUCTURE; 1-DEPENDENT AUTOPHAGY; TERMINAL DOMAIN; COILED-COIL; ATG14; GENE	Beclin 1 (BECN1) is a key regulator of autophagy, a critical catabolic homeostasis pathway that involves sequestration of selected cytoplasmic components by multilayered vesicles called autophagosomes, followed by lysosomal fusion and degradation. BECN1 is a core component of class III phosphatidy-linositol-3-kinase complexes responsible for autophagosome nucleation. Without heterologous binding partners, BECN1 forms an antiparallel homodimer via its coiled-coil domain (CCD). However, the last 16 CCD residues, composing an "overlap helix" (OH), have been crystallized in two mutually exclusive states: either as part of the CCD or packed against the C-terminal beta-alpha repeated, autophagy-specific domain (BARAD). Here, using CD spectroscopy, isothermal titration calorimetry, and small-angle X-ray scattering, we show that in the homodimeric state, the OH transitions between these two different packing states, with the predominant state comprising the OH packed against the BARAD, contrary to expectations based on known BECN1 interactions with heterologous partners. We confirmed this observation by comparing the impact of mutating four residues that mediate packing of the OH against both the CCD and BARAD on structure and stability of the CCD, the OH+ BARAD, and the two-domain CCD-BARAD. Last, we used cellular assays to demonstrate that mutation of these OH-interface residues abrogates starvation-induced up-regulation of autophagy but does not affect basal autophagy. In summary, we have identified a BECN1 helical region that transitions between packing as part of either one of two conserved domains (i.e. the CCD or the BARAD). Our findings have important implications for the relative stability of autophagy-inactive and autophagy-active BECN1 complexes.	[Glover, Karen; Li, Yue; Mukhopadhyay, Shreya; Leuthner, Zoe; Colbert, Christopher L.; Sinha, Sangita C.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Chakravarthy, Srinivas] BioCAT, Adv Photon Source, Sect 18ID, Argonne, IL 60439 USA	North Dakota State University Fargo; United States Department of Energy (DOE); Argonne National Laboratory	Sinha, SC (corresponding author), North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	sangita.sinha@ndsu.edu		Mukhopadhyay, Shreya/0000-0002-2419-1409; Sinha, Sangita/0000-0003-0953-4263; Colbert, Christopher/0000-0001-9577-9544; Leuthner, Zoe/0000-0001-6502-1126	NIH NIGMS Grant [9P41 GM103622, S10 OD018090]; NIGMS, National Institutes of Health (NIH) [1S10OD018090-01]; Department of Energy Office of Science [DE-AC02-06CH11357]; NIH [P30 GM103332-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R15GM113227, P30GM103332, R15GM122035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090939] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	NIH NIGMS Grant; NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work performed at Bio-CAT was supported by NIH NIGMS Grant 9P41 GM103622 and and S10 OD018090. The use of the Pilatus 3 1M detector was supported by NIGMS, National Institutes of Health (NIH), Grant 1S10OD018090-01. This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We acknowledge the North Dakota State University (NDSU) Core Biology Facility (funded by NIH Grant P30 GM103332-01) for access to tissue culture facilities and the NDSU Advanced Imaging and Microscopy Core Laboratory for access to microscopy and imaging equipment. We also thank Dr. Pawel Borowicz for assistance with imaging and puncta quantification method development.	Adi-Harel S, 2010, J CELL BIOCHEM, V110, P1262, DOI 10.1002/jcb.22642; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Baskaran S, 2014, ELIFE, V3, DOI 10.7554/eLife.05115; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Itakura E, 2009, AUTOPHAGY, V5, P534, DOI 10.4161/auto.5.4.8062; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2010, DEV CELL, V19, P11, DOI 10.1016/j.devcel.2010.07.005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koneri K, 2007, ANTICANCER RES, V27, P1453; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Lee EF, 2016, AUTOPHAGY, V12, P460, DOI 10.1080/15548627.2016.1140292; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mei Y, 2016, PROTEIN SCI, V25, P1767, DOI 10.1002/pro.2984; Mei Y, 2016, BIOCHEMISTRY-US, V55, P4239, DOI 10.1021/acs.biochem.6b00246; Mei Y, 2016, BIOCHEMISTRY-US, V55, P1945, DOI 10.1021/acs.biochem.5b01264; Mei Y, 2014, PROTEINS, V82, P565, DOI 10.1002/prot.24424; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Miracco C, 2007, INT J ONCOL, V30, P429; Noda NN, 2012, J BIOL CHEM, V287, P16256, DOI 10.1074/jbc.M112.348250; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; Su MF, 2017, PROTEIN SCI, V26, P972, DOI 10.1002/pro.3140; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Kun, 2014, P 14THWORKSHOP DOMAI, P1, DOI DOI 10.1038/KI.2014.274	54	7	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16235	16248		10.1074/jbc.M117.804195	http://dx.doi.org/10.1074/jbc.M117.804195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798234	hybrid, Green Published			2022-12-28	WOS:000412109400022
J	Yang, LN; Wang, CY; Li, FD; Zhang, JH; Nayab, A; Wu, JH; Shi, YY; Gong, QG				Yang, Lingna; Wang, Chongyuan; Li, Fudong; Zhang, Jiahai; Nayab, Anam; Wu, Jihui; Shi, Yunyu; Gong, Qingguo			The human RNA-binding protein and E3 ligase MEX-3C binds the MEX-3-recognition element (MRE) motif with high affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I MESSENGER-RNA; FRAGILE-X GENE; KH DOMAIN; CRYSTAL-STRUCTURE; ZINC-FINGER; RECOGNITION; UBIQUITIN; COMPLEX; MEX3C; TOTIPOTENCY	MEX-3 is a K-homology (KH) domain-containing RNA-binding protein first identified as a translational repressor in Caenorhabditis elegans, and its four orthologs (MEX-3A-D) in human and mouse were subsequently found to have E3 ubiquitin ligase activity mediated by a RING domain and critical for RNAdegradation. Current evidence implicates human MEX-3C in many essential biological processes and suggests a strong connection with immune diseases and carcinogenesis. The highly conserved dual KH domains in MEX-3 proteins enable RNA binding and are essential for the recognition of the 3'-UTR and post-transcriptional regulation of MEX-3 target transcripts. However, the molecular mechanisms of translational repression and the consensus RNA sequence recognized by the MEX-3C KH domain are unknown. Here, using X-ray crystallography and isothermal titration calorimetry, we investigated the RNA-binding activity and selectivity of human MEX-3C dual KH domains. Our high-resolution crystal structures of individual KH domains complexed with a noncanonical U-rich and a GA-rich RNA sequence revealed that the KH1/2 domains of human MEX-3C bound MRE10, a 10-mer RNA (5'-CAGAGUUUAG-3') consisting of an eight-nucleotide MEX-3-recognition element (MRE) motif, with high affinity. Of note, we also identified a consensus RNA motif recognized by human MEX-3C. The potential RNA-binding sites in the 3'-UTR of the human leukocyte antigen serotype (HLA-A2) mRNA were mapped with this RNA-binding motif and further confirmed by fluorescence polarization. The binding motif identified here will provide valuable information for future investigations of the functional pathways controlled by human MEX-3C and for predicting potential mRNAs regulated by this enzyme.	[Yang, Lingna; Wang, Chongyuan; Li, Fudong; Zhang, Jiahai; Nayab, Anam; Wu, Jihui; Shi, Yunyu; Gong, Qingguo] Univ Sci & Technol China, Collaborat Innovat Ctr Chem Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Yang, Lingna; Wang, Chongyuan; Li, Fudong; Zhang, Jiahai; Nayab, Anam; Wu, Jihui; Shi, Yunyu; Gong, Qingguo] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Shi, Yunyu] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Gong, QG (corresponding author), Univ Sci & Technol China, Collaborat Innovat Ctr Chem Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Gong, QG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	qgg@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	Strategic Priority Research Program of the Chinese Academy of Science [XDB08010101, XDB08030302]; Chinese National Natural Science Foundation [91540103, 31330018, 31270782]	Strategic Priority Research Program of the Chinese Academy of Science(Chinese Academy of Sciences); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Science Grants XDB08010101 and XDB08030302 and Chinese National Natural Science Foundation Grants 91540103, 31330018, and 31270782. The authors declare that they have no conflicts of interest with the contents of this article.	Achsel T, 2016, CURR OPIN NEUROBIOL, V39, P146, DOI 10.1016/j.conb.2016.06.007; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9670; Cano F, 2013, MOL IMMUNOL, V55, P135, DOI 10.1016/j.molimm.2012.10.015; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Currie JR, 1999, AM J MED GENET, V84, P272, DOI 10.1002/(SICI)1096-8628(19990528)84:3<272::AID-AJMG21>3.3.CO;2-4; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Goddard T.D., 2004, SPARKY 3; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Jiao Y, 2012, MOL CELL BIOL, V32, P4350, DOI 10.1128/MCB.00452-12; Jiao Y, 2012, MOL BIOL CELL, V23, P1404, DOI 10.1091/mbc.E11-11-0960; KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MCKNIGHT GL, 1992, J BIOL CHEM, V267, P12131; MORELLI MAC, 1995, FEBS LETT, V358, P193, DOI 10.1016/0014-5793(94)01422-W; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Nicastro G, 2012, NAT STRUCT MOL BIOL, V19, P1282, DOI 10.1038/nsmb.2427; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pagano JM, 2009, P NATL ACAD SCI USA, V106, P20252, DOI 10.1073/pnas.0907916106; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Wang WW, 2011, GENE DEV, V25, P2106, DOI 10.1101/gad.16746011; Yoga YMK, 2012, NUCLEIC ACIDS RES, V40, P5101, DOI 10.1093/nar/gks058	52	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16221	16234		10.1074/jbc.M117.797746	http://dx.doi.org/10.1074/jbc.M117.797746			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28808060	hybrid, Green Published			2022-12-28	WOS:000412109400021
J	Gajiwala, KS; Grodsky, N; Bolanos, B; Feng, JL; Ferre, R; Timofeevski, S; Xu, MR; Murray, BW; Johnson, TW; Al Stewart,				Gajiwala, Ketan S.; Grodsky, Neil; Bolanos, Ben; Feng, Junli; Ferre, RoseAnn; Timofeevski, Sergei; Xu, Meirong; Murray, Brion W.; Johnson, Ted W.; Stewart, Al			The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; GROWTH-ARREST; ACTIVATION; RESISTANCE; CANCER; FAMILY; DISCOVERY; MECHANISM; CELLS; IDENTIFICATION	The receptor tyrosine kinase family consisting of Tyro3, Axl, and Mer (TAM) is one of the most recently identified receptor tyrosine kinase families. TAM receptors are up-regulated postnatally and maintained at high levels in adults. They all play an important role in immunity, but Axl has also been implicated in cancer and therefore is a target in the discovery and development of novel therapeutics. However, of the three members of the TAM family, the Axl kinase domain is the only one that has so far eluded structure determination. To this end, using differential scanning fluorimetry and hydrogen-deuterium exchange mass spectrometry, we show here that a lower stability and greater dynamic nature of the Axl kinase domain may account for its poor crystallizability. Wepresent the first structural characterization of the Axl kinase domain in complex with a smallmolecule macrocyclic inhibitor. The Axl crystal structure revealed two distinct conformational states of the enzyme, providing a first glimpse of what an activeTAMreceptor kinase may look like and suggesting a potential role for the juxtamembrane region in enzyme activity. We noted that the ATP/ inhibitorbinding sites of the TAM members closely resemble each other, posing a challenge for the design of a selective inhibitor. We propose that the differences in the conformational dynamics among the TAM family members could potentially be exploited to achieve inhibitor selectivity for targeted receptors.	[Gajiwala, Ketan S.; Grodsky, Neil; Bolanos, Ben; Feng, Junli; Ferre, RoseAnn; Johnson, Ted W.; Stewart, Al] Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA 92121 USA; [Timofeevski, Sergei; Xu, Meirong; Murray, Brion W.] Pfizer Worldwide Res & Dev, Oncol Res & Dev, San Diego, CA 92121 USA	Pfizer; Pfizer	Gajiwala, KS (corresponding author), Pfizer Worldwide Res & Dev, Oncol Med Chem, San Diego, CA 92121 USA.	ketan.gajiwala@pfizer.com						Bailey S., 2013, [No title captured], Patent No. [2013132376 A1, 2013132376, WO2013132376]; Baladi T, 2015, EUR J MED CHEM, V105, P220, DOI 10.1016/j.ejmech.2015.10.003; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Bricogne G, 2016, BUSTER; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feneyrolles C, 2014, MOL CANCER THER, V13, P2141, DOI 10.1158/1535-7163.MCT-13-1083; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Huang XD, 2009, J STRUCT BIOL, V165, P88, DOI 10.1016/j.jsb.2008.10.003; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Johnson TW, 2014, J MED CHEM, V57, P4720, DOI 10.1021/jm500261q; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kimani SG, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0142-1; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu J, 2012, ACS MED CHEM LETT, V3, P129, DOI 10.1021/ml200239k; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mollard A, 2011, ACS MED CHEM LETT, V2, P907, DOI 10.1021/ml200198x; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Northrup AB, 2013, J MED CHEM, V56, P2294, DOI 10.1021/jm301619u; Ostergaard E, 2011, MOL VIS, V17, P1485; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Powell NA, 2012, BIOORG MED CHEM LETT, V22, P190, DOI 10.1016/j.bmcl.2011.11.036; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Rickert KW, 2011, J BIOL CHEM, V286, P11218, DOI 10.1074/jbc.M110.204404; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Tan L, 2016, J MED CHEM, V59, P6807, DOI 10.1021/acs.jmedchem.6b00608; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wang J, 2010, BIOCHEMISTRY-US, V49, P7972, DOI 10.1021/bi100409w; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yao TW, 2017, ONCOTARGET, V8, P583, DOI 10.18632/oncotarget.11882; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	59	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15705	15716		10.1074/jbc.M116.771485	http://dx.doi.org/10.1074/jbc.M116.771485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28724631	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000411512200011
J	Kumar, R; Ozorowski, G; Kumar, V; Holden, LG; Shrivastava, T; Patil, S; Deshpande, S; Ward, AB; Bhattacharya, J				Kumar, Rajesh; Ozorowski, Gabriel; Kumar, Vivek; Holden, Lauren G.; Shrivastava, Tripti; Patil, Shilpa; Deshpande, Suprit; Ward, Andrew B.; Bhattacharya, Jayanta			Characterization of a stable HIV-1B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV; CD4; MUTATIONS; VACCINE; RESPONSES; ESCAPE; DESIGN; PLASMA; GENES	The HIV-1 envelope (Env) is a glycoprotein consisting of a trimer of heterodimers containing gp 120 and gp41 subunits that mediates virus entry and is a major target of broadly neutralizing antibodies (bnAbs) developed during infection in some individuals. The engagement of the HIV-1 gp120 glycoprotein to the host CD4 protein triggers conformational changes in gp120 that allow its binding to co-receptors and is necessary for virus entry to establish infection. Native-like HIV-1 Env immunogens representing distinct clades have been proposed to improve immunogenicity. In the present study, we examined the basis of resistance of an HIV-1 B/C recombinant Env (LT5. J4b12C) to non-neutralizing antibodies targeting CD4-induced Env epitopes in the presence of soluble CD4 (sCD4). Using native polyacrylamide gel shift assay and negative-stain EM, we found that the prefusion conformational state of LT5. J4b12C trimeric Env was largely unaffected in the presence of excess sCD4 with most Env trimers appearing to be in a ligand-free state. This resistance to CD4-induced conformational changes was associated with a lower affinity for CD4. Moreover, the LT5. J4b12C trimeric Env preferentially bound to the neutralizing antibodies compared with non-neutralizing antibodies. Taken together, we report on an HIV-1 B/C recombinant, native-like trimeric Env protein that is highly resistant to CD4-induced conformational changes but displays epitopes recognized by a diverse array of bnAbs. Such features make this B/C recombinant trimeric Env a useful addition to the pool of other recently identified native-like HIV-1 Env trimers suitable for use as antigenic bait for bnAb isolation, structural studies, and use as potential immunogens.	[Kumar, Rajesh; Kumar, Vivek; Shrivastava, Tripti; Patil, Shilpa; Deshpande, Suprit; Bhattacharya, Jayanta] Natl Capital Reg Biotech Sci Cluster, HIV Vaccine Translat Res Lab, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India; [Ozorowski, Gabriel; Holden, Lauren G.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Holden, Lauren G.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Bhattacharya, Jayanta] Int AIDS Vaccine Initiat, New York, NY 10004 USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Bhattacharya, J (corresponding author), Natl Capital Reg Biotech Sci Cluster, HIV Vaccine Translat Res Lab, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India.; Bhattacharya, J (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.	JBhattacharya@iavi.org	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Ozorowski, Gabriel/HCH-0634-2022	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Holden, Lauren/0000-0001-8014-4503; Deshpande, Suprit/0000-0002-6170-3661	Bill and Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development(United States Agency for International Development (USAID))	We thank Prof. John P. Moore and the members of the SOSIP trimer HIV Vaccine Research and Design team, Weill Cornell Medical College, New York, for the generous gift of the BG505 SOSIP. 664 plasmid DNA. We thank Dr. Shubbir Ahmed for helpful discussions. The work of the International AIDS Vaccine Initiative (IAVI) is made possible by generous support from many donors, including the Bill and Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation, the United Kingdom Department for International Development, and the United States Agency for International Development.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BACK NKT, 1993, J VIROL, V67, P6897, DOI 10.1128/JVI.67.11.6897-6902.1993; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Mukhopadhyay S, 2012, AIDS RES HUM RETROV, V28, P739, DOI [10.1089/AID.2011.0238, 10.1089/aid.2011.0238]; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Patil S, 2016, J VIROL, V90, P3446, DOI 10.1128/JVI.03090-15; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046713; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	44	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15849	15858		10.1074/jbc.M117.803056	http://dx.doi.org/10.1074/jbc.M117.803056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28743743	Green Published, hybrid			2022-12-28	WOS:000411512200022
J	Sawai, M; Uchida, Y; Ohno, Y; Miyamoto, M; Nishioka, C; Itohara, S; Sassa, T; Kihara, A				Sawai, Megumi; Uchida, Yukiko; Ohno, Yusuke; Miyamoto, Masatoshi; Nishioka, Chieko; Itohara, Shigeyoshi; Sassa, Takayuki; Kihara, Akio			The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-2-ENOYL-COA REDUCTASE TER; PERMEABILITY BARRIER; METABOLIC PATHWAY; GENE; IDENTIFICATION; RESIDUES; MUTATION; PROTEIN; GENOME; CELLS	Differences among fatty acids (FAs) in chain length and number of double bonds create lipid diversity. FA elongation proceeds via a four-step reaction cycle, in which the 3-hydroxyacyl-CoA dehydratases (HACDs) HACD1-4 catalyze the third step. However, the contribution of each HACD to 3-hydroxyacyl-CoA dehydratase activity in certain tissues or in different FA elongation pathways remains unclear. HACD1 is specifically expressed in muscles and is a myopathy-causative gene. Here, we generated Hacd1 KO mice and observed that these mice had reduced body and skeletal muscle weights. In skeletal muscle, HACD1 mRNA expression was by far the highest among the HACDs. However, we observed only an similar to 40% reduction in HACD activity and no changes in membrane lipid composition in Hacd1-KO skeletal muscle, suggesting that some HACD activities are redundant. Moreover, when expressed in yeast, both HACD1 and HACD2 participated in saturated and monounsaturated FA elongation pathways. Disruption of HACD2 in the haploid human cell line HAP1 significantly reduced FA elongation activities toward both saturated and unsaturated FAs, and HACD1 HACD2 double disruption resulted in a further reduction. Overexpressed HACD3 exhibited weak activity in saturated and monounsaturated FA elongation pathways, and no activity was detected for HACD4. We therefore conclude that HACD1 and HACD2 exhibit redundant activities in a wide range of FA elongation pathways, including those for saturated to polyunsaturated FAs, with HACD2 being the major 3-hydroxyacyl-CoA dehydratase. Our findings are important for furthering the understanding of the molecular mechanisms in FA elongation and diversity.	[Sawai, Megumi; Uchida, Yukiko; Ohno, Yusuke; Miyamoto, Masatoshi; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Nishioka, Chieko; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	Hokkaido University; RIKEN	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Ohno, Yusuke/B-5621-2014; Ohno, Yusuke/Q-3285-2019; KIHARA, AKIO/A-3802-2012; Itohara, Shigeyoshi/I-8769-2012; SASSA, Takayuki/B-2519-2012	Ohno, Yusuke/0000-0003-3702-1043; Ohno, Yusuke/0000-0003-3702-1043; KIHARA, AKIO/0000-0001-5889-0788; Itohara, Shigeyoshi/0000-0002-2410-9989; SASSA, Takayuki/0000-0003-3145-9829; Sawai-Ogawa, Megumi/0000-0002-7406-802X; Miyamoto, Masatoshi/0000-0002-7785-7438	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) of the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science [26251010, 15H05589]; Grants-in-Aid for Scientific Research [16K08220, 26251010] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) of the Japan Agency for Medical Research and Development (AMED), by Grant-in-aid for Scientific Research (A) 26251010 (to A. K.) from the Japan Society for the Promotion of Science, and by Grant-in-aid for Young Scientists (A) 15H05589 (to Y. O.) from Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Blondelle J, 2015, J MOL CELL BIOL, V7, P429, DOI 10.1093/jmcb/mjv049; Brachmann CB, 1998, YEAST, V14, P115; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Harkewicz R, 2012, J BIOL CHEM, V287, P11469, DOI 10.1074/jbc.M111.256073; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2017, P NATL ACAD SCI USA, V114, pE2616, DOI 10.1073/pnas.1700138114; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Naganuma T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101823; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; REVARDEL E, 1995, BBA-GENE STRUCT EXPR, V1263, P261, DOI 10.1016/0167-4781(95)00124-Y; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Steimle A, 2016, INT J MED MICROBIOL, V306, P290, DOI 10.1016/j.ijmm.2016.03.001; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yazawa T, 2013, FEBS LETT, V587, P804, DOI 10.1016/j.febslet.2013.02.006	51	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15538	15551		10.1074/jbc.M117.803171	http://dx.doi.org/10.1074/jbc.M117.803171			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28784662	hybrid, Green Published			2022-12-28	WOS:000410809800032
J	Wu, XZ; Dayanand, KK; Thylur, RP; Norbury, CC; Gowda, DC				Wu, Xianzhu; Dayanand, Kiran K.; Thylur, Ramesh P.; Norbury, Christopher C.; Gowda, D. Channe			Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE PLASMODIUM-CHABAUDI; CD8(+) T-CELLS; CEREBRAL MALARIA; DENDRITIC CELLS; INNATE IMMUNITY; PROTECTIVE-IMMUNITY; FALCIPARUM; IGM; INFECTION; MICE	Malaria infections cause several systemic and severe single- or multi-organ pathologies, killing hundreds of thousands of people annually. Considering the existing widespread resistance of malaria parasites to anti-parasitic drugs and their high propensity to develop drug resistance, alternative strategies are required to manage malaria infections. Because malaria is a host immune response-driven disease, one approach is based on gaining a detailed understanding of the molecular and cellular processes that modulate malaria-induced innate and adaptive immune responses. Here, using a mouse cerebral malaria model and small-molecule inhibitors, we demonstrate that inhibiting MEK1/2, the upstream kinases of ERK1/2 signaling, alters multifactorial components of the innate and adaptive immune responses, controls parasitemia, and blocks pathogenesis. Specifically, MEK1/2 inhibitor treatment up-regulated B1 cell expansion, IgM production, phagocytic receptor expression, and phagocytic activity, enhancing parasite clearance by macrophages and neutrophils. Further, the MEK1/2 inhibitor treatment down-regulated pathogenic pro-inflammatory and helper T cell 1 (Th1) responses and up-regulated beneficial anti-inflammatory cytokine responses and Th2 responses. These inhibitor effects resulted in reduced granzyme B expression byT cells, chemokine and intracellular cell adhesion molecule 1 (ICAM-1) expression in the brain, and chemokine receptor expression by both myeloid and T cells. These bimodal effects of the MEK1/2 inhibitor treatment on immune responses contributed to decreased parasite biomass, organ inflammation, and immune cell recruitment, preventing tissue damage and death. In summary, we have identified several previously unrecognized immune regulatory processes through which a MEK1/2 inhibitor approach controls malaria parasitemia and mitigates pathogenic effects on host organs.	[Wu, Xianzhu; Dayanand, Kiran K.; Thylur, Ramesh P.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Norbury, Christopher C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Penn State Univ, Sch Med, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu	Puttalingaiah, Ramesh Thylur/AAH-9087-2020	Gowda, Channe/0000-0002-6860-5108	NIAID, National Institutes of Health [R01 AI41139]; Fogarty International Center under Global Infectious Disease Program, National Institutes of Health [D43TW008268]; FOGARTY INTERNATIONAL CENTER [D43TW008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center under Global Infectious Disease Program, National Institutes of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIAID, National Institutes of Health, Grant R01 AI41139. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Fogarty International Center under the Global Infectious Disease Program, National Institutes of Health, Grant D43TW008268.	Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Cabrera A, 2014, TRENDS PARASITOL, V30, P436, DOI 10.1016/j.pt.2014.07.006; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Clark CJ, 2011, PARASITE IMMUNOL, V33, P637, DOI 10.1111/j.1365-3024.2011.01329.x; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; CONTRERAS C, 1980, CLIN EXP IMMUNOL, V42, P403; Couper KN, 2005, PARASITE IMMUNOL, V27, P171, DOI 10.1111/j.1365-3024.2005.00760.x; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Deroost K, 2016, FEMS MICROBIOL REV, V40, P208, DOI 10.1093/femsre/fuv046; Farooq Umar, 2004, Journal of Vector Borne Diseases, V41, P45; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; HENTATI B, 1994, EUR J IMMUNOL, V24, P8, DOI 10.1002/eji.1830240103; Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; KWIATKOWSKI D, 1991, P NATL ACAD SCI USA, V88, P5111, DOI 10.1073/pnas.88.12.5111; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Lobo PI, 2015, J IMMUNOL, V195, P5215, DOI 10.4049/jimmunol.1500052; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Notley CA, 2011, J IMMUNOL, V186, P4967, DOI 10.4049/jimmunol.1003021; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Ryg-Cornejo V, 2013, IMMUNOBIOLOGY, V218, P263, DOI 10.1016/j.imbio.2012.05.018; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schumak B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124080; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Stanisic DI, 2015, VACCINE, V33, P7469, DOI 10.1016/j.vaccine.2015.09.057; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Storm J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00100; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Teo A, 2016, TRENDS PARASITOL, V32, P887, DOI 10.1016/j.pt.2016.07.003; TURRINI F, 1992, BLOOD, V80, P801; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Vinayaka AC, 2014, ORG BIOMOL CHEM, V12, P8555, DOI 10.1039/c4ob01455c; Weiss GE, 2016, TRENDS PARASITOL, V32, P284, DOI 10.1016/j.pt.2015.12.007; World Health Organization, 2015, WORLD MAL REP 2015; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	66	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13615	13634		10.1074/jbc.M116.770313	http://dx.doi.org/10.1074/jbc.M116.770313			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28679535	hybrid, Green Published			2022-12-28	WOS:000407942400031
J	Ahn, DH; Lee, KY; Lee, SJ; Park, SJ; Yoon, HJ; Kim, SJ; Lee, BJ				Ahn, Do-Hwan; Lee, Ki-Young; Lee, Sang Jae; Park, Sung Jean; Yoon, Hye-Jin; Kim, Soon-Jong; Lee, Bong-Jin			Structural analyses of the MazEF4 toxin-antitoxin pair in Mycobacterium tuberculosis provide evidence for a unique extracellular death factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; nuclear magnetic resonance (NMR); protein structure; quorum sensing; X-ray crystallography; MazEF system; extracellular death factor; toxin-antitoxin system	MEDIATED CELL-DEATH; MESSENGER-RNA INTERFERASES; ESCHERICHIA-COLI; PROTEIN; SYSTEMS; MAZF; FEATURES; VISUALIZATION; ENDONUCLEASE; CONSERVATION	The bacterial toxin-antitoxin MazEF system in the tuberculosis (TB)-causing bacterium Mycobacterium tuberculosis is activated under unfavorable conditions, including starvation, antibiotic exposure, and oxidative stress. This system contains the ribonucleolytic enzyme MazF and has emerged as a promising drug target for TB treatments targeting the latent stage of M. tuberculosis infection and reportedly mediates a cell death process via a peptide called extracellular death factor (EDF). Although it is well established that the increase in EDF-mediated toxicity of MazF drives a cell-killing phenomenon, the molecular details are poorly understood. Moreover, the divergence in sequences among reported EDFs suggests that each bacterial species has a unique EDF. To address these open questions, we report here the structures of MazF4 and MazEF4 complexes from M. tuberculosis, representing the first MazEF structures from this organism. We found that MazF4 possesses a negatively charged MazE4-binding pocket in contrast to the positively charged MazE-binding pockets in homologous MazEF complex structures from other bacteria. Moreover, using NMR spectroscopy and biochemical assays, we unraveled the molecular interactions of MazF4 with its RNA substrate and with a new EDF homolog originating from M. tuberculosis. The EDF homolog discovered here possesses a positively charged residue at the C terminus, making this EDF distinct from previously reported EDFs. Overall, our results suggest that M. tuberculosis evolved a unique MazF and EDF and that the distinctive EDF sequence could serve as a starting point for designing new anti-tuberculosis drugs. We therefore conclude that this study might contribute to the development of a new line of anti-tuberculosis agents.	[Ahn, Do-Hwan; Lee, Ki-Young; Lee, Sang Jae; Lee, Bong-Jin] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea; [Park, Sung Jean] Gachon Univ, Coll Pharm, 534-2 Yeonsu Dong, Incheon, South Korea; [Yoon, Hye-Jin] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam 534729, South Korea	Seoul National University (SNU); Gachon University; Seoul National University (SNU); Mokpo National University	Lee, BJ (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Sang Jae/AAX-7611-2021; Lee, Bong-Jin/AAQ-1609-2020	Lee, Sang Jae/0000-0002-5366-2900; Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea grants - Korean government [2015R1A2A1A05001894, 2014K1A3A1A19067618]; Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A092006]; BK21plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea grants - Korean government; Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; BK21plus Project for Medicine, Dentistry and Pharmacy	This work was supported by National Research Foundation of Korea grants funded by the Korean government 2015R1A2A1A05001894 and 2014K1A3A1A19067618, Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea Grant A092006, and 2016 BK21plus Project for Medicine, Dentistry and Pharmacy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen R, 2017, BIOCHEM BIOPH RES CO, V486, P804, DOI 10.1016/j.bbrc.2017.03.132; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diago-Navarro E, 2010, FEBS J, V277, P3097, DOI 10.1111/j.1742-4658.2010.07722.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hoffer ED, 2017, J BIOL CHEM, V292, P7718, DOI 10.1074/jbc.M117.779306; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2016, MBIO, V7, DOI 10.1128/mBio.02034-15; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schluger NW, 2013, SEMIN RESP CRIT CARE, V34, P60, DOI 10.1055/s-0032-1333545; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verma S, 2015, J BIOMOL STRUCT DYN, V33, P606, DOI 10.1080/07391102.2014.899924; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; WL D, 2002, PYMOL MOL GRAPHICS S; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zorzini V, 2016, J BIOL CHEM, V291, P10950, DOI 10.1074/jbc.M116.715912; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	53	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18832	18847		10.1074/jbc.M117.807974	http://dx.doi.org/10.1074/jbc.M117.807974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972145	Green Published, hybrid			2022-12-28	WOS:000415848000010
J	Kurt, TD; Aguilar-Calvo, P; Jiang, L; Rodriguez, JA; Alderson, N; Eisenberg, DS; Sigurdson, CJ				Kurt, Timothy D.; Aguilar-Calvo, Patricia; Jiang, Lin; Rodriguez, Jose A.; Alderson, Nazilla; Eisenberg, David S.; Sigurdson, Christina J.			Asparagine and glutamine ladders promote cross-species prion conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; fibril; neurodegeneration; prion; prion disease; steric zipper; transmission	CHRONIC WASTING DISEASE; BANK VOLE; NEURODEGENERATIVE DISEASES; MAMMALIAN PRIONS; AMYLOID FIBRILS; SHEEP SCRAPIE; NMR STRUCTURE; HAMSTER PRP; IN-VITRO; PROTEIN	Prion transmission between species is governed in part by primary sequence similarity between the infectious prion aggregate, PrPSc, and the cellular prion protein of the host, PrPC. A puzzling feature of prion formation is that certain PrPC sequences, such as that of bank vole, can be converted by a remarkably broad array of different mammalian prions, whereas others, such as rabbit, show robust resistance to cross-species prion conversion. To examine the structural determinants that confer susceptibility or resistance to prion conversion, we systematically tested over 40 PrPC variants of susceptible and resistant PrPC sequences in a prion conversion assay. Five key residue positions markedly impacted prion conversion, four of which were in steric zipper segments where side chains from amino acids tightly interdigitate in a dry interface. Strikingly, all five residue substitutions modulating prion conversion involved the gain or loss of an asparagine or glutamine residue. For two of the four positions, Asn and Gln residues were not interchangeable, revealing a strict requirement for either an Asn or Gln residue. Bank voles have a high number of Asn and Gln residues and a high Asn:Gln ratio. These findings suggest that a high number of Asn and Gln residues at specific positions may stabilize -sheets and lower the energy barrier for cross-species prion transmission, potentially because of hydrogen bond networks from side chain amides forming extended Asn/Gln ladders. These data also suggest that multiple PrPC segments containing Asn/Gln residues may act in concert along a replicative interface to promote prion conversion.	[Kurt, Timothy D.; Aguilar-Calvo, Patricia; Alderson, Nazilla; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kurt, Timothy D.; Aguilar-Calvo, Patricia; Alderson, Nazilla; Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rodriguez, Jose A.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, DOE Inst, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.; Eisenberg, David S.] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jiang, Lin] UCLA, Dept Neurol, Los Angeles, CA 90095 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu			National Institutes of Health [NS069566, NS076896, OD019919, OD017853]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076896, R01NS069566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029430] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019919, T32OD017863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants NS069566 (to C. J. S.), NS076896 (to C. J. S.), OD019919 (to T. D. K.), and OD017853 (to T. D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Avbelj M, 2011, BIOCHEM BIOPH RES CO, V413, P521, DOI 10.1016/j.bbrc.2011.08.125; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CHANDLER RL, 1971, LANCET, V1, P232; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Di Bari MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003219; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Espinosa JC, 2016, J VIROL, V90, P10660, DOI 10.1128/JVI.01592-16; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Kurt TD, 2015, J CLIN INVEST, V125, P1485, DOI 10.1172/JCI79408; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Pirisinu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20443; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990; Watts JC, 2012, P NATL ACAD SCI USA, V109, P3498, DOI 10.1073/pnas.1121556109; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	62	13	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19076	19086		10.1074/jbc.M117.794107	http://dx.doi.org/10.1074/jbc.M117.794107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28931606	hybrid, Green Published			2022-12-28	WOS:000415848000030
J	He, SW; Sun, H; Lin, LL; Zhang, YX; Chen, JL; Liang, LN; Li, Y; Zhang, MD; Yang, X; Wang, XS; Wang, FH; Zhu, FY; Chen, JK; Pei, DQ; Zheng, H				He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui			Passive DNA demethylation preferentially up-regulates pluripotency-related genes and facilitates the generation of induced pluripotent stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; DNA methylation; DNA methyltransferase; p53; reprogramming	METHYLATION; REPLICATION; MAINTENANCE; INDUCTION; REVEALS; DNMT1; CYCLE; TET1	A high proliferation rate has been observed to facilitate somatic cell reprogramming, but the pathways that connect proliferation and reprogramming have not been reported. DNA methyltransferase 1 (DNMT1) methylates hemimethylated CpG sites produced during S phase and maintains stable inheritance of DNA methylation. Impairing this process results in passive DNA demethylation. In this study, we show that the cell proliferation rate positively correlated with the expression of Dnmt1 in G(1) phase. In addition, as determined by whole-genome bisulfate sequencing and high-performance liquid chromatography, global DNA methylation of mouse embryonic fibroblasts was significantly higher in G(1) phase than in G(2)/M phase. Thus, we suspected that high cellular proliferation requires more Dnmt1 expression in G(1) phase to prevent passive DNA demethylation. The methylation differences of individual CpG sites between G(1) and G(2)/M phase were related to the methylation status and the positions of their surrounding CpG sites. In addition, larger methylation differences were observed on the promoters of pluripotency-related genes; for example, Oct4, Nanog, Sox2, Esrrb, Cdh1, and Epcam. When such methylation differences or passive DNA demethylation accumulated with Dnmt1 suppression and proliferation acceleration, DNA methylation on pluripotency-related genes was decreased, and their expression was up-regulated, which subsequently promoted pluripotency and mesenchymal-epithelial transition, a necessary step for reprogramming. We infer that high cellular proliferation rates promote generation of induced pluripotent stem cells at least partially by inducing passive DNA demethylation and up-regulating pluripotency-related genes. Therefore, these results uncover a connection between cell reprogramming and DNA methylation.	[He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Joint Sch Life Sci Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China; [He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Joint Sch Life Sci Guangzhou Inst Hlth, Guangzhou 510530, Guangdong, Peoples R China; [He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui] Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China; [He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [He, Songwei; Sun, Hao; Lin, Lilong; Zhang, Yixin; Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Mengdan; Yang, Xiao; Wang, Xiaoshan; Wang, Fuhui; Zhu, Feiyan; Chen, Jiekai; Pei, Duanqing; Zheng, Hui] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 511436, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zheng, H (corresponding author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangzhou Inst Biomed, Sci City, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.; Zheng, H (corresponding author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangzhou Inst Hlth, Sci City, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.	zheng_hui@gibh.ac.cn	Chen, Jinlong/GLT-0135-2022	Zheng, Hui/0000-0001-6801-0529	Guangzhou Branch of the Supercomputing Center of the Chinese Academy of Sciences	Guangzhou Branch of the Supercomputing Center of the Chinese Academy of Sciences	We thank the Guangzhou Branch of the Supercomputing Center of the Chinese Academy of Sciences for support.	Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JN, 2013, KNOWL-BASED SYST, V45, P1, DOI 10.1016/j.knosys.2013.01.031; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hervouet E, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-5; Kheir TB, 2010, ESSAYS BIOCHEM, V48, P107, DOI [10.1042/BSE0480107, 10.1042/bse0480107]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Vandiver AR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17911; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Zheng H, 2014, CELL RES, V24, P1162, DOI 10.1038/cr.2014.93	22	19	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18542	18555		10.1074/jbc.M117.810457	http://dx.doi.org/10.1074/jbc.M117.810457			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924038	hybrid, Green Published			2022-12-28	WOS:000414958100013
J	Rahman, K; Mandalasi, M; Zhao, P; Sheikh, MO; Taujale, R; Kim, HW; van der Wel, H; Matta, K; Kannan, N; Glushka, JN; Wells, L; West, CM				Rahman, Kazi; Mandalasi, Msano; Zhao, Peng; Sheikh, M. Osman; Taujale, Rahil; Kim, Hyun W.; van der Wel, Hanke; Matta, Khushi; Kannan, Natarajan; Glushka, John N.; Wells, Lance; West, Christopher M.			Characterization of a cytoplasmic glucosyltransferase that extends the core trisaccharide of the Toxoplasma Skp1 E3 ubiquitin ligase subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; E3 ubiquitin ligase; evolution; glycobiology; glycosyltransferase; mass spectrometry (MS); Toxoplasma gondii; cytoplasmic glycosylation	CHEMICAL-SYNTHESIS; PROTEIN; DICTYOSTELIUM; GONDII; GLYCOSYLATION; GLYCOSYLTRANSFERASES; COMPLEXES; FAMILIES; MODEL; SCF	Skp1 is a subunit of the SCF (Skp1/Cullin 1/F-box protein) class of E3 ubiquitin ligases that are important for eukaryotic protein degradation. Unlike its animal counterparts, Skp1 from Toxoplasma gondii is hydroxylated by an O-2-dependent prolyl-4-hydroxylase (PhyA), and the resulting hydroxyproline can subsequently be modified by a five-sugar chain. A similar modification is found in the social amoeba Dictyostelium, where it regulates SCF assembly and O-2-dependent development. Homologous glycosyltransferases assemble a similar core trisaccharide in both organisms, and a bifunctional -galactosyltransferase from CAZy family GT77 mediates the addition of the final two sugars in Dictyostelium, generating Gal1, 3Gal1,3Fuc1,2Gal1,3GlcNAc1-. Here, we found that Toxoplasma utilizes a cytoplasmic glycosyltransferase from an ancient clade of CAZy family GT32 to catalyze transfer of the fourth sugar. Catalytically active Glt1 was required for the addition of the terminal disaccharide in cells, and cytosolic extracts catalyzed transfer of [H-3]glucose from UDP-[H-3]glucose to the trisaccharide form of Skp1 in a glt1-dependent fashion. Recombinant Glt1 catalyzed the same reaction, confirming that it directly mediates Skp1 glucosylation, and NMR demonstrated formation of a Glc1,3Fuc linkage. Recombinant Glt1 strongly preferred the full core trisaccharide attached to Skp1 and labeled only Skp1 in glt1 extracts, suggesting specificity for Skp1. glt1-knock-out parasites exhibited a growth defect not rescued by catalytically inactive Glt1, indicating that the glycan acts in concert with the first enzyme in the pathway, PhyA, in cells. A genomic bioinformatics survey suggested that Glt1 belongs to the ancestral Skp1 glycosylation pathway in protists and evolved separately from related Golgi-resident GT32 glycosyltransferases.	[Rahman, Kazi; Mandalasi, Msano; Kim, Hyun W.; van der Wel, Hanke; Kannan, Natarajan; Wells, Lance; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St, Athens, GA 30602 USA; [Zhao, Peng; Sheikh, M. Osman; Taujale, Rahil; Glushka, John N.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Taujale, Rahil; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Rahman, Kazi] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Mandalasi, Msano; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Matta, Khushi] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Rahman, Kazi] NCI, Ctr Canc Res, HIV Dynam & Replicat Program, Frederick, MD 21702 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St, Athens, GA 30602 USA.	westcm@uga.edu		Sheikh, Mohammed/0000-0002-9481-8318; Rahman, Kazi/0000-0003-2986-0007; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293; Mandalasi, Msano/0000-0002-5906-7387	Mizutani Foundation for Glycoscience [14-140]; National Institutes of Health [R01-GM084383, P41-GM103490, 8P41-GM103390]; National Institutes of Health Grant [T32-GM107004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM084383, P41GM103490] Funding Source: NIH RePORTER	Mizutani Foundation for Glycoscience; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 14-140 from the Mizutani Foundation for Glycoscience (to C. M. W.) and National Institutes of Health Grants R01-GM084383 (to C. M. W.), P41-GM103490 (to L. W., senior investigator), and 8P41-GM103390 (Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32-GM107004.	Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Blader IJ, 2014, EUKARYOT CELL, V13, P965, DOI 10.1128/EC.00081-14; Bonner JT, 2005, MYCOLOGIA, V97, P178, DOI 10.3852/mycologia.97.1.178; Chinoy ZS, 2015, CHEM-EUR J, V21, P11779, DOI 10.1002/chem.201501598; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Fussy Z, 2017, PROTIST, V168, P80, DOI 10.1016/j.protis.2016.12.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; Li ZP, 2011, APPL MICROBIOL BIOT, V91, P1203, DOI 10.1007/s00253-011-3407-z; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; RANA SS, 1981, CARBOHYD RES, V96, P231, DOI 10.1016/S0008-6215(00)81873-X; Ronnols J, 2013, CARBOHYD RES, V380, P156, DOI 10.1016/j.carres.2013.06.026; Schafer CM, 2014, J BIOL CHEM, V289, P9076, DOI 10.1074/jbc.M113.528679; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheikh MO, 2017, J BIOL CHEM, V292, P18897, DOI 10.1074/jbc.M117.809160; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sun SH, 2015, BIOTECHNOL BIOTEC EQ, V29, P105, DOI 10.1080/13102818.2014.988094; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu YC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-31; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	34	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18644	18659		10.1074/jbc.M117.809301	http://dx.doi.org/10.1074/jbc.M117.809301			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28928220	Green Published, hybrid			2022-12-28	WOS:000414958100021
J	Yang, XB; Chen, GB; Weng, NP; Mariuzza, RA				Yang, Xinbo; Chen, Guobing; Weng, Nan-ping; Mariuzza, Roy A.			Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; influenza virus; major histocompatibility complex (MHC); protein complex; surface plasmon resonance (SPR); T-cell receptor; epitope	MEMORY REPERTOIRES; RECEPTOR; ALPHA; TCR; MHC; RECOGNITION; EXPANSION; SELECTION; FEATURES; DISTINCT	Influenza A virus (IAV) causes an acute infection in humans that is normally eliminated by CD8(+) cytotoxic T lymphocytes. Individuals expressing the MHC class I molecule HLA-A2 produce cytotoxic T lymphocytes bearing T-cell receptors (TCRs) that recognize the immunodominant IAV epitope GILGFVFTL (GIL). Most GIL-specific TCRs utilize / chain pairs encoded by the TRAV27/TRBV19 gene combination to recognize this relatively featureless peptide epitope (canonical TCRs). However, approximate to 40% of GIL-specific TCRs express a wide variety of other TRAV/TRBV combinations (non-canonical TCRs). To investigate the structural underpinnings of this remarkable diversity, we determined the crystal structure of a non-canonical GIL-specific TCR (F50) expressing the TRAV13-1/TRBV27 gene combination bound to GIL-HLA-A2 to 1.7 resolution. Comparison of the F50-GIL-HLA-A2 complex with the previously published complex formed by a canonical TCR (JM22) revealed that F50 and JM22 engage GIL-HLA-A2 in markedly different orientations. These orientations are distinguished by crossing angles of TCR to peptide-MHC of 29 degrees for F50 versus 69 degrees for JM22 and by a focus by F50 on the C terminus rather than the center of the MHC 1 helix for JM22. In addition, F50, unlike JM22, uses a tryptophan instead of an arginine to fill a critical notch between GIL and the HLA-A2 2 helix. The F50-GIL-HLA-A2 complex shows that there are multiple structurally distinct solutions to recognizing an identical peptide-MHC ligand with sufficient affinity to elicit a broad anti-IAV response that protects against viral escape and T-cell clonal loss.	[Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chen, Guobing; Weng, Nan-ping] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA.; Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Weng, Nan-ping/AAC-5037-2020; Chen, Guobing/D-9572-2012	Chen, Guobing/0000-0002-2401-6168	US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000499] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the National Institutes of Health Tetramer Core Facility for providing biotinylated GIL-HLA-A2. The X-ray SER-CAT beamlines at the Advanced Photon Source are supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38. We thank Edwin Pozharski and Swarna Lakshmi Pigudu for generous assistance with X-ray data collection.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Gil A, 2015, J VIROL, V89, P4102, DOI 10.1128/JVI.03020-14; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Klarenbeek PL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002889; La Gruta NL, 2014, TRENDS IMMUNOL, V35, P396, DOI 10.1016/j.it.2014.06.004; La Gruta NL, 2013, CURR OPIN VIROL, V3, P447, DOI 10.1016/j.coviro.2013.06.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Li HM, 2016, J LEUKOCYTE BIOL, V99, P505, DOI 10.1189/jlb.6A0215-071RR; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Miconnet I, 2012, CURR OPIN HIV AIDS, V7, P64, DOI 10.1097/COH.0b013e32834ddcae; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Naumov YN, 2008, J IMMUNOL, V181, P7407, DOI 10.4049/jimmunol.181.10.7407; Naumov YN, 2006, J IMMUNOL, V177, P2006, DOI 10.4049/jimmunol.177.3.2006; Naumov YN, 2011, J IMMUNOL, V186, P6617, DOI 10.4049/jimmunol.1100091; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Song I, 2017, NAT STRUCT MOL BIOL, V24, P395, DOI 10.1038/nsmb.3383; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stewart-Jones GB, 2012, P NATL ACAD SCI USA, V109, pE3483, DOI 10.1073/pnas.1207896109; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yang XB, 2015, J BIOL CHEM, V290, P29106, DOI 10.1074/jbc.M115.691311; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	52	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18618	18627		10.1074/jbc.M117.810382	http://dx.doi.org/10.1074/jbc.M117.810382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28931605	hybrid, Green Published			2022-12-28	WOS:000414958100019
J	Yu, ZY; Cohen, JB				Yu, Zhiyi; Cohen, Jonathan B.			Enantiomeric barbiturates bind distinct inter- and intrasubunit binding sites in a nicotinic acetylcholine receptor (nAChR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN; ION-CHANNEL; ALLOSTERIC MODULATION; IDENTIFICATION; AGONIST; ANTAGONISTS; ETOMIDATE; PROTEINS; SUBUNIT; STATE	Nicotinic acetylcholine receptors (nAChRs) and gamma-aminobutyric acid type A receptors (GABA(A)Rs) are members of the pentameric ligand-gated ion channel superfamily. Drugs acting as positive allosteric modulators of muscle-type alpha 2 beta gamma delta nAChRs, of use in treatment of neuromuscular disorders, have been hard to identify. However, identification of nAChR allosteric modulator binding sites has been facilitated by using drugs developed as photoreactive GABA(A)R modulators. Recently, R-1-methyl-5-allyl-5-(m-trifluoromethyl-diazirinylphenyl) barbituric acid (R-mTFD-MPAB), an anesthetic and GABA(A)R potentiator, has been shown to inhibit Torpedo alpha 2 beta gamma delta nAChRs, binding in the ion channel and to a gamma(+) - alpha(-) subunit interface site similar to its GABA(A)R intersubunit binding site. In contrast, S-1-methyl-5-propyl- 5-(m-trifluoromethyl-diazirinylphenyl) barbituric acid (S-mTFD-MPPB) acts as a convulsant and GABA(A)R inhibitor. Photolabeling studies established that S-mTFD-MPPB binds to the same GABA(A)R intersubunit binding site as R-mTFD-MPAB, but with negative rather than positive energetic coupling to GABA binding. We now show that S-mTFD-MPPB binds with the same state (agonist) dependence as R-mTFD-MPAB within the nAChR ion channel, but it does not bind to the intersubunit binding site. Rather, S-mTFD-MPPB binds to intrasubunit sites within the alpha and delta subunits, photolabeling alpha Val-218 (alpha M1), delta Phe-232(delta M1), delta Thr-274 (delta M2), and delta Ile-288 (delta M3). Propofol, a general anesthetic that binds to GABA(A)R intersubunit sites, inhibited [H-3] S-mTFD-MPPB photolabeling of these nAChR intrasubunit binding sites. These results demonstrate that in an nAChR, the subtle difference in structure between S-mTFD-MPPB and R-mTFD-MPAB (chirality; 5-propyl versus 5-allyl) determines selectivity for intra-versus intersubunit sites, in contrast to GABAARs, where this difference affects state dependence of binding to a common site.	[Yu, Zhiyi; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; Edward and Anne Lefler Center of Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward and Anne Lefler Center of Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grant GM-58448 (to J. B. C.) and by the Edward and Anne Lefler Center of Harvard Medical School. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Arias HR, 2001, MOL PHARMACOL, V60, P497; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cohen J. B., 1986, MOL CELLULAR MECHANI, P111; DEARMENDI AJ, 1993, ANESTHESIOLOGY, V79, P1033, DOI 10.1097/00000542-199311000-00022; Desai R, 2015, J PHYSIOL-LONDON, V593, P4943, DOI 10.1113/JP270971; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Fourati Z, 2017, J BIOL CHEM, V292, P1550, DOI 10.1074/jbc.M116.766964; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Hamouda AK, 2015, MOL PHARMACOL, V88, P1, DOI 10.1124/mol.115.098913; Hamouda AK, 2014, J MOL NEUROSCI, V53, P480, DOI 10.1007/s12031-013-0150-1; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MOORE MA, 1995, BBA-BIOMEMBRANES, V1235, P336, DOI 10.1016/0005-2736(95)80022-8; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nemecz A, 2016, NEURON, V90, P452, DOI 10.1016/j.neuron.2016.03.032; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p	55	1	1	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17258	17271		10.1074/jbc.M117.808592	http://dx.doi.org/10.1074/jbc.M117.808592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878016	Green Published, hybrid			2022-12-28	WOS:000414009300010
J	Jang, KK; Lee, ZW; Kim, B; Jung, YH; Han, HJ; Kim, MH; Kim, BS; Choi, SH				Jang, Kyung Ku; Lee, Zee-Won; Kim, Bityeoul; Jung, Young Hyun; Han, Ho Jae; Kim, Myung Hee; Kim, Byoung Sik; Choi, Sang Ho			Identification and characterization of Vibrio vulnificus plpA encoding a phospholipase A(2) essential for pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; microbial pathogenesis; Phospholipase A; transcription factor; virulence factor; CRP; HlyU; PlpA; Vibrio vulnificus	VIRULENCE GENE-EXPRESSION; SENSING MASTER REGULATOR; GRAM-NEGATIVE BACTERIA; AMP RECEPTOR PROTEIN; NECROTIC CELL-DEATH; CYCLIC-AMP; GLOBAL REGULATOR; BINDING PROTEIN; HEMOLYSIN; TRANSCRIPTION	The marine bacterium Vibrio vulnificus causes food-borne diseases, which may lead to life-threatening septicemia in some individuals. Therefore, identifying virulence factors in V. vulnificus is of high priority. We performed a transcriptome analysis on V. vulnificus after infection of human intestinal HT29-methotrexate cells and found induction of plpA, encoding a putative phospholipase, VvPlpA. Bioinformatics, biochemical, and genetic analyses demonstrated that VvPlpA is a phospholipase A(2) secreted in a type II secretion system-dependent manner. Compared with the wild type, the plpA mutant exhibited reduced mortality, systemic infection, and inflammation in mice as well as low cytotoxicity toward the human epithelial INT-407 cells. Moreover, plpA mutation attenuated the release of actin and cytosolic cyclophilin A from INT-407 cells, indicating that VvPlpA is a virulence factor essential for causing lysis and necrotic death of the epithelial cells. plpA transcription was growth phase-dependent, reaching maximum levels during the early stationary phase. Also, transcription factor HlyU and cAMP receptor protein (CRP) mediate additive activation and host-dependent induction of plpA. Molecular biological analyses revealed that plpA expression is controlled via the promoter, P-plpA, and that HlyU and CRP directly bind to P-plpA upstream sequences. Taken together, this study demonstrated that VvPlpA is a type II secretion system-dependent secretory phospholipase A(2) regulated by HlyU and CRP and is essential for the pathogenicity of V. vulnificus.	[Jang, Kyung Ku; Lee, Zee-Won; Kim, Bityeoul; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea; [Jung, Young Hyun; Han, Ho Jae] Seoul Natl Univ, Coll Vet Med, PLUS Creat Vet Res Ctr BK21, Dept Vet Physiol,Res Inst Vet Med, Seoul 08826, South Korea; [Kim, Myung Hee; Kim, Byoung Sik] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon 34141, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Dept Agr Biotechnol, Seoul 08826, South Korea.; Kim, BS (corresponding author), Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon 34141, South Korea.	bskim@kribb.re.kr; choish@snu.ac.kr	Kim, Byoungsik/AAE-6239-2021; Jang, Kyungku/GLT-4101-2022	Jang, Kyungku/0000-0002-0403-1256; Choi, Sang Ho/0000-0003-3865-1039; Lee, Zee-Won/0000-0003-0376-1860; Kim, Byoung Sik/0000-0001-9820-6071	National Research Foundation from Ministry of Science, ICT, and Future Planning [2015R1A2A1A13001654]; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	National Research Foundation from Ministry of Science, ICT, and Future Planning; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This work was supported by National Research Foundation Mid-career Researcher Program Grant 2015R1A2A1A13001654 from the Ministry of Science, ICT, and Future Planning and the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea (to S. H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Bisharat N, 2013, MICROBIOL-SGM, V159, P1878, DOI 10.1099/mic.0.067900-0; Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; Christofferson DE, 2010, CELL DEATH DIFFER, V17, P1942, DOI 10.1038/cdd.2010.123; de los Reyes-Gavilan CG, 2011, RES MICROBIOL, V162, P514, DOI 10.1016/j.resmic.2011.03.009; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fang FC, 2016, CELL HOST MICROBE, V20, P133, DOI 10.1016/j.chom.2016.07.009; Gavin HE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006119; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Green J, 2014, VIRULENCE, V5, P794, DOI 10.4161/viru.27794; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Hering NA, 2011, LAB INVEST, V91, P310, DOI 10.1038/labinvest.2010.180; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; Jang KK, 2016, J BIOL CHEM, V291, P5774, DOI 10.1074/jbc.M115.685321; Jeong HG, 2008, J BACTERIOL, V190, P3768, DOI 10.1128/JB.00058-08; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim BS, 2015, MBIO, V6, DOI 10.1128/mBio.00324-15; Kim BS, 2011, J BIOL CHEM, V286, P40889, DOI 10.1074/jbc.M111.300988; Kim JA, 2015, MOL MICROBIOL, V97, P330, DOI 10.1111/mmi.13028; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kirk JS, 2015, ONCOTARGET, V6, P3136, DOI 10.18632/oncotarget.3077; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lee HJ, 2013, MOL MICROBIOL, V88, P813, DOI 10.1111/mmi.12224; Lee KE, 2007, J MICROBIOL BIOTECHN, V17, P234; Lee SE, 2004, BIOCHEM BIOPH RES CO, V324, P86, DOI 10.1016/j.bbrc.2004.09.020; Lee SJ, 2016, INT J MED MICROBIOL, V306, P10, DOI 10.1016/j.ijmm.2015.10.006; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-271; Li L, 2011, J BACTERIOL, V193, P4779, DOI 10.1128/JB.01033-10; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Lim MS, 2011, J BACTERIOL, V193, P3722, DOI 10.1128/JB.00314-11; Liu MQ, 2011, J BACTERIOL, V193, P6895, DOI 10.1128/JB.05950-11; Liu MQ, 2009, MOL MICROBIOL, V72, P491, DOI 10.1111/j.1365-2958.2009.06664.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NouriSorkhabi MH, 1996, COMP BIOCHEM PHYS B, V113, P221, DOI 10.1016/0305-0491(95)02011-X; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Oliver JD, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.VE-0001-2014; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips KE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006053; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Williams TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114376; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; Xie DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181454; Yonezawa K, 2010, INT J LAB HEMATOL, V32, P598, DOI 10.1111/j.1751-553X.2010.01227.x; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	67	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17129	17143		10.1074/jbc.M117.791657	http://dx.doi.org/10.1074/jbc.M117.791657			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28855258	Green Published, hybrid			2022-12-28	WOS:000413140600032
J	Privat, N; Levavasseur, E; Yildirim, S; Hannaoui, S; Brandel, JP; Laplanche, JL; Beringue, V; Seilhean, D; Haik, S				Privat, Nicolas; Levavasseur, Etienne; Yildirim, Serfildan; Hannaoui, Samia; Brandel, Jean-Philippe; Laplanche, Jean-Louis; Beringue, Vincent; Seilhean, Danielle; Haik, Stephane			Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; IN-VITRO; INFECTIOUS PRIONS; AGENT STRAIN; VARIANT; TRANSMISSION; SCRAPIE; MICE; PROPAGATION; MOLECULES	Human prion diseases such as Creutzfeldt-Jakob disease are transmissible brain proteinopathies, characterized by the accumulation of a misfolded isoform of the host cellular prion protein (PrP) in the brain. According to the prion model, prions are defined as proteinaceous infectious particles composed solely of this abnormal isoform of PrP (PrPSc). Even in the absence of genetic material, various prion strains can be propagated in experimental models. They can be distinguished by the pattern of disease they produce and especially by the localization of PrPSc deposits within the brain and the spongiform lesions they induce. The mechanisms involved in this strain-specific targeting of distinct brain regions still are a fundamental, unresolved question in prion research. To address this question, we exploited a prion conversion in vitro assay, protein misfolding cyclic amplification (PMCA), by using experimental scrapie and human prion strains as seeds and specific brain regions from mice and humans as substrates. We show here that region-specific PMCA in part reproduces the specific brain targeting observed in experimental, acquired, and sporadic Creutzfeldt-Jakob diseases. Furthermore, we provide evidence that, in addition to cellular prion protein, other region-and species-specific molecular factors influence the strain-dependent prion conversion process. This important step toward understanding prion strain propagation in the human brain may impact research on the molecular factors involved in protein misfolding and the development of ultrasensitive methods for diagnosing prion disease.	[Privat, Nicolas; Levavasseur, Etienne; Yildirim, Serfildan; Hannaoui, Samia; Brandel, Jean-Philippe; Haik, Stephane] INSERM, UMR S1127, F-75013 Paris, France; [Privat, Nicolas; Levavasseur, Etienne; Yildirim, Serfildan; Hannaoui, Samia; Brandel, Jean-Philippe; Haik, Stephane] CNRS, UMR 7225, F-75013 Paris, France; [Privat, Nicolas; Levavasseur, Etienne; Yildirim, Serfildan; Hannaoui, Samia; Brandel, Jean-Philippe; Seilhean, Danielle; Haik, Stephane] UPMC, Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France; [Brandel, Jean-Philippe; Haik, Stephane] GH Pitie Salpetriere, AP HP, Cellule Natl Reference MCJ, F-75013 Paris, France; [Laplanche, Jean-Louis] Hop Lariboisiere, AP HP, Serv Biochim & Biol Mol, F-75010 Paris, France; [Beringue, Vincent] INRA, UR892, F-78350 Jouy En Josas, France; [Seilhean, Danielle; Haik, Stephane] GH Pitie Salpetriere, AP HP, Lab Neuropathol, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Haik, S (corresponding author), INSERM, Hop Salpetriere, ICM, Equipe Malad Alzheimer & Malad A Prions,UMR S1127, 47-83 Blvd Hop, F-75651 Paris, France.	stephane.haik@upmc.fr	Seilhean, Danielle D/O-6899-2018; Haik, Stephane/M-7247-2018	Seilhean, Danielle D/0000-0003-3498-4602; LAPLANCHE, Jean-Louis/0000-0003-2836-2903; Haik, Stephane/0000-0001-6022-1188	Institut national de Veille Sanitaire	Institut national de Veille Sanitaire	This work was supported by the Institut national de Veille Sanitaire. The authors declare that they have no conflicts of interest with the contents of this article.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Aguzzi A, 2008, NAT NEUROSCI, V11, P1239, DOI 10.1038/nn1108-1239; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Brandel JP, 2009, ANN NEUROL, V65, P249, DOI 10.1002/ana.21583; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Bucalossi C, 2011, J VIROL, V85, P8386, DOI 10.1128/JVI.00241-11; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 1996, LANCET, V347, P916, DOI 10.1016/S0140-6736(96)91407-5; Concha-Marambio L, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6188; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Gao C, 2017, MOL NEUROBIOL, V54, P3771, DOI 10.1007/s12035-016-9945-8; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Giles K, 2010, ANN NEUROL, V68, P151, DOI 10.1002/ana.22104; Hannaoui S, 2013, J VIROL, V87, P2535, DOI 10.1128/JVI.03082-12; Hu PP, 2016, J BIOL CHEM, V291, P12880, DOI 10.1074/jbc.M115.681791; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, EMERG INFECT DIS, V15, P2013, DOI 10.3201/eid1512.090194; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; LAPLANCHE JL, 1994, NEUROLOGY, V44, P2347, DOI 10.1212/WNL.44.12.2347; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Levavasseur E, 2014, VIRUSES-BASEL, V6, P3766, DOI 10.3390/v6103766; Levavasseur E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002786; Moda F, 2014, NEW ENGL J MED, V371, P530, DOI 10.1056/NEJMoa1404401; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Privat N, 2008, MODERN PATHOL, V21, P140, DOI 10.1038/modpathol.3800994; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Vana K, 2007, CELL MOL NEUROBIOL, V27, P107, DOI 10.1007/s10571-006-9121-1	38	4	4	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16688	16696		10.1074/jbc.M117.793646	http://dx.doi.org/10.1074/jbc.M117.793646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28821618	Green Published, hybrid			2022-12-28	WOS:000412414800028
J	Bakouh, N; Bellanca, S; Nyboer, B; Cubel, SM; Karim, Z; Sanchez, CP; Stein, WD; Planelles, G; Lanzer, M				Bakouh, Naziha; Bellanca, Sebastiano; Nyboer, Britta; Cubel, Sonia Moliner; Karim, Zoubida; Sanchez, Cecilia P.; Stein, Wilfred D.; Planelles, Gabrielle; Lanzer, Michael			Iron is a substrate of the Plasmodium falciparum chloroquine resistance transporter PfCRT in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; DIGESTIVE VACUOLE; DRUG-RESISTANCE; H+ LEAK; CHANNEL; PROTEIN; ACTIVATION; INHIBITION; MUTATIONS; MEMBRANE	The chloroquine resistance transporter of the human malaria parasite Plasmodium falciparum, PfCRT, is an important determinant of resistance to several quinoline and quinoline-like antimalarial drugs. PfCRT also plays an essential role in the physiology of the parasite during development inside erythrocytes. However, the function of this transporter besides its role in drug resistance is still unclear. Using electrophysiological and flux experiments conducted on PfCRT-expressing Xenopus laevis oocytes, we show here that both wild-type PfCRT and a PfCRT variant associated with chloroquine resistance transport both ferrous and ferric iron, albeit with different kinetics. In particular, we found that the ability to transport ferrous iron is reduced by the specific polymorphisms acquired by the PfCRT variant as a result of chloroquine selection. We further show that iron and chloroquine transport via PfCRT is electrogenic. If these findings in the Xenopus model extend to P. falciparum in vivo, our data suggest that PfCRT might play a role in iron homeostasis, which is essential for the parasite's development in erythrocytes.	[Bakouh, Naziha; Planelles, Gabrielle] Univ Paris 06, INSERM, Ctr Rech Cordeliers, CNRS ERL8228,Unite 1138, F-75006 Paris, France; [Bakouh, Naziha; Planelles, Gabrielle] Univ Paris 05, F-75006 Paris, France; [Bellanca, Sebastiano; Nyboer, Britta; Cubel, Sonia Moliner; Sanchez, Cecilia P.; Lanzer, Michael] Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany; [Karim, Zoubida] Univ Paris Diderot, INSERM, CNRS ERL 8252, UMR1149, F-75890 Paris, France; [Stein, Wilfred D.] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Biol Chem, IL-91904 Jerusalem, Israel; [Planelles, Gabrielle] CNRS, INSERM, Paris, France; [Lanzer, Michael] Res Cluster Excellence CellNetworks, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Planelles, G (corresponding author), Univ Paris 06, INSERM, Ctr Rech Cordeliers, CNRS ERL8228,Unite 1138, F-75006 Paris, France.; Planelles, G (corresponding author), Univ Paris 05, F-75006 Paris, France.; Lanzer, M (corresponding author), Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	gabrielle.planelles@inserm.fr; michael.lanzer@med.uni-heidelberg.de	Lanzer, Michael/E-9752-2013; Planelles, Gabrielle/F-9603-2013	Lanzer, Michael/0000-0002-0220-6526; Planelles, Gabrielle/0000-0002-7314-8837; KARIM, Zoubida/0000-0002-3724-5592	French-German Research Initiative - Agence Nationale de la Recherche (ANR); Deutsche Forschungsgemeinschaft (DFG) [EVOTRANSPORT/ANR-14-CE35-0012-01, LA 941/11-1]; PHC PROCOPE Grants [30995WE, 57051467]; INSERM; CNRS; Universite Paris-Descartes	French-German Research Initiative - Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); PHC PROCOPE Grants; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes	This work was supported by the joint French-German Research Initiative sponsored by the Agence Nationale de la Recherche (ANR) and the Deutsche Forschungsgemeinschaft (DFG) Grants EVOTRANSPORT/ANR-14-CE35-0012-01 and LA 941/11-1 and PHC PROCOPE Grants 30995WE and ID 57051467. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by INSERM, CNRS, and the Universite Paris-Descartes. To whom correspondence may be addressed. Tel.: 33-1-44-27-50-55; E-mail: gabrielle.planelles@inserm.fr.	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; BATAILLE N, 1990, J CELL BIOL, V111, P1571, DOI 10.1083/jcb.111.4.1571; BD Biosciences, 2006, BD BION TECHN MAN; Bellanca S, 2014, J BIOL CHEM, V289, P36336, DOI 10.1074/jbc.M114.614206; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Cougnon M, 2002, AM J PHYSIOL-CELL PH, V282, pC1445, DOI 10.1152/ajpcell.00410.2001; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; GOGELEIN H, 1989, PFLUG ARCH EUR J PHY, V413, P287, DOI 10.1007/BF00583543; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Juge N, 2015, P NATL ACAD SCI USA, V112, P3356, DOI 10.1073/pnas.1417102112; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Labarbuta P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42850; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lehane AM, 2010, MOL MICROBIOL, V77, P1039, DOI 10.1111/j.1365-2958.2010.07272.x; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Mylonas C, 1999, IN VIVO, V13, P295; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; NEWMEYER DD, 1986, EMBO J, V5, P501, DOI 10.1002/j.1460-2075.1986.tb04239.x; Papakrivos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039569; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Pujol-Gimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06446-y; Richards SN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005725; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Rotmann A, 2010, MOL MICROBIOL, V76, P1591, DOI 10.1111/j.1365-2958.2010.07187.x; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Slavic K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10403; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7	55	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16109	16121		10.1074/jbc.M117.805200	http://dx.doi.org/10.1074/jbc.M117.805200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28768767	hybrid, Green Published			2022-12-28	WOS:000412109400011
J	Lomash, RM; Sheng, NY; Li, Y; Nicoll, RA; Roche, KW				Lomash, Richa Madan; Sheng, Nengyin; Li, Yan; Nicoll, Roger A.; Roche, Katherine W.			Phosphorylation of the kainate receptor (KAR) auxiliary subunit Neto2 at serine 409 regulates synaptic targeting of the KAR subunit GluK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTORS; POSTTRANSLATIONAL MODIFICATIONS; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; TRAFFICKING; STARGAZIN; PROTEINS; DISTINCT; MODULATION; PSD-95	Synaptic strength at excitatory synapses is determined by the presence of glutamate receptors (i.e. AMPA, NMDA, and kainate receptors) at the synapse. Synaptic strength is modulated by multiple factors including assembly of different receptor subunits, interaction with auxiliary subunits, and post-translational modifications of either the receptors or their auxiliary subunits. Using mass spectrometry, we found that the intracellular region of neuropilin and tolloid-like proteins (Neto) 1 and Neto2, the auxiliary subunits of kainate receptor (KARs), are phosphorylated by multiple kinases in vitro. Specifically, Neto 2 was phosphorylated at serine 409 (Ser-409) by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and protein kinase A (PKA) both in vitro and in heterologous cells. Interestingly, we observed a substantial increase in Neto2 Ser-409 phosphorylation in the presence of CaMKII, and this phosphorylation was reduced in the presence of the KAR subunit GluK1 or GluK2. We also found endogenous phosphorylation of Neto2 at Ser-409 in the brain. Moreover, Neto2 Ser-409 phosphorylation inhibited synaptic targeting of GluK1 because, unlike WT Neto2 and the phospho-deficient mutant Neto2 S409A, the Neto2 S409D phosphomimetic mutant impeded GluK1 trafficking to synapses. These results support a molecular mechanism by which Neto2 phosphorylation at Ser-409 helps restrict GluK1 targeting to the synapse.	[Lomash, Richa Madan; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Porter Neurosci Res Ctr, Bldg 35,Rm 2C-903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Lomash, Richa Madan/I-1307-2019; Roche, Katherine/W-9893-2019	Sheng, Nengyin/0000-0003-3086-3950	National Institutes of Health NINDS Intramural Research Program; National Institute of Mental Health [R01MH080379-09, R01MH070957-11A1]; National Institutes of Health [ZIA-NS002994-15]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957, R01MH080379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	National Institutes of Health NINDS Intramural Research Program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health NINDS Intramural Research Program (to R. M. L., Y. L., and K. W. R.), National Institute of Mental Health Grants R01MH080379-09 and R01MH070957-11A1 (to N. S. and R. A. N.), and National Institutes of Health Grant ZIA-NS002994-15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bemben MA, 2014, NAT NEUROSCI, V17, P56, DOI 10.1038/nn.3601; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Fisher JL, 2015, NEUROPHARMACOLOGY, V99, P471, DOI 10.1016/j.neuropharm.2015.08.018; Fisher JL, 2012, J NEUROSCI, V32, P12928, DOI 10.1523/JNEUROSCI.2211-12.2012; Hayes DM, 2003, BIOCHEM BIOPH RES CO, V310, P8, DOI 10.1016/j.bbrc.2003.08.115; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Lussier MP, 2014, EUR J NEUROSCI, V39, P1148, DOI 10.1111/ejn.12494; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Pahl S, 2014, MEMBRANES, V4, P565, DOI 10.3390/membranes4030565; Palacios-Filardo J, 2016, CEREB CORTEX, V26, P1464, DOI 10.1093/cercor/bhu244; Park J, 2016, NEURON, V92, P75, DOI 10.1016/j.neuron.2016.09.002; Sheng NY, 2015, ELIFE, V4, DOI 10.7554/eLife.11682; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Tang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051433; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vernon CG, 2017, J NEUROSCI, V37, P3352, DOI 10.1523/JNEUROSCI.2978-16.2017; Wyeth MS, 2014, J NEUROSCI, V34, P622, DOI 10.1523/JNEUROSCI.3098-13.2014; Xu J, 2010, BRAIN RES, V1366, P197, DOI 10.1016/j.brainres.2010.09.087; Zhang W, 2014, EUR J NEUROSCI, V39, P1138, DOI 10.1111/ejn.12519; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	29	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15369	15377		10.1074/jbc.M117.787903	http://dx.doi.org/10.1074/jbc.M117.787903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717010	Green Published, hybrid			2022-12-28	WOS:000410809800018
J	Sallon, C; Callebaut, I; Boulay, I; Fontaine, J; Logeart-Avrannoglou, D; Henriquet, C; Pugniere, M; Cayla, X; Monget, P; Harichaux, G; Labas, V; Canepa, S; Taragnat, C				Sallon, Celine; Callebaut, Isabelle; Boulay, Ida; Fontaine, Joel; Logeart-Avrannoglou, Delphine; Henriquet, Corinne; Pugniere, Martine; Cayla, Xavier; Monget, Philippe; Harichaux, Gregoire; Labas, Valerie; Canepa, Syvie; Taragnat, Catherine			Thrombospondin-1 (TSP-1), a new bone morphogenetic protein-2 and-4 ( BMP-2/4) antagonist identified in pituitary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DYNAMIC REGULATION; STATISTICAL-MODEL; ACTIVIN; HORMONE; GROWTH; INVOLVEMENT; SECRETION; FSH; ACTIVATION	Bone morphogenetic proteins (BMPs) regulate diverse cellular responses during embryogenesis and in adulthood including cell differentiation, proliferation, and death in various tissues. In the adult pituitary, BMPs participate in the control of hormone secretion and cell proliferation, suggesting a potential endocrine/paracrine role for BMPs, but some of the mechanisms are unclear. Here, using a bioactivity test based on embryonic cells (C3H10T1/2) transfected with a BMP-responsive element, we sought to determine whether pituitary cells secrete BMPs or BMP antagonists. Interestingly, we found that pituitary-conditioned medium contains a factor that inhibits action of BMP-2 and -4. Combining surface plasmon resonance and high-resolution mass spectrometry helped pinpoint this factor as thrombospondin-1 (TSP-1). Surface plasmon resonance and co-immunoprecipitation confirmed that recombinant human TSP-1 can bind BMP-2 and -4 and antagonize their effects on C3H10T1/2 cells. Moreover, TSP-1 inhibited the action of serum BMPs. We also report that the von Willebrand type C domain of TSP-1 is likely responsible for this BMP-2/4-binding activity, an assertion based on sequence similarity that TSP-1 shares with the von Willebrand type C domain of Crossveinless 2 (CV-2), a BMP antagonist and member of the chordin family. In summary, we identified for the first time TSP-1 as a BMP-2/-4 antagonist and presented a structural basis for the physical interaction between TSP-1 and BMP-4. We propose that TSP-1 could regulate bioavailability of BMPs, either produced locally or reaching the pituitary via blood circulation. In conclusion, our findings provide new insights into the involvement of TSP-1 in the BMP-2/-4 mechanisms of action.	[Sallon, Celine; Boulay, Ida; Fontaine, Joel; Cayla, Xavier; Monget, Philippe; Harichaux, Gregoire; Labas, Valerie; Canepa, Syvie; Taragnat, Catherine] Univ Tours, CNRS,Inst Natl Rech Agr, Inst Francais Cheval & Equitat,UMR85, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Callebaut, Isabelle] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, CNRS, MNHN,IRD,IUC,UMR 7590, F-75005 Paris, France; [Logeart-Avrannoglou, Delphine] Univ Paris Diderot, CNRS, UMR 7052, Sorbonne Paris Cite,B2OA, F-75010 Paris, France; [Henriquet, Corinne; Pugniere, Martine] Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, ICM Inst Reg Canc,IRCM,U1194, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Taragnat, C (corresponding author), INRA, UMR Physiol Reprod & Comportements, F-37380 Nouzilly, France.	catherine.taragnat@inra.fr	PUGNIERE, Martine/AAD-4315-2020; Logeart-Avramoglou, Delphine/N-7390-2017; Pugniere, Martine/T-1355-2017	PUGNIERE, Martine/0000-0002-2049-2909; Logeart-Avramoglou, Delphine/0000-0002-2052-9425; Pugniere, Martine/0000-0002-2049-2909	Institut National de Recherche Agronomique; French "Region Centre"; Ministere de la Recherche et de la Technologie	Institut National de Recherche Agronomique; French "Region Centre"(Region Centre-Val de Loire); Ministere de la Recherche et de la Technologie	This work was supported by Institut National de Recherche Agronomique and the French "Region Centre." The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ph.D. fellowship from the Ministere de la Recherche et de la Technologie.	Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Faure MO, 2005, J ENDOCRINOL, V186, P109, DOI 10.1677/joe.1.05988; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Nudi M, 2005, MOL ENDOCRINOL, V19, P1329, DOI 10.1210/me.2004-0425; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Otsuka F, 2013, ACTA MED OKAYAMA, V67, P75; Otsuka F, 2010, ENDOCR J, V57, P3, DOI 10.1507/endocrj.K09E-310; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Sallon C, 2010, J ENDOCRINOL, V207, P55, DOI 10.1677/JOE-10-0035; Sarkar AJ, 2007, J ENDOCRINOL, V192, P395, DOI 10.1677/joe.1.06925; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song KN, 2010, J BIOL CHEM, V285, P12169, DOI 10.1074/jbc.M109.087197; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Tsukamoto N, 2011, MOL CELL ENDOCRINOL, V332, P163, DOI 10.1016/j.mce.2010.10.008; Vailhe B, 2003, CURR PHARM DESIGN, V9, P583, DOI 10.2174/1381612033391342; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WEISS J, 1992, ENDOCRINOLOGY, V131, P1403, DOI 10.1210/en.131.3.1403; WEISS J, 1995, ENDOCRINOLOGY, V136, P1885, DOI 10.1210/en.136.5.1885; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Ye L, 2016, CANCER LETT, V380, P586, DOI 10.1016/j.canlet.2015.10.036; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young JM, 2008, J ENDOCRINOL, V196, P251, DOI 10.1677/JOE-07-0148; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	56	5	5	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15352	15368		10.1074/jbc.M116.736207	http://dx.doi.org/10.1074/jbc.M116.736207			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747434	Green Published, hybrid			2022-12-28	WOS:000410809800017
J	Lobo, GP; Fulmer, D; Guo, LL; Zuo, XF; Dang, YJ; Kim, SH; Su, YH; George, K; Obert, E; Ben Fogelgren; Nihalani, D; Norris, RA; Rohrer, B; Lipschutz, JH				Lobo, Glenn P.; Fulmer, Diana; Guo, Lilong; Zuo, Xiaofeng; Dang, Yujing; Kim, Seok-Hyung; Su, Yanhui; George, Kola; Obert, Elisabeth; Ben Fogelgren; Nihalani, Deepak; Norris, Russell A.; Rohrer, Barbel; Lipschutz, Joshua H.			The exocyst is required for photoreceptor ciliogenesis and retinal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY CILIA; ZEBRAFISH; RHODOPSIN; TRANSPORT; PROTEINS; GOLGI; CDC42; RAB8; DEGENERATION; CILIOPATHY	We previously have shown that the highly conserved eightprotein exocyst trafficking complex is required for ciliogenesis in kidney tubule cells. We hypothesized here that ciliogenic programs are conserved across organs and species. To determine whether renal primary ciliogenic programs are conserved in the eye, and to characterize the function and mechanisms by which the exocyst regulates eye development in zebrafish, we focused on exoc5, a central component of the exocyst complex, by analyzing both exoc5 zebrafish mutants, and photoreceptorspecific Exoc5 knock-out mice. Two separate exoc5 mutant zebrafish lines phenocopied exoc5 morphants and, strikingly, exhibited a virtual absence of photoreceptors, along with abnormal retinal development and cell death. Because the zebrafish mutant was a global knockout, we also observed defects in several ciliated organs, including the brain (hydrocephalus), heart (cardiac edema), and kidney (disordered and shorter cilia). exoc5 knockout increased phosphorylation of the regulatory protein Mob1, consistent with Hippo pathway activation. exoc5 mutant zebrafish rescue with human EXOC5 mRNA completely reversed the mutant phenotype. We accomplished photoreceptor-specific knockout of Exoc5 with our Exoc5 fl/fl mouse line crossed with a rhodopsin-Cre driver line. In Exoc5 photoreceptor-specific knock-out mice, the photoreceptor outer segment structure was severely impaired at 4 weeks of age, although a full-field electroretinogram indicated a visual response was still present. However, by 6 weeks, visual responses were eliminated. In summary, we show that ciliogenesis programs are conserved in the kidneys and eyes of zebrafish and mice and that the exocyst is necessary for photoreceptor ciliogenesis and retinal development, most likely by trafficking cilia and outer-segment proteins.	[Lobo, Glenn P.; Fulmer, Diana; Guo, Lilong; Zuo, Xiaofeng; Dang, Yujing; Kim, Seok-Hyung; Su, Yanhui; George, Kola; Nihalani, Deepak; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Lobo, Glenn P.; Obert, Elisabeth; Rohrer, Barbel] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Fulmer, Diana; Guo, Lilong; Norris, Russell A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Ben Fogelgren] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96813 USA; [Rohrer, Barbel] Ralph H Johnson Vet Affairs Med Ctr, Div Res, Charleston, SC 29401 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	lipschut@musc.edu	nihalani, deepak/AAK-9453-2020; Guo, Lilong/AAJ-8492-2021; GUO, LILONG/AAH-7104-2019; Lobo, Glenn P./AAI-9736-2020	Guo, Lilong/0000-0001-9376-3274; Fulmer, Diana/0000-0001-7675-9951	National Institutes of Health [P30DK074038]; NATIONAL EYE INSTITUTE [R21EY025034, R01EY024581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131546, R01HL127692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444, P20GM103457] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444, I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The UAB P30 Hepatorenal Fibrocystic Disease Core Center (supported by National Institutes of Health Grant P30DK074038) is gratefully acknowledged for generating the second exoc5 zebrafish mutant line using CRISPR gene editing, as well as for previously generating the Exoc5fl/fl mouse line.	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Baye LM, 2011, HUM MOL GENET, V20, P1467, DOI 10.1093/hmg/ddr025; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; DERETIC D, 1993, J CELL SCI, V106, P803; DERETIC D, 1995, J CELL SCI, V108, P215; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Fruhmesser A, 2013, EUR J HUM GENET, V21, P1177, DOI 10.1038/ejhg.2013.18; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Luna G, 2016, INVEST OPHTH VIS SCI, V57, P4641, DOI 10.1167/iovs.15-19044; Luo N, 2012, VISION RES, V75, P98, DOI 10.1016/j.visres.2012.09.011; Meire F, 2011, MOL VIS, V17, P2072; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Smyth BJ, 2003, INT REV CYTOL, V231, P51, DOI 10.1016/S0074-7696(03)31002-2; Stoetzel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13586; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Tsujikawa M, 2004, INT J DEV BIOL, V48, P925, DOI 10.1387/ijdb.041890mt; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	45	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14814	14826		10.1074/jbc.M117.795674	http://dx.doi.org/10.1074/jbc.M117.795674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729419	Green Published, hybrid			2022-12-28	WOS:000409902100010
J	Bakou, M; Hille, K; Kracklauer, M; Spanopoulou, A; Frost, CV; Malideli, E; Yan, LM; Caporale, A; Zacharias, M; Kapurniotu, A				Bakou, Maria; Hille, Kathleen; Kracklauer, Michael; Spanopoulou, Anna; Frost, Christina V.; Malideli, Eleni; Yan, Li-Mei; Caporale, Andrea; Zacharias, Martin; Kapurniotu, Aphrodite			Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MOLECULAR-DYNAMICS SIMULATIONS; A-BETA; CIRCULAR-DICHROISM; POLYPEPTIDE IAPP; ALZHEIMERS-DISEASE; FIBRIL FORMATION; AROMATIC INTERACTIONS; IN-VIVO; AMYLIN	The interaction of the intrinsically disordered polypeptide islet amyloid polypeptide (IAPP), which is associated with type 2 diabetes (T2D), with the Alzheimer's disease amyloid-beta (A beta) peptide modulates their self-assembly into amyloid fibrils and may link the pathogeneses of these two cell-degenerative diseases. However, the molecular determinants of this interaction remain elusive. Using a systematic alanine scan approach, fluorescence spectroscopy, and other biophysical methods, including heterocomplex pulldown assays, far-UV CD spectroscopy, the thioflavin T binding assay, transmission EM, and molecular dynamics simulations, here we identified single aromatic/hydrophobic residues within the amyloid core IAPP region as hot spots or key residues of its cross-interaction with A beta 40(42) peptide. Importantly, we also find that none of these residues in isolation plays a key role in IAPP self-assembly, whereas simultaneous substitution of four aromatic/hydrophobic residues with Ala dramatically impairs both IAPP self-assembly and hetero-assembly with A beta 40(42). Furthermore, our experiments yielded several novel IAPP analogs, whose sequences are highly similar to that of IAPP but have distinct amyloid self-or crossinteraction potentials. The identified similarities and major differences controlling IAPP cross-peptide interaction with A beta 40(42) versus its amyloid self-assembly offer a molecular basis for understanding the underlying mechanisms. We propose that these insights will aid in designing intervention strategies and novel IAPP analogs for the management of type 2 diabetes, Alzheimer's disease, or other diseases related to IAPP dysfunction or cross-amyloid interactions.	[Bakou, Maria; Hille, Kathleen; Kracklauer, Michael; Spanopoulou, Anna; Malideli, Eleni; Yan, Li-Mei; Caporale, Andrea; Kapurniotu, Aphrodite] Tech Univ Munich, Div Peptide Biochem, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany; [Frost, Christina V.; Zacharias, Martin] Tech Univ Munich, Phys Dept, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich	Kapurniotu, A (corresponding author), Tech Univ Munich, Div Peptide Biochem, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany.	akapurniotu@wzw.tum.de	Caporale, Andrea/ABA-8445-2021		Deutsche Forschungsgemeinschaft [SFB 1035 B06, B02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 1035 B06 (to A. K.) and B02 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Adler BL, 2014, NEUROBIOL AGING, V35, P793, DOI 10.1016/j.neurobiolaging.2013.10.076; Andreetto E, 2015, ANGEW CHEM INT EDIT, V54, P13095, DOI 10.1002/anie.201504973; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Baram M, 2016, PHYS CHEM CHEM PHYS, V18, P2330, DOI 10.1039/c5cp03338a; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berhanu WM, 2013, ACS CHEM NEUROSCI, V4, P1488, DOI 10.1021/cn400141x; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Case DA, 2014, AMBER 14; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Espinoza-Fonseca LM, 2012, MOL BIOSYST, V8, P237, DOI 10.1039/c1mb05239j; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fox A, 2010, BIOCHEMISTRY-US, V49, P7783, DOI 10.1021/bi100337p; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Horvath I, 2016, P NATL ACAD SCI USA, V113, P12473, DOI 10.1073/pnas.1610371113; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson K, 2013, ANN NEUROL, V74, P517, DOI 10.1002/ana.23956; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kapurniotu A, 2003, CHEM BIOL, V10, P149, DOI 10.1016/S1074-5521(03)00022-X; Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kazantzis A, 2002, EUR J BIOCHEM, V269, P780, DOI 10.1046/j.0014-2956.2001.02689.x; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Lutz TA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00216; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2; Mirecka EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33474; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schwierz N, 2016, J AM CHEM SOC, V138, P527, DOI 10.1021/jacs.5b08717; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Tatarek-Nossol M, 2005, CHEM BIOL, V12, P797, DOI 10.1016/j.chembiol.2005.05.010; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tu LH, 2013, BIOCHEMISTRY-US, V52, P333, DOI 10.1021/bi3014278; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Weirich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161243; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wineman-Fisher V, 2015, BIOMACROMOLECULES, V16, P156, DOI 10.1021/bm501326y; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yan LM, 2014, CURR PHARM DESIGN, V20, P1182, DOI 10.2174/13816128113199990064; Yan LM, 2013, ANGEW CHEM INT EDIT, V52, P10378, DOI 10.1002/anie.201302840; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Young LM, 2015, ANALYST, V14, P6990, DOI 10.1039/c5an00865d	63	36	37	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14587	14602		10.1074/jbc.M117.774893	http://dx.doi.org/10.1074/jbc.M117.774893			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684415	hybrid, Green Published			2022-12-28	WOS:000408747500024
J	Ewing, TA; Nguyen, QT; Allan, RC; Gygli, G; Romero, E; Binda, C; Fraaije, MW; Mattevi, A; van Berkel, WJH				Ewing, Tom A.; Quoc-Thai Nguyen; Allan, Robert C.; Gygli, Gudrun; Romero, Elvira; Binda, Claudia; Fraaije, Marco W.; Mattevi, Andrea; van Berkel, Willem J. H.			Two tyrosine residues, Tyr-108 and Tyr-503, are responsible for the deprotonation of phenolic substrates in vanillyl-alcohol oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-CRESOL METHYLHYDROXYLASE; CATALYTIC MECHANISM; ACID DECARBOXYLASE; ACTIVE-SITE; PENICILLIUM-SIMPLICISSIMUM; MOLECULAR-GRAPHICS; DATA QUALITY; OXIDOREDUCTASE; SPECIFICITY; BINDING	A number of oxidoreductases from the VAO/para-cresol methylhydroxylase flavoprotein family catalyze the oxidation of para-substituted phenols. One of the best-studied is vanillyl-alcohol oxidase (VAO) from the fungus Penicillium simplicissimum. For oxidation of phenols by VAO to occur, they must first be bound in the active site of the enzyme in their phenolate anion form. The crystal structure of VAO reveals that two tyrosine residues, Tyr-108 and Tyr-503, are positioned to facilitate this deprotonation. To investigate their role in catalysis, we created three VAO variants, Y108F, Y503F, and Y108F/Y503F, and studied their biochemical properties. Steady-state kinetics indicated that the presence of at least one of the tyrosine residues is essential for efficient catalysis by VAO. Stopped-flow kinetics revealed that the reduction of VAO by chavicol or vanillyl alcohol occurs at two different rates: k(obs1), which corresponds to its reaction with the deprotonated form of the substrate, and k(obs2), which corresponds to its reaction with the protonated form of the substrate. In Y108F, Y503F, and Y108F/Y503F, the relative contribution of k(obs2) to the reduction is larger than in wild-type VAO, suggesting deprotonation is impaired in these variants. Binding studies disclosed that the competitive inhibitor isoeugenol is predominantly in its deprotonated form when bound to wild-type VAO, but predominantly in its protonated form when bound to the variants. These results indicate that Tyr-108 and Tyr-503 are responsible for the activation of substrates in VAO, providing new insights into the catalytic mechanism of VAO and related enzymes that oxidize para-substituted phenols.	[Ewing, Tom A.; Allan, Robert C.; Gygli, Gudrun; van Berkel, Willem J. H.] Wageningen Univ & Res, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Quoc-Thai Nguyen; Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, Via Ferrata 9, I-27100 Pavia, Italy; [Quoc-Thai Nguyen; Romero, Elvira; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; [Quoc-Thai Nguyen] Univ Med & Pharm, Fac Pharm, Ben Nghe Ward, 41 Dinh Tien Hoang St,Dist 1, Ho Chi Minh City, Vietnam	Wageningen University & Research; University of Pavia; University of Groningen; Hochiminh City University of Medicine & Pharmacy	van Berkel, WJH (corresponding author), Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	willem.vanberkel@wur.nl	Mattevi, Andrea/R-4469-2019; van Berkel, Willem J.H./O-2431-2014; mattevi, andrea/K-5464-2012; Gygli, Gudrun/W-9217-2019; Romero, Elvira/AAA-3555-2020	Mattevi, Andrea/0000-0002-9523-7128; van Berkel, Willem J.H./0000-0002-6551-2782; mattevi, andrea/0000-0002-9523-7128; Gygli, Gudrun/0000-0001-9119-1778; Ewing, Tom/0000-0002-6944-887X; Romero, Elvira/0000-0003-4199-9458; Fraaije, Marco/0000-0001-6346-5014; Nguyen, Quoc-Thai/0000-0001-6315-2974	European Community [7551, 10205]	European Community(European Commission)	We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for providing beam time and assistance and the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grants 7551 and 10205) for funding synchrotron trips.	Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bennett JP, 2008, BIOCHEM J, V414, P281, DOI 10.1042/BJ20080714; Brady SF, 2002, J AM CHEM SOC, V124, P9968, DOI 10.1021/ja0268985; Brandt K, 2001, APPL MICROBIOL BIOT, V56, P724, DOI 10.1007/s002530100698; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; Efimov I, 2004, BIOCHEMISTRY-US, V43, P6138, DOI 10.1021/bi035772x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P16620, DOI 10.1021/bi991273d; Ewing TA, 2016, FEBS J, V283, P2546, DOI 10.1111/febs.13762; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Fraaije MW, 1998, EUR J BIOCHEM, V253, P712, DOI 10.1046/j.1432-1327.1998.2530712.x; FRAAIJE MW, 1995, EUR J BIOCHEM, V234, P271, DOI 10.1111/j.1432-1033.1995.271_c.x; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Frank A, 2012, CATAL SCI TECHNOL, V2, P1568, DOI 10.1039/c2cy20015e; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Liu YC, 2011, NAT CHEM BIOL, V7, P304, DOI 10.1038/nchembio.556; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J BIOL CHEM, V286, P23533, DOI 10.1074/jbc.M111.247833; Nguyen QT, 2016, CHEMBIOCHEM, V17, P1359, DOI 10.1002/cbic.201600148; Rachid S, 2010, J BIOL CHEM, V285, P12482, DOI 10.1074/jbc.M109.079707; Rodriguez H, 2010, PROTEINS, V78, P1662, DOI 10.1002/prot.22684; Sheng X, 2015, FEBS J, V282, P4703, DOI 10.1111/febs.13525; Ullmann GM, 2013, BIOL CHEM, V394, P611, DOI 10.1515/hsz-2012-0329; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; van den Heuvel RHH, 1998, J BACTERIOL, V180, P5646, DOI 10.1128/JB.180.21.5646-5651.1998; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	8	8	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14668	14679		10.1074/jbc.M117.778449	http://dx.doi.org/10.1074/jbc.M117.778449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28717004	Green Published, hybrid			2022-12-28	WOS:000408747500031
J	Qasem-Abdullah, H; Perach, M; Livnat-Levanon, N; Lewinson, O				Qasem-Abdullah, Hiba; Perach, Michal; Livnat-Levanon, Nurit; Lewinson, Oded			ATP binding and hydrolysis disrupt the high-affinity interaction between the heme ABC transporter HmuUV and its cognate substrate-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRACIS VIRULENCE DETERMINANT; ESCHERICHIA-COLI; MALTOSE TRANSPORT; BTUCD-F; CASSETTE TRANSPORTER; YERSINIA-PESTIS; MULTIDRUG-RESISTANCE; HISTIDINE PERMEASE; CRYSTAL-STRUCTURES; MECHANISM	Using the energy of ATP hydrolysis, ABC transporters catalyze the trans-membrane transport of molecules. In bacteria, these transporters partner with a high-affinity substrate-binding protein (SBP) to import essential micronutrients. ATP-binding by Type I ABC transporters (importers of amino acids, sugars, peptides, and small ions) stabilizes the interaction between the transporter and the SBP, thus allowing transfer of the substrate from the latter to the former. In Type II ABC transporters (importers of trace elements, e.g. vitamin B12, heme, and iron-siderophores) the role of ATP remains debatable. Here we studied the interaction between the Yersinia pestis ABC heme importer (HmuUV) and its partner substrate-binding protein (HmuT). Using real-time surface plasmon resonance experiments and interaction studies in membrane vesicles, we find that in the absence of ATP the transporter and the SBP tightly bind. Substrate in excess inhibits this interaction, and ATP binding by the transporter completely abolishes it. To release the stable docked SBP from the transporter hydrolysis of ATP is required. Based on these results we propose a mechanism for heme acquisition by HmuUV-T where the substrate-loaded SBP docks to the nucleotide-free outward-facing conformation of the transporter. ATP binding leads to formation of an occluded state with the substrate trapped in the trans-membrane translocation cavity. Subsequent ATP hydrolysis leads to substrate delivery to the cytoplasm, release of the SBP, and resetting of the system. We propose that other Type II ABC transporters likely share the fundamentals of this mechanism.	[Qasem-Abdullah, Hiba; Perach, Michal; Livnat-Levanon, Nurit; Lewinson, Oded] Technion Israel Inst Technol, Bruce & Ruth Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Lewinson, O (corresponding author), Technion Israel Inst Technol, Bruce & Ruth Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel.	lewinson@tx.technion.ac.il			Rappaport Family Institute for biomedical research; Merieux research foundation; NATO Science for Peace Grant [SPS-984622]	Rappaport Family Institute for biomedical research; Merieux research foundation; NATO Science for Peace Grant	This work was supported in part by grants from the Rappaport Family Institute for biomedical research (to O. L.), the Merieux research foundation (to O. L.), and NATO Science for Peace Grant SPS-984622 (to O. L.). The authors declare that they have no conflicts of interest with the contents of this article.	AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bulut H, 2012, J MOL BIOL, V415, P560, DOI 10.1016/j.jmb.2011.11.030; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Haber A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006161; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jones PM, 2005, INT J PARASITOL, V35, P555, DOI 10.1016/j.ijpara.2005.01.012; Joseph B, 2014, J BIOL CHEM, V289, P3176, DOI 10.1074/jbc.M113.512178; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; KERPPOLA RE, 1991, J BIOL CHEM, V266, P9857; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Levanon NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51937; Lewinson O, 2017, J MOL BIOL, V429, P606, DOI 10.1016/j.jmb.2017.01.010; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Livnat-Levanon N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21696; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Naoe Y, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms13411; Nguyen PT, 2015, BIOL CHEM, V396, P1127, DOI 10.1515/hsz-2015-0131; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; Vigonsky E, 2015, METALLOMICS, V7, P1407, DOI [10.1039/c5mt00100e, 10.1039/C5MT00100E]; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Wuttge S, 2012, MOL MICROBIOL, V86, P908, DOI 10.1111/mmi.12025	60	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14617	14624		10.1074/jbc.M117.779975	http://dx.doi.org/10.1074/jbc.M117.779975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710276	Green Published, hybrid			2022-12-28	WOS:000408747500026
J	Field, SJ				Field, Seth J.			Spelunking for lipids in caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SCAFFOLDING REGION; MEMBRANE-BINDING; PHOSPHATIDYLSERINE	Phosphatidylserine (PtdSer) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) have been implicated in the maintenance of caveolae, but direct evidence that these lipids are required for normal caveolar structure and dynamics in living cells has been lacking. A new study by Fairn and colleagues uses sophisticated tools to perturb specific lipids in living cells to assess the consequences for caveolae. This study demonstrates disparate roles for these lipids in the stability and mobility of caveolae and points the way for future work to understand how these lipids contribute to the biology of caveolae.	[Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Field, SJ (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	sjfield@ucsd.edu		Field, Seth/0000-0002-8893-4806	National Institutes of Health [R01 CA201303, R01 GM120055]; Scholar-Innovator Award from the Harrington Discovery Institute; Career Award in Biomedical Science from the Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA201303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scholar-Innovator Award from the Harrington Discovery Institute; Career Award in Biomedical Science from the Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants R01 CA201303 and R01 GM120055, a Scholar-Innovator Award from the Harrington Discovery Institute, and a Career Award in Biomedical Science from the Burroughs Wellcome Fund. To whom correspondence should be addressed. E-mail: sjfield@ucsd.edu.	Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Busija AR, 2017, AM J PHYSIOL-CELL PH, V312, pC459, DOI 10.1152/ajpcell.00355.2016; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hirama T, 2017, J BIOL CHEM, V292, P14292, DOI 10.1074/jbc.M117.791400; Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	10	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14308	14309		10.1074/jbc.H117.791400	http://dx.doi.org/10.1074/jbc.H117.791400			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28842476	Green Published, hybrid			2022-12-28	WOS:000408439800035
J	Kolimi, N; Ajjugal, Y; Rathinavelan, T				Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi			A B-Z junction induced by an A ... A mismatch in GAC repeats in the gene for cartilage oligomeric matrix protein promotes binding with the hZ(ADAR1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD; molecular dynamics; NMR; RNA editing; trinucleotide repeat disease; cartilage oligomeric matrix protein; human adar1 protein; pseudoachdroplasia	Z-ALPHA DOMAIN; HANDED Z-DNA; MULTIPLE EPIPHYSEAL DYSPLASIA; BASE TRIPLET NONISOMORPHISM; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; NONCODING RNAS; EDITING ENZYME; Z TRANSITION; PSEUDOACHONDROPLASIA	GAC repeat expansion from five to seven in the exonic region of the gene for cartilage oligomeric matrix protein (COMP) leads to pseudoachondroplasia, a skeletal abnormality. However, the molecular mechanism by which GAC expansions in the COMP gene lead to skeletal dysplasias is poorly understood. Here we used molecular dynamics simulations, which indicate that an A ... A mismatch in a d(GAC)(6)<bold>d</bold>(GAC)(6) duplex induces negative supercoiling, leading to a local B-to-Z DNA transition. This transition facilitates the binding of d(GAC)(7)<bold>d</bold>(GAC)(7) with the Z-binding domain of human adenosine deaminase acting on RNA 1 (ADAR1, hZ(ADAR1)), as confirmed by CD, NMR, and microscale thermophoresis studies. The CD results indicated that hZ(ADAR1) recognizes the zigzag backbone of d(GAC)(7)<bold>d</bold>(GAC)(7) at the B-Z junction and subsequently converts it into Z-DNA via the so-called passive mechanism. Molecular dynamics simulations carried out for the modeled hZ(ADAR1)-d(GAC)(6).d(GAC)(6) complex confirmed the retention of previously reported important interactions between the two molecules. These findings suggest that hZ(ADAR1) binding with the GAC hairpin stem in COMP can lead to a non-genetic, RNA editing-mediated substitution in COMP that may then play a crucial role in the development of pseudoachondroplasia.	[Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi] Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Rathinavelan, T (corresponding author), Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India.	tr@iith.ac.in			Department of Biotechnology, Government of India IYBA [BT/06/IYBA/2012]; Department of Biotechnology, Government of India BIO-CaRE [102/IFD/SAN/1811/2013-2014]; Department of Biotechnology, Government of India RD [102/IFD/SAN/3426/2013-2014]; Indian Institute of Technology Hyderabad; Ministry of Human Resources Development, Government of India	Department of Biotechnology, Government of India IYBA; Department of Biotechnology, Government of India BIO-CaRE; Department of Biotechnology, Government of India RD; Indian Institute of Technology Hyderabad; Ministry of Human Resources Development, Government of India	This work was supported by the Department of Biotechnology, Government of India IYBA-2012 (D.O. No. BT/06/IYBA/2012), BIO-CaRE (SAN. No. 102/IFD/SAN/1811/2013-2014), and R&D (SAN. No. 102/IFD/SAN/3426/2013-2014) and the Indian Institute of Technology Hyderabad (to T. R.). The Ministry of Human Resources Development, Government of India provided fellowships to N. K. and Y. A. The authors declare that they have no conflicts of interest with the contents of this article.	Ananth P, 2013, RNA, V19, P1038, DOI 10.1261/rna.036905.112; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Berger I, 1998, BIOCHEMISTRY-US, V37, P13313, DOI 10.1021/bi9813126; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Case DA, 2012, AMBER 12; Dans PD, 2014, NUCLEIC ACIDS RES, V42, P11304, DOI 10.1093/nar/gku809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Goldsmith G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155090; Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; Jeong M, 2014, ARCH BIOCHEM BIOPHYS, V558, P95, DOI 10.1016/j.abb.2014.06.026; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kang YM, 2009, J AM CHEM SOC, V131, P11485, DOI 10.1021/ja902654u; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; Khan N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004162; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189; Kim D, 2009, NUCLEIC ACIDS RES, V37, P4353, DOI 10.1093/nar/gkp364; Kimura T, 2004, J ORG CHEM, V69, P1169, DOI 10.1021/jo035194q; Krepl M, 2012, J CHEM THEORY COMPUT, V8, P2506, DOI 10.1021/ct300275s; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MEIER JC, 2016, FRONT MOL NEUROSCI, V9; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Mochmann LH, 2004, NUCLEIC ACIDS RES, V32, P4469, DOI 10.1093/nar/gkh787; Moradi M, 2013, NUCLEIC ACIDS RES, V41, P33, DOI 10.1093/nar/gks1003; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; NORDHEIM A, 1982, CELL, V31, P309, DOI 10.1016/0092-8674(82)90124-6; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Patro LPP, 2017, J MOL BIOL, V429, P2438, DOI 10.1016/j.jmb.2017.06.013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3; Rathinavelan T, 2006, BIOPOLYMERS, V82, P443, DOI [10.1002/bip.20484, 10.1002/BIP.20484]; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Rathinavelan T, 2011, J BIOL CHEM, V286, P4922, DOI 10.1074/jbc.M110.159434; Schade M, 1999, P NATL ACAD SCI USA, V96, P12465, DOI 10.1073/pnas.96.22.12465; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Singh Minati, 2013, Frontiers in Genetics, V3, P326, DOI 10.3389/fgene.2012.00326; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Susic S, 1998, HUM MUTAT, pS125; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Thenmalarchelvi R, 2005, NUCLEIC ACIDS RES, V33, P43, DOI 10.1093/nar/gki143; Tufan AC, 2007, EUR J HUM GENET, V15, P1023, DOI 10.1038/sj.ejhg.5201882; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vorlickova M, 2001, EUR BIOPHYS J BIOPHY, V30, P179, DOI 10.1007/s002490000121; Vorlickova M, 1999, NUCLEIC ACIDS RES, V27, P581, DOI 10.1093/nar/27.2.581; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627	57	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18732	18746		10.1074/jbc.M117.796235	http://dx.doi.org/10.1074/jbc.M117.796235			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924040	hybrid, Green Published			2022-12-28	WOS:000415848000001
J	Gaspar, ML; Chang, YF; Jesch, SA; Aregullin, M; Henry, SA				Gaspar, Maria L.; Chang, Yu-Fang; Jesch, Stephen A.; Aregullin, Manuel; Henry, Susan A.			Interaction between repressor Opi1p and ER membrane protein Scs2p facilitates transit of phosphatidic acid from the ER to mitochondria and is essential for INO1 gene expression in the presence of choline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; choline; lipid droplet; phosphatidic acid; triacylglycerol; inositol	YEAST SACCHAROMYCES-CEREVISIAE; STORAGE LIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID BIOSYNTHESIS; INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHATIDYLCHOLINE SYNTHESIS; CARDIOLIPIN BIOSYNTHESIS; BINDING PROTEINS; CONTACT SITES; METABOLISM	In the yeast Saccharomyces cerevisiae, the Opi1p repressor controls the expression of INO1 via the Opi1p/Ino2p-Ino4p regulatory circuit. Inositol depletion favors Opi1p interaction with both Scs2p and phosphatidic acid at the endoplasmic reticulum (ER) membrane. Inositol supplementation, however, favors the translocation of Opi1p from the ER into the nucleus, where it interacts with the Ino2p-Ino4p complex, attenuating transcription of INO1. A strain devoid of Scs2p (scs2) and a mutant, OPI1FFAT, lacking the ability to interact with Scs2p were utilized to examine the specific role(s) of the Opi1p-Scs2p interaction in the regulation of INO1 expression and overall lipid metabolism. Loss of the Opi1p-Scs2p interaction reduced INO1 expression and conferred inositol auxotrophy. Moreover, inositol depletion in strains lacking this interaction resulted in Opi1p being localized to sites of lipid droplet formation, coincident with increased synthesis of triacylglycerol. Supplementation of choline to inositol-depleted growth medium led to decreased TAG synthesis in all three strains. However, in strains lacking the Opi1p-Scs2p interaction, Opi1p remained in the nucleus, preventing expression of INO1. These data support the conclusion that a specific pool of phosphatidic acid, associated with lipid droplet formation in the perinuclear ER, is responsible for the initial rapid exit of Opi1p from the nucleus to the ER and is required for INO1 expression in the presence of choline. Moreover, the mitochondria-specific phospholipid, cardiolipin, was significantly reduced in both strains compromised for Opi1p-Scs2p interaction, indicating that this interaction is required for the transfer of phosphatidic acid from the ER to the mitochondria for cardiolipin synthesis.	[Gaspar, Maria L.; Chang, Yu-Fang; Jesch, Stephen A.; Aregullin, Manuel; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA; [Chang, Yu-Fang] Harvard Med Sch, Dept Syst Biol, Warren Alpert Bldg 412,200 Longwood Ave, Boston, MA 02115 USA	Cornell University; Harvard University; Harvard Medical School	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu			National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-19629 (to S. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Brachmann CB, 1998, YEAST, V14, P115; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chao JT, 2014, CELL, V158, P620, DOI 10.1016/j.cell.2014.06.033; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; CULBERTSON MR, 1975, GENETICS, V80, P23; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Di Bartolomeo F, 2017, BBA-MOL CELL BIOL L, V1862, P25, DOI 10.1016/j.bbalip.2016.09.007; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GREENBERG ML, 1982, GENETICS, V100, P19; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Han S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0075-3; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SAa H., 2005, CELL BIOL DYNAMICS Y, P105; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kannan M, 2015, TRAFFIC, V16, P123, DOI 10.1111/tra.12236; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luevano-Martinez LA, 2013, FUNGAL GENET BIOL, V60, P150, DOI 10.1016/j.fgb.2013.03.005; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; WEISS SB, 1958, J BIOL CHEM, V231, P53; Wilson JD, 2011, MOL BIOL CELL, V22, P1430, DOI 10.1091/mbc.E10-07-0559; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	72	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18713	18728		10.1074/jbc.M117.809970	http://dx.doi.org/10.1074/jbc.M117.809970			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924045	Green Published, hybrid			2022-12-28	WOS:000414958100027
J	Inoshita, M; Mima, J				Inoshita, Motoki; Mima, Joji			Human Rab small GTPase- and class V myosin-mediated membrane tethering in a chemically defined reconstitution system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liposome; membrane reconstitution; membrane trafficking; myosin; Rab; small GTPase; Myo5; membrane tethering	SNARE PROTEINS; FUSION; SPECIFICITY; VESICLE; TRANSPORT; CARGO; LOCALIZATION; SUPERFAMILY; MOLECULES; MECHANISM	Membrane tethering is a fundamental process essential for the compartmental specificity of intracellular membrane trafficking in eukaryotic cells. Rab-family small GTPases and specific sets of Rab-interacting effector proteins, including coiled-coil tethering proteins and multisubunit tethering complexes, are reported to be responsible for membrane tethering. However, whether and how these key components directly and specifically tether subcellular membranes remains enigmatic. Using chemically defined proteoliposomal systems reconstituted with purified human Rab proteins and synthetic liposomal membranes to study the molecular basis of membrane tethering, we established here that Rab-family GTPases have a highly conserved function to directly mediate membrane tethering, even in the absence of any types of Rab effectors such as the so-called tethering proteins. Moreover, we demonstrate that membrane tethering mediated by endosomal Rab11a is drastically and selectively stimulated by its cognate Rab effectors, class V myosins (Myo5A and Myo5B), in a GTP-dependent manner. Of note, Myo5A and Myo5B exclusively recognized and cooperated with the membrane-anchored form of their cognate Rab11a to support membrane tethering mediated by trans-Rab assemblies on opposing membranes. Our findings support the novel concept that Rab-family proteins provide a bona fide membrane tether to physically and specifically link two distinct lipid bilayers of subcellular membranes. They further indicate that Rab-interacting effector proteins, including class V myosins, can regulate these Rab-mediated membrane-tethering reactions.	[Inoshita, Motoki; Mima, Joji] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Mima, J (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	joji.mima@protein.osaka-u.ac.jp		Mima, Joji/0000-0002-0454-8669	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) and by grants-in-aid for scientific research from MEXT (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunet S, 2014, TRAFFIC, V15, P1282, DOI 10.1111/tra.12200; Cabrera M, 2013, J BIOL CHEM, V288, P28704, DOI 10.1074/jbc.M113.488213; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Donovan KW, 2012, DEV CELL, V23, P769, DOI 10.1016/j.devcel.2012.09.001; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Furukawa N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04277; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Ho RY, 2016, TRAFFIC, V17, P1078, DOI 10.1111/tra.12421; Ho RY, 2015, MOL BIOL CELL, V26, P2655, DOI 10.1091/mbc.E14-04-0922; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Kuhlee A, 2015, FEBS LETT, V589, P2487, DOI 10.1016/j.febslet.2015.06.001; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lindsay AJ, 2013, MOL BIOL CELL, V24, P3420, DOI 10.1091/mbc.E13-05-0236; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; OHKI S, 1982, BIOCHEMISTRY-US, V21, P2127, DOI 10.1021/bi00538a022; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/elife.17523, 10.7554/eLife.17523]; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Stein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034870; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sugiura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20407; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tamura N, 2014, BIOL OPEN, V3, P1108, DOI 10.1242/bio.20149340; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	53	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18500	18517		10.1074/jbc.M117.811356	http://dx.doi.org/10.1074/jbc.M117.811356			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939769	Green Published, hybrid			2022-12-28	WOS:000414958100010
J	Bessa, LM; Launay, H; Dujardin, M; Cantrelle, FX; Lippens, G; Landrieu, I; Schneider, R; Hanoulle, X				Bessa, Luiza M.; Launay, Helene; Dujardin, Marie; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle; Schneider, Robert; Hanoulle, Xavier			NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; nuclear magnetic resonance (NMR); protein dynamic; protein-protein interaction; RNA-protein interaction	MOLECULAR-WEIGHT PROTEINS; RELAXATION DISPERSION EXPERIMENTS; CRYSTAL-STRUCTURE; NONNUCLEOSIDE INHIBITORS; NONSTRUCTURAL PROTEIN; REPLICATION COMPARTMENT; VIRAL REPLICATION; STRUCTURAL BASIS; FUZZY COMPLEXES; METHYL-TROSY	Non-structural protein 5B (NS5B) is the RNA-dependent RNA polymerase that catalyzes replication of the hepatitis C virus (HCV) RNA genome and therefore is central for its life cycle. NS5B interacts with the intrinsically disordered domain 2 of NS5A (NS5A-D2), another essential multifunctional HCV protein that is required for RNA replication. As a result, these two proteins represent important targets for anti-HCV chemotherapies. Despite this importance and the existence of NS5B crystal structures, our understanding of the conformational and dynamic behavior of NS5B in solution and its relationship with NS5A-D2 remains incomplete. To address these points, we report the first detailed NMR spectroscopic study of HCV NS5B lacking its membrane anchor (NS5B(21)). Analysis of constructs with selective isotope labeling of the 1 methyl groups of isoleucine side chains demonstrates that, in solution, NS5B(21) is highly dynamic but predominantly adopts a closed conformation. The addition of NS5A-D2 leads to spectral changes indicative of binding to both allosteric thumb sites I and II of NS5B(21) and induces long-range perturbations that affect the RNA-binding properties of the polymerase. We compared these modifications with the short- and long-range effects triggered in NS5B(21) upon binding of filibuvir, an allosteric inhibitor. We demonstrate that filibuvir-bound NS5B(21) is strongly impaired in the binding of both NS5A-D2 and RNA. NS5A-D2 induces conformational and functional perturbations in NS5B similar to those triggered by filibuvir. Thus, our work highlights NS5A-D2 as an allosteric regulator of the HCV polymerase and provides new insight into the dynamics of NS5B in solution.	[Bessa, Luiza M.; Launay, Helene; Dujardin, Marie; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle; Schneider, Robert; Hanoulle, Xavier] Univ Lille, CNRS, UMR 8576, UGSF,Unite Glycobiol Struct & Fonct, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France; [Launay, Helene] Univ Aix Marseille, CNRS, UMR 7258, INSERM,U1068,Inst Pauli Calmettes,CRCM, F-13273 Marseille, France; [Dujardin, Marie] Univ Lyon, CNRS, UMR 5086, MMSB, F-69367 Lyon, France; [Lippens, Guy] Univ Toulouse, INSA, CNRS, Lab Ingn Syst Biol & Procedes,INRA, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Schneider, R; Hanoulle, X (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF,Unite Glycobiol Struct & Fonct, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France.	robert.schneider@univ-lille1.fr; xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021; Landrieu, Isabelle/AAF-8495-2019; Schneider, Robert/C-1868-2013	Hanoulle, Xavier/0000-0002-3755-2680; Landrieu, Isabelle/0000-0002-4883-2637; Schneider, Robert/0000-0003-3279-5365; Lippens, Guy/0000-0002-8236-0901; cantrelle, francois-xavier/0000-0002-3413-5443; Launay, Helene/0000-0003-0639-2642; Bessa, Luiza/0000-0002-1993-3105	European Community; CNRS (IR RMN THC) [FR-3050]; University of Lille; Region Hauts-de-France (France); Pasteur Institute of Lille (IPL)	European Community(European Commission); CNRS (IR RMN THC); University of Lille; Region Hauts-de-France (France)(Region Hauts-de-France); Pasteur Institute of Lille (IPL)	The NMR facility was supported by the European Community, the CNRS (IR RMN THC, FR-3050), the University of Lille, the Region Hauts-de-France (France), and the Pasteur Institute of Lille (IPL).	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; [Anonymous], 2017, HEP C FACT SHEET; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Badillo A, 2017, BIOCHEMISTRY-US, V56, P3029, DOI 10.1021/acs.biochem.7b00212; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Boyce SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084808; Brass V, 2010, J VIROL, V84, P11580, DOI 10.1128/JVI.01519-10; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Cho NJ, 2016, ACS CENTRAL SCI, V2, P456, DOI 10.1021/acscentsci.6b00112; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Davis BC, 2015, BIOPHYS J, V108, P1785, DOI 10.1016/j.bpj.2015.03.005; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Di Maio VC, 2014, ANTIMICROB AGENTS CH, V58, P2781, DOI 10.1128/AAC.02386-13; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dujardin M, 2015, J BIOL CHEM, V290, P19104, DOI 10.1074/jbc.M115.644419; Eastman KJ, 2017, MEDCHEMCOMM, V8, P796, DOI 10.1039/c6md00636a; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Eltahla AA, 2015, VIRUSES-BASEL, V7, P5206, DOI 10.3390/v7102868; Eltahla AA, 2014, ANTIMICROB AGENTS CH, V58, P7215, DOI 10.1128/AAC.03699-14; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ishima R, 2005, J BIOMOL NMR, V32, P41, DOI 10.1007/s10858-005-3593-z; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Korzhnev DM, 2005, J AM CHEM SOC, V127, P15602, DOI 10.1021/ja054550e; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Li JW, 2016, J BIOL CHEM, V291, P10067, DOI 10.1074/jbc.M115.708354; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Ngure M, 2016, ACS INFECT DIS, V2, P839, DOI 10.1021/acsinfecdis.6b00143; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Ollerenshaw JE, 2003, MAGN RESON CHEM, V41, P843, DOI 10.1002/mrc.1256; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Ramiere C, 2014, J VIROL, V88, P3246, DOI 10.1128/JVI.02862-13; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rice CM, 2014, NATURE, V510, P43, DOI 10.1038/510043a; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Schlutter J, 2011, NATURE, V474, pS5, DOI 10.1038/474S5a; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Scrima N, 2012, J VIROL, V86, P7107, DOI 10.1128/JVI.00459-12; Sesmero E, 2015, VIRUSES-BASEL, V7, P3974, DOI 10.3390/v7072808; Shi ST, 2009, ANTIMICROB AGENTS CH, V53, P2544, DOI 10.1128/AAC.01599-08; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Solyom Z, 2015, BIOPHYS J, V109, P1483, DOI 10.1016/j.bpj.2015.06.040; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Troke PJF, 2012, ANTIMICROB AGENTS CH, V56, P1331, DOI 10.1128/AAC.05611-11; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11	104	5	5	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18024	18043		10.1074/jbc.M117.813766	http://dx.doi.org/10.1074/jbc.M117.813766			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912275	Green Published, hybrid			2022-12-28	WOS:000414458200004
J	Fortini, F; Dalla Sega, FV; Caliceti, C; Aquila, G; Pannella, M; Pannuti, A; Miele, L; Ferrari, R; Rizzo, P				Fortini, Francesca; Dalla Sega, Francesco Vieceli; Caliceti, Cristiana; Aquila, Giorgio; Pannella, Micaela; Pannuti, Antonio; Miele, Lucio; Ferrari, Roberto; Rizzo, Paola			Estrogen receptor -dependent Notch1 activation protects vascular endothelium against tumor necrosis factor (TNF)-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; endothelial dysfunction; estrogen; estrogen receptor; Notch pathway; tumor necrosis factor (TNF); Akt; ER; Notch1	NF-KAPPA-B; CARDIOVASCULAR-DISEASE; CELL APOPTOSIS; THERAPEUTIC TARGET; BREAST-CANCER; TNF-ALPHA; INFLAMMATION; PATHWAY; ATHEROSCLEROSIS; ANGIOGENESIS	Unlike age-matched men, premenopausal women benefit from cardiovascular protection. Estrogens protect against apoptosis of endothelial cells (ECs), one of the hallmarks of endothelial dysfunction leading to cardiovascular disorders, but the underlying molecular mechanisms remain poorly understood. The inflammatory cytokine TNF causes EC apoptosis while dysregulating the Notch pathway, a major contributor to EC survival. We have previously reported that 17-estradiol (E2) treatment activates Notch signaling in ECs. Here, we sought to assess whether in TNF-induced inflammation Notch is involved in E2-mediated protection of the endothelium. We treated human umbilical vein endothelial cells (HUVECs) with E2, TNF, or both and found that E2 counteracts TNF-induced apoptosis. When Notch1 was inhibited, this E2-mediated protection was not observed, whereas ectopic overexpression of Notch1 diminished TNF-induced apoptosis. Moreover, TNF reduced the levels of active Notch1 protein, which were partially restored by E2 treatment. Moreover, siRNA-mediated knockdown of estrogen receptor (ER), but not ER, abolished the effect of E2 on apoptosis. Additionally, the E2-mediated regulation of the levels of active Notch1 was abrogated after silencing ER. In summary, our results indicate that E2 requires active Notch1 through a mechanism involving ER to protect the endothelium in TNF-induced inflammation. These findings could be relevant for assessing the efficacy and applicability of menopausal hormone treatment, because they may indicate that in women with impaired Notch signaling, hormone therapy might not effectively protect the endothelium.	[Fortini, Francesca; Dalla Sega, Francesco Vieceli; Aquila, Giorgio; Ferrari, Roberto] Univ Ferrara, Dept Med Sci, I-44121 Ferrara, Italy; [Rizzo, Paola] Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato Mortara 64-B, I-44121 Ferrara, Italy; [Caliceti, Cristiana] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy; [Caliceti, Cristiana] Univ Bologna, Interdept Ctr Ind Res Energy & Environm CIRI EA, I-40126 Bologna, Italy; [Caliceti, Cristiana] Natl Inst Biostruct & Biosyst INBB, I-00136 Rome, Italy; [Pannella, Micaela] Univ Bologna, Fdn IRET, Interdept Ctr Ind Res & Life Sci CIRI SDV, I-40064 Ozzano Dell Emilia, BO, Italy; [Pannuti, Antonio; Miele, Lucio] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA; [Pannuti, Antonio; Miele, Lucio] Louisiana Canc Res Consortium, New Orleans, LA 70112 USA; [Ferrari, Roberto; Rizzo, Paola] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care & Res, I-48033 Cotignola, Italy; [Ferrari, Roberto; Rizzo, Paola] Univ Ferrara, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Bologna; University of Bologna; University of Bologna; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Maria Cecilia Hospital; University of Ferrara	Rizzo, P (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato Mortara 64-B, I-44121 Ferrara, Italy.	rzzpla@unife.it	FERRARI, ROBERTO/ABD-5169-2020; Aquila, Giorgio/X-4412-2019; Vieceli Dalla Sega, Francesco/GQZ-1869-2022	Aquila, Giorgio/0000-0002-3936-8895; rizzo, paola/0000-0001-7174-9674; Ferrari, Roberto/0000-0003-2046-9175; Miele, Lucio/0000-0002-5853-7287	NIGMS NIH HHS [U54 GM104940] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnabas O, 2013, J GERIATR CARDIOL, V10, P377, DOI 10.3969/j.issn.1671-5411.2013.04.008; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Billon-Gales A, 2009, CIRCULATION, V120, P2567, DOI 10.1161/CIRCULATIONAHA.109.898445; Briot A, 2015, J EXP MED, V212, P2147, DOI 10.1084/jem.20150603; Caliceti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071440; Chakrabarti S, 2016, METHODS MOL BIOL, V1366, P503, DOI 10.1007/978-1-4939-3127-9_39; Dabral S, 2016, EUR RESPIR J, V48, P1137, DOI 10.1183/13993003.00773-2015; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Florian M, 2008, STEROIDS, V73, P47, DOI 10.1016/j.steroids.2007.08.010; Girdler F, 2000, BREAST, V9, P194, DOI 10.1054/brst.2000.0203; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Hatsumi T, 2006, EXP BIOL MED, V231, P311; Jensen HA, 2016, EXPERT REV CARDIOVAS, V14, P1021, DOI 10.1080/14779072.2016.1207527; Karsan A, 1998, TRENDS CARDIOVAS MED, V8, P19, DOI 10.1016/S1050-1738(97)00126-6; Kim KH, 2014, MOL CELL ENDOCRINOL, V389, P65, DOI 10.1016/j.mce.2014.02.001; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Koga M, 2004, BIOCHEM BIOPH RES CO, V324, P321, DOI 10.1016/j.bbrc.2004.09.060; Koh KK, 2003, INT J CARDIOL, V87, P1; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Lin CC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0165-8; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Nichols M, 2014, EUR HEART J, V35, P2929, DOI 10.1093/eurheartj/ehu378; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Pannella M, 2016, J CELL PHYSIOL, V231, P2700, DOI 10.1002/jcp.25373; Pedrosa AR, 2015, ARTERIOSCL THROM VAS, V35, P1134, DOI 10.1161/ATVBAHA.114.304741; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rizzo P, 2013, EUR HEART J, V34, P2504, DOI 10.1093/eurheartj/ehs141; Rostama B, 2014, VASC PHARMACOL, V63, P97, DOI 10.1016/j.vph.2014.10.003; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Sites CK, 2002, FERTIL STERIL, V77, P128, DOI 10.1016/S0015-0282(01)02934-X; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Smirnova NF, 2015, CIRC RES, V117, P770, DOI 10.1161/CIRCRESAHA.115.306416; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Sobrino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008242; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Sudoh N, 2001, CIRCULATION, V103, P724; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Villablanca AC, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-214; Villablanca AC, 2009, J CARDIOVASC TRANSL, V2, P289, DOI 10.1007/s12265-009-9103-z; Walshe TE, 2011, INVEST OPHTH VIS SCI, V52, P4472, DOI 10.1167/iovs.10-7061; Wang X.J., 2010, J INEQUAL APPL, V2010, DOI DOI 10.1155/2010/465915; Yang XP, 2011, CURR OPIN NEPHROL HY, V20, P133, DOI 10.1097/MNH.0b013e3283431921; Zhou Z, 2008, AM J PHYSIOL-RENAL, V295, pF932, DOI 10.1152/ajprenal.00066.2008	58	39	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18178	18191		10.1074/jbc.M117.790121	http://dx.doi.org/10.1074/jbc.M117.790121			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28893903	hybrid, Green Published			2022-12-28	WOS:000414458200016
J	Blumer, T; Coto-Llerena, M; Duong, FHT; Heim, MH				Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.			SOCS1 is an inducible negative regulator of interferon lambda (IFN-lambda)-induced gene expression in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; IFN-LAMBDA; STIMULATED GENES; HCV CLEARANCE; CYTOKINE; ALPHA; RECEPTOR; CELLS; IFN-LAMBDA-4; HEPATOCYTES	Type I (alpha and beta) and type III (lambda) IFNs are induced upon viral infection through host sensory pathways that activate IFN regulatory factors (IRFs) and nuclear factor kappa B. Secreted IFNs induce autocrine and paracrine signaling through the JAK-STAT pathway, leading to the transcriptional induction of hundreds of IFN-stimulated genes, among them sensory pathway components such as cGAS, STING, RIG-I, MDA5, and the transcription factor IRF7, which enhance the induction of IFN-alpha s and IFN-alpha s. This positive feedback loop enables a very rapid and strong host response that, at some point, has to be controlled by negative regulators to maintain tissue homeostasis. Type I IFN signaling is controlled by the inducible negative regulators suppressor of cytokine signaling 1 (SOCS1), SOCS3, and ubiquitin-specific peptidase 18 (USP18). The physiological role of these proteins in IFN-gamma signaling has not been clarified. Here we used knockout cell lines and mice to show that IFN-lambda signaling is regulated by SOCS1 but not by SOCS3 or USP18. These differences were the basis for the distinct kinetic properties of type I and III IFNs. We found that IFN-alpha signaling is transient and becomes refractory after hours, whereas IFN-lambda provides a long-lasting IFN-stimulated gene induction.	[Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.] Univ Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland; [Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.] Univ Hosp Basel, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Heim, MH (corresponding author), Univ Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	markus.heim@unibas.ch	Heim, Markus/A-7526-2008	Heim, Markus/0000-0002-7523-4894; DUONG, Hong Tuan Francois/0000-0003-0928-2123	Swiss National Science Foundation [310030B_147089, 310030_166202]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B_147089 and 310030_166202 (to M. H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lauber C, 2015, GENES IMMUN, V16, P414, DOI 10.1038/gene.2015.23; Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506; Liu B.L., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1186/S40467-015-0036-6; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Wei HT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003845; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	39	35	36	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17928	17938		10.1074/jbc.M117.788877	http://dx.doi.org/10.1074/jbc.M117.788877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900038	hybrid, Green Published			2022-12-28	WOS:000414013000028
J	Lyman, KA; Han, Y; Heuermann, RJ; Cheng, XY; Kurz, JE; Lyman, RE; Van Veldhoven, PP; Chetkovich, DM				Lyman, Kyle A.; Han, Ye; Heuermann, Robert J.; Cheng, Xiangying; Kurz, Jonathan E.; Lyman, Reagan E.; Van Veldhoven, Paul P.; Chetkovich, Dane M.			Allostery between two binding sites in the ion channel subunit TRIP8b confers binding specificity to HCN channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PEROXISOME-TARGETING SIGNAL; CA1 PYRAMIDAL NEURONS; IMPORT RECEPTOR; MATRIX PROTEINS; TERMINAL DOMAIN; PEX5; PTS1; CAMP; LOCALIZATION	Tetratricopeptide repeat (TPR) domains are ubiquitous structural motifs that mediate protein-protein interactions. For example, the TPR domains in the peroxisomal import receptor PEX5 enable binding to a range of type 1 peroxisomal targeting signal motifs. A homolog of PEX5, tetratricopeptide repeatcontaining Rab8b-interacting protein (TRIP8b), binds to and functions as an auxiliary subunit of hyperpolarization-activated cyclic nucleotide (HCN)-gated channels. Given the similarity between TRIP8b and PEX5, this difference in function raises the question of what mechanism accounts for their binding specificity. In this report, we found that the cyclic nucleotidebinding domain and the C terminus of the HCN channel are critical for conferring specificity to TRIP8b binding. We show that TRIP8b binds the HCN cyclic nucleotide-binding domain through a 37-residue domain and the HCN C terminus through the TPR domains. Using a combination of fluorescence polarization-and co-immunoprecipitation-based assays, we establish that binding at either site increases affinity at the other. Thus, allosteric coupling of the TRIP8b TPR domains both promotes binding to HCN channels and limits binding to type 1 peroxisomal targeting signal substrates. These results raise the possibility that other TPR domains may be similarly influenced by allosteric mechanisms as a general feature of protein-protein interactions.	[Lyman, Kyle A.; Han, Ye; Heuermann, Robert J.; Cheng, Xiangying; Lyman, Reagan E.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Kurz, Jonathan E.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Campus Gasthuisberg, B-3000 Leuven, Belgium	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; KU Leuven	Chetkovich, DM (corresponding author), 303 E Chicago Ave,Ward Bldg 10-201, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Chetkovich, Dane/AAV-5457-2021; , Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Kurz, Jonathan/0000-0002-2259-4263	NCI, National Institutes of Health [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150, UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104471, T32MH067564, R01MH106511, R21MH113262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Structural Biology facility at Northwestern University and the Northwestern University Center for Advanced Microscopy are generously supported by NCI, National Institutes of Health CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center.	Amery L, 1998, BIOCHEM J, V336, P367, DOI 10.1042/bj3360367; Amery L, 2001, BIOCHEM J, V357, P635, DOI 10.1042/0264-6021:3570635; Apanasets O, 2014, TRAFFIC, V15, P94, DOI 10.1111/tra.12129; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; Effelsberg D, 2016, J CELL SCI, V129, P4057; Emmanouilidis L, 2016, BBA-MOL CELL RES, V1863, P804, DOI 10.1016/j.bbamcr.2015.09.034; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hagen S, 2015, J BIOL CHEM, V290, P26610, DOI 10.1074/jbc.M115.657973; Han Y, 2017, MOL PSYCHIATR, V22, P458, DOI 10.1038/mp.2016.99; Han Y., 2016, JOVE-J VIS EXP; Han Y, 2015, J BIOMOL SCREEN, V20, P1124, DOI 10.1177/1087057115589590; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; Lanyon-Hogg T, 2014, FEBS LETT, V588, P2223, DOI 10.1016/j.febslet.2014.05.038; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lyman KA, 2017, EXPERT OPIN THER TAR, V21, P235, DOI 10.1080/14728222.2017.1287899; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Shin M, 2006, BRAIN RES, V1083, P14, DOI 10.1016/j.brainres.2006.01.102; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Yifrach E, 2016, J CELL SCI, V129, P4067, DOI 10.1242/jcs.195255; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	51	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17718	17730		10.1074/jbc.M117.802256	http://dx.doi.org/10.1074/jbc.M117.802256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887304	Green Published, hybrid			2022-12-28	WOS:000414013000012
J	Reynoso, E; Liu, H; Li, L; Yuan, AL; Chen, S; Wang, ZG				Reynoso, Eduardo; Liu, Hua; Li, Lin; Yuan, Anthony L.; Chen, She; Wang, Zhigao			Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; TUMOR-NECROSIS-FACTOR; NECROTIC CELL-DEATH; PROGRAMMED NECROSIS; TNF-ALPHA; OXIDATIVE STRESS; ACTIVATION; RIP3; APOPTOSIS	Necroptosis is an immunogenic cell death program that is associated with a host of human diseases, including inflammation, infections, and cancer. Receptor-interacting protein kinase 3 (RIPK3) and its substrate mixed lineage kinase domain-like protein (MLKL) are required for necroptosis activation. Specifically, RIPK3-dependent MLKL phosphorylation promotes the assembly of disulfide bond-dependent MLKL polymers that drive the execution of necroptosis. However, how MLKL disulfide bond formation is regulated is not clear. In this study we discovered that the MLKL-modifying compound necrosulfonamide cross-links cysteine 86 of human MLKL to cysteine 32 of the thiol oxidoreductase thioredoxin-1 (Trx1). Recombinant Trx1 preferentially binds to monomeric MLKL and blocks MLKL disulfide bond formation and polymerization in vitro. Inhibition of MLKL polymer formation requires the reducing activity of Trx1. Importantly, shRNA-mediated knockdown of Trx1 promotes MLKL polymerization and sensitizes cells to necroptosis. Furthermore, pharmacological inhibition of Trx1 with compound PX-12 induces necroptosis in multiple cancer cell lines. Altogether, these findings demonstrate that Trx1 is a critical regulator of necroptosis that suppresses cell death by maintaining MLKL in a reduced inactive state. Our results further suggest new directions for targeted cancer therapy in which thioredoxin inhibitors like PX-12 could potentially be used to specifically target cancers expressing high levels of MLKL or MLKL short isoforms.	[Reynoso, Eduardo; Liu, Hua; Yuan, Anthony L.; Wang, Zhigao] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Liu, Hua] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330006, Jiangxi, Peoples R China; [Li, Lin; Chen, She] Natl Inst Biol Sci, Prote Facil, Beijing 102206, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Jiangxi University of Traditional Chinese Medicine; National Institute of Biological Sciences, Beijing	Wang, ZG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhigao.wang@utsouthwestern.edu	Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302	Welch Foundation [I-1827]; F31 fellowship [GM111049-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM111049] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); F31 fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Welch Foundation (I-1827) and an F31 fellowship (GM111049-01A1; to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galmarini CM, 2006, CURR OPIN INVESTIG D, V7, P1108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Najafov A, 2017, TRENDS CANCER, V3, P294, DOI 10.1016/j.trecan.2017.03.002; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Quarato G, 2016, MOL CELL, V61, P589, DOI 10.1016/j.molcel.2016.01.011; Ramanathan RK, 2012, INVEST NEW DRUG, V30, P1591, DOI 10.1007/s10637-011-9739-9; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xu YF, 2015, J AM SOC NEPHROL, V26, P2647, DOI 10.1681/ASN.2014080741; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	51	20	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17514	17524		10.1074/jbc.M117.799353	http://dx.doi.org/10.1074/jbc.M117.799353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878015	hybrid, Green Published			2022-12-28	WOS:000414009300031
J	Liu, J; Shang, DT; Xiao, Y; Zhong, P; Cheng, HH; Zhou, RJ				Liu, Jing; Shang, Dantong; Xiao, Yao; Zhong, Pei; Cheng, Hanhua; Zhou, Rongjia			Isolation and characterization of string-forming female germline stem cells from ovaries of neonatal mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-MOUSE; DIFFERENTIATION; MIGRATION; RENEWAL; LINE; SUPPRESSOR; OOGENESIS; CONTACT; FAILURE; RATHER	Germline stem cells are essential in the generation of both male and female gametes. In mammals, the male testis produces sperm throughout the entire lifetime, facilitated by testicular germline stem cells. Oocyte renewal ceases in postnatal or adult life in mammalian females, suggesting that germline stem cells are absent from the mammalian ovary. However, studies in mice, rats, and humans have recently provided evidence for ovarian female germline stem cells (FGSCs). A better understanding of the role of FGSCs in ovaries could help improve fertility treatments. Here, we developed a rapid and efficient method for isolating FGSCs from ovaries of neonatal mice. Notably, our FGSC isolation method could efficiently isolate on average 15 cell "strings" per ovary from mice at 1-3 days postpartum. FGSCs isolated from neonatal mice displayed the string-forming cell configuration at mitosis (i.e. a "stringing" FGSC (sFGSC) phenotype) and a disperse phenotype in postnatal mice. We also found that sFGSCs undergo vigorous mitosis especially at 1-3 days postpartum. After cell division, the sFGSC membranes tended to be connected to form sFGSCs. Moreover, F-actin filaments exhibited a cell-cortex distribution in sFGSCs, and E-cadherin converged in cell-cell connection regions, resulting in the string-forming morphology. Our new method provides a platform for isolating FGSCs from the neonatal ovary, and our findings indicate that FGCSs exhibit string-forming features in neonatal mice. The sFGSCs represent a valuable resource for analysis of ovary function and an in vitro model for future clinical use to address ovarian dysfunction.	[Liu, Jing; Shang, Dantong; Xiao, Yao; Zhong, Pei; Cheng, Hanhua; Zhou, Rongjia] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Cheng, HH; Zhou, RJ (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009; Xiao, Yao/0000-0002-5153-6839	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Abban G, 2009, HUM REPROD, V24, P2974, DOI 10.1093/humrep/dep281; Anderson L D, 1992, Md Med J, V41, P614; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; DEROOIJ DG, 1968, Z ZELLFORSCH MIK ANA, V92, P400; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Fakih M. H., 2015, MED GENET, V3, P154, DOI DOI 10.4172/2375-4508.1000154; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; Gordon MB, 2001, J CELL BIOL, V152, P425, DOI 10.1083/jcb.152.3.425; Guan K, 2009, NAT PROTOC, V4, P143, DOI 10.1038/nprot.2008.242; He YN, 2015, CYTOTECHNOLOGY, V67, P921, DOI 10.1007/s10616-015-9850-4; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Imudia AN, 2013, FERTIL STERIL, V100, P1451, DOI 10.1016/j.fertnstert.2013.06.036; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kowalska E, 2013, P NATL ACAD SCI USA, V110, P1592, DOI 10.1073/pnas.1213317110; Liu SX, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-141; Massasa E, 2010, AGING-US, V2, P1; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Ogino H, 2008, MOL MICROBIOL, V67, P597, DOI 10.1111/j.1365-2958.2007.06069.x; Pacchiarotti J, 2010, DIFFERENTIATION, V79, P159, DOI 10.1016/j.diff.2010.01.001; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Truman AM, 2017, MOL CELL ENDOCRINOL, V445, P74, DOI 10.1016/j.mce.2016.10.012; Wang H, 2014, J MOL CELL BIOL, V6, P164, DOI 10.1093/jmcb/mju004; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Woods DC, 2013, NAT PROTOC, V8, P966, DOI 10.1038/nprot.2013.047; Xiao Y, 2016, STEM CELL REP, V7, P370, DOI 10.1016/j.stemcr.2016.07.020; Xie WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05580; Yuan J, 2015, AUTOPHAGY, V11, P1081, DOI 10.1080/15548627.2015.1040970; Zhang XL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1023-z; Zhang Y, 2011, J MOL CELL BIOL, V3, P132, DOI 10.1093/jmcb/mjq043; Zhou L, 2014, MOL HUM REPROD, V20, P271, DOI 10.1093/molehr/gat081; Zou K, 2011, STEM CELLS DEV, V20, P2197, DOI 10.1089/scd.2011.0091; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	43	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16003	16013		10.1074/jbc.M117.799403	http://dx.doi.org/10.1074/jbc.M117.799403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28827310	hybrid, Green Published			2022-12-28	WOS:000412109400002
J	Castro-Fernandez, V; Herrera-Morande, A; Zamora, R; Merino, F; Gonzalez-Ordenes, F; Padilla-Salinas, F; Pereira, HM; Brandao-Neto, J; Garratt, RC; Guixe, V				Castro-Fernandez, Victor; Herrera-Morande, Alejandra; Zamora, Ricardo; Merino, Felipe; Gonzalez-Ordenes, Felipe; Padilla-Salinas, Felipe; Pereira, Humberto M.; Brandao-Neto, Jose; Garratt, Richard C.; Guixe, Victoria			Reconstructed ancestral enzymes reveal that negative selection drove the evolution of substrate specificity in ADP-dependent kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; PYROCOCCUS-FURIOSUS; DISCRETE CHARACTERS; BIFUNCTIONAL ENZYME; BAYESIAN-ESTIMATION; GLUCOKINASE; SEQUENCE; GLUCOKINASE/PHOSPHOFRUCTOKINASE; GLYCOLYSIS; MUTATIONS	One central goal in molecular evolution is to pinpoint the mechanisms and evolutionary forces that cause an enzyme to change its substrate specificity; however, these processes remain largely unexplored. Using the glycolytic ADP-dependent kinases of archaea, including the orders Thermococcales, Methanosarcinales, and Methanococcales, as a model and employing an approach involving paleoenzymology, evolutionary statistics, and protein structural analysis, we could track changes in substrate specificity during ADP-dependent kinase evolution along with the structural determinants of these changes. To do so, we studied five key resurrected ancestral enzymes as well as their extant counterparts. We found that a major shift in function from a bifunctional ancestor that could phosphorylate either glucose or fructose 6-phosphate (fructose6-P) as a substrate to a fructose 6-P-specific enzyme was started by a single amino acid substitution resulting in negative selection with a ground-state mode against glucose and a subsequent 1,600-fold change in specificity of the ancestral protein. This change rendered the residual phosphorylation of glucose a promiscuous and physiologically irrelevant activity, highlighting how promiscuity may be an evolutionary vestige of ancestral enzyme activities, which have been eliminated over time. We also could reconstruct the evolutionary history of substrate utilization by using an evolutionary model of discrete binary characters, indicating that substrate uses can be discretely lost or acquired during enzyme evolution. These findings exemplify how negative selection and subtle enzyme changes can lead to major evolutionary shifts in function, which can subsequently generate important adaptive advantages, for example, in improving glycolytic efficiency in Thermococcales.	[Castro-Fernandez, Victor; Herrera-Morande, Alejandra; Zamora, Ricardo; Merino, Felipe; Gonzalez-Ordenes, Felipe; Padilla-Salinas, Felipe; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago 800003, Chile; [Pereira, Humberto M.; Garratt, Richard C.] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13563120 Sao Paulo, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DF, Oxon, England; [Merino, Felipe] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	Universidad de Chile; Universidade de Sao Paulo; Diamond Light Source; Max Planck Society	Guixe, V (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago 800003, Chile.	vguixe@uchile.cl	Merino, Felipe/D-2740-2013; Zamora, Ricardo A/O-8717-2018; Castro-Fernandez, Victor/K-9621-2018; garratt, richard c/F-6921-2011	Merino, Felipe/0000-0003-4166-8747; Zamora, Ricardo A/0000-0002-7707-7482; Castro-Fernandez, Victor/0000-0002-4309-6415; Brandao-Neto, Jose/0000-0001-6015-320X; Herrera-Morande, Alejandra/0000-0002-4140-0743; garratt, richard/0000-0002-2016-3179	Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile [FONDECYT 1150460, 3160332]	Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile	This work was supported in part by Fondo Nacional de Desarrollo Cientifico y Tecnologico from Chile Grants FONDECYT 1150460 (to V. G.) and FONDECYT Postdoctorado 3160332 (to V. C-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allewell NM, 2012, J BIOL CHEM, V287, P1, DOI 10.1074/jbc.R111.307322; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bar-Rogovsky H, 2015, PROTEIN ENG DES SEL, V28, P507, DOI 10.1093/protein/gzv038; Battistuzzi FU, 2009, TIMETREE LIFE, P101; Benner Steven A., 2007, V75, P1; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Castro-Fernandez V, 2014, FEBS J, V281, P2017, DOI 10.1111/febs.12757; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Santiago-Martinez MG, 2016, FEBS J, V283, P1979, DOI 10.1111/febs.13717; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Heilbron K, 2014, GENETICS, V197, P981, DOI 10.1534/genetics.114.163147; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanehisa M., 2016, KYOTO ENCY GENES GEN; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newton MS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0036; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petitjean C, 2015, MOL BIOL EVOL, V32, P1242, DOI 10.1093/molbev/msv015; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tawfik DS, 2014, CURR OPIN CHEM BIOL, V21, P73, DOI 10.1016/j.cbpa.2014.05.008; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	62	8	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15598	15610		10.1074/jbc.M117.790865	http://dx.doi.org/10.1074/jbc.M117.790865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28726643	Green Published, hybrid			2022-12-28	WOS:000411512200002
J	Parajuli, S; Teasley, DC; Murali, B; Jackso, J; Vindigni, A; Stewart, SA				Parajuli, Shankar; Teasley, Daniel C.; Murali, Bhavna; Jackso, Jessica; Vindigni, Alessandro; Stewart, Sheila A.			Human ribonuclease H1 resolves R-loops and thereby enables progression of the DNA replication fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL PAUSE SITES; GENOME INSTABILITY; RNASE H1; CELLS; HYBRIDS; MITOCHONDRIAL; TELOMERES; STRAND; REPAIR; CHROMOSOMES	Faithful DNA replication is essential for genome stability. To ensure accurate replication, numerous complex and redundant replication and repair mechanisms function in tandem with the core replication proteins to ensure DNA replication continues even when replication challenges are present that could impede progression of the replication fork. A unique topological challenge to the replication machinery is posed by RNA-DNA hybrids, commonly referred to as R-loops. Although R-loops play important roles in gene expression and recombination at immunoglobulin sites, their persistence is thought to interfere with DNA replication by slowing or impeding replication fork progression. Therefore, it is of interest to identify DNA-associated enzymes that help resolve replication-impeding R-loops. Here, using DNA fiber analysis, we demonstrate that human ribonuclease H1 (RNH1) plays an important role in replication fork movement in the mammalian nucleus by resolving R-loops. We found that RNH1 depletion results in accumulation of RNA-DNA hybrids, slowing of replication forks, and increased DNA damage. Our data uncovered a role for RNH1 in global DNA replication in the mammalian nucleus. Because accumulation of RNA-DNA hybrids is linked to various human cancers and neurodegenerative disorders, our study raises the possibility that replication fork progression might be impeded, adding to increased genomic instability and contributing to disease.	[Parajuli, Shankar; Teasley, Daniel C.; Murali, Bhavna; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Vindigni, Alessandro; Stewart, Sheila A.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63110 USA; [Jackso, Jessica; Vindigni, Alessandro] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Vindigni, A; Stewart, SA (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63110 USA.; Vindigni, A (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	avindign@slu.edu; sheila.stewart@wustl.edu	Murali, Bhavna/ABA-4295-2021	Stewart, Sheila/0000-0002-2260-9576; Murali, Bhavna/0000-0003-3546-1416	Predoctoral Cancer Biology Pathway grant; Siteman Cancer Center/Barnes Jewish Hospital; National Institutes of Health Molecular Oncology Training Grant [T32CA113275]; National Institutes of Health [R01GM108648]; United States Department of Defense Breast Cancer Research Program Breakthrough Award [BC151728]; National Institutes of Health Grant [CA130919]; American Cancer Society research scholar award; NATIONAL CANCER INSTITUTE [T32CA113275, R01CA130919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108648] Funding Source: NIH RePORTER	Predoctoral Cancer Biology Pathway grant; Siteman Cancer Center/Barnes Jewish Hospital; National Institutes of Health Molecular Oncology Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense Breast Cancer Research Program Breakthrough Award(United States Department of Defense); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society research scholar award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Predoctoral Cancer Biology Pathway grant, Siteman Cancer Center/Barnes Jewish Hospital (to S.P.); National Institutes of Health Molecular Oncology Training Grant T32CA113275 (to B.M.); National Institutes of Health Grant R01GM108648 (to A.V.); United States Department of Defense Breast Cancer Research Program Breakthrough Award BC151728 (to A. V.); National Institutes of Health Grant CA130919 (to S. A. S.); and an American Cancer Society research scholar award (to S. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7720; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; O'Driscoll M., 2017, PATHOLOGICAL CONSEQU; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Richard P, 2017, J MOL BIOL, V429, P3168, DOI 10.1016/j.jmb.2016.08.031; Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008; Sagie S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14015; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH7; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Takikawa M, 2017, NUCLEIC ACIDS RES, V45, P1255, DOI 10.1093/nar/gkw1176; Teasley DC, 2015, J BIOL CHEM, V290, P15133, DOI 10.1074/jbc.M115.647388; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	45	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15216	15224		10.1074/jbc.M117.787473	http://dx.doi.org/10.1074/jbc.M117.787473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717002	hybrid, Green Published			2022-12-28	WOS:000410809800005
J	Seno, K; Hayashi, F				Seno, Keiji; Hayashi, Fumio			Palmitoylation is a prerequisite for dimerization-dependent raftophilicity of rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENT; PROTEIN-COUPLED RECEPTOR; RESISTANT MEMBRANE RAFTS; DISK MEMBRANES; CRYSTAL-STRUCTURE; NATIVE MEMBRANES; BOVINE RHODOPSIN; PHOTOTRANSDUCTION; TRANSDUCIN; PHOTORECEPTORS	The visual photopigment rhodopsin (Rh) is a prototypical G protein-coupled receptor (GPCR) responsible for initiation of the phototransduction cascade in rod photoreceptors. Similar to other GPCRs, Rh can form dimers or even higher oligomers and tends to have a supramolecular organization that is likely important in the dim light response. Rh also exhibits high affinity for lipid rafts (i.e. raftophilicity) upon light-dependent binding with the cognate G protein transducin (G(t)), suggesting the presence of lipid raft-like domains in the retinal disk membrane and their importance in phototransduction. However, the relationship between Rh oligomerization and lipid rafts in the disk membrane remains to be explored. Given previous findings that G(t) binds to dimeric Rh and that Rh is posttranslationally modified with two highly raftophilic palmitoyl moieties, we hypothesized that Rh becomes raftophilic upon dimerization. Here, using biochemical assays, we found that Rh*-G(t) complexes in the detergent-resistant membrane are partially resistant to cholesterol depletion by methyl-beta-cyclodextrin and that the Rh-to-G(t) stoichiometry in this methyl-beta-cyclodextrinresistant complex is 2:1. Next, we found that IgG-mediated Rh-Rh cross-linking renders Rh highly raftophilic, supporting the premise that Rh becomes raftophilic upon dimerization. Rh depalmitoylation via reduction of thioester linkages blocked the translocation of IgG-cross-linked Rh to the detergent-resistant membrane, highlighting that the two palmitoyl moieties are important for the dimerization-dependent raftophilicity of Rh. These results indicate that palmitoylated GPCRs such as Rh can acquire raftophilicity upon G protein-stabilized dimerization and thereby organize receptor-cluster rafts by recruiting raftophilic lipids.	[Seno, Keiji] Hamamatsu Univ Sch Med, Fac Med, Dept Biol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Seno, Keiji] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Hayashi, Fumio] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kobe University	Hayashi, F (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	fhayashi@port.kobe-u.ac.jp		Hayashi, Fumio/0000-0002-9253-5488	Japan Society for the Promotion of Science [26291031]; Grants-in-Aid for Scientific Research [17H03666, 17KT0024] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research 26291031 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Ablonczy Z, 2006, VISION RES, V46, P4493, DOI 10.1016/j.visres.2006.08.003; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P18867; Buzhynskyy N, 2011, J MOL RECOGNIT, V24, P483, DOI 10.1002/jmr.1086; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CORLESS JM, 1982, P NATL ACAD SCI-BIOL, V79, P1116, DOI 10.1073/pnas.79.4.1116; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; DRATZ EA, 1985, BIOCHIM BIOPHYS ACTA, V832, P337, DOI 10.1016/0167-4838(85)90268-7; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; Jastrzebska B., 2015, MOTHODS MOL BIOL, V1271, P221; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Kawamura S, 2002, ADV EXP MED BIOL, V514, P61; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mazzolini M, 2015, P NATL ACAD SCI USA, V112, pE2715, DOI 10.1073/pnas.1423162112; MORRISON DF, 1991, J BIOL CHEM, V266, P20118; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Polozova A, 2000, BIOPHYS J, V79, P2632, DOI 10.1016/S0006-3495(00)76502-7; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Senin II, 2004, J BIOL CHEM, V279, P48647, DOI 10.1074/jbc.M402516200; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Tanimoto Y, 2015, BIOPHYS J, V109, P2307, DOI 10.1016/j.bpj.2015.10.015; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; YAMAZAKI A, 1987, J BIOL CHEM, V262, P9316; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	51	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15321	15328		10.1074/jbc.M117.804880	http://dx.doi.org/10.1074/jbc.M117.804880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747438	Green Published, hybrid			2022-12-28	WOS:000410809800014
J	Wu, Y; Fortin, DA; Cochrane, VA; Chen, PC; Shyng, SL				Wu, Yi; Fortin, Dale A.; Cochrane, Veronica A.; Chen, Pei-Chun; Shyng, Show-Ling			NMDA receptors mediate leptin signaling and regulate potassium channel trafficking in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; TRANSCRIPTION FACTOR; EXPRESSION; ISLETS; IDENTIFICATION; DIVERSITY; SECRETION; SUBTYPES; CURRENTS; RELEASE	NMDA receptors (NMDARs) are Ca2+-permeant, ligand-gated ion channels activated by the excitatory neurotransmitter glutamate and have well-characterized roles in the nervous system. The expression and function of NMDARs in pancreatic beta-cells, by contrast, are poorly understood. Here, we report a novel function of NMDARs in beta-cells. Using a combination of biochemistry, electrophysiology, and imaging techniques, we now show that NMDARs have a key role in mediating the effect of leptin to modulate beta-cells electrical activity by promoting AMP-activated protein kinase (AMPK)-dependent trafficking of KATP and Kv2.1 channels to the plasma membrane. Blocking NMDAR activity inhibited the ability of leptin to activate AMPK, induce KATP and Kv2.1 channel trafficking, and promote membrane hyperpolarization. Conversely, activation of NMDARs mimicked the effect of leptin, causing Ca2+ influx, AMPK activation, and increased trafficking of KATP and Kv2.1 channels to the plasma membrane, and triggered membrane hyperpolarization. Moreover, leptin potentiated NMDAR currents and triggered NMDAR-dependent Ca2+ influx. Importantly, NMDAR-mediated signaling was observed in rat insulinoma 832/13 cells and in human beta-cells, indicating that this pathway is conserved across species. The ability of NMDARs to regulate potassium channel surface expression and thus, beta-cells excitability provides mechanistic insight into the recently reported insulinotropic effects of NMDAR antagonists and therefore highlights the therapeutic potential of these drugs in managing type 2 diabetes.	[Wu, Yi; Fortin, Dale A.; Cochrane, Veronica A.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chen, Pei-Chun] Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan	Oregon Health & Science University; National Cheng Kung University	Chen, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan.; Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pcchen@mail.ncku.edu.tw; shyngs@ohsu.edu		Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health Grants [R01DK057699, 3R01DK057699-14S1]; Ministry of Science and Technology Grant [MOST105-2628-B-006-006-MY3]; National Institutes of Health T32 Training Grant [GM071338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology Grant; National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01DK057699 and 3R01DK057699-14S1 (to S.-L. S.) and by Ministry of Science and Technology Grant MOST105-2628-B-006-006-MY3 (to P.-C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant GM071338.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bai L., 2003, AM J PHYSL GASTEROIN, V284, pG808; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Corless M, 2006, J ENDOCRINOL, V190, P719, DOI 10.1677/joe.1.06892; Di Cairano ES, 2011, J BIOL CHEM, V286, P14007, DOI 10.1074/jbc.M110.183517; DIVIRGILIO F, 1988, BIOCHEM J, V256, P959, DOI 10.1042/bj2560959; Feldmann N, 2011, MOL CELL ENDOCRINOL, V338, P46, DOI 10.1016/j.mce.2011.02.019; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Liu JSE, 2017, GENE DEV, V31, P228, DOI 10.1101/gad.294389.116; Luo X, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0007-15.2015; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Marquard J, 2015, NAT MED, V21, P363, DOI 10.1038/nm.3822; Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Otters S, 2016, TRENDS ENDOCRIN MET, V27, P177, DOI 10.1016/j.tem.2015.12.004; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Patterson S, 2016, EUR J PHARMACOL, V771, P107, DOI 10.1016/j.ejphar.2015.12.015; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Shanley LJ, 2002, J PHYSIOL-LONDON, V545, P933, DOI 10.1113/jphysiol.2002.029488; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shen KZ, 2014, NEUROSCIENCE, V274, P138, DOI 10.1016/j.neuroscience.2014.05.031; Shen KZ, 2010, J NEUROSCI, V30, P1882, DOI 10.1523/JNEUROSCI.3200-09.2010; Silva JR, 2014, BIOPHYS J, V107, P2016, DOI 10.1016/j.bpj.2014.09.037; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Wu Y, 2015, J BIOL CHEM, V290, P29676, DOI 10.1074/jbc.M115.670877; Wu ZY, 2012, TRAFFIC, V13, P1124, DOI 10.1111/j.1600-0854.2012.01373.x; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002	52	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15512	15524		10.1074/jbc.M117.802249	http://dx.doi.org/10.1074/jbc.M117.802249			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768770	hybrid, Green Published			2022-12-28	WOS:000410809800030
J	Sullivan, LC; Walpole, NG; Farenc, C; Pietra, G; Sum, MJW; Clements, CS; Lee, EJ; Beddoe, T; Falco, M; Mingari, MC; Moretta, L; Gras, S; Rossjohn, J; Brooks, AG				Sullivan, Lucy C.; Walpole, Nicholas G.; Farenc, Carine; Pietra, Gabriella; Sum, Matthew J. W.; Clements, Craig S.; Lee, Eleanor J.; Beddoe, Travis; Falco, Michela; Mingari, Maria Cristina; Moretta, Lorenzo; Gras, Stephanie; Rossjohn, Jamie; Brooks, Andrew G.			A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct alpha beta T cell receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; E-RESTRICTED RECOGNITION; CLASS IB MOLECULES; HLA-E; STRUCTURAL BASIS; HUMAN CYTOMEGALOVIRUS; ANTIVIRAL IMMUNITY; PEPTIDE; IDENTIFICATION; LYMPHOCYTES	alpha beta T cell receptors (TCRs) interact with peptides bound to the polymorphic major histocompatibility complex class Ia (MHC-Ia) and class II (MHC-II) molecules as well as the essentially monomorphic MHC class Ib (MHC-Ib) molecules. Although there is a large amount of information on how TCRs engage with MHC-Ia and MHC-II, our understanding of TCR/MHC-Ib interactions is very limited. Infection with cytomegalovirus (CMV) can elicit a CD8(+) Tcell response restricted by the human MHC-Ib molecule human leukocyte antigen (HLA)-E and specific for an epitope from UL40 (VMAPRTLIL), which is characterized by biased TRBV14 gene usage. Here we describe an HLA-E-restricted CD8(+) T cell able to recognize an allotypic variant of the UL40 peptide with a modification at position 8 (P8) of the peptide (VMAPRTLVL) that uses the TRBV9 gene segment. Wereport the structures of a TRBV9(+) TCR in complex with the HLA-E molecule presenting the two peptides. Our data revealed that the TRBV9(+) TCR adopts a different docking mode and molecular footprint atop HLA-E when compared with the TRBV14(+) TCR-HLA-E ternary complex. Additionally, despite their differing V gene segment usage and different docking mechanisms, mutational analyses showed that the TCRs shared a conserved energetic footprint on the HLA-E molecule, focused around the peptide-binding groove. Hence, we provide new insights into how monomorphic MHC molecules interact with T cells.	[Sullivan, Lucy C.; Sum, Matthew J. W.; Lee, Eleanor J.; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Sullivan, Lucy C.; Sum, Matthew J. W.; Lee, Eleanor J.; Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia; [Walpole, Nicholas G.; Farenc, Carine; Clements, Craig S.; Beddoe, Travis; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Walpole, Nicholas G.; Farenc, Carine; Clements, Craig S.; Beddoe, Travis; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Pietra, Gabriella; Mingari, Maria Cristina] Univ Genoa, Dept Expt Med DiMES, I-16132 Genoa, Italy; [Mingari, Maria Cristina] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Pietra, Gabriella; Mingari, Maria Cristina] Osped Policlin San Martino, Unita Operat Complessa Immunol, I-16132 Genoa, Italy; [Falco, Michela; Moretta, Lorenzo] Osped Pediat Bambino Gesu, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; University of Melbourne; Monash University; Monash University; Monash University; University of Genoa; University of Genoa; IRCCS Bambino Gesu; Cardiff University	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.; Brooks, AG (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia.; Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	jamie.rossjohn@monash.edu; agbrooks@unimelb.edu.au	pietra, gabriella/J-7204-2016; Rossjohn, Jamie/F-9032-2013; Moretta, Lorenzo/AAA-7239-2020; Mingari, Maria Cristina/AAB-1315-2019; Beddoe, Travis/F-3415-2014; Falco, Michela/K-1574-2016	pietra, gabriella/0000-0002-7080-531X; Rossjohn, Jamie/0000-0002-2020-7522; Moretta, Lorenzo/0000-0003-4658-1747; Beddoe, Travis/0000-0003-4550-2277; gras, stephanie/0000-0001-7416-038X; Sullivan, Lucy/0000-0003-2907-4989; Farenc, Carine/0000-0001-6383-3032; Brooks, Andrew/0000-0002-4085-9683; Falco, Michela/0000-0002-0317-9830				Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bricogne G, 2016, BUSTER; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chang L, 2003, TISSUE ANTIGENS, V62, P408, DOI 10.1034/j.1399-0039.2003.00122.x; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Grimsley C, 2002, TISSUE ANTIGENS, V60, P206, DOI 10.1034/j.1399-0039.2002.600302.x; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Joly E, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-2; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kulski JK, 2000, J MOL EVOL, V50, P510, DOI 10.1007/s002390010054; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; Mazzarino P, 2005, EUR J IMMUNOL, V35, P3240, DOI 10.1002/eji.200535343; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Romagnani C, 2004, HUM IMMUNOL, V65, P437, DOI 10.1016/j.humimm.2004.02.001; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Soloski MJ, 2001, MICROBES INFECT, V3, P1249, DOI 10.1016/S1286-4579(01)01485-X; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Sullivan LC, 2006, TRENDS IMMUNOL, V27, P413, DOI 10.1016/j.it.2006.07.006; Swanson PA, 2008, J EXP MED, V205, P1647, DOI 10.1084/jem.20080570; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21149	21158		10.1074/jbc.M117.807719	http://dx.doi.org/10.1074/jbc.M117.807719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	28972140	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000418453400029
J	Carney, SM; Gomathinayagam, S; Leuba, SH; Trakselis, MA				Carney, Sean M.; Gomathinayagam, Shivasankari; Leuba, Sanford H.; Trakselis, Michael A.			Bacterial DnaB helicase interacts with the excluded strand to regulate unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA replication; DNA-protein interaction; nucleic acid enzymology; single-molecule biophysics; DnaB; steric exclusion and wrapping; unwinding	SINGLE-MOLECULE FRET; ESCHERICHIA-COLI; REPLICATIVE HELICASE; HEXAMERIC HELICASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BRANCH MIGRATION; STRUCTURAL BASIS; PROTEIN HEXAMER; MCM HELICASE	Replicative hexameric helicases are thought to unwind duplex DNA by steric exclusion (SE) where one DNA strand is encircled by the hexamer and the other is excluded from the central channel. However, interactions with the excluded strand on the exterior surface of hexameric helicases have also been shown to be important for DNA unwinding, giving rise to the steric exclusion and wrapping (SEW) model. For example, the archaeal Sulfolobus solfataricus minichromosome maintenance (SsoMCM) helicase has been shown to unwind DNA via a SEW mode to enhance unwinding efficiency. Using single-molecule FRET, we now show that the analogous Escherichia coli (Ec) DnaB helicase also interacts specifically with the excluded DNA strand during unwinding. Mutation of several conserved and positively charged residues on the exterior surface of EcDnaB resulted in increased interaction dynamics and states compared with wild type. Surprisingly, these mutations also increased the DNA unwinding rate, suggesting that electrostatic contacts with the excluded strand act as a regulator for unwinding activity. In support of this, experiments neutralizing the charge of the excluded strand with a morpholino substrate instead of DNA also dramatically increased the unwinding rate. Of note, although the stability of the excluded strand was nearly identical for EcDnaB and SsoMCM, these enzymes are from different superfamilies and unwind DNA with opposite polarities. These results support the SEW model of unwinding for EcDnaB that expands on the existing SE model of hexameric helicase unwinding to include contributions from the excluded strand to regulate the DNA unwinding rate.	[Carney, Sean M.; Leuba, Sanford H.; Trakselis, Michael A.] Univ Pittsburgh, Mol Biophys & Struct Biol Program, Pittsburgh, PA 15260 USA; [Gomathinayagam, Shivasankari; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, One Bear Pl 97365, Waco, TX 76798 USA; [Leuba, Sanford H.] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15261 USA; [Carney, Sean M.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School	Trakselis, MA (corresponding author), Baylor Univ, Dept Chem & Biochem, One Bear Pl 97365, Waco, TX 76798 USA.	michael_trakselis@baylor.edu	Trakselis, Michael/V-3806-2019	Leuba, Sanford/0000-0003-0278-7997; Trakselis, Michael/0000-0001-7054-8475; Carney, Sean/0000-0002-2674-1064	Baylor University; University of Pittsburgh; American Cancer Society Research Scholar Grant [RSG-11-049-01-DMC]; National Science Foundation Division of Molecular and Cellular Biosciences [NSF1613534]; National Institutes of Health [AI081571, GM068406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068406] Funding Source: NIH RePORTER	Baylor University; University of Pittsburgh(University of Pittsburgh); American Cancer Society Research Scholar Grant(American Cancer Society); National Science Foundation Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Baylor University, The University of Pittsburgh, American Cancer Society Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.), National Science Foundation Division of Molecular and Cellular Biosciences Grant NSF1613534 (to M. A. T.), and National Institutes of Health Grants AI081571 and GM068406 (to S. H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10929, DOI 10.1021/bi990049l; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Fagerburg MV, 2011, METHODS MOL BIOL, V749, P273, DOI 10.1007/978-1-61779-142-0_19; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2016, J BIOL CHEM, V291, P12467, DOI 10.1074/jbc.M116.719591; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Nhieu GTV, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3495, 10.1038/ncomms2561]; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jeong YJ, 2013, NUCLEIC ACIDS RES, V41, P4219, DOI 10.1093/nar/gkt133; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Lee SJ, 2014, P NATL ACAD SCI USA, V111, pE827, DOI 10.1073/pnas.1322254111; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6187, DOI 10.1093/nar/gks254; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Rasband W., 2006, IMAGEJ; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sambrook J., 2001, MOL CLONING LAB MANU; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Schauer GD, 2014, NUCLEIC ACIDS RES, V42, P11687, DOI 10.1093/nar/gku819; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Trakselis M.A., 2016, F1000RES, V5; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19001	19012		10.1074/jbc.M117.814178	http://dx.doi.org/10.1074/jbc.M117.814178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939774	Green Published, hybrid			2022-12-28	WOS:000415848000023
J	Oka, S; Hirata, T; Suzuki, W; Naito, D; Chen, YB; Chin, A; Yaginuma, H; Saito, T; Nagarajan, N; Zhai, PY; Bhat, S; Schesing, K; Shao, D; Hirabayashi, Y; Yodoi, J; Sciarretta, S; Sadoshima, J				Oka, Shin-ichi; Hirata, Tsuyoshi; Suzuki, Wataru; Naito, Daichi; Chen, Yanbin; Chin, Adave; Yaginuma, Hiroaki; Saito, Toshiro; Nagarajan, Narayani; Zhai, Peiyong; Bhat, Santosh; Schesing, Kevin; Shao, Dan; Hirabayashi, Yoko; Yodoi, Junji; Sciarretta, Sebastiano; Sadoshima, Junichi			Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart; mechanistic target of rapamycin (mTOR); oxidative stress; redox regulation; thioredoxin	CARDIAC-HYPERTROPHY; MAMMALIAN TARGET; PATHWAY; MITOCHONDRIAL; COMPLEX; DISEASE; HEART; INHIBITION; ACTIVATION; APOPTOSIS	Thioredoxin 1 (Trx1) is a 12-kDa oxidoreductase that catalyzes thiol-disulfide exchange reactions to reduce proteins with disulfide bonds. As such, Trx1 helps protect the heart against stresses, such as ischemia and pressure overload. Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that regulates cell growth, metabolism, and survival. We have shown previously that mTOR activity is increased in response to myocardial ischemia-reperfusion injury. However, whether Trx1 interacts with mTOR to preserve heart function remains unknown. Using a substrate-trapping mutant of Trx1 (Trx1C35S), we show here that mTOR is a direct interacting partner of Trx1 in the heart. In response to H2O2 treatment in cardiomyocytes, mTOR exhibited a high molecular weight shift in non-reducing SDS-PAGE in a 2-mercaptoethanol-sensitive manner, suggesting that mTOR is oxidized and forms disulfide bonds with itself or other proteins. The mTOR oxidation was accompanied by reduced phosphorylation of endogenous substrates, such as S6 kinase (S6K) and 4E-binding protein 1 (4E-BP1) in cardiomyocytes. Immune complex kinase assays disclosed that H2O2 treatment diminished mTOR kinase activity, indicating that mTOR is inhibited by oxidation. Of note, Trx1 overexpression attenuated both H2O2-mediated mTOR oxidation and inhibition, whereas Trx1 knockdown increased mTOR oxidation and inhibition. Moreover, Trx1 normalized H2O2-induced down-regulation of metabolic genes and stimulation of cell death, and an mTOR inhibitor abolished Trx1-mediated rescue of gene expression. H2O2-induced oxidation and inhibition of mTOR were attenuated when Cys-1483 of mTOR was mutated to phenylalanine. These results suggest that Trx1 protects cardiomyocytes against stress by reducing mTOR at Cys-1483, thereby preserving the activity of mTOR and inhibiting cell death.	[Oka, Shin-ichi; Hirata, Tsuyoshi; Suzuki, Wataru; Naito, Daichi; Chin, Adave; Yaginuma, Hiroaki; Saito, Toshiro; Nagarajan, Narayani; Zhai, Peiyong; Bhat, Santosh; Schesing, Kevin; Shao, Dan; Sadoshima, Junichi] Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave,MSB G609, Newark, NJ 07101 USA; [Chen, Yanbin] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, 899 Pinghai Rd, Suzhou 215000, Peoples R China; [Hirabayashi, Yoko] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Ctr Biol Safety & Res, Tokyo 1588501, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent,Sakyo Ku, Kyoto 6068397, Japan; [Sciarretta, Sebastiano] Univ Rome, Dept Med Surg Sci & Biotechnol, I-04100 Latina, Italy	Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China; National Institute of Health Sciences - Japan; Kyoto University	Sadoshima, J (corresponding author), Rutgers Biomed & Hlth Sci, Dept Cell Biol & Mol Med, 185 S Orange Ave,MSB G609, Newark, NJ 07101 USA.	sadoshju@njms.rutgers.edu	Masutani, Hiroshi/B-5114-2014; saito, toshiro/AAW-8979-2021; Sciarretta, Sebastiano/K-5161-2016	saito, toshiro/0000-0003-0845-9265; Sadoshima, Junichi/0000-0003-3724-4132; Sciarretta, Sebastiano/0000-0002-8633-6896	Public Health Service [HL67724, HL91469, HL102738, HL112330, AG23039]; Leducq Foundation Transatlantic Network of Excellence; American Heart Association [12SDG11890014, 17GRNT33440031]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112330, R01HL102738, R01HL091469, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Leducq Foundation Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Public Health Service Grants HL67724, HL91469, HL102738, HL112330, and AG23039 (to J. S.) and by the Leducq Foundation Transatlantic Network of Excellence (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Scientist Development Grant 12SDG11890014 and Grant-in-Aid 17GRNT33440031 from the American Heart Association.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ago T, 2006, ANTIOXID REDOX SIGN, V8, P1635, DOI 10.1089/ars.2006.8.1635; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Du CY, 2016, INT J BIOCHEM CELL B, V79, P1, DOI 10.1016/j.biocel.2016.08.006; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29196; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Matsushima S, 2016, J CLIN INVEST, V126, P3403, DOI 10.1172/JCI85624; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nagarajan N, 2017, FREE RADICAL BIO MED, V109, P125, DOI 10.1016/j.freeradbiomed.2016.12.020; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Sanchez-Villamil JP, 2016, INT J BIOCHEM CELL B, V81, P323, DOI 10.1016/j.biocel.2016.08.045; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Simon MC, 2008, ANNU REV PHYSIOL, V70, P51, DOI 10.1146/annurev.physiol.70.113006.100526; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang LQ, 2009, FREE RADICAL BIO MED, V46, P1500, DOI 10.1016/j.freeradbiomed.2009.03.001	36	30	30	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18988	19000		10.1074/jbc.M117.807735	http://dx.doi.org/10.1074/jbc.M117.807735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939765	Green Published, hybrid			2022-12-28	WOS:000415848000022
J	Cushing, L; Winkler, A; Jelinsky, SA; Lee, K; Korver, W; Hawtin, R; Rao, VR; Fleming, M; Lin, LL				Cushing, Leah; Winkler, Aaron; Jelinsky, Scott A.; Lee, Katherine; Korver, Wouter; Hawtin, Rachael; Rao, Vikram R.; Fleming, Margaret; Lin, Lih-Ling			IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; inflammation; interferon regulatory factor; IRF5; NFB; Toll-like receptor; TLR; IRAK4; TAK1; IKK	NF-KAPPA-B; INTERFERON REGULATORY FACTOR; GENE-EXPRESSION SIGNATURE; IKK-BETA; PERIPHERAL-BLOOD; INTERLEUKIN-1; ACTIVATION; LUPUS; INDUCTION; PROTEIN	Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in innate immune signaling by Toll-like receptors (TLRs), and loss of IRAK4 activity in mice and humans increases susceptibility to bacterial infections and causes defects in TLR and IL1 ligand sensing. However, the mechanism by which IRAK4 activity regulates the production of downstream inflammatory cytokines is unclear. Using transcriptomic and biochemical analyses of human monocytes treated with a highly potent and selective inhibitor of IRAK4, we show that IRAK4 kinase activity controls the activation of interferon regulatory factor 5 (IRF5), a transcription factor implicated in the pathogenesis of multiple autoimmune diseases. Following TLR7/8 stimulation by its agonist R848, chemical inhibition of IRAK4 abolished IRF5 translocation to the nucleus and thus prevented IRF5 binding to and activation of the promoters of inflammatory cytokines in human monocytes. We also found that IKK, an upstream IRF5 activator, is phosphorylated in response to the agonist-induced TLR signaling. Of note, IRAK4 inhibition blocked IKK phosphorylation but did not block the nuclear translocation of NFB, which was surprising, given the canonical role of IKK in phosphorylating IB to allow NFB activation. Moreover, pharmacological inhibition of either IKK or the serine/threonine protein kinase TAK1 in monocytes blocked TLR-induced cytokine production and IRF5 translocation to the nucleus, but not nuclear translocation of NFB. Taken together, our data suggest a mechanism by which IRAK4 activity regulates TAK1 and IKK activation, leading to the nuclear translocation of IRF5 and induction of inflammatory cytokines in human monocytes.	[Cushing, Leah; Winkler, Aaron; Jelinsky, Scott A.; Rao, Vikram R.; Fleming, Margaret; Lin, Lih-Ling] Pfizer Inc, Dept Inflammat & Immunol, Cambridge, MA 02139 USA; [Lee, Katherine] Pfizer Inc, Dept Med Chem, Cambridge, MA 02139 USA; [Korver, Wouter; Hawtin, Rachael] Nodality Inc, San Francisco, CA 94080 USA; [Cushing, Leah] EMD Serono Inc, 45 Middlesex Turnpike, Billerica, MA 01821 USA; [Korver, Wouter] Allakos Inc, 75 Shoreway Rd,Suite A, San Carlos, CA 94070 USA; [Hawtin, Rachael] Gilead Sci, 333 Lakeside Dr, Foster City, CA 94404 USA; [Fleming, Margaret] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Pfizer; Pfizer; Merck KGaA; EMD Serono Inc.; Gilead Sciences; Novartis	Lin, LL (corresponding author), 1 Portland St, Cambridge, MA 02139 USA.	lih-ling.lin@pfizer.com						Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cesano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056714; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Cushing L, 2014, J BIOL CHEM, V289, P10865, DOI 10.1074/jbc.M113.544809; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; Dudhgaonkar S, 2017, J IMMUNOL, V198, P1308, DOI 10.4049/jimmunol.1600583; Feng D, 2012, EUR J IMMUNOL, V42, P1477, DOI 10.1002/eji.201141642; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Hayden MS, 2014, P NATL ACAD SCI USA, V111, P17348, DOI 10.1073/pnas.1419689111; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Richez C, 2010, JOINT BONE SPINE, V77, P525, DOI 10.1016/j.jbspin.2010.08.005; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Seganish WM, 2016, EXPERT OPIN THER PAT, V26, P917, DOI 10.1080/13543776.2016.1202926; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	43	43	47	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18689	18698		10.1074/jbc.M117.796912	http://dx.doi.org/10.1074/jbc.M117.796912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924041	Green Published, hybrid			2022-12-28	WOS:000414958100025
J	Hu, ZY; Chen, B; Zhang, JP; Ma, YY				Hu, Zhan-ying; Chen, Bo; Zhang, Jing-pu; Ma, Yuan-yuan			Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein; autophagy; neurodegenerative disease; Parkin; Parkinson disease; PTEN-induced putative kinase 1 (PINK1); zebrafish; atg5	LIVE TRANSGENIC ZEBRAFISH; ALPHA-SYNUCLEIN; MOUSE MODEL; IN-VIVO; PINK1; MPTP; MITOPHAGY; MECHANISMS; APOPTOSIS; NEURODEGENERATION	Parkinson's disease (PD) is one of the most epidemic neurodegenerative diseases and is characterized by movement disorders arising from loss of midbrain dopaminergic (DA) neurons. Recently, the relationship between PD and autophagy has received considerable attention, but information about the mechanisms involved is lacking. Here, we report that autophagy-related gene 5 (ATG5) is potentially important in protecting dopaminergic neurons in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model in zebrafish. Using analyses of zebrafish swimming behavior, in situ hybridization, immunofluorescence, and expressions of genes and proteins related to PD and autophagy, we found that the ATG5 expression level was decreased and autophagy flux was blocked in this model. The ATG5 down-regulation led to the upgrade of PD-associated proteins, such as -synuclein, Parkin, and PINK1, aggravation of MPTP-induced PD-mimicking pathological locomotor behavior, DA neuron loss labeled by tyrosine hydroxylase (TH) or dopamine transporter (DAT), and blocked autophagy flux in the zebrafish model. ATG5 overexpression alleviated or reversed these PD pathological features, rescued DA neuron cells as indicated by elevated TH/DAT levels, and restored autophagy flux. The role of ATG5 in protecting DA neurons was confirmed by expression of the human atg5 gene in the zebrafish model. Our findings reveal that ATG5 has a role in neuroprotection, and up-regulation of ATG5 may serve as a goal in the development of drugs for PD prevention and management.	[Zhang, Jing-pu] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JP (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.	zhangjingpu@imb.pumc.edu.cn	Hu, Zhanying/AAE-8790-2019	Hu, Zhanying/0000-0002-4169-7778	National Natural Science Foundation of China [81173043]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81321004]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-2-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This work was supported by National Natural Science Foundation of China Grant 81173043, Foundation for Innovative Research Groups of the National Natural Science Foundation of China Grant 81321004, and Chinese Academy of Medical Sciences Initiative for Innovative Medicine Grant 2016-I2M-2-006). The authors declare that they have no conflicts of interest with the contents of this article.	Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Arnold MC, 2016, ARCH ENVIRON CON TOX, V70, P311, DOI 10.1007/s00244-015-0235-7; Barodia SK, 2017, BRAIN RES BULL, V133, P51, DOI 10.1016/j.brainresbull.2016.12.004; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Colasanti T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.211; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Emamzadeh FN, 2016, J RES MED SCI, V21, P165, DOI 10.4103/1735-1995.181989; Gallegos S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00059; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Garcia-Garcia A, 2013, TOXICOL SCI, V136, P166, DOI 10.1093/toxsci/kft188; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hu ZY, 2011, AUTOPHAGY, V7, P1514, DOI 10.4161/auto.7.12.18040; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Kanaan NM, 2012, J PARKINSON DIS, V2, P249, DOI 10.3233/JPD-012138; Kesidou E, 2013, NEURAL REGEN RES, V8, P2275, DOI 10.3969/j.issn.1673-5374.2013.24.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; L'Episcopo F, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-83; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li JJ, 2015, ONCOTARGET, V6, P40480, DOI 10.18632/oncotarget.5803; Longhena F, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5012129; Lv XH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06010; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Giraldez-Perez RM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0176-9; Martinez-Vicente M, 2015, SEMIN CELL DEV BIOL, V40, P115, DOI 10.1016/j.semcdb.2015.03.005; Meredith GE, 2009, EXP NEUROL, V219, P334, DOI 10.1016/j.expneurol.2009.06.005; Miki Y, 2016, BRAIN PATHOL, V26, P359, DOI 10.1111/bpa.12297; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Mizushima N, 2002, SEIKAGAKU, V74, P523; Murakami T, 2007, J NEUROL NEUROSUR PS, V78, P653, DOI 10.1136/jnnp.2006.100123; Nah J, 2015, MOL CELLS, V38, P381, DOI 10.14348/molcells.2015.0034; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nardin A, 2016, CURR NEUROPHARMACOL, V14, P250, DOI 10.2174/1570159X13666151030104414; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Norris KL, 2015, J BIOL CHEM, V290, P13862, DOI 10.1074/jbc.M114.634063; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Toni M, 2015, MAR DRUGS, V13, P6665, DOI 10.3390/md13116665; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Varga M, 2014, CELL DEATH DIFFER, V21, P547, DOI 10.1038/cdd.2013.175; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2; Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477; Xu M, 2016, FRONT BIOSCI-LANDMRK, V21, P696, DOI 10.2741/4415; Yokoyama H, 2011, ACTA NEUROBIOL EXP, V71, P269; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang H, 2015, MOL NEUROBIOL, V51, P89, DOI 10.1007/s12035-014-8787-5	70	45	48	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18062	18074		10.1074/jbc.M116.764795	http://dx.doi.org/10.1074/jbc.M116.764795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28928221	Green Published, hybrid			2022-12-28	WOS:000414458200007
J	Waraky, A; Lin, YB; Warsito, D; Haglund, F; Aleem, E; Larsson, O				Waraky, Ahmed; Lin, Yingbo; Warsito, Dudi; Haglund, Felix; Aleem, Eiman; Larsson, Olle			Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); phosphorylation; post-transcriptional regulation; proliferating cell nuclear antigen (PCNA); ubiquitin	IGF-1 RECEPTOR; POLYMERASE-ETA; FACTOR-I; TYROSINE PHOSPHORYLATION; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; UBIQUITIN LIGASE; HUMAN SHPRH; POL-ETA; PCNA	We have previously shown that the insulin-like growth factor 1 receptor (IGF-1R) translocates to the cell nucleus, where it binds to enhancer-like regions and increases gene transcription. Further studies have demonstrated that nuclear IGF-1R (nIGF-1R) physically and functionally interacts with some nuclear proteins, i.e. the lymphoid enhancer-binding factor 1 (Lef1), histone H3, and Brahma-related gene-1 proteins. In this study, we identified the proliferating cell nuclear antigen (PCNA) as a nIGF-1R-binding partner. PCNA is a pivotal component of the replication fork machinery and a main regulator of the DNA damage tolerance (DDT) pathway. We found that IGF-1R interacts with and phosphorylates PCNA in human embryonic stem cells and other cell lines. In vitro MS analysis of PCNA co-incubated with the IGF-1R kinase indicated tyrosine residues 60, 133, and 250 in PCNA as IGF-1R targets, and PCNA phosphorylation was followed by mono- and polyubiquitination. Co-immunoprecipitation experiments suggested that these ubiquitination events may be mediated by DDT-dependent E2/E3 ligases (e.g. RAD18 and SHPRH/HLTF). Absence of IGF-1R or mutation of Tyr-60, Tyr-133, or Tyr-250 in PCNA abrogated its ubiquitination. Unlike in cells expressing IGF-1R, externally induced DNA damage in IGF-1R-negative cells caused G(1) cell cycle arrest and S phase fork stalling. Taken together, our results suggest a role of IGF-1R in DDT.	[Waraky, Ahmed; Lin, Yingbo; Warsito, Dudi; Haglund, Felix; Aleem, Eiman; Larsson, Olle] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Aleem, Eiman] Univ Arizona, Phoenix Childrens Hosp, Inst Mol Med, Phoenix, AZ 85004 USA; [Aleem, Eiman] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA	Karolinska Institutet; Phoenix Children's Hospital; University of Arizona; University of Arizona	Larsson, O (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, SE-17176 Stockholm, Sweden.	olle.larsson@ki.se	Aleem, Eiman/AAK-3208-2021	Aleem, Eiman/0000-0002-9215-8213; Waraky, Ahmed/0000-0003-4635-021X	Swedish Cancer Foundation; Swedish Research Council; Cancer Society in Stockholm; Swedish Children Cancer Society; Stockholm County Council; Karolinska Institutet	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Swedish Children Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the Cancer Society in Stockholm, the Swedish Children Cancer Society, Stockholm County Council, and the Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Baple EL, 2014, J CLIN INVEST, V124, P3137, DOI 10.1172/JCI74593; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; Castells-Roca L, 2015, CELL CYCLE, V14, P467, DOI 10.1080/15384101.2015.1006543; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chitnis MM, 2014, ONCOGENE, V33, P5262, DOI 10.1038/onc.2013.460; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; de Feraudy S, 2007, ONCOGENE, V26, P5713, DOI 10.1038/sj.onc.1210385; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Ermolaeva MA, 2015, AGEING RES REV, V23, P3, DOI 10.1016/j.arr.2014.12.009; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Lin YB, 2017, J CELL PHYSIOL, V232, P2722, DOI 10.1002/jcp.25818; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Niu MZ, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-4; Olsen H, 2006, EXP CELL RES, V312, P1371, DOI 10.1016/j.yexcr.2005.12.023; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; Parvaresch S, 2002, FEBS LETT, V532, P357, DOI 10.1016/S0014-5793(02)03708-0; PIETRZKOWSKI Z, 1992, MOL CELL BIOL, V12, P3883, DOI 10.1128/MCB.12.9.3883; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Pohlhaus JR, 2006, METHOD ENZYMOL, V409, P477, DOI 10.1016/S0076-6879(05)09028-2; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; PROSPERI E, 1993, EXP CELL RES, V205, P320, DOI 10.1006/excr.1993.1092; Schwab R. A., 2011, JOVE-J VIS EXP, V27; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stary A, 2002, RES MICROBIOL, V153, P441, DOI 10.1016/S0923-2508(02)01343-8; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Waraky A, 2016, BIOCHEM BIOPH RES CO, V478, P1575, DOI 10.1016/j.bbrc.2016.08.157; Waraky A, 2014, ONCOTARGET, V5, P8379, DOI 10.18632/oncotarget.2292; Warsito D, 2016, ONCOTARGET, V7, P42288, DOI 10.18632/oncotarget.9785; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang XH, 2009, CELL CYCLE, V8, P191, DOI 10.4161/cc.8.2.7357; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84	53	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18227	18239		10.1074/jbc.M117.781492	http://dx.doi.org/10.1074/jbc.M117.781492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924044	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000414458200020
J	Siripurapu, P; Kankanamge, D; Ratnayake, K; Senarath, K; Karunarathne, A				Siripurapu, Praneeth; Kankanamge, Dinesh; Ratnayake, Kasun; Senarath, Kanishka; Karunarathne, Ajith			Two independent but synchronized G beta gamma subunit-controlled pathways are essential for trailing-edge retraction during macrophage migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; NUCLEOTIDE EXCHANGE FACTOR; PROTEIN-COUPLED RECEPTORS; IMMUNE CELL-MIGRATION; PHOSPHOLIPASE-C-BETA; NEUTROPHIL CHEMOTAXIS; ADENYLYL-CYCLASE; SMOOTH-MUSCLE; RHO-KINASE; SIGNALING PATHWAYS	Chemokine-induced directional cell migration is a universal cellular mechanism and plays crucial roles in numerous biological processes, including embryonic development, immune system function, and tissue remodeling and regeneration. During the migration of a stationary cell, the cell polarizes, forms lamel-lipodia at the leading edge (LE), and triggers the concurrent retraction of the trailing edge (TE). During cell migration governed by inhibitory G protein (G(i))-coupled receptors (GPCRs), G protein beta gamma (G beta gamma) subunits control the LE signaling. Interestingly, TE retraction has been linked to the activation of the small GTPase Ras homolog family member A (RhoA) by the G alpha(12/13) pathway. However, it is not clear how the activation of Gi-coupled GPCRs at the LE orchestrates the TE retraction in RAW264.7 macrophages. Here, using an optogenetic approach involving an opsin to activate the Gi pathway in defined subcellular regions of RAW cells, we show that in addition to their LE activities, free G beta gamma subunits also govern TE retraction by operating two independent, yet synchronized, pathways. The first pathway involves RhoA activation, which prevents dephosphorylation of the myosin light chain, allowing actomyosin contractility to proceed. The second pathway activates phospholipase C beta and induces myosin light chain phosphorylation to enhance actomyosin contractility through increasing cytosolic calcium. We further show that both of these pathways are essential, and inhibition of either one is sufficient to abolish the G(i)-coupled GPCR-governed TE retraction and subsequent migration of RAW cells.	[Siripurapu, Praneeth; Kankanamge, Dinesh; Ratnayake, Kasun; Senarath, Kanishka; Karunarathne, Ajith] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Karunarathne, A (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	Ajith.karunarathne@utoledo.edu		Kankanamge, Dinesh/0000-0001-9647-0258; Karunarathne, Ajith/0000-0003-3136-2015; Senarath, Kanishka/0000-0003-3326-9738	University of Toledo	University of Toledo	This work was supported by the University of Toledo. The authors declare that they have no conflicts of interest with the contents of this article.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Burdyga A, 2013, BBA-MOL CELL RES, V1833, P2664, DOI 10.1016/j.bbamcr.2013.06.011; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Czepielewski RS, 2012, P NATL ACAD SCI USA, V109, P547, DOI 10.1073/pnas.1110996109; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fogg VC, 2001, J BIOL CHEM, V276, P41797, DOI 10.1074/jbc.M107661200; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x; Ghosh P., 2008, J CELL BIOL; Giri L, 2014, BIOPHYS J, V107, P242, DOI 10.1016/j.bpj.2014.05.020; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Hutchins BI, 2013, J NEUROSCI, V33, P11361, DOI 10.1523/JNEUROSCI.3758-12.2013; ISHIKAWA S, 1993, BIOCHEM BIOPH RES CO, V194, P287, DOI 10.1006/bbrc.1993.1817; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Karunarathne WKA, 2015, J CELL SCI, V128, P15, DOI 10.1242/jcs.154435; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1575, DOI 10.1073/pnas.1220755110; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kranenburg O., 1999, MOL, V12; Legler DF, 2014, INT J BIOCHEM CELL B, V54, P78, DOI 10.1016/j.biocel.2014.07.002; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liu LH, 2014, MOL BIOL CELL, V25, P1446, DOI 10.1091/mbc.E14-01-0037; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nalli AD, 2014, J PHARMACOL EXP THER, V350, P89, DOI 10.1124/jpet.113.212522; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; O'Neill PR, 2016, MOL BIOL CELL, V27, P1442, DOI 10.1091/mbc.E15-12-0832; O'Neill PR, 2014, MOL BIOL CELL, V25, P2305, DOI 10.1091/mbc.E14-04-0870; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Senarath K, 2016, ANAL CHEM, V88, P11450, DOI 10.1021/acs.analchem.6b02512; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yost EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116575; Zhao ZQ, 2014, NEURON, V84, P821, DOI 10.1016/j.neuron.2014.10.003	85	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17482	17495		10.1074/jbc.M117.787838	http://dx.doi.org/10.1074/jbc.M117.787838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28864771	Green Published, hybrid			2022-12-28	WOS:000414009300028
J	Stiegler, SC; Rubbelke, M; Korotkov, VS; Weiwad, M; John, C; Fischer, G; Sieber, SA; Sattler, M; Buchner, J				Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; Weiwad, Matthias; John, Christine; Fischer, Gunter; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes			A chemical compound inhibiting the Aha1-Hsp90 chaperone complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; biophysics; heat shock protein 90 (Hsp90); molecular chaperone; protein folding; co-chaperones	TRANSMEMBRANE CONDUCTANCE REGULATOR; GLUCOCORTICOID-RECEPTOR FUNCTION; CLIENT PROTEIN-ACTIVATION; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; CYSTIC-FIBROSIS; COCHAPERONE AHA1; ATPASE ACTIVITY; MINERALOCORTICOID RECEPTOR; CONFORMATIONAL-CHANGES	The eukaryotic Hsp90 chaperone machinery comprises many co-chaperones and regulates the conformation of hundreds of cytosolic client proteins. Therefore, it is not surprising that the Hsp90 machinery has become an attractive therapeutic target for diseases such as cancer. The compounds used so far to target this machinery affect the entire Hsp90 system. However, it would be desirable to achieve a more selective targeting of Hsp90-co-chaperone complexes. To test this concept, in this-proof-of-principle study, we screened for modulators of the interaction between Hsp90 and its co-chaperone Aha1, which accelerates the ATPase activity of Hsp90. A FRET-based assay that monitored Aha1 binding to Hsp90 enabled identification of several chemical compounds modulating the effect of Aha1 on Hsp90 activity. We found that one of these inhibitors can abrogate the Aha1-induced ATPase stimulation of Hsp90 without significantly affecting Hsp90 ATPase activity in the absence of Aha1. NMR spectroscopy revealed that this inhibitory compound binds the N-terminal domain of Hsp90 close to its ATP-binding site and overlapping with a transient Aha1-interaction site. We also noted that this inhibitor does not dissociate the Aha1-Hsp90 complex but prevents the specific interaction with the N-terminal domain of Hsp90 required for catalysis. In consequence, the inhibitor affected the activation and processing of Hsp90-Aha1-dependent client proteins in vivo. We conclude that it is possible to abrogate a specific co-chaperone function of Hsp90 without inhibiting the entire Hsp90 machinery. This concept may also hold true for other co-chaperones of Hsp90.	[Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; John, Christine; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Weiwad, Matthias; Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Ruebbelke, Martin; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Weiwad, Matthias] Martin Luther Univ Halle Wittenberg, Inst Biochem, Weinbergweg 22, D-06120 Halle, Germany; [Fischer, Gunter] Max Planck Inst Biophys Chem Goettingen, Weinbergweg 22, D-06120 Halle, Germany	Technical University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany.	johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010; Sattler, Michael/A-2407-2012	Sattler, Michael/0000-0002-1594-0527; Buchner, Johannes/0000-0003-1282-7737	BMBF [ProNet T3]; Deutsche Forschungsgemeinschaft [SFB 1035]; Studienstiftung des deutschen Volkes	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by a grant from the BMBF Project ProNet T3 (to J. B.), Deutsche Forschungsgemeinschaft Grant SFB 1035 (to J. B., M. S., and S. A. S.), and a doctoral scholarship from the Studienstiftung des deutschen Volkes (to S. C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Brodsky JL, 1998, BIOCHEMISTRY-US, V37, P18045, DOI 10.1021/bi980900g; Bruner KL, 1997, RECEPT SIGNAL TRANS, V7, P85; Buchner J, 1998, METHOD ENZYMOL, V290, P418, DOI 10.1016/S0076-6879(98)90035-0; Burlison JA, 2006, ORG LETT, V8, P4855, DOI 10.1021/ol061918j; Chong P. A., 2013, COLD SPRING HARB PER, V3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunn DM, 2015, CELL REP, V12, P1006, DOI 10.1016/j.celrep.2015.07.004; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eskew JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-468; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Ihrig V, 2017, SLAS DISCOV, V22, P923, DOI 10.1177/2472555216688312; Johnson JL, 2000, MOL CELL BIOL, V20, P3027, DOI 10.1128/MCB.20.9.3027-3036.2000; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; PIND S, 1994, J BIOL CHEM, V269, P12784; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Ratzke C, 2012, J MOL BIOL, V423, P462, DOI 10.1016/j.jmb.2012.07.026; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Sahasrabudhe P, 2017, MOL CELL, V67, P947, DOI 10.1016/j.molcel.2017.08.004; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Smale S. T., 2010, COLD SPRING HARB PRO, V5, P5423, DOI DOI 10.1101/PDB.PROT5423; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zierer BK, 2014, ANGEW CHEM INT EDIT, V53, P12257, DOI 10.1002/anie.201406578	65	25	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17073	17083		10.1074/jbc.M117.797829	http://dx.doi.org/10.1074/jbc.M117.797829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28851842	hybrid, Green Published			2022-12-28	WOS:000413140600026
J	Zhang, TT; Bu, PL; Zeng, J; Vancura, A				Zhang, Tiantian; Bu, Pengli; Zeng, Joey; Vancura, Ales			Increased heme synthesis in yeast induces a metabolic switch from fermentation to respiration even under conditions of glucose repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; metabolic regulation; metabolism; respiration; transcription; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); HAP complex; Hap1; metabolic reprogramming; oxidative phosphorylation	MITOCHONDRIAL PYRUVATE CARRIER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; GENE-EXPRESSION; LIFE-SPAN; HISTONE ACETYLATION; DIAUXIC SHIFT; HYPOXIC GENES; NF-Y; ROX1	Regulation of mitochondrial biogenesis and respiration is a complex process that involves several signaling pathways and transcription factors as well as communication between the nuclear and mitochondrial genomes. Under aerobic conditions, the budding yeast Saccharomyces cerevisiae metabolizes glucose predominantly by glycolysis and fermentation. We have recently shown that altered chromatin structure in yeast induces respiration by a mechanism that requires transport and metabolism of pyruvate in mitochondria. However, how pyruvate controls the transcriptional responses underlying the metabolic switch from fermentation to respiration is unknown. Here, we report that this pyruvate effect involves heme. We found that heme induces transcription of HAP4, the transcriptional activation subunit of the Hap2/3/4/5p complex, required for growth on nonfermentable carbon sources, in a Hap1p- and Hap2/3/4/5p-dependent manner. Increasing cellular heme levels by inactivating ROX1, which encodes a repressor of many hypoxic genes, or by overexpressing HEM3 or HEM12 induced respiration and elevated ATP levels. Increased heme synthesis, even under conditions of glucose repression, activated Hap1p and the Hap2/3/4/5p complex and induced transcription of HAP4 and genes required for the tricarboxylic acid (TCA) cycle, electron transport chain, and oxidative phosphorylation, leading to a switch from fermentation to respiration. Conversely, inhibiting metabolic flux into the TCA cycle reduced cellular heme levels and HAP4 transcription. Together, our results indicate that the glucose-mediated repression of respiration in budding yeast is at least partly due to the low cellular heme level.	[Zhang, Tiantian; Bu, Pengli; Zeng, Joey; Vancura, Ales] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA	Saint John's University	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; Vancura, Ales/0000-0002-5895-1218	National Institutes of Health [GM120710]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM120710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM120710 (to A. V). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Becerra M, 2002, MOL MICROBIOL, V43, P545, DOI 10.1046/j.1365-2958.2002.02724.x; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bonander N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-365; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Chang TP, 2014, METHODS MOL BIOL, V1172, P329, DOI 10.1007/978-1-4939-0928-5_30; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Danziger SA, 2014, NUCLEIC ACIDS RES, V42, P1442, DOI 10.1093/nar/gkt938; DECKERT J, 1995, GENETICS, V139, P1149; Denby CM, 2012, P NATL ACAD SCI USA, V109, P3874, DOI 10.1073/pnas.1116360109; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Galdieri L, 2016, MOL CELL BIOL, V36, P1064, DOI 10.1128/MCB.00770-15; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; Hoffman M, 2003, BIOCHEM BIOPH RES CO, V310, P1247, DOI 10.1016/j.bbrc.2003.09.151; Hon T, 2005, GENETICS, V169, P1343, DOI 10.1534/genetics.104.037143; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Huang ZW, 2011, EUKARYOT CELL, V10, P1536, DOI 10.1128/EC.05170-11; KENG T, 1992, MOL CELL BIOL, V12, P2616, DOI 10.1128/MCB.12.6.2616; KENG T, 1987, P NATL ACAD SCI USA, V84, P9113, DOI 10.1073/pnas.84.24.9113; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Klinkenberg LG, 2005, EUKARYOT CELL, V4, P649, DOI 10.1128/EC.4.4.649-660.2005; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lascaris R, 2003, GENOME BIOL, V4; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Liesen T, 1996, MOL MICROBIOL, V21, P621, DOI 10.1111/j.1365-2958.1996.tb02570.x; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Marziali G, 1997, MOL CELL BIOL, V17, P1387, DOI 10.1128/MCB.17.3.1387; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sertil O, 2003, NUCLEIC ACIDS RES, V31, P5831, DOI 10.1093/nar/gkg792; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; Zhang M, 2013, MOL CELL BIOL, V33, P4701, DOI 10.1128/MCB.00198-13; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	66	31	32	6	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16942	16954		10.1074/jbc.M117.790923	http://dx.doi.org/10.1074/jbc.M117.790923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28830930	hybrid, Green Published			2022-12-28	WOS:000413140600015
J	Breslin, C; Mani, RS; Fanta, M; Hoch, N; Weinfeld, M; Caldecott, KW				Breslin, Claire; Mani, Rajam S.; Fanta, Mesfin; Hoch, Nicolas; Weinfeld, Michael; Caldecott, Keith W.			The Rev1 interacting region (RIR) motif in the scaffold protein XRCC1 mediates a low-affinity interaction with polynucleotide kinase/phosphatase (PNKP) during DNA single-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE-III; POLY(ADP-RIBOSE) POLYMERASE; CELLULAR-RESPONSES; IONIZING-RADIATION; OXIDATIVE STRESS; MAMMALIAN-CELLS; IN-VITRO; DAMAGE; KINASE; GENE	The scaffold protein X-ray repair cross-complementing 1 (XRCC1) interacts with multiple enzymes involved in DNA base excision repair and single-strand break repair (SSBR) and is important for genetic integrity and normal neurological function. One of the most important interactions of XRCC1 is that with polynucleotide kinase/phosphatase (PNKP), a dual-function DNA kinase/phosphatase that processes damaged DNA termini and that, if mutated, results in ataxia with oculomotor apraxia 4 (AOA4) and microcephaly with early-onset seizures and developmental delay (MCSZ). XRCC1 and PNKP interact via a high-affinity phosphorylation-dependent interaction site in XRCC1 and a forkhead-associated domain in PNKP. Here, we identified using biochemical and biophysical approaches a second PNKP interaction site in XRCC1 that binds PNKP with lower affinity and independently of XRCC1 phosphorylation. However, this interaction nevertheless stimulated PNKP activity and promoted SSBR and cell survival. The low-affinity interaction site required the highly conserved Rev1-interacting region (RIR) motif in XRCC1 and included three critical and evolutionarily invariant phenylalanine residues. We propose a bipartite interaction model in which the previously identified high-affinity interaction acts as a molecular tether, holding XRCC1 and PNKP together and thereby promoting the low-affinity interaction identified here, which then stimulates PNKP directly.	[Breslin, Claire; Hoch, Nicolas; Caldecott, Keith W.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England; [Mani, Rajam S.; Fanta, Mesfin; Weinfeld, Michael] Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Hoch, Nicolas] CAPES Fdn, Minist Educ Brazil, BR-70040020 Brasilia, DF, Brazil	University of Sussex; University of Alberta; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Weinfeld, M (corresponding author), Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada.; Caldecott, KW (corresponding author), CAPES Fdn, Minist Educ Brazil, BR-70040020 Brasilia, DF, Brazil.	Michael.Weinfeld@albertahealthservices.ca; k.w.caldecott@sussex.ac.uk	Hoch, Nicolas/J-5288-2012; Caldecott, Keith/S-4245-2019	Hoch, Nicolas/0000-0002-7610-1305; Caldecott, Keith/0000-0003-4255-9016	Medical Research Council [MR/J006750/1, MR/P010121/1]; Canadian Institutes of Health Research [MOP 15385]; MRC [MR/P010121/1, MR/J006750/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Programme Grants MR/J006750/1 and MR/P010121/1 (to K. W. C.) and Canadian Institutes of Health Research Grant MOP 15385 (to M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; BERTONCINI CRA, 1995, NUCLEIC ACIDS RES, V23, P2995, DOI 10.1093/nar/23.15.2995; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Breslin C, 2006, METHOD ENZYMOL, V409, P410, DOI 10.1016/S0076-6879(05)09024-5; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; BUCHKO GW, 1993, BIOCHEMISTRY-US, V32, P2186, DOI 10.1021/bi00060a009; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2014, EXP CELL RES, V329, P2, DOI 10.1016/j.yexcr.2014.08.027; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Gabel SA, 2013, DNA REPAIR, V12, P1105, DOI 10.1016/j.dnarep.2013.08.015; Gao Y, 2017, CANCER RES, V77, P2674, DOI 10.1158/0008-5472.CAN-16-3128; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; HENNER WD, 1983, J BIOL CHEM, V258, P711; HENNER WD, 1983, J BIOL CHEM, V258, P5198; HENNER WD, 1982, J BIOL CHEM, V257, P1750; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Okano S, 2000, J BIOL CHEM, V275, P32635, DOI 10.1074/jbc.M004085200; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Poulton C, 2013, NEUROGENETICS, V14, P43, DOI 10.1007/s10048-012-0351-8; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363; TAKAYAMA K, 1995, CANCER RES, V55, P5656; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7	44	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16024	16031		10.1074/jbc.M117.806638	http://dx.doi.org/10.1074/jbc.M117.806638			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821613	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000412109400004
J	Bakker, H; Gerardy-Schahn, R				Bakker, Hans; Gerardy-Schahn, Rita			A sweet development in Notch regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The transmembrane signaling protein Notch, which is crucial for embryonic cell fate decisions, has 36 extracellular EGF domains that are glycosylated in variable and complex ways. A new study shows that O-fucose and O-glucose stabilize the repeats but that extension of glucose by xylose weakens stability, explained by the binding of the glycan to a protein groove. This work shows how different types of glycosylation can distinctly influence protein stability and structure.	[Bakker, Hans; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Clin Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany	Hannover Medical School	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Clin Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Gerardy-Schahn.Rita@mh-hannover.de	Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154	Deutsche Forschungsgemeinschaft [BA4091/5-1]; Cluster of Excellence REBIRTH [EXC 62/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence REBIRTH	This work was supported by Deutsche Forschungsgemeinschaft Grant BA4091/5-1 and Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy, EXC 62/2). The authors declare that they have no conflicts of interest with the contents of this article.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049	10	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15974	15975		10.1074/jbc.H117.800102	http://dx.doi.org/10.1074/jbc.H117.800102			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939751	hybrid, Green Published			2022-12-28	WOS:000411512200033
J	Shi, SJ; Buck, TM; Kinlough, CL; Marciszyn, AL; Hughey, RP; Chalfie, M; Brodsky, JL; Kleyman, TR				Shi, Shujie; Buck, Teresa M.; Kinlough, Carol L.; Marciszyn, Allison L.; Hughey, Rebecca P.; Chalfie, Martin; Brodsky, Jeffrey L.; Kleyman, Thomas R.			Regulation of the epithelial Na+ channel by paraoxonase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; SODIUM-CHANNELS; SURFACE EXPRESSION; OXIDATIVE STRESS; GAMMA-SUBUNIT; ION CHANNELS; ENAC; PROTEIN; FAMILY; HSC70	Paraoxonase-2 (PON-2) is a membrane-bound lactonase with unique anti-oxidative and anti-atherosclerotic properties. PON-2 shares key structural elements with MEC-6, an endoplasmic reticulum-resident molecular chaperone in Caenorhabditis elegans. MEC-6 modulates the expression of a mechanotransductive ion channel comprising MEC-4 and MEC-10 in touch-receptor neurons. Because pon-2 mRNA resides in multiple rat nephron segments, including the aldosterone-sensitive distal nephron where the epithelial Na+ channel (ENaC) is expressed, we hypothesized that PON-2 would similarly regulate ENaC expression. We observed PON-2 expression in aquaporin 2-positive principal cells of the distal nephron of adult human kidney. PON-2 also co-immunoprecipitated with ENaC when co-expressed in HEK293 cells. When PON-2 was co-expressed with ENaC in Xenopus oocytes, ENaC activity was reduced, reflecting a reduction in ENaC surface expression. MEC-6 also reduced ENaC activity when co-expressed in Xenopus oocytes. The PON-2 inhibitory effect was ENaC-specific, as PON-2 had no effect on functional expression of the renal outer medullary potassium channel. PON-2 did not alter the response of ENaC to extracellular Na+, mechanical shear stress, or alpha-chymotrypsin-mediated proteolysis, suggesting that PON-2 did not alter the regulation of ENaC by these factors. Together, our data suggest that PON-2 regulates ENaC activity by modulating its intracellular trafficking and surface expression.	[Shi, Shujie; Kinlough, Carol L.; Marciszyn, Allison L.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Buck, Teresa M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chalfie, Martin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu		Buck, Teresa/0000-0002-9013-9756	National Institutes of Health [DK103834, DK090195, GM075061, GM030997, DK051391, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, P30DK079307, K01DK090195, K01DK103834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R01GM075061, R37GM030997, R35GM122522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part by National Institutes of Health Grants DK103834 (to S.S.) DK090195 (to T.M.B.), GM075061 (to J.L.B.), GM030997 (to M.C.), DK051391 (to T.R.K.), and DK079307 (Pittsburgh Center for Kidney Research). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chanoux RA, 2013, AM J PHYSIOL-CELL PH, V305, pC776, DOI 10.1152/ajpcell.00059.2013; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grifoni SC, 2008, AM J PHYSIOL-HEART C, V294, pH2022, DOI 10.1152/ajpheart.01271.2007; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2008, BIOCHEM J, V416, P395, DOI 10.1042/BJ20080775; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mack KL, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00008; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vila-Carriles WH, 2007, J BIOL CHEM, V282, P34381, DOI 10.1074/jbc.M705354200; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242; Zhou H, 1996, AM J PHYSIOL-CELL PH, V271, pC1949, DOI 10.1152/ajpcell.1996.271.6.C1949	68	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15927	15938		10.1074/jbc.M117.785253	http://dx.doi.org/10.1074/jbc.M117.785253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768768	Green Published, hybrid			2022-12-28	WOS:000411512200029
J	Carlonnagno, Y; Chung, DEC; Yue, M; Castanedes-Casey, M; Madden, BJ; Dunmore, J; Tong, JM; DeTure, M; Dickson, DW; Petrucelli, L; Cook, C				Carlonnagno, Yari; Chung, Dah-eun Chloe; Yue, Mei; Castanedes-Casey, Monica; Madden, Benjamin J.; Dunmore, Judy; Tong, Jimei; DeTure, Michael; Dickson, Dennis W.; Petrucelli, Leonard; Cook, Casey			An acetylation-phosphorylation switch that regulates tau aggregation propensity and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; PROTEIN; DEGRADATION; CHIP; NEURODEGENERATION; DEPOSITION; CLEARANCE; FILAMENTS; SITES	The aberrant accumulation of tau protein is a pathological hallmark of a class of neurodegenerative diseases known as tauopathies, including Alzheimer's disease and related dementias. On the basis of previous observations that tau is a direct substrate of histone deacetylase 6 (HDAC6), we sought to map all HDAC6-responsive sites in tau and determine how acetylation in a site-specific manner affects tau's biophysical properties in vitro. Our findings indicate that several acetylation sites in tau are responsive to HDAC6 and that acetylation on Lys-321 (within aKCGSmotif) is both essential for acetylation-mediated inhibition of tau aggregation in vitro and a molecular tactic for preventing phosphorylation on the downstream Ser-324 residue. To determine the functional consequence of this HDAC6-regulated phosphorylation event, we examined tau's ability to promote microtubule assembly and found that phosphorylation of Ser-324 interferes with the normal microtubule-stabilizing function of tau. Tau phosphorylation of Ser-324 (pSer-324) has not previously been evaluated in the context of tauopathy, and here we observed increased deposition of pSer-324-positive tau both in mouse models of tauopathy and in patients with Alzheimer's disease. These findings uncover a novel acetylation-phosphorylation switch at Lys-321/Ser-324 that coordinately regulates tau polymerization and function. Because the disease relevance of this finding is evident, additional studies are needed to examine the role of pSer-324 in tau pathobiology and to determine whether therapeutically modulating this acetylation-phosphorylation switch affects disease progression in vivo.	[Carlonnagno, Yari; Chung, Dah-eun Chloe; Yue, Mei; Castanedes-Casey, Monica; Dunmore, Judy; Tong, Jimei; DeTure, Michael; Dickson, Dennis W.; Petrucelli, Leonard; Cook, Casey] Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Chung, Dah-eun Chloe; Dickson, Dennis W.; Petrucelli, Leonard; Cook, Casey] Mayo Clin, Grad Sch Biomed Sci, Neurobiol Dis Grad Program, Jacksonville, FL 32224 USA; [Madden, Benjamin J.] Mayo Clin, Med Genome Facil Prote Core, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Petrucelli, L; Cook, C (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu; cook.casey@mayo.edu			Mayo Clinic Foundation; Liston Family Foundation; National Institutes of Health/NIA Grant [ADRC 2 P50 AG016574-16]; National Institutes of Health/NINDS [U54NS100693, R35NS097273, R01NS089544, R21NS094489]; Bright-Focus Foundation [A2013546S]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS100693, R21NS094489, R01NS089544, R35NS097273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574] Funding Source: NIH RePORTER	Mayo Clinic Foundation; Liston Family Foundation; National Institutes of Health/NIA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bright-Focus Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Mayo Clinic Foundation (to L. P. and D. D.); the Liston Family Foundation (to L. P.); National Institutes of Health/NIA Grant ADRC 2 P50 AG016574-16 (to L. P. and D. D.); National Institutes of Health/NINDS Grants U54NS100693 (to L. P., D. D., and C. C.), R35NS097273 (to L. P.), R01NS089544 (to L. P.), and R21NS094489 (to C. C.); and Bright-Focus Foundation Grant A2013546S (to L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2015, HUM MOL GENET, V24, P6198, DOI 10.1093/hmg/ddv336; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cook C, 2012, HUM MOL GENET, V21, P2936, DOI 10.1093/hmg/dds125; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickson DW, 1999, BRAIN PATHOL, V9, P657; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Kim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042983; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Selenica ML, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt241; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576; Zhang L, 2013, J ALZHEIMERS DIS, V33, P283, DOI 10.3233/JAD-2012-120727	36	78	79	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15277	15286		10.1074/jbc.M117.794602	http://dx.doi.org/10.1074/jbc.M117.794602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28760828	Green Published, hybrid			2022-12-28	WOS:000410809800010
J	Kampmeyer, C; Karakostova, A; Schenstrom, SM; Abildgaard, AB; Lauridsen, AM; Jourdain, I; Hartmann-Petersen, R				Kampmeyer, Caroline; Karakostova, Antonina; Schenstrom, Signe M.; Abildgaard, Amanda B.; Lauridsen, Anne-Marie; Jourdain, Isabelle; Hartmann-Petersen, Rasmus			The exocyst subunit Sec3 is regulated by a protein quality control pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDED CYTOSOLIC PROTEINS; UBIQUITIN LIGASE; MOLECULAR CHAPERONES; PROTEASOMAL DEGRADATION; CELL-SEPARATION; COMPLEX; TARGETS; GENE; MEMBRANE; RSP5	Exocytosis involves fusion of secretory vesicles with the plasma membrane, thereby delivering membrane proteins to the cell surface and releasing material into the extracellular space. The tethering of the secretory vesicles before membrane fusion is mediated by the exocyst, an essential phylogenetically conserved octameric protein complex. Exocyst biogenesis is regulated by several processes, but the mechanisms by which the exocyst is degraded are unknown. Here, to unravel the components of the exocyst degradation pathway, we screened for extragenic suppressors of a temperature-sensitive fission yeast strain mutated in the exocyst subunit Sec3 (sec3-913). Oneof the suppressing DNAs encoded a truncated dominant-negative variant of the 26S proteasome subunit, Rpt2, indicating that exocyst degradation is controlled by the ubiquitin-proteasome system. The temperature-dependent growth defect of the sec3-913 strain was gene dosage-dependent and suppressed by blocking the proteasome, Hsp70-type molecular chaperones, the Pib1 E3 ubiquitin-protein ligase, and the deubiquitylating enzyme Ubp3. Moreover, defects in cell septation, exocytosis, and endocytosis in sec3 mutant strains were similarly alleviated by mutation of components in this pathway. We also found that, particularly under stress conditions, wild-type Sec3 degradation is regulated by Pib1 and the 26S proteasome. In conclusion, our results suggest that a cytosolic protein quality control pathway monitors folding and proteasome-dependent turnover of an exocyst subunit and, thereby, controls exocytosis in fission yeast.	[Kampmeyer, Caroline; Karakostova, Antonina; Schenstrom, Signe M.; Abildgaard, Amanda B.; Lauridsen, Anne-Marie; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Jourdain, Isabelle] Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England	University of Copenhagen; University of Exeter	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.; Jourdain, I (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	i.jourdain@exeter.ac.uk; rhpetersen@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Karakostova, Antonina/0000-0002-1309-5323	Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; A. P. Moller Foundation; Aase and Ejnar Danielsens Foundation; Danish Rheumatism Association; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden [NNF15OC0017100] Funding Source: researchfish; The Danish Cancer Society [R124-A7466] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A. P. Moller Foundation; Aase and Ejnar Danielsens Foundation; Danish Rheumatism Association; Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by the Lundbeck Foundation (to R. H. P.), the Danish Cancer Society (to R. H. P.), the Novo Nordisk Foundation (to R. H. P.), the A. P. Moller Foundation (to R. H. P.), the Aase and Ejnar Danielsens Foundation (to R. H. P.), the Danish Rheumatism Association (to R. H. P.), and the Danish Council for Independent Research (Natural Sciences) (to R. H. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Amm I, 2016, FEBS LETT, V590, P1765, DOI 10.1002/1873-3468.12213; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Arlow T, 2013, P NATL ACAD SCI USA, V110, P246, DOI 10.1073/pnas.1215510110; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bendezu FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040248; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; CAPECCHI MR, 1974, P NATL ACAD SCI USA, V71, P4732, DOI 10.1073/pnas.71.12.4732; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Drummond DA, 2009, CURR BIOL, V19, pR740, DOI 10.1016/j.cub.2009.07.039; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fang NN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12907; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Fang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085238; Finley D, 2011, NAT CELL BIOL, V13, P1290, DOI 10.1038/ncb2371; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Geffen Y, 2016, MOL CELL, V63, P1055, DOI 10.1016/j.molcel.2016.08.005; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2016, NAT STRUCT MOL BIOL, V23, P59, DOI 10.1038/nsmb.3146; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Jourdain I, 2012, TRAFFIC, V13, P1481, DOI 10.1111/j.1600-0854.2012.01408.x; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kono K, 2012, CELL, V150, P151, DOI 10.1016/j.cell.2012.05.030; Kragelund BB, 2016, TRENDS BIOCHEM SCI, V41, P446, DOI 10.1016/j.tibs.2016.02.004; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Le Goff X, 2016, J CELL SCI, V129, P2638, DOI 10.1242/jcs.184846; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Liu XM, 2015, MOL CELL, V59, P1035, DOI 10.1016/j.molcel.2015.07.034; Lucocq JM, 2013, AUTOPHAGY, V9, P1443, DOI 10.4161/auto.25570; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; Mathiassen SG, 2015, J BIOL CHEM, V290, P21141, DOI 10.1074/jbc.M115.662312; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nielsen SV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006739; Nielsen SV, 2014, BIOMOLECULES, V4, P646, DOI 10.3390/biom4030646; Nishino K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141796; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Penney M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050796; Pleskot R, 2015, BBA-BIOMEMBRANES, V1848, P1481, DOI 10.1016/j.bbamem.2015.03.026; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; Shin ME, 2001, J BIOL CHEM, V276, P41388, DOI 10.1074/jbc.M105665200; Tamai KK, 2002, J CELL SCI, V115, P1847; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200	80	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15240	15253		10.1074/jbc.M117.789867	http://dx.doi.org/10.1074/jbc.M117.789867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765280	Green Published, hybrid			2022-12-28	WOS:000410809800007
J	Li, LT; Kaplan, J; Ward, DM				Li, Liangtao; Kaplan, Jerry; Ward, Diane M.			The glucose sensor Snf1 and the transcription factors Msn2 and Msn4 regulate transcription of the vacuolar iron importer gene CCC1 and iron resistance in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSPORTER; EXPRESSION; PATHWAYS; METABOLISM; MECHANISM	The budding yeast Saccharomyces cerevisiae stores iron in the vacuole, which is a major resistance mechanism against iron toxicity. One key protein involved in vacuolar iron storage is the iron importer Ccc1, which facilitates iron entry into the vacuole. Transcription of the CCC1 gene is largely regulated by the binding of iron-sulfur clusters to the activator domain of the transcriptional activator Yap5. Additional evidence, however, suggests that Yap5-independent transcriptional activation of CCC1 also contributes to iron resistance. Here, we demonstrate that components of the signaling pathway involving the low-glucose sensor Snf1 regulate CCC1 transcription and iron resistance. We found that SNF1 deletion acts synergistically with YAP5 deletion to regulate CCC1 transcription and iron resistance. A kinase-dead mutation of Snf1 lowered iron resistance as did deletion of SNF4, which encodes a partner protein of Snf1. Deletion of all three alternative partners of Snf1 encoded by SIT1, SIT2, and GAL83 decreased both CCC1 transcription and iron resistance. The Snf1 complex is known to activate the general stress transcription factors Msn2 and Msn4. We show that Msn2 and Msn4 contribute to Snf1-mediated CCC1 transcription. Of note, SNF1 deletion in combination with MSN2 and MSN4 deletion resulted in additive effects on CCC1 transcription, suggesting that other activators contribute to the regulation of CCC1 transcription. In conclusion, we show that yeast have developed multiple transcriptional mechanisms to regulate Ccc1 expression and to protect against high cytosolic iron toxicity.	[Li, Liangtao; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu			National Institutes of Health Grant [DK030534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, U54DK110858, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK030534 (to D. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Caetano SM, 2015, J BIOL CHEM, V290, P18584, DOI 10.1074/jbc.M114.600742; Crisp RJ, 2006, EMBO J, V25, P512, DOI 10.1038/sj.emboj.7600961; Du Y, 2012, MOL CELLS, V34, P127, DOI 10.1007/s10059-012-2242-0; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Slavic K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10403; Martinez-Pastor MT, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2215-8; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	30	16	17	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15577	15586		10.1074/jbc.M117.802504	http://dx.doi.org/10.1074/jbc.M117.802504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28760824	Green Published, hybrid			2022-12-28	WOS:000410809800035
J	Murray, AS; Varela, FA; Hyland, TE; Schoenbeck, AJ; White, JM; Tanabe, LM; Todi, SV; List, K				Murray, Andrew S.; Varela, Fausto A.; Hyland, Thomas E.; Schoenbeck, Andrew J.; White, Jordan M.; Tanabe, Lauren M.; Todi, Sokol V.; List, Karin			Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and-2-mediated cell-surface localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIPTASE; EXPRESSION; PROTEINS; HAI-2; PROSTASIN; VIRUSES; KINASES; DOMAIN; MSPL	TMPRSS13 is a member of the type II transmembrane serine protease (TTSP) family. Although various TTSPs have been characterized in detail biochemically and functionally, the basic properties of TMPRSS13 remain unclear. Here, we investigate the activation, inhibition, post-translational modification, and localization of TMPRSS13. Weshow that TMPRSS13 is a glycosylated, active protease and that its own proteolytic activity mediates zymogen cleavage. Full-length, active TMPRSS13 exhibits impaired cell-surface expression in the absence of the cognate Kunitz-type serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 or HAI-2. Concomitant presence of TMPRSS13 with either HAI-1 or -2 mediates phosphorylation of residues in the intracellular domain of the protease, and it coincides with efficient transport of the protease to the cell surface and its subsequent shedding. Cell-surface labeling experiments indicate that the dominant form of TMPRSS13 on the cell surface is phosphorylated, whereas intracellular TMPRSS13 is predominantly non-phosphorylated. These data provide novel insight into the cellular properties of TMPRSS13 and highlight phosphorylation of TMPRSS13 as a novel post-translational modification of this TTSP family member and potentially other members of this family of proteases.	[Murray, Andrew S.; Varela, Fausto A.; Hyland, Thomas E.; Schoenbeck, Andrew J.; White, Jordan M.; Tanabe, Lauren M.; Todi, Sokol V.; List, Karin] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Murray, Andrew S.; White, Jordan M.; List, Karin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Murray, Andrew S.; White, Jordan M.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI 48201 USA; [Varela, Fausto A.] Wayne State Univ, Sch Med, Pharmacol Grad Program, Detroit, MI 48201 USA; [Murray, Andrew S.; List, Karin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	List, K (corresponding author), Gordon H Scott Hall Basic Med Sci, Dept Pharmacol, Rm 6332,540 East Canfield, Detroit, MI 48201 USA.; List, K (corresponding author), Gordon H Scott Hall Basic Med Sci, Dept Oncol, Rm 6332,540 East Canfield, Detroit, MI 48201 USA.	klist@med.wayne.edu		Murray, Andrew/0000-0002-2899-4970	National Institutes of Health from NCI [R01CA160565, R01CA160565-05S1]; Ruth L. Kirschstein National Research Service [T32CA009531]; NIGMS [R25 GM 058905-15]; NINDS [R01NS086778]; American Cancer Society [126605-PF-14-168-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA160565, T32CA009531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086778] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01CA160565 from NCI (to K. L.), Grant R01CA160565-05S1 from NCI (to K. L. and F. A. V.), Ruth L. Kirschstein National Research Service Award T32CA009531 (to A. S. M.), Grant R25 GM 058905-15 from NIGMS (to F. A. V.), and Grant R01NS086778 from NINDS (to S. V. T.), and American Cancer Society Grant 126605-PF-14-168-01-CSM (to L. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Burgi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158594; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kido H, 2008, FRONT BIOSCI-LANDMRK, V13, P754, DOI 10.2741/2717; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DR, 2001, BBA-GENE STRUCT EXPR, V1518, P204, DOI 10.1016/S0167-4781(01)00184-1; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Madsen DH, 2014, BIOCHEM J, V461, P487, DOI 10.1042/BJ20140337; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Miller GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087675; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Okumura Y, 2010, J VIROL, V84, P5089, DOI 10.1128/JVI.02605-09; Poghosyan Z, 2002, J BIOL CHEM, V277, P4999, DOI 10.1074/jbc.M107430200; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Singh SK, 2016, J AM CHEM SOC, V138, P16004, DOI 10.1021/jacs.6b09611; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	43	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14867	14884		10.1074/jbc.M117.775999	http://dx.doi.org/10.1074/jbc.M117.775999			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28710277	hybrid, Green Published			2022-12-28	WOS:000409902100014
J	An, D; Hao, F; Zhang, FQ; Kong, W; Chun, J; Xu, XM; Cui, MZ				An, Dong; Hao, Feng; Zhang, Fuqiang; Kong, Wei; Chun, Jerold; Xu, Xuemin; Cui, Mei-Zhen			CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; MACROPHAGE SCAVENGER RECEPTORS; LYSOPHOSPHOLIPASE-D; ATHEROSCLEROSIS DEVELOPMENT; ENDOTHELIAL-CELLS; LIPID MEDIATOR; LPS; EXPRESSION; MEMBRANE	Macrophage uptake of oxidized low-density lipoprotein (oxLDL) plays an important role in foam cell formation and the pathogenesis of atherosclerosis. We report here that lysophosphatidic acid (LPA) enhances lipopolysaccharide (LPS)-induced oxLDL uptake in macrophages. Our data revealed that both LPA and LPS highly induce the CD14 expression at messenger RNA and protein levels in macrophages. The role of CD14, one component of the LPS receptor cluster, in LPA-induced biological functions has been unknown. We took several steps to examine the role of CD14 in LPA signaling pathways. Knockdown of CD14 expression nearly completely blocked LPA/LPS-induced oxLDL uptake in macrophages, demonstrating for the first time that CD14 is a key mediator responsible for both LPA- and LPS-induced oxLDL uptake/foam cell formation. To determine the molecular mechanism mediating CD14 function, we demonstrated that both LPA and LPS significantly induce the expression of scavenger receptor classAtype I (SR-AI), which has been implicated in lipid uptake process, and depletion of CD14 levels blocked LPA/LPS-induced SR-AI expression. We further showed that the SR-AI-specific antibody, which quenches SR-AI function, blocked LPA- and LPS-induced foam cell formation. Thus, SR-AI is the downstream mediator of CD14 in regulating LPA-, LPS-, and LPA/LPS-induced foam cell formation. Taken together, our results provide the first experimental evidence that CD14 is a novel connecting molecule linking both LPA and LPS pathways and is a key mediator responsible for LPA/LPS-induced foam cell formation. The LPA/LPS-CD14SR-AI nexus might be the new convergent pathway, contributing to the worsening of atherosclerosis.	[An, Dong; Hao, Feng; Zhang, Fuqiang; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [An, Dong; Kong, Wei] Jilin Univ, China Japan Union Hosp, Coll Life Sci, Changchun, Jilin, Peoples R China; [Zhang, Fuqiang] Jilin Univ, China Japan Union Hosp, Sci & Res Ctr, Changchun 130021, Jilin, Peoples R China; [Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University; Jilin University; Sanford Burnham Prebys Medical Discovery Institute	Cui, MZ (corresponding author), 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	An, Dong/ABB-6635-2021; Chun, Jerold/Y-4670-2019	An, Dong/0000-0002-7770-2284; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL107466, NS095256]; University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants HL107466 (to M.-Z.C.) and NS095256 (to X. X.). This work was also supported by the University of Tennessee Center of Excellence in Livestock Diseases and Human Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai S, 2001, ATHEROSCLEROSIS, V155, P321, DOI 10.1016/S0021-9150(00)00585-2; Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Bot M, 2013, J LIPID RES, V54, P1265, DOI 10.1194/jlr.M032862; Brown JM, 2015, ANNU REV MED, V66, P343, DOI 10.1146/annurev-med-060513-093205; Chang CL, 2008, PROSTAG OTH LIPID M, V87, P20, DOI 10.1016/j.prostaglandins.2008.05.002; Chien HY, 2015, INNATE IMMUN-LONDON, V21, P635, DOI 10.1177/1753425915576345; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Cui MZ, 2003, ARTERIOSCL THROM VAS, V23, P224, DOI 10.1161/01.ATV.0000054660.61191.7D; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Engelmann MG, 2004, LAB INVEST, V84, P425, DOI 10.1038/labinvest.3700065; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Hao F, 2016, AM J PHYSIOL-CELL PH, V311, pC975, DOI 10.1152/ajpcell.00227.2016; HAZIOT A, 1988, J IMMUNOL, V141, P547; Howell KW, 2011, J SURG RES, V171, pE27, DOI 10.1016/j.jss.2011.06.033; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Levy E, 2009, PEDIATR RES, V66, P179, DOI 10.1203/PDR.0b013e3181a9f41b; Ley K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00204; Lin CI, 2006, J CELL BIOCHEM, V99, P1216, DOI 10.1002/jcb.20963; Lougheed M, 1997, J BIOL CHEM, V272, P12938, DOI 10.1074/jbc.272.20.12938; MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morishita M, 2013, J DENT RES, V92, P241, DOI 10.1177/0022034512473309; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3; Palmetshofer A, 1999, THROMB HAEMOSTASIS, V82, P1532; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; SIMMONS DL, 1989, BLOOD, V73, P284; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; Tokumura A, 2002, J LIPID RES, V43, P307; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Westerterp M, 2007, CIRCULATION, V116, P2173, DOI 10.1161/CIRCULATIONAHA.107.693382; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu DD, 2014, J BIOL CHEM, V289, P5774, DOI 10.1074/jbc.M113.533042; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhao YT, 2013, AM J PHYSIOL-LUNG C, V305, pL56, DOI 10.1152/ajplung.00417.2012	67	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14391	14400		10.1074/jbc.M117.781807	http://dx.doi.org/10.1074/jbc.M117.781807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28705936	hybrid, Green Published			2022-12-28	WOS:000408747500008
J	Constantinescu, P; Brown, RA; Wyatt, AR; Ranson, M; Wilson, MR				Constantinescu, Patrick; Brown, Rebecca A.; Wyatt, Amy R.; Ranson, Marie; Wilson, Mark R.			Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENATURED PROTEINS; AMYLOID FORMATION; HUMAN-PLASMA; MOLECULAR-MECHANISMS; FIBRINOLYTIC SYSTEM; MISFOLDING DISEASES; A-BETA; CLUSTERIN; TOXICITY; DEGRADATION	The misfolding of proteins and their accumulation in extracellular tissue compartments as insoluble amyloid or amorphous protein aggregates are a hallmark feature of many debilitating protein deposition diseases such as Alzheimer's disease, prion diseases, and type II diabetes. The plasminogen activation system is best known as an extracellular fibrinolytic system but was previously reported to also be capable of degrading amyloid fibrils. Here we show that amorphous protein aggregates interact with tissue-type plasminogen activator and plasminogen, via an exposed lysine-dependent mechanism, to efficiently generate plasmin. The insoluble aggregate-bound plasmin is shielded from inhibition by alpha(2)-antiplasmin and degrades amorphous protein aggregates to release smaller, soluble but relatively hydrophobic fragments of protein (plasmin-generated protein fragments (PGPFs)) that are cytotoxic. In vitro, both endothelial and microglial cells bound and internalized PGPFs before trafficking them to lysosomes. Clusterin and alpha(2)-macroglobulin bound to PGPFs to significantly ameliorate their toxicity. On the basis of these findings, we hypothesize that, as part of the in vivo extracellular proteostasis system, the plasminogen activation system may work synergistically with extracellular chaperones to safely clear large and otherwise pathological protein aggregates from the body.	Univ Wollongong, Proteostasis & Dis Res Ctr, Illawarra Hlth & Med Res Inst, Northfields Ave, Wollongong, NSW 2522, Australia; Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Bldg 32,Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu.au	Ranson, Marie/GRO-5792-2022; Wilson, Mark R/B-3254-2018; Ranson, Marie/AAC-4468-2019; Ranson, Marie/A-6324-2008	Ranson, Marie/0000-0002-5570-9645; Wilson, Mark R/0000-0002-9551-7445; Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Wyatt, Amy/0000-0002-3650-2438	Australian Government; Australian National Health and Medical Research Council Early Career Fellowship [GNT1012521]; Australian Research Council [DP160100011]	Australian Government(Australian GovernmentCGIAR); Australian National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Recipients of Australian Government postgraduate awards.; Supported by Australian National Health and Medical Research Council Early Career Fellowship GNT1012521.; Supported by Australian Research Council Grant DP160100011. To whom correspondence should be addressed: School of Biological Sciences, Illawarra Health and Medical Research Institute (IHMRI), Bldg. 32, University of Wollongong, Northfields Ave., Wollongong, NSW 2522, Australia. Tel.: 61-2-42214534; Fax: 61-2-42218130; E-mail: mrw@uow.edu.au.	Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Beringer DX, 2013, AMYLOID, V20, P113, DOI 10.3109/13506129.2013.791810; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carpenter SL, 2008, HAEMOPHILIA, V14, P1250, DOI 10.1111/j.1365-2516.2008.01766.x; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLEMMENSEN I, 1982, SEMIN ARTHRITIS RHEU, V11, P390, DOI 10.1016/0049-0172(82)90026-9; COLLEN D, 1976, EUR J BIOCHEM, V69, P209, DOI 10.1111/j.1432-1033.1976.tb10875.x; COLLEN D, 1978, BLOOD, V51, P563; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Ellis V, 2002, BIOCHEMISTRY-US, V41, P6891, DOI 10.1021/bi025676g; Gebbink MFBG, 2011, J THROMB HAEMOST, V9, P174, DOI 10.1111/j.1538-7836.2011.04278.x; Gething MJ, 1996, CURR BIOL, V6, P1573, DOI 10.1016/S0960-9822(02)70775-6; Gilabert J, 1995, HUM REPROD, V10, P121, DOI 10.1093/humrep/10.suppl_2.121; Gillmore JD, 2006, NAT CLIN PRACT NEPHR, V2, P263, DOI 10.1038/ncpneph0169; Guo YH, 2009, BLOOD, V113, P4431, DOI 10.1182/blood-2008-07-169433; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; KWAAN HC, 1992, CANCER METAST REV, V11, P291, DOI 10.1007/BF01307184; LIJNEN HR, 1982, SEMIN THROMB HEMOST, V8, P2, DOI 10.1055/s-2007-1005038; LIJNEN HR, 1982, THROMB HAEMOSTASIS, V48, P257; Machovich R, 1997, ARCH BIOCHEM BIOPHYS, V344, P343, DOI 10.1006/abbi.1997.0221; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mathias M., 2007, PAEDIAT CHILD HLTH, V17, P317; Melchor JP, 2003, J NEUROSCI, V23, P8867; Mezzapesa A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0154-y; MOSESSON MW, 1989, P NATL ACAD SCI USA, V86, P1113, DOI 10.1073/pnas.86.4.1113; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Oh SB, 2014, NEUROBIOL AGING, V35, P511, DOI 10.1016/j.neurobiolaging.2013.09.020; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; RADCLIFFE R, 1983, BIOCHIM BIOPHYS ACTA, V743, P422, DOI 10.1016/0167-4838(83)90401-6; RADCLIFFE R, 1981, ARCH BIOCHEM BIOPHYS, V211, P750, DOI 10.1016/0003-9861(81)90512-9; Ranson M, 2003, FRONT BIOSCI, V8, pS294, DOI 10.2741/1044; Roberts K, 2013, GLIA, V61, P409, DOI 10.1002/glia.22444; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stief TW, 2006, CLIN APPL THROMB-HEM, V12, P213, DOI 10.1177/107602960601200210; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Tucker HM, 2000, J NEUROCHEM, V75, P2172, DOI 10.1046/j.1471-4159.2000.0752172.x; Tucker HM, 2000, J NEUROSCI, V20, P3937; WU HL, 1987, P NATL ACAD SCI USA, V84, P8292, DOI 10.1073/pnas.84.23.8292; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	54	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14425	14437		10.1074/jbc.M117.786657	http://dx.doi.org/10.1074/jbc.M117.786657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710283	hybrid, Green Published			2022-12-28	WOS:000408747500011
J	Kishor, A; White, EJF; Matsangos, AE; Yan, ZS; Tandukar, B; Wilson, GM				Kishor, Aparna; White, Elizabeth J. F.; Matsangos, Aerielle E.; Yan, Zisui; Tandukar, Bishal; Wilson, Gerald M.			Hsp70's RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; heat shock protein (HSP); mRNA decay; RNA-binding protein	AU-RICH ELEMENTS; MOLECULAR CHAPERONES; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; DESTABILIZING SEQUENCES; INTERDOMAIN LINKER; DECAY; STRESS; TRISTETRAPROLIN; DOMAIN	Hsp70 is a protein chaperone that prevents protein aggregation and aids protein folding by binding to hydrophobic peptide domains through a reversible mechanism directed by an ATPase cycle. However, Hsp70 also binds U-rich RNA including some AU-rich elements (AREs) that regulate the decay kinetics of select mRNAs and has recently been shown to bind and stabilize some ARE-containing transcripts in cells. Previous studies indicated that both the ATP- and peptide-binding domains of Hsp70 contributed to the stability of Hsp70-RNA complexes and that ATP might inhibit RNA recruitment. This suggested the possibility that RNA binding by Hsp70 might mimic features of its peptide-directed chaperone activities. Here, using purified, cofactor-free preparations of recombinant human Hsp70 and quantitative biochemical approaches, we found that high-affinity RNA binding requires at least 30 nucleotides of RNA sequence but is independent of Hsp70's nucleotide-bound status, ATPase activity, or peptide-binding roles. Furthermore, although both the ATP- and peptide-binding domains of Hsp70 could form complexes with an ARE sequence from VEGFA mRNA in vitro, only the peptide-binding domain could recover cellular VEGFA mRNA in ribonucleoprotein immunoprecipitations. Finally, Hsp70-directed stabilization of VEGFA mRNA in cells was mediated exclusively by the protein's peptide-binding domain. Together, these findings indicate that the RNA-binding and mRNA-stabilizing functions of Hsp70 are independent of its protein chaperone cycle but also provide potential mechanical explanations for several well-established and recently discovered cytoprotective and RNA-based Hsp70 functions.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwilson@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019	Tandukar, Bishal/0000-0002-9650-1664; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health [R01 CA102428]; University of Maryland Greenebaum Comprehensive Cancer Center; UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant [R25 CA186872]; NATIONAL CANCER INSTITUTE [R25CA186872, R01CA102428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Comprehensive Cancer Center; UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA102428. This work was also supported by a pilot grant from the University of Maryland Greenebaum Comprehensive Cancer Center (to G.M.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the UMGCCC Nathan Schnaper Intern Program in Translational Cancer Research through NCI Grant R25 CA186872 (to Bret A. Hassel).	Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Griseri P, 2014, J INTERF CYTOK RES, V34, P242, DOI 10.1089/jir.2013.0140; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kishor A., 2012, BIOPHYSICAL APPROACH, P173; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Moore AE, 2014, WIRES RNA, V5, P549, DOI 10.1002/wrna.1230; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Ozgur S, 2015, FEBS J, V282, P850, DOI 10.1111/febs.13198; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Patury S., 2012, THESIS; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SMITH JS, 1994, J VIROL, V68, P5721, DOI 10.1128/JVI.68.9.5721-5729.1994; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Waris S, 2014, INT J MOL SCI, V15, P23377, DOI 10.3390/ijms151223377; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zimmer C, 2001, RNA, V7, P1628; Zucconi BE, 2013, J BIOL CHEM, V288, P28034, DOI 10.1074/jbc.M113.489559; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14122	14133		10.1074/jbc.M117.785394	http://dx.doi.org/10.1074/jbc.M117.785394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28679534	hybrid, Green Published			2022-12-28	WOS:000408439800018
J	Maheshwari, S; Miller, MS; O'Meally, R; Cole, RN; Amzel, LM; Gabelli, SB				Maheshwari, Sweta; Miller, Michelle S.; O'Meally, Robert; Cole, Robert N.; Amzel, L. Mario; Gabelli, Sandra B.			Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase alpha that are critical for catalysis and substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; LIPID KINASE; BREAST CANCERS; HIGH-FREQUENCY; ATP-BINDING; P-LOOP; MUTATIONS; SUBUNIT	Phosphoinositide 3-kinases (PI3Ks) are ubiquitous lipid kinases that activate signaling cascades controlling cell survival, proliferation, protein synthesis, and vesicle trafficking. PI3Ks have dual kinase specificity: a lipid kinase activity that phosphorylates the 3'-hydroxyl of phosphoinositides and a protein-kinase activity that includes autophosphorylation. Despite the wealth of biochemical and structural information on PI3K alpha, little is known about the identity and roles of individual active-site residues in catalysis. To close this gap, we explored the roles of residues of the catalytic domain and the regulatory subunit of human PI3K alpha in lipid and protein phosphorylation. Using site-directed mutagenesis, kinetic assays, and quantitative mass spectrometry, we precisely mapped key residues involved in substrate recognition and catalysis by PI3K alpha. Our results revealed that Lys-776, located in the P-loop of PI3K alpha, is essential for the recognition of lipid and ATP substrates and also plays an important role in PI3K alpha autophosphorylation. Replacement of the residues His-936 and His-917 in the activation and catalytic loops, respectively, with alanine dramatically changed PI3K alpha kinetics. Although H936A inactivated the lipid kinase activity without affecting autophosphorylation, H917A abolished both the lipid and protein kinase activities of PI3K alpha. On the basis of these kinetic and structural analyses, we propose possible mechanistic roles of these critical residues in PI3K alpha catalysis.	[Maheshwari, Sweta; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Miller, Michelle S.; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [O'Meally, Robert; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Amzel, LM; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA.	mamzel@jhmi.edu; gabelli@jhmi.edu	Gabelli, Sandra/A-3705-2008	Gabelli, Sandra/0000-0003-1205-5204; Miller, Michelle/0000-0003-1972-4503	Johns Hopkins University; Sidney Kimmel Comprehensive Cancer Center (NCI) [2P30 CA006973]; NATIONAL CANCER INSTITUTE [R37CA043460, P30CA006973, P50CA062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); Sidney Kimmel Comprehensive Cancer Center (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Cole laboratory for the gift of CK2 kinase, Dr. Valerie O'Shea for help with the radioactive experiments, and Dr. B. Vogelstein and Dr. K. Kinzler for helpful discussions. Part of this research was undertaken in the Eukaryotic Tissue Culture Facility, which is supported by The Johns Hopkins University. We thank Dr. Li, manager of the facility, for help and suggestions on insect cell protein expression. We acknowledge the use and service of the Johns Hopkins University School of Medicine Mass Spectrometry and Proteomics Core supported by the Sidney Kimmel Comprehensive Cancer Center (NCI Grant 2P30 CA006973).	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Buchanan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071337; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; Koorella C, 2014, J BIOL CHEM, V289, P7747, DOI 10.1074/jbc.M113.519686; Layton MJ, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-30; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Maira SM, 2011, CURR TOP MICROBIOL, V347, P209, DOI 10.1007/82_2010_60; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Miller MS, 2014, ONCOTARGET, V5, P5198, DOI 10.18632/oncotarget.2263; Miyaki M, 2007, INT J CANCER, V121, P1627, DOI 10.1002/ijc.22829; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Segel I. H., 1975, ENZYME KINETICS, P320; SigmaPlot, 2015, SIGMAPLOT VERS 13; STACK JH, 1994, J BIOL CHEM, V269, P31552; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thomas D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001515; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	49	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13541	13550		10.1074/jbc.M116.772426	http://dx.doi.org/10.1074/jbc.M116.772426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28676499	hybrid, Green Published			2022-12-28	WOS:000407942400016
J	Sheikh, MO; Wells, L				Sheikh, M. Osman; Wells, Lance			Whoa man! Unexpected protein O-mannosylation pathways in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CONGENITAL MUSCULAR-DYSTROPHY; DYSTROGLYCAN	The recent expansion of well-characterized O-mannosylated mammalian proteins beyond the archetypical example of alpha-dystroglycan has inspired new interest in the possibility of additional functional roles of this modification. In an effort to explore those roles, a new study now serendipitously uncovers the existence of an alternative pathway to the well-described POMT(protein O-mannosyltransferase) family of O-mannosyltransferases.	[Sheikh, M. Osman; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu		Wells, Lance/0000-0003-4956-5363; Sheikh, Mohammed/0000-0002-9481-8318	National Institutes of Health [R01GM111939, P41GM103490, P01GM107012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, R01GM111939, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM111939, P41GM103490, and P01GM107012 (to L.W. (Senior Investigator)). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Larsen ISB, 2017, J BIOL CHEM, V292, P11586, DOI 10.1074/jbc.M117.794487; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Taniguchi-Ikeda M, 2016, MOL ASPECTS MED, V51, P115, DOI 10.1016/j.mam.2016.07.003; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021	10	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11599	11600		10.1074/jbc.H117.794487	http://dx.doi.org/10.1074/jbc.H117.794487			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28687598	hybrid, Green Published			2022-12-28	WOS:000405119600038
J	Li, YY; Wang, R; Qiao, N; Peng, GD; Zhang, K; Tang, K; Han, JDJ; Jing, NH				Li, Yuanyuan; Wang, Ran; Qiao, Nan; Peng, Guangdun; Zhang, Ke; Tang, Ke; Han, Jing-Dong J.; Jing, Naihe			Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; human; neurodevelopment; neurodifferentiation; transcriptomics	CEREBRAL-CORTEX DEVELOPMENT; SEPTO-OPTIC DYSPLASIA; MOUSE EMBRYO; NEURAL-STEM; HUMAN NEUROECTODERM; HESX1 MUTATIONS; HUMAN BRAIN; DIRECTED DIFFERENTIATION; CLINICAL SPECTRUM; GENE-FUNCTION	Proper neural commitment is essential for ensuring the appropriate development of the human brain and for preventing neurodevelopmental diseases such as autism spectrum disorders, schizophrenia, and intellectual disorders. However, the molecular mechanisms underlying the neural commitment in humans remain elusive. Here, we report the establishment of a neural differentiation system based on human embryonic stem cells (hESCs) and on comprehensive RNA sequencing analysis of transcriptome dynamics during early hESC differentiation. Using weighted gene co-expression network analysis, we reveal that the hESC neurodevelopmental trajectory has five stages: pluripotency (day 0); differentiation initiation (days 2, 4, and 6); neural commitment (days 8-10); neural progenitor cell proliferation (days 12, 14, and 16); and neuronal differentiation (days 18, 20, and 22). These stages were characterized by unique module genes, which may recapitulate the early human cortical development. Moreover, a comparison of our RNA-sequencing data with several other transcriptome profiling datasets from mice and humans indicated that Module 3 associated with the day 8-10 stage is a critical window of fate switch from the pluripotency to the neural lineage. Interestingly, at this stage, no key extrinsic signals were activated. In contrast, using CRISPR/Cas9-mediated gene knockouts, we also found that intrinsic hub transcription factors, including the schizophrenia-associated SIX3 gene and septo-optic dysplasia-related HESX1 gene, are required to program hESC neural determination. Our results improve the understanding of the mechanism of neural commitment in the human brain and may help elucidate the etiology of human mental disorders and advance therapies for managing these conditions.	[Li, Yuanyuan; Wang, Ran; Peng, Guangdun; Zhang, Ke; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Qiao, Nan; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Key Lab Computat Biol, Chinese Acad Sci Max Planck Partner Inst Computat, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Jing, Naihe] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Nanchang University; ShanghaiTech University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Jing, NH (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	njing@sibcb.ac.cn	Peng, Guangdun/AAH-9044-2019	Peng, Guangdun/0000-0002-8586-0637	"Strategic Priority Research Program" of the Chinese Academy of Sciences Grant [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [31430058, 31571513, 31630043, 91519314, 31661143042]	"Strategic Priority Research Program" of the Chinese Academy of Sciences Grant; National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01010201, National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and National Natural Science Foundation of China Grants 31430058, 31571513, 31630043, 91519314, and 31661143042. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bhinge A, 2014, EMBO J, V33, P1271, DOI 10.1002/embj.201387215; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Cajal M, 2012, DEVELOPMENT, V139, P423, DOI 10.1242/dev.075499; Carlin D, 2012, DEVELOPMENT, V139, P2614, DOI 10.1242/dev.076018; Carvalho LR, 2003, J CLIN INVEST, V112, P1192, DOI 10.1172/JCI200318589; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Chovsepian A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00036; Cohen RN, 2003, J CLIN ENDOCR METAB, V88, P4832, DOI 10.1210/jc.2002-021868; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hehr U, 2010, HUM GENET, V127, P555, DOI 10.1007/s00439-010-0797-4; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kostovic I, 2006, DEV MED CHILD NEUROL, V48, P388, DOI 10.1017/S0012162206000831; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Ozair MZ, 2013, WIRES DEV BIOL, V2, P479, DOI 10.1002/wdev.90; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Parish EV, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0311-6; Pasquier L, 2000, EUR J HUM GENET, V8, P797, DOI 10.1038/sj.ejhg.5200540; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2577, DOI 10.1002/ajmg.a.31377; Sansom S. N., 2009, COLD SPRING HARB PER, V1; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Solomon BD, 2009, AM J MED GENET A, V149A, P919, DOI 10.1002/ajmg.a.32813; Strangward P, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006267; Tajima T, 2003, J CLIN ENDOCR METAB, V88, P45, DOI 10.1210/jc.2002-020818; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weinstein DC, 1997, CURR OPIN NEUROBIOL, V7, P7, DOI 10.1016/S0959-4388(97)80114-6; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yeung J, 2016, J NEUROSCI, V36, P9057, DOI 10.1523/JNEUROSCI.4385-15.2016; Yoo YD, 2011, STEM CELLS, V29, P1975, DOI 10.1002/stem.758; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224	76	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19590	19604		10.1074/jbc.M117.796383	http://dx.doi.org/10.1074/jbc.M117.796383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972157	hybrid, Green Published			2022-12-28	WOS:000416911300005
J	Sultana, S; Solotchi, M; Ramachandran, A; Patel, SS				Sultana, Shemaila; Solotchi, Mihai; Ramachandran, Aparna; Patel, Smita S.			Transcriptional fidelities of human mitochondrial POLRMT, yeast mitochondrial Rpo41, and phage T7 single-subunit RNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); mitochondrial DNA (mtDNA); RNA; RNA polymerase; transcription; fidelity	DNA-POLYMERASE; TRANSLESION SYNTHESIS; PROMOTER RECOGNITION; ELONGATION COMPLEX; KINETIC MECHANISM; IN-VIVO; INITIATION; MISINCORPORATION; TEMPLATE; CLEAVAGE	Single-subunit RNA polymerases (RNAPs) are present in phage T7 and in mitochondria of all eukaryotes. This RNAP class plays important roles in biotechnology and cellular energy production, but we know little about its fidelity and error rates. Herein, we report the error rates of three single-subunit RNAPs measured from the catalytic efficiencies of correct and all possible incorrect nucleotides. The average error rates of T7 RNAP (2 x 10(-6)), yeast mitochondrial Rpo41 (6 x 10(-6)), and human mitochondrial POLRMT (RNA polymerase mitochondrial) (2 x 10(-5)) indicate high accuracy/fidelity of RNA synthesis resembling those of replicative DNA polymerases. All three RNAPs exhibit a distinctly high propensity for GTP misincorporation opposite dT, predicting frequent AG errors in RNA with rates of approximate to 10(-4). The AC, GA, AU, CU, GU, UC, and UG errors mostly due to pyrimidine-purine mismatches were relatively frequent (10(-5)-10(-6)), whereas CG, UA, GC, and CA errors from purine-purine and pyrimidine-pyrimidine mismatches were rare (10(-7)-10(-10)). POLRMT also shows a high CA error rate on 8-oxo-dG templates (approximate to 10(-4)). Strikingly, POLRMT shows a high mutagenic bypass rate, which is exacerbated by TEFM (transcription elongation factor mitochondrial). The lifetime of POLRMT on terminally mismatched elongation substrate is increased in the presence of TEFM, which allows POLRMT to efficiently bypass the error and continue with transcription. This investigation of nucleotide selectivity on normal and oxidatively damaged DNA by three single-subunit RNAPs provides the basic information to understand the error rates in mitochondria and, in the case of T7 RNAP, to assess the quality of in vitro transcribed RNAs.	[Sultana, Shemaila; Ramachandran, Aparna; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes Lane, Piscataway, NJ 08854 USA; [Solotchi, Mihai] Rutgers State Univ, Sch Arts & Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Patel, SS (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes Lane, Piscataway, NJ 08854 USA.	patelss@rutgers.edu			NIGMS, National Institutes of Health [R35118086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118086] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R35118086. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Carey LB, 2015, ELIFE, V4, DOI 10.7554/eLife.09945; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Deshpande AP, 2012, BBA-GENE REGUL MECH, V1819, P930, DOI 10.1016/j.bbagrm.2012.02.003; Doetsch PW, 2002, MUTAT RES-FUND MOL M, V510, P131, DOI 10.1016/S0027-5107(02)00258-0; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gaillard H, 2016, ANNU REV BIOCHEM, V85, P291, DOI 10.1146/annurev-biochem-060815-014908; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gout JF, 2013, P NATL ACAD SCI USA, V110, P18584, DOI 10.1073/pnas.1309843110; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Imashimizu M, 2013, NUCLEIC ACIDS RES, V41, P9090, DOI 10.1093/nar/gkt698; James K, 2017, NUCLEIC ACIDS RES, V45, P1105, DOI 10.1093/nar/gkw969; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235; Morreall JF, 2013, J CELL PHYSIOL, V228, P2257, DOI 10.1002/jcp.24400; Nakanishi N, 2013, MUTAGENESIS, V28, P117, DOI 10.1093/mutage/ges060; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008; Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105; Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P896, DOI 10.1093/nar/gkv1299; Remington KM, 1998, J BIOL CHEM, V273, P13170, DOI 10.1074/jbc.273.21.13170; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Sousa R, 2003, PROG NUCLEIC ACID RE, V73, P1, DOI 10.1016/S0079-6603(03)01001-8; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; STRAZEWSKI P, 1988, NUCLEIC ACIDS RES, V16, P9377, DOI 10.1093/nar/16.20.9377; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2011, J BIOL CHEM, V286, P38805, DOI 10.1074/jbc.M111.261966; Tang GQ, 2011, J MOL BIOL, V405, P666, DOI 10.1016/j.jmb.2010.10.020; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Traverse CC, 2016, P NATL ACAD SCI USA, V113, P3311, DOI 10.1073/pnas.1525329113; VERMULST M, 2015, NAT COMMUN, V6, P60861; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	59	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18145	18160		10.1074/jbc.M117.797480	http://dx.doi.org/10.1074/jbc.M117.797480			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882896	Green Published, hybrid			2022-12-28	WOS:000414458200013
J	Wang, HC; Shears, SB				Wang, Huanchen; Shears, Stephen B.			Structural features of human inositol phosphate multikinase rationalize its inositol phosphate kinase and phosphoinositide 3-kinase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; inositol phosphate; phosphatidylinositol kinase (PI kinase); phosphatidylinositol signaling; protein kinase A (PKA); signaling; substrate specificity; X-ray crystallography; kinase	POLYPHOSPHATE MULTIKINASE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; 1,4,5-TRISPHOSPHATE 3-KINASE; CRYSTAL-STRUCTURE; PROTEIN; HEXAKISPHOSPHATE; ARGRIII	Human inositol phosphate multikinase (HsIPMK) critically contributes to intracellular signaling through its inositol-1,4,5-trisphosphate (Ins(1,4,5)P-3) 3-kinase and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) 3-kinase activities. This catalytic profile is not conserved; orthologs from Arabidopsis thaliana and Saccharomyces cerevisiae are predominantly Ins(1,4,5)P-3 6-kinases, and the plant enzyme cannot phosphorylate PtdIns(4,5)P-2. Therefore, crystallographic analysis of the yeast and plant enzymes, without bound inositol phosphates, do not structurally rationalize HsIPMK activities. Here, we present 1.6- resolution crystal structures of HsIPMK in complex with either Ins(1,4,5)P-3 or PtdIns(4,5)P-2. The Ins(1,4,5)P-3 headgroup of PtdIns(4,5)P-2 binds in precisely the same orientation as free Ins(1,4,5)P-3 itself, indicative of evolutionary optimization of 3-kinase activities against both substrates. We report on nucleotide binding between the separate N- and C-lobes of HsIPMK. The N-lobe exhibits a remarkable degree of conservation with protein kinase A (root mean square deviation = 1.8 ), indicating common ancestry. We also describe structural features unique to HsIPMK. First, we observed a constrained, horseshoe-shaped substrate pocket, formed from an -helix, a 3(10) helix, and a recently evolved tri-proline loop. We further found HsIPMK activities rely on a preponderance of Gln residues, in contrast to the larger Lys and Arg residues in yeast and plant orthologs. These conclusions are supported by analyzing 14 single-site HsIPMK mutants, some of which differentially affect 3-kinase and 6-kinase activities. Overall, we structurally rationalize phosphorylation of Ins(1,4,5)P-3 and PtdIns(4,5)P-2 by HsIPMK.	[Wang, Huanchen; Shears, Stephen B.] NIEHS, Inositol Signaling Grp, Signal Transduct Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wang, HC (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wangh7@niehs.nih.gov	Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916; Wang, Huanchen/0000-0003-2701-7155	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed I, 2015, P NATL ACAD SCI USA, V112, P9751, DOI 10.1073/pnas.1511810112; Bang S, 2012, P NATL ACAD SCI USA, V109, P616, DOI 10.1073/pnas.1119751109; Barker CJ, 1999, ANTICANCER RES, V19, P3737; Blind RD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003111; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; CRAXTON A, 1994, J BIOL CHEM, V269, P4337; Davies D. D., 1961, INTERMEDIARY METABOL; El Bakkoury M, 2000, MOL MICROBIOL, V35, P15, DOI 10.1046/j.1365-2958.2000.01665.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo-Streeter S, 2012, J BIOL CHEM, V287, P35360, DOI 10.1074/jbc.M112.365031; Frederick JP, 2005, P NATL ACAD SCI USA, V102, P8454, DOI 10.1073/pnas.0503706102; Fujii M, 2005, J BIOL CHEM, V280, P1156, DOI 10.1074/jbc.M412006200; Gao Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702106200; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gu CF, 2017, J BIOL CHEM, V292, P4544, DOI 10.1074/jbc.M116.765743; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Kim Eunha, 2016, Advances in Biological Regulation, V61, P25, DOI 10.1016/j.jbior.2015.11.005; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Leyman A, 2007, CELL SIGNAL, V19, P1497, DOI 10.1016/j.cellsig.2007.01.024; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Meyer R, 2012, BIOL CHEM, V393, P149, DOI 10.1515/hsz-2011-0209; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramazzotti Giulia, 2017, Advances in Biological Regulation, V63, P1, DOI 10.1016/j.jbior.2016.10.005; Resnick AC, 2005, P NATL ACAD SCI USA, V102, P12783, DOI 10.1073/pnas.0506184102; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sei Y, 2015, GASTROENTEROLOGY, V149, P67, DOI 10.1053/j.gastro.2015.04.008; Shears SB, 1997, PRACT APPROACH SER, V176, P33; Shears SB, 2018, J CELL PHYSIOL, V233, P1897, DOI 10.1002/jcp.26017; Stevenson-Paulik J, 2006, METHODS, V39, P112, DOI 10.1016/j.ymeth.2006.05.012; Stout TJ, 2004, CURR PHARM DESIGN, V10, P1069, DOI 10.2174/1381612043452695; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wickramasinghe VO, 2013, MOL CELL, V51, P737, DOI 10.1016/j.molcel.2013.08.031; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xu RS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003405; Yokoyama JS, 2016, JAMA NEUROL, V73, P691, DOI 10.1001/jamaneurol.2016.0150	41	14	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18192	18202		10.1074/jbc.M117.801845	http://dx.doi.org/10.1074/jbc.M117.801845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882892	Green Published, hybrid			2022-12-28	WOS:000414458200017
J	Zhang, XW; Rui, ML; Gan, GM; Huang, C; Yi, JK; Lv, HH; Xie, W				Zhang, Xinwang; Rui, Menglong; Gan, Guangmin; Huang, Cong; Yi, Jukang; Lv, Huihui; Xie, Wei			Neuroligin 4 regulates synaptic growth via the bone morphogenetic protein (BMP) signaling pathway at the Drosophila neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); development; Drosophila; neurodevelopment; synaptic plasticity; NMJ; Neuroligin 4	EXCITATORY SYNAPSES; INHIBITORY SYNAPSES; II RECEPTOR; HOMOLOG GBB; NEUREXIN; DIFFERENTIATION; BETA; TRANSMISSION; EXPRESSION; MUTATIONS	The neuroligin (Nlg) family of neural cell adhesion molecules is thought to be required for synapse formation and development and has been linked to the development of autism spectrum disorders in humans. In Drosophila melanogaster, mutations in the neuroligin 1-3 genes have been reported to induce synapse developmental defects at neuromuscular junctions (NMJs), but the role of neuroligin 4 (dnlg4) in synapse development has not been determined. Here, we report that the Drosophila neuroligin 4 (DNlg4) is different from DNlg1-3 in that it presynaptically regulates NMJ synapse development. Loss of dnlg4 results in reduced growth of NMJs with fewer synaptic boutons. The morphological defects caused by dnlg4 mutant are associated with a corresponding decrease in synaptic transmission efficacy. All of these defects could only be rescued when DNlg4 was expressed in the presynapse of NMJs. To understand the basis of DNlg4 function, we looked for genetic interactions and found connections with the components of the bone morphogenetic protein (BMP) signaling pathway. Immunostaining and Western blot analyses demonstrated that the regulation of NMJ growth by DNlg4 was due to the positive modulation of BMP signaling by DNlg4. Specifically, BMP type I receptor thickvein (Tkv) abundance was reduced in dnlg4 mutants, and immunoprecipitation assays showed that DNlg4 and Tkv physically interacted in vivo. Our study demonstrates that DNlg4 presynaptically regulates neuromuscular synaptic growth via the BMP signaling pathway by modulating Tkv.	[Zhang, Xinwang; Rui, Menglong; Huang, Cong; Lv, Huihui; Xie, Wei] Southeast Univ, Inst Life Sci, Collaborat Innovat Ctr Brain Sci, Nanjing 210096, Jiangsu, Peoples R China; [Rui, Menglong; Gan, Guangmin; Yi, Jukang; Lv, Huihui; Xie, Wei] Southeast Univ, Jiangsu Coinnovat Ctr Neuroregenerat, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Zhang, Xinwang] Shanxi Med Univ, Dept Biol, Basic Med Sch, Taiyuan 030001, Shanxi, Peoples R China	Southeast University - China; Southeast University - China; Shanxi Medical University	Xie, W (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	wei.xie@seu.edu.cn		Colbran, Roger/0000-0001-7401-8244; Rui, Menglong/0000-0002-1911-8397	National Natural Science Foundation of China [31171041, 31430035]; China National Basic Research Program (973 Program) [2012CB517903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31171041, 31430035 to W.X.) and the China National Basic Research Program (973 Program 2012CB517903 to W.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Berke B, 2013, J NEUROSCI, V33, P17937, DOI 10.1523/JNEUROSCI.6075-11.2013; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dong T, 2016, P NATL ACAD SCI USA, V113, P7644, DOI 10.1073/pnas.1602152113; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Hu W, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002115; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li WH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006062; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Liu ZH, 2014, J NEUROSCI, V34, P2785, DOI 10.1523/JNEUROSCI.3547-13.2014; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Piccioli ZD, 2014, J NEUROSCI, V34, P4371, DOI 10.1523/JNEUROSCI.4943-13.2014; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Sand P, 2006, SCHIZOPHR RES, V82, P277, DOI 10.1016/j.schres.2005.11.003; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi WW, 2013, J NEUROSCI, V33, P12352, DOI 10.1523/JNEUROSCI.0386-13.2013; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tian Y, 2017, NEUROSCI BULL, V33, P737, DOI 10.1007/s12264-017-0166-6; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Zhao GL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004984; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	62	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					17991	18005		10.1074/jbc.M117.810242	http://dx.doi.org/10.1074/jbc.M117.810242			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912273	Green Published, hybrid			2022-12-28	WOS:000414458200002
J	Bankston, JR; DeBerg, HA; Stoll, S; Zagotta, WN				Bankston, John R.; DeBerg, Hannah A.; Stoll, Stefan; Zagotta, William N.			Mechanism for the inhibition of the cAMP dependence of HCN ion channels by the auxiliary subunit TRIP8b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; STRUCTURAL BASIS; PROTEIN TRIP8B; TRAFFICKING; MODULATION; EXPRESSION; SITES; BRAIN; DEER	TRIP8b, an accessory subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels, alters both the cell surface expression and cyclic nucleotide dependence of these channels. However, the mechanism by which TRIP8b exerts these dual effects is still poorly understood. In addition to binding to the carboxyl-terminal tripeptide of HCN channels, TRIP8b also binds directly to the cyclic nucleotide-binding domain (CNBD). That interaction, which requires a small central portion of TRIP8b termed TRIP8bcore, is both necessary and sufficient for reducing the cAMP-dependent regulation ofHCN channels. Here, using fluorescence anisotropy, we report that TRIP8b binding to the CNBD of HCN2 channels decreases the apparent affinity of cAMP for the CNBD. We explored two possible mechanisms for this inhibition. A noncompetitive mechanism in which TRIP8b inhibits the conformational change of the CNBD associated with cAMP regulation and a competitive mechanism in which TRIP8b and cAMP compete for the same binding site. To test these two mechanisms, we used a combination of fluorescence anisotropy, biolayer interferometry, and double electron-electron resonance spectroscopy. Fitting these models to our fluorescence anisotropy binding data revealed that, surprisingly, the TRIP8b-dependent reduction of cAMP binding to the CNBD can largely be explained by partial competition between TRIP8b and cAMP. On the basis of these findings, we propose that TRIP8b competes with a portion of the cAMP-binding site or distorts the binding site by making interactions with the binding pocket, thus acting predominantly as a competitive antagonist that inhibits the cyclic-nucleotide dependence of HCN channels.	[Bankston, John R.; DeBerg, Hannah A.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA; [DeBerg, Hannah A.; Stoll, Stefan] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu	Bankston, John/I-7429-2019; Stoll, Stefan/C-5225-2008	Bankston, John/0000-0002-9478-2335; Stoll, Stefan/0000-0003-4255-9550	NIGMS, National Institutes of Health Grant [P41GM103311]; NATIONAL EYE INSTITUTE [K99EY024267, R01EY010329, R00EY024267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074053] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Tom Hinds for technical assistance and Dr. Ning Zheng for the use of the Octet Red96 system. Chimera is developed by the Resource of Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health Grant P41GM103311).	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Collauto A, 2017, PHYS CHEM CHEM PHYS, V19, P15324, DOI 10.1039/c7cp01925d; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	30	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17794	17803		10.1074/jbc.M117.800722	http://dx.doi.org/10.1074/jbc.M117.800722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28864772	Green Published, hybrid			2022-12-28	WOS:000414013000017
J	Ren, YL; Shang, JH; Li, JL; Liu, WJ; Zhang, Z; Yuan, JP; Yang, M				Ren, Yanli; Shang, Jinhua; Li, Jinliang; Liu, Wenjuan; Zhang, Zhao; Yuan, Jupeng; Yang, Ming			The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; POOR-PROGNOSIS; IDENTIFIES CRKL; PROSTATE-CANCER; LUNG-CANCER; PROLIFERATION; REVEALS; RISK; TUMORIGENESIS; TRANSCRIPTOME	The long non-coding RNA (lncRNA) PCAT-1 resides in the chromosome 8q24 cancer-risk locus and acts as a vital oncogene during tumorigenesis and progression. However, how PCAT-1 is post-transcriptionally regulated, for example, by small ncRNAs, such as microRNAs (miRNAs) is largely unknown. Here, we report how miRNAs regulate PCAT-1 expression and also investigate the biological significance of this regulation in hepatocellular carcinoma (HCC). We found that miR-215, a P53-inducible miRNA, is a key regulator of PCAT-1 expression in HCC and identified an interaction between miR-215 and PCAT-1 in dual luciferase reporter gene assays. We also found that post-transcriptional silencing of PCAT-1 by miR-215 or PCAT-1 siRNAs significantly inhibited proliferation of HCC cells and, conversely, that inhibition of endogenous miR-215 up-regulated PCAT-1 expression and promoted cell viability. The tumor-suppressing role of miR-215 was further confirmed in an in vivo mouse HCC xenograft model. Of note, gene profiling assays suggested that the kinase CRK-like proto-oncogene, adaptor protein (CRKL), is a potential downstream target of the miR-215-PCAT-1 axis in HCC, and we demonstrated that CRKL silencing significantly suppresses cell proliferation. Taken together and considering the essential role of CRKL in cancer cells, we propose that the TP53-miR-215-PCAT-1-CRKL axis might represent an important regulatory pathway in HCC. In summary, our results highlight the involvement of several ncRNAs in HCC and thus provide critical insights into the molecular pathways operating in this malignancy.	[Ren, Yanli; Liu, Wenjuan; Yuan, Jupeng; Yang, Ming] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Canc Res Ctr,Shandong Prov Key Lab Radiat Oncol, Jinan 250117, Shandong, Peoples R China; [Shang, Jinhua; Li, Jinliang; Zhang, Zhao] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100021, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; Beijing University of Chemical Technology	Yang, M (corresponding author), Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Canc Res Ctr,Shandong Prov Key Lab Radiat Oncol, Jinan 250117, Shandong, Peoples R China.	aaryoung@yeah.net	liu, wen/HGE-3071-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487	National Natural Science Foundation of China [31671300]; National High-Tech Research and Development Program of China [2015AA020950]; Taishan Scholars Program of Shandong Province [tsqn20161060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Taishan Scholars Program of Shandong Province	This work was supported by National Natural Science Foundation of China Grant 31671300, the National High-Tech Research and Development Program of China Grant 2015AA020950, and Taishan Scholars Program of Shandong Province (tsqn20161060). The authors declare that they have no conflicts of interest with the contents of this article.	Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chen ZH, 2016, BIOCHEM BIOPH RES CO, V479, P482, DOI 10.1016/j.bbrc.2016.09.089; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Deng YJ, 2014, CANCER LETT, V342, P27, DOI 10.1016/j.canlet.2013.08.033; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Evans JR, 2016, J CLIN INVEST, V126, P2775, DOI 10.1172/JCI84421; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ge GQ, 2016, ONCOL REP, V35, P1816, DOI 10.3892/or.2015.4482; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Goff LA, 2015, GENOME RES, V25, P1456, DOI 10.1101/gr.191122.115; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hu J, 2016, CANCER CELL, V29, P49, DOI 10.1016/j.ccell.2015.12.005; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Laursen Lucas, 2014, Nature, V516, pS2, DOI 10.1038/516S2a; Liu CH, 2013, MOL CELL PROTEOMICS, V12, P1335, DOI 10.1074/mcp.O112.020404; Liu L, 2015, TUMOR BIOL, V36, P7685, DOI 10.1007/s13277-015-3490-3; Madhavan D, 2016, CARCINOGENESIS, V37, P461, DOI 10.1093/carcin/bgw008; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Prensner JR, 2014, CANCER RES, V74, P1651, DOI 10.1158/0008-5472.CAN-13-3159; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qin HD, 2016, AM J HUM GENET, V98, P709, DOI 10.1016/j.ajhg.2016.02.021; Ren YL, 2016, ADV FUNCT MATER, V26, P7314, DOI 10.1002/adfm.201603041; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Shi WH, 2015, TUMOR BIOL, V36, P2501, DOI 10.1007/s13277-014-2863-3; Tamura M, 2015, CANCER SCI, V106, P1033, DOI 10.1111/cas.12713; Tang L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.41; Wang XY, 2015, FEBS LETT, V589, P4079, DOI 10.1016/j.febslet.2015.11.024; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wang YX, 2016, JPN J CLIN ONCOL, V46, P350, DOI 10.1093/jjco/hyv204; Wen JF, 2016, MOL MED REP, V13, P4481, DOI 10.3892/mmr.2016.5075; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Worns MA, 2014, NAT REV GASTRO HEPAT, V11, P447, DOI 10.1038/nrgastro.2014.10; Yan TH, 2015, INT J CLIN EXP PATHO, V8, P4126; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yang X, 2015, CANCER LETT, V360, P119, DOI 10.1016/j.canlet.2015.02.035; Yang XY, 2016, AM J HUM GENET, V99, P275, DOI 10.1016/j.ajhg.2016.05.029; Yao J, 2017, ONCOL LETT, V14, P1097, DOI 10.3892/ol.2017.6200; Ye MX, 2015, CANCER LETT, V357, P196, DOI 10.1016/j.canlet.2014.11.028; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yuan SX, 2016, HEPATOLOGY, V63, P499, DOI 10.1002/hep.27893	46	52	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17939	17949		10.1074/jbc.M116.773978	http://dx.doi.org/10.1074/jbc.M116.773978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887306	hybrid, Green Published			2022-12-28	WOS:000414013000029
J	Howard, MJ; Wilson, SH				Howard, Michael J.; Wilson, Samuel H.			Processive searching ability varies among members of the gap-filling DNA polymerase X family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATED DIFFUSION; INTERSEGMENT TRANSFER; RNA-POLYMERASE; COGNATE SITES; GLYCOSYLASE; REPAIR; DAMAGE; TRANSLOCATION; MECHANISM; PROTEIN	DNA repair proteins must locate rare damaged sites within the genome. DNA polymerase beta (Pol beta), a member of the DNA polymeraseXfamily that is involved in base excision repair, uses a processive hopping search mechanism to locate substrates. This effectively enhances its search footprint on DNA, increasing the probability of locating damaged sites. Processive searching has been reported or proposed for many DNA-binding proteins, raising the question of how widespread or specific to certain enzymes the ability to perform this function is. To provide insight into this question, we compared the ability of three homologous DNA Pol X family members to perform a processive search for 1-nucleotide gaps in DNA using a previously developed biochemical assay. We found that at near-predicted physiological ionic strengths, the intramolecular searching ability of Pol beta is at least 4-fold higher than that of Pol mu and similar to 2-fold higher than that of Pol beta. Pol beta also was able to perform intersegmental transfer with the intersegmental searching ability of Pol beta being at least 6- and similar to 2-fold higher than that of Pols mu and lambda, respectively. Mutational analysis suggested that differences in the N-terminal domains of these polymerases are responsible for the varying degrees of searching competence. Of note, the differences in processive searching ability observed among the DNA Pol X family members correlated with their proposed biological functions in base excision repair and nonhomologous end joining.	[Howard, Michael J.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Howard, Michael/0000-0001-9990-930X	NIEHS, National Institutes of Health Intramural Research Program [Z01-ES050158, Z01-ES050161]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050161, Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Intramural Research Program Grants Z01-ES050158 and Z01-ES050161 (to S.H.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beard WA, 1995, METHOD ENZYMOL, V262, P98; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bienstock RJ, 2014, DNA REPAIR, V22, P77, DOI 10.1016/j.dnarep.2014.07.003; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Cravens SL, 2015, NUCLEIC ACIDS RES, V43, P4087, DOI 10.1093/nar/gkv301; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Esadze A, 2014, NUCLEIC ACIDS RES, V42, P7039, DOI 10.1093/nar/gku418; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; Friedman LJ, 2013, P NATL ACAD SCI USA, V110, P9740, DOI 10.1073/pnas.1300221110; Frouin I, 2005, NUCLEIC ACIDS RES, V33, P5354, DOI 10.1093/nar/gki845; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2013, J BIOL CHEM, V288, P24550, DOI 10.1074/jbc.M113.477018; Hendershot JM, 2017, J BIOL CHEM, V292, P16070, DOI 10.1074/jbc.M117.782813; Howard MJ, 2017, NUCLEIC ACIDS RES, V45, P3822, DOI 10.1093/nar/gkx047; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Redding S, 2013, CHEM PHYS LETT, V570, P1, DOI 10.1016/j.cplett.2013.03.035; Rowland MM, 2014, NUCLEIC ACIDS RES, V42, P9295, DOI 10.1093/nar/gku621; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Schmidt H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102444; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wentzell LM, 1998, J MOL BIOL, V281, P433, DOI 10.1006/jmbi.1998.1967; Zhang YR, 2015, ACS CHEM BIOL, V10, P2606, DOI 10.1021/acschembio.5b00409	39	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17473	17481		10.1074/jbc.M117.801860	http://dx.doi.org/10.1074/jbc.M117.801860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28893909	hybrid, Green Published			2022-12-28	WOS:000414009300027
J	Wong, HS; Dighe, PA; Mezera, V; Monternier, PA; Brand, MD				Wong, Hoi-Shan; Dighe, Pratiksha A.; Mezera, Vojtech; Monternier, Pierre-Axel; Brand, Martin D.			Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Complex I; hydrogen peroxide; mitochondria; reactive oxygen species (ROS); superoxide ion; complex III	SKELETAL-MUSCLE MITOCHONDRIA; OXIDOREDUCTASE COMPLEX-I; REACTIVE OXYGEN; CALORIC RESTRICTION; HEART-MITOCHONDRIA; OXIDATIVE STRESS; RESPIRATORY-CHAIN; TISSUE-DAMAGE; FREE-RADICALS; RAT-HEART	Mitochondrial production of superoxide and hydrogen peroxide is potentially important in cell signaling and disease. Eleven distinct mitochondrial sites that differ markedly in capacity are known to leak electrons to oxygen to produce O-2(center dot-). and/or H2O2. We discuss their contributions to O-2(center dot-)./H2O2 production under native conditions in mitochondria oxidizing different substrates and in conditions mimicking physical exercise and the changes in their capacities after caloric restriction. We review the use of S1QELs and S3QELs, suppressors of mitochondrial O-2(center dot-)./H2O2 generation that do not inhibit oxidative phosphorylation, as tools to characterize the contributions of specific sites in situ and in vivo.	[Wong, Hoi-Shan; Dighe, Pratiksha A.; Mezera, Vojtech; Monternier, Pierre-Axel; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Wong, HS (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	hwong@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Dighe, Pratiksha/0000-0002-8862-295X				Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Bartosz G, 2006, CLIN CHIM ACTA, V368, P53, DOI 10.1016/j.cca.2005.12.039; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; DILEEPAN KN, 1985, BIOCHEM J, V225, P189, DOI 10.1042/bj2250189; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gorlach A, 2015, REDOX BIOL, V6, P372, DOI 10.1016/j.redox.2015.08.016; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Hagopian K, 2011, J BIOENERG BIOMEMBR, V43, P227, DOI 10.1007/s10863-011-9353-8; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; JACKSON MJ, 1985, BIOCHIM BIOPHYS ACTA, V847, P185, DOI 10.1016/0167-4889(85)90019-9; Kanter M, 1998, P NUTR SOC, V57, P9, DOI 10.1079/PNS19980004; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; Loschen G, 1975, Recent Adv Stud Cardiac Struct Metab, V7, P3; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rizza W, 2014, AGEING RES REV, V13, P38, DOI 10.1016/j.arr.2013.11.002; SEKHAR BS, 1987, J BIOENERG BIOMEMBR, V19, P397, DOI 10.1007/BF00768542; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Teodoro JS, 2013, MOL CELL BIOCHEM, V376, P103, DOI 10.1007/s11010-012-1555-9; Tonkonogi M, 2002, EXERC SPORT SCI REV, V30, P129, DOI 10.1097/00003677-200207000-00007; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Trepanowski JF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-107; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011	75	232	240	12	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16804	16809		10.1074/jbc.R117.789271	http://dx.doi.org/10.1074/jbc.R117.789271			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842493	hybrid, Green Published			2022-12-28	WOS:000413140600002
J	Yu, XJ; Niks, D; Mulchandani, A; Hille, R				Yu, Xuejun; Niks, Dimitri; Mulchandani, Ashok; Hille, Russ			Efficient reduction of CO2 by the molybdenum-containing formate dehydrogenase from Cupriavidus necator (Ralstonia eutropha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofuel; carbon dioxide; enzyme catalysis; molybdenum; multifunctional enzyme	CARBON-DIOXIDE; CONVERSION; METHANOL	The ability of the FdsABG formate dehydrogenase from Cupriavidus necator (formerly known as Ralstonia eutropha) to catalyze the reverse of the physiological reaction, the reduction of CO2 to formate utilizing NADH as electron donor, has been investigated. Contrary to previous studies of this enzyme, we demonstrate that it is in fact effective in catalyzing the reverse reaction with a k(cat) of 11 +/- 0.4 s(-1). We also quantify the stoichiometric accumulation of formic acid as the product of the reaction and demonstrate that the observed kinetic parameters for catalysis in the forward and reverse reactions are thermodynamically consistent, complying with the expected Haldane relationships. Finally, we demonstrate the reaction conditions necessary for gauging the ability of a given formate dehydrogenase or other CO2-utilizing enzyme to catalyze the reverse direction to avoid false negative results. In conjunction with our earlier studies on the reaction mechanism of this enzyme and on the basis of the present work, we conclude that all molybdenum- and tungsten-containing formate dehydrogenases and related enzymes likely operate via a simple hydride transfer mechanism and are effective in catalyzing the reversible interconversion of CO2 and formate under the appropriate experimental conditions.	[Yu, Xuejun; Mulchandani, Ashok] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Yu, Xuejun] Univ Calif Riverside, Dept Bioengn Engn, Riverside, CA 92521 USA; [Mulchandani, Ashok] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Mulchandani, A (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.; Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Mulchandani, A (corresponding author), Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.	adani@engr.ucr.edu; russ.hille@ucr.edu	Mulchandani, Ashok/R-6130-2019		National Science Foundation [NSF-CBET 1265044]; United States Department of Energy [DE-SC0010666]; University of California, Riverside; Directorate For Engineering [1265044] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); University of California, Riverside(University of California System); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation Grant NSF-CBET 1265044 (to A. M.) and United States Department of Energy Grant DE-SC0010666 (to R. H.) as well as a seed grant from the University of California, Riverside. The authors declare that they have no conflicts of interest with the contents of this article.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Butler JN, 1991, CARBON DIOXIDE EQUIL; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Maia LB, 2017, INORG CHIM ACTA, V455, P350, DOI 10.1016/j.ica.2016.07.010; Maia LB, 2016, J AM CHEM SOC, V138, P8834, DOI 10.1021/jacs.6b03941; Maia LB, 2015, J BIOL INORG CHEM, V20, P287, DOI 10.1007/s00775-014-1218-2; Mondal B, 2015, CURR OPIN CHEM BIOL, V25, P103, DOI 10.1016/j.cbpa.2014.12.022; Niks D, 2016, J BIOL CHEM, V291, P1162, DOI 10.1074/jbc.M115.688457; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Olah GA, 2005, ANGEW CHEM INT EDIT, V44, P2636, DOI 10.1002/anie.200462121; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Qiao JL, 2014, CHEM SOC REV, V43, P631, DOI 10.1039/c3cs60323g; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Segel I. H., 1993, ENZYME KINETICS BEHA; Shi JF, 2015, CHEM SOC REV, V44, P5981, DOI 10.1039/c5cs00182j; Sun QY, 2009, IND ENG CHEM RES, V48, P4210, DOI 10.1021/ie801931j; Wagner T, 2016, SCIENCE, V354, P114, DOI 10.1126/science.aaf9284	22	49	50	3	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16872	16879		10.1074/jbc.M117.785576	http://dx.doi.org/10.1074/jbc.M117.785576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28784661	Green Published, hybrid			2022-12-28	WOS:000413140600009
J	Shen, ZF; Chen, Y; Hong, LJ; Cui, ZT; Yang, HP; He, XB; Shi, Y; Shi, LG; Han, F; Zhou, NM				Shen, Zhangfei; Chen, Yu; Hong, Lingjuan; Cui, Zhenteng; Yang, Huipeng; He, Xiaobai; Shi, Ying; Shi, Liangen; Han, Feng; Zhou, Naiming			BNGR-A25L and-A27 are two functional G protein-coupled receptors for CAPA periviscerokinin neuropeptides in the silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; ANTIDIURETIC-HORMONE; INSECT NEUROPEPTIDES; NEUROHORMONE GPCRS; SIGNALING PATHWAY; MOLECULAR-CLONING; TOBACCO HAWKMOTH; ACTIVATION; PEPTIDES; EXPRESSION	CAPA peptides, such as periviscerokinin (PVK), are insect neuropeptides involved in many signaling pathways controlling, for example, metabolism, behavior, and reproduction. They are present in a large number of insects and, together with their cognate receptors, are important for research into approaches for improving insect control. However, the CAPA receptors in the silkworm (Bombyx mori) insect model are unknown. Here, we cloned cDNAs of two putative CAPA peptide receptor genes, BNGR-A27 and -A25, from the brain of B. mori larvae. We found that the predicted BNGR-A27 ORF encodes 450 amino acids and that one BNGRA-25 splice variant encodes a full-length isoform (BNGR-A25L) of 418 amino acid residues and another a short isoform (BNGRA-25S) of 341 amino acids with a truncated C-terminal tail. Functional assays indicated that both BNGR-A25L and -A27 are activated by the PVK neuropeptides Bom-CAPA-PVK-1 and -PVK-2, leading to a significant increase in cAMP-response element-controlled luciferase activity and Ca2+ mobilization in a G(q) inhibitor-sensitive manner. In contrast, BNGR-A25S was not significantly activated in response to the PVK peptides. Moreover, Bom-CAPA-PVK-1 directly bound to BNGR-A25L and -A27, but not BNGR-A25S. Of note, CAPA-PVK-mediated ERK1/2 phosphorylation and receptor internalization confirmed that BNGR-A25L and -A27 are two canonical receptors for Bombyx CAPA-PVKs. However, BNGR-A25S alone is a nonfunctional receptor but serves as a dominant-negative protein for BNGR-A25L. These results provide evidence that BNGR-A25L and -A27 are two functional G(q)-coupled receptors for Bombyx CAPA-PVKs, enabling the further elucidation of the endocrinological roles of Bom-CAPA-PVKs and their receptors in insect biology.	[Shen, Zhangfei; Yang, Huipeng; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Inst Biochem, Coll Life Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Zhangfei; Cui, Zhenteng; Shi, Liangen] Zhejiang Univ, Dept Econ Zool, Coll Anim Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Hong, Lingjuan; Han, Feng] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huipeng] CAAS, Inst Apicultural Res, Beijing 100093, Peoples R China; [He, Xiaobai] Jiangsu Univ Sci & Technol, Coll Biotechnol, Zhenjiang 212018, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Jiangsu University of Science & Technology	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022	shen, zhangfei/0000-0002-3707-2265	Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [31272375, 31572462, 31072090]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2012CB910402 and National Natural Science Foundation of China Grants 31272375, 31572462, and 31072090. The authors declare that they have no conflicts of interest with the contents of this article.	Altstein M., 2013, HDB BIOL ACTIVE PEPT, P255, DOI DOI 10.1016/B978-0-12-385095-9.00037-3; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Davies SA, 1997, AM J PHYSIOL-REG I, V273, pR823, DOI 10.1152/ajpregu.1997.273.2.R823; Deng XY, 2014, INSECT BIOCHEM MOLEC, V45, P77, DOI 10.1016/j.ibmb.2013.12.007; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Fan YZ, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/173865; Gondalia K., 2016, IXODES SCAPULARIS PE, V86, P42; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; HUESMANN GR, 1995, FEBS LETT, V371, P311, DOI 10.1016/0014-5793(95)00929-4; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang X, 2016, INSECT BIOCHEM MOLEC, V75, P78, DOI 10.1016/j.ibmb.2016.06.005; Kapustin Y., 2004, 8 ANN INT C RECOMB 2, P741; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Lee HJ, 2008, PIGM CELL MELANOMA R, V21, P415, DOI 10.1111/j.1755-148X.2008.00478.x; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Liu Xiaoguang, 2012, Int J Pept, V2012, P640359, DOI 10.1155/2012/640359; Lu ZG, 2015, J CLIN INVEST, V125, P2626, DOI 10.1172/JCI81070; MacPherson MR, 2001, AM J PHYSIOL-CELL PH, V280, pC394, DOI 10.1152/ajpcell.2001.280.2.C394; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; MASLER EP, 1993, ARCH INSECT BIOCHEM, V22, P87, DOI 10.1002/arch.940220109; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; ODonnell M. J., 1996, J EXP BIOL, V199; Oladosu FA, 2015, MAYO CLIN PROC, V90, P1135, DOI 10.1016/j.mayocp.2015.06.010; Olsen SS, 2007, BIOCHEM BIOPH RES CO, V362, P245, DOI 10.1016/j.bbrc.2007.06.190; Paluzzi JP, 2008, ENDOCRINOLOGY, V149, P4638, DOI 10.1210/en.2008-0353; Paluzzi JP, 2010, P NATL ACAD SCI USA, V107, P10290, DOI 10.1073/pnas.1003666107; Paluzzi JP, 2010, MOL CELL ENDOCRINOL, V317, P53, DOI 10.1016/j.mce.2009.11.004; Paluzzi JP, 2006, J EXP BIOL, V209, P907, DOI 10.1242/jeb.02083; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pollock VP, 2004, J EXP BIOL, V207, P4135, DOI 10.1242/jeb.01255; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Rosay P, 1997, J CELL SCI, V110, P1683; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Schooley D.A., 2012, INSECT ENDOCRINOLOGY, P366, DOI DOI 10.1016/B978-0-12-384749-2.10009-3; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Terhzaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029897; TUBLITZ NJ, 1985, J EXP BIOL, V116, P395; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wegener C, 2000, J NEUROPHYSIOL, V84, P3056, DOI 10.1152/jn.2000.84.6.3056; Wise Helen, 2012, J Mol Signal, V7, P13, DOI 10.1186/1750-2187-7-13; Woodley Louise, 2002, Briefings in Functional Genomics & Proteomics, V1, P266, DOI 10.1093/bfgp/1.3.266; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675; Yang YL, 2015, INSECT BIOCHEM MOLEC, V60, P13, DOI 10.1016/j.ibmb.2015.02.010; Yang YL, 2013, GEN COMP ENDOCR, V194, P142, DOI 10.1016/j.ygcen.2013.09.001	69	9	9	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16554	16570		10.1074/jbc.M117.803445	http://dx.doi.org/10.1074/jbc.M117.803445			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842502	hybrid, Green Published			2022-12-28	WOS:000412414800017
J	Tripathi, SK; Xu, T; Feng, Q; Avula, B; Shi, XM; Pan, XW; Mask, MM; Baerson, SR; Jacob, MR; Ravu, RR; Khan, SI; Li, XC; Khan, IA; Clark, AM; Agarwal, AK				Tripathi, Siddharth K.; Xu, Tao; Feng, Qin; Avula, Bharathi; Shi, Xiaomin; Pan, Xuewen; Mask, Melanie M.; Baerson, Scott R.; Jacob, Melissa R.; Ravu, Ranga Rao; Khan, Shabana I.; Li, Xing-Cong; Khan, Ikhlas A.; Clark, Alice M.; Agarwal, Ameeta K.			Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PROTEIN BIOGENESIS; OXOAPORPHINE ALKALOIDS; CLEISTOPHOLIS-PATENS; SCAFFOLD PROTEIN; YEAST GENOME; FRATAXIN; EUPOLAURIDINE; DEFICIENCY	Eupolauridine and liriodenine are plant-derived aporphinoid alkaloids that exhibit potent inhibitory activity against the opportunistic fungal pathogens Candida albicans and Cryptococcus neoformans. However, the molecular mechanism of this antifungal activity is unknown. In this study, we show that eupolauridine 9591 (E9591), a synthetic analog of eupolauridine, and liriodenine methiodide (LMT), a methiodide salt of liriodenine, mediate their antifungal activities by disrupting mitochondrial iron-sulfur (Fe-S) cluster synthesis. Several lines of evidence supported this conclusion. First, both E9591 and LMT elicited a transcriptional response indicative of iron imbalance, causing the induction of genes that are required for iron uptake and for the maintenance of cellular iron homeostasis. Second, a genome-wide fitness profile analysis showed that yeast mutants with deletions in iron homeostasis-related genes were hypersensitive to E9591 and LMT. Third, treatment of wild-type yeast cells with E9591 or LMT generated cellular defects that mimicked deficiencies in mitochondrial Fe-S cluster synthesis including an increase in mitochondrial iron levels, a decrease in the activities of Fe-S cluster enzymes, a decrease in respiratory function, and an increase in oxidative stress. Collectively, our results demonstrate that E9591 and LMT perturb mitochondrial Fe-S cluster biosynthesis; thus, these two compounds target a cellular pathway that is distinct from the pathways commonly targeted by clinically used antifungal drugs. Therefore, the identification of this pathway as a target for antifungal compounds has potential applications in the development of new antifungal therapies.	[Tripathi, Siddharth K.; Xu, Tao; Feng, Qin; Avula, Bharathi; Jacob, Melissa R.; Ravu, Ranga Rao; Khan, Shabana I.; Li, Xing-Cong; Khan, Ikhlas A.; Clark, Alice M.; Agarwal, Ameeta K.] Univ Mississippi, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Khan, Shabana I.; Li, Xing-Cong; Khan, Ikhlas A.; Clark, Alice M.] Univ Mississippi, Sch Pharm, Dept Biomol Sci, Div Pharmacognosy, University, MS 38677 USA; [Agarwal, Ameeta K.] Univ Mississippi, Sch Pharm, Dept Biomol Sci, Div Pharmacol, University, MS 38677 USA; [Shi, Xiaomin; Pan, Xuewen] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Mask, Melanie M.; Baerson, Scott R.] ARS, USDA, Nat Prod Utilizat Res Unit, University, MS 38677 USA; [Xu, Tao] Univ Michigan, Med Sch, Pathol Dept, Ann Arbor, MI 48109 USA; [Shi, Xiaomin] Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China; [Pan, Xuewen] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	University of Mississippi; University of Mississippi; University of Mississippi; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Michigan System; University of Michigan; Sun Yat Sen University; Novartis	Agarwal, AK (corresponding author), Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA.	aagarwal@olemiss.edu	Khan, Ikhlas/AAA-1829-2020; , Siddharth/B-5151-2009; Khan, Ikhlas/AAA-1490-2020; Agarwal, Ameeta K./H-3935-2019	, Siddharth/0000-0002-4324-2814; 	National Institutes of Health; Public Health Service; NIAID [R01 AI27094]; USDA-ARS [58-6408-2-0009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, Public Health Service, NIAID Grant R01 AI27094 and USDA-ARS Specific Cooperative Agreement number 58-6408-2-0009. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Agarwal AK, 2008, EUKARYOT CELL, V7, P387, DOI 10.1128/EC.00323-07; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Chen ChungYi, 2013, African Journal of Pharmacy and Pharmacology, V7, P1067; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Clark A.M., 1992, THE ALKALOIDS, V42, P117; CLARK AM, 1987, PHARMACEUT RES, V4, P495, DOI 10.1023/A:1016479622383; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; GUINAUDEAU H, 1994, J NAT PROD, V57, P1033, DOI 10.1021/np50110a001; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; HUFFORD CD, 1980, J PHARM SCI, V69, P1180, DOI 10.1002/jps.2600691016; HUFFORD CD, 1987, J NAT PROD, V50, P961, DOI 10.1021/np50053a037; HUFFORD CD, 1975, J PHARM SCI-US, V64, P789, DOI 10.1002/jps.2600640512; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Jo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-130; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Khan SI, 2002, ANTIMICROB AGENTS CH, V46, P1785, DOI 10.1128/AAC.46.6.1785-1792.2002; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LIU SC, 1990, ANTIMICROB AGENTS CH, V34, P529, DOI 10.1128/AAC.34.4.529; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Norris M, 2013, G3-GENES GENOM GENET, V3, P1965, DOI 10.1534/g3.113.008144; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Pan E, 2011, J NAT PROD, V74, P1169, DOI 10.1021/np200093n; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santos R, 2003, BIOCHEM J, V375, P247, DOI 10.1042/BJ20030835; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Simon R, 2007, CANCER INFORM, V3, P11; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864; Taghavi-Moghadam S, 2016, BIOORGAN MED CHEM, V24, P6119, DOI 10.1016/j.bmc.2016.02.028; Uzarska MA, 2013, MOL BIOL CELL, V24, P1830, DOI 10.1091/mbc.E12-09-0644; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Xu T, 2011, ANTIMICROB AGENTS CH, V55, P1611, DOI 10.1128/AAC.01022-10; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yuan DS, 2000, GENETICS, V156, P45; Zhang ZZ, 2002, J NAT PROD, V65, P856, DOI 10.1021/np0200717	68	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16578	16593		10.1074/jbc.M117.781773	http://dx.doi.org/10.1074/jbc.M117.781773			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28821607	Green Published, hybrid			2022-12-28	WOS:000412414800019
J	Nitzsche, R; Gunay-Esiyok, O; Tischer, M; Zagoriy, V; Gupta, N				Nitzsche, Richard; Guenay-Esiyok, Oezlem; Tischer, Maximilian; Zagoriy, Vyacheslav; Gupta, Nishith			A plant/fungal-type phosphoenolpyruvate carboxykinase located in the parasite mitochondrion ensures glucoseindependent survival of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; GLUTAMINE-METABOLISM; AEROBIC GLYCOLYSIS; LYTIC CYCLE; GLUCOSE; GENE; MARKER; TRANSFORMATION; LOCALIZATION; CARBOXYLASE	Toxoplasma gondii is considered to be one of the most successful intracellular pathogens, because it can reproduce in varied nutritional milieus, encountered in diverse host cell types of essentially any warm-blooded organism. Our earlier work demonstrated that the acute (tachyzoite) stage of T. gondii depends on cooperativity of glucose and glutamine catabolism to meet biosynthetic demands. Either of these two nutrients can sustain the parasite survival; however, what determines the metabolic plasticity has not yet been resolved. Here, we reveal two discrete phosphoenolpyruvate carboxykinase (PEPCK) enzymes in the parasite, one of which resides in the mitochondrion (TgPEPCKmt), whereas the other protein is not expressed in tachyzoites (TgPEPCKnet). Parasites with an intact glycolysis can tolerate genetic deletions of TgPEPCKmt as well as of TgPEPCKnet, indicating their nonessential roles for tachyzoite survival. TgPEPCKnet can also be ablated in a glycolysis-deficient mutant, while TgPEPCKmt is refractory to deletion. Consistent with this, the lytic cycle of a conditional mutant of TgPEPCKmt in the glycolysis-impaired strain was aborted upon induced repression of the mitochondrial isoform, demonstrating its essential role for the glucose-independent survival of parasites. Isotope-resolved metabolomics of the conditional mutant revealed defective flux of glutamine-derived carbon into RNA-bound ribose sugar as well as metabolites associated with gluconeogenesis, entailing a critical nodal role of PEPCKmt in linking catabolism of glucose and glutamine with anabolic pathways. Our data also suggest a homeostatic function of TgPEPCKmt in cohesive operation of glycolysis and the tricarboxylic acid cycle in a normal glucose-replete milieu. Conversely, we found that the otherwise integrative enzyme pyruvate carboxylase (TgPyC) is dispensable not only in glycolysis-competent but also in glycolysis-deficient tachyzoites despite a mitochondrial localization. Last but not least, the observed physiology of T. gondii tachyzoites appears to phenocopy cancer cells, which holds promise for developing common therapeutics against both threats.	[Nitzsche, Richard; Guenay-Esiyok, Oezlem; Tischer, Maximilian; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10115 Berlin, Germany; [Zagoriy, Vyacheslav] metaSysX GmbH, D-14476 Potsdam, Germany	Humboldt University of Berlin	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126; Gunay-Esiyok, Ozlem/0000-0003-1245-9030	German Research Foundation [GU1100/3-1, GU1100/4-1]; Heisenberg Fellowship [GU1100/8-1]; Elsa Neumann fellowship	German Research Foundation(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG)); Elsa Neumann fellowship	This work was supported by German Research Foundation Grants GU1100/3-1 and GU1100/4-1 and Heisenberg Fellowship GU1100/8-1 (to N. G.). Financial support to R. N. was provided through grants awarded to N. G. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of an Elsa Neumann fellowship.	Al Bratty M, 2012, FEBS OPEN BIO, V2, P217, DOI 10.1016/j.fob.2012.07.007; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Blader IJ, 2015, ANNU REV MICROBIOL, V69, P463, DOI 10.1146/annurev-micro-091014-104100; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Echeverria PC, 2010, MOL BIOCHEM PARASIT, V172, P129, DOI 10.1016/j.molbiopara.2010.04.004; Fleige T, 2008, INT J PARASITOL, V38, P1121, DOI 10.1016/j.ijpara.2008.01.007; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Giavalisco P, 2009, ANAL CHEM, V81, P6546, DOI 10.1021/ac900979e; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Hehl AB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1225-x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; Limenitakis J, 2013, MOL MICROBIOL, V87, P894, DOI 10.1111/mmi.12139; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Nitzsche R, 2016, J BIOL CHEM, V291, P126, DOI 10.1074/jbc.M114.624619; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; STEIN WH, 1954, J BIOL CHEM, V211, P915; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200	45	17	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15225	15239		10.1074/jbc.M117.802702	http://dx.doi.org/10.1074/jbc.M117.802702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28726641	Green Published, hybrid			2022-12-28	WOS:000410809800006
J	Sorenson, KS; Mahaney, BL; Lees-Miller, SP; Cobb, JA				Sorenson, Kyle S.; Mahaney, Brandi L.; Lees-Miller, Susan P.; Cobb, Jennifer A.			The non-homologous end-joining factor Nej1 inhibits resection mediated by Dna2-Sgs1 nuclease-helicase at DNA double strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; CHROMOSOMAL REARRANGEMENTS; REPAIR; PROTEINS; YEAST; SGS1; EXO1	Double strand breaks (DSBs) represent highly deleterious DNA damage and need to be accurately repaired. Homology-directed repair and non-homologous end joining (NHEJ) are the two major DSB repair pathways that are highly conserved from yeast to mammals. The choice between these pathways is largely based on 5' to 3' DNA resection, and NHEJ proceeds only if resection has not been initiated. In yeast, yKu70/80 rapidly localizes to the break, protecting DNA ends from nuclease accessibility, and recruits additional NHEJ factors, including Nej1 and Lif1. Cells harboring the nej1-V338A mutant exhibit NHEJ-mediated repair deficiencies and hyper-resection 0.15 kb from the DSB that was dependent on the nuclease activity of Dna2-Sgs1. The integrity of Nej1 is also important for inhibiting long-range resection, 4.8 kb from the break, and for preventing the formation of large genomic deletions at sizes >700 bp around the break. Nej1(V338A) localized to a DSB similarly to WT Nej1, indicating that the Nej1-Lif1 interaction becomes critical for blocking hyper-resection mainly after their recruitment to the DSB. This work highlights that Nej1 inhibits 5' DNA hyperresection mediated by Dna2-Sgs1, a function distinct from its previously reported role in supporting Dnl4 ligase activity, and has implications for repair pathway choice and resection regulation upon DSB formation.	[Cobb, Jennifer A.] Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Oncol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Cobb, JA (corresponding author), Univ Calgary, Cumming Sch Med, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol,Robson DNA Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jcobb@ucalgary.ca		Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institutes of Health Research (CIHR) [MOP-82736, MOP-137062]; Natural Sciences and Engineering Research Council of Canada [418122]; CIHR Grant [MOP-13639]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from Canadian Institutes of Health Research (CIHR) Grants MOP-82736 and MOP-137062 and Natural Sciences and Engineering Research Council of Canada Grant 418122 (to J. A. C.) and CIHR Grant MOP-13639 (to S. P. L.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Balestrini A, 2013, CELL REP, V3, P2033, DOI 10.1016/j.celrep.2013.05.026; Bressan DA, 1998, GENETICS, V150, P591; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Chen XF, 2016, NUCLEIC ACIDS RES, V44, P2742, DOI 10.1093/nar/gkv1544; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Ferrari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004928; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Horigome C, 2016, GENE DEV, V30, P931, DOI 10.1101/gad.277665.116; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jain S, 2016, GENETICS, V203, P667, DOI 10.1534/genetics.115.184317; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Mahaney BL, 2014, DNA REPAIR, V14, P9, DOI 10.1016/j.dnarep.2013.12.002; Matsuzaki K, 2008, GENETICS, V179, P213, DOI 10.1534/genetics.107.079236; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Schar P., 1997, GENE DEV, V11, P1912; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yu X, 2003, GENETICS, V163, P843; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhang Y, 2009, DNA REPAIR, V8, P1235, DOI 10.1016/j.dnarep.2009.07.007; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	51	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14576	14586		10.1074/jbc.M117.796011	http://dx.doi.org/10.1074/jbc.M117.796011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28679532	Green Published, hybrid			2022-12-28	WOS:000408747500023
J	Pfaff, DH; Fleming, T; Nawroth, P; Teleman, AA				Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter; Teleman, Aurelio A.			Reply to Richarme: Evidence against a role of DJ-1 in methylglyoxal detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Letter							PROTEIN DJ-1		[Pfaff, Daniel H.; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter] Heidelberg Univ Hosp, Dept Internal Med & Clin Chem 1, Heidelberg, Germany; [Nawroth, Peter] German Ctr Diabet Res DZD, Munich, Germany; [Nawroth, Peter] Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association	Teleman, AA (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.; Nawroth, P (corresponding author), Heidelberg Univ Hosp, Dept Internal Med & Clin Chem 1, Heidelberg, Germany.; Nawroth, P (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.; Nawroth, P (corresponding author), Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, Munich, Germany.	Peter.Nawroth@med.uni-heidelberg.de; a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013	Teleman, Aurelio A/0000-0002-4237-9368				Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Pfaff DH, 2017, J BIOL CHEM, V292, P685, DOI 10.1074/jbc.M116.743823; Richarme G, 2017, J BIOL CHEM, V292, P12783, DOI 10.1074/jbc.L117.797464; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815	4	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12784	12785		10.1074/jbc.L117.798579	http://dx.doi.org/10.1074/jbc.L117.798579			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28778882	Green Published, hybrid			2022-12-28	WOS:000407220100009
J	Acosta-Sampson, L; Doring, K; Lin, YP; Yu, VY; Bukau, B; Kramer, G; Cate, JHD				Acosta-Sampson, Ligia; Doering, Kristina; Lin, Yuping; Yu, Vivian Y.; Bukau, Bernd; Kramer, Guenter; Cate, Jamie H. D.			Role for ribosome-associated complex and stress-seventy subfamily B (RAC-Ssb) in integral membrane protein translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; membrane protein; protein synthesis; translation control; unfolded protein response (UPR); stress-seventy subfamily B (Ssb); major facilitator superfamily (MFS); ribosome associated complex (RAC)	SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE-ASSOCIATED COMPLEX; MAJOR FACILITATOR SUPERFAMILY; NASCENT CHAIN-LENGTH; GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CODON USAGE; QUALITY-CONTROL; IN-VIVO	Targeting of most integral membrane proteins to the endoplasmic reticulum is controlled by the signal recognition particle, which recognizes a hydrophobic signal sequence near the protein N terminus. Proper folding of these proteins is monitored by the unfolded protein response and involves protein degradation pathways to ensure quality control. Here, we identify a new pathway for quality control of major facilitator superfamily transporters that occurs before the first transmembrane helix, the signal sequence recognized by the signal recognition particle, is made by the ribosome. Increased rates of translation elongation of the N-terminal sequence of these integral membrane proteins can divert the nascent protein chains to the ribosome-associated complex and stress-seventy subfamily B chaperones. We also show that quality control of integral membrane proteins by ribosome-associated complex-stress-seventy subfamily B couples translation rate to the unfolded protein response, which has implications for understanding mechanisms underlying human disease and protein production in biotechnology.	[Acosta-Sampson, Ligia; Lin, Yuping; Yu, Vivian Y.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doering, Kristina; Bukau, Bernd; Kramer, Guenter] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Doering, Kristina; Bukau, Bernd; Kramer, Guenter] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Lin, Yuping] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	jcate@lbl.gov		Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Cate, Jamie/0000-0001-5965-7902	Energy Biosciences Institute; National Institutes of Health [R01-GM065050]; Deutsche Forschungsgemeinschaft [SFB638, FOR1805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050] Funding Source: NIH RePORTER	Energy Biosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Energy Biosciences Institute (to J. H. D. C.), National Institutes of Health Grant R01-GM065050 (to J. H. D. C), and Deutsche Forschungsgemeinschaft Grants SFB638 and FOR1805 (to G. K. and B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Ashe MP, 2011, BIOTECHNOL J, V6, P707, DOI 10.1002/biot.201000333; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Buck TM, 2015, PHYSIOL GENOMICS, V47, P198, DOI 10.1152/physiolgenomics.00101.2014; Buziol S, 2008, J BIOTECHNOL, V134, P203, DOI 10.1016/j.jbiotec.2008.02.002; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Dinh PX, 2012, VIROLOGY, V432, P460, DOI 10.1016/j.virol.2012.07.004; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kahm M, 2010, J STAT SOFTW, V33, P1; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Mahlab S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003294; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Noriega TR, 2014, ELIFE, V3, DOI 10.7554/eLife.04418; Noriega TR, 2014, J BIOL CHEM, V289, P19294, DOI 10.1074/jbc.M114.563239; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Power PM, 2004, BIOCHEM BIOPH RES CO, V322, P1038, DOI 10.1016/j.bbrc.2004.08.022; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Roy A, 2014, BBA-GEN SUBJECTS, V1840, P2878, DOI 10.1016/j.bbagen.2014.05.004; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Shah K, 2015, J MOL BIOL, V427, P1464, DOI 10.1016/j.jmb.2015.02.003; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Verwaal R, 2002, YEAST, V19, P1029, DOI 10.1002/yea.895; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	91	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19610	19627		10.1074/jbc.M117.813857	http://dx.doi.org/10.1074/jbc.M117.813857			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972146	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000416911300010
J	Brifault, C; Gilder, AS; Laudati, E; Banki, M; Gonias, SL				Brifault, Coralie; Gilder, Andrew S.; Laudati, Emilia; Banki, Michael; Gonias, Steven L.			Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein receptor-related protein (LRP); metalloprotease; microglia; neuroinflammation; shedding; receptor-associated protein	NF-KAPPA-B; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; NEUROPATHIC PAIN; INNATE IMMUNITY; NERVOUS-SYSTEM; SCHWANN-CELLS; GLIAL-CELLS	In the CNS, microglia are activated in response to injury or infection and in neurodegenerative diseases. The endocytic and cell signaling receptor, LDL receptor-related protein-1 (LRP1), is reported to suppress innate immunity in macrophages and oppose microglial activation. The goal of this study was to identify novel mechanisms by which LRP1 may regulate microglial activation. Using primary cultures of microglia isolated from mouse brains, we demonstrated that LRP1 gene silencing increases expression of proinflammatory mediators; however, the observed response was modest. By contrast, the LRP1 ligand, receptor-associated protein (RAP), robustly activated microglia, and its activity was attenuated in LRP1-deficient cells. An important element of the mechanism by which RAP activated microglia was its ability to cause LRP1 shedding from the plasma membrane. This process eliminated cellular LRP1, which is anti-inflammatory, and generated a soluble product, shed LRP1 (sLRP1), which is potently proinflammatory. Purified sLRP1 induced expression of multiple proinflammatory cytokines and the mRNA encoding inducible nitric-oxide synthase in both LRP1-expressing and -deficient microglia. LPS also stimulated LRP1 shedding, as did the heat-shock protein and LRP1 ligand, calreticulin. Other LRP1 ligands, including (2)-macroglobulin and tissue-type plasminogen activator, failed to cause LRP1 shedding. Treatment of microglia with a metalloproteinase inhibitor inhibited LRP1 shedding and significantly attenuated RAP-induced cytokine expression. RAP and sLRP1 both caused neuroinflammation in vivo when administered by stereotaxic injection into mouse spinal cords. Collectively, these results suggest that LRP1 shedding from microglia may amplify and sustain neuroinflammation in response to proinflammatory stimuli.	[Brifault, Coralie; Gilder, Andrew S.; Laudati, Emilia; Banki, Michael; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu		brifault, coralie/0000-0002-9831-4491; Banki, Michael/0000-0002-8910-4695	National Institutes of Health [R01 HL136395, R01 NS097590]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants R01 HL136395 and R01 NS097590 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Campana WM, 2017, FASEB J, V31, P1744, DOI 10.1096/fj.201601121R; Chuang TY, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0343-2; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Costales P, 2013, ATHEROSCLEROSIS, V227, P79, DOI 10.1016/j.atherosclerosis.2012.12.021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Duus K, 2010, FEBS J, V277, P3526, DOI 10.1111/j.1742-4658.2010.07762.x; Fernandez-Castaneda A, 2013, J BIOL CHEM, V288, P4538, DOI 10.1074/jbc.M112.384693; Flutsch A, 2016, NEUROREPORT, V27, P1305, DOI 10.1097/WNR.0000000000000691; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Grimsley PG, 1999, THROMB RES, V94, P153, DOI 10.1016/S0049-3848(98)00208-4; Guillot-Sestier MV, 2015, TRENDS NEUROSCI, V38, P674, DOI 10.1016/j.tins.2015.08.008; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HUSSAINI IM, 1990, J BIOL CHEM, V265, P19441; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kavanagh E, 2015, AGING-US, V7, P673, DOI 10.18632/aging.100805; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; Mantuano E, 2017, BLOOD, V130, P1364, DOI 10.1182/blood-2017-04-780205; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; May P, 2013, CELL TISSUE RES, V354, P887, DOI 10.1007/s00441-013-1699-2; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Ni M, 2010, CURR PROTOC TOXICOL; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Staudt ND, 2013, CANCER RES, V73, P3902, DOI 10.1158/0008-5472.CAN-12-4233; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Van Gool B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00271; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Webb DJ, 1999, J BIOL CHEM, V274, P7412, DOI 10.1074/jbc.274.11.7412; WOLF BB, 1992, AM J PATHOL, V141, P37; Wygrecka M, 2011, AM J RESP CRIT CARE, V184, P438, DOI 10.1164/rccm.201009-1422OC; Yamamoto K, 2017, ARTHRITIS RHEUMATOL, V69, P1246, DOI 10.1002/art.40080; Yang LY, 2017, NAT PROD RES, V31, P487, DOI 10.1080/14786419.2016.1190719; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	64	27	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18699	18712		10.1074/jbc.M117.798413	http://dx.doi.org/10.1074/jbc.M117.798413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972143	hybrid, Green Published			2022-12-28	WOS:000414958100026
J	Pereyra, AS; Hasek, LY; Harris, KL; Berman, AG; Damen, FW; Goergen, CJ; Ellis, JM				Pereyra, Andrea S.; Hasek, Like Y.; Harris, Kate L.; Berman, Alycia G.; Damen, Frederick W.; Goergen, Craig J.; Ellis, Jessica M.			Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cardiac hypertrophy; cardiac metabolism; fatty acid oxidation; mammalian target of rapamycin (mTOR)	LEFT-VENTRICULAR HYPERTROPHY; FATTY-ACID OXIDATION; CORONARY-HEART-DISEASE; PATHOLOGICAL HYPERTROPHY; DIASTOLIC DYSFUNCTION; HDAC INHIBITION; FAILURE; METABOLISM; MORTALITY; TARGET	Cardiac hypertrophy is closely linked to impaired fatty acid oxidation, but the molecular basis of this link is unclear. Here, we investigated the loss of an obligate enzyme in mitochondrial long-chain fatty acid oxidation, carnitine palmitoyltransferase 2 (CPT2), on muscle and heart structure, function, and molecular signatures in a muscle- and heart-specific CPT2-deficient mouse (Cpt2(M-/-)) model. CPT2 loss in heart and muscle reduced complete oxidation of long-chain fatty acids by 87 and 69%, respectively, without altering body weight, energy expenditure, respiratory quotient, or adiposity. Cpt2M(-/-) mice developed cardiac hypertrophy and systolic dysfunction, evidenced by a 5-fold greater heart mass, 60-90% reduction in blood ejection fraction relative to control mice, and eventual lethality in the absence of cardiac fibrosis. The hypertrophy-inducing mammalian target of rapamycin complex 1 (mTORC1) pathway was activated in Cpt2M(-/-) hearts; however, daily rapamycin exposure failed to attenuate hypertrophy in Cpt2M(-/-) mice. Lysine acetylation was reduced by approximate to 50% in Cpt2M(-/-) hearts, but trichostatin A, a histone deacetylase inhibitor that improves cardiac remodeling, failed to attenuate Cpt2M(-/-) hypertrophy. Strikingly, a ketogenic diet increased lysine acetylation in Cpt2M(-/-) hearts 2.3-fold compared with littermate control mice fed a ketogenic diet, yet it did not improve cardiac hypertrophy. Together, these results suggest that a shift away from mitochondrial fatty acid oxidation initiates deleterious hypertrophic cardiac remodeling independent of fibrosis. The data also indicate that CPT2-deficient hearts are impervious to hypertrophy attenuators, that mitochondrial metabolism regulates cardiac acetylation, and that signals derived from alterations in mitochondrial metabolism are the key mediators of cardiac hypertrophic growth.	[Pereyra, Andrea S.; Hasek, Like Y.; Ellis, Jessica M.] Purdue Univ, Dept Nutr Sci, 700 W State St, W Lafayette, IN 47907 USA; [Harris, Kate L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Berman, Alycia G.; Damen, Frederick W.; Goergen, Craig J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ellis, JM (corresponding author), Purdue Univ, Dept Nutr Sci, 700 W State St, W Lafayette, IN 47907 USA.	jmellis@purdue.edu	Damen, Frederick/HHM-6021-2022; Goergen, Craig J./I-2416-2019	Goergen, Craig J./0000-0001-8883-7953; Damen, Frederick/0000-0001-9213-5508; Harris, Kate/0000-0002-0663-9302	Ralph W. and Grace M. Showalter Research Trust Fund Grant [208453]; McKinley Education Foundation [770520401]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK101001] Funding Source: NIH RePORTER	Ralph W. and Grace M. Showalter Research Trust Fund Grant; McKinley Education Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ralph W. and Grace M. Showalter Research Trust Fund Grant 208453 and McKinley Education Foundation 770520401. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Balasubramanian Sundaravadivel, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P52; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Bianco HT, 2014, INT J CARDIOL, V176, P1167, DOI 10.1016/j.ijcard.2014.07.251; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brady TM, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0608-3; Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Carley AN, 2014, CIRC RES, V114, P717, DOI 10.1161/CIRCRESAHA.114.301863; Chiao YA, 2016, AGING-US, V8, P314, DOI 10.18632/aging.100881; Cho IJ, 2015, J HYPERTENS, V33, P1633, DOI 10.1097/HJH.0000000000000607; Cox KB, 2009, LAB INVEST, V89, P1348, DOI 10.1038/labinvest.2009.86; Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gu J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00104; Haynie KR, 2014, DIABETES OBES METAB, V16, P757, DOI 10.1111/dom.12248; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099; Lee CF, 2015, CIRC J, V79, P1863, DOI 10.1253/circj.CJ-15-0742; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Levelt E, 2016, DIABETES, V65, P44, DOI 10.2337/db15-0627; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Murdolo G, 2015, HIGH BLOOD PRESS CAR, V22, P29, DOI 10.1007/s40292-014-0068-x; Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009; Ooi JYY, 2015, EPIGENETICS-US, V10, P418, DOI 10.1080/15592294.2015.1024406; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer BM, 2005, HEART FAIL REV, V10, P187, DOI 10.1007/s10741-005-5249-1; Paul DS, 2014, BBA-MOL CELL BIOL L, V1841, P880, DOI 10.1016/j.bbalip.2014.03.001; Rupp H, 2002, HERZ, V27, P621, DOI 10.1007/s00059-002-2428-x; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Schisler JC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001136; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Soesanto W, 2009, HYPERTENSION, V54, P1321, DOI 10.1161/HYPERTENSIONAHA.109.138818; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; Turcani M, 1999, BRIT J PHARMACOL, V126, P501, DOI 10.1038/sj.bjp.0702312; Turcani M, 1997, CIRCULATION, V96, P3681; Wang JC, 2016, INT J CARDIOL, V214, P41, DOI 10.1016/j.ijcard.2016.03.188; Xie M, 2013, TRENDS CARDIOVAS MED, V23, P229, DOI 10.1016/j.tcm.2012.12.006	55	35	36	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18443	18456		10.1074/jbc.M117.800839	http://dx.doi.org/10.1074/jbc.M117.800839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28916721	hybrid, Green Published			2022-12-28	WOS:000414958100006
J	Ebina-Shibuya, R; Matsumoto, M; Kuwahara, M; Jang, KJ; Sugai, M; Ito, Y; Funayama, R; Nakayama, K; Sato, Y; Ishii, N; Okamura, Y; Kinoshita, K; Kometani, K; Kurosaki, T; Muto, A; Ichinose, M; Yamashita, M; Igarashi, K				Ebina-Shibuya, Risa; Matsumoto, Mitsuyo; Kuwahara, Makoto; Jang, Kyoung-Jin; Sugai, Manabu; Ito, Yoshiaki; Funayama, Ryo; Nakayama, Keiko; Sato, Yuki; Ishii, Naoto; Okamura, Yasunobu; Kinoshita, Kengo; Kometani, Kohei; Kurosaki, Tomohiro; Muto, Akihiko; Ichinose, Masakazu; Yamashita, Masakatsu; Igarashi, Kazuhiko			Inflammatory responses induce an identity crisis of alveolar macrophages, leading to pulmonary alveolar proteinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; inflammation; macrophage; pulmonary surfactant; transcription factor	B-CELLS; BACH2; DIFFERENTIATION; EXPRESSION; ANTIBODY; POLARIZATION; MONOCYTES; ALIGNMENT; DYNAMICS; PROGRAM	Pulmonary alveolar proteinosis (PAP) is a severe respiratory disease characterized by dyspnea caused by accumulation of surfactant protein. Dysfunction of alveolar macrophages (AMs), which regulate the homeostasis of surfactant protein, leads to the development of PAP; for example, in mice lacking BTB and CNC homology 2 (Bach2). However, how Bach2 helps prevent PAP is unknown, and the cell-specific effects of Bach2 are undefined. Using mice lacking Bach2 in specific cell types, we found that the PAP phenotype of Bach2-deficient mice is due to Bach2 deficiency in more than two types of immune cells. Depletion of hyperactivated T cells in Bach2-deficient mice restored normal function of AMs and ameliorated PAP. We also found that, in Bach2-deficient mice, hyperactivated T cells induced gene expression patterns that are specific to other tissue-resident macrophages and dendritic cells. Moreover, Bach2-deficient AMs exhibited a reduction in cell cycle progression. IFN- released from T cells induced Bach2 expression in AMs, in which Bach2 then bound to regulatory regions of inflammation-associated genes in myeloid cells. Of note, in AMs, Bach2 restricted aberrant responses to excessive T cell-induced inflammation, whereas, in T cells, Bach2 puts a brake on T cell activation. Moreover, Bach2 stimulated the expression of multiple histone genes in AMs, suggesting a role of Bach2 in proper histone expression. We conclude that Bach2 is critical for the maintenance of AM identity and self-renewal in inflammatory environments. Treatments targeting T cells may offer new therapeutic strategies for managing secondary PAP.	[Ebina-Shibuya, Risa; Matsumoto, Mitsuyo; Sato, Yuki; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Cell Proliferat, United Ctr Adv Res & Translat Med, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Immunol, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Matsumoto, Mitsuyo; Funayama, Ryo; Nakayama, Keiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ebina-Shibuya, Risa; Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Seiryo Machi 1-1, Sendai, Miyagi 9808575, Japan; [Kuwahara, Makoto; Yamashita, Masakatsu] Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime 7910295, Japan; [Jang, Kyoung-Jin; Sugai, Manabu] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Sakyo Ku, Yoshidakonoe Machi, Kyoto 6068501, Japan; [Jang, Kyoung-Jin; Sugai, Manabu] Univ Fukui, Div Mol Genet, Dept Biochem & Bioinformat Sci, Sch Med, Matsuokashimoaizuki 23-3,Yoshida Gun Eiheiji Cho, Fukui 9801193, Japan; [Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Canc Stem Cells & Biol Programme, Singapore 117599, Singapore; [Okamura, Yasunobu; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Aoba 6-3-09, Sendai, Miyagi 9808579, Japan; [Kometani, Kohei; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho 1-7-22, Yokohama, Kanagawa 2300045, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kometani, Kohei] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Ehime University; Kyoto University; University of Fukui; National University of Singapore; Tohoku University; RIKEN; Osaka University; Max Planck Society	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.; Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019; Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kometani, Kohei/0000-0003-4281-4371; Ebina-Shibuya, Risa/0000-0001-9031-5070; Okamura, Yasunobu/0000-0001-9847-9037; Igarashi, Kazuhiko/0000-0002-2470-2475; Sugai, Manabu/0000-0003-1668-7647	Japan Society for the Promotion of Science [15H02506, 24390066, 23116003, 21249014]; Uehara Foundation; Takeda Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [15H02506, 16K07108] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H02506, 24390066, 23116003, and 21249014 from the Japan Society for the Promotion of Science. Additional initiative supports were from the Uehara Foundation, Takeda Foundation, and Astellas Foundation for Research on Metabolic Disorders. The authors declare that they have no conflicts of interest with the contents of this article.	Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Ebina-Shibuya R, 2016, J BIOCHEM, V160, P333, DOI 10.1093/jb/mvw041; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Iriguchi S, 2015, BLOOD, V125, P370, DOI 10.1182/blood-2014-05-575225; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Kamezaki K, 2004, INT IMMUNOL, V16, P1173, DOI 10.1093/intimm/dxh118; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nogee LM, 2000, AM J RESP CRIT CARE, V161, P973, DOI 10.1164/ajrccm.161.3.9903153; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Tanaka H, 2016, J BIOL CHEM, V291, P6316, DOI 10.1074/jbc.M116.713842; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Yashiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137699; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117112; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18098	18112		10.1074/jbc.M117.808535	http://dx.doi.org/10.1074/jbc.M117.808535			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28916727	hybrid, Green Published			2022-12-28	WOS:000414458200010
J	Shibayama, N; Ohki, M; Tame, JRH; Park, SY				Shibayama, Naoya; Ohki, Mio; Tame, Jeremy R. H.; Park, Sam-Yong			Direct observation of conformational population shifts in crystalline human hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; cooperativity; hemoglobin; oxygen transport; protein conformation; X-ray crystallography; allostery	X-RAY-DIFFRACTION; OXYGEN EQUILIBRIUM PROPERTIES; 82-BETA-2 LYSYL RESIDUES; QUATERNARY STRUCTURE; AFFINITY CONFORMATIONS; ALLOSTERIC TRANSITION; LIGANDED HEMOGLOBIN; HYBRID HEMOGLOBINS; SINGLE-CRYSTALS; HUMAN ADULT	Although X-ray crystallography is the most commonly used technique for studying the molecular structure of proteins, it is not generally able to monitor the dynamic changes or global domain motions that often underlie allostery. These motions often prevent crystal growth or reduce crystal order. We have recently discovered a crystal form of human hemoglobin that contains three protein molecules allowed to express a full range of quaternary structures, whereas maintaining strong X-ray diffraction. Here we use this crystal form to investigate the effects of two allosteric effectors, phosphate and bezafibrate, by tracking the structures and functions of the three hemoglobin molecules following the addition of each effector. The X-ray analysis shows that the addition of either phosphate or bezafibrate not only induces conformational changes in a direction from a relaxed-state to a tense-state, but also within relaxed-state populations. The microspectrophotometric O-2 equilibrium measurements on the crystals demonstrate that the binding of each effector energetically stabilizes the lowest affinity conformer more strongly than the intermediate affinity one, thereby reducing the O-2 affinity of tense-state populations, and that the addition of bezafibrate causes an approximate to 5-fold decrease in the O-2 affinity of relaxed-state populations. These results show that the allosteric pathway of hemoglobin involves shifts of populations rather than a unidirectional conversion of one quaternary structure to another, and that minor conformers of hemoglobin may have a disproportionate effect on the overall O-2 affinity.	[Shibayama, Naoya] Jichi Med Univ, Div Biophys, Dept Physiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Ohki, Mio; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan	Jichi Medical University; Yokohama City University	Shibayama, N (corresponding author), Jichi Med Univ, Div Biophys, Dept Physiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	shibayam@jichi.ac.jp		Shibayama, Naoya/0000-0002-2208-1126; Tame, Jeremy/0000-0002-9341-7280	Japan Society for the Promotion of Science (JSPS) [JP15H01646, JP16K07326]; Grants-in-Aid for Scientific Research [15K21719, 26105001] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP15H01646 (to N. S.) and JP16K07326 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; ARNONE A, 1986, J MOL BIOL, V188, P693, DOI 10.1016/S0022-2836(86)80015-8; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Biswal BK, 2001, CURR SCI INDIA, V81, P1100; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bricogne G., 2011, BUSTER VERSION 2 10, V10, P2; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COBAU WG, 1985, BIOPHYS J, V47, P781, DOI 10.1016/S0006-3495(85)83981-3; Colombo MF, 1999, BIOCHEMISTRY-US, V38, P11741, DOI 10.1021/bi9905361; DEREWENDA Z, 1990, J MOL BIOL, V211, P515, DOI 10.1016/0022-2836(90)90262-K; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Henry ER, 2015, BIOPHYS J, V109, P1264, DOI 10.1016/j.bpj.2015.04.037; IMAI K, 1979, J MOL BIOL, V133, P233, DOI 10.1016/0022-2836(79)90532-1; JONES CM, 1992, BIOCHEMISTRY-US, V31, P6692, DOI 10.1021/bi00144a008; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEE AWM, 1983, P NATL ACAD SCI-BIOL, V80, P7055, DOI 10.1073/pnas.80.23.7055; LUISI B, 1990, J MOL BIOL, V214, P7, DOI 10.1016/0022-2836(90)90139-D; LUISI B, 1989, J MOL BIOL, V206, P723, DOI 10.1016/0022-2836(89)90579-2; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHANNA AS, 1990, BIOCHEMISTRY-US, V29, P3944, DOI 10.1021/bi00468a022; MINTON A P, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1418, DOI 10.1073/pnas.71.4.1418; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mozzarelli A, 1997, PROTEIN SCI, V6, P484; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Park SY, 2004, BIOCHEMISTRY-US, V43, P8711, DOI 10.1021/bi049932w; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERRELLA M, 1990, BIOPHYS CHEM, V37, P211, DOI 10.1016/0301-4622(90)88020-S; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; PERUTZ MF, 1986, J AM CHEM SOC, V108, P1064, DOI 10.1021/ja00265a036; Ren Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077141; Ringe D, 1986, Methods Enzymol, V131, P389; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; SCHUMACHER MA, 1995, NATURE, V375, P84, DOI 10.1038/375084a0; Seixas FAV, 1999, ACTA CRYSTALLOGR D, V55, P1914, DOI 10.1107/S0907444999009750; Sen U, 2004, BIOCHEMISTRY-US, V43, P12477, DOI 10.1021/bi048903i; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Shibayama N, 1999, J MOL BIOL, V285, P1383, DOI 10.1006/jmbi.1998.2407; SHIBAYAMA N, 1986, J MOL BIOL, V192, P331, DOI 10.1016/0022-2836(86)90368-2; SHIBAYAMA N, 1986, J MOL BIOL, V192, P323, DOI 10.1016/0022-2836(86)90367-0; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SHIBAYAMA N, 1991, BIOCHEMISTRY-US, V30, P8158, DOI 10.1021/bi00247a010; Shibayama N, 2001, FEBS LETT, V492, P50, DOI 10.1016/S0014-5793(01)02225-6; Shibayama N., 2011, HEMOGLOBIN RECENT DE, P138; Shibayama N, 2014, J AM CHEM SOC, V136, P5097, DOI 10.1021/ja500380e; Shibayama N, 2011, J BIOL CHEM, V286, P33661, DOI 10.1074/jbc.M111.266056; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SZABO A, 1972, J MOL BIOL, V72, P163, DOI 10.1016/0022-2836(72)90077-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	56	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18258	18269		10.1074/jbc.M117.781146	http://dx.doi.org/10.1074/jbc.M117.781146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28931607	Green Published, hybrid			2022-12-28	WOS:000414458200023
J	Bruder, LM; Gruninger, RJ; Cleland, CP; Mosimann, SC				Bruder, Lisza M.; Gruninger, Robert J.; Cleland, Colyn P.; Mosimann, Steven C.			Bacterial PhyA protein-tyrosine phosphatase-like myo-inositol phosphatases in complex with the Ins(1,3,4,5)P-4 and Ins(1,4,5)P-3 second messengers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL POLYPHOSPHATASE; STRUCTURAL-ANALYSIS; SECRETED PROTEIN; HEXAKISPHOSPHATE; PHYTASE; STEREOSPECIFICITY; SPECIFICITY; VIRULENCE; QUALITY; BINDING	myo-Inositol phosphates (IPs) are important bioactive molecules that have multiple activities within eukaryotic cells, including well-known roles as second messengers and cofactors that help regulate diverse biochemical processes such as transcription and hormone receptor activity. Despite the typical absence of IPs in prokaryotes, many of these organisms express IPases (or phytases) that dephosphorylate IPs. Functionally, these enzymes participate in phosphate-scavenging pathways and in plant pathogenesis. Here, we determined the X-ray crystallographic structures of two catalytically inactive mutants of protein-tyrosine phosphatase like myo-inositol phosphatases (PTPLPs) from the non-pathogenic bacteria Selenomonas ruminantium (PhyAsr) and Mitsuokella multacida (PhyAmm) in complex with the known eukaryotic second messengers Ins(1,3,4,5)P-4 and Ins(1,4,5)P-3. Both enzymes bound these less-phosphorylated IPs in a catalytically competent manner, suggesting that IP hydrolysis has a role in plant pathogenesis. The less-phosphorylated IP binding differed in both the myo-inositol ring position and orientation when compared with a previously determined complex structure in the presence of myoinositol-1,2,3,4,5,6-hexakisphosphate (InsP(6) or phytate). Further, we have demonstrated that PhyAsr and PhyAmm have different specificities for Ins(1,2,4,5,6)P-5, have identified structural features that account for this difference, and have shown that the absence of these features results in a broad specificity toward Ins(1,2,4,5,6) P5. These features are main-chain conformational differences in loops adjacent to the active site that include the extended loop prior to the penultimate helix, the extended Omega-loop, and a beta-hairpin turn of the Phy-specific domain.	[Bruder, Lisza M.; Cleland, Colyn P.; Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Gruninger, Robert J.] Agr & Agri Foods Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada	University of Lethbridge	Mosimann, SC (corresponding author), Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada.	steven.mosimann@uleth.ca			National Science and Engineering Research Council of Canada (NSERC); NSERC; Alberta Innovates-Technology Futures studentship	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Technology Futures studentship	This work was supported by Discovery Grants from the National Science and Engineering Research Council of Canada (NSERC) (to S.C.M.), NSERC studentships (to L.M.B. and R.J.G.), and an Alberta Innovates-Technology Futures studentship (to L.M.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blaabjerg K, 2010, J CHROMATOGR B, V878, P347, DOI 10.1016/j.jchromb.2009.11.046; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; Chatterjee S, 2003, MOL PLANT MICROBE IN, V16, P973, DOI 10.1094/MPMI.2003.16.11.973; Chen LJ, 1999, APPL ENVIRON MICROB, V65, P4559; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; GAWLER DJ, 1990, BIOCHEM J, V272, P519, DOI 10.1042/bj2720519; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094403; Gruninger RJ, 2012, J BIOL CHEM, V287, P9722, DOI 10.1074/jbc.M111.309872; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lee DC, 2003, J BIOL CHEM, V278, P31412, DOI 10.1074/jbc.M213154200; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Majerus PW, 2008, ADV ENZYME REGUL, V48, P10, DOI 10.1016/j.advenzreg.2008.04.001; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mullaney EJ, 2000, ADV APPL MICROBIOL, V47, P157, DOI 10.1016/S0065-2164(00)47004-8; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Weber S, 2014, J BIOL CHEM, V289, P34175, DOI 10.1074/jbc.M114.592568; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	36	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17302	17311		10.1074/jbc.M117.787853	http://dx.doi.org/10.1074/jbc.M117.787853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28848052	hybrid, Green Published			2022-12-28	WOS:000414009300013
J	Mobbs, JI; Illing, PT; Dudek, NL; Brooks, AG; Baker, DG; Purcell, AW; Rossjohn, J; Vivian, JP				Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Brooks, Andrew G.; Baker, Daniel G.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.			The molecular basis for peptide repertoire selection in the human leukocyte antigen (HLA) C*06:02 molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; NATURAL-KILLER; PSORIATIC-ARTHRITIS; COMPLEX; EPITOPE; SUSCEPTIBILITY; ASSOCIATIONS; RECOGNITION; REFINEMENT; EXPRESSION	Human leukocyte antigen (HLA)-C*06:02 is identified as the allele associated with the highest risk for the development of the autoimmune skin disease psoriasis. However, the diversity and mode of peptide presentation by the HLA-C*06:02 molecule remains unclear. Here, we describe the endogenous peptide repertoire of similar to 3,000 sequences for HLA-C*06:02 that defines the peptide-binding motif for this HLA allomorph. We found that HLA-C*06:02 predominantly presents nonamer peptides with dominant arginine anchors at the P2 and P7 positions and a preference for small hydrophobic residues at the C terminus (P Omega). To determine the structural basis of this selectivity, we determined crystal structures of HLA-C*06:02 in complex with two self-peptides (ARTELYRSL and ARFNDLRFV) and an analogue of a melanocyte autoantigen (ADAMTSL5, VRSRR-abu-LRL) implicated in psoriasis. These structures revealed that HLA-C*06:02 possesses a deep peptide-binding groove comprising two electronegative Band E-pockets that coincide with the preference for P2 and P7 arginine anchors. The ADAMTSL5 autoantigen possessed a P7-Leu instead of the P7-Arg residue, but nevertheless was accommodated within the HLA-C*06:02 antigen-binding cleft. Collectively, our results provide the structural basis for understanding peptide repertoire selection in HLA-C*06:02.	[Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Mobbs, Jesse I.; Illing, Patricia T.; Dudek, Nadine L.; Purcell, Anthony W.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Baker, Daniel G.] Janssen Res & Dev LLC, Philadelphia, PA 19044 USA; [Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Melbourne; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Monash University; Cardiff University	Purcell, AW; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Purcell, AW; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Vivian, JP (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.	Anthony.purcell@monash.edu; Jamie.rossjohn@monash.edu; Julian.vivian@monash.edu	Purcell, Anthony/AAH-1942-2019; Illing, Patricia/AAP-6045-2021; Rossjohn, Jamie/F-9032-2013	Purcell, Anthony/0000-0003-0532-8331; Illing, Patricia/0000-0002-3870-0796; Rossjohn, Jamie/0000-0002-2020-7522; Brooks, Andrew/0000-0002-4085-9683; Mobbs, Jesse/0000-0001-6979-1427; Vivian, Julian/0000-0002-9400-4437	Janssen Pty. Ltd.; Australian National Health and Medical Research Council (NHMRC); NHMRC [1044215]; NMHRC [1072159]; Australian Research Council (ARC); ARC	Janssen Pty. Ltd.; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NMHRC; Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council)	This work was supported by Janssen Pty. Ltd., the Australian National Health and Medical Research Council (NHMRC), grants from the Australian Research Council (ARC) (to J. R., and A. W. P.), a ARC Laureate fellowship (to J.R.), NHMRC Senior Research Fellowship 1044215 (to A. W. P.), and NMHRC early career fellowship 1072159 (to P. T. I.). D .G. B. is an employee of Janssen Pty Ltd., which provided support for this work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa A, 2015, J EXP MED, V212, P2203, DOI 10.1084/jem.20151093; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Badrinath S, 2012, HAEMATOL-HEMATOL J, V97, P98, DOI 10.3324/haematol.2011.046037; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Chang JCC, 1997, ARCH DERMATOL, V133, P703, DOI 10.1001/archderm.133.6.703; CHANG JCC, 1994, P NATL ACAD SCI USA, V91, P9282, DOI 10.1073/pnas.91.20.9282; Chen B., 2017, MOL MED REP; Choo JAL, 2014, J VIROL, V88, P10613, DOI 10.1128/JVI.00855-14; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dudek NL, 2014, VITAM HORM, V95, P115, DOI 10.1016/B978-0-12-800174-5.00005-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunphy SE, 2017, CLIN IMMUNOL, V177, P43, DOI 10.1016/j.clim.2015.10.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gudjonsson JE, 2003, BRIT J DERMATOL, V148, P233, DOI 10.1046/j.1365-2133.2003.05115.x; Gudmundsdottir AS, 1999, CLIN EXP IMMUNOL, V117, P580; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Johnston A, 2004, CLIN EXP IMMUNOL, V138, P83, DOI 10.1111/j.1365-2249.2004.00600.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15924; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037338; Kraemer T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/346714; Kunze-Schumacher H., 2014, J IMMUNOL RES, V2014, DOI DOI 10.1155/2014/246171; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; MCFADDEN J, 1991, BRIT J DERMATOL, V125, P443, DOI 10.1111/j.1365-2133.1991.tb14769.x; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; Minos E, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0429-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Rasmussen M, 2014, J IMMUNOL, V193, P4790, DOI 10.4049/jimmunol.1401689; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schittenhelm RB, 2014, TISSUE ANTIGENS, V83, P174, DOI 10.1111/tan.12282; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Valdimarsson H, 2009, TRENDS IMMUNOL, V30, P494, DOI 10.1016/j.it.2009.07.008; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vollmer S, 2001, J INVEST DERMATOL, V117, P1296, DOI 10.1046/j.0022-202x.2001.01494.x; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415	66	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17203	17215		10.1074/jbc.M117.806976	http://dx.doi.org/10.1074/jbc.M117.806976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855257	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000414009300005
J	Filippova, N; Yang, XH; Ananthan, S; Sorochinsky, A; Hackney, JR; Gentry, Z; Bae, S; King, P; Nabors, LB				Filippova, Natalia; Yang, Xiuhua; Ananthan, Subramaniam; Sorochinsky, Anastasia; Hackney, James R.; Gentry, Zachery; Bae, Sejong; King, Peter; Nabors, L. Burt			Hu antigen R (HuR) multimerization contributes to glioma disease progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); cancer biology; cell proliferation; ELAV-like protein 1 (HuR (human antigen R)); RNA; glioma	BINDING PROTEIN HUR; MESSENGER-RNA STABILITY; CENTROSOME FUNCTION; GLIOBLASTOMA CELLS; RECOGNITION MOTIF; IDH1 MUTATIONS; CANCER; RICH; ELAV; TRANSLATION	Among primary brain cancers, gliomas are the most deadly and most refractory to current treatment modalities. Previous reports overwhelmingly support the role of the RNA-binding protein Hu antigen R (HuR) as a positive regulator of glioma disease progression. HuR expression is consistently elevated in tumor tissues, and a cytoplasmic localization appears essential for HuR-dependent oncogenic transformation. Here, we report HuR aggregation (multimerization) in glioma and the analysis of this tumor-specific HuR protein multimerization in clinical brain tumor samples. Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and site-directed mutagenesis, we examined the domains involved in HuR multimerization. Results obtained with the combination of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique suggested that multiple (at least three) HuR molecules come together during HuR multimerization in glioma cells. Using these data, we developed a model of HuR multimerization in glioma cells. We also demonstrate that exposing glioma cells to the HuR inhibitor tanshinone group compound 15,16-dihydrotanshinone-I or to the newly identified compound 5 disrupts HuR multimerization modules and reduces tumor cell survival and proliferation. In summary, our findings provide new insights into HuR multimerization in glioma and highlight possible pharmacological approaches for targeting HuR domains involved in cancer cell-specific multimerization.	[Filippova, Natalia; Yang, Xiuhua; Sorochinsky, Anastasia; Gentry, Zachery; King, Peter; Nabors, L. Burt] Univ Alabama Birmingham, Sch Med, Dept Neurol, Birmingham, AL 35294 USA; [Hackney, James R.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; [Bae, Sejong] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Ananthan, Subramaniam] Southern Res, Drug Discovery Div, Birmingham, AL 35294 USA; [King, Peter] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Nabors, LB (corresponding author), Dept Neurol, Div Neurooncol, 510 20th St South,FOT 1020, Birmingham, AL 35294 USA.	bnabors@uab.edu	Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511; bae, sejong/0000-0001-9982-3223	National Institutes of Health [R01 CA200624]; University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund; NATIONAL CANCER INSTITUTE [R01CA200624] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant R01 CA200624 (to L. B. N.) and the University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benoit RM, 2011, RNA BIOL, V8, P18, DOI 10.4161/rna.8.1.13555; Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bronicki LM, 2013, RNA, V19, P1019, DOI 10.1261/rna.039164.113; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Chou SD, 2015, ONCOGENE, V34, P2178, DOI 10.1038/onc.2014.177; Chu PC, 2012, J BIOL CHEM, V287, P43639, DOI 10.1074/jbc.M112.393678; Cobbs CS, 2013, CURR OPIN ONCOL, V25, P682, DOI 10.1097/CCO.0000000000000005; D'Agostino VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16478; David PS, 2007, RNA, V13, P1453, DOI 10.1261/rna.501707; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Diaz-Quintana A, 2015, FEBS LETT, V589, P1059, DOI 10.1016/j.febslet.2015.03.013; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Filippova N, 2015, BIOMOLECULES, V5, P263, DOI 10.3390/biom5010263; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Gurgis FMS, 2015, ONCOGENE, V34, P2934, DOI 10.1038/onc.2014.225; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hinman MN, 2013, NUCLEIC ACIDS RES, V41, P5049, DOI 10.1093/nar/gkt166; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kasashima K, 2002, NUCLEIC ACIDS RES, V30, P4519, DOI 10.1093/nar/gkf567; Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P216, DOI 10.1016/j.spen.2013.09.003; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kodiha M., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/208650; Lucchesi C, 2016, ONCOGENE, V35, P2565, DOI 10.1038/onc.2015.339; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Nabors LB, 2001, CANCER RES, V61, P2154; Poria DK, 2016, ONCOGENE, V35, P1703, DOI 10.1038/onc.2015.235; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Scheiba RM, 2014, RNA BIOL, V11, P1250, DOI 10.1080/15476286.2014.996069; Sharma S, 2013, RNA BIOL, V10, P1283, DOI 10.4161/rna.25482; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Thota B, 2012, AM J CLIN PATHOL, V138, P177, DOI 10.1309/AJCPZOIY3WY4KIKE; Toba G, 2008, NUCLEIC ACIDS RES, V36, P1390, DOI 10.1093/nar/gkm1168; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Zhang LF, 2015, EMBO J, V34, P2671, DOI 10.15252/embj.201591803	52	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16999	17010		10.1074/jbc.M117.797878	http://dx.doi.org/10.1074/jbc.M117.797878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28790173	hybrid, Green Published			2022-12-28	WOS:000413140600020
J	Huang, CQ; Xiao, X; Yang, Y; Mishra, A; Liang, YR; Zeng, XM; Yang, XY; Xu, D; Blackburn, MR; Henke, CA; Liu, L				Huang, Chaoqun; Xiao, Xiao; Yang, Ye; Mishra, Amorite; Liang, Yurong; Zeng, Xiangming; Yang, Xiaoyun; Xu, Dao; Blackburn, Michael R.; Henke, Craig A.; Liu, Lin			MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; LUNG FIBROSIS; APOPTOSIS; GROWTH-FACTOR-BETA-1; PATHOGENESIS; EXPRESSION	Aberrant proliferation and activation of lung fibroblasts contribute to the initiation and progression of idiopathic pulmonary fibrosis (IPF). However, the mechanisms responsible for the proliferation and activation of fibroblasts are not fully understood. The objective of this study was to investigate the role of miR-101 in the proliferation and activation of lung fibroblasts. miR-101 expression was determined in lung tissues from patients with IPF and mice with bleomycin-induced pulmonary fibrosis. The regulation of miR-101 and cellular signaling was investigated in pulmonary fibroblasts in vitro. The role of miR-101 in pulmonary fibrosis in vivo was studied using adenovirus-mediated gene transfer in mice. The expression of miR-101 was down-regulated in fibrotic lungs from patients with IPF and bleomycin-treated mice. The down-regulation of miR-101 occurred via the E26 transformation-specific (ETS) transcription factor. miR-101 suppressed the WNT5a-induced proliferation of lung fibroblasts by inhibiting NFATc2 signaling via targeting Frizzled receptor 4/6 and the TGF-beta-induced activation of lung fibroblasts by inhibition of SMAD2/3 signaling via targeting the TGF-beta receptor 1. Adenovirus-mediated miR-101 gene transfer in the mouse lung attenuated bleomycin-induced lung fibrosis and improved lung function. Our data suggest that miR-101 is an anti-fibrotic microRNA and a potential therapeutic target for pulmonary fibrosis.	[Huang, Chaoqun; Xiao, Xiao; Liang, Yurong; Yang, Xiaoyun; Xu, Dao; Liu, Lin] Oklahoma State Univ, Oklahoma Ctr Resp & Infect Dis, Stillwater, OK 74078 USA; [Huang, Chaoqun; Xiao, Xiao; Yang, Ye; Mishra, Amorite; Liang, Yurong; Zeng, Xiangming; Yang, Xiaoyun; Xu, Dao; Liu, Lin] Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA; [Blackburn, Michael R.] Univ Texas Houston, Med Sch, Dept Biochem & Mol Biol, Houston, TX USA; [Henke, Craig A.] Univ Minnesota, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Box 736 UMHC, Minneapolis, MN 55455 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Liang, Yurong/DWV-1204-2022	Huang, Chaoqun/0000-0001-8015-6467	National Institutes of Health [R01HL116876, R03HL95383, P20GM103648, R01HL125227, P01HL 091775]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091775, R01HL116876, R03HL095383, R01HL125227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL116876, R03HL95383, and P20GM103648 (to L. L.) and R01HL125227 and P01HL 091775 (to C. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Baran CP, 2011, AM J RESP CELL MOL, V45, P999, DOI 10.1165/rcmb.2010-0490OC; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bodempudi V, 2014, AM J PHYSIOL-LUNG C, V307, pL283, DOI 10.1152/ajplung.00069.2014; Bruce MC, 1999, AM J RESP CELL MOL, V20, P228, DOI 10.1165/ajrcmb.20.2.3150; Chen ZM, 2007, FREE RADICAL BIO MED, V43, P628, DOI 10.1016/j.freeradbiomed.2007.05.024; Chen ZM, 2005, PHYSIOL GENOMICS, V21, P284, DOI 10.1152/physiolgenomics.00236.2004; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Huang CQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-46; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Kim JH, 2014, ANTIOXID REDOX SIGN, V21, P2469, DOI 10.1089/ars.2014.5856; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Oak SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021253; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Smits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Xia H, 2014, AM J PATHOL, V184, P1369, DOI 10.1016/j.ajpath.2014.01.012; Xiao X, 2015, ARCH BIOCHEM BIOPHYS, V566, P49, DOI 10.1016/j.abb.2014.12.007; Xu YH, 2013, ONCOL REP, V29, P2019, DOI 10.3892/or.2013.2338; Zhao Chunling, 2012, BMC Res Notes, V5, P91, DOI 10.1186/1756-0500-5-91; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	42	76	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16420	16439		10.1074/jbc.M117.805747	http://dx.doi.org/10.1074/jbc.M117.805747			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28726637	hybrid, Green Published			2022-12-28	WOS:000412414800003
J	Langini, C; Caflisch, A; Vitalis, A				Langini, Cassiano; Caflisch, Amedeo; Vitalis, Andreas			The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC DISORDER; SELECTIVE RECOGNITION; MOLECULAR RECOGNITION; INTERACTION NETWORKS; PROTEIN DISORDER; LYSINE BINDING; CHROMATIN; DYNAMICS; ASSOCIATION; DISCOVERY	Bromodomains are protein modules adopting conserved helix bundle folds. Some bromodomain-containing proteins, such as ATPase family AAA domain-containing protein 2 (ATAD2), isoform A, have attracted much interest because they are overexpressed in many types of cancer. Bromodomains bind to acetylated lysine residues on histone tails and thereby facilitate the reading of the histone code. Epigenetic regulators in general have been implicated as indicators, mediators, or causes of a large number of diseases and disorders. To interfere with or modulate these processes, it is therefore of fundamental interest to understand the molecular mechanisms by which epigenetic regulation occurs. Here, we present results from molecular dynamics simulations of a doubly acetylated histone H4 peptide bound to the bromodomain of ATAD2 (hereafter referred to as ATAD2A). These simulations revealed how the flexibility of ATAD2A's major loop, the so-called ZA loop, creates an adaptable interface that preserves the disorder of both peptide and loop in the bound state. We further demonstrate that the binding involves an almost identical average pattern of interactions irrespective of which acetyl mark is inserted into the pocket. In conjunction with a likely mechanism of electrostatically driven recruitment, our simulation results highlight how the bromodomain is built toward promiscuous binding with low specificity. In conclusion, the simulations indicate that disorder and electrostatic steering function jointly to recruit ATAD2A to the histone core and that these fuzzy interactions may promote cooperativity between nearby epigenetic marks.	[Langini, Cassiano; Caflisch, Amedeo; Vitalis, Andreas] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich	Vitalis, A (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	caflisch@bioc.uzh.ch; vitalis@bioc.uzh.ch		Caflisch, Amedeo/0000-0002-2317-6792	Swiss National Science Foundation [149897]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 149897 from the Swiss National Science Foundation (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bamborough P, 2015, J MED CHEM, V58, P6151, DOI 10.1021/acs.jmedchem.5b00773; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bjorneras J, 2014, FEBS J, V281, P814, DOI 10.1111/febs.12626; Blochliger N, 2015, BIOPHYS J, V108, P2362, DOI 10.1016/j.bpj.2015.03.038; Blochliger N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06264; Blochliger N, 2013, COMPUT PHYS COMMUN, V184, P2446, DOI 10.1016/j.cpc.2013.06.009; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Chaikuad A, 2014, MEDCHEMCOMM, V5, P1843, DOI 10.1039/c4md00237g; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Convertino M, 2011, J BIOL CHEM, V286, P41578, DOI 10.1074/jbc.M111.285957; Demont EH, 2015, J MED CHEM, V58, P5649, DOI 10.1021/acs.jmedchem.5b00772; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Duan ZJ, 2013, PROSTATE, V73, P455, DOI 10.1002/pros.22587; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Harner MJ, 2014, J MED CHEM, V57, P9687, DOI 10.1021/jm501035j; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Jain AK, 2017, J MOL BIOL, V429, P2003, DOI 10.1016/j.jmb.2016.11.020; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Koo SJ, 2016, ONCOTARGET, V7, P70323, DOI 10.18632/oncotarget.11855; Magno A, 2013, J CHEM THEORY COMPUT, V9, P4225, DOI 10.1021/ct400361k; Marchand JR, 2016, J MED CHEM, V59, P9919, DOI 10.1021/acs.jmedchem.6b01258; Marchand JR, 2015, CHEMMEDCHEM, V10, P1327, DOI 10.1002/cmdc.201500141; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Morozumi Y, 2016, J MOL CELL BIOL, V8, P349, DOI 10.1093/jmcb/mjv060; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Philpott M, 2011, MOL BIOSYST, V7, P2899, DOI 10.1039/c1mb05099k; Poncet-Montange G, 2015, BIOCHEM J, V466, P337, DOI 10.1042/BJ20140933; Potoyan DA, 2012, P NATL ACAD SCI USA, V109, P17857, DOI 10.1073/pnas.1201805109; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Sanchez R, 2014, BBA-GENE REGUL MECH, V1839, P676, DOI 10.1016/j.bbagrm.2014.03.011; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Steffen PA, 2012, BIOESSAYS, V34, P901, DOI 10.1002/bies.201200076; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2015, CURR OPIN STRUC BIOL, V35, P49, DOI 10.1016/j.sbi.2015.08.009; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Unzue A, 2016, J MED CHEM, V59, P3087, DOI 10.1021/acs.jmedchem.5b01757; Vitalis A, 2012, J CHEM THEORY COMPUT, V8, P1108, DOI 10.1021/ct200801b; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu Y, 2017, NUCLEIC ACIDS RES, V45, pD264, DOI 10.1093/nar/gkw1011; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203; Zhu J, 2016, J MED CHEM, V59, P5555, DOI 10.1021/acs.jmedchem.6b00215	65	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16734	16745		10.1074/jbc.M117.786350	http://dx.doi.org/10.1074/jbc.M117.786350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798233	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000412414800032
J	Zhuang, XL; Watts, NR; Palmer, IW; Kaufman, JD; Dearborn, AD; Trenbeath, JL; Eren, E; Steven, AC; Rader, C; Wingfield, PT				Zhuang, Xiaolei; Watts, Norman R.; Palmer, Ira W.; Kaufman, Joshua D.; Dearborn, Altaira D.; Trenbeath, Joni L.; Eren, Elif; Steven, Alasdair C.; Rader, Christoph; Wingfield, Paul T.			Chimeric rabbit/human Fab antibodies against the hepatitis B e-antigen and their potential applications in assays, characterization, and therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS E-ANTIGEN; CORE ANTIGEN; PRECORE PROTEIN; ESCHERICHIA-COLI; PHAGE DISPLAY; HIV-1 REV; IN-VITRO; MONOCLONAL-ANTIBODIES; SURFACE-ANTIGEN; GENERATION	Hepatitis B virus (HBV) infection afflicts millions worldwide, causing cirrhosis and liver cancer. HBV e-antigen (HBeAg), a clinical marker for disease severity, is a soluble variant of the viral capsid protein. HBeAg is not required for viral replication but is implicated in establishing immune tolerance and chronic infection. The structure of recombinant e-antigen (rHBeAg) was recently determined, yet to date, the exact nature and quantitation of HBeAg still remain uncertain. Here, to further characterize HBeAg, we used phage display to produce a panel of chimeric rabbit/human monoclonal antibody fragments (both Fab and scFv) against rHBeAg. Several of the Fab/scFv, expressed in Escherichia coli, had unprecedentedly high binding affinities (K-d similar to 10(-12) M) and high specificity. We used Fab/scFv in the context of an enzyme-linked immunosorbent assay (ELISA) for HBeAg quantification, which we compared with commercially available kits and verified with seroconversion panels, the WHO HBeAg standard, rHBeAg, and patient plasma samples. We found that the specificity and sensitivity are superior to those of existing commercial assays. To identify potential fine differences between rHBeAg and HBeAg, we used these Fabs in microscale immunoaffinity chromatography to purify HBeAg from individual patient plasmas. Western blotting and MS results indicated that rHBeAg and HBeAg are essentially structurally identical, although HBeAg from different patients exhibits minor carboxyl-terminal heterogeneity. We discuss several potential applications for the humanized Fab/scFv.	[Zhuang, Xiaolei; Watts, Norman R.; Palmer, Ira W.; Kaufman, Joshua D.; Dearborn, Altaira D.; Wingfield, Paul T.] NIAMS, Prot Express Lab, NIH, Bldg 6B,Rm 1B 130,9000 Rockville Pike, Bethesda, MD 20892 USA; [Eren, Elif; Steven, Alasdair C.] NIAMS, Lab Struct Biol Res, NIH, Bethesda, MD 20892 USA; [Trenbeath, Joni L.] Warren Grant Magnuson Clin Ctr, Dept Transfus Med, NIH, Bethesda, MD 20892 USA; [Rader, Christoph] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; Scripps Research Institute	Wingfield, PT (corresponding author), NIAMS, Prot Express Lab, NIH, Bldg 6B,Rm 1B 130,9000 Rockville Pike, Bethesda, MD 20892 USA.	wingfiep@mail.nih.gov		Eren, Elif/0000-0002-7942-4943; Rader, Christoph/0000-0001-9955-3454; Dearborn, Altaira/0000-0003-0463-5233; Wingfield, Paul/0000-0002-9515-4752	Intramural Research Program of the NIAMS; Center for Cancer Research of the NCI, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER	Intramural Research Program of the NIAMS; Center for Cancer Research of the NCI, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program of the NIAMS, and the Center for Cancer Research of the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumeister MA, 2000, J MED VIROL, V60, P256, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;256::AID-JMV2&gt;3.0.CO;2-H; Bereszczak JZ, 2013, J AM CHEM SOC, V135, P6504, DOI 10.1021/ja402023x; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brunetto MR, 2010, J HEPATOL, V52, P475, DOI 10.1016/j.jhep.2009.12.020; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen GF, 2017, LIVER INT, V37, P59, DOI 10.1111/liv.13309; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; COHEN BJ, 1982, NATURE, V296, P677, DOI 10.1038/296677a0; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; DiMattia MA, 2016, STRUCTURE, V24, P1068, DOI 10.1016/j.str.2016.04.015; DiMattia MA, 2013, STRUCTURE, V21, P133, DOI 10.1016/j.str.2012.10.017; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Duriez M, 2008, J BIOL CHEM, V283, P32352, DOI 10.1074/jbc.M807178200; Duriez M, 2014, VIROLOGY, V462, P273, DOI 10.1016/j.virol.2014.06.013; FERNANDO SA, 1992, J IMMUNOL METHODS, V151, P47; FERNS RB, 1984, J GEN VIROL, V65, P899, DOI 10.1099/0022-1317-65-5-899; Hofer T, 2007, J IMMUNOL METHODS, V318, P75, DOI 10.1016/j.jim.2006.10.007; HOWARD CR, 1979, J MED VIROL, V4, P303, DOI 10.1002/jmv.1890040408; Hu DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129125; IMAI M, 1982, J IMMUNOL, V128, P69; Ito K, 2009, J VIROL, V83, P3507, DOI 10.1128/JVI.02348-08; Kimura T, 2005, J BIOL CHEM, V280, P21713, DOI 10.1074/jbc.M501564200; King TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101904; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; MACKAY P, 1981, J MED VIROL, V8, P237, DOI 10.1002/jmv.1890080404; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Maini MK, 2017, NAT REV GASTRO HEPAT, V14, P71, DOI 10.1038/nrgastro.2016.196; Messageot F, 2003, J BIOL CHEM, V278, P891, DOI 10.1074/jbc.M207634200; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; MURRAY K, 1984, EMBO J, V3, P645, DOI 10.1002/j.1460-2075.1984.tb01861.x; MURRAY K, 1987, J MED VIROL, V23, P101, DOI 10.1002/jmv.1890230202; NEURATH AR, 1979, J GEN VIROL, V42, P493, DOI 10.1099/0022-1317-42-3-493; Nguyen T, 2009, HEPATOL INT, V3, pS5, DOI 10.1007/s12072-009-9149-7; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; Popkov M, 2004, J IMMUNOL METHODS, V288, P149, DOI 10.1016/j.jim.2004.03.005; Rader C, 1997, CURR OPIN BIOTECH, V8, P503, DOI 10.1016/S0958-1669(97)80075-4; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Stahl SJ, 2014, METHODS MOL BIOL, V1131, P549, DOI 10.1007/978-1-62703-992-5_35; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; STANDRING DN, 1988, P NATL ACAD SCI USA, V85, P8405, DOI 10.1073/pnas.85.22.8405; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Vanlandschoot P, 2003, TRENDS IMMUNOL, V24, P144, DOI 10.1016/S1471-4906(03)00026-7; Venkatakrishnan B, 2016, ANNU REV VIROL, V3, P429, DOI 10.1146/annurev-virology-110615-042238; Volkers M, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-28; Walsh R, 2012, YONSEI MED J, V53, P875, DOI 10.3349/ymj.2012.53.5.875; Watts NR, 2011, J MOL BIOL, V409, P202, DOI 10.1016/j.jmb.2011.03.049; Watts NR, 2010, J MOL BIOL, V398, P530, DOI 10.1016/j.jmb.2010.03.026; Weber J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.23; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; WINGFIELD PT, 1987, YEAST, V3, P43, DOI 10.1002/yea.320030107; Wu WM, 2013, J STRUCT BIOL, V181, P53, DOI 10.1016/j.jsb.2012.10.004; Xun YH, 2013, INT J MOL MED, V31, P369, DOI 10.3892/ijmm.2012.1210; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647	56	5	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16760	16772		10.1074/jbc.M117.802272	http://dx.doi.org/10.1074/jbc.M117.802272			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842495	Green Published, hybrid			2022-12-28	WOS:000412414800034
J	Seguin, A; Takahashi-Makise, N; Yien, YY; Huston, NC; Whitman, JC; Musso, G; Wallace, JA; Bradley, T; Bergonia, HA; Kafina, MD; Matsumoto, M; Igarashi, K; Phillips, JD; Paw, BH; Kaplan, J; Ward, DM				Seguin, Alexandra; Takahashi-Makise, Naoko; Yien, Yvette Y.; Huston, Nicholas C.; Whitman, Jared C.; Musso, Gabriel; Wallace, Jared A.; Bradley, Thomas; Bergonia, Hector A.; Kafina, Martin D.; Matsumoto, Mitsuyo; Igarashi, Kazuhiko; Phillips, John D.; Paw, Barry H.; Kaplan, Jerry; Ward, Diane M.			Reductions in the mitochondrial ABC transporter Abcb10 affect the transcriptional profile of heme biosynthesis genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; BETA-GLOBIN; ERYTHROID-DIFFERENTIATION; TRANSFERRIN RECEPTOR; IN-VIVO; EXPRESSION; PROTEINS; ERYTHROPOIESIS; BINDING; GATA-1	ATP-binding cassette subfamily B member 10 (Abcb10) is a mitochondrial ATP-binding cassette (ABC) transporter that complexes with mitoferrin1 and ferrochelatase to enhance heme biosynthesis in developing red blood cells. Reductions in Abcb10 levels have been shown to reduce mitoferrin1 protein levels and iron import into mitochondria, resulting in reduced heme biosynthesis. As an ABC transporter, Abcb10 binds and hydrolyzes ATP, but its transported substrate is unknown. Here, we determined that decreases in Abcb10 did not result in protoporphyrin IX accumulation in morphant-treated zebrafish embryos or in differentiated Abcb10-specific shRNA murine Friend erythroleukemia (MEL) cells in which Abcb10 was specifically silenced with shRNA. We also found that the ATPase activity of Abcb10 is necessary for hemoglobinization in MEL cells, suggesting that the substrate transported by Abcb10 is important in mediating increased heme biosynthesis during erythroid development. Inhibition of 5-aminolevulinic acid dehydratase (EC 4.2.1.24) with succinylacetone resulted in both 5-aminolevulinic acid (ALA) accumulation in control and Abcb10-specific shRNA MEL cells, demonstrating that reductions in Abcb10 do not affect ALA export from mitochondria and indicating that Abcb10 does not transport ALA. Abcb10 silencing resulted in an alteration in the hemebiosynthesis transcriptional profile due to repression by the transcriptional regulator Bach1, which could be partially rescued by overexpression of Alas2 or Gata1, providing a mechanistic explanation for why Abcb10 shRNA MEL cells exhibit reduced hemoglobinization. In conclusion, our findings rule out that Abcb10 transports ALA and indicate that Abcb10's ATP-hydrolysis activity is critical for hemoglobinization and that the substrate transported by Abcb10 provides a signal that optimizes hemoglobinization.	[Seguin, Alexandra; Takahashi-Makise, Naoko; Wallace, Jared A.; Bradley, Thomas; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Div Microbiol & Immunol, Dept Pathol, Salt Lake City, UT 84132 USA; [Bergonia, Hector A.; Phillips, John D.] Univ Utah, Sch Med, Div Hematol Oncol, Dept Med, Salt Lake City, UT 84132 USA; [Yien, Yvette Y.; Huston, Nicholas C.; Whitman, Jared C.; Kafina, Martin D.; Paw, Barry H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Musso, Gabriel] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808576, Japan; [Paw, Barry H.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; [Paw, Barry H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tohoku University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ward, DM (corresponding author), Univ Utah, Sch Med, Div Microbiol & Immunol, Dept Pathol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu	Bradley, Thomas/ABF-5356-2021; Bradley, Thomas/AAD-9244-2022; Matsumoto, Mitsuyo/AAC-3065-2019	Bradley, Thomas/0000-0003-3533-293X; Musso, Gabriel/0000-0001-8778-8248	National Institutes of Health [DK052380, DK070838, P01 HL032262, U54DK110858]; Grants-in-Aid for Scientific Research [15H02506] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858, R01DK052380, R01DK070838, R01DK090257, F32DK098866, R01DK030534, K01DK106156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants DK052380 (to D. M. W.), DK070838 and P01 HL032262 (to B. H. P.), and U54DK110858 (to J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Bergonia HA, 2015, CLIN BIOCHEM, V48, P788, DOI 10.1016/j.clinbiochem.2015.04.023; Byrska-Bishop M, 2015, J CLIN INVEST, V125, P993, DOI 10.1172/JCI75714; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Dailey HA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011676; Doty RT, 2015, J CLIN INVEST, V125, P4681, DOI 10.1172/JCI83054; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Huber TL, 1998, BLOOD, V92, P4128, DOI 10.1182/blood.V92.11.4128.423k46_4128_4137; Hyde BB, 2012, CELL DEATH DIFFER, V19, P1117, DOI 10.1038/cdd.2011.195; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Matsumoto M, 2016, GENES CELLS, V21, P553, DOI 10.1111/gtc.12365; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Qiu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129772; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shakya A, 2015, MOL CELL BIOL, V35, P1014, DOI 10.1128/MCB.01105-14; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Tang LL, 2012, BRIT J HAEMATOL, V157, P151, DOI 10.1111/j.1365-2141.2011.08936.x; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; TSCHUDY DP, 1980, BIOCHEM PHARMACOL, V29, P1825, DOI 10.1016/0006-2952(80)90145-8; Verrier JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020553; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Yamamoto M, 2014, MOL CELL BIOL, V34, P1077, DOI 10.1128/MCB.00865-13; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	41	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16284	16299		10.1074/jbc.M117.797415	http://dx.doi.org/10.1074/jbc.M117.797415			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28808058	hybrid, Green Published			2022-12-28	WOS:000412109400027
J	Kamizaki, K; Doi, R; Hayashi, M; Saji, T; Kanagawa, M; Toda, T; Fukada, S; Ho, HYH; Greenberg, ME; Endo, M; Minami, Y				Kamizaki, Koki; Doi, Ryosuke; Hayashi, Makoto; Saji, Takeshi; Kanagawa, Motoi; Toda, Tatsushi; Fukada, So-ichiro; Ho, Hsin-Yi Henry; Greenberg, Michael Eldon; Endo, Mitsuharu; Minami, Yasuhiro			The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; POLARITY PATHWAY; BINDING-SITES; EXPRESSION; GENE; MORPHOGENESIS; ACTIVATION; PROMOTES; PAX7; MICE	The Ror family receptor tyrosine kinases, Ror1 and Ror2, play important roles in regulating developmental morphogenesis and tissue-and organogenesis, but their roles in tissue regeneration in adult animals remain largely unknown. In this study, we examined the expression and function of Ror1 and Ror2 during skeletal muscle regeneration. Using an in vivo skeletal muscle injury model, we show that expression of Ror1 and Ror2 in skeletal muscles is induced transiently by the inflammatory cytokines, TNF-alpha and IL-1 beta, after injury and that inhibition of TNF-alpha and IL-1 beta by neutralizing antibodies suppresses expression of Ror1 and Ror2 in injured muscles. Importantly, expression of Ror1, but not Ror2, was induced primarily in Pax7-positive satellite cells (SCs) after muscle injury, and administration of neutralizing antibodies decreased the proportion of Pax7positive proliferative SCs after muscle injury. We also found that stimulation of a mouse myogenic cell line, C2C12 cells, with TNF-alpha or IL-1 beta induced expression of Ror1 via NF-kappa B activation and that suppressed expression of Ror1 inhibited their proliferative responses in SCs. Intriguingly, SC-specific depletion of Ror1 decreased the number of Pax7-positive SCs after muscle injury. Collectively, these findings indicate for the first time that Ror1 has a critical role in regulating SC proliferation during skeletal muscle regeneration. Weconclude that Ror1 might be a suitable target in the development of diagnostic and therapeutic approaches to manage muscular disorders.	[Kamizaki, Koki; Doi, Ryosuke; Hayashi, Makoto; Saji, Takeshi; Endo, Mitsuharu; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan; [Kanagawa, Motoi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Fukada, So-ichiro] Osaka Univ, Lab Mol & Cellular Physiol, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan; [Ho, Hsin-Yi Henry; Greenberg, Michael Eldon] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Ho, Hsin-Yi Henry] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Kobe University; Kobe University; Osaka University; Harvard University; Harvard Medical School; University of California System; University of California Davis	Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp	Fukada, So-ichiro/AAI-9151-2020	Fukada, So-ichiro/0000-0003-4051-5108; Kanagawa, Motoi/0000-0003-0984-6398; DOI, RYOSUKE/0000-0002-1725-2082	Scientific Research on Innovative Areas [23112007]; Ministry of Education, Culture, Sports, Science and Technology, Japan [26670157];  [15K18968];  [17K15596];  [16H05152]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants-in-aid for Young Scientists (B) 15K18968 and 17K15596 (to M.H.), for Scientific Research (B) 16H05152 (to Y.M.), for Scientific Research on Innovative Areas 23112007 (to Y.M.), and for Challenging Exploratory Research 26670157 (to Y.M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Diaz-Horta O, 2016, P NATL ACAD SCI USA, V113, P5993, DOI 10.1073/pnas.1522512113; Doi R, 2014, GENES CELLS, V19, P287, DOI 10.1111/gtc.12132; Endo M., 2015, RECEPTOR TYROSINE KI, P593; Endo M, 2017, GLIA, V65, P182, DOI 10.1002/glia.23086; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Fukuyo S, 2014, RHEUMATOLOGY, V53, P1282, DOI 10.1093/rheumatology/ket496; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Parisi A, 2015, J CELL BIOL, V210, P717, DOI 10.1083/jcb.201501053; Sato A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10536; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	50	18	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15939	15951		10.1074/jbc.M117.785709	http://dx.doi.org/10.1074/jbc.M117.785709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28790171	Green Published, hybrid			2022-12-28	WOS:000411512200030
J	Zhang, B; Lu, W				Zhang, Bin; Lu, Wen			Src homology 2 domain-containing phosphotyrosine phosphatase 2 (Shp2) controls surface GluA1 protein in synaptic homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; TYROSINE-PHOSPHATASE; CANCER PROGRESSION; NOONAN-SYNDROME; PLASTICITY; PHOSPHORYLATION; MEMORY; ACTIVATION; MECHANISMS; PATHWAY	Src Homology 2 domain-containing phosphotyrosine phosphatase 2 (Shp2) functions in synaptic plasticity, learning, and memory. However, the precise mechanisms by which this multifunctional protein contributes to synaptic function remains largely unknown. Homeostatic plasticity may be viewed as a process of bidirectional synaptic scaling, up or down. Through this process, neuronal circuitry stability is maintained so that changes in synaptic strength may be preserved under changing conditions. Abetter understanding of these processes is needed. In this regard, we report that phosphorylation of Shp2 at tyrosine 542 and its translocation to the postsynaptic compartment are integral processes in synaptic scaling. Furthermore, we show, using both pharmacological and genetic approaches, that Shp2 phosphatase activity is critical to the regulation of Ser(P)(845) GluA1 and surface expression of this AMPA receptor subunit during synaptic scaling. Thus, Shp2 may contribute meaningfully to synaptic homeostasis.	[Lu, Wen] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou 571199, Hainan, Peoples R China; [Zhang, Bin] Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou 310036, Zhejiang, Peoples R China	Hainan Medical University; Hangzhou Normal University	Lu, W (corresponding author), Hainan Med Univ, Dept Biochem & Mol Biol, Haikou 571199, Hainan, Peoples R China.; Zhang, B (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou 310036, Zhejiang, Peoples R China.	zhangbin890124@163.com; swkxlw@163.com	Lu, Wen/AAL-8524-2020		National Natural Science Foundation of China Grant [31600863]; Hainan Medical University	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Hainan Medical University	This work was supported by National Natural Science Foundation of China Grant 31600863 (to W.L.) and a start-up fund of Hainan Medical University (to W.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Bateup HS, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00028; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Han T, 2015, J HEPATOL, V63, P651, DOI 10.1016/j.jhep.2015.03.036; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kusakari S, 2015, MOL CELL BIOL, V35, P1557, DOI 10.1128/MCB.01339-14; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Meng SS, 2010, J MOL CELL BIOL, V2, P223, DOI 10.1093/jmcb/mjq017; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Park CY, 1999, J BIOL CHEM, V274, P7583, DOI 10.1074/jbc.274.11.7583; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Yan XY, 2017, MOL NEUROBIOL, V54, P7235, DOI 10.1007/s12035-016-0222-7; Zhang B, 2016, J BIOL CHEM, V291, P18856, DOI 10.1074/jbc.M116.714501; Zhang XM, 2015, CELL RES, V25, P818, DOI 10.1038/cr.2015.75	30	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15481	15488		10.1074/jbc.M117.775239	http://dx.doi.org/10.1074/jbc.M117.775239			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768764	Green Published, hybrid			2022-12-28	WOS:000410809800027
J	Kotla, S; Singh, NK; Kirchhofer, D; Rao, GN				Kotla, Sivareddy; Singh, Nikhlesh K.; Kirchhofer, Daniel; Rao, Gadiparthi N.			Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)hydroxyeicosatetraenoic acid-induced monocyte trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; HIGH-RISK PLAQUE; OXIDATIVE STRESS; CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; MESSENGER-RNA; VESSEL WALL; FACTOR GENE; PROTEIN	Tissue factor (TF) is expressed in vascular and nonvascular tissues and functions in several pathways, including embryonic development, inflammation, and cell migration. Many risk factors for atherosclerosis, including hypertension, diabetes, obesity, and smoking, increase TF expression. To better understand the TF-related mechanisms in atherosclerosis, here we investigated the role of 12/15-lipoxygenase (12/15-LOX) in TF expression. 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), the major product of human 15-LOXs 1 and 2, induced TF expression and activity in a time-dependent manner in the human monocytic cell line THP1. Moreover, TF suppression with neutralizing antibodies blocked 15(S)-HETE-induced monocyte migration. We also found that NADPH-and xanthine oxidase-dependent reactive oxygen species (ROS) production, calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation, and interactions between nuclear factor of activated T cells 3 (NFATc3) and FosB proto-oncogene, AP-1 transcription factor subunit (FosB) are involved in 15(S)-HETE-induced TF expression. Interestingly, NFATc3 first induced the expression of its interaction partner FosB before forming the heterodimeric NFATc3-FosB transcription factor complex, which bound the proximal AP-1 site in the TF gene promoter and activated TF expression. We also observed that macrophages from 12/15-LOX-/- mice exhibit diminished migratory response to monocyte chemotactic protein 1 (MCP-1) and lipopolysaccharide compared with WT mouse macrophages. Similarly, compared with WT macrophages, monocytes from 12/15-LOX-/- mice displayed diminished trafficking, which was rescued by prior treatment with 12(S)-HETE, in a peritonitis model. These observations indicate that 15(S)-HETE-induced monocyte/macrophage migration and trafficking require ROS-mediated CaMKIV activation leading to formation of NFATc3 and FosB heterodimer, which binds and activates the TF promoter.	[Kotla, Sivareddy; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	University of Tennessee System; University of Tennessee Health Science Center; Roche Holding; Genentech	Rao, GN (corresponding author), 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020	kotla, sivareddy/0000-0001-7516-7647; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL064165, HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165, R01HL103575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL064165 and HL103575 (to G. N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Celi A, 2010, EXPERT REV CARDIOVAS, V8, P1723, DOI 10.1586/ERC.10.161; Chen J, 2005, DIABETES, V54, P2143, DOI 10.2337/diabetes.54.7.2143; Chu AJ, 2005, ARCH BIOCHEM BIOPHYS, V440, P123, DOI 10.1016/j.abb.2005.06.005; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Fuster V, 2005, J AM COLL CARDIOL, V46, P1209, DOI 10.1016/j.jacc.2005.03.075; Golino P, 1996, NAT MED, V2, P35, DOI 10.1038/nm0196-35; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Kirchhofer D, 2000, THROMB HAEMOSTASIS, V84, P1072; Kotla S, 2017, REDOX BIOL, V11, P350, DOI 10.1016/j.redox.2016.12.005; Kotla S, 2015, J BIOL CHEM, V290, P30306, DOI 10.1074/jbc.M115.686865; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lopez-Pedrera C, 2006, LEUKEMIA, V20, P1331, DOI 10.1038/sj.leu.2404264; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Matetzky S, 2000, CIRCULATION, V102, P602, DOI 10.1161/01.CIR.102.6.602; McGillicuddy FC, 2012, MOL NUTR FOOD RES, V56, P1173, DOI 10.1002/mnfr.201100785; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Nishibe T, 2001, BLOOD, V97, P692, DOI 10.1182/blood.V97.3.692; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; Ott I, 2005, CIRCULATION, V111, P349, DOI 10.1161/01.CIR.0000153333.52294.42; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Palkovits J, 2013, J CROHNS COLITIS, V7, P222, DOI 10.1016/j.crohns.2012.05.016; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parry GCN, 2000, J CLIN INVEST, V105, P1547, DOI 10.1172/JCI9458; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Segal J, 2000, J RHEUMATOL, V27, P2827; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TIPPING PG, 1995, AM J PATHOL, V147, P1736; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Vijil C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088546; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959	57	3	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14885	14901		10.1074/jbc.M117.804344	http://dx.doi.org/10.1074/jbc.M117.804344			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724635	Green Published, hybrid			2022-12-28	WOS:000409902100015
J	Choi, S; Quan, XL; Bang, S; Yoo, H; Kim, J; Park, J; Park, KS; Chung, J				Choi, Sekyu; Quan, Xianglan; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Park, Kyu-Sang; Chung, Jongkyeong			Mitochondrial calcium uniporter in Drosophila transfers calcium between the endoplasmic reticulum and mitochondria in oxidative stress-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RELEASING CELLS; CA2+ UNIPORTER; INOSITOL 1,4,5-TRISPHOSPHATE; ESSENTIAL COMPONENT; HYDROGEN-PEROXIDE; MICE LACKING; MCU; PROTEIN; METABOLISM; MEMBRANE	Mitochondrial calcium plays critical roles in diverse cellular processes ranging from energy metabolism to cell death. Previous studies have demonstrated that mitochondrial calcium uptake is mainly mediated by the mitochondrial calcium uniporter (MCU) complex. However, the roles of the MCU complex in calcium transport, signaling, and dysregulation by oxidative stress still remain unclear. Here, we confirmed that Drosophila MCU contains evolutionarily conserved structures and requires essential MCU regulator (EMRE) for its calcium channel activities. We generated Drosophila MCU loss-of-function mutants, which lacked mitochondrial calcium uptake in response to caffeine stimulation. Basal metabolic activities were not significantly affected in these MCU mutants, as observed in examinations of body weight, food intake, body sugar level, and starvation-induced autophagy. However, oxidative stress-induced increases in mitochondrial calcium, mitochondrial membrane potential depolarization, and cell death were prevented in these mutants. We also found that inositol 1,4,5-trisphosphate receptor genetically interacts with Drosophila MCU and effectively modulates mitochondrial calcium uptake upon oxidative stress. Taken together, these results support the idea that Drosophila MCU is responsible for endoplasmic reticulum-to-mitochondrial calcium transfer and for cell death due to mitochondrial dysfunction under oxidative stress.	[Choi, Sekyu; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 08826, South Korea; [Choi, Sekyu; Bang, Sunhoe; Yoo, Heesuk; Kim, Jiyoung; Park, Jiwon; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Quan, Xianglan; Park, Kyu-Sang] Yonsei Univ, Dept Physiol, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea; [Quan, Xianglan] Yanbian Univ, Dept Oncol, Affiliated Hosp, Yanji 133000, Jilin, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yanbian University	Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, Gangwon Do, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea.	qsang@yonsei.ac.kr; jkc@snu.ac.kr		Park, Kyu-Sang/0000-0003-0322-9807; Choi, Sekyu/0000-0003-2928-0942	BK21 Plus Program from the Ministry of Education (MOE), Korea; National Research Foundation of Korea (NRF) Grant [2016R1A2B4014565]	BK21 Plus Program from the Ministry of Education (MOE), Korea; National Research Foundation of Korea (NRF) Grant	Supported by the BK21 Plus Program from the Ministry of Education (MOE), Korea.; Supported by National Research Foundation of Korea (NRF) Grant 2016R1A2B4014565. To whom correspondence may be addressed: Dept. of Physiology, Yonsei University Wonju College of Medicine, 20 Ilsan-Ro, Wonju, Gangwon-Do 26426, Korea. Tel.: 82-33-741-0294; Fax: 82-33-745-6461; E-mail: qsang@yonsei.ac.kr.	Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; Chaudhuri D, 2016, P NATL ACAD SCI USA, V113, pE1872, DOI 10.1073/pnas.1602264113; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Marchi U, 2014, J BIOL CHEM, V289, P20377, DOI 10.1074/jbc.M113.540898; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Dong ZW, 2017, MOL CELL, V65, P1014, DOI 10.1016/j.molcel.2017.01.032; Drago I, 2016, CELL REP, V16, P2763, DOI 10.1016/j.celrep.2016.08.017; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Gouriou Y, 2013, J BIOL CHEM, V288, P12459, DOI 10.1074/jbc.M112.428128; Jhun BS, 2016, AM J PHYSIOL-CELL PH, V311, pC67, DOI 10.1152/ajpcell.00319.2015; Kim W, 2015, J BIOL CHEM, V290, P13591, DOI 10.1074/jbc.M114.607036; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; Lee SK, 2016, CELL CHEM BIOL, V23, P1157, DOI 10.1016/j.chembiol.2016.07.012; Lee Y, 2015, EMBO REP, V16, P1318, DOI 10.15252/embr.201540436; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Liao YJ, 2015, PROTEIN CELL, V6, P434, DOI 10.1007/s13238-015-0144-6; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lye CM, 2014, DEVELOPMENT, V141, P4006, DOI 10.1242/dev.111310; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; Min S, 2016, CURR BIOL, V26, P814, DOI 10.1016/j.cub.2016.01.029; Murphy E, 2014, BIOCHEM BIOPH RES CO, V449, P384, DOI 10.1016/j.bbrc.2014.04.144; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Quan XL, 2015, J BIOL CHEM, V290, P4086, DOI 10.1074/jbc.M114.632547; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; RAGHU P, 1995, DEV BIOL, V171, P564, DOI 10.1006/dbio.1995.1305; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; RENARD DC, 1992, BIOCHEM J, V284, P507, DOI 10.1042/bj2840507; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROVERI A, 1992, ARCH BIOCHEM BIOPHYS, V297, P265, DOI 10.1016/0003-9861(92)90671-I; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai MF, 2016, ELIFE, V5, DOI 10.7554/eLife.15545; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002	58	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14473	14485		10.1074/jbc.M116.765578	http://dx.doi.org/10.1074/jbc.M116.765578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28726639	hybrid, Green Published			2022-12-28	WOS:000408747500014
J	Dessauer, CW				Dessauer, Carmen W.			Shining a light on GPCR complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; RHODOPSIN; TRANSDUCIN	The G protein-coupled receptor (GPCR) signaling pathways mediating information exchange across the cell membrane are central to a variety of biological processes and therapeutic strategies, but visualizing the molecular-level details of this exchange has been difficult for all but a few GPCR-G protein complexes. A study by Gao et al. now reports new strategies and tools to obtain receptor complexes in a near-native state, revealing insights into the gross conformational features of rhodopsin-transducin interactions and setting the stage for future studies.	[Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	carmen.w.dessauer@uth.tmc.edu			National Institutes of Health [GM60419, NS091759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM60419 and NS091759. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Gao Y, 2017, J BIOL CHEM, V292, P14280, DOI 10.1074/jbc.M117.797100; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	10	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14290	14291		10.1074/jbc.H117.797100	http://dx.doi.org/10.1074/jbc.H117.797100			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28842475	Green Published, hybrid			2022-12-28	WOS:000408439800033
J	Yoshizaki, K; Hu, LZ; Nguyen, T; Sakai, K; Ishikawa, M; Takahashi, I; Fukumoto, S; DenBesten, PK; Bikle, DD; Oda, Y; Yamada, Y				Yoshizaki, Keigo; Hu, Lizhi; Thai Nguyen; Sakai, Kiyoshi; Ishikawa, Masaki; Takahashi, Ichiro; Fukumoto, Satoshi; DenBesten, Pamela K.; Bikle, Daniel D.; Oda, Yuko; Yamada, Yoshihiko			Mediator 1 contributes to enamel mineralization as a coactivator for Notch1 signaling and stimulates transcription of the alkaline phosphatase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; RNA-POLYMERASE-II; TOOTH MORPHOGENESIS; CELL-DIFFERENTIATION; SUBUNIT MED1; MICE; DEFECTS; COMPLEX; LINEAGE	Tooth enamel is mineralized through the differentiation of multiple dental epithelia including ameloblasts and the stratum intermedium (SI), and this differentiation is controlled by several signaling pathways. Previously, we demonstrated that the transcriptional coactivator Mediator 1 (MED1) plays a critical role in enamel formation. For instance, conditional ablation of Med1 in dental epithelia causes functional changes in incisor-specific dental epithelial stem cells, resulting in mineralization defects in the adult incisors. However, the molecular mechanism by which Med1 deficiency causes these abnormalities is not clear. Here, we demonstrated that Med1 ablation causes early SI differentiation defects resulting in enamel hypoplasia of the Med1-deficient molars. Med1 deletion prevented Notch1-mediated differentiation of the SI cells resulting in decreased alkaline phosphatase (ALPL), which is essential for mineralization. However, it does not affect the ability of ameloblasts to produce enamel matrix proteins. Using the dental epithelial SF2 cell line, we demonstrated that MED1 directly activates transcription of the Alpl gene through the stimulation of Notch1 signaling by forming a complex with cleaved Notch1-RBP-Jk on the Alpl promoter. These results suggest that MED1 may be essential for enamel matrix mineralization by serving as a coactivator for Notch1 signaling regulating transcription of the Alpl gene.	[Yoshizaki, Keigo; Sakai, Kiyoshi; Ishikawa, Masaki; Yamada, Yoshihiko] NIH, Lab Cell & Dev Biol, NIDCR, Bldg 10, Bethesda, MD 20892 USA; [Yoshizaki, Keigo; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94158 USA; [Hu, Lizhi; Thai Nguyen; Bikle, Daniel D.; Oda, Yuko] Vet Affairs Med Ctr, Endocrine Res 111N MB,1700 Owens St, San Francisco, CA 94158 USA; [Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [DenBesten, Pamela K.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA; [Hu, Lizhi] Tianjin Med Univ, Minist Educ, Key Lab Immune Microenvironm & Dis, Dept Immunol, Tianjin 300070, Peoples R China; [Sakai, Kiyoshi] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Ishikawa, Masaki] Tohoku Univ, Grad Sch Dent, Div Operat Dent, Dept Restorat Dent, Sendai, Miyagi 9808575, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tohoku University; University of California System; University of California San Francisco; Tianjin Medical University; Nagoya University; Tohoku University	Yamada, Y (corresponding author), Vet Affairs Med Ctr, Endocrine Res 111N MB,1700 Owens St, San Francisco, CA 94158 USA.; Oda, Y (corresponding author), NIH, NIDCR, 30 Convent Dr,Bldg 30,Rm 430, Bethesda, MD 20814 USA.	yuko.oda@ucsf.edu; yoshi.yamada@nih.gov		Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	National Institutes of Health from NIDCR Intramural Research Program [DE000720-07]; National Institutes of Health [R21 DE025357, R21 DE023411, R01 AR050023]; U. S. Department of Defense [CA110338]; Veterans Affairs Merit Review Award; Ministry of Education, Science, and Culture of Japan [15H05688, 26670886, 26670880]; NEXT program [LS010]; Japan Society for the Promotion of Science for Young Scientists [09J03228]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025357, R21DE023411, ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05688] Funding Source: KAKEN	National Institutes of Health from NIDCR Intramural Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Defense(United States Department of Defense); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grant DE000720-07 (to Y. Y.) from the NIDCR Intramural Research Program and National Institutes of Health Grants R21 DE025357 (to Y. O.), R21 DE023411 (to P. D.), and R01 AR050023 (to D. D. B.). This work also was supported by U. S. Department of Defense Grant CA110338 (to D. D. B.), a Veterans Affairs Merit Review Award (to D. D. B.), Grants-in-aid for Scientific Research 15H05688 and 26670886 (to K. Y.), Grant-in-aid 26670880 (to S. F.) from the Ministry of Education, Science, and Culture of Japan, and Grant LS010 from the NEXT program (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by Research Fellowship 09J03228 from the Japan Society for the Promotion of Science for Young Scientists.	Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Cai X, 2011, CELL PROLIFERAT, V44, P495, DOI 10.1111/j.1365-2184.2011.00780.x; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Gasque KCS, 2015, BONE, V72, P137, DOI 10.1016/j.bone.2014.11.017; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Jia YZ, 2005, J BIOL CHEM, V280, P10766, DOI 10.1074/jbc.M413331200; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawano S, 2004, J DENT RES, V83, P129, DOI 10.1177/154405910408300209; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; Mitsiadis TA, 2010, DEVELOPMENT, V137, P3025, DOI 10.1242/dev.049528; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Oda Y, 2010, J INVEST DERMATOL, V130, P2377, DOI 10.1038/jid.2010.148; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yoshizaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099991; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040; Yue XJ, 2011, P NATL ACAD SCI USA, V108, P17105, DOI 10.1073/pnas.1109095108	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13531	13540		10.1074/jbc.M117.780866	http://dx.doi.org/10.1074/jbc.M117.780866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28673966	hybrid, Green Published			2022-12-28	WOS:000407942400034
J	Orogo, AM; Gonzalez, ER; Kubli, DA; Baptista, IL; Ong, SB; Prolla, TA; Sussman, MA; Murphy, AN; Gustafsson, AB				Orogo, Amabel M.; Gonzalez, Eileen R.; Kubli, Dieter A.; Baptista, Igor L.; Ong, Sang-Bing; Prolla, Tomas A.; Sussman, Mark A.; Murphy, Anne N.; Gustafsson, Asa B.			Accumulation of mitochondrial DNA mutations disrupts cardiac progenitor cell function and reduces survival (vol 290, pg 22061, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Prolla, Tomas A.] CyteGen Inc, Shorewood, WI USA				ONG, SANG-BING/B-7786-2014; Baptista, Igor/ABC-1551-2021	ONG, SANG-BING/0000-0001-7421-2610; Baptista, Igor/0000-0001-5185-0185				Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657	1	1	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11348	11348		10.1074/jbc.A115.649657	http://dx.doi.org/10.1074/jbc.A115.649657			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28687597	Green Published, hybrid			2022-12-28	WOS:000405119600018
J	Tse, H; Gu, QS; Sze, KH; Chu, IK; Kao, RYT; Lee, KC; Lam, CW; Yang, D; Tai, SSC; Ke, YH; Chan, E; Chan, WM; Dai, J; Leung, SP; Leung, SY; Yuen, KY				Tse, Herman; Gu, Qiangshuai; Sze, Kong-Hung; Chu, Ivan K.; Kao, Richard Y. -T.; Lee, Kam-Chung; Lam, Ching-Wan; Yang, Dan; Tai, Sherlock Shing-Chiu; Ke, Yihong; Chan, Elaine; Chan, Wan-Mui; Dai, Jun; Leung, Sze-Pui; Leung, Suet-Yi; Yuen, Kwok-Yung			A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; apoptosis; bacterial toxin; colitis; infectious disease	ESCHERICHIA-COLI; RECOMBINATION; TILIVALLINE; METABOLITE; BACTERIA; CELLS; SET; DNA	Cytotoxin-producing Klebsiella oxytoca is the causative agent of antibiotic-associated hemorrhagic colitis (AAHC). Recently, the cytotoxin associated with AAHC was identified as tilivalline, a known pentacyclic pyrrolobenzodiazepine (PBD) metabolite produced by K. oxytoca. Although this assertion of tilivalline's role in AAHC is supported by evidence from animal experiments, some key aspects of this finding appear to be incompatible with toxicity mechanisms of known PBD toxins. We therefore hypothesized that K. oxytoca may produce some other uncharacterized cytotoxins. To address this question, we investigated whether tilivalline alone is indeed necessary and sufficient to induce cytotoxicity or whether K. oxytoca also produces other cytotoxins. LC-MS- and NMR-based metabolomic analyses revealed the presence of an abundant tricyclic PBD, provisionally designated kleboxymycin, in the supernatant of toxigenic K. oxytoca strains. Moreover, by generating multiple mutants with gene deletions affecting tilivalline biosynthesis, we show that a tryptophanase-deficient, tilivalline-negative K. oxytoca mutant induced cytotoxicity in vitro similar to tilivalline-positive K. oxytoca strains. Furthermore, synthetic kleboxymycin exhibited greater than 9-fold higher cytotoxicity than tilivalline in TC50 cell culture assays. We also found that the biosynthetic pathways for kleboxymycin and tilivalline appear to overlap, as tilivalline is an indole derivative of kleboxymycin. In summary, our results indicate that tilivalline is not essential for inducing cytotoxicity observed in K. oxytoca-associated AAHC and that kleboxymycin is a tilivalline-related bacterial metabolite with even higher cytotoxicity.	[Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Ke, Yihong; Chan, Elaine; Chan, Wan-Mui; Dai, Jun; Leung, Sze-Pui; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immun, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pok Fu Lam, Hong Kong, Peoples R China; [Gu, Qiangshuai; Chu, Ivan K.; Yang, Dan; Tai, Sherlock Shing-Chiu] Univ Hong Kong, Dept Chem, Pok Fu Lam, Hong Kong, Peoples R China; [Lam, Ching-Wan; Leung, Suet-Yi] Univ Hong Kong, Dept Pathol, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Res Ctr Infect & Immun, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hku.hk	Gu, Qiang-Shuai/C-3956-2008; Chan, Elaine/GRR-5490-2022; YANG, Dan/HHD-2733-2022; Leung, Suet Yi/T-9620-2019	Gu, Qiang-Shuai/0000-0002-3840-425X; Yuen, Kwok-yung/0000-0002-2083-1552; Leung, Suet Yi/0000-0001-8614-4619	Commissioned Research on Control of Infectious Diseases (Phase III) Project of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region [HKM-15-M06]	Commissioned Research on Control of Infectious Diseases (Phase III) Project of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region	This work was supported by a donation from Michael Tong and the Providence Foundation in memory of Lui Hac Minh and the Commissioned Research on Control of Infectious Diseases (Phase III) Project Number HKM-15-M06 of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region. The authors declare that they have no conflicts of interest with the contents of this article.	Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Chen J, 2004, GASTROINTEST ENDOSC, V60, P142, DOI 10.1016/S0016-5107(04)01537-8; Cheng VCC, 2012, J CLIN MICROBIOL, V50, P1571, DOI 10.1128/JCM.00163-12; Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032; Chua LS, 2011, J CHROMATOGR B, V879, P3909, DOI 10.1016/j.jchromb.2011.11.002; Darby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100542; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Donnenberg M. S, 2014, MANDELL DOUGLAS BENN, P2503; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; HIGAKI M, 1990, MICROBIOL IMMUNOL, V34, P147, DOI 10.1111/j.1348-0421.1990.tb00999.x; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; HURLEY LH, 1984, PHARMACEUT RES, P52, DOI 10.1023/A:1016395113085; KIM DH, 1995, ARCH PHARM RES, V18, P351, DOI 10.1007/BF02976331; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; MINAMI J, 1992, J GEN MICROBIOL, V138, P1921, DOI 10.1099/00221287-138-9-1921; MINAMI J, 1989, MICROB PATHOGENESIS, V7, P203, DOI 10.1016/0882-4010(89)90056-9; MOHR N, 1982, TETRAHEDRON, V38, P147, DOI 10.1016/0040-4020(82)85058-8; Nagasaka T, 1998, J ORG CHEM, V63, P6797, DOI 10.1021/jo972158g; Nemet Z, 2011, Vet Rec, V168, P243, DOI 10.1136/vr.c6350; Philbrick AM, 2007, PHARMACOTHERAPY, V27, P1603, DOI 10.1592/phco.27.11.1603; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Schneditz G, 2014, P NATL ACAD SCI USA, V111, P13181, DOI 10.1073/pnas.1403274111; Shinjoh M, 2010, PEDIATR INT, V52, P132, DOI 10.1111/j.1442-200X.2009.02949.x; Sweetser S, 2009, AM J GASTROENTEROL, V104, P2366, DOI 10.1038/ajg.2009.289; Takanabe A., 1980, Patent No. [4,185,016, 4185016]; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Yamada M, 2014, GLOB PEDIAT HLTH, V1; Yilmaz M, 2012, EUR J GASTROEN HEPAT, V24, P688, DOI 10.1097/MEG.0b013e328352721a; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	34	24	27	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19503	19520		10.1074/jbc.M117.791558	http://dx.doi.org/10.1074/jbc.M117.791558			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972161	Green Published, hybrid			2022-12-28	WOS:000416226700029
J	Challasivakanaka, S; Zhen, J; Smith, ME; Reith, MEA; Foster, JD; Vaughan, RA				Challasivakanaka, Sathya; Zhen, Juan; Smith, Margaret E.; Reith, Maarten E. A.; Foster, James D.; Vaughan, Roxanne A.			Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); phosphorylation; protein kinase C (PKC); methamphetamine; phospho-specific antibody; proline directed phosphorylation; rotating disc electrode voltammetry	PROLINE-DIRECTED PHOSPHORYLATION; NEUROTRANSMITTER TRANSPORTERS; RAT STRIATUM; MECHANISMS; SUBSTRATE; EXPRESSION; SPECIFICITY; INHIBITORS; RECEPTORS; DISORDER	The dopamine transporter (DAT) controls the spatial and temporal dynamics of dopamine neurotransmission through reuptake of extracellular transmitter and is a target for addictive compounds such as cocaine, amphetamine (AMPH), and methamphetamine (METH). Reuptake is regulated by kinase pathways and drug exposure, allowing for fine-tuning of clearance in response to specific conditions, and here we examine the impact of transporter ligands on DAT residue Thr-53, a proline-directed phosphorylation site previously implicated in AMPH-stimulated efflux mechanisms. Our findings show that Thr-53 phosphorylation is stimulated in a transporter-dependent manner by AMPH and METH in model cells and rat striatal synaptosomes, and in striatum of rats given subcutaneous injection of METH. Rotating disc electrode voltammetry revealed that initial rates of uptake and AMPH-induced efflux were elevated in phosphorylation-null T53A DAT relative to WT and charge-substituted T53D DATs, consistent with functions related to charge or polarity. These effects occurred without alterations of surface transporter levels, and mutants also showed reduced cocaine analog binding affinity that was not rescued by Zn2+. Together these findings support a role for Thr-53 phosphorylation in regulation of transporter kinetic properties that could impact DAT responses to amphetamines and cocaine.	[Challasivakanaka, Sathya; Smith, Margaret E.; Foster, James D.; Vaughan, Roxanne A.] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Zhen, Juan; Reith, Maarten E. A.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	University of North Dakota Grand Forks; New York University; New York University	Vaughan, RA (corresponding author), 1301 N Columbia Rd, Grand Forks, ND 58201 USA.	roxanne.vaughan@med.und.edu	ChallaSivaKanaka, Sathyavathi/AAL-7212-2021; Reith, Maarten E./AAD-2303-2019; Zhen, Juan/E-8593-2016	ChallaSivaKanaka, Sathyavathi/0000-0001-8487-5485; Reith, Maarten E./0000-0002-1900-842X; Zhen, Juan/0000-0002-6111-9692	COBRE program of the National Center for Research Resources through National Institutes of Health [P20 GM104360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA031991, R01DA019676, R01DA013147] Funding Source: NIH RePORTER	COBRE program of the National Center for Research Resources through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The University of North Dakota was supported by the COBRE program of the National Center for Research Resources through Grant P20 GM104360 from the National Institutes of Health.	Alyea RA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-59; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; Calipari ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13877; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen NH, 1998, J NEUROCHEM, V71, P653; Chen NH, 2000, MOL BRAIN RES, V75, P208, DOI 10.1016/S0169-328X(99)00288-0; Dehnes Y, 2014, NEUROCHEM INT, V73, P4, DOI 10.1016/j.neuint.2014.02.003; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JD, 2017, J CHEM NEUROANAT, V83, P10, DOI 10.1016/j.jchemneu.2016.10.004; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mao LM, 2013, BRAIN RES, V1494, P101, DOI 10.1016/j.brainres.2012.11.038; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Moron JA, 2003, J NEUROSCI, V23, P8480; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Shi X, 2006, NEUROSCIENCE, V138, P1289, DOI 10.1016/j.neuroscience.2005.12.024; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Thompson AC, 2000, J NEUROSCI, V20, P9333; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang Q, 2016, NEUROSCI LETT, V622, P78, DOI 10.1016/j.neulet.2016.04.051; Xie T, 2000, J NEUROSCI, V20, P7838	51	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19066	19075		10.1074/jbc.M117.787002	http://dx.doi.org/10.1074/jbc.M117.787002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939767	Green Published, hybrid			2022-12-28	WOS:000415848000029
J	Jayakanthan, S; Braiterman, LT; Hasan, NM; Unger, VM; Lutsenko, S				Jayakanthan, Samuel; Braiterman, Lelita T.; Hasan, Nesrin M.; Unger, Vinzenz M.; Lutsenko, Svetlana			Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; calcium ATPase; copper transport; dimerization; membrane transport	POLARIZED HEPATIC CELLS; METAL-BINDING DOMAIN; FULGIDUS CU+-ATPASE; PARTICLE CRYO-EM; ELECTRON-MICROSCOPY; FUNCTIONAL-PROPERTIES; UCSF CHIMERA; TRAFFICKING; PHOSPHORYLATION; MECHANISM	ATP7B is a copper-transporting P-1B-type ATPase (Cu-ATPase) with an essential role in human physiology. Mutations in ATP7B cause the potentially fatal Wilson disease, and changes in ATP7B expression are observed in several cancers. Despite its physiologic importance, the biochemical information about ATP7B remains limited because of a complex multidomain organization of the protein. By analogy with the better characterized prokaryotic Cu-ATPases, ATP7B is assumed to be a single-chain monomer. We show that in eukaryotic cells, human ATP7B forms dimers that can be purified following solubilization. Deletion of the four N-terminal metal-binding domains, characteristic for human ATP7B, does not disrupt dimerization, i.e. the dimer interface is formed by the domains that are conserved among Cu-ATPases. Unlike the full-length ATP7B, which is targeted to the trans-Golgi network, 1-4MBD-7B is targeted primarily to vesicles. This result and the analysis of differentially tagged ATP7B variants indicate that the dimeric structure is retained during ATP7B trafficking between the intracellular compartments. Purified dimeric species of 1-4MBD-7B were characterized by a negative stain electron microscopy in the presence of ADP/MgCl2. Single-particle analysis yielded a low-resolution 3D model that provides the first insight into an overall architecture of a human Cu-ATPase, positions of the main domains, and a dimer interface.	[Jayakanthan, Samuel; Hasan, Nesrin M.; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Hunterian 203,725 N Wolfe St, Baltimore, MD 21205 USA; [Braiterman, Lelita T.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Unger, Vinzenz M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Johns Hopkins University; Johns Hopkins University; Northwestern University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Hunterian 203,725 N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu		Lutsenko, Svetlana/0000-0001-5275-2587	National Institutes of Health [P01GM067166, R01DK071865, 1R01GM115211-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115211, P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01GM067166 and R01DK071865 (to S. L.) and 1R01GM115211-01A1 (to V. M. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal S, 2010, PROTEINS, V78, P2450, DOI 10.1002/prot.22753; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Braiterman LT, 2015, J BIOL CHEM, V290, P8803, DOI 10.1074/jbc.M114.627414; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hauer F, 2015, STRUCTURE, V23, P1769, DOI 10.1016/j.str.2015.06.029; Huster D, 2012, GASTROENTEROLOGY, V142, P947, DOI 10.1053/j.gastro.2011.12.048; Jayakanthan S, 2012, BIOSCIENCE REP, V32, P443, DOI 10.1042/BSR20120048; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Safaei R, 2013, METALLOMICS, V5, P964, DOI 10.1039/c3mt00131h; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Squitti R, 2013, NEUROMOL MED, V15, P515, DOI 10.1007/s12017-013-8237-y; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025	40	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18760	18774		10.1074/jbc.M117.807263	http://dx.doi.org/10.1074/jbc.M117.807263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28842499	Green Published, hybrid			2022-12-28	WOS:000415848000003
J	Jackson, RM; Griesel, BA; Gurley, JM; Szweda, LI; Olson, AL				Jackson, Robert M.; Griesel, Beth A.; Gurley, Jami M.; Szweda, Luke I.; Olson, Ann Louise			Glucose availability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of nicotinamide metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; glucose metabolism; glucose transporter type 4 (GLUT4); lipogenesis; NAD; adipocyte differentiation	ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; RECEPTOR LXR; GLUT4 TRANSCRIPTION; INSULIN SENSITIVITY; GENE-EXPRESSION; TRANSGENIC MICE; FAT; OBESITY; LIVER	Expansion of adipose tissue in response to a positive energy balance underlies obesity and occurs through both hypertrophy of existing cells and increased differentiation of adipocyte precursors (hyperplasia). To better understand the nutrient signals that promote adipocyte differentiation, we investigated the role of glucose availability in regulating adipocyte differentiation and maturation. 3T3-L1 preadipocytes were grown and differentiated in medium containing a standard differentiation hormone mixture and either 4 or 25 mm glucose. Adipocyte maturation at day 9 post-differentiation was determined by key adipocyte markers, including glucose transporter 4 (GLUT4) and adiponectin expression and Oil Red O staining of neutral lipids. We found that adipocyte differentiation and maturation required a pulse of 25 mm glucose only during the first 3 days of differentiation. Importantly, fatty acids were unable to substitute for the 25 mm glucose pulse during this period. The 25 mm glucose pulse increased adiponectin and GLUT4 expression and accumulation of neutral lipids via distinct mechanisms. Adiponectin expression and other early markers of differentiation required an increase in the intracellular pool of total NAD/P. In contrast, GLUT4 protein expression was only partially restored by increased NAD/P levels. Furthermore, GLUT4 mRNA expression was mediated by glucose-dependent activation of GLUT4 gene transcription through the cis-acting GLUT4-liver X receptor element (LXRE) promoter element. In summary, this study supports the conclusion that high glucose promotes adipocyte differentiation via distinct metabolic pathways and independently of fatty acids. This may partly explain the mechanism underlying adipocyte hyperplasia that occurs much later than adipocyte hypertrophy in the development of obesity.	[Jackson, Robert M.; Griesel, Beth A.; Gurley, Jami M.; Szweda, Luke I.; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,Rm 853-BMSB, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Olson, Ann Louise] Oklahoma Med Res Fdn, Program Aging & Metab, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,Rm 853-BMSB, Oklahoma City, OK 73104 USA.	ann-olson@ouhsc.edu		Gurley, Jami/0000-0002-7919-9328	Harold Hamm Diabetes Center	Harold Hamm Diabetes Center	This manuscript was supported in part by a grant from the Harold Hamm Diabetes Center. The authors declare that they have no conflicts of interest with the contents of this article.	Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Budihardjo II, 1998, CLIN CANCER RES, V4, P117; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Devalaraja-Narashimha K, 2010, J ENDOCRINOL, V205, P242, DOI 10.1677/JOE-09-0402; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HASSID WZ, 1957, METHOD ENZYMOL, V3, P34, DOI 10.1016/S0076-6879(57)03345-5; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Letexier D, 2003, J LIPID RES, V44, P2127, DOI 10.1194/jlr.M300235-JLR200; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Luo X, 2017, MOL CELL, V65, P260, DOI 10.1016/j.molcel.2016.11.015; MacKellar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008197; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rindler PM, 2016, AM J PHYSIOL-HEART C, V311, pH1091, DOI 10.1152/ajpheart.00066.2016; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shapiro ALB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159575; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001	42	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18556	18564		10.1074/jbc.M117.791970	http://dx.doi.org/10.1074/jbc.M117.791970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28916720	Green Published, hybrid			2022-12-28	WOS:000414958100014
J	Zattelman, L; Regev, R; Usaj, M; Reinke, PYA; Giese, S; Samson, AO; Taft, MH; Manstein, DJ; Henn, A				Zattelman, Lilach; Regev, Ronit; Usaj, Marko; Reinke, Patrick Y. A.; Giese, Sven; Samson, Abraham O.; Taft, Manuel H.; Manstein, Dietmar J.; Henn, Arnon			N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MEMBRANE TENSION; INNER-EAR; DUTY RATIO; MOTOR; NUCLEUS; BINDING; TRANSCRIPTION; SENSITIVITY; ACTIN; IDENTIFICATION	The MYO1C gene produces three alternatively spliced isoforms, differing only in their N-terminal regions (NTRs). These isoforms, which exhibit both specific and overlapping nuclear and cytoplasmic functions, have different expression levels and nuclear-cytoplasmic partitioning. To investigate the effect of NTR extensions on the enzymatic behavior of individual isoforms, we overexpressed and purified the three full-length human isoforms from suspension-adapted HEK cells. MYO1C(C) favored the actomyosin closed state (AMC), MYO1C16 populated the actomyosin open state (AMO) and AMC equally, and MYO1C(35) favored theAMOstate. Moreover, the full-length constructs isomerized before ADP release, which has not been observed previously in truncated MYO1CC constructs. Furthermore, global numerical simulation analysis predicted that MYO1C35 populated the actomyosin "ADP closed state (AMDC) 5-fold more than the actomyosin " ADP open state (AMDO) and to a greater degree than MYO1CC and MYO1C(16) (4-and 2-fold, respectively). On the basis of a homology model of the 35-amino acid NTR of MYO1C35 (NTR35) docked to the X-ray structure ofMYO1CC, we predicted thatMYO1C(35)NTRresidue Arg-21 would engage in a specific interaction with post-relay helix residue Glu-469, which affects the mechanics of the myosin power stroke. In addition, we found that adding the NTR35 peptide to MYO1C(C) yielded a protein that transiently mimics MYO1C(35) kinetic behavior. By contrast, NTR35, which harbors the R21G mutation, was unable to confer MYO1C(35)-like kinetic behavior. Thus, the NTRs affect the specific nucleotide-binding properties ofMYO1Cisoforms, adding to their kinetic diversity. We propose that this level of fine-tuning within MYO1C broadens its adaptability within cells.	[Zattelman, Lilach; Regev, Ronit; Usaj, Marko; Henn, Arnon] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Samson, Abraham O.] Bar Ilan Univ, Fac Med Galilee, IL-1311520 Safed, Israel; [Reinke, Patrick Y. A.; Giese, Sven; Taft, Manuel H.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE 4350,Carl Neuberg Str 1, D-30625 Hannover, Germany	Technion Israel Institute of Technology; Bar Ilan University; Hannover Medical School	Henn, A (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel.	arnon.henn@technion.ac.il	Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019; Henn, Arnon/O-1896-2019; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Henn, Arnon/0000-0001-6360-7211; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Zattelman, Lilach/0000-0002-2658-9031; Giese, Sven/0000-0003-0984-0543; Reinke, Patrick/0000-0002-7354-0839	Marie Curie Career Integration Grant from the Israeli Scientific Foundation [1403705/11, 296/13]; Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects [VWZN3012]	Marie Curie Career Integration Grant from the Israeli Scientific Foundation; Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects	This work was supported by Marie Curie Career Integration Grant 1403705/11 and Grant 296/13 from the Israeli Scientific Foundation (to A. H.). This work also was supported by the Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects (Grant VWZN3012) (to A. H., M. H. T., and D. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Adamek Nancy, 2014, Exp Suppl, V105, P87, DOI 10.1007/978-3-0348-0856-9_5; ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Desmond Molecular Dynamics System, 2017, REL 2017 1; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Greenberg MJ, 2012, P NATL ACAD SCI USA, V109, pE2433, DOI 10.1073/pnas.1207811109; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Lewis JH, 2012, BIOPHYS J, V102, P2799, DOI 10.1016/j.bpj.2012.05.014; Lin TM, 2011, BIOCHEMISTRY-US, V50, P1831, DOI 10.1021/bi1016777; Maly IV, 2016, CYTOSKELETON, V73, P341, DOI 10.1002/cm.21310; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Obrdlik A, 2010, FASEB J, V24, P146, DOI 10.1096/fj.09-135863; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Schru┬dinger, 2017, 1 MAESTR; Schwab RS, 2013, EXP CELL RES, V319, P1111, DOI 10.1016/j.yexcr.2013.02.008; Shneyer BI, 2016, J CELL SCI, V129, P543, DOI 10.1242/jcs.175349; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Sielski NL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-8; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Venit T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30864; Venit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061406; Zuo J, 2002, J NEUROBIOL, V53, P286, DOI 10.1002/neu.10128	53	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17804	17818		10.1074/jbc.M117.794008	http://dx.doi.org/10.1074/jbc.M117.794008			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893906	Green Published, hybrid			2022-12-28	WOS:000414013000018
J	Johnson, ZI; Doolittle, AC; Snuggs, JW; Shapiro, IM; Le Maitre, CL; Risbud, MV				Johnson, Zariel I.; Doolittle, Alexandra C.; Snuggs, Joseph W.; Shapiro, Irving M.; Le Maitre, Christine L.; Risbud, Makarand V.			TNF-alpha promotes nuclear enrichment of the transcription factor TonEBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; NF-KAPPA-B; INTERVERTEBRAL DISC DEGENERATION; NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; CELLULAR-RESPONSE; WATER-CONTENT; EXPRESSION; MATRIX; REGULATOR	Intervertebral disc degeneration (IDD) causes chronic back pain and is linked to production of proinflammatory molecules by nucleus pulposus (NP) and other disc cells. Activation of tonicity-responsive enhancer-binding protein (TonEBP)/NFAT5 by non-osmotic stimuli, including proinflammatory molecules, occurs in cells involved in immune response. However, whether inflammatory stimuli activate TonEBP in NP cells and whether TonEBP controls inflammation during IDD is unknown. We show that TNF-alpha, but not IL-1 beta or LPS, promoted nuclear enrichment of TonEBP protein. However, TNF-alpha -mediated activation of TonEBP did not cause induction of osmoregulatory genes. RNA sequencing showed that 8.5% of TNF-alpha transcriptional responses were TonEBP-dependent and identified genes regulated by both TNF-alpha and TonEBP. These genes were over-enriched in pathways and diseases related to inflammatory response and inhibition of matrix metalloproteases. Based on RNA-sequencing results, we further investigated regulation of novel TonEBP targets CXCL1, CXCL2, and CXCL3. TonEBP acted synergistically with TNF-alpha and LPS to induce CXCL1-proximal promoter activity. Interestingly, this regulation required a highly conserved TNF-alpha B-binding site but not a predicted TonE, suggesting cross-talk between these two members of the Rel family. Finally, analysis of human NP tissue showed that TonEBP expression correlated with canonical osmoregulatory targets TauT/SLC6A6, SMIT/SLC5A3, and AR/AKR1B1, supporting in vitro findings that the inflammatory milieu during IDD does not interfere with TonEBP osmoregulation. In summary, whereas TonEBP participates in the proinflammatory response to TNF-alpha, therapeutic strategies targeting this transcription factor for treatment of disc disease must spare osmoprotective, prosurvival, and matrix homeostatic activities.	[Johnson, Zariel I.; Doolittle, Alexandra C.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA; [Snuggs, Joseph W.; Le Maitre, Christine L.] Sheffield Hallam Univ, Biomol Sci Res Ctr, Sheffield S1 1WB, S Yorkshire, England	Jefferson University; Sheffield Hallam University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu		Snuggs, Joseph/0000-0002-0200-4596	National Institutes of Health [AR055655, AR064733, T32AR052273]; Sheffield Hallam University Vice Chancellor Ph. D. Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052273, R01AR064733, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sheffield Hallam University Vice Chancellor Ph. D. Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grants AR055655 and AR064733 (to M.V.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32AR052273.; Supported by a Sheffield Hallam University Vice Chancellor Ph. D. Scholarship.	ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Binch ALA, 2016, MATRIX BIOL, V52-54, P355, DOI 10.1016/j.matbio.2016.01.005; BOOS N, 1993, RADIOLOGY, V188, P351, DOI 10.1148/radiology.188.2.8327677; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Caron MMJ, 2013, BONE, V53, P94, DOI 10.1016/j.bone.2012.11.032; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Gawri R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4449; Hatanaka E, 2007, SHOCK, V27, P32, DOI 10.1097/01.shk.0000238061.69579.a5; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeong GR, 2016, J NEUROIMMUNOL, V295, P21, DOI 10.1016/j.jneuroim.2016.04.009; Johnson ZI, 2015, EUR CELLS MATER, V30, P104, DOI 10.22203/eCM.v030a08; Johnson ZI, 2016, J BIOL CHEM, V291, P26686, DOI 10.1074/jbc.M116.757732; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kepler CK, 2013, SPINE, V38, pE1291, DOI 10.1097/BRS.0b013e3182a42bc2; Kepler CK, 2013, SPINE, V38, P873, DOI 10.1097/BRS.0b013e318285ae08; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kumaresan S, 2000, BIOMED SCI INSTRUM, V395, P141; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee H., 2014, J NANOMATER, V2014, P6; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; NACHEMSON A, 1964, J BONE JOINT SURG AM, V46, P1077, DOI 10.2106/00004623-196446050-00012; Nazari J, 2015, MAGN RESON IMAGING, V33, P459, DOI 10.1016/j.mri.2015.01.006; PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407; Phillips KLE, 2015, OSTEOARTHR CARTILAGE, V23, P1165, DOI 10.1016/j.joca.2015.02.017; Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408; Purmessur D, 2013, BIOCHEM BIOPH RES CO, V433, P151, DOI 10.1016/j.bbrc.2013.02.034; Quero L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4274; Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Shen B, 2003, EUR SPINE J, V12, P66, DOI 10.1007/s00586-002-0454-2; Shen C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3443; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Ueno M, 2013, J LIPID RES, V54, P734, DOI 10.1194/jlr.M033365; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; URBAN JPG, 1985, BIORHEOLOGY, V22, P145; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang X, 2014, AM J PATHOL, V184, P2560, DOI 10.1016/j.ajpath.2014.06.006; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zhang D, 2015, MEDIAT INFLAMM, V2015	62	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17561	17575		10.1074/jbc.M117.790378	http://dx.doi.org/10.1074/jbc.M117.790378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842479	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000414009300035
J	Kenniston, JA; Taylor, BM; Conley, GP; Cosic, J; Kopacz, KJ; Lindberg, AP; Comeau, SR; Atkins, K; Bullen, J; TenHoor, C; Adelman, BA; Sexton, DJ; Edwards, TE; Nixon, AE				Kenniston, Jon A.; Taylor, Brandy M.; Conley, Gregory P.; Cosic, Janja; Kopacz, Kris J.; Lindberg, Allison P.; Comeau, Stephen R.; Atkins, Kateri; Bullen, Jameson; TenHoor, Christopher; Adelman, Burt A.; Sexton, Daniel J.; Edwards, Thomas E.; Nixon, Andrew E.			Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAVENOUS IMMUNOGLOBULIN; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; HUMAN IGG1; ANTIINFLAMMATORY ACTIVITY; GLOBULIN THERAPY; AUTOIMMUNE; IMMUNE; COMPLEX; BINDING	The neonatal Fc receptor FcRn plays a critical role in the trafficking of IgGs across tissue barriers and in retaining high circulating concentrations of both IgG and albumin. Although generally beneficial from an immunological perspective in maintaining IgG populations, FcRn can contribute to the pathogenesis of autoimmune disorders when an abnormal immune response targets normal biological components. We previously described a monoclonal antibody (DX-2507) that binds to FcRn with high affinity at both neutral and acidic pH, prevents the simultaneous binding of IgG, and reduces circulating IgG levels in preclinical animal models. Here, we report a 2.5 angstrom resolution X-ray crystal structure of an FcRn-DX-2507 Fab complex, revealing a nearly complete overlap of the IgG-Fc binding site in FcRn by complementarity-determining regions in DX-2507. This overlap explains how DX-2507 blocks IgG binding to FcRn and thereby shortens IgG half-life by preventing IgGs from recycling back into circulation. Moreover, the complex structure explains how the DX-2507 interaction is pH-insensitive unlike normal Fc interactions and how serum albumin levels are unaffected by DX-2507 binding. These structural studies could inform antibody-based therapeutic approaches for limiting the effects of IgG-mediated autoimmune disease.	[Kenniston, Jon A.; Kopacz, Kris J.; Sexton, Daniel J.] Shire, 300 Shire Way, Lexington, MA 02421 USA; [Taylor, Brandy M.; Atkins, Kateri; Bullen, Jameson; Edwards, Thomas E.] Beryllium Discovery Corp, Bainbridge Isl, WA 98110 USA; [Kenniston, Jon A.; Conley, Gregory P.; Cosic, Janja; Lindberg, Allison P.; Comeau, Stephen R.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.] Dyax Corp, Burlington, MA 01803 USA	Shire Pharmaceuticals Limited	Kenniston, JA (corresponding author), Shire, 300 Shire Way, Lexington, MA 02421 USA.	jkenniston0@shire.com		Nixon, Andrew/0000-0002-6090-0583; Edwards, Thomas/0000-0002-0474-8003	Shire Pharmaceuticals	Shire Pharmaceuticals	This investigation was supported by Dyax Corp., now a wholly owned subsidiary of Shire Pharmaceuticals. J. A. K., G. P. C., J. C., K. J. K., A. P. L., S. R. C., C. T., B. A. A., D. J. S., and A. E. N. were employees of Dyax at the time of the study. J. A. K. and D. J. S. are currently Shire employees.	Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayry J, 2007, NAT CLIN PRACT NEURO, V3, P120, DOI 10.1038/ncpneuro0429; Bleeker WK, 2001, BLOOD, V98, P3136, DOI 10.1182/blood.V98.10.3136; Castillo J, 2009, EXPERT OPIN INV DRUG, V18, P491, DOI [10.1517/13543780902832679, 10.1517/13543780902832679 ]; Challa DK, 2013, MABS-AUSTIN, V5, P655, DOI 10.4161/mabs.25439; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crow AR, 2011, BLOOD, V118, P6403, DOI 10.1182/blood-2011-08-374223; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkan D, 2014, AUTOIMMUN REV, V13, P685, DOI 10.1016/j.autrev.2014.01.053; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Hansen RJ, 2002, BLOOD, V100, P2087, DOI 10.1182/blood.V100.6.2087.h81802002087_2087_2093; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Huda R, 2014, REV NEUROSCIENCE, V25, P575, DOI 10.1515/revneuro-2014-0021; IMBACH P, 1981, HELV PAEDIATR ACTA, V36, P81; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kessary-Shoham H, 1999, J AUTOIMMUN, V13, P129, DOI 10.1006/jaut.1999.0302; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Liu LM, 2007, J IMMUNOL, V178, P5390, DOI 10.4049/jimmunol.178.8.5390; Liu Z, 1997, J EXP MED, V186, P777, DOI 10.1084/jem.186.5.777; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; McPherson R. A., 2017, HENRYS CLIN DIAGNOSI, pe12; Mezo AR, 2008, P NATL ACAD SCI USA, V105, P2337, DOI 10.1073/pnas.0708960105; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Neuber T, 2014, MABS-AUSTIN, V6, P928, DOI 10.4161/mabs.28744; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Nixon AE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00176; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Patel DA, 2011, J IMMUNOL, V187, P1015, DOI 10.4049/jimmunol.1003780; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Roopenian DC, 2016, METHODS MOL BIOL, V1438, P103, DOI 10.1007/978-1-4939-3661-8_6; Sand KMK, 2014, J BIOL CHEM, V289, P17228, DOI 10.1074/jbc.M113.522565; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Sesarman A, 2010, CELL MOL LIFE SCI, V67, P2533, DOI 10.1007/s00018-010-0318-6; Sexton DJ, 2009, BIOCHEM J, V422, P383, DOI 10.1042/BJ20090010; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Szczeklik W, 2013, ANAESTH INTENSIVE TH, V45, P7, DOI 10.5603/AIT.2013.0002; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	55	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17449	17460		10.1074/jbc.M117.807396	http://dx.doi.org/10.1074/jbc.M117.807396			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878017	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000414009300025
J	Rahlwes, KC; Ha, SA; Motooka, D; Mayfield, JA; Baumoel, LR; Strickland, JN; Torres-Ocampo, AP; Nakamura, S; Morita, YS				Rahlwes, Kathryn C.; Ha, Stephanie A.; Motooka, Daisuke; Mayfield, Jacob A.; Baumoel, Lisa R.; Strickland, Justin N.; Torres-Ocampo, Ana P.; Nakamura, Shota; Morita, Yasu S.			The cell envelope-associated phospholipid-binding protein LmeA is required for mannan polymerization in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMEGMATIS ATCC 607; CORYNEBACTERIUM-GLUTAMICUM; OUTER-MEMBRANE; PHOSPHATIDYLINOSITOL MANNOSIDES; LIPOARABINOMANNAN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; LIPID-COMPOSITION; CONSERVED GENE; IDENTIFICATION; TUBERCULOSIS	The integrity of the distinguishing, multilaminate cell envelope surrounding mycobacteria is critical to their survival and pathogenesis. The prevalence of phosphatidylinositol manno-sides in the cell envelope suggests an important role in the mycobacterial life cycle. Indeed, deletion of the pimE gene (Delta pimE) encoding the first committed step in phosphatidylinositol hexamannoside biosynthesis in Mycobacterium smegmatis results in the formation of smaller colonies than wild-type colonies on Middlebrook 7H10 agar. To further investigate potential contributors to cell-envelope mannan biosynthesis while taking advantage of this colony morphology defect, we isolated spontaneous suppressor mutants of Delta pimE that reverted to wild-type colony size. Of 22 suppressor mutants, 6 accumulated significantly shorter lipomannan or lipoarabinomannan. Genome sequencing of these mutants revealed mutations in genes involved in the lipomannan/lipoarabinomannan biosynthesis, such as those encoding the arabinosyltransferase EmbC and the mannosyltransferase MptA. Furthermore, we identified three mutants carrying a mutation in a previously uncharacterized gene, MSMEG_5785, that we designated lmeA. Complementation of these suppressor mutants with lmeA restored the original Delta pimE phenotypes and deletion of lmeA in wild-type M. smegmatis resulted in smaller lipomannan, as observed in the suppressor mutants. LmeA carries a predicted N-terminal signal peptide, and density gradient fractionation and detergent extractability experiments indicated that LmeA localizes to the cell envelope. Using a lipid ELISA, we found that LmeA binds to plasma membrane phospholipids, such as phosphatidylethanolamine and phosphatidylinositol. LmeA is widespread throughout the Corynebacteriales; therefore, we concluded that LmeA is an evolutionarily conserved cell-envelope protein critical for controlling the mannan chain length of lipomannan/lipoarabinomannan.	[Rahlwes, Kathryn C.; Ha, Stephanie A.; Baumoel, Lisa R.; Strickland, Justin N.; Torres-Ocampo, Ana P.; Morita, Yasu S.] Univ Massachusetts, Dept Microbiol, 639 N Pleasant St, Amherst, MA 01003 USA; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Dept Infect Metagen, Osaka 5650871, Japan; [Mayfield, Jacob A.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02445 USA	University of Massachusetts System; University of Massachusetts Amherst; Osaka University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Morita, YS (corresponding author), Univ Massachusetts, Dept Microbiol, 639 N Pleasant St, Amherst, MA 01003 USA.	ymorita@microbio.umass.edu	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Rahlwes, Kathryn/0000-0002-8101-5604; Morita, Yasu/0000-0002-4514-9242; Torres-Ocampo, Ana P./0000-0003-1223-7120	American Lung Association [RG-414805]; Pittsfield AntiTuberculosis Association; UMass Amherst PREP Program	American Lung Association; Pittsfield AntiTuberculosis Association; UMass Amherst PREP Program	This work was supported by Biomedical Research Grant RG-414805 from the American Lung Association and a Research Grant from the Pittsfield AntiTuberculosis Association (to Y. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Summer research student supported by the UMass Amherst PREP Program.	Alva V, 2016, BBA-MOL CELL BIOL L, V1861, P913, DOI 10.1016/j.bbalip.2016.01.016; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Cashmore TJ, 2017, J BIOL CHEM, V292, P4976, DOI 10.1074/jbc.M116.772202; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Fukuda T, 2013, MBIO, V4, DOI 10.1128/mBio.00472-12; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Hayashi JM, 2016, P NATL ACAD SCI USA, V113, P5400, DOI 10.1073/pnas.1525165113; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Ishikawa E, 2017, TRENDS IMMUNOL, V38, P66, DOI 10.1016/j.it.2016.10.009; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Jayaraman N., 2017, CHEMBIOCHEM, DOI [10.1002/cbic.201700247, DOI 10.1002/CBIC.201700247]; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; KHULLER GK, 1983, J APPL BACTERIOL, V54, P63, DOI 10.1111/j.1365-2672.1983.tb01301.x; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen M. H., 2007, CURR PROTOC MICROBIO, DOI [10.1002/mc10a02s69780471729259, DOI 10.1002/MC10A02S69780471729259]; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Leversen NA, 2009, MICROBIOL-SGM, V155, P2375, DOI 10.1099/mic.0.025270-0; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maes E, 2007, GLYCOCONJUGATE J, V24, P439, DOI 10.1007/s10719-007-9036-1; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2010, J BIOL CHEM, V285, P16643, DOI 10.1074/jbc.M110.119263; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Perkowski EF, 2017, MBIO, V8, DOI 10.1128/mBio.00333-17; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; SUBRAMONIAM A, 1982, J GEN MICROBIOL, V128, P419; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van der Woude AD, 2013, J BACTERIOL, V195, P2050, DOI 10.1128/JB.02236-12; Vergne I, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00187; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005	55	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17407	17417		10.1074/jbc.M117.804377	http://dx.doi.org/10.1074/jbc.M117.804377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855252	Green Published, hybrid			2022-12-28	WOS:000414009300022
J	Reddy, VB; Lerner, EA				Reddy, Vemuri B.; Lerner, Ethan A.			Activation of mas-related G-protein-coupled receptors by the house dust mite cysteine protease Der p1 provides a new mechanism linking allergy and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS	Cysteine and serine proteases function via protease-activated and mas-related G-protein-coupled receptors (Mrgprs) to contribute to allergy and inflammation. Der p1 is a cysteine protease and major allergen from the house dust mite and is associated with allergic rhinitis and allergic asthma. Der p1 activates protease-activated receptor 2 and induces the release of the pro-inflammatory cytokine IL-6 from cells. However, the possibility that Der p1 acts on Mrgprs has not been considered. We report here that ratiometric calcium imaging reveals that Der p1 activates the human receptor MRGPRX1 and the mouse homolog MrgprC11, implicated previously in itch. Der p1 cleavage of N-terminal receptor peptides followed by site-directed mutagenesis of the cleavage sites links receptor activation to specific amino acid residues. Der p1 also induced the release of IL-6 from heterologous cells expressing MRGPRX1. In summary, activation of Mrgprs by the allergen Der p1 may contribute to inflammation.	[Lerner, Ethan A.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149,13th St, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Lerner, EA (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149,13th St, Charlestown, MA 02129 USA.	elerner@mgh.harvard.edu		Lerner, Ethan/0000-0001-5480-4133	NIAMS, National Institutes of Health [R01AR057744, R21AR067399]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057744, R21AR067399] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grants R01AR057744 and R21AR067399. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Elmariah SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099702; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Sharlow ER, 2000, J CELL SCI, V113, P3093; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007	11	18	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17399	17406		10.1074/jbc.M117.787887	http://dx.doi.org/10.1074/jbc.M117.787887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28768771	hybrid, Green Published			2022-12-28	WOS:000414009300021
J	Prakasam, G; Singh, RK; Iqbal, MA; Saini, SK; Tiku, AB; Bannezai, RNK				Prakasam, Gopinath; Singh, Rajnish Kumar; Iqbal, Mohammad Askandar; Saini, Sunil Kumar; Tiku, Ashu Bhan; Bannezai, Ranneshwar N. K.			Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; SUBCELLULAR-LOCALIZATION; GENE-TRANSCRIPTION; TUMOR-SUPPRESSOR; PKM2; LKB1; METABOLISM; ISOFORM; GROWTH; PREDICTION	Preferential expression of the low-activity (dimeric) M2 isoform of pyruvate kinase (PK) over its constitutively active splice variant M1 isoform is considered critical for aerobic glycolysis in cancer cells. However, our results reported here indicate co-expression of PKM1 and PKM2 and their possible physical interaction in cancer cells. We show that knockdown of either PKM1 or PKM2 differentially affects net PK activity, viability, and cellular ATP levels of the lung carcinoma cell lines H1299 and A549. The stable knockdown of PK isoforms in A549 cells significantly reduced the cellular ATP level, whereas in H1299 cells the level of ATP was unaltered. Interestingly, the PKM1/2 knockdown in H1299 cells activated AMP-activated protein kinase (AMPK) signaling and stimulated mitochondrial biogenesis and autophagy to maintain energy homeostasis. In contrast, knocking down either of the PKM isoforms in A549 cells lacking LKB1, a serine/threonine protein kinase upstream of AMPK, failed to activate AMPK and sustain energy homeostasis and resulted in apoptosis. Moreover, in a similar genetic background of silenced PKM1 or PKM2, the knocking down of AMPK alpha 1/2 catalytic subunit in H1299 cells induced apoptosis. Our findings help explain why previous targeting of PKM2 in cancer cells to control tumor growth has not met with the expected success. We suggest that this lack of success is because of AMPK-mediated energy metabolism rewiring, protecting cancer cell viability. On the basis of our observations, we propose an alternative therapeutic strategy of silencing either of the PKM isoforms along with AMPK in tumors.	[Prakasam, Gopinath; Singh, Rajnish Kumar; Iqbal, Mohammad Askandar; Saini, Sunil Kumar; Bannezai, Ranneshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Tiku, Ashu Bhan] Jawaharlal Nehru Univ, Radiat & Canc Therapeut Lab, Sch Life Sci, New Delhi 110067, India; [Singh, Rajnish Kumar] Univ Penn, Dept Microbiol, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Singh, Rajnish Kumar] Univ Penn, Tumor Virol Program, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Iqbal, Mohammad Askandar] Jamia Millia Islamia, Fac Nat Sci, Dept Biotechnol, New Delhi 110025, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jamia Millia Islamia	Bannezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	bamezai@hotmail.com	Tiku, A/R-9353-2019; prakasam, Gopinath/S-8438-2017	prakasam, Gopinath/0000-0003-1839-7969; SINGH, RAJNISH/0000-0001-7414-1170; Bamezai, R.N.K/0000-0002-5128-2859; Iqbal, Mohammad Askandar/0000-0003-3485-3530; Saini, Sunil/0000-0002-1124-5930	Government of India, University Grant Commission Grant [17-4/2001]; University Grant Commission, Government of India	Government of India, University Grant Commission Grant; University Grant Commission, Government of India(University Grants Commission, India)	This work was supported in part by Government of India, University Grant Commission Grant F. No 17-4/2001 (NS/PE), provided to the National Centre for Applied Human Genetics (NCAHG) for up to March 2012. This work was also supported by a meritorious science research fellowship from University Grant Commission, Government of India (to G. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Azoitei N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0490-2; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chu BB, 2015, MOL MED REP, V12, P4358, DOI 10.3892/mmr.2015.3943; Chu C, 2013, ACTA BIOCH BIOPH SIN, V45, P1079, DOI 10.1093/abbs/gmt112; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; COLOMBO G, 1975, J BIOL CHEM, V250, P9404; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dupuy F, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-18; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Inge LJ, 2009, J THORAC CARDIOV SUR, V137, P580, DOI 10.1016/j.jtcvs.2008.11.029; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Iqbal MA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-72; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13875; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Pal R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-303; Pal R, 2011, BREAST CANCER RES TR, V126, P333, DOI 10.1007/s10549-010-0900-5; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qin XD, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-20; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Sun H, 2015, INT J MOL SCI, V16, P24574, DOI 10.3390/ijms161024574; Walsh MJ, 2010, PROBE REPORTS NIH MO; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Whang YM, 2016, ONCOGENE, V35, P856, DOI 10.1038/onc.2015.140; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang M, 2017, J BIOL CHEM, V292, P7888, DOI 10.1074/jbc.M117.779447	58	40	42	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15561	15576		10.1074/jbc.M117.791343	http://dx.doi.org/10.1074/jbc.M117.791343			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28778925	hybrid, Green Published			2022-12-28	WOS:000410809800034
J	Yang, Q; Zhang, RS; Cai, H; Wang, LX				Yang, Qiang; Zhang, Roushu; Cai, Hui; Wang, Lai-Xi			Revisiting the substrate specificity of mammalian alpha 1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking alpha 1,3-arm GlcNAc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-TYPE OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEIN-SYNTHESIS; L-FUCOSE; CELLS; IDENTIFICATION; GLYCOSYLATION; TRANSFERASES; PURIFICATION; RECOGNITION	The mammalian alpha 1,6-fucosyltransferase (FUT8) catalyzes the core fucosylation of N-glycans in the biosynthesis of glycoproteins. Previously, intensive in vitro studies with crude extract or purified enzyme concluded that the attachment of a GlcNAc on the alpha 1,3 mannose arm of N-glycan is essential for FUT8-catalyzed core fucosylation. In contrast, we have recently shown that expression of erythropoietin in a GnTI knock-out, FUT8-overexpressing cell line results in the production of fully core-fucosylated glycoforms of the oligomannose substrate Man(5)GlcNAc(2), suggesting that FUT8 can catalyze core fucosylation of N-glycans lacking an alpha 1,3-arm GlcNAc in cells. Here, we revisited the substrate specificity of FUT8 by examining its in vitro activity toward an array of selected N-glycans, glycopeptides, and glycoproteins. Consistent with previous studies, we found that free N-glycans lacking an unmasked alpha 1,3-arm GlcNAc moiety are not FUT8 substrates. However, Man(5)GlcNAc(2) glycan could be efficiently core-fucosylated by FUT8 in an appropriate protein/peptide context, such as with the erythropoietin protein, a V3 polypeptide derived from HIV-1 gp120, or a simple 9-fluorenylmethyl chloroformate-protected Asn moiety. Interestingly, when placed in the V3 polypeptide context, a mature bi-antennary complex-type N-glycan also could be core-fucosylated by FUT8, albeit at much lower efficiency than the Man(5)GlcNAc(2) peptide. This study represents the first report of in vitro FUT8-catalyzed core fucosylation of N-glycans lacking the alpha 1,3-arm GlcNAc moiety. Our results suggest that an appropriate polypeptide context or other adequate structural elements in the acceptor substrate could facilitate the core fucosylation by FUT8.	[Yang, Qiang; Zhang, Roushu; Cai, Hui; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr, College Pk, MD 20742 USA.	wang518@umd.edu	Wang, Lai-Xi/E-8755-2019; ZHANG, ROUSHU/GYR-1974-2022; Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021; wang, xiao/HGB-7081-2022; Wang, Xin/GYU-1129-2022	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; wang, xiao/0000-0002-4088-3341; 	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM080374. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; BOSMANN HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P470, DOI 10.1016/0003-9861(68)90053-2; Calderon AD, 2016, ORG BIOMOL CHEM, V14, P4027, DOI 10.1039/c6ob00586a; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kaminska J, 1998, GLYCOCONJUGATE J, V15, P783, DOI 10.1023/A:1006959915435; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Mimura Y, 2018, PROTEIN CELL, V9, P47, DOI 10.1007/s13238-017-0433-3; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Saribas AS, 2007, BIOCHEM BIOPH RES CO, V362, P381, DOI 10.1016/j.bbrc.2007.07.199; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Serna S, 2011, J AM CHEM SOC, V133, P16495, DOI 10.1021/ja205392z; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; Snovida SI, 2008, J AM SOC MASS SPECTR, V19, P1138, DOI 10.1016/j.jasms.2008.04.033; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Yang Q, 2016, J BIOL CHEM, V291, P11064, DOI 10.1074/jbc.M116.720789; Yang Q, 2010, BIOCONJUGATE CHEM, V21, P875, DOI 10.1021/bc9004238; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	28	30	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14796	14803		10.1074/jbc.M117.804070	http://dx.doi.org/10.1074/jbc.M117.804070			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729420	Green Published, hybrid			2022-12-28	WOS:000409902100008
J	Guo, XH; Li, TT; Xu, Y; Xu, XY; Zhu, ZY; Zhang, Y; Xu, JQ; Xu, KH; Cheng, HQ; Zhang, X; Ke, YH				Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Xu, Kaihong; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai			Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; Akt PKB; macrophage; pulmonary fibrosis; STAT transcription factor; AKT signaling; Gabs; M2 polarization; STAT6 signaling	ALTERNATIVELY ACTIVATED MACROPHAGES; GROWTH-FACTOR; LUNG FIBROSIS; IN-VIVO; DOCKING PROTEIN; TISSUE-REPAIR; MOUSE LUNG; POLARIZATION; PATHWAY; CELLS	M2-polarized macrophages, also known as alternatively activated macrophages, have long been associated with pulmonary fibrosis; however, the mechanism has not been fully defined. Gab1 and Gab2 proteins belong to the Gab family of adaptors and are integral components of the signal specificity in response to various extracellular stimuli. In this report, we found that levels of both Gab1 and Gab2 were elevated in M2-polarized macrophages isolated from bleomycin-induced fibrotic lungs. In vitro Gab1/2 deficiency in bone marrow-derived macrophages abrogated IL-4-mediated M2 polarization. Furthermore, in vivo conditional removal of Gab1 (Gab1(MyKO)) and germ line knock-out of Gab2 (Gab2(-/-)) in macrophages prevented a bias toward the M2 phenotype and attenuated bleomycin-induced fibrotic lung remodeling. In support of these observations, Gab1/2 were involved in responses predominated by IL-4 signaling, an essential determinant for macrophage M2 polarization. Further investigation revealed that both Gab1 and -2 are recruited to the IL-4 receptor, synergistically enhancing downstream signal amplification but conferring IL-4 signal preference. Mechanistically, the loss of Gab1 attenuated AKT activation, whereas the absence of Gab2 suppressed STAT6 activation in response to IL-4 stimulation, both of which are commonly attributed to M2-driven pulmonary fibrosis in mice. Taken together, these observations define a non-redundant role of Gab docking proteins in M2 polarization, adding critical insights into the pathogenesis of idiopathic pulmonary fibrosis.	[Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Xiaohong; Li, Tingting; Xu, Yun; Xu, Xiayan; Zhu, Zhengyi; Zhang, Yun; Xu, Jiaqi; Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Zhejiang Univ, Program Mol Cell Biol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Cheng, Hongqiang; Zhang, Xue; Ke, Yuehai] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Kaihong] Zhejiang Univ, Womens Hosp, Dept Gynecol, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zhang, X; Ke, YH (corresponding author), Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X; Ke, YH (corresponding author), Zhejiang Univ, Program Mol Cell Biol, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhangxue@zju.edu.cn; yke@zju.edu.cn			Key Project of the National Natural Science Foundation of China [81530001]; Chinese Ministry of Science and Technology [2016YFA0501800]; National Natural Science Foundation of China [81671426]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project of the National Natural Science Foundation of China Grant 81530001 (to Y.K.), Chinese Ministry of Science and Technology Grant 2016YFA0501800 (to Y.K.), and National Natural Science Foundation of China Grant 81671426 (to K.X.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Ballinger MN, 2015, J IMMUNOL, V194, P1894, DOI 10.4049/jimmunol.1402377; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Gangadharan B, 2008, J LEUKOCYTE BIOL, V84, P50, DOI 10.1189/jlb.0507270; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Liu J., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.EJMECH.2013.11.036; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schutzman JL, 2001, MOL CELL BIOL, V21, P8104, DOI 10.1128/MCB.21.23.8104-8116.2001; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yao YY, 2016, MOL THER, V24, P915, DOI 10.1038/mt.2016.36; Zhang X, 2012, FASEB J, V26, P4603, DOI 10.1096/fj.12-211755; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207	71	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14003	14015		10.1074/jbc.M117.802066	http://dx.doi.org/10.1074/jbc.M117.802066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28687632	Green Published, hybrid			2022-12-28	WOS:000408439800009
J	Lu, YY; Hao, BX; Graeff, R; Wong, CWM; Wu, WT; Yue, JB				Lu, Ying-Ying; Hao, Bai-Xia; Graeff, Richard; Wong, Connie W. M.; Wu, Wu-Tian; Yue, Jianbo			RETRACTION: Two pore channel 2 (TPC2) inhibits autophagosomallysosomal fusion by alkalinizing lysosomal pH (vol 288, pg 24247, 2013) (Retraction of Vol 288, Pg 24247, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Yue, Jianbo/AAC-4588-2019					Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253	1	2	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12088	12088		10.1074/jbc.A113.484253	http://dx.doi.org/10.1074/jbc.A113.484253			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28733483	Green Published, hybrid			2022-12-28	WOS:000406053300008
J	Harper, TM; Taatjes, DJ				Harper, Thomas M.; Taatjes, Dylan J.			The complex structure and function of Mediator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cryo-electron microscopy; gene expression; protein structure; transcription; X-ray crystallography; CDK8 module; Mediator; RNA polymerase II; cross-linking mass spectrometry	RNA-POLYMERASE-II; TRANSCRIPTION INITIATION COMPLEX; TERMINAL REPEAT DOMAIN; HUMAN CDK8 SUBCOMPLEX; MAMMALIAN MEDIATOR; PROMOTER DNA; HEAD MODULE; KINASE MODULE; IN-VIVO; ARCHITECTURE	In eukaryotes, RNA polymerase II (pol II) transcribes all protein-coding genes and many noncoding RNAs. Whereas many factors contribute to the regulation of pol II activity, the Mediator complex is required for expression of most, if not all, pol II transcripts. Structural characterization of Mediator is challenging due to its large size (approximate to 20 subunits in yeast and 26 subunits in humans) and conformational flexibility. However, recent studies have revealed structural details at higher resolution. Here, we summarize recent findings and place in context with previous results, highlighting regions within Mediator that are important for regulating its structure and function.	[Harper, Thomas M.; Taatjes, Dylan J.] Univ Colorado, Dept Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Taatjes, DJ (corresponding author), Univ Colorado, Dept Biochem, Boulder, CO 80303 USA.	taatjes@colorado.edu			National Institutes of Health from the NCI [GM117370, CA170741]; National Science Foundation [MCB-1244175]; NATIONAL CANCER INSTITUTE [R01CA170741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117370] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM117370 and CA170741 from the NCI and National Science Foundation Grant MCB-1244175. This is the first article in the Thematic Minireview series "Chromatin and Transcription." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bernecky C, 2012, J MOL BIOL, V417, P387, DOI 10.1016/j.jmb.2012.02.014; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Callaway E, 2015, NATURE, V525, P172, DOI 10.1038/525172a; Cantin GT, 2003, P NATL ACAD SCI USA, V100, P12003, DOI 10.1073/pnas.2035253100; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Clarke PA, 2016, ELIFE, V5, DOI 10.7554/eLife.20722; Dale T, 2015, NAT CHEM BIOL, V11, P973, DOI 10.1038/nchembio.1952; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Fan HY, 1996, GENETICS, V142, P749; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Hantsche M, 2017, CURR OPIN STRUC BIOL, V47, P17, DOI 10.1016/j.sbi.2017.03.013; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Jeronimo C, 2016, MOL CELL, V64, P455, DOI 10.1016/j.molcel.2016.09.002; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Malik S, 2017, J MOL BIOL, V429, P48, DOI 10.1016/j.jmb.2016.11.026; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Nishikawa JL, 2016, NATURE, V530, P485, DOI 10.1038/nature16963; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Petrenko N, 2016, MOL CELL, V64, P443, DOI 10.1016/j.molcel.2016.09.015; Phillips AJ, 2013, ISR J CHEM, V53, P588, DOI 10.1002/ijch.201300039; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Plaschka C, 2016, J MOL BIOL, V428, P2569, DOI 10.1016/j.jmb.2016.01.028; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sato S, 2016, J BIOL CHEM, V291, P26886, DOI 10.1074/jbc.M116.756098; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Schneider M, 2015, CELL, V162, P1016, DOI 10.1016/j.cell.2015.07.059; Sennett NC, 2014, CELL RES, V24, P775, DOI 10.1038/cr.2014.76; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; Velazquez-Muriel J, 2012, P NATL ACAD SCI USA, V109, P18821, DOI 10.1073/pnas.1216549109; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64	77	48	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13778	13785		10.1074/jbc.R117.794438	http://dx.doi.org/10.1074/jbc.R117.794438			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	28912271	hybrid, Green Published			2022-12-28	WOS:000444070700003
J	Niesen, MJM; Marshall, SS; Miller, TF; Clemons, WM				Niesen, Michiel J. M.; Marshall, Stephen S.; Miller, Thomas F., III; Clemons, William M., Jr.			Improving membrane protein expression by optimizing integration efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flow cytometry; membrane protein; molecular dynamics; protein expression; protein translocation; Sec translocon; TatC; topogenesis	TOPOLOGY; SEQUENCE; OVEREXPRESSION; INSERTION; DESIGN; TRANSLOCATION; RECOGNITION; PREDICTION; STABILITY; INDICATOR	The heterologous overexpression of integral membrane proteins in Escherichia coli often yields insufficient quantities of purifiable protein for applications of interest. The current study leverages a recently demonstrated link between co-translational membrane integration efficiency and protein expression levels to predict protein sequence modifications that improve expression. Membrane integration efficiencies, obtained using a coarse-grained simulation approach, robustly predicted effects on expression of the integral membrane protein TatC for a set of 140 sequence modifications, including loop-swap chimeras and single-residue mutations distributed throughout the protein sequence. Mutations that improve simulated integration efficiency were 4-fold enriched with respect to improved experimentally observed expression levels. Furthermore, the effects of double mutations on both simulated integration efficiency and experimentally observed expression levels were cumulative and largely independent, suggesting that multiple mutations can be introduced to yield higher levels of purifiable protein. This work provides a foundation for a general method for the rational overexpression of integral membrane proteins based on computationally simulated membrane integration efficiencies.	[Niesen, Michiel J. M.; Marshall, Stephen S.; Miller, Thomas F., III; Clemons, William M., Jr.] CALTECH, Dept Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Miller, TF; Clemons, WM (corresponding author), CALTECH, Dept Chem & Chem Engn, Pasadena, CA 91125 USA.	tfm@caltech.edu; clemons@caltech.edu	Clemons, William M/D-1026-2009; Niesen, Michiel/AAF-6824-2020	Clemons, William M/0000-0002-0021-889X; 	NIGMS, National Institutes of Health [1R01GM125063]; National Institutes of Health Pioneer Award [5DP1GM105385]; Caltech's Center for Environmental Microbial Interactions; NRSA, National Institutes of Health [5T32GM07616]; Office of Naval Research [N00014-10-1-0884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125063, T32GM007616, DP1GM105385] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech's Center for Environmental Microbial Interactions; NRSA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant 1R01GM125063 (to T. F. M. and W. M. C.). Work in the Clemons laboratory was supported by National Institutes of Health Pioneer Award 5DP1GM105385 (to W. M. C.), funds from Caltech's Center for Environmental Microbial Interactions, and NRSA, National Institutes of Health, Training Grant 5T32GM07616 (to S. S. M.). Work in the Miller group is supported in part by Office of Naval Research Grant N00014-10-1-0884. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fluman N, 2017, P NATL ACAD SCI USA, V114, P7987, DOI 10.1073/pnas.1706905114; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Hanke F, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/53001; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Lundstrom K, 2006, CELL MOL LIFE SCI, V63, P2597, DOI 10.1007/s00018-006-6252-y; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marshall SS, 2016, CELL REP, V16, P2169, DOI 10.1016/j.celrep.2016.07.042; Niesen MJM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005427; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Saladi S. M., 2017, BIORXIV, DOI [10.1101/098673, DOI 10.1101/098673]; Saraogi I, 2014, BBA-MOL CELL RES, V1843, P1433, DOI 10.1016/j.bbamcr.2013.10.013; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DJ, 2013, CURR OPIN CHEM BIOL, V17, P427, DOI 10.1016/j.cbpa.2013.04.002; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Staple DB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248301; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Tress ML, 2010, PROTEINS, V78, P1980, DOI 10.1002/prot.22714; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Woodall NB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9099; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zhang B, 2012, J AM CHEM SOC, V134, P13700, DOI 10.1021/ja3034526; Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107	55	10	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19537	19545		10.1074/jbc.M117.813469	http://dx.doi.org/10.1074/jbc.M117.813469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28918393	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000416226700031
J	Sato-Matsubara, M; Matsubara, T; Daikoku, A; Okina, Y; Longato, L; Rombouts, K; Thuy, LTT; Adachi, J; Tomonaga, T; Ikeda, K; Yoshizato, K; Pinzani, M; Kawada, N				Sato-Matsubara, Misako; Matsubara, Tsutomu; Daikoku, Atsuko; Okina, Yoshinori; Longato, Lisa; Rombouts, Krista; Le Thi Thanh Thuy; Adachi, Jun; Tomonaga, Takeshi; Ikeda, Kazuo; Yoshizato, Katsutoshi; Pinzani, Massimo; Kawada, Norifumi			Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); fibroblast growth factor (FGF); fibrosis; hepatic stellate cell (HSC); liver; cytoglobin	FAT-STORING CELLS; LIVER FIBROSIS; OXIDATIVE STRESS; RAT; FIBROGENESIS; KINASE; PHOSPHORYLATION; PROLIFERATION; TRANSCRIPTION; MECHANISMS	Cytoglobin (CYGB) belongs to the mammalian globin family and is exclusively expressed in hepatic stellate cells (HSCs) in the liver. In addition to its gas-binding ability, CYGB is relevant to hepatic inflammation, fibrosis, and cancer because of its anti-oxidative properties; however, the regulation of CYGB gene expression remains unknown. Here, we sought to identify factors that induce CYGB expression in HSCs and to clarify the molecular mechanism involved. We used the human HSC cell line HHSteC and primary human HSCs isolated from intact human liver tissues. In HHSteC cells, treatment with a culture supplement solution that included fibroblast growth factor 2 (FGF2) increased CYGB expression with concomitant and time-dependent -smooth muscle actin (SMA) down-regulation. We found that FGF2 is a key factor in inducing the alteration in both CYGB and SMA expression in HHSteCs and primary HSCs and that FGF2 triggered the rapid phosphorylation of both c-Jun N-terminal kinase (JNK) and c-JUN. Both the JNK inhibitor PS600125 and transfection of c-JUN-targeting siRNA abrogated FGF2-mediated CYGB induction, and conversely, c-JUN overexpression induced CYGB and reduced SMA expression. Chromatin immunoprecipitation analyses revealed that upon FGF2 stimulation, phospho-c-JUN bound to its consensus motif (5-TGA(C/G)TCA), located -218 to -222 bases from the transcription initiation site in the CYGB promoter. Of note, in bile duct-ligated mice, FGF2 administration ameliorated liver fibrosis and significantly reduced HSC activation. In conclusion, FGF2 triggers CYGB gene expression and deactivation of myofibroblastic human HSCs, indicating that FGF2 has therapeutic potential for managing liver fibrosis.	[Sato-Matsubara, Misako; Daikoku, Atsuko; Okina, Yoshinori; Le Thi Thanh Thuy; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Sato-Matsubara, Misako; Yoshizato, Katsutoshi] Osaka City Univ, Grad Sch Med, Endowed Lab Synthet Biol, Osaka 5458585, Japan; [Matsubara, Tsutomu; Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 5458585, Japan; [Longato, Lisa; Rombouts, Krista; Pinzani, Massimo] UCL, Inst Liver & Digest Hlth, Regenerat Med & Fibrosis Grp, Royal Free, London NW3 2PF, England; [Adachi, Jun; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Proteome Res Ctr, Lab Proteome Res, Osaka 5670085, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; University of London; University College London; Royal Free London NHS Foundation Trust; National Institute of Health Sciences - Japan	Kawada, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan.	kawadanori@med.osaka-cu.ac.jp	kawada, norifumi/AAS-1367-2020; Adachi, Jun/H-2813-2014; Thuy, Le Thi Thanh/GLS-7476-2022; Rombouts, Krista/ABB-2602-2020; Rombouts, Krista/AAE-8179-2020	Adachi, Jun/0000-0003-1220-3246; Rombouts, Krista/0000-0001-9440-0571; Thuy, Le Thi Thanh/0000-0003-4460-735X	Japan Society for the Promotion of Science KAKENHI [15K08314]; Japan Society for the Promotion of Science [25293177, 16H05290]; Japan Agency for Medical Research and Development	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant-in-aid for Scientific Research (C) 15K08314. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Grants-in-aid for Scientific Research 25293177 and 16H05290 from Japan Society for the Promotion of Science and a Grant for Research Program on Hepatitis from the Japan Agency for Medical Research and Development. To whom correspondence should be addressed: Dept. of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, 545-8585, Japan. Tel.: 81-6-6645-3897; Fax: 81-6-6646-6072; E-mail: kawadanori@med.osaka-cu.ac.jp.	Ahmad A, 2012, SAUDI J GASTROENTERO, V18, P155, DOI 10.4103/1319-3767.96445; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Das A, 2010, AM J PHYSIOL-GASTR L, V298, pG908, DOI 10.1152/ajpgi.00510.2009; de Andrade KQ, 2015, INT J MOL SCI, V16, P30269, DOI 10.3390/ijms161226225; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; El Taghdouini A, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0031-z; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Gandhi C. R., 2015, STELLATE CELLS HLTH; Gursel DB, 2011, NEURO-ONCOLOGY, V13, P610, DOI 10.1093/neuonc/nor035; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; He X, 2011, PROTEIN J, V30, P437, DOI 10.1007/s10930-011-9340-2; Heier CR, 2009, HUM MOL GENET, V18, P1310, DOI 10.1093/hmg/ddp030; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kawada N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00329; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Thuy LTT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24990; Thuy LTT, 2015, AM J PATHOL, V185, P1045, DOI 10.1016/j.ajpath.2014.12.017; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep23508; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Nakatani K, 2002, VIRCHOWS ARCH, V441, P466, DOI 10.1007/s00428-002-0631-z; Pan RL, 2015, HEPATOLOGY, V61, P1708, DOI 10.1002/hep.27649; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Rombouts K, 2016, METHODS MOL BIOL, V1376, P203, DOI 10.1007/978-1-4939-3170-5_17; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuppan D, 2012, J HEPATOL, V56, pS66, DOI 10.1016/S0168-8278(12)60008-7; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Thuy TTV, 2017, SCI REP-UK, V7, DOI 10.1038/srep41888; Wake K, 1980, Int Rev Cytol, V66, P303; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; Welsh JA, 2013, J PEDIATR-US, V162, P496, DOI 10.1016/j.jpeds.2012.08.043; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5	55	21	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18961	18972		10.1074/jbc.M117.793794	http://dx.doi.org/10.1074/jbc.M117.793794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28916723	Green Published, hybrid			2022-12-28	WOS:000415848000020
J	Dirice, E; Ng, RWS; Martinez, R; Hu, J; Wagner, FF; Holson, EB; Wagner, BK; Kulkarni, RN				Dirice, Ercument; Ng, Raymond W. S.; Martinez, Rachael; Hu, Jiang; Wagner, Florence F.; Holson, Edward B.; Wagner, Bridget K.; Kulkarni, Rohit N.			Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROGRAM; BETA-CELL PROLIFERATION; T-CELLS; IN-VITRO; CANCER; TISSUE; MACROPHAGES; CYTOKINES; VIVO	Preservation of insulin-secreting beta-cells is an important goal for therapies aimed at restoring normoglycemia in patients with diabetes. One approach, the inhibition of histone deacetylases (HDACs), has been reported to suppress pancreatic islet inflammation and beta-cell apoptosis in vitro. In this report, we demonstrate the efficacy of HDAC inhibitors (HDACi) in vivo. We show that daily administration of BRD3308, an isoform-selective HDAC3 inhibitor, for 2 weeks to female nonobese diabetic (NOD) mice, beginning at 3 weeks of age, followed by twice-weekly injections until age 25 weeks, protects the animals from diabetes. The preservation of beta-cells was because of a significant decrease in islet infiltration of mononuclear cells. Moreover, the BRD3308 treatment increased basal insulin secretion from islets cultured in vitro. All metabolic tissues tested in vehicle- or BRD3308-treated groups showed virtually no sign of immune cell infiltration, except minimal infiltration in white adipose tissue in animals treated with the highest BRD3308 dose (10 mg/kg), providing additional evidence of protection from immune attack in the treated groups. Furthermore, pancreata from animals treated with 10 mg/kg BRD3308 exhibited significantly decreased numbers of apoptotic beta-cells compared with those treated with vehicle or low-dose BRD3308. Finally, animals treated with 1 or 10 mg/kg BRD3308 had enhanced beta-cell proliferation. These in vivo results point to the potential use of selective HDAC3 inhibitors as a therapeutic approach to suppress pancreatic islet infiltration and prevent beta-cell death with the long-term goal of limiting the progression of type 1 diabetes.	[Dirice, Ercument; Ng, Raymond W. S.; Martinez, Rachael; Hu, Jiang; Kulkarni, Rohit N.] Joslin Diabet Ctr, Dept Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Wagner, Florence F.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Holson, Edward B.; Wagner, Bridget K.] Broad Inst Harvard & MIT, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Kulkarni, Rohit N.] Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University	Wagner, BK (corresponding author), Broad Inst, Ctr Sci Therapeut, 415 Main St, Cambridge, MA 02142 USA.; Kulkarni, RN (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	bwagner@broadinstitute.org; Kulkarni@joslin.harvard.edu		Dirice, Ercument/0000-0003-2792-7204	Juvenile Diabetes Research Foundation (JDRF) [17-2013-437]; Senior JDRF Fellowship [JDRF-3-APF-2014-220-A-N]; National Institutes of Health [RO1 DK67536, RO1 DK103215]; Stanley Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, P30DK036836, R01DK103215] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Senior JDRF Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Juvenile Diabetes Research Foundation (JDRF) Grant 17-2013-437 (to B. K. W. and R. N. K.) and Senior JDRF Fellowship JDRF-3-APF-2014-220-A-N (to E. D.). This work was also supported in part by National Institutes of Health Grants RO1 DK67536 and RO1 DK103215 (to R. N. K.). Support was also provided by the Stanley Medical Research Institute (E. B. H. and F. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chou DHC, 2012, CHEM BIOL, V19, P669, DOI 10.1016/j.chembiol.2012.05.010; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Grant CW, 2012, COMPARATIVE MED, V62, P381; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hsu FC, 2015, J IMMUNOL, V195, P1578, DOI 10.4049/jimmunol.1500435; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Krusche CA, 2005, BREAST CANCER RES TR, V90, P15, DOI 10.1007/s10549-004-1668-2; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152; Lundh M, 2015, DIABETES OBES METAB, V17, P703, DOI 10.1111/dom.12470; Makino S, 1980, Jikken Dobutsu, V29, P1; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Minamiya Y, 2011, LUNG CANCER, V74, P300, DOI 10.1016/j.lungcan.2011.02.019; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Ozdag H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-90; Patel T, 2011, IMMUNOL CELL BIOL, V89, P640, DOI 10.1038/icb.2010.144; Philips RL, 2016, J IMMUNOL, V197, P541, DOI 10.4049/jimmunol.1502529; Reilly CM, 2008, J AUTOIMMUN, V31, P123, DOI 10.1016/j.jaut.2008.04.020; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Thapa P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2580; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Wagner FF, 2016, ACS CHEM BIOL, V11, P363, DOI 10.1021/acschembio.5b00640; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738	33	27	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17598	17608		10.1074/jbc.M117.804328	http://dx.doi.org/10.1074/jbc.M117.804328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28860191	Green Published, hybrid			2022-12-28	WOS:000414013000003
J	Bhat, S; Hasenhuetl, PS; Kasture, A; El-Kasaby, A; Baumann, MH; Blough, BE; Sucic, S; Sandtner, W; Freissmuth, M				Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Baumann, Michael H.; Blough, Bruce E.; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael			Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENIC-AMINE TRANSPORTERS; DOPAMINE TRANSPORTER; PHARMACOLOGICAL CHAPERONES; CEREBRAL-CORTEX; BINDING; MUTATIONS; CYCLE; AMPHETAMINES; TERMINUS; IBOGAINE	Point mutations in SLC6 transporters cause misfolding, which can be remedied by pharmacochaperones. The serotonin transporter (SERT/SLC6A4) has a rich pharmacology including inhibitors, releasers (amphetamines, which promote the exchange mode), and more recently, discovered partial substrates. We hypothesized that partial substrates trapped the transporter in one or several states of the transport cycle. This conformational trapping may also be conducive to folding. We selected naphthylpropane-2-amines of the phenethylamine library (PAL) including the partial substrate PAL1045 and its congeners PAL287 and PAL1046. We analyzed their impact on the transport cycle of SERT by biochemical approaches and by electrophysiological recordings; substrate-induced peak currents and steady-state currents monitored the translocation of substrate and co-substrate Na+ across the lipid bilayer and the transport cycle, respectively. These experiments showed that PAL1045 and its congeners bound with different affinities (ranging from nM to mu M) to various conformational intermediates of SERT during the transport cycle. Consistent with the working hypothesis, PAL1045 was the most efficacious compound in restoring surface expression and transport activity to the folding-deficient mutant SERT-(601)PG(602)-AA. These experiments provide a proof-of-principle for a rational search for pharmacochaperones, which may be useful to restore function to clinically relevant folding-deficient transporter mutants.	[Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Bhat, Shreyas; Hasenhuetl, Peter S.; Kasture, Ameya; El-Kasaby, Ali; Sucic, Sonja; Sandtner, Walter; Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, A-1090 Vienna, Austria; [Baumann, Michael H.] NIDA, Translat Pharmacol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Blough, Bruce E.] Res Triangle Inst, Ctr Drug Discovery, Res Triangle Pk, NC 27709 USA	Medical University of Vienna; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Research Triangle Institute	Freissmuth, M (corresponding author), Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Hasenhuetl, Peter/AAG-6335-2019	Hasenhuetl, Peter/0000-0002-3121-9502; Freissmuth, Michael/0000-0001-9398-1765; Kasture, Ameya/0000-0002-2947-4803; Bhat, Shreyas/0000-0001-7019-9180; Baumann, Michael/0000-0001-7758-1470; Sucic, Sonja/0000-0001-5136-8022	National Institute on Drug Abuse [DA12970]; Austrian Science Fund/FWF Projects [P28090, P27518-B27]; doctoral program CCHD (Cell Communication in Health and Disease) [W1205]; Austrian Science Fund/FWF [W1205]; Medical University of Vienna;  [SFB35];  [F3510]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012970, ZIADA000522] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund/FWF Projects(Austrian Science Fund (FWF)); doctoral program CCHD (Cell Communication in Health and Disease); Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna; ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grant DA12970 (to B. E. B.). This work was also supported by the Austrian Science Fund/FWF Projects P28090 (to W. S.) and P27518-B27 (to S. S.) and Project Program Grant SFB35 (F3510 to M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the doctoral program CCHD (Cell Communication in Health and Disease/W1205), which was jointly funded by Grant W1205 from the Austrian Science Fund/FWF and the Medical University of Vienna. This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree.	Beerepoot P, 2016, J BIOL CHEM, V291, P22053, DOI 10.1074/jbc.M116.749119; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; DESCARRIES L, 1977, BRAIN RES, V133, P197, DOI 10.1016/0006-8993(77)90759-4; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kasture A, 2016, J BIOL CHEM, V291, P20876, DOI 10.1074/jbc.M116.737551; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Kuum M, 2015, CELL CALCIUM, V58, P79, DOI 10.1016/j.ceca.2014.11.004; LIDOV HGW, 1980, NEUROSCIENCE, V5, P207, DOI 10.1016/0306-4522(80)90099-8; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Rothman RB, 2012, J PHARMACOL EXP THER, V341, P251, DOI 10.1124/jpet.111.188946; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmid D, 2015, BRIT J PHARMACOL, V172, P4775, DOI 10.1111/bph.12766; Schmitt KC, 2008, J NEUROCHEM, V107, P928, DOI 10.1111/j.1471-4159.2008.05667.x; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sucic Sonja, 2016, J Neurol Neuromedicine, V1, P34; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154	34	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16773	16786		10.1074/jbc.M117.794081	http://dx.doi.org/10.1074/jbc.M117.794081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842491	hybrid, Green Published			2022-12-28	WOS:000412414800035
J	Jang, B; Jung, H; Choi, S; Lee, YH; Lee, ST; Oh, ES				Jang, Bohee; Jung, Hyejung; Choi, Sojoong; Lee, Young Hun; Lee, Seung-Taek; Oh, Eok-Soo			Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase C gamma-mediated FAK/ERK signaling pathway in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL-ADHESION KINASE; CELL-MIGRATION; GROWTH-FACTOR; CLEAVAGE SITES; PKC-ALPHA; PROTEOGLYCAN; MATRILYSIN; PHOSPHORYLATION; IDENTIFICATION; RECEPTORS	The syndecan family of heparan sulfate proteoglycans contributes to cell adhesion and communication by serving as co-receptors for cell signaling and extracellular matrix molecules. Syndecan-2 is located at the cell surface, and we previously reported that it induces matrix metalloproteinase-7 (MMP-7) expression in colon cancer cells. However, the underlying regulatory mechanisms are unknown. Here, we report that overexpression of syndecan-2 in HT-29 colon cancer cells increases the phosphorylation of focal adhesion kinase (FAK) and ERK in parallel with up-regulated MMP-7 expression, but a syndecan-2 mutant lacking the cytoplasmic domain showed significant reductions in these effects. Consistent with this observation, FAK inhibition via FAK-related non-kinase expression or inhibition of ERK with the ERK1/2 inhibitor SCH772984 diminished the syndecan-2-mediated up-regulation of MMP-7. Activation of PKC enhanced syndecan-2-mediated MMP-7 expression, whereas inhibition of PKC had the opposite effect. Of note, the exogenous expression of syndecan-2 triggered localization of PKC gamma to the membrane. Expression of syndecan-2 harboring a phosphomimetic (S198E) mutation of the variable region of the cytoplasmic domain enhanced MMP-7 expression and FAK phosphorylation. Finally, experimental suppression of shedding of the syndecan-2 extracellular domain did not significantly affect the syndecan-2-mediated up-regulation of MMP-7 in the early period after syndecan-2 overexpression. Taken together, these findings suggest that syndecan-2's cytoplasmic domain up-regulates MMP-7 expression in colon cancer cells via PKC gamma-mediated activation of FAK/ERK signaling.	[Jang, Bohee; Jung, Hyejung; Choi, Sojoong; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul 03760, South Korea; [Lee, Young Hun; Lee, Seung-Taek] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea	Ewha Womans University; Yonsei University	Oh, ES (corresponding author), Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul 03760, South Korea.	OhES@ewha.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014K1A3A7A03075056, 2016R1D1A1B03934873]; Seabury Foundation	National Research Foundation of Korea (NRF) - Korean government (MSIP); Seabury Foundation	This research was supported by National Research Foundation of Korea (NRF) Grants 2014K1A3A7A03075056 and 2016R1D1A1B03934873 funded by the Korean government (MSIP) and the Seabury Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2001, INT J CANCER, V95, P290, DOI 10.1002/1097-0215(20010920)95:5<290::AID-IJC1050>3.0.CO;2-I; Afratis NA, 2017, FEBS J, V284, P27, DOI 10.1111/febs.13940; Carey DJ, 1997, BIOCHEM J, V327, P1; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chen KY, 2013, J BIOL CHEM, V288, P13988, DOI 10.1074/jbc.M112.444737; Choi S, 2015, ONCOTARGET, V6, P3874, DOI 10.18632/oncotarget.2885; Choi S, 2012, BIOCHEM BIOPH RES CO, V417, P1260, DOI 10.1016/j.bbrc.2011.12.120; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hauck CR, 2001, CANCER RES, V61, P7079; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Jang B, 2016, BIOCHEM BIOPH RES CO, V477, P47, DOI 10.1016/j.bbrc.2016.06.019; Jo Y, 2000, BIOCHEM J, V345, P511, DOI 10.1042/bj3450511; Jung H, 2014, PIGM CELL MELANOMA R, V27, P387, DOI 10.1111/pcmr.12223; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Koo HM, 2002, MOL CELLS, V13, P118; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kwon MJ, 2012, FEBS LETT, V586, P2207, DOI 10.1016/j.febslet.2012.05.037; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; Masaki T, 2001, BRIT J CANCER, V84, P1317, DOI 10.1054/bjoc.2001.1790; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Orosco A, 2006, J CELL BIOCHEM, V98, P838, DOI 10.1002/jcb.20826; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Prasthofer T, 1995, BIOCHEM MOL BIOL INT, V36, P793; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Sengupta N, 2007, PHYSIOLOGY, V22, P401, DOI 10.1152/physiol.00027.2007; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2	51	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16321	16332		10.1074/jbc.M117.793752	http://dx.doi.org/10.1074/jbc.M117.793752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821612	Green Published, hybrid			2022-12-28	WOS:000412109400030
J	Landau, M				Landau, Meytal			Getting in charge of beta-synuclein fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ALPHA-SYNUCLEIN	The synuclein family has long been associated with Parkinson's disease and dementia. Although the self-assembly of alpha-synuclein (alpha S) into oligomers and amyloid fibrils is well established, the aggregation propensity of other members of the family and their role in disease is still under debate. Moriarty et al. now suggest that the pH switching that occurs between different cellular environments could control beta-synuclein (beta S) aggregation via altering its charge distribution, thus opening new possible roles for beta S in Parkinson's and other neurodegenerative diseases.	[Landau, Meytal] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel	Technion Israel Institute of Technology	Landau, M (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel.	mlandau@technion.ac.il	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation; Center of Excellence in Integrated Structural Cell Biology [1775/12]; Israel Science Foundation [560/16]	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Center of Excellence in Integrated Structural Cell Biology; Israel Science Foundation(Israel Science Foundation)	Supported by the I-CORE Program of the Planning and Budgeting Committee, the Israel Science Foundation, Center of Excellence in Integrated Structural Cell Biology Grant 1775/12, and Israel Science Foundation Grant 560/16. To whom correspondence should be addressed. E-mail: mlandau@technion.ac.il.	DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Moriarty GM, 2017, J BIOL CHEM, V292, P16368, DOI 10.1074/jbc.M117.780528; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Taschenberger G, 2013, ANN NEUROL, V74, P109, DOI 10.1002/ana.23905; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16380	16381		10.1074/jbc.H117.780528	http://dx.doi.org/10.1074/jbc.H117.780528			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28963338	Green Published, hybrid			2022-12-28	WOS:000412109400035
J	Su, CH; Tzagoloff, A				Su, Chen-Hsien; Tzagoloff, Alexander			Cox16 protein is physically associated with Cox1p assembly intermediates and with cytochrome oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; NUCLEAR GENE; MITOCHONDRIAL COX1P; YEAST; SUBUNIT; IDENTIFICATION; TRANSLATION; MATURATION	Mitochondrial cytochrome oxidase (COX) catalyzes the last step in the respiratory pathway. In the yeast Saccharomyces cerevisiae, this inner membrane complex is composed of 11 protein subunits. Expression of COX is assisted by some two dozen ancillary proteins that intercede at different stages of the assembly pathway. One such protein, Cox16p, encoded by COX16, was shown to be essential for the activity and assembly of COX. The function of Cox16p, however, has not been determined. We present evidence that Cox16p is present in Cox1p assembly intermediates and in COX. This is based on the finding that Cox16p, tagged with a dual polyhistidine and protein C tag, co-immunopurified with Cox1p assembly intermediates. The pulldown assays also indicated the presence of Cox16p in mature COX and in supercomplexes consisting of COX and the bc(1) complex. From the Western signal strengths, Cox16p appears to be substoichiometric with Cox1p and Cox4p, which could indicate that Cox16p is only present in a fraction of COX. In conclusion, our results indicate that Cox16p is a constituent of several Cox1p assembly intermediates and of COX.	[Su, Chen-Hsien; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Su, CH (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu			NIGMS National Institutes of Health [5R01GM111864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111864] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS National Institutes of Health Grant 5R01GM111864. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; COSTANZO MC, 1988, P NATL ACAD SCI USA, V85, P2677, DOI 10.1073/pnas.85.8.2677; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; GEORGENASCIMENTO C, 1981, J BIOL CHEM, V256, P9363; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMARCHE AEP, 1992, J BIOL CHEM, V267, P22473; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; MULERO JJ, 1993, GENETICS, V133, P509; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POWER SD, 1984, J BIOL CHEM, V259, P6564; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rigby K, 2008, J BIOL CHEM, V283, P15015, DOI 10.1074/jbc.M710072200; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WU M, 1989, J BIOL CHEM, V264, P11122	39	10	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16277	16283		10.1074/jbc.M117.801811	http://dx.doi.org/10.1074/jbc.M117.801811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821616	hybrid, Green Published			2022-12-28	WOS:000412109400026
J	Yao, XQ; Cato, MC; Labudde, E; Beyett, TS; Tesmer, JJG; Grant, BJ				Yao, Xin-Qiu; Cato, M. Claire; Labudde, Emily; Beyett, Tyler S.; Tesmer, John J. G.; Grant, Barry J.			Navigating the conformational landscape of G protein-coupled receptor kinases during allosteric activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INSIGHTS; MOLECULAR-DYNAMICS; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; TERMINAL TAIL; DOMAIN; COMPLEX; DESENSITIZATION; PARAMETERS; RHODOPSIN	G protein-coupled receptors (GPCRs) are essential for transferring extracellular signals into carefully choreographed intracellular responses controlling diverse aspects of cell physiology. The duration of GPCR-mediated signaling is primarily regulated via GPCR kinase (GRK)-mediated phosphorylation of activated receptors. Although many GRK structures have been reported, the mechanisms underlying GRK activation are not well-understood, in part because it is unknown how these structures map to the conformational landscape available to this enzyme family. Unlike most other AGC kinases, GRKs rely on their interaction with GPCRs for activation and not phosphorylation. Here, we used principal component analysis of available GRK and protein kinase A crystal structures to identify their dominant domain motions and to provide a framework that helps evaluate how close each GRK structure is to being a catalytically competent state. Our results indicated that disruption of an interface formed between the large lobe of the kinase domain and the regulator of G protein signaling homology domain (RHD) is highly correlated with establishment of the active conformation. By introducing point mutations in the GRK5 RHD-kinase domain interface, we show with both in silico and in vitro experiments that perturbation of this interface leads to higher phosphorylation activity. Navigation of the conformational landscape defined by this bioinformatics-based study is likely common to all GPCR-activated GRKs.	[Yao, Xin-Qiu] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Cato, M. Claire; Tesmer, John J. G.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Cato, M. Claire; Labudde, Emily; Beyett, Tyler S.; Tesmer, John J. G.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Beyett, Tyler S.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Grant, Barry J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Tesmer, JJG (corresponding author), Univ Michigan, Life Sci Inst, Med Sch, Dept Pharmacol, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.; Tesmer, JJG (corresponding author), Univ Michigan, Life Sci Inst, Med Sch, Dept Biol Chem, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.; Grant, BJ (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tesmerjj@umich.edu; bjgrant@ucsd.edu	Yao, Xinqiu/D-3220-2011	Yao, Xinqiu/0000-0003-2706-2028; Tesmer, John/0000-0003-1125-3727; Grant, Barry/0000-0002-2215-4196	National Institutes of Health [2R01GM070862-10A1, R01DK100319, R01HL122416, R01HL071818]; University of Michigan Chemistry-Biology Interface training program through National Institutes of Health [5T32GM008597]; National Institutes of Health Pharmacological Sciences Training Program Fellowship [T32-GM007767]; United States Department of Education Graduate Assistance in Areas of National Need Fellowship [P200A150164]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL122416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, T32GM007767, R01GM070862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Chemistry-Biology Interface training program through National Institutes of Health; National Institutes of Health Pharmacological Sciences Training Program Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Education Graduate Assistance in Areas of National Need Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 2R01GM070862-10A1 (to B. J. G.), the University of Michigan Chemistry-Biology Interface training program through National Institutes of Health Grant 5T32GM008597 (to M. C. C.), National Institutes of Health Pharmacological Sciences Training Program Fellowship T32-GM007767 and a United States Department of Education Graduate Assistance in Areas of National Need Fellowship P200A150164 (to T. S. B.), and National Institutes of Health Grants R01DK100319, R01HL122416, and R01HL071818 (to J. J. G. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Case DA, 2012, AMBER 12; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; GERSTEIN M, 1995, J MOL BIOL, V251, P161, DOI 10.1006/jmbi.1995.0423; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He YZ, 2017, CELL RES, V27, P728, DOI 10.1038/cr.2017.72; Homan KT, 2015, J BIOL CHEM, V290, P20649, DOI 10.1074/jbc.M115.647370; Homan KT, 2014, CURR OPIN CELL BIOL, V27, P25, DOI 10.1016/j.ceb.2013.10.009; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Komolov KE, 2017, CELL, V169, P407, DOI 10.1016/j.cell.2017.03.047; Komolov KE, 2015, J BIOL CHEM, V290, P20629, DOI 10.1074/jbc.M115.647297; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Orban T, 2012, BIOCHEMISTRY-US, V51, P3404, DOI 10.1021/bi300295y; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Shukla AK, 2014, TRENDS BIOCHEM SCI, V39, P594, DOI 10.1016/j.tibs.2014.10.001; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Sterne-Marr R, 2009, BIOCHEMISTRY-US, V48, P4285, DOI 10.1021/bi900151g; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; vanAalten DMF, 1997, BIOPHYS J, V73, P2891, DOI 10.1016/S0006-3495(97)78317-6; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	48	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16032	16043		10.1074/jbc.M117.807461	http://dx.doi.org/10.1074/jbc.M117.807461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28808053	Green Published, hybrid			2022-12-28	WOS:000412109400005
J	Demasi, M; Cleland, LG; Cook-Johnson, RJ; Caughey, GE; James, MJ				Demasi, Maryanne; Cleland, Leslie G.; Cook-Johnson, Rebecca J.; Caughey, Gillian E.; James, Michael J.			Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis (Expression of Concern of Vol 278, Pg 38607, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Demasi M, 2003, J BIOL CHEM, V278, P38607, DOI 10.1074/jbc.M305944200	1	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15993	15993		10.1074/jbc.A117.305944	http://dx.doi.org/10.1074/jbc.A117.305944			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939754	hybrid, Green Published			2022-12-28	WOS:000411512200037
J	Hino, T; Hamamoto, H; Suzuki, H; Yagi, H; Ohshiro, T; Nagano, S				Hino, Tomoya; Hamamoto, Haruka; Suzuki, Hirokazu; Yagi, Hisashi; Ohshiro, Takashi; Nagano, Shingo			Crystal structures of TdsC, a dibenzothiophene monooxygenase from the thermophile Paenibacillus sp A11-2, reveal potential for expanding its substrate selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-DEPENDENT MONOOXYGENASE; DESULFURIZING ENZYMES; HYDROXYBENZOATE HYDROXYLASE; SULFONE MONOOXYGENASE; OXYGENASE COMPONENT; DBT DESULFURIZATION; FUNCTIONAL-ANALYSIS; PURIFICATION; DSZC; C4A-HYDROPEROXYFLAVIN	Sulfur compounds in fossil fuels are a major source of environmental pollution, and microbial desulfurization has emerged as a promising technology for removing sulfur under mild conditions. The enzyme TdsC from the thermophile Paenibacillus sp. A11-2 is a two-component flavin-dependent monooxygenase that catalyzes the oxygenation of dibenzothiophene (DBT) to its sulfoxide (DBTO) and sulfone (DBTO2) during microbial desulfurization. The crystal structures of the apo and flavin mononucleotide (FMN)-bound forms of DszC, an ortholog of TdsC, were previously determined, although the structure of the ternary substrate-FMN-enzyme complex remains unknown. Herein, we report the crystal structures of the DBT-FMN-TdsC and DBTO-FMN-TdsC complexes. These ternary structures revealed many hydrophobic and hydrogen-bonding interactions with the substrate, and the position of the substrate could reasonably explain the two-step oxygenation of DBT by TdsC. Wealso determined the crystal structure of the indole-bound enzyme because TdsC, but not DszC, can also oxidize indole, and we observed that indole binding did not induce global conformational changes in TdsC with or without bound FMN. We also found that the two loop regions close to the FMN-binding site are disordered in apo-TdsC and become structured upon FMN binding. Alanine substitutions of Tyr-93 and His-388, which are located close to the substrate and FMNbound to TdsC, significantly decreased benzothiophene oxygenation activity, suggesting their involvement in supplying protons to the active site. Interestingly, these substitutions increased DBT oxygenation activity by TdsC, indicating that expanding the substrate-binding site can increase the oxygenation activity of TdsConlargersulfur-containingsubstrates, apropertythatshould prove useful for future microbial desulfurization applications.	[Hino, Tomoya; Hamamoto, Haruka; Suzuki, Hirokazu; Yagi, Hisashi; Ohshiro, Takashi; Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamacho Minami, Tottori 6808552, Japan	Tottori University	Ohshiro, T; Nagano, S (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamacho Minami, Tottori 6808552, Japan.	ohshiro@bio.tottori-u.ac.jp; snagano@bio.tottori-u.ac.jp	Suzuki, Hirokazu/AAG-2285-2020	Suzuki, Hirokazu/0000-0002-9507-6467				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Duan X, 2013, ACTA CRYSTALLOGR F, V69, P597, DOI 10.1107/S1744309113011172; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gonzalez-Osorio L, 2016, BIOCHEM BIOPH RES CO, V481, P189, DOI 10.1016/j.bbrc.2016.10.145; Gray KA, 2003, CURR OPIN MICROBIOL, V6, P229, DOI 10.1016/S1369-5274(03)00065-1; Guan LJ, 2015, FEBS J, V282, P3126, DOI 10.1111/febs.13216; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Ishii Y, 2000, BIOCHEM BIOPH RES CO, V270, P81, DOI 10.1006/bbrc.2000.2370; JONES KC, 1986, J BIOL CHEM, V261, P2553; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirimura K, 2004, APPL MICROBIOL BIOT, V65, P703, DOI 10.1007/s00253-004-1652-0; Kirimura K, 2001, J BIOSCI BIOENG, V91, P262, DOI 10.1263/jbb.91.262; Konishi J, 2003, APPL MICROBIOL BIOT, V62, P356, DOI 10.1007/s00253-003-1331-6; Konishi J, 2002, APPL MICROBIOL BIOT, V60, P128, DOI 10.1007/s00253-002-1096-3; Konishi J, 1997, APPL ENVIRON MICROB, V63, P3164, DOI 10.1128/AEM.63.8.3164-3169.1997; Konishi J, 2000, J BIOSCI BIOENG, V90, P607, DOI 10.1263/jbb.90.607; Li JC, 2009, BIORESOURCE TECHNOL, V100, P2594, DOI 10.1016/j.biortech.2008.12.009; Liu SH, 2014, PROTEINS, V82, P1708, DOI 10.1002/prot.24525; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Nakayama N, 2002, BBA-PROTEINS PROTEOM, V1598, P122, DOI 10.1016/S0167-4838(02)00365-5; Ohshiro T, 2005, J BIOSCI BIOENG, V100, P266, DOI 10.1263/jbb.100.266; Ohshiro T, 1997, J FERMENT BIOENG, V83, P233, DOI 10.1016/S0922-338X(97)80985-3; Ohshiro T, 1999, J BIOSCI BIOENG, V88, P610, DOI 10.1016/S1389-1723(00)87088-7; Ohshiro T., 2003, ENCY ENV MICROBIOLOG, P1041; Ohshiro T, 2009, BIOSCI BIOTECH BIOCH, V73, P2128, DOI 10.1271/bbb.90284; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; PIDDINGTON CS, 1995, APPL ENVIRON MICROB, V61, P468, DOI 10.1128/AEM.61.2.468-475.1995; SCHREUDER HA, 1990, BIOCHEMISTRY-US, V29, P3101, DOI 10.1021/bi00464a029; Terwilliger TC, 2012, ACTA CRYSTALLOGR D, V68, P861, DOI 10.1107/S0907444912015636; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Ueno G, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952941; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Zhang L, 2014, PROTEINS, V82, P2733, DOI 10.1002/prot.24638	49	10	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15804	15813		10.1074/jbc.M117.788513	http://dx.doi.org/10.1074/jbc.M117.788513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768765	Green Published, hybrid			2022-12-28	WOS:000411512200018
J	Pence, N; Tokmina-Lukaszewska, M; Yang, ZY; Ledbetter, RN; Seefeldt, LC; Bothner, B; Peters, JW				Pence, Natasha; Tokmina-Lukaszewska, Monika; Yang, Zhi-Yong; Ledbetter, Rhesa N.; Seefeldt, Lance C.; Bothner, Brian; Peters, John W.			Unraveling the interactions of the physiological reductant flavodoxin with the different conformations of the Fe protein in the nitrogenase cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM-IRON PROTEIN; RATE-LIMITING STEP; AZOTOBACTER-VINELANDII; ELECTRON-TRANSFER; MOFE-PROTEIN; KLEBSIELLA-PNEUMONIAE; CATALYTIC CYCLE; 4FE-4S CLUSTER; MGATP; MECHANISM	Nitrogenase reduces dinitrogen (N-2) to ammonia in biological nitrogen fixation. The nitrogenase Fe protein cycle involves a transient association between the reduced, MgATP-bound Fe protein and the MoFe protein and includes electron transfer, ATP hydrolysis, release of Pi, and dissociation of the oxidized, MgADP-bound Fe protein from the MoFe protein. The cycle is completed by reduction of oxidized Fe protein and nucleotide exchange. Recently, a kinetic study of the nitrogenase Fe protein cycle involving the physiological reductant flavodoxin reported a major revision of the rate-limiting step from MoFe protein and Fe protein dissociation to release of Pi. Because the Fe protein cannot interact with flavodoxin and the MoFe protein simultaneously, knowledge of the interactions between flavodoxin and the different nucleotide states of the Fe protein is critically important for understanding the Fe protein cycle. Here we used time-resolved limited proteolysis and chemical cross-linking to examine nucleotide-induced structural changes in the Fe protein and their effects on interactions with flavodoxin. Differences in proteolytic cleavage patterns and chemical cross-linking patterns were consistent with known nucleotide-induced structural differences in the Fe protein and indicated that MgATP-bound Fe protein resembles the structure of the Fe protein in the stabilized nitrogenase complex structures. Docking models and cross-linking patterns between the Fe protein and flavodoxin revealed that the MgADP-bound state of the Fe protein has the most complementary docking interface with flavodoxin compared with the MgATP-bound state. Together, these findings provide new insights into the control mechanisms in protein-protein interactions during the Fe protein cycle.	[Pence, Natasha; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Pence, Natasha; Tokmina-Lukaszewska, Monika; Bothner, Brian; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Yang, Zhi-Yong; Ledbetter, Rhesa N.; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Washington State University; Montana State University System; Montana State University Bozeman; Utah System of Higher Education; Utah State University	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.; Peters, JW (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jw.peters@wsu.edu	Yang, Zhiyong/E-7834-2013	Yang, Zhiyong/0000-0001-8186-9450; Pence, Natasha/0000-0002-6096-4894	Biological Electron Transfer and Catalysis Energy Frontier Research Center - Department of Energy, Office of Science, Basic Energy Sciences under Award [SC0012518]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	Biological Electron Transfer and Catalysis Energy Frontier Research Center - Department of Energy, Office of Science, Basic Energy Sciences under Award(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported as part of the Biological Electron Transfer and Catalysis Energy Frontier Research Center funded by the Department of Energy, Office of Science, Basic Energy Sciences under Award DE-SC0012518. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Bursey EH, 1998, J BIOL CHEM, V273, P16927, DOI 10.1074/jbc.273.27.16927; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Danyal K, 2011, BIOCHEMISTRY-US, V50, P9255, DOI 10.1021/bi201003a; Danyal K, 2010, J AM CHEM SOC, V132, P6894, DOI 10.1021/ja101737f; Duval S, 2013, P NATL ACAD SCI USA, V110, P16414, DOI 10.1073/pnas.1311218110; Duyvis MG, 1998, BIOCHEMISTRY-US, V37, P17345, DOI 10.1021/bi981509y; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HAGEMAN RV, 1980, BIOCHEMISTRY-US, V19, P2333, DOI 10.1021/bi00552a009; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; LANZILOTTA WN, 1995, BIOCHEMISTRY-US, V34, P15646, DOI 10.1021/bi00048a007; Lanzilotta WN, 1999, BBA-PROTEIN STRUCT M, V1429, P411, DOI 10.1016/S0167-4838(98)00251-9; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ryle MJ, 1996, J BIOL CHEM, V271, P1551, DOI 10.1074/jbc.271.3.1551; RYLE MJ, 1995, J BIOL CHEM, V270, P13112, DOI 10.1074/jbc.270.22.13112; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P9424, DOI 10.1021/bi9608572; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schlessman JL, 1998, J MOL BIOL, V280, P669, DOI 10.1006/jmbi.1998.1898; Seefeldt LC, 2012, CURR OPIN CHEM BIOL, V16, P19, DOI 10.1016/j.cbpa.2012.02.012; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; SEEFELDT LC, 1994, PROTEIN SCI, V3, P2073, DOI 10.1002/pro.5560031120; SEEFELDT LC, 1992, J BIOL CHEM, V267, P6680; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; Sen S, 2004, BIOCHEMISTRY-US, V43, P1787, DOI 10.1021/bi0358465; Sen S, 2006, J INORG BIOCHEM, V100, P1041, DOI 10.1016/j.jinorgbio.2006.02.016; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; THORNELEY RNF, 1988, BIOCHEM J, V253, P587, DOI 10.1042/bj2530587; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; Thorneley RNF, 1979, BIOCHEM SOC T, V7, P633, DOI 10.1042/bst0070633; Wilson PE, 2001, BIOPHYS CHEM, V91, P281, DOI 10.1016/S0301-4622(01)00182-X; WOLLE D, 1992, J BIOL CHEM, V267, P3667; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421	42	13	13	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15661	15669		10.1074/jbc.M117.801548	http://dx.doi.org/10.1074/jbc.M117.801548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28784660	Green Published, hybrid			2022-12-28	WOS:000411512200007
J	Kamgar-Parsi, K; Hong, L; Naito, A; Brooks, CL; Ramamoorthy, A				Kamgar-Parsi, Kian; Hong, Liu; Naito, Akira; Brooks, Charles L., III; Ramamoorthy, Ayyalusamy			Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; GENERALIZED BORN MODEL; STATE C-13 NMR; SALMON-CALCITONIN; MOLECULAR-DYNAMICS; STRUCTURAL-CHARACTERIZATION; AROMATIC INTERACTIONS; CLINICAL RESISTANCE; ALPHA-SYNUCLEIN; PAGETS-DISEASE	The role of the peptide hormone calcitonin in skeletal protection has led to its use as a therapeutic for osteoporosis. However, calcitonin aggregation into amyloid fibrils limits its therapeutic efficacy, necessitating a modification of calcitonin's aggregation kinetics. Here, we report a direct relationship between human calcitonin (hCT) concentration and aggregation lag time. This kinetic trend was contrary to the conventional understanding of amyloid aggregation and persisted over a range of aggregation conditions, as confirmed by thioflavin-T kinetics assays, CD spectroscopy, and transmission EM. Dynamic light scattering, 1H NMR experiments, and seeded thioflavin-T assay results indicated that differences in initial peptide species contribute to this trend more than variations in the primary nucleus formation rate. On the basis of kinetics modeling results, we propose a mechanism whereby a structural conversion of hCT monomers is needed before incorporation into the fibril. Our kinetic mechanism recapitulates the experimentally observed relationship between peptide concentration and lag time and represents a novel mechanism in amyloid aggregation. Interestingly, hCT at low pH and salmon calcitonin (sCT) exhibited the canonical inverse relationship between concentration and lag time. Comparative studies of hCT and sCT with molecular dynamics simulations and CD indicated an increased alpha-helical structure in sCT and low-pH hCT monomers compared with neutral-pH hCT, suggesting that alpha-helical monomers represent a growthcompetent species, whereas unstructured random coil monomers represent a growth-incompetent species. Our finding that initial monomer concentration is positively correlated with lag time in hCT aggregation could help inform future efforts for improving therapeutic applications of CT.	[Kamgar-Parsi, Kian] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; [Hong, Liu] Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China; [Naito, Akira] Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan; [Brooks, Charles L., III; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Brooks, Charles L., III; Ramamoorthy, Ayyalusamy] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tsinghua University; Yokohama National University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Ramamoorthy, A (corresponding author), Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu			National Institutes of Health [AG048934]; Protein Folding Disease center at the University of Michigan; NATIONAL INSTITUTE ON AGING [R01AG048934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Disease center at the University of Michigan; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG048934 (to A. R.). This work was also supported by the Protein Folding Disease center at the University of Michigan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiar J, 2003, J COLLOID INTERF SCI, V258, P116, DOI 10.1016/S0021-9797(02)00082-6; Amodeo P, 1999, J BIOMOL NMR, V13, P161, DOI 10.1023/A:1008365322148; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arthur EJ, 2016, J COMPUT CHEM, V37, P927, DOI 10.1002/jcc.24280; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; ARVINTE T, 1993, J BIOL CHEM, V268, P6408; Avidan-Shpalter C, 2006, AMYLOID, V13, P216, DOI 10.1080/13506120600960643; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Batzli KM, 2015, MAT SCI ENG C-MATER, V48, P359, DOI 10.1016/j.msec.2014.09.015; BAUER HH, 1994, BIOCHEMISTRY-US, V33, P12276, DOI 10.1021/bi00206a034; Bertolani A, 2017, CHEM-EUR J, V23, P2051, DOI 10.1002/chem.201604639; Blancas-Mejia LM, 2017, BIOCHEMISTRY-US, V56, P757, DOI 10.1021/acs.biochem.6b01043; Brender JR, 2015, J PHYS CHEM B, V119, P2886, DOI 10.1021/jp511758w; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Dean DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40787; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Diociaiuti M, 2014, BBA-MOL BASIS DIS, V1842, P1622, DOI 10.1016/j.bbadis.2014.06.006; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FELETTI C, 1979, NEPHRON, V24, P85, DOI 10.1159/000181689; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Gaudiano MC, 2005, BBA-PROTEINS PROTEOM, V1750, P134, DOI 10.1016/j.bbapap.2005.04.008; GRAUER A, 1993, HORM METAB RES, V25, P486, DOI 10.1055/s-2007-1002156; Guo CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13556; Gupta V, 2013, J CONTROL RELEASE, V172, P753, DOI 10.1016/j.jconrel.2013.09.004; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hingant E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003735; Hong L, 2012, J PHYS CHEM B, V116, P6611, DOI 10.1021/jp205702u; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P16956, DOI 10.1039/c3cp52810c; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P8890, DOI 10.1039/c3cp44544e; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Kamgar-Parsi K, 2017, ISR J CHEM, V57, P634, DOI 10.1002/ijch.201600096; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; KANAORI K, 1995, BIOCHEMISTRY-US, V34, P12138, DOI 10.1021/bi00038a006; Kashchiev D, 2017, J PHYS CHEM B, V121, P35, DOI 10.1021/acs.jpcb.6b09302; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P2027; Lakshmanan A, 2013, P NATL ACAD SCI USA, V110, P519, DOI 10.1073/pnas.1217742110; Levin A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6219; Matougui N, 2016, INT J PHARMACEUT, V502, P80, DOI 10.1016/j.ijpharm.2016.02.019; MEYER JP, 1991, BIOPOLYMERS, V31, P233, DOI 10.1002/bip.360310210; Milton NGN, 2013, MICRON, V44, P246, DOI 10.1016/j.micron.2012.07.001; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Ogi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06960; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Pettersson-Kastberg J, 2009, ANN MED, V41, P162, DOI 10.1080/07853890802502614; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Robbins KJ, 2011, J PHYS CHEM LETT, V2, P735, DOI 10.1021/jz200066b; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; Schneider D, 2002, AM FAM PHYSICIAN, V65, P2069; Shoffner SK, 2016, PHYS CHEM CHEM PHYS, V18, P21259, DOI 10.1039/c5cp07845h; Shtainfeld A, 2010, BIOCHEMISTRY-US, V49, P5299, DOI 10.1021/bi1002713; SILIGARDI G, 1994, EUR J BIOCHEM, V221, P1117, DOI 10.1111/j.1432-1033.1994.tb18832.x; SINGER FR, 1972, J CLIN INVEST, V51, P2331, DOI 10.1172/JCI107044; SINGER FR, 1980, ARTHRITIS RHEUM, V23, P1148, DOI 10.1002/art.1780231012; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Surmacz-Chwedoruk W, 2016, SCI REP-UK, V6, DOI 10.1038/srep32022; Umerska A, 2016, INT J PHARMACEUT, V506, P191, DOI 10.1016/j.ijpharm.2016.04.028; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Wagner K, 2004, BIOPHYS J, V87, P386, DOI 10.1529/biophysj.103.036921; Wang Q, 2014, LECT NOTES COMPUT SC, V8679, P1, DOI 10.1007/978-3-319-10581-9_1; Werle M, 2009, INT J PHARMACEUT, V370, P26, DOI 10.1016/j.ijpharm.2008.11.013; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yoo HS, 2004, J PHARM SCI-US, V93, P488, DOI 10.1002/jps.10573; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9	82	11	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14963	14976		10.1074/jbc.M117.791236	http://dx.doi.org/10.1074/jbc.M117.791236			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739873	hybrid, Green Published			2022-12-28	WOS:000409902100020
J	Sakamoto, T; Imai, H				Sakamoto, Taro; Imai, Hirotaka			Hydrogen peroxide produced by superoxide dismutase SOD-2 activates sperm in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMINAL PLASMA; INFERTILE MEN; MULTIGENE FAMILY; AMEBOID MOVEMENT; SEMEN QUALITY; GENE FAMILY; C-ELEGANS; NEMATODE; SPERMATOZOA; PROTEIN	Superoxide dismutase (SOD) is a ubiquitous antioxidant enzyme that catalytically converts the superoxide radical to hydrogen peroxide (H2O2). In mammals, high SOD activity is detectable in sperm and seminal plasma, and loss of SOD activity has been correlated with male infertility; however, the underlying mechanisms of sperm infertility remain to be clarified. Here we report that the deletion of two major SOD genes in Caenorhabditis elegans, sod-1 and sod-2, causes sperm activation defects, leading to a significant reduction in brood size. By examining the reactivity to the sperm activation signals Pronase and triethanolamine, we found that sod-1; sod-2 double mutant sperm cells display defects in pseudopod extension. Neither the content nor oxidative modification of major sperm protein, an essential cytoskeletal component for crawling movement, were significantly affected in sod-1; sod-2 mutant sperm. Surprisingly, H2O2, the dismutation product of SOD, could activate sod-1; sod-2 mutant sperm treated with Pronase. Moreover, the H2O2 scavenger ebselen completely inhibited pseudopod extension in wild-type sperm treated with Pronase, and H2O2 could directly induce pseudopod extension in wild-type sperm. Analysis of Pronase-triggered sperm activation in sod-1 and sod-2 single mutants revealed that sod-2 is required for pseudopod extension. These results suggest that SOD-2 plays an important role in the sperm activation of C. elegans by producing H2O2 as an activator of pseudopod extension.	[Sakamoto, Taro; Imai, Hirotaka] Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shinokane, Tokyo 1088641, Japan	Kitasato University	Sakamoto, T (corresponding author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shinokane, Tokyo 1088641, Japan.	sakamotot@pharm.kitasato-u.ac.jp			National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Fujita, C. Kagami, and Y. Nakagawa for technical assistance; Dr. S. Mitani (Tokyo Women's Medical University School of Medicine) for providing the alleles of sod-1 and sod-5; and Dr. Y. Nakagawa (Iwaki Meisei University) for helpful discussions and comments on this study. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; BARTON MK, 1987, GENETICS, V115, P107; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BRENNER S, 1974, GENETICS, V77, P71; BURKE DJ, 1983, J MOL BIOL, V171, P1, DOI 10.1016/S0022-2836(83)80312-X; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KLASS MR, 1984, MOL CELL BIOL, V4, P529, DOI 10.1128/MCB.4.3.529; LAMUNYON CW, 1995, EXPERIENTIA, V51, P817, DOI 10.1007/BF01922436; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Liau WS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-8; Liu ZY, 2014, BBA-MOL CELL RES, V1843, P299, DOI 10.1016/j.bbamcr.2013.11.001; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; MAZZILLI F, 1994, FERTIL STERIL, V62, P862; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Murawski M, 2007, FOLIA HISTOCHEM CYTO, V45, P123; NELSON GA, 1980, CELL, V19, P457, DOI 10.1016/0092-8674(80)90520-6; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Ochsendorf FR, 1998, HUM REPROD, V13, P353, DOI 10.1093/humrep/13.2.353; Oueslati K, 2016, FOOD CHEM, V209, P43, DOI 10.1016/j.foodchem.2016.04.041; Pearson JK, 2007, J PHYS CHEM A, V111, P3152, DOI 10.1021/jp071499n; Peeker R, 1997, MOL HUM REPROD, V3, P1061, DOI 10.1093/molehr/3.12.1061; ROBERTS TM, 1982, J CELL BIOL, V92, P132, DOI 10.1083/jcb.92.1.132; Said TM, 2004, FERTIL STERIL, V82, P871, DOI 10.1016/j.fertnstert.2004.02.132; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Smith HE, 1998, J MOL BIOL, V279, P605, DOI 10.1006/jmbi.1998.1793; Song GJ, 2006, INT J ANDROL, V29, P569, DOI 10.1111/j.1365-2605.2006.00700.x; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Takada M, 2011, BIOL PHARM BULL, V34, P954, DOI 10.1248/bpb.34.954; Tramer F, 1998, BIOL REPROD, V59, P753, DOI 10.1095/biolreprod59.4.753; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9; Wdowiak A, 2015, ANDROLOGY-US, V3, P748, DOI 10.1111/andr.12061; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; WISPE JR, 1989, BIOCHIM BIOPHYS ACTA, V994, P30, DOI 10.1016/0167-4838(89)90058-7; Yan LF, 2014, J ASSIST REPROD GEN, V31, P549, DOI 10.1007/s10815-014-0215-2; Yang CF, 1999, BIOCHEM PHARMACOL, V57, P273, DOI 10.1016/S0006-2952(98)00299-8; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	51	40	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14804	14813		10.1074/jbc.M117.788901	http://dx.doi.org/10.1074/jbc.M117.788901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724632	Green Published, hybrid			2022-12-28	WOS:000409902100009
J	Zeng, YJ; Stauffer, S; Zhou, JL; Chen, XC; Chen, YH; Dong, JX				Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin			Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK1 PHOSPHORYLATION; CELL-PROLIFERATION; GASTRIC-CANCER; HIPPO PATHWAY; SIZE-CONTROL; YAP; KIBRA; MITOSIS; TUMORIGENESIS; PROGRESSION	The Hippo pathway is an evolutionarily conserved signaling pathway that plays important roles in stem cell biology, tissue homeostasis, and cancer development. Vestigial-like 4 (Vgll4) functions as a transcriptional co-repressor in the Hippo-Yes-associated protein (YAP) pathway. Vgll4 inhibits cell proliferation and tumor growth by competing with YAP for binding to TEA-domain proteins (TEADs). However, the mechanisms by which Vgll4 itself is regulated are unclear. Here we identified a mechanism that regulates Vgll4's tumor-suppressing function. We found that Vgll4 is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) during antimitotic drug-induced mitotic arrest and also in normal mitosis. We further identified Ser-58, Ser-155, Thr-159, and Ser-280 as the main mitotic phosphorylation sites in Vgll4. We also noted that the nonphosphorylatable mutant Vgll4-4A (S58A/S155A/T159A/S280A) suppressed tumorigenesis in pancreatic cancer cells in vitro and in vivo to a greater extent than did wild-type Vgll4, suggesting that mitotic phosphorylation inhibits Vgll4's tumor-suppressive activity. Consistent with these observations, the Vgll4-4A mutant possessed higher-binding affinity to TEAD1 than wild-type Vgll4. Interestingly, Vgll4 and Vgll4-4A markedly suppressedYAPand beta-catenin signaling activity. Together, these findings reveal a previously unrecognized mechanism for Vgll4 regulation in mitosis and its role in tumorigenesis.	[Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Dong, Jixin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Dong, Jixin] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Zeng, Yongji/AAY-1227-2021; Zeng, Yongji/AAM-8712-2021; Chen, Xingcheng/AAL-3210-2020	Zeng, Yongji/0000-0002-1184-1900; 	National Institutes of Health [P30 GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109066, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Lei Zhang and Zhaocai Zhou for the Vgll4 cDNA. All fluorescence images were acquired by Zeiss LSM 710 confocal microscope at the Advanced Microscopy Core at the University of Nebraska Medical Center. The Core is supported in part by Grant P30 GM106397 from the National Institutes of Health. We also thank Dr. Joyce Solheim for critical reading and comments on the manuscript.	Chen XC, 2016, CELL SIGNAL, V28, P1826, DOI 10.1016/j.cellsig.2016.08.013; Chen XC, 2016, J BIOL CHEM, V291, P14761, DOI 10.1074/jbc.M116.722751; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Jiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14058; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Jube S, 2012, CANCER RES, V72, P3290, DOI 10.1158/0008-5472.CAN-11-3481; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; LI H, 2015, MED ONCOL, V32; Li N, 2015, AM J CANCER RES, V5, P1158; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang SP, 2015, ONCOTARGET, V6, P36019, DOI 10.18632/oncotarget.5935; Yang SP, 2015, J BIOL CHEM, V290, P6191, DOI 10.1074/jbc.M114.624411; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang L, 2015, ONCOTARGET, V6, P31399, DOI 10.18632/oncotarget.5189; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	29	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15028	15038		10.1074/jbc.M117.796284	http://dx.doi.org/10.1074/jbc.M117.796284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739871	hybrid, Green Published			2022-12-28	WOS:000409902100025
J	Nguyen, DMN; Schut, GJ; Zadvornyy, OA; Tokmina-Lukaszewska, M; Poudel, S; Lipscomb, GL; Adams, LA; Dinsmore, JT; Nixon, WJ; Boyd, ES; Bothner, B; Peters, JW; Adams, MWW				Nguyen, Diep M. N.; Schut, Gerrit J.; Zadvornyy, Oleg A.; Tokmina-Lukaszewska, Monika; Poudel, Saroj; Lipscomb, Gina L.; Adams, Leslie A.; Dinsmore, Jessica T.; Nixon, William J.; Boyd, Eric S.; Bothner, Brian; Peters, John W.; Adams, Michael W. W.			Two functionally distinct NADP(+)-dependent ferredoxin oxidoreductases maintain the primary redox balance of Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTHERMOPHILIC ARCHAEON; ELEMENTAL SULFUR; METABOLISM; SYSTEM; NADH; DEHYDROGENASE; REDUCTION; INSIGHTS; HYDROGEN; ENZYME	Electron bifurcation has recently gained acceptance as the third mechanism of energy conservation in which energy is conserved through the coupling of exergonic and endergonic reactions. A structure-based mechanism of bifurcation has been elucidated recently for the flavin-based enzyme NADH-dependent ferredoxin NADP(+) oxidoreductase I (NfnI) from the hyperther-mophillic archaeon Pyrococcus furiosus. NfnI is thought to be involved in maintaining the cellular redox balance, producing NADPH for biosynthesis by recycling the two other primary redox carriers, NADH and ferredoxin. The P. furiosus genome encodes an NfnI paralog termed NfnII, and the two are differentially expressed, depending on the growth conditions. In this study, we show that deletion of the genes encoding either NfnI or NfnII affects the cellular concentrations of NAD(P)H and particularly NADPH. This results in a moderate to severe growth phenotype in deletion mutants, demonstrating a key role for each enzyme in maintaining redox homeostasis. Despite their similarity in primary sequence and cofactor content, crystallographic, kinetic, and mass spectrometry analyses reveal that there are fundamental structural differences between the two enzymes, and NfnII does not catalyze the NfnI bifurcating reaction. Instead, it exhibits non-bifurcating ferredoxin NADP oxidoreductase-type activity. NfnII is therefore proposed to be a bifunctional enzyme and also to catalyze a bifurcating reaction, although its third substrate, in addition to ferredoxin and NADP(H), is as yet unknown.	[Nguyen, Diep M. N.; Schut, Gerrit J.; Lipscomb, Gina L.; Adams, Leslie A.; Dinsmore, Jessica T.; Nixon, William J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Zadvornyy, Oleg A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Tokmina-Lukaszewska, Monika; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Poudel, Saroj; Boyd, Eric S.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	University System of Georgia; University of Georgia; Washington State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adamsm@uga.edu	Zadvornyy, Oleg/P-5294-2019	Zadvornyy, Oleg A./0000-0002-5374-6856; Poudel, Saroj/0000-0001-7147-1836	Murdock Charitable Trust; National Institutes of Health IDEA Program Grant [P20GM103474]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P20GM103474] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health IDEA Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Montana State University Microfabrication Facility for help in preparation of gold-coated borosilica capillaries for non-covalent mass spectrometry and Dr. Ravi Kant for assistance with protein identification. The Mass Spectrometry Facility at Montana State University is supported in part by the Murdock Charitable Trust and National Institutes of Health IDEA Program Grant P20GM103474. The use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by NIGMS, National Institutes of Health (including Grant P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AONO S, 1989, J BACTERIOL, V171, P3433, DOI 10.1128/jb.171.6.3433-3439.1989; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farkas J, 2012, APPL ENVIRON MICROB, V78, P4669, DOI 10.1128/AEM.00936-12; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kanai T, 2003, J BACTERIOL, V185, P1705, DOI 10.1128/JB.185.5.1705-1711.2003; Keller MW, 2015, METAB ENG, V27, P101, DOI 10.1016/j.ymben.2014.11.004; Keller MW, 2013, P NATL ACAD SCI USA, V110, P5840, DOI 10.1073/pnas.1222607110; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipscomb GL, 2017, MOL MICROBIOL, V104, P869, DOI 10.1111/mmi.13668; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Lo J, 2017, METAB ENG, V39, P71, DOI 10.1016/j.ymben.2016.10.018; Lo J, 2015, J BACTERIOL, V197, P2920, DOI 10.1128/JB.00347-15; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; MA K, 1994, J BACTERIOL, V176, P6509, DOI 10.1128/JB.176.21.6509-6517.1994; Ma K, 2001, METHOD ENZYMOL, V334, P40; Maddocks ODK, 2014, MOL CELL, V55, P158, DOI 10.1016/j.molcel.2014.07.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poudel S, 2016, BBA-GEN SUBJECTS, V1860, P1910, DOI 10.1016/j.bbagen.2016.05.034; ROBB FT, 1992, BIOCHIM BIOPHYS ACTA, V1120, P267, DOI 10.1016/0167-4838(92)90247-B; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421	49	26	26	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14603	14616		10.1074/jbc.M117.794172	http://dx.doi.org/10.1074/jbc.M117.794172			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28705933	hybrid, Green Published			2022-12-28	WOS:000408747500025
J	Rathkey, JK; Benson, BL; Chirieleison, SM; Yang, J; Xiao, TS; Dubyak, GR; Huang, AY; Abbott, DW				Rathkey, Joseph K.; Benson, Bryan L.; Chirieleison, Steven M.; Yang, Jie; Xiao, Tsan S.; Dubyak, George R.; Huang, Alex Y.; Abbott, Derek W.			Live-cell visualization of gasdermin D-driven pyroptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; CASPASE-11; GSDMD; PORE; GREEN	Pyroptosis is a form of cell death important in defenses against pathogens that can also result in a potent and sometimes pathological inflammatory response. During pyroptosis, GSDMD (gasdermin D), the pore-forming effector protein, is cleaved, forms oligomers, and inserts into the membranes of the cell, resulting in rapid cell death. However, the potent cell death induction caused by GSDMD has complicated our ability to understand the biology of this protein. Studies aimed at visualizing GSDMD have relied on expression of GSDMD fragments in epithelial cell lines that naturally lack GSDMD expression and also lack the proteases necessary to cleave GSDMD. In this work, we performed mutagenesis and molecular modeling to strategically place tags and fluorescent proteins within GSDMD that support native pyroptosis and facilitate live-cell imaging of pyroptotic cell death. Here, we demonstrate that these fusion proteins are cleaved by caspases-1 and -11 at Asp-276. Mutations that disrupted the predicted p30-p20 autoinhibitory interface resulted in GSDMD aggregation, supporting the oligomerizing activity of these mutations. Furthermore, we show that these novel GSDMD fusions execute inflammasomedependent pyroptotic cell death in response to multiple stimuli and allow for visualization of the morphological changes associated with pyroptotic cell death in real time. This work therefore provides new tools that not only expand the molecular understanding of pyroptosis but also enable its direct visualization.	[Rathkey, Joseph K.; Benson, Bryan L.; Chirieleison, Steven M.; Yang, Jie; Xiao, Tsan S.; Huang, Alex Y.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Benson, Bryan L.; Huang, Alex Y.] Case Western Reserve Univ, Div Pediat Hematol Oncol, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Yang, Jie; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Abbott, DW (corresponding author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Xiao, Tsan Sam/A-8590-2010; Huang, Alex/R-4662-2017; Huang, Alex Y./ABG-8182-2021	Xiao, Tsan Sam/0000-0001-9688-475X; Huang, Alex/0000-0002-5701-4521; Huang, Alex Y./0000-0002-5701-4521; Chirieleison, Steven/0000-0002-3997-5652; Benson, Bryan/0000-0003-4318-5693; Abbott, Derek/0000-0003-4387-8094; YANG, JIE/0000-0001-6662-4236	National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant [S10ODO16164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, TL1TR002549, TL1TR000441] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM086550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077888, F31NS096857] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016164] Funding Source: NIH RePORTER	National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Parameswaran Ramakrishnan and Xiaoxia Li for lending helpful comments and expertise. We thank the Abbott, Huang, Dubyak, Xiao, and Ramakrishnan laboratories for insightful discussions and comments on the project and manuscript. We also thank the Case Western Reserve University (CWRU) Imaging Core. Confocal microscopy was supported in part by National Institutes of Health-Office of Research Infrastructure Programs (NIH-ORIP) Grant S10ODO16164 to the CWRU Imaging Facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Chirieleison SM, 2017, J BIOL CHEM, V292, P9666, DOI 10.1074/jbc.M117.781500; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	30	36	36	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14649	14658		10.1074/jbc.M117.797217	http://dx.doi.org/10.1074/jbc.M117.797217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28726636	Green Published, hybrid			2022-12-28	WOS:000408747500029
J	Su, Y; Egli, M; Guengerich, FP				Su, Yan; Egli, Martin; Guengerich, F. Peter			Human DNA polymerase eta accommodates RNA for strand extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA enzyme; DNA polymerase; reverse transcription; RNA; DNA enzyme; DNA enzymes; replication initiation; reverse transcriptase	RIBONUCLEOTIDE INCORPORATION; XERODERMA-PIGMENTOSUM; REVERSE-TRANSCRIPTASE; REPLICATION; MECHANISM; BYPASS; REPAIR; DISCRIMINATION; FIDELITY; BIOLOGY	Ribonucleotides are the natural analogs of deoxyribonucleotides, which can be misinserted by DNA polymerases, leading to the most abundant DNA lesions in genomes. During replication, DNA polymerases tolerate patches of ribonucleotides on the parental strands to different extents. The majority of human DNA polymerases have been reported to misinsert ribonucleotides into genomes. However, only PrimPol, DNA polymerase , telomerase, and the mitochondrial human DNA polymerase (hpol) have been shown to tolerate an entire RNA strand. Y-family hpol is known for translesion synthesis opposite the UV-induced DNA lesion cyclobutane pyrimidine dimer and was recently found to incorporate ribonucleotides into DNA. Here, we report that hpol is able to bind DNA/DNA, RNA/DNA, and DNA/RNA duplexes with similar affinities. In addition, hpol , as well as another Y-family DNA polymerase, hpol , accommodates RNA as one of the two strands during primer extension, mainly by inserting dNMPs opposite unmodified templates or DNA lesions, such as 8-oxo-2-deoxyguanosine or cyclobutane pyrimidine dimer, even in the presence of an equal amount of the DNA/DNA substrate. The discovery of this RNA-accommodating ability of hpol redefines the traditional concept of human DNA polymerases and indicates potential new functions of hpol in vivo.	[Su, Yan; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES026955, R01 ES010546, P01 CA160032]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, R01ES026955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES026955 (to F. P. G. and M. E.), R01 ES010546 (to F. P. G.), and P01 CA160032 (to M. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Boule JB, 2001, J BIOL CHEM, V276, P31388, DOI 10.1074/jbc.M105272200; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Donigan KA, 2014, J BIOL CHEM, V289, P9136, DOI 10.1074/jbc.M113.545442; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; KATI WM, 1992, J BIOL CHEM, V267, P25988; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; Mentegari E, 2017, NUCLEIC ACIDS RES, V45, P2600, DOI 10.1093/nar/gkw1275; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Su Y, 2016, J BIOL CHEM, V291, P3747, DOI 10.1074/jbc.M115.706226; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; van Loon B, 2015, DNA REPAIR, V29, P1, DOI 10.1016/j.dnarep.2015.04.001; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s	30	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18044	18051		10.1074/jbc.M117.809723	http://dx.doi.org/10.1074/jbc.M117.809723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28972162	hybrid, Green Published			2022-12-28	WOS:000414458200005
J	Sakurai, S; Shimizu, T; Ohto, U				Sakurai, Shunya; Shimizu, Toshiyuki; Ohto, Umeharu			The crystal structure of the AhRR-ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; X-ASSOCIATED PROTEIN-2; DIOXIN RECEPTOR; MICE LACKING; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ACTIVATION; MECHANISM; BINDING; DIMERIZATION; TOXICITY	2,3,7,8-Tetrachlorodibenzo-p-dioxin and related compounds are extraordinarily potent environmental toxic pollutants. Most of the 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicities are mediated by aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor belonging to the basic helix-loop-helix (bHLH) Per-ARNT-Sim (PAS) family. Upon ligand binding, AhR forms a heterodimer with AhR nuclear translocator (ARNT) and induces the expression of genes involved in various biological responses. One of the genes induced by AhR encodes AhR repressor (AhRR), which also forms a heterodimer with ARNT and represses the activation of AhR-dependent transcription. The control of AhR activation is critical for managing AhR-mediated diseases, but the mechanisms by which AhRR represses AhR activation remain poorly understood, because of the lack of structural information. Here, we determined the structure of the AhRR-ARNT heterodimer by X-ray crystallography, which revealed an asymmetric intertwined domain organization presenting structural features that are both conserved and distinct among bHLH-PAS family members. The structures of AhRR-ARNT and AhR-ARNT were similar in the bHLH-PAS-A region, whereas the PAS-B of ARNT in the AhRR-ARNT complex exhibited a different domain arrangement in this family reported so far. The structure clearly disclosed that AhRR competitively represses AhR binding to ARNT and target DNA and further suggested the existence of an AhRR-ARNT-specific repression mechanism. This study provides a structural basis for understanding the mechanism by which AhRR represses AhR-mediated gene transcription.	[Sakurai, Shunya; Shimizu, Toshiyuki; Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Shimizu, Toshiyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Shimizu, T; Ohto, U (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp; umeji@mol.f.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Naito Foundation; Grants-in-Aid for Scientific Research [16H02494] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to U. O. and T. S.), the Takeda Science Foundation (to U. O. and T. S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to U. O.), the Daiichi Sankyo Foundation of Life Science (to U. O.), and the Naito Foundation (to U. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox MB, 2002, TOXICOL LETT, V129, P13, DOI 10.1016/S0378-4274(01)00465-9; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oshima M, 2007, BIOCHEM BIOPH RES CO, V364, P276, DOI 10.1016/j.bbrc.2007.09.131; Oshima M, 2009, J BIOL CHEM, V284, P11017, DOI 10.1074/jbc.M808694200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schulte KW, 2017, STRUCTURE, V25, P1025, DOI 10.1016/j.str.2017.05.008; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Wu DL, 2017, CURR OPIN STRUC BIOL, V43, P1, DOI 10.1016/j.sbi.2016.09.011; Wu DL, 2016, ELIFE, V5, DOI 10.7554/eLife.18790; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13	39	27	30	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17609	17616		10.1074/jbc.M117.812974	http://dx.doi.org/10.1074/jbc.M117.812974			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28904176	hybrid, Green Published			2022-12-28	WOS:000414013000004
J	Vance, DE				Vance, Dennis E.			From masochistic enzymology to mechanistic physiology and disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; LOW-DENSITY LIPOPROTEINS; FATTY-ACID SYNTHETASE; SEMLIKI-FOREST-VIRUS; RAT-LIVER; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; HELA-CELLS; ENDOPLASMIC-RETICULUM; MYCOBACTERIUM-PHLEI	The pioneering work of Eugene Kennedy in the 1950s established the choline pathway for phosphatidylcholine (PC) biosynthesis. However, the regulation of PC biosynthesis was poorly understood at that time. When I started my lab at the University of British Columbia in the 1970s, this was the focus of my research. This article provides my reflections on these studies that began with enzymology and the use of cultured mammalian cells, and progressed to utilize the techniques of molecular biology and gene-targeted mice. The research inmylab and others demonstrated that the regulated and rate-limiting step in the choline pathway for PC biosynthesis was catalyzed by CTP: phosphocholine cytidylyltransferase. This enzyme is regulated by its movement from a soluble form (largely in the nucleus) to a membrane-associated form where the enzyme becomes activated. Gene targeting in mice subsequently demonstrated that this gene is essential for development of mouse embryos. The other mammalian pathway for PC biosynthesis is catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT) that converts phosphatidylethanolamine to PC. Understanding of the regulation and function of the integral membrane protein PEMT was improved when the enzyme was purified (a masochistic endeavor) in 1987, leading to the cloning of the Pemt cDNA. Generation of knock-out mice that lacked PEMT showed that they were protected from atherosclerosis, diet-induced obesity, and insulin resistance. The protection from atherosclerosis appears to be due to decreased secretion of lipoproteins from the liver. We continue to investigate themechanism(s) by which Pemt(-/-) mice are protected from weight gain and insulin resistance.	[Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.; Vance, DE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dvance@ualberta.ca						BROPHY PJ, 1976, FEBS LETT, V62, P123, DOI 10.1016/0014-5793(76)80033-6; CHOY PC, 1978, J BIOL CHEM, V253, P5163; CHOY PC, 1980, J BIOL CHEM, V255, P1070; CHOY PC, 1977, J BIOL CHEM, V252, P7673; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; CUI Z, 1993, J BIOL CHEM, V268, P16655; FELDMAN DA, 1987, J BIOL CHEM, V262, P9075; ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87; ISHIDATE K, 1984, J BIOL CHEM, V259, P4706; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; KENT C, 1979, P NATL ACAD SCI USA, V76, P4474, DOI 10.1073/pnas.76.9.4474; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; PELECH SL, 1982, J BIOL CHEM, V257, P4198; PELECH SL, 1983, J BIOL CHEM, V258, P6782; RICHARDSON CD, 1976, J BIOL CHEM, V251, P5544; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; SCHNEIDER WJ, 1979, J BIOL CHEM, V254, P3886; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Vance D. E., 1985, BIOCH LIPIDS LIPOPRO; VANCE DE, 1971, NATURE, V229, P121, DOI 10.1038/229121a0; VANCE DE, 1980, J BIOL CHEM, V255, P1064; VANCE DE, 1975, J BIOL CHEM, V250, P8119; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; VANCE DE, 1973, J BIOL CHEM, V248, P2303; VANCE DE, 1967, J LIPID RES, V8, P621; VANCE DE, 1984, TRENDS BIOCHEM SCI, V9, P17, DOI 10.1016/0968-0004(84)90041-0; VANCE DE, 1974, EUR J BIOCHEM, V43, P327, DOI 10.1111/j.1432-1033.1974.tb03416.x; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Walkey CJ, 1996, J LIPID RES, V37, P2341; WANG YL, 1993, J BIOL CHEM, V268, P5899; YAMAKAWA T, 1952, J BIOCHEM-TOKYO, V39, P393, DOI 10.1093/oxfordjournals.jbchem.a126309; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1990, J BIOL CHEM, V265, P4326; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672	47	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17169	17177		10.1074/jbc.X117.815100	http://dx.doi.org/10.1074/jbc.X117.815100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855256	Green Published, hybrid			2022-12-28	WOS:000414009300002
J	Shao, XQ; Kang, H; Loveless, T; Lee, GR; Seok, C; Weis, WI; Choi, HJ; Hardin, J				Shao, Xiangqiang; Kang, Hyunook; Loveless, Timothy; Lee, Gyu Rie; Seok, Chaok; Weis, William I.; Choi, Hee-Jung; Hardin, Jeff			Cell-cell adhesion in metazoans relies on evolutionarily conserved features of the alpha-catenin center dot beta-catenin-binding interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; ACTIN-BINDING; E-CADHERIN; F-ACTIN; TYROSINE PHOSPHORYLATION; IN-VITRO; SUBCELLULAR-LOCALIZATION; STRUCTURE REFINEMENT; SIGNALING FUNCTIONS; ADHERENS JUNCTIONS	Stable tissue integrity during embryonic development relies on the function of the cadherin center dot catenin complex (CCC). The Caenorhabditis elegans CCC is a useful paradigm for analyzing in vivo requirements for specific interactions among the core components of the CCC, and it provides a unique opportunity to examine evolutionarily conserved mechanisms that govern the interaction between alpha- and beta-catenin. HMP-1, unlike its mammalian homolog alpha-catenin, is constitutively monomeric, and its binding affinity for HMP-2/beta-catenin is higher than that of alpha-catenin for beta-catenin. A crystal structure shows that the HMP-1 center dot HMP-2 complex forms a five-helical bundle structure distinct from the structure of the mammalian alpha-catenin beta-catenin complex. Deletion analysis based on the crystal structure shows that the first helix of HMP-1 is necessary for binding HMP-2 avidly in vitro and for efficient recruitment of HMP-1 to adherens junctions in embryos. HMP-2 Ser-47 and Tyr-69 flank its binding interface with HMP-1, and we show that phosphomimetic mutations at these two sites decrease binding affinity of HMP-1 to HMP-2 by 40-100-fold in vitro. In vivo experiments using HMP-2 S47E and Y69E mutants showed that they are unable to rescue hmp-2(zu364) mutants, suggesting that phosphorylation of HMP-2 on Ser-47 and Tyr-69 could be important for regulating CCC formation in C. elegans. Our data provide novel insights into how cadherin-dependent cell-cell adhesion is modulated in metazoans by conserved elements as well as features unique to specific organisms.	[Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Program Genet, Madison, WI 53706 USA; [Shao, Xiangqiang; Loveless, Timothy; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Loveless, Timothy; Hardin, Jeff] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Kang, Hyunook; Choi, Hee-Jung] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea; [Lee, Gyu Rie; Seok, Chaok] Seoul Natl Univ, Dept Chem, Seoul 08826, South Korea; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Seoul National University (SNU); Seoul National University (SNU); Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.; Hardin, J (corresponding author), Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA.	choihj@snu.ac.kr; jdhardin@wisc.edu	; Weis, William/G-1437-2011	Shao, Xiangqiang/0000-0002-8789-2333; Lee, Gyu Rie/0000-0002-9119-5303; Weis, William/0000-0002-5583-6150; Choi, Hee Jung/0000-0002-1468-4074	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS from the National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114462, P41GM103393, U01GM094663, R01GM058038] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS from the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Members of the Hardin laboratory thank Bethany Lucas for helpful discussions. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by Department of Energy Office of Biological and Environmental Research and by NIGMS Grant P41GM103393 from the National Institutes of Health.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; ABERLE H, 1994, J CELL SCI, V107, P3655; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; BRENNER S, 1974, GENETICS, V77, P71; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Callaci S, 2015, BIOCHEM J, V472, P339, DOI 10.1042/BJ20150410; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Choi HJ, 2015, DEV CELL, V33, P82, DOI 10.1016/j.devcel.2015.02.005; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; David MD, 2008, J CELL SCI, V121, P2718, DOI 10.1242/jcs.029660; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Du C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033830; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huber O, 1997, J CELL SCI, V110, P1759; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Kang H, 2017, J BIOL CHEM, V292, P7077, DOI 10.1074/jbc.M116.769778; Kang H, 2016, ACTA CRYSTALLOGR F, V72, P234, DOI 10.1107/S2053230X16001862; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Lee GR, 2016, PROTEINS, V84, P293, DOI 10.1002/prot.24858; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Maiden SL, 2013, J BIOL CHEM, V288, P5694, DOI 10.1074/jbc.M112.438093; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; McEwen AE, 2014, MOL BIOL CELL, V25, P2365, DOI 10.1091/mbc.E14-01-0690; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Natarajan L, 2001, GENETICS, V159, P159; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113811; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Taddei ML, 2002, CANCER RES, V62, P6489; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	68	6	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16477	16490		10.1074/jbc.M117.795567	http://dx.doi.org/10.1074/jbc.M117.795567			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842483	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000412414800006
J	Lee, S; Devamani, T; Song, HD; Sandhu, M; Larsen, A; Sommese, R; Jain, A; Vaidehi, N; Sivaramakrishnan, S				Lee, Sangbae; Devamani, Titu; Song, Hyun Deok; Sandhu, Manbir; Larsen, Adrien; Sommese, Ruth; Jain, Abhinandan; Vaidehi, Nagarajan; Sivaramakrishnan, Sivaraj			Distinct structural mechanisms determine substrate affinity and kinase activity of protein kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTRAINED MOLECULAR-DYNAMICS; PARTICLE MESH EWALD; PHOSPHORYL TRANSFER; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; SIMULATION; DISORDER; INSIGHTS; DOMAINS; MOTIFS	Protein kinase C alpha (PKC alpha) belongs to the family of AGC kinases that phosphorylate multiple peptide substrates. Although the consensus sequence motif has been identified and used to explain substrate specificity for PKC alpha, it does not inform the structural basis of substrate-binding and kinase activity for diverse substrates phosphorylated by this kinase. The transient, dynamic, and unstructured nature of this protein-protein interaction has limited structural mapping of kinase-substrate interfaces. Here, using multiscale MD simulation-based predictions and FRET sensor-based experiments, we investigated the conformational dynamics of the kinase-substrate interface. We found that the binding strength of the kinase-substrate interaction is primarily determined by long-range columbic interactions between basic (Arg/Lys) residues located N-terminally to the phosphorylated Ser/Thr residues in the substrate and by an acidic patch in the kinase catalytic domain. Kinase activity stemmed from conformational flexibility in the region C-terminal to the phosphorylated Ser/Thr residues. Flexibility of the substrate-kinase interaction enabled an Arg/Lys two to three amino acids C-terminal to the phosphorylated Ser/Thr to prime a catalytically active conformation, facilitating phosphoryl transfer to the substrate. The structural mechanisms determining substrate binding and catalytic activity formed the basis of diverse binding affinities and kinase activities of PKC alpha for 14 substrates with varying degrees of sequence conservation. Our findings provide insight into the dynamic properties of the kinase-substrate interaction that govern substrate binding and turnover. Moreover, this study establishes a modeling and experimental method to elucidate the structural dynamics underlying substrate selectivity among eukaryotic kinases.	[Lee, Sangbae; Song, Hyun Deok; Sandhu, Manbir; Larsen, Adrien; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Dept Mol Immunol, Beckman Res Inst, Duarte, CA 91010 USA; [Devamani, Titu; Sommese, Ruth; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Jain, Abhinandan] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA	City of Hope; Beckman Research Institute of City of Hope; University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Vaidehi, N (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.; Sivaramakrishnan, S (corresponding author), Univ Minnesota, 420 Washington Ave SE, Minneapolis, MN 55455 USA.	NVaidehi@coh.org; sivaraj@umn.edu	Sandhu, Manbir/AAI-2124-2019	Sandhu, Manbir/0000-0003-1182-7268	National Institutes of Health Director's New Innovator Award [1DP2 CA186752-01]; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646, T32GM007276] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Director's New Innovator Award 1DP2 CA186752-01 (to S. S.) and the Beckman Research Institute of the City of Hope (to N. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alford R. F., 2017, ROSETTA 3 5; Balaraman GS, 2011, J PHYS CHEM B, V115, P7588, DOI 10.1021/jp200414z; Bastidas AC, 2013, J AM CHEM SOC, V135, P4788, DOI 10.1021/ja312237q; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Oliveira PSL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4016; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gerlits O, 2015, J BIOL CHEM, V290, P15538, DOI 10.1074/jbc.M115.643213; Gerlits O, 2013, BIOCHEMISTRY-US, V52, P3721, DOI 10.1021/bi400066a; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; JAIN A, 1993, J COMPUT PHYS, V106, P258; Larsen AB, 2014, J COMPUT CHEM, V35, P2245, DOI 10.1002/jcc.23743; Larsen AB, 2014, J CHEM INF MODEL, V54, P508, DOI [10.1021/ci4004841, 10.1021/ci400484c]; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Park IH, 2012, J PHYS CHEM B, V116, P2365, DOI 10.1021/jp209657n; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sommese RF, 2017, J BIOL CHEM, V292, P2873, DOI 10.1074/jbc.M116.768457; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vaidehi N, 1996, J PHYS CHEM-US, V100, P10508, DOI 10.1021/jp953043o; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wagner JR, 2013, J COMPUT CHEM, V34, P904, DOI 10.1002/jcc.23200; Webb B., 2014, CURR PROTOC BIOINFOR, V2014; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	38	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16300	16309		10.1074/jbc.M117.804781	http://dx.doi.org/10.1074/jbc.M117.804781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821615	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000412109400028
J	Neill, T; Sharpe, C; Owens, RT; Iozzo, RV				Neill, Thomas; Sharpe, Catherine; Owens, Rick T.; Iozzo, Renato V.			Decorin-evoked paternally expressed gene 3 (PEG3) is an upstream regulator of the transcription factor EB (TFEB) in endothelial cell autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPRINTED GENE; MATRIX METALLOPROTEINASES; LYSOSOMAL BIOGENESIS; SIGNALING PATHWAYS; LIPID-METABOLISM; VII COLLAGEN; IN-VIVO; GROWTH; ENDOREPELLIN; CANCER	Macroautophagy is a fundamental and evolutionarily conserved catabolic process that eradicates damaged and aging macromolecules and organelles in eukaryotic cells. Decorin, an archetypical small leucine-rich proteoglycan, initiates a protracted autophagic program downstream of VEGF receptor 2 (VEGFR2) signaling that requires paternally expressed gene 3 (PEG3). We have discovered that PEG3 is an upstream transcriptional regulator of transcription factor EB (TFEB), a master transcription factor of lysosomal biogenesis, for decorin-evoked endothelial cell autophagy. We found a functional requirement of PEG3 for TFEB transcriptional induction and nuclear translocation in human umbilical vein endothelial and PAER2 cells. Mechanistically, inhibiting VEGFR2 or AMP-activated protein kinase (AMPK), a major decorin-activated energy sensor kinase, prevented decorin-evoked TFEB induction and nuclear localization. In conclusion, our findings indicate a non-canonical (nutrient-and energy-independent) mechanism underlying the pro-autophagic bioactivity of decorin via PEG3 and TFEB.	[Neill, Thomas; Sharpe, Catherine; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA; [Neill, Thomas; Sharpe, Catherine; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	sharpe, catherine/0000-0003-0704-3380	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462, 5T32 AR060715-05]; Biotechnology and Biological Sciences Research Council [1618838] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA164462, R01CA047282, R01CA039481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The original research was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant 5T32 AR060715-05.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2013, AUTOPHAGY, V9, P1110, DOI 10.4161/auto.24877; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2013, AUTOPHAGY, V9, P1626, DOI 10.4161/auto.25881; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Wells A, 2016, MATRIX BIOL, V49, P25, DOI 10.1016/j.matbio.2015.08.001; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	76	37	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16211	16220		10.1074/jbc.M116.769950	http://dx.doi.org/10.1074/jbc.M116.769950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798237	hybrid, Green Published			2022-12-28	WOS:000412109400020
J	Wu, Q; Sun, M; Bernard, LP; Zhang, HY				Wu, Qian; Sun, Miao; Bernard, Laura P.; Zhang, Huaye			Postsynaptic density 95 (PSD-95) serine 561 phosphorylation regulates a conformational switch and bidirectional dendritic spine structural plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; AMPA RECEPTORS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; PROTEIN; MAGUK; POLARITY; IDENTIFICATION	Postsynaptic density 95 (PSD-95) is a major synaptic scaffolding protein that plays a key role in bidirectional synaptic plasticity, which is a process important for learning and memory. It is known that PSD-95 shows increased dynamics upon induction of plasticity. However, the underlying structural and functional changes in PSD-95 that mediate its role in plasticity remain unclear. Here we show that phosphorylation of PSD-95 at Ser-561 in its guanylate kinase (GK) domain, which is mediated by the partitioning-defective 1 (Par1) kinases, regulates a conformational switch and is important for bidirectional plasticity. Using a fluorescence resonance energy transfer (FRET) biosensor, we show that a phosphomimetic mutation of Ser-561 promotes an intramolecular interaction between GK and the nearby Src homology 3 (SH3) domain, leading to a closed conformation, whereas a non-phosphorylatable S561A mutation or inhibition of Par1 kinase activity decreases SH3-GK interaction, causing PSD-95 to adopt an open conformation. In addition, S561A mutation facilitates the interaction between PSD-95 and its binding partners. Fluorescence recovery after photobleaching imaging reveals that the S561A mutant shows increased stability, whereas the phosphomimetic S561D mutation increases PSD-95 dynamics at the synapse. Moreover, molecular replacement of endogenous PSD-95 with the S561A mutant blocks dendritic spine structural plasticity during chemical long-term potentiation and long-term depression. Endogenous Ser-561 phosphorylation is induced by synaptic NMDA receptor activation, and the SH3-GK domains exhibit a Ser-561 phosphorylation-dependent switch to a closed conformation during synaptic plasticity. Our results provide novel mechanistic insight into the regulation of PSD-95 in dendritic spine structural plasticity through phosphorylation-mediated regulation of protein dynamics and conformation.	[Wu, Qian; Sun, Miao; Bernard, Laura P.; Zhang, Huaye] Rutgers State Univ, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Wu, Qian] NewYork Univ, Sch Med, Dept Neurosci & Physiol, 550 First Ave, New York, NY 10016 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane West, Piscataway, NJ 08854 USA.	huaye.zhang@rutgers.edu			National Institutes of Health [NS065183, NS089578]; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089578, K99NS065183, R00NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS065183 and NS089578 and startup funds from the Rutgers Robert Wood Johnson Medical School (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bernard LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124816; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou HL, 2013, J CELL BIOL, V203, P521, DOI 10.1083/jcb.201303035; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nelson CD, 2013, J NEUROSCI, V33, P12122, DOI 10.1523/JNEUROSCI.0131-13.2013; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sun M, 2013, JOVE-J VIS EXP, DOI 10.3791/50808; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	48	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16150	16160		10.1074/jbc.M117.782490	http://dx.doi.org/10.1074/jbc.M117.782490			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28790172	hybrid, Green Published			2022-12-28	WOS:000412109400015
J	He, W; Felderman, M; Evans, AC; Geng, J; Homan, D; Bourguet, F; Fischer, NO; Li, YP; Lam, KS; Noy, A; Xing, L; Cheng, RH; Rasley, A; Blanchette, CD; Kamrud, K; Wang, N; Gouvis, H; Peterson, TC; Hubby, B; Coleman, MA				He, Wei; Felderman, Martina; Evans, Angela C.; Geng, Jia; Homan, David; Bourguet, Feliza; Fischer, Nicholas O.; Li, Yuanpei; Lam, Kit S.; Noy, Aleksandr; Xing, Li; Cheng, R. Holland; Rasley, Amy; Blanchette, Craig D.; Kamrud, Kurt; Wang, Nathaniel; Gouvis, Heather; Peterson, Todd C.; Hubby, Bolyn; Coleman, Matthew A.			Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHELATING NANOLIPOPROTEIN PARTICLES; MURIDARUM GENITAL-INFECTION; IMMUNE-RESPONSE; BILAYER NANODISCS; FREE EXPRESSION; LIPID-BILAYERS; TRACHOMATIS; CHALLENGE; PROTECTION; COMPLEX	Chlamydia is a prevalent sexually transmitted disease that infects more than 100 million people worldwide. Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, symptoms can arise if left undiagnosed. Longterm infection can result in debilitating conditions such as pelvic inflammatory disease, infertility, and blindness. Chlamydia infection, therefore, constitutes a significant public health threat, underscoring the need for a Chlamydia-specific vaccine. Chlamydia strains express a major outer-membrane protein (MOMP) that has been shown to be an effective vaccine antigen. However, approaches to produce a functional recombinant MOMP protein for vaccine development are limited by poor solubility, low yield, and protein misfolding. Here, we used an Escherichia coli-based cell-free system to express a MOMP protein from the mouse-specific species Chlamydia muridarum (MoPn-MOMP or mMOMP). The codon-optimized mMOMP gene was co-translated with Delta 49apolipoprotein A1(Delta 49ApoA1), a truncated version of mouse ApoA1 in which the N-terminal 49 amino acids were removed. This co-translation process produced mMOMP supported within a telodendrimer nanolipoprotein particle (mMOMP-tNLP). The cell-free expressed mMOMP-tNLPs contain mMOMP multimers similar to the native MOMP protein. This cell-free process produced on average 1.5 mg of purified, water-soluble mMOMP-tNLP complex in a 1-ml cell-free reaction. The mMOMP-tNLP particle also accommodated the co-localization of CpG oligodeoxynucleotide 1826, a single-stranded synthetic DNA adjuvant, eliciting an enhanced humoral immune response in vaccinated mice. Using our mMOMP-tNLP formulation, we demonstrate a unique approach to solubilizing and administering membrane-bound proteins for future vaccine development. This method can be applied to other previously difficult-to-obtain antigens while maintaining full functionality and immunogenicity.	[He, Wei; Evans, Angela C.; Geng, Jia; Homan, David; Bourguet, Feliza; Fischer, Nicholas O.; Noy, Aleksandr; Rasley, Amy; Blanchette, Craig D.; Coleman, Matthew A.] Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA; [Felderman, Martina; Kamrud, Kurt; Wang, Nathaniel; Gouvis, Heather; Peterson, Todd C.; Hubby, Bolyn] Synthet Genom Vaccine Inc, La Jolla, CA 92037 USA; [Geng, Jia; Noy, Aleksandr] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Li, Yuanpei; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Coleman, Matthew A.] Univ Calif Davis, Radiat Oncol, Sch Med, Sacramento, CA 95817 USA; [Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95618 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Coleman, MA (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	coleman16@llnl.gov	Geng, Jia/AAR-2192-2021; He, Wei/X-1574-2019; Cheng, Holland/A-8973-2008; Geng, Jia/G-4332-2010; Fischer, Nicholas/AAE-2409-2019	He, Wei/0000-0003-2795-0324; Geng, Jia/0000-0003-4753-1039; Fischer, Nicholas/0000-0001-7575-4390; Bourguet, Feliza/0000-0003-3557-404X; Coleman, Matthew/0000-0003-1389-4018; Rasley, Amy/0000-0002-4767-6628; Noy, Aleksandr/0000-0003-4924-2652	United States Department of Energy [DE-AC52-07NA27344]; NCI, National Institutes of Health [R01CA115483, R01CA199668]; NIAID, National Institutes of Health [R21 RAI120925A]; Synthetic Genomics Vaccine Inc.; NATIONAL CANCER INSTITUTE [R01CA115483, R01CA199668, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120925] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Synthetic Genomics Vaccine Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Department of Energy Contract DE-AC52-07NA27344; NCI, National Institutes of Health Grants R01CA115483 and R01CA199668; and NIAID, National Institutes of Health Grant R21 RAI120925A. M. Felderman, K. Kamrud, N. Wang, H. Gouvis, T.C. Peterson, and B. Hubby are employed by Synthetic Genomics Vaccine Inc. Synthetic Genomics Vaccine Inc. (La Jolla, CA) provided funding under a Work for Others Agreement to Lawrence Livermore National Laboratory. As a funding agency they had no role in study design or data collection and analysis for publication of the data. They do have a financial interest through the development of novel synthetic biology strategies for vaccine development. This does not alter the authors' adherence to all the JBC policies on sharing data and materials. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2010, BIOCONJUGATE CHEM, V21, P1321, DOI 10.1021/bc100129s; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Coleman MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150166; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Feher VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068934; Ferrara LGM, 2016, J MOL BIOL, V428, P4528, DOI 10.1016/j.jmb.2016.09.021; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Fischer NO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093342; Fischer NO, 2013, J AM CHEM SOC, V135, P2044, DOI 10.1021/ja3063293; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; GABAY JE, 1985, J BACTERIOL, V162, P85, DOI 10.1128/JB.162.1.85-91.1985; Gao TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044911; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Garda HA, 2002, J BIOL CHEM, V277, P19773, DOI 10.1074/jbc.M110089200; Gogol EP, 2013, PROTEIN SCI, V22, P586, DOI 10.1002/pro.2241; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Haque F, 2013, NAT PROTOC, V8, P373, DOI 10.1038/nprot.2013.001; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12896; He W, 2013, PROTEIN SCI, V22, P1078, DOI 10.1002/pro.2292; JONAS A, 1984, J BIOL CHEM, V259, P6369; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Lai G, 2015, BIOPHYS CHEM, V197, P47, DOI 10.1016/j.bpc.2015.01.006; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Luo JT, 2010, BIOCONJUGATE CHEM, V21, P1216, DOI 10.1021/bc1000033; MANNING DS, 1993, INFECT IMMUN, V61, P4093, DOI 10.1128/IAI.61.10.4093-4098.1993; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2001, INFECT IMMUN, V69, P6240, DOI 10.1128/IAI.69.10.6240-6247.2001; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Proverbio D, 2013, BBA-BIOMEMBRANES, V1828, P2182, DOI 10.1016/j.bbamem.2013.05.031; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; SONAR S, 1993, BIOCHEMISTRY-US, V32, P13777, DOI 10.1021/bi00213a004; Stratton K. R., 2000, VACCINES 21 CENTURY, P362; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Sun GF, 2009, VACCINE, V27, P5020, DOI 10.1016/j.vaccine.2009.05.008; Sunahara H, 2007, J AM CHEM SOC, V129, P5597, DOI 10.1021/ja068551y; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Tifrea DF, 2014, J IMMUNOL, V192, P5201, DOI 10.4049/jimmunol.1303392; Tifrea DF, 2011, VACCINE, V29, P4623, DOI 10.1016/j.vaccine.2011.04.065; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Wen ZY, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0787-3; Xiao K, 2013, THER DELIV, V4, P1279, DOI [10.4155/tde.13.91, 10.4155/TDE.13.91]; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210	60	18	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15121	15132		10.1074/jbc.M117.784561	http://dx.doi.org/10.1074/jbc.M117.784561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739800	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000409902100033
J	Sahu, U; Rajendra, VKH; Kapnoor, SS; Bhagavat, R; Chandra, N; Rangarajan, PN				Sahu, Umakant; Rajendra, Vinod K. H.; Kapnoor, Shankar S.; Bhagavat, Raghu; Chandra, Nagasuma; Rangarajan, Pundi N.			Methionine synthase is localized to the nucleus in Pichia pastoris and Candida albicans and to the cytoplasm in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOL UTILIZATION PATHWAY; REGULATOR 1 MXR1P; METHYLOTROPHIC YEAST; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PROTEIN; EXPRESSION; GENE; IDENTIFICATION; ZINC	Methionine synthase (MS) catalyzes methylation of homocysteine, the last step in the biosynthesis of methionine, which is essential for the regeneration of tetrahydrofolate and biosynthesis of S-adenosylmethionine. Here, we report that MS is localized to the nucleus of Pichia pastoris and Candida albicans but is cytoplasmic in Saccharomyces cerevisiae. The P. pastoris strain carrying a deletion of the MET6 gene encoding MS (Ppmet6) exhibits methionine as well as adenine auxotrophy indicating that MS is required for methionine as well as adenine biosynthesis. Nuclear localization of P. pastoris MS (PpMS) was abrogated by the deletion of 107 C-terminal amino acids or the R742A mutation. In silico analysis of the PpMS structure indicated that PpMS may exist in a dimer-like configuration in which Arg-742 of a monomer forms a salt bridge with Asp-113 of another monomer. Biochemical studies indicate that R742A as well as D113R mutations abrogate nuclear localization of PpMS and its ability to reverse methionine auxotrophy of Ppmet6. Thus, association of two PpMS monomers through the interaction of Arg-742 and Asp-113 is essential for catalytic activity and nuclear localization. When PpMS is targeted to the cytoplasm employing a heterologous nuclear export signal, it is expressed at very low levels and is unable to reverse methionine and adenine auxotrophy of Ppmet6. Thus, nuclear localization is essential for the stability and function of MS in P. pastoris. We conclude that nuclear localization of MS is a unique feature of respiratory yeasts such as P. pastoris and C. albicans, and it may have novel moonlighting functions in the nucleus.	[Sahu, Umakant; Rajendra, Vinod K. H.; Kapnoor, Shankar S.; Bhagavat, Raghu; Chandra, Nagasuma; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in		Chandra, Nagasuma/0000-0002-9939-8439	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India [SB/S2/JCB-025/2015, EMR/2015/000567]; Department of Biotechnology-Indian Institute of Science; Department of Biotechnology, New Delhi, India	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India; Department of Biotechnology-Indian Institute of Science; Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported in part by Research Grant EMR/2015/000567 and J.C. Bose Fellowship Grant SB/S2/JCB-025/2015 from the Science and Engineering Research Board, Department of Science and Technology, New Delhi, India (to P.N.R.), and by the Department of Biotechnology-Indian Institute of Science partnership program. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of post-doctoral fellowship of Department of Biotechnology, New Delhi, India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; GONZALEZ JC, 1992, BIOCHEMISTRY-US, V31, P6045, DOI 10.1021/bi00141a013; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; Huang L, 2005, ACTA BIOCH BIOPH SIN, V37, P371, DOI 10.1111/j.1745-7270.2005.00054.x; IDE GJ, 1981, CURR GENET, V4, P85, DOI 10.1007/BF00365686; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Kacprzak MM, 2003, BIOCHEM J, V376, P517, DOI 10.1042/BJ20030747; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Matthews RG, 2003, HELV CHIM ACTA, V86, P3939, DOI 10.1002/hlca.200390329; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; Prasannan P, 2009, BIOCHEM BIOPH RES CO, V382, P730, DOI 10.1016/j.bbrc.2009.03.098; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Sahu U, 2016, J BIOL CHEM, V291, P20588, DOI 10.1074/jbc.M116.740191; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Mir L, 2012, J BIOL CHEM, V287, P26038, DOI 10.1074/jbc.M112.345611; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shulga N, 1999, J BIOL CHEM, V274, P16501, DOI 10.1074/jbc.274.23.16501; Sohn MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100725; Suliman HS, 2007, ARCH BIOCHEM BIOPHYS, V467, P218, DOI 10.1016/j.abb.2007.09.003; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Ubhi D, 2014, J MOL BIOL, V426, P1839, DOI 10.1016/j.jmb.2014.02.006; Ubhi D, 2011, ARCH BIOCHEM BIOPHYS, V513, P19, DOI 10.1016/j.abb.2011.06.002; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zameitat E, 2006, FEBS J, V273, P3183, DOI 10.1111/j.1742-4658.2006.05327.x	57	3	5	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14730	14746		10.1074/jbc.M117.783019	http://dx.doi.org/10.1074/jbc.M117.783019			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28701466	Green Published, hybrid			2022-12-28	WOS:000409902100002
J	Shay, AE; Diwakar, BT; Guan, BJ; Narayan, V; Urban, JF; Prabhu, KS				Shay, Ashley E.; Diwakar, Bastihalli T.; Guan, Bo-Jhih; Narayan, Vivek; Urban, Joseph F., Jr.; Prabhu, K. Sandeep			IL-4 up-regulates cyclooxygenase-1 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONIC MYOFIBROBLAST MIGRATION; FES PROTOONCOGENE PRODUCT; RECEPTOR PPAR-GAMMA; ALTERNATIVE ACTIVATION; LIPID MEDIATORS; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN-KINASE; CANCER CELLS; INFLAMMATION	Macrophages use various cell-surface receptors to sense their environment and undergo polarized responses. The cytokines, interleukin (IL)-4 and IL-13, released from T-helper type 2 (Th2) cells, drive macrophage polarization toward an alternatively activated phenotype (M2). This phenotype is associated with the expression of potent pro-resolving mediators, such as the prostaglandin (PG) D2-derived cyclopentenone metabolite, 15d-PGJ2, produced by the cyclooxygenase (Ptgs; Cox) pathway. Interestingly, IL-4 treatment of bone marrow-derived macrophages (BMDMs) significantly down-regulates Cox-2 protein expression, whereas Cox-1 levels are significantly increased. This phenomenon not only challenges the dogma that Cox-1 is only developmentally regulated, but also demonstrates a novel mechanism in which IL-4-dependent regulation of Cox-1 involves the activation of the mechanistic target of rapamycin complex (mTORC). Using specific chemical inhibitors, we demonstrate here that IL-4-dependent Cox-1 up-regulation occurs at the post-transcriptional level via the Fes-Akt-mTORC axis. Activation of AMP-activated protein kinase (AMPK) by metformin, inhibition of mTORC by torin 1, or CRISPR/Cas9-mediated genetic knock-out of tuberous sclerosis complex-2 (Tsc2) blocked the IL-4-dependent expression of Cox-1 and the ability of macrophages to polarize to M2. However, use of 15d-PGJ2 partially rescued the effects of AMPK activation, suggesting the importance of Cox-1 in macrophage polarization as also observed in a model of gastrointestinal helminth clearance. In summary, these findings suggest a new paradigm where IL-4-dependent up-regulation of Cox-1 expression may play a key role in tissue homeostasis and wound healing during Th2-mediated immune responses, such as parasitic infections.	[Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Guan, Bo-Jhih] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Narayan, Vivek] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Case Western Reserve University; Cleveland Clinic Foundation; United States Department of Agriculture (USDA)	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.; Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ksprabhu@psu.edu	Tukaramra, Diwakar Bastihalli/AFC-2245-2022	Tukaramra, Diwakar Bastihalli/0000-0002-9503-3424; Urban, Joseph/0000-0002-1590-8869; Narayan, Vivek/0000-0002-3232-7898	United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant [R01DK077152]; USDA Hatch Funds [4605]; National Institutes of Health [5T32AI074551-05]; NATIONAL CANCER INSTITUTE [R01CA162665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant; USDA Hatch Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant R01DK077152, and by USDA Hatch Funds Grant 4605 (to K. S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant 5T32AI074551-05.	Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Cho W, 2011, MOL IMMUNOL, V48, P966, DOI 10.1016/j.molimm.2011.01.007; Chu E, 2017, J SURG RES, V209, P191, DOI 10.1016/j.jss.2016.10.014; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Erices R, 2013, REPROD SCI, V20, P1433, DOI 10.1177/1933719113488441; Fagone P, 2012, INFLAMM RES, V61, P1131, DOI 10.1007/s00011-012-0506-y; Fitzpatrick FA, 2004, CURR PHARM DESIGN, V10, P577, DOI 10.2174/1381612043453144; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; Harrington LS, 2008, FASEB J, V22, P4005, DOI 10.1096/fj.08-107979; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Incio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141392; Izuhara K, 1996, BLOOD, V88, P3910, DOI 10.1182/blood.V88.10.3910.bloodjournal88103910; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang H, 2001, J IMMUNOL, V166, P2627, DOI 10.4049/jimmunol.166.4.2627; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Miller-Graziano Carol L, 2008, Novartis Found Symp, V291, P196; Mohammadi A, 2016, INFLAMMATION, V39, P1116, DOI 10.1007/s10753-016-0343-1; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Nelson SM, 2016, J BIOL CHEM, V291, P2787, DOI 10.1074/jbc.M115.684738; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Saini S, 2016, J SURG RES, V204, P145, DOI 10.1016/j.jss.2016.04.034; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	53	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14544	14555		10.1074/jbc.M117.785014	http://dx.doi.org/10.1074/jbc.M117.785014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684424	Green Published, hybrid			2022-12-28	WOS:000408747500020
J	Willy, JA; Young, SK; Mosley, AL; Gawrieh, S; Stevens, JL; Masuoka, HC; Wek, RC				Willy, Jeffrey A.; Young, Sara K.; Mosley, Amber L.; Gawrieh, Samer; Stevens, James L.; Masuoka, Howard C.; Wek, Ronald C.			Function of inhibitor of Bruton's tyrosine kinase isoform (IBTK) in nonalcoholic steatohepatitis links autophagy and the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; eukaryotic initiation factor 2 (eIF2); eukaryotic translation initiation; translation control; unfolded protein response (UPR)	ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; TRANSLATIONAL CONTROL; CELL-DEATH; PHOSPHORYLATION; PATHOGENESIS; BIOGENESIS; APOPTOSIS; PATHWAY; SITES	Nonalcoholic fatty liver disease (steatosis) is the most prevalent liver disease in the Western world. One of the advanced pathologies is nonalcoholic steatohepatitis (NASH), which is associated with induction of the unfolded protein response (UPR) and disruption of autophagic flux. However, the mechanisms by which these processes contribute to the pathogenesis of human diseases are unclear. Herein, we identify the isoform of the inhibitor of Bruton's tyrosine kinase (IBTK) as a member of the UPR, whose expression is preferentially translated during endoplasmic reticulum (ER) stress. We found that IBTK is located in the ER and associates with proteins LC3b, SEC16A, and SEC31A and plays a previously unrecognized role in phagophore initiation from ER exit sites. Depletion of IBTK helps prevent accumulation of autophagosome intermediates stemming from exposure to saturated free fatty acids and rescues hepatocytes from death. Of note, induction of IBTK and the UPR, along with inhibition of autophagic flux, was associated with progression from steatosis to NASH in liver biopsies. These results indicate a function for IBTK in NASH that links autophagy with activation of the UPR.	[Willy, Jeffrey A.; Young, Sara K.; Mosley, Amber L.; Stevens, James L.; Masuoka, Howard C.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Gawrieh, Samer] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu	Gawrieh, Samer/AAS-8904-2020	Young-Baird, Sara/0000-0002-8915-3139	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; Lilly Graduate Research Advanced Degrees program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; Lilly Graduate Research Advanced Degrees program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Lilly Graduate Research Advanced Degrees program.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; CHEN Q, 1990, J BIOL CHEM, V265, P21603; Choi H., 2012, CURR PROTOC BIOINFOR; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Graef M, 2013, MOL BIOL CELL, V24, P2918, DOI 10.1091/mbc.E13-07-0381; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gual P, 2017, AM J PHYSIOL-CELL PH, V312, pC263, DOI 10.1152/ajpcell.00295.2016; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Luo M, 2010, CELL RES, V20, P211, DOI 10.1038/cr.2010.9; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Pisano A, 2015, J BIOL CHEM, V290, P13958, DOI 10.1074/jbc.M114.634535; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sanchez-Wandelmer J, 2015, J CELL SCI, V128, P185, DOI 10.1242/jcs.158758; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Tan DY, 2013, P NATL ACAD SCI USA, V110, P19432, DOI 10.1073/pnas.1316356110; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	46	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14050	14065		10.1074/jbc.M117.799304	http://dx.doi.org/10.1074/jbc.M117.799304			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28710282	hybrid, Green Published			2022-12-28	WOS:000408439800013
J	Shen, D; Podolnikova, NP; Yakubenko, VP; Ardell, CL; Balabiyev, A; Ugarova, TP; Wang, X				Shen, Di; Podolnikova, Nataly P.; Yakubenko, Valentin P.; Ardell, Christopher L.; Balabiyev, Arnat; Ugarova, Tatiana P.; Wang, Xu			Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; cell migration; integrin; nuclear magnetic resonance (NMR); pleiotrophin; CD11b; CD18; Mac-1; M2	HEPARIN-BINDING CYTOKINE; MOLECULE HB-GAM; CELL-MIGRATION; ALPHA(M)BETA(2) MAC-1; A-DOMAIN; IN-VIVO; MIDKINE; EXPRESSION; IDENTIFICATION; RECEPTOR	Pleiotrophin (PTN) is a multifunctional, cationic, glycosaminoglycan-binding cytokine and growth factor involved in numerous physiological and pathological processes, including tissue repair and inflammation-related diseases. PTN has been shown to promote leukocyte responses by inducing their migration and expression of inflammatory cytokines. However, the mechanisms through which PTN mediates these responses remain unclear. Here, we identified the integrin Mac-1 (M2, CD11b/CD18) as the receptor mediating macrophage adhesion and migration to PTN. We also found that expression of Mac-1 on the surface of human embryonic kidney (HEK) 293 cells induced their adhesion and migration to PTN. Accordingly, PTN promoted Mac-1-dependent cell spreading and initiated intracellular signaling manifested in phosphorylation of Erk1/2. While binding to PTN, Mac-1 on Mac-1-expressing HEK293 cells appears to cooperate with cell-surface proteoglycans because both anti-Mac-1 function-blocking mAb and heparin were required to block adhesion. Moreover, biolayer interferometry and NMR indicated a direct interaction between the I-M domain, the major ligand-binding region of Mac-1, and PTN. Using peptide libraries, we found that in PTN the I-M domain bound sequences enriched in basic and hydrophobic residues, indicating that PTN conforms to the general principle of ligand-recognition specificity of the I-M domain toward cationic proteins/peptides. Finally, using recombinant PTN-derived fragments, we show that PTN contains two distinct Mac-1-binding sites in each of its constitutive domains. Collectively, these results identify PTN as a ligand for the integrin Mac-1 on the surface of leukocytes and suggest that this interaction may play a role in inflammatory responses.	[Shen, Di; Wang, Xu] Arizona State Univ, Sch Mol, Tempe, AZ 85287 USA; [Podolnikova, Nataly P.; Balabiyev, Arnat; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Yakubenko, Valentin P.; Ardell, Christopher L.] East Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; East Tennessee State University	Wang, X (corresponding author), Arizona State Univ, Sch Mol, Tempe, AZ 85287 USA.; Ugarova, TP (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Tatiana.Ugarova@asu.edu; xuwang@asu.edu	Di, Shen/AAK-7950-2021; Shen, Di/AGZ-1567-2022	Balabiyev, Arnat/0000-0002-8904-598X; Wang, Xu/0000-0002-7369-677X	National Institutes of Health [GM118339, GM118518, HL63199, DK102020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK102020, R01DK102020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118518, R21GM118339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118339 (to X. W.), GM118518 (to X. W.), HL63199 (to T. P. U.), and DK102020 (to V. P. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achour A, 2008, BIOCHIMIE, V90, P1791, DOI 10.1016/j.biochi.2008.04.010; Ajroud K, 2004, J BIOL CHEM, V279, P25483, DOI 10.1074/jbc.M402901200; Besse S, 2013, CYTOKINE, V62, P44, DOI 10.1016/j.cyto.2013.02.002; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Ding ZM, 1999, J IMMUNOL, V163, P5029; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gonzalez-Castillo C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00443; Hatziapostolou M, 2005, PROSTATE, V65, P151, DOI 10.1002/pros.20270; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Jager R, 1997, INT J CANCER, V73, P537; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kadomatsu Kenji, 2005, Nagoya J Med Sci, V67, P71; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; Kong Y, 2012, INT J COLORECTAL DIS, V27, P287, DOI 10.1007/s00384-011-1344-z; Koutsioumpa M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0287-3; Koutsioumpa M, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-4; Kramer A, 1998, METH MOL B, V87, P25; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lishko VK, 2016, RES REP BIOCHEM, V6, P39, DOI 10.2147/RRBC.S107070; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P814, DOI 10.1111/bph.12353; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Paveliev M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33916; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Podolnikova NP, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0027-0; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; RAULO E, 1994, J BIOL CHEM, V269, P12999; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; Ryan E, 2016, FEBS J, V283, P1488, DOI 10.1111/febs.13686; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Silver K, 2012, GROWTH FACTORS, V30, P258, DOI 10.3109/08977194.2012.693920; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Weber D, 2000, CANCER RES, V60, P5284; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305; Yu Yong, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P289; Yu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069883; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	62	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18848	18861		10.1074/jbc.M116.773713	http://dx.doi.org/10.1074/jbc.M116.773713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939773	Green Published, hybrid			2022-12-28	WOS:000415848000011
J	Xie, H; Simon, MC				Xie, Hong; Simon, M. Celeste			Oxygen availability and metabolic reprogramming in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer; glucose; glutamine; hypoxia; lipid metabolism; metabolism; IDH; ROS	MITOCHONDRIAL-COMPLEX-III; RENAL-CELL CARCINOMA; ACETYL-COA SYNTHETASE; PYRUVATE-KINASE M2; INDUCIBLE FACTOR-I; GLUTAMINE-METABOLISM; LIPID STORAGE; GLYCOGEN-METABOLISM; TUMOR-GROWTH; DESATURASE 1	Hypoxia and dysregulated metabolism are defining features of solid tumors. How cancer cells adapt to low O-2 has been illuminated by numerous studies, with reprogrammed metabolism being one of the most important mechanisms. This metabolic reprogramming not only promotes cancer cell plasticity, but also provides novel insights for treatment strategies. As the most studied O-2 sensor, hypoxia-inducible factor (HIF) is regarded as an important regulator of hypoxia-induced transcriptional responses. This minireview will summarize our current understanding of hypoxia-induced changes in cancer cell metabolism, with an initial focus on HIF-mediated effects, and will highlight how these metabolic alterations affect malignant phenotypes.	[Xie, Hong; Simon, M. Celeste] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Xie, Hong] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Pennsylvania, Perelman Sch Med, Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Simon, MC (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.; Simon, MC (corresponding author), Univ Pennsylvania, Perelman Sch Med, Cell & Dev Biol, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		Alex's Lemonade Stand Foundation; National Institutes of Health NCI [P01 CA104838, R01 158301]; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA158301, R35CA220483] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a fellowship from Alex's Lemonade Stand Foundation.; Supported by National Institutes of Health NCI Grants P01 CA104838 and R01 158301. To whom correspondence should be addressed. Tel.: 215-746-5532; Fax: 215-746-5511; E-mail: celeste2@mail.med.upenn.edu.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Anso E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bertero T, 2017, INT REV CEL MOL BIO, V333, P91, DOI 10.1016/bs.ircmb.2017.03.006; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Engqvist MKM, 2014, MITOCHONDRION, V19, P275, DOI 10.1016/j.mito.2014.02.009; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Lee KE, 2015, CELL, V163, P1288, DOI 10.1016/j.cell.2015.11.011; Lee WNP, 2004, BRIT J CANCER, V91, P2094, DOI 10.1038/sj.bjc.6602243; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Okazaki A, 2017, J CLIN INVEST, V127, P1631, DOI 10.1172/JCI87800; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; ROUSSET M, 1981, CANCER RES, V41, P1165; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Shih AH, 2017, CANCER DISCOV, V7, P494, DOI 10.1158/2159-8290.CD-16-1049; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	68	107	111	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16825	16832		10.1074/jbc.R117.799973	http://dx.doi.org/10.1074/jbc.R117.799973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842498	Green Published, hybrid			2022-12-28	WOS:000413140600005
J	Khalafalla, MG; Woods, LT; Camden, JM; Khan, AA; Limesand, KH; Petris, MJ; Erb, L; Weisman, GA				Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Limesand, Kirsten H.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.			P2X7 receptor antagonism prevents IL-1 beta release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SJOGRENS-SYNDROME; P2X(7) RECEPTOR; NLRP3 INFLAMMASOME; SUBMANDIBULAR-GLAND; UP-REGULATION; NALP3 INFLAMMASOME; LUNG INFLAMMATION; EXTRACELLULAR ATP; IMMUNE-RESPONSES; ACTIVATION	Salivary gland inflammation is a hallmark of Sjogren's syndrome (SS), a common autoimmune disease characterized by lymphocytic infiltration of the salivary gland and loss of saliva secretion, predominantly in women. The P2X7 receptor (P2X7R) is an ATP-gated nonselective cation channel that induces inflammatory responses in cells and tissues, including salivary gland epithelium. In immune cells, P2X7R activation induces the production of proinflammatory cytokines, including IL-1 beta and IL-18, by inducing the oligomerization of the multiprotein complex NLRP3-type inflammasome. Here, our results show that in primary mouse submandibular gland (SMG) epithelial cells, P2X7R activation also induces the assembly of the NLRP3 inflammasome and the maturation and release of IL-1 beta, a response that is absent in SMG cells isolated from mice deficient in P2X7Rs (P2X7R(-/-)). P2X7R-mediated IL-1 beta release in SMG epithelial cells is dependent on transmembrane Na+ and/or K+ flux and the activation of heat shock protein 90 (HSP90), a protein required for the activation and stabilization of the NLRP3 inflammasome. Also, using the reactive oxygen species (ROS) scavengers N-acetyl cysteine and Mito-TEMPO, we determined that mitochondrial reactive oxygen species are required for P2X7R-mediated IL-1 beta release. Lastly, in vivo administration of the P2X7R antagonist A438079 in the CD28(-/-), IFN gamma(-/-), NOD.H-2(h4) mouse model of salivary gland exocrinopathy ameliorated salivary gland inflammation and enhanced carbachol-induced saliva secretion. These findings demonstrate that P2X7R antagonism in vivo represents a promising therapeutic strategy to limit salivary gland inflammation and improve secretory function.	[Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arizona	Weisman, GA (corresponding author), Univ Missouri, 540E Life Sci Ctr,1201 Rollins Rd, Columbia, MO 65211 USA.	weismang@missouri.edu		Khalafalla, Mahmoud/0000-0002-7171-8162	National Institute of Dental and Craniofacial Research, National Institutes of Health [DE023342]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023342] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research, National Institutes of Health Grant DE023342. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Ahn JS, 2000, AM J PHYSIOL-CELL PH, V279, pC286, DOI 10.1152/ajpcell.2000.279.2.C286; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Atkinson Jane C, 2005, Dent Clin North Am, V49, P309, DOI 10.1016/j.cden.2004.10.002; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Baldini C, 2013, J INTERN MED, V274, P480, DOI 10.1111/joim.12115; Barrera MJ, 2013, J AUTOIMMUN, V42, P7, DOI 10.1016/j.jaut.2013.02.001; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Delaleu N, 2005, EUR J ORAL SCI, V113, P101, DOI 10.1111/j.1600-0722.2004.00183.x; Delaleu N, 2016, RHEUMATOLOGY, V55, P1127, DOI 10.1093/rheumatology/kew013; Deplano S, 2013, J LEUKOCYTE BIOL, V93, P127, DOI 10.1189/jlb.0612284; Di Virgilio F, 1998, BIOFACTORS, V8, P301; Di Virgilio F, 2015, CURR MED CHEM, V22, P866; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; El-Sayed FG, 2014, AM J PHYSIOL-CELL PH, V307, pC83, DOI 10.1152/ajpcell.00380.2013; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Fox PC, 2004, CARIES RES, V38, P241, DOI 10.1159/000077761; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hwang SM, 2009, KOREAN J PHYSIOL PHA, V13, P175, DOI 10.4196/kjpp.2009.13.3.175; Jonsson MV, 2006, ARTHRITIS RHEUM, V54, P2300, DOI 10.1002/art.21945; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kayes TD, 2016, J IMMUNOL, V197, P2119, DOI 10.4049/jimmunol.1600133; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Lee YA, 2012, EXP MOL MED, V44, P440, DOI 10.3858/emm.2012.44.7.049; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Manoussakis MN, 2007, CLIN REV ALLERG IMMU, V32, P225, DOI 10.1007/s12016-007-8007-4; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Peterson TS, 2013, J NEUROCHEM, V125, P885, DOI 10.1111/jnc.12252; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Scroggins BT, 2007, EXPERT OPIN DRUG DIS, V2, P1403, DOI 10.1517/17460441.2.10.1403; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Shimoda S, 2008, HEPATOLOGY, V47, P958, DOI 10.1002/hep.22102; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2009, J AM SOC NEPHROL, V20, P1275, DOI 10.1681/ASN.2008060559; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; Tincani A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-93; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Turner JT, 1997, AM J PHYSIOL-CELL PH, V273, pC1100, DOI 10.1152/ajpcell.1997.273.3.C1100; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WEISMAN GA, 1984, J CELL PHYSIOL, V119, P211, DOI 10.1002/jcp.1041190211; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Witte E, 2016, J MOL MED, V94, P391, DOI 10.1007/s00109-015-1367-y; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	85	51	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16626	16637		10.1074/jbc.M117.790741	http://dx.doi.org/10.1074/jbc.M117.790741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798231	Green Published, hybrid			2022-12-28	WOS:000412414800023
J	Knappenberger, AJ; Grandhi, S; Sheth, R; Ahmad, MF; Viswanathan, R; Harris, ME				Knappenberger, Andrew J.; Grandhi, Sneha; Sheth, Reena; Ahmad, Md. Faiz; Viswanathan, Rajesh; Harris, Michael E.			Phylogenetic sequence analysis and functional studies reveal compensatory amino acid substitutions in loop 2 of human ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMBALANCED DNTP POOLS; ALLOSTERIC REGULATION; COMPREHENSIVE MODEL; INDUCED OLIGOMERIZATION; SUBSTRATE-SPECIFICITY; STRUCTURAL MECHANISM; ENZYME SPECIFICITY; LARGE SUBUNIT; PROTEIN R1; IN-VIVO	Eukaryotic class I ribonucleotide reductases (RRs) generate deoxyribonucleotides for DNA synthesis. Binding of dNTP effectors is coupled to the formation of active dimers and induces conformational changes in a short loop (loop 2) to regulate RR specificity among its nucleoside diphosphate substrates. Moreover, ATP and dATP bind at an additional allosteric site 40 angstrom away from loop 2 and thereby drive formation of activated or inactive hexamers, respectively. To better understand how dNTP binding influences specificity, activity, and oligomerization of human RR, we aligned >300 eukaryotic RR sequences to examine natural sequence variation in loop 2. We found that most amino acids in eukaryotic loop 2 were nearly invariant in this sample; however, two positions co-varied as nonconservative substitutions (N291G and P294K; human numbering). We also found that the individual N291G and P294K substitutions in human RR additively affect substrate specificity. The P294K substitution significantly impaired effector-induced oligomerization required for enzyme activity, and oligomerization was rescued in the N291G/P294K enzyme. None of the other mutants exhibited altered ATP-mediated hexamerization; however, certain combinations of loop 2 mutations and dNTP effectors perturbed ATP's role as an allosteric activator. Our results demonstrate that the observed compensatory covariation of amino acids in eukaryotic loop 2 is essential for its role in dNTP-induced dimerization. In contrast, defects in substrate specificity are not rescued in the double mutant, implying that functional sequence variation elsewhere in the protein is necessary. These findings yield insight into loop 2's roles in regulating RR specificity, allostery, and oligomerization.	[Knappenberger, Andrew J.; Sheth, Reena; Harris, Michael E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Grandhi, Sneha] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Ahmad, Md. Faiz] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Viswanathan, Rajesh] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Harris, ME (corresponding author), Univ Florida, Dept Chem, 302F Hernandez Hall, Gainesville, FL 32611 USA.	harris@chem.ufl.edu		Knappenberger, Andrew/0000-0003-2659-4305	National Institutes of Health [R01 GM096000, T32 GM008056]; Department of Biochemistry at Case Western Reserve University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096000, T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry at Case Western Reserve University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM096000 and T32 GM008056. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Department of Biochemistry at Case Western Reserve University.	Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Ahmad MF, 2012, MOL CANCER THER, V11, P2077, DOI 10.1158/1535-7163.MCT-12-0199; Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; Chimploy K, 2001, J BIOL CHEM, V276, P7093, DOI 10.1074/jbc.M006232200; Cooperman BS, 2003, ADV ENZYME REGUL, V43, P167, DOI 10.1016/S0065-2571(02)00035-3; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; DAVIS R, 1994, J BIOL CHEM, V269, P23171; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gupta V, 2004, BIOCHEMISTRY-US, V43, P8568, DOI 10.1021/bi0361721; Hendricks SP, 1997, J BIOL CHEM, V272, P2861, DOI 10.1074/jbc.272.5.2861; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Ingemarson R, 1996, BIOCHEMISTRY-US, V35, P8603, DOI 10.1021/bi960184n; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Knappenberger AJ, 2016, BIOCHEMISTRY-US, V55, P5884, DOI 10.1021/acs.biochem.6b00594; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; McCullough MJ, 1996, INT J ORAL MAX SURG, V25, P136, DOI 10.1016/S0901-5027(96)80060-9; Northrop DB, 1999, ADV ENZYMOL RAMB, V73, P25, DOI 10.1002/9780470123195.ch2; NORTHROP DB, 1983, ANAL BIOCHEM, V132, P457, DOI 10.1016/0003-2697(83)90034-9; Pessia E, 2012, GENOME BIOL EVOL, V4, P787, DOI 10.1093/gbe/evs052; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Scott CP, 2001, BIOCHEMISTRY-US, V40, P1651, DOI 10.1021/bi002335z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Wisitpitthaya S, 2016, ACS CHEM BIOL, V11, P2021, DOI 10.1021/acschembio.6b00303; Xu H, 2006, P NATL ACAD SCI USA, V103, P4022, DOI 10.1073/pnas.0600443103; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141; Zimanyi CM, 2012, STRUCTURE, V20, P1374, DOI 10.1016/j.str.2012.05.009	48	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16463	16476		10.1074/jbc.M117.798769	http://dx.doi.org/10.1074/jbc.M117.798769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28808063	Green Published, hybrid			2022-12-28	WOS:000412414800005
J	Li, C; Park, S; Zhang, XW; Eisenberg, LM; Zhao, H; Darzynkiewicz, Z; Xu, DZ				Li, Cen; Park, Soyoung; Zhang, Xiaowen; Eisenberg, Leonard M.; Zhao, Hong; Darzynkiewicz, Zbigniew; Xu, Dazhong			Nuclear Gene 33/Mig6 regulates the DNA damage response through an ATM serine/threonine kinase-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ABL; TYROSINE KINASE; EGF RECEPTOR; ENDOGENOUS INHIBITOR; APOPTOTIC RESPONSE; LATE TRANSDUCER; KAPPA-B; ACTIVATION; BINDING; PROTEIN	Gene 33 (Mig6, ERRFI1) is an adaptor protein with multiple cellular functions. We recently linked Gene 33 to the DNA damage response (DDR) induced by hexavalent chromium (Cr(VI)), but the molecular mechanism remains unknown. Here we show that ectopic expression of Gene 33 triggers DDR in an ATM serine/threonine kinase (ATM)-dependent fashion and through pathways dependent or not dependent on ABL proto-oncogene 1 non-receptor tyrosine kinase (c-Abl). We observed the clear presence of Gene 33 in the nucleus and chromatin fractions of the cell. We also found that the nuclear localization of Gene 33 is regulated by its 14-3-3-binding domain and that the chromatin localization of Gene 33 is partially dependent on its ErbB-binding domain. Our data further indicated that Gene 33 may regulate the targeting of c-Abl to chromatin. Moreover, we observed a clear association of Gene 33 with histone H2AX and that ectopic expression of Gene 33 promotes the interaction between ATM and histone H2AX without triggering DNA damage. In summary, our results reveal nuclear functions of Gene 33 that regulate DDR. The nuclear localization of Gene 33 also provides a spatial explanation of the previously reported regulation of apoptosis by Gene 33 via the c-Abl/p73 pathway. On the basis of these findings and our previous studies, we propose that Gene 33 is a proximal regulator of DDR that promotes DNA repair.	[Li, Cen; Park, Soyoung; Zhang, Xiaowen; Zhao, Hong; Darzynkiewicz, Zbigniew; Xu, Dazhong] New York Med Coll, Sch Med, Dept Pathol, 15 Dana Rd, Valhalla, NY 10595 USA; [Eisenberg, Leonard M.] New York Med Coll, Sch Med, Dept Physiol, Valhalla, NY 10595 USA; [Zhao, Hong; Darzynkiewicz, Zbigniew] New York Med Coll, Sch Med, Brander Canc Res Inst, Valhalla, NY 10595 USA	New York Medical College; New York Medical College; New York Medical College	Xu, DZ (corresponding author), New York Med Coll, Sch Med, Dept Pathol, 15 Dana Rd, Valhalla, NY 10595 USA.	Dazhong_xu@nymc.edu			National Institutes of Health [R21ES023862]; startup fund from New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program; Robert A. Welke Cancer Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); startup fund from New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program; Robert A. Welke Cancer Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant R21ES023862 (to D. X.), a startup fund from New York Medical College (to D. X.), funds from the New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program (to D. X.), and the Robert A. Welke Cancer Research Foundation (to Z. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agami R, 1999, NATURE, V399, P809; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cai J, 2009, HYPERTENSION, V53, P539, DOI 10.1161/HYPERTENSIONAHA.108.120816; Chen YC, 2014, DIABETOLOGIA, V57, P2066, DOI 10.1007/s00125-014-3311-z; Chen YC, 2013, MOL ENDOCRINOL, V27, P162, DOI 10.1210/me.2012-1174; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Gong JG, 1999, NATURE, V399, P806; Gu JJ, 2001, CANCER RES, V61, P6703; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu N, 2012, EMBO J, V31, P2365, DOI 10.1038/emboj.2012.88; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Park S, 2016, ONCOTARGET, V7, P8916, DOI 10.18632/oncotarget.6866; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; REDDEL RR, 1988, CANCER RES, V48, P1904; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeda K, 2013, GENES CELLS, V18, P369, DOI 10.1111/gtc.12043; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tsunoda T, 2002, CANCER RES, V62, P5668; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; van Laar T, 2001, MOL CARCINOGEN, V31, P63, DOI 10.1002/mc.1040; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Xie BS, 2013, BIOL CELL, V105, P488, DOI 10.1111/boc.201200052; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Xu J, 2005, BREAST CANCER RES TR, V91, P207, DOI 10.1007/s10549-005-1040-1; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	56	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16746	16759		10.1074/jbc.M117.803338	http://dx.doi.org/10.1074/jbc.M117.803338			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842482	hybrid, Green Published			2022-12-28	WOS:000412414800033
J	Park, SJ; Foote, PK; Krist, DT; Rice, SE; Statsyuk, AV				Park, Sungjin; Foote, Peter K.; Krist, David T.; Rice, Sarah E.; Statsyuk, Alexander V.			UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1-DEPENDENT PHOSPHORYLATION; PATHOGENIC MUTATIONS; AUTOINHIBITED STATE; CATALYTIC-ACTIVITY; SELF-ASSOCIATION; ACTIVATE PARKIN; PINK1; MECHANISM; REVEALS; DISEASE	Ring-between-ring (RBR) E3 ligases have been implicated in autoimmune disorders and neurodegenerative diseases. The functions of many RBR E3s are poorly defined, and their regulation is complex, involving post-translational modifications and allosteric regulation with other protein partners. The functional complexity of RBRs, coupled with the complexity of the native ubiquitination reaction that requires ATP and E1 and E2 enzymes, makes it difficult to study these ligases for basic research and therapeutic purposes. To address this challenge, we developed novel chemical probes, ubiquitin C-terminal fluorescein thioesters UbMES and UbFluor, to qualitatively and quantitatively assess the activity of the RBR E3 ligase PARKIN in a simple experimental setup and in real time using fluorescence polarization. First, we confirmed that PARKIN does not require an E2 enzyme for substrate ubiquitination, lysine selection, and polyubiquitin chain formation. Second, we confirmed that UbFluor quantitatively detects naturally occurring activation states of PARKIN caused by Ser65 phosphorylation (pPARKIN) and phosphorylated ubiquitin (pUb). Third, we showed that both pUb and the ubiquitin-accepting substrate contribute to maximal pPARKIN ubiquitin conjugation turnover. pUb enhances the transthiolation step, whereas the substrate clears the pPARKIN similar to Ub thioester intermediate. Finally, we established that UbFluor can quantify activation or inhibition of PARKIN by structural mutations. These results demonstrate the feasibility of using UbFluor for quantitative studies of the biochemistry of RBR E3s and for high-throughput screening of small-molecule activators or inhibitors of PARKIN and other RBR E3 ligases.	[Park, Sungjin; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Foote, Peter K.; Krist, David T.; Statsyuk, Alexander V.] Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60208 USA; [Statsyuk, Alexander V.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	Northwestern University; Northwestern University; University of Houston System; University of Houston	Statsyuk, AV (corresponding author), Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60208 USA.; Statsyuk, AV (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	avstatsy@central.uh.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Krist, David/0000-0003-2471-4596	National Institutes of Health from NIGMS [R01GM072656, R01GM115632]; Northwestern University; CLP Cornew Innovation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R01GM072656, R01GM115632] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Northwestern University; CLP Cornew Innovation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Awards R01GM072656 (to S. E. R.) and R01GM115632 (to A. V. S.) from NIGMS, Northwestern University, and CLP Cornew Innovation Award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Baumann S, 2010, J AM CHEM SOC, V132, P6973, DOI 10.1021/ja909317n; BENDER ML, 1967, J CHEM EDUC, V44, P84, DOI 10.1021/ed044p84; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birsa N, 2013, BIOCHEM SOC T, V41, P1525, DOI 10.1042/BST20130234; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dove KK, 2017, J MOL BIOL, V429, P3363, DOI 10.1016/j.jmb.2017.08.008; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Fiesel FC, 2015, HUM MUTAT, V36, P774, DOI 10.1002/humu.22808; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Ho SR, 2015, J BIOL CHEM, V290, P23026, DOI 10.1074/jbc.M115.645499; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klosowiak JL, 2013, EMBO REP, V14, P968, DOI 10.1038/embor.2013.151; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Krist David T, 2017, Curr Protoc Chem Biol, V9, P11, DOI 10.1002/cpch.17; Krist DT, 2016, CHEM SCI, V7, P5587, DOI 10.1039/c6sc01167e; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lucking C. B., NEW ENGL J MED, P1560; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park S, 2015, CHEM SCI, V6, P1770, DOI [10.1039/C4SC02340D, 10.1039/c4sc02340d]; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Regnstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066879; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Tang MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14697; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yamano K, 2015, J BIOL CHEM, V290, P25199, DOI 10.1074/jbc.M115.671446; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	70	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16539	16553		10.1074/jbc.M116.773200	http://dx.doi.org/10.1074/jbc.M116.773200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28710279	hybrid, Green Published			2022-12-28	WOS:000412414800016
J	Whitfield, J; Paglialunga, S; Smith, BK; Miotto, PM; Simnett, G; Robson, HL; Jain, SS; Herbst, EAF; Desjardins, EM; Dyck, DJ; Spriet, LL; Steinberg, GR; Holloway, GP				Whitfield, Jamie; Paglialunga, Sabina; Smith, Brennan K.; Miotto, Paula M.; Simnett, Genevieve; Robson, Holly L.; Jain, Swati S.; Herbst, Eric A. F.; Desjardins, Eric M.; Dyck, David J.; Spriet, Lawrence L.; Steinberg, Gregory R.; Holloway, Graham P.			Ablating the protein TBC1D1 impairs contraction-induced sarcolemmal glucose transporter 4 redistribution but not insulin-mediated responses in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; HUMAN SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; GLUCOSE-HOMEOSTASIS; PLASMA-MEMBRANE; RAB; PHOSPHORYLATION; EXERCISE; CELLS; DISRUPTION	TBC1 domain family member 1 (TBC1D1), a Rab GTPase-activating protein and paralogue of Akt substrate of 160 kDa (AS160), has been implicated in both insulin-and 5-aminoim-idazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase-mediated glucose transporter type 4 (GLUT4) translocation. However, the role of TBC1D1 in contracting muscle remains ambiguous. We therefore explored the metabolic consequence of ablating TBC1D1 in both resting and contracting skeletal muscles, utilizing a rat TBC1D1 KO model. Although insulin administration rapidly increased (p < 0.05) plasma membrane GLUT4 content in both red and white gastrocnemius muscles, the TBC1D1 ablation did not alter this response nor did it affect whole-body insulin tolerance, suggesting that TBC1D1 is not required for insulin-induced GLUT4 trafficking events. Consistent with findings in other models of altered TBC1D1 protein levels, whole-animal and ex vivo skeletal muscle fat oxidation was increased in the TBC1D1 KO rats. Although there was no change in mitochondrial content in the KO rats, maximal ADP-stimulated respiration was higher in permeabilized muscle fibers, which may contribute to the increased reliance on fatty acids in resting KO animals. Despite this increase in mitochondrial oxidative capacity, run time to exhaustion at various intensities was impaired in the KO rats. Moreover, contraction-induced increases in sarcolemmal GLUT4 content and glucose uptake were lower in the white gastrocnemius of the KO animals. Altogether, our results highlight a critical role for TBC1D1 in exercise tolerance and contraction-mediated translocation of GLUT4 to the plasma membrane in skeletal muscle.	[Whitfield, Jamie; Paglialunga, Sabina; Miotto, Paula M.; Simnett, Genevieve; Robson, Holly L.; Jain, Swati S.; Herbst, Eric A. F.; Dyck, David J.; Spriet, Lawrence L.; Holloway, Graham P.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Smith, Brennan K.; Desjardins, Eric M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON L8N 3Z5, Canada; [Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Guelph; McMaster University; McMaster University	Holloway, GP (corresponding author), Univ Guelph, Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	ghollowa@uoguelph.ca	Miotto, Paula M/C-6472-2019; Whitfield, Jamie/J-1570-2018	Whitfield, Jamie/0000-0002-8961-8872; Desjardins, Eric/0000-0003-2687-055X; Steinberg, Gregory/0000-0001-5425-8275	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC graduate scholarships; Canadian Institute for Health Research [125980-1]; Ontario Research Fund; Canada Research Chair in Metabolism and Obesity; J. Bruce Duncan Chair in Metabolic Diseases	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC graduate scholarships(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canada Research Chair in Metabolism and Obesity; J. Bruce Duncan Chair in Metabolic Diseases	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC) (to L. L. S. and G. P. H.), NSERC graduate scholarships (to P. M. M. and E. A. F. H.), and Canadian Institute for Health Research Grant 125980-1 (to G. R. S.). Infrastructure was purchased with the assistance of the Canadian Foundation for Innovation (to G. P. H.) as well as the Ontario Research Fund (to G. P. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Canada Research Chair in Metabolism and Obesity and the J. Bruce Duncan Chair in Metabolic Diseases.	An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Bergmeyer HU., 1974, METHOD ENZYMAT AN, V1, P474; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Frosig C, 2010, J PHYSIOL-LONDON, V588, P4539, DOI 10.1113/jphysiol.2010.194811; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; GAO JP, 1994, J APPL PHYSIOL, V77, P1597, DOI 10.1152/jappl.1994.77.4.1597; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; GOODYEAR LJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE987, DOI 10.1152/ajpendo.1995.268.5.E987; GOODYEAR LJ, 1990, AM J PHYSIOL, V258, pE667, DOI 10.1152/ajpendo.1990.258.4.E667; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; LEE AD, 1995, FEBS LETT, V361, P51, DOI 10.1016/0014-5793(95)00147-2; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Maher AC, 2014, AM J PHYSIOL-REG I, V307, pR1115, DOI 10.1152/ajpregu.00014.2014; McFarlan JT, 2012, J BIOL CHEM, V287, P23502, DOI 10.1074/jbc.M111.315358; Paglialunga S, 2017, APPL PHYSIOL NUTR ME, V42, P647, DOI 10.1139/apnm-2016-0585; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Perry CGR, 2012, J PHYSIOL-LONDON, V590, P5475, DOI 10.1113/jphysiol.2012.234682; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; PLOUG T, 1984, AM J PHYSIOL, V247, pE726, DOI 10.1152/ajpendo.1984.247.6.E726; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Rutti S, 2014, FEBS LETT, V588, P15, DOI 10.1016/j.febslet.2013.10.050; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Szekeres F, 2012, AM J PHYSIOL-ENDOC M, V303, pE524, DOI 10.1152/ajpendo.00605.2011; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	37	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16653	16664		10.1074/jbc.M117.806786	http://dx.doi.org/10.1074/jbc.M117.806786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28808062	hybrid, Green Published			2022-12-28	WOS:000412414800025
J	Lin, QS; Liou, YC				Lin, Qingsong; Liou, Yih-Cherng			Fishing for key players in ER-mitochondrial contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEOMICS	Endoplasmic reticulum-mitochondrial contacts (EMCs) regulate multiple critical cellular activities, dysregulation of which correlates with various human maladies such as neurodegenerative diseases. Anew study makes use of the ascorbate peroxidase proximity-labeling proteomics approach to scrutinize the components of EMCs in live cells, leading to the identification of reticulon 1A as a novel promoter of EMCs.	[Lin, Qingsong; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore	National University of Singapore	Lin, QS; Liou, YC (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslinqs@nus.edu.sg; dbslyc@nus.edu.sg			Ministry of Education [R -154-000-A15-114]; National Medical Research Council, Singapore [NMRC CBRG-0067-2014]	Ministry of Education; National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This work was supported in part by a Tier1 grant (R -154-000-A15-114) from the Ministry of Education and NMRC CBRG-0067-2014 from the National Medical Research Council, Singapore (to Y.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Cho IT, 2017, J BIOL CHEM, V292, P16382, DOI 10.1074/jbc.M117.795286; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rees JS, 2015, MOL CELL PROTEOMICS, V14, P2848, DOI 10.1074/mcp.R115.052902; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Schrader M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00056; Tytgat HLP, 2015, MICROB BIOTECHNOL, V8, P164, DOI 10.1111/1751-7915.12150; Zheng WL, 2015, ARCH PHARM RES, V38, P1661, DOI 10.1007/s12272-015-0635-2	8	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16393	16394		10.1074/jbc.H117.795286	http://dx.doi.org/10.1074/jbc.H117.795286			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28963339	Green Published, hybrid			2022-12-28	WOS:000412109400037
J	Banerjee, V; Oren, O; Ben-Zeev, E; Taube, R; Engel, S; Papo, N				Banerjee, Victor; Oren, Ofek; Ben-Zeev, Efrat; Taube, Ran; Engel, Stanislav; Papo, Niv			A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALS-LINKED SOD1; MOTOR-NEURON DISEASE; IN-VITRO EVOLUTION; FAMILIAL ALS; DELIVERY; STABILITY; ANTIBODY; DOCKING; DESIGN	Molecular agents that specifically bind and neutralize misfolded and toxic superoxide dismutase 1 (SOD1) mutant proteins may find application in attenuating the disease progression of familial amyotrophic lateral sclerosis. However, high structural similarities between the wild-type and mutant SOD1 proteins limit the utility of this approach. Here we addressed this challenge by converting a promiscuous natural human IgG-binding domain, the hyperthermophilic variant of protein G (HTB1), into a highly specific aggregation inhibitor (designated HTB1M) of two familial amyotrophic lateral sclerosis-linked SOD1 mutants, SOD1(G93A) and SOD1(G85R). We utilized a computational algorithm for mapping protein surfaces predisposed to HTB1 intermolecular interactions to construct a focused HTB1 library, complemented with an experimental platform based on yeast surface display for affinity and specificity screening. HTB1M displayed high binding specificity toward SOD1 mutants, inhibited their amyloid aggregation in vitro, prevented the accumulation of misfolded proteins in living cells, and reduced the cytotoxicity of SOD1(G93A) expressed in motor neuron-like cells. Competition assays and molecular docking simulations suggested that HTB1M binds to SOD1 via both its alpha -helical and beta -sheet domains at the native dimer interface that becomes exposed upon mutated SOD1 misfolding and monomerization. Our results demonstrate the utility of computational mapping of the protein-protein interaction potential for designing focused protein libraries to be used in directed evolution. They also provide new insight into the mechanism of conversion of broad-spectrum immunoglobulin-binding proteins, such as HTB1, into target-specific proteins, thereby paving the way for the development of new selective drugs targeting the amyloidogenic proteins implicated in a variety of human diseases.	[Banerjee, Victor; Oren, Ofek; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-8410501 Beer Sheva, Israel; [Banerjee, Victor; Oren, Ofek; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Engel, Stanislav] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel; [Engel, Stanislav] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Oren, Ofek; Taube, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Ben-Zeev, Efrat] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Weizmann Institute of Science	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, POB 653, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol, POB 653, IL-84105 Beer Sheva, Israel.	papo@bgu.ac.il	Engel, Stanislav/G-2799-2013; Papo, Niv/R-3946-2017; TAUBE, RAN/F-2029-2012; Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019	Engel, Stanislav/0000-0001-5916-5190; TAUBE, RAN/0000-0002-2062-4537; Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362				Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Al-Chalabi Ammar, 2000, Current Opinion in Neurology, V13, P397, DOI 10.1097/00019052-200008000-00006; Banerjee V, 2016, ACS CHEM NEUROSCI, V7, P1595, DOI 10.1021/acschemneuro.6b00227; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Battistini S, 2005, J NEUROL, V252, P782, DOI 10.1007/s00415-005-0742-y; Benmohamed R, 2011, AMYOTROPH LATERAL SC, V12, P87, DOI 10.3109/17482968.2010.522586; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bidhendi EE, 2016, J CLIN INVEST, V126, P2249, DOI 10.1172/JCI84360; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen T, 2012, J MED CHEM, V55, P515, DOI 10.1021/jm2014277; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2014, LANCET NEUROL, V13, P1083, DOI 10.1016/S1474-4422(14)70222-4; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Furukawa Y., 2012, PROTEIN AGGREGATES I, P335; Gera N, 2013, METHODS, V60, P15, DOI 10.1016/j.ymeth.2012.03.014; Ghadge GD, 2013, NEUROBIOL DIS, V56, P74, DOI 10.1016/j.nbd.2013.04.007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Janson C, 2002, HUM GENE THER, V13, P1391, DOI 10.1089/104303402760128612; Khare SD, 2006, AMYLOID, V13, P226, DOI 10.1080/13506120600960486; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kuttner YY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003028; Kuttner YY, 2012, J MOL BIOL, V415, P419, DOI 10.1016/j.jmb.2011.11.009; Leal SS, 2013, J BIOL CHEM, V288, P25219, DOI 10.1074/jbc.M113.470740; Lee S, 2015, EXP NEUROBIOL, V24, P1, DOI 10.5607/en.2015.24.1.1; LEIGH PN, 1991, CURR OPIN NEUROL NEU, V4, P586; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Limpert AS, 2013, BEILSTEIN J ORG CHEM, V9, P717, DOI 10.3762/bjoc.9.82; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Lorenzen S, 2007, PROTEINS, V68, P187, DOI 10.1002/prot.21442; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Messori A, 1999, PHARMACOECONOMICS, V16, P153, DOI 10.2165/00019053-199916020-00004; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Osman R, 2016, J COMPUT CHEM, V37, P913, DOI 10.1002/jcc.24276; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pratt AJ, 2014, P NATL ACAD SCI USA, V111, pE4568, DOI 10.1073/pnas.1308531111; Rajagopal S, 2004, BIOORG MED CHEM LETT, V14, P1389, DOI 10.1016/j.bmcl.2003.09.098; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Rosenfeld L, 2015, J BIOL CHEM, V290, P26180, DOI 10.1074/jbc.M115.671271; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Smith TJ, 2006, J AM CHEM SOC, V128, P14456, DOI 10.1021/ja065557e; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Sugaya K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00359; Wang LJ, 2014, NEUROBIOL DIS, V71, P317, DOI 10.1016/j.nbd.2014.08.010; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wunderlich M, 2007, J MOL BIOL, V373, P775, DOI 10.1016/j.jmb.2007.08.004; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193	82	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15777	15788		10.1074/jbc.M117.789610	http://dx.doi.org/10.1074/jbc.M117.789610			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768772	hybrid, Green Published			2022-12-28	WOS:000411512200016
J	Renart, ML; Montoya, E; Giudici, AM; Poveda, JA; Fernandez, AM; Morales, A; Gonzalez-Ros, JM				Lourdes Renart, M.; Montoya, Estefania; Marcela Giudici, A.; Poveda, Jose A.; Fernandez, Asia M.; Morales, Andres; Gonzalez-Ros, Jose M.			Selective exclusion and selective binding both contribute to ion selectivity in KcsA, a model potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+-CHANNEL; CONFORMATIONAL DYNAMICS; INACTIVATION GATE; MEMBRANE-PROTEIN; MECHANISM; STABILITY; TETRABUTYLAMMONIUM; ACTIVATION; CONDUCTION; FILTER	The selectivity filter in potassium channels, a main component of the ion permeation pathway, configures a stack of binding sites (sites S1-S4) to which K+ and other cations may bind. Specific ion binding to such sites induces changes in the filter conformation, which play a key role in defining both selectivity and permeation. Here, using the potassium channel KcsA as a model, we contribute new evidence to reinforce this assertion. First, ion binding to KcsA blocked by tetrabutylammonium at the most cytoplasmic site in the selectivity filter (S4) suggests that such a site, when in the nonconductive filter conformation, has a higher affinity for cation binding than the most extracellular S1 site. This filter asymmetry, along with differences in intracellular and extracellular concentrations of K+ versus Na+ under physiological conditions, should strengthen selection of the permeant K+ by the channel. Second, we used different K+ concentrations to shift the equilibrium between nonconductive and conductive states of the selectivity filter in which to test competitive binding of Na+. These experiments disclosed a marked decrease in the affinity of Na+ to bind the channel when the conformational equilibrium shifts toward the conductive state. This finding suggested that in addition to the selective binding of K+ and other permeant species over Na+, there is a selective exclusion of nonpermeant species from binding the channel filter, once it reaches a fully conductive conformation. We conclude that selective binding and selective exclusion of permeant and nonpermeant cations, respectively, are important determinants of ion channel selectivity.	[Lourdes Renart, M.; Montoya, Estefania; Marcela Giudici, A.; Poveda, Jose A.; Fernandez, Asia M.; Gonzalez-Ros, Jose M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Morales, Andres] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat d'Alacant	Gonzalez-Ros, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain.	gonzalez.ros@umh.es	Carvajal, Asia Fernandez/G-8877-2015; Morales, Andrés/M-5128-2015	Morales, Andrés/0000-0002-1526-3327; Giudici, Ana Marcela/0000-0002-3753-4861; Renart, Maria Lourdes/0000-0002-6717-4756	Spanish MINECO/FEDER [BFU2012-31359, BFU2015-66612-P]	Spanish MINECO/FEDER	This work was funded in part by Grants BFU2012-31359 and BFU2015-66612-P from the Spanish MINECO/FEDER. The authors declare that they have no conflicts of interest with the contents of this article.	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/bi050845t; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Cheng WWL, 2011, P NATL ACAD SCI USA, V108, P5272, DOI 10.1073/pnas.1014186108; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hirano M, 2011, BIOPHYS J, V101, P2157, DOI 10.1016/j.bpj.2011.09.024; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Molina ML, 2004, BIOCHEMISTRY-US, V43, P14924, DOI 10.1021/bi048889+; Montoya E, 2017, BBA-BIOMEMBRANES, V1859, P779, DOI 10.1016/j.bbamem.2017.01.014; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Posson DJ, 2013, J GEN PHYSIOL, V142, P613, DOI 10.1085/jgp.201311057; Renart ML, 2012, BIOCHEMISTRY-US, V51, P3891, DOI 10.1021/bi201497n; Renart ML, 2010, BIOCHEMISTRY-US, V49, P9480, DOI 10.1021/bi101235v; Renart ML, 2006, J BIOL CHEM, V281, P29905, DOI 10.1074/jbc.M602636200; Sehgal P, 2006, PROTEIN SCI, V15, P890, DOI 10.1110/ps.052031306; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Triano I, 2010, BIOCHEMISTRY-US, V49, P5397, DOI 10.1021/bi1003712; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Wylie BJ, 2014, P NATL ACAD SCI USA, V111, P185, DOI 10.1073/pnas.1319577110; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	39	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15552	15560		10.1074/jbc.M117.795807	http://dx.doi.org/10.1074/jbc.M117.795807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28778926	hybrid, Green Published			2022-12-28	WOS:000410809800033
J	Rahman, MF; Askwith, C; Govindarajan, R				Rahman, Md Fazlur; Askwith, Candice; Govindarajan, Rajgopal			Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTED HYPERTRICHOTIC DERMATOSIS; H-SYNDROME; FUNCTIONAL-CHARACTERIZATION; FAISALABAD HISTIOCYTOSIS; NUCLEOBASE TRANSPORTER; HUMAN INTESTINE; ENT FAMILY; SLC29A3; MUTATIONS; PROTEIN	Equilibrative nucleoside transporters (ENTs) translocate hydrophilic nucleosides across cellular membranes and are essential for salvage nucleotide synthesis and purinergic signaling. Unlike the prototypic human ENT members hENT1 and hENT2, which mediate plasma membrane nucleoside transport at pH 7.4, hENT3 is an acidic pH-activated lysosomal transporter partially localized to mitochondria. Recent studies demonstrate that hENT3 is indispensable for lysosomal homeostasis, and that mutations in hENT3 can result in a spectrum of lysosomal storage-like disorders. However, despite hENT3's prominent role in lysosome pathophysiology, the molecular basis of hENT3-mediated transport is unknown. Therefore, we sought to examine the mechanistic basis of acidic pH-driven hENT3nucleoside transport with site-directed mutagenesis, homology modeling, and [H-3] adenosine flux measurements in mutant RNA-injected Xenopus oocytes. Scanning mutagenesis of putative residues responsible for pH-dependent transport via hENT3 revealed that the ionization states of Asp-219 and Glu-447, and not His, strongly determined the pH-dependent transport permissible-impermissible states of the transporter. Except for substitution with certain isosteric and polar residues, substitution of either Asp-219 or Glu-447 with any other residues resulted in robust activity that was pH-independent. Dual substitution of Asp-219 and Glu-447 to Ala sustained pH-independent activity over a broad range of physiological pH (pH 5.5-7.4), which also maintained stringent substrate selectivity toward endogenous nucleosides and clinically used nucleoside drugs. Our results suggest a putative pH-sensing role for Asp-219 and Glu-447 in hENT3 and that the size, ionization state, or electronegative polarity at these positions is crucial for obligate acidic pH-dependent activity.	[Rahman, Md Fazlur; Govindarajan, Rajgopal] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, Comprehens Canc Ctr, 500 W 12Th Ave, Columbus, OH 43210 USA; [Askwith, Candice] Ohio State Univ, Dept Neurosci, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Govindarajan, Rajgopal] Ohio State Univ, Translat Therapeut Program, Comprehens Canc Ctr, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Govindarajan, R (corresponding author), Ohio State Univ, Pharmaceut & Pharmaceut Chem, Coll Pharm, 542 Riffe Bldg,12th Ave, Columbus, OH 43210 USA.	govindarajan.21@osu.edu			National Institutes of Health [R03AR063326, R01CA188464]; NATIONAL CANCER INSTITUTE [R01CA188464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS104177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AR063326 (to R. G.) and R01CA188464 (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achilonu I, 2012, BIOCHEMISTRY-US, V51, P995, DOI 10.1021/bi201541w; Al-Haggar M, 2015, PEDIATR DIABETES, V16, P305, DOI 10.1111/pedi.12160; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Boswell-Casteel RC, 2014, J BIOL CHEM, V289, P24440, DOI 10.1074/jbc.M114.553503; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Cano-Soldado P, 2012, AM J PHYSIOL-CELL PH, V302, pC257, DOI 10.1152/ajpcell.00198.2011; Cauet E, 2005, J CHEM THEORY COMPUT, V1, P472, DOI 10.1021/ct049875k; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Colmenero I, 2012, AM J DERMATOPATH, V34, P315, DOI 10.1097/DAD.0b013e31823b99fc; de Jesus J, 2013, DIABETES METAB, V39, P281, DOI 10.1016/j.diabet.2013.03.007; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Dougherty DA, 2007, J NUTR, V137, p1516S; Elbarbary NS, 2013, PEDIATR DIABETES, V14, P466, DOI 10.1111/j.1399-5448.2012.00925.x; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Farooq M, 2012, DERMATOLOGY, V224, P277, DOI 10.1159/000338886; Felipe A, 1998, BIOCHEM J, V330, P997, DOI 10.1042/bj3300997; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hirschi M, 2017, NATURE, V545, P66, DOI 10.1038/nature22057; Hsu CL, 2012, SCIENCE, V335, P89, DOI 10.1126/science.1213682; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Larrayoz IM, 2006, AM J PHYSIOL-CELL PH, V291, pC1395, DOI 10.1152/ajpcell.00110.2006; Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Mueller DS, 2008, BIOCHEM SOC T, V36, P43, DOI 10.1042/BST0360043; Ngo LY, 2001, AM J PHYSIOL-GASTR L, V280, pG475, DOI 10.1152/ajpgi.2001.280.3.G475; Pastor-Anglada M, 2008, XENOBIOTICA, V38, P972, DOI 10.1080/00498250802069096 ; Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priya TP, 2010, BRIT J DERMATOL, V162, P1132, DOI 10.1111/j.1365-2133.2010.09653.x; Ramot Y, 2010, INT J PEDIATR OTORHI, V74, P825, DOI 10.1016/j.ijporl.2010.03.053; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; STENNICKE HR, 1994, PROTEIN ENG, V7, P911, DOI 10.1093/protein/7.7.911; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wang S, 2014, P NATL ACAD SCI USA, V111, P12734, DOI 10.1073/pnas.1414093111; Warraich S, 2013, J BONE MINER RES, V28, P1135, DOI 10.1002/jbmr.1826; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	54	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14775	14785		10.1074/jbc.M117.787952	http://dx.doi.org/10.1074/jbc.M117.787952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729424	hybrid, Green Published			2022-12-28	WOS:000409902100006
J	Tan, EP; McGreal, SR; Graw, S; Tessman, R; Koppel, SJ; Dhakal, P; Zhang, Z; Machacek, M; Zachara, NE; Koestler, DC; Peterson, KR; Thyfault, JP; Swerdlow, RH; Krishnamurthy, P; DiTacchio, L; Apte, U; Slawson, C				Tan, Ee Phie; McGreal, Steven R.; Graw, Stefan; Tessman, Robert; Koppel, Scott J.; Dhakal, Pramod; Zhang, Zhen; Machacek, Miranda; Zachara, Natasha E.; Koestler, Devin C.; Peterson, Kenneth R.; Thyfault, John P.; Swerdlow, Russell H.; Krishnamurthy, Partha; DiTacchio, Luciano; Apte, Udayan; Slawson, Chad			Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; 3T3-L1 ADIPOCYTES; HIGH GLUCOSE; CROSS-TALK; PHOSPHORYLATION; PROTEIN; NEURODEGENERATION	Dysfunctional mitochondria and generation of reactive oxygen species (ROS) promote chronic diseases, which have spurred interest in the molecular mechanisms underlying these conditions. Previously, we have demonstrated that disruption of post-translational modification of proteins with beta-linked N-acetylglucosamine (O-GlcNAcylation) via overexpression of the O-GlcNAc-regulating enzymes O-GlcNAc transferase (OGT) or O-GlcNAcase (OGA) impairs mitochondrial function. Here, we report that sustained alterations in O-GlcNAcylation either by pharmacological or genetic manipulation also alter metabolic function. Sustained O-GlcNAcelevation inSH-SY5Yneuroblastoma cells increased OGA expression and reduced cellular respiration and ROS generation. Cells with elevated O-GlcNAc levels had elongated mitochondria and increased mitochondrial membrane potential, and RNA-sequencing analysis indicated transcriptome reprogramming and down-regulation of the NRF2-mediated antioxidant response. Sustained O-GlcNAcylation in mouse brain and liver validated the metabolic phenotypes observed in the cells, and OGT knockdown in the liver elevated ROS levels, impaired respiration, and increased the NRF2 antioxidant response. Moreover, elevated O-GlcNAc levels promoted weight loss and lowered respiration in mice and skewed the mice toward carbohydrate-dependent metabolism as determined by indirect calorimetry. In summary, sustained elevation in O-GlcNAcylation coupled with increased OGA expression reprograms energy metabolism, a finding that has potential implications for the etiology, development, and management of metabolic diseases.	[Tan, Ee Phie; Zhang, Zhen; Machacek, Miranda; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [McGreal, Steven R.; Tessman, Robert; Krishnamurthy, Partha; DiTacchio, Luciano; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS USA; [Graw, Stefan; Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA; [Koppel, Scott J.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Dhakal, Pramod; Machacek, Miranda; Thyfault, John P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS USA; [Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA; [Swerdlow, Russell H.; Krishnamurthy, Partha; Slawson, Chad] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA; [Zachara, Natasha E.] Johns Hopkins Univ Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; Johns Hopkins University	Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA.; Slawson, C (corresponding author), Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA.	cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021	Koppel, Scott/0000-0001-9001-4454; Graw, Stefan/0000-0002-6386-8267	Electron Microscope (EM) Core Facility - National Institutes of Health NIGMS COBRE [P20GM104936]; National Institutes of Health [1S10RR027564]; National Institutes of Health NIGMS COBRE [P30GM103326]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098414, R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P30GM103326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002567] Funding Source: NIH RePORTER	Electron Microscope (EM) Core Facility - National Institutes of Health NIGMS COBRE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIGMS COBRE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Christy Hagan, Kay Minn, Heather Wilkins, and Ian Weilding for their technical support. We thank both Barbara Fegley and Pat St. John for their help and the support of the Electron Microscope (EM) Core Facility, sponsored in part by National Institutes of Health NIGMS COBRE Grant P20GM104936 and National Institutes of Health Grant 1S10RR027564. We also thank Richard Hasting and the Flow Cytometry Laboratory, sponsored by the National Institutes of Health NIGMS COBRE Grant P30GM103326.	Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chaves I, 2014, CURR BIOL, V24, P1248, DOI 10.1016/j.cub.2014.04.018; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dassanayaka S, 2015, BIOCHEM J, V467, P115, DOI 10.1042/BJ20141018; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lezi E, 2016, BIOCHEM PHARMACOL, V99, P88, DOI 10.1016/j.bcp.2015.11.002; Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12; Li H. H., 2017, PLANT CELL TISSUE OR, V2017, P1, DOI DOI 10.1016/J.EC0LM0DEL.2017.01.003; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Makino A, 2015, AM J PHYSIOL-CELL PH, V309, pC593, DOI 10.1152/ajpcell.00069.2015; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Mosconi L, 2011, J ALZHEIMERS DIS, V27, P483, DOI 10.3233/JAD-2011-110866; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Muthusamy S, 2015, J BIOL CHEM, V290, P31013, DOI 10.1074/jbc.M115.677534; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Pendergast DR, 2000, J AM COLL NUTR, V19, P345, DOI 10.1080/07315724.2000.10718930; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sacoman JL, 2017, J BIOL CHEM, V292, P4499, DOI 10.1074/jbc.M116.726752; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stivers PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145151; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tangmansakulchai K, 2016, MITOCHONDRION, V30, P151, DOI 10.1016/j.mito.2016.07.009; Trapannone R, 2016, BIOCHEM J, V473, P1693, DOI 10.1042/BCJ20160092; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2014, J MOL BIOL, V426, P1736, DOI 10.1016/j.jmb.2014.01.004; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zhang Z, 2016, J BIOL CHEM, V291, P15628, DOI 10.1074/jbc.M116.721928; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	60	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14940	14962		10.1074/jbc.M117.797944	http://dx.doi.org/10.1074/jbc.M117.797944			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739801	hybrid, Green Published			2022-12-28	WOS:000409902100019
J	Bell, KM; Cha, HK; Sindelar, CV; Cochran, JC				Bell, Kayla M.; Cha, Hyo Keun; Sindelar, Charles V.; Cochran, Jared C.			The yeast kinesin-5 Cin8 interacts with the microtubule in a noncanonical manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ADENOSINE-TRIPHOSPHATASE; BIDIRECTIONAL MOTILITY; STRUCTURAL MODEL; ATP HYDROLYSIS; DIMERIC EG5; MOTOR; CYCLE; NECK; MODULATION	Kinesin motors play central roles in establishing and maintaining the mitotic spindle during cell division. Unlike most other kinesins, Cin8, a kinesin-5 motor in Saccharomyces cerevisiae, can move bidirectionally along microtubules, switching directionality according to biochemical conditions, a behavior that remains largely unexplained. To this end, we used biochemical rate and equilibrium constant measurements as well as cryo-electron microscopy methodologies to investigate the microtubule interactions of the Cin8 motor domain. These experiments unexpectedly revealed that, whereas Cin8 ATPase kinetics fell within measured ranges for kinesins (especially kinesin-5 proteins), approximately four motors can bind each alpha beta-tubulin dimer within the microtubule lattice. This result contrasted with those observations on other known kinesins, which can bind only a single "canonical" site per tubulin dimer. Competition assays with human kinesin-5 (Eg5) only partially abrogated this behavior, indicating that Cin8 binds microtubules not only at the canonical site, but also one or more separate ("noncanonical") sites. Moreover, we found that deleting the large, class-specific insert in the microtubule-binding loop 8 reverts Cin8 to one motor per alpha beta-tubulin in the microtubule. The novel microtubule-binding mode of Cin8 identified here provides a potential explanation for Cin8 clustering along microtubules and potentially may contribute to the mechanism for direction reversal.	[Bell, Kayla M.; Cochran, Jared C.] Indiana Univ, Dept Mol & Cellular Biochem, 405C Simon Hall,212 S Hawthorne Dr, Bloomington, IN 47405 USA; [Cha, Hyo Keun] Yale Univ, Yale Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Sindelar, Charles V.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Indiana University System; Indiana University Bloomington; Yale University; Yale University	Cochran, JC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, 405C Simon Hall,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	jcc6@indiana.edu			Indiana University, National Institutes of Health [T32 GM007223, R01 GM110530]; National Science Foundation [MCB 1614514]; Div Of Molecular and Cellular Bioscience [1614514] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM110530] Funding Source: NIH RePORTER	Indiana University, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Indiana University, National Institutes of Health Grants T32 GM007223 (to H. K. C.) and R01 GM110530 (to C. V. S.), and National Science Foundation Grant MCB 1614514 (to J. C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audu CO, 2013, J PEPT SCI, V19, P504, DOI 10.1002/psc.2528; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Britto M, 2016, P NATL ACAD SCI USA, V113, pE7483, DOI 10.1073/pnas.1611581113; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Chen GY, 2016, J BIOL CHEM, V291, P20283, DOI 10.1074/jbc.M116.730697; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Cochran J C, 2015, Biophys Rev, V7, P269, DOI 10.1007/s12551-014-0150-6; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duselder A, 2015, J BIOL CHEM, V290, P16841, DOI 10.1074/jbc.M114.620799; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Edamatsu M, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017799; Edamatsu M, 2014, BIOCHEM BIOPH RES CO, V446, P231, DOI 10.1016/j.bbrc.2014.02.106; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; Fridman V, 2013, J CELL SCI, V126, P4147, DOI 10.1242/jcs.125153; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Goldstein A, 2017, CELL MOL LIFE SCI, V74, P3395, DOI 10.1007/s00018-017-2523-z; Gordon DM, 1999, J BIOL CHEM, V274, P28779, DOI 10.1074/jbc.274.40.28779; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Goulet A, 2012, J BIOL CHEM, V287, P44654, DOI 10.1074/jbc.M112.404228; Grant T, 2015, J STRUCT BIOL, V192, P204, DOI 10.1016/j.jsb.2015.08.006; Harrington TD, 2011, J THEOR BIOL, V289, P107, DOI 10.1016/j.jtbi.2011.08.017; HASS LF, 1961, J BIOL CHEM, V236, P2284; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; IMAMURA K, 1966, J BIOCHEM-TOKYO, V59, P280; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Jun B, 2010, J BIOL CHEM, V285, P11073, DOI 10.1074/jbc.C110.103762; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murata JM, 2013, J BIOL CHEM, V288, P34839, DOI 10.1074/jbc.M113.518845; Muretta JM, 2015, P NATL ACAD SCI USA, V112, pE6606, DOI 10.1073/pnas.1512305112; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; Shapira O, 2017, J CELL SCI, V130, P725, DOI 10.1242/jcs.195040; Shapira O, 2016, SCI REP-UK, V6, DOI 10.1038/srep25597; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Thiede Christina, 2012, Bioarchitecture, V2, P70; Thiede C, 2013, BIOPHYS J, V104, P432, DOI 10.1016/j.bpj.2012.11.3810; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Wade RH, 2000, NAT STRUCT BIOL, V7, P456, DOI 10.1038/75850; Waitzman JS, 2014, BIOL CELL, V106, P1, DOI 10.1111/boc.201300054; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067	97	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14680	14694		10.1074/jbc.M117.797662	http://dx.doi.org/10.1074/jbc.M117.797662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28701465	hybrid, Green Published			2022-12-28	WOS:000408747500032
J	Liu, FG; He, C				Liu, Fange; He, Chuan			A new modification for mammalian messenger RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BINDING PROTEIN ABP140; 3-METHYLCYTIDINE MODIFICATION; SACCHAROMYCES-CEREVISIAE; METHYLTRANSFERASE; LOOP	The discovery of multiple RNA modifications in the past few years has broadened our views of the structures and potential functions of RNA species, but deciphering which modifications are made where and how remains a challenge. Anew study by Xu et al. applies a combination of mass spectrometry, biochemistry, genetics, and cellular biology tools to reveal the two mammalian methyltransferases that are responsible for m(3)C installation in tRNA and a third that mediates the previously unknown installation of m3C in mammalian mRNA.	[Liu, Fange; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Liu, Fange; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA.	chuanhe@uchicago.edu						Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611; Han L, 2017, RNA, V23, P406, DOI 10.1261/rna.059667.116; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411; OLSON MV, 1981, NATURE, V291, P464, DOI 10.1038/291464a0; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Vandivier LE, 2015, PLANT CELL, V27, P3024, DOI 10.1105/tpc.15.00591; Xu L, 2017, J BIOL CHEM, V292, P14695, DOI 10.1074/jbc.M117.798298	10	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14704	14705		10.1074/jbc.H117.798298	http://dx.doi.org/10.1074/jbc.H117.798298			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28864714	Green Published, hybrid			2022-12-28	WOS:000408747500034
J	Minko, IG; Rizzo, CJ; Lloyd, RS				Minko, Irina G.; Rizzo, Carmelo J.; Lloyd, R. Stephen			Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical -anomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-Oxoguanine (8-oxoG); cancer therapy; DNA damage; DNA polymerase; Escherichia coli (E; coli); mutagenesis; COS7 cells; DNA alkylation; Fapy lesion; replication bypass	N,N-BIS(2-CHLOROETHYL)-P-AMINOPHENYLBUTYRIC ACID CHLORAMBUCIL; RING-OPENED FORMAMIDOPYRIMIDINE; ERROR-PRONE REPLICATION; PROTEIN CROSS-LINKING; CENTER-DOT-DG; PHOSPHORAMIDE MUSTARD; TRANSLESION SYNTHESIS; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE BYPASS; POLYMERASE BETA; FIDELITY	Nitrogen mustards (NMs) are DNA-alkylating compounds that represent the earliest anticancer drugs. However, clinical use of NMs is limited because of their own mutagenic properties. The mechanisms of NM-induced mutagenesis remain unclear. The major product of DNA alkylation by NMs is a cationic NM-N7-dG adduct that can yield the imidazole ring-fragmented lesion, N-5-NM-substituted formamidopyrimidine (NM-Fapy-dG). Characterization of this adduct is complicated because it adopts different conformations, including both a canonical - and an unnatural -anomeric configuration. Although formation of NM-Fapy-dG in cellular DNA has been demonstrated, its potential role in NM-induced mutagenesis is unknown. Here, we created site-specifically modified single-stranded vectors for replication in primate (COS7) or Escherichia coli cells. In COS7 cells, NM-Fapy-dG caused targeted mutations, predominantly G T transversions, with overall frequencies of approximate to 11-12%. These frequencies were approximate to 2-fold higher than that induced by 8-oxo-dG adduct. Replication in E. coli was essentially error-free. To elucidate the mechanisms of bypass of NM-Fapy-dG, we performed replication assays in vitro with a high-fidelity DNA polymerase, Saccharomyces cerevisiae polymerase (pol) . It was found that pol could catalyze high-fidelity synthesis past NM-Fapy-dG, but only on a template subpopulation, presumably containing the -anomeric adduct. Consistent with the low mutagenic potential of the -anomer in vitro, the mutation frequency was significantly reduced when conditions for vector preparation were modified to favor this configuration. Collectively, these data implicate the -anomer as a major contributor to NM-Fapy-dG-induced mutagenesis in primate cells.	[Minko, Irina G.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Rizzo, Carmelo J.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Chem, Nashville, TN 37235 USA; [Rizzo, Carmelo J.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Biochem, Nashville, TN 37235 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Vanderbilt University; Vanderbilt University	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA.; Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.; Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X; Rizzo, Carmelo/0000-0001-9005-611X	National Institutes of Health; NCI [T32 CA106195, P01 CA160032, P30 CA068485]; NIEHS [P30 ES000267, T32 ES0007060]; NATIONAL CANCER INSTITUTE [T32CA106195, P01CA160032, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health, NCI Grants T32 CA106195, P01 CA160032, and P30 CA068485 and NIEHS Grants P30 ES000267 and T32 ES0007060. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amato NJ, 2015, NUCLEIC ACIDS RES, V43, P8314, DOI 10.1093/nar/gkv725; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; BROOKES P, 1961, BIOCHEM J, V80, P496, DOI 10.1042/bj0800496; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; CHETSANGA CJ, 1982, CANCER RES, V42, P2616; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Christov PP, 2014, CHEM RES TOXICOL, V27, P1610, DOI 10.1021/tx5002354; Christov PP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/850234; Christov PP, 2012, CHEM RES TOXICOL, V25, P1652, DOI 10.1021/tx300113e; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Earley LF, 2013, CHEM RES TOXICOL, V26, P1108, DOI 10.1021/tx4001495; Efrati E, 1997, J BIOL CHEM, V272, P2559; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; Florea-Wang D, 2004, CHEM RES TOXICOL, V17, P383, DOI 10.1021/tx034233q; Florea-Wang D, 2003, CHEM RES TOXICOL, V16, P403, DOI 10.1021/tx0256735; Florea-Wang D, 2009, CHEM BIODIVERS, V6, P1002, DOI 10.1002/cbdv.200800327; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Gruppi F, 2015, CHEM RES TOXICOL, V28, P1850, DOI 10.1021/acs.chemrestox.5b00297; Haapala E, 2001, CHEM RES TOXICOL, V14, P988, DOI 10.1021/tx000249u; HEMMINKI K, 1987, CHEM-BIOL INTERACT, V61, P75, DOI 10.1016/0009-2797(87)90020-2; Hosing C, 2002, ANN ONCOL, V13, P450, DOI 10.1093/annonc/mdf109; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; KALLAMA S, 1986, CHEM-BIOL INTERACT, V57, P85, DOI 10.1016/0009-2797(86)90051-7; KALLAMA S, 1984, ACTA PHARMACOL TOX, V54, P214; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P20401, DOI 10.1073/pnas.1211532109; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; Minko IG, 2014, ENVIRON MOL MUTAGEN, V55, P601, DOI 10.1002/em.21882; Mohamed D, 2009, CHEM RES TOXICOL, V22, P1435, DOI 10.1021/tx900123r; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; OSBORNE MR, 1993, CHEM-BIOL INTERACT, V89, P49, DOI 10.1016/0009-2797(93)03197-3; OSBORNE MR, 1995, CHEM RES TOXICOL, V8, P316, DOI 10.1021/tx00044a018; Pande P, 2015, BIOCHEMISTRY-US, V54, P1859, DOI 10.1021/acs.biochem.5b00119; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Patro JN, 2007, BIOCHEMISTRY-US, V46, P10202, DOI 10.1021/bi700628c; Patro JN, 2004, BIOCHEMISTRY-US, V43, P13397, DOI 10.1021/bi049035s; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Sha Y, 2017, ENVIRON MOL MUTAGEN, V58, P182, DOI 10.1002/em.22089; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Taggart DJ, 2014, CHEM RES TOXICOL, V27, P931, DOI 10.1021/tx500088e; Valdez BC, 2010, ENVIRON MOL MUTAGEN, V51, P659, DOI 10.1002/em.20603; Weerasooriya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107915; Williams NL, 2017, CHEM RES TOXICOL, V30, P1127, DOI 10.1021/acs.chemrestox.6b00439; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200	57	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18790	18799		10.1074/jbc.M117.802520	http://dx.doi.org/10.1074/jbc.M117.802520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972137	Green Published, hybrid			2022-12-28	WOS:000415848000005
J	Sheikh, MO; Thieker, D; Chalmers, G; Schafer, CM; Ishihara, M; Azadi, P; Woods, RJ; Glushka, JN; Bendiak, B; Prestegard, JH; West, CM				Sheikh, M. Osman; Thieker, David; Chalmers, Gordon; Schafer, Christopher M.; Ishihara, Mayumi; Azadi, Parastoo; Woods, Robert J.; Glushka, John N.; Bendiak, Brad; Prestegard, James H.; West, Christopher M.			O-2 sensing-associated glycosylation exposes the F-box-combining site of the Dictyostelium Skp1 subunit in E3 ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; Dictyostelium; E3 ubiquitin ligase; glycoprotein structure; glycosylation; mathematical modeling; molecular dynamics; nuclear magnetic resonance (NMR)	MOLECULAR-DYNAMICS SIMULATIONS; NUCLEAR-MAGNETIC-RESONANCE; COMPUTER-PROGRAM CASPER; MODEL-FREE APPROACH; PROLYL 4-HYDROXYLASE; SYMBOL NOMENCLATURE; PROMOTES FORMATION; NMR-SPECTROSCOPY; PROTEIN SKP1; OLIGOSACCHARIDES	Skp1 is a conserved protein linking cullin-1 to F-box proteins in SCF (Skp1/Cullin-1/F-box protein) E3 ubiquitin ligases, which modify protein substrates with polyubiquitin chains that typically target them for 26S proteasome-mediated degradation. In Dictyostelium (a social amoeba), Toxoplasma gondii (the agent for human toxoplasmosis), and other protists, Skp1 is regulated by a unique pentasaccharide attached to hydroxylated Pro-143 within its C-terminal F-box-binding domain. Prolyl hydroxylation of Skp1 contributes to O-2-dependent Dictyostelium development, but full glycosylation at that position is required for optimal O-2 sensing. Previous studies have shown that the glycan promotes organization of the F-box-binding region in Skp1 and aids in Skp1's association with F-box proteins. Here, NMR and MS approaches were used to determine the glycan structure, and then a combination of NMR and molecular dynamics simulations were employed to characterize the impact of the glycan on the conformation and motions of the intrinsically flexible F-box-binding domain of Skp1. Molecular dynamics trajectories of glycosylated Skp1 whose calculated monosaccharide relaxation kinetics and rotational correlation times agreed with the NMR data indicated that the glycan interacts with the loop connecting two -helices of the F-box-combining site. In these trajectories, the helices separated from one another to create a more accessible and dynamic F-box interface. These results offer an unprecedented view of how a glycan modification influences a disordered region of a full-length protein. The increased sampling of an open Skp1 conformation can explain how glycosylation enhances interactions with F-box proteins in cells.	[Sheikh, M. Osman; Woods, Robert J.; Prestegard, James H.; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Sheikh, M. Osman; Thieker, David; Chalmers, Gordon; Ishihara, Mayumi; Azadi, Parastoo; Woods, Robert J.; Glushka, John N.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Chalmers, Gordon] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Sheikh, M. Osman; Schafer, Christopher M.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Bendiak, Brad] Univ Colorado Anschutz Med Campus, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Anschutz Medical Campus	West, CM (corresponding author), 120 E Green St,Davison Life Sci A310, Athens, GA 30602 USA.	westcm@uga.edu		Thieker, David/0000-0003-0786-8278; Aoki, Mayumi/0000-0002-8368-8546; Sheikh, Mohammed/0000-0002-9481-8318; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [R01 GM037539, U01 CA207824, P41 GM103390, P41 RR018502]; NATIONAL CANCER INSTITUTE [U01CA207824] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM037539, P41GM103490] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01 GM037539, U01 CA207824, P41 GM103390, and P41 RR018502. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almond A, 2004, BIOCHEMISTRY-US, V43, P5853, DOI 10.1021/bi0354886; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Boutet Emmanuel, 2007, V406, P89; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER 12; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Chalmers G, 2016, J MAGN RESON, V265, P1, DOI 10.1016/j.jmr.2016.01.006; Chinoy ZS, 2015, CHEM-EUR J, V21, P11779, DOI 10.1002/chem.201501598; Dantu SC, 2016, PROTEINS, V84, P159, DOI 10.1002/prot.24963; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Goddard D., 2008, SPARKY 3; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURD RE, 1990, J MAGN RESON, V87, P422, DOI 10.1016/0022-2364(90)90021-Z; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kachariya NN, 2016, BIOMOL NMR ASSIGN, V10, P351, DOI 10.1007/s12104-016-9699-2; Kapaev RR, 2015, ANAL CHEM, V87, P7006, DOI 10.1021/acs.analchem.5b01413; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Levitt M., 2008, SPIN DYNAMICS BASICS, P543; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Martin-Pastor M, 2000, BIOCHEMISTRY-US, V39, P4674, DOI 10.1021/bi992050q; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; NEUROHR KJ, 1980, BIOPHYS J, V32, P931, DOI 10.1016/S0006-3495(80)85027-2; Owens NW, 2007, J AM CHEM SOC, V129, P11670, DOI 10.1021/ja073488d; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pochapsky T. C, 2007, NMR PHYS BIOL SCI, P95; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ronnols J, 2013, CARBOHYD RES, V380, P156, DOI 10.1016/j.carres.2013.06.026; Schafer CM, 2014, J BIOL CHEM, V289, P9076, DOI 10.1074/jbc.M113.528679; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spencer N.D., 2001, ENCY CHEM PHYS PHYS; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Taylor M. E, 2011, INTRO GLYCOBIOLOGY; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Thieker DF, 2016, GLYCOBIOLOGY, V26, P786, DOI 10.1093/glycob/cww076; Thrippleton MJ, 2003, ANGEW CHEM INT EDIT, V42, P3938, DOI 10.1002/anie.200351947; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Venkatramani L, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-7; Wang XY, 2012, J PHYS CHEM B, V116, P11570, DOI 10.1021/jp304116d; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Woods R. J., 2014, GLYCAM WEB; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Yumimoto K, 2013, J BIOL CHEM, V288, P32766, DOI 10.1074/jbc.M113.511303; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021; Zierke M, 2013, J AM CHEM SOC, V135, P13464, DOI 10.1021/ja4054702; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	78	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18897	18915		10.1074/jbc.M117.809160	http://dx.doi.org/10.1074/jbc.M117.809160			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28928219	Green Published, hybrid			2022-12-28	WOS:000415848000015
J	Ouyang, WM; Guo, PF; Fang, H; Frucht, DM				Ouyang, Weiming; Guo, Pengfei; Fang, Hui; Frucht, David M.			Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-KINASE; ACTIVATION; PATHWAY; CELLS; FRA-1; MKK7; RAS; PHOSPHORYLATION; INACTIVATION; ANGIOGENESIS	Anthrax is a life-threatening disease caused by infection with Bacillus anthracis, which expresses lethal factor and the receptor-binding protective antigen. These two proteins combine to form anthrax lethal toxin (LT), whose proximal targets are mitogen-activated kinase kinases (MKKs). However, the downstream mediators of LT toxicity remain elusive. Here we report that LT exposure rapidly reduces the levels of c-Jun, a key regulator of cell proliferation and survival. Blockade of proteasome-dependent protein degradation with the 26S proteasome inhibitor MG132 largely restored c-Jun protein levels, suggesting that LT promotes degradation of c-Jun protein. Using the MKK1/2 inhibitor U0126, we further show that MKK1/2-Erk1/2 pathway inactivation similarly reduces c-Jun protein, which was also restored by MG132 pre-exposure. Interestingly, c-Jun protein rebounded to normal levels 4 h following U0126 exposure but not after LT exposure. The restoration of c-Jun in U0126-exposed cells was associated with increased c-Jun mRNA levels and was blocked by inactivation of the JNK1/2 signaling pathway. These results indicate that LT reduces c-Jun both by promoting c-Jun protein degradation via inactivation of MKK1/2Erk1/2 signaling and by blocking c-Jun gene transcription via inactivation of MKK4-JNK1/2 signaling. In line with the known functions of c-Jun, LT also inhibited cell proliferation. Ectopic expression of LT-resistant MKK2 and MKK4 variants partially restored Erk1/2 and JNK1/2 signaling in LT-exposed cells, enabling the cells to maintain relatively normal c-Jun protein levels and cell proliferation. Taken together, these findings indicate that LT reduces c-Jun protein levels via two distinct mechanisms, thereby inhibiting critical cell functions, including cellular proliferation.	[Ouyang, Weiming; Guo, Pengfei; Fang, Hui; Frucht, David M.] US FDA, Div Biotechnol Review & Res 2, Off Biotechnol Prod, Off Pharmaceut Qual,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Div Biotechnol Review & Res 2, Off Biotechnol Prod, Off Pharmaceut Qual,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	david.frucht@fda.hhs.gov	Guo, pengfei/GPK-2872-2022; Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019		internal Food and Drug Administration	internal Food and Drug Administration	This work was partially supported by an internal Food and Drug Administration medical countermeasures grant. The authors declare that they have no conflicts of interest with the contents of this article. This manuscript reflects the views of the authors and should not be construed to represent FDA's views or policies.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Alfano RW, 2008, CELL CYCLE, V7, P745, DOI 10.4161/cc.7.6.5627; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Depeille P, 2007, CLIN CANCER RES, V13, P5926, DOI 10.1158/1078-0432.CCR-07-0732; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; King JW, 2014, FUTURE ONCOL, V10, P1559, DOI [10.2217/FON.14.89, 10.2217/fon.14.89]; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Ouyang WM, 2014, J BIOL CHEM, V289, P4180, DOI 10.1074/jbc.M113.530006; Pakay JL, 2012, ONCOGENE, V31, P1817, DOI 10.1038/onc.2011.375; Peters DE, 2014, TOXICOL APPL PHARM, V279, P220, DOI 10.1016/j.taap.2014.06.010; Phillips DD, 2013, J BIOL CHEM, V288, P9058, DOI 10.1074/jbc.M113.452110; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114; Zhu ZQ, 2016, CRIT REV ONCOL HEMAT, V99, P91, DOI 10.1016/j.critrevonc.2015.12.002	57	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17919	17927		10.1074/jbc.M117.805648	http://dx.doi.org/10.1074/jbc.M117.805648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893904	Green Published, hybrid			2022-12-28	WOS:000414013000027
J	Xu, Y; Chen, GQ; Greer, MS; Caldo, KMP; Ramakrishnan, G; Shah, S; Wu, LM; Lemieux, MJ; Ozga, J; Weselake, RJ				Xu, Yang; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Ramakrishnan, Geetha; Shah, Saleh; Wu, Limin; Lemieux, M. Joanne; Ozga, Jocelyn; Weselake, Randall J.			Multiple mechanisms contribute to increased neutral lipid accumulation in yeast producing recombinant variants of plant diacylglycerol acyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFORMED GENETIC MANIPULATION; METABOLIC-CONTROL ANALYSIS; SEED OIL CONTENT; SUBSTRATE-INHIBITION; DIRECTED EVOLUTION; BRASSICA-NAPUS; TRIACYLGLYCEROL ACCUMULATION; OVER-EXPRESSION; CAMELINA-SATIVA; OILSEED RAPE	The apparent bottleneck in the accumulation of oil during seed development in some oleaginous plant species is the formation of triacylglycerol (TAG) by the acyl-CoA-dependent acylation of sn-1,2-diacylglycerol catalyzed by diacylglycerol acyltransferase (DGAT, EC 2.3.1.20). Improving DGAT activity using protein engineering could lead to improvements in seed oil yield (e.g. in canola-type Brassica napus). Directed evolution of B. napus DGAT1 (BnaDGAT1) previously revealed that one of the regions where amino acid residue substitutions lead to higher performance in BnaDGAT1 is in the ninth predicted transmembrane domain (PTMD9). In this study, several BnaDGAT1 variants with amino acid residue substitutions in PTMD9 were characterized. Among these enzyme variants, the extent of yeast TAG production was affected by different mechanisms, including increased enzyme activity, increased polypeptide accumulation, and possibly reduced substrate inhibition. The kinetic properties of the BnaDGAT1 variants were affected by the amino acid residue substitutions, and a new kinetic model based on substrate inhibition and sigmoidicity was generated. Based on sequence alignment and further biochemical analysis, the amino acid residue substitutions that conferred increased TAG accumulation were shown to be present in the DGAT1-PTMD9 region of other higher plant species. When amino acid residue substitutions that increased BnaDGAT1 enzyme activity were introduced into recombinant Camelina sativa DGAT1, they also improved enzyme performance. Thus, the knowledge generated from directed evolution of DGAT1 in one plant species can be transferred to other plant species and has potentially broad applications in genetic engineering of oleaginous crops and microorganisms.	[Xu, Yang; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Ramakrishnan, Geetha; Shah, Saleh; Ozga, Jocelyn; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Caldo, Kristian Mark P.; Lemieux, M. Joanne] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Wu, Limin] InnoTech Alberta, Crop Pathol & Biotechnol, Vegreville, AB T9C 1T4, Canada	University of Alberta; University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	Chen, Guanqun/K-7009-2012; Caldo, Kristian/AAM-8663-2020	Chen, Guanqun/0000-0001-5790-3903; Xu, Yang/0000-0001-7587-2194; Lemieux, Joanne/0000-0003-4745-9153	Alberta Innovates Bio Solutions; Natural Science and Engineering Research Council of Canada [RGPIN-2014-04585, RGPIN-2016-05926]; Canada Research Chairs Program; National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany); MITACS Elevate Award; Alberta Innovates Technology Futures	Alberta Innovates Bio Solutions; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany); MITACS Elevate Award; Alberta Innovates Technology Futures	This work was supported by Alberta Innovates Bio Solutions, Natural Science and Engineering Research Council of Canada Grants RGPIN-2014-04585 (to R. J. W.) and RGPIN-2016-05926 (to G. C.), and the Canada Research Chairs Program. This work was also supported by the National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany), MITACS Elevate Award (to G. R.), and Alberta Innovates Technology Futures. The authors declare that they have no conflicts of interest with the contents of this article.	Aznar-Moreno JA, 2017, PLANT CELL PHYSIOL, V58, P1260, DOI 10.1093/pcp/pcx058; BAFOR M, 1990, J AM OIL CHEM SOC, V67, P217, DOI 10.1007/BF02540647; Bansal S, 2016, BIOCHIMIE, V120, P9, DOI 10.1016/j.biochi.2015.06.009; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt C, 2016, BIOCHEM BIOPH RES CO, V475, P264, DOI 10.1016/j.bbrc.2016.05.071; Caldo KMP, 2017, PLANT PHYSIOL, V175, P667, DOI 10.1104/pp.17.00934; Caldo KMP, 2015, FEBS LETT, V589, P773, DOI 10.1016/j.febslet.2015.02.008; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Chapman KD, 2012, J BIOL CHEM, V287, P2288, DOI 10.1074/jbc.R111.290072; Chen GQ, 2017, PLANT J, V92, P167, DOI 10.1111/tpj.13652; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Cheng F, 2015, CHEM COMMUN, V51, P9760, DOI 10.1039/c5cc01594d; Chung MY, 2006, PLANTA MED, V72, P267, DOI 10.1055/s-2005-916178; Cohen G. N., 2014, MICROBIAL BIOCH, P59; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g; Elamin AA, 2011, MOL MICROBIOL, V81, P1577, DOI 10.1111/j.1365-2958.2011.07792.x; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Harwood JL, 2013, EUR J LIPID SCI TECH, V115, P1239, DOI 10.1002/ejlt.201300257; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karim AS, 2013, FEMS YEAST RES, V13, P107, DOI 10.1111/1567-1364.12016; Kim H, 2016, PLANT BIOTECHNOL REP, V10, P141, DOI 10.1007/s11816-016-0394-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Liao JL, 2016, BIOSCI BIOTECH BIOCH, V80, P1747, DOI 10.1080/09168451.2015.1136884; LITTLE D, 1994, BIOCHEM J, V304, P951, DOI 10.1042/bj3040951; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Lopes JLS, 2014, BBA-BIOMEMBRANES, V1838, P3145, DOI 10.1016/j.bbamem.2014.08.017; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Misra A, 2013, PHYTOCHEMISTRY, V96, P37, DOI 10.1016/j.phytochem.2013.09.020; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roesler K, 2016, PLANT PHYSIOL, V171, P878, DOI 10.1104/pp.16.00315; Ruiz-Lopez N, 2010, PLANT PHYSIOL BIOCH, V48, P73, DOI 10.1016/j.plaphy.2009.12.001; Salas JJ, 2014, PROG LIPID RES, V55, P30, DOI 10.1016/j.plipres.2014.05.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siloto RMP, 2008, BIOCHEM BIOPH RES CO, V373, P350, DOI 10.1016/j.bbrc.2008.06.031; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; Stoveken T, 2005, J BACTERIOL, V187, P1369, DOI 10.1128/JB.187.4.1369-1376.2005; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Taylor DC, 2009, BOTANY, V87, P533, DOI 10.1139/B08-101; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	61	17	18	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17819	17831		10.1074/jbc.M117.811489	http://dx.doi.org/10.1074/jbc.M117.811489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900030	Green Published, hybrid			2022-12-28	WOS:000414013000019
J	Xu, Z; Gakhar, L; Bain, FE; Spies, M; Fuentes, EJ				Xu, Zhen; Gakhar, Lokesh; Bain, Fletcher E.; Spies, Maria; Fuentes, Ernesto J.			The Tiam1 guanine nucleotide exchange factor is auto-inhibited by its pleckstrin homology coiled-coil extension domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ASSOCIATION RATES; RAC ACTIVATOR TIAM1; RHO GTPASES; RESOLUTION STRUCTURE; REGULATES TIAM1; MOLECULE; BINDING; MECHANISM; DYNAMICS; GEFS	T-cell lymphoma invasion and metastasis 1 (Tiam1) is a Dblfamily guanine nucleotide exchange factor (GEF) that specifically activates the Rho-family GTPase Rac1 in response to upstream signals, thereby regulating cellular processes including cell adhesion and migration. Tiam1 contains multiple domains, including an N-terminal pleckstrin homology coiledcoiled extension (PHn-CC-Ex) and catalytic Dbl homology and C-terminal pleckstrin homology (DH-PHc) domain. Previous studies indicate that larger fragments of Tiam1, such as the region encompassing the N-terminal to C-terminal pleckstrin homology domains (PHn-PHc), are auto-inhibited. However, the domains in this region responsible for inhibition remain unknown. Here, we show that the PHn-CC-Ex domain inhibits Tiam1 GEF activity by directly interacting with the catalytic DH-PHc domain, preventing Rac1 binding and activation. Enzyme kinetics experiments suggested that Tiam1 is auto-inhibited through occlusion of the catalytic site rather than by allostery. Small angle X-ray scattering and ensemble modeling yielded models of the PHn-PHc fragment that indicate it is in equilibrium between "open" and "closed" conformational states. Finally, single-molecule experiments support a model in which conformational sampling between the open and closed states of Tiam1 contributes to Rac1 dissociation. Our results highlight the role of the PHn-CC-Ex domain in Tiam1 GEF regulation and suggest a combinatorial model for GEF inhibition and activation of the Rac1 signaling pathway.	[Xu, Zhen; Gakhar, Lokesh; Bain, Fletcher E.; Spies, Maria; Fuentes, Ernesto J.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Prot Crystallog Facil, Iowa City, IA 52242 USA; [Spies, Maria; Fuentes, Ernesto J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Fuentes, EJ (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	ernesto-fuentes@uiowa.edu	Gakhar, Lokesh/F-2113-2010; Xu, Zhen/I-5540-2018	Gakhar, Lokesh/0000-0002-3319-1902; Spies, Maria/0000-0002-7375-8037; Xu, Zhen/0000-0001-8855-0565; Fuentes, Ernesto/0000-0001-5812-8187	DOE Office of Science User Facility [DE-AC02-05CH11231]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108617] Funding Source: NIH RePORTER	DOE Office of Science User Facility(United States Department of Energy (DOE)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members in the Fuentes laboratory for discussions and technical assistance. We thank the staff at the University of Iowa Protein Crystallography Core, BioCAT beamline 18-ID-D at the Argonne National Laboratory and the SIBYLS beamline 12.3.1 at the Berkeley National Laboratory for assistance with SAXS data collection. We thank Dr. Casey Andrews and Shuxiang Li for assistance in the construction of atomic models. We thank Dr. Elizabeth Boehm and Dr. Todd Washington for preliminary single-molecule experiments. We acknowledge that this research used the resources of the Advanced Light Source, which is a DOE Office of Science User Facility under Contract DE-AC02-05CH11231. In addition, this research used the resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; Bain FE, 2016, METHODS, V108, P14, DOI 10.1016/j.ymeth.2016.05.009; Barreira M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004993; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Bustelo Xose R, 2014, Small GTPases, V5, P9, DOI 10.4161/21541248.2014.973757; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Durand E, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-4; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fuentes EJ, 2003, J BIOL CHEM, V278, P21188, DOI 10.1074/jbc.M211792200; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joo C., 2012, COLD SPRING HARB PRO, V2012, P1104, DOI [DOI 10.1101/PDB.PROT071530, DOI 10.1101/PDB.PR0T071530]; Joshi M, 2013, ACTA CRYSTALLOGR F, V69, P744, DOI 10.1107/S1744309113014206; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mathew E, 2004, J SYNCHROTRON RADIAT, V11, P314, DOI 10.1107/S0909049504014086; Matsuzawa K, 2016, MOL BIOL CELL, V27, P1511, DOI 10.1091/mbc.E15-09-0670; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pugh RA, 2008, J MOL BIOL, V383, P982, DOI 10.1016/j.jmb.2008.09.001; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Randazzo P. A., 2013, CELLULAR LOGISTICS, V3, pe27609, DOI [10.4161/cl.27609, DOI 10.4161/CL.27609]; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Shi XH, 2012, NAT METHODS, V9, P499, DOI [10.1038/NMETH.1954, 10.1038/nmeth.1954]; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vagenende V, 2013, ACS CHEM BIOL, V8, P416, DOI 10.1021/cb300440x; Viaud J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5080; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	79	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17777	17793		10.1074/jbc.M117.799114	http://dx.doi.org/10.1074/jbc.M117.799114			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882897	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000414013000016
J	Gamage, DG; Leikina, E; Quinn, ME; Ratinov, A; Chernomordik, LV; Millay, DP				Gamage, Dilani G.; Leikina, Eugenia; Quinn, Malgorzata E.; Ratinov, Anthony; Chernomordik, Leonid V.; Millay, Douglas P.			Insights into the localization and function of myomaker during myoblast fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE FORMATION; PLASMA-MEMBRANE; SIGNAL PEPTIDE; CELL-FUSION; RAB GTPASES; PROTEIN; PALMITOYLATION; MECHANISMS; ACYLATION; MYOCYTES	Multinucleated skeletal muscle fibers form through the fusion of myoblasts during development and regeneration. Previous studies identified myomaker (Tmem8c) as a muscle-specific membrane protein essential for fusion. However, the specific function of myomaker and how its function is regulated are unknown. To explore these questions, we first examined the cellular localization of endogenous myomaker. Two independent antibodies showed that whereas myomaker does localize to the plasma membrane in cultured myoblasts, the protein also resides in the Golgi and post-Golgi vesicles. These results raised questions regarding the precise cellular location of myomaker function and mechanisms that govern myomaker trafficking between these cellular compartments. Using a synchronized fusion assay, we demonstrated that myomaker functions at the plasma membrane to drive fusion. Trafficking of myomaker is regulated by palmitoylation of C-terminal cysteine residues that allows Golgi localization. Moreover, dissection of the C terminus revealed that palmitoylation was not sufficient for complete fusogenic activity suggesting a function for other amino acids within this C-terminal region. Indeed, C-terminal mutagenesis analysis highlighted the importance of a C-terminal leucine for function. These data reveal that myoblast fusion requires myomaker activity at the plasma membrane and is potentially regulated by proper myomaker trafficking.	[Gamage, Dilani G.; Quinn, Malgorzata E.; Millay, Douglas P.] Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Leikina, Eugenia; Ratinov, Anthony; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, NIH, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Millay, DP (corresponding author), 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA.	douglas.millay@cchmc.org			Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health [R01AR068286]; Muscular Dystrophy Association; Pew Charitable Trusts; Eunice Kennedy Shriver NICHD, National Institutes of Health; United States-Israel Binational Science Foundation (BSF) [2013151]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068286] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health; Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health Grant R01AR068286, the Muscular Dystrophy Association, and Pew Charitable Trusts (to D.P.M.) and the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health, and United States-Israel Binational Science Foundation (BF) Grant 2013151 (to L.V.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; COLEMAN J, 1985, CELL, V43, P351, DOI 10.1016/0092-8674(85)90040-6; Di Gioia SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16077; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Landemaine A, 2014, BIOCHEM BIOPH RES CO, V451, P480, DOI 10.1016/j.bbrc.2014.07.093; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Luo W, 2015, INT J MOL SCI, V16, P26186, DOI 10.3390/ijms161125946; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Pierson TC, 2012, STRUCTURE, V20, P200, DOI 10.1016/j.str.2012.01.014; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schejter ED, 2016, SEMIN CELL DEV BIOL, V60, P112, DOI 10.1016/j.semcdb.2016.07.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smurova K, 2016, CELL REP, V14, P1517, DOI 10.1016/j.celrep.2016.01.027; Vivian JP, 2003, BIOCHEM BIOPH RES CO, V310, P1096, DOI 10.1016/j.bbrc.2003.09.126; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	33	32	34	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17272	17289		10.1074/jbc.M117.811372	http://dx.doi.org/10.1074/jbc.M117.811372			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860190	Green Published, hybrid			2022-12-28	WOS:000414009300011
J	Sobe, RC; Bond, WG; Wotanis, CK; Zayner, JP; Burriss, MA; Fernandez, N; Bruger, EL; Waters, CM; Neufeld, HS; Karatan, E				Sobe, Richard C.; Bond, Whitney G.; Wotanis, Caitlin K.; Zayner, Josiah P.; Burriss, Marybeth A.; Fernandez, Nicolas; Bruger, Eric L.; Waters, Christopher M.; Neufeld, Howard S.; Karatan, Ece			Spermine inhibits Vibrio cholerae biofilm formation through the NspS-MbaA polyamine signaling system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; biofilm; cyclic di-GMP (c-di-GMP); polyamine; Vibrio cholerae	CYCLIC DI-GMP; MANNOSE-SENSITIVE HEMAGGLUTININ; RUGOSE COLONY MORPHOLOGY; SOLUTE-BINDING-PROTEINS; EL-TOR; IDENTIFICATION; NORSPERMIDINE; COLONIZATION; MOTILITY; CHITIN	The aquatic bacterium and human intestinal pathogen, Vibrio cholerae, senses and responds to a variety of environment-specific cues to regulate biofilm formation. Specifically, the polyamines norspermidine and spermidine enhance and repress V. cholerae biofilm formation, respectively. These effects are relevant for understanding V. cholerae pathogenicity and are mediated through the periplasmic binding protein NspS and the transmembrane bis-(3-5) cyclic diguanosine monophosphate (c-di-GMP) phosphodiesterase MbaA. However, the levels of spermidine required to inhibit biofilm formation through this pathway are unlikely to be encountered by V. cholerae in aquatic reservoirs or within the human host during infection. We therefore hypothesized that other polyamines in the gastrointestinal tract may control V. cholerae biofilm formation at physiological levels. The tetramine spermine has been reported to be present at nearly 50 m concentrations in the intestinal lumen. Here, we report that spermine acts as an exogenous cue that inhibits V. cholerae biofilm formation through the NspS-MbaA signaling system. We found that this effect probably occurs through a direct interaction of spermine with NspS, as purified NspS protein could bind spermine in vitro. Spermine also inhibited biofilm formation by altering the transcription of the vps genes involved in biofilm matrix production. Global c-di-GMP levels were unaffected by spermine supplementation, suggesting that biofilm formation may be regulated by variations in local rather than global c-di-GMP pools. Finally, we propose a model illustrating how the NspS-MbaA signaling system may communicate exogenous polyamine content to the cell to control biofilm formation in the aquatic environment and within the human intestine.	[Sobe, Richard C.; Bond, Whitney G.; Wotanis, Caitlin K.; Zayner, Josiah P.; Burriss, Marybeth A.; Neufeld, Howard S.; Karatan, Ece] Appalachian State Univ, Dept Biol, 572 Rivers St, Boone, NC 28608 USA; [Fernandez, Nicolas; Bruger, Eric L.; Waters, Christopher M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University of North Carolina; Appalachian State University; Michigan State University	Karatan, E (corresponding author), Appalachian State Univ, Dept Biol, 572 Rivers St, Boone, NC 28608 USA.	karatane@appstate.edu		Bond, Whitney/0000-0001-9529-4360	National Institutes of Health [AI096358, GM109259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI096358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI096358 (to E. K.) and GM109259 (to C. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MA, 2011, FOOD NUTR RES, V55, DOI [10.3402/fnr.v55i0.5455, 10.3402/fnr.v55i0.5572]; Antonova ES, 2015, MOL MICROBIOL, V97, P605, DOI 10.1111/mmi.13107; BARDOCZ S, 1993, J NUTR BIOCHEM, V4, P66, DOI 10.1016/0955-2863(93)90001-D; Bardocz S., 1999, POLYAMINES HLTH NUTR; Benamouzig R, 1997, AM J CLIN NUTR, V65, P766, DOI 10.1093/ajcn/65.3.766; Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cockerell SR, 2014, MICROBIOL-SGM, V160, P832, DOI 10.1099/mic.0.075903-0; Correa NE, 2000, MOL MICROBIOL, V35, P743, DOI 10.1046/j.1365-2958.2000.01745.x; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; Goytia M, 2013, FEMS MICROBIOL LETT, V343, P64, DOI 10.1111/1574-6968.12130; HALLAK A, 1993, CLIN SCI, V85, P451, DOI 10.1042/cs0850451; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Hamana K, 2004, J GEN APPL MICROBIOL, V50, P289, DOI 10.2323/jgam.50.289; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Hay AJ, 2015, INFECT IMMUN, V83, P317, DOI 10.1128/IAI.02617-14; HOLMGREN J, 1977, J INFECT DIS, V136, pS105, DOI 10.1093/infdis/136.Supplement.S105; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Koestler BJ, 2014, INFECT IMMUN, V82, P3002, DOI 10.1128/IAI.01664-14; KOSKI P, 1991, J BACTERIOL, V173, P3695, DOI 10.1128/JB.173.12.3695-3699.1991; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Liu XX, 2010, J BACTERIOL, V192, P4541, DOI 10.1128/JB.00209-10; Liu ZY, 2015, INFECT IMMUN, V83, P1114, DOI 10.1128/IAI.02841-14; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; MCEVOY FA, 1975, PEDIATR RES, V9, P721, DOI 10.1203/00006450-197509000-00007; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Nishibori N, 2001, FISHERIES SCI, V67, P79, DOI 10.1046/j.1444-2906.2001.00202.x; OSBORNE DL, 1990, AM J PHYSIOL, V258, pG576, DOI 10.1152/ajpgi.1990.258.4.G576; Parker ZM, 2012, FEMS MICROBIOL LETT, V329, P18, DOI 10.1111/j.1574-6968.2012.02498.x; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shikuma NJ, 2009, J BACTERIOL, V191, P4082, DOI 10.1128/JB.01540-08; SHUKLA BN, 1995, FEMS IMMUNOL MED MIC, V12, P113, DOI 10.1111/j.1574-695X.1995.tb00182.x; Sun SY, 2015, ISME J, V9, P1812, DOI 10.1038/ismej.2014.265; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Townsley L, 2015, ENVIRON MICROBIOL, V17, P4290, DOI 10.1111/1462-2920.12799; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; WALDOR MK, 1994, J INFECT DIS, V170, P278, DOI 10.1093/infdis/170.2.278; Zampini M, 2003, APPL ENVIRON MICROB, V69, P5711, DOI 10.1128/AEM.69.9.5711-5715.2003; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8	58	24	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17025	17036		10.1074/jbc.M117.801068	http://dx.doi.org/10.1074/jbc.M117.801068			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28827313	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000413140600022
J	Takahara, T; Inoue, K; Arai, Y; Kuwata, K; Shibata, H; Maki, M				Takahara, Terunao; Inoue, Kuniko; Arai, Yumika; Kuwata, Keiko; Shibata, Hideki; Maki, Masatoshi			The calcium-binding protein ALG-2 regulates protein secretion and trafficking via interactions with MISSL and MAP1B proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium-binding protein; microtubule-associated protein (MAP); secretion; transport	RETICULUM EXIT SITES; ENDOPLASMIC-RETICULUM; CA2+-DEPENDENT MANNER; MICROTUBULE DYNAMICS; SUBCELLULAR-LOCALIZATION; CA2+-BINDING PROTEINS; TRANSPORT; SEC31A; DYNEIN; COPII	Mobilization of intracellular calcium is essential for a wide range of cellular processes, including signal transduction, apoptosis, and vesicular trafficking. Several lines of evidence have suggested that apoptosis-linked gene 2 (ALG-2, also known as PDCD6), a calcium-binding protein, acts as a calcium sensor linking calcium levels with efficient vesicular trafficking, especially at the endoplasmic reticulum (ER)-to-Golgi transport step. However, how ALG-2 regulates these processes remains largely unclear. Here, we report that MAPK1-interacting and spindle-stabilizing (MISS)-like (MISSL), a previously uncharacterized protein, interacts with ALG-2 in a calcium-dependent manner. Live-cell imaging revealed that upon a rise in intracellular calcium levels, GFP-tagged MISSL (GFP-MISSL) dynamically relocalizes in a punctate pattern and colocalizes with ALG-2. MISSL knockdown caused disorganization of the components of the ER exit site, the ER-Golgi intermediate compartment, and Golgi. Importantly, knockdown of either MISSL or ALG-2 attenuated the secretion of secreted alkaline phosphatase (SEAP), a model secreted cargo protein, with similar reductions in secretion by single- and double-protein knockdowns, suggesting that MISSL and ALG-2 act in the same pathway to regulate the secretion process. Furthermore, ALG-2 or MISSL knockdown delayed ER-to-Golgi transport of procollagen type I. We also found that ALG-2 and MISSL interact with microtubule-associated protein 1B (MAP1B) and that MAP1B knockdown reverts the reduced secretion of SEAP caused by MISSL or ALG-2 depletion. These results suggest that a change in the intracellular calcium level plays a role in regulation of the secretory pathway via interaction of ALG-2 with MISSL and MAP1B.	[Takahara, Terunao; Inoue, Kuniko; Arai, Yumika; Shibata, Hideki; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Kuwata, Keiko] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Takahara, T; Maki, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	takahara@agr.nagoya-u.ac.jp; mmaki@agr.nagoya-u.ac.jp	Kuwata, Keiko/I-6128-2014; Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491	World Premier International Research Center Initiative, Japan	World Premier International Research Center Initiative, Japan	We thank Dr. Sasaki-Osugi and all members of the laboratory of Molecular Cell Regulation for their valuable support and discussion. We also thank Dr. Ayano Satoh for providing HeLa cells stably expressing SEAP. The Institute of Transformative Bio-Molecules is supported by the World Premier International Research Center Initiative, Japan.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Amodio G, 2013, FEBS LETT, V587, P3261, DOI 10.1016/j.febslet.2013.08.021; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Barnat M, 2016, MOL CELL NEUROSCI, V72, P9, DOI 10.1016/j.mcn.2016.01.001; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Goold RG, 1999, J CELL SCI, V112, P3373; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Jimenez-Mateos EM, 2005, BIOCHEM J, V389, P333, DOI 10.1042/BJ20050244; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kanadome T, 2017, FEBS J, V284, P56, DOI 10.1111/febs.13949; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091401; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; MIZUNO M, 1994, J CELL SCI, V107, P1321; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Qin J, 2017, J CELL PHYSIOL, V232, P3067, DOI 10.1002/jcp.25754; Qin J, 2017, ONCOTARGET, V8, P2745, DOI 10.18632/oncotarget.13740; Qin SY, 2012, GLYCOBIOLOGY, V22, P1709, DOI 10.1093/glycob/cws114; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rayl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157227; Sasaki-Osugi K, 2013, J BIOL CHEM, V288, P33361, DOI 10.1074/jbc.M113.497479; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Tortosa E, 2013, EMBO J, V32, P1293, DOI 10.1038/emboj.2013.76; Tymanskyj SR, 2012, MOL CELL NEUROSCI, V49, P110, DOI 10.1016/j.mcn.2011.10.003; Villarroel-Campos D, 2014, DEV NEUROBIOL, V74, P953, DOI 10.1002/dneu.22178; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	65	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17057	17072		10.1074/jbc.M117.800201	http://dx.doi.org/10.1074/jbc.M117.800201			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28864773	hybrid, Green Published			2022-12-28	WOS:000413140600025
J	Steffen, W; Ko, FC; Patel, J; Lyamichev, V; Albert, TJ; Benz, J; Rudolph, MG; Bergmann, F; Streidl, T; Kratzsch, P; Boenitz-Dulat, M; Oelschlaegel, T; Schraeml, M				Steffen, Wojtek; Ko, Fu Chong; Patel, Jigar; Lyamichev, Victor; Albert, Thomas J.; Benz, Jorg; Rudolph, Markus G.; Bergmann, Frank; Streidl, Thomas; Kratzsch, Peter; Boenitz-Dulat, Mara; Oelschlaegel, Tobias; Schraeml, Michael			Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-MOBARAENSIS; PRO-TRANSGLUTAMINASE; BACTERIAL TRANSGLUTAMINASE; ESCHERICHIA-COLI; PEPTIDE; PURIFICATION; ACTIVATION; EXPRESSION; SUBSTRATE; SEQUENCE	Microbial transglutaminases (MTGs) catalyze the formation of Gln-Lys isopeptide bonds and are widely used for the crosslinking of proteins and peptides in food and biotechnological applications (e. g.to improve the texture of protein-rich foods or in generating antibody-drug conjugates). Currently used MTGs have low substrate specificity, impeding their biotechnological use as enzymes that do not cross-react with nontarget substrates (i.e. as bio-orthogonal labeling systems). Here, we report the discovery of an MTG from Kutzneria albida (KalbTG), which exhibited no cross-reactivity with known MTG substrates or commonly used target proteins, such as antibodies. KalbTG was produced in Escherichia coli as soluble and active enzyme in the presence of its natural inhibitor ammonium to prevent potentially toxic cross-linking activity. The crystal structure of KalbTG revealed a conserved core similar to other MTGs but very short surface loops, making it the smallestMTGcharacterized to date. Ultra-dense peptide array technology involving a pool of 1.4 million unique peptides identified specific recognition motifs for KalbTG in these peptides. We determined that the motifs YRYRQ and RYESK are the best Gln and Lys substrates of KalbTG, respectively. By first reacting a bifunctionalized peptide with the more specific KalbTG and in a second step with the less specific MTG from Streptomyces mobaraensis, a successful bio-orthogonal labeling system was demonstrated. Fusing the KalbTG recognition motif to an antibody allowed for site-specific and ratio-controlled labeling using low label excess. Its site specificity, favorable kinetics, ease of use, and cost-effective production render KalbTG an attractive tool for a broad range of applications, including production of therapeutic antibody-drug conjugates.	[Steffen, Wojtek; Ko, Fu Chong; Bergmann, Frank; Streidl, Thomas; Kratzsch, Peter; Boenitz-Dulat, Mara; Oelschlaegel, Tobias; Schraeml, Michael] Roche Diagnost GmbH, CPS, Nonnenwald 2, D-82377 Penzberg, Germany; [Patel, Jigar; Lyamichev, Victor; Albert, Thomas J.] NimbleGen, Roche Sequencing, Madison, WI 53719 USA; [Benz, Jorg; Rudolph, Markus G.] F Hoffmann Roche Ltd, pRED, Grenzacherstr 124, CH-4070 Basel, Switzerland	Roche Holding; Roche Holding; Roche NimbleGen; Roche Holding	Steffen, W (corresponding author), Roche Diagnost GmbH, CPS, Nonnenwald 2, D-82377 Penzberg, Germany.	wojtek.steffen@roche.com		Rudolph, Markus/0000-0003-0447-1101	Roche Diagnostics GmbH, Penzberg, Germany	Roche Diagnostics GmbH, Penzberg, Germany	W. S., F. C. K., F. Bergmann, T. Streidl, P. Kratzsch, M. Boenitz-Dulat, T. Oelschlaegel, and M. Schraeml are employees of Roche Diagnostics GmbH, Penzberg, Germany. J. Patel, V. Lyamichev, and T. J. Albert are employees of Roche Sequencing, NimbleGen, Madison, USA. J. Benz and M. G. Rudolph are employed by F. Hoffmann-La Roche Ltd, pRED, Basel, Switzerland. The authors have filed patent applications on aspects of this research. This study was sponsored and designed by Roche Diagnostics GmbH, Penzberg, Germany.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; Andres H., 2012, International Patent, Patent No. [WO/2012/150321, 2012150321]; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Date M, 2004, J BIOTECHNOL, V110, P219, DOI 10.1016/j.jbiotec.2004.02.011; Dennler P, 2014, BIOCONJUGATE CHEM, V25, P569, DOI 10.1021/bc400574z; Du K, 2014, APPL ENVIRON MICROB, V80, P723, DOI 10.1128/AEM.02820-13; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes CG, 2015, BIOCHEMISTRY-US, V54, P5723, DOI 10.1021/acs.biochem.5b00661; FOLK JE, 1966, BIOCHIM BIOPHYS ACTA, V122, P244, DOI 10.1016/0926-6593(66)90066-X; Forsstrom B, 2014, MOL CELL PROTEOMICS, V13, P1585, DOI 10.1074/mcp.M113.033308; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gerber P., 1986, MOLOC MOLECULAR MODE; Green MR, 2012, MOL CLONING LAB MANU, V1; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Josten AE, 2000, J IMMUNOL METHODS, V240, P47, DOI 10.1016/S0022-1759(00)00172-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya N, 2007, J BIOSCI BIOENG, V104, P195, DOI 10.1263/jbb.104.195; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kieliszek M, 2014, FOLIA MICROBIOL, V59, P241, DOI 10.1007/s12223-013-0287-x; Lee JH, 2013, BIOTECHNOL BIOENG, V110, P2865, DOI 10.1002/bit.24970; Lin SJ, 2007, BIOTECHNOL LETT, V29, P111, DOI 10.1007/s10529-006-9205-5; Liu S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-112; Malesevic M, 2015, CHEMBIOCHEM, V16, P1169, DOI 10.1002/cbic.201402709; Martins IM, 2014, APPL MICROBIOL BIOT, V98, P6957, DOI 10.1007/s00253-014-5894-1; Marx CK, 2008, J BIOTECHNOL, V136, P156, DOI 10.1016/j.jbiotec.2008.06.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori Y, 2011, BIOCHEM BIOPH RES CO, V410, P829, DOI 10.1016/j.bbrc.2011.06.073; Oteng-Pabi SK, 2013, ANAL BIOCHEM, V441, P169, DOI 10.1016/j.ab.2013.07.014; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pfleiderer C, 2005, MICROBIOL RES, V160, P265, DOI 10.1016/j.micres.2005.01.001; Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w; Rebets Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-885; Rickert M, 2016, PROTEIN SCI, V25, P442, DOI 10.1002/pro.2833; Sarafeddinov A, 2011, J MICROBIOL BIOTECHN, V21, P617, DOI 10.4014/jmb.1012.12004; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Seguro K, 1996, ACS SYM SER, V650, P271; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer C, 2012, AMINO ACIDS, V42, P997, DOI 10.1007/s00726-011-1016-x; Sommer C, 2011, PROTEIN EXPRES PURIF, V77, P9, DOI 10.1016/j.pep.2010.12.005; Strop P, 2015, NAT BIOTECHNOL, V33, P694, DOI 10.1038/nbt.3274; Strop P, 2014, BIOCONJUGATE CHEM, V25, P855, DOI 10.1021/bc500099v; Sugimura Y, 2008, ARCH BIOCHEM BIOPHYS, V477, P379, DOI 10.1016/j.abb.2008.06.014; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang K, 2013, BIOTECHNOL LETT, V35, P383, DOI 10.1007/s10529-012-1090-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HL, 2009, BIOSCI BIOTECH BIOCH, V73, P2531, DOI 10.1271/bbb.90422; Yang MT, 2011, J BIOL CHEM, V286, P7301, DOI 10.1074/jbc.M110.203315; Zhou Q, 2015, ANTI-CANCER AGENT ME, V15, P828, DOI 10.2174/1871520615666150302125448; Zotzel J, 2003, EUR J BIOCHEM, V270, P4149, DOI 10.1046/j.1432-1033.2003.03809.x	54	30	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15622	15635		10.1074/jbc.M117.797811	http://dx.doi.org/10.1074/jbc.M117.797811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28751378	Green Published, hybrid			2022-12-28	WOS:000411512200004
J	Chen, C; Barbieri, JT				Chen, Chen; Barbieri, Joseph T.			When Escherichia coli doesn't fit the mold: A pertussis-like toxin with altered specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CATALYZED ADP-RIBOSYLATION	Bacterial toxins introduce protein modifications such as ADP-ribosylation to manipulate host cell signaling and physiology. Several general mechanisms for toxin function have been established, but the extent to which previously uncharacterized toxins utilize these mechanisms is unknown. A study of an Escherichia coli pertussis-like toxin demonstrates that this protein acts on a known toxin substrate but displays distinct and dual chemoselectivity, suggesting this E. coli pertussis-like toxin may serve as a unique tool to study G-protein signaling in eukaryotic cells.	[Chen, Chen; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health [AI030162, AI118389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by National Institutes of Health Grants AI030162 and AI118389.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; CARROLL SF, 1985, P NATL ACAD SCI USA, V82, P7237, DOI 10.1073/pnas.82.21.7237; Ganesan AK, 1999, J BIOL CHEM, V274, P9503, DOI 10.1074/jbc.274.14.9503; Littler DR, 2017, J BIOL CHEM, V292, P15143, DOI 10.1074/jbc.M117.796094; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MOSS J, 1984, J RECEPTOR RES, V4, P459, DOI 10.3109/10799898409042567; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; WEST RE, 1985, J BIOL CHEM, V260, P4428	10	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15159	15160		10.1074/jbc.H117.796094	http://dx.doi.org/10.1074/jbc.H117.796094			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28887436	Green Published, hybrid			2022-12-28	WOS:000409902100037
J	Cunha, DA; Cito, M; Grieco, FA; Cosentino, C; Danilova, T; Ladriere, L; Lindahl, M; Domanskyi, A; Bugliani, M; Marchetti, P; Eizirik, DL; Cnop, M				Cunha, Daniel A.; Cito, Monia; Grieco, Fabio Arturo; Cosentino, Cristina; Danilova, Tatiana; Ladriere, Laurence; Lindahl, Maria; Domanskyi, Andrii; Bugliani, Marco; Marchetti, Piero; Eizirik, Decio L.; Cnop, Miriam			Pancreatic beta-cell protection from inflammatory stress by the endoplasmic reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived neutrotrophic factor (MANF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; CANDIDATE GENE; FATTY-ACIDS; TYPE-1; APOPTOSIS; CYTOKINES; DEATH; DYSFUNCTION; ACTIVATION; PATHWAY	Cytokine-induced endoplasmic reticulum (ER) stress is one of the molecular mechanisms underlying pancreatic beta-cell demise in type 1 diabetes. Thrombospondin 1 (THBS1) was recently shown to promote beta-cell survival during lipotoxic stress. Here we show that ER-localized THBS1 is cytoprotective to rat, mouse, andhuman beta-cells exposed to cytokines or thapsigargin-induced ER stress. THBS1 confers cytoprotection by maintaining expression of mesencephalic astrocyte-derived neutrotrophic factor (MANF) in beta-cells and thereby prevents the BH3-only protein BIM (BCL2-interacting mediator of cell death)-dependent triggering of the mitochondrial pathway of apoptosis. Prolonged exposure of beta-cells to cytokines or thapsigargin leads to THBS1 and MANF degradation and loss of this prosurvival mechanism. Approaches that sustain intracellular THBS1 and MANF expression in beta-cells should be explored as a cytoprotective strategy in type 1 diabetes.	[Cunha, Daniel A.; Cito, Monia; Grieco, Fabio Arturo; Cosentino, Cristina; Ladriere, Laurence; Eizirik, Decio L.; Cnop, Miriam] Univ Libre Bruxelles, Fac Med, Ctr Diabet Res, B-1070 Brussels, Belgium; [Danilova, Tatiana; Lindahl, Maria; Domanskyi, Andrii] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56100 Pisa, Italy; [Cnop, Miriam] Univ Libre Bruxelles, Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; University of Helsinki; University of Pisa; Universite Libre de Bruxelles	Cnop, M (corresponding author), Univ Libre Bruxelles, ULB Ctr Diabet Res, CP 618,Route Lennik 808, B-1070 Brussels, Belgium.	mcnop@ulb.ac.be	Bugliani, Marco/I-3168-2019; Lindahl, Maria/AHE-1252-2022; Domanskyi, Andrii/H-3437-2012	Bugliani, Marco/0000-0002-1744-1561; Domanskyi, Andrii/0000-0002-4755-5981; Lindahl, Maria/0000-0002-5674-8830; Cnop, Miriam/0000-0002-5112-1692	European Foundation for the Study of Diabetes/Lilly Program; European Union Horizon Research and Innovation Program, Project T2DSystems [667191]; Fonds National de la Recherche Scientifique; Actions de Recherche Concertees de la Communaute Francaise, Belgium; Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA [115797]; European Union Horizon Research and Innovation Program; EFPIA; JDRF; Leona M. and Harry B. Helmsley Charitable Trust	European Foundation for the Study of Diabetes/Lilly Program; European Union Horizon Research and Innovation Program, Project T2DSystems; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees de la Communaute Francaise, Belgium; Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA; European Union Horizon Research and Innovation Program; EFPIA; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust	This was supported by the European Foundation for the Study of Diabetes/Lilly Program; the European Union Horizon 2020 Research and Innovation Program, Project T2DSystems, under Grant Agreement 667191; the Fonds National de la Recherche Scientifique; Actions de Recherche Concertees de la Communaute Francaise, Belgium; and the Innovative Medicines Initiative 2 Joint Undertaking, Project INNODIA, under Grant Agreement 115797, which receives support from the European Union Horizon 2020 Research and Innovation Program, EFPIA, JDRF, and the Leona M. and Harry B. Helmsley Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulkarim B, 2015, DIABETES, V64, P3951, DOI 10.2337/db15-0477; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cunha DA, 2014, CELL DEATH DIFFER, V21, P1313, DOI 10.1038/cdd.2014.53; Cunha DA, 2016, CELL DEATH DIFFER, V23, P1995, DOI 10.1038/cdd.2016.89; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Dooley J, 2016, NAT GENET, V48, P519, DOI 10.1038/ng.3531; Drott CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047451; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Galli E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29058; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lundberg M, 2016, DIABETES, V65, P3104, DOI 10.2337/db16-0616; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Maganti AV, 2016, J BIOL CHEM, V291, P22524, DOI 10.1074/jbc.M116.741694; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marroqui L, 2015, DIABETES, V64, P3808, DOI 10.2337/db15-0362; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Matlik K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.371; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Olerud J, 2008, DIABETES, V57, P1870, DOI 10.2337/db07-0724; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Oliveira AF, 2015, BIOTECHNIQUES, V58, P228, DOI 10.2144/000114285; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Veliceasa D, 2007, FEBS J, V274, P6365, DOI 10.1111/j.1742-4658.2007.06159.x; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0	52	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14977	14988		10.1074/jbc.M116.769877	http://dx.doi.org/10.1074/jbc.M116.769877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28698383	Green Published, hybrid			2022-12-28	WOS:000409902100021
J	Yuan, Y; Zajicek, J; Qiu, CJ; Chandrahas, V; Lee, SW; Ploplis, VA; Castellino, FJ				Yuan, Yue; Zajicek, Jaroslav; Qiu, Cunjia; Chandrahas, Vishwanatha; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Conformationally organized lysine isosteres in Streptococcus pyogenes M protein mediate direct high-affinity binding to human plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; GROUP-A STREPTOCOCCUS; NMR CHEMICAL-SHIFT; BACTERIAL SURFACE; KRINGLE 2; IMPROVED SENSITIVITY; XPLOR-NIH; SPECTROSCOPY; PAM; RECEPTOR	The binding of human plasminogen (hPg) to the surface of the human pathogen group A Streptococcus pyogenes (GAS) and subsequent hPg activation to the protease plasmin generate a proteolytic surface that GAS employs to circumvent host innate immunity. Direct high-affinity binding of hPg/plasmin to pattern D GAS is fully recapitulated by the hPg kringle 2 domain (K2(hPg)) and a short internal peptide region (a1a2) of a specific subtype of bacterial surface M protein, present in all GAS pattern D strains. To better understand the nature of this binding, critical to the virulence of many GAS skin-tropic strains, we used high-resolutionNMRto define the interaction of recombinant K2(hPg) with recombinant a1a2 (VKK38) of the M protein from GAS isolate NS455. Wefound a 2: 1 (m/m) binding stoichiometry of K2(hPg)/VKK38, with the lysine-binding sites of two K2(hPg) domains anchored to two regions of monomeric VKK38. The K2(hPg)/VKK38 binding altered the VKK38 secondary structure from a helical apo-peptide with a flexible center to an end-to-end K2(hPg)-bound alpha-helix. The K2(hPg) residues occupied opposite faces of this helix, an arrangement that minimized steric clashing of K2(hPg). We conclude that VKK38 provides two conformational lysine isosteres that each interact with the lysine-binding sites in K2(hPg). Further, the adoption of an alpha-helix by VKK38 upon binding to K2(hPg) sterically optimizes the side chains of VKK38 for maximal binding to K2(hPg) and minimizes steric overlap between the K2(hPg) domains. The mechanism for hPg/M protein binding uncovered here may facilitate targeting of GAS virulence factors for disease management.	[Yuan, Yue; Qiu, Cunjia; Chandrahas, Vishwanatha; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Yuan, Yue; Zajicek, Jaroslav; Qiu, Cunjia; Chandrahas, Vishwanatha; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Chandrahas, Vishwanatha K./I-8256-2019; Yuan, Yue/S-5884-2017	Chandrahas, Vishwanatha K./0000-0001-8227-5021; Yuan, Yue/0000-0003-1003-379X	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrahari G, 2016, J BIOL CHEM, V291, P9181, DOI 10.1074/jbc.M115.704221; Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Arza B, 1997, THROMB HAEMOSTASIS, V78, P1097; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hawley SB, 2001, J BIOL CHEM, V276, P179, DOI 10.1074/jbc.M004919200; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; LIOTTA LA, 1981, THROMB RES, V21, P663, DOI 10.1016/0049-3848(81)90268-1; LIOTTA LA, 1981, CANCER RES, V41, P4629; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Wang M, 2010, BIOPHYS J, V99, P302, DOI 10.1016/j.bpj.2010.04.019; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	50	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15016	15027		10.1074/jbc.M117.794198	http://dx.doi.org/10.1074/jbc.M117.794198			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724633	Green Published, hybrid			2022-12-28	WOS:000409902100024
J	Grabon, A; Orlowski, A; Tripathi, A; Vuorio, J; Javanainen, M; Rog, T; Lonnfors, M; McDermott, MI; Siebert, G; Somerharju, P; Vattulainen, I; Bankaitis, VA				Grabon, Aby; Orlowski, Adam; Tripathi, Ashutosh; Vuorio, Joni; Javanainen, Matti; Rog, Tomasz; Lonnfors, Max; McDermott, Mark I.; Siebert, Garland; Somerharju, Pentti; Vattulainen, Ilpo; Bankaitis, Vytas A.			Dynamics and energetics of the mammalian phosphatidylinositol transfer protein phospholipid exchange cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; POTENTIAL FUNCTIONS; MEMBRANE; BINDING; ALPHA; YEAST; PHOSPHATIDYLCHOLINE; SEC14; GENE; DEGENERATION	Phosphatidylinositol-transfer proteins (PITPs) regulate phosphoinositide signaling in eukaryotic cells. The defining feature of PITPs is their ability to exchange phosphatidylinositol (PtdIns) molecules between membranes, and this property is central to PITP-mediated regulation of lipid signaling. However, the details of the PITP-mediated lipid exchange cycle remain entirely obscure. Here, all-atom molecular dynamics simulations of the mammalian StART-like PtdIns/phosphatidylcholine (PtdCho) transfer protein PITP alpha, both on membrane bilayers and in solvated systems, informed downstream biochemical analyses that tested key aspects of the hypotheses generated by the molecular dynamics simulations. These studies provided five key insights into the PITP alpha lipid exchange cycle: (i) interaction of PITP alpha with the membrane is spontaneous and mediated by four specific protein substructures; (ii) the ability of PITP alpha to initiate closure around the PtdCho ligand is accompanied by loss of flexibility of two helix/loop regions, as well as of the C-terminal helix; (iii) the energy barrier of phospholipid extraction from the membrane is lowered by a network of hydrogen bonds between the lipid molecule and PITP alpha; (iv) the trajectory of PtdIns or PtdCho into and through the lipidbinding pocket is chaperoned by sets of PITP alpha residues conserved throughout the StART-like PITP family; and (v) conformational transitions in the C-terminal helix have specific functional involvements in PtdIns transfer activity. Taken together, these findings provide the first mechanistic description of key aspects of the PITP alpha PtdIns/PtdCho exchange cycle and offer a rationale for the high conservation of particular sets of residues across evolutionarily distant members of the metazoan StART-like PITP family.	[Grabon, Aby; Tripathi, Ashutosh; Lonnfors, Max; McDermott, Mark I.; Siebert, Garland; Bankaitis, Vytas A.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Orlowski, Adam; Vuorio, Joni; Javanainen, Matti; Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Lab Phys, FI-33720 Tampere, Finland; [Orlowski, Adam] Univ Limerick, Dept Phys & Energy, Limerick V94 T9PX, Ireland; [Vuorio, Joni; Rog, Tomasz; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, POB 64, FI-00014 Helsinki, Finland; [Somerharju, Pentti] Univ Helsinki, Dept Biochem & Dev Biol, POB 63, FI-00014 Helsinki, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, Dept Phys & Chem, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense, Denmark; [Bankaitis, Vytas A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Bankaitis, Vytas A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Tampere University; University of Limerick; University of Helsinki; University of Helsinki; University of Southern Denmark; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bankaitis, VA (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Vattulainen, I (corresponding author), Tampere Univ Technol, Lab Phys, FI-33720 Tampere, Finland.; Vattulainen, I (corresponding author), Univ Helsinki, Dept Phys, POB 64, FI-00014 Helsinki, Finland.; Vattulainen, I (corresponding author), Univ Southern Denmark, Dept Phys & Chem, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense, Denmark.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	ilpo.vattulainen@tut.fi; vytas@tamhsc.edu	Javanainen, Matti/GZA-9227-2022; Rog, Tomasz/ABE-3044-2020	Javanainen, Matti/0000-0003-4858-364X; Rog, Tomasz/0000-0001-6765-7013; Orlowski, Adam/0000-0003-1599-1022; Vuorio, Joni/0000-0003-2404-4545; Vattulainen, Ilpo/0000-0001-7408-3214	Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112591, P41GM103311] Funding Source: NIH RePORTER	Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Laboratory for Molecular Simulation and High Performance Research Computing at Texas A&M University for providing software, support, and computer time. We also thank CSC - IT Centre for Science (Espoo, Finland) for providing ample computer resources.	Alb JG, 2007, J LIPID RES, V48, P1857, DOI 10.1194/jlr.M700145-JLR200; ALB JG, 1995, P NATL ACAD SCI USA, V92, P8826, DOI 10.1073/pnas.92.19.8826; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garner K, 2012, J BIOL CHEM, V287, P32263, DOI 10.1074/jbc.M112.375840; Ghosh R, 2015, MOL BIOL CELL, V26, P1764, DOI 10.1091/mbc.E14-10-1475; Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GORDESKY SE, 1973, BIOCHEM BIOPH RES CO, V50, P1027, DOI 10.1016/0006-291X(73)91509-X; Grabon A, 2015, BBA-MOL CELL BIOL L, V1851, P724, DOI 10.1016/j.bbalip.2014.12.011; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HELMKAMP GM, 1974, J BIOL CHEM, V249, P6382; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang J, 2013, PLANT MOL BIOL, V82, P39, DOI 10.1007/s11103-013-0033-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ile KE, 2010, TRAFFIC, V11, P1151, DOI 10.1111/j.1600-0854.2010.01085.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; Kulig W, 2015, DATA BRIEF, V5, P333, DOI 10.1016/j.dib.2015.09.013; Kulig W, 2016, CHEM PHYS LIPIDS, V195, P12, DOI 10.1016/j.chemphyslip.2015.07.002; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Maciejewski A, 2014, J PHYS CHEM B, V118, P4571, DOI 10.1021/jp5016627; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Orlowski A, 2011, J PHYS CHEM B, V115, P13541, DOI 10.1021/jp207177p; Paloncyova M, 2012, J CHEM THEORY COMPUT, V8, P1200, DOI 10.1021/ct2009208; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PATTON GM, 1982, J LIPID RES, V23, P190; Phillips SE, 2006, MOL BIOL CELL, V17, P2498, DOI 10.1091/mbc.E06-01-0089; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren JH, 2014, MOL BIOL CELL, V25, P712, DOI 10.1091/mbc.E13-11-0634; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; SELINGER Z, 1966, J LIPID RES, V7, P174; Sherman F., 1983, METHODS YEAST GENETI; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; Smirnova TI, 2007, BIOPHYS J, V92, P3686, DOI 10.1529/biophysj.106.097899; Smirnova TI, 2006, J BIOL CHEM, V281, P34897, DOI 10.1074/jbc.M603054200; SOMERHARJU P, 1982, CHEM PHYS LIPIDS, V30, P81, DOI 10.1016/0009-3084(82)90009-3; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; VIHTELIC TS, 1991, GENETICS, V127, P761; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Yadav S, 2015, J CELL SCI, V128, P3330, DOI 10.1242/jcs.173476; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	64	19	20	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14438	14455		10.1074/jbc.M117.791467	http://dx.doi.org/10.1074/jbc.M117.791467			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28718450	Green Published, hybrid			2022-12-28	WOS:000408747500012
J	Bian, SS; Zheng, XL; Sun, HQ; Chen, JH; Lu, YL; Liu, YQ; Tao, DC; Ma, YX				Bian, Sha-Sha; Zheng, Xu-Lei; Sun, Hua-Qin; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin			Clock1a affects mesoderm development and primitive hematopoiesis by regulating Nodal-Smad3 signaling in the zebrafish embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clock gene; hematopoiesis; SMAD transcription factor; transcription promoter; zebrafish; mesoderm; nodal	LOOP-HELIX PROTEINS; CIRCADIAN CLOCK; VERTEBRATE DEVELOPMENT; MOUSE EMBRYO; TGF-BETA; SMAD3; TRANSCRIPTION; INDUCTION; CELL; GASTRULATION	Circadian clock and Smad2/3/4-mediated Nodal signaling regulate multiple physiological and pathological processes. However, it remains unknown whether Clock directly cross-talks with Nodal signaling and how this would regulate embryonic development. Here we show that Clock1a coordinated mesoderm development and primitive hematopoiesis in zebrafish embryos by directly up-regulating Nodal-Smad3 signaling. We found that Clock1a is expressed both maternally and zygotically throughout early zebrafish development. We also noted that Clock1a alterations produce embryonic defects with shortened body length, lack of the ventral tail fin, or partial defect of the eyes. Clock1a regulates the expression of the mesodermal markers ntl, gsc, and eve1 and of the hematopoietic markers scl, lmo2, and fli1a. Biochemical analyses revealed that Clock1a stimulates Nodal signaling by increasing expression of Smad2/3/4. Mechanistically, Clock1a activates the smad3a promoter via its E-box1 element (CAGATG). Taken together, these findings provide mechanistic insight into the role of Clock1a in the regulation of mesoderm development and primitive hematopoiesis via modulation of Nodal-Smad3 signaling and indicate that Smad3a is directly controlled by the circadian clock in zebrafish.	[Bian, Sha-Sha; Zheng, Xu-Lei; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin] Sichuan Univ, West China Hosp, Lab Med Genet, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Bian, Sha-Sha; Zheng, Xu-Lei; Chen, Jian-Hui; Lu, Yi-Lu; Liu, Yun-Qiang; Tao, Da-Chang; Ma, Yong-Xin] Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China; [Sun, Hua-Qin] Sichuan Univ, West China Univ Hosp 2, Minist Educ,SCU CUHK Joint Lab Reprod Med, Dept Pediat,Key Lab Birth Defects & Related Dis W, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University	Ma, YX (corresponding author), Sichuan Univ, West China Hosp, Lab Med Genet, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; Ma, YX (corresponding author), Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China.	mayongxin@gmail.com			National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China [31571381, 31300961]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2012CB947600) and National Natural Science Foundation of China (31571381 and 31300961). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Bosler O, 2015, FRONT NEUROENDOCRIN, V38, P50, DOI 10.1016/j.yfrne.2015.02.001; Chen HJ, 2014, BMB REP, V47, P21, DOI 10.5483/BMBRep.2014.47.1.048; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Feillet C, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00096, 10.3389/fneur.2015.00096]; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Hurley JM, 2016, TRENDS BIOCHEM SCI, V41, P834, DOI 10.1016/j.tibs.2016.07.009; Isorna E, 2017, J ENDOCRINOL, V232, pR141, DOI 10.1530/JOE-16-0330; Jessen JR, 2015, DEV BIOL, V401, P110, DOI 10.1016/j.ydbio.2014.12.022; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Kiecker C, 2016, CELL MOL LIFE SCI, V73, P923, DOI 10.1007/s00018-015-2092-y; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Li Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004086; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meyer-Bernstein EL, 2001, NEUROSCIENTIST, V7, P496, DOI 10.1177/107385840100700606; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Paranjpe SS, 2015, BBA-GENE REGUL MECH, V1849, P626, DOI 10.1016/j.bbagrm.2015.03.006; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Sato F, 2012, BIOCHEM BIOPH RES CO, V419, P441, DOI 10.1016/j.bbrc.2012.02.076; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Sotak M, 2014, ANN MED, V46, P221, DOI 10.3109/07853890.2014.892296; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; Vaidya Anuradha, 2015, Syst Synth Biol, V9, P1, DOI 10.1007/s11693-015-9161-2; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Wang H, 2008, MAR GENOM, V1, P69, DOI 10.1016/j.margen.2008.06.003; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weng Wei, 2003, Birth Defects Research, V69, P325, DOI 10.1002/bdrc.10027; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Zhang L, 2011, FEBS LETT, V585, P1400, DOI 10.1016/j.febslet.2011.03.018	48	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14165	14175		10.1074/jbc.M117.794289	http://dx.doi.org/10.1074/jbc.M117.794289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28687631	hybrid, Green Published			2022-12-28	WOS:000408439800021
J	Goetze, RW; Kim, DH; Schinazi, RF; Kim, B				Goetze, Russell W.; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			A CRISPR/Cas9 approach reveals that the polymerase activity of DNA polymerase is dispensable for HIV-1 infection in dividing and nondividing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; DNA repair; human immunodeficiency virus (HIV); macrophage; nucleotide; DNA polymerase; integration	HUMAN-IMMUNODEFICIENCY-VIRUS; BASE-EXCISION-REPAIR; REVERSE TRANSCRIPTASES; INDUCED APOPTOSIS; LEUKEMIA-VIRUS; BETA; INTEGRATION; SAMHD1; TYPE-1; CYCLE	Retrovirus integration into the host genome relies on several host enzymes, potentially including DNA polymerase (Pol ). However, whether human Pol is essential for lentivirus replication in human cells is unclear. Here, we abolished DNA polymerase (Pol ) expression by targeting its DNA polymerase domain with CRISPR/Cas9 in human monocytic THP-1 cells to investigate the role of Pol in HIV-1 transduction in both dividing and nondividing macrophage stages of THP-1 cells. Pol -knock-out was confirmed by enhanced sensitivity to methyl methanesulfonate-induced DNA damage. Of note, nuclear extracts from Pol -knock-out THP-1 cells prepared from both dividing and nondividing stages displayed significantly reduced capability to repair the gapped HIV-1 integration intermediate DNA substrate in a biochemical simulation. However, nuclear extract from both dividing and nondividing stages of the Pol -KO cells had detectable gap repair activity, suggesting that other host DNA polymerases also repair gapped HIV-1 DNA, particularly in dividing cells. Next, when we compared transduction using HIV-1 and simian immunodeficiency virus in control and Pol -KO cells, the loss of the Pol expression did not affect transduction efficiency of these lentiviruses in both dividing and nondividing stages. Finally, the gap repair assay indicated that limited cellular dNTP pools, but not Pol expression, are a primary factor for HIV-1 DNA gap repair, particularly in nondividing cells. These data support the idea that Pol polymerase activity is dispensable for HIV-1 infection in both dividing and nondividing stages of human cells targeted by the virus.	[Goetze, Russell W.; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Sch Pharm, Seoul 2447, South Korea; [Kim, Baek] Childrens Healthcare Atlanta, Atlanta, GA 30329 USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), 1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [GM104198, AI049781, MH100999, T32-GM008602]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198, T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM104198 (to B. K.), AI049781 (to B. K.), MH100999 (to R. F. S), and T32-GM008602 (to R. W. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abmayr S. M., 2006, CURR PROTOC MOL BIOL; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bennett GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103164; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Brin E, 2000, J BIOL CHEM, V275, P39287, DOI 10.1074/jbc.M006929200; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Coffin J, 1997, RETROVIRUSES; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; FORNACE AJ, 1989, MOL CELL BIOL, V9, P851, DOI 10.1128/MCB.9.2.851; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MENEGAZZI M, 1992, FEBS LETT, V310, P135, DOI 10.1016/0014-5793(92)81314-C; Nishida M, 2008, FOOD CHEM, V108, P551, DOI 10.1016/j.foodchem.2007.11.007; Ochs K, 1999, CANCER RES, V59, P1544; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Roe T, 1997, J VIROL, V71, P1334, DOI 10.1128/JVI.71.2.1334-1340.1997; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHINAZI RF, 1989, ANTIMICROB AGENTS CH, V33, P115, DOI 10.1128/AAC.33.1.115; Schmitt MW, 2010, J BIOL CHEM, V285, P32264, DOI 10.1074/jbc.M110.147017; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUZUKI H, 1991, BIOCHEM BIOPH RES CO, V181, P623, DOI 10.1016/0006-291X(91)91236-6; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Van Cor-Hosmer SK, 2013, J BIOL CHEM, V288, P33253, DOI 10.1074/jbc.M113.486787; WANG LM, 1992, CANCER RES, V52, P4824; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862	52	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14016	14025		10.1074/jbc.M117.793661	http://dx.doi.org/10.1074/jbc.M117.793661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28684413	Green Published, hybrid			2022-12-28	WOS:000408439800010
J	Chua, NK; Howe, V; Jatana, N; Thukral, L; Brown, AJ				Chua, Ngee Kiat; Howe, Vicky; Jatana, Nidhi; Thukral, Lipi; Brown, Andrew J.			A conserved degron containing an amphipathic helix regulates the cholesterol-mediated turnover of human squalene monooxygenase, a rate-limiting enzyme in cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; endoplasmic reticulum (ER); membrane protein; protein degradation; degron; squalene monooxygenase	UBIQUITIN-PROTEASOME SYSTEM; NUCLEAR-QUALITY CONTROL; ENDOPLASMIC-RETICULUM; WEB SERVER; HEDGEHOG ACYLTRANSFERASE; DEGRADATION SIGNALS; DISORDERED REGION; FORCE-FIELD; PROTEIN; MEMBRANE	Cholesterol biosynthesis in the endoplasmic reticulum (ER) is tightly controlled by multiple mechanisms to regulate cellular cholesterol levels. Squalene monooxygenase (SM) is the second rate-limiting enzyme in cholesterol biosynthesis and is regulated both transcriptionally and post-translationally. SM undergoes cholesterol-dependent proteasomal degradation when cholesterol is in excess. The first 100 amino acids of SM (designated SM N100) are necessary for this degradative process and represent the shortest cholesterol-regulated degron identified to date. However, the fundamental intrinsic characteristics of this degron remain unknown. In this study, we performed a series of deletions, point mutations, and domain swaps to identify a 12-residue region (residues Gln-62-Leu-73), required for SM cholesterol-mediated turnover. Molecular dynamics and circular dichroism revealed an amphipathic helix within this 12-residue region. Moreover, 70% of the variation in cholesterol regulation was dependent on the hydrophobicity of this region. Of note, the earliest known Doa10 yeast degron, Deg1, also contains an amphipathic helix and exhibits 42% amino acid similarity with SM N100. Mutating SM residues Phe-35/Ser-37/Leu-65/Ile-69 into alanine, based on the key residues in Deg1, blunted SM cholesterol-mediated turnover. Taken together, our results support a model whereby the amphipathic helix in SM N100 attaches reversibly to the ER membrane depending on cholesterol levels; with excess, the helix is ejected and unravels, exposing a hydrophobic patch, which then serves as a degradation signal. Our findings shed new light on the regulation of a key cholesterol synthesis enzyme, highlighting the conservation of critical degron features from yeast to humans.	[Chua, Ngee Kiat; Howe, Vicky; Brown, Andrew J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia; [Jatana, Nidhi; Thukral, Lipi] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110020, India	University of New South Wales Sydney; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Brown, AJ (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767; Howe, Vicky/0000-0002-7319-0664	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Department of Biotechnology, Government of India; DST-INSPIRE Faculty Grant [LSBM-45]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST-INSPIRE Faculty Grant	This work was supported in part by National Health and Medical Research Council Grant 1060515 and the Australian Research Council Grant DP170101178. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Department of Biotechnology, Government of India, Research associateship.; Supported by DST-INSPIRE Faculty Grant LSBM-45.	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19435; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding JZ, 2015, DIABETES, V64, P3464, DOI 10.2337/db14-1314; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giang H, 2014, BIOPHYS J, V107, P2337, DOI 10.1016/j.bpj.2014.10.012; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Smith N, 2016, J BIOL CHEM, V291, P12420, DOI 10.1074/jbc.M116.724930; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Stopsack KH, 2016, CANCER RES, V76, P4785, DOI 10.1158/0008-5472.CAN-16-0903; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tanaka H, 2016, FEBS J, V283, P662, DOI 10.1111/febs.13618; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	66	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19959	19973		10.1074/jbc.M117.794230	http://dx.doi.org/10.1074/jbc.M117.794230			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972164	Green Published, hybrid			2022-12-28	WOS:000417696400002
J	Powell, CJ; Jenkins, ML; Parker, ML; Ramaswamy, R; Kelsen, A; Warshaw, DM; Ward, GE; Burke, JE; Boulanger, MJ				Powell, Cameron J.; Jenkins, Meredith L.; Parker, Michelle L.; Ramaswamy, Raghavendran; Kelsen, Anne; Warshaw, David M.; Ward, Gary E.; Burke, John E.; Boulanger, Martin J.			Dissecting the molecular assembly of the Toxoplasma gondii MyoA motility complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell motility; crystal structure; isothermal titration calorimetry (ITC); myosin; protein structure; Toxoplasma gondii; X-ray crystallography; host cell invasion	HOST-CELL INVASION; MOTOR COMPLEX; APICOMPLEXAN GLIDEOSOME; PROTEIN SECRETION; GLIDING MOTILITY; GLOBAL BURDEN; LIGHT-CHAIN; MYOSIN-A; PHOSPHORYLATION; RESOLUTION	Apicomplexan parasites such as Toxoplasma gondii rely on a unique form of locomotion known as gliding motility. Generating the mechanical forces to support motility are divergent class XIV myosins (MyoA) coordinated by accessory proteins known as light chains. Although the importance of the MyoA-light chain complex is well-established, the detailed mechanisms governing its assembly and regulation are relatively unknown. To establish a molecular blueprint of this dynamic complex, we first mapped the adjacent binding sites of light chains MLC1 and ELC1 on the MyoA neck (residues 775-818) using a combination of hydrogen-deuterium exchange mass spectrometry and isothermal titration calorimetry. We then determined the 1.85 resolution crystal structure of MLC1 in complex with its cognate MyoA peptide. Structural analysis revealed a bilobed architecture with MLC1 clamping tightly around the helical MyoA peptide, consistent with the stable 10 nmK(d) measured by isothermal titration calorimetry. We next showed that coordination of calcium by an EF-hand in ELC1 and prebinding of MLC1 to the MyoA neck enhanced the affinity of ELC1 for the MyoA neck 7- and 8-fold, respectively. When combined, these factors enhanced ELC1 binding 49-fold (to a K-d of 12 nm). Using the full-length MyoA motor (residues 1-831), we then showed that, in addition to coordinating the neck region, ELC1 appears to engage the MyoA converter subdomain, which couples the motor domain to the neck. These data support an assembly model where staged binding events cooperate to yield high-affinity complexes that are able to maximize force transduction.	[Powell, Cameron J.; Jenkins, Meredith L.; Parker, Michelle L.; Ramaswamy, Raghavendran; Burke, John E.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, 200 Petch,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada; [Kelsen, Anne; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Victoria; University of Vermont; University of Vermont	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, 200 Petch,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	mboulang@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Jenkins, Meredith/0000-0002-0685-5048; Ward, Gary/0000-0003-4138-3055	Canadian Institutes of Health Research [MOP82916, 148596]; U. S. Public Health Service [AI054961, GM094229]; Natural Sciences and Engineering Research Council of Canada [NSERC-2014-05218]; Canada Research Chair program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094229] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair program(Canada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grants MOP82916 and 148596 (to M. J. B.), U. S. Public Health Service Grants AI054961 (to G. E. W.) and GM094229 (to D. M. W.), and Natural Sciences and Engineering Research Council of Canada Grant NSERC-2014-05218 (to J. E. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of salary support from the Canada Research Chair program. To whom correspondence should be addressed: Dept. of Biochemistry and Microbiology, University of Victoria, 200 Petch, 3800 Finnerty Rd., Victoria, BC V8P 5C2, Canada. Tel.: 250-721-7072; E-mail:mboulang@uvic.ca.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bookwalter C. S., 2017, BIORXIV, DOI [10.1101/127118, DOI 10.1101/127118]; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Debreczeni JE, 2005, J BIOL CHEM, V280, P41458, DOI 10.1074/jbc.M506315200; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Douse CH, 2015, CHEMMEDCHEM, V10, P134, DOI 10.1002/cmdc.201402357; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2008, MYOS SUP MOL MOT, P421; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Heintzelman MB, 2006, INT REV CYTOL, V251, P79, DOI 10.1016/S0074-7696(06)51003-4; Heintzelman MB, 2015, SEMIN CELL DEV BIOL, V46, P135, DOI 10.1016/j.semcdb.2015.09.020; Heintzelman MB, 2001, J PARASITOL, V87, P429, DOI 10.1645/0022-3395(2001)087[0429:MDIA]2.0.CO;2; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kortagere S, 2011, J COMPUT AID MOL DES, V25, P403, DOI 10.1007/s10822-011-9420-6; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098056; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meissner M, 2002, J CELL SCI, V115, P563; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; World Health Organization, 2015, GUID TREATM MAL, Vthird	47	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19469	19477		10.1074/jbc.M117.809632	http://dx.doi.org/10.1074/jbc.M117.809632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972141	Green Published, hybrid			2022-12-28	WOS:000416226700026
J	Shinde, MY; Sidoli, S; Kulej, K; Mallory, MJ; Radens, CM; Reicherter, AL; Myers, RL; Barash, Y; Lynch, KW; Garcia, BA; Klein, PS				Shinde, Mansi Y.; Sidoli, Simone; Kulej, Katarzyna; Mallory, Michael J.; Radens, Caleb M.; Reicherter, Amanda L.; Myers, Rebecca L.; Barash, Yoseph; Lynch, Kristen W.; Garcia, Benjamin A.; Klein, Peter S.			Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; embryonic stem cell; glycogen synthase kinase 3 (GSK-3); leukemia; phosphoproteomics; spliceosome; Wnt signaling; SILAC; lithium	POLYPOSIS-COLI APC; MULTISITE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; STRUCTURAL BASIS; GLOBAL ANALYSIS; C-JUN; CELL	Glycogen synthase kinase-3 (GSK-3) is a constitutively active, ubiquitously expressed protein kinase that regulates multiple signaling pathways. In vitro kinase assays and genetic and pharmacological manipulations of GSK-3 have identified more than 100 putative GSK-3 substrates in diverse cell types. Many more have been predicted on the basis of a recurrent GSK-3 consensus motif ((pS/pT)XXX(S/T)), but this prediction has not been tested by analyzing the GSK-3 phosphoproteome. Using stable isotope labeling of amino acids in culture (SILAC) and MS techniques to analyze the repertoire of GSK-3-dependent phosphorylation in mouse embryonic stem cells (ESCs), we found that approximate to 2.4% of (pS/pT)XXX(S/T) sites are phosphorylated in a GSK-3-dependent manner. A comparison of WT and Gsk3a;Gsk3b knock-out (Gsk3 DKO) ESCs revealed prominent GSK-3-dependent phosphorylation of multiple splicing factors and regulators of RNA biosynthesis as well as proteins that regulate transcription, translation, and cell division. Gsk3 DKO reduced phosphorylation of the splicing factors RBM8A, SRSF9, and PSF as well as the nucleolar proteins NPM1 and PHF6, and recombinant GSK-3 phosphorylated these proteins in vitro. RNA-Seq of WT and Gsk3 DKO ESCs identified approximate to 190 genes that are alternatively spliced in a GSK-3-dependent manner, supporting a broad role for GSK-3 in regulating alternative splicing. The MS data also identified posttranscriptional regulation of protein abundance by GSK-3, with approximate to 47 proteins (1.4%) whose levels increased and approximate to 78 (2.4%) whose levels decreased in the absence of GSK-3. This study provides the first unbiased analysis of the GSK-3 phosphoproteome and strong evidence that GSK-3 broadly regulates alternative splicing.	[Shinde, Mansi Y.; Myers, Rebecca L.; Klein, Peter S.] Univ Penn, Pharmacol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone; Kulej, Katarzyna; Garcia, Benjamin A.] Univ Penn, Penn Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone; Kulej, Katarzyna; Mallory, Michael J.; Lynch, Kristen W.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Radens, Caleb M.; Klein, Peter S.] Univ Penn, Cell & Mol Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reicherter, Amanda L.; Klein, Peter S.] Univ Penn, Dept Med Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barash, Yoseph] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, 9-103 SCTR,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	pklein@pennmedicine.upenn.edu	Sidoli, Simone/AAC-2196-2019	Sidoli, Simone/0000-0001-9073-6641	 [1290]; NATIONAL CANCER INSTITUTE [P01CA196539, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115517, T32GM008076, R01GM110174, R35GM118048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046544] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Bradley Doble and James Woodgett for generously providing the wild-type and DKO mESCs. We also thank Drs. Judy Meinkoth, Paul Gadue, and Ed Morrisey for helpful discussions. Data presented herein were obtained at the Genomics Division of the Iowa Institute of Human Genetics, which is supported, in part, by the University of Iowa Carver College of Medicine. RNA-Seq data were deposited in the Gene Expression Omnibus repository (GEO accession number GSE90921). MS raw files are available at https://chorusproject.org<SUP>3</SUP> at project number 1290.	Acebron SP, 2016, TRENDS CELL BIOL, V26, P956, DOI 10.1016/j.tcb.2016.07.009; Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Adamia S, 2014, CLIN CANCER RES, V20, P1135, DOI 10.1158/1078-0432.CCR-13-0956; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Box JK, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0073-9; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Chen XC, 2016, J BIOL CHEM, V291, P14761, DOI 10.1074/jbc.M116.722751; Cole BS, 2015, RNA, V21, P2053, DOI 10.1261/rna.052969.115; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crews LA, 2016, CELL STEM CELL, V19, P599, DOI 10.1016/j.stem.2016.08.003; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Guezguez B, 2016, CANCER CELL, V29, P61, DOI 10.1016/j.ccell.2015.11.012; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Huang YL, 2015, P NATL ACAD SCI USA, V112, P5732, DOI 10.1073/pnas.1423533112; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Inoue D, 2016, GENE DEV, V30, P989, DOI 10.1101/gad.278424.116; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ishigaki Y, 2015, EXP BIOL MED, V240, P438, DOI 10.1177/1535370214556945; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Martinez NM, 2015, GENE DEV, V29, P2054, DOI 10.1101/gad.267245.115; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Saldi T, 2016, J MOL BIOL, V428, P2623, DOI 10.1016/j.jmb.2016.04.017; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schimizzi GV, 2015, CURR BIOL, V25, pR445, DOI 10.1016/j.cub.2015.02.034; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Thingholm TE, 2016, METHODS MOL BIOL, V1355, P135, DOI 10.1007/978-1-4939-3049-4_9; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Top D, 2016, CELL REP, V16, P357, DOI 10.1016/j.celrep.2016.06.005; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Valvezan AJ, 2014, DIS MODEL MECH, V7, P63, DOI 10.1242/dmm.012625; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Vaquero-Garcia J, 2016, ELIFE, V5, DOI 10.7554/eLife.11752; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZHANG WM, 1993, ARCH BIOCHEM BIOPHYS, V304, P219, DOI 10.1006/abbi.1993.1342	92	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18240	18255		10.1074/jbc.M117.813527	http://dx.doi.org/10.1074/jbc.M117.813527			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28916722	Green Published, hybrid			2022-12-28	WOS:000414458200021
J	Silvers, MA; Deja, S; Singh, N; Egnatchik, RA; Sudderth, J; Luo, XQ; Beg, MS; Burgess, SC; DeBerardinis, RJ; Boothman, DA; Merritt, ME				Silvers, Molly A.; Deja, Stanislaw; Singh, Naveen; Egnatchik, Robert A.; Sudderth, Jessica; Luo, Xiuquan; Beg, Muhammad S.; Burgess, Shawn C.; DeBerardinis, Ralph J.; Boothman, David A.; Merritt, Matthew E.			The NQO1 bioactivatable drug, -lapachone, alters the redox state of NQO1+pancreatic cancer cells, causing perturbation in central carbon metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anaerobic glycolysis; drug metabolism; energy metabolism; isotopic tracer; nicotinamide adenine dinucleotide (NAD); nuclear magnetic resonance (NMR); oxidation-reduction (redox); oxidative stress; pyruvate; pyruvate dehydrogenase complex (PDC)	OXIDOREDUCTASE(1) DT-DIAPHORASE; BETA-LAPACHONE; PANCREATIC-CANCER; MAGNETIC-RESONANCE; C-13 NMR; EXPRESSION; GROWTH; APOPTOSIS; BIOMARKER; EXCHANGE	Many cancer treatments, such as those for managing recalcitrant tumors like pancreatic ductal adenocarcinoma, cause off-target toxicities in normal, healthy tissue, highlighting the need for more tumor-selective chemotherapies. -Lapachone is bioactivated by NAD(P)H:quinone oxidoreductase 1 (NQO1). This enzyme exhibits elevated expression in most solid cancers and therefore is a potential cancer-specific target. -Lapachone's therapeutic efficacy partially stems from the drug's induction of a futile NQO1-mediated redox cycle that causes high levels of superoxide and then peroxide formation, which damages DNA and causes hyperactivation of poly(ADP-ribose) polymerase, resulting in extensive NAD(+)/ATP depletion. However, the effects of this drug on energy metabolism due to NAD(+) depletion were never described. The futile redox cycle rapidly consumes O-2, rendering standard assays of Krebs cycle turnover unusable. In this study, a multimodal analysis, including metabolic imaging using hyperpolarized pyruvate, points to reduced oxidative flux due to NAD(+) depletion after -lapachone treatment of NQO1+ human pancreatic cancer cells. NAD(+)-sensitive pathways, such as glycolysis, flux through lactate dehydrogenase, and the citric acid cycle (as inferred by flux through pyruvate dehydrogenase), were down-regulated by -lapachone treatment. Changes in flux through these pathways should generate biomarkers useful for in vivo dose responses of -lapachone treatment in humans, avoiding toxic side effects. Targeting the enzymes in these pathways for therapeutic treatment may have the potential to synergize with -lapachone treatment, creating unique NQO1-selective combinatorial therapies for specific cancers. These findings warrant future studies of intermediary metabolism in patients treated with -lapachone.	[Silvers, Molly A.; Singh, Naveen; Luo, Xiuquan; Boothman, David A.] Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Silvers, Molly A.; Singh, Naveen; Luo, Xiuquan; Boothman, David A.] Simmons Comprehens Canc Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA; [Deja, Stanislaw; Burgess, Shawn C.] Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr AIRC, Div Metab Mech Dis, Dallas, TX 75390 USA; [Egnatchik, Robert A.; Sudderth, Jessica; DeBerardinis, Ralph J.] Simmons Comprehens Canc Ctr, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Beg, Muhammad S.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas Southwestern Med Ctr Dallas, AIRC, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida	Boothman, DA (corresponding author), Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA.; Boothman, DA (corresponding author), Simmons Comprehens Canc Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), Univ Texas Southwestern Med Ctr Dallas, AIRC, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	David.Boothman@utsouthwestern.edu; matthewmerritt@ufl.edu	Boothman, David/Q-7776-2019; Deja, Stanislaw/AAI-7526-2020	Deja, Stanislaw/0000-0002-7714-2547; Singh, Naveen/0000-0003-3465-8591; Merritt, Matthew/0000-0003-4617-9651	Robert A. Welch Foundation [I-1804]; National Institutes of Health [P41 EB015908, R01DK078184, R01CA157996-06]; AACR/PanCan Rising Tide Grant [14-65-25-BOOT]; NCI, National Institutes of Health [R01CA102792-19, R01CA221158-01]; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087977, R01DK078184, U24DK097209, R01DK105346] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR/PanCan Rising Tide Grant; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Robert A. Welch Foundation Grant I-1804 and National Institutes of Health Grant P41 EB015908.; Supported by National Institutes of Health Grant R01DK078184.; Supported by National Institutes of Health Grant R01CA157996-06.; Supported by AACR/PanCan Rising Tide Grant 14-65-25-BOOT and NCI, National Institutes of Health, Grants R01CA102792-19 and R01CA221158-01. To whom correspondence may be addressed. E-mail: David.Boothman@utsouthwestern.edu.	Allison SJ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.16; Awadallah NS, 2008, APPL IMMUNOHISTO M M, V16, P24, DOI 10.1097/pai.0b013e31802e91d0; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Bey E. A., 2016, STRATEGIES ENHANCE T, P225; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bey EA, 2013, MOL CANCER THER, V12, P2110, DOI 10.1158/1535-7163.MCT-12-0962; Cao LF, 2014, ANTIOXID REDOX SIGN, V21, P237, DOI 10.1089/ars.2013.5462; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakrabarti G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17066; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; Cunningham CH, 2016, CIRC RES, V119, P1177, DOI 10.1161/CIRCRESAHA.116.309769; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dong Y, 2010, CANCER RES, V70, P8088, DOI 10.1158/0008-5472.CAN-10-1418; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; Huang XM, 2016, CANCER CELL, V30, P940, DOI 10.1016/j.ccell.2016.11.006; Huang XM, 2012, CANCER RES, V72, P3038, DOI 10.1158/0008-5472.CAN-11-3135; JOSEPH P, 1994, ONCOL RES, V6, P525; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Keshari KR, 2013, CANCER RES, V73, P529, DOI 10.1158/0008-5472.CAN-12-3461; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Khemtong C, 2015, MAGN RESON MED, V74, P312, DOI 10.1002/mrm.25419; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Li LS, 2011, CLIN CANCER RES, V17, P275, DOI 10.1158/1078-0432.CCR-10-1983; Logsdon CD, 2003, CANCER RES, V63, P2649; Lumata L, 2015, METHOD ENZYMOL, V561, P73, DOI 10.1016/bs.mie.2015.04.006; Ma XP, 2015, J DRUG TARGET, V23, P672, DOI 10.3109/1061186X.2015.1073296; Ma XP, 2015, J CONTROL RELEASE, V200, P201, DOI 10.1016/j.jconrel.2014.12.027; Madajewski B, 2016, MOL CANCER RES, V14, P14, DOI 10.1158/1541-7786.MCR-15-0207-T; Moore Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.564; Murphy TA, 2013, BIOTECHNOL BIOENG, V110, P1748, DOI 10.1002/bit.24836; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Ough M, 2005, CANCER BIOL THER, V4, P95; Park JM, 2016, NMR BIOMED, V29, P650, DOI 10.1002/nbm.3509; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Planchon SM, 2001, EXP CELL RES, V267, P95, DOI 10.1006/excr.2001.5234; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reinicke KE, 2005, CLIN CANCER RES, V11, P3055, DOI 10.1158/1078-0432.CCR-04-2185; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Ross D, 2004, METHOD ENZYMOL, V382, P115; Salamanca-Cardona L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0136-2; Serrao EM, 2016, GUT, V65, P465, DOI 10.1136/gutjnl-2015-310114; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sriram R, 2015, NMR BIOMED, V28, P1141, DOI 10.1002/nbm.3354; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegner A, 2014, ANAL CHEM, V86, P2221, DOI 10.1021/ac403879d; Wilson DM, 2010, J MAGN RESON, V205, P141, DOI 10.1016/j.jmr.2010.04.012; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637	60	50	52	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18203	18216		10.1074/jbc.M117.813923	http://dx.doi.org/10.1074/jbc.M117.813923			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28916726	Green Published, hybrid			2022-12-28	WOS:000414458200018
J	Zhuo, Y; Cordeiro, CD; Hekmatyar, SK; Docampo, R; Prestegard, JH				Zhuo, You; Cordeiro, Ciro D.; Hekmatyar, S. Khan; Docampo, Roberto; Prestegard, James H.			Dynamic nuclear polarization facilitates monitoring of pyruvate metabolism in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lactic acid; metabolism; nuclear magnetic resonance (NMR); pyruvate; Trypanosoma brucei; dynamic nuclear polarization	C-13 MAGNETIC-RESONANCE; CHAGAS-DISEASE; NMR; CRUZI; DEHYDROGENASE; CHEMOTHERAPY; METABOLOMICS; BIOMARKER; CELLS; STATE	Dynamic nuclear polarization provides sensitivity improvements that make NMR a viable method for following metabolic conversions in real time. There are now many in vivo applications to animal systems and even to diagnosis of human disease. However, application to microbial systems is rare. Here we demonstrate its application to the pathogenic protozoan, Trypanosoma brucei, using hyperpolarized (13)C1 pyruvate as a substrate and compare the parasite metabolism with that of commonly cultured mammalian cell lines, HEK-293 and Hep-G2. Metabolic differences between insect and bloodstream forms of T. brucei were also investigated. Significant differences are noted with respect to lactate, alanine, and CO2 production. Conversion of pyruvate to CO2 in the T. brucei bloodstream form provides new support for the presence of an active pyruvate dehydrogenase in this stage.	[Zhuo, You; Hekmatyar, S. Khan; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Cordeiro, Ciro D.; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Cordeiro, Ciro D.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Prestegard, JH (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu	Hekmatyar, Khan/AAC-3677-2020		NIGMS, National Institutes of Health [GM103390]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The DNP instrumentation used in this study was supported by the NIGMS, National Institutes of Health Grant GM103390.	Akbey U, 2010, ANGEW CHEM INT EDIT, V49, P7803, DOI 10.1002/anie.201002044; Ardenkjaer-Larsen JH, 2016, J MAGN RESON, V264, P3, DOI 10.1016/j.jmr.2016.01.015; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Barb AW, 2013, J MAGN RESON, V228, P59, DOI 10.1016/j.jmr.2012.12.013; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bowen S, 2013, J MAGN RESON, V236, P26, DOI 10.1016/j.jmr.2013.08.007; Canape C, 2015, MAGN RESON MED, V73, P2296, DOI 10.1002/mrm.25360; Chaumeil MM, 2015, METHOD ENZYMOL, V561, P1, DOI 10.1016/bs.mie.2015.04.001; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Lama B, 2016, NMR BIOMED, V29, P226, DOI 10.1002/nbm.3473; Larive CK, 2015, ANAL CHEM, V87, P133, DOI 10.1021/ac504075g; Lau JYC, 2016, NMR BIOMED, V29, P1038, DOI 10.1002/nbm.3564; Lelli M, 2014, CHEM COMMUN, V50, P10198, DOI 10.1039/c4cc02152e; Lerche MH, 2015, ANAL CHEM, V87, P119, DOI 10.1021/ac501467x; Leroux AE, 2011, FEMS MICROBIOL LETT, V314, P25, DOI 10.1111/j.1574-6968.2010.02142.x; Lumata L, 2015, METHOD ENZYMOL, V561, P73, DOI 10.1016/bs.mie.2015.04.006; Lumata L, 2012, J PHYS CHEM A, V116, P5129, DOI 10.1021/jp302399f; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Meier S, 2012, CHEMBIOCHEM, V13, P2265, DOI 10.1002/cbic.201200450; MONTEMARTINI M, 1994, FEMS MICROBIOL LETT, V118, P89, DOI 10.1016/0378-1097(94)90601-7; Roldan A, 2011, MOL MICROBIOL, V81, P623, DOI 10.1111/j.1365-2958.2011.07721.x; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Sriram R, 2016, TOMOGRAPHY, V2, P35, DOI 10.18383/j.tom.2016.00106; Sriram R, 2015, NMR BIOMED, V28, P1141, DOI 10.1002/nbm.3354; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; TAYLOR MB, 1986, FEBS LETT, V199, P237, DOI 10.1016/0014-5793(86)80487-2; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637	37	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18161	18168		10.1074/jbc.M117.807495	http://dx.doi.org/10.1074/jbc.M117.807495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28887303	Green Published, hybrid			2022-12-28	WOS:000414458200014
J	Yu, J; Wang, XX; Xu, T; Jin, QH; Duan, JY; Wu, J; Wu, HY; Xu, T; Ye, S				Yu, Jie; Wang, Xiaoxiao; Xu, Tao; Jin, Qiuheng; Duan, Jinyuan; Wu, Jie; Wu, Haiyan; Xu, Ting; Ye, Sheng			A rational approach to enhancing antibody Fc homodimer formation for robust production of antibody mixture in a single cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN POLYCLONAL ANTIBODIES; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; ANTITUMOR-ACTIVITY; NEXT-GENERATION; BISPECIFIC IGG; CANCER; PHARMACOKINETICS; STRATEGIES	Combinations of different antibodies have been shown to be more effective for managing certain diseases than monotherapy. Co-expression of the antibody mixture in a single cell line is key to reducing complexity during antibody development and manufacturing. However, co-transfection of multiple light and heavy chains into cells often leads to production of mismatched, heterodimeric by-products that are inactive, making the development of co-expression systems that robustly and efficiently produce highly active antibody mixtures a high priority. In this study, we modified the CH3 domain interface of the antibody fragment crystallizable (Fc) region by changing several charge pairs to create electrostatic interactions favoring Fc homodimer formation and disfavoring Fc heterodimer formation. When co-expressed, these modified antibodies with altered charge polarity across the Fc dimer interface preferentially formed homodimers that fully preserved the functions of each component, rather than inactive heterodimers whose formation was reduced because of rationally designed repulsive interactions. We designed eight different combinations and experimentally screened the best one, which enabled us to produce a binary antibody mixture against the EGF receptor with a minimal heterodimer contaminant. We further determined the crystal structure of a triple-mutated Fc variant in the best combination, and we elucidated the molecular interactions favoring Fc homodimer over heterodimer formation, which provided a structural basis for further optimization. The approach presented here demonstrates the feasibility of rational antibody modification for efficient and consistent production of monoclonal antibody mixtures in a single cell line and thus broadens our options for manufacturing more effective antibody-based therapeutic agents.	[Yu, Jie; Jin, Qiuheng; Duan, Jinyuan; Ye, Sheng] Zhejiang Univ, Life Sci Inst, 866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Jie; Jin, Qiuheng; Duan, Jinyuan; Ye, Sheng] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Xiaoxiao; Xu, Tao; Wu, Jie; Wu, Haiyan; Xu, Ting] Alphamab Co Ltd, Suzhou 215125, Peoples R China	Zhejiang University; Zhejiang University	Ye, S (corresponding author), Zhejiang Univ, Life Sci Inst, 866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Xu, T (corresponding author), Alphamab Co Ltd, Suzhou 215125, Peoples R China.	tingxu@alphamab.com; sye@zju.edu.cn		Jin, Qiuheng/0000-0002-5869-0310	Ministry of Science and Technology of China [2016YFA0500404, 2014CB910300]; National Natural Science Foundation of China [31525001, 31430019, 31370721]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by Ministry of Science and Technology of China Grants 2016YFA0500404 and 2014CB910300, National Natural Science Foundation of China Grants 31525001, 31430019, and 31370721, and the Fundamental Research Funds for the Central Universities (to S. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baselga J, 2010, CLIN BREAST CANCER, V10, P489, DOI 10.3816/CBC.2010.n.065; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; de Kruif J, 2010, BIOTECHNOL BIOENG, V106, P741, DOI 10.1002/bit.22763; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Demarest SJ, 2011, MABS-AUSTIN, V3, P338, DOI 10.4161/mabs.3.4.16615; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Frandsen TP, 2011, BIOTECHNOL BIOENG, V108, P2171, DOI 10.1002/bit.23166; Fukai J, 2008, CANCER SCI, V99, P2062, DOI 10.1111/j.1349-7006.2008.00945.x; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Ha JH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00394; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Jutten B, 2009, RADIOTHER ONCOL, V92, P393, DOI 10.1016/j.radonc.2009.06.021; Logtenberg T, 2007, TRENDS BIOTECHNOL, V25, P390, DOI 10.1016/j.tibtech.2007.07.005; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Nayak SU, 2014, ANTIMICROB AGENTS CH, V58, P5047, DOI 10.1128/AAC.02830-14; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nielsen LS, 2010, MOL BIOTECHNOL, V45, P257, DOI 10.1007/s12033-010-9270-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Perera RM, 2005, CLIN CANCER RES, V11, P6390, DOI 10.1158/1078-0432.CCR-04-2653; Raju TS, 2013, EXPERT OPIN BIOL TH, V13, P1347, DOI 10.1517/14712598.2013.822065; Rasmussen SK, 2007, BIOTECHNOL LETT, V29, P845, DOI 10.1007/s10529-007-9331-8; Rasmussen SK, 2012, ARCH BIOCHEM BIOPHYS, V526, P139, DOI 10.1016/j.abb.2012.07.001; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Skartved NJO, 2011, CLIN CANCER RES, V17, P5962, DOI 10.1158/1078-0432.CCR-11-1209; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiberg FC, 2006, BIOTECHNOL BIOENG, V94, P396, DOI 10.1002/bit.20865	40	1	1	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17885	17896		10.1074/jbc.M116.771188	http://dx.doi.org/10.1074/jbc.M116.771188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28878018	Green Published, hybrid			2022-12-28	WOS:000414013000024
J	Liu, CY; Hutchens, S; Jursa, T; Shawlot, W; Polishchuk, EV; Polishchuk, RS; Dray, BK; Gore, AC; Aschner, M; Smith, DR; Mukhopadhyay, S				Liu, Chunyi; Hutchens, Steven; Jursa, Thomas; Shawlot, William; Polishchuk, Elena V.; Polishchuk, Roman S.; Dray, Beth K.; Gore, Andrea C.; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION TRANSPORTER; INTRACELLULAR TRAFFICKING; ZINC TRANSPORTERS; INTELLECTUAL FUNCTION; HEPATIC CIRRHOSIS; DRINKING-WATER; SHIGA TOXIN; IRON UPTAKE; EXPOSURE; ZIP14	SLC30A10 and SLC39A14 are manganese efflux and influx transporters, respectively. Loss-of-function mutations in genes encoding either transporter induce hereditary manganese toxicity. Patients have elevated manganese in the blood and brain and develop neurotoxicity. Liver manganese is increased in patients lacking SLC30A10 but not SLC39A14. These organ-specific changes in manganese were recently recapitulated in knockout mice. Surprisingly, Slc30a10 knockouts also had elevated thyroid manganese and developed hypothyroidism. To determine the mechanisms of manganese-induced hypothyroidism and understand how SLC30A10 and SLC39A14 cooperatively mediate manganese detoxification, here we produced Slc39a14 single and Slc30a10/Slc39a14 double knockout mice and compared their phenotypes with that of Slc30a10 single knockouts. Compared with wild-type controls, Slc39a14 single and Slc30a10/Slc39a14 double knockouts had higher manganese levels in the blood and brain but not in the liver. In contrast, Slc30a10 single knockouts had elevated manganese levels in the liver as well as in the blood and brain. Furthermore, SLC30A10 and SLC39A14 localized to the canalicular and basolateral domains of polarized hepatic cells, respectively. Thus, transport activities of both SLC39A14 and SLC30A10 are required for hepatic manganese excretion. Compared with Slc30a10 single knockouts, Slc39a14 single and Slc30a10/Slc39a14 double knockouts had lower thyroid manganese levels and normal thyroid function. Moreover, intrathyroid thyroxine levels of Slc30a10 single knockouts were lower than those of controls. Thus, the hypothyroidism phenotype of Slc30a10 single knockouts is induced by elevated thyroid manganese, which blocks thyroxine production. These findings provide new insights into the mechanisms of manganese detoxification and manganese-induced thyroid dysfunction.	[Liu, Chunyi; Hutchens, Steven; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Cellular & Mol Biol, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Liu, Chunyi; Hutchens, Steven; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Polishchuk, Elena V.; Polishchuk, Roman S.] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Dray, Beth K.] MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Dept Vet Sci, Bastrop, TX 78602 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	Polishchuk, Roman/0000-0002-7698-1955	NIEHS, National Institutes of Health [R01-ES024812, R00-ES020844]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812, R00ES020844] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Grants R01-ES024812 and R00-ES020844 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Braveman L. E., 2013, WERNER INGBARS THYRO; BUTHIEAU AM, 1983, ARCH TOXICOL, V54, P243, DOI 10.1007/BF01239208; BUTHIEAU AM, 1977, CR SOC BIOL, V171, P1024; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Chesi G, 2016, HEPATOLOGY, V63, P1842, DOI 10.1002/hep.28398; Giray B, 2010, J TRACE ELEM MED BIO, V24, P106, DOI 10.1016/j.jtemb.2009.11.003; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Hall J. E., 2016, TXB MED PHYSL, P951; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KAWADA J, 1985, ENDOCRINOL JAPON, V32, P635; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Khan K, 2011, ENVIRON HEALTH PERSP, V119, P1501, DOI 10.1289/ehp.1003397; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Le SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142615; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Misiewicz A, 1993, Endokrynol Pol, V44, P57; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Mukhopadhyay S, 2013, MOL BIOL CELL, V24, P2311, DOI 10.1091/mbc.E13-01-0057; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riojas-Rodriguez H, 2010, ENVIRON HEALTH PERSP, V118, P1465, DOI 10.1289/ehp.0901229; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Xia ZD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006892; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	65	36	38	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16605	16615		10.1074/jbc.M117.804989	http://dx.doi.org/10.1074/jbc.M117.804989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28860195	Green Published, hybrid			2022-12-28	WOS:000412414800021
J	Allam, H; Johnson, BP; Zhang, M; Lu, ZP; Cannon, MJ; Abbott, KL				Allam, Heba; Johnson, Blake P.; Zhang, Mao; Lu, Zhongpeng; Cannon, Martin J.; Abbott, Karen L.			The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOMIC ANALYSIS; MICROARRAY DATA; IDENTIFICATION; GLYCOSYLATION; PATHWAY; SITES; TOOL	Glycosylation changes associated with cellular transformation can facilitate the growth and progression of tumors. Previously we discovered that the gene Mgat3 encoding the glycosyltransferase GnT-III is elevated in epithelial ovarian carcinomas (EOCs) and leads to the production of abnormal truncated N-linked glycan structures instead of the typical bisected forms. In this study, we are interested in discovering how these abnormal glycans impact the growth and progression of ovarian cancer. We have discovered using stable shRNA gene suppression that GnT-III expression controls the expansion of side-population cells, also known as cancer stem cells. More specifically, we found that GnT-III expression regulates the levels and activation of the heavily glycosylated Notch receptor involved in normal and malignant development. Suppression of GnT-III in EOC cell lines and primary tumor-derived cells resulted in an inhibition of Notch signaling that was more potent than pharmacologic blockage of Notch activation via gamma-secretase inhibition. The inhibition resulted from the redirection of the Notch receptor to the lysosome, a novel mechanism. These findings demonstrate a new role for bisecting glycosylation in the control of Notch transport and demonstrate the therapeutic potential of inhibiting GnT-III as a treatment for controlling EOC growth and recurrence.	[Allam, Heba] Menofiya Univ, Med Microbiol & Immunol Dept, Cairo 11795, Egypt; [Johnson, Blake P.] Ouachita Baptist Univ, Dept Biol, Arkadelphia, AR 71998 USA; [Zhang, Mao; Lu, Zhongpeng; Abbott, Karen L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Cannon, Martin J.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	Egyptian Knowledge Bank (EKB); Menofia University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Abbott, KL (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	kabbott@uams.edu	Allam, Heba/AAC-9226-2019	Allam, Heba/0000-0003-3053-8066	NCI, National Institutes of Health [UO1CA168870]; NATIONAL CANCER INSTITUTE [U01CA168870] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant UO1CA168870 (to K. L. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Allam H, 2015, J PROTEOME RES, V14, P434, DOI 10.1021/pr501174p; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Iida A, 1998, GENE CHROMOSOME CANC, V21, P108, DOI 10.1002/(SICI)1098-2264(199802)21:2<108::AID-GCC5>3.0.CO;2-4; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Nagahata Takemitsu, 2002, Breast Cancer, V9, P208, DOI 10.1007/BF02967591; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NYE JS, 1994, DEVELOPMENT, V120, P2421; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rose SL, 2010, GYNECOL ONCOL, V117, P130, DOI 10.1016/j.ygyno.2009.12.003; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; YOSHIMURA M, 1995, INT J CANCER, V60, P443, DOI 10.1002/ijc.2910600404; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	28	26	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16351	16359		10.1074/jbc.M117.783936	http://dx.doi.org/10.1074/jbc.M117.783936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28842505	Green Published, hybrid			2022-12-28	WOS:000412109400032
J	Gliniak, CM; Brown, JM; Noy, N				Gliniak, Christy M.; Brown, J. Mark; Noy, Noa			The retinol-binding protein receptor STRA6 regulates diurnal insulin responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; VITAMIN-A; LIPID MOBILIZATION; METABOLIC SYNDROME; CIRCADIAN-RHYTHMS; CIRCULATING RBP4; GENE-EXPRESSION; CELLULAR UPTAKE; SHIFT WORK; RESISTANCE	It has long been appreciated that insulin action is closely tied to circadian rhythms. However, the mechanisms that dictate diurnal insulin sensitivity in metabolic tissues are not well understood. Retinol-binding protein 4 (RBP4) has been implicated as a driver of insulin resistance in rodents and humans, and it has become an attractive drug target in type II diabetes. RBP4 is synthesized primarily in the liver where it binds retinol and transports it to tissues throughout the body. The retinolRBP4 complex (holo-RBP) can be recognized by a cell-surface receptor known as stimulated by retinoic acid 6 (STRA6), which transports retinol into cells. Coupled to retinol transport, holo-RBP can activate STRA6-driven Janus kinase (JAK) signaling and downstream induction of signal transducer and activator of transcription (STAT) target genes. STRA6 signaling in white adipose tissue has been shown to inhibit insulin receptor responses. Here, we examined diurnal rhythmicity of the RBP4/STRA6 signaling axis and investigated whether STRA6 is necessary for diurnal variations in insulin sensitivity. We show that adipose tissue STRA6 undergoes circadian patterning driven in part by the nuclear transcription factor REV-ERB alpha. Furthermore, STRA6 is necessary for diurnal rhythmicity of insulin action and JAK/STAT signaling in adipose tissue. These findings establish that holo-RBP and its receptor STRA6 are potent regulators of diurnal insulin responses and suggest that the holo-RBP/STRA6 signaling axis may represent a novel therapeutic target in type II diabetes.	[Gliniak, Christy M.; Brown, J. Mark; Noy, Noa] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Brown, J. Mark] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44195 USA; [Gliniak, Christy M.; Brown, J. Mark] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Brown, JM (corresponding author), Cleveland Clin, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	brownm5@ccf.org		Gliniak, Christy/0000-0003-3806-6112	National Institutes of Health [R01 DK060684, R01 HL122283, P50 AA024333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants R01 DK060684 (to N.N. and J.M.B.), R01 HL122283 (to J.M.B.), and P50 AA024333 (to J.M.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Berry DC, 2014, CANCER RES, V74, P6341, DOI 10.1158/0008-5472.CAN-14-1052; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Boden G, 2013, OBESITY, V21, P1208, DOI 10.1002/oby.20134; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Carrasco-Benso MP, 2016, FASEB J, V30, P3117, DOI 10.1096/fj.201600269RR; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Emilsson V, 1999, FEBS LETT, V455, P170, DOI 10.1016/S0014-5793(99)00874-1; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; GIBSON T, 1972, LANCET, V2, P947; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Guo FJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003619; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Hughey JJ, 2016, J BIOL RHYTHM, V31, P588, DOI 10.1177/0748730416668049; Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024; Kaltenecker D, 2017, DIABETOLOGIA, V60, P296, DOI 10.1007/s00125-016-4152-8; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma X, 2016, DIABETOLOGIA, V59, P354, DOI 10.1007/s00125-015-3807-1; Marwarha G, 2014, FASEB J, V28, P26, DOI 10.1096/fj.13-234310; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mody N, 2014, BIOCHEM PHARMACOL, V91, P277, DOI 10.1016/j.bcp.2014.07.012; Nagaya T, 2002, INT ARCH OCC ENV HEA, V75, P562, DOI 10.1007/s00420-002-0370-0; Napoli Joseph L, 2016, Subcell Biochem, V81, P21; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Pfeffer B, 2004, MOL VIS, V10, P23; Prasai MJ, 2013, DIABETES, V62, P1981, DOI 10.2337/db11-1740; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Saad A, 2012, DIABETES, V61, P2691, DOI 10.2337/db11-1478; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; SMITH JE, 1973, J BIOL CHEM, V248, P1544; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Szeto W, 2001, CANCER RES, V61, P4197; Thompson SJ, 2017, DIABETES, V66, P58, DOI 10.2337/db16-0286; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; White UA, 2016, AM J PHYSIOL-ENDOC M, V310, pE129, DOI 10.1152/ajpendo.00068.2015; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	78	12	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15080	15093		10.1074/jbc.M117.782334	http://dx.doi.org/10.1074/jbc.M117.782334			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28733465	Green Published, hybrid			2022-12-28	WOS:000409902100030
J	Kara, E; Marks, JD; Fan, ZY; Klickstein, JA; Roe, AD; Krogh, KA; Wegmann, S; Maesako, M; Luo, CC; Mylvaganam, R; Berezovska, O; Hudry, E; Hyman, BT				Kara, Eleanna; Marks, Jordan D.; Fan, Zhanyun; Klickstein, Jacob A.; Roe, Allyson D.; Krogh, Kelly A.; Wegmann, Susanne; Maesako, Masato; Luo, Christina C.; Mylvaganam, Ravi; Berezovska, Oksana; Hudry, Eloise; Hyman, Bradley T.			Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN INTERACTION; AMYLOID-BETA; DENSITY-LIPOPROTEINS; RECEPTOR-BINDING; MECHANISM; DISEASE; FORMS	Apolipoprotein E (apoE) has an important role in the pathogenesis of Alzheimer's disease with its three isoforms having distinct effects on disease risk. Here, we assessed the conformational differences between those isoforms using a novel flow cytometry-Forster resonance energy transfer (FRET) assay. We showed that the conformation of intracellular apoE within HEK cells and astrocytes adopts a directional pattern; in other words, E4 adopts the most closed conformation, E2 adopts the most open conformation, and E3 adopts an intermediate conformation. However, this pattern was not maintained upon secretion of apoE from astrocytes. Intermolecular interactions between apoE molecules were isoform-specific, indicating a great diversity in the structure of apoE lipoparticles. Finally, we showed that secreted E4 is the most lipidated isoform in astrocytes, suggesting that increased lipidation acts as a folding chaperone enabling E4 to adopt a closed conformation. In conclusion, this study gives insights into apoE biology and establishes a robust screening system to monitor apoE conformation.	[Kara, Eleanna; Marks, Jordan D.; Fan, Zhanyun; Klickstein, Jacob A.; Roe, Allyson D.; Krogh, Kelly A.; Wegmann, Susanne; Maesako, Masato; Berezovska, Oksana; Hudry, Eloise; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, Alzheimers Dis Res Lab, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Luo, Christina C.; Mylvaganam, Ravi] Massachusetts Gen Hosp, Mol Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, 114,16th St, Charlestown, MA 02129 USA.	bhyman@mgh.harvard.edu		Kara, Eleanna/0000-0001-5428-6743; Klickstein, Jacob/0000-0002-0759-4724	National Institutes of Health [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023440, S10RR020936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044486, K99AG047336, RF1AG044486, P01AG015379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016372, S10OD012027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Cytometric findings reported here were performed in the Massachusetts General Hospital Department of Pathology Flow and Image Cytometry Research Core, which obtained support from the National Institutes of Health Shared Instrumentation program with Grants 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1.	Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chou CY, 2005, BIOPHYS J, V88, P455, DOI 10.1529/biophysj.104.046813; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Dong LM, 1996, NAT STRUCT BIOL, V3, P718, DOI 10.1038/nsb0896-718; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Elliott DA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-23; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Fu Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0099-y; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; Liu M, 2012, AM J PHYSIOL-REG I, V303, pR903, DOI 10.1152/ajpregu.00219.2012; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rebeck GW, 1998, EXP NEUROL, V149, P175, DOI 10.1006/exnr.1997.6710; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200	29	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14720	14729		10.1074/jbc.M117.784264	http://dx.doi.org/10.1074/jbc.M117.784264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28684412	Green Published, hybrid			2022-12-28	WOS:000409902100001
J	Korkmaz, G; Sanyal, S				Korkmaz, Gurkan; Sanyal, Suparna			R213I mutation in release factor 2 (RF2) is one step forward for engineering an omnipotent release factor in bacteria Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION TERMINATION; POLYPEPTIDE RELEASE; STOP-CODON; PEPTIDE RELEASE; MESSENGER-RNA; AMINO-ACID; RIBOSOME; RECOGNITION; SPECIFICITY; ACCURACY	The current understanding of the specificity of the bacterial class I release factors (RFs) in decoding stop codons has evolved beyond a simple tripeptide anticodon model. A recent molecular dynamics study for deciphering the principles for specific stop codon recognition by RFs identified Arg-213 as a crucial residue on Escherichia coli RF2 for discriminating guanine in the third position (G3). Interestingly, Arg-213 is highly conserved in RF2 and substituted by Ile-196 in the corresponding position in RF1. Another similar pair is Leu-126 in RF1 and Asp-143 in RF2, which are also conserved within their respective groups. With the hypothesis that replacement of Arg-213 and Asp-143 with the corresponding RF1 residues will reduce G3 discrimination by RF2, we swapped these residues between E. coli RF1 and RF2 by site-directed mutagenesis and characterized their preference for different codons using a competitive peptide release assay. Among these, the R213I mutant of RF2 showed 5-fold improved reading of the RF1-specific UAG codon relative to UAA, the universal stop codon, compared with the wild type (WT). In-depth fast kinetic studies revealed that the gain in UAG reading by RF2 R213I is associated with a reduced efficiency of termination on the cognate UAA codon. Our work highlights the notion that stop codon recognition involves complex interactions with multiple residues beyond the PXT/SPF motifs. We propose that the R213I mutation in RF2 brings us one step forward toward engineering an omnipotent RF in bacteria, capable of reading all three stop codons.	[Korkmaz, Gurkan; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se		Korkmaz, Gurkan/0000-0003-1911-027X	Swedish Research Council [2016-06264, 2013-8778, 2014-4423, 2008-6593]; Knut and Alice Wallenberg Foundation [KAW2011.0081]; Sven and Lilly Lawski Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sven and Lilly Lawski Foundation	This work was supported by research grants from Swedish Research Council 2016-06264, 2013-8778, and 2014-4423 (to S.S.) and 2008-6593 (Linnaeus grant to Uppsala RNA Research Center) and by the Knut and Alice Wallenberg Foundation to RiboCORE (KAW2011.0081). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the Sven and Lilly Lawski Foundation for Scientific Research.	Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Field A, 2010, BIOCHEMISTRY-US, V49, P9385, DOI 10.1021/bi1012047; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Indrisiunaite G, 2015, J MOL BIOL, V427, P1848, DOI 10.1016/j.jmb.2015.01.007; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Korkmaz G, 2014, J BIOL CHEM, V289, P30334, DOI 10.1074/jbc.M114.606632; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Lind C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3940; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Pallesen J, 2013, ELIFE, V2, DOI 10.7554/eLife.00411; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Trappl K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094058; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323	29	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15134	15142		10.1074/jbc.M117.785238	http://dx.doi.org/10.1074/jbc.M117.785238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28743745	hybrid, Green Published			2022-12-28	WOS:000409902100035
J	Chen, J; Martindale, JL; Cramer, C; Gorospe, M; Atasoy, U; Drew, PD; Yu, SG				Chen, Jing; Martindale, Jennifer L.; Cramer, Carole; Gorospe, Myriam; Atasoy, Ulus; Drew, Paul D.; Yu, Shiguang			The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; INFLAMMATORY PROTEIN-3-ALPHA/CCL20; AUTOIMMUNE ENCEPHALOMYELITIS; RHEUMATOID-ARTHRITIS; MEDIATED GENERATION; ANTIGEN R; ACTIVATION; DIFFERENTIATION; RECRUITMENT; LINEAGE	In both multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), the C-C chemokine receptor 6 (CCR6) is critical for pathogenicThelper 17 (Th17) cell migration to the central nervous system (CNS). Whereas many cytokines and their receptors are potently regulated via post-transcriptional mechanisms in response to various stimuli, how CCR6 expression is post-transcriptionally regulated in Th17 cells is unknown. Here, using RNA-binding protein HuR conditional knock-out (KO) and wild-type (WT) mice, we present evidence that HuR post-transcriptionally regulates CCR6 expression by binding to and stabilizing Ccr6 mRNA and by promoting CCR6 translation. We also found that HuR down-regulates several microRNA expressions, which could target the 3'-UTR of Ccr6 mRNA for decay. Accordingly, knock-out of HuR reduced CCR6 expression on Th17 cells and impaired their migration to CNS compared with the response of WT Th17 cells and thereby ameliorated EAE. Together, these findings highlight how HuR contributes to Th17 cell-mediated autoimmune neuroinflammation and support the notion that targeting HuR might be a potential therapeutic intervention for managing autoimmune disorders of the CNS.	[Chen, Jing; Cramer, Carole] Arkansas State Univ, Arkansas Biosci Inst, Dept Biol Sci, Jonesboro, AR 72467 USA; [Chen, Jing; Yu, Shiguang] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Chen, Jing] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Martindale, Jennifer L.; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Atasoy, Ulus] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Atasoy, Ulus] Univ Missouri, Dept Surg, Columbia, MO 65211 USA; [Drew, Paul D.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Coll Med, Little Rock, AR 72205 USA; [Yu, Shiguang] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72467 USA	Arkansas State University; Jefferson University; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas State University	Chen, J; Yu, SG (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	jing.chen@jefferson.edu; shiguang.yu@jefferson.edu	Gorospe, Myriam/Y-3613-2019; Martindale, Jennifer Luethy/AAD-1963-2022	Martindale, Jennifer Luethy/0000-0002-3234-6861	National Institutes of Health from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources [p20GM103429]; National Institutes of Health [R01AI119135]; NIA-Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119135, R01AI080870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000511, ZIAAG000393] Funding Source: NIH RePORTER	National Institutes of Health from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA-Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant p20GM103429 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources and National Institutes of Health Grant R01AI119135. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NIA-Intramural Research Program, National Institutes of Health.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Atasoy U, 1998, J CELL SCI, V111, P3145; Axtell RC, 2009, NAT IMMUNOL, V10, P453, DOI 10.1038/ni0509-453; Chen J, 2013, J IMMUNOL, V191, P5441, DOI 10.4049/jimmunol.1301188; Chen WJ, 2015, EUR J IMMUNOL, V45, P958, DOI 10.1002/eji.201444999; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Gunzburg MJ, 2015, CELL CYCLE, V14, P2729, DOI 10.1080/15384101.2015.1069930; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeyaraj SC, 2010, J BIOL CHEM, V285, P4432, DOI 10.1074/jbc.M109.062216; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lu L, 2014, J BIOL CHEM, V289, P31792, DOI 10.1074/jbc.M114.573246; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palm NW, 2007, NAT IMMUNOL, V8, P549, DOI 10.1038/ni0607-549; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ransohoff RM, 2009, NATURE, V462, P41, DOI 10.1038/462041a; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Tracey KJ, 2012, CELL, V148, P392, DOI 10.1016/j.cell.2012.01.025; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; Wan WZ, 2011, CIRC RES, V109, P374, DOI 10.1161/CIRCRESAHA.111.242578; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie L, 2014, J NEUROIMMUNOL, V273, P31, DOI 10.1016/j.jneuroim.2014.05.015; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu SG, 2006, J EXP MED, V203, P349, DOI 10.1084/jem.20051438; Yu SG, 2012, INT IMMUNOL, V24, P233, DOI 10.1093/intimm/dxs003; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	53	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14532	14543		10.1074/jbc.M117.782771	http://dx.doi.org/10.1074/jbc.M117.782771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684423	Green Published, hybrid			2022-12-28	WOS:000408747500019
J	Hiruma, Y; Koch, A; Hazraty, N; Tsakou, F; Medema, RH; Joosten, RP; Perrakis, A				Hiruma, Yoshitaka; Koch, Andre; Hazraty, Nazila; Tsakou, Foteini; Medema, Rene H.; Joosten, Robbie P.; Perrakis, Anastassis			Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; MOLECULAR-GRAPHICS; DRUG-RESISTANCE; DESIGN; MODEL; OPTIMIZATION; KINETOCHORES; SELECTIVITY; VALIDATION; ACTIVATION	Monopolar spindle 1 (Mps1/TTK) is a protein kinase essential in mitotic checkpoint signaling, preventing anaphase until all chromosomes are properly attached to spindle microtubules. Mps1 has emerged as a potential target for cancer therapy, and a variety of compounds have been developed to inhibit its kinase activity. Mutations in the catalytic domain of Mps1 that give rise to inhibitor resistance, but retain catalytic activity and do not display cross-resistance to other Mps1 inhibitors, have been described. Here we characterize the interactions of two such mutants, Mps1 C604Y and C604W, which raise resistance to two closely related compounds, NMS-P715 and its derivative Cpd-5, but not to the well characterized Mps1 inhibitor, reversine. We show that estimates of the IC50 (employing a novel specific and efficient assay that utilizes a fluorescently labeled substrate) and the binding affinity (K-D) indicate that, in both mutants, Cpd-5 should be better tolerated than the closely related NMS-P715. To gain further insight, we determined the crystal structure of the Mps1 kinase mutants bound to Cpd-5 and NMS-P715 and compared the binding modes of Cpd-5, NMS-P715, and reversine. The difference in steric hindrance between Tyr/Trp(604) and the trifluoromethoxy moiety of NMSP715, the methoxy moiety of Cpd-5, and complete absence of such a group in reversine, account for differences we observe in vitro. Our analysis enforces the notion that inhibitors targeting Mps1 drug-resistant mutations can emerge as a feasible intervention strategy based on existing scaffolds, if the clinical need arises.	[Hiruma, Yoshitaka; Hazraty, Nazila; Tsakou, Foteini; Joosten, Robbie P.; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Koch, Andre; Medema, Rene H.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Perrakis, A (corresponding author), Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Joosten, Robbie P./I-9317-2012; Perrakis, Anastassis/E-8704-2013	Joosten, Robbie P./0000-0002-2323-2686; Perrakis, Anastassis/0000-0002-1151-6227; Medema, Rene/0000-0002-6754-0381; Koch, Andre/0000-0003-3502-382X	Netherlands Organization for Scientific Research (NWO) Veni Grants [722.015.008, 723.013.003]; Dutch Cancer Society (KWF) Grant [2012-5427]	Netherlands Organization for Scientific Research (NWO) Veni Grants(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF) Grant	This work was supported by The Netherlands Organization for Scientific Research (NWO) Veni Grants 722.015.008 (to Y. H.) and 723.013.003 (to R. P. J.) and Dutch Cancer Society (KWF) Grant 2012-5427 (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Alimova I, 2016, ONCOL REP, V36, P2633, DOI 10.3892/or.2016.5085; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Card A, 2009, J BIOMOL SCREEN, V14, P31, DOI 10.1177/1087057108326663; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dym O, 2016, PROTEIN SCI, V25, P1096, DOI 10.1002/pro.2923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gurden MD, 2015, CANCER RES, V75, P3340, DOI 10.1158/0008-5472.CAN-14-3272; Hiruma Y, 2016, PROTEINS, V84, P1761, DOI 10.1002/prot.25174; Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1; Innocenti P, 2016, J MED CHEM, V59, P3671, DOI 10.1021/acs.jmedchem.5b01811; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Koch A, 2016, ONCOGENE, V35, P2518, DOI 10.1038/onc.2015.319; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Long F, 2017, ACTA CRYSTALLOGR D, V73, P112, DOI 10.1107/S2059798317000067; Maia ARR, 2015, ANN ONCOL, V26, P2180, DOI 10.1093/annonc/mdv293; Marina Caldarelli MA, 2009, Pyrazolo-quinazolines, Patent No. [WO 2009156315 A1, 2009156315]; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naud S, 2013, J MED CHEM, V56, P10045, DOI 10.1021/jm401395s; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Uitdehaag JCM, 2017, J MOL BIOL, V429, P2211, DOI 10.1016/j.jmb.2017.05.014; van Beusekom B., BIORXIV, DOI [10.1101/147231, DOI 10.1101/147231]; Vleugel M, 2015, MOL CELL, V57, P824, DOI 10.1016/j.molcel.2014.12.036	39	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14496	14504		10.1074/jbc.M117.783555	http://dx.doi.org/10.1074/jbc.M117.783555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28726638	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000408747500016
J	Rui, ML; Qian, JJ; Liu, LJ; Cai, YH; Lv, HH; Han, JH; Jia, ZP; Xie, W				Rui, Menglong; Qian, Jinjun; Liu, Lijuan; Cai, Yihan; Lv, Huihui; Han, Junhai; Jia, Zhengping; Xie, Wei			The neuronal protein Neurexin directly interacts with the Scribble-Pix complex to stimulate F-actin assembly for synaptic vesicle clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTISM SPECTRUM DISORDER; DROSOPHILA NEUREXIN; EXCHANGE FACTOR; CELL-ADHESION; DYNAMICS; LOCALIZATION; RECRUITMENT; EXOCYTOSIS; SYNAPSES; POLYMERIZATION	Synaptic vesicles (SVs) form distinct pools at synaptic terminals, and this well-regulated separation is necessary for normal neurotransmission. However, how the SV cluster, in particular synaptic compartments, maintains normal neurotransmitter release remains a mystery. The presynaptic protein Neurexin (NRX) plays a significant role in synaptic architecture and function, and some evidence suggests that NRX is associated with neurological disorders, including autism spectrum disorders. However, the role of NRX in SV clustering is unclear. Here, using the neuromuscular junction at the 2-3 instar stages of Drosophila larvae as a model and biochemical imaging and electrophysiology techniques, we demonstrate that Drosophila NRX (DNRX) plays critical roles in regulating synaptic terminal clustering and release of SVs. We found that DNRX controls the terminal clustering and release of SVs by stimulating presynaptic F-actin. Furthermore, our results indicate that DNRX functions through the scaffold protein Scribble and the GEF protein DPix to activate the small GTPase Ras-related C3 Botulinum toxin substrate 1 (Rac1). We observed a direct interaction between the C-terminal PDZ-binding motif of DNRX and the PDZ domains of Scribble and that Scribble bridges DNRX to DPix, forming a DNRX-Scribble-DPix complex that activates Rac1 and subsequently stimulates presynaptic F-actin assembly and SV clustering. Taken together, our work provides important insights into the function of DNRX in regulating SV clustering, which could help inform further research into pathological neurexin-mediated mechanisms in neurological disorders such as autism.	[Rui, Menglong; Qian, Jinjun; Liu, Lijuan; Cai, Yihan; Lv, Huihui; Han, Junhai; Xie, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Han, Junhai; Xie, Wei] Southeast Univ, Inst Life Sci, Collaborat Innovat Ctr Brain Sci, Nanjing 210096, Jiangsu, Peoples R China; [Jia, Zhengping] Hosp Sick Children, Dept Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Jia, Zhengping] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON M5S IA8, Canada	Southeast University - China; Southeast University - China; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Xie, W (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	wei.xie@seu.edu.cn	Jia, zhengping/AAZ-4190-2021	Rui, Menglong/0000-0002-1911-8397	National Natural Science Foundation of China [31430035, 30930051, 31600824]; China National Basic Research Program 973 Program [2012CB517903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31430035 and 30930051 (to W. X.) and 31600824 (to L. L.) and China National Basic Research Program 973 Program Grant 2012CB517903 (to W. X. and Z. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alabi AA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013680; Attias O, 2010, NEPHRON EXP NEPHROL, V114, pE93, DOI 10.1159/000262317; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Cervantes-Sandoval I, 2016, NEURON, V90, P1230, DOI 10.1016/j.neuron.2016.05.010; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dong T, 2016, P NATL ACAD SCI USA, V113, P7644, DOI 10.1073/pnas.1602152113; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Ganguly I, 2003, GENETICS, V164, P1447; Harris JC, 2016, NAT NEUROSCI, V19, P1390, DOI 10.1038/nn.4427; Hata Y, 1996, J NEUROSCI, V16, P2488; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lee JS, 2012, P NATL ACAD SCI USA, V109, pE765, DOI 10.1073/pnas.1114072109; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li T, 2015, J BIOL CHEM, V290, P17656, DOI 10.1074/jbc.M115.644583; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Merriam EB, 2012, J NEUROSCI, V32, P3955, DOI 10.1523/JNEUROSCI.0191-12.2012; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Moreau MM, 2010, J NEUROSCI, V30, P9738, DOI 10.1523/JNEUROSCI.6007-09.2010; Muhammad K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9362; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Nelson JC, 2013, CELL ADHES MIGR, V7, P379, DOI 10.4161/cam.24803; Nunes P, 2006, MOL BIOL CELL, V17, P4709, DOI 10.1091/mbc.E06-03-0253; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Richier L, 2010, J NEUROSCI, V30, P4796, DOI 10.1523/JNEUROSCI.3726-09.2010; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun MK, 2016, SCI CHINA LIFE SCI, V59, P68, DOI 10.1007/s11427-015-4946-9; Sun MK, 2009, NEUROSCI RES, V64, P362, DOI 10.1016/j.neures.2009.04.009; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tejada-Simon MV, 2015, J NEUROCHEM, V133, P767, DOI 10.1111/jnc.13100; Tian Y, 2013, NEURON, V77, P311, DOI 10.1016/j.neuron.2012.11.012; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wolf M, 2015, CEREB CORTEX, V25, P2863, DOI 10.1093/cercor/bhu081; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang HF, 2016, NEUROSCI BULL, V32, P423, DOI 10.1007/s12264-016-0046-5; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	57	16	16	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14334	14348		10.1074/jbc.M117.794040	http://dx.doi.org/10.1074/jbc.M117.794040			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710284	Green Published, hybrid			2022-12-28	WOS:000408747500003
J	Nelson, DL; Applegate, GA; Beio, ML; Graham, DL; Berkowitz, DB				Nelson, David L.; Applegate, Greg A.; Beio, Matthew L.; Graham, Danielle L.; Berkowitz, David B.			Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for -elimination function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; molecular modeling; pyridoxal phosphate; site-directed mutagenesis	CYSTATHIONINE BETA-SYNTHASE; LYS CATALYTIC TRIAD; AMINO-ACIDS; L-THREO-3-HYDROXYASPARTATE DEHYDRATASE; REACTION SPECIFICITY; CRYSTAL-STRUCTURE; HYDROGEN-SULFIDE; STRUCTURAL BASIS; GLYCINE SITE; AMIDASE	There is currently great interest in human serine racemase, the enzyme responsible for producing the NMDA co-agonist d-serine. Reported correlation of d-serine levels with disorders including Alzheimer's disease, ALS, and ischemic brain damage (elevated d-serine) and schizophrenia (reduced d-serine) has further piqued this interest. Reported here is a structure/activity relationship study of position Ser(84), the putative re-face base. In the most extreme case of functional reprogramming, the S84D mutant displays a dramatic reversal of -elimination substrate specificity in favor of l-serine over the normally preferred l-serine-O-sulfate (approximate to 1200-fold change in k(cat)/K-m ratios) and l (l-THA; approximate to 5000-fold change in k(cat)/K-m ratios) alternative substrates. On the other hand, the S84T (which performs l-Ser racemization activity), S84A (good k(cat) but high K-m for l-THA elimination), and S84N mutants (nearly WT efficiency for l-Ser elimination) displayed intermediate activity, all showing a preference for the anionic substrates, but generally attenuated compared with the native enzyme. Inhibition studies with l-erythro--hydroxyaspartate follow this trend, with both WT serine racemase and the S84N mutant being competitively inhibited, with K-i = 31 +/- 1.5 m and 1.5 +/- 0.1 mm, respectively, and the S84D being inert to inhibition. Computational modeling pointed to a key role for residue Arg-135 in binding and properly positioning the l-THA and l-serine-O-sulfate substrates and the l-erythro--hydroxyaspartate inhibitor. Examination of available sequence data suggests that Arg-135 may have originated for l-THA-like -elimination function in earlier evolutionary variants, and examination of available structural data suggests that a Ser(84)-H2O-Lys(114) hydrogen-bonding network in human serine racemase lowers the pK(a) of the Ser(84)re-face base.	[Nelson, David L.; Applegate, Greg A.; Beio, Matthew L.; Graham, Danielle L.; Berkowitz, David B.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Berkowitz, DB (corresponding author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.	dberkowitz1@unl.edu		Berkowitz, David/0000-0001-7550-0112	National Institutes of Health [RR016544]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Facilities in this work were supported by a Grant-in-Aid from the National Institutes of Health Grant RR016544.	Abe T, 2014, J CEREBR BLOOD F MET, V34, P1928, DOI 10.1038/jcbfm.2014.164; Akiyama T, 2017, BIOCHEM BIOPH RES CO, V482, P1007, DOI 10.1016/j.bbrc.2016.11.148; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Baumgart F, 2007, FEBS J, V274, P4561, DOI 10.1111/j.1742-4658.2007.05986.x; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Berkowitz DB, 2008, J FLUORINE CHEM, V129, P731, DOI 10.1016/j.jfluchem.2008.05.016; Berkowitz DB, 2000, J AM CHEM SOC, V122, P11031, DOI 10.1021/ja0055110; Berkowitz DB, 2006, ORG LETT, V8, P971, DOI 10.1021/ol060019s; Berkowitz DB, 2004, ORG LETT, V6, P1821, DOI 10.1021/ol049422u; Berkowitz DB, 1996, BIOORG MED CHEM LETT, V6, P2151, DOI 10.1016/0960-894X(96)00366-6; Berkowitz DB, 1996, SYNTHESIS-STUTTGART, P39, DOI 10.1055/s-1996-4177; Bruno S, 2017, BBA-PROTEINS PROTEOM, V1865, P381, DOI 10.1016/j.bbapap.2017.01.001; Caulkins BG, 2016, J AM CHEM SOC, V138, P15214, DOI 10.1021/jacs.6b08937; Cerqueira NMFSA, 2017, PHYS CHEM CHEM PHYS, V19, P12343, DOI 10.1039/c7cp00277g; de Miranda J, 2002, P NATL ACAD SCI USA, V99, P14542, DOI 10.1073/pnas.222421299; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Foltyn VN, 2010, FEBS LETT, V584, P2937, DOI 10.1016/j.febslet.2010.05.022; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoffman HE, 2009, PROTEIN EXPRES PURIF, V63, P62, DOI 10.1016/j.pep.2008.09.003; Hoffman HE, 2009, J MED CHEM, V52, P6032, DOI 10.1021/jm900775q; Ishiwata S, 2015, J NEURAL TRANSM, V122, P1099, DOI 10.1007/s00702-015-1388-2; Ito T, 2013, AMINO ACIDS, V44, P1073, DOI 10.1007/s00726-012-1442-4; Karukurichi KR, 2007, J AM CHEM SOC, V129, P258, DOI 10.1021/ja067240k; Katane M, 2016, GENES CELLS, V21, P966, DOI 10.1111/gtc.12398; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; Lee S, 2015, BIOCHEM BIOPH RES CO, V467, P268, DOI 10.1016/j.bbrc.2015.09.177; Ma TM, 2014, J BIOL CHEM, V289, P29631, DOI 10.1074/jbc.M114.571604; Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52; Marchetti M, 2013, FEBS J, V280, P5853, DOI 10.1111/febs.12510; McCune CD, 2016, ACS CENTRAL SCI, V2, P242, DOI 10.1021/acscentsci.6b00019; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; McKinney MK, 2003, J BIOL CHEM, V278, P37393, DOI 10.1074/jbc.M303922200; Mileni M, 2010, J MOL BIOL, V400, P743, DOI 10.1016/j.jmb.2010.05.034; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Murakami T, 2009, J BIOCHEM, V145, P661, DOI 10.1093/jb/mvp023; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Neidle A, 2002, NEUROCHEM RES, V27, P1719, DOI 10.1023/A:1021607715824; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Nitoker N, 2015, BIOCHEMISTRY-US, V54, P516, DOI 10.1021/bi500984m; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Paul Praveen, 2014, Front Synaptic Neurosci, V6, P10, DOI 10.3389/fnsyn.2014.00010; Pratt RF, 2010, BIOCHEMISTRY-US, V49, P9688, DOI 10.1021/bi1012222; Puhl MD, 2015, NEUROBIOL DIS, V73, P269, DOI 10.1016/j.nbd.2014.10.009; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Shoji K, 2006, NEUROSCI LETT, V392, P75, DOI 10.1016/j.neulet.2005.08.063; Smith MA, 2010, J BIOL CHEM, V285, P12873, DOI 10.1074/jbc.M109.050062; Soo VWC, 2016, J BIOL CHEM, V291, P19873, DOI 10.1074/jbc.M116.739557; Strisovsky K, 2005, BIOCHEMISTRY-US, V44, P13091, DOI 10.1021/bi051201o; Strisovsky K, 2003, FEBS LETT, V535, P44, DOI 10.1016/S0014-5793(02)03855-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valina ALB, 2004, BIOCHEMISTRY-US, V43, P15657, DOI 10.1021/bi049025r; Van der Auwera S, 2016, EUR NEUROPSYCHOPHARM, V26, P1507, DOI 10.1016/j.euroneuro.2016.03.019; Vorlova B, 2015, EUR J MED CHEM, V89, P189, DOI 10.1016/j.ejmech.2014.10.043; Wada M, 2003, FEMS MICROBIOL LETT, V225, P189, DOI 10.1016/S0378-1097(03)00484-1; Wang CY, 2012, PROTEIN ENG DES SEL, V25, P1, DOI 10.1093/protein/gzs078; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Wolosker H, 2016, TRENDS NEUROSCI, V39, P712, DOI 10.1016/j.tins.2016.09.007; Wu ZM, 2017, PROTEIN EXPRES PURIF, V129, P60, DOI 10.1016/j.pep.2016.09.005; Xia M, 2016, J NEUROCHEM, V138, P518, DOI 10.1111/jnc.13663; Yamauchi T, 2009, J BIOCHEM, V145, P421, DOI 10.1093/jb/mvp010; Zou LL, 2016, ACTA CRYSTALLOGR F, V72, P165, DOI 10.1107/S2053230X16000960	75	15	15	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13986	14002		10.1074/jbc.M117.777904	http://dx.doi.org/10.1074/jbc.M117.777904			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696262	Green Published, hybrid			2022-12-28	WOS:000408439800008
J	Qureshi, MA; Haynes, CM; Pellegrino, MW				Qureshi, Mohammed A.; Haynes, Cole M.; Pellegrino, Mark W.			The mitochondrial unfolded protein response: Signaling from the powerhouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTION FACTOR ATFS-1; CAENORHABDITIS-ELEGANS; STRESS-RESPONSE; FACTOR ATF5; C. ELEGANS; UPR; LONGEVITY; CELLS; INFECTION; IMMUNITY	Mitochondria are multifaceted and indispensable organelles required for cell performance. Accordingly, dysfunction to mitochondria can result in cellular decline and possibly the onset of disease. Cells use a variety of means to recover mitochondria and restore homeostasis, including the activation of retrograde pathways such as the mitochondrial unfolded protein response (UPRmt). In this Minireview, we will discuss how cells adapt to mitochondrial stress through UPRmt regulation. Furthermore, we will explore the current repertoire of biological functions that are associated with this essential stress-response pathway.	[Qureshi, Mohammed A.; Pellegrino, Mark W.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Haynes, Cole M.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	University of Texas System; University of Texas Arlington; University of Massachusetts System; University of Massachusetts Worcester	Pellegrino, MW (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	mark.pellegrino@uta.edu		Qureshi, Mohammed Adnan/0000-0003-3091-9555	Cancer Prevention Research Institute of Texas Grant [RR160053]; University of Texas Arlington;  [R01AG047182]; NATIONAL INSTITUTE ON AGING [R37AG047182, R01AG047182] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas Grant; University of Texas Arlington; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Cancer Prevention Research Institute of Texas Grant RR160053 and the University of Texas Arlington (to M. W. P.) and Grant R01AG047182 (to C. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cappello F, 2002, PATHOBIOLOGY, V70, P83, DOI 10.1159/000067304; Castle PE, 2005, CANCER LETT, V229, P245, DOI 10.1016/j.canlet.2005.06.045; Chen YG, 2016, FISH SHELLFISH IMMUN, V54, P144, DOI 10.1016/j.fsi.2015.10.019; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111; Itzen A, 2011, SEMIN CELL DEV BIOL, V22, P48, DOI 10.1016/j.semcdb.2010.10.003; Jeong DE, 2017, EMBO J, V36, P1046, DOI 10.15252/embj.201694781; Khan MH, 2013, AGING-US, V5, P741, DOI 10.18632/aging.100604; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lee CH, 2011, AM J PATHOL, V178, P2066, DOI 10.1016/j.ajpath.2011.01.056; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Shao LW, 2016, CELL RES, V26, P1182, DOI 10.1038/cr.2016.118; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Suzuki M, 2014, CELL HOST MICROBE, V16, P581, DOI 10.1016/j.chom.2014.09.015; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Walter L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001084; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	66	93	94	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13500	13506		10.1074/jbc.R117.791061	http://dx.doi.org/10.1074/jbc.R117.791061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28687630	Green Published, hybrid			2022-12-28	WOS:000407942400023
J	Moritz, LE; Trievel, RC				Moritz, Lindsay E.; Trievel, Raymond C.			Structure, mechanism, and regulation of polycomb-repressive complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer; chromatin; crystal structure; epigenetics; gene silencing; histone methylation; Enhancer of Zeste 2 (EZH2); Polycomb repressive complex 2 (PRC2); SET domain; lysine methyltransferase	HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN COMPLEX; EMBRYONIC STEM-CELLS; PRC2 RECRUITMENT; LYSINE METHYLTRANSFERASES; SELECTIVE-INHIBITION; H2A UBIQUITINATION; MOUSE DEVELOPMENT; X-INACTIVATION; H3 LYSINE-27	Polycomb repressive complex 2 (PRC2) methylates lysine 27 in histone H3, a modification associated with epigenetic gene silencing. This complex plays a fundamental role in regulating cellular differentiation and development, and PRC2 overexpression and mutations have been implicated in numerous cancers. In this Minireview, we examine recent studies elucidating the first crystal structures of the PRC2 core complex, yielding seminal insights into its catalytic mechanism, substrate specificity, allosteric regulation, and inhibition by a class of small molecules that are currently undergoing cancer clinical trials. We conclude by exploring unresolved questions and future directions for inquiry regarding PRC2 structure and function.	[Moritz, Lindsay E.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Trievel, Raymond C.] Univ Michigan, Dept Biol Chem, 1150 West Med Ctr Dr,5301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Trievel, RC (corresponding author), Univ Michigan, Dept Biol Chem, 1150 West Med Ctr Dr,5301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu		Moritz, Lindsay/0000-0001-6704-8453	National Science Foundation [CHE-1508492]; National Institutes of Health [T32-GM007315]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part National Science Foundation Grant CHE-1508492. This is the fourth article in the Thematic Minireview series "Chromatin and Transcription." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32-GM007315 and a recipient of a National Science Foundation Graduate Research Fellowship.	Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Baker T, 2015, ONCOTARGET, V6, P32646, DOI 10.18632/oncotarget.5066; Bechet D, 2014, ACTA NEUROPATHOL, V128, P733, DOI 10.1007/s00401-014-1337-4; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bratkowski M, 2017, J BIOL CHEM, V292, P13323, DOI 10.1074/jbc.M117.787572; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Cooper S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13661; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; FAUST C, 1995, DEVELOPMENT, V121, P273; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Gibaja V, 2016, ONCOGENE, V35, P558, DOI 10.1038/onc.2015.114; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Holoch D, 2017, TRENDS BIOCHEM SCI, V42, P531, DOI 10.1016/j.tibs.2017.04.003; Jiao LY, 2016, SCIENCE, V354, DOI 10.1126/science.aaj2335; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kawano S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158888; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Kuntz KW, 2016, J MED CHEM, V59, P1556, DOI 10.1021/acs.jmedchem.5b01501; Kurmasheva RT, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26218; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nasveschuk CG, 2014, ACS MED CHEM LETT, V5, P378, DOI 10.1021/ml400494b; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Soumyanarayanan U, 2016, FUTURE MED CHEM, V8, P1635, DOI 10.4155/fmc-2016-0096; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Trievel RC, 2004, CRIT REV EUKAR GENE, V14, P147, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.10; Vaswani RG, 2016, J MED CHEM, V59, P9928, DOI 10.1021/acs.jmedchem.6b01315; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wen YP, 2017, ONCOTARGET, V8, P37974, DOI 10.18632/oncotarget.16467; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236	82	48	48	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13805	13814		10.1074/jbc.R117.800367	http://dx.doi.org/10.1074/jbc.R117.800367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	28912274	hybrid, Green Published			2022-12-28	WOS:000444070700006
J	Rahman, S; Luetje, CW				Rahman, Suhaila; Luetje, Charles W.			Mutant cycle analysis identifies a ligand interaction site in an odorant receptor of the malaria vector Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; insect; oocyte; receptor; Xenopus; olfaction; structure	DROSOPHILA-MELANOGASTER; OLFACTORY RECEPTORS; CARBON-DIOXIDE; CHANNEL; SUBUNIT; BINDING; SYSTEM; SPECIFICITY; INTERFACE; AFFINITY	Lack of information about the structure of insect odorant receptors (ORs) hinders the development of more effective repellants to control disease-transmitting insects. Mutagenesis and functional analyses using agonists to map the odorant-binding sites of these receptors have been limited because mutations distant from an agonist-binding site can alter agonist sensitivity. Here we use mutant cycle analysis, an approach for exploring the energetics of protein-protein or protein-ligand interactions, with inhibitors, to identify a component of the odorant-binding site of an OR from the malaria vector, Anopheles gambiae. The closely related odorant-specificity subunits Agam/Or15 and Agam/Or13 were each co-expressed with Agam/Orco (odorant receptor co-receptor subunit) in Xenopus oocytes and assayed by two-electrode voltage clamp electrophysiology. We identified (-)-fenchone as a competitive inhibitor with different potencies at the two receptors and used this difference to screen a panel of 37 Agam/Or15 mutants, surveying all positions that differ between Agam/Or15 and Agam/Or13 in the transmembrane and extracellular regions, identifying position 195 as a determinant of (-)-fenchone sensitivity. Inhibition by (-)-fenchone and six structurally related inhibitors of Agam/Or15 receptors containing each of four different hydrophobic residues at position 195 served as input data for mutant cycle analysis. Several mutant cycles, calculated from the inhibition of two receptors by each of two ligands, yielded coupling energies of 1 kcal/mol, indicating a close, physical interaction between the ligand and residue 195 of Agam/Or15. This approach should be useful in further expanding our knowledge of odorant-binding site structures in ORs of disease vector insects.	[Rahman, Suhaila; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; [Rahman, Suhaila] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Miami; Vanderbilt University	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, R-189,POB 016189, Miami, FL 33136 USA.	cluetje@med.miami.edu			National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grant RO1 DC011091. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carraher C, 2015, INSECT BIOCHEM MOLEC, V66, P31, DOI 10.1016/j.ibmb.2015.09.010; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Guidobaldi F, 2014, J PHYSIOL-PARIS, V108, P96, DOI 10.1016/j.jphysparis.2014.04.006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hallem EA, 2004, NEURON, V42, P359, DOI 10.1016/S0896-6273(04)00256-9; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hopf TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7077; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Hughes DT, 2014, CHEM SENSES, V39, P761, DOI 10.1093/chemse/bju048; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; LEFF P, 1993, TRENDS PHARMACOL SCI, V14, P110, DOI 10.1016/0165-6147(93)90080-4; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Nyce HL, 2010, BIOPHYS J, V98, P1847, DOI 10.1016/j.bpj.2010.01.034; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Penzotti JL, 2001, BIOPHYS J, V80, P698, DOI 10.1016/S0006-3495(01)76049-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Thomas-Tran R, 2016, P NATL ACAD SCI USA, V113, P5856, DOI 10.1073/pnas.1603486113; Tondi D, 2014, J MED CHEM, V57, P5449, DOI 10.1021/jm5006572; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2009, ANN NY ACAD SCI, V1170, P164, DOI 10.1111/j.1749-6632.2009.04101.x; Willcockson IU, 2002, J BIOL CHEM, V277, P42249, DOI 10.1074/jbc.M205383200; Xu PX, 2013, BIOCHEM BIOPH RES CO, V435, P477, DOI 10.1016/j.bbrc.2013.05.015; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	48	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18916	18923		10.1074/jbc.M117.810374	http://dx.doi.org/10.1074/jbc.M117.810374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972152	Green Published, hybrid			2022-12-28	WOS:000415848000016
J	Taskinen, B; Ferrada, E; Fowler, DM				Taskinen, Barbara; Ferrada, Evandro; Fowler, Douglas M.			Early emergence of negative regulation of the tyrosine kinase Src by the C-terminal Src kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibition mechanism; molecular biology; non-receptor tyrosine kinase (nRTK); protein evolution; protein phosphorylation	CONVERGENT EVOLUTION; MONOSIGA-BREVICOLLIS; SIGNALING PROPERTIES; STRUCTURAL BASIS; PROTEIN-KINASES; COMMUNICATION; EXPRESSION; SEQUENCE; ORIGIN; TRANSFORMATION	Stringent regulation of tyrosine kinase activity is essential for normal cellular function. In humans, the tyrosine kinase Src is inhibited via phosphorylation of its C-terminal tail by another kinase, C-terminal Src kinase (Csk). Although Src and Csk orthologs are present across holozoan organisms, including animals and protists, the Csk-Src negative regulatory mechanism appears to have evolved gradually. For example, in choanoflagellates, Src and Csk are both active, but the negative regulatory mechanism is reportedly absent. In filastereans, a protist clade closely related to choanoflagellates, Src is active, but Csk is apparently inactive. In this study, we use a combination of bioinformatics, in vitro kinase assays, and yeast-based growth assays to characterize holozoan Src and Csk orthologs. We show that, despite appreciable differences in domain architecture, Csk from Corallochytrium limacisporum, a highly diverged holozoan marine protist, is active and can inhibit Src. However, in comparison with other Csk orthologs, Corallochytrium Csk displays broad substrate specificity and inhibits Src in an activity-independent manner. Furthermore, in contrast to previous studies, we show that Csk from the filasterean Capsaspora owczarzaki is active and that the Csk-Src negative regulatory mechanism is present in Csk and Src proteins from C. owczarzaki and the choanoflagellate Monosiga brevicollis. Our results suggest that negative regulation of Src by Csk is more ancient than previously thought and that it might be conserved across all holozoan species.	[Taskinen, Barbara; Ferrada, Evandro; Fowler, Douglas M.] Univ Washington, Dept Genome Sci, Foege Bldg S-041,3720 15th Ave NE, Seattle, WA 98195 USA; [Fowler, Douglas M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fowler, DM (corresponding author), Univ Washington, Dept Genome Sci, Foege Bldg S-041,3720 15th Ave NE, Seattle, WA 98195 USA.	dfowler@uw.edu		Ferrada, Evandro/0000-0003-3242-1726; Fowler, Douglas/0000-0001-7614-1713; Taskinen, Barbara/0000-0003-2989-7563	National Institutes of Health [R01GM109110]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM109110 (to D. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRUGGE JS, 1987, MOL CELL BIOL, V7, P2180, DOI 10.1128/MCB.7.6.2180; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koegl M, 1995, ONCOGENE, V11, P2317; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Li WQ, 2008, J BIOL CHEM, V283, P15491, DOI 10.1074/jbc.M800002200; Li WQ, 2009, BIOCHEMISTRY-US, V48, P5180, DOI 10.1021/bi9000672; LI WH, 1980, GENETICS, V95, P237; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Miller MA, 2000, ONCOGENE, V19, P3925, DOI 10.1038/sj.onc.1203714; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Paps J., 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0022853, DOI 10.1002/9780470015902.A0022853]; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Schultheiss KP, 2014, BIOCHEMISTRY-US, V53, P1320, DOI 10.1021/bi4016499; Schultheiss KP, 2012, BIOCHEMISTRY-US, V51, P8267, DOI 10.1021/bi300965h; Sebe-Pedros A, 2016, DEV CELL, V39, P186, DOI 10.1016/j.devcel.2016.09.019; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga H, 2014, MOL BIOL EVOL, V31, P517, DOI 10.1093/molbev/mst241; Suga H, 2013, DEV BIOL, V377, P284, DOI 10.1016/j.ydbio.2013.01.009; Suga H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002733; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Torruella G, 2015, CURR BIOL, V25, P2404, DOI 10.1016/j.cub.2015.07.053; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	62	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18518	18529		10.1074/jbc.M117.811174	http://dx.doi.org/10.1074/jbc.M117.811174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939764	hybrid, Green Published			2022-12-28	WOS:000414958100011
J	Zhang, C; Miller, DJ; Guibao, CD; Donato, DM; Hanks, SK; Zheng, JJ				Zhang, Chi; Miller, Darcie J.; Guibao, Cristina D.; Donato, Dominique M.; Hanks, Steven K.; Zheng, Jie J.			Structural and functional insights into the interaction between the Cas family scaffolding protein p130Cas and the focal adhesion-associated protein paxillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; nuclear magnetic resonance (NMR); PTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK); scaffold protein; X-ray crystallography; p130Cas; BCAR1; paxillin	LD MOTIFS; 4-HELIX BUNDLE; KINASE; BINDS; LOCALIZATION; RECOGNITION; VINCULIN; DOMAIN	The Cas family scaffolding protein p130Cas is a Src substrate localized in focal adhesions (FAs) and functions in integrin signaling to promote cell motility, invasion, proliferation, and survival. p130Cas targeting to FAs is essential for its tyrosine phosphorylation and downstream signaling. Although the N-terminal SH3 domain is important for p130Cas localization, it has also been reported that the C-terminal region is involved in p130Cas FA targeting. The C-terminal region of p130Cas or Cas family homology domain (CCHD) has been reported to adopt a structure similar to that of the focal adhesion kinase C-terminal focal adhesion-targeting domain. The mechanism by which the CCHD promotes FA targeting of p130Cas, however, remains unclear. In this study, using a calorimetry approach, we identified the first LD motif (LD1) of the FA-associated protein paxillin as the binding partner of the p130Cas CCHD (in a 1:1 stoichiometry with a K-d approximate to 4.2 m) and elucidated the structure of the p130Cas CCHD in complex with the paxillin LD1 motif by X-ray crystallography. Of note, a comparison of the CCHD/LD1 complex with a previously solved structure of CCHD in complex with the SH2-containing protein NSP3 revealed that LD1 had almost identical positioning of key hydrophobic and acidic residues relative to NSP3. Because paxillin is one of the key scaffold molecules in FAs, we propose that the interaction between the p130Cas CCHD and the LD1 motif of paxillin plays an important role in p130Cas FA targeting.	[Zhang, Chi; Zheng, Jie J.] UCLA, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA; [Zhang, Chi; Miller, Darcie J.; Guibao, Cristina D.; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhang, Chi; Zheng, Jie J.] Univ Tennessee, Dept Mol Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Donato, Dominique M.; Hanks, Steven K.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Donato, Dominique M.] Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, NL-2300 RE Leiden, Netherlands; [Zheng, Jie J.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Los Angeles	Zheng, JJ (corresponding author), UCLA, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.	jzheng@jsei.ucla.edu		Zheng, Jie/0000-0001-6524-6800	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100909] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. We thank Dr. Weixing Zhang and Dr. Christy R. R. Grace for assistance with NMR experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Janostiak R, 2014, CELL MOL LIFE SCI, V71, P727, DOI 10.1007/s00018-013-1450-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vanarotti MS, 2014, J MOL BIOL, V426, P3985, DOI 10.1016/j.jmb.2014.08.014; Wang CY, 2001, J BIOMOL NMR, V21, P361, DOI 10.1023/A:1013328206498; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200	23	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18281	18289		10.1074/jbc.M117.807271	http://dx.doi.org/10.1074/jbc.M117.807271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28860193	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000414458200025
J	Campanello, GC; Lofgren, M; Yokom, AL; Southworth, DR; Banerjee, R				Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma			Switch I-dependent allosteric signaling in a G-protein chaperone-B-12 enzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; RADICAL B-12 ENZYME; COENZYME B-12; VITAMIN-B-12 METABOLISM; COMPLEMENTATION GROUP; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GTP HYDROLYSIS; RAS PROTEIN; MMAA GENE	G-proteins regulate various processes ranging from DNA replication and protein synthesis to cytoskeletal dynamics and cofactor assimilation and serve as models for uncovering strategies deployed for allosteric signal transduction. MeaB is a multifunctional G-protein chaperone, which gates loading of the active 5 '-deoxyadenosylcobalamin cofactor onto methylmalonyl-CoA mutase (MCM) and precludes loading of inactive cofactor forms. MeaB also safeguards MCM, which uses radical chemistry, against inactivation and rescues MCM inactivated during catalytic turnover by using the GTP-binding energy to offload inactive cofactor. The conserved switch I and II signaling motifs used by G-proteins are predicted to mediate allosteric regulation in response to nucleotide binding and hydrolysis in MeaB. Herein, we targeted conserved residues in the MeaB switch I motif to interrogate the function of this loop. Unexpectedly, the switch I mutations had only modest effects on GTP binding and on GTPase activity and did not perturb stability of the MCM-MeaB complex. However, these mutations disrupted multiple MeaB chaperone functions, including cofactor editing, loading, and offloading. Hence, although residues in the switch I motif are not essential for catalysis, they are important for allosteric regulation. Furthermore, single-particle EM analysis revealed, for the first time, the overall architecture of the MCM MeaB complex, which exhibits a 2:1 stoichiometry. These EM studies also demonstrate that the complex exhibits considerable conformational flexibility. In conclusion, the switch I element does not significantly stabilize the MCM-MeaB complex or influence the affinity of MeaB for GTP but is required for transducing signals between MeaB and MCM.	[Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Med Ctr, Life Sci Inst, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.] Univ Michigan, Med Ctr, Life Sci Inst, Grad Program Chem Biol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, 5 F32 GM113405, GM110001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110001, F32GM113405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK45776 (to to R. B.), 5 F32 GM113405 (to G. C. C.), and GM110001 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jost M, 2015, J BIOL CHEM, V290, P26882, DOI 10.1074/jbc.M115.676890; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2006, MOL GENET METAB, V87, P219, DOI 10.1016/j.ymgme.2005.11.011; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; Li Z, 2017, J BIOL CHEM, V292, P3977, DOI 10.1074/jbc.M117.775957; Lofgren M, 2013, J BIOL CHEM, V288, P30980, DOI 10.1074/jbc.M113.499970; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tanpaiboon P, 2005, MOL GENET METAB, V85, P2; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zhang J, 2006, MOL GENET METAB, V87, P315, DOI 10.1016/j.ymgme.2005.12.003	42	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17617	17625		10.1074/jbc.M117.786095	http://dx.doi.org/10.1074/jbc.M117.786095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882898	Green Published, hybrid			2022-12-28	WOS:000414013000005
J	Goedegebuur, F; Dankmeyer, L; Gualfetti, P; Karkehabadi, S; Hansson, H; Jana, S; Huynh, V; Kelemen, BR; Kruithof, P; Larenas, EA; Teunissen, PJM; Stahlberg, J; Payne, CM; Mitchinson, C; Sandgren, M				Goedegebuur, Frits; Dankmeyer, Lydia; Gualfetti, Peter; Karkehabadi, Saeid; Hansson, Henrik; Jana, Suvamay; Huynh, Vicky; Kelemen, Bradley R.; Kruithof, Paulien; Larenas, Edmund A.; Teunissen, Pauline J. M.; Stahlberg, Jerry; Payne, Christina M.; Mitchinson, Colin; Sandgren, Mats			Improving the thermal stability of cellobiohydrolase Cel7A from Hypocrea jecorina by directed evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; AROMATIC-CARBOHYDRATE INTERACTIONS; STRUCTURE-GUIDED RECOMBINATION; ELECTRON-DENSITY MAPS; MOLECULAR-DYNAMICS; PHANEROCHAETE-CHRYSOSPORIUM; MACROMOLECULAR STRUCTURES; SACCHAROMYCES-CEREVISIAE; GLYCOSIDE HYDROLASES; CRYSTAL-STRUCTURES	Secreted mixtures of Hypocrea jecorina cellulases are able to efficiently degrade cellulosic biomass to fermentable sugars at large, commercially relevant scales. H. jecorina Cel7A, cellobiohydrolase I, from glycoside hydrolase family 7, is the workhorse enzyme of the process. However, the thermal stability of Cel7A limits its use to processes where temperatures are no higher than 50 degrees C. Enhanced thermal stability is desirable to enable the use of higher processing temperatures and to improve the economic feasibility of industrial biomass conversion. Here, we enhanced the thermal stability of Cel7A through directed evolution. Sites with increased thermal stability properties were combined, and a Cel7A variant (FCA398) was obtained, which exhibited a 10.4 degrees C increase in T-m and a 44-fold greater half-life compared with the wild-type enzyme. This Cel7A variant contains 18 mutated sites and is active under application conditions up to at least 75 degrees C. The X-ray crystal structure of the catalytic domain was determined at 2.1 angstrom resolution and showed that the effects of the mutations are local and do not introduce major backbone conformational changes. Molecular dynamics simulations revealed that the catalytic domain of wild-type Cel7A and the FCA398 variant exhibit similar behavior at 300 K, whereas at elevated temperature (475 and 525 K), the FCA398 variant fluctuates less and maintains more native contacts over time. Combining the structural and dynamic investigations, rationales were developed for the stabilizing effect at many of the mutated sites.	[Goedegebuur, Frits; Dankmeyer, Lydia; Kruithof, Paulien] DuPont Ind Biosci, Archimedesweg 30, NL-2333 CN Leiden, Netherlands; [Gualfetti, Peter; Huynh, Vicky; Kelemen, Bradley R.; Larenas, Edmund A.; Mitchinson, Colin] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Karkehabadi, Saeid; Hansson, Henrik; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden; [Jana, Suvamay; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA	Swedish University of Agricultural Sciences; University of Kentucky	Goedegebuur, F (corresponding author), DuPont Ind Biosci, Archimedesweg 30, NL-2333 CN Leiden, Netherlands.; Stahlberg, J; Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden.; Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	frits.goedegebuur@dupont.com; jerry.stahlberg@slu.se; christy.payne@uky.edu; mats.sandgren@slu.se	Payne, Christina/ABE-8330-2020; Stahlberg, Jerry/D-4163-2013	Payne, Christina/0000-0001-5264-0964; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534; Stahlberg, Jerry/0000-0003-4059-8580	NSF [ACI-1053575, MCB090159]	NSF(National Science Foundation (NSF))	Computing resources were provided by the University of Kentucky and National Science Foundation (NSF) Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by NSF Grant ACI-1053575 (under allocation MCB090159). We thank Dr. Nils Mikkelsen (Swedish University of Agricultural Sciences) for help with X-ray data collection.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; BELL JA, 1992, BIOCHEMISTRY-US, V31, P3590, DOI 10.1021/bi00129a006; Benko Z, 2007, APPL BIOCHEM BIOTECH, V137, P195, DOI 10.1007/s12010-007-9051-5; BERKA RM, 1989, BIOTECHNOL ADV, V7, P127, DOI 10.1016/0734-9750(89)90356-X; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cao QN, 2000, PROTEIN SCI, V9, P991; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Chundawat SPS, 2011, J PROTEOME RES, V10, P4365, DOI 10.1021/pr101234z; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dana CM, 2014, BIOTECHNOL BIOENG, V111, P842, DOI 10.1002/bit.25178; Dana CM, 2012, BIOTECHNOL BIOENG, V109, P2710, DOI 10.1002/bit.24708; Day A., 2014, US Patent, Patent No. [8,637,294B2, 8637294]; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Godbole S, 1999, BIOTECHNOL PROGR, V15, P828, DOI 10.1021/bp9901116; Goedegebuur F, 2002, CURR GENET, V41, P89, DOI 10.1007/s00294-002-0290-2; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.0.CO;2-M; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; Heinzelman P, 2010, PROTEIN ENG DES SEL, V23, P871, DOI 10.1093/protein/gzq063; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hobdey SE, 2016, APPL ENVIRON MICROB, V82, P3395, DOI 10.1128/AEM.00163-16; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang XQ, 2006, BIOPHYS J, V91, P2451, DOI 10.1529/biophysj.106.082891; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Jacobson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070562; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanaya S., 2000, BIOTECHNOLOGY SUSTAI, V14, P186; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim P, 2001, BIOTECHNOL APPL BIOC, V34, P99, DOI 10.1042/BA20010025; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Laymon RA, 1996, APPL BIOCHEM BIOTECH, V57-8, P389, DOI 10.1007/BF02941718; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPherson A, 1982, PREPARATION ANAL PRO; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; MITCHINSON C, 1986, Proteins Structure Function and Genetics, V1, P23, DOI 10.1002/prot.340010106; Momeni MH, 2014, ACTA CRYSTALLOGR D, V70, P2356, DOI 10.1107/S1399004714013844; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Munoz IG, 2003, ACTA CRYSTALLOGR D, V59, P637, DOI 10.1107/S0907444903001938; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okada H, 1998, APPL ENVIRON MICROB, V64, P555; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PENTTILA ME, 1988, GENE, V63, P103, DOI 10.1016/0378-1119(88)90549-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Rignall TR, 2002, APPL BIOCHEM BIOTECH, V98, P383, DOI 10.1385/ABAB:98-100:1-9:383; Sakaue R, 2003, APPL ENVIRON MICROB, V69, P139, DOI 10.1128/AEM.69.1.139-145.2002; SALOHEIMO A, 1994, MOL MICROBIOL, V13, P219, DOI 10.1111/j.1365-2958.1994.tb00417.x; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sammond DW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145848; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Sham YY, 2002, PROTEINS, V46, P308, DOI 10.1002/prot.10040; Sheinerman FB, 1998, J MOL BIOL, V278, P439, DOI 10.1006/jmbi.1998.1688; Smith MA, 2013, ACS SYNTH BIOL, V2, P690, DOI 10.1021/sb400010m; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; SUOMINEN PL, 1993, MOL GEN GENET, V241, P523, DOI 10.1007/BF00279894; Takashima S, 1999, J BIOTECHNOL, V67, P85, DOI 10.1016/S0168-1656(98)00168-0; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; VANDENBURG B, 1993, PROTEIN ENG, V6, P521, DOI 10.1093/protein/6.5.521; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9; WALSETH CS, 1952, TAPPI, V35, P233; Ward M., 1993, P 2 TRIC S TRICH CEL, V8, P153; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353	102	33	35	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17418	17430		10.1074/jbc.M117.803270	http://dx.doi.org/10.1074/jbc.M117.803270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860192	Green Published, hybrid			2022-12-28	WOS:000414009300023
J	Ishikawa, Y; Holden, P; Bachinger, HP				Ishikawa, Yoshihiro; Holden, Paul; Bachinger, Hans Peter			Heat shock protein 47 and 65-kDa FK506-binding protein weakly but synergistically interact during collagen folding in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; PROLYL 3-HYDROXYLASE 1; OSTEOGENESIS IMPERFECTA; MOLECULAR CHAPERONE; LYSYL HYDROXYLATION; BINDING-PROTEIN; CROSS-LINKING; IV COLLAGEN; IN-VITRO; FKBP65	Collagen is the most abundant protein in the extracellular matrix in humans and is critical to the integrity and function of many musculoskeletal tissues. A molecular ensemble comprising more than 20 molecules is involved in collagen biosynthesis in the rough endoplasmic reticulum. Two proteins, heat shock protein 47 (Hsp47/SERPINH1) and 65-kDa FK506-binding protein (FKBP65/FKBP10), have been shown to play important roles in this ensemble. In humans, autosomal recessive mutations in both genes cause similar osteogenesis imperfecta phenotypes. Whereas it has been proposed that Hsp47 and FKBP65 interact in the rough endoplasmic reticulum, there is neither clear evidence for this interaction nor any data regarding their binding affinities for each other. In this study using purified endogenous proteins, we examined the interaction between Hsp47, FKBP65, and collagen and also determined their binding affinities and functions in vitro. Hsp47 and FKBP65 show a direct but weak interaction, and FKBP65 prefers to interact with Hsp47 rather than type I collagen. Our results suggest that a weak interaction between Hsp47 and FKBP65 confers mutual molecular stability and also allows for a synergistic effect during collagen folding. We also propose that Hsp47 likely acts as a hub molecule during collagen folding and secretion by directing other molecules to reach their target sites on collagens. Our findings may explain why osteogenesis imperfecta-causing mutations in both genes result in similar phenotypes.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital for Children [85100, 85500]	Shriners Hospital for Children	This work was supported by Shriners Hospital for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Barnes AM, 2013, HUM MUTAT, V34, P1279, DOI 10.1002/humu.22362; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Bella J, 2017, SUBCELL BIOCHEM, V82, P457, DOI 10.1007/978-3-319-49674-0_14; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; BOYER B, 1991, EXP GERONTOL, V26, P375, DOI 10.1016/0531-5565(91)90049-R; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Chen YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46021; Chernorudskiy AL, 2017, J MOL BIOL, V429, P620, DOI 10.1016/j.jmb.2017.01.017; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P917, DOI 10.1139/O10-137; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Duran I, 2017, J BONE MINER RES, V32, P1309, DOI 10.1002/jbmr.3095; Duran I, 2015, HUM MOL GENET, V24, P1918, DOI 10.1093/hmg/ddu608; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Feru J, 2016, EUR J DERMATOL, V26, P350, DOI 10.1684/ejd.2016.2782; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Gjaltema RAF, 2016, P NATL ACAD SCI USA, V113, P7142, DOI 10.1073/pnas.1600074113; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2017, J BIOL CHEM, V292, P9273, DOI 10.1074/jbc.M116.772657; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Islam M, 2013, J BIOL CHEM, V288, P35526, DOI 10.1074/jbc.M113.504530; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; Kersteen EA, 2004, PROTEIN EXPRES PURIF, V38, P279, DOI 10.1016/j.pep.2004.09.008; Knuppel L, 2017, AM J RESP CELL MOL, V57, P77, DOI 10.1165/rcmb.2016-0217OC; Koski MK, 2017, BIOCHEM J, V474, P751, DOI 10.1042/BCJ20161000; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Liu PF, 2009, ANAL BIOCHEM, V389, P165, DOI 10.1016/j.ab.2009.03.028; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Miao M, 2013, BIOCHEMISTRY-US, V52, P7731, DOI 10.1021/bi400760f; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murphy LA, 2011, CELL STRESS CHAPERON, V16, P607, DOI 10.1007/s12192-011-0270-x; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Patterson CE, 2005, CELL STRESS CHAPERON, V10, P285, DOI 10.1379/CSC-118R.1; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Takagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036809; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	64	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17216	17224		10.1074/jbc.M117.802298	http://dx.doi.org/10.1074/jbc.M117.802298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860186	Green Published, hybrid			2022-12-28	WOS:000414009300006
J	Lemonidis, K; MacLeod, R; Baillie, GS; Chamberlain, LH				Lemonidis, Kimon; MacLeod, Ruth; Baillie, George S.; Chamberlain, Luke H.			Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zDHHC17 S-acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; PALMITOYL ACYLTRANSFERASE; SUBSTRATE RECOGNITION; STRUCTURAL BASIS; HUNTINGTONS-DISEASE; MEMBRANE SUPPORTS; HIP14; DIFFERENTIATION; CELLS; MICE	zDHHC S-acyltransferases are enzymes catalyzing protein S-acylation, a common post-translational modification on proteins frequently affecting their membrane targeting and trafficking. The ankyrin repeat (AR) domain of zDHHC17 (HIP14) and zDHHC13 (HIP14L) S-acyltransferases, which is involved in both substrate recruitment and S-acylation-independent functions, was recently shown to bind at least six proteins, by specific recognition of a consensus sequence in them. To further refine the rules governing binding to the AR of zDHHC17, we employed peptide arrays based onz DHHCAR-binding motif(zDABM) sequences of synaptosom-al-associated protein 25 (SNAP25) and cysteine string protein alpha (CSP alpha). Quantitative comparisons of the binding preferences of 400 peptides allowed us to construct a position-specific scoring matrix(PSSM) for zDHHC17 AR binding, with which we predicted and subsequently validated many putative zDHHC17 interactors. We identified 95 human zDABM sequences with unexpected versatility in amino acid usage; these sequences were distributed among 90 proteins, of which 62 have not been previously implicated in zDHHC17/13 binding. These zDABM-containing proteins included all family members of the SNAP25, sprouty, cornifelin, ankyrin, and SLAIN-motif containing families; seven endogenous Gag polyproteins sharing the same binding sequence; and several proteins involved in cytoskeletal organization, cell communication, and regulation of signaling. A dozen of the zDABM-containing proteins had more than one zDABM sequence, whereas isoform-specific binding to the AR of zDHHC17 was identified for the Ena/VASP-like protein. The large number of zDABM sequences within the human proteome suggests that zDHHC17 may be an interaction hub regulating many cellular processes.	[Lemonidis, Kimon; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [MacLeod, Ruth; Baillie, George S.] Univ Glasgow, Inst Cardiovasc & Med Sci, Wolfson Link Bldg, Glasgow G12 8QQ, Lanark, Scotland	University of Strathclyde; University of Glasgow	Lemonidis, K; Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	kimon.lemonidis@strath.ac.uk; luke.chamberlain@strath.ac.uk		Baillie, George/0000-0003-2469-6316; Lemonidis, Kimon/0000-0003-1332-6002	Biotechnology and Biological Sciences Research Council [BB/L022087/1, BB/J006432/1]; BBSRC [BB/L022087/1, BB/J006432/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/L022087/1 and BB/J006432/1 (to L.H.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett V, 2016, CURR TOP MEMBR, V77, P143, DOI 10.1016/bs.ctm.2015.10.001; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Butland SL, 2014, HUM MOL GENET, V23, P4142, DOI 10.1093/hmg/ddu137; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Harripaul R, 2018, MOL PSYCHIATR, V23, P973, DOI 10.1038/mp.2017.60; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Jimenez-Preitner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048767; Jimenez-Preitner M, 2011, CELL METAB, V14, P658, DOI 10.1016/j.cmet.2011.08.008; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Koldehoff M, 2008, INT J HEMATOL, V87, P39, DOI 10.1007/s12185-007-0013-z; Kramer A, 1998, METH MOL B, V87, P25; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Lemonidis K, 2015, J BIOL CHEM, V290, P21939, DOI 10.1074/jbc.M115.657668; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Liu KM, 2015, J INVEST DERMATOL, V135, P2603, DOI 10.1038/jid.2015.240; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Michibata H, 2004, BIOCHEM BIOPH RES CO, V318, P803, DOI 10.1016/j.bbrc.2004.04.109; Milde S, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582338; Milnerwood AJ, 2013, P NATL ACAD SCI USA, V110, P20296, DOI 10.1073/pnas.1222384110; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Montersino A, 2015, MOL MEMBR BIOL, V32, P179, DOI 10.1080/09687688.2016.1182652; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sanders SS, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0333-7; Shi W, 2015, MOL CELL NEUROSCI, V68, P194, DOI 10.1016/j.mcn.2015.07.005; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Skotte NH, 2017, CELL DEATH DIFFER, V24, P433, DOI 10.1038/cdd.2016.139; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trela M, 2016, APMIS, V124, P88, DOI 10.1111/apm.12487; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; van der Vaart B, 2012, J NEUROSCI, V32, P14722, DOI 10.1523/JNEUROSCI.1240-12.2012; Verardi R, 2017, STRUCTURE, V25, P1337, DOI 10.1016/j.str.2017.06.018; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Wang CY, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862798; Wanner SJ, 2005, GENE EXPR PATTERNS, V5, P423, DOI 10.1016/j.modgep.2004.09.004; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Yang G, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003727; Yang G, 2011, J NEUROSCI, V31, P11980, DOI 10.1523/JNEUROSCI.2510-11.2011; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zhang MZM, 2017, BIOCHEM SOC T, V45, P275, DOI 10.1042/BST20160236	55	18	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17190	17202		10.1074/jbc.M117.799650	http://dx.doi.org/10.1074/jbc.M117.799650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882895	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000414009300004
J	Gomes, F; Palma, FR; Barros, MH; Tsuchida, ET; Turano, HG; Alegria, TGP; Demasi, M; Netto, LES				Gomes, Fernando; Palma, Flavio Romero; Barros, Mario H.; Tsuchida, Eduardo T.; Turano, Helena G.; Alegria, Thiago G. P.; Demasi, Marilene; Netto, Luis E. S.			Proteolytic cleavage by the inner membrane peptidase (IMP) complex or Oct1 peptidase controls the localization of the yeast peroxiredoxin Prx1 to distinct mitochondrial compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; mitochondria; oxidative stress; peroxiredoxin; protein import; protein sorting; yeast; inner membrane peptidase complex; IMP complex; mitochondrial processing peptidase (MPP); octapeptidylpeptidase 1; Oct1	COLI SHUTTLE VECTORS; INTERMEMBRANE SPACE; INTERMEDIATE PEPTIDASE; 1-CYS PEROXIREDOXIN; THIOREDOXIN SYSTEM; IRON ACCUMULATION; THIOL PEROXIDASE; PROTEIN IMPORT; GENE; GLUTATHIONE	Yeast Prx1 is a mitochondrial 1-Cys peroxiredoxin that catalyzes the reduction of endogenously generated H2O2. Prx1 is synthesized on cytosolic ribosomes as a preprotein with a cleavable N-terminal presequence that is the mitochondrial targeting signal, but the mechanisms underlying Prx1 distribution to distinct mitochondrial subcompartments are unknown. Here, we provide direct evidence of the following dual mitochondrial localization of Prx1: a soluble form in the intermembrane space and a form in the matrix weakly associated with the inner mitochondrial membrane. We show that Prx1 sorting into the intermembrane space likely involves the release of the protein precursor within the lipid bilayer of the inner membrane, followed by cleavage by the inner membrane peptidase. We also found that during its import into the matrix compartment, Prx1 is sequentially cleaved by mitochondrial processing peptidase and then by octapeptidyl aminopeptidase 1 (Oct1). Oct1 cleaved eight amino acid residues from the N-terminal region of Prx1 inside the matrix, without interfering with its peroxidase activity in vitro. Remarkably, the processing of peroxiredoxin (Prx) proteins by Oct1 appears to be an evolutionarily conserved process because yeast Oct1 could cleave the human mitochondrial peroxiredoxin Prx3 when expressed in Saccharomyces cerevisiae. Altogether, the processing of peroxiredoxins by Imp2 or Oct1 likely represents systems that control the localization of Prxs into distinct compartments and thereby contribute to various mitochondrial redox processes.	[Gomes, Fernando; Palma, Flavio Romero; Tsuchida, Eduardo T.; Alegria, Thiago G. P.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508090 Sao Paulo, Brazil; [Barros, Mario H.; Turano, Helena G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; [Demasi, Marilene] Inst Butantan, Lab Bioquim & Biofis, BR-05503001 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Gomes, F; Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508090 Sao Paulo, Brazil.	fernandopgdna@hotmail.com; nettoles@ib.usp.br	Gomes, Fernando/H-2094-2017; Demasi, Marilene/E-5873-2012; Barros, Mario H/B-8118-2012; Netto, Luis/A-3783-2008; Turano, Helena/H-3887-2017; Barros, Mario/Q-6358-2019	Gomes, Fernando/0000-0003-4642-9729; Netto, Luis/0000-0002-4250-9177; Turano, Helena/0000-0001-5738-5325; Barros, Mario/0000-0003-2977-9815; Tassoni Tsuchida, Eduardo/0000-0001-8062-6027; Palma, Flavio/0000-0003-4350-2708; Demasi, Marilene/0000-0002-3749-1160; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/07937-8]; FAPESP [2008/07971-3, 2012/21722-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 13/07937-8 (Redox Processes in Biomedicine) (to L. E. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of FAPESP Fellowship 2008/07971-3. To whom correspondence may be addressed. E-mail: fernandopgdna@hotmail.com.; Recipient of FAPESP Fellowship 2012/21722-1.	Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bertelsen B, 2014, EUR J HUM GENET, V22, P1283, DOI 10.1038/ejhg.2014.24; Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6; Bomer U, 1997, J BIOL CHEM, V272, P30439, DOI 10.1074/jbc.272.48.30439; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Durigon R, 2012, EMBO REP, V13, P916, DOI 10.1038/embor.2012.116; Fisher AB, 2017, ARCH BIOCHEM BIOPHYS, V617, P68, DOI 10.1016/j.abb.2016.12.003; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Greetham D, 2009, MOL CELL BIOL, V29, P3229, DOI 10.1128/MCB.01918-08; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Haucke V, 1997, MOL CELL BIOL, V17, P4024, DOI 10.1128/MCB.17.7.4024; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; ISAYA G, 1994, MOL CELL BIOL, V14, P5603, DOI 10.1128/MCB.14.8.5603; Jacome ASV, 2015, PROTEOMICS, V15, P2519, DOI 10.1002/pmic.201400617; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Kil IS, 2015, MOL CELL, V59, P651, DOI 10.1016/j.molcel.2015.06.031; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kritsiligkou P, 2017, CELL REP, V18, P2729, DOI 10.1016/j.celrep.2017.02.053; Kruger N J, 1994, Methods Mol Biol, V32, P9; Luo WT, 2006, MOL GENET GENOMICS, V275, P431, DOI 10.1007/s00438-006-0099-7; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Moda BS, 2016, CURR GENET, V62, P607, DOI 10.1007/s00294-016-0566-6; Monteiro G, 2004, ARCH BIOCHEM BIOPHYS, V425, P14, DOI 10.1016/j.abb.2004.03.005; Monteiro G, 2002, FREE RADICAL BIO MED, V32, P278, DOI 10.1016/S0891-5849(01)00801-2; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Patel C, 2011, EUR J HUM GENET, V19, P634, DOI 10.1038/ejhg.2010.238; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; Penefsky H. S., 1971, METHOD ENZYMOL, V22, P204; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Poveda-Huertes D, 2017, CELL TISSUE RES, V367, P73, DOI 10.1007/s00441-016-2492-9; Pedrajas JR, 2016, ANTIOXID REDOX SIGN, V24, P115, DOI 10.1089/ars.2015.6366; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; REPETTO B, 1990, MOL CELL BIOL, V10, P4221, DOI 10.1128/MCB.10.8.4221; Rhee SG, 2016, FREE RADICAL BIO MED, V100, P73, DOI 10.1016/j.freeradbiomed.2016.10.011; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Teixeira PF, 2013, BBA-MOL CELL RES, V1833, P360, DOI 10.1016/j.bbamcr.2012.03.012; Toledano MB, 2013, ANTIOXID REDOX SIGN, V18, P1699, DOI 10.1089/ars.2012.5033; Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352	71	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17011	17024		10.1074/jbc.M117.788588	http://dx.doi.org/10.1074/jbc.M117.788588			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28821623	Green Published, hybrid			2022-12-28	WOS:000413140600021
J	Lopez-Jimenez, AJ; Basak, T; Vanacore, RM				Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.			Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; collagen; enzyme processing; extracellular matrix; lysyl oxidase; posttranslational modification (PTM); protein crosslinking; LOXL2; proteolytic processing	IDIOPATHIC PULMONARY-FIBROSIS; PEPTIDE IDENTIFICATION; AMINE OXIDASE; PROTEIN; EXPRESSION; FAMILY; ENZYME; DISEASE; LOXL2; FORMS	Lysyl oxidase-like-2 (LOXL2) is an enzyme secreted into the extracellular matrix that crosslinks collagens by mediating oxidative deamination of lysine residues. Our previous work demonstrated that this enzyme crosslinks the 7S domain, a structural domain that stabilizes collagen IV scaffolds in the basement membrane. Despite its relevant role in extracellular matrix biosynthesis, little is known about the structural requirements of LOXL2 that enable collagen IV crosslinking. In this study, we demonstrate that LOXL2 is processed extracellularly by serine proteases, generating a 65-kDa form lacking the first two scavenger receptor cysteine-rich domains. Site-specific mutagenesis to prevent proteolytic processing generated a full-length enzyme that is active in vitro toward a soluble substrate, but fails to crosslink insoluble collagen IV within the extracellular matrix. In contrast, the processed form of LOXL2 binds to collagen IV and crosslinks the 7S domain. Together, our data demonstrate that proteolytic processing is an important event that allows LOXL2-mediated crosslinking of basement membrane collagen IV.	[Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.] Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Vanacore, RM (corresponding author), 1161 21st Ave South,B-3113 Med Ctr North, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Lopez, Alberto/GWC-5652-2022; Basak, Trayambak/AAB-8534-2020; Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X; Basak, Trayambak/0000-0001-7683-3189	National Institutes of Health [R01 DK099467]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK099467. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiri G, 2003, CANCER RES, V63, P1657; Anazco C, 2016, J BIOL CHEM, V291, P25999, DOI 10.1074/jbc.M116.738856; Aumiller V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00270-0; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barre O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105984; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Breyer MD, 2016, NAT REV DRUG DISCOV, V15, P568, DOI 10.1038/nrd.2016.67; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Chien JW, 2014, EUR RESPIR J, V43, P1430, DOI 10.1183/09031936.00141013; Colon S, 2016, J BIOL CHEM, V291, P24009, DOI 10.1074/jbc.M116.745935; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; DENAULT JB, 1995, J CARDIOVASC PHARM, V26, pS47; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Ferguson TEG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159868; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hutchinson JH, 2017, ACS MED CHEM LETT, V8, P423, DOI 10.1021/acsmedchemlett.7b00014; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Kagan HM, 2011, BIOL EXTRACELL MATR, P303, DOI 10.1007/978-3-642-16555-9_9; KAGAN HM, 1994, PATHOL RES PRACT, V190, P910; Kim MS, 2003, J BIOL CHEM, V278, P52071, DOI 10.1074/jbc.M308856200; Kim YM, 2011, MOL BIOL REP, V38, P145, DOI 10.1007/s11033-010-0088-0; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Ma L, 2017, MOL CELL, V65, P296, DOI 10.1016/j.molcel.2016.12.002; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Raghu G, 2017, LANCET RESP MED, V5, P22, DOI 10.1016/S2213-2600(16)30421-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	52	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16970	16982		10.1074/jbc.M117.798603	http://dx.doi.org/10.1074/jbc.M117.798603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28864775	Green Published, hybrid			2022-12-28	WOS:000413140600018
J	Ma, XY; Zhang, HB; Xue, X; Shah, YM				Ma, Xiaoya; Zhang, Huabing; Xue, Xiang; Shah, Yatrik M.			Hypoxia-inducible factor 2 alpha (HIF-2 alpha) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colon cancer; Hippo pathway; hypoxia; hypoxia-inducible factor (HIF); yes-associated protein (YAP)	CELL-PROLIFERATION; HIPPO PATHWAY; SIGNALING PATHWAY; FACTOR-I; TAZ; INDUCTION; HIF-1-ALPHA; ACTIVATION; COLITIS; COMPLEX	Colorectal cancer (CRC) is the third-leading cause of cancer mortality in the United States and other industrialized countries. A hypoxic microenvironment is a hallmark for solid tumors. The hypoxia-induced signal transduction is transcriptionally mediated by hypoxia-inducible factor (HIF). Three major HIF isoforms, HIF-1, HIF-2, and HIF-3, are present in the intestine. Our previous work demonstrates that HIF-2 is essential for CRC growth and progression. However, the mechanisms mediating cell proliferation after hypoxia or HIF-2 activation in CRC are unclear. Data mining of RNA-Seq experiments with mouse models of intestinal HIF-2 or Yes-associated protein 1 (YAP1) overexpression indicates a significant overlap of genes in these conditions. YAP1 is a transcriptional co-activator in the Hippo signaling pathway, and YAP1-induced transcriptional responses are essential in cancer cell proliferation. Here, we report that HIF-2 robustly increases YAP1 expression and activity in CRC-derived cell lines and in mouse models. The potentiation of YAP1 activity by HIF-2 was not via canonical signaling mechanisms such as Src (non-receptor tyrosine kinase), PI3K, ERK, or MAPK pathways. Moreover, we detected no direct interaction of HIF-2 with YAP1. Of note, YAP1 activation was critical for cancer cell growth under hypoxia. Our findings indicate that HIF-2 increases cancer cell growth by up-regulating YAP1 activity, suggesting that this pathway might be targeted in potential anti-cancer approaches for treating CRC patients.	[Ma, Xiaoya; Zhang, Huabing; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shah, YM (corresponding author), 1137 Catherine St MSII R7703, Ann Arbor, MI 48109 USA.	shahy@umich.edu	Xue, Xiang/P-9071-2014	Xue, Xiang/0000-0003-4704-1814	National Institutes of Health [CA148828, DK095201]; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA148828 and DK095201 (to Y. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cai J, 2015, GENE DEV, V29, P1493, DOI 10.1101/gad.264515.115; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chen LF, 2012, PROTEIN CELL, V3, P305, DOI 10.1007/s13238-012-2913-9; Dai XY, 2016, ONCOTARGET, V7, P6933, DOI 10.18632/oncotarget.6903; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng JT, 2016, ONCOTARGETS THER, V9, P5371, DOI 10.2147/OTT.S109979; Feng Y, 2013, AM J PATHOL, V183, P493, DOI 10.1016/j.ajpath.2013.04.013; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Imada S, 2016, MOL CELL BIOL, V36, P2811, DOI 10.1128/MCB.00311-16; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim HB, 2017, GASTROENTEROLOGY, V152, P616, DOI 10.1053/j.gastro.2016.11.005; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Liao T, 2017, ONCOTARGET, V8, P11719, DOI 10.18632/oncotarget.14319; Ma XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179889; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Sostres Carlos, 2014, World J Gastrointest Pharmacol Ther, V5, P40, DOI 10.4292/wjgpt.v5.i1.40; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xiang LS, 2015, ONCOTARGET, V6, P11768, DOI 10.18632/oncotarget.4190; Xie LW, 2014, MOL CELL BIOL, V34, P3013, DOI 10.1128/MCB.00324-14; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Xue X, 2014, AM J PHYSIOL-GASTR L, V307, pG187, DOI 10.1152/ajpgi.00112.2014; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489	61	35	37	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17046	17056		10.1074/jbc.M117.805655	http://dx.doi.org/10.1074/jbc.M117.805655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848049	Green Published, hybrid			2022-12-28	WOS:000413140600024
J	Cho, IT; Adelmant, G; Lim, Y; Marto, JA; Cho, G; Golden, JA				Cho, Il-Taeg; Adelmant, Guillaume; Lim, Youngshin; Marto, Jarrod A.; Cho, Ginam; Golden, Jeffrey A.			Ascorbate peroxidase proximity labeling coupled with biochemical fractionation identifies promoters of endoplasmic reticulum-mitochondrial contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NEURODEGENERATIVE DISEASES; ORGANELLE COMMUNICATION; PLASMA-MEMBRANE; VAPB INTERACTS; CROSS-TALK; ER STRESS; SITES; PROTEIN; PROTEOMICS	To maintain cellular homeostasis, subcellular organelles communicate with each other and form physical and functional networks through membrane contact sites coupled by protein tethers. In particular, endoplasmic reticulum (ER)-mitochondrial contacts (EMC) regulate diverse cellular activities such as metabolite exchange (Ca2+ and lipids), intracellular signaling, apoptosis, and autophagy. The significance of EMCs has been highlighted by reports indicating that EMC dysregulation is linked to neurodegenerative diseases. Therefore, obtaining a better understanding of the physical and functional components of EMCs should provide new insights into the pathogenesis of several neurodegenerative diseases. Here, we applied engineered ascorbate peroxidase (APEX) to map the proteome at EMCs in live HEK293 cells. APEX was targeted to the outer mitochondrial membrane, and proximity-labeled proteins were analyzed by stable isotope labeling with amino acids in culture (SILAC)-LC/MS-MS. We further refined the specificity of the proteins identified by combining biochemical subcellular fractionation to the protein isolation method. We identified 405 proteins with a 2.0-fold cutoff ratio (log base 2) in SILAC quantification from replicate experiments. We performed validation screening with a Split-Rluc8 complementation assay that identified reticulon 1A (RTN1A), an ER-shaping protein localized to EMCs as an EMC promoter. Proximity mapping augmented with biochemical fractionation and additional validation methods reported here could be useful to discover other components of EMCs, identify mitochondrial contacts with other organelles, and further unravel their communication.	[Cho, Il-Taeg; Lim, Youngshin; Marto, Jarrod A.; Cho, Ginam; Golden, Jeffrey A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Harvard Med Sch, Dana Farber Canc Inst, Blais Prote Ctr, Dept Canc Biol, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Harvard Med Sch, Dana Farber Canc Inst, Blais Prote Ctr, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Cho, G; Golden, JA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	gpcho@bwh.harvard.edu; jagolden@bwh.harvard.edu	Lim, Youngshin/HGV-0369-2022	Lim, Youngshin/0000-0002-7842-3244; Golden, Jeffrey/0000-0001-9933-5502	Cotran Endowment Fund	Cotran Endowment Fund	This work was supported by the Cotran Endowment Fund (to J. A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Askenazi M, 2009, NAT METHODS, V6, P240, DOI 10.1038/nmeth0409-240; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Bravo-Sagua R, 2014, INT J BIOCHEM CELL B, V50, P55, DOI 10.1016/j.biocel.2014.01.019; Cacciagli P, 2013, AM J HUM GENET, V93, P579, DOI 10.1016/j.ajhg.2013.07.023; Chen CL, 2015, P NATL ACAD SCI USA, V112, P12093, DOI 10.1073/pnas.1515623112; Chen XL, 2015, PROTEOMICS, V15, P3175, DOI 10.1002/pmic.201500108; Chiurchiu V, 2014, NEUROMOL MED, V16, P3, DOI 10.1007/s12017-013-8271-9; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Matteis MA, 2015, CURR OPIN CELL BIOL, V35, P43, DOI 10.1016/j.ceb.2015.04.001; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dolman NJ, 2005, J BIOL CHEM, V280, P15794, DOI 10.1074/jbc.M412694200; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Fan Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8841; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Hariri Hanaa, 2016, Commun Integr Biol, V9, pe1156278, DOI 10.1080/19420889.2016.1156278; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Hwang J, 2016, BIOCHEM J, V473, P2463, DOI 10.1042/BCJ20160106; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kornmann B, 2010, M S-MED SCI, V26, P145, DOI 10.1051/medsci/2010262145; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krols M, 2016, ACTA NEUROPATHOL, V131, P505, DOI 10.1007/s00401-015-1528-7; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488; Lismont C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00035; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Mayer G, 1997, J HISTOCHEM CYTOCHEM, V45, P1449, DOI 10.1177/002215549704501101; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Niu KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44809; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Parikh JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-364; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Ping HA, 2016, J CELL BIOL, V213, P513, DOI 10.1083/jcb.201511021; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Prachar J, 2003, GEN PHYSIOL BIOPHYS, V22, P525; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rodriguez-Arribas M., 2016, MOL NEUROBIOL; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011; Schrader M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00056; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Wanders RJA, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00083; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang SY, 2016, ELIFE, V5, DOI 10.7554/eLife.18605; Westermann B, 2015, CURR OPIN CELL BIOL, V35, P1, DOI 10.1016/j.ceb.2015.03.001; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108	79	49	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16382	16392		10.1074/jbc.M117.795286	http://dx.doi.org/10.1074/jbc.M117.795286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28760823	hybrid, Green Published			2022-12-28	WOS:000412109400036
J	Foreman, HCC; Armstrong, J; Santana, AL; Krug, LT; Reich, NC				Foreman, Hui-Chen Chang; Armstrong, Julie; Santana, Alexis L.; Krug, Laurie T.; Reich, Nancy C.			The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; LYTIC SWITCH PROTEIN; NF-KAPPA-B; CREB-BINDING PROTEIN; ACUTE-PHASE RESPONSE; READING FRAME 50; BARR-VIRUS EBV; DNA-BINDING; VIRAL REACTIVATION; IFN-GAMMA	Gammaherpesviruses (gamma HVs) have a dynamic strategy for lifelong persistence, involving productive infection, latency, and intermittent reactivation. In latency reservoirs, such as B lymphocytes, gamma HVs exist as viral episomes and express few viral genes. Although the ability of gamma HV to reactivate from latency and re-enter the lytic phase is challenging to investigate and control, it is known that the gamma HV replication and transcription activator (RTA) can promote lytic reactivation. In this study, we provide first evidence that RTA of murine gamma HV68 (MHV68) selectively binds and enhances the activity of tyrosine-phosphorylated host STAT3. STAT3 is a transcription factor classically activated by specific tyrosine 705 phosphorylation (pTyr(705)-STAT3) in response to cytokine stimulation. pTyr(705)-STAT3 forms a dimer that avidly binds a consensus target site in the promoters of regulated genes, and our results indicate that RTA cooperatively enhances the ability of pTyr(705)-STAT3 to induce expression of a STAT3-responsive reporter gene. As indicated by coimmunoprecipitation, in latently infected B cells that are stimulated to reactivate MHV68, RTA bound specifically to endogenous pTyr(705)-STAT3. An in vitro binding assay confirmed that RTA selectively recognizes pTyr(705)-STAT3 and indicated that the C-terminal transactivation domain of RTA was required for enhancing STAT3-directed gene expression. The cooperation of these transcription factors may influence both viral and host genes. During MHV68 de novo infection, pTyr(705)-STAT3 promoted the temporal expression of ORF59, a viral replication protein. Our results demonstrate that MHV68 RTA specifically recognizes and recruits activated pTyr(705)-STAT3 during the lytic phase of infection.	[Foreman, Hui-Chen Chang; Armstrong, Julie; Santana, Alexis L.; Krug, Laurie T.; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Santana, Alexis L.] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University	Krug, LT; Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	laurie.krug@stonybrook.edu; nancy.reich@stonybrook.edu	Foreman, Hui-Chen (Jane)/GMW-4448-2022; Krug, Laurie T/H-5315-2019	Foreman, Hui-Chen (Jane)/0000-0001-9640-9780; Krug, Laurie T/0000-0002-9648-522X	National Institutes of Health [RO1AI119079, RO1AI105114, R03AI094054, CA009176]; American Cancer Society [RSG-11-160-01-MPC]; Carol Baldwin Breast Cancer Research Award; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI094054, R01AI119079, R01AI105114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR064184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Carol Baldwin Breast Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants RO1AI119079 (to L. T. K.) and RO1AI105114 and R03AI094054 (to N. C. R.), American Cancer Society Research Scholar Grant RSG-11-160-01-MPC (to L. T. K.), National Institutes of Health Cancer Training Grant CA009176 (to A. L. S. and H.-C. C. F.), and Carol Baldwin Breast Cancer Research Award (to N. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bowser BS, 2006, VIROLOGY, V348, P309, DOI 10.1016/j.virol.2006.02.007; Bu W, 2007, J VIROL, V81, P5788, DOI 10.1128/JVI.00140-07; Canny SP, 2014, J VIROL, V88, P730, DOI 10.1128/JVI.02708-13; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Chen JG, 2009, VIROLOGY, V386, P290, DOI 10.1016/j.virol.2009.01.031; Chen MQ, 2016, ONCOTARGET, V7, P33363, DOI 10.18632/oncotarget.9221; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Collins CM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004831; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Cousins E, 2014, RECENT RESULTS CANC, V193, P227, DOI 10.1007/978-3-642-38965-8_13; Daigle D, 2010, J VIROL, V84, P993, DOI 10.1128/JVI.01745-09; Damania B, 2004, J VIROL, V78, P5491, DOI 10.1128/JVI.78.10.5491-5499.2004; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Dong XN, 2012, J VIROL, V86, P1930, DOI 10.1128/JVI.06127-11; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Guito J, 2015, VIRUSES-BASEL, V7, P72, DOI 10.3390/v7010072; Guito Jonathan, 2012, Front Microbiol, V3, P30, DOI 10.3389/fmicb.2012.00030; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HARDWICK JM, 1992, J VIROL, V66, P5500, DOI 10.1128/JVI.66.9.5500-5508.1992; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hill ER, 2013, J VIROL, V87, P11438, DOI 10.1128/JVI.01762-13; Ho Y, 2013, CANCER LETT, V330, P141, DOI 10.1016/j.canlet.2012.11.052; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; Hwang S, 2001, J VIROL, V75, P9509, DOI 10.1128/JVI.75.19.9509-9516.2001; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; King CA, 2015, J VIROL, V89, P11347, DOI 10.1128/JVI.02008-15; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Koganti S, 2014, P NATL ACAD SCI USA, V111, P4946, DOI 10.1073/pnas.1400683111; Kung CP, 2011, J VIROL, V85, P4399, DOI 10.1128/JVI.01703-10; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li XF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01052; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; MANET E, 1991, NUCLEIC ACIDS RES, V19, P2661, DOI 10.1093/nar/19.10.2661; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Muller M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004899; Muromoto R, 2009, BIOCHEM BIOPH RES CO, V378, P439, DOI 10.1016/j.bbrc.2008.11.053; O'Flaherty BM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004302; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Reddy SS, 2016, MBIO, V7, DOI 10.1128/mBio.00723-16; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; Rickabaugh TM, 2005, J VIROL, V79, P3217, DOI 10.1128/JVI.79.5.3217-3222.2005; Santana AL, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010009; Santarelli R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04241; Sarawar SR, 1998, VIROLOGY, V249, P359, DOI 10.1006/viro.1998.9309; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Song MJ, 2004, J VIROL, V78, P12940, DOI 10.1128/JVI.78.23.12940-12950.2004; Sparks-Thissen RL, 2005, VIROLOGY, V338, P201, DOI 10.1016/j.virol.2005.05.011; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Steed A, 2007, J VIROL, V81, P6134, DOI 10.1128/JVI.00108-07; Stewart S, 2004, P NATL ACAD SCI USA, V101, P15730, DOI 10.1073/pnas.0402135101; Tan CSE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005654; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; TOSATO G, 1990, J VIROL, V64, P3033, DOI 10.1128/JVI.64.6.3033-3041.1990; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Wu TT, 2001, J VIROL, V75, P9262, DOI 10.1128/JVI.75.19.9262-9273.2001; Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	77	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16257	16266		10.1074/jbc.M117.786970	http://dx.doi.org/10.1074/jbc.M117.786970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821622	Green Published, hybrid			2022-12-28	WOS:000412109400024
J	Lee, I; Kim, GS; Bae, JS; Kim, J; Rhee, K; Hwang, DS				Lee, Inyoung; Kim, Gwang Su; Bae, Jun Sung; Kim, Jaeyoun; Rhee, Kunsoo; Hwang, Deog Su			The DNA replication protein Cdc6 inhibits the microtubule-organizing activity of the centrosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CELL-CYCLE; S-PHASE; PERICENTRIOLAR MATERIAL; RING COMPLEX; MCM PROTEINS; PHOSPHORYLATION; DUPLICATION; ACTIVATION; MECHANISMS; NUCLEATION	The centrosome serves as a major microtubule-organizing center (MTOC). The Cdc6 protein is a component of the pre-replicative complex and a licensing factor for the initiation of chromosome replication and localizes to centrosomes during the S and G(2) phases of the cfell cycle of human cells. This cell cycle-dependent localization of Cdc6 to the centrosome motivated us to investigate whether Cdc6 negatively regulates MTOC activity and to determine the integral proteins that comprise the pericentriolar material (PCM). Time-lapse live-cell imaging of microtubule regrowth revealed that Cdc6 depletion increased microtubule nucleation at the centrosomes and that expression of Cdc6 in Cdc6-depleted cells reversed this effect. This increase and decrease in microtubule nucleation correlated with the centrosomal intensities of PCM proteins such as gamma-tubulin, pericentrin, CDK5 regulatory subunit-associated protein 2 (CDK5RAP2), and centrosomal protein 192 (Cep192). The regulation of microtubule nucleation and the recruitment of PCM proteins to the centrosome required Cdc6 ATPase activity, as well as a centrosomal localization of Cdc6. These results suggest a novel function for Cdc6 in coordinating centrosome assembly and function.	[Lee, Inyoung; Kim, Gwang Su; Bae, Jun Sung; Kim, Jaeyoun; Rhee, Kunsoo; Hwang, Deog Su] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea	Seoul National University (SNU)	Hwang, DS (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea.	dshwang@snu.ac.kr		Kim, Jaeyoun/0000-0001-8809-8054	National Research Foundation of Korea [NRF-2014R1A4A10052590]; BK21 Research Fellowship from the Ministry of Education, Science and Technology, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); BK21 Research Fellowship from the Ministry of Education, Science and Technology, Republic of Korea	This work was supported by Basic Research Laboratory Grant NRF-2014R1A4A10052590 through the National Research Foundation of Korea and a BK21 Research Fellowship from the Ministry of Education, Science and Technology, Republic of Korea (to I. L., G. S. K., J. B., and J. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Clijsters L, 2014, J CELL SCI, V127, P1336, DOI 10.1242/jcs.145862; Coverley D, 2000, J CELL SCI, V113, P1929; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Ferguson RL, 2010, J CELL SCI, V123, P2743, DOI 10.1242/jcs.073098; FONTALBA A, 1993, J CELL SCI, V106, P627; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Ganguly A, 2012, J BIOL CHEM, V287, P43359, DOI 10.1074/jbc.M112.423905; Gillingham AK, 2000, EMBO REP, V1, P524; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gonczy P, 2004, CURR BIOL, V14, pR268, DOI 10.1016/j.cub.2004.03.020; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Han JS, 2014, P NATL ACAD SCI USA, V111, pE4185, DOI 10.1073/pnas.1416277111; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kim GS, 2015, BIOCHEM BIOPH RES CO, V456, P763, DOI 10.1016/j.bbrc.2014.12.018; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087016; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Lu F, 2009, BIOL CELL, V101, P273, DOI 10.1042/BC20080109; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; Narasimhachar Y, 2012, CELL CYCLE, V11, P524, DOI 10.4161/cc.11.3.19033; Niimi S, 2012, J BIOL CHEM, V287, P18573, DOI 10.1074/jbc.M112.347690; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Park J, 2013, BIOCHEM BIOPH RES CO, V431, P302, DOI 10.1016/j.bbrc.2012.12.106; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; Shin W, 2015, CELL CYCLE, V14, P1925, DOI 10.1080/15384101.2015.1041683; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Stuermer A, 2007, EUR J CELL BIOL, V86, P37, DOI 10.1016/j.ejcb.2006.09.002; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Vaughan S, 2011, TRENDS CELL BIOL, V21, P57, DOI 10.1016/j.tcb.2010.09.004; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	65	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16267	16276		10.1074/jbc.M116.763680	http://dx.doi.org/10.1074/jbc.M116.763680			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28827311	Green Published, hybrid			2022-12-28	WOS:000412109400025
J	McQueen, AE; Kanamaluru, D; Yan, K; Gray, NE; Wu, L; Li, ML; Chang, A; Hasan, A; Stifler, D; Koliwad, SK; Wang, JC				McQueen, Allison E.; Kanamaluru, Deepthi; Yan, Kimberly; Gray, Nora E.; Wu, Leslie; Li, Mei-Lan; Chang, Anthony; Hasan, Adeeba; Stifler, Daniel; Koliwad, Suneil K.; Wang, Jen-Chywan			The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-TOLERANCE; BEIGE FAT DEVELOPMENT; INSULIN-RESISTANCE; BROWN FAT; LIPOPROTEIN-LIPASE; PROTEIN-KINASE; ANGPTL4; ADIPOCYTES; MICE; GENE	Angptl4 (Angiopoietin-like 4) is a circulating protein secreted by white and brown adipose tissues and the liver. Structurally, Angptl4 contains an N-terminal coiled-coil domain (CCD) connected to a C-terminal fibrinogen-like domain (FLD) via a cleavable linker, and both full-length Angptl4 and its individual domains circulate in the bloodstream. Angptl4 inhibits extracellular lipoprotein lipase (LPL) activity and stimulates the lipolysis of triacylglycerol stored by adipocytes in the white adipose tissue (WAT). The former activity is furnished by the CCD, but the Angptl4 domain responsible for stimulating adipocyte lipolysis is unknown. We show here that the purified FLD of Angptl4 is sufficient to stimulate lipolysis in mouse primary adipocytes and that increasing circulating FLD levels in mice through adenovirus-mediated overexpression (Ad-FLD) not only induces WAT lipolysis in vivo but also reduces diet-induced obesity without affecting LPL activity. Intriguingly, reduced adiposity in Ad-FLD mice was associated with increased oxygen consumption, fat utilization, and the expression of thermogenic genes (Ucp1 and Ppargc1a) in subcutaneous WAT. Moreover, Ad-FLD mice exhibited increased glucose tolerance. Chronically enhancing WAT lipolysis could produce ectopic steatosis because of an overflow of lipids from the WAT to peripheral tissues; however, this did not occur when Ad-FLD mice were fed a high-fat diet. Rather, these mice had reductions in both circulating triacylglycerol levels and the mRNA levels of lipogenic genes in the liver and skeletal muscle. We conclude that separating the FLD from the CCD-mediated LPL-inhibitory activity of full-length Angptl4 reveals lipolytic and thermo-genic properties with therapeutic relevance to obesity and diabetes.	[McQueen, Allison E.; Gray, Nora E.; Wang, Jen-Chywan] Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA; [McQueen, Allison E.; Kanamaluru, Deepthi; Yan, Kimberly; Gray, Nora E.; Wu, Leslie; Li, Mei-Lan; Chang, Anthony; Hasan, Adeeba; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 315 Morgan Hall, Berkeley, CA 94720 USA; [Stifler, Daniel; Koliwad, Suneil K.] Univ Calif San Francisco, Diabet Ctr, Med Sci S1230A,513 Parnassus Ave, San Francisco, CA 94143 USA; [Koliwad, Suneil K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, JC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 315 Morgan Hall, Berkeley, CA 94720 USA.; Koliwad, SK (corresponding author), Univ Calif San Francisco, Diabet Ctr, Med Sci S1230A,513 Parnassus Ave, San Francisco, CA 94143 USA.	skoliwad@diabetes.ucsf.edu; walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health [R01DK084591]; American Heart Association [15GRNT22920008]; NIDDK, National Institutes of Health [P30 DK098722-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, P30DK098722, R44DK084591, P30DK063720, R01DK103175, R43DK084591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01DK084591 (to J.-C.W.) and American Heart Association Grant 15GRNT22920008 (to J.-C.W.). The UCSF Nutrition and Obesity Research Center Mouse Metabolism Core is supported by NIDDK, National Institutes of Health Grant P30 DK098722-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Catoire M, 2014, P NATL ACAD SCI USA, V111, pE1043, DOI 10.1073/pnas.1400889111; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dickson LM, 2016, AM J PHYSIOL-REG I, V311, pR79, DOI 10.1152/ajpregu.00114.2016; Dijk W, 2015, ELIFE, V4, DOI 10.7554/eLife.08428; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Inagaki T, 2016, NAT REV MOL CELL BIO, V17, P480, DOI 10.1038/nrm.2016.62; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim HK, 2010, DIABETES, V59, P2772, DOI 10.2337/db10-0145; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Koliwad SK, 2012, ADIPOCYTE, V1, P182, DOI 10.4161/adip.20787; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kuo TY, 2014, J LIPID RES, V55, P919, DOI 10.1194/jlr.M047860; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Perdiguero EG, 2016, J PATHOL, V240, P461, DOI 10.1002/path.4805; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wang Y, 2016, MOL MED REP, V14, P3293, DOI 10.3892/mmr.2016.5637; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	46	33	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16122	16134		10.1074/jbc.M117.803973	http://dx.doi.org/10.1074/jbc.M117.803973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28842503	Green Published, hybrid			2022-12-28	WOS:000412109400012
J	Wang, XR; Chemmama, IE; Yu, C; Huszagh, A; Xu, Y; Viner, R; Block, SA; Cimermancic, P; Rychnovsky, SD; Ye, YH; Sali, A; Huang, L				Wang, Xiaorong; Chemmama, Ilan E.; Yu, Clinton; Huszagh, Alexander; Xu, Yue; Viner, Rosa; Block, Sarah A.; Cimermancic, Peter; Rychnovsky, Scott D.; Ye, Yihong; Sali, Andrej; Huang, Lan			The proteasome-interacting Ecm29 protein disassembles the 26S proteasome in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MASS-SPECTROMETRY; MOLECULAR ARCHITECTURE; AFFINITY PURIFICATION; REGULATORY PARTICLE; INTERACTION NETWORK; CORE PARTICLE; S-PROTEASOME; DEGRADATION; STRATEGY	Oxidative stress has been implicated in multiple human neurological and other disorders. Proteasomes are multi-subunit proteases critical for the removal of oxidatively damaged proteins. To understand stress-associated human pathologies, it is important to uncover the molecular events underlying the regulation of proteasomes upon oxidative stress. To this end, we investigated H2O2 stress-induced molecular changes of the human 26S proteasome and determined that stress-induced 26S proteasome disassembly is conserved from yeast to human. Moreover, we developed and employed a new proteomic approach, XAP (in vivo cross-linking-assisted affinity purification), coupled with stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative MS, to capture and quantify several weakly bound proteasome-interacting proteins and examine their roles in stress-mediated proteasomal remodeling. Our results indicate that the adapter protein Ecm29 is the main proteasome-interacting protein responsible for stress-triggered remodeling of the 26S proteasome in human cells. Importantly, using a disuccinimidyl sulfoxide-based cross-linking MS platform, we mapped the interactions of Ecm29 within itself and with proteasome subunits and determined the architecture of the Ecm29-proteasome complex with integrative structure modeling. These results enabled us to propose a structural model in which Ecm29 intrudes on the interaction between the 20S core particle and the 19S regulatory particle in the 26S proteasome, disrupting the proteasome structure in response to oxidative stress.	[Wang, Xiaorong; Yu, Clinton; Huszagh, Alexander; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Chemmama, Ilan E.; Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Chemmama, Ilan E.; Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Xu, Yue; Ye, Yihong] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Viner, Rosa] Thermo Fisher Sci, San Jose, CA 95134 USA; [Block, Sarah A.; Rychnovsky, Scott D.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Thermo Fisher Scientific; University of California System; University of California Irvine	Huang, L (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	lanhuang@uci.edu	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Rychnovsky, Scott/0000-0002-7223-4389; Chemmama, Ilan E./0000-0002-5657-3516	National Institutes of Health [R01GM074830, R01GM106003, R01GM083960, P41GM109824]; National Science Foundation [1650113]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960, R01GM074830, R01GM106003, T32GM008284, P41GM109824] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01GM074830 (to L. H.), R01GM106003 (to L. H. and S. R.), and R01GM083960 and P41GM109824 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Graduate Research Fellowship 1650113.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Akahane T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3234; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Byvaltsev V, 2012, WORLD NEUROSURG, V77, P5, DOI 10.1016/j.wneu.2011.11.001; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Fang L, 2008, J PROTEOME RES, V7, P4914, DOI 10.1021/pr800574c; Fernandez-Martinez J, 2016, CELL, V167, pe25, DOI DOI 10.1016/J.CELL.2016.10.028; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004301; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Shi Y, 2015, NAT METHODS, V12, P1135, DOI 10.1038/nmeth.3617; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Silva GM, 2012, ANTIOXID REDOX SIGN, V16, P1183, DOI 10.1089/ars.2011.4210; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Subbotin RI, 2014, MOL CELL PROTEOMICS, V13, P2824, DOI 10.1074/mcp.M114.041095; Upla P, 2017, STRUCTURE, V25, P434, DOI 10.1016/j.str.2017.01.006; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang XR, 2017, MOL CELL PROTEOMICS, V16, P840, DOI 10.1074/mcp.M116.065326; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Yu C, 2016, ANAL CHEM, V88, P10301, DOI 10.1021/acs.analchem.6b03148; Yu C, 2016, MOL CELL PROTEOMICS, V15, P2279, DOI 10.1074/mcp.M116.058271	46	58	59	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16310	16320		10.1074/jbc.M117.803619	http://dx.doi.org/10.1074/jbc.M117.803619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821611	Green Published, hybrid			2022-12-28	WOS:000412109400029
J	Blaszczyk, AJ; Wang, B; Silakov, A; Ho, JV; Booker, SJ				Blaszczyk, Anthony J.; Wang, Bo; Silakov, Alexey; Ho, Jackson V.; Booker, Squire J.			Efficient methylation of C2 in L-tryptophan by the cobalamin-dependent radical S-adenosylmethionine methylase TsrM requires an unmodified N1 amine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATECHOL O-METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; SAM ENZYME; THIOPEPTIDE ANTIBIOTICS; IRON-SULFUR; BIOSYNTHESIS; THIOSTREPTON; CATALYSIS; SYNTHASE; NUCLEOPHILICITY	TsrM catalyzes the methylation of C2 in L-tryptophan (Trp). This reaction is the first step in the biosynthesis of the quinaldic acid moiety of the thiopeptide antibiotic thiostrepton, which exhibits potent activity against Gram-positive pathogens. TsrM is a member of the radical S-adenosylmethionine (SAM) superfamily of enzymes, but it does not catalyze the formation of 5' -deoxyadenosin-5' -yl or any other SAM-derived radical. In addition to a [4Fe-4S] cluster, TsrM contains a cobalamin cofactor that serves as an intermediate methyl carrier in its reaction. However, how this cofactor donates a methyl moiety to the Trp substrate is unknown. Here, we showed that the unmodified N1 position of Trp is important for turnover and that 1-thia-Trp and 1-oxa-Trp serve as competitive inhibitors. We also showed that beta-cyclopropyl-Trp undergoes C2 methylation in the absence of cyclopropyl ring opening, disfavoring mechanisms that involve unpaired electron density at C3 of the indole ring. Moreover, we showed that all other indole-substituted analogs of Trp undergo methylation at varying but measurable rates and that the analog 7-aza-Trp, which is expected to temper the nucleophilicity of C2 in Trp, is a very poor substrate. Last, no formation of cob(II) alamin or substrate radicals was observed during the reaction with Trp or any molecule within a tested panel of Trp analogs. In summary, our results are most consistent with a mechanism that involves two polar nucleophilic displacements, the second of which requires deprotonation of the indole nitrogen in Trp during its attack on methylcobalamin.	[Blaszczyk, Anthony J.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wang, Bo; Silakov, Alexey; Ho, Jackson V.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.	squire@psu.edu	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253; Ho, Jackson/0000-0002-6195-1235	National Institutes of Health [GM-103268, GM-101957, GM-122595, AI-111419]; Penn State Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122595, R01GM101957, R01GM103268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-103268, GM-101957, GM-122595, and AI-111419 and by Penn State Funds for Undergraduate Research (to J. V. H.).	Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bandarian V, 2004, METHOD ENZYMOL, V380, P152; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Bhandari DM, 2015, BIOCHEMISTRY-US, V54, P4767, DOI 10.1021/acs.biochem.5b00764; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Bridwell-Rabb J, 2017, NATURE, V544, P322, DOI 10.1038/nature21689; Chamorro E, 2016, THEOR CHEM ACC, V135, DOI 10.1007/s00214-016-1974-x; Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frisch M. J., 2004, REVISION E 01; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Hughes RA, 2007, ANGEW CHEM INT EDIT, V46, P7930, DOI 10.1002/anie.200700728; Ilu W, 2010, ORG LETT, V12, P956; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Ji XJ, 2015, ANGEW CHEM INT EDIT, V54, P9021, DOI 10.1002/anie.201503976; Joule J.A., 2010, HETEROCYCLIC CHEM, P373; Just-Baringo X, 2014, ANGEW CHEM INT EDIT, V53, P6602, DOI 10.1002/anie.201307288; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lakhdar S, 2006, J ORG CHEM, V71, P9088, DOI 10.1021/jo0614339; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Limbach M, 2005, EUR J ORG CHEM, V2005, P610, DOI 10.1002/ejoc.200400617; LOTT WB, 1995, J AM CHEM SOC, V117, P12194, DOI 10.1021/ja00154a020; Marous DR, 2015, P NATL ACAD SCI USA, V112, P10354, DOI 10.1073/pnas.1508615112; MARTIN BD, 1992, J AM CHEM SOC, V114, P585, DOI 10.1021/ja00028a027; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Phillips RS, 2004, TETRAHEDRON-ASYMMETR, V15, P2787, DOI 10.1016/j.tetasy.2004.06.054; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Podea PV, 2008, TETRAHEDRON-ASYMMETR, V19, P500, DOI 10.1016/j.tetasy.2008.01.031; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Sharma PK, 2007, P NATL ACAD SCI USA, V104, P9661, DOI 10.1073/pnas.0702238104; Stoll S, 2011, J AM CHEM SOC, V133, P18098, DOI 10.1021/ja208462t; TAYLOR RT, 1966, J BIOL CHEM, V241, P3641; Walsh CT, 2014, ACS CHEM BIOL, V9, P2718, DOI 10.1021/cb500695k; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2; Zhang FF, 2016, ACS CHEM BIOL, V11, P415, DOI 10.1021/acschembio.5b00731; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	53	24	24	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15456	15467		10.1074/jbc.M117.778548	http://dx.doi.org/10.1074/jbc.M117.778548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747433	hybrid, Green Published			2022-12-28	WOS:000410809800025
J	Jansson, AM; Csiszar, A; Maier, J; Nystrom, AC; Ax, E; Johansson, P; Schiavone, LH				Jansson, Anna M.; Csiszar, Agnes; Maier, Joachim; Nystrom, Ann-Christin; Ax, Elisabeth; Johansson, Patrik; Schiavone, Lovisa Holmberg			The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PROGRESSION; CANCER; TGF-BETA-1; CARCINOMA; PATHOLOGY; FAM3C; CELLS; RAS	Production and secretion of pro-metastatic proteins is a feature of many tumor cells. The FAM3C interleukin-like epithelialto-mesenchymal-transition (EMT) inducer (ILEI) has been shown to be strongly up-regulated in several cancers and to be essential for tumor formation and metastasis in epithelial cells, correlating with a significant decrease in overall survival in colon and breast cancer patients. ILEI has been seen to interact with the gamma-secretase presenilin 1 subunit (PS1). However, not much is known about the mechanism-of-action or the detailed ILEI structure. We present here the crystal structures of FAM3C ILEI and show that it exists as monomers but also as covalent dimers. The observed ILEI beta-beta-alpha fold confirmed previous indications that the FAM3C proteins do not form classical four-helix-bundle structures as was initially predicted. This provides the first experimental evidence that the interleukin-like EMT inducers are not evolutionarily related to the interleukins. However, more surprisingly, the ILEI dimer structure was found to feature a trans-linked domain swap, converting an intramolecular disulfide to intermolecular. Interestingly, dimeric but not monomeric ILEI was subsequently found to cause a dose-dependent increase in EpRas cell invasiveness comparable with TGF-alpha, indicating that the dimer might be the active ILEI species. This is in line with a parallel study showing that covalent oligomerization of ILEI is essential for EMT and tumor progression in vivo. The structures and the activity data give some first insight into the relationship between dimerization and ILEI function as well as indicate an intriguing link between ILEI, the PS1-protease, TGF-beta, and the TGF-beta receptor 1.	[Jansson, Anna M.; Maier, Joachim; Ax, Elisabeth; Schiavone, Lovisa Holmberg] AstraZeneca, Discovery Sci Dept, Reagents & Assay Dev Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Nystrom, Ann-Christin] AstraZeneca, Cardiovas & Metab Dis Dept, Translat Sci Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Johansson, Patrik] AstraZeneca, Discovery Sci Dept, Struct & Biophys Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Csiszar, Agnes] Med Univ Vienna, Dept Med 1, Inst Canc Res, Borschkegasse 8a, A-1090 Vienna, Austria	AstraZeneca; AstraZeneca; AstraZeneca; Medical University of Vienna	Johansson, P (corresponding author), AstraZeneca, Discovery Sci Dept, Struct & Biophys Div, Pepparedsleden 1, S-43183 Molndal, Sweden.; Schiavone, LH (corresponding author), AstraZeneca R&D, Reagents & Assay Dev, Discovery Sci, Pepparedsleden 1, S-43183 Molndal, Sweden.	patrik.johansson@astrazeneca.com; lovisa.holmberg.schiavone@astrazeneca.com	Csiszar, Agnes/I-2747-2019	Csiszar, Agnes/0000-0001-7911-3427; Ax, Elisabeth/0000-0001-7553-5059	Discovery Sciences, AstraZeneca; Austrian Science Foundation (FWF) [P25834-B23]; Austrian Science Fund (FWF) [P 25834] Funding Source: researchfish	Discovery Sciences, AstraZeneca; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Discovery Sciences, AstraZeneca. This work was also supported by the Austrian Science Foundation (FWF) Grant P25834-B23) (to A.C.). A. M. J., J. M., A.-C. N., E. A., P. J., and L. H. S. are employees of AstraZeneca, which provided funding.	Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bettye T. G., 2017, ACTA CRYSTALLOGR D, V67, P271; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Bricogne G., 2016, BUSTER VERSION 2 11; Caraci F, 2012, EUR NEUROPSYCHOPHARM, V22, P281, DOI 10.1016/j.euroneuro.2011.08.006; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Halberg N, 2016, CANCER CELL, V29, P339, DOI 10.1016/j.ccell.2016.02.013; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Johansson P, 2013, STRUCTURE, V21, P306, DOI 10.1016/j.str.2012.12.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2005, COMP LIF SCI 1 INT S; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Liu L, 2016, NEUROSCIENCE, V330, P236, DOI 10.1016/j.neuroscience.2016.05.050; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Song Q, 2014, TUMOR BIOL, V35, P1377, DOI 10.1007/s13277-013-1188-y; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zhu YH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0424-8	30	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15501	15511		10.1074/jbc.M117.782904	http://dx.doi.org/10.1074/jbc.M117.782904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28751379	hybrid, Green Published			2022-12-28	WOS:000410809800029
J	Okamoto, N; Mizote, K; Honda, H; Saeki, A; Watanabe, Y; Yamaguchi-Miyamoto, T; Fukui, R; Tanimura, N; Motoi, Y; Akashi-Takamura, S; Kato, T; Fujishita, S; Kimura, T; Ohto, U; Shimizu, T; Hirokawa, T; Miyake, K; Fukase, K; Fujimoto, Y; Nagai, Y; Takatsu, K				Okamoto, Naoki; Mizote, Keisuke; Honda, Hiroe; Saeki, Akinori; Watanabe, Yasuharu; Yamaguchi-Miyamoto, Tomonni; Fukui, Ryutaro; Tanimura, Natsuko; Motoi, Yuji; Akashi-Takamura, Sachiko; Kato, Tatsuhisa; Fujishita, Shigeto; Kimura, Takahito; Ohto, Umeharu; Shimizu, Toshiyuki; Hirokawa, Takatsugu; Miyake, Kensuke; Fukase, Koichi; Fujimoto, Yukari; Nagai, Yoshinori; Takatsu, Kiyoshi			Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; CELL-SURFACE EXPRESSION; MONOPHOSPHORYL-LIPID-A; DENDRITIC CELLS; CRYSTAL-STRUCTURES; ACCURATE DOCKING; STRUCTURAL BASIS; GENE-EXPRESSION; CUTTING EDGE; B-CELLS	The Toll-like receptor 4 (TLR4)/myeloid differentiation factor-2 (MD-2) complex is essential for LPS recognition and induces innate immune responses against Gram-negative bacteria. As activation of TLR4/MD-2 is also critical for the induction of adaptive immune responses, TLR4/MD-2 agonists have been developed as vaccine adjuvants, but their efficacy has not yet been ascertained. Here, we demonstrate that a funiculosin (FNC) variant, FNC-RED, and FNC-RED and FNC derivatives are agonists for both murine and human TLR4/MD-2. FNC-RED induced nuclear factor-kappa B (NF-kappa B) activation via murine TLR4/MD-2, whereas FNC had no TLR4/MD-2 stimulatory activity. Biacore analysis revealed that FNC-RED binds to murine TLR4/MD-2 but not murine radioprotective 105 (RP105)/myeloid differentiation factor-1 (MD-1), another LPS sensor. FNC-RED induced CD14-independent expressions of pro-inflammatory cytokines and co-stimulatory molecules in murine macrophages and dendritic cells. In contrast, FNC-RED stimulation was reduced in CD14-dependent LPS responses, including dimerization and internalization of TLR4/MD-2 and IFN-beta expression. FNC-RED-induced IL-12p40 production from murine dendritic cells was dependent on NF-kappa B but not MAPK pathway. In addition, fetal bovine serum augmented lipid A-induced NF-kappa B activation but blocked FNC-RED-mediated responses. Two synthetic phosphate group-containing FNC-RED and FNC derivatives, FNC-RED-P01 and FNC-P01, respectively, activated human TLR4/MD-2, unlike FNC-RED. Finally, computational analysis revealed that this species-specific activation by FNC-RED and FNC-RED-P01 resulted from differences in electrostatic surface potentials between murine and human TLR4/MD-2. We conclude that FNC-RED and its synthetic derivative represent a novel category of murine and human TLR4/MD-2 agonist.	[Okamoto, Naoki; Honda, Hiroe; Watanabe, Yasuharu; Nagai, Yoshinori; Takatsu, Kiyoshi] Univ Toyama, Grad Sch Med & Pharmaceut Sci Res, Dept Immunobiol & Pharmacol Genet, 2630 Sugitani, Toyama 9300194, Japan; [Okamoto, Naoki; Kato, Tatsuhisa; Fujishita, Shigeto; Kimura, Takahito] Teika Pharmaceut Co Ltd, 1-3-27 Arakawa, Toyama 9300982, Japan; [Mizote, Keisuke; Saeki, Akinori; Fukase, Koichi] Osaka Univ, Sch Sci, Dept Chem, Lab Nat Prod Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan; [Honda, Hiroe; Yamaguchi-Miyamoto, Tomonni; Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, 17-1 Nakataikouyama, Imizu, Toyama 9390363, Japan; [Fukui, Ryutaro; Tanimura, Natsuko; Motoi, Yuji; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Akashi-Takamura, Sachiko] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Hirokawa, Takatsugu] AIST, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Innate Immun,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Fujimoto, Yukari] Keio Univ, Fac Sci & Technol, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Nagai, Yoshinori] Japan Sci & Technol Agcy JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	University of Toyama; Osaka University; University of Tokyo; Aichi Medical University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Nagai, Y; Takatsu, K (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci Res, Dept Immunobiol & Pharmacol Genet, 2630 Sugitani, Toyama 9300194, Japan.	ynagai@med.u-toyama.ac.jp; takatsuk@med.u-toyama.ac.jp	Fujimoto, Yukari/M-7282-2014; Saeki, Akinori/B-7756-2011	Fujimoto, Yukari/0000-0001-5320-3192; Saeki, Akinori/0000-0001-7429-2200	Hokuriku Life Science Cluster, MEXT Regional Innovation Strategy Support Program; Hokuriku Innovation Cluster for Health Science, MEXT Regional Innovation Cluster Program, Toyama/Ishikawa Region; Japan Society for the Promotion of Science (JSPS) JSPS KAKENHI [JP16K19596, JP16K19532, JP15K07960]; NEXT Program [LR025]; JST, PRESTO [JPMJPR13M1]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development; Teika Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [15H05836, 16K19596] Funding Source: KAKEN	Hokuriku Life Science Cluster, MEXT Regional Innovation Strategy Support Program; Hokuriku Innovation Cluster for Health Science, MEXT Regional Innovation Cluster Program, Toyama/Ishikawa Region; Japan Society for the Promotion of Science (JSPS) JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST, PRESTO(Japan Science & Technology Agency (JST)); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Teika Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Hokuriku Life Science Cluster, MEXT Regional Innovation Strategy Support Program (to K. T.); Hokuriku Innovation Cluster for Health Science, MEXT Regional Innovation Cluster Program, Toyama/Ishikawa Region (to K. T.); Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) JSPS KAKENHI JP16K19596 (to N. O.), JP16K19532 (to Y. W.), and JP15K07960 (to H. H.); NEXT Program (LR025 to Y. F.); and JST, PRESTO (JPMJPR13M1 to Y. N.). This work supported in part by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (to T. H.). Our laboratory (Dept. of Immunobiology and Pharmacological Genetics, University of Toyama) has Grant/Research support from Teika Pharmaceutical Co., Ltd. N. O., T. Kato, S. F., and T. Kimura are employees of Teika Pharmaceutical Co., Ltd.	Airhart CL, 2008, MICROBIOL-SGM, V154, P2131, DOI 10.1099/mic.0.2008/017566-0; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; ANDO K, 1978, J ANTIBIOT, V31, P533, DOI 10.7164/antibiotics.31.533; ANDO K, 1969, J ANTIBIOT, V22, P189, DOI 10.7164/antibiotics.22.189; ARDITI M, 1995, J IMMUNOL, V155, P3994; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Baldridge JR, 2002, J ENDOTOXIN RES, V8, P453, DOI 10.1179/096805102125001064; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Bowers K.J., 2006, P 2006 ACM IEEE C SU, V06, P84; BRASSEUR G, 1994, FEBS LETT, V354, P23, DOI 10.1016/0014-5793(94)01077-3; Casella CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062622; COOPERSTOCK MS, 1974, ANTIMICROB AGENTS CH, V6, P422, DOI 10.1128/AAC.6.4.422; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Honda H, 2012, J LEUKOCYTE BIOL, V91, P967, DOI 10.1189/jlb.0112038; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Julier Z, 2016, VACCINE, V34, P2453, DOI 10.1016/j.vaccine.2016.03.057; Jurgens G, 2002, J ENDOTOXIN RES, V8, P115, DOI 10.1179/096805102125000263; KACA W, 1994, J BIOL CHEM, V269, P25078; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyake K, 1998, J IMMUNOL, V161, P1348; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nhu QM, 2010, MUCOSAL IMMUNOL, V3, P29, DOI 10.1038/mi.2009.120; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Ohto U, 2011, J MOL BIOL, V413, P815, DOI 10.1016/j.jmb.2011.09.020; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Rescigno M, 1997, J LEUKOCYTE BIOL, V61, P415, DOI 10.1002/jlb.61.4.415; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shin HJ, 2007, MOL CELLS, V24, P119; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Tanimura N, 2014, INT IMMUNOL, V26, P307, DOI 10.1093/intimm/dxt071; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Wang Y, 2016, P NATL ACAD SCI USA, V113, pE884, DOI 10.1073/pnas.1525639113; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu MN, 2014, HUM VACC IMMUNOTHER, V10, P3711, DOI 10.4161/21645515.2014.980682; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	62	4	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15378	15394		10.1074/jbc.M117.791780	http://dx.doi.org/10.1074/jbc.M117.791780			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28754693	hybrid, Green Published			2022-12-28	WOS:000410809800019
J	Badolia, R; Inamdar, V; Manne, BK; Dangelmaier, C; Eble, JA; Kunapuli, SP				Badolia, Rachit; Inamdar, Vaishali; Manne, Bhanu Kanth; Dangelmaier, Carol; Eble, Johannes A.; Kunapuli, Satya P.			G(q) pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SRC FAMILY KINASES; ACTIVATION MOTIF ITAM; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TYROSINE KINASES; SYK; PHOSPHORYLATION; PHOSPHATASE; INTEGRIN	Platelets play a key role in the physiological hemostasis or pathological process of thrombosis. Rhodocytin, an agonist of the C-type lectin-like receptor-2 (CLEC-2), elicits powerful platelet activation signals in conjunction with Src family kinases (SFKs), spleen tyrosine kinase (Syk), and phospholipase gamma 2 (PLC gamma 2). Previous reports have shown that rhodocytin-induced platelet aggregation depends on secondary mediators such as thromboxane A2 (TxA2) and ADP, which are agonists for G-protein-coupled receptors (GPCRs) on platelets. How the secondary mediators regulate CLEC-2-mediated platelet activation in terms of signaling is not clearly defined. In this study, we report that CLEC-2-induced Syk and PLC gamma 2 phosphorylation is potentiated by TxA2 and that TxA2 plays a critical role in the most proximal event of CLEC-2 signaling, i.e. the CLEC-2 receptor tyrosine phosphorylation. We show that the activation of other GPCRs, such as the ADP receptors and protease-activated receptors, can also potentiate CLEC-2 signaling. By using the specific G(q) inhibitor, UBO-QIC, or G(q) knock-out murine platelets, we demonstrate that G(q) signaling, but not other G-proteins, is essential for GPCR-induced potentiation of Syk phosphorylation downstream of CLEC-2. We further elucidated the signaling downstream of G(q) and identified an important role for the PLC beta-PKC alpha pathway, possibly regulating activation of SFKs, which are crucial for initiation of CLEC-2 signaling. Together, these results provide evidence for novel G(q)-PLC beta-PKC alpha-mediated regulation of proximal CLEC-2 signaling by G(q)-coupled receptors.	[Badolia, Rachit; Inamdar, Vaishali; Manne, Bhanu Kanth; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Badolia, Rachit; Inamdar, Vaishali; Manne, Bhanu Kanth; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Eble, Johannes A.] Univ Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Munster	Kunapuli, SP (corresponding author), Temple Univ, Sol Sherry Thrombosis Res Ctr, Rm 414 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Inamdar, Vaishali/R-5093-2019	Inamdar, Vaishali/0000-0002-3049-1977	National Institutes of Health [HL93231, HL118593, HL132171]; Deutsche Forschungsgemeinschaft (DFG) [EB177/13-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118593, R01HL093231, R01HL132171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL93231, HL118593, and HL132171 (to S. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Deutsche Forschungsgemeinschaft (DFG) Grant EB177/13-1.	Atkinson BT, 2003, J THROMB HAEMOST, V1, P1278, DOI 10.1046/j.1538-7836.2003.00245.x; Boulaftali Y, 2014, CIRC RES, V114, P1174, DOI 10.1161/CIRCRESAHA.114.301611; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Dutting S, 2015, J THROMB HAEMOST, V13, P827, DOI 10.1111/jth.12861; GRABAREK J, 1993, J BIOL CHEM, V268, P5543; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Hardy AR, 2005, PLATELETS, V16, P415, DOI 10.1080/09537100500163424; Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hooley E, 2008, BIOCHEMISTRY-US, V47, P7831, DOI 10.1021/bi800528t; Humphries R., 2000, HAEMATOLOGICA S, V85, P66; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kim S, 2013, J BIOL CHEM, V288, P18194, DOI 10.1074/jbc.M113.461087; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; LIEBENHOFF U, 1994, CELL MOL BIOL, V40, P645; Lowes VL, 2002, NEUROSIGNALS, V11, P5, DOI 10.1159/000057317; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Manne BK, 2015, J BIOL CHEM, V290, P11557, DOI 10.1074/jbc.M114.629527; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Musumeci L, 2015, CIRCULATION, V131, P656, DOI 10.1161/CIRCULATIONAHA.114.010186; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Paris LL, 2010, J BIOL CHEM, V285, P39844, DOI 10.1074/jbc.M110.164509; Pollitt AY, 2014, J BIOL CHEM, V289, P35695, DOI 10.1074/jbc.M114.584284; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Reppschlager K, 2016, J BIOL CHEM, V291, P22427, DOI 10.1074/jbc.M116.743732; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2001, J BIOL CHEM, V276, P1643, DOI 10.1074/jbc.M006191200; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; WARE JA, 1989, AM J PHYSIOL, V256, pC35, DOI 10.1152/ajpcell.1989.256.1.C35; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Watson AA, 2008, PROTEIN SCI, V17, P1611, DOI 10.1110/ps.035568.108; Xiang BG, 2012, J BIOL CHEM, V287, P41277, DOI 10.1074/jbc.M112.393124	42	16	18	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14516	14531		10.1074/jbc.M117.791012	http://dx.doi.org/10.1074/jbc.M117.791012			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28705934	Green Published, hybrid			2022-12-28	WOS:000408747500018
J	Hirama, T; Das, R; Yang, YB; Ferguson, C; Won, A; Yip, CM; Kay, JG; Grinstein, S; Parton, RG; Fairn, GD				Hirama, Takashi; Das, Raibatak; Yang, Yanbo; Ferguson, Charles; Won, Amy; Yip, Christopher M.; Kay, Jason G.; Grinstein, Sergio; Parton, Robert G.; Fairn, Gregory D.			Phosphatidylserine dictates the assembly and dynamics of caveolae in the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; microscopic imaging; phosphatidylinositol signaling; phosphatidylserine; single-particle analysis; phosphoinositides; TIRF microscopy; single-particle analysis	SINGLE-PARTICLE TRACKING; PHOSPHOLIPID-BILAYERS; SCAFFOLDING REGION; LOCAL-ANESTHETICS; PROTEIN; CAVIN; CELL; ORGANIZATION; BINDING; DOMAINS	Caveolae are bulb-shaped nanodomains of the plasma membrane that are enriched in cholesterol and sphingolipids. They have many physiological functions, including endocytic transport, mechanosensing, and regulation of membrane and lipid transport. Caveola formation relies on integral membrane proteins termed caveolins (Cavs) and the cavin family of peripheral proteins. Both protein families bind anionic phospholipids, but the precise roles of these lipids are unknown. Here, we studied the effects of phosphatidylserine (PtdSer), phosphatidylinositol 4-phosphate (PtdIns4P), and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) on caveolar formation and dynamics. Using live-cell, single-particle tracking of GFP-labeled Cav1 and ultrastructural analyses, we compared the effect of PtdSer disruption or phosphoinositide depletion with caveola disassembly caused by cavin1 loss. We found that PtdSer plays a crucial role in both caveola formation and stability. Sequestration or depletion of PtdSer decreased the number of detectable Cav1-GFP puncta and the number of caveolae visualized by electron microscopy. Under PtdSer-limiting conditions, the co-localization of Cav1 and cavin1 was diminished, and cavin1 degradation was increased. Using rapamycin-recruitable phosphatases, we also found that the acute depletion of PtdIns4P and PtdIns(4,5)P-2 has minimal impact on caveola assembly but results in decreased lateral confinement. Finally, we show in a model of phospholipid scrambling, a feature of apoptotic cells, that caveola stability is acutely affected by the scrambling. We conclude that the predominant plasmalemmal anionic lipid PtdSer is essential for proper Cav clustering, caveola formation, and caveola dynamics and that membrane scrambling can perturb caveolar stability.	[Hirama, Takashi; Yang, Yanbo; Fairn, Gregory D.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Hirama, Takashi; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Hirama, Takashi] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama 3500495, Japan; [Das, Raibatak] Univ Colorado, Dept Integrat Biol, Denver, CO 80204 USA; [Yang, Yanbo; Grinstein, Sergio; Fairn, Gregory D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Won, Amy; Yip, Christopher M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Kay, Jason G.] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA; [Fairn, Gregory D.] Ryerson Univ, IBEST, Toronto, ON M5B 2K3, Canada; [Fairn, Gregory D.] St Michaels Hosp, Toronto, ON M5B 2K3, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Saitama Medical University; University of Colorado System; University of Colorado Denver; University of Toronto; University of Queensland; University of Queensland; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Fairn, GD (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	fairng@smh.ca		Kay, Jason/0000-0001-8944-6612; Hirama, Takashi/0000-0002-9390-5057	Canadian Institutes of Health Research [MOP-133656]; Li Ka Shing Knowledge Institute; Alzheimer Society of Canada; New Investigator Award from Canadian Institutes of Health Research; Early Researcher Award from the Government of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); Alzheimer Society of Canada; New Investigator Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Early Researcher Award from the Government of Ontario	This work was supported in part by Operating Grant MOP-133656 from the Canadian Institutes of Health Research (to G. D. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by scholarships from the Li Ka Shing Knowledge Institute and the Alzheimer Society of Canada.; Recipient of a New Investigator Award from Canadian Institutes of Health Research and an Early Researcher Award from the Government of Ontario. To whom correspondence should be addressed: Keenan Research Centre for Biomedical Science, St. Michael's Hospital, 30 Bond St., Toronto, Ontario M5B 1W8, Canada. Tel.: 416-864-6060 (Ext. 77330); E-mail: fairng@smh.ca.	Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Ariotti N, 2015, J BIOL CHEM, V290, P24875, DOI 10.1074/jbc.M115.644336; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; BRADFORD P, 1981, J MEMBRANE BIOL, V61, P193, DOI 10.1007/BF01870523; Chatterjee M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10867; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Fairn GD, 2012, SCIENCE, V337, P653, DOI 10.1126/science.1227096; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gambin Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01434; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Katsogiannou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007068; Kovtun O, 2014, DEV CELL, V31, P405, DOI 10.1016/j.devcel.2014.10.002; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maekawa M, 2014, J CELL SCI, V127, P4801, DOI 10.1242/jcs.150524; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Nassar Zeyad D, 2015, Oncoscience, V2, P635; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Oreopoulos J, 2009, J STRUCT BIOL, V168, P21, DOI 10.1016/j.jsb.2009.02.011; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P504, DOI 10.1016/0005-2736(75)90137-6; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; PERLMAN BJ, 1984, MOL PHARMACOL, V26, P83; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNEIDER E, 1986, BIOCHIM BIOPHYS ACTA, V855, P325, DOI 10.1016/0005-2736(86)90078-7; SCHROEDER F, 1978, BIOCHIM BIOPHYS ACTA, V511, P356, DOI 10.1016/0005-2736(78)90273-0; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tillu VA, 2015, MOL BIOL CELL, V26, P3561, DOI 10.1091/mbc.E15-06-0359; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhang WL, 2011, INT J MOL SCI, V12, P2125, DOI 10.3390/ijms12042125	64	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14292	14307		10.1074/jbc.M117.791400	http://dx.doi.org/10.1074/jbc.M117.791400			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28698382	Green Published, hybrid			2022-12-28	WOS:000408439800034
J	Klein, RH; Hu, W; Kashgari, G; Lin, ZG; Nguyen, T; Doan, M; Andersen, B				Klein, Rachel Herndon; Hu, William; Kashgari, Ghaidaa; Lin, Ziguang; Nguyen, Tuyen; Doan, Michael; Andersen, Bogi			Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; chromatin; epithelial cell; eye; gene regulation; Kruppel-like factor 4 (KLF4); KLF7; corneal epithelium; superenhancer	SUPER-ENHANCERS; CELL IDENTITY; MOUSE CORNEA; HUMAN GENOME; ETS FAMILY; FACTOR EHF; IDENTIFICATION; EXPRESSION; REGIONS; DISEASE	During tissue development, transcription factors bind regulatory DNA regions called enhancers, often located at great distances from the genes they regulate, to control gene expression. The enhancer landscape during embryonic stem cell differentiation has been well characterized. By contrast, little is known about the shared and unique enhancer regulatory mechanisms in different ectodermally derived epithelial cells. Here we use ChIP sequencing (ChIP-seq) to identify domains enriched for the histone marks histone H3 lysine 4 trimethylation, histone H3 lysine 4 monomethylation, and histone H3 lysine 27 acetylation (H3K4me3, H3K4me1, and H3K27ac) and define, for the first time, the super enhancers and typical enhancers active in primary human corneal epithelial cells. We show that regulatory regions are often shared between cell types of the ectodermal lineage and that corneal epithelial super enhancers are already marked as potential regulatory domains in embryonic stem cells. Kruppel-like factor (KLF) motifs were enriched in corneal epithelial enhancers, consistent with the important roles of KLF4 and KLF5 in promoting corneal epithelial differentiation. We now show that the Kruppel family member KLF7 promotes the corneal progenitor cell state; on many genes, KLF7 antagonized the corneal differentiation-promoting KLF4. Furthermore, we found that two SNPs linked previously to corneal diseases, astigmatism, and Stevens-Johnson syndrome fall within corneal epithelial enhancers and alter their activity by disrupting transcription factor motifs that overlap these SNPs. Taken together, our work defines regulatory enhancers in corneal epithelial cells, highlights global gene-regulatory relationships shared among different epithelial cells, identifies a role for KLF7 as a KLF4 antagonist in corneal epithelial cell differentiation, and explains how two SNPs may contribute to corneal diseases.	[Klein, Rachel Herndon; Hu, William; Kashgari, Ghaidaa; Lin, Ziguang; Nguyen, Tuyen; Doan, Michael; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Andersen, Bogi] Univ Calif Irvine, Dept Med, Div Endocrinol, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Nguyen, Tuyen] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), 839 Hlth Sci Dr, Irvine, CA 92697 USA.	bogi@uci.edu			National Institutes of Health [R01EY019413, R01AR44882]; National Library of Medicine [T15LM00744]; NCI, National Institutes of Health [5T32CA09054-38]; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01EY019413 and R01AR44882 (to B. A.), National Library of Medicine Grant T15LM00744 (to R. H. K.), and NCI, National Institutes of Health Grant 5T32CA09054-38 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Cavazza A, 2016, STEM CELL REP, V6, P618, DOI 10.1016/j.stemcr.2016.03.003; Courville CB, 2004, EXP EYE RES, V78, P417, DOI 10.1016/j.exer.2003.10.012; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Erokhin M, 2015, CELL MOL LIFE SCI, V72, P2361, DOI 10.1007/s00018-015-1871-9; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; Fossum SL, 2017, J BIOL CHEM, V292, P10938, DOI 10.1074/jbc.M117.775304; Foster J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106556; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kenchegowda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044771; Klein RH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006745; Klein RH, 2016, J BIOL CHEM, V291, P13271, DOI 10.1074/jbc.M115.709386; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ritchey ER, 2012, EXP EYE RES, V99, P1, DOI 10.1016/j.exer.2012.03.019; Robertson DM, 2011, CURR EYE RES, V36, P706, DOI 10.3109/02713683.2011.582662; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yoon Jinny J, 2014, World J Stem Cells, V6, P391, DOI 10.4252/wjsc.v6.i4.391; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	55	14	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18937	18950		10.1074/jbc.M117.793117	http://dx.doi.org/10.1074/jbc.M117.793117			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28916725	hybrid, Green Published			2022-12-28	WOS:000415848000018
J	Interlandi, G; Yakovenko, O; Tu, AY; Harris, J; Le, J; Chen, JM; Lopez, JA; Thomas, WE				Interlandi, Gianluca; Yakovenko, Olga; Tu, An-Yue; Harris, Jeff; Le, Jennie; Chen, Junmei; Lopez, Jose A.; Thomas, Wendy E.			Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; hemostasis; molecular dynamics; thrombosis; von Willebrand factor; dynamic flow assay; parasteric inhibition; protein binding	GLYCOPROTEIN IB-ALPHA; FACTOR A1 DOMAIN; MOLECULAR-DYNAMICS SIMULATIONS; FORMS CATCH BONDS; VONWILLEBRAND-FACTOR; DEPENDENT BINDING; CRYSTAL-STRUCTURE; FORCE-FIELDS; IIB-IIIA; DISEASE	The plasma protein von Willebrand factor (VWF) is essential for hemostasis initiation at sites of vascular injury. The platelet-binding A1 domain of VWF is connected to the VWF N-terminally located DD3 domain through a relatively unstructured amino acid sequence, called here the N-terminal linker. This region has previously been shown to inhibit the binding of VWF to the platelet surface receptor glycoprotein Ib (GpIb). However, the molecular mechanism underlying the inhibitory function of the N-terminal linker has not been elucidated. Here, we show that an aspartate at position 1261 is the most critical residue of the N-terminal linker for inhibiting binding of the VWF A1 domain to GpIb on platelets in blood flow. Through a combination of molecular dynamics simulations, mutagenesis, and A1-GpIb binding experiments, we identified a network of salt bridges between Asp(1261) and the rest of A1 that lock the N-terminal linker in place such that it reduces binding to GpIb. Mutations aimed at disrupting any of these salt bridges activated binding unless the mutated residue also formed a salt bridge with GpIb, in which case the mutations inhibited the binding. These results show that interactions between charged amino acid residues are important both to directly stabilize the A1-GpIb complex and to indirectly destabilize the complex through the N-terminal linker.	[Interlandi, Gianluca; Yakovenko, Olga; Tu, An-Yue; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA; [Harris, Jeff; Le, Jennie; Chen, Junmei; Lopez, Jose A.] Bloodworks Res Inst, Seattle, WA 98102 USA; [Lopez, Jose A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Interlandi, G; Thomas, WE (corresponding author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.	gianluca@u.washington.edu; wendyt@uw.edu		Thomas, Wendy/0000-0001-8602-0819	National Science Foundation [TG-MCB060069N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106074, R21HL129526, R01HL112633, R01HL117639, K25HL118137] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dominic Chung for helpful and interesting discussions and John Kulman for providing the pBIG expression vector. The simulations were performed on the Ranger supercomputer at the Texas Advanced Computing Center thanks to an allocation on the Extreme Science and Engineering Development Environment with Grant TG-MCB060069N, which is made available in part through support from the National Science Foundation.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chung DW, 2016, BLOOD, V127, P637, DOI 10.1182/blood-2014-09-599530; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doggett TA, 2003, BLOOD, V102, P152, DOI 10.1182/blood-2003-01-0072; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Ju LN, 2013, J BIOL CHEM, V288, P32289, DOI 10.1074/jbc.M113.504001; Kada G, 1999, BBA-GEN SUBJECTS, V1427, P33, DOI 10.1016/S0304-4165(98)00178-0; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Kisiela DI, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004857; Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3; Kulman JD, 2007, PROTEIN EXPRES PURIF, V52, P320, DOI 10.1016/j.pep.2006.09.011; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; Miyata S, 1999, J BIOL CHEM, V274, P6586, DOI 10.1074/jbc.274.10.6586; PETERSON DM, 1987, BLOOD, V69, P625; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; SUGIMOTO M, 1993, J BIOL CHEM, V268, P12185; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	37	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18608	18617		10.1074/jbc.M117.797456	http://dx.doi.org/10.1074/jbc.M117.797456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924049	Green Published, hybrid			2022-12-28	WOS:000414958100018
J	Woolger, N; Bournazos, A; Sophocleous, RA; Evesson, FJ; Lek, A; Driemer, B; Sutton, RB; Cooper, ST				Woolger, Natalie; Bournazos, Adam; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Sutton, R. Bryan; Cooper, Sandra T.			Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; protein conformation; protein domain; proteolysis; tertiary structure; dysferlin; patient missense variant	GIRDLE MUSCULAR-DYSTROPHY; INNER DYSF DOMAIN; MEMBRANE REPAIR; MIYOSHI MYOPATHY; C2 DOMAINS; BINDING PROPERTIES; VESICLE FUSION; PROTEIN; CALCIUM; GENE	Dysferlin is a large transmembrane protein that plays a key role in cell membrane repair and underlies a recessive form of inherited muscular dystrophy. Dysferlinopathy is characterized by absence or marked reduction of dysferlin protein with 43% of reported pathogenic variants being missense variants that span the length of the dysferlin protein. The unique structure of dysferlin, with seven tandem C2 domains separated by linkers, suggests dysferlin may dynamically associate with phospholipid membranes in response to Ca2+ signaling. However, the overall conformation of the dysferlin protein is uncharacterized. To dissect the structural architecture of dysferlin, we have applied the method of limited proteolysis, which allows nonspecific digestion of unfolded peptides by trypsin. Using five antibodies spanning the dysferlin protein, we identified a highly reproducible jigsaw map of dysferlin fragments protected from digestion. Our data infer a modular architecture of four tertiary domains: 1) C2A, which is readily removed as a solo domain; 2) midregion C2B-C2C-Fer-DysF, commonly excised as an intact module, with subdigestion to different fragments suggesting several dynamic folding options; 3) C-terminal four-C2 domain module; and 4) calpain-cleaved mini-dysferlin(C72), which is particularly resistant to proteolysis. Importantly, we reveal a patient missense variant, L344P, that largely escapes proteasomal surveillance and shows subtle but clear changes in tertiary conformation. Accompanying evidence from immunohistochemistry and flow cytometry using antibodies with conformationally sensitive epitopes supports proteolysis data. Collectively, we provide insight into the structural topology of dysferlin and show how a single missense mutation within dysferlin can exert local changes in tertiary conformation.	[Woolger, Natalie; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Kids Res Inst, Locked Bag 4001, Westmead, NSW 2145, Australia; [Woolger, Natalie; Bournazos, Adam; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Cooper, Sandra T.] Univ Sydney, Fac Med, Discipline Child & Adolescent Hlth, Sydney, NSW 2006, Australia; [Sutton, R. Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	University of Sydney; University of Sydney; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Cooper, ST (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Kids Res Inst, Locked Bag 4001, Westmead, NSW 2145, Australia.; Cooper, ST (corresponding author), Univ Sydney, Fac Med, Discipline Child & Adolescent Hlth, Sydney, NSW 2006, Australia.	sandra.cooper@sydney.edu.au	Sophocleous, Reece/ABE-4539-2020	Sophocleous, Reece/0000-0002-8339-9090; Bournazos, Adam/0000-0002-6464-4548; Cooper, Sandra/0000-0002-7314-5097	Australian National Health and Medical Research Council [APP1048814, APP1103618, APP1048816]; Jain Foundation; University of Sydney; NIAMS, National Institutes of Health Grant [R01AR063634]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063634] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jain Foundation; University of Sydney(University of Sydney); NIAMS, National Institutes of Health Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Australian National Health and Medical Research Council Project Grants APP1048814 and APP1103618 (to S. T. C.) and Career Development Fellowship APP1048816 (to S. T. C.), the Jain Foundation (to S. T. C.), University of Sydney postgraduate award funding (to N. W.), and NIAMS, National Institutes of Health Grant R01AR063634 (to R. B. S). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; Achanzar WE, 1997, J CELL SCI, V110, P1073; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barohn RJ, 1998, NEUROMUSCULAR DISORD, V8, P309, DOI 10.1016/S0960-8966(98)00030-3; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Choi ER, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-31; Cooper ST, 2015, NEUROSCIENTIST, V21, P653, DOI 10.1177/1073858414558336; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Diaz J, 2016, MUSCLE NERVE, V54, P203, DOI 10.1002/mus.25045; Espinoza-Fonseca LM, 2016, MOL BIOSYST, V12, P973, DOI 10.1039/c5mb00772k; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fuson K, 2014, STRUCTURE, V22, P104, DOI 10.1016/j.str.2013.10.001; Gallardo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029061; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Ho MF, 2002, ANN NEUROL, V51, P129, DOI 10.1002/ana.10080; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Linssen WHJP, 1997, BRAIN, V120, P1989, DOI 10.1093/brain/120.11.1989; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Marty NJ, 2013, BIOCHEMISTRY-US, V52, P5585, DOI 10.1021/bi400432f; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Pramono ZAD, 2006, HUM GENET, V120, P410, DOI 10.1007/s00439-006-0230-1; Pramono ZAD, 2009, HUM GENET, V125, P413, DOI 10.1007/s00439-009-0632-y; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Redpath GMI, 2016, TRAFFIC, V17, P245, DOI 10.1111/tra.12370; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rosales XQ, 2010, MUSCLE NERVE, V42, P14, DOI 10.1002/mus.21650; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sula A, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-3; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wenzel K, 2007, J MOL MED, V85, P1203, DOI 10.1007/s00109-007-0253-7; Woudt L, 2016, MUSCLE NERVE, V53, P49, DOI 10.1002/mus.24685; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Yin X, 2015, INT J CLIN EXP PATHO, V8, P3069	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18577	18591		10.1074/jbc.M117.790014	http://dx.doi.org/10.1074/jbc.M117.790014			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28904177	hybrid, Green Published			2022-12-28	WOS:000414958100016
J	Grabinska, KA; Edani, BH; Park, EJ; Kraehling, JR; Sessa, WC				Grabinska, Kariona A.; Edani, Ban H.; Park, Eon Joo; Kraehling, Jan R.; Sessa, William C.			A conserved C-terminal RXG motif in the NgBR subunit of cis-prenyltransferase is critical for prenyltransferase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; UNDECAPRENYL-PYROPHOSPHATE SYNTHASE; NOGO-B RECEPTOR; DOLICHYL-PHOSPHATE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; RUBBER BIOSYNTHESIS; KEY ENZYME; IDENTIFICATION; GLYCOSYLATION	cis-Prenyltransferases (cis-PTs) constitute a large family of enzymes conserved during evolution and present in all domains of life. In eukaryotes and archaea, cis-PT is the first enzyme committed to the synthesis of dolichyl phosphate, an obligate lipid carrier in protein glycosylation reactions. The homodimeric bacterial enzyme, undecaprenyl diphosphate synthase, generates 11 isoprene units and has been structurally and mechanistically characterized in great detail. Recently, we discovered that unlike undecaprenyl diphosphate synthase, mammalian cis-PT is a heteromer consisting of NgBR (Nus1) and hCIT (dehydrodolichol diphosphate synthase) subunits, and this composition has been confirmed in plants and fungal cis-PTs. Here, we establish the first purification system for heteromeric cis-PT and show that both NgBR and hCIT subunits function in catalysis and substrate binding. Finally, we identified a critical RXG sequence in the C-terminal tail of NgBR that is conserved and essential for enzyme activity across phyla. In summary, our findings show that eukaryotic cis-PT is composed of the NgBR and hCIT subunits. The strong conservation of the RXG motif among NgBR orthologs indicates that this subunit is critical for the synthesis of polyprenol diphosphates and cellular function.	Yale Univ, Sch Med, Dept Pharmacol & Vasc Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Therapeut Program, New Haven, CT 06520 USA	Yale University; Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Grabinska, Kariona A./0000-0002-1232-2555	National Institutes of Health [R01 HL64793, R01 HL61371, HL133018]; Leducq Fondation (MIRVAD network); American Heart Association Scientist Development Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133018, R01HL064793, R01HL061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Fondation (MIRVAD network); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, and HL133018; a grant from the Leducq Fondation (MIRVAD network; to W. C. S.); and an American Heart Association Scientist Development Grant (to E. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAIR WL, 1987, ARCH BIOCHEM BIOPHYS, V259, P589; ADAIR WL, 1984, J BIOL CHEM, V259, P4441; Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; Brasher MI, 2015, PLANT J, V82, P903, DOI 10.1111/tpj.12859; Chan YT, 2017, ACS OMEGA, V2, P930, DOI 10.1021/acsomega.6b00562; Chang SY, 2003, J BIOL CHEM, V278, P29298, DOI 10.1074/jbc.M302687200; Cunillera N, 2000, FEBS LETT, V477, P170, DOI 10.1016/S0014-5793(00)01798-1; DENNIS MS, 1989, J BIOL CHEM, V264, P18618; Dowhan W, 2017, J BIOL CHEM, V292, P10755, DOI 10.1074/jbc.X117.794891; Endo S, 2003, BBA-GENE STRUCT EXPR, V1625, P291, DOI 10.1016/S0167-4781(02)00628-0; Epping J, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.48; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Grabinska K, 2005, ACTA BIOCHIM POL, V52, P221; Grabinska KA, 2016, J BIOL CHEM, V291, P18582, DOI 10.1074/jbc.R116.739490; Grabinska KA, 2010, GLYCOBIOLOGY, V20, P824, DOI 10.1093/glycob/cwq036; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Kera K, 2012, FEBS J, V279, P3813, DOI 10.1111/j.1742-4658.2012.08742.x; Ko TP, 2001, J BIOL CHEM, V276, P47474, DOI 10.1074/jbc.M106747200; KOYAMA T, 1988, J BIOCHEM-TOKYO, V103, P867, DOI 10.1093/oxfordjournals.jbchem.a122363; Kurisaki A, 1996, BIOSCI BIOTECH BIOCH, V60, P1109, DOI 10.1271/bbb.60.1109; Kwon M, 2016, METHOD ENZYMOL, V576, P121, DOI 10.1016/bs.mie.2016.02.026; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Milani D, 2016, CONGENIT ANOM, V56, P187, DOI 10.1111/cga.12164; Ogawa T, 2016, FEBS J, V283, P2369, DOI 10.1111/febs.13749; Oh SK, 2000, J BIOL CHEM, V275, P18482, DOI 10.1074/jbc.M002000200; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Qu Y, 2015, J BIOL CHEM, V290, P1898, DOI 10.1074/jbc.M114.616920; Sabry S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0468-1; Sato M, 1999, MOL CELL BIOL, V19, P471; Shridas P, 2003, BIOCHEM BIOPH RES CO, V312, P1349, DOI 10.1016/j.bbrc.2003.11.065; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Surmacz L, 2014, BBA-MOL CELL BIOL L, V1841, P240, DOI 10.1016/j.bbalip.2013.11.011; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Szkopinska A, 1997, J LIPID RES, V38, P962; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; Teng KH, 2012, BIOORG CHEM, V43, P51, DOI 10.1016/j.bioorg.2011.09.004; Venturini G, 2015, GENET MED, V17, P285, DOI 10.1038/gim.2014.132; Wang W, 2008, J MOL BIOL, V381, P129, DOI 10.1016/j.jmb.2008.05.060; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]; Yamashita S., 2016, HEVEA BRASILIENSIS E, V5; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	47	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17351	17361		10.1074/jbc.M117.806034	http://dx.doi.org/10.1074/jbc.M117.806034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842490	Green Published, hybrid			2022-12-28	WOS:000414009300017
J	Bansal, T; Chatterjee, E; Singh, J; Ray, A; Kundu, B; Thankamani, V; Sengupta, S; Sarkar, S				Bansal, Trisha; Chatterjee, Emeli; Singh, Jasdeep; Ray, Arjun; Kundu, Bishwajit; Thankamani, V.; Sengupta, Shantanu; Sarkar, Sagartirtha			Arjunolic acid, a peroxisome proliferator-activated receptor alpha agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; TERMINALIA-ARJUNA; MYOCARDIAL FIBROSIS; PRESSURE-OVERLOAD; FORCE-FIELD; KAPPA-B; CARDIOVASCULAR DISORDERS; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; HYPERTROPHY	Cardiac hypertrophy and associated heart fibrosis remain a major cause of death worldwide. Phytochemicals have gained attention as alternative therapeutics for managing cardiovascular diseases. These include the extract from the plant Terminalia arjuna, which is a popular cardioprotectant and may prevent or slow progression of pathological hypertrophy to heart failure. Here, we investigated the mode of action of a principal bioactive T. arjuna compound, arjunolic acid (AA), in ameliorating hemodynamic load-induced cardiac fibrosis and identified its intracellular target. Our data revealed that AA significantly represses collagen expression and improves cardiac function during hypertrophy. We found that AA binds to and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPAR alpha) and increases its expression during cardiac hypertrophy. PPAR alpha knockdown during AA treatment in hypertrophy samples, including angiotensin II-treated adult cardiac fibroblasts and renal artery-ligated rat heart, suggests that AA-driven cardioprotection primarily arises from PPAR alpha agonism. Moreover, AA-induced PPAR alpha up-regulation leads to repression of TGF-beta signaling, specifically by inhibiting TGF-beta-activated kinase1 (TAK1) phosphorylation. We observed that PPAR alpha directly interacts with TAK1, predominantly via PPAR alpha N-terminal transactivation domain (AF-1) thereby masking the TAK1 kinase domain. The AA-induced PPAR alpha bound TAK1 level thereby shows inverse correlation with the phosphorylation level of TAK1 and subsequent reduction in p38 MAPK and NF-kappa Bp65 activation, ultimately culminating in amelioration of excess collagen synthesis in cardiac hypertrophy. In conclusion, our findings unravel the mechanism of AA action in regressing hypertrophy-associated cardiac fibrosis by assigning a role of AA as a PPAR alpha agonist that inactivates non-canonical TGF-beta signaling.	[Bansal, Trisha; Chatterjee, Emeli; Sarkar, Sagartirtha] Univ Calcutta, Dept Zool, Genet & Mol Cardiol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, West Bengal, India; [Singh, Jasdeep; Kundu, Bishwajit] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi 110016, India; [Ray, Arjun; Sengupta, Shantanu] Inst Genom & Integrat Biol, CSIR, Genom & Mol Med Unit, Mathura Rd, New Delhi 110020, India; [Thankamani, V.] Univ Kerala, Dept Biotechnol, Thiruvananthapuram 695014, Kerala, India; [Thankamani, V.] Santhigiri Inst Biosci, Santhigiri 695598, Kerala, India	University of Calcutta; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Kerala	Sarkar, S (corresponding author), Univ Calcutta, Dept Zool, Genet & Mol Cardiol Lab, 35 Ballygunge Circular Rd, Kolkata 700019, West Bengal, India.	sagartirtha.sarkar@gmail.com	Singh, Jasdeep/ABD-2820-2021; Bansal, Trisha/HGA-8082-2022; Ray, Arjun/AAD-9162-2019	Singh, Jasdeep/0000-0002-4318-8360; Kundu, Bishwajit/0000-0002-5786-3144; Ray, Arjun/0000-0002-6020-5863	Department of Biotechnology, Ministry of Science and Technology, India [BT-PR3709/BRB/10/980/2011, BT/PR7016/NNT/28/641/2012]; Department of Science and Technology, Government of India [SB/SO/HS-148/2013]; Council of Scientific and Industrial Research (CSIR), India [09/028(0878)/2012-EMR-I]	Department of Biotechnology, Ministry of Science and Technology, India; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Department of Biotechnology, Ministry of Science and Technology, India Grants BT-PR3709/BRB/10/980/2011 and BT/PR7016/NNT/28/641/2012 and Department of Science and Technology, Government of India, Grant SB/SO/HS-148/2013 (to S. Sarkar). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Fellowship 09/028(0878)/2012-EMR-I from the Council of Scientific and Industrial Research (CSIR), India.	Ajees AA, 2002, ACTA CRYSTALLOGR E, V58, pO682, DOI 10.1107/S1600536802006451; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Amalraj Augustine, 2017, J Tradit Complement Med, V7, P65, DOI 10.1016/j.jtcme.2016.02.003; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen JC, 2000, AM J CHINESE MED, V28, P175, DOI 10.1142/S0192415X00000222; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Datta R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00611-16; Datta R, 2015, CELL SIGNAL, V27, P2410, DOI 10.1016/j.cellsig.2015.09.005; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Denning EJ, 2011, J COMPUT CHEM, V32, P1929, DOI 10.1002/jcc.21777; Diep QN, 2004, J MOL CELL CARDIOL, V36, P295, DOI 10.1016/j.yjmcc.2003.11.004; Divakaran V., 2009, CIRC HEART FAIL; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; dos Santos JC, 2015, J STRUCT BIOL, V191, P332, DOI 10.1016/j.jsb.2015.07.006; Dwivedi S, 2007, J ETHNOPHARMACOL, V114, P114, DOI 10.1016/j.jep.2007.08.003; Dwivedi Shridhar, 2014, J Tradit Complement Med, V4, P224, DOI 10.4103/2225-4110.139103; Fang JA, 2010, PHYTOMEDICINE, V18, P58, DOI 10.1016/j.phymed.2010.06.002; Ghosh J, 2013, BIOCHIMIE, V95, P1098, DOI 10.1016/j.biochi.2013.01.016; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hemalatha T, 2010, INDIAN J EXP BIOL, V48, P238; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jiao M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.361; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Kelly DP, 2003, CIRC RES, V92, P482, DOI 10.1161/01.RES.0000064382.46274.95; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kumar S, 2009, J PHARM PHARMACOL, V61, P1529, DOI [10.1211/jpp/61.11.0013, 10.1211/jpp.61.11.0013]; Kurdi M, 2011, HYPERTENSION, V57, P1034, DOI 10.1161/HYPERTENSIONAHA.111.172700; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Lee HK, 2006, EXP DERMATOL, V15, P66, DOI 10.1111/j.0906-6705.2005.00386.x; Lee HS, 2012, PROTEINS, V80, P93, DOI 10.1002/prot.23165; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Maulik SK, 2012, AM J CARDIOVASC DRUG, V12, P157, DOI 10.2165/11598990-000000000-00000; McMullen PD, 2014, CHEM-BIOL INTERACT, V209, P14, DOI 10.1016/j.cbi.2013.11.006; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mitra A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.114; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ogata T, 2004, J AM COLL CARDIOL, V43, P1481, DOI 10.1016/j.jacc.2003.11.043; Ono K, 2003, BIOCHEM BIOPH RES CO, V307, P332, DOI 10.1016/S0006-291X(03)01207-5; Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935; Park MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076820; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poleni PE, 2007, OSTEOARTHR CARTILAGE, V15, P493, DOI 10.1016/j.joca.2006.10.009; Ramesh AS, 2012, NAT PROD RES, V26, P1549, DOI 10.1080/14786419.2011.566870; Rana S, 2015, J CONTROL RELEASE, V200, P167, DOI 10.1016/j.jconrel.2015.01.008; Ray A, 2016, TOXICOL APPL PHARM, V290, P54, DOI 10.1016/j.taap.2015.11.011; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Seymour EM, 2010, HYPERTENSION, V55, P1179, DOI 10.1161/HYPERTENSIONAHA.109.149393; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Smeets PJH, 2007, ACTA PHYSIOL, V191, P171, DOI 10.1111/j.1748-1716.2007.01752.x; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Stockert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063011; Subramanian V, 2017, J PROTEOME RES, V16, P307, DOI 10.1021/acs.jproteome.6b00795; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tzeng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134996; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Wei CY, 2013, J CELL PHYSIOL, V228, P1433, DOI 10.1002/jcp.24296; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Youssef J., 2015, NUCL RECEPTOR RES, V2, P1; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	77	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16440	16462		10.1074/jbc.M117.788299	http://dx.doi.org/10.1074/jbc.M117.788299			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28821620	hybrid, Green Published			2022-12-28	WOS:000412414800004
J	Hendershot, JM; O'Brien, PJ				Hendershot, Jenna M.; O'Brien, Patrick J.			Search for DNA damage by human alkyladenine DNA glycosylase involves early intercalation by an aromatic residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; BASE EXCISION; REPAIR; BINDING; CELLS; AAG	DNA repair enzymes recognize and remove damaged bases that are embedded in the duplex. To gain access, most enzymes use nucleotide flipping, whereby the target nucleotide is rotated 180 degrees into the active site. In human alkyladenine DNA glycosylase (AAG), the enzyme that initiates base excision repair of alkylated bases, the flipped-out nucleotide is stabilized by intercalation of the side chain of tyrosine 162 that replaces the lesion nucleobase. Previous kinetic studies provided evidence for the formation of a transient complex that precedes the stable flipped-out complex, but it is not clear how this complex differs from nonspecific complexes. We used site-directed mutagenesis and transient-kinetic approaches to investigate the timing of Tyr(162) intercalation for AAG. The tryptophan substitution (Y162W) appeared to be conservative, because the mutant protein retained a highly favorable equilibrium constant for flipping the 1,N-6-ethenoadenine (epsilon A) lesion, and the rate of N-glycosidic bond cleavage was identical to that of the wild-type enzyme. We assigned the tryptophan fluorescence signal from Y162W by removing two native tryptophan residues (W270A/W284A). Stopped-flow experiments then demonstrated that the change in tryptophan fluorescence of the Y162W mutant is extremely rapid upon binding to either damaged or undamaged DNA, much faster than the lesion-recognition and nucleotide flipping steps that were independently determined by monitoring the epsilon A fluorescence. These observations suggest that intercalation by this aromatic residue is one of the earliest steps in the search for DNA damage and that this interaction is important for the progression of AAG from nonspecific searching to specific-recognition complexes.	[Hendershot, Jenna M.; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Med Sch, 5301 MSRB 3,1150 W Med Ctr Dr,SPC 5606, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Dept Biol Chem, Med Sch, 5301 MSRB 3,1150 W Med Ctr Dr,SPC 5606, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu			NIGMS of the National Institutes of Health [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM108022] Funding Source: NIH RePORTER	NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the O'Brien laboratory for helpful discussions and comments on the manuscript. The University of Michigan Comprehensive Cancer Center is supported by NIGMS of the National Institutes of Health Grant P30CA036727.	Cao CY, 2006, J AM CHEM SOC, V128, P13034, DOI 10.1021/ja062978n; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hendershot JM, 2014, NUCLEIC ACIDS RES, V42, P12681, DOI 10.1093/nar/gku919; Hendershot JM, 2011, BIOCHEMISTRY-US, V50, P1864, DOI 10.1021/bi101856a; Hsieh J, 2009, RNA, V15, P224, DOI 10.1261/rna.1309409; IBEANU G, 1992, CARCINOGENESIS, V13, P1989, DOI 10.1093/carcin/13.11.1989; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Li DY, 2012, J AM CHEM SOC, V134, P8896, DOI 10.1021/ja3010094; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lingaraju GM, 2011, J BIOL CHEM, V286, P13205, DOI 10.1074/jbc.M110.192435; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; Setser JW, 2012, BIOCHEMISTRY-US, V51, P382, DOI 10.1021/bi201484k; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082	26	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16070	16080		10.1074/jbc.M117.782813	http://dx.doi.org/10.1074/jbc.M117.782813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28747435	hybrid, Green Published			2022-12-28	WOS:000412109400008
J	Malmos, KG; Bjerring, M; Jessen, CM; Nielsen, EHT; Poulsen, ET; Christiansen, G; Vosegaard, T; Skrydstrup, T; Enghild, JJ; Pedersen, JS; Otzen, DE				Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Poulsen, Ebbe T.; Christiansen, Gunna; Vosegaard, Thomas; Skrydstrup, Troels; Enghild, Jan J.; Pedersen, Jan Skov; Otzen, Daniel E.			How glycosaminoglycans promote fibrillation of salmon calcitonin (vol 291, pg 16849, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Vosegaard, Thomas/0000-0001-5414-4550; Enghild, Jan Johannes/0000-0001-9292-9172; Christiansen, Gunna/0000-0003-0540-1367				Malmos KG, 2016, J BIOL CHEM, V291, P16849, DOI 10.1074/jbc.M116.715466	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15992	15992		10.1074/jbc.A116.715466	http://dx.doi.org/10.1074/jbc.A116.715466			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939753	Green Published, hybrid			2022-12-28	WOS:000411512200036
J	Yan, Y; Xu, TH; Harikumar, KG; Miller, LJ; Melcher, K; Xu, HE				Yan, Yan; Xu, Ting-Hai; Harikumar, Kaleeckal G.; Miller, Laurence J.; Melcher, Karsten; Xu, H. Eric			Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the gamma - secretase cleavage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ALZHEIMERS-DISEASE; APP DIMERIZATION; COUPLED SECRETIN; GXXXG MOTIFS; HOMODIMERIZATION; DIMER; BETA; OLIGOMERIZATION; DUPLICATION	One of the hallmarks of Alzheimer's disease is the formation of extracellular amyloid plaques that consist mainly of abnormally aggregated forms of amyloid beta (A beta) peptides. These peptides are generated by gamma-secretase-catalyzed cleavage of a dimeric membrane-bound C-terminal fragment (C99) of the amyloid precursor protein. Although C99 homodimerization has been linked to A beta production and changes in the aggregation-determining A beta 42/40 ratio, the motif through which C99 dimerizes has remained controversial. Here, we have used two independent assays to gain insight in to C99homodimerization in the context of the membrane of live cells: bioluminescence resonance energy transfer and Tango membrane proteinprotein interaction assays, which were further confirmed by traditional pull-down assays. Our results indicate a four-amino acid region within the C99 transmembrane helix (43TVIV46) as well as its local secondary structure as critical determinants for homodimerization. These four amino acids are also a hot spot of familial Alzheimer's disease-linked mutations that both decrease C99 homodimerization and gamma-secretase cleavage and alter the initial cleavage site to increase the A beta 42/40 ratio.	[Yan, Yan; Xu, Ting-Hai; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr, Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Yan, Yan; Xu, Ting-Hai] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yan, Yan; Xu, Ting-Hai; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix	Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr, Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Melcher, K; Xu, HE (corresponding author), Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA.	Karsten.melcher@vai.org; eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Xu, Tinghai/0000-0003-2239-1420	NIDDK NIH HHS [R01 DK071662] Funding Source: Medline; NIGMS NIH HHS [R01 GM102545, R01 GM104212] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545, R01GM104212] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; De-Paula Vanessa J, 2012, Subcell Biochem, V65, P329, DOI 10.1007/978-94-007-5416-4_14; Decock M, 2015, FEBS OPEN BIO, V5, P763, DOI 10.1016/j.fob.2015.09.002; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Dominguez L, 2016, P NATL ACAD SCI USA, V113, pE5281, DOI 10.1073/pnas.1606482113; Dominguez L, 2014, J AM CHEM SOC, V136, P9619, DOI 10.1021/ja503150x; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2016, J BIOL CHEM, V291, P17332, DOI 10.1074/jbc.M116.730754; Higashide H, 2017, J NEUROCHEM, V140, P955, DOI 10.1111/jnc.13942; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelly DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010532; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kinoshita June, 2007, Methods Mol Biol, V401, P365, DOI 10.1007/978-1-59745-520-6_19; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; So Pauline Pl, 2013, Am J Neurodegener Dis, V2, P15; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Xu TH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.26; Yan Y, 2017, ACTA PHARMACOL SIN, V38, P1412, DOI 10.1038/aps.2017.35; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	46	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15826	15837		10.1074/jbc.M117.789669	http://dx.doi.org/10.1074/jbc.M117.789669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28790170	Green Published, hybrid			2022-12-28	WOS:000411512200020
J	Akinfenwa, PY; Bond, WS; Ildefonso, CJ; Hurwitz, MY; Hurwitz, RL				Akinfenwa, Patricia Y.; Bond, Wesley S.; Ildefonso, Cristhian J.; Hurwitz, Mary Y.; Hurwitz, Richard L.			Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; HYALURONAN; ACTIVATION; DIFFERENTIATION; RETINOBLASTOMA; RECEPTOR; GROWTH; CD44; PROLIFERATION; PROTEOGLYCAN	Toexamine the biochemical influences that may contribute to the success of gene therapy for ocular disorders, the role of versican, a vitreous component, in adenoviral-mediated transgene expression was examined. Versican is a large chondroitin sulfate-containing, hyaluronic acid-binding proteoglycan present in the extracellular matrix and in ocular vitreous body. Y79 retinoblastoma cells and CD44-negative SK-N-DZ neuroblastoma cells transduced with adenoviral vectors in the presence of versican respond with an activation of transgene expression. Proteolysis of versican generates a hyaluronan-binding G1 domain. The addition of recombinant versican G1 to SK-N-DZ cells results in a similar activation of transgene expression, and treatment with dasatinib, an inhibitor of Src family kinases, also mimics the effects of versican. Enhancement is accompanied by an increase in signal transducer and activator of transcription 5 (STAT5) phosphorylation and is abrogated by treatment with C188-9, a STAT3/5 inhibitor, or with ruxolitinib, a Janus kinase 1/2 (JAK1/2) inhibitor. These data implicate versican G1 in enhancing adenoviral vector transgene expression in a hyaluronic acid-CD44 independent manner that is down-regulated by inhibitors of the JAK/STAT pathway and enhanced by inhibitors of the Src kinase pathway.	[Akinfenwa, Patricia Y.; Bond, Wesley S.; Ildefonso, Cristhian J.; Hurwitz, Richard L.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bond, Wesley S.; Ildefonso, Cristhian J.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA; [Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Akinfenwa, Patricia Y.; Bond, Wesley S.; Ildefonso, Cristhian J.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Akinfenwa, Patricia Y.] Methodist Hosp, Houston, TX 77030 USA; [Bond, Wesley S.] Spark Therapeut Inc, Philadelphia, PA 19104 USA; [Ildefonso, Cristhian J.] Univ Florida, Dept Ophthalmol, Coll Med, Gainesville, FL 32610 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; State University System of Florida; University of Florida	Hurwitz, RL (corresponding author), Baylor Coll Med, 1102 Bates St,Ste 1025, Houston, TX 77030 USA.	rhurwitz@bcm.edu	Ildefonso, Cristhian/AAC-3576-2021	Ildefonso, Cristhian/0000-0001-6179-720X	National Institutes of Health [F31-GM085793, T32-DK064717, T32-EY07001]; Retina Research Foundation; Golfers Against Cancer; NATIONAL EYE INSTITUTE [T32EY007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; Golfers Against Cancer; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31-GM085793 (to C. J. I.), T32-DK064717 (to C. J. I.), and T32-EY07001 (to P. Y. A.). This work was also supported in part by awards from the Retina Research Foundation (to R. L. H. and M. Y. H.) and Golfers Against Cancer (to R. L. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittomaki S, 2014, BASIC CLIN PHARMACOL, V114, P18, DOI 10.1111/bcpt.12164; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Chaudhuri SR, 2007, MOL THER, V15, P566, DOI 10.1038/sj.mt.6300044; Du WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026396; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; Foulcer SJ, 2014, J BIOL CHEM, V289, P27859, DOI 10.1074/jbc.M114.573287; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; GROSS N, 1994, CANCER RES, V54, P4238; Hasegawa K, 2007, J INVEST DERMATOL, V127, P1657, DOI 10.1038/sj.jid.5700754; Hudson KS, 2010, ANAT REC, V293, P1669, DOI 10.1002/ar.21235; Hurwitz MY, 1999, HUM GENE THER, V10, P441, DOI 10.1089/10430349950018887; Ildefonso CJ, 2012, J BIOL CHEM, V287, P32697, DOI 10.1074/jbc.M112.347369; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; KATO G, 1990, EXP CELL RES, V189, P51, DOI 10.1016/0014-4827(90)90255-9; Kawashima H, 1999, INT IMMUNOL, V11, P393, DOI 10.1093/intimm/11.3.393; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Murasawa Y, 2013, J BIOL CHEM, V288, P29170, DOI 10.1074/jbc.M113.456947; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Ohno-Jinno A, 2008, INVEST OPHTH VIS SCI, V49, P2870, DOI 10.1167/iovs.07-1488; Phan AT, 2016, CANCER MED-US, V5, P2953, DOI 10.1002/cam4.742; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Robak T, 2012, EXPERT OPIN INV DRUG, V21, P921, DOI 10.1517/13543784.2012.685650; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066; Streilein JW, 1997, OCUL IMMUNOL INFLAMM, V5, P217, DOI 10.3109/09273949709116898; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Waters MJ, 2016, GROWTH HORM IGF RES, V28, P6, DOI 10.1016/j.ghir.2015.06.001; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	37	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14381	14390		10.1074/jbc.M116.773549	http://dx.doi.org/10.1074/jbc.M116.773549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684419	Green Published, hybrid			2022-12-28	WOS:000408747500007
J	Asjad, HMM; Kasture, A; El-Kasaby, A; Sackel, M; Hummel, T; Freissmuth, M; Sucic, S				Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Sackel, Michael; Hummel, Thomas; Freissmuth, Michael; Sucic, Sonja			Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; dopamine; dopamine transporter; endoplasmic reticulum (ER); neurotransmitter transport; dopamine	HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; DEFICIENCY SYNDROME; PHARMACOLOGICAL CHAPERONES; BEHAVIORAL-RESPONSES; OLIGOMER FORMATION; SLC6 TRANSPORTERS; PLASMA-MEMBRANE; LIVING CELLS	Point mutations in the gene encoding the human dopamine transporter (hDAT, SLC6A3) cause a syndrome of infantile/juvenile dystonia and parkinsonism. To unravel the molecular mechanism underlying these disorders and investigate possible pharmacological therapies, here we examined 13 disease-causing DAT mutants that were retained in the endoplasmic reticulum when heterologously expressed in HEK293 cells. In three of these mutants, i.e. hDAT-V158F, hDAT-G327R, and hDAT-L368Q, the folding deficit was remedied with the pharmacochaperone noribogaine or the heat shock protein 70 (HSP70) inhibitor pifithrin- such that endoplasmic reticulum export of and radioligand binding and substrate uptake by these DAT mutants were restored. In Drosophila melanogaster, DAT deficiency results in reduced sleep. We therefore exploited the power of targeted transgene expression of mutant hDAT in Drosophila to explore whether these hDAT mutants could also be pharmacologically rescued in an intact organism. Noribogaine or pifithrin- treatment supported hDAT delivery to the presynaptic terminals of dopaminergic neurons and restored sleep to normal length in DAT-deficient (fumin) Drosophila lines expressing hDAT-V158F or hDAT-G327R. In contrast, expression of hDAT-L368Q in the Drosophila DAT mutant background caused developmental lethality, indicating a toxic action not remedied by pharmacochaperoning. Our observations identified those mutations most likely amenable to pharmacological rescue in the affected children. In addition, our findings also highlight the challenges of translating insights from pharmacochaperoning in cell culture to the clinical situation. Because of the evolutionary conservation in dopaminergic neurotransmission between Drosophila and people, pharmacochaperoning of DAT in D. melanogaster may allow us to bridge that gap.	[Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria; [Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Gaston H Glock Res Labs Exploratory Drug Dev, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Sackel, Michael; Hummel, Thomas] Univ Vienna, Dept Neurobiol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Sucic, Sonja/0000-0001-5136-8022; Asjad, Hafiz Muhammad Mazhar/0000-0001-6155-9113; Kasture, Ameya/0000-0002-2947-4803	Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF) [P27518-B27, SFB35 F3510]; Higher Education Commission of Pakistan; Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service; doctoral program Cell Communication in Health and Disease; Austrian Science Fund/FWF [W1205]; Medical University of Vienna	Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service; doctoral program Cell Communication in Health and Disease; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF)-funded Project P27518-B27 (to S. S.) and Project Program Grant SFB35 F3510 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. stipend jointly awarded by the Higher Education Commission of Pakistan and the Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service.; Supported by the doctoral program Cell Communication in Health and Disease, which was jointly funded by Grant W1205 from the Austrian Science Fund/FWF and the Medical University of Vienna. This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree.	Anderluh A, 2014, BIOPHYS J, V106, pL33, DOI 10.1016/j.bpj.2014.03.019; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Arribas-Gonzalez E, 2015, J BIOL CHEM, V290, P2150, DOI 10.1074/jbc.M114.587055; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baumann MH, 2001, J PHARMACOL EXP THER, V297, P531; Beerepoot P, 2016, J BIOL CHEM, V291, P22053, DOI 10.1074/jbc.M116.749119; Bhat S, 2017, J BIOL CHEM, V292, P16773, DOI 10.1074/jbc.M117.794081; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Germain DP, 2016, NEW ENGL J MED, V375, P545, DOI 10.1056/NEJMoa1510198; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Glue P, 2016, CLIN PHARM DRUG DEV, V5, P460, DOI 10.1002/cpdd.254; Glue P, 2015, J CLIN PHARMACOL, V55, P189, DOI 10.1002/jcph.404; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Illiano P, 2017, EUR J NEUROSCI, V45, P207, DOI 10.1111/ejn.13366; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kasture A, 2016, J BIOL CHEM, V291, P20876, DOI 10.1074/jbc.M116.737551; King LB, 2016, G3-GENES GENOM GENET, V6, P1083, DOI 10.1534/g3.115.026484; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Li Y, 2017, J BIOL CHEM, V292, P4235, DOI 10.1074/jbc.M116.760140; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Pathak T, 2017, G3-GENES GENOM GENET, V7, P923, DOI 10.1534/g3.116.038539; Pendleton RG, 2005, PHARMACOL BIOCHEM BE, V81, P849, DOI 10.1016/j.pbb.2005.06.008; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Pitmon E, 2016, GENES BRAIN BEHAV, V15, P327, DOI 10.1111/gbb.12264; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Robinson SB, 2017, MOL CELL NEUROSCI, V78, P41, DOI 10.1016/j.mcn.2016.11.011; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic Sonja, 2016, J Neurol Neuromedicine, V1, P34; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	55	24	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19250	19265		10.1074/jbc.M117.797092	http://dx.doi.org/10.1074/jbc.M117.797092			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972153	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000416226700009
J	Gulyas, G; Radvanszki, G; Matuska, R; Balla, A; Hunyady, L; Balla, T; Varnai, P				Gulyas, Gergo; Radvanszki, Gloria; Matuska, Rita; Balla, Andras; Hunyady, Laszlo; Balla, Tamas; Varnai, Peter			Plasma membrane phosphatidylinositol 4-phosphate and 4,5-bisphosphate determine the distribution and function of K-Ras4B but not H-Ras proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); G protein-coupled receptor (GPCR); Golgi; GTPase Kras (KRAS); phosphoinositide	K-RAS; ENDOPLASMIC-RETICULUM; DYNAMIC CHANGES; LOCALIZATION; TRAFFICKING; ACTIVATION; PHOSPHOINOSITIDES; VISUALIZATION; ASSOCIATION; RECEPTOR	Plasma membrane (PM) localization of Ras proteins is crucial for transmitting signals upon mitogen stimulation. Post-translational lipid modification of Ras proteins plays an important role in their recruitment to the PM. Electrostatic interactions between negatively charged PM phospholipids and basic amino acids found in K-Ras4B (K-Ras) but not in H-Ras are important for permanent K-Ras localization to the PM. Here, we investigated how acute depletion of negatively charged PM polyphosphoinositides (PPIns) from the PM alters the intracellular distribution and activity of K- and H-Ras proteins. PPIns depletion from the PM was achieved either by agonist-induced activation of phospholipase C or with a rapamycin-inducible system in which various phosphatidylinositol phosphatases were recruited to the PM. Redistribution of the two Ras proteins was monitored with confocal microscopy or with a recently developed bioluminescence resonance energy transfer-based approach involving fusion of the Ras C-terminal targeting sequences or the entire Ras proteins to Venus fluorescent protein. We found that PM PPIns depletion caused rapid translocation of K-Ras but not H-Ras from the PM to the Golgi. PM depletion of either phosphatidylinositol 4-phosphate (PtdIns4P) or PtdIns(4,5)P-2 but not PtdIns(3,4,5)P-3 was sufficient to evoke K-Ras translocation. This effect was diminished by deltarasin, an inhibitor of the Ras-phosphodiesterase interaction, or by simultaneous depletion of the Golgi PtdIns4P. The PPIns depletion decreased incorporation of [H-3]leucine in K-Ras-expressing cells, suggesting that Golgi-localized K-Ras is not as signaling-competent as its PM-bound form. We conclude that PPIns in the PM are important regulators of K-Ras-mediated signals.	[Gulyas, Gergo; Radvanszki, Gloria; Matuska, Rita; Balla, Andras; Hunyady, Laszlo; Varnai, Peter] Semmelweis Univ, Dept Physiol, Fac Med, H-1094 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Hungarian Acad Sci, MTA SE Lab Mol Physiol, H-1094 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Semmelweis Univ, H-1094 Budapest, Hungary; [Balla, Andras] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Varnai, P (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	varnai.peter@med.semmelweis-univ.hu	; Gulyas, Gergo/I-8923-2017; Varnai, Peter/F-4902-2019	Balla, Andras/0000-0002-6450-2793; Balla, Tamas/0000-0002-9077-3335; Gulyas, Gergo/0000-0002-5491-8699; Varnai, Peter/0000-0002-7777-806X	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; National Research, Development and Innovation Fund [NKFIH K105006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; National Research, Development and Innovation Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health.; Supported by National Research, Development and Innovation Fund Grant NKFIH K105006. To whom correspondence should be addressed: Dept. of Physiology, Faculty of Medicine, Semmelweis University, Budapest, P. O. Box 259, H-1444 Budapest, Hungary. E-mail: varnai.peter@med.semmelweis-univ.hu.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Balla A, 2011, J BIOL CHEM, V286, P5319, DOI 10.1074/jbc.M110.176933; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Calimeri T, 2017, BRIT J HAEMATOL, V177, P684, DOI 10.1111/bjh.14529; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Carquin M, 2016, PROG LIPID RES, V62, P1, DOI 10.1016/j.plipres.2015.12.004; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Goldfinger LE, 2017, BIOSCI TRENDS, V11, P23, DOI 10.5582/bst.2016.01220; Gregory MC, 2017, BIOCHEM BIOPH RES CO, V487, P351, DOI 10.1016/j.bbrc.2017.04.063; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Ji C, 2015, J BIOL CHEM, V290, P26978, DOI 10.1074/jbc.M115.663013; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Koveal D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003289; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lorenzo PS, 2001, CANCER RES, V61, P943; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Scheidt HA, 2009, BIOPHYS J, V96, P3663, DOI 10.1016/j.bpj.2009.02.028; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varma S, 2007, BBA-GEN SUBJECTS, V1770, P71, DOI 10.1016/j.bbagen.2006.07.016; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18862	18877		10.1074/jbc.M117.806679	http://dx.doi.org/10.1074/jbc.M117.806679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28939768	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000415848000012
J	Heissler, SM; Chinthalapudi, K; Sellers, JR				Heissler, Sarah M.; Chinthalapudi, Krishna; Sellers, James R.			Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; ATPase; inhibitor; kinetics; myosin; myoVin-1	CLASS-V MYOSINS; DROSOPHILA-MELANOGASTER; PROCESSIVE MOVEMENT; EPITHELIAL-CELLS; ADP DISSOCIATION; MYO5B MUTATIONS; MOLECULAR MOTOR; NECK LENGTH; DUTY RATIO; ACTIN	Myosin-5B is a ubiquitous molecular motor that transports cargo vesicles of the endomembrane system in intracellular recycling pathways. Myosin-5B malfunction causes the congenital enteropathy microvillus inclusion disease, underlining its importance in cellular homeostasis. Here we describe the interaction of myosin-5B with F-actin, nucleotides, and the pyrazolopyrimidine compound myoVin-1. We show that single-headed myosin-5B is an intermediate duty ratio motor with a kinetic ATPase cycle that is rate-limited by the release of phosphate. The presence of a second head generates strain and gating in the myosin-5B dimer that alters the kinetic signature by reducing the actin-activated ADP release rate to become rate-limiting. This kinetic transition into a high-duty ratio motor is a prerequisite for the proposed transport function of myosin-5B in cellular recycling pathways. Moreover, we show that the small molecule compound myoVin-1 inhibits the enzymatic and functional activity of myosin-5B in vitro. Partial inhibition of the actin-activated steady-state ATPase activity and sliding velocity suggests that caution should be used when probing the effect of myoVin-1 on myosin-5-dependent transport processes in cells.	[Heissler, Sarah M.; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3529, Bethesda, MD 20892 USA; [Chinthalapudi, Krishna] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Heissler, SM; Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3529, Bethesda, MD 20892 USA.	sarah.heissler@nih.gov; sellersj@nhlbi.nih.gov	Chinthalapudi, Krishna/B-4550-2018	Chinthalapudi, Krishna/0000-0003-3669-561X	National Heart, Lung, and Blood Institute of the National Institutes of Health [HL004229]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004229, ZIAHL004232, Z01HL004229] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL004229). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamek Nancy, 2014, Exp Suppl, V105, P87, DOI 10.1007/978-3-0348-0856-9_5; Avasthi P, 2014, CURR BIOL, V24, P2025, DOI 10.1016/j.cub.2014.07.038; Bao JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074936; Cheeseman LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13726; Clayton JE, 2014, MOL BIOL CELL, V25, P66, DOI 10.1091/mbc.E13-04-0200; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Deguchi H, 2016, BLOOD, V128, P1870, DOI 10.1182/blood-2016-03-707679; Dong WJ, 2012, DIGEST DIS SCI, V57, P1247, DOI 10.1007/s10620-011-1989-z; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; GEEVES MA, 1989, BIOCHEMISTRY-US, V28, P5864, DOI 10.1021/bi00440a024; Gramlich MW, 2017, CELL REP, V18, P2096, DOI 10.1016/j.celrep.2017.02.010; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; Heissler SM, 2016, J MOL BIOL, V428, P1927, DOI 10.1016/j.jmb.2016.01.022; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Heissler SM, 2015, FASEB J, V29, P1456, DOI 10.1096/fj.14-266742; Heissler SM, 2012, FEBS LETT, V586, P3208, DOI 10.1016/j.febslet.2012.07.014; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Islam K, 2010, ANGEW CHEM INT EDIT, V49, P8484, DOI 10.1002/anie.201004026; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Ji HH, 2015, BIOCHEM J, V469, P135, DOI 10.1042/BJ20141330; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Katsimitsoulia Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/781456; Knowles BC, 2014, J CLIN INVEST, V124, P2947, DOI 10.1172/JCI71651; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Miller KE, 2000, J BIOL CHEM, V275, P2598, DOI 10.1074/jbc.275.4.2598; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Olivares AO, 2006, J BIOL CHEM, V281, P31326, DOI 10.1074/jbc.M603898200; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Ropars V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12456; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sckolnick M, 2016, MOL BIOL CELL, V27, P2889, DOI 10.1091/mbc.E15-09-0641; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Silva R, 2003, J MUSCLE RES CELL M, V24, P489, DOI 10.1023/B:JURE.0000009809.69829.74; Sirigu S, 2016, P NATL ACAD SCI USA, V113, pE7448, DOI 10.1073/pnas.1609342113; Sladewski TE, 2016, CURR BIOL, V26, P2202, DOI 10.1016/j.cub.2016.06.029; Szperl AM, 2011, J PEDIATR GASTR NUTR, V52, P307, DOI 10.1097/MPG.0b013e3181eea177; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; van der Velde KJ, 2013, HUM MUTAT, V34, P1597, DOI 10.1002/humu.22440; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vogel GF, 2017, TRAFFIC, V18, P453, DOI 10.1111/tra.12486; Vogel GF, 2015, J CELL BIOL, V211, P587, DOI 10.1083/jcb.201506112; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Wu XF, 2001, J CELL SCI, V114, P1091; Zorca CE, 2015, P NATL ACAD SCI USA, V112, pE1587, DOI 10.1073/pnas.1502461112	81	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18372	18385		10.1074/jbc.M117.801456	http://dx.doi.org/10.1074/jbc.M117.801456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882893	hybrid, Green Published			2022-12-28	WOS:000414458200032
J	Williams, JK; Shcherbakov, AA; Wang, J; Hong, M				Williams, Jonathan K.; Shcherbakov, Alexander A.; Wang, Jun; Hong, Mei			Protonation equilibria and pore-opening structure of the dual-histidine influenza B virus M2 transmembrane proton channel from solid-state NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS; TRYPTOPHAN RESIDUE; CONDUCTION; MECHANISM; PROTEIN; CONFORMATION; SPECTROSCOPY; EXCHANGE; INHIBITION; RESONANCE	The influenza A and B viruses are the primary cause of seasonal flu epidemics. Common to both viruses is the M2 protein, a homotetrameric transmembrane proton channel that acidifies the virion after endocytosis. Although influenza A M2 (AM2) and B M2 (BM2) are functional analogs, they have little sequence homology, except for a conserved HXXXW motif, which is responsible for proton selectivity and channel gating. Importantly, BM2contains a second titratable histidine, His-27, in the tetrameric transmembrane domain that forms a reverse WXXXH motif with the gating tryptophan. To understand how His-27 affects the proton conduction property of BM2, we have used solid-state NMR to characterize the pH-dependent structure and dynamics of His-27. In cholesterol-containing lipid membranes mimicking the virus envelope, N-15 NMR spectra show that the His-27 tetrad protonates with higher pKa values than His-19, indicating that the solvent-accessible His-27 facilitates proton conduction of the channel by increasing the proton dissociation rates of His-19. AM2is inhibited by the amantadine class of antiviral drugs, whereas BM2 has no known inhibitors. Wemeasured the N-terminal interhelical separation of the BM2 channel using fluorinated Phe-5. The interhelical F-19-F-19 distances show a bimodal distribution of a short distance of 7 angstrom and a long distance of 15-20 angstrom, indicating that the phenylene rings do not block small-molecule entry into the channel pore. These results give insights into the lack of amantadine inhibition of BM2 and reveal structural diversities in this family of viral proton channels.	[Williams, Jonathan K.; Shcherbakov, Alexander A.; Hong, Mei] MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA; [Wang, Jun] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Williams, Jonathan K.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Massachusetts Institute of Technology (MIT); University of Arizona; Rutgers State University New Brunswick	Hong, M (corresponding author), MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA.	meihong@mit.edu	Wang, Jun/G-6504-2010; Williams, Jonathan/AAO-2040-2020	Wang, Jun/0000-0002-4845-4621; Hong, Mei/0000-0001-5255-5858; Shcherbakov, Alexander/0000-0002-5728-7175; Williams, Jonathan/0000-0002-7272-6885	National Institutes of Health [GM088204]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI119187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088204 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Andreas LB, 2015, J AM CHEM SOC, V137, P14877, DOI 10.1021/jacs.5b04802; Betakova T, 2006, ACTA VIROL, V50, P187; Cady SD, 2011, J AM CHEM SOC, V133, P4274, DOI 10.1021/ja102581n; deAzevedo ER, 1999, J AM CHEM SOC, V121, P8411, DOI 10.1021/ja992022v; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hong M, 1999, J MAGN RESON, V136, P86, DOI 10.1006/jmre.1998.1631; Hong M, 1998, J AM CHEM SOC, V120, P7113, DOI 10.1021/ja980775w; Hong M, 2012, PROTEIN SCI, V21, P1620, DOI 10.1002/pro.2158; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Li SH, 2011, J AM CHEM SOC, V133, P1534, DOI 10.1021/ja108943n; Liao SY, 2015, J AM CHEM SOC, V137, P6067, DOI 10.1021/jacs.5b02510; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo W, 2006, J AM CHEM SOC, V128, P7242, DOI 10.1021/ja0603406; Ma CL, 2008, J BIOL CHEM, V283, P15921, DOI 10.1074/jbc.M710302200; Mandela VS, 2017, J MOL BIOL, V429, P2192, DOI 10.1016/j.jmb.2017.05.015; Mould JA, 2003, DEV CELL, V5, P175, DOI 10.1016/S1534-5807(03)00190-4; Otomo K, 2009, J BIOCHEM, V145, P543, DOI 10.1093/jb/mvp009; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Schmidt-Rohr K., 2007, EMAGRES, DOI [10.1002/9780470034590.emrstm0063, DOI 10.1002/9780470034590.EMRSTM0063]; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Thomaston JL, 2015, P NATL ACAD SCI USA, V112, P14260, DOI 10.1073/pnas.1518493112; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Williams JK, 2016, J AM CHEM SOC, V138, P8143, DOI 10.1021/jacs.6b03142; Williams JK, 2013, J AM CHEM SOC, V135, P9885, DOI 10.1021/ja4041412; Williams JK, 2013, BIOPHYS J, V104, P1698, DOI 10.1016/j.bpj.2013.02.054	33	20	20	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17876	17884		10.1074/jbc.M117.813998	http://dx.doi.org/10.1074/jbc.M117.813998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893910	Green Published, hybrid			2022-12-28	WOS:000414013000023
J	Wang, XH; Marks, CR; Perfitt, TL; Nakagawa, T; Lee, A; Jacobson, DA; Colbran, RJ				Wang, Xiaohan; Marks, Christian R.; Perfitt, Tyler L.; Nakagawa, Terunaga; Lee, Amy; Jacobson, David A.; Colbran, Roger J.			A novel mechanism for Ca2+/calmodulin-dependent protein kinase II targeting to L-type Ca2+ channels that initiates long-range signaling to the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED GENE-EXPRESSION; CALCIUM-CHANNELS; BETA-SUBUNIT; CAM KINASE; SYNAPTIC-TRANSMISSION; CREB PHOSPHORYLATION; CALMODULIN; CA(V)1.3; BINDING; DISTINCT	Neuronal excitation can induce new mRNA transcription, a phenomenon called excitation-transcription (E-T) coupling. Among several pathways implicated in E-T coupling, activation of voltage-gated L-type Ca2+ channels (LTCCs) in the plasma membrane can initiate a signaling pathway that ultimately increases nuclear CREB phosphorylation and, in most cases, expression of immediate early genes. Initiation of this long-range pathway has been shown to require recruitment of Ca2+-sensitive enzymes to a nanodomain in the immediate vicinity of the LTCC by an unknown mechanism. Here, we show that activated Ca2+/calmodulin-dependent protein kinase II (CaMKII) strongly interacts with a novel binding motif in the N-terminal domain of Ca(V)1 LTCC alpha 1 subunitsthat is not conserved in Ca(V)2 or Ca(V)3 voltage-gated Ca2+ channel subunits. Mutations in the Ca(V)1.3 alpha 1 subunit N-terminal domain or in the CaMKII catalytic domain that largely prevent the in vitrointeraction also disrupt CaMKII association with intact LTCC complexes isolated by immunoprecipitation. Furthermore, these same mutations interfere with E-T coupling in cultured hippocampal neurons. Taken together, our findings define a novel molecular interaction with the neuronal LTCC that is required for the initiation of a long-range signal to the nucleus that is critical for learning and memory.	[Wang, Xiaohan; Nakagawa, Terunaga; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Marks, Christian R.; Perfitt, Tyler L.; Nakagawa, Terunaga; Jacobson, David A.; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Iowa; University of Iowa; University of Iowa	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Rm 702 Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Wang, Xiaohan/V-3920-2019	Colbran, Roger/0000-0001-7401-8244; Wang, Xiaohan/0000-0001-7895-2333; Perfitt, Tyler/0000-0002-2381-3341; Lee, Amy/0000-0001-8021-0443; Jacobson, David A./0000-0003-1816-5375	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543, U54HD083211] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK058404, R01DK097392, P30DK020593, U2CDK059637, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH109196, R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291, R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Kevin P.M. Currie for helpful discussions, Nicholas C. Vierra for help with whole-cell patch clamp, Keeley Spiess for assistance with Ca<SUP>2+</SUP> imaging, and Elena I. Zaika for assistance with rat hippocampal neuron cultures. We also thank Diane Lipscombe, William Thiel, Gerald W. Zamponi, Aaron Fox, Edward Perez-Reyes, Winship Herr, and Luk Van Parijs for providing various plasmids, as detailed throughout. Confocal imaging and analysis were performed in part through the use of the Vanderbilt Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Baucum AJ, 2015, ACS CHEM NEUROSCI, V6, P615, DOI 10.1021/cn500337u; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Cohen SM, 2016, NEURON, V90, P292, DOI 10.1016/j.neuron.2016.03.001; Cohen SM, 2015, BIOCHEM BIOPH RES CO, V460, P88, DOI 10.1016/j.bbrc.2015.02.146; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; Jin DZ, 2013, J NEUROSCI, V33, P3402, DOI 10.1523/JNEUROSCI.3192-12.2013; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ludwig A, 1997, J NEUROSCI, V17, P1339; Ma HK, 2014, P IEEE SEMICOND THER, P159, DOI 10.1109/SEMI-THERM.2014.6892233; Ma H, 2013, BIOSCIENCE REP, V33, P97, DOI 10.1042/BSR20120099; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Sala C, 2003, J NEUROSCI, V23, P6327; Simms BA, 2015, PFLUG ARCH EUR J PHY, V467, P677, DOI 10.1007/s00424-014-1538-7; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Stephenson JR, 2017, J NEUROSCI, V37, P2216, DOI 10.1523/JNEUROSCI.2068-16.2017; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	52	16	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17324	17336		10.1074/jbc.M117.788331	http://dx.doi.org/10.1074/jbc.M117.788331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28916724	Green Published, hybrid			2022-12-28	WOS:000414009300015
J	Bal, NC; Singh, S; Reis, FCG; Maurya, SK; Pani, S; Rowland, LA; Periasamy, M				Bal, Naresh C.; Singh, Sushant; Reis, Felipe C. G.; Maurya, Santosh K.; Pani, Sunil; Rowland, Leslie A.; Periasamy, Muthu			Both brown adipose tissue and skeletal muscle thermogenesis processes are activated during mild to severe cold adaptation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTIVE NONSHIVERING THERMOGENESIS; MITOCHONDRIAL UNCOUPLING PROTEIN; DIET-INDUCED THERMOGENESIS; DORSOMEDIAL HYPOTHALAMUS; ENERGY-EXPENDITURE; ADULT HUMANS; CROSS-TALK; SARCOLIPIN; UCP1; RATS	Thermogenesis is an important homeostatic mechanism essential for survival and normal physiological functions in mammals. Both brown adipose tissue (BAT) (i.e. uncoupling protein 1 (UCP1)-based) and skeletal muscle (i.e. sarcolipin (SLN)-based) thermogenesis processes play important roles in temperature homeostasis, but their relative contributions differ from small to large mammals. In this study, we investigated the functional interplay between skeletal muscle-and BAT-based thermogenesis under mild versus severe cold adaptation by employing UCP1(-/-) and SLN-/- mice. Interestingly, adaptation of SLN-/- mice to mild cold conditions (16 degrees C) significantly increased UCP1 expression, suggesting increased reliance on BAT-based thermogenesis. This was also evident from structural alterations in BAT morphology, including mitochondrial architecture, increased expression of electron transport chain proteins, and depletion of fat droplets. Similarly, UCP1(-/-) mice adapted to mild cold up-regulated muscle-based thermogenesis, indicated by increases in muscle succinate dehydrogenase activity, SLN expression, mitochondrial content, and neovascularization, compared with WT mice. These results further confirm that SLN-based thermogenesis is a key player in muscle non-shivering thermogenesis (NST) and can compensate for loss of BAT activity. We also present evidence that the increased reliance on BAT-based NST depends on increased autonomic input, as indicated by abundant levels of tyrosine hydroxylase and neuropeptide Y. Our findings demonstrate that both BAT and muscle-based NST are equally recruited during mild and severe cold adaptation and that loss of heat production from one thermogenic pathway leads to increased recruitment of the other, indicating a functional interplay between these two thermogenic processes.	[Bal, Naresh C.; Pani, Sunil] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India; [Bal, Naresh C.; Singh, Sushant; Maurya, Santosh K.; Rowland, Leslie A.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.; Singh, Sushant; Reis, Felipe C. G.; Maurya, Santosh K.; Periasamy, Muthu] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA	Kalinga Institute of Industrial Technology (KIIT); University System of Ohio; Ohio State University; Sanford Burnham Prebys Medical Discovery Institute	Bal, NC (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India.; Bal, NC; Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.; Bal, NC; Periasamy, M (corresponding author), Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA.	naresh.bal@kiitbiotech.ac.in; mperiasamy@sbpdiscovery.org	Singh, Sushant/AAP-3860-2020; Maurya, Santosh/O-9066-2017; Singh, Sushant/AAQ-7930-2021; dos Reis, Felipe C Gomes/J-9867-2012	Maurya, Santosh/0000-0002-7610-2463; Singh, Sushant/0000-0002-0858-4405; dos Reis, Felipe C Gomes/0000-0001-8357-5261	National Institutes of Health [R01-HL-088555, R01 DK098240-01]; American Diabetes Association Basic Science Research Award [7-13-BS-131]; NIDDK, National Institutes of Health [DK102772]; Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK102772, R01DK098240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Science Research Award; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-HL-088555 and R01 DK098240-01 and American Diabetes Association Basic Science Research Award (7-13-BS-131) (to M. P.). The research reported in this work was supported in part by NIDDK, National Institutes of Health under Award DK102772 and a Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India (to N. C. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2016, J BIOL CHEM, V291, P17247, DOI 10.1074/jbc.M116.728188; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Blondin DP, 2017, J PHYSIOL-LONDON, V595, P2099, DOI 10.1113/JP273395; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen PL, 2004, J NEUROSCI, V24, P5091, DOI 10.1523/JNEUROSCI.0588-04.2004; DAVIS TRA, 1967, AM J PHYSIOL, V213, P1423, DOI 10.1152/ajplegacy.1967.213.6.1423; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; De Matteis R, 1998, J NEUROCYTOL, V27, P877, DOI 10.1023/A:1006996922657; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fredriksson JM, 2005, FEBS LETT, V579, P5680, DOI 10.1016/j.febslet.2005.09.044; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Giorgino F, 2009, AM J PHYSIOL-ENDOC M, V297, pE975, DOI 10.1152/ajpendo.00488.2009; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; GREENWAY DC, 1978, AM J PHYSIOL, V234, pC7, DOI 10.1152/ajpcell.1978.234.1.C7; Huang-Doran I, 2017, TRENDS ENDOCRIN MET, V28, P3, DOI 10.1016/j.tem.2016.10.003; Indrakusuma I, 2015, CURR OBES REP, V4, P411, DOI 10.1007/s13679-015-0174-7; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Kanatous SB, 2008, J EXP BIOL, V211, P2559, DOI 10.1242/jeb.018119; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 2008, BBA-BIOENERGETICS, V1777, P637, DOI 10.1016/j.bbabio.2008.03.006; Labbe SM, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00150; LEAN MEJ, 1986, CLIN SCI, V71, P291, DOI 10.1042/cs0710291; Li FN, 2017, CYTOKINE GROWTH F R, V33, P73, DOI 10.1016/j.cytogfr.2016.10.003; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loiselle DS, 2016, AM J PHYSIOL-HEART C, V310, pH311, DOI 10.1152/ajpheart.00569.2015; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; MCCARTHY HD, 1993, NEUROSCIENCE, V54, P127, DOI 10.1016/0306-4522(93)90388-V; McKay WP, 2013, APPL PHYSIOL NUTR ME, V38, P227, DOI 10.1139/apnm-2011-0358; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nishimura T, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0051-9; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Oelkrug R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3140; Pant M, 2016, TRENDS ENDOCRIN MET, V27, P881, DOI 10.1016/j.tem.2016.08.006; Pant M, 2015, J EXP BIOL, V218, P2321, DOI 10.1242/jeb.119164; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reis M, 2002, MOL MEMBR BIOL, V19, P301, DOI 10.1080/09687680210166217; Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018; Rodriguez A, 2017, ACTA PHYSIOL, V219, P362, DOI 10.1111/apha.12686; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Silva J Enrique, 2011, Front Biosci (Schol Ed), V3, P352, DOI 10.2741/s156; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Tupone D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00014; Wakabayashi H, 2017, INT J BIOMETEOROL, V61, P1261, DOI 10.1007/s00484-016-1303-z; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zaretskaia MV, 2002, BRAIN RES, V928, P113, DOI 10.1016/S0006-8993(01)03369-8	59	66	67	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16616	16625		10.1074/jbc.M117.790451	http://dx.doi.org/10.1074/jbc.M117.790451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28794154	hybrid, Green Published			2022-12-28	WOS:000412414800022
J	Bond, R; Ly, NN; Cyert, MS				Bond, Rachel; Ly, Nina; Cyert, Martha S.			The unique C terminus of the calcineurin isoform CNA beta 1 confers non-canonical regulation of enzyme activity by Ca2+ and calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN-CYCLOSPORINE-A; PHOSPHATASE-ACTIVITY; AUTOINHIBITORY DOMAIN; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE; VARIANT CNA-BETA-1; GENE-EXPRESSION; NFAT ACTIVATION	Calcineurin, the conserved Ca2+/calmodulin-regulated phosphatase and target of immunosuppressants, plays important roles in the circulatory, nervous, and immune systems. Calcineurin activity strictly depends on Ca2+ and Ca2+-bound calmodulin (Ca2+/CaM) to relieve autoinhibition of the catalytic subunit (CNA) by its C terminus. The C terminus contains two regulatory domains, the autoinhibitory domain (AID) and calmodulin-binding domain (CBD), which block the catalytic center and a conserved substrate-binding groove, respectively. However, this mechanism cannot apply to CNA beta 1, an atypical CNA isoform generated by alternative 3'-end processing, whose divergent C terminus shares the CBD common to all isoforms, but lacks the AID. We present the first biochemical characterization of CNA beta 1, which is ubiquitously expressed and conserved in vertebrates. We identify a distinct C-terminal autoinhibitory four-residue sequence in CNA beta 1, (462)LAVP(465), which competitively inhibits substrate dephosphorylation. In vitro and cell-based assays revealed that the CNA beta 1-containing holoenzyme, CN beta 1, is autoinhibited at a single site by either of two inhibitory regions, CBD and LAVP, which block substrate access to the substrate-binding groove. We found that the autoinhibitory segment (AIS), located within the CBD, is progressively removed by Ca2+ and Ca2+/CaM, whereas LAVP remains engaged. This regulatory strategy conferred higher basal and Ca2+-dependent activity to CN beta 1, decreasing its dependence on CaM, but also limited maximal enzyme activity through persistence of LAVP-mediated autoinhibiton during Ca2+/CaM stimulation. These regulatory properties may underlie observed differences between the biological activities of CN beta 1 and canonical CN beta 2. Our insights lay the groundwork for further studies of CN beta 1, whose physiological substrates are currently unknown.	[Bond, Rachel; Ly, Nina; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mcyert@stanford.edu		Cyert, Martha/0000-0003-3825-7437	National Institutes of Health NIGMS Grant [1R01GM119336]; National Institutes of Health [2T32GM007276, 5T32GM008412]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119336, T32GM007276] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 1R01GM119336. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant 2T32GM007276.; Supported by National Institutes of Health Grant 5T32GM008412.	Becker D. M., 2001, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1307s27, DOI 10.1002/0471142727]; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Davey NE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0120-z; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; DONELLADEANA A, 1994, EUR J BIOCHEM, V219, P109, DOI 10.1111/j.1432-1033.1994.tb19920.x; ETZKORN FA, 1994, BIOCHEMISTRY-US, V33, P2380, DOI 10.1021/bi00175a005; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Felkin LE, 2011, CIRCULATION, V123, P2838, DOI 10.1161/CIRCULATIONAHA.110.012211; Goldman A, 2014, MOL CELL, V55, P422, DOI 10.1016/j.molcel.2014.05.012; Gomez-Salinero JM, 2016, CELL CHEM BIOL, V23, P1372, DOI 10.1016/j.chembiol.2016.09.010; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Li SJ, 2016, CELL RES, V26, P336, DOI 10.1038/cr.2016.14; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Olaneta MM, 2014, CARDIOVASC RES, V102, P396, DOI 10.1093/cvr/cvu068; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; MARTIN BL, 1986, J BIOL CHEM, V261, P4545; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Perrino BA, 1999, ARCH BIOCHEM BIOPHYS, V372, P159, DOI 10.1006/abbi.1999.1485; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rumi-Masante J, 2012, J MOL BIOL, V415, P307, DOI 10.1016/j.jmb.2011.11.008; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Sheftic SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38920; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q	49	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16709	16721		10.1074/jbc.M117.795146	http://dx.doi.org/10.1074/jbc.M117.795146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842480	Green Published, hybrid			2022-12-28	WOS:000412414800030
J	Bermek, O; Weller, SK; Griffith, JD				Bermek, Oya; Weller, Sandra K.; Griffith, Jack D.			The UL8 subunit of the helicase-primase complex of herpes simplex virus promotes DNA annealing and has a high affinity for replication forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BINDING-PROTEIN; UL52 SUBUNITS; TYPE-1 ICP8; RECOMBINATION; NUCLEASE; EXCHANGE; GENE; INTERDEPENDENCE; VISUALIZATION	During lytic infection, herpes simplex virus (HSV) DNA is replicated by a mechanism involving DNA recombination. For instance, replication of the HSV-1 genome produces X-and Y-branched structures, reminiscent of recombination intermediates. HSV-1's replication machinery includes a trimeric helicase-primase composed of helicase (UL5) and primase (UL52) subunits and a third subunit, UL8. UL8 has been reported to stimulate the helicase and primase activities of the complex in the presence of ICP8, an HSV-1 protein that functions as an annealase, a protein that binds complementary single-stranded DNA (ssDNA) and facilitates its annealing to duplex DNA. UL8 also influences the intracellular localization of the UL5/UL52 subunits, but UL8' s catalytic activities are not known. In this study we used a combination of biochemical techniques and transmission electron microscopy. First, we report that UL8 alone forms protein filaments in solution. Moreover, we also found that UL8 binds to ssDNAs >50-nucletides long and promotes the annealing of complementary ssDNA to generate highly branched duplexDNAstructures. Finally, UL8 has a very high affinity for replication fork structures containing a gap in the lagging strand as short as 15 nucleotides, suggesting that UL8 may aid in directing or loading the trimeric complex onto a replication fork. The properties of UL8 uncovered here suggest that UL8 may be involved in the generation of the X-and Y-branched structures that are the hallmarks of HSV replication.	[Bermek, Oya; Griffith, Jack D.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA; [Weller, Sandra K.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Weller, Sandra K.] Univ Connecticut, Ctr Hlth, Mol Biol & Biochem Grad Program, Farmington, CT 06030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Connecticut; University of Connecticut	Bermek, O (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	oya_bermek@med.unc.edu			National Institutes of Health [GM31819, CA19014, AI021747]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021747, R01AI069136, R01AI021747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM31819 and CA19014 ( to J.D.G.) and AI021747 ( to S.K.W.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnard EC, 1997, VIROLOGY, V237, P97, DOI 10.1006/viro.1997.8763; BARRY J, 1994, J BIOL CHEM, V269, P33049; Bermek O, 2015, J BIOL CHEM, V290, P2539, DOI 10.1074/jbc.M114.623009; Biswas N, 2001, J BIOL CHEM, V276, P17610, DOI 10.1074/jbc.M010107200; Blumel J, 2000, VIROLOGY, V276, P445, DOI 10.1006/viro.2000.0574; BOEHMER PE, 1993, J VIROL, V67, P711, DOI 10.1128/JVI.67.2.711-715.1993; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; CARMICHAEL EP, 1989, J VIROL, V63, P591, DOI 10.1128/JVI.63.2.591-599.1989; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; Chen Y, 2011, J VIROL, V85, P968, DOI 10.1128/JVI.01690-10; Darwish AS, 2016, J VIROL, V90, P2561, DOI 10.1128/JVI.02854-15; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; DRACHEVA S, 1995, J BIOL CHEM, V270, P14148, DOI 10.1074/jbc.270.23.14148; DUTCH RE, 1993, J VIROL, V67, P6945, DOI 10.1128/JVI.67.12.6945-6949.1993; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; FRIEDMANN A, 1977, J GEN VIROL, V34, P507, DOI 10.1099/0022-1317-34-3-507; GORBALENYA AE, 1988, NUCLEIC ACIDS RES, V16, P7734, DOI 10.1093/nar/16.15.7734; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grady LM, 2014, METHODS MOL BIOL, V1144, P293, DOI 10.1007/978-1-4939-0428-0_20; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hamatake RK, 1997, J GEN VIROL, V78, P857, DOI 10.1099/0022-1317-78-4-857; JACOB RJ, 1977, J VIROL, V23, P394, DOI 10.1128/JVI.23.2.394-411.1977; KLINEDINST DK, 1994, J VIROL, V68, P3693, DOI 10.1128/JVI.68.6.3693-3701.1994; KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9; LeGac NT, 1996, J BIOL CHEM, V271, P21645; Makhov AM, 2009, J MOL BIOL, V386, P273, DOI 10.1016/j.jmb.2008.12.059; Makhov AM, 2006, J MOL BIOL, V355, P911, DOI 10.1016/j.jmb.2005.11.022; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Ozgur S, 2014, J VIROL, V88, P8687, DOI 10.1128/JVI.03652-13; Ozgur S, 2011, J STRUCT BIOL, V174, P37, DOI 10.1016/j.jsb.2010.10.015; PARRY ME, 1993, J GEN VIROL, V74, P607, DOI 10.1099/0022-1317-74-4-607; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Reuven NB, 2004, J VIROL, V78, P4599, DOI 10.1128/JVI.78.9.4599-4608.2004; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; RUYECHAN WT, 1983, J VIROL, V46, P661, DOI 10.1128/JVI.46.2.661-666.1983; RUYECHAN WT, 1984, J VIROL, V52, P727, DOI 10.1128/JVI.52.3.727-733.1984; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; SEVERINI A, 1994, VIROLOGY, V200, P428, DOI 10.1006/viro.1994.1206; SHERMAN G, 1992, J VIROL, V66, P4884, DOI 10.1128/JVI.66.8.4884-4892.1992; SHLOMAI J, 1976, VIROLOGY, V69, P647, DOI 10.1016/0042-6822(76)90493-1; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; TENNEY DJ, 1994, J BIOL CHEM, V269, P5030; Tolun G, 2013, NUCLEIC ACIDS RES, V41, P5927, DOI 10.1093/nar/gkt266; Weller SK, 2014, ANNU REV MICROBIOL, V68, P237, DOI 10.1146/annurev-micro-091313-103424; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100	49	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15611	15621		10.1074/jbc.M117.799064	http://dx.doi.org/10.1074/jbc.M117.799064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28743747	hybrid, Green Published			2022-12-28	WOS:000411512200003
J	Bush, KT; Wu, W; Lun, C; Nigam, SK				Bush, Kevin T.; Wu, Wei; Lun, Christina; Nigam, Sanjay K.			The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; BASOLATERAL MEMBRANE-VESICLES; KNOCKOUT MICE; OLFACTORY MUCOSA; SYSTEMS BIOLOGY; FAMILY-MEMBERS; CHOROID-PLEXUS; UREMIC TOXINS; URIC-ACID; METABOLOMICS	The organic anion transporters OAT1 (SLC22A6) and OAT3 (SLC22A8) have similar substrate specificity for drugs, but it is far from clear whether this holds for endogenous substrates. By analysis of more than 600 metabolites in the Oat3KO (Oat3 knockout) by LC/MS, we demonstrateOAT3involvement in the movement of gut microbiome products, key metabolites, and signaling molecules, including those flowing through the gutliver-kidney axis. Major pathways affected included those involved in metabolism of bile acids, flavonoids, nutrients, amino acids (including tryptophan-derivatives that are uremic toxins), and lipids. OAT3 is also critical in elimination of liverderived phase II metabolites, particularly those undergoing glucuronidation. Analysis of physicochemical features revealed nine distinct metabolite groups; at least one member of most clusters has been previously validated in transport assays. In contrast to drugs interacting with the OATs, endogenous metabolites accumulating in the Oat1KO (Oat1 knockout) versus Oat3KO have distinct differences in their physicochemical properties; they are very different in size, number of rings, hydrophobicity, and molecular complexity. Consistent with the Remote Sensing and Signaling Hypothesis, the data support the importance of the OAT transporters in inter-organ and interorganismal remote communication via transporter-mediated movement of key metabolites and signaling molecules (e. g. gut microbiome-to-intestine-to-blood-to-liver-to-kidney-tourine). We discuss the possibility of an intimate connection between OATs and metabolite sensing and signaling pathways (e. g. bile acids). Furthermore, the metabolomics and pathway analysis support the view that OAT1 plays a greater role in kidney proximal tubule metabolism and OAT3 appears relatively more important in systemic metabolism, modulating levels of metabolites flowing through intestine, liver, and kidney.	[Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Wu, Wei] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lun, Christina] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr MC0693, La Jolla, CA 92093 USA.	snigam@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090259, P50HD090259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD090259, U54 HD090259] Funding Source: Medline; NIDDK NIH HHS [R01 DK109392] Funding Source: Medline; NIGMS NIH HHS [R01 GM104098, R01 GM098449] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Badenhorst CPS, 2014, DRUG METAB REV, V46, P343, DOI 10.3109/03602532.2014.908903; Beebe K., 2016, METABOLON; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Chen J, 2008, AM J PHYSIOL-RENAL, V295, pF247, DOI 10.1152/ajprenal.00139.2008; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chu L, 2015, INT UROL NEPHROL, V47, P345, DOI 10.1007/s11255-014-0901-0; Deng HY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00373; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Food and Drug Administration Guidance for Industry, 2012, STUD DES DAT AN IMPL; Gallegos TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040796; GIBSON DT, 1968, SCIENCE, V161, P1093, DOI 10.1126/science.161.3846.1093; Guo C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00646; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Jimenez F, 2002, DIGEST DIS SCI, V47, P2398, DOI 10.1023/A:1020575001944; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y; Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m; Lennerz BS, 2015, MOL GENET METAB, V114, P73, DOI 10.1016/j.ymgme.2014.11.010; Liu HC, 2016, J PHARMACOL EXP THER, V359, P215, DOI 10.1124/jpet.116.232660; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; LopezNieto CE, 1996, NAT BIOTECHNOL, V14, P857, DOI 10.1038/nbt0796-857; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Mackenzie AE, 2017, NEUROPHARMACOLOGY, V113, P661, DOI 10.1016/j.neuropharm.2015.07.035; Martinot E, 2017, MOL ASPECTS MED, V56, P2, DOI 10.1016/j.mam.2017.01.006; Martovetsky G, 2016, DRUG METAB DISPOS, V44, P1050, DOI 10.1124/dmd.115.068254; Martovetsky G, 2013, MOL PHARMACOL, V84, P808, DOI 10.1124/mol.113.088229; Mazerska Z, 2016, PHARMACOL THERAPEUT, V159, P35, DOI 10.1016/j.pharmthera.2016.01.009; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Namkung J, 2015, MOL CELLS, V38, P1023, DOI 10.14348/molcells.2015.0258; Ney DM, 2014, CURR OPIN CLIN NUTR, V17, P61, DOI 10.1097/MCO.0000000000000002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Peters J C, 1991, Adv Exp Med Biol, V294, P345; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; PRITCHARD JB, 1988, AM J PHYSIOL, V255, pF597, DOI 10.1152/ajprenal.1988.255.4.F597; Rechner AR, 2002, FREE RADICAL BIO MED, V33, P220, DOI 10.1016/S0891-5849(02)00877-8; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Sahu M., 2013, COMP ENG INTELL SYST, V4, P22; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; SHIMADA H, 1987, AM J PHYSIOL, V253, pF795, DOI 10.1152/ajprenal.1987.253.5.F795; Sweeney DE, 2011, MOL PHARMACOL, V80, P147, DOI 10.1124/mol.110.070680; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VANBERGEHENEGOUWEN GP, 1976, GUT, V17, P861, DOI 10.1136/gut.17.11.861; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wolman AT, 2013, DRUG METAB DISPOS, V41, P791, DOI 10.1124/dmd.112.049569; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; WU WT, 2017, SCI REP, V7; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	85	62	62	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15789	15803		10.1074/jbc.M117.796516	http://dx.doi.org/10.1074/jbc.M117.796516			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28765282	hybrid, Green Published			2022-12-28	WOS:000411512200017
J	Outten, CE				Outten, Caryn E.			Checks and balances for the iron bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SULFUR PROTEINS; HOMEOSTASIS; MATURATION; LIGASE; RNA	The RNA-binding iron regulatory proteins IRP1 and IRP2 are inactivated by either Fe-S cluster insertion or protein degradation mediated by the E3 ligase component FBXL5. However, the mechanisms for coordination between Fe-S cluster assembly, FBXL5, and IRP1/IRP2 activity are poorly defined. A new study reveals that FBXL5 plays a critical role in limiting IRP1 and IRP2 overaccumulation when cytosolic Fe-S cluster assembly is impaired in order to maintain optimal iron levels for cell viability.	[Outten, Caryn E.] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Outten, CE (corresponding author), 631 Sumter St, Columbia, SC 29208 USA.	outten@sc.edu	Outten, Caryn E./I-9433-2019	Outten, Caryn E./0000-0003-0335-6531	National Institutes of Health [GM118164]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM118164.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Johnson NB, 2017, J BIOL CHEM, V292, P15976, DOI 10.1074/jbc.M117.785741; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116	8	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15990	15991		10.1074/jbc.H117.785741	http://dx.doi.org/10.1074/jbc.H117.785741			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28939752	Green Published, hybrid			2022-12-28	WOS:000411512200035
J	Barclay, RA; Schwab, A; DeMarino, C; Akpamagbo, Y; Lepene, B; Kassaye, S; Iordanskiy, S; Kashanchi, F				Barclay, Robert A.; Schwab, Angela; DeMarino, Catherine; Akpamagbo, Yao; Lepene, Benjamin; Kassaye, Seble; Iordanskiy, Sergey; Kashanchi, Fatah			Exosomes from uninfected cells activate transcription of latent HIV-1 (vol 292, pg 11682, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NCATS NIH HHS [KL2 TR001432] Funding Source: Medline; NIAID NIH HHS [R01 AI043894] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043894] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barclay RA, 2017, J BIOL CHEM, V292, P11682, DOI 10.1074/jbc.M117.793521	1	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14764	14764		10.1074/jbc.A117.793521	http://dx.doi.org/10.1074/jbc.A117.793521			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28887434	Green Published, hybrid			2022-12-28	WOS:000409902100004
J	Zhi, XD; Dages, S; Dages, K; Liu, YT; Hua, ZC; Makemson, J; Leng, FF				Zhi, Xiaoduo; Dages, Samantha; Dages, Kelley; Liu, Yingting; Hua, Zi-Chun; Makemson, John; Leng, Fenfei			Transient and dynamic DNA supercoiling potently stimulates the leu-500 promoter in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA TRANSCRIPTION; I-DEFICIENT STRAINS; TOPOISOMERASE-I; SALMONELLA-TYPHIMURIUM; TORSIONAL STRESS; GENE-EXPRESSION; ILVYC OPERON; PLASMID DNA; ACTIVATION; MUTATION	The inactive prokaryotic leu-500 promoter (Pleu-500) contains a single A-to-G point mutation in the -10 region of the leucine operon promoter, which causes leucine auxotrophy. This promoter can be activated by (-) DNA supercoiling in Escherichia coli topA strains. However, whether this activation arises from global, permanent, or transient, dynamic supercoiling is still not fully understood. In this article, using a newly established in vivo system carrying a pair of divergently coupled promoters, i.e. an IPTG-inducible promoter and Pleu-500 that control the expression of lacZ and luc (the firefly luciferase gene), respectively, we demonstrate that transient, dynamic (-) DNA supercoiling provided by divergent transcription in both wild-type and topA strains can potently activate Pleu-500. We found that this activation depended on the promoter strength and the length of RNA transcripts, which are functional characteristics of transcription-coupled DNA supercoiling (TCDS) precisely predicted by the twin-supercoiled domain model of transcription in which a (+) supercoiled domain is produced ahead of the RNA polymerase and a (-) supercoiled domain behind it. We also demonstrate that TCDS can be generated on topologically open DNA molecules, i.e. linear DNA molecules, in Escherichia coli, suggesting that topological boundaries or barriers are not required for the production of TCDS in vivo. This work demonstrates that transient, dynamic TCDS by RNA polymerases is a major chromosome remodeling force in E. coli and greatly influences the nearby, coupled promoters/transcription.	[Zhi, Xiaoduo; Dages, Samantha; Dages, Kelley; Liu, Yingting; Leng, Fenfei] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Zhi, Xiaoduo; Dages, Samantha; Dages, Kelley; Liu, Yingting; Leng, Fenfei] Florida Int Univ, Dept Chem & Biochem, 11200 SW 8th St, Miami, FL 33199 USA; [Makemson, John] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Liu, Yingting; Hua, Zi-Chun] Nanjing Univ, Sch Life Sci, Nanjing 210023, Jiangsu, Peoples R China	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Nanjing University	Leng, FF (corresponding author), Florida Int Univ, Dept Chem & Biochem, 11200 SW 8th St, Miami, FL 33199 USA.	lengf@fiu.edu			National Institutes of Health [1R15GM109254-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI125973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by Grant 1R15GM109254-01A1 from the National Institutes of Health (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appleman JA, 1998, J BACTERIOL, V180, P1525, DOI 10.1128/JB.180.6.1525-1532.1998; Bates A. D., 2005, DNA TOPOLOGY; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Chen CC, 2003, FRONT BIOSCI, V8, pD430, DOI 10.2741/968; CHEN DR, 1992, P NATL ACAD SCI USA, V89, P8784, DOI 10.1073/pnas.89.18.8784; COOK DN, 1992, P NATL ACAD SCI USA, V89, P10603, DOI 10.1073/pnas.89.22.10603; Cozzarelli N.R., 1990, DNA TOPOLOGY ITS BIO; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; DROLET M, 1994, J BIOL CHEM, V269, P2068; DUBNAU E, 1972, MOL GEN GENET, V117, P91, DOI 10.1007/BF00267607; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; El Hanafi D, 2000, MOL MICROBIOL, V37, P583; Fang M, 1998, J BIOL CHEM, V273, P29929, DOI 10.1074/jbc.273.45.29929; Fang M, 1998, J BACTERIOL, V180, P626, DOI 10.1128/JB.180.3.626-633.1998; Fulcrand G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19243; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Leng FF, 2004, J BIOL CHEM, V279, P47564, DOI 10.1074/jbc.M403798200; Leng FF, 2002, P NATL ACAD SCI USA, V99, P9139, DOI 10.1073/pnas.142002099; Lim HM, 2003, BIOCHEMISTRY-US, V42, P10718, DOI 10.1021/bi030110t; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOCKSHON D, 1983, NUCLEIC ACIDS RES, V11, P2999, DOI 10.1093/nar/11.10.2999; LODGE JK, 1989, J BACTERIOL, V171, P2181, DOI 10.1128/jb.171.4.2181-2187.1989; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Ma J, 2014, CELL CYCLE, V13, P337, DOI 10.4161/cc.27508; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Mielke SP, 2004, J CHEM PHYS, V121, P8104, DOI 10.1063/1.1799613; Miller J. H, 1972, EXPT MOL GENETICS; MUKAI FH, 1963, P NATL ACAD SCI USA, V50, P140, DOI 10.1073/pnas.50.1.140; Nelson P, 1999, P NATL ACAD SCI USA, V96, P14342, DOI 10.1073/pnas.96.25.14342; Opel ML, 2001, MOL MICROBIOL, V39, P191, DOI 10.1046/j.1365-2958.2001.02249.x; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; PRUSS GJ, 1985, J BACTERIOL, V164, P947, DOI 10.1128/JB.164.2.947-949.1985; PRUSS GJ, 1985, J MOL BIOL, V185, P51, DOI 10.1016/0022-2836(85)90182-2; Rhee KY, 1999, P NATL ACAD SCI USA, V96, P14294, DOI 10.1073/pnas.96.25.14294; RICHARDSON SMH, 1988, EMBO J, V7, P1863, DOI 10.1002/j.1460-2075.1988.tb03019.x; RICHARDSON SMH, 1984, EMBO J, V3, P1745, DOI 10.1002/j.1460-2075.1984.tb02041.x; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Samul R, 2007, J MOL BIOL, V374, P925, DOI 10.1016/j.jmb.2007.10.011; Santos TD, 2016, NUCLEIC ACIDS RES, V44, P9638, DOI 10.1093/nar/gkw639; Snoep JL, 2002, EUR J BIOCHEM, V269, P1662, DOI 10.1046/j.1432-1327.2002.02803.x; Sobetzko P, 2016, NUCLEIC ACIDS RES, V44, P1514, DOI 10.1093/nar/gkw007; TAN JY, 1994, J BACTERIOL, V176, P1077, DOI 10.1128/JB.176.4.1077-1086.1994; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; WADDELL CS, 1989, P NATL ACAD SCI USA, V86, P3958, DOI 10.1073/pnas.86.11.3958; Wang J. C., 2008, UNTANGLING DOUBLE HE; WU HY, 1995, CELL, V82, P445, DOI 10.1016/0092-8674(95)90433-6; Wu HY, 2003, PROG NUCLEIC ACID RE, V73, P43, DOI 10.1016/S0079-6603(03)01002-X; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103; Zhi XD, 2013, GENE, V514, P82, DOI 10.1016/j.gene.2012.11.011	57	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14566	14575		10.1074/jbc.M117.794628	http://dx.doi.org/10.1074/jbc.M117.794628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28696257	Green Published, hybrid			2022-12-28	WOS:000408747500022
J	Li, L; Zviti, R; Ha, C; Wang, ZV; Hill, JA; Lin, FM				Li, Ling; Zviti, Ronald; Ha, Catherine; Wang, Zhao V.; Hill, Joseph A.; Lin, Fangming			Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; UNILATERAL URETERAL OBSTRUCTION; TRANSCRIPTION FACTORS; MITOCHONDRIAL AUTOPHAGY; IN-VIVO; HYPOXIA; CELLS; ADAPTATION; DISEASE; MAINTENANCE	Autophagy has been shown to be important for normal homeostasis and adaptation to stress in the kidney. Yet, the molecular mechanisms regulating renal epithelial autophagy are not fully understood. Here, we explored the role of the stress-responsive transcription factor forkhead box O3 (FoxO3) in mediating injury-induced proximal tubular autophagy in mice with unilateral ureteral obstruction (UUO). We show that following UUO, FoxO3 is activated and displays nuclear expression in the hypoxic proximal tubules exhibiting high levels of autophagy. Activation of FoxO3 by mutating phosphorylation sites to enhance its nuclear expression induces profound autophagy in cultured renal epithelial cells. Conversely, deleting FoxO3 in mice results in fewer numbers of autophagic cells in the proximal tubules and reduced ratio of the autophagy-related protein LC3-II/I in the kidney post-UUO. Interestingly, autophagic cells deficient in FoxO3 contain lower numbers of autophagic vesicles per cell. Analyses of individual cells treated with autophagic inhibitors to sequentially block the autophagic flux suggest that FoxO3 stimulates the formation of autophagosomes to increase autophagic capacity but has no significant effect on autophagosome-lysosome fusion or autolysosomal clearance. Furthermore, in kidneys with persistent UUO for 7 days, FoxO3 activation increases the abundance of mRNA and protein levels of the core autophagy-related (Atg) proteins including Ulk1, Beclin-1, Atg9A, Atg4B, and Bnip3, suggesting that FoxO3 may function to maintain components of the autophagic machinery that would otherwise be consumed during prolonged autophagy. Taken together, our findings indicate that FoxO3 activation can both induce and maintain autophagic activities in renal epithelial cells in response to injury from urinary tract obstruction.	[Li, Ling; Zviti, Ronald; Ha, Catherine; Lin, Fangming] Columbia Univ Coll Phys & Surg, Dept Pediat, 622 West 168th St,PH17-102F, New York, NY 10032 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Lin, Fangming] Morgan Stanley Childrens Hosp, New York Presbyterian Hosp System, Samberg Scholar Childrens Hlth, New York, NY USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital	Lin, FM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pediat, Div Pediat Nephrol, 622 West 168th St,PH17-102F, New York, NY 10032 USA.	FL2300@columbia.edu			National Institutes of Health [R01DK083411, R01DK107653, HL-120732, HL-100401]; March of Dimes research grant; American Heart Association [14SFRN20740000]; Cancer Prevention and Research Institute of Texas (CPRIT) Grant [RP110486P3]; Leducq Foundation [11CVD04]; Scientist Development Grant from American Heart Association [14SDG18440002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120732, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107653, R01DK083411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes research grant(March of Dimes); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas (CPRIT) Grant; Leducq Foundation(Leducq Foundation); Scientist Development Grant from American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK083411 and R01DK107653 and a March of Dimes research grant (to F.L.) and National Institutes of Health Grants HL-120732 and HL-100401, American Heart Association Grant 14SFRN20740000, Cancer Prevention and Research Institute of Texas (CPRIT) Grant RP110486P3, and the Leducq Foundation (11CVD04) (to J.A.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Scientist Development Grant 14SDG18440002 from the American Heart Association.	Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Basile DP, 2003, AM J PHYSIOL-RENAL, V284, pF338, DOI 10.1152/ajprenal.00169.2002; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hernandez SL, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-17; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; Kaushal GP, 2008, AUTOPHAGY, V4, P710, DOI 10.4161/auto.6309; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Li H, 2015, AM J PHYSIOL-RENAL, V309, pF414, DOI 10.1152/ajprenal.00463.2014; Li L, 2007, J AM SOC NEPHROL, V18, P3067, DOI 10.1681/ASN.2007030284; Li L, 2014, J AM SOC NEPHROL, V25, P305, DOI 10.1681/ASN.2013040374; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li L, 2009, AM J PHYSIOL-RENAL, V297, pF1526, DOI 10.1152/ajprenal.00318.2009; Lin F, 2017, ACTA PHYSIOL, V220, P229, DOI 10.1111/apha.12852; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Livingston MJ, 2014, SEMIN NEPHROL, V34, P17, DOI 10.1016/j.semnephrol.2013.11.004; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Sweeney WE, 2001, AM J PHYSIOL-CELL PH, V281, pC1695, DOI 10.1152/ajpcell.2001.281.5.C1695; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	40	32	34	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13774	13783		10.1074/jbc.M117.791483	http://dx.doi.org/10.1074/jbc.M117.791483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28705935	Green Published, hybrid			2022-12-28	WOS:000407942400013
J	Beshr, G; Sikandar, A; Jemiller, EM; Klymiuk, N; Hauck, D; Wagner, S; Wolf, E; Koehnke, J; Titz, A				Beshr, Ghamdan; Sikandar, Asfandyar; Jemiller, Eva-Maria; Klymiuk, Nikolai; Hauck, Dirk; Wagner, Stefanie; Wolf, Eckhard; Koehnke, Jesko; Titz, Alexander			Photorhabdus luminescens lectin A (PllA): A new probe for detecting -galactoside-terminating glycoconjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; carbohydrate-binding protein; glycobiology; lectin; protein structure; structural biology	BURKHOLDERIA-CENOCEPACIA LECTIN; COMPETITIVE-BINDING ASSAY; ALPHA-GAL EPITOPE; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; SP NOV.; PA-IL; PROTEIN; SEQUENCE; XENORHABDUS	Lectins play important roles in infections by pathogenic bacteria, for example, in host colonization, persistence, and biofilm formation. The Gram-negative entomopathogenic bacterium Photorhabdus luminescens symbiotically lives in insect-infecting Heterorhabditis nematodes and kills the insect host upon invasion by the nematode. The P. luminescens genome harbors the gene plu2096, coding for a novel lectin that we named PllA. We analyzed the binding properties of purified PllA with a glycan array and a binding assay in solution. Both assays revealed a strict specificity of PllA for -galactoside-terminating glycoconjugates. The crystal structures of apo PllA and complexes with three different ligands revealed the molecular basis for the strict specificity of this lectin. Furthermore, we found that a 90 degrees twist in subunit orientation leads to a peculiar quaternary structure compared with that of its ortholog LecA from Pseudomonas aeruginosa. We also investigated the utility of PllA as a probe for detecting -galactosides. The -Gal epitope is present on wild-type pig cells and is the main reason for hyperacute organ rejection in pig to primate xenotransplantation. We noted that PllA specifically recognizes this epitope on the glycan array and demonstrated that PllA can be used as a fluorescent probe to detect this epitope on primary porcine cells in vitro. In summary, our biochemical and structural analyses of the P. luminescens lectin PllA have disclosed the structural basis for PllA's high specificity for -galactoside-containing ligands, and we show that PllA can be used to visualize the -Gal epitope on porcine tissues.	[Beshr, Ghamdan; Hauck, Dirk; Wagner, Stefanie; Titz, Alexander] Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Chem Biol Carbohydrates, D-66123 Saarbrucken, Germany; [Sikandar, Asfandyar; Koehnke, Jesko] Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Struct Biol Biosynth Enzymes, D-66123 Saarbrucken, Germany; [Beshr, Ghamdan; Hauck, Dirk; Wagner, Stefanie; Titz, Alexander] Saarland Univ, Standort Hannover Braunschweig, Deutsch Zentrum Infektionsforsch DZIF, D-66123 Saarbrucken, Germany; [Beshr, Ghamdan; Sikandar, Asfandyar; Koehnke, Jesko; Titz, Alexander] Saarland Univ, Dept Pharm, D-66123 Saarbrucken, Germany; [Jemiller, Eva-Maria; Klymiuk, Nikolai; Wolf, Eckhard] Ludwig Maximilian Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Jemiller, Eva-Maria; Klymiuk, Nikolai; Wolf, Eckhard] Ludwig Maximilian Univ Munich, Dept Vet Sci, D-81377 Munich, Germany	Helmholtz Association; Helmholtz Association; German Center for Infection Research; Saarland University; Saarland University; University of Munich; University of Munich	Titz, A (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Chem Biol Carbohydrates, D-66123 Saarbrucken, Germany.; Koehnke, J (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Struct Biol Biosynth Enzymes, D-66123 Saarbrucken, Germany.; Titz, A (corresponding author), Saarland Univ, Standort Hannover Braunschweig, Deutsch Zentrum Infektionsforsch DZIF, D-66123 Saarbrucken, Germany.; Koehnke, J; Titz, A (corresponding author), Saarland Univ, Dept Pharm, D-66123 Saarbrucken, Germany.	jesko.koehnke@helmholtz-hzi.de; alexander.titz@helmholtz-hzi.de	Koehnke, Jesko/M-4861-2017; Koehnke, Jesko/AAC-7363-2021; Wolf, Eckhard/AAT-7500-2021; Titz, Alexander/E-6701-2010; Klymiuk, Nikolai/AAB-8345-2022	Koehnke, Jesko/0000-0002-7153-1365; Koehnke, Jesko/0000-0002-7153-1365; Wolf, Eckhard/0000-0002-0430-9510; Titz, Alexander/0000-0001-7408-5084; Klymiuk, Nikolai/0000-0003-3532-1659; Wagner, Stefanie/0000-0002-3873-7011	National Institutes of Health [R24 GM098791]; Deutsche Forschungsgemeinschaft [TRR 127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Rolf Muller (HIPS Saarbrucken) for providing the P. luminescens strain used in this study and to the Consortium for Functional Glycomics (Core H, Protein-Glycan Interaction Resource of the Consortium for Functional Glycomics and National Institutes of Health Supporting Grant R24 GM098791) for the glycan array analysis of PllA. We acknowledge use of the ESRF synchrotron (beamlines ID23-2 and ID30-B). GTKO pigs were produced with funding from Deutsche Forschungsgemeinschaft Grant TRR 127 "Biology of xenogeneic cell, tissue, and organ transplantation-from bench to bedside."	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akhurst R., 2012, PARASITES PATHOGENS, P1; Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; Beshr G, 2016, MEDCHEMCOMM, V7, P519, DOI 10.1039/c5md00557d; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Chen CP, 1998, GLYCOBIOLOGY, V8, P7, DOI 10.1093/glycob/8.1.7; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; DENNIS RD, 1985, EUR J BIOCHEM, V146, P51, DOI 10.1111/j.1432-1033.1985.tb08618.x; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Duffy MS, 2006, GLYCOBIOLOGY, V16, P854, DOI 10.1093/glycob/cwl001; Eierhoff T, 2014, P NATL ACAD SCI USA, V111, P12895, DOI 10.1073/pnas.1402637111; Ekser B, 2010, EXPERT REV CLIN IMMU, V6, P219, DOI 10.1586/ECI.09.81; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira T, 2014, INT J SYST EVOL MICR, V64, P1540, DOI 10.1099/ijs.0.059840-0; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Garber N, 1997, NOVA ACTA LEOPOLDINA, V1997, P75; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Guo LN, 1999, J BIOL CHEM, V274, P9836, DOI 10.1074/jbc.274.14.9836; Hapeshi A, 2017, CURR TOP MICROBIOL, V402, P159, DOI 10.1007/82_2016_29; Hauck D, 2013, ACS CHEM BIOL, V8, P1775, DOI 10.1021/cb400371r; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Joachim I, 2016, ORG BIOMOL CHEM, V14, P7933, DOI 10.1039/c6ob01313a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan F., 2002, MED SCI MONITOR, V8, P293; Kim HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25318; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127; Kumar A, 2016, J BIOL CHEM, V291, P25032, DOI 10.1074/jbc.M115.693473; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Landsteiner K, 1927, P SOC EXP BIOL MED, V24, P941; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Marchetti R, 2012, GLYCOBIOLOGY, V22, P1387, DOI 10.1093/glycob/cws105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon K, 2009, THESIS; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obukhova P, 2007, XENOTRANSPLANTATION, V14, P627, DOI 10.1111/j.1399-3089.2007.00436.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; POINAR GO, 1977, NEMATOLOGICA, V23, P97, DOI 10.1163/187529277X00273; Richter A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-84; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Sommer R, 2016, BEILSTEIN J ORG CHEM, V12, P2828, DOI 10.3762/bjoc.12.282; Sommer R, 2016, CHEM SCI, V7, P4990, DOI 10.1039/c6sc00696e; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sudakevitz D, 2004, MOL MICROBIOL, V52, P691, DOI 10.1111/j.1365-2958.2004.04020.x; Tempel W, 2002, J BIOL CHEM, V277, P6615, DOI 10.1074/jbc.M109919200; THOMAS GM, 1979, INT J SYST BACTERIOL, V29, P352, DOI 10.1099/00207713-29-4-352; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; van Stijn CMW, 2010, INT J PARASITOL, V40, P215, DOI 10.1016/j.ijpara.2009.07.009; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yan S, 2015, J PROTEOME RES, V14, P5291, DOI 10.1021/acs.jproteome.5b00746; Yan S, 2015, MOL CELL PROTEOMICS, V14, P2111, DOI 10.1074/mcp.M115.049817; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Yung GLP, 2012, XENOTRANSPLANTATION, V19, P196, DOI 10.1111/j.1399-3089.2012.00705.x; Zinger-Yosovich K, 2006, MICROBIOL-SGM, V152, P457, DOI 10.1099/mic.0.28500-0	70	7	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19935	19951		10.1074/jbc.M117.812792	http://dx.doi.org/10.1074/jbc.M117.812792			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972138	Green Published, hybrid			2022-12-28	WOS:000416911300034
J	Chen, CH; Adler, L; Goletz, P; Gonzalez-Fernandez, F; Thompson, DA; Koutalos, Y				Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Gonzalez-Fernandez, Federico; Thompson, Debra A.; Koutalos, Yiannis			Interphotoreceptor retinoid-binding protein removes all-trans-retinol and retinal from rod outer segments, preventing lipofuscin precursor formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; photoreceptor; retina; retinoid-binding protein; retinol	PHYSIOLOGICALLY RELEVANT CARRIER; VISUAL PIGMENT REGENERATION; TARGETED DISRUPTION; KNOCKOUT MICE; MOUSE RETINA; PHOTORECEPTORS; CYCLE; RDH12; EPITHELIUM; REDUCTION	Interphotoreceptor retinoid-binding protein (IRBP) is a specialized lipophilic carrier that binds the all-trans and 11-cis isomers of retinal and retinol, and this facilitates their transport between photoreceptors and cells in the retina. One of these retinoids, all-trans-retinal, is released in the rod outer segment by photoactivated rhodopsin after light excitation. Following its release, all-trans-retinal is reduced by the retinol dehydrogenase RDH8 to all-trans-retinol in an NADPH-dependent reaction. However, all-trans-retinal can also react with outer segment components, sometimes forming lipofuscin precursors, which after conversion to lipofuscin accumulate in the lysosomes of the retinal pigment epithelium and display cytotoxic effects. Here, we have imaged the fluorescence of all-trans-retinol, all-trans-retinal, and lipofuscin precursors in real time in single isolated mouse rod photoreceptors. We found that IRBP removes all-trans-retinol from individual rod photoreceptors in a concentration-dependent manner. The rate constant for retinol removal increased linearly with IRBP concentration with a slope of 0.012 min(-1) m(-1). IRBP also removed all-trans-retinal, but with much less efficacy, indicating that the reduction of retinal to retinol promotes faster clearance of the photoisomerized rhodopsin chromophore. The presence of physiological IRBP concentrations in the extracellular medium resulted in lower levels of all-trans-retinal and retinol in rod outer segments following light exposure. It also prevented light-induced lipofuscin precursor formation, but it did not remove precursors that were already present. These findings reveal an important and previously unappreciated role of IRBP in protecting the photoreceptor cells against the cytotoxic effects of accumulated all-trans-retinal.	[Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Koutalos, Yiannis] Med Univ South Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA; [Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Koutalos, Yiannis] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Gonzalez-Fernandez, Federico] Univ Mississippi, Dept Ophthalmol, Jackson, MS 39216 USA; [Gonzalez-Fernandez, Federico] Univ Mississippi, Dept Pathol, Jackson, MS 39216 USA; [Gonzalez-Fernandez, Federico] GV Sonny Montgomery Vet Affairs Med Ctr, Jackson, MS 39216 USA; [Thompson, Debra A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48105 USA	Medical University of South Carolina; Medical University of South Carolina; University of Mississippi; University of Mississippi; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Koutalos, Y (corresponding author), Med Univ South Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu		Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [R01-EY014850, R01-EY09412]; Merit Review Award from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I01BX007080]; Research Mississippi, Inc.; Research to Prevent Blindness Senior Scientific Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014850, R01EY009412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Research Mississippi, Inc.; Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants R01-EY014850 (to Y. K.) and R01-EY09412 (to F. G.-F.), Merit Review Award I01BX007080 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (to F. G.-F.), and a start-up award from Research Mississippi, Inc. (to F. G.-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Veterans Affairs.; Recipient of Research to Prevent Blindness Senior Scientific Investigator Award.	ADLER AJ, 1985, INVEST OPHTH VIS SCI, V26, P273; Adler AJ, 2000, EXP EYE RES, V70, P227, DOI 10.1006/exer.1999.0780; Adler L, 2017, EXP EYE RES, V155, P121, DOI 10.1016/j.exer.2017.02.007; Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; Adler Leopold 4th, 2015, Methods Mol Biol, V1271, P327, DOI 10.1007/978-1-4939-2330-4_21; Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; Chrispell JD, 2009, J BIOL CHEM, V284, P21468, DOI 10.1074/jbc.M109.020966; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; Gonzalez-Fernandez F, 2008, EXP EYE RES, V86, P169, DOI 10.1016/j.exer.2006.09.003; Gonzalez-Fernandez F, 2015, PHOTOCHEM PHOTOBIOL, V91, P371, DOI 10.1111/php.12416; Gonzalez-Fernandez F, 2014, EXP EYE RES, V120, P167, DOI 10.1016/j.exer.2014.01.002; HO MTP, 1989, J BIOL CHEM, V264, P928; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee M, 2016, INVEST OPHTH VIS SCI, V57, P1553, DOI 10.1167/iovs.15-18551; LIOU GI, 1986, VISION RES, V26, P1645, DOI 10.1016/0042-6989(86)90052-0; Liou GI, 1998, J NEUROSCI, V18, P4511; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; OKAJIMA TIL, 1989, EXP EYE RES, V49, P629, DOI 10.1016/S0014-4835(89)80059-4; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SAARI JC, 1985, J BIOL CHEM, V260, P195; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Wu QQ, 2006, BIOPHYS J, V91, P4678, DOI 10.1529/biophysj.106.086728	55	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19356	19365		10.1074/jbc.M117.795187	http://dx.doi.org/10.1074/jbc.M117.795187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972139	Green Published, hybrid			2022-12-28	WOS:000416226700017
J	Cao, ST; Yu, SY; Chen, Y; Wang, XS; Zhou, CH; Liu, YT; Kuang, JQ; Liu, H; Li, DW; Ye, J; Qin, Y; Chu, SL; Wu, LL; Guo, L; Li, YX; Shu, XD; Chen, JK; Liu, J; Pei, DQ				Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing			Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; chemical biology; hepatocyte; reprogramming; small molecule; MET; endoderm progenitor cells	PLURIPOTENT STEM-CELLS; DIRECT CONVERSION; SOMATIC-CELLS; FUNCTIONAL-NEURONS; GENERATION; INDUCTION; EXPRESSION; SOX17	We report here an approach to redirecting somatic cell fate under chemically defined conditions without transcription factors. We start by converting mouse embryonic fibroblasts to epithelial-like cells with chemicals and growth factors. Subsequent cell fate mapping reveals a robust induction of SOX17 in the resulting epithelial-like cells that can be further reprogrammed to endodermal progenitor cells. Interestingly, these cells can self-renew in vitro and further differentiate into albumin-producing hepatocytes that can rescue mice from acute liver injury. Our results demonstrate a rational approach to convert mouse embryonic fibroblasts to hepatocytes and suggest that this mechanism-driven approach may be generalized for other cells.	[Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Beijing 100049, Peoples R China; [Cao, Shangtao; Yu, Shengyong; Chen, Yan; Wang, Xiaoshan; Zhou, Chunhua; Liu, Yuting; Kuang, Junqi; Liu, He; Li, Dongwei; Ye, Jing; Qin, Yue; Chu, Shilong; Wu, Linlin; Guo, Lin; Li, Yinxiong; Shu, Xiaodong; Chen, Jiekai; Liu, Jing; Pei, Duanqing] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Xiaoshan; Li, Dongwei; Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Branch, Supercomp Ctr, Guangzhou 510530, Guangdong, Peoples R China; [Cao, Shangtao; Wang, Xiaoshan; Zhou, Chunhua; Kuang, Junqi; Liu, He; Li, Dongwei; Qin, Yue; Wu, Linlin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, J; Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Beijing 100049, Peoples R China.; Liu, J; Pei, DQ (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.; Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Branch, Supercomp Ctr, Guangzhou 510530, Guangdong, Peoples R China.	liu_jing@gibh.ac.cn; pei_duanqing@gibh.ac.cn	Qin, Yue/GWV-0264-2022		Chinese Academy of Sciences [XDA01020307, XDA01020401]; National Key R&D Program of China [2017YFJC040188, 2016YFA0101800]; National Natural Science Foundation of China [31421004, 31530038, 31522033, 91419310]; National Basic Research Program of China [2014CB965200]; Science and Technology Planning Project of Guangdong Province [2015B020228003, 2014B020225002, 2014B030301058, 2014B05052012]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Planning Project of Guangdong Province	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01020307 and XDA01020401; National Key R&D Program of China Grants 2017YFJC040188 and 2016YFA0101800; National Natural Science Foundation of China Grants 31421004, 31530038, 31522033, and 91419310; National Basic Research Program of China Grant 2014CB965200; and Science and Technology Planning Project of Guangdong Province Grants 2015B020228003, 2014B020225002, 2014B030301058, and 2014B05052012. The authors declare that they have no conflicts of interest with the contents of this article.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JN, 2013, KNOWL-BASED SYST, V45, P1, DOI 10.1016/j.knosys.2013.01.031; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Long Y, 2015, CELL RES, V25, P1171, DOI 10.1038/cr.2015.96; McDonald ACH, 2014, CELL REP, V9, P780, DOI 10.1016/j.celrep.2014.09.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nobuhisa I, 2014, MOL CELL BIOL, V34, P1976, DOI 10.1128/MCB.01485-13; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017	45	16	17	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19122	19132		10.1074/jbc.M117.812537	http://dx.doi.org/10.1074/jbc.M117.812537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28935668	hybrid, Green Published			2022-12-28	WOS:000415848000035
J	Hansson, H; Karkehabadi, S; Mikkelsen, N; Douglas, NR; Kim, S; Lam, A; Kaper, T; Kelemen, B; Meier, KK; Jones, SM; Solomon, EI; Sandgren, M				Hansson, Henrik; Karkehabadi, Saeid; Mikkelsen, Nils; Douglas, Nicholai R.; Kim, Steve; Lam, Anna; Kaper, Thijs; Kelemen, Brad; Meier, Katlyn K.; Jones, Stephen M.; Solomon, Edward I.; Sandgren, Mats			High-resolution structure of a lytic polysaccharide monooxygenase from Hypocrea jecorina reveals a predicted linker as an integral part of the catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); enzyme mechanism; enzyme structure; Hypocrea jecorina; X-ray crystallography; auxiliary activity family 9 (AA9); lytic polysaccharide monooxygenase (LPMO)	GLYCOSIDE HYDROLASE FAMILY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CELLULOSE DEGRADATION; CELLOBIOHYDROLASE-I; COPPER SITE; EXPRESSION; GLUCOAMYLASE; ACTIVATION	For decades, the enzymes of the fungus Hypocrea jecorina have served as a model system for the breakdown of cellulose. Three-dimensional structures for almost all H. jecorina cellulose-degrading enzymes are available, except for HjLPMO9A, belonging to the AA9 family of lytic polysaccharide monooxygenases (LPMOs). These enzymes enhance the hydrolytic activity of cellulases and are essential for cost-efficient conversion of lignocellulosic biomass. Here, using structural and spectroscopic analyses, we found that native HjLPMO9A contains a catalytic domain and a family-1 carbohydrate-binding module (CBM1) connected via a linker sequence. A C terminally truncated variant of HjLPMO9A containing 21 residues of the predicted linker was expressed at levels sufficient for analysis. Here, using structural, spectroscopic, and biochemical analyses, we found that this truncated variant exhibited reduced binding to and activity on cellulose compared with the full-length enzyme. Importantly, a 0.95- resolution X-ray structure of truncated HjLPMO9A revealed that the linker forms an integral part of the catalytic domain structure, covering a hydrophobic patch on the catalytic AA9 module. We noted that the oxidized catalytic center contains a Cu(II) coordinated by two His ligands, one of which has a His-brace in which the His-1 terminal amine group also coordinates to a copper. The final equatorial position of the Cu(II) is occupied by a water-derived ligand. The spectroscopic characteristics of the truncated variant were not measurably different from those of full-length HjLPMO9A, indicating that the presence of the CBM1 module increases the affinity of HjLPMO9A for cellulose binding, but does not affect the active site.	[Hansson, Henrik; Karkehabadi, Saeid; Mikkelsen, Nils; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, POB 7015, SE-75007 Uppsala, Sweden; [Douglas, Nicholai R.; Kim, Steve; Lam, Anna; Kaper, Thijs; Kelemen, Brad] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Meier, Katlyn K.; Jones, Stephen M.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Swedish University of Agricultural Sciences; Stanford University	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Chem & Biotechnol, POB 7015, SE-75007 Uppsala, Sweden.; Solomon, EI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	edward.solomon@stanford.edu; mats.sandgren@slu.se	; Meier, Katlyn/C-4478-2015	Sandgren, Mats/0000-0002-2358-4534; Hansson, Henrik/0000-0002-6003-2982; Solomon, Edward/0000-0003-0291-3199; Meier, Katlyn/0000-0002-8316-9199	Swedish Energy Agency [40144-1]; NIDDK of the National Institutes of Health [R01DK031450]; Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health [F32GM116240]; Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences through the faculty research program MicroDrivE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116240] Funding Source: NIH RePORTER	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health; Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences through the faculty research program MicroDrivE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Swedish Energy Agency under award number 40144-1 (to M. S.), the NIDDK of the National Institutes of Health under Grant R01DK031450 (to E. I. S.), the Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health under Grant F32GM116240 (to K. K. M.), and the Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences (to M. S., H. H., S. K., and N. M.) through the faculty research program MicroDrivE. N. D., S. T. K., A. L., and B. K. are employees of DuPont Industrial Biosciences, a producer of enzymes for industrial use. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Agirre J, 2016, ACTA CRYSTALLOGR D, V72, P254, DOI 10.1107/S2059798315024237; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Bott R, 2008, BIOCHEMISTRY-US, V47, P5746, DOI 10.1021/bi702413k; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen P, 2004, BIOCHEMISTRY-US, V43, P5735, DOI 10.1021/bi0362830; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; GEWIRTH AA, 1988, J AM CHEM SOC, V110, P3811, DOI 10.1021/ja00220a015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee TM, 2011, PROTEIN SCI, V20, P1935, DOI 10.1002/pro.730; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Machonkin TE, 2001, J AM CHEM SOC, V123, P5507, DOI 10.1021/ja003975s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moses V, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0655-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rojas J, 2011, J ADV PHARM TECHNOL, V2, P144, DOI 10.4103/2231-4040.85527; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Srisodsuk M, 1997, J BIOTECHNOL, V57, P49, DOI 10.1016/S0168-1656(97)00088-6; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tanghe M, 2015, MOL BIOTECHNOL, V57, P1010, DOI 10.1007/s12033-015-9887-9; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vejdovszky K, 2016, TOXICOL LETT, V241, P1, DOI 10.1016/j.toxlet.2015.10.024; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	57	37	39	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19099	19109		10.1074/jbc.M117.799767	http://dx.doi.org/10.1074/jbc.M117.799767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900033	hybrid, Green Published			2022-12-28	WOS:000415848000032
J	Yoon, JH; Choudhury, JR; Park, J; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise			Translesion synthesis DNA polymerases promote error-free replication through the minor-groove DNA adduct 3-deaza-3-methyladenine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA enzyme; DNA polymerase; DNA repair; N3-methyladenine; translesion synthesis in human cells	HUMAN-CELLS; PROTEIN-TEMPLATE; THYMINE GLYCOL; BYPASS; IOTA; ZETA; YEAST; REV1; REPAIR; KAPPA	N3-Methyladenine (3-MeA) is formed in DNA by reaction with S-adenosylmethionine, the reactive methyl donor, and by reaction with alkylating agents. 3-MeA protrudes into the DNA minor groove and strongly blocks synthesis by replicative DNA polymerases (Pols). However, the mechanisms for replicating through this lesion in human cells remain unidentified. Here we analyzed the roles of translesion synthesis (TLS) Pols in the replication of 3-MeA-damaged DNA in human cells. Because 3-MeA has a short half-life in vitro, we used the stable 3-deaza analog, 3-deaza-3-methyladenine (3-dMeA), which blocks the DNA minor groove similarly to 3-MeA. We found that replication through the 3-dMeA adduct is mediated via three different pathways, dependent upon Pol/Pol, Pol, and Pol. As inferred from biochemical studies, in the Pol/Pol pathway, Pol inserts a nucleotide (nt) opposite 3-dMeA and Pol extends synthesis from the inserted nt. In the Pol pathway, Pol carries out both the insertion and extension steps of TLS opposite 3-dMeA, and in the Pol pathway, Pol extends synthesis following nt insertion by an as yet unidentified Pol. Steady-state kinetic analyses indicated that Pol and Pol insert the correct nt T opposite 3-dMeA with a much reduced catalytic efficiency and that both Pols exhibit a high propensity for inserting a wrong nt opposite this adduct. However, despite their low fidelity of synthesis opposite 3-dMeA, TLS opposite this lesion replicates DNA in a highly error-free manner in human cells. We discuss the implications of these observations for TLS mechanisms in human cells.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	l.prakash@utmb.edu		Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	National Institutes of Health [ES021452, ES022948, ES020833]; National Institutes of Health NIEHS Center Grant [P30 ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021452, P30ES006676, R01ES022948, R01ES020833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIEHS Center Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES021452, ES022948, and ES020833, and in part by National Institutes of Health NIEHS Center Grant P30 ES06676. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	25	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18682	18688		10.1074/jbc.M117.808659	http://dx.doi.org/10.1074/jbc.M117.808659			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939775	Green Published, hybrid			2022-12-28	WOS:000414958100024
J	Ronchi, VP; Kim, ED; Summa, CM; Klein, JM; Haas, AL				Ronchi, Virginia P.; Kim, Elizabeth D.; Summa, Christopher M.; Klein, Jennifer M.; Haas, Arthur L.			In silico modeling of the cryptic E2 approximate to ubiquitin-binding site of E6-associated protein (E6AP)/UBE3A reveals the mechanism of polyubiquitin chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; enzyme mechanism; polyubiquitin chain; protein degradation; ubiquitin; E6AP; Hect; UbcH7	UBIQUITIN-ACTIVATING ENZYME; ANGELMAN-SYNDROME; LIGASE ACTIVITY; HECT FAMILY; E3 LIGASE; SUBCELLULAR-LOCALIZATION; PROTEASOMAL DEGRADATION; ALLOSTERIC MECHANISM; CONJUGATING ENZYMES; E6 ONCOPROTEINS	To understand the mechanism for assembly of Lys(48)-linked polyubiquitin degradation signals, we previously demonstrated that the E6AP/UBE3A ligase harbors two functionally distinct E2 approximate to ubiquitin-binding sites: a high-affinity Site 1 required for E6AP Cys(820)approximate to ubiquitin thioester formation and a canonical Site 2 responsible for subsequent chain elongation. Ordered binding to Sites 1 and 2 is here revealed by observation of UbcH7 approximate to ubiquitin-dependent substrate inhibition of chain formation at micromolar concentrations. To understand substrate inhibition, we exploited the PatchDock algorithm to model in silico UbcH7 approximate to ubiquitin bound to Site 1, validated by chain assembly kinetics of selected point mutants. The predicted structure buries an extensive solvent-excluded surface bringing the UbcH7 approximate to ubiquitin thioester bond within 6 angstrom of the Cys(820) nucleophile. Modeling onto the active E6AP trimer suggests that substrate inhibition arises from steric hindrance between Sites 1 and 2 of adjacent subunits. Confirmation that Sites 1 and 2 function in trans was demonstrated by examining the effect of E6APC820A on wild-type activity and single-turnover pulse-chase kinetics. A cyclic proximal indexation model proposes that Sites 1 and 2 function in tandem to assemble thioester-linked polyubiquitin chains from the proximal end attached to Cys(820) before stochastic en bloc transfer to the target protein. Non-reducing SDS-PAGE confirms assembly of the predicted Cys(820)-linked I-125-polyubiquitin thioester intermediate. Other studies suggest that Glu(550) serves as a general base to generate the Cys(820) thiolate within the low dielectric binding interface and Arg(506) functions to orient Glu(550) and to stabilize the incipient anionic transition state during thioester exchange.	[Ronchi, Virginia P.; Kim, Elizabeth D.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Summa, Christopher M.] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Louisiana System; University of New Orleans	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034009 (to A. L. H.) and an appropriation from the Louisiana State University School of Medicine (New Orleans, LA). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Benyamini H, 2009, PROTEINS, V77, P602, DOI 10.1002/prot.22473; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bracher PJ, 2011, ORIGINS LIFE EVOL B, V41, P399, DOI 10.1007/s11084-011-9243-4; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Castro EA, 1999, CHEM REV, V99, P3505, DOI 10.1021/cr990001d; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUHOVNY D, 2002, P 2 WORKSH ALG, V2452, P185; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; FEDOR LR, 1965, J AM CHEM SOC, V87, P4138, DOI 10.1021/ja01096a024; Gao QS, 2001, J VIROL, V75, P4459, DOI 10.1128/JVI.75.9.4459-4466.2001; Gao QS, 1999, MOL CELL BIOL, V19, P733; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hu Y, 2009, CANCER INVEST, V27, P298, DOI 10.1080/07357900802350798; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Inbar Y, 2005, J MOL BIOL, V349, P435, DOI 10.1016/j.jmb.2005.03.039; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; JENCKS WP, 1976, ACCOUNTS CHEM RES, V9, P425, DOI 10.1021/ar50108a001; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LeMaster DM, 1996, BIOCHEMISTRY-US, V35, P14876, DOI 10.1021/bi961607o; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-56; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Pal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065330; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	88	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18006	18023		10.1074/jbc.M117.813477	http://dx.doi.org/10.1074/jbc.M117.813477			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924046	Green Published, hybrid			2022-12-28	WOS:000414458200003
J	Green, JL; Wall, RJ; Vahokoski, J; Yusuf, NA; Ridzuan, MAM; Stanway, RR; Stock, J; Knuepfer, E; Brady, D; Martin, SR; Howell, SA; Pires, IP; Moon, RW; Molloy, JE; Kursula, I; Tewari, R; Holder, AA				Green, Judith L.; Wall, Richard J.; Vahokoski, Juha; Yusuf, Noor A.; Ridzuan, Mohd A. Mohd; Stanway, Rebecca R.; Stock, Jessica; Knuepfer, Ellen; Brady, Declan; Martin, Stephen R.; Howell, Steven A.; Pires, Isa P.; Moon, Robert W.; Molloy, Justin E.; Kursula, Inari; Tewari, Rita; Holder, Anthony A.			Compositional and expression analyses of the glideosome during the Plasmodium life cycle reveal an additional myosin light chain required for maximum motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-XIV MYOSIN; HOST-CELL INVASION; TOXOPLASMA-GONDII; MALARIA PARASITE; APICOMPLEXAN GLIDEOSOME; PROTEIN EXPRESSION; GLIDING MOTILITY; GENE DELETION; FALCIPARUM; MOTOR	Myosin A (MyoA) is a Class XIV myosin implicated in gliding motility and host cell and tissue invasion by malaria parasites. MyoA is part of a membrane-associated protein complex called the glideosome, which is essential for parasite motility and includes the MyoA light chain myosin tail domain-interacting protein (MTIP) and several glideosome-associated proteins (GAPs). However, most studies of MyoA have focused on single stages of the parasite life cycle. We examined MyoA expression throughout the Plasmodium berghei life cycle in both mammalian and insect hosts. In extracellular ookinetes, sporozoites, and merozoites, MyoA was located at the parasite periphery. In the sexual stages, zygote formation and initial ookinete differentiation precede MyoA synthesis and deposition, which occurred only in the developing protuberance. In developing intracellular asexual blood stages, MyoA was synthesized in mature schizonts and was located at the periphery of segmenting merozoites, where it remained throughout maturation, merozoite egress, and host cell invasion. Besides the known GAPs in the malaria parasite, the complex included GAP40, an additional myosin light chain designated essential light chain (ELC), and several other candidate components. This ELC bound theMyoAneck region adjacent to the MTIP-binding site, and both myosin light chains co-located to the glideosome. Coexpression of MyoA with its two light chains revealed that the presence of both light chains enhances MyoA-dependent actin motility. In conclusion, we have established a system to study the interplay and function of the three glideosome components, enabling the assessment of inhibitors that target this motor complex to block host cell invasion.	[Green, Judith L.; Yusuf, Noor A.; Ridzuan, Mohd A. Mohd; Knuepfer, Ellen; Moon, Robert W.; Holder, Anthony A.] Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England; [Martin, Stephen R.] Francis Crick Inst, Struct Biol, 1 Midland Rd, London NW1 1AT, England; [Howell, Steven A.] Francis Crick Inst, Mass Spectrometry Sci Technol Platforms, 1 Midland Rd, London NW1 1AT, England; [Molloy, Justin E.] Francis Crick Inst, Single Mol Enzymol Lab, 1 Midland Rd, London NW1 1AT, England; [Wall, Richard J.; Stock, Jessica; Brady, Declan; Tewari, Rita] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England; [Vahokoski, Juha; Kursula, Inari] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Stanway, Rebecca R.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Pires, Isa P.; Kursula, Inari] Univ Oulu, Bioctr Oulu, Aapistie 7, SF-90220 Oulu, Finland; [Pires, Isa P.; Kursula, Inari] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, SF-90220 Oulu, Finland; [Wall, Richard J.] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Yusuf, Noor A.; Ridzuan, Mohd A. Mohd] Inst Med Res, Jalan Pahang, Kuala Lumpur 50588, Malaysia; [Stock, Jessica] Res Inst Mol Pathol, Campus Vienna Bioctr 1, A-1030 Vienna, Austria; [Moon, Robert W.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; University of Nottingham; University of Bergen; University of Bern; University of Oulu; University of Oulu; University of Dundee; Kementerian Kesihatan Malaysia; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; London School of Hygiene & Tropical Medicine	Green, JL; Holder, AA (corresponding author), Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England.	judith.green@crick.ac.uk; tony.holder@crick.ac.uk	Holder, Anthony A/A-7554-2013; Mohd Abd Razak, Mohd Ridzuan/GXZ-7049-2022; Moon, Robert/AAF-9808-2019; Kursula, Inari/AHB-9980-2022	Holder, Anthony A/0000-0002-8490-6058; Kursula, Inari/0000-0001-5236-7056; Pires, Isa/0000-0001-8359-9028; Mohd Abd Razak, Mohd Ridzuan/0000-0002-9589-5892; Tewari, Rita/0000-0003-3943-1847; Knuepfer, Ellen/0000-0002-6090-1877; Molloy, Justin/0000-0002-8307-2450; Moon, Robert/0000-0002-9070-4292; Wall, Richard J./0000-0003-3487-3187; Green, Judith/0000-0001-6825-9404	Francis Crick Institute - Cancer Research UK [FC001097, FC001119]; Medical Research Council (MRC) [FC001097, FC001119]; Wellcome Trust [FC001097, FC001119]; MRC Project [G0900278, MR/K011782/1]; School of Life Sciences, University of Nottingham; Faculty of Medicine and Dentistry, University of Bergen [2015/13383-EVR]; Faculty of Medicine and Dentistry, University of Bergen; BBSRC [BB/N017609/1] Funding Source: UKRI; MRC [MR/K011782/1, G0900109, G0900278, MR/N023048/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N017609/1] Funding Source: researchfish; Medical Research Council [G0900278, G0900109, MR/N023048/1, MR/K011782/1] Funding Source: researchfish; The Francis Crick Institute [10119, 10015, 10097] Funding Source: researchfish	Francis Crick Institute - Cancer Research UK; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); School of Life Sciences, University of Nottingham; Faculty of Medicine and Dentistry, University of Bergen; Faculty of Medicine and Dentistry, University of Bergen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (Grants FC001097 and FC001119), the Medical Research Council (MRC) (Grants FC001097 and FC001119), and the the Wellcome Trust (Grants FC001097 and FC001119); by MRC Project Grant G0900278, MR/K011782/1; and small grant funding from the School of Life Sciences, University of Nottingham (2015) (to R. T.). This work was also supported by a research grant 2015/13383-EVR and postdoc fellowship from the Faculty of Medicine and Dentistry, University of Bergen (to J. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Buchs Mirjam, 2009, V498, P199, DOI 10.1007/978-1-59745-196-3_14; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; COPPEL RL, 1988, MOL BIOCHEM PARASIT, V31, P223, DOI 10.1016/0166-6851(88)90152-1; Diaz SA, 2014, MOL BIOCHEM PARASIT, V197, P9, DOI 10.1016/j.molbiopara.2014.09.006; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002554; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1985, PARASITOLOGY, V91, P219, DOI 10.1017/S0031182000057322; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Knuepfer E, 2014, CELL MICROBIOL, V16, P657, DOI 10.1111/cmi.12181; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lasonder E, 2015, PROTEOMICS, V15, P2716, DOI 10.1002/pmic.201400508; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinder JC, 1998, J CELL SCI, V111, P1831; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; ROGER N, 1988, MOL BIOCHEM PARASIT, V27, P135, DOI 10.1016/0166-6851(88)90033-3; Roques M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005273; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Syamaladevi DP, 2012, BIOINFORM BIOL INSIG, V6, P11, DOI 10.4137/BBI.S8451; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10; Yusuf NA, 2015, J BIOL CHEM, V290, P12147, DOI 10.1074/jbc.M115.637694	72	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17857	17875		10.1074/jbc.M117.802769	http://dx.doi.org/10.1074/jbc.M117.802769			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893907	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000414013000022
J	Kostrhon, S; Kontaxis, G; Kaufmann, T; Schirghuber, E; Kubicek, S; Konrat, R; Slade, D				Kostrhon, Sebastian; Kontaxis, Georg; Kaufmann, Tanja; Schirghuber, Erika; Kubicek, Stefan; Konrat, Robert; Slade, Dea			A histone-mimicking interdomain linker in a multidomain protein modulates multivalent histone binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; CHROMATIN MODIFICATIONS; INTRINSIC DISORDER; MOLECULAR-BASIS; RECOGNITION; COMPLEX; MIMICRY; POLY(ADP-RIBOSE); TRIMETHYLATION; BROMODOMAIN	N-terminal histone tails are subject to many posttranslational modifications that are recognized by and interact with designated reader domains in histone-binding proteins. BROMO domain adjacent to zinc finger 2B (BAZ2B) is a multidomain histone-binding protein that contains two histone reader modules, a plant homeodomain (PHD) and a bromodomain (BRD), linked by a largely disordered linker. Although previous studies have reported specificity of the PHD domain for the unmodified N terminus of histone H3 and of the BRD domain for H3 acetylated at Lys(14) (H3K14ac), the exact mode of H3 binding by BAZ2B and its regulation are underexplored. Here, using isothermal titration calorimetry and NMR spectroscopy, we report that acidic residues in the BAZ2B PHD domain are essential for H3 binding and that BAZ2B PHD-BRD establishes a polyvalent interaction with H3K14ac. Furthermore, we provide evidence that the disordered interdomain linker modulates the histone-binding affinity by interacting with the PHD domain. In particular, lysine-rich stretches in the linker, which resemble the positively charged N terminus of histone H3, reduce the binding affinity of the PHD finger toward the histone substrate. Phosphorylation, acetylation, or poly(ADP-ribosyl) ation of the linker residues may therefore act as a cellular mechanism to transiently tune BAZ2B histone-binding affinity. Our findings further support the concept of interdomain linkers serving a dual role in substrate binding by appropriately positioning the adjacent domains and by electrostatically modulating substrate binding. Moreover, inhibition of histone binding by a histone-mimicking interdomain linker represents another example of regulation of protein-protein interactions by intramolecular mimicry.	[Kostrhon, Sebastian; Kaufmann, Tanja; Slade, Dea] Univ Vienna, Campus Vienna Bioctr, Max F Perutz Labs, Dept Biochem, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Kontaxis, Georg; Konrat, Robert] Univ Vienna, Campus Vienna Bioctr 5, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Schirghuber, Erika; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1030 Vienna, Austria; [Schirghuber, Erika; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Epigenet & Antiinfect, A-1030 Vienna, Austria; [Kostrhon, Sebastian] Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society	Slade, D (corresponding author), Univ Vienna, Campus Vienna Bioctr, Max F Perutz Labs, Dept Biochem, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	dea.slade@univie.ac.at	Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Konrat, Robert/0000-0001-6489-4080; Slade, Dea/0000-0002-0052-5910	Max F. Perutz Laboratories (MFPL); Vienna Science and Technology Fund [LS14-001]; Austrian Science Fund [W1258]	Max F. Perutz Laboratories (MFPL); Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by an Max F. Perutz Laboratories (MFPL) start-up grant, Vienna Science and Technology Fund Grant LS14-001, and Austrian Science Fund Grant "DK: Integrative Structural Biology" W1258. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Altmeyer M, 2013, CURR OPIN GENET DEV, V23, P156, DOI 10.1016/j.gde.2012.11.001; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Baron R, 2011, STRUCTURE, V19, P212, DOI 10.1016/j.str.2011.01.001; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bortoluzzi A, 2017, BIOCHEM J, V474, P1633, DOI 10.1042/BCJ20161053; Bua DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02137; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Chen LH, 2015, P NATL ACAD SCI USA, V112, P4624, DOI 10.1073/pnas.1420833112; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Fischer PM, 2002, J PEPT SCI, V8, P529, DOI 10.1002/psc.413; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lewis AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003376; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; MacAlpine DM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010207; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4952; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Tallant C, 2015, STRUCTURE, V23, P80, DOI 10.1016/j.str.2014.10.017; Tauber M, 2015, NUCLEUS-PHILA, V6, P123, DOI 10.1080/19491034.2015.1026022; Teloni F, 2016, NUCLEIC ACIDS RES, V44, P993, DOI 10.1093/nar/gkv1383; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang ZX, 2011, J BIOL CHEM, V286, P18363, DOI 10.1074/jbc.R111.219139; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	51	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17643	17657		10.1074/jbc.M117.801464	http://dx.doi.org/10.1074/jbc.M117.801464			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28864776	hybrid, Green Published			2022-12-28	WOS:000414013000007
J	Cooper, PE; McClenaghan, C; Chen, XY; Stary-Weinzinger, A; Nichols, CG				Cooper, Paige E.; McClenaghan, Conor; Chen, Xingyu; Stary-Weinzinger, Anna; Nichols, Colin G.			Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANTU SYNDROME; K+ CHANNELS; BETA-CELL; SULFONYLUREA BLOCK; MODULATION; MECHANISM; INSULIN; PROTEIN; KCNJ8; GAIN	Cantu syndrome (CS) is a condition characterized by a range of anatomical defects, including cardiomegaly, hyperflexibility of the joints, hypertrichosis, and craniofacial dysmorphology. CS is associated with multiple missense mutations in the genes encoding the regulatory sulfonylurea receptor 2 (SUR2) sub-units of the ATP-sensitive K+ (K-ATP) channel as well as two mutations (V65M and C176S) in the Kir6.1 (KCNJ8) subunit. Previous analysis of leucine and alanine substitutions at the Val-65- equivalent site (Val-64) in Kir6.2 indicated no major effects on channel function. In this study, we characterized the effects of both valine-to-methionine and valine-to-leucine substitutions at this position in both Kir6.1 and Kir6.2 using ion flux and patch clamp techniques. We report that methionine substitution, but not leucine substitution, results in increased open state stability and hence significantly reduced ATP sensitivity and a marked increase of channel activity in the intact cell irrespective of the identity of the coassembled SUR subunit. Sulfonylurea inhibitors, such as glibenclamide, are potential therapies for CS. However, as a consequence of the increased open state stability, both Kir6.1(V65M) and Kir6.2(V64M) mutations essentially abolish high-affinity sensitivity to the KATP blocker glibenclamide in both intact cells and excised patches. This raises the possibility that, at least for some CS mutations, sulfonylurea therapy may not prove to be successful and highlights the need for detailed pharmacogenomic analyses of CS mutations.	[Cooper, Paige E.; McClenaghan, Conor; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA; [Cooper, Paige E.; McClenaghan, Conor; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Chen, Xingyu; Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria	Washington University (WUSTL); Washington University (WUSTL); University of Vienna	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Stary-Weinzinger, Anna/A-3629-2014	Stary-Weinzinger, Anna/0000-0002-9202-0484; McClenaghan, Conor/0000-0002-0859-3854	National Institutes of Health [HL45742, HL007275]; Austrian Science Fund [W1232]; E-Rare Joint Transnational CantuTreat Program [I-2101-B26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL140024, R01HL045742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); E-Rare Joint Transnational CantuTreat Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL45742 (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant HL007275.; Supported by Austrian Science Fund Grant W1232.; Supported by E-Rare Joint Transnational CantuTreat Program Grant I-2101-B26.	Afifi HH, 2016, PEDIATR DERMATOL, V33, pE109, DOI 10.1111/pde.12821; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Cooper PE, 2015, J GEN PHYSIOL, V146, P527, DOI 10.1085/jgp.201511495; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Gribble FM, 1999, DIABETOLOGIA, V42, P845, DOI 10.1007/s001250051236; Guerrero CRL, 2016, NEUROLOGY, V87, P270, DOI 10.1212/WNL.0000000000002861; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lee SJ, 2016, J GEN PHYSIOL, V148, P227, DOI 10.1085/jgp.201611616; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Reimann F, 2003, J PHYSIOL-LONDON, V547, P159, DOI 10.1113/jphysiol.2002.031625; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; Wambach JA, 2010, PEDIATR DIABETES, V11, P286, DOI 10.1111/j.1399-5448.2009.00557.x; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507	34	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17387	17398		10.1074/jbc.M117.804971	http://dx.doi.org/10.1074/jbc.M117.804971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842488	Green Published, hybrid			2022-12-28	WOS:000414009300020
J	Meyer, MB; Benkusky, NA; Kaufmann, M; Lee, SM; Onal, M; Jones, G; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Kaufmann, Martin; Lee, Seong Min; Onal, Melda; Jones, Glenville; Pike, J. Wesley			A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D-3 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; MULTIPLE-SCLEROSIS; CYP24A1 EXPRESSION; TARGETED ABLATION; ANIMAL-MODEL; D METABOLISM; BONE MASS; PHOSPHATE	The vitamin D endocrine system regulates mineral homeostasis through its activities in the intestine, kidney, and bone. Terminal activation of vitamin D-3 to its hormonal form, 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), occurs in the kidney via the cytochrome P450 enzyme CYP27B1. Despite its importance in vitamin D metabolism, the molecular mechanisms underlying the regulation of the gene for this enzyme, Cyp27b1, are unknown. Here, we identified a kidney-specific control module governed by a renal cell-specific chromatin structure located distal to Cyp27b1 that mediates unique basal and parathyroid hormone (PTH)-, fibroblast growth factor 23 (FGF23)-, and 1,25(OH)(2)D-3- mediated regulation of Cyp27b1 expression. Selective genomic deletion of key components within this module in mice resulted in loss of either PTH induction or FGF23 and 1,25(OH) 2D3 suppression of Cyp27b1 gene expression; the former loss caused a debilitating skeletal phenotype, whereas the latter conferred a quasi-normal bone mineral phenotype through compensatory homeostatic mechanisms involving Cyp24a1. We found that Cyp27b1 is also expressed at low levels in non-renal cells, in which transcription was modulated exclusively by inflammatory factors via a process that was unaffected by deletion of the kidney-specific module. These results reveal that differential regulation of Cyp27b1 expression represents a mechanism whereby 1,25(OH)(2)D-3 can fulfill separate functional roles, first in the kidney to control mineral homeostasis and second in extra-renal cells to regulate target genes linked to specific biological responses. Furthermore, we conclude that these mouse models open new avenues for the study of vitamin D metabolism and its involvement in therapeutic strategies for human health and disease.	[Meyer, Mark B.; Benkusky, Nancy A.; Lee, Seong Min; Onal, Melda; Jones, Glenville; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kaufmann, Martin] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	University of Wisconsin System; University of Wisconsin Madison; Queens University - Canada	Meyer, MB (corresponding author), Univ Wisconsin, Dept Biochem, Hector F DeLuca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	markmeyer@wisc.edu			Department of Biochemistry, University of Wisconsin-Madison; University of Wisconsin Carbone Cancer Center Support Grant from the National Institutes of Health [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Department of Biochemistry, University of Wisconsin-Madison; University of Wisconsin Carbone Cancer Center Support Grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Biochemistry, University of Wisconsin-Madison, and University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Adams JS, 2014, J STEROID BIOCHEM, V144, P22, DOI 10.1016/j.jsbmb.2013.12.009; Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Armbrecht HJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P298, DOI 10.1016/S0003-9861(02)00636-7; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Bouillon R, 2017, NAT REV ENDOCRINOL, V13, P466, DOI 10.1038/nrendo.2017.31; Bouillon R, 2017, ENDOCRINE, V56, P225, DOI 10.1007/s12020-017-1245-1; Bouillon R, 2014, NAT REV ENDOCRINOL, V10, P79, DOI 10.1038/nrendo.2013.226; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cartlidge RA, 2005, EMBO J, V24, P1696, DOI 10.1038/sj.emboj.7600648; CHANDLER JS, 1984, J BIOL CHEM, V259, P2214; CHANDLER JS, 1982, J STEROID BIOCHEM, V16, P303, DOI 10.1016/0022-4731(82)90181-9; Chow ECY, 2013, AM J PHYSIOL-ENDOC M, V304, pE977, DOI 10.1152/ajpendo.00489.2012; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DELUCA HF, 1972, NEW ENGL J MED, V287, P250, DOI 10.1056/NEJM197208032870511; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Haussler MR, 2016, VITAM HORM, V100, P165, DOI 10.1016/bs.vh.2015.11.005; Healy KD, 2003, P NATL ACAD SCI USA, V100, P9733, DOI 10.1073/pnas.1633774100; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Karaky M, 2016, MULT SCLER J, V22, P999, DOI 10.1177/1352458515610208; Kaufmann M, 2017, J BONE MINER RES, V32, P1589, DOI 10.1002/jbmr.3135; Kaufmann M, 2015, ENDOCRINOLOGY, V156, P4388, DOI 10.1210/en.2015-1664; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Kaufmann M, 2011, J BIOL CHEM, V286, P28729, DOI 10.1074/jbc.M111.236679; Laha TJ, 2012, CLIN CHEM, V58, P1711, DOI 10.1373/clinchem.2012.185827; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Liu F, 2017, GENOM PROTEOM BIOINF, V15, P196, DOI 10.1016/j.gpb.2016.12.006; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Nguyen-Yamamoto L, 2017, J AM SOC NEPHROL, V28, P586, DOI 10.1681/ASN.2016010066; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Meir T, 2009, AM J PHYSIOL-RENAL, V297, pF1192, DOI 10.1152/ajprenal.00360.2009; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Meyer MB, 2016, J STEROID BIOCHEM, V164, P258, DOI 10.1016/j.jsbmb.2015.09.001; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Pike JW, 2016, VITAM HORM, V100, P21, DOI 10.1016/bs.vh.2015.10.011; Pike JW, 2012, ARCH BIOCHEM BIOPHYS, V523, P2, DOI 10.1016/j.abb.2011.12.003; PIKE JW, 1982, P NATL ACAD SCI-BIOL, V79, P7719, DOI 10.1073/pnas.79.24.7719; Portale AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142924; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Ritter CS, 2012, J STEROID BIOCHEM, V130, P73, DOI 10.1016/j.jsbmb.2012.01.010; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segersten U, 2002, J CLIN ENDOCR METAB, V87, P2967, DOI 10.1210/jc.87.6.2967; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; TANAKA Y, 1984, AM J PHYSIOL, V246, pE168, DOI 10.1152/ajpendo.1984.246.2.E168; THOMASSET M, 1980, MOL PHARMACOL, V17, P362; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	70	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17541	17558		10.1074/jbc.M117.806901	http://dx.doi.org/10.1074/jbc.M117.806901			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28808057	hybrid, Green Published			2022-12-28	WOS:000414009300033
J	Neupane, DP; Avalos, D; Fullam, S; Roychowdhury, H; Yukl, ET				Neupane, Durga P.; Avalos, Dante; Fullam, Stephanie; Roychowdhury, Hridindu; Yukl, Erik T.			Mechanisms of zinc binding to the solute-binding protein AztC and transfer from the metallochaperone AztD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN; METAL-BINDING; CRYSTAL-STRUCTURE; ZNUA; AFFINITY; ACQUISITION; HOMEOSTASIS; COMPONENT; REVEALS	Bacteria can acquire the essential metal zinc from extremely zinc-limited environments by using ATP-binding cassette (ABC) transporters. These transporters are critical virulence factors, relying on specific and high-affinity binding of zinc by a periplasmic solute-binding protein (SBP). As such, the mechanisms of zinc binding and release among bacterial SBPs are of considerable interest as antibacterial drug targets. Zinc SBPs are characterized by a flexible loop near the high-affinity zinc-binding site. The function of this structure is not always clear, and its flexibility has thus far prevented structural characterization by X-ray crystallography. Here, we present intact structures for the zinc-specific SBP AztC from the bacterium Paracoccus denitrificans in the zinc-bound and apo-states. A comparison of these structures revealed that zinc loss prompts significant structural rearrangements, mediated by the formation of a sodium-binding site in the apo-structure. We further show that the AztC flexible loop has no impact on zinc-binding affinity, stoichiometry, or protein structure, yet is essential for zinc transfer from the metallochaperone AztD. We also found that 3 His residues in the loop appear to temporarily coordinate zinc and then convey it to the high-affinity binding site. Thus, mutation of any of these residues to Ala abrogated zinc transfer from AztD. Our structural and mechanistic findings conclusively identify a role for the AztC flexible loop in zinc acquisition from the metallochaperone AztD, yielding critical insights into metal binding by AztC from both solution and AztD. These proteins are highly conserved in human pathogens, making this work potentially useful for the development of novel antibiotics.	[Neupane, Durga P.; Avalos, Dante; Fullam, Stephanie; Roychowdhury, Hridindu; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Roychowdhury, Hridindu] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	New Mexico State University; University of Wisconsin System; University of Wisconsin Madison	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Avalos, Dante/0000-0002-9160-9713	National Institutes of Health; National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Berkeley Center for Structural Biology at Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Abate F, 2014, BIOSCIENCE REP, V34, P743, DOI 10.1042/BSR20140088; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bersch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081168; Bhubhani S, 2014, MICROBIOL-SGM, V160, P2452, DOI 10.1099/mic.0.082446-0; Cerasi M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00108; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Handali M, 2015, J BIOL CHEM, V290, P29984, DOI 10.1074/jbc.M115.684506; Handali M, 2015, J BIOL CHEM, V290, P11878, DOI 10.1074/jbc.M115.645853; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ilari A, 2016, BBA-GEN SUBJECTS, V1860, P534, DOI 10.1016/j.bbagen.2015.12.006; Ilari A, 2014, BBA-GEN SUBJECTS, V1840, P535, DOI 10.1016/j.bbagen.2013.10.010; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Sharma N, 2015, J STRUCT BIOL, V189, P184, DOI 10.1016/j.jsb.2015.01.012; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	44	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17496	17505		10.1074/jbc.M117.804799	http://dx.doi.org/10.1074/jbc.M117.804799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28887302	Green Published, hybrid			2022-12-28	WOS:000414009300029
J	Aguila, S; Izaguirre, G; Martinez-Martinez, I; Vicente, V; Olson, ST; Corral, J				Aguila, Sonia; Izaguirre, Gonzalo; Martinez-Martinez, Irene; Vicente, Vicente; Olson, Steven T.; Corral, Javier			Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; HEPARIN ACTIVATION; FACTOR-XA; BETA-ANTITHROMBIN; RAPID INHIBITION; CAMBRIDGE-II; FACTOR-IXA; BINDING; AFFINITY; EXOSITE	Antithrombin mainly inhibits factor Xa and thrombin. The reactive center loop (RCL) is crucial for its interactions with its protease targets and is fully inserted into the A-sheet after its cleavage, causing translocation of the covalently linked protease to the opposite end of the A-sheet. Antithrombin variants with altered RCL hinge residues behave as substrates rather than inhibitors, resulting in stoichiometries of inhibition greater than one. Other antithrombin residues have been suggested to interfere with RCL insertion or the stability of the antithrombin-protease complex, but available crystal structures or mutagenesis studies have failed to identify such residues. Here, we characterized two mutations, S365L and I207T, present in individuals with type II antithrombin deficiency and identified a new antithrombin functional domain. S365L did not form stable complexes with thrombin or factor Xa, and the I207T/I207A variants inhibited both proteases with elevated stoichiometries of inhibition. Close proximity of Ile-207 and Ser-365 to the inserted RCL suggested that the preferred reaction of these mutants as protease substrates reflects an effect on the rate of the RCL insertion and protease translocation. However, both residues lie within the final docking site for the protease in the antithrombin-protease complex, supporting the idea that the enhanced substrate reactions may result from an increased dissociation of the final complexes. Our findings demonstrate that the distal end of the antithrombin A-sheet is crucial for the last steps of protease inhibition either by affecting the rate of RCL insertion or through critical interactions with proteases at the end of the A-sheet.	[Aguila, Sonia; Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Univ Murcia, Inst Murciano Invest Biosanit IMIB Virgen de la A, Ctr Reg Hemodonac, Murcia 30003, Spain; [Aguila, Sonia; Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Univ Murcia, Inst Murciano Invest Biosanit IMIB Virgen de la A, Hosp Univ Morales Meseguer, Murcia 30003, Spain; [Izaguirre, Gonzalo; Olson, Steven T.] Univ Illinois, Dept Periodont, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain	University of Murcia; Meseguer General University Hospital Morales; University of Murcia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Martinez, I (corresponding author), Ctr Reg Hemodonac, Ronda Garay S-N, Murcia 30003, Spain.; Olson, ST (corresponding author), 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	immlgi@um.es; stolson@uic.edu	Vicente, Vicente/L-6185-2019; Aguila, Sonia/Q-2822-2019; Martínez-Martínez, Irene/AAM-8862-2020	Vicente, Vicente/0000-0002-4278-3264; Aguila, Sonia/0000-0001-5794-5177; Martínez-Martínez, Irene/0000-0002-1067-6464; Corral, Javier/0000-0003-0288-1107	Instituto de Salud Carlos III; Fundacion Seneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Seneca(Fundacion Seneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Bohdan, J. Padilla, S. Espin, and Lixin Qi for their excellent technical assistance, and Instituto de Salud Carlos III and Fundacion Seneca for supporting this work.	Aguila S, 2014, J THROMB HAEMOST, V12, P1131, DOI 10.1111/jth.12606; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Carrell RW, 2003, BIOCHEM SOC SYMP, V70, P163, DOI 10.1042/bss0700163; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; DEVRAJKIZUK R, 1988, BLOOD, V72, P1518; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gils A, 1998, THROMB HAEMOSTASIS, V80, P531; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2004, J BIOL CHEM, V279, P4913, DOI 10.1074/jbc.M311644200; KOIDE T, 1984, P NATL ACAD SCI-BIOL, V81, P289, DOI 10.1073/pnas.81.2.289; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; Maddur AA, 2013, J BIOL CHEM, V288, P32020, DOI 10.1074/jbc.M113.510990; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; Picard V, 2000, BRIT J HAEMATOL, V110, P731, DOI 10.1046/j.1365-2141.2000.02245.x; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Raja SM, 2003, J BIOL CHEM, V278, P13688, DOI 10.1074/jbc.M300062200; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200	37	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16513	16520		10.1074/jbc.M117.787325	http://dx.doi.org/10.1074/jbc.M117.787325			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28743742	Green Published, hybrid			2022-12-28	WOS:000412414800010
J	Tiller, KE; Li, LJ; Kumar, S; Julian, MC; Garde, S; Tessier, PM				Tiller, Kathryn E.; Li, Lijuan; Kumar, Sandeep; Julian, Mark C.; Garde, Shekhar; Tessier, Peter M.			Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HYDROPHOBIC INTERACTIONS; AFFINITY MATURATION; MOLECULAR-DYNAMICS; COMPUTATIONAL DESIGN; PEPTIDE INHIBITORS; MEMBRANE-PROTEINS; VARIABLE DOMAINS; FORCE-FIELD; AMINO-ACIDS	Antibodies commonly accumulate charged mutations in their complementarity-determining regions (CDRs) during affinity maturation to enhance electrostatic interactions. However, charged mutations can mediate non-specific interactions, and it is unclear to what extent CDRs can accumulate charged residues to increase antibody affinity without compromising specificity. This is especially concerning for positively charged CDR mutations that are linked to antibody polyspecificity. To better understand antibody affinity/specificity trade-offs, we have selected single-chain antibody fragments specific for the negatively charged and hydrophobic Alzheimer's amyloid beta peptide using weak and stringent selections for antibody specificity. Antibody variants isolated using weak selections for specificity were enriched in arginine CDR mutations and displayed low specificity. Alanine-scanning mutagenesis revealed that the affinities of these antibodies were strongly dependent on their arginine mutations. Antibody variants isolated using stringent selections for specificity were also enriched in arginine CDR mutations, but these antibodies possessed significant improvements in specificity. Importantly, the affinities of the most specific antibodies were much less dependent on their arginine mutations, suggesting that over-reliance on arginine for affinity leads to reduced specificity. Structural modeling and molecular simulations reveal unique hydrophobic environments near the arginine CDR mutations. The more specific antibodies contained arginine mutations in the most hydrophobic portions of the CDRs, whereas the less specific antibodies contained arginine mutations in more hydrophilic regions. These findings demonstrate that arginine mutations in antibody CDRs display context-dependent impacts on specificity and that affinity/specificity trade-offs are governed by the relative contribution of arginine CDR residues to the overall antibody affinity.	[Tiller, Kathryn E.; Li, Lijuan; Julian, Mark C.; Garde, Shekhar; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Kumar, Sandeep] Pfizer Inc, Pharmaceut Res & Dev, Biotherapeut Pharmaceut Sci, Chesterfield, MO 63017 USA	Rensselaer Polytechnic Institute; Pfizer	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn & Pharmaceut Sci, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Tessier, Peter/GPP-3396-2022; Li, Lijuan/L-6073-2018	Li, Lijuan/0000-0002-9490-6844	National Institutes of Health [R01GM104130]; National Science Foundation [CBET 1159943, 1605266]; Richard Baruch M.D. Chair; MedImmune; Eli Lilly; Bristol-Myers Squibb; Janssen; Merck; Genentech; Amgen; Pfizer; Adimab; Abbvie; Roche; Boehringer Ingelheim; Bayer; Abbott; DuPont; Schrodinger; Novo Nordisk; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130] Funding Source: NIH RePORTER; Directorate For Engineering [1813963] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1605266] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Richard Baruch M.D. Chair; MedImmune(AstraZenecaMedimmune); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Genentech(Roche HoldingGenentech); Amgen(Amgen); Pfizer(Pfizer); Adimab; Abbvie(AbbVie); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Abbott(Abbott Laboratories); DuPont; Schrodinger(Austrian Science Fund (FWF)); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Institutes of Health Grant R01GM104130 (to P. M. T.), National Science Foundation Grants CBET 1159943 and 1605266 (to P. M. T.), Graduate Research Fellowships (to K. E. T. and M. C. J.), and the Richard Baruch M.D. Chair (to P. M. T.). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at MedImmune, Eli Lilly, Bristol-Myers Squibb, Janssen, Merck, Genentech, Amgen, Pfizer, Adimab, Abbvie, Roche, Boehringer Ingelheim, Bayer, Abbott, DuPont, Schrodinger, and Novo Nordisk. S. K. is an employee of Pfizer, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; [Anonymous], 2017, MOL OP ENV MOE 2013; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brockmann EC, 2005, J IMMUNOL METHODS, V296, P159, DOI 10.1016/j.jim.2004.11.008; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; CHANDLER D, 1983, SCIENCE, V220, P787, DOI 10.1126/science.220.4599.787; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cho YK, 2010, PROTEIN ENG DES SEL, V23, P567, DOI 10.1093/protein/gzq029; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Garde S, 2015, NATURE, V517, P277, DOI 10.1038/517277a; Giles I, 2005, ARTHRITIS RES THER, V7, pR47, DOI 10.1186/ar1449; Godawat R, 2009, P NATL ACAD SCI USA, V106, P15119, DOI 10.1073/pnas.0902778106; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Haley J, 2004, MOL IMMUNOL, V40, P745, DOI 10.1016/j.molimm.2003.10.018; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; Hennecke F, 1998, PROTEIN ENG, V11, P405, DOI 10.1093/protein/11.5.405; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Houlihan G, 2015, PROTEIN ENG DES SEL, V28, P269, DOI 10.1093/protein/gzv029; Huang DM, 2002, J PHYS CHEM B, V106, P2047, DOI 10.1021/jp013289v; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Kawasaki T, 2012, BIOSCI BIOTECH BIOCH, V76, P762, DOI 10.1271/bbb.110879; Kawasaki T, 2011, BIOSCI BIOTECH BIOCH, V75, P1496, DOI 10.1271/bbb.110198; Kawasaki T, 2010, BIOSCI BIOTECH BIOCH, V74, P2214, DOI 10.1271/bbb.100388; Kim DY, 2014, MABS-AUSTIN, V6, P219, DOI 10.4161/mabs.26844; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lambrianides A, 2007, ARTHRITIS RHEUM-US, V56, P2392, DOI 10.1002/art.22743; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Lipovsek D, 2007, CHEM BIOL, V14, P1176, DOI 10.1016/j.chembiol.2007.09.008; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; Monnet C, 2002, J MOL BIOL, V315, P699, DOI 10.1006/jmbi.2001.5284; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel AJ, 2014, J PHYS CHEM B, V118, P1564, DOI 10.1021/jp4081977; Patel AJ, 2010, J PHYS CHEM B, V114, P1632, DOI 10.1021/jp909048f; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Short MK, 2002, J BIOL CHEM, V277, P16365, DOI 10.1074/jbc.M110444200; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun SB, 2013, J AM CHEM SOC, V135, P9980, DOI 10.1021/ja402927u; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; Tillotson BJ, 2013, METHODS, V60, P27, DOI 10.1016/j.ymeth.2012.03.010; Tillotson BJ, 2013, PROTEIN ENG DES SEL, V26, P101, DOI 10.1093/protein/gzs077; Varilly P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3532939; VILLAR HO, 1994, FEBS LETT, V349, P125, DOI 10.1016/0014-5793(94)00648-2; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Willard AP, 2010, J PHYS CHEM B, V114, P1954, DOI 10.1021/jp909219k; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	88	35	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16638	16652		10.1074/jbc.M117.783837	http://dx.doi.org/10.1074/jbc.M117.783837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28778924	Green Published, hybrid			2022-12-28	WOS:000412414800024
J	Moriarty, GM; Olson, MP; Atieh, TB; Janowska, MK; Khare, SD; Baum, J				Moriarty, Gina M.; Olson, Michael P.; Atieh, Tamr B.; Janowska, Maria K.; Khare, Sagar D.; Baum, Jean			A pH-dependent switch promotes beta-synuclein fibril formation via glutamate residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GAMMA-SYNUCLEIN; LEWY BODIES; AMYLOID FIBRILS; AGGREGATION PROPENSITIES; SEQUENCE DETERMINANTS; SECONDARY STRUCTURE; DIPOLAR COUPLINGS; TOXICITY	alpha-Synuclein (alpha S) is the primary protein associated with Parkinson's disease, and it undergoes aggregation from its intrinsically disordered monomeric form to a cross-beta fibrillar form. The closely related homolog beta-synuclein (beta S) is essentially fibril-resistant under cytoplasmic physiological conditions. Toxic gain-of-function by beta S has been linked to dysfunction, but the aggregation behavior of beta S under altered pH is not well-understood. In this work, we compare fibril formation of alpha S and beta S at pH 7.3 and mildly acidic pH 5.8, and we demonstrate that pH serves as an on/off switch for beta S fibrillation. Using alpha S/beta S domain-swapped chimera constructs and single residue substitutions in beta S, we localized the switch to acidic residues in the N-terminal and non-amyloid component domains of beta S. Computational models of beta S fibril structures indicate that key glutamate residues (Glu-31 and Glu-61) in these domains may be sites of pH-sensitive interactions, and variants E31A and E61A show dramatically altered pH sensitivity for fibril formation supporting the importance of these charged side chains in fibril formation of beta S. Our results demonstrate that relatively small changes in pH, which occur frequently in the cytoplasm and in secretory pathways, may induce the formation of beta S fibrils and suggest a complex role for beta S in synuclein cellular homeostasis and Parkinson's disease.	[Moriarty, Gina M.; Olson, Michael P.; Atieh, Tamr B.; Janowska, Maria K.; Khare, Sagar D.; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, 610 Taylor Rd, Piscataway, NJ 08854 USA; [Janowska, Maria K.] Univ Washington, Dept Biochem, Seattle, WA 98105 USA	Rutgers State University New Brunswick; University of Washington; University of Washington Seattle	Khare, SD; Baum, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, 610 Taylor Rd, Piscataway, NJ 08854 USA.	sagar.khare@rutgers.edu; jean.baum@rutgers.edu			National Institutes of Health [GM110577]; Graduate Assistance in Areas of National Need (GAANN) fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Assistance in Areas of National Need (GAANN) fellowship(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM110577 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Both authors were supported by a Graduate Assistance in Areas of National Need (GAANN) fellowship.	Allison JR, 2014, BIOCHEMISTRY-US, V53, P7170, DOI 10.1021/bi5009326; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Brown JWP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36010; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Ducas VC, 2012, J MOL BIOL, V423, P528, DOI 10.1016/j.jmb.2012.08.008; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; French KC, 2012, BIOCHEMISTRY-US, V51, P10127, DOI 10.1021/bi301406d; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Janowska MK, 2016, PROTEIN SCI, V25, P286, DOI 10.1002/pro.2798; Janowska MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15164; Kang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075018; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kett LR, 2016, MOVEMENT DISORD, V31, P1433, DOI 10.1002/mds.26797; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Majdi A, 2016, J NEUROSCI RES, V94, P879, DOI 10.1002/jnr.23757; Marsh JA, 2008, J AM CHEM SOC, V130, P7804, DOI 10.1021/ja802220c; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McGlinchey RP, 2014, CHEMBIOCHEM, V15, P1569, DOI 10.1002/cbic.201402074; McGlinchey RP, 2013, BIOCHEM SOC T, V41, P1509, DOI 10.1042/BST20130158; Moriarty GM, 2013, FEBS LETT, V587, P1128, DOI 10.1016/j.febslet.2013.02.049; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Roodveldt C, 2012, BIOCHEMISTRY-US, V51, P8771, DOI 10.1021/bi300558q; Rostovtseva TK, 2015, J BIOL CHEM, V290, P18467, DOI 10.1074/jbc.M115.641746; Ruffin VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00043; Schwalbe M, 2014, STRUCTURE, V22, P238, DOI 10.1016/j.str.2013.10.020; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Surguchov A, 2015, INT REV CEL MOL BIO, V320, P103, DOI 10.1016/bs.ircmb.2015.07.007; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Taschenberger G, 2013, ANN NEUROL, V74, P109, DOI 10.1002/ana.23905; Tenreiro S, 2016, HUM MOL GENET, V25, P275, DOI 10.1093/hmg/ddv470; Tipping KW, 2015, P NATL ACAD SCI USA, V112, P5691, DOI 10.1073/pnas.1423174112; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Villar-Pique A, 2016, P NATL ACAD SCI USA, V113, pE6506, DOI 10.1073/pnas.1606791113; Wang T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00433; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Wu KP, 2009, J MOL BIOL, V391, P784, DOI 10.1016/j.jmb.2009.06.063; Xu L, 2017, ACS CHEM NEUROSCI, V8, P837, DOI 10.1021/acschemneuro.6b00406; Xu L, 2016, EUR J MED CHEM, V121, P841, DOI 10.1016/j.ejmech.2016.01.044; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	74	26	26	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16368	16379		10.1074/jbc.M117.780528	http://dx.doi.org/10.1074/jbc.M117.780528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28710275	Green Published, hybrid			2022-12-28	WOS:000412109400034
J	Li, YC; Naveen, V; Lin, MG; Hsiao, CD				Li, Yi-Ching; Naveen, Vankadari; Lin, Min-Guan; Hsiao, Chwan-Deng			Structural analyses of the bacterial primosomal protein DnaB reveal that it is a tetramer and forms a complex with a primosomal re-initiation protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS-DNAB; REPLICATION INITIATION; CHROMOSOMAL REPLICATION; PLASMID REPLICATION; HELICASE; MEMBRANE; DOMAIN; SCATTERING; MECHANISM; RESTART	The DnaB primosomal protein from Gram-positive bacteria plays a key role in DNA replication and restart as a loader protein for the recruitment of replisome cascade proteins. Previous investigations have established that DnaB is composed of an N-terminal domain, a middle domain, and a C-terminal domain. However, structural evidence for how DnaB functions at the atomic level is lacking. Here, we report the crystal structure of DnaB, encompassing the N-terminal and middle domains (residues 1-300), from Geobacillus stearothermophilus (GstDnaB(1-300)) at 2.8 angstrom resolution. Our structure revealed that GstDnaB1-300 forms a tetramer with two basketlike architectures, a finding consistent with those from solution studies using analytical ultracentrifugation. Furthermore, our results from both GST pulldown assays and analytical ultracentrifugation show that GstDnaB1-300 is sufficient to form a complex with PriA, the primosomal reinitiation protein. Moreover, with the aid of small angle X-ray scattering experiments, we also determined the structural envelope of full-length DnaB (GstDnaBFL) in solution. These small angle X-ray scattering studies indicated that GstDnaBFL has an elongated conformation and that the protruding density envelopes originating from GstDnaB1-300 could completely accommodate the GstDnaB C-terminal domain (residues 301-461). Taken together with biochemical assays, our results suggest that GstDnaB uses different domains to distinguish the PriA interaction and singlestranded DNA binding. These findings can further extend our understanding of primosomal assembly in replication restart.	[Li, Yi-Ching; Naveen, Vankadari; Lin, Min-Guan; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Lin, Min-Guan] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University	Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021; Vankadari, Naveen/AAE-7381-2020	Hsiao, Chwan-Deng/0000-0002-7012-1532; Vankadari, Naveen/0000-0001-9363-080X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Grainger WH, 2010, NUCLEIC ACIDS RES, V38, P2851, DOI 10.1093/nar/gkp1236; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOSHINO T, 1987, P NATL ACAD SCI USA, V84, P653, DOI 10.1073/pnas.84.3.653; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li Y, 2007, MICROBIOL-SGM, V153, P3370, DOI 10.1099/mic.0.2007/009001-0; Lin YC, 2016, BIOCHEM BIOPH RES CO, V473, P243, DOI 10.1016/j.bbrc.2016.03.086; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Marians KJ, 2000, STRUCTURE, V8, pR227, DOI 10.1016/S0969-2126(00)00539-6; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Naue N, 2013, NUCLEIC ACIDS RES, V41, P4507, DOI 10.1093/nar/gkt107; Nunez-Ramirez R, 2007, J MOL BIOL, V367, P764, DOI 10.1016/j.jmb.2006.12.075; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; SATO Y, 1991, J BACTERIOL, V173, P7732, DOI 10.1128/jb.173.23.7732-7735.1991; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2014, P NATL ACAD SCI USA, V111, P9121, DOI 10.1073/pnas.1406065111; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WATABE K, 1987, J BACTERIOL, V169, P4141, DOI 10.1128/jb.169.9.4141-4146.1987; WINSTON S, 1980, P NATL ACAD SCI-BIOL, V77, P2834, DOI 10.1073/pnas.77.5.2834; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zhang WK, 2005, J MOL BIOL, V351, P66, DOI 10.1016/j.jmb.2005.05.065	52	5	5	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15744	15757		10.1074/jbc.M117.792002	http://dx.doi.org/10.1074/jbc.M117.792002			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28808061	hybrid, Green Published			2022-12-28	WOS:000411512200014
J	Saha, D; Singh, A; Hussain, T; Srivastava, V; Sengopta, S; Kar, A; Dhapola, P; Dhople, V; Unnmanni, R; Chowdhury, S				Saha, Dhurjhoti; Singh, Ankita; Hussain, Tabish; Srivastava, Vivek; Sengopta, Sunnan; Kar, Anirban; Dhapola, Parashar; Dhople, Vishnu; Unnmanni, Ramesh; Chowdhury, Shantanu			Epigenetic suppression of human telomerase (hTERT) is mediated by the metastasis suppressor NME2 in a G-quadruplex-dependent fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HUMAN CANCERS; DNA; PROMOTER; GENOME; CELLS; NM23-H2; KINASE; TRANSCRIPTION; ACTIVATION	Transcriptional activation of the human telomerase reverse transcriptase (hTERT) gene, which remains repressed in adult somatic cells, is critical during tumorigenesis. Several transcription factors and the epigenetic state of the hTERT promoter are known to be important for tight control of hTERT in normal tissues, but the molecular mechanisms leading to hTERT reactivation in cancer are not well-understood. Surprisingly, here we found occupancy of the metastasis suppressor non-metastatic 2 (NME2) within the hTERT core promoter in HT1080 fibrosarcoma cells and HCT116 colon cancer cells and NME2-mediated transcriptional repression of hTERT in these cells. We also report that loss of NME2 results in up-regulated hTERT expression. Mechanistically, additional results indicated that the RE1-silencing transcription factor (REST)-lysine-specific histone demethylase 1 (LSD1) co-repressor complex associates with the hTERT promoter in an NME2-dependent way and that this assembly is required for maintaining repressive chromatin at the hTERT promoter. Interestingly, a G-quadruplex motif at the hTERT promoter was essential for occupancy of NME2 and the REST repressor complex on the hTERT promoter. In light of this mechanistic insight, we studied the effects of G-quadruplex-binding ligands on hTERT expression and observed that several of these ligands repressed hTERT expression. Together, our results support a mechanism of hTERT epigenetic control involving a G-quadruplex promoter motif, which potentially can be targeted by tailored small molecules.	[Saha, Dhurjhoti; Singh, Ankita; Hussain, Tabish; Srivastava, Vivek; Sengopta, Sunnan; Kar, Anirban; Chowdhury, Shantanu] CSIR, CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Mathura Rd, New Delhi 110025, India; [Dhapola, Parashar; Chowdhury, Shantanu] CSIR, CSIR Inst Genom & Integrat Biol, GNR Knowledge Ctr Genome Informat, Mathura Rd, New Delhi 110025, India; [Saha, Dhurjhoti; Singh, Ankita; Dhapola, Parashar; Chowdhury, Shantanu] Council Sci & Ind Res CSIR, CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res AcSIR, Mathura Rd, New Delhi 110025, India; [Dhople, Vishnu; Unnmanni, Ramesh] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Andhra Pradesh, India; [Singh, Ankita] Natl Inst Canc Prevent & Res, Noida 201301, Uttarpradesh, India; [Srivastava, Vivek] Sharda Univ, Sch Basic Sci & Res, Dept Biochem, Greater Noida 201306, Uttar Pradesh, India; [Kar, Anirban] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Dhople, Vishnu] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Domstr 11, D-17489 Greifswald, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Sharda University; University of North Carolina; University of North Carolina Chapel Hill; Ernst Moritz Arndt Universitat Greifswald	Chowdhury, S (corresponding author), CSIR, CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Mathura Rd, New Delhi 110025, India.; Chowdhury, S (corresponding author), CSIR, CSIR Inst Genom & Integrat Biol, GNR Knowledge Ctr Genome Informat, Mathura Rd, New Delhi 110025, India.; Chowdhury, S (corresponding author), Council Sci & Ind Res CSIR, CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res AcSIR, Mathura Rd, New Delhi 110025, India.	shantanuc@igib.res.in	Hussain, Tabish/AAE-1481-2019; Kar, Anirban/ABF-9178-2021	Dhapola, Parashar/0000-0002-8070-7238	Wellcome Trust/Department of Biotechnology (DBT) India Alliance [500127/Z/09/Z]; Wellcome Trust/DBT India Alliance; Indian Council of Medical Research; Council of Scientific and Industrial Research	Wellcome Trust/Department of Biotechnology (DBT) India Alliance(Wellcome Trust DBT India Alliance); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant 500127/Z/09/Z (to S.C.) and fellowships from the Wellcome Trust/DBT India Alliance (to D.S., S.S., V.S., and A.K.), Indian Council of Medical Research (to A.S.), and Council of Scientific and Industrial Research (to T.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Akincilar SC, 2016, CELL MOL LIFE SCI, V73, P1659, DOI 10.1007/s00018-016-2146-9; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Bithell A, 2011, EPIGENOMICS-UK, V3, P47, DOI 10.2217/EPI.10.76; Bosnar MH, 2008, NEOPLASMA, V55, P447; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Galasso A, 2009, MOL CELL BIOCHEM, V329, P149, DOI 10.1007/s11010-009-0115-4; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hartman J, 2009, STEROIDS, V74, P635, DOI 10.1016/j.steroids.2009.02.005; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Kang HJ, 2016, J AM CHEM SOC, V138, P13673, DOI 10.1021/jacs.6b07598; Kar A, 2012, NUCLEIC ACIDS RES, V40, P2554, DOI 10.1093/nar/gkr1109; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Li YH, 2016, P NATL ACAD SCI USA, V113, P14402, DOI 10.1073/pnas.1611106113; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Postel EH, 2002, BIOCHEMISTRY-US, V41, P6330, DOI 10.1021/bi025606+; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Ramlee M. K., 2016, GENES, V7, pE50, DOI DOI 10.3390/GENES7080050); Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Roizman B, 2011, J VIROL, V85, P7474, DOI 10.1128/JVI.00180-11; Sandin S, 2014, CURR OPIN STRUC BIOL, V25, P104, DOI 10.1016/j.sbi.2014.02.003; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Shan C, 2017, J MED CHEM, V60, P1292, DOI 10.1021/acs.jmedchem.6b01218; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Steeg PS, 2011, N-S ARCH PHARMACOL, V384, P331, DOI 10.1007/s00210-011-0651-9; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Thakur RK, 2014, NUCLEIC ACIDS RES, V42, P11589, DOI 10.1093/nar/gku860; Thakur RK, 2011, N-S ARCH PHARMACOL, V384, P397, DOI 10.1007/s00210-011-0631-0; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Yadav VK, 2014, NUCLEIC ACIDS RES, V42, P9602, DOI 10.1093/nar/gku596; Yadav VK, 2014, NUCLEIC ACIDS RES, V42, P764, DOI 10.1093/nar/gkt946; Yu ZB, 2012, J AM CHEM SOC, V134, P5157, DOI 10.1021/ja210399h; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	52	35	36	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15205	15215		10.1074/jbc.M117.792077	http://dx.doi.org/10.1074/jbc.M117.792077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717007	Green Published, hybrid			2022-12-28	WOS:000410809800004
J	Hoyte, AC; Jamin, AV; Koneru, PC; Kobe, MJ; Larue, RC; Fuchs, JR; Engelman, AN; Kvaratskhelia, M				Hoyte, Ashley C.; Jamin, Augusta V.; Koneru, Pratibha C.; Kobe, Matthew J.; Larue, Ross C.; Fuchs, James R.; Engelman, Alan N.; Kvaratskhelia, Mamuka			Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); integrase; protein aggregation; protein drug interaction; viral replication; HIV; allosteric inhibitors	VIRUS TYPE-1 INTEGRASE; CATALYTIC DOMAIN; REPLICATION; MECHANISM; MATURE; MODEL; MULTIMERIZATION; MUTATIONS; KNOCKOUT; PROTEIN	The pyridine-based multimerization selective HIV-1 integrase (IN) inhibitors (MINIs) are a distinct subclass of allosteric IN inhibitors. MINIs potently inhibit HIV-1 replication during virion maturation by inducing hyper- or aberrant IN multimerization but are largely ineffective during the early steps of viral replication. Here, we investigated the mechanism for the evolution of a triple IN substitution (T124N/V165I/T174I) that emerges in cell culture with a representative MINI, KF116. We show that HIV-1 NL4-3(IN T124N/V165I/T174I) confers marked (>2000-fold) resistance to KF116. Two IN substitutions (T124N/T174I) directly weaken inhibitor binding at the dimer interface of the catalytic core domain but at the same time markedly impair HIV-1 replication capacity. Unexpectedly, T124N/T174I IN substitutions inhibited proteolytic processing of HIV-1 polyproteins Gag and Gag-Pol, resulting in immature virions. Strikingly, the addition of the third IN substitution (V165I) restored polyprotein processing, virus particle maturation, and significant levels of replication capacity. These results reveal an unanticipated role of IN for polyprotein proteolytic processing during virion morphogenesis. The complex evolutionary pathway for the emergence of resistant viruses, which includes the need for the compensatory V165I IN substitution, highlights a relatively high genetic barrier exerted by MINI KF116. Additionally, we have solved the X-ray structure of the drug-resistant catalytic core domain protein, which provides means for rational development of second-generation MINIs.	[Hoyte, Ashley C.; Koneru, Pratibha C.; Kobe, Matthew J.; Larue, Ross C.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Hoyte, Ashley C.; Koneru, Pratibha C.; Kvaratskhelia, Mamuka] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO 80045 USA; [Jamin, Augusta V.] Harvard Med Sch, Dept Canc Immunol & Virol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Jamin, Augusta V.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO 80045 USA.	mamuka.kvaratskhelia@ucdenver.edu		Fuchs, James/0000-0002-8743-6389; Larue, Ross/0000-0002-0170-7345; Koneru, Pratibha Chowdary/0000-0003-3955-4548	National Institutes of Health [R01 AI110310, R01 AI062520, R01 AI039394, U54 GM103368, KL2 TR001068]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110310, R37AI039394, R01AI039394, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI110310 and R01 AI062520 (to M. K.), R01 AI039394 (to A. N. E.), U54 GM103368 (to A. N. E. and M. K.), and KL2 TR001068 (to R. C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P711, DOI 10.1021/ml500110j; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Grawenhoff Julia, 2017, World J Biol Chem, V8, P32, DOI 10.4331/wjbc.v8.i1.32; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	41	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19814	19825		10.1074/jbc.M117.816645	http://dx.doi.org/10.1074/jbc.M117.816645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972144	Green Published, hybrid			2022-12-28	WOS:000416911300025
J	Kuatsjah, E; Chan, ACK; Kobylarz, MJ; Murphy, MEP; Eltis, LD				Kuatsjah, Eugene; Chan, Anson C. K.; Kobylarz, Marek J.; Murphy, Michael E. P.; Eltis, Lindsay D.			The bacterial meta-cleavage hydrolase LigY belongs to the amidohydrolase superfamily, not to the alpha/beta-hydrolase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; hydrolase; lignin degradation; metalloenzyme; zinc; C-C hydrolase; amidohydrolase superfamily; aromatic compound; meta-cleavage	EPSILON-SEMIALDEHYDE DECARBOXYLASE; LIGNIN-RELATED BIPHENYL; C BOND HYDROLASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; DEGRADATION; CATABOLISM; ACID; BPHD; GENE	Strain SYK-6 of the bacterium Sphingobium sp. catabolizes lignin-derived biphenyl via a meta-cleavage pathway. In this pathway, LigY is proposed to catalyze the hydrolysis of the meta-cleavage product (MCP) 4,11-dicarboxy-8-hydroxy-9-methoxy-2-hydroxy-6-oxo-6-phenyl-hexa-2,4-dienoate. Here, we validated this reaction by identifying 5-carboxyvanillate and 4-carboxy-2-hydroxypenta-2,4-dienoate as the products and determined the k(cat) and k(cat)/K-m values as 9.3 +/- 0.6 s(-1) and 2.5 +/- 0.2 x 10(7) m(-1) s(-1), respectively. Sequence analyses and a 1.9 resolution crystal structure established that LigY belongs to the amidohydrolase superfamily, unlike previously characterized MCP hydrolases, which are serine-dependent enzymes of the /-hydrolase superfamily. The active-site architecture of LigY resembled that of -amino--carboxymuconic-E-semialdehyde decarboxylase, a class III amidohydrolase, with a single zinc ion coordinated by His-6, His-8, His-179, and Glu-282. Interestingly, we found that LigY lacks the acidic residue proposed to activate water for hydrolysis in other class III amidohydrolases. Moreover, substitution of His-223, a conserved residue proposed to activate water in other amidohydrolases, reduced the k(cat) to a much lesser extent than what has been reported for other amidohydrolases, suggesting that His-223 has a different role in LigY. Substitution of Arg-72, Tyr-190, Arg-234, or Glu-282 reduced LigY activity over 100-fold. On the basis of these results, we propose a catalytic mechanism involving substrate tautomerization, substrate-assisted activation of water for hydrolysis, and formation of a gem-diol intermediate. This last step diverges from what occurs in serine-dependent MCP hydrolases. This study provides insight into C-C-hydrolyzing enzymes and expands the known range of reactions catalyzed by the amidohydrolase superfamily.	[Kuatsjah, Eugene; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Genome Sci & Technol Program, Vancouver, BC V6T 1Z3, Canada; [Chan, Anson C. K.; Kobylarz, Marek J.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Kuatsjah, Eugene/GLN-5085-2022; Murphy, Michael/R-6805-2017; Eltis, Lindsay/J-8272-2015	Murphy, Michael/0000-0003-2589-0014; Eltis, Lindsay/0000-0002-6774-8158; Chan, Anson/0000-0001-6625-8942; Kuatsjah, Eugene/0000-0002-8793-2331	Canadian Foundation for Innovation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Hong-Ming Chen and Prof. Stephen G. Withers synthesized OH-DDVA. Mariko Ikehata assisted with the ICP-MS. We thank the Laboratory of Molecular Biophysics for the use of the spectrofluorometer and CD spectrometer. The Laboratory of Molecular Biophysics is funded by the Canadian Foundation for Innovation. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health, Grant including P41GM103393. Research described in this paper was performed using beamline 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cooper BF, 1997, PROTEIN SCI, V6, P1031, DOI 10.1002/pro.5560060509; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOWDEN L, 1955, BIOCHEM J, V59, P228, DOI 10.1042/bj0590228; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Goto M, 2006, J BIOL CHEM, V281, P34365, DOI 10.1074/jbc.M607270200; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Horsman GP, 2007, J BIOL CHEM, V282, P19894, DOI 10.1074/jbc.M702237200; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Jackson CA, 2017, J APPL MICROBIOL, V122, P940, DOI 10.1111/jam.13401; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuatsjah E, 2017, FEBS LETT, V591, P1001, DOI 10.1002/1873-3468.12611; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Liu XX, 2015, ACTA CRYSTALLOGR E, V71, P272, DOI 10.1107/S2056989015002807; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otani H, 2014, J BACTERIOL, V196, P4293, DOI 10.1128/JB.02247-14; Peng X, 1999, APPL ENVIRON MICROB, V65, P2789; Peng X, 1998, APPL ENVIRON MICROB, V64, P2520; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ruzzini AC, 2013, BIOCHEMISTRY-US, V52, P7428, DOI 10.1021/bi401156a; Ruzzini AC, 2012, J AM CHEM SOC, V134, P4615, DOI 10.1021/ja208544g; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shiel AE, 2012, GEOCHIM COSMOCHIM AC, V76, P175, DOI 10.1016/j.gca.2011.10.005; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Varman AM, 2016, P NATL ACAD SCI USA, V113, pE5802, DOI 10.1073/pnas.1606043113; Vladimirova A, 2016, J AM CHEM SOC, V138, P826, DOI 10.1021/jacs.5b08251; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu ST, 2013, CELL RES, V23, P1296, DOI 10.1038/cr.2013.107; Yoshikata T, 2014, APPL ENVIRON MICROB, V80, P7142, DOI 10.1128/AEM.02236-14	58	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18290	18302		10.1074/jbc.M117.797696	http://dx.doi.org/10.1074/jbc.M117.797696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28935670	Green Published, hybrid			2022-12-28	WOS:000414458200026
J	Kwon, S; Seok, S; Yau, P; Li, XL; Kemper, B; Kemper, JK				Kwon, Sanghoon; Seok, Sunmi; Yau, Peter; Li, Xiaoling; Kemper, Byron; Kemper, Jongsook Kim			Obesity and aging diminish sirtuin 1(SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL PROTEIN HYPERACETYLATION; SMALL HETERODIMER PARTNER; DIET-INDUCED OBESITY; CALORIE RESTRICTION; LYSINE ACETYLATION; INSULIN-RESISTANCE; METABOLIC DISEASE; COA; PGC-1-ALPHA	Sirtuin 3 (SIRT3) deacetylates and regulates many mitochondrial proteins to maintain health, but its functions are depressed in aging and obesity. The best-studied sirtuin, SIRT1, counteracts aging-and obesity-related diseases by deacetylating many proteins, but whether SIRT1 has a role in deacetylating and altering the function of SIRT3 is unknown. Here we show that SIRT3 is reversibly acetylated in the mitochondria and unexpectedly is a target of SIRT1 deacetylation. SIRT3 is hyperacety-lated in aged and obese mice, in which SIRT1 activity is low, and SIRT3 acetylation at Lys(57) inhibits its deacetylase activity and promotes protein degradation. Adenovirus-mediated expression of SIRT3 or an acetylation-defective SIRT3-K57R mutant in diet-induced obese mice decreased acetylation of mitochondrial long-chain acyl-CoA dehydrogenase, a known SIRT3 deacetylation target; improved fatty acid beta-oxidation; and ameliorated liver steatosis and glucose intolerance. These SIRT3-mediated beneficial effects were not observed with an acetylation-mimic SIRT3-K57Q mutant. Our findings reveal an unexpected mechanism for SIRT3 regulation via SIRT1-mediated deacetylation. Improving mitochondrial SIRT3 functions by inhibiting SIRT3 acetylation may offer a new therapeutic approach for obesity-and aging-related diseases associated with mitochondrial dysfunction.	[Kwon, Sanghoon; Seok, Sunmi; Kemper, Byron; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Yau, Peter] Univ Illinois, Prote Ctr, Urbana, IL 61801 USA; [Li, Xiaoling] NIEHS, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jongsook@illinois.edu	Li, Xiaoling/A-2994-2015	Li, Xiaoling/0000-0001-5920-7784; Kemper, Jongsook/0000-0002-5534-0286	National Institutes of Health [DK062777, DK095842]; American Diabetes Association [1-16-IBS-156]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062777, R01DK095842, R01DK062777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants DK062777 and DK095842 and a Basic Science Award 1-16-IBS-156 from the American Diabetes Association (to J.K.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2; Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Choi SE, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00006-17; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Ghisays F, 2015, CELL REP, V10, P1665, DOI 10.1016/j.celrep.2015.02.036; Nguyen GTT, 2013, CHEM BIOL, V20, P1375, DOI 10.1016/j.chembiol.2013.09.019; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2009, FRONT BIOSCI-LANDMRK, V14, P2983, DOI 10.2741/3428; Ji H, 2008, INT J OBESITY, V32, P1331, DOI 10.1038/ijo.2008.71; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee J, 2010, AGING-US, V2, P527, DOI 10.18632/aging.100184; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	50	57	58	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17312	17323		10.1074/jbc.M117.778720	http://dx.doi.org/10.1074/jbc.M117.778720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28808064	Green Published, hybrid			2022-12-28	WOS:000414009300014
J	Tanishima, M; Takashima, S; Honda, A; Yasuda, D; Tanikawa, T; Ishii, S; MaruYama, T				Tanishima, Mitsuyoshi; Takashima, Shigeo; Honda, Arata; Yasuda, Daisuke; Tanikawa, Takashi; Ishii, Satoshi; MaruYama, Takashi			Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; ACTIVATION; PATHWAY; OSTEOPETROSIS; TRANSCRIPTION; RECOGNITION; BINDING	Upon stimulation of toll-like receptors with various microbial ligands, induction of a variety of inflammatory genes is elicited by activation of a myeloid differentiation primary-response protein 88 (MyD88)-dependent signaling pathway. Interleukin-1 (IL-1) receptor-associated kinase 1 (IRAK1) plays an essential role in this pathway by activating nuclear factor kappa B (NF-kappa B) and mitogen-activated kinases (MAPKs). Here, we identified optineurin (OPTN) as an IRAK1-binding protein by yeast two-hybrid screening using IRAK1 as bait. A C-terminal fragment of OPTN harboring a ubiquitin-binding domain was co-immunoprecipitated with IRAK1. In reporter analyses, overexpression of OPTN inhibited IL-1 beta-, IRAK1-, and LPS-induced NF-kappa B activation. Consistently, OPTN deficiency resulted in increased NF-kappa B activation in response to IL-1 beta/LPS stimulation. To address the mechanisms underlying the inhibitory effect of OPTN on NF-kappa B signaling, we focused on tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), which is an adaptor protein of IRAK1 and upon polyubiquitination plays a crucial role during NF-kappa Bactivation. Overexpression of OPTN prevented TRAF6 polyubiquitination. Furthermore, OPTN H486R mutant, which is unable to recruit the deubiquitinase CYLD, failed to inhibit IRAK1-induced NF-kappa Bactivation. These results suggest that the IRAK1-binding protein OPTN negatively regulates IL-1 beta/LPS-induced NF-kappa Bactivation by preventing polyubiquitination of TRAF6.	[Tanishima, Mitsuyoshi; MaruYama, Takashi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Takashima, Shigeo] Gifu Univ, Life Sci Res Ctr, Gifu 5011194, Japan; [Honda, Arata] Univ Miyazaki, Org Promot Tenure Track, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Yasuda, Daisuke; Ishii, Satoshi; MaruYama, Takashi] Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan; [Tanikawa, Takashi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan	Tohoku University; Gifu University; University of Miyazaki; Akita University; Teikyo University	MaruYama, T (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan.	ta-maru@umin.ac.jp	MaruYama, Takashi/N-5994-2014	MaruYama, Takashi/0000-0003-0820-3219; Yasuda, Daisuke/0000-0001-5513-0695	JSPS KAKENHI [JP 16H05136]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant JP 16H05136 (to S. I.). The authors declare that they have no conflicts of interest regarding the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akizuki M, 2013, J NEUROCHEM, V126, P699, DOI 10.1111/jnc.12326; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Sambrook J., 2006, CSH PROTOC, V2006, DOI [10.1101/pdb.prot3880, DOI 10.1101/PDB.PROT3880, DOI 10.1101/PDB.PR0T4455]; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Thomas R, 2005, ARTHRITIS RES THER, V7, P170, DOI 10.1186/ar1784; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	32	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17250	17257		10.1074/jbc.M117.813899	http://dx.doi.org/10.1074/jbc.M117.813899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882891	Green Published, hybrid			2022-12-28	WOS:000414009300009
J	Chen, X; Cheng, HF; Zhou, JW; Chan, CY; Lau, KF; Tsui, SKW; Au, SWN				Chen, Xin; Cheng, Hiu-fu; Zhou, Junwei; Chan, Chiu-yeung; Lau, Kwok-fai; Tsui, Stephen Kwok-wing; Au, Shannon Wing-ngor			Structural basis of the PE-PPE protein interaction in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; protein complex; protein secretion; protein structure; tuberculosis	PE/PPE MULTIGENE FAMILY; VII SECRETION SYSTEM; VIRULENCE; COMPLEX; ESX-1; CLUSTERS; INSIGHTS; PHENIX; EXPORT; ESPB	Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, has developed multiple strategies to adapt to the human host. The five type VII secretion systems, ESX-1-5, direct the export of many virulence-promoting protein effectors across the complex mycobacterial cell wall. One class of ESX substrates is the PE-PPE family of proteins, which is unique to mycobacteria and essential for infection, antigenic variation, and host-pathogen interactions. The genome of Mtb encodes 168 PE-PPE proteins. Many of them are thought to be secreted through ESX-5 secretion system and to function in pairs. However, understanding of the specific pairing of PE-PPE proteins and their structure-function relationship is limited by the challenging purification of many PE-PPE proteins, and our knowledge of the PE-PPE interactions therefore has been restricted to the PE25-PPE41 pair and its complex with the ESX-5 secretion system chaperone EspG5. Here, we report the crystal structure of a new PE-PPE pair, PE8-PPE15, in complex with EspG5. Our structure revealed that the EspG5-binding sites on PPE15 are relatively conserved among Mtb PPE proteins, suggesting that EspG5-PPE15 represents a more typical model for EspG5-PPE interactions than EspG5-PPE41. A structural comparison with the PE25-PPE41 complex disclosed conformational changes in the four-helix bundle structure and a unique binding mode in the PE8-PPE15 pair. Moreover, homology-modeling and mutagenesis studies further delineated the molecular determinants of the specific PE-PPE interactions. These findings help develop an atomic algorithm of ESX-5 substrate recognition and PE-PPE pairing.	[Chen, Xin; Cheng, Hiu-fu; Zhou, Junwei; Lau, Kwok-fai; Au, Shannon Wing-ngor] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Chiu-yeung] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tsui, Stephen Kwok-wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Au, SWN (corresponding author), Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	shannon-au@cuhk.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Lau, Kwok-Fai/0000-0002-0193-1152	University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant [SEG UCHK08]	University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant	We thank the University Grants Council of Hong Kong Special Administrative Region One-Off Special Equipment Grant SEG UCHK08 for the equipment used in this work. We also thank the staff of Beamline 13B1 at National Synchrotron Radiation Research Center in Taiwan.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bottai D, 2009, MOL MICROBIOL, V73, P325, DOI 10.1111/j.1365-2958.2009.06784.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Ejeta E., 2013, SCI TECHNOL ARTS RES, V2, P97, DOI DOI 10.4314/STAR.V2I2.98895; Ekiert DC, 2014, P NATL ACAD SCI USA, V111, P14758, DOI 10.1073/pnas.1409345111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fu Li M, 2009, Int J Microbiol, V2009, P879621, DOI 10.1155/2009/879621; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Kaufmann S. H, 2016, CAN WE IMPROVE EXIST; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; Korotkova N, 2015, J STRUCT BIOL, V191, P236, DOI 10.1016/j.jsb.2015.06.003; Korotkova N, 2014, MOL MICROBIOL, V94, P367, DOI 10.1111/mmi.12770; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00049; Shah S, 2015, INFECT IMMUN, V83, P4349, DOI 10.1128/IAI.00827-15; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; WHO, 2016, GLOB TUB REP	44	24	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16880	16890		10.1074/jbc.M117.802645	http://dx.doi.org/10.1074/jbc.M117.802645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842489	Green Published, hybrid			2022-12-28	WOS:000413140600010
J	Sugitani, N; Voehler, MW; Roh, MS; Topolska-Wos, AM; Chazin, WJ				Sugitani, Norie; Voehler, Markus W.; Roh, Michelle S.; Topolska-Wos, Agnieszka M.; Chazin, Walter J.			Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA repair; nuclear magnetic resonance (NMR); nucleotide excision repair; protein-DNA interaction	REPLICATION PROTEIN-A; TRANSCRIPTION-COUPLED REPAIR; DAMAGED-DNA; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; DUAL-INCISION; FACTOR IIH; NMR DATA; RECOGNITION; DOMAIN	Xeroderma pigmentosum (XP) complementation group A (XPA) is an essential scaffolding protein in the multiprotein nucleotide excision repair (NER) machinery. The interaction of XPA with DNA is a core function of this protein; a number of mutations in the DNA-binding domain (DBD) are associated with XP disease. Although structures of the central globular domain of human XPA and data on binding of DNA substrates have been reported, the structural basis for XPA's DNA-binding activity remains unknown. X-ray crystal structures of the central globular domain of yeast XPA (Rad14) with lesion-containing DNA duplexes have provided valuable insights, but the DNA substrates used for this study do not correspond to the substrates of XPA as it functions within the NER machinery. To better understand the DNA-binding activity of human XPA in NER, we used NMR to investigate the interaction of its DBD with a range of DNA substrates. We found that XPA binds different single-stranded/double-stranded junction DNA substrates with a common surface. Comparisons of our NMR-based mapping of binding residues with the previously reported Rad14-DNA crystal structures revealed similarities and differences in substrate binding between XPA and Rad14. This includes direct evidence for DNA contacts to the residues extending C-terminally from the globular core, which are lacking in the Rad14 construct. Moreover, mutation of the XPA residue corresponding to Phe-262 in Rad14, previously reported as being critical for DNA binding, had only a moderate effect on the DNA-binding activity of XPA. The DNA-binding properties of several disease-associated mutations in the DBD were investigated. These results suggest that for XPA mutants exhibiting altered DNA-binding properties, a correlation exists between the extent of reduction in DNA-binding affinity and the severity of symptoms in XP patients.	[Sugitani, Norie; Voehler, Markus W.; Roh, Michelle S.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Topolska-Wos, Agnieszka M.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Sugitani, Norie; Voehler, Markus W.; Topolska-Wos, Agnieszka M.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140,PMB 407917, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140,PMB 407917, Nashville, TN 37232 USA.	walter.j.chazin@vanderbilt.edu	Classen, Scott/AAY-8176-2020		National Science Foundation [0922862]; National Institutes of Health [S10 RR025677, S10 OD021483]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R35GM118089] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021483] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Nicole Eckart from NanoTemper Technologies for the valuable input to optimize and interpret MST data, Dr. Jonathan Sheehan for assistance with construction of the homology model, and Dr. Sarah E. Soss for advice on backbone resonance assignment. NMR instrumentation was acquired with support from the National Science Foundation through Grant 0922862, from the National Institutes of Health through Grant S10 RR025677, and from Vanderbilt University. MST instrumentation was acquired from National Institutes of Health through Grant S10 OD021483.	Alekseev S, 2015, CELL MOL LIFE SCI, V72, P2177, DOI 10.1007/s00018-015-1859-5; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Breitsprecher D, 2016, METHODS MOL BIOL, V1380, P99, DOI 10.1007/978-1-4939-3197-2_8; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 1998, NUCLEIC ACIDS RES, V26, P2779, DOI 10.1093/nar/26.11.2779; Camenisch U, 2007, DNA REPAIR, V6, P1819, DOI 10.1016/j.dnarep.2007.07.011; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Dusinska M, 2006, MUTAGENESIS, V21, P205, DOI 10.1093/mutage/gel016; Fadda E, 2016, COMPUT STRUCT BIOTEC, V14, P78, DOI 10.1016/j.csbj.2015.11.007; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Goddard T. D., SPARKY 3; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hermanson-Miller IL, 2002, BIOCHEMISTRY-US, V41, P2402, DOI 10.1021/bi0112863; Hilton B, 2014, BIOSCIENCE REP, V34, P831, DOI 10.1042/BSR20140158; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Koch SC, 2015, P NATL ACAD SCI USA, V112, P8272, DOI 10.1073/pnas.1508509112; Krasikova YS, 2010, NUCLEIC ACIDS RES, V38, P8083, DOI 10.1093/nar/gkq649; Kuraoka I, 1996, MUTAT RES-DNA REPAIR, V362, P87, DOI 10.1016/0921-8777(95)00038-0; LEE SH, 1995, J BIOL CHEM, V270, P21800, DOI 10.1074/jbc.270.37.21800; Lehmann AR, 2012, DNA REPAIR, V11, P328, DOI 10.1016/j.dnarep.2011.05.008; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Lembo F, 2003, MOL CELL BIOL, V23, P1656, DOI 10.1128/MCB.23.5.1656-1665.2003; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; Liu Y, 2005, BIOCHEMISTRY-US, V44, P7361, DOI 10.1021/bi047598y; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Morita EH, 1996, GENES CELLS, V1, P437, DOI 10.1046/j.1365-2443.1996.d01-252.x; Mou TC, 2006, CHIRALITY, V18, P370, DOI 10.1002/chir.20262; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shell SM, 2013, DNA REPAIR, V12, P947, DOI 10.1016/j.dnarep.2013.08.013; Shivji MKK, 1999, METH MOL B, V113, P373; Spivak G, 2016, ARCH TOXICOL, V90, P2583, DOI 10.1007/s00204-016-1820-x; Spivak G, 2015, DNA REPAIR, V36, P13, DOI 10.1016/j.dnarep.2015.09.003; Spivak G, 2014, DNA REPAIR, V19, P64, DOI 10.1016/j.dnarep.2014.03.025; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; Sugasawa K, 2016, DNA REPAIR, V44, P110, DOI 10.1016/j.dnarep.2016.05.015; Sugitani N, 2016, DNA REPAIR, V44, P123, DOI 10.1016/j.dnarep.2016.05.018; Sugitani N, 2014, J AM CHEM SOC, V136, P10830, DOI 10.1021/ja503020f; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Uchida A, 2002, DNA REPAIR, V1, P449, DOI 10.1016/S1568-7864(02)00031-9; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 2009, NUCLEIC ACIDS RES, V37, P516, DOI 10.1093/nar/gkn964; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Ziani S, 2014, J CELL BIOL, V206, P589, DOI 10.1083/jcb.201403096	82	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16847	16857		10.1074/jbc.M117.800078	http://dx.doi.org/10.1074/jbc.M117.800078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28860187	Green Published, hybrid			2022-12-28	WOS:000413140600007
J	Takano, T; Motozono, C; Imai, T; Sonoda, KH; Nakanishi, Y; Yamasaki, S				Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Sonoda, Koh-Hei; Nakanishi, Yoichi; Yamasaki, Sho			Dectin-1 intracellular domain determines species-specific ligand spectrum by modulating receptor sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; lectin; polysaccharide; receptor; signal transduction; glucan	C-TYPE LECTIN; BETA-GLUCAN RECOGNITION; KAPPA-B-ALPHA; PATTERN-RECOGNITION; CANDIDA-ALBICANS; SITE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; MINCLE	C-type lectin receptors (CLRs) comprise a large family of immunoreceptors that recognize polysaccharide ligands exposed on pathogen surfaces and are conserved among mammals. However, interspecies differences in their ligand spectrums are not fully understood. Dectin-1 is a well-characterized CLR that recognizes -glucan. We report here that seaweed-derived fucan activates cells expressing human Dectin-1 but not mouse Dectin-1. Low-valency -glucan components within fucan appeared to be responsible for this activation, as the ligand activity was eliminated by -glucanase treatment. The low-valency -glucan laminarin also acted as an agonist for human Dectin-1 but not for mouse Dectin-1, whereas the high-valency -glucan curdlan activated both human and mouse Dectin-1. Reciprocal mutagenesis analysis revealed that the ligand-binding domain of human Dectin-1 does not determine its unique sensitivity to low-valency -glucan. Rather, we found that its intracellular domain renders human Dectin-1 reactive to low-valency -glucan ligand. Substitution with two amino acids, Glu(2) and Pro(5), located in the human Dectin-1 intracellular domain was sufficient to confer sensitivity to low-valency -glucan in mouse Dectin-1. Conversely, the introduction of mouse-specific amino acids, Lys(2) and Ser(5), to human Dectin-1 reduced the reactivity to low-valency -glucan. Indeed, low-valency ligands induced a set of proinflammatory genes in human but not mouse dendritic cells. These results suggest that the intracellular domain, not ligand-binding domain, of Dectin-1 determines the species-specific ligand profile.	[Takano, Tomotsugu; Imai, Takashi; Yamasaki, Sho] Kyushu Univ, Grad Sch Med Sci, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan; [Takano, Tomotsugu; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 8128582, Japan; [Motozono, Chihiro; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka 8128582, Japan; [Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Yamasaki, Sho] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; [Takano, Tomotsugu; Motozono, Chihiro; Imai, Takashi; Yamasaki, Sho] Osaka Univ, Dept Mol Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan	Kyushu University; Kyushu University; Kyushu University; Osaka University; Osaka University; Chiba University	Yamasaki, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan.; Motozono, C (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka 8128582, Japan.; Motozono, C; Yamasaki, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan.; Motozono, C; Yamasaki, S (corresponding author), Osaka Univ, Dept Mol Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.; Yamasaki, S (corresponding author), Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan.	motozono@biken.osaka-u.ac.jp; yamasaki@biken.osaka-u.ac.jp			Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [26110009, 17K15730]; Research on Development of New Drugs Grants from Japan Agency for Medical Research and Development (AMED) [16ak0101010h0005, 17933742]; Takeda Science Foundation	Advanced Research and Development Programs for Medical Innovation (AMED-CREST); Research on Development of New Drugs Grants from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid 26110009 for Scientific Research on Innovative Areas, Young Scientists (B) Grant 17K15730, Advanced Research and Development Programs for Medical Innovation (AMED-CREST), and Research on Development of New Drugs Grants (16ak0101010h0005 and 17933742) from the Japan Agency for Medical Research and Development (AMED), and Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Hattori Y, 2014, J BIOL CHEM, V289, P15405, DOI 10.1074/jbc.M114.566489; Iborra S, 2015, IMMUNOBIOLOGY, V220, P175, DOI 10.1016/j.imbio.2014.09.013; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Mori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169562; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sahasrabudhe NM, 2016, MOL NUTR FOOD RES, V60, P458, DOI 10.1002/mnfr.201500582; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shah S, 2017, J LEUKOCYTE BIOL, V101, P421, DOI 10.1189/jlb.2AB0516-228R; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiao Y, 2016, NAT MED, V22, P906, DOI 10.1038/nm.4141; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005	31	15	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16933	16941		10.1074/jbc.M117.800847	http://dx.doi.org/10.1074/jbc.M117.800847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848046	Green Published, hybrid			2022-12-28	WOS:000413140600014
J	Navaratnarajah, P; Gershenson, A; Ross, EM				Navaratnarajah, Punya; Gershenson, Anne; Ross, Elliott M.			The binding of activated G alpha(q) to phospholipase C-beta exhibits anomalous affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; MUSCARINIC RECEPTOR; ALPHA-SUBUNIT; RHO GTPASES; PROTEIN; G(Q); DOMAIN; MEMBRANE; C-BETA-1; SITE	Upon activation by the G(q) family of G alpha subunits, G beta gamma subunits, and some Rho family GTPases, phospholipase C-beta (PLC-beta) isoforms hydrolyze phosphatidylinositol 4,5-bisphosphate to the second messengers inositol 1,4,5-trisphosphate and diacylglycerol. PLC-beta isoforms also function as GTPase-activating proteins, potentiating G(q) deactivation. To elucidate the mechanism of this mutual regulation, we measured the thermodynamics and kinetics of PLC-beta 3 binding to G alpha(q). FRET and fluorescence correlation spectroscopy, two physically distinct methods, both yielded K-d values of about 200 nM for PLC-beta 3-G alpha(q) binding. This K-d is 50-100 times greater than the EC50 for G alpha(q)-mediated PLC-beta 3 activation and for the G alpha(q) GTPase-activating protein activity of PLC-beta. The measured K-d was not altered either by the presence of phospholipid vesicles, phosphatidylinositol 4,5-bisphosphate and Ca2+, or by the identity of the fluorescent labels. FRET-based kinetic measurements were also consistent with a K-d of 200 nM. We determined that PLC-beta 3 hysteresis, whereby PLC-beta 3 remains active for some time following either G alpha(q)-PLC-beta 3 dissociation or PLC-beta 3-potentiated G alpha(q) deactivation, is not sufficient to explain the observed discrepancy between EC50 and K-d. These results indicate that the mechanism by which G alpha(q) and PLC-beta 3 mutually regulate each other is far more complex than a simple, two-state allosteric model and instead is probably kinetically determined.	[Navaratnarajah, Punya; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Navaratnarajah, Punya; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Amherst	Ross, EM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [R01GM030355, R21DC015744, R01GM060418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355, R01GM060418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC015744] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01GM030355 and R21DC015744 (to E. M. R.) and R01GM060418 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASSEL D, 1977, J CYCLIC NUCL PROT, V3, P393; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Cheng JJ, 2013, BIOPHYS J, V104, P185, DOI 10.1016/j.bpj.2012.11.015; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P., 1999, J BIOL; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2016, J BIOL CHEM, V291, P11394, DOI 10.1074/jbc.M116.723940; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kozasa T., 1995, J BIOL CHEM; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LEE CW, 1994, J BIOL CHEM, V269, P25335; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Padrick SB, 2011, METHODS, V54, P39, DOI 10.1016/j.ymeth.2011.01.002; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Segel IH., 1975, ENZYME KINETICS, P227; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Widengren J., 1996, Bioimaging, V4, P149, DOI 10.1002/1361-6374(199609)4:3<149::AID-BIO5>3.3.CO;2-4	48	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16788	16801		10.1074/jbc.M117.809673	http://dx.doi.org/10.1074/jbc.M117.809673			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842497	Green Published, hybrid			2022-12-28	WOS:000412414800036
J	Muehl, EM; Gajsiewicz, JM; Medfisch, SM; Wiersma, ZSB; Morrissey, JH; Bailey, RC				Muehl, Ellen M.; Gajsiewicz, Joshua M.; Medfisch, Sara M.; Wiersma, Zachary S. B.; Morrissey, James H.; Bailey, Ryan C.			Multiplexed silicon photonic sensor arrays enable facile characterization of coagulation protein binding to nanodiscs with variable lipid content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT PROTEINS; BLOOD-COAGULATION; MICRORING RESONATORS; MEMBRANE-BINDING; BILAYER NANODISCS; ACID; ENHANCEMENT; ACTIVATION; ANTIBODIES; IMPROVE	Interactions of soluble proteins with the cell membrane are critical within the blood coagulation cascade. Of particular interest are the interactions of gamma-carboxyglutamic acid-rich domain-containing clotting proteins with lipids. Variability among conventional analytical methods presents challenges for comparing clotting protein-lipid interactions. Most previous studies have investigated only a single clotting protein and lipid composition and have yielded widely different binding constants. Herein, we demonstrate that a combination of lipid bilayer nanodiscs and a multiplexed silicon photonic analysis technology enables high-throughput probing of many protein-lipid interactions among blood-clotting proteins. This approach allowed direct comparison of the binding constants of prothrombin, factor X, activated factor VII, and activated protein C to seven different binary lipid compositions. In a single experiment, the binding constants of one protein interacting with all lipid compositions were simultaneously determined. A simple surface regeneration then facilitated similar binding measurements for three other coagulation proteins. As expected, our results indicated that all proteins exhibit tighter binding (lower K-d) as the proportion of anionic lipid increases. Interestingly, at high proportions of phosphatidylserine, the Kd values of all four proteins began to converge. We also found that although k(off) values for all four proteins followed trends similar to those observed for the Kd values, the variation among the proteins was much lower, indicating that much of the variation came from the kinetic binding (k(on)) of the proteins. These findings indicate that the combination of silicon photonic microring resonator arrays and nanodiscs enables rapid interrogation of biomolecular binding interactions at model cell membrane interfaces.	[Muehl, Ellen M.; Wiersma, Zachary S. B.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gajsiewicz, Joshua M.; Morrissey, James H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Medfisch, Sara M.; Bailey, Ryan C.] Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Bailey, RC (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.; Morrissey, JH (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	jhmorris@umich.edu; ryancb@umich.edu	Morrissey, James H/H-4933-2011; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; Medfisch, Sara/0000-0002-6367-0031	National Institutes of Health [GM110432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM110432. R. C. B. has a financial interest in Genalyte, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Boettcher JM, 2011, BIOCHEMISTRY-US, V50, P2264, DOI 10.1021/bi1013694; Byeon JY, 2011, ANALYST, V136, P3430, DOI 10.1039/c0an00853b; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2017, CHEM REV, V117, P4669, DOI 10.1021/acs.chemrev.6b00690; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Iqbal M, 2010, IEEE J SEL TOP QUANT, V16, P654, DOI 10.1109/JSTQE.2009.2032510; Kindt JT, 2013, ANAL CHEM, V85, P10653, DOI 10.1021/ac402972d; Kindt JT, 2012, ANAL CHEM, V84, P8067, DOI 10.1021/ac3019813; Marty MT, 2012, ANAL CHEM, V84, P8957, DOI 10.1021/ac302663f; Marty MT, 2012, ANAL CHEM, V84, P5556, DOI 10.1021/ac300478f; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; Ohkubo YZ, 2008, STRUCTURE, V16, P72, DOI 10.1016/j.str.2007.10.021; Qavi AJ, 2011, ANAL CHEM, V83, P5949, DOI 10.1021/ac201340s; Qavi AJ, 2009, ANAL BIOANAL CHEM, V394, P121, DOI 10.1007/s00216-009-2637-8; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Sloan CDK, 2013, ANAL CHEM, V85, P2970, DOI 10.1021/ac3037359; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; SUNNERHAGEN M, 1995, NAT STRUCT BIOL, V2, P504, DOI 10.1038/nsb0695-504; Tavoosi N, 2013, BIOCHEMISTRY-US, V52, P5545, DOI 10.1021/bi4006368; Tavoosi N, 2011, J BIOL CHEM, V286, P23247, DOI 10.1074/jbc.M111.251769; Wade JH, 2015, ACS CENTRAL SCI, V1, P374, DOI 10.1021/acscentsci.5b00250; Washburn AL, 2011, ANAL CHEM, V83, P3572, DOI 10.1021/ac200317z; Washburn AL, 2009, ANAL CHEM, V81, P9499, DOI 10.1021/ac902006p; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	33	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16249	16256		10.1074/jbc.M117.800938	http://dx.doi.org/10.1074/jbc.M117.800938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28801460	Green Published, hybrid			2022-12-28	WOS:000412109400023
J	Hu, JC; Selby, CP; Adar, S; Adebali, O; Sancar, A				Hu, Jinchuan; Selby, Christopher P.; Adar, Sheera; Adebali, Ogun; Sancar, Aziz			Molecular mechanisms and genomic maps of DNA excision repair in Escherichia coli and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTION-COUPLED REPAIR; STRAND-SPECIFIC REPAIR; RNA-POLYMERASE; DAMAGE RECOGNITION; THYMINE DIMER; UV DAMAGE; IN-VITRO; CHROMATIN STATE; HELICASE-II; PROTEIN	Nucleotide excision repair is a major DNA repair mechanism in all cellular organisms. In this repair system, the DNA damage is removed by concerted dual incisions bracketing the damage and at a precise distance from the damage. Here, we review the basic mechanisms of excision repair in Escherichia coli and humans and the recent genome-wide mapping of DNA damage and repair in these organisms at single-nucleotide resolution.	[Hu, Jinchuan; Selby, Christopher P.; Adar, Sheera; Adebali, Ogun; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Adar, Sheera] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-71120 Jerusalem, Israel	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Hebrew University of Jerusalem	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Hu, Jinchuan/V-9913-2017; Adebali, Ogun/N-4159-2016	Adebali, Ogun/0000-0001-9213-4070; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [GM118102, ES027255]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bar-Ziv R, 2002, P NATL ACAD SCI USA, V99, P11589, DOI 10.1073/pnas.162369099; Besaratinia Ahmad, 2012, Methods Mol Biol, V920, P189, DOI 10.1007/978-1-61779-998-3_14; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Canturk F, 2016, P NATL ACAD SCI USA, V113, P4706, DOI 10.1073/pnas.1604097113; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145794; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; CRICK F, 1974, NATURE, V248, P766, DOI 10.1038/248766a0; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fan J, 2016, NATURE, V536, P234, DOI 10.1038/nature19080; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2017, PHOTOCHEM PHOTOBIOL, V93, P199, DOI 10.1111/php.12668; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kesseler KJ, 2007, J THEOR BIOL, V249, P361, DOI 10.1016/j.jtbi.2007.07.025; KIRSCHNER MW, 1980, J CELL BIOL, V86, P330, DOI 10.1083/jcb.86.1.330; Koch SC, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583515000268; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Larson MH, 2012, P NATL ACAD SCI USA, V109, P6555, DOI 10.1073/pnas.1200939109; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; LIN JJ, 1992, J BIOL CHEM, V267, P17688; Lindahl T, 2016, ANGEW CHEM INT EDIT, V55, P8528, DOI 10.1002/anie.201602159; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Llorens-Rico V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501363; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; MacGlashan D, 2001, P NATL ACAD SCI USA, V98, P6989, DOI 10.1073/pnas.131215498; Mao P, 2017, PHOTOCHEM PHOTOBIOL, V93, P216, DOI 10.1111/php.12646; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Modrich P, 2016, ANGEW CHEM INT EDIT, V55, P8490, DOI 10.1002/anie.201601412; Moore PB, 2013, P NATL ACAD SCI USA, V110, P9627, DOI 10.1073/pnas.1307288110; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; ORREN DK, 1992, J BIOL CHEM, V267, P780; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Raghavan R, 2012, MBIO, V3, DOI 10.1128/mBio.00156-12; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2004, CELL CYCLE, V3, P141; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; RUPERT CS, 1958, J GEN PHYSIOL, V41, P451, DOI 10.1085/jgp.41.3.451; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; SIBGHATULLAH, 1990, NUCLEIC ACIDS RES, V18, P5051, DOI 10.1093/nar/18.17.5051; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; TANG MS, 1994, J BIOL CHEM, V269, P12749; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Uphoff S, 2017, ANNU REV BIOPHYS, V46, P411, DOI 10.1146/annurev-biophys-070816-034106; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zavala AG, 2014, NUCLEIC ACIDS RES, V42, P893, DOI 10.1093/nar/gkt912	99	52	52	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15588	15597		10.1074/jbc.R117.807453	http://dx.doi.org/10.1074/jbc.R117.807453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28798238	Green Published, hybrid			2022-12-28	WOS:000411512200001
J	Kaneko, A; Uenishi, K; Maruyama, Y; Mizuno, N; Baba, S; Kumasaka, T; Mikami, B; Murata, K; Hashimoto, W				Kaneko, Ai; Uenishi, Kasumi; Maruyama, Yukie; Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			A solute-binding protein in the closed conformation induces ATP hydrolysis in a bacterial ATP-binding cassette transporter involved in the import of alginate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMONAS SP A1; MACROMOLECULE (ALGINATE)-BINDING PROTEIN; ABC TRANSPORTER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; SYSTEM; TRANSLOCATION; RECOGNITION; SUBSTRATE	The Gram-negative bacterium Sphingomonas sp. A1 incorporates alginate into cells via the cell-surface pit without prior depolymerization by extracellular enzymes. Alginate import across cytoplasmic membranes thereby depends on the ATPbinding cassette transporter AlgM1M2SS (a heterotetramer of AlgM1, AlgM2, and AlgS), which cooperates with the periplasmic solute-binding protein AlgQ1 or AlgQ2; however, several details of AlgM1M2SS-mediated alginate import are not wellunderstood. Herein, we analyzed ATPase and transport activities of AlgM1M2SS after reconstitution into liposomes with AlgQ2 and alginate oligosaccharide substrates having different polymerization degrees (PDs). Longer alginate oligosaccharides (PD >= 5) stimulated the ATPase activity of AlgM1M2SS but were inert as substrates of AlgM1M2SS-mediated transport, indicating that AlgM1M2SS-mediated ATP hydrolysis can be stimulated independently of substrate transport. Using X-ray crystallography in the presence of AlgQ2 and long alginate oligosaccharides (PD 6-8) and with the humid air and glue-coating method, we determined the crystal structure of AlgM1M2SS in complex with oligosaccharide-bound AlgQ2 at 3.6 angstrom resolution. The structure of the ATP-binding cassette transporter in complex with non-transport ligand-bound periplasmic solutebinding protein revealed that AlgM1M2SS and AlgQ2 adopt inward-facing and closed conformations, respectively. These in vitro assays and structural analyses indicated that interactions between AlgM1M2SS in the inward-facing conformation and periplasmic ligand-bound AlgQ2 in the closed conformation induce ATP hydrolysis by the ATP-binding protein AlgS. We conclude that substrate-bound AlgQ2 in the closed conformation initially interacts with AlgM1M2SS, the AlgM1M2SS-AlgQ2 complex then forms, and this formation is followed by ATP hydrolysis.	[Kaneko, Ai; Uenishi, Kasumi; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan; [Maruyama, Yukie; Murata, Kousaku] Setsunan Univ, Fac Sci & Engn, Dept Life Sci, Food Microbiol Lab, Neyagawa, Osaka 5728508, Japan; [Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Kyoto University; Kyoto University; Setsunan University; Japan Synchrotron Radiation Research Institute	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp	Kumasaka, Takashi/D-7428-2018	Kumasaka, Takashi/0000-0001-9289-1557; baba, seiki/0000-0002-2589-232X	Japan Society for the Promotion of Science; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid Scientific Research from the Japan Society for the Promotion of Science (to K. M., Y. M., and W. H.) and the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baba S, 2013, ACTA CRYSTALLOGR D, V69, P1839, DOI 10.1107/S0907444913018027; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao H, 2015, J BIOL CHEM, V290, P25452, DOI 10.1074/jbc.M115.671826; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hayashi C, 2014, J BACTERIOL, V196, P2691, DOI 10.1128/JB.01666-14; Hisano T, 1996, BIOCHEM BIOPH RES CO, V220, P979, DOI 10.1006/bbrc.1996.0526; JACKSON P, 1994, METHOD ENZYMOL, V230, P250; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2004, FEBS LETT, V564, P264, DOI 10.1016/S0014-5793(04)00289-3; Maruyama Y, 2015, STRUCTURE, V23, P1643, DOI 10.1016/j.str.2015.06.021; Mishima Y, 2003, J BIOL CHEM, V278, P6552, DOI 10.1074/jbc.M209932200; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; Momma K, 2005, BIOCHEMISTRY-US, V44, P5053, DOI 10.1021/bi047781r; Momma K, 2002, J MOL BIOL, V316, P1051, DOI 10.1006/jmbi.2001.5393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishitani Y, 2012, BIOCHEMISTRY-US, V51, P3622, DOI 10.1021/bi300194f; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	28	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15681	15690		10.1074/jbc.M117.793992	http://dx.doi.org/10.1074/jbc.M117.793992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768763	Green Published, hybrid			2022-12-28	WOS:000411512200009
J	Quintana, J; Novoa-Aponte, L; Arguello, JM				Quintana, Julia; Novoa-Aponte, Lorena; Arguello, Jose M.			Copper homeostasis networks in the bacterium Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TRANSPOSON MUTANT LIBRARY; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL RESPONSE; TRANSPORTING ATPASES; 2-COMPONENT SYSTEM; FUNCTIONAL ROLES; METAL TRANSPORT; ION-SELECTIVITY	Bacterial copper (Cu+) homeostasis enables both precise metallation of diverse cuproproteins and control of variable metal levels. To this end, protein networks mobilize Cu+ to cellular targets with remarkable specificity. However, the understanding of these processes is rather fragmented. Here, we use genome-wide transcriptomic analysis by RNA-Seq to characterize the response of Pseudomonas aeruginosa to external 0.5 mM CuSO4, a condition that did not generate pleiotropic effects. Pre-steady-state (5-min) and steady-state (2-h) Cu+ fluxes resulted in distinct transcriptome landscapes. Cells quickly responded to Cu2+ stress by slowing down metabolism. This was restored once steady state was reached. Specific Cu+ homeostasis genes were strongly regulated in both conditions. Our system-wide analysis revealed induction of three Cu+ efflux systems (a P-1B-ATPase, a porin, and a resistance-nodulationdivision (RND) system) and of a putative Cu+ -binding periplasmic chaperone and the unusual presence of two cytoplasmic CopZ proteins. Both CopZ chaperones could bind Cu+ with high affinity. Importantly, novel transmembrane transporters probably mediating Cu+ influx were among those largely repressed upon Cu+ stress. Compartmental Cu+ levels appear independently controlled; the cytoplasmic Cu+ sensor CueR controls cytoplasmic chaperones and plasma membrane transporters, whereas CopR/S responds to periplasmic Cu+. Analysis of Delta copR and Delta cueR mutant strains revealed a CopR regulon composed of genes involved in periplasmic Cu+ homeostasis and its putative DNA recognition sequence. In conclusion, our study establishes a system-wide model of a network of sensors/regulators, soluble chaperones, and influx/efflux transporters that control the Cu+ levels in P. aeruginosa compartments.	[Quintana, Julia; Novoa-Aponte, Lorena; Arguello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, 60 Prescott St, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 60 Prescott St, Worcester, MA 01609 USA.	arguello@wpi.edu	Quintana, Julia/AAE-5099-2020; Arguello, Jose/D-1997-2012	Quintana, Julia/0000-0002-5145-3590; Arguello, Jose/0000-0003-3940-6297; Novoa-Aponte, Lorena/0000-0003-3348-8383	NIGMS, National Institutes of Health [R01 GM114949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM114949 (to J. M. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Caille O, 2007, J BACTERIOL, V189, P4561, DOI 10.1128/JB.00095-07; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Cubillas C, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.452; Djoko KY, 2008, CHEMBIOCHEM, V9, P1579, DOI 10.1002/cbic.200800100; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elsen S, 2011, J BACTERIOL, V193, P3376, DOI 10.1128/JB.00159-11; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gudipaty SA, 2012, FEMS MICROBIOL LETT, V330, P30, DOI 10.1111/j.1574-6968.2012.02529.x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Harrison MD, 1999, BBA-MOL BASIS DIS, V1453, P254, DOI 10.1016/S0925-4439(98)00110-0; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Huffman DL, 2002, BIOCHEMISTRY-US, V41, P10046, DOI 10.1021/bi0259960; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lee SM, 2002, BIOCHEM BIOPH RES CO, V295, P616, DOI 10.1016/S0006-291X(02)00726-X; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Pezza A, 2016, P NATL ACAD SCI USA, V113, P11573, DOI 10.1073/pnas.1603192113; Pontel LB, 2014, MICROBIOL-SGM, V160, P1659, DOI 10.1099/mic.0.080473-0; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 2012, CURR TOP MEMBR, V69, P113, DOI 10.1016/B978-0-12-394390-3.00005-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strausak D, 1997, J BIOL CHEM, V272, P8932; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Thaden JT, 2010, J BACTERIOL, V192, P2557, DOI 10.1128/JB.01528-09; Trasnea PI, 2016, MOL MICROBIOL, V100, P345, DOI 10.1111/mmi.13321; Vita N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39065; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Wunsch P, 2003, J BACTERIOL, V185, P887, DOI 10.1128/JB.185.3.887-896.2003; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Yoneyama H, 1996, MICROBIOL-UK, V142, P2137, DOI 10.1099/13500872-142-8-2137	90	59	61	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15691	15704		10.1074/jbc.M117.804492	http://dx.doi.org/10.1074/jbc.M117.804492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28760827	hybrid, Green Published			2022-12-28	WOS:000411512200010
J	Ray, S; Maitra, A; Biswas, A; Panjikar, S; Mondal, J; Anand, R				Ray, Shamayeeta; Maitra, Anwesha; Biswas, Anwesha; Panjikar, Santosh; Mondal, Jagannath; Anand, Ruchi			Functional insights into the mode of DNA and ligand binding of the TetR family regulator TylP from Streptomyces fradiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TYLOSIN PRODUCTION; PROTEIN CPRB; EFFLUX PUMP; REPRESSOR; BIOSYNTHESIS; RESISTANCE; GENES; ROLES	Tetracycline repressors (TetRs) modulate multidrug efflux pathways in several pathogenic bacteria. In Streptomyces, they additionally regulate secondary metabolic pathways like antibiotic production. For instance, in the antibiotic producer Streptomyces fradiae, a layered network of TetRs regulates the levels of the commercially important antibiotic tylosin, with TylP occupying the top of this cascading network. TetRs exist in two functional states, the DNA-bound and the ligand-bound form, which are allosterically regulated. Here, to develop deeper insights into the factors that govern allostery, the crystal structure of TylP was solved to a resolution of 2.3 angstrom. The structure revealed that TylP possesses several unique features; notably, it harbors a unique C-terminal helix-loop extension that spans the entire length of the structure. This anchor connects the DNA-binding domain (DBD) with the ligand-binding domain (LBD) via a mix of positively charged and hydrogen-bonding interactions. Supporting EMSA studies with a series of Delta C truncated versions show that a systematic deletion of this region results in complete loss of DNA binding. The structure additionally revealed that TylP is markedly different in the orientation of its DBD and LBD architecture and the dimeric geometry from its hypothesized Streptomyces homologue CprB, which is a gamma-butyrolactone regulator. Rather, TylP is closer in structural design to macrolide-binding TetRs found in pathogens. Supporting molecular dynamic studies suggested that TylP binds a macrolide intermediate in the tylosin pathway. Collectively, the structure along with corroborating biochemical studies provided insights into the novel mode of regulation of TetRs in antibiotic-producing organisms.	[Ray, Shamayeeta; Maitra, Anwesha; Biswas, Anwesha; Anand, Ruchi] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Ray, Shamayeeta] IITB Monash Res Acad, Bombay 400076, Maharashtra, India; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Mondal, Jagannath] Ctr Interdisciplinary Sci, TIFR, Hyderabad, Andhra Pradesh 500075, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Anand, R (corresponding author), Indian Inst Technol, Dept Chem, Struct Biochem Lab, Mumbai 400076, Maharashtra, India.	ruchi@chem.iitb.ac.in	Panjikar, Santosh/D-2709-2012; Ray, Shamayeeta/HCH-9284-2022	Panjikar, Santosh/0000-0001-7429-3879; Anand, Ruchi/0000-0002-2045-3758; Ray, Shamayeeta/0000-0001-7906-0572	Department of Science & Technology (DST), Government of India [EMR/2015/002121]; Board of Research in Nuclear Sciences (BRNS), Government of India [37(1)/14/05/2017-BRNS/37039]; Australia-India Council grant; TIFR; DST-SERB	Department of Science & Technology (DST), Government of India(Department of Science & Technology (India)); Board of Research in Nuclear Sciences (BRNS), Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Australia-India Council grant; TIFR; DST-SERB	This work was supported by Department of Science & Technology (DST), Government of India, Grant EMR/2015/002121, Board of Research in Nuclear Sciences (BRNS), Government of India, Grant 37(1)/14/05/2017-BRNS/37039, Australia-India Council grant, and start-up funds provided by TIFR. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ramanujan fellowship provided by DST-SERB.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bate N, 2002, MOL MICROBIOL, V43, P449, DOI 10.1046/j.1365-2958.2002.02756.x; Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhukya H, 2017, J INDIAN I SCI, V97, P245, DOI 10.1007/s41745-017-0025-5; Bhukya H, 2014, NUCLEIC ACIDS RES, V42, P10122, DOI 10.1093/nar/gku587; Bignell DRD, 2007, MOL MICROBIOL, V63, P838, DOI 10.1111/j.1365-2958.2006.05541.x; Biswas A, 2014, J PHYS CHEM B, V118, P10035, DOI 10.1021/jp503589h; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHMAN SE, 1987, P NATL ACAD SCI USA, V84, P8248, DOI 10.1073/pnas.84.23.8248; Fouces R, 1999, MICROBIOL-UK, V145, P855, DOI 10.1099/13500872-145-4-855; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Liang I., 1998, PROTEIN SCI, V7, P1884; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Premkumar L, 2007, PROTEINS, V68, P418, DOI 10.1002/prot.21436; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sengupta S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00047; Stratigopoulos G, 2002, MOL MICROBIOL, V45, P735, DOI 10.1046/j.1365-2958.2002.03044.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yamazaki H, 2000, J BACTERIOL, V182, P4596, DOI 10.1128/JB.182.16.4596-4605.2000; Zheng JT, 2009, J MOL BIOL, V387, P1250, DOI 10.1016/j.jmb.2009.02.058	41	9	12	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15301	15311		10.1074/jbc.M117.788000	http://dx.doi.org/10.1074/jbc.M117.788000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28739805	Green Published, hybrid			2022-12-28	WOS:000410809800012
J	Du, W; Hu, JKH; Du, W; Klein, OD				Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.			Lineage tracing of epithelial cells in developing teeth reveals two strategies for building signaling centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL ECTODERMAL RIDGE; TOOTH DEVELOPMENT; SONIC-HEDGEHOG; ENAMEL KNOT; MOUSE MOLAR; 3-DIMENSIONAL RECONSTRUCTION; FLOOR PLATE; STEM-CELLS; MORPHOGENESIS; EXPRESSION	An important event in organogenesis is the formation of signaling centers, which are clusters of growth factor-secreting cells. In the case of tooth development, sequentially formed signaling centers known as the initiation knot (IK) and the enamel knot (EK) regulate morphogenesis. However, despite the importance of signaling centers, their origin, as well as the fate of the cells composing them, remain open questions. Here, using lineage tracing of distinct epithelial populations, we found that the EK of the mouse incisor is derived de novo from a group of SRY-box 2 (Sox2)-expressing cells in the posterior half of the tooth germ. Specifically, EK progenitors are located in the posterior ventral basal layer, as demonstrated by DiI labeling of cells. Lineage tracing the formed EK with Shh(CreER), which encodes an inducible Cre recombinase under the control of the Sonic hedgehog promoter, at subsequent developmental stages showed that, once formed, some EK cells in the incisor give rise to differentiated cells, whereas in the molar, EK cells give rise to the buccal secondary EK. This work thus establishes the developmental origin as well as the fate of the EK and reveals two strategies for the emergence of serially formed signaling centers: one through de novo establishment and the other by incorporation of progeny from previously formed signaling centers.	[Du, Wei; Du, Wen] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China; [Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Sichuan University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Klein, OD (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	ophir.klein@ucsf.edu		Klein, Ophir/0000-0002-6254-7082; Hu, Jimmy/0000-0003-1035-0779; Du, Wen/0000-0002-3361-088X	National Institutes of Health [R35-DE026602]; NIDCR [F32-DE023705, K99-DE025874]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R35DE026602, K99DE025874, F32DE023705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R35-DE026602 (to O.D.K.) and F32-DE023705 and K99-DE025874 (to J.K.H.) from the NIDCR. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahtiainen L, 2016, J CELL BIOL, V214, P753, DOI 10.1083/jcb.201512074; Alexandre P, 2003, DEVELOPMENT, V130, P5331, DOI 10.1242/dev.00756; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Cho SW, 2007, DIFFERENTIATION, V75, P441, DOI 10.1111/j.1432-0436.2006.00153.x; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Coin R, 1999, INT J DEV BIOL, V43, P261; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Haara O, 2012, DEVELOPMENT, V139, P3189, DOI 10.1242/dev.079558; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hovorakova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162523; Hovorakova M, 2013, J EXP ZOOL PART B, V320, P455, DOI 10.1002/jez.b.22522; Hovorakova M, 2011, J EXP ZOOL PART B, V316B, P347, DOI 10.1002/jez.b.21408; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jussila M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008425; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kieffer S, 1999, INT J DEV BIOL, V43, P531; Kimmel RA, 2000, GENE DEV, V14, P1377; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Lesot H, 1996, INT J DEV BIOL, V40, P1017; Li CY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12133; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; Matalova E, 2005, DEV DYNAM, V233, P754, DOI 10.1002/dvdy.20396; Miard S, 1999, INT J DEV BIOL, V43, P517; Mitsiadis TA, 2008, DEV BIOL, V320, P39, DOI 10.1016/j.ydbio.2008.04.006; Morita R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161336; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Peterkova R, 1996, INT J DEV BIOL, V40, P1009; Peterkova R, 2002, CONNECT TISSUE RES, V43, P120, DOI 10.1080/03008200290000745; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shirokova V, 2013, DEV DYNAM, V242, P593, DOI 10.1002/dvdy.23952; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Viriot L, 2000, INT J DEV BIOL, V44, P233; Wassef M, 1997, PERSPECT DEV NEUROBI, V5, P3; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	52	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15062	15069		10.1074/jbc.M117.785923	http://dx.doi.org/10.1074/jbc.M117.785923			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28733464	Green Published, hybrid			2022-12-28	WOS:000409902100028
J	Broom, A; Jacobi, Z; Trainor, K; Meiering, EM				Broom, Aron; Jacobi, Zachary; Trainor, Kyle; Meiering, Elizabeth M.			Computational tools help improve protein stability but with a solubility tradeoff	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; IN-SILICO DESIGN; ENERGY FUNCTIONS; STATISTICAL POTENTIALS; HYDROPHOBIC RESIDUES; SECONDARY STRUCTURE; BACKBONE ENSEMBLES; THERMAL-STABILITY; GLOBULAR-PROTEINS; ESCHERICHIA-COLI	Accurately predicting changes in protein stability upon amino acid substitution is a much sought after goal. Destabilizing mutations are often implicated in disease, whereas stabilizing mutations are of great value for industrial and therapeutic biotechnology. Increasing protein stability is an especially challenging task, with random substitution yielding stabilizing mutations in only similar to 2% of cases. To overcome this bottleneck, computational tools that aim to predict the effect of mutations have been developed; however, achieving accuracy and consistency remains challenging. Here, we combined 11 freely available tools into a meta-predictor (meieringlab.uwaterloo.ca/stabilitypredict/). Validation against similar to 600 experimental mutations indicated that our meta-predictor has improved performance over any of the individual tools. The meta-predictor was then used to recommend 10 mutations in a previously designed protein of moderate thermodynamic stability, ThreeFoil. Experimental characterization showed that four mutations increased protein stability and could be amplified through ThreeFoil's structural symmetry to yield several multiple mutants with >2-kcal/mol stabilization. By avoiding residues within functional ties, we could maintain ThreeFoil's glycan-binding capacity. Despite successfully achieving substantial stabilization, however, almost all mutations decreased protein solubility, the most common cause of protein design failure. Examination of the 600-mutation data set revealed that stabilizing mutations on the protein surface tend to increase hydrophobicity and that the individual tools favor this approach to gain stability. Thus, whereas currently available tools can increase protein stability and combining them into a meta-predictor yields enhanced reliability, improvements to the potentials/force fields underlying these tools are needed to avoid gaining protein stability at the cost of solubility.	[Broom, Aron; Jacobi, Zachary; Trainor, Kyle; Meiering, Elizabeth M.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Meiering, EM (corresponding author), Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada.	meiering@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) grant [RGPIN-102173]	Natural Sciences and Engineering Research Council of Canada (NSERC) grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant (RGPIN-102173 to E. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Ayuso-Tejedor S, 2011, PROTEIN ENG DES SEL, V24, P171, DOI 10.1093/protein/gzq072; Balaji S, 2015, CURR OPIN STRUC BIOL, V32, P156, DOI 10.1016/j.sbi.2015.05.004; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Bazzoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140359; Bednar D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004556; Bendl J, 2016, NUCLEIC ACIDS RES, V44, pW479, DOI 10.1093/nar/gkw416; Berliner N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107353; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Bolon DN, 2003, J MOL BIOL, V329, P611, DOI 10.1016/S0022-2836(03)00423-6; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Boulet-Audet M, 2014, ANAL CHEM, V86, P9786, DOI 10.1021/ac502529q; Broom A, 2016, CURR OPIN STRUC BIOL, V38, P26, DOI 10.1016/j.sbi.2016.05.007; Broom A, 2015, P NATL ACAD SCI USA, V112, P14605, DOI 10.1073/pnas.1510748112; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Cordes MHJ, 1999, PROTEIN SCI, V8, P318; Cota E, 2000, PROTEIN SCI, V9, P112; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Davey JA, 2015, STRUCTURE, V23, P2011, DOI 10.1016/j.str.2015.07.021; Davey JA, 2014, PROTEINS, V82, P771, DOI 10.1002/prot.24457; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Deng ZF, 2012, J MOL BIOL, V424, P150, DOI 10.1016/j.jmb.2012.09.014; Deng ZM, 2014, APPL MICROBIOL BIOT, V98, P3997, DOI 10.1007/s00253-013-5375-y; Deutsch C, 2007, BIOINFORMATICS, V23, P3009, DOI 10.1093/bioinformatics/btm481; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Floor RJ, 2014, CHEMBIOCHEM, V15, P1659, DOI 10.1002/cbic.201402128; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Funahashi J, 2002, J BIOL CHEM, V277, P21792, DOI 10.1074/jbc.M110728200; Gilis D, 2003, J MOL BIOL, V325, P581, DOI 10.1016/S0022-2836(02)01221-4; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Heselpoth RD, 2015, PROTEIN ENG DES SEL, V28, P85, DOI 10.1093/protein/gzv004; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Klesmith JR, 2017, P NATL ACAD SCI USA, V114, P2265, DOI 10.1073/pnas.1614437114; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kwon WS, 1996, PROTEIN ENG, V9, P1197, DOI 10.1093/protein/9.12.1197; Larsen DM, 2015, APPL MICROBIOL BIOT, V99, P4245, DOI 10.1007/s00253-014-6244-z; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; MCLENDON G, 1978, J BIOL CHEM, V253, P6335; MEIERING EM, 1992, J MOL BIOL, V225, P585, DOI 10.1016/0022-2836(92)90387-Y; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Poso D, 2000, J BIOL CHEM, V275, P35723, DOI 10.1074/jbc.M001747200; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Redington JM, 2017, PROTEIN PEPTIDE LETT, V24, P340, DOI 10.2174/0929866524666170209153421; Risso VA, 2014, ENVIRON MICROBIOL, V16, P1485, DOI 10.1111/1462-2920.12319; Rockah-Shmuel L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004421; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rooman M, 1998, EUR J BIOCHEM, V254, P135, DOI 10.1046/j.1432-1327.1998.2540135.x; Rykunov D, 2007, PROTEINS, V67, P559, DOI 10.1002/prot.21279; Sauerborn M, 2010, TRENDS PHARMACOL SCI, V31, P53, DOI 10.1016/j.tips.2009.11.001; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Silva IR, 2013, APPL MICROBIOL BIOT, V97, P9727, DOI 10.1007/s00253-013-5184-3; Song XF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003129; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tripathi A, 2014, CURR OPIN STRUC BIOL, V24, P63, DOI 10.1016/j.sbi.2013.12.001; Tzul FO, 2015, P NATL ACAD SCI USA, V112, pE259, DOI 10.1073/pnas.1410424112; Voynov V, 2009, MABS-AUSTIN, V1, P580, DOI 10.4161/mabs.1.6.9773; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Warwicker J, 2014, MOL PHARMACEUT, V11, P294, DOI 10.1021/mp4004749; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Wijma HJ, 2014, PROTEIN ENG DES SEL, V27, P49, DOI 10.1093/protein/gzt061; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Worth CL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-161; Yang DF, 2007, BIOSCI BIOTECH BIOCH, V71, P746, DOI 10.1271/bbb.60576; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; Zambrano R, 2015, NUCLEIC ACIDS RES, V43, pW306, DOI 10.1093/nar/gkv359; Zhang SB, 2011, BIORESOURCE TECHNOL, V102, P2093, DOI 10.1016/j.biortech.2010.08.019; [No title captured]	103	60	61	4	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14349	14361		10.1074/jbc.M117.784165	http://dx.doi.org/10.1074/jbc.M117.784165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710274	Green Published, hybrid			2022-12-28	WOS:000408747500004
J	Gates, LA; Shi, JJ; Rohira, AD; Feng, Q; Zhu, BK; Bedford, MT; Sagum, CA; Jung, SY; Qin, J; Tsai, MJ; Tsai, SY; Li, W; Foulds, CE; O'Malley, BW				Gates, Leah A.; Shi, Jiejun; Rohira, Aarti D.; Feng, Qin; Zhu, Bokai; Bedford, Mark T.; Sagum, Cari A.; Jung, Sung Yun; Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.; Li, Wei; Foulds, Charles E.; O'Malley, Bert W.			Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; HIV-1 TAT; GENE-EXPRESSION; COMPLEX SEC; CHROMATIN; PROTEIN; SAGA; METHYLATION; BROMODOMAIN	The transition from transcription initiation to elongation is a key regulatory step in gene expression, which requires RNA polymerase II (pol II) to escape promoter proximal pausing on chromatin. Although elongation factors promote pause release leading to transcription elongation, the role of epigenetic modifications during this critical transition step is poorly understood. Two histone marks on histone H3, lysine 4 trimethylation (H3K4me3) and lysine 9 acetylation (H3K9ac), co-localize on active gene promoters and are associated with active transcription. H3K4me3 can promote transcription initiation, yet the functional role of H3K9ac is much less understood. We hypothesized that H3K9ac may function downstream of transcription initiation by recruiting proteins important for the next step of transcription. Here, we describe a functional role for H3K9ac in promoting pol II pause release by directly recruiting the super elongation complex (SEC) to chromatin. H3K9ac serves as a substrate for direct binding of the SEC, as does acetylation of histone H4 lysine 5 to a lesser extent. Furthermore, lysine 9 on histone H3 is necessary for maximal pol II pause release through SEC action, and loss of H3K9ac increases the pol II pausing index on a subset of genes in HeLa cells. At select gene promoters, H3K9ac loss or SEC depletion reduces gene expression and increases paused pol II occupancy. We therefore propose that an ordered histone code can promote progression through the transcription cycle, providing new mechanistic insight indicating that SEC recruitment to certain acetylated histones on a subset of genes stimulates the subsequent release of paused pol II needed for transcription elongation.	[Gates, Leah A.; Rohira, Aarti D.; Feng, Qin; Zhu, Bokai; Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.; Li, Wei; Foulds, Charles E.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shi, Jiejun; Li, Wei] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Foulds, Charles E.] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA; [Bedford, Mark T.; Sagum, Cari A.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Foulds, CE; O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Foulds, CE (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.	foulds@bcm.edu; berto@bcm.edu	Zhu, Bokai/AAF-7502-2020; Shi, Jiejun/P-3329-2019	Zhu, Bokai/0000-0003-0827-5757; Shi, Jiejun/0000-0001-9777-1183; Foulds, Charles/0000-0003-4908-1473; Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health from NCI [P30 CA125123]; National Institutes of Health Cancer Center Support Grant from NCI [5 P30 CA125123]; Cancer Prevention Research Institute of Texas Grant [RP130432]; Center for Environmental and Molecular Carcinogenesis at M.D. Anderson Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD008188] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA193466] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Cancer Center Support Grant from NCI; Cancer Prevention Research Institute of Texas Grant; Center for Environmental and Molecular Carcinogenesis at M.D. Anderson Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Xiaobing Shi (M.D. Anderson Cancer Center) for sharing AF9-related reagents and helpful discussions; Jeffrey Parvin (Ohio State University) for the G-less pG5-E4-array construct; Eric Smith for assistance with cloning the 4xERE-G-less cassettes; Ross Hamilton and Philip Lavere for preparing HeLa S-3 nuclear extract; Doug Chan for the small-scale nuclear extract protocol; the Proteomics Core at BCM (supported by National Institutes of Health Grant P30 CA125123 from NCI) for assistance with mass spectrometry; the BCM Tissue Culture Core for assistance with cell culture; the Monoclonal Antibody/Recombinant Protein Shared Resource (funded by National Institutes of Health Cancer Center Support Grant 5 P30 CA125123 from NCI) for assistance with protein purification; and the BCM Gene Vector Core for assistance with sequencing. M. T. B. directs the Protein Array Core, which is supported by the Cancer Prevention Research Institute of Texas Grant RP130432, and by the Center for Environmental and Molecular Carcinogenesis at M.D. Anderson Cancer Center.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Day DS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0984-2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Liu XL, 2015, TRENDS BIOCHEM SCI, V40, P516, DOI 10.1016/j.tibs.2015.07.003; Lu HS, 2015, NUCLEIC ACIDS RES, V43, P5868, DOI 10.1093/nar/gkv541; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Mondal N, 2003, NUCLEIC ACIDS RES, V31, P5016, DOI 10.1093/nar/gkg705; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang L, 2014, EPIGENOMICS-UK, V6, P329, DOI [10.2217/EPI.14.22, 10.2217/epi.14.22]; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamamoto S, 2001, MOL CELL BIOL, V21, P1, DOI 10.1128/MCB.21.1.1-15.2001; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zaborowska J, 2016, NAT STRUCT MOL BIOL, V23, P771, DOI 10.1038/nsmb.3285	69	109	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14456	14472		10.1074/jbc.M117.802074	http://dx.doi.org/10.1074/jbc.M117.802074			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28717009	Green Published, hybrid			2022-12-28	WOS:000408747500013
J	Azakir, BA; Di Fulvio, S; Salomon, S; Brockhoff, M; Therrien, C; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Salomon, Steven; Brockhoff, Marielle; Therrien, Christian; Sinnreich, Michael			RETRACTION: Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules. (Retraction of Vol 287, Pg 27629, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Sinnreich, Michael/0000-0002-9835-1276				Azakir BA, 2012, J BIOL CHEM, V287, P27629, DOI 10.1074/jbc.M112.391722	1	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12543	12543		10.1074/jbc.A112.391722	http://dx.doi.org/10.1074/jbc.A112.391722			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28754768	Green Published, hybrid			2022-12-28	WOS:000406636900019
J	Cao, HC; Zhang, SJ; Shan, SF; Sun, C; Li, Y; Wang, H; Yu, SX; Liu, Y; Guo, FF; Zhai, QW; Wang, YC; Jiang, JJ; Wang, H; Yan, J; Liu, W; Ying, H				Cao, Hongchao; Zhang, Shengjie; Shan, Shifang; Sun, Chao; Li, Yan; Wang, Hui; Yu, Shuxian; Liu, Yi; Guo, Feifan; Zhai, Qiwei; Wang, Yu-cheng; Jiang, Jingjing; Wang, Hui; Yan, Jun; Liu, Wei; Ying, Hao			Ligand-dependent corepressor (LCoR) represses the transcription factor C/EBP during early adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; CCAAT-enhancer-binding protein (C; EBP); nuclear receptor; peroxisome proliferator-activated receptor (PPAR); transcription corepressor	MITOTIC CLONAL EXPANSION; RECEPTOR COREPRESSOR; 3T3-L1 PREADIPOCYTES; BINDING-PROTEINS; ADIPOGENESIS; COREGULATORS; BETA; HOMEOSTASIS; KINASE; GENE	Nuclear receptors (NRs) regulate gene transcription by recruiting coregulators, involved in chromatin remodeling and assembly of the basal transcription machinery. The NR-associated protein ligand-dependent corepressor (LCoR) has previously been shown to suppress hepatic lipogenesis by decreasing the binding of steroid receptor coactivators to thyroid hormone receptor. However, the role of LCoR in adipogenesis has not been established. Here, we show that LCoR expression is reduced in the early stage of adipogenesis in vitro. LCoR overexpression inhibited 3T3-L1 adipocyte differentiation, whereas LCoR knockdown promoted it. Using an unbiased affinity purification approach, we identified CCAAT/enhancer-binding protein (C/EBP), a key transcriptional regulator in early adipogenesis, and corepressor C-terminal binding proteins as potential components of an LCoR-containing complex in 3T3-L1 adipocytes. We found that LCoR directly interacts with C/EBP through its C-terminal helix-turn-helix domain, required for LCoR's inhibitory effects on adipogenesis. LCoR overexpression also inhibited C/EBP transcriptional activity, leading to inhibition of mitotic clonal expansion and transcriptional repression of C/EBP and peroxisome proliferator-activated receptor 2 (PPAR2). However, LCoR overexpression did not affect the recruitment of C/EBP to the promoters of C/EBP and PPAR2 in 3T3-L1 adipocytes. Of note, restoration of PPAR2 or C/EBP expression attenuated the inhibitory effect of LCoR on adipogenesis. Mechanistically, LCoR suppressed C/EBP-mediated transcription by recruiting C-terminal binding proteins to the C/EBP and PPAR2 promoters and by modulating histone modifications. Taken together, our results indicate that LCoR negatively regulates early adipogenesis by repressing C/EBP transcriptional activity and add LCoR to the growing list of transcriptional corepressors of adipogenesis.	[Cao, Hongchao; Zhang, Shengjie; Sun, Chao; Li, Yan; Wang, Hui; Yu, Shuxian; Wang, Hui; Liu, Wei; Ying, Hao] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Labs Food Safety Res, Shanghai 200031, Peoples R China; [Shan, Shifang; Liu, Yi; Guo, Feifan; Zhai, Qiwei] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Labs Nutr & Metab, Shanghai 200031, Peoples R China; [Wang, Yu-cheng; Ying, Hao] Chinese Acad Sci, Shanghai Xuhui Cent Hosp, Shanghai Clin Ctr, Shanghai 200031, Peoples R China; [Jiang, Jingjing] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200031, Peoples R China; [Wang, Hui; Ying, Hao] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Yan, Jun] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Yan, Jun] Nanjing Univ, Minist Educt, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fudan University; Nanjing University; Nanjing University	Liu, W; Ying, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	liuwei01@sibs.ac.cn; yinghao@sibs.ac.cn	Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952; Zhai, Qiwei/0000-0002-9617-7403	Ministry of Science and Technology of China [2016YFA0500102, 2016YFC1304905]; National Natural Science Foundation [31371189, 31525012, 31100550, 81570768, 81471016]; Natural Science Foundation for Universities in Jiangsu Province, China [BK20151396]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Chinese Academy of Sciences [ZDBS-SSW-DQC-02]; Xuhui Central Hospital (Shanghai, China)	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Universities in Jiangsu Province, China; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Xuhui Central Hospital (Shanghai, China)	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0500102 and 2016YFC1304905; National Natural Science Foundation Grants 31371189, 31525012, 31100550, 81570768, and 81471016; Natural Science Foundation for Universities in Jiangsu Province, China Grant BK20151396 (to J. Y.), Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Chinese Academy of Sciences Grant ZDBS-SSW-DQC-02; and Xuhui Central Hospital (Shanghai, China). The authors declare that they have no conflicts of interest with the contents of this article.	Asim M, 2011, J BIOL CHEM, V286, P37108, DOI 10.1074/jbc.M111.292771; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Calderon MR, 2012, J BIOL CHEM, V287, P8662, DOI 10.1074/jbc.M111.311605; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fowler Amy M, 2004, Sci STKE, V2004, ppe51, DOI 10.1126/stke.2562004pe51; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Hartig SM, 2011, J CELL BIOL, V192, P55, DOI 10.1083/jcb.201004026; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Jack BHA, 2010, J BIOL CHEM, V285, P32405, DOI 10.1074/jbc.M110.141317; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Louet JF, 2007, CELL CYCLE, V6, P2448, DOI 10.4161/cc.6.20.4777; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	34	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18973	18987		10.1074/jbc.M117.793984	http://dx.doi.org/10.1074/jbc.M117.793984			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972158	Green Published, hybrid			2022-12-28	WOS:000415848000021
J	Sperandeo, P; Martorana, AM; Polissi, A				Sperandeo, Paola; Martorana, Alessandra M.; Polissi, Alessandra			The lipopolysaccharide transport (Lpt) machinery: A nonconventional transporter for lipopolysaccharide assembly at the outer membrane of Gram-negative bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ABC transporter; gram-negative bacteria; lipopolysaccharide (LPS); outer membrane; protein-protein interaction; LPS transport	ESCHERICHIA-COLI MSBA; DEFICIENT ACINETOBACTER-BAUMANNII; TRANSENVELOPE PROTEIN COMPLEX; ABC FAMILY TRANSPORTER; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; CELL-SURFACE; FUNCTIONAL-CHARACTERIZATION; PEPTIDOMIMETIC ANTIBIOTICS; CHEMICAL CONDITIONALITY	The outer membrane (OM) of Gram-negative is a unique lipid bilayer containing LPS in its outer leaflet. Because of the presence of amphipathic LPS molecules, the OM behaves as an effective permeability barrier that makes Gram-negative bacteria inherently resistant to many antibiotics. This review focuses on LPS biogenesis and discusses recent advances that have contributed to our understanding of how this complex molecule is transported across the cellular envelope and is assembled at the OM outer leaflet. Clearly, this knowledge represents an important platform for the development of novel therapeutic options to manage Gram-negative infections.	[Sperandeo, Paola; Polissi, Alessandra] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Martorana, Alessandra M.] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy	University of Milan; University of Milano-Bicocca	Polissi, A (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy.	alessandra.polissi@unimi.it	Martorana, Alessandra M./AAB-2017-2021; Sperandeo, Paola/AAF-2755-2019	Martorana, Alessandra M./0000-0003-3996-4141; POLISSI, ALESSANDRA/0000-0003-0903-8024	Train2Target project from the European Union [721484]	Train2Target project from the European Union	This work was supported by the Train2Target project (Grant 721484) granted from the European Union's Horizon 2020. The authors declare that they have no conflicts of interest with the contents of this article.	Benedet M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161354; Boll JM, 2016, P NATL ACAD SCI USA, V113, pE6228, DOI 10.1073/pnas.1611594113; Bollati M, 2015, FEBS J, V282, P1980, DOI 10.1111/febs.13254; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Botos I, 2016, STRUCTURE, V24, P965, DOI 10.1016/j.str.2016.03.026; Braun V, 2006, ACS CHEM BIOL, V1, P352, DOI 10.1021/cb600256k; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Gu YH, 2015, STRUCTURE, V23, P496, DOI 10.1016/j.str.2015.01.001; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Laguri C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10136-0; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11883; LIU D, 1994, GENETICS, V138, P7; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Luo QS, 2017, NAT STRUCT MOL BIOL, V24, P469, DOI 10.1038/nsmb.3399; Malojcic G, 2014, P NATL ACAD SCI USA, V111, P9467, DOI 10.1073/pnas.1402746111; Martorana AM, 2016, J BACTERIOL, V198, P2192, DOI 10.1128/JB.00329-16; Merten JA, 2012, PROTEIN SCI, V21, P211, DOI 10.1002/pro.2004; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moehle K, 2016, BIOCHEMISTRY-US, V55, P2936, DOI 10.1021/acs.biochem.6b00313; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Narita S, 2017, BBA-MOL CELL BIOL L, V1862, P1414, DOI 10.1016/j.bbalip.2016.11.009; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Putker F, 2015, FEMS MICROBIOL REV, V39, P985, DOI 10.1093/femsre/fuv026; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2006, ACS CHEM BIOL, V1, P385, DOI 10.1021/cb600128v; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Santambrogio C, 2013, J AM SOC MASS SPECTR, V24, P1593, DOI 10.1007/s13361-013-0687-9; Schultz KM, 2017, PROTEIN SCI, V26, P1517, DOI 10.1002/pro.3177; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Sestito SE, 2014, CHEMBIOCHEM, V15, P734, DOI 10.1002/cbic.201300805; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Sherman DJ, 2013, BIOORGAN MED CHEM, V21, P4846, DOI 10.1016/j.bmc.2013.04.020; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Simpson BW, 2016, MBIO, V7, DOI 10.1128/mBio.01729-16; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Stokes JM, 2016, CELL CHEM BIOL, V23, P267, DOI 10.1016/j.chembiol.2015.12.011; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Sutterlin HA, 2016, P NATL ACAD SCI USA, V113, pE1565, DOI 10.1073/pnas.1601375113; Sutterlin HA, 2014, J BACTERIOL, V196, P3214, DOI 10.1128/JB.01876-14; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Werneburg M, 2012, CHEMBIOCHEM, V13, P1767, DOI 10.1002/cbic.201200276; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zabawa TP, 2016, CURR OPIN MICROBIOL, V33, P7, DOI 10.1016/j.mib.2016.05.005; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	88	36	39	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					17981	17990		10.1074/jbc.R117.802512	http://dx.doi.org/10.1074/jbc.R117.802512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28878019	Green Published, hybrid			2022-12-28	WOS:000414458200001
J	Zhao, J; Nussinov, R; Ma, BY				Zhao, Jun; Nussinov, Ruth; Ma, Buyong			Mechanisms of recognition of amyloid-beta (A beta) monomer, oligomer, and fibril by homologous antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; amyloid-beta (AB); antibody; immunotherapy; protein dynamic	HUMAN SERUM-ALBUMIN; PROTEIN-PROTEIN DOCKING; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; CONFORMATIONAL SELECTION; CONSTANT-REGION; IMMUNOGLOBULIN CONSTANT; STRUCTURE REVEALS; LIGHT-CHAINS; BINDING	Alzheimer's disease is one of the most devastating neurodegenerative diseases without effective therapies. Immunotherapy is a promising approach, but amyloid antibody structural information is limited. Here we simulate the recognition of monomeric, oligomeric, and fibril amyloid- (A) by three homologous antibodies (solanezumab, crenezumab, and their chimera, CreneFab). Solanezumab only binds the monomer, whereas crenezumab and CreneFab can recognize different oligomerization states; however, the structural basis for this observation is not understood. We successfully identified stable complexes of crenezumab with A pentamer (oligomer model) and 16-mer (fibril model). It is noteworthy that solanezumab targets A residues 16-26 preferentially in the monomeric state; conversely, crenezumab consistently targets residues 13-16 in different oligomeric states. Unlike the buried monomeric peptide in solanezumab's complementarity-determining region, crenezumab binds the oligomer's lateral and edge residues. Surprisingly, crenezumab's complementarity-determining region loops can effectively bind the A fibril lateral surface around the same 13-16 region. The constant domain influences antigen recognition through entropy redistribution. Different constant domain residues in solanezumab/crenezumab/chimera influence the binding of A aggregates. Collectively, we provide molecular insight into the recognition mechanisms facilitating antibody design.	[Zhao, Jun] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Nussinov, Ruth; Ma, Buyong] NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21702 USA.	mabuyong@mail.nih.gov	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	NCI, National Institutes of Health [HHSN261200800001E]; NCI, National Institutes of Health, Center for Cancer Research; NIDCD, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010442] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, National Institutes of Health, Center for Cancer Research; NIDCD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part by Federal funds from the NCI, National Institutes of Health, under Contract HHSN261200800001E. This work was also supported in part by the Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Intramural Research Program of NIDCD, National Institutes of Health.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Adachi M, 2003, PROTEIN SCI, V12, P2125, DOI 10.1110/ps.03100803; Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Algamal M, 2013, BIOPHYS J, V105, P1700, DOI 10.1016/j.bpj.2013.08.025; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Crespi GAN, 2015, SCI REP-UK, V5, DOI 10.1038/srep09649; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; De Genst E, 2014, BBA-PROTEINS PROTEOM, V1844, P1907, DOI 10.1016/j.bbapap.2014.08.016; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eargle J, 2012, BIOINFORMATICS, V28, P3000, DOI 10.1093/bioinformatics/bts546; Feinberg H, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt261; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Helms LR, 1996, J MOL BIOL, V257, P77, DOI 10.1006/jmbi.1996.0148; Herrmann A, 2015, J NEUROCHEM, V132, P1, DOI 10.1111/jnc.12845; HOOFT C, 1973, J PEDIATR-US, V82, P1098, DOI 10.1016/S0022-3476(73)80465-2; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Keskin O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-31; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; La Porte SL, 2012, J MOL BIOL, V421, P525, DOI 10.1016/j.jmb.2011.11.047; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Li TJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082499, 10.1371/journal.pone.0092870]; Li T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004327; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2016, BBA-GEN SUBJECTS, V1860, P2672, DOI 10.1016/j.bbagen.2016.05.040; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Milojevic J, 2014, J ALZHEIMERS DIS, V38, P753, DOI 10.3233/JAD-131169; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; OZAKI S, 1994, CLIN IMMUNOL IMMUNOP, V71, P183, DOI 10.1006/clin.1994.1070; Panza F, 2014, CURR OPIN PSYCHIATR, V27, P128, DOI 10.1097/YCO.0000000000000041; Pellequer JL, 1999, J MOL RECOGNIT, V12, P267, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<267::AID-JMR465>3.0.CO;2-9; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietal MJ, 2007, BIOINFORMATICS, V23, P1429, DOI 10.1093/bioinformatics/btm124; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; Pritsch O, 1996, J CLIN INVEST, V98, P2235, DOI 10.1172/JCI119033; Raditsis AV, 2013, BIOPHYS J, V105, P473, DOI 10.1016/j.bpj.2013.03.065; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sharp KA, 2015, PROTEINS, V83, P922, DOI 10.1002/prot.24789; SOLOMON A, 1982, J CLIN INVEST, V70, P453, DOI 10.1172/JCI110635; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Ultsch M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39374; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zhao J, 2017, ISR J CHEM, V57, P622, DOI 10.1002/ijch.201600093; Zhao J, 2017, PROTEIN ENG DES SEL, V30, P67, DOI 10.1093/protein/gzw065	85	37	40	1	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18325	18343		10.1074/jbc.M117.801514	http://dx.doi.org/10.1074/jbc.M117.801514			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924036	Green Published, hybrid			2022-12-28	WOS:000414458200029
J	Feng, D; Chen, Z; Yang, K; Miao, SS; Xu, BL; Kang, YS; Xie, HB; Zhao, CT				Feng, Dong; Chen, Zhe; Yang, Kuang; Miao, Shanshan; Xu, Bolin; Kang, Yunsi; Xie, Haibo; Zhao, Chengtian			The cytoplasmic tail of rhodopsin triggers rapid rod degeneration in kinesin-2 mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; HETEROTRIMERIC KINESIN-2; VERTEBRATE PHOTORECEPTOR; OUTER SEGMENTS; RETINITIS-PIGMENTOSA; IFT-PARTICLE; DOUBLE CONE; CELL-DEATH; ZEBRAFISH; CILIARY	Photoreceptor degeneration can lead to blindness and represents the most common form of neural degenerative disease worldwide. Although many genes involved in photoreceptor degeneration have been identified, the underlying mechanisms remain to be elucidated. Here we examined photoreceptor development in zebrafish kif3a and kif3b mutants, which affect two subunits of the kinesin-2 complex. In both mutants, rods degenerated quickly, whereas cones underwent a slow degeneration process. Notably, the photoreceptor defects were considerably more severe in kif3a mutants than in kif3b mutants. In the cone photoreceptors of kif3a mutants, opsin proteins accumulated in the apical region and formed abnormal membrane structures. In contrast, rhodopsins were enriched in the rod cell body membrane and represented the primary reason for rapid rod degeneration in these mutants. Moreover, removal of the cytoplasmic tail of rhodopsin to reduce its function, but not decreasing rhodopsin expression levels, prevented rod degeneration in both kif3a and kif3b mutants. Of note, overexpression of full-length rhodopsin or its cytoplasmic tail domain, but not of rhodopsin lacking the cytoplasmic tail, exacerbated rod degeneration in kif3a mutants, implying an important role of the cytoplasmic tail in rod degeneration. Finally, we showed that the cytoplasmic tail of rhodopsin might trigger rod degeneration through activating the downstream calcium signaling pathway, as drug treatment with inhibitors of intracellular calcium release prevented rod degeneration in kif3a mutants. Our results demonstrate a previously unknown function of the rhodopsin cytoplasmic domain during opsin-triggered photoreceptor degeneration and may open up new avenues for managing this disease.	[Feng, Dong; Chen, Zhe; Yang, Kuang; Miao, Shanshan; Xu, Bolin; Kang, Yunsi; Xie, Haibo; Zhao, Chengtian] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Zhao, Chengtian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China; [Zhao, Chengtian] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao 266003, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Ocean University of China	Zhao, CT (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China.; Zhao, CT (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China.; Zhao, CT (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao 266003, Peoples R China.	chengtian_zhao@ouc.edu.cn			National Natural Science Foundation of China [31372274, 31422051, 81301718]; Shandong Provincial Natural Science Foundation [JQ201506]; Fundamental Research Funds for the Central Universities [201562029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31372274, 31422051, and 81301718; Shandong Provincial Natural Science Foundation Grant JQ201506; and Fundamental Research Funds for the Central Universities Grant 201562029. The authors declare that they have no conflicts of interest with the contents of this article.	Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; [陈哲 Chen Zhe], 2015, [中国实验动物学报, Acta Laboratorium Animalis Scientia Sinica], V23, P453; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Ile KE, 2010, TRAFFIC, V11, P1151, DOI 10.1111/j.1600-0854.2010.01085.x; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Kang YY, 2016, FEBS J, V283, P816, DOI 10.1111/febs.13561; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kisselev OG, 2004, J BIOL CHEM, V279, P51203, DOI 10.1074/jbc.M407341200; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; LARISON KD, 1990, DEVELOPMENT, V109, P567; Leventea E, 2016, METHOD CELL BIOL, V133, P179, DOI 10.1016/bs.mcb.2016.04.016; Lopes VS, 2010, MOL BIOL CELL, V21, P4076, DOI 10.1091/mbc.E10-08-0715; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pooranachandran N, 2016, GENETICS, V203, P771, DOI 10.1534/genetics.115.180943; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song Z, 2016, J GENET GENOMICS, V43, P107, DOI 10.1016/j.jgg.2016.02.001; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Trivedi D, 2012, J NEUROSCI, V32, P10587, DOI 10.1523/JNEUROSCI.0015-12.2012; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yin J, 2012, INVEST OPHTH VIS SCI, V53, P4943, DOI 10.1167/iovs.12-9511; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, INVEST OPHTH VISUAL, V8, P222; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	48	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17375	17386		10.1074/jbc.M117.784017	http://dx.doi.org/10.1074/jbc.M117.784017			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855254	Green Published, hybrid			2022-12-28	WOS:000414009300019
J	Scott, NE; Giogha, C; Pollock, GL; Kennedy, CL; Webb, AI; Williamson, NA; Pearson, JS; Hartland, EL				Scott, Nichollas E.; Giogha, Cristina; Pollock, Georgina L.; Kennedy, Catherine L.; Webb, Andrew I.; Williamson, Nicholas A.; Pearson, Jaclyn S.; Hartland, Elizabeth L.			The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; CITROBACTER-RODENTIUM; SUBSTRATE-SPECIFICITY; UBIQUITINATION SITES; MASS-SPECTROMETRY; PROTEOMICS; RECEPTOR; QUANTIFICATION; IDENTIFICATION; ENRICHMENT	The inhibition of host innate immunity pathways is essential for the persistence of attaching and effacing pathogens such as enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium during mammalian infections. To subvert these pathways and suppress the antimicrobial response, attaching and effacing pathogens use type III secretion systems to introduce effectors targeting key signaling pathways in host cells. One such effector is the arginine glycosyltransferase NleB1 (NleB(CR) in C. rodentium) that modifies conserved arginine residues in death domain-containing host proteins with N-acetylglucosamine (GlcNAc), thereby blocking extrinsic apoptosis signaling. Ectopically expressed NleB1 modifies the host proteins Fas-associated via death domain (FADD), TNFRSF1A-associated via death domain (TRADD), and receptor-interacting serine/threonine protein kinase 1 (RIPK1). However, the full repertoire of arginine GlcNAcylation induced by pathogen-delivered NleB1 is unknown. Using an affinity proteomic approach for measuring arginine-GlcNAcylated glycopeptides, we assessed the global profile of arginine GlcNAcylation during ectopic expression of NleB1, EPEC infection in vitro, or C. rodentium infection in vivo. NleB overexpression resulted in arginine GlcNAcylation of multiple host proteins. However, NleB delivery during EPEC and C. rodentium infection caused rapid and preferential modification of Arg(117) in FADD. This FADD modification was extremely stable and insensitive to physiological temperatures, glycosidases, or host cell degradation. Despite its stability and effect on the inhibition of apoptosis, arginine GlcNAcylation did not elicit any proteomic changes, even in response to prolonged NleB1 expression. We conclude that, at normal levels of expression during bacterial infection, NleB1/NleB(CR) antagonizes death receptor-induced apoptosis of infected cells by modifying FADD in an irreversible manner.	[Scott, Nichollas E.; Giogha, Cristina; Pollock, Georgina L.; Kennedy, Catherine L.; Pearson, Jaclyn S.; Hartland, Elizabeth L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Scott, NE (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	nichollas.scott@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Hartland, Elizabeth/O-2569-2014	Williamson, Nicholas A/0000-0002-2173-3452; Kennedy, Catherine/0000-0001-6359-6161; Hartland, Elizabeth/0000-0003-4254-2863; Scott, Nichollas/0000-0003-2556-8316; Pearson, Jaclyn/0000-0002-7358-4479; Giogha, Cristina/0000-0002-9075-9840	National Health and Medical Research Council of Australia (NHMRC) [APP1098826, APP1100164]; NHMRC [APP1037373, APP1090108]; University of Melbourne [603107]; Australian postgraduate award; Australian Government Research Training Program scholarship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Australian postgraduate award(Australian Government); Australian Government Research Training Program scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported in part by National Health and Medical Research Council of Australia (NHMRC) Project Grants APP1098826 (to E.L.H.) and APP1100164 (to N.E.S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NHMRC Overseas (Biomedical) Fellowship APP1037373 and University of Melbourne Early Career Researcher Grant Scheme Proposal 603107.; Recipient of an Australian postgraduate award.; Recipient of an Australian Government Research Training Program scholarship.; Supported by NHMRC Early Career Fellowship APP1090108.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Aquino-Gil M, 2017, BIOCHEM SOC T, V45, P365, DOI 10.1042/BST20160404; Blasche S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058937; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen Y, 2009, J PROTEOME RES, V8, P3141, DOI 10.1021/pr900172v; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; El Qaidi S, 2017, J BIOL CHEM, V292, P11423, DOI 10.1074/jbc.M117.790675; Gao XF, 2016, J BIOL CHEM, V291, P18232, DOI 10.1074/jbc.M116.738278; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Hartland EL, 1999, MOL MICROBIOL, V32, P151, DOI 10.1046/j.1365-2958.1999.01338.x; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jochim N, 2014, RAPID COMMUN MASS SP, V28, P1089, DOI 10.1002/rcm.6882; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Law RJ, 2016, J PROTEOME RES, V15, P1613, DOI 10.1021/acs.jproteome.6b00074; LEVINE MM, 1978, LANCET, V1, P1119; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Meijer BM, 2017, J BIOL CHEM, V292, P7784, DOI 10.1074/jbc.M117.775940; Mills E, 2013, MBIO, V4, DOI 10.1128/mBio.00303-13; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mundy R, 2003, MOL MICROBIOL, V48, P795, DOI 10.1046/j.1365-2958.2003.03470.x; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Pallett MA, 2017, MUCOSAL IMMUNOL, V10, P602, DOI 10.1038/mi.2016.77; Pan M, 2014, ANGEW CHEM INT EDIT, V53, P14517, DOI 10.1002/anie.201407824; Pearson JS, 2016, ANNU REV GENET, V50, P493, DOI 10.1146/annurev-genet-120215-035138; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; PEARSON JS, 2017, NAT MICROBIOL, V2; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pollock GL, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01071-16; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott NE, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167067; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Stoehr G, 2013, MOL CELL PROTEOMICS, V12, P1436, DOI 10.1074/mcp.M112.024679; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Valguarnera E, 2016, J MOL BIOL, V428, P3206, DOI 10.1016/j.jmb.2016.04.013; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang SY, 2017, CHEM SCI, V8, P2296, DOI 10.1039/c6sc03847f; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zeiser J, 2013, J PROTEOME RES, V12, P1604, DOI 10.1021/pr300973q; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	61	33	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17337	17350		10.1074/jbc.M117.805036	http://dx.doi.org/10.1074/jbc.M117.805036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860194	Green Published, hybrid			2022-12-28	WOS:000414009300016
J	Kumar, R; Grosbart, M; Nurse, P; Bahng, S; Wyman, CL; Marians, KJ				Kumar, Rupesh; Grosbart, Malgorzata; Nurse, Pearl; Bahng, Soon; Wyman, Claire L.; Marians, Kenneth J.			The bacterial condensin MukB compacts DNA by sequestering supercoils and stabilizing topologically isolated loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromosomes; DNA; DNA structure; DNA topology; nucleic acid enzymology; DNA enzymes; nucleic acids; nucleic acid enzymes	ESCHERICHIA-COLI CHROMOSOME; SEPARATE CELL HALVES; STRUCTURAL MAINTENANCE; CRYSTAL-STRUCTURE; TOPOISOMERASE-IV; HINGE DOMAIN; COMPLEX; PROTEIN; ATP; ORGANIZATION	MukB is a structural maintenance of chromosome-like protein required for DNA condensation. The complete condensin is a large tripartite complex of MukB, the kleisin, MukF, and an accessory protein, MukE. As found previously, MukB DNA condensation is a stepwise process. We have defined these steps topologically. They proceed first via the formation of negative supercoils that are sequestered by the protein followed by hinge-hinge interactions between MukB dimers that stabilize topologically isolated loops in the DNA. MukB itself is sufficient to mediate both of these topological alterations; neither ATP nor MukEF is required. We show that the MukB hinge region binds DNA and that this region of the protein is involved in sequestration of supercoils. Cells carrying mutations in the MukB hinge that reduce DNA condensation in vitro exhibit nucleoid decondensation in vivo.	[Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA; [Grosbart, Malgorzata; Wyman, Claire L.] Erasmus Univ, Med Ctr, Dept Mol Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Wyman, Claire L.] Erasmus Univ, Med Ctr, Dept Radiat Oncol, POB 2040, NL-3000 CA Rotterdam, Netherlands	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health Cancer Center Core Support Grant from NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Berger and Chris Lima for discussion. The Memorial Sloan Kettering Cancer Center was recipient of National Institutes of Health Cancer Center Core Support Grant P30CA008748 from NCI.	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Ku B, 2010, PROTEINS, V78, P1483, DOI 10.1002/prot.22664; Kumar R, 2017, J BIOL CHEM, V292, P16921, DOI 10.1074/jbc.M117.803346; LEHMAN IR, 1974, SCIENCE, V186, P790; Li YY, 2010, J MOL BIOL, V395, P11, DOI 10.1016/j.jmb.2009.10.040; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Michieletto D, 2015, P NATL ACAD SCI USA, V112, pE5471, DOI 10.1073/pnas.1506907112; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Murphy LD, 1997, J STRUCT BIOL, V119, P321, DOI 10.1006/jsbi.1997.3883; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Niki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29469; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Ristic D, 2011, METHODS MOL BIOL, V783, P213, DOI 10.1007/978-1-61779-282-3_12; Rybenkov VV, 2014, J MOL MICROB BIOTECH, V24, P371, DOI 10.1159/000369099; Sanchez H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0457-8; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Sun MX, 2013, NUCLEIC ACIDS RES, V41, P6149, DOI 10.1093/nar/gkt303; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Youngren B, 2014, GENE DEV, V28, P71, DOI 10.1101/gad.231050.113	52	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16904	16920		10.1074/jbc.M117.803312	http://dx.doi.org/10.1074/jbc.M117.803312			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842486	hybrid, Green Published			2022-12-28	WOS:000413140600012
J	Trabjerg, E; Kartberg, F; Christensen, S; Rand, KD				Trabjerg, Esben; Kartberg, Fredrik; Christensen, Soren; Rand, Kasper D.			Conformational characterization of nerve growth factor-beta reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; HYDROGEN-EXCHANGE; NEUROTROPHIN RECEPTOR; N-GLYCOSYLATION; O-GLYCOSYLATION; ELECTROCHEMICAL REDUCTION; CRYSTAL-STRUCTURE; PROTEINS; BINDING	Nerve growth factor-beta (NGF) is essential for the correct development of the nervous system. NGF exists in both a mature form and a pro-form (proNGF). The two forms have opposing effects on neurons: NGF induces proliferation, whereas proNGF induces apoptosis via binding to a receptor complex of the common neurotrophin receptor (p75NTR) and sortilin. The overexpression of both proNGF and sortilin has been associated with several neurodegenerative diseases. Insights into the conformational differences between proNGF and NGF are central to a better understanding of the opposing mechanisms of action of NGF and proNGF on neurons. However, whereas the structure of NGF has been determined by X-ray crystallography, the structural details for proNGF remain elusive. Here, using a sensitive MS-based analytical method to measure the hydrogen/deuterium exchange of proteins in solution, we analyzed the conformational properties of proNGF and NGF. We detected the presence of a localized higher-order structure motif in the pro-part of proNGF. Furthermore, by comparing the hydrogen/deuterium exchange in the mature part of NGF and proNGF, we found that the presence of the pro-part in proNGF causes a structural stabilization of three loop regions in the mature part, possibly through a direct molecular interaction. Moreover, using tandem MS analyses, we identified two N-linked and two O-linked glycosylations in the pro-part of proNGF. These results advance our knowledge of the conformational properties of proNGF and NGF and help provide a rationale for the diverse biological effects of NGF and proNGF at the molecular level.	[Trabjerg, Esben; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen E, Denmark; [Trabjerg, Esben; Kartberg, Fredrik; Christensen, Soren] H Lundbeck & Co AS, Dept Biol, Ottiliavej 9, DK-2500 Valby, Denmark	University of Copenhagen; Lundbeck Corporation	Rand, KD (corresponding author), Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen E, Denmark.	kasper.rand@sund.ku.dk	Rand, Kasper/ABG-7446-2021; Trabjerg, Esben/HCI-4358-2022	Trabjerg, Esben/0000-0002-9883-4956; Christensen, Soren/0000-0003-2500-0085; Rand, Kasper/0000-0002-6337-5489	Innovation Fund Denmark [1355-00165]; Marie Curie Actions Programme of the European Union [PCIG09-GA-2011-294214]; Steno Grant from the Danish Council for Independent Research, Natural Sciences [11-104058]	Innovation Fund Denmark; Marie Curie Actions Programme of the European Union; Steno Grant from the Danish Council for Independent Research, Natural Sciences	This work was supported by Grant 1355-00165 from the Innovation Fund Denmark, Grant PCIG09-GA-2011-294214 from the Marie Curie Actions Programme of the European Union, and Steno Grant 11-104058 from the Danish Council for Independent Research, Natural Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao L, 2014, ANAL BIOCHEM, V452, P96, DOI 10.1016/j.ab.2014.01.003; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Christensen S, 2005, BIOTECHNOL APPL BIOC, V41, P225, DOI 10.1042/BA20040144; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Engen JR, 2015, ANNU REV ANAL CHEM, V8, P127, DOI 10.1146/annurev-anchem-062011-143113; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Geoghegan KF, 2013, PROTEIN EXPRES PURIF, V87, P27, DOI 10.1016/j.pep.2012.09.013; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Guttman M, 2011, ANAL CHEM, V83, P7492, DOI 10.1021/ac201729v; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; Iwase H, 1993, Methods Mol Biol, V14, P151; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jensen PF, 2015, MOL CELL PROTEOMICS, V14, P148, DOI 10.1074/mcp.M114.042044; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kliemannel M, 2004, FEBS LETT, V566, P207, DOI 10.1016/j.febslet.2004.04.034; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kraj A, 2013, ANAL BIOANAL CHEM, V405, P9311, DOI 10.1007/s00216-013-7374-3; Lopez-Llano J, 2006, PROTEINS, V64, P769, DOI 10.1002/prot.21041; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mayampurath AM, 2011, RAPID COMMUN MASS SP, V25, P2007, DOI 10.1002/rcm.5059; McAllister RG, 2015, BIOCHEMISTRY-US, V54, P2683, DOI 10.1021/acs.biochem.5b00215; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Mysling S, 2014, ANAL CHEM, V86, P340, DOI 10.1021/ac403269a; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Paoletti F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022615; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Perez SE, 2015, BIOL PSYCHIAT, V77, P693, DOI 10.1016/j.biopsych.2013.12.016; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Pompach P, 2012, J PROTEOME RES, V11, P1728, DOI 10.1021/pr201183w; Rand KD, 2011, J AM SOC MASS SPECTR, V22, P1784, DOI 10.1007/s13361-011-0196-7; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Sheff JG, 2013, J AM SOC MASS SPECTR, V24, P1006, DOI 10.1007/s13361-013-0639-4; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Trabjerg E, 2015, ANAL CHEM, V87, P8880, DOI 10.1021/acs.analchem.5b01996; Trelle MB, 2014, ACS CHEM BIOL, V9, P174, DOI 10.1021/cb400619v; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; van Maarschalkerweerd A, 2015, Intrinsically Disord Proteins, V3, pe1071302, DOI 10.1080/21690707.2015.1071302; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vestrheim AC, 2013, SCAND J IMMUNOL, V77, P419, DOI 10.1111/sji.12046; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Walters BT, 2012, J AM SOC MASS SPECTR, V23, P2132, DOI 10.1007/s13361-012-0476-x; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	72	14	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16665	16676		10.1074/jbc.M117.803320	http://dx.doi.org/10.1074/jbc.M117.803320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798232	Green Published, hybrid			2022-12-28	WOS:000412414800026
J	Patel, A; Zhang, X; Blumenthal, RM; Cheng, XD				Patel, Anamika; Zhang, Xing; Blumenthal, Robert M.; Cheng, Xiaodong			Structural basis of human PR/SET domain 9 (PRDM9) allele C-specific recognition of its cognate DNA sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ZINC FINGERS; BINDING; METHYLATION; INSTABILITY; EVOLUTION; COMPLEX; EVENTS	PRDM9 is the only mammalian gene that has been associated with speciation. The PR/SET domain 9 (PRDM9) protein is a major determinant of meiotic recombination hot spots and acts through sequence-specific DNA binding via its C2H2 zinc finger (ZF) tandem array, which is highly polymorphic within and between species. The most common human variant, PRDM9 allele A (PRDM9a), contains 13 fingers (ZF1-13). Allele C (PRDM9c) is the second-most common among African populations and differs from PRDM9a by an arginine-to-serine change (R764S) in ZF9 and by replacement of ZF11 with two other fingers, yielding 14 fingers in PRDM9c. Here we co-crystallized the six-finger fragment ZF8-13 of PRDM9c, in complex with an oligonucleotide representing a known PRDM9c-specific hot spot sequence, and compared the structure with that of a characterized PRDM9a-specific complex. There are three major differences. First, Ser(764) in ZF9 allows PRDM9c to accommodate a variable base, whereas PRDM9a Arg(764) recognizes a conserved guanine. Second, the two-finger expansion of ZF11 allows PRDM9c to recognize three-base-pair-longer sequences. A tryptophan in the additional ZF interacts with a conserved thymine methyl group. Third, an Arg-Asp dipeptide immediately preceding the ZF helix, conserved in two PRDM9a fingers and three PRDM9c fingers, permits adaptability to variations from a C:G base pair (G-Arg interaction) to a G: C base pair (C-Asp interaction). This Arg-Asp conformational switch allows identical ZF modules to recognize different sequences. Our findings illuminate the molecular mechanisms for flexible and conserved binding of human PRDM9 alleles to their cognate DNA sequences.	[Patel, Anamika; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Blumenthal, Robert M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, Toledo, OH 43614 USA; [Blumenthal, Robert M.] Univ Toledo, Program Bioinformat, Coll Med & Life Sci, Toledo, OH 43614 USA	Emory University; University of Texas System; UTMD Anderson Cancer Center; University of Toledo; University of Toledo	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	xcheng5@mdanderson.org		Blumenthal, Robert/0000-0002-0873-0724	National Institutes of Health [GM049245-23]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM049245-23 to (X. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker Z, 2017, ELIFE, V6, DOI 10.7554/eLife.24133; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; Davies B, 2016, NATURE, V530, P171, DOI 10.1038/nature16931; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eram MS, 2014, J BIOL CHEM, V289, P12177, DOI 10.1074/jbc.M113.523183; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Hashimoto H, 2017, MOL CELL, V66, P711, DOI 10.1016/j.molcel.2017.05.004; Hashimoto H, 2016, NUCLEIC ACIDS RES, V44, P10177, DOI 10.1093/nar/gkw774; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Jeffreys AJ, 2013, P NATL ACAD SCI USA, V110, P600, DOI 10.1073/pnas.1220813110; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Koh-Stenta X, 2014, BIOCHEM J, V461, P323, DOI 10.1042/BJ20140374; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Patel A, 2016, METHOD ENZYMOL, V573, P387, DOI 10.1016/bs.mie.2016.01.019; Patel A, 2016, GENE DEV, V30, P257, DOI 10.1101/gad.274928.115; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peisach E, 2003, J MOL BIOL, V330, P1, DOI 10.1016/S0022-2836(03)00572-2; Persikov AV, 2015, NUCLEIC ACIDS RES, V43, P1965, DOI 10.1093/nar/gku1395; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Striedner Y, 2017, CHROMOSOME RES, V25, P155, DOI 10.1007/s10577-017-9552-1; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Vanamee ES, 2005, EMBO J, V24, P4198, DOI 10.1038/sj.emboj.7600880; Vandevenne M, 2013, J BIOL CHEM, V288, P10616, DOI 10.1074/jbc.M112.441451; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035	46	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					15994	16002		10.1074/jbc.M117.805754	http://dx.doi.org/10.1074/jbc.M117.805754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28801461	hybrid, Green Published			2022-12-28	WOS:000412109400001
J	Fujii, M; Yoneda, A; Takei, N; Sakai-Sawada, K; Kosaka, M; Minomi, K; Yokoyama, A; Tamura, Y				Fujii, Mizuki; Yoneda, Akihiro; Takei, Norio; Sakai-Sawada, Kaori; Kosaka, Marina; Minomi, Kenjiro; Yokoyama, Atsuro; Tamura, Yasuaki			Endoplasmic reticulum oxidase 1 alpha is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MATRIX-METALLOPROTEINASE; LIVER FIBROSIS; INHIBITS PROLIFERATION; MISFOLDED PROCOLLAGEN; EXTRACELLULAR-MATRIX; MOLECULAR CHAPERONE; SELECTIVE AUTOPHAGY; MAP KINASE; GROWTH	Upon liver injury, excessive deposition of collagen from activated hepatic stellate cells (HSCs) is a leading cause of liver fibrosis. An understanding of the mechanism by which collagen biosynthesis is regulated in HSCs will provide important clues for practical anti-fibrotic therapy. Endoplasmic reticulum oxidase 1 alpha (ERO1 alpha) functions as an oxidative enzyme of protein disulfide isomerase, which forms intramolecular disulfide bonds of membrane and secreted proteins. However, the role of ERO1 alpha in HSCs remains unclear. Here, we show that ERO1 alpha is expressed and mainly localized in the endoplasmic reticulum in human HSCs. When HSCs were transfected with ERO1 alpha siRNA or an ERO1 alpha shRNA-expressing plasmid, expression of ERO1 alpha was completely silenced. Silencing of ERO1 alpha expression in HSCs markedly suppressed their proliferation but did not induce apoptosis, which was accompanied by impaired secretion of collagen type 1. Silencing of ERO1 alpha expression induced impaired disulfide bond formation and inhibited autophagy via activation of the Akt/mammalian target of rapamycin signaling pathway, resulting in intracellular accumulation of collagen type 1 in HSCs. Furthermore, silencing of ERO1 alpha expression also promoted proteasome-dependent degradation of membrane type 1-matrix metalloproteinase (MT1-MMP), which stimulates cell proliferation through cleavage of secreted collagens. The inhibition of HSC proliferation was reversed by treatment with MT1-MMP-cleaved collagen type 1. The results suggest that ERO1 alpha plays a crucial role in HSC proliferation via posttranslational modification of collagen and MT1-MMP and, therefore, may be a suitable therapeutic target for managing liver fibrosis.	[Fujii, Mizuki; Yokoyama, Atsuro] Hokkaido Univ, Grad Sch Dent Med, Div Oral Funct Sci, Dept Oral Funct Prosthodont,Kita Ku, Nishi 7,Kita 13, Sapporo, Hokkaido 0608486, Japan; [Fujii, Mizuki; Yoneda, Akihiro; Takei, Norio; Sakai-Sawada, Kaori; Kosaka, Marina; Minomi, Kenjiro; Tamura, Yasuaki] Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan; [Kosaka, Marina; Minomi, Kenjiro] Nitto Denko Corp, Dept Res & Dev, Nucle Acid Med Business Div, Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; Nitto Denko Corporation	Yoneda, A (corresponding author), Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan.	ayoneda@fmi.hokudai.ac.jp			Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST); Nitto Denko Corporation (Osaka, Japan)	Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Nitto Denko Corporation (Osaka, Japan)	This work was supported in part by grants from the Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Science and Technology Agency (JST). This work was supported in part by Nitto Denko Corporation (Osaka, Japan). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Birukawa NK, 2014, J BIOL CHEM, V289, P20209, DOI 10.1074/jbc.M113.544494; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Caligiuri A, 2008, HEPATOLOGY, V47, P668, DOI 10.1002/hep.21995; Calvente CJ, 2015, HEPATOLOGY, V62, P1285, DOI 10.1002/hep.27936; Carloni V, 2002, HEPATOLOGY, V36, P582, DOI 10.1053/jhep.2002.35277; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao RP, 2004, J HEPATOL, V40, P431, DOI 10.1016/j.jhep.2003.11.012; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Karsdal MA, 2015, AM J PHYSIOL-GASTR L, V308, pG807, DOI 10.1152/ajpgi.00447.2014; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110405; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mehal WZ, 2015, SEMIN LIVER DIS, V35, P184, DOI 10.1055/s-0035-1550055; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wake K, 1980, Int Rev Cytol, V66, P303; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou XY, 2006, J BIOL CHEM, V281, P39757, DOI 10.1074/jbc.M605621200; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	52	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15649	15660		10.1074/jbc.M117.783126	http://dx.doi.org/10.1074/jbc.M117.783126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28774960	hybrid, Green Published			2022-12-28	WOS:000411512200006
J	Myrach, T; Zhu, AT; Witte, CP				Myrach, Till; Zhu, Anting; Witte, Claus-Peter			The assembly of the plant urease activation complex and the essential role of the urease accessory protein G (UreG) in delivery of nickel to urease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI; FUNCTIONAL-ANALYSIS; IN-VIVO; IDENTIFICATION; BINDING; METALLOCHAPERONE; APOPROTEIN; PURIFICATION; ARABIDOPSIS; CHAPERONE	Urease is a ubiquitous nickel metalloenzyme. In plants, its activation requires three urease accessory proteins (UAPs), UreD, UreF, and UreG. In bacteria, the UAPs interact with urease and facilitate activation, which involves the channeling of two nickel ions into the active site. So far this process has not been investigated in eukaryotes. Using affinity pulldowns of Strep-tagged UAPs from Arabidopsis and rice transiently expressed in planta, we demonstrate that a urease-UreD-UreF-UreG complex exists in plants and show its stepwise assembly. UreG is crucial for nickel delivery because UreG-dependent urease activation in vitro was observed only with UreG obtained from nickel-sufficient plants. This activation competence could not be generated in vitro by incubation of UreG with nickel, bicarbonate, and GTP. Compared with their bacterial orthologs, plant UreGs possess an N-terminal extension containing a His-and Asp/Glu-rich hypervariable region followed by a highly conserved sequence comprising two potential HXH metal-binding sites. Complementing the ureG-1 mutant of Arabidopsis with N-terminal deletion variants of UreG demonstrated that the hypervariable region has a minor impact on activation efficiency, whereas the conserved region up to the first HXH motif is highly beneficial and up to the second HXH motif strictly required for activation. We also show that urease reaches its full activity several days after nickel becomes available in the leaves, indicating that urease activation is limited by nickel accessibility in vivo. Our data uncover the crucial role of UreG for nickel delivery during eukaryotic urease activation, inciting further investigations of the details of this process.	[Myrach, Till] Free Univ Berlin, Dahlem Ctr Plant Sci, Dept Plant Biochem, Konigin Luise Str 12-16, D-14195 Berlin, Germany; [Zhu, Anting; Witte, Claus-Peter] Leibniz Univ Hannover, Inst Plant Nutr Mol Nutr & Biochem Plants, Herrenhauser Str 2, D-30419 Hannover, Germany	Free University of Berlin; Leibniz University Hannover	Witte, CP (corresponding author), Leibniz Univ Hannover, Inst Plant Nutr Mol Nutr & Biochem Plants, Herrenhauser Str 2, D-30419 Hannover, Germany.	cpwitte@pflern.uni-hannover.de	Witte, Claus-Peter/L-1676-2017	Witte, Claus-Peter/0000-0002-3617-7807	German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups [57041752]	German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups	This work was supported by the German Academic Exchange Service from funds of the German Federal Ministry for Education and Research, program Modern Applications of Biotechnology-Binational Junior Research Groups (Grant ID 57041752). The authors declare that they have no conflicts of interest with the contents of this article.	Bacanamwo M, 2002, MOL GENET GENOMICS, V268, P525, DOI 10.1007/s00438-002-0769-z; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Boer JL, 2012, BIOCHEMISTRY-US, V51, P2298, DOI 10.1021/bi3000897; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; Cao FQ, 2010, PLANT PHYSIOL, V154, P98, DOI 10.1104/pp.110.160929; Carter EL, 2011, BIOCHEMISTRY-US, V50, P9296, DOI 10.1021/bi2011064; Colpas GJ, 1999, BIOCHEMISTRY-US, V38, P4078, DOI 10.1021/bi982435t; Colpas GJ, 2000, J BIOL CHEM, V275, P10731, DOI 10.1074/jbc.275.15.10731; D'Urzo A, 2014, J BIOL INORG CHEM, V19, P1341, DOI 10.1007/s00775-014-1191-9; Dahncke K, 2013, PLANT CELL, V25, P4101, DOI 10.1105/tpc.113.117184; Farrugia MA, 2015, BIOCHEMISTRY-US, V54, P6392, DOI 10.1021/acs.biochem.5b00942; Farrugia MA, 2013, J AM SOC MASS SPECTR, V24, P1328, DOI 10.1007/s13361-013-0677-y; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Freyermuth SK, 2000, PLANT J, V21, P53, DOI 10.1046/j.1365-313x.2000.00655.x; Glinski M, 2003, RAPID COMMUN MASS SP, V17, P1579, DOI 10.1002/rcm.1093; Goldraij A, 1999, PLANT PHYSIOL, V119, P297, DOI 10.1104/pp.119.1.297; Hauck OK, 2014, PLANT CELL, V26, P3090, DOI 10.1105/tpc.114.124008; LEE MH, 1992, J BACTERIOL, V174, P4324, DOI 10.1128/JB.174.13.4324-4330.1992; Liu GW, 2015, PLANTA, V241, P861, DOI 10.1007/s00425-014-2219-7; Liu LH, 2003, PLANT CELL, V15, P790, DOI 10.1105/tpc.007120; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Soriano A, 2000, BIOCHEMISTRY-US, V39, P12435, DOI 10.1021/bi001296o; Wang WH, 2012, NEW PHYTOL, V193, P432, DOI 10.1111/j.1469-8137.2011.03929.x; Werner AK, 2008, PLANT PHYSIOL, V146, P418, DOI 10.1104/pp.107.110809; Witte CP, 2005, PLANT PHYSIOL, V139, P1155, DOI 10.1104/pp.105.070292; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Witte CP, 2001, PLANT MOL BIOL, V45, P169, DOI 10.1023/A:1006429315851; Witte CP, 2001, ANAL BIOCHEM, V290, P102, DOI 10.1006/abio.2000.4933; Yang XM, 2015, J BIOL CHEM, V290, P12474, DOI 10.1074/jbc.M114.632364; Yang XM, 2014, METALLOMICS, V6, P1731, DOI 10.1039/c4mt00134f; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zambelli B, 2013, J BIOL INORG CHEM, V18, P1005, DOI 10.1007/s00775-013-1049-6; Zanin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0222-6	43	21	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14556	14565		10.1074/jbc.M117.780403	http://dx.doi.org/10.1074/jbc.M117.780403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710280	Green Published, hybrid			2022-12-28	WOS:000408747500021
J	Manhardt, CT; Punch, PR; Dougher, CWL; Lau, JTY				Manhardt, Charles T.; Punch, Patrick R.; Dougher, Christopher W. L.; Lau, Joseph T. Y.			Extrinsic sialylation is dynamically regulated by systemic triggers in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECTO-SIALYLTRANSFERASE; INFLAMMATION; SURFACE; PLATELETS; GLYCOSYLTRANSFERASES; DEFICIENCY; INJURY; BLOOD; CELLS; MICE	Recent reports have documented that extracellular sialyltransferases can remodel both cell-surface and secreted glycans by a process other than the canonical cell-autonomous glycosylation that occurs within the intracellular secretory apparatus. Despite association of the abundance of these extracellular sialyltransferases, particularly ST6Gal-1, with disease states such as cancer and a variety of inflammatory conditions, the prevalence of this extrinsic glycosylation pathway in vivo remains unknown. Here we observed no significant extrinsic sialylation in resting mice, suggesting that extrinsic sialylation is not a constitutive process. However, extrinsic sialylation in the periphery could be triggered by inflammatory challenges, such as exposure to ionizing radiation or to bacterial lipopolysaccharides. Sialic acids from circulating platelets were used in vivo to remodel target cell surfaces. Platelet activation was minimally sufficient to elicit extrinsic sialylation, as demonstrated with the FeCl3 model of mesenteric artery thrombosis. Although extracellular ST6Gal-1 supports extrinsic sialylation, other sialyltransferases are present in systemic circulation. We also observed in vivo extrinsic sialylation in animals deficient in ST6Gal-1, demonstrating that extrinsic sialylation is not mediated exclusively by ST6Gal-1. Together, these observations form an emerging picture of glycans biosynthesized by the canonical cell-autonomous glycosylation pathway, but subjected to remodeling by extracellular glycan-modifying enzymes.	[Manhardt, Charles T.; Punch, Patrick R.; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Dougher, Christopher W. L.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Institutes of Health NCI Cancer Center Support Grant [CA076056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI140736, R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The core facilities of Roswell Park Cancer Institute used in this work were supported in part by National Institutes of Health NCI Cancer Center Support Grant CA076056. The expert technical assistance of Valerie Andersen and Joseph Hassett is gratefully acknowledged. We also thank Dr. Himangi Marathe for help in flow cytometry.	Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Dougher CWL, 2017, J LEUKOCYTE BIOL, V102, P507, DOI 10.1189/jlb.3A1216-538RR; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gros A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00678; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; HATHAWAY HJ, 1992, J CELL BIOL, V117, P369, DOI 10.1083/jcb.117.2.369; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; JAMIESON JC, 1993, COMP BIOCHEM PHYS B, V105, P29, DOI 10.1016/0305-0491(93)90165-2; Jones MB, 2016, P NATL ACAD SCI USA, V113, P7207, DOI 10.1073/pnas.1523968113; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Jones MB, 2010, J BIOL CHEM, V285, P25009, DOI 10.1074/jbc.M110.104406; KORCZAK B, 1993, INT J CANCER, V53, P634, DOI 10.1002/ijc.2910530418; Lee MM, 2014, J BIOL CHEM, V289, P8742, DOI 10.1074/jbc.C113.546713; Lee-Sundlov MM, 2017, GLYCOBIOLOGY, V27, P188, DOI 10.1093/glycob/cww108; Li W, 2013, REDOX BIOL, V1, P50, DOI 10.1016/j.redox.2012.11.001; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; MATSUI Y, 1983, BIOCHEM BIOPH RES CO, V113, P446, DOI 10.1016/0006-291X(83)91746-1; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2014, J BIOL CHEM, V289, P7178, DOI 10.1074/jbc.M113.508457; Neeves KB, 2015, BLOOD, V126, P700, DOI 10.1182/blood-2015-05-644708; PATT LM, 1975, BIOCHEM BIOPH RES CO, V67, P483, DOI 10.1016/0006-291X(75)90341-1; PORTER CW, 1975, NATURE, V256, P648, DOI 10.1038/256648a0; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; ROTH S, 1971, J CELL BIOL, V51, P536, DOI 10.1083/jcb.51.2.536; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schwartz-Albiez R, 2004, GLYCOCONJUGATE J, V21, P451, DOI 10.1007/s10719-004-5535-5; SHUR B D, 1991, Glycobiology, V1, P563, DOI 10.1093/glycob/1.6.563; Silva M, 2016, ONCOTARGET, V7, P41053, DOI 10.18632/oncotarget.9419; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Yuan L, 2015, MOL MED REP, V11, P2449, DOI 10.3892/mmr.2014.3082; Zhao YF, 2014, MOL CELL PROTEOMICS, V13, P520, DOI 10.1074/mcp.M113.034025; Zhong WT, 2014, INFLAMMATION, V37, P1148, DOI 10.1007/s10753-014-9839-8	37	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13514	13520		10.1074/jbc.C117.795138	http://dx.doi.org/10.1074/jbc.C117.795138			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28717006	hybrid, Green Published			2022-12-28	WOS:000407942400017
J	Kig, C; Beullens, M; Beke, L; Van Eynde, A; Linders, JT; Brehmer, D; Bollen, M				Kig, Cenk; Beullens, Monique; Beke, Lijs; Van Eynde, Aleyde; Linders, Johannes T.; Brehmer, Dirk; Bollen, Mathieu			RETRACTION: Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells (Retraction of Vol 288, Pg 24200, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Kig C, 2013, J BIOL CHEM, V288, P24200, DOI 10.1074/jbc.M113.471433	1	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12786	12786		10.1074/jbc.A113.471433	http://dx.doi.org/10.1074/jbc.A113.471433			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28778883	Green Published, hybrid			2022-12-28	WOS:000407220100010
J	Atkin, JD; Farg, MA; Turner, BJ; Tomas, D; Lysaght, JA; Nunan, J; Rembach, A; Nagley, P; Beart, PM; Cheema, SS; Horne, MK				Atkin, Julie D.; Farg, Manal A.; Turner, Bradley J.; Tomas, Doris; Lysaght, Judith A.; Nunan, Janelle; Rembach, Alan; Nagley, Phillip; Beart, Philip M.; Cheema, Surindar S.; Horne, Malcolm K.			RETRACTION: Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. (Retraction of Vol 281, Pg 30152, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Horne, Malcolm/AAL-5214-2020	Horne, Malcolm/0000-0001-9427-2100				Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200	1	3	3	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					12007	12007		10.1074/jbc.A117.603393	http://dx.doi.org/10.1074/jbc.A117.603393			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28710340	Green Published, hybrid			2022-12-28	WOS:000405485600035
J	Srivastava, S; Savanur, MA; Sinha, D; Birje, A; Vigneshwaran, R; Saha, PP; D'Silva, P				Srivastava, Shubhi; Savanur, Mohammad Azharuddin; Sinha, Devanjan; Birje, Abhijit; Vigneshwaran, R.; Saha, Prasenjit Prasad; D'Silva, Patrick			Regulation of mitochondrial protein import by the nucleotide exchange factors GrpEL1 and GrpEL2 in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); cell culture; mitochondria; mitochondrial transport; protein import; protein translocation; yeast; nucleotide exchange factor; mitochondrial Hsp70	HSP70 CHAPERONES; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; MATRIX HSP70; TRANSLOCATION; EXISTENCE; MECHANISM; INTERACTS; HOMOLOG; MTHSP70	Mitochondria are organelles indispensable for maintenance of cellular energy homeostasis. Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. The affinity of mtHsp70 for its protein clients and its chaperone function are regulated by binding of ATP/ADP to mtHsp70's nucleotide-binding domain. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. A single NEF, Mge1, regulates mtHsp70's chaperone activity in lower eukaryotes, but the mammalian orthologs are unknown. Here, we report that two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, modulate mtHsp70's function in human cells. We found that both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters. Our results also suggested that GrpEL2 has evolved as a possible stress resistance protein in higher vertebrates to maintain chaperone activity under stress conditions. In conclusion, our findings support the idea that GrpEL1 has a role as a stress modulator in mammalian cells and highlight that multiple NEFs are involved in controlling protein quality in mammalian mitochondria.	[Srivastava, Shubhi; Savanur, Mohammad Azharuddin; Sinha, Devanjan; Birje, Abhijit; Vigneshwaran, R.; Saha, Prasenjit Prasad; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India; [Sinha, Devanjan] Banaras Hindu Univ, Inst Sci, Dept Zool, Varanasi 221005, Uttar Pradesh, India; [Saha, Prasenjit Prasad] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Indian Institute of Science (IISC) - Bangalore; Banaras Hindu University (BHU); Cleveland Clinic Foundation	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@iisc.ac.in	Sinha, Devanjan/A-3953-2017; Saha, Prasenjit/ABC-6481-2020; D'Silva, Patrick/L-6653-2019; Srivastava, Shubhi/C-7048-2018	Sinha, Devanjan/0000-0001-5060-2075; Srivastava, Shubhi/0000-0001-9922-1943; Saha, Prasenjit/0000-0003-4679-2368	Department of Science and Technology (DST) [DST/SJF/LS-01/2011-2012]; Lady Tata Memorial Trust Young Researcher Award; Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant [DBT/BF/PR/INS/2011-12/IISc]; DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program [SR/FST/LSII-023/2009]; University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC [LT. F. 5-2/2012.SAP-II]; DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship; Council of Scientific and Industrial Research fellowship; UGC-D. S. Kothari postdoctoral fellowship	Department of Science and Technology (DST)(Department of Science & Technology (India)); Lady Tata Memorial Trust Young Researcher Award; Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant; DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program; University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC; DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship; Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); UGC-D. S. Kothari postdoctoral fellowship	This work was supported by Department of Science and Technology (DST) Swarnajayanti Fellowship DST/SJF/LS-01/2011-2012, a Lady Tata Memorial Trust Young Researcher Award, Department of Biochemistry-Indian Institute of Science (DBT-IISc) Partnership Program Grant DBT/BF/PR/INS/2011-12/IISc, DST-Fund for Improvement of Science and Technology Infrastructure (FIST) Program Grant SR/FST/LSII-023/2009, and University Grants Commission (UGC)-Centre of Advanced Study (CAS) Special Assistance Programme (SAP)-II program Grant UGC LT. F. 5-2/2012.SAP-II) (to P. D.); a DST-Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship (to S. S.); a Council of Scientific and Industrial Research fellowship (to P. P. S. and A. B.); and a UGC-D. S. Kothari postdoctoral fellowship (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Copley SD, 2014, BIOCHEM SOC T, V42, P1684, DOI 10.1042/BST20140245; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Fernandez-Cabezudo MJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86873; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Hoogenraad NJ, 2001, IUBMB LIFE, V51, P345; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Marada A, 2013, MOL BIOL CELL, V24, P692, DOI 10.1091/mbc.E12-10-0719; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Naylor DJ, 1998, J BIOL CHEM, V273, P21169, DOI 10.1074/jbc.273.33.21169; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Schusdziarra C, 2013, HUM MOL GENET, V22, P1348, DOI 10.1093/hmg/dds541; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; SEPTINUS M, 1983, HISTOCHEMISTRY, V79, P443, DOI 10.1007/BF00491779; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Sinha D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.72; Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x	52	20	21	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18075	18090		10.1074/jbc.M117.788463	http://dx.doi.org/10.1074/jbc.M117.788463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28848044	Green Published, hybrid			2022-12-28	WOS:000414458200008
J	Cooney, KA; Molden, BM; Kowalczyk, NS; Russell, S; Baldini, G				Cooney, Kimberly A.; Molden, Brent M.; Kowalczyk, Nicholas S.; Russell, Susan; Baldini, Giulia			Lipid stress inhibits endocytosis of melanocortin-4 receptor from modified clathrin-enriched sites and impairs receptor desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MODERATE-FAT DIET; HYPOTHALAMIC NEURONS; INSULIN-RESISTANCE; LEPTIN RESISTANCE; LATE ENDOSOMES; CELLS; MC4R; AGONIST; DYNAMIN	Melanocortin-4 receptor (MC4R) is a G-protein-coupled receptor expressed in the brain's hypothalamus where it regulates energy homeostasis. MC4R agonists function to lower food intake and weight. In this respect, although obesity promotes hyperlipidemia and hypothalamic injury, MC4R agonists are nevertheless more effective to reduce food intake within hours of administration in overweight, rather than lean, mice. MC4R undergoes constitutive internalization and recycling to the plasma membrane with agonist binding inducing receptor retention along the intracellular route and, under prolonged exposure, desensitization. Here, we found that, in neuronal cells, lipid stress by exposure to elevated palmitate leaves unchanged the rate by which MC4R and transferrin receptor are constitutively excluded from the cell surface. However, lipid stress disrupted later steps of MC4R and transferrin receptor internalization to endosomes as well as traffic of agonist-occupied MC4R to lysosomes and MC4R desensitization. In the lipid-stressed cells, MC4R and clathrin were redistributed to the plasma membrane where they colocalized to sites that appeared by super-resolution microscopy to be modified and to have higher clathrin content than those of cells not exposed to elevated palmitate. The data suggest that lipid stress disrupts steps of endocytosis following MC4R localization to clathrin-coated sites and exclusion of the receptor from the extracellular medium. We conclude that increased effectiveness of MC4R agonists in obesity may be an unexpected outcome of neuronal injury with disrupted clathrin-dependent endocytosis and impaired receptor desensitization.	[Cooney, Kimberly A.; Molden, Brent M.; Kowalczyk, Nicholas S.; Russell, Susan; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	gbaldini@uams.edu			National Institutes of Health [R01-DK102206, F30 DK095569, UL1TR000039]; University of Arkansas for Medical Sciences College of Medicine Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095569, R01DK102206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083247] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences College of Medicine Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01-DK102206 (to G. B.), F30 DK095569 (to B. M. M.), and UL1TR000039 and by intramural funding support from the University of Arkansas for Medical Sciences College of Medicine Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2016, CELL REP, V17, P2966, DOI 10.1016/j.celrep.2016.11.050; ALVAREZ E, 1989, EMBO J, V8, P2231, DOI 10.1002/j.1460-2075.1989.tb08347.x; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bluher S, 2004, DIABETES, V53, P82, DOI 10.2337/diabetes.53.1.82; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Cao H, 2000, J CELL SCI, V113, P1993; Chazotte B., 2011, COLD SPRING HARB PRO; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Clegg DJ, 2005, AM J PHYSIOL-REG I, V288, pR981, DOI 10.1152/ajpregu.00675.2004; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cragle FK, 2014, MOL ENDOCRINOL, V28, P357, DOI 10.1210/me.2013-1357; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Granell S, 2013, P NATL ACAD SCI USA, V110, pE4733, DOI 10.1073/pnas.1219808110; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Irani BG, 2007, ENDOCRINOLOGY, V148, P310, DOI 10.1210/en.2006-1126; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kim GL, 2010, ENDOCRINOLOGY, V151, P5038, DOI 10.1210/en.2010-0521; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McDaniel FK, 2012, J BIOL CHEM, V287, P21873, DOI 10.1074/jbc.M112.346890; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Molden BM, 2015, MOL ENDOCRINOL, V29, P1619, DOI 10.1210/me.2015-1071; MULLER WA, 1983, J CELL BIOL, V96, P29, DOI 10.1083/jcb.96.1.29; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Zhang JH, 2010, CELL RES, V20, P492, DOI 10.1038/cr.2010.33	44	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17731	17745		10.1074/jbc.M117.785758	http://dx.doi.org/10.1074/jbc.M117.785758			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28878020	Green Published, hybrid			2022-12-28	WOS:000414013000013
J	Seo, HD; Choi, Y; Kim, M; Kang, K; Urano, T; Lee, D				Seo, Hogyu David; Choi, Yoonjung; Kim, Minhoo; Kang, Keunsoo; Urano, Takeshi; Lee, Daeyoup			The 19S proteasome is directly involved in the regulation of heterochromatin spreading in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; epigenetics; heterochromatin; proteasome; RNA interference (RNAi); 19S RP; Epe1; RNAi; heterochromatin spreading; non-proteolytic function	JMJC DOMAIN PROTEIN; 26S PROTEASOME; HISTONE TURNOVER; S-PHASE; TRANSCRIPTION; RNAI; CHROMATIN; PARTICLE; LOCALIZATION; SUBUNIT	Cumulative evidence suggests that non-proteolytic functions of the proteasome are involved in transcriptional regulation, mRNA export, and ubiquitin-dependent histone modification and thereby modulate the intracellular levels of regulatory proteins implicated in controlling key cellular functions. To date, the non-proteolytic roles of the proteasome have been mainly investigated in euchromatin; their effects on heterochromatin are largely unknown. Here, using fission yeast as a model, we randomly mutagenized the subunits of the 19S proteasome subcomplex and sought to uncover a direct role of the proteasome in heterochromatin regulation. We identified a mutant allele, rpt4-1, that disrupts a non-proteolytic function of the proteasome, also known as a non-proteolytic allele. Experiments performed using rpt4-1 cells revealed that the proteasome is involved in the regulation of heterochromatin spreading to prevent its uncontrolled invasion into neighboring euchromatin regions. Intriguingly, the phenotype of the non-proteolytic rpt4-1 mutant resembled that of epe1 cells, which lack the Epe1 protein that counteracts heterochromatin spreading. Both mutants exhibited variegated gene-silencing phenotypes across yeast colonies, spreading of heterochromatin, bypassing of the requirement for RNAi in heterochromatin formation at the outer repeat region (otr), and up-regulation of RNA polymerase II. Further analysis revealed Mst2, another factor that antagonizes heterochromatin spreading, may function redundantly with Rpt4. These observations suggest that the 19S proteasome may be involved in modulating the activities of Epe1 and Mst2. In conclusion, our findings indicate that the proteasome appears to have a heterochromatin-regulating function that is independent of its canonical function in proteolysis.	[Seo, Hogyu David; Choi, Yoonjung; Kim, Minhoo; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Kang, Keunsoo] Dankook Univ, Dept Microbiol, Cheonan 31116, Chungnam, South Korea; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6908504, Japan	Korea Advanced Institute of Science & Technology (KAIST); Dankook University; Shimane University	Lee, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.	daeyoup@kaist.ac.kr	Seo, Hogyu David/AAC-7382-2021; Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Research Foundation of Korea [2016R1A2B2006354]; KAIST Future Systems Healthcare Project - Ministry of Science, ICT, and Future Planning; Grants-in-Aid for Scientific Research [17K08983] Funding Source: KAKEN	National Research Foundation of Korea(National Research Foundation of Korea); KAIST Future Systems Healthcare Project - Ministry of Science, ICT, and Future Planning; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Mid-career Researcher Program through the National Research Foundation of Korea Grants 2016R1A2B2006354 and the KAIST Future Systems Healthcare Project funded by the Ministry of Science, ICT, and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	Aygun O, 2013, NAT STRUCT MOL BIOL, V20, P547, DOI 10.1038/nsmb.2565; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Barrales RR, 2016, GENE DEV, V30, P133, DOI 10.1101/gad.271288.115; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; EKWALL K, 1994, GENETICS, V136, P53; Ekwall K, 1999, GENETICS, V153, P1153; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Flury V, 2017, MOL CELL, V67, P294, DOI 10.1016/j.molcel.2017.05.026; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Javerzat JP, 1999, MOL CELL BIOL, V19, P5155; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kitagawa T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4597; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Kwak J, 2011, BBA-GENE REGUL MECH, V1809, P88, DOI 10.1016/j.bbagrm.2010.08.001; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee JE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02403-5; Lim S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3641; Maganti N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091200; McCann TS, 2014, BIOMOLECULES, V4, P1026, DOI 10.3390/biom4041026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sadeghi L, 2015, EMBO REP, V16, P1673, DOI 10.15252/embr.201541214; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shim YS, 2012, EMBO J, V31, P4375, DOI 10.1038/emboj.2012.267; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; THON G, 1994, GENETICS, V138, P29; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Wang J., 2015, ELIFE, V015, P4; Wang JY, 2013, GENE DEV, V27, P1886, DOI 10.1101/gad.221010.113; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	60	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17144	17155		10.1074/jbc.M117.790824	http://dx.doi.org/10.1074/jbc.M117.790824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28784663	Green Published, hybrid			2022-12-28	WOS:000413140600033
J	Song, K; Fu, JX; Song, JH; Herzog, BH; Bergstrom, K; Kondo, Y; McDaniel, JM; McGee, S; Silasi-Mansat, R; Lupu, F; Chen, H; Bagavant, H; Xia, LJ				Song, Kai; Fu, Jianxin; Song, Jianhua; Herzog, Brett H.; Bergstrom, Kirk; Kondo, Yuji; McDaniel, J. Michael; McGee, Samuel; Silasi-Mansat, Robert; Lupu, Florea; Chen, Hong; Bagavant, Harini; Xia, Lijun			Loss of mucin-type O-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR SIALOPROTEIN; EPITHELIAL-CELL; MDCK CELLS; PODOCYTE; PODOCALYXIN; MICE; PODOPLANIN; POLARIZATION; SIALYLATION; EXPRESSION	The kidney's filtration activity is essential for removing toxins and waste products from the body. The vascular endothelial cells of the glomerulus are fenestrated, flattened, and surrounded by podocytes, specialized cells that support glomerular endothelial cells. Mucin-type core 1-derived O-glycans (O-glycans) are highly expressed on both glomerular capillary endothelial cells and their supporting podocytes, but their biological role is unclear. Biosynthesis of core 1-derived O-glycans is catalyzed by the glycosyltransferase core 1 beta 1,3-galactosyltransferase (C1galt1). Here we report that neonatal or adult mice with inducible deletion of C1galt1 (iC1galt1(-/-)) exhibit spontaneous proteinuria and rapidly progressing glomerulosclerosis. Ultrastructural analysis of the glomerular filtration barrier components revealed that loss of O-glycans results in altered podocyte foot processes. Further analysis indicated that O-glycan is essential for the normal signaling function of podocalyxin, a podocyte foot process-associated glycoprotein. Our results reveal a new function of O-glycosylation in the integrity of the glomerular filtration barrier.	[Song, Kai; Fu, Jianxin; Song, Jianhua; Herzog, Brett H.; Bergstrom, Kirk; Kondo, Yuji; McDaniel, J. Michael; McGee, Samuel; Silasi-Mansat, Robert; Lupu, Florea; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Song, Kai; Chen, Hong] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Bagavant, Harini] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Xia, Lijun] Soochow Univ, Key Lab Thrombosis & Hemostasis, Collaborat Innovat Ctr Hematol, Jiangsu Inst Hematol,Minist Hlth,Affiliated Hosp, Suzhou 215006, Jiangsu, Peoples R China; [Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Mol Biol & Biochem, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Harvard University; Boston Children's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; Soochow University - China; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xia, LJ (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	lijun-xia@omrf.org	Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009; Bagavant, Harini/V-7735-2019; Bergstrom, Kirk/AAZ-8856-2021	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Silasi, Robert/0000-0001-9590-6160; Fu, Jianxin/0000-0002-3067-8539	National Institutes of Health [GM114731, HL128390, HD083418, DK085691, HL093242, HL118676]; National Natural Science Foundation of China [81520108005, 81470825, 81370617]; Jiangsu Province Key Medical Center Grant [ZX201102]; Scientist Development Grants from the American Heart Association [11SDG7410022, 17SDG33630161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083418] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093242, R01HL128390, R01HL118676, R01HL133216, R01HL137229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Key Medical Center Grant; Scientist Development Grants from the American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM114731, HL128390, HD083418, DK085691, HL093242, and HL118676; National Natural Science Foundation of China Grants 81520108005, 81470825, and 81370617; Jiangsu Province Key Medical Center Grant ZX201102; and Scientist Development Grants from the American Heart Association 11SDG7410022 (to J. F.) and 17SDG33630161 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Chang BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7380; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Liu ZH, 2014, CONTRIB NEPHROL, V183, P1; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Matsui K, 1999, NEPHROL DIAL TRANSPL, V14, P9, DOI 10.1093/ndt/14.suppl_1.9; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tian X, 2014, J CLIN INVEST, V124, P1098, DOI 10.1172/JCI69778; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P1, DOI [10.1101/9781621824213, DOI 10.1101/9781621824213]; Wang JR, 2010, GENESIS, V48, P446, DOI 10.1002/dvg.20635; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yang ZF, 2016, DEV BIOL, V418, P66, DOI 10.1016/j.ydbio.2016.08.009; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629	33	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16491	16497		10.1074/jbc.M117.798512	http://dx.doi.org/10.1074/jbc.M117.798512			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842487	hybrid, Green Published			2022-12-28	WOS:000412414800007
J	Brasher, MI; Martynowicz, DM; Grafinger, OR; Hucik, A; Shanks-Skinner, E; Uniacke, J; Coppolino, MG				Brasher, Megan I.; Martynowicz, David M.; Grafinger, Olivia R.; Hucik, Andrea; Shanks-Skinner, Emma; Uniacke, James; Coppolino, Marc G.			Interaction of Munc18c and syntaxin4 facilitates invadopodium formation and extracellular matrix invasion of tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT4 TRANSLOCATION; MEMBRANE-FUSION; PLASMA-MEMBRANE; SM PROTEIN; SNARE; TRAFFICKING; MIGRATION; VAMP3; METALLOPROTEINASE; INVOLVEMENT	Tumor cell invasion involves targeted localization of proteins required for interactions with the extracellular matrix and for proteolysis. The localization of many proteins during these cell-extracellular matrix interactions relies on membrane trafficking mediated in part by SNAREs. The SNARE protein syntaxin4 (Stx4) is involved in the formation of invasive structures called invadopodia; however, it is unclear how Stx4 function is regulated during tumor cell invasion. Munc18c is known to regulate Stx4 activity, and here we show that Munc18c is required for Stx4-mediated invadopodium formation and cell invasion. Biochemical and microscopic analyses revealed a physical association between Munc18c and Stx4, which was enhanced during invadopodium formation, and that a reduction in Munc18c expression decreases invadopodium formation. We also found that an N-terminal Stx4-derived peptide associates with Munc18c and inhibits endogenous interactions of Stx4 with synaptosome-associated protein 23 (SNAP23) and vesicle-associated membrane protein 2 (VAMP2). Furthermore, expression of the Stx4 N-terminal peptide decreased invadopodium formation and cell invasion in vitro. Of note, cells expressing the Stx4 N-terminal peptide exhibited impaired trafficking of membrane type 1 matrix metalloproteinase (MT1-MMP) and EGF receptor (EGFR) to the cell surface during invadopodium formation. Our findings implicate Munc18c as a regulator of Stx4-mediated trafficking of MT1-MMP and EGFR, advancing our understanding of the role of SNARE function in the localization of proteins that drive tumor cell invasion.	[Brasher, Megan I.; Martynowicz, David M.; Grafinger, Olivia R.; Hucik, Andrea; Shanks-Skinner, Emma; Uniacke, James; Coppolino, Marc G.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Coppolino, MG (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mcoppoli@uoguelph.ca		Grafinger, Olivia/0000-0001-8082-1594	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Artym VV, 2015, J CELL BIOL, V208, P331, DOI 10.1083/jcb.201405099; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; Gurung P., 2016, BRIT J HAEMATOL, V21, P193; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoover H, 2005, METHOD ENZYMOL, V404, P134, DOI 10.1016/S0076-6879(05)04014-0; Jewell J., 2010, AM J PHYSIOL-REG I, V298, P517; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lohmer LL, 2014, CELL ADHES MIGR, V8, P246, DOI 10.4161/cam.28406; Miyata T, 2004, BIOCHEM BIOPH RES CO, V323, P118, DOI 10.1016/j.bbrc.2004.08.064; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tolde O, 2010, EUR J CELL BIOL, V89, P674, DOI 10.1016/j.ejcb.2010.04.003; Veale KJ, 2011, EXP CELL RES, V317, P1817, DOI 10.1016/j.yexcr.2011.04.016; Williams KC, 2014, MOL BIOL CELL, V25, P2061, DOI 10.1091/mbc.E13-10-0582; Williams KC, 2014, J CELL SCI, V127, P1712, DOI 10.1242/jcs.134734; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004	38	14	15	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16199	16210		10.1074/jbc.M117.807438	http://dx.doi.org/10.1074/jbc.M117.807438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798239	hybrid, Green Published			2022-12-28	WOS:000412109400019
J	Esaki, S; Evich, MG; Erlitzki, N; Germann, MW; Poon, GMK				Esaki, Shingo; Evich, Marina G.; Erlitzki, Noa; Germann, Markus W.; Poon, Gregory M. K.			Multiple DNA-binding modes for the ETS family transcription factor PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; COOPERATIVE INTERACTIONS; SITE RECOGNITION; DOMAIN; PROTEIN; AUTOINHIBITION; DIMERIZATION; GATA-1; DIFFERENTIATION; DISCRIMINATION	The eponymous DNA-binding domain of ETS (E26 transformation-specific) transcription factors binds a single sequence-specific site as a monomer over a single helical turn. Following our previous observation by titration calorimetry that the ETS member PU.1 dimerizes sequentially at a single sequence-specific DNA-binding site to form a 2:1 complex, we have carried out an extensive spectroscopic and biochemical characterization of site-specific PU.1 ETS complexes. Whereas 10 bp ofDNA was sufficient to support PU.1 binding as a monomer, additional flanking bases were required to invoke sequential dimerization of the bound protein. NMRspectroscopy revealed a marked loss of signal intensity in the 2:1 complex, and mutational analysis implicated the distal surface away from the bound DNA as the dimerization interface. Hydroxyl radical DNA footprinting indicated that the site-specifically bound PU.1 dimers occupied an extended DNA interface downstream from the 5'-GGAA-3' core consensus relative to its 1:1 counterpart, thus explaining the apparent site size requirement for sequential dimerization. The site-specifically bound PU.1 dimer resisted competition from nonspecific DNA and showed affinities similar to other functionally significant PU.1 interactions. As sequential dimerization did not occur with the ETS domain of Ets-1, a close structural homolog of PU.1, 2:1 complex formation may represent an alternative autoinhibitory mechanism in the ETS family at the protein-DNA level.	[Esaki, Shingo; Evich, Marina G.; Erlitzki, Noa; Germann, Markus W.; Poon, Gregory M. K.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Germann, Markus W.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Poon, Gregory M. K.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Esaki, Shingo] Georgia State Univ, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Germann, MW; Poon, GMK (corresponding author), POB 3965, Atlanta, GA 30302 USA.	mwg@gsu.edu; gpoon@gsu.edu	Evich, Marina/AAB-5434-2020	Evich, Marina/0000-0002-2386-0682; Germann, Markus/0000-0002-1674-8166; Erlitzki, Noa/0000-0002-4126-522X	National Science Foundation [MCB 15451600]; National Institutes of Health [R21 HL129063]; Georgia State University Brains and Behavior Fellowship; Barry Goldwater Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM109442] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University Brains and Behavior Fellowship; Barry Goldwater Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 15451600 and National Institutes of Health Grant R21 HL129063 (to G. M. K. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Georgia State University Brains and Behavior Fellowship.; Supported by a 2017 Barry Goldwater Scholarship.	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; BAINS G, 1991, ANAL BIOCHEM, V192, P203, DOI 10.1016/0003-2697(91)90207-A; Cann JR, 1996, ANAL BIOCHEM, V237, P1, DOI 10.1006/abio.1996.0193; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dozmorov MG, 2014, EPIGENETICS-US, V9, P276, DOI 10.4161/epi.27021; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Gross P, 1998, BIOCHEMISTRY-US, V37, P9802, DOI 10.1021/bi9731448; Gross P, 1998, BIOCHEMISTRY-US, V37, P5129, DOI 10.1021/bi972591k; He GF, 2015, NUCLEIC ACIDS RES, V43, P4322, DOI 10.1093/nar/gkv267; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hou CX, 2015, BIOCHEMISTRY-US, V54, P7365, DOI 10.1021/acs.biochem.5b01121; Imoto A, 2010, J BIOL CHEM, V285, P10300, DOI 10.1074/jbc.M109.095810; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; JIN LH, 1993, BIOCHEMISTRY-US, V32, P7302, DOI 10.1021/bi00079a029; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mimeault M, 2000, CRIT REV ONCOGENESIS, V11, P227; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; PIO F, 1995, J BIOL CHEM, V270, P24258, DOI 10.1074/jbc.270.41.24258; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2017, TRANSCR-AUSTIN, V8, P193, DOI 10.1080/21541264.2017.1302901; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Poon GMK, 2010, ANAL BIOCHEM, V400, P229, DOI 10.1016/j.ab.2010.01.025; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Samorodnitsky D, 2015, J BIOL CHEM, V290, P22101, DOI 10.1074/jbc.M115.671339; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Stephens DC, 2016, NUCLEIC ACIDS RES, V44, P4005, DOI 10.1093/nar/gkw229; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; Wang S, 2014, J BIOL CHEM, V289, P21605, DOI 10.1074/jbc.M114.575340; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Xhani S, 2017, J PHYS CHEM B, V121, P2748, DOI 10.1021/acs.jpcb.7b00325; Xu ZQ, 2014, SCI WORLD J, DOI [10.1155/2014/915740, 10.1155/2014/707294]	48	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16044	16054		10.1074/jbc.M117.798207	http://dx.doi.org/10.1074/jbc.M117.798207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28790174	Green Published, hybrid			2022-12-28	WOS:000412109400006
J	Gray, NE; Lam, LN; Yang, K; Zhou, AY; Koliwad, S; Wang, JC				Gray, Nora E.; Lam, Lily N.; Yang, Karen; Zhou, Anna Y.; Koliwad, Suneil; Wang, Jen-Chywan			Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes (vol 287, pg 8444, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124	1	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16135	16135		10.1074/jbc.A111.294124	http://dx.doi.org/10.1074/jbc.A111.294124			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28963337	Green Published, hybrid			2022-12-28	WOS:000412109400013
J	Bemena, LD; Mukama, O; Neiman, AM; Li, ZJ; Gao, XD; Nakanishi, H				Bemena, Leo D.; Mukama, Omar; Neiman, Aaron M.; Li, Zijie; Gao, Xiao-Dong; Nakanishi, Hideki			In vitro reconstitution of the yeast spore wall dityrosine layer discloses the mechanism of its assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ASCOSPORE WALL; CHITIN; CHITOSAN; GENES; MEMBRANE; MATURATION; PRECURSOR; PROTEINS; PATHWAY	In response to nutrient starvation, diploid cells of the budding yeast Saccharomyces cerevisiae differentiate into a dormant form of haploid cell termed a spore. The dityrosine layer forms the outermost layer of the wall of S. cerevisiae spores and endows them with resistance to environmental stresses. LL-Bisformyl dityrosine is the main constituent of the dityrosine layer, but the mechanism of its assembly remains elusive. Here, we found that LL-bisformyl dityrosine, but not LL-dityrosine, stably associated in vitro with dit1 Delta spores, which lack the dityrosine layer. No other soluble cytosolic materials were required for this incorporation. In several aspects, the dityrosine incorporated in trans resembled the dityrosine layer. For example, dityrosine incorporation obscured access of the dye calcofluor white to the underlying chitosan layer, and LL-bisformyl dityrosine molecules bound to dit1 Delta spores were partly isomerized to the DL-form. Mutational analyses revealed several spore wall components required for this binding. One was the chitosan layer located immediately below the dityrosine layer in the spore wall. However, LL-bisformyl dityrosine did not stably bind to chitosan particles, indicating that chitosan is not sufficient for this association. Several lines of evidence demonstrated that spore-resident proteins are involved in the incorporation, including the Lds proteins, which are localized to lipid droplets attached to the developing spore wall. In conclusion, our results provide insight into the mechanism of dityrosine layer formation, and the in vitro assay described here may be used to investigate additional mechanisms in spore wall assembly.	[Bemena, Leo D.; Mukama, Omar; Li, Zijie; Gao, Xiao-Dong; Nakanishi, Hideki] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Jiangnan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gao, XD; Nakanishi, H (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	xdgao@jiangnan.edu.cn; hideki@jiangnan.edu.cn	MUKAMA, Omar/AAJ-2096-2021	Neiman, Aaron/0000-0002-6600-6996	National Natural Science Foundation of China [21576118]; Fundamental Research Funds for the Central Universities [JUSRP51629B, JUSRP51319B]; National Institutes of Health [R01 GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 21576118 and Fundamental Research Funds for the Central Universities Grant JUSRP51629B (to H.N.), Fundamental Research Funds for the Central Universities Grant JUSRP51319B (to X.-D.G.), and National Institutes of Health Grant R01 GM072540 (to A.M.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMADO R, 1984, METHOD ENZYMOL, V107, P377; Atyabi F, 2009, J NANOSCI NANOTECHNO, V9, P4593, DOI 10.1166/jnn.2009.1090; BALLOU CE, 1977, P NATL ACAD SCI USA, V74, P4351, DOI 10.1073/pnas.74.10.4351; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Briza P, 1996, EUR J BIOCHEM, V239, P124, DOI 10.1111/j.1432-1033.1996.0124u.x; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1990, J BIOL CHEM, V265, P15118; BRIZA P, 1988, J BIOL CHEM, V263, P11569; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Christodoulidou A, 1999, FEBS LETT, V460, P275, DOI 10.1016/S0014-5793(99)01334-4; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; DEITS T, 1984, J BIOL CHEM, V259, P3525; Esposito R. E., 1981, MOL BIOL YEAST SACCH, V11, P211; Felder T, 2002, EUKARYOT CELL, V1, P799, DOI 10.1128/EC.1.5.799-810.2002; Fujii N, 1999, MECH AGEING DEV, V107, P347, DOI 10.1016/S0047-6374(98)00129-8; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Kong J, 2017, BIOENGINEERED, V8, P411, DOI 10.1080/21655979.2016.1241926; KREGERVANRIJ NJW, 1978, ARCH MICROBIOL, V117, P73, DOI 10.1007/BF00689354; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynn R R, 1970, J Cell Biol, V44, P688, DOI 10.1083/jcb.44.3.688; Mishra C, 1997, YEAST, V13, P327, DOI 10.1002/(SICI)1097-0061(19970330)13:4<327::AID-YEA96>3.0.CO;2-T; MOENS PB, 1971, CAN J MICROBIOL, V17, P507, DOI 10.1139/m71-084; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Tan YP, 2015, NAT CHEM BIOL, V11, P488, DOI [10.1038/NCHEMBIO.1833, 10.1038/nchembio.1833]; Ueno K, 2016, BIOCHEM BIOPH RES CO, V475, P315, DOI 10.1016/j.bbrc.2016.05.099; Wagner M, 1999, GENETICS, V151, P1327; Zhang HN, 2014, APPL ENVIRON MICROB, V80, P5098, DOI 10.1128/AEM.00677-14	38	5	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15880	15891		10.1074/jbc.M117.786202	http://dx.doi.org/10.1074/jbc.M117.786202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794156	Green Published, hybrid			2022-12-28	WOS:000411512200025
J	Hayward, J; Sanchez, J; Perry, A; Huang, C; Valle, MR; Canals, M; Payne, RJ; Stone, MJ				Hayward, Jenni; Sanchez, Julie; Perry, Andrew; Huang, Cheng; Valle, Manuel Rodriguez; Canals, Meritxell; Payne, Richard J.; Stone, Martin J.			Ticks from diverse genera encode chemokine-inhibitory evasin proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOOPHILUS-MICROPLUS INFESTATION; BINDING-PROTEIN; TYROSINE SULFATION; LYME-DISEASE; RHIPICEPHALUS-SANGUINEUS; IXODES-SCAPULARIS; IMMUNE-RESPONSE; RNA-SEQ; VECTOR; FAMILY	To prolong residence on their hosts, ticks secrete many salivary factors that target host defense molecules. In particular, the tick Rhipicephalus sanguineus has been shown to produce three salivary glycoproteins named "evasins," which bind to host chemokines, thereby inhibiting the recruitment of leukocytes to the location of the tick bite. Using sequence similarity searches, we have identified 257 new putative evasin sequences encoded by the genomes or salivary or visceral transcriptomes of numerous hard ticks, spanning the genera Rhipicephalus, Amblyomma, and Ixodes of the Ixodidae family. Nine representative sequences were successfully expressed in Escherichia coli, and eight of the nine candidates exhibited high-affinity binding to human chemokines. Sequence alignments enabled classification of the evasins into two subfamilies: C-8 evasins share a conserved set of eight Cys residues (four disulfide bonds), whereas C-6 evasins have only three of these disulfide bonds. Most of the identified sequences contain predicted secretion leader sequences, N-linked glycosylation sites, and a putative site of tyrosine sulfation. We conclude that chemokine-binding evasin proteins are widely expressed among tick species of the Ixodidae family, are likely to play important roles in subverting host defenses, and constitute a valuable pool of anti-inflammatory proteins for potential future therapeutic applications.	[Hayward, Jenni; Sanchez, Julie; Huang, Cheng; Stone, Martin J.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Hayward, Jenni; Sanchez, Julie; Huang, Cheng; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Perry, Andrew] Monash Univ, Monash Bioinformat Platform, Clayton, Vic 3800, Australia; [Valle, Manuel Rodriguez] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Parkville, Vic 3010, Australia; [Canals, Meritxell] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Melbourne; Monash University; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Rodriguez-Valle, Manuel/AAA-3819-2021; Payne, Richard/AAH-3666-2021; Rodriguez-Valle, Manuel/A-5272-2010; Perry, Andrew/E-5607-2010; Stone, Martin/C-2492-2012	Rodriguez-Valle, Manuel/0000-0003-2304-8085; Sanchez, Julie/0000-0002-5765-4342; Perry, Andrew/0000-0001-9256-6068; Payne, Richard/0000-0002-3618-9226; Canals, Meritxell/0000-0002-7942-5006; Hayward, Jenni/0000-0001-8228-8797; Stone, Martin/0000-0002-6468-4427	Australian Research Council Discovery [DP120100194]; Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; ANZTrustees [12-3831]	Australian Research Council Discovery(Australian Research Council); Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; ANZTrustees	This work was supported in part by Australian Research Council Discovery Grant DP120100194 (to M. J. S. and R. J. P.), the Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme (to M. C.), andANZTrustees Grant 12-3831 (to M. J. S. and M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anatriello E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-450; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Becker CAM, 2009, EMERG INFECT DIS, V15, P320, DOI 10.3201/eid1502.081247; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Copin JC, 2013, J CEREBR BLOOD F MET, V33, P490, DOI 10.1038/jcbfm.2012.198; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de Castro MH, 2016, TICKS TICK-BORNE DIS, V7, P536, DOI 10.1016/j.ttbdis.2016.01.014; De La Fuente J, 2006, ANN NY ACAD SCI, V1078, P416, DOI 10.1196/annals.1374.081; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fivaz B., 1992, TICK VECTOR BIOL; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Garcia GR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-430; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Gulia-Nuss M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10507; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; HUFF S, 1994, J BIOL CHEM, V269, P15563; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Jonsson NN, 2006, VET PARASITOL, V137, P1, DOI 10.1016/j.vetpar.2006.01.010; Jonsson NN, 2001, AUST VET J, V79, P826, DOI 10.1111/j.1751-0813.2001.tb10929.x; Karim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131292; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Ludeman JP, 2015, ORG BIOMOL CHEM, V13, P2162, DOI 10.1039/c4ob02262a; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Radulovic ZM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-518; Rodriguez-Valle M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0605-4; Rodriguez-Valle M, 2013, INT J PARASITOL, V43, P739, DOI 10.1016/j.ijpara.2013.04.005; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh K, 2017, SCI REP, P7; Stone MJ, 2015, ACCOUNTS CHEM RES, V48, P2251, DOI 10.1021/acs.accounts.5b00255; Tan AWL, 2015, J PROTEOMICS, V117, P120, DOI 10.1016/j.jprot.2014.12.014; Thompson GL, 2015, MOL PHARMACOL, V88, P335, DOI 10.1124/mol.115.098848; Thompson RE, 2017, NAT CHEM, V9, P909, DOI [10.1038/NCHEM.2744, 10.1038/nchem.2744]; Vancova I, 2010, PARASITE IMMUNOL, V32, P460, DOI 10.1111/j.1365-3024.2010.01203.x; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; Wang XY, 2017, ANGEW CHEM INT EDIT, V56, P8490, DOI 10.1002/anie.201703059; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	53	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15670	15680		10.1074/jbc.M117.807255	http://dx.doi.org/10.1074/jbc.M117.807255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28778927	Green Published, hybrid			2022-12-28	WOS:000411512200008
J	Li, JY; Cui, Y; Xu, J; Wang, QH; Yang, XQ; Li, Y; Zhang, XY; Qiu, MS; Zhang, Z; Zhang, Z				Li, Jianying; Cui, Ying; Xu, Jie; Wang, Qihui; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			Suppressor of Fused restraint of Hedgehog activity level iscritical for osteogenic proliferation and differentiation during calvarial bone development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; INDIAN HEDGEHOG; OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN; CELL-PROLIFERATION; PRIMARY CILIA; GLI PROTEINS; EXPRESSION; MOUSE; SHH	Hedgehog signaling plays crucial roles in the development of calvarial bone, relying on the activation of Gli transcription factors. However, the molecular mechanism of the role of regulated Gli protein level in osteogenic specification of mesenchyme still remains elusive. Here, we show by conditionally inactivating Suppressor of Fused (Sufu), a critical repressor of Hedgehog signaling, in Wnt1-Cre-mediated cranial neural crest (CNC) or Dermo1-Cre-mediated mesodermal lineages that Sufu restraint of Hedgehog activity level is critical for differentiation of preosteogenic mesenchyme. Ablation of Sufu results in failure of calvarial bone formation, including CNC-derived bones and mesoderm-derived bones, depending on the Cre line being used. Although mesenchymal cells populate to frontonasal destinations, where they are then condensed, Sufu deletion significantly inhibits the proliferation of osteoprogenitor cells, and these cells no longer differentiate into osteoblasts. Weshow that there is suppression of Runx2 and Osterix, the osteogenic regulators, in calvarial mesenchyme in the Sufu mutant. We show that down-regulation of several genes upstream to Runx2 and Osterix is manifested within the calvarial primordia, including Bmp2 and its downstream genes Msx1/ 2 and Dlx5. By contrast, we find that Gli1, the Hedgehog activity readout gene, is excessively activated in mesenchyme. Deletion of Sufu in CNC leads to a discernible decrease in the repressive Gli3 form and an increase in the full-length Gli2. Finally, we demonstrate that simultaneous deletion of Gli2 and Sufu in CNCcompletely restores calvarial bone formation, suggesting that a sustained level of Hedgehog activity is critical in specification of the osteogenic mesenchymal cells.	[Li, Jianying; Cui, Ying; Xu, Jie; Wang, Qihui; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Life Sci, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Ze] Tulane Univ, Tulane Med Ctr, Dept Ophthamol, New Orleans, LA 70112 USA; [Wang, Qihui] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China	Hangzhou Normal University; Tulane University; Nanjing University	Zhang, Z (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Life Sci, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org		Li, Jianying/0000-0003-1488-8322				Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chung IH, 2010, GENESIS, V48, P645, DOI 10.1002/dvg.20671; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jacob S, 2007, ANN PLAS SURG, V58, P215, DOI 10.1097/01.sap.0000232833.41739.a5; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Li J, 2015, CHEM GEOL, V406, P10, DOI 10.1016/j.chemgeo.2015.04.010; Lin CW, 2014, GENE DEV, V28, P2547, DOI 10.1101/gad.249425.114; Lin CW, 2014, DEV BIOL, V392, P324, DOI 10.1016/j.ydbio.2014.05.014; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Ma XX, 2017, NEUROREPORT, V28, P141, DOI 10.1097/WNR.0000000000000725; Maxson Robert, 2008, V12, P197, DOI 10.1159/000115042; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Murakami S, 1997, ENDOCRINOLOGY, V138, P1972, DOI 10.1210/en.138.5.1972; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Naruse I, 2010, CONGENIT ANOM, V50, P1, DOI 10.1111/j.1741-4520.2009.00266.x; Nott RL, 2002, PLAST RECONSTR SURG, V110, P523, DOI 10.1097/00006534-200208000-00024; Pan A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00061; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Park HL, 2000, DEVELOPMENT, V127, P1593; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roybal PG, 2010, DEV BIOL, V343, P28, DOI 10.1016/j.ydbio.2010.04.007; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun JJ, 2013, DEVELOPMENT, V140, P1034, DOI 10.1242/dev.085225; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takarada T, 2016, DEVELOPMENT, V143, P211, DOI 10.1242/dev.128793; Tanimoto Y, 2012, J BIOL CHEM, V287, P21429, DOI 10.1074/jbc.M112.362145; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Veistinen L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00121; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	69	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15814	15825		10.1074/jbc.M117.777532	http://dx.doi.org/10.1074/jbc.M117.777532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794157	hybrid, Green Published			2022-12-28	WOS:000411512200019
J	Liu, J; Zhou, YY; Hingorani, MM				Liu, Juan; Zhou, Yayan; Hingorani, Manju M.			Linchpin DNA-binding residues serve as go/no-go controls in the replication factor C-catalyzed clamp-loading mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE PROCESSIVITY FACTOR; ESCHERICHIA-COLI CLAMP; BETA SLIDING CLAMP; CRYSTAL-STRUCTURE; GAMMA COMPLEX; ATP SITES; LOADER; PCNA; DYNAMICS; RELEASE	DNA polymerases depend on circular sliding clamps for processive replication. Clamps must be loaded onto primer-template DNA (ptDNA) by clamp loaders that open and close clamps around ptDNA in an ATP-fueled reaction. All clamp loaders share a core structure in which five subunits form a spiral chamber that binds the clamp at its base in a twisted open form and encloses ptDNA within, while binding and hydrolyzing ATP to topologically link the clamp and ptDNA. To understand how clamp loaders perform this complex task, here we focused on conserved arginines that might play a central coordinating role in the mechanism because they can alternately contact ptDNA or Walker B glutamate in the ATPase site and lie close to the clamp loader-clamp-binding interface. We mutated Arg-84, Arg-88, and Arg-101 in the ATPase-active B, C, and D subunits of Saccharomyces cerevisiae replication factor C (RFC) clamp loader, respectively, and assessed the impact on multiple transient events in the reaction: proliferating cell nuclear antigen (PCNA) clamp binding/opening/closure/release, ptDNA binding/release, and ATP hydrolysis/product release. The results show that these arginines relay critical information between the PCNA-binding, DNA-binding, and ATPase sites at all steps of the reaction, particularly at a checkpoint before RFC commits to ATP hydrolysis. Moreover, their actions are subunit-specific with RFC-C Arg-88 serving as an accelerator that enables rapid ATP hydrolysis upon contact with ptDNA and RFC-D Arg-101 serving as a brake that confers specificity for ptDNA as the correct substrate for loading PCNA.	[Liu, Juan; Zhou, Yayan; Hingorani, Manju M.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA	Wesleyan University	Hingorani, MM (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	mhingorani@wesleyan.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114743] Funding Source: NIH RePORTER; NIGMS NIH HHS [R15 GM114743] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman JL, 2010, BIOPHYS J, V98, P3062, DOI 10.1016/j.bpj.2010.03.056; Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Bloom LB, 2009, DNA REPAIR, V8, P570, DOI 10.1016/j.dnarep.2008.12.014; Boehm EM, 2016, ENZYMES, V39, P231, DOI 10.1016/bs.enz.2016.03.003; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Chen SY, 2009, J MOL BIOL, V388, P431, DOI 10.1016/j.jmb.2009.03.014; Chiraniya A, 2013, GENES-BASEL, V4, P134, DOI 10.3390/genes4020134; Choe KN, 2017, MOL CELL, V65, P380, DOI 10.1016/j.molcel.2016.12.020; De March M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13935; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Hayner JN, 2013, J BIOL CHEM, V288, P1162, DOI 10.1074/jbc.M112.406231; Hingorani MM, 2002, J BIOL CHEM, V277, P47213, DOI 10.1074/jbc.M206764200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kelch BA, 2016, BIOPOLYMERS, V105, P532, DOI 10.1002/bip.22827; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kumar R, 2010, P NATL ACAD SCI USA, V107, P19736, DOI 10.1073/pnas.1014139107; Marzahn MR, 2015, BBA-PROTEINS PROTEOM, V1854, P31, DOI 10.1016/j.bbapap.2014.09.019; Marzahn MR, 2014, J BIOL CHEM, V289, P5537, DOI 10.1074/jbc.M113.541466; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; Miller J, 2016, ARCHAEA, V2016, DOI 10.1155/2016/9294307; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Paschall CO, 2011, J BIOL CHEM, V286, P42704, DOI 10.1074/jbc.M111.268169; Sakato M, 2012, J MOL BIOL, V416, P176, DOI 10.1016/j.jmb.2011.12.018; Sakato M, 2012, J MOL BIOL, V416, P163, DOI 10.1016/j.jmb.2011.12.017; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2012, J BIOL CHEM, V287, P2203, DOI 10.1074/jbc.C111.318899; Tondnevis F, 2016, J STRUCT BIOL, V194, P272, DOI 10.1016/j.jsb.2016.03.003; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhou Yayan, 2012, J Biol Chem, V287, P35370, DOI 10.1074/jbc.M112.399071; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	46	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15892	15906		10.1074/jbc.M117.798702	http://dx.doi.org/10.1074/jbc.M117.798702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28808059	Green Published, hybrid			2022-12-28	WOS:000411512200026
J	Dierck, F; Kuhn, C; Rohr, C; Hiile, S; Braune, J; Sossalla, S; Molt, S; van der Ven, PFM; Furst, DO; Frey, N				Dierck, Franziska; Kuhn, Christian; Rohr, Claudia; Hiile, Susanne; Braune, Julia; Sossalla, Samuel; Molt, Sibylle; van der Ven, Peter F. M.; Fuerst, Dieter O.; Frey, Norbert			The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE LIM PROTEIN; DILATED CARDIOMYOPATHY; HUMAN HEART; FILAMIN C; IN-VIVO; FHL2; MICE; MAINTENANCE; CALSARCIN-1; INTERACTS	The z-disc is a structural component at the lateral borders of the sarcomere and is important for mechanical stability and contractility of both cardiac and skeletal muscles. Of note, the sarcomeric z-disc also represents a nodal point in cardiomyocyte function and signaling. Mutations of numerous z-disc proteins are associated with cardiomyopathies and muscle diseases. To identify additional z-disc proteins that might contribute to cardiac disease, we employed an in silico screen for cardiac-enriched cDNAs. This screen yielded a previously uncharacterized protein named cardiac-enriched FHL2-interacting protein (CEFIP), which exhibited a heart-and skeletal muscle-specific expression profile. Importantly, CEFIP was located at the z-disc and was up-regulated in several models of cardiomyopathy. We also found that CEFIP overexpression induced the fetal gene program and cardiomyocyte hypertrophy. Yeast two-hybrid screens revealed that CEFIP interacts with the calcineurin-binding protein four and a half LIM domains 2 (FHL2). Because FHL2 binds calcineurin, a phosphatase controlling hypertrophic signaling, we examined the effects of CEFIP on the calcineurin/ nuclear factor of activated T-cell (NFAT) pathway. These experiments revealed that CEFIP overexpression further enhances calcineurin-dependent hypertrophic signal transduction, and its knockdown repressed hypertrophy and calcineurin/ NFAT activity. In summary, we report on a previously uncharacterized protein CEFIP that modulates calcineurin/ NFAT signaling in cardiomyocytes, a finding with possible implications for the pathogenesis of cardiomyopathy.	[Dierck, Franziska; Kuhn, Christian; Hiile, Susanne; Sossalla, Samuel; Frey, Norbert] Univ Med Ctr Schleswig Holstein, Dept Internal Med 3, Campus Kiel, D-24105 Kiel, Germany; [Dierck, Franziska; Kuhn, Christian; Hiile, Susanne; Sossalla, Samuel; Frey, Norbert] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, D-24105 Kiel, Germany; [Rohr, Claudia] Heidelberg Univ, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Braune, Julia; Molt, Sibylle; van der Ven, Peter F. M.; Fuerst, Dieter O.] Univ Bonn, Inst Cell Biol, Dept Mol Cell Biol, D-53121 Bonn, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; University of Bonn	Frey, N (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Internal Med 3, Campus Kiel, D-24105 Kiel, Germany.	norbert.frey@uksh.de	Fürst, Dieter O./H-8561-2013; Frey, Norbert/M-7749-2019; Frey, Norbert/A-9695-2010; Sossalla, Samuel/AAF-3611-2020	Fürst, Dieter O./0000-0001-8805-6444; Frey, Norbert/0000-0001-7611-378X; Hille, Susanne/0000-0002-9809-4636; van der Ven, Peter/0000-0002-9750-8913; Sossalla, Samuel/0000-0001-8034-2673	Deutsche Forschungsgemeinschaft (German Research Foundation) [Forschergruppe 1352]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (German Research Foundation) Forschergruppe 1352: "Structure, Function and Regulation of the Myofibrillar z-disc Interactome." The authors declare that they have no conflicts of interest with the contents of this article.	Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Arimura T, 2007, BIOCHEM BIOPH RES CO, V357, P162, DOI 10.1016/j.bbrc.2007.03.128; Bovill E, 2009, J THORAC CARDIOV SUR, V137, P853, DOI 10.1016/j.jtcvs.2008.09.006; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Friedrich FW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0451-8; Heineke J, 2012, J MOL CELL CARDIOL, V52, P62, DOI 10.1016/j.yjmcc.2011.10.018; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; Knoll Ralph, 2002, Exp Clin Cardiol, V7, P104; Kong YF, 2001, CIRCULATION, V103, P2731; Kuhn C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0262-8; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopes KD, 2011, J CELL BIOL, V193, P785, DOI 10.1083/jcb.201010099; Luedde M, 2009, J MOL MED, V87, P411, DOI 10.1007/s00109-008-0436-x; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molt S, 2014, J CELL SCI, V127, P3578, DOI 10.1242/jcs.152157; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Ritter O, 2002, CIRCULATION, V105, P2265, DOI 10.1161/01.CIR.0000016044.19527.96; Schoensiegel F, 2007, COMPARATIVE MED, V57, P546; Spaich S, 2012, CIRC RES, V111, P1504, DOI 10.1161/CIRCRESAHA.112.271007; Tran MK, 2016, BBA-MOL CELL RES, V1863, P219, DOI 10.1016/j.bbamcr.2015.11.002; Wang J, 2011, CYTOSKELETON, V68, P661, DOI 10.1002/cm.20542; Will RD, 2010, CIRC RES, V107, P1253, DOI 10.1161/CIRCRESAHA.110.222372	35	7	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15180	15191		10.1074/jbc.M117.786764	http://dx.doi.org/10.1074/jbc.M117.786764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717008	Green Published, hybrid			2022-12-28	WOS:000410809800002
J	Nakata, K; Sugi, Y; Narabayashi, H; Kobayakawa, T; Nakanishi, Y; Tsuda, M; Hosono, A; Kaminogawa, S; Hanazawa, S; Takahashi, K				Nakata, Kazuaki; Sugi, Yutaka; Narabayashi, Hikari; Kobayakawa, Tetsuro; Nakanishi, Yusuke; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi; Hanazawa, Shigemasa; Takahashi, Kyoko			Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL; COLITIS; PATHWAY; PDCD4; HOST	The intestinal tract contains many commensal bacteria that modulate various physiological host functions. Dysbiosis of commensal bacteria triggers dysfunction of the intestinal epithelial barrier, leading to the induction or aggravation of intestinal inflammation. Toelucidate whether microRNA plays a role in commensal microbiome-dependent intestinal epithelial barrier regulation, we compared transcripts in intestinal epithelial cells (IECs) from conventional and germ-free mice and found that commensal bacteria induced the expression of miR-21-5p in IECs. miR-21-5p increased intestinal epithelial permeability and up-regulated ADP ribosylation factor 4 (ARF4), a small GTPase, in the IEC line Caco-2. We also found that ARF4 expression was up-regulated upon suppression of phosphatase and tensin homolog (PTEN) and programmed cell death 4 (PDCD4), which are known miR-21-5p targets, by RNAi. Furthermore, ARF4 expression in epithelial cells of the large intestine was higher in conventional mice than in germ-free mice. ARF4 suppression in the IEC line increased the expression of tight junction proteins and decreased intestinal epithelial permeability. These results indicate that commensal microbiomedependent miR-21-5p expression in IECs regulates intestinal epithelial permeability via ARF4, which may therefore represent a target for preventing or managing dysfunction of the intestinal epithelial barrier.	[Nakata, Kazuaki; Sugi, Yutaka; Narabayashi, Hikari; Kobayakawa, Tetsuro; Nakanishi, Yusuke; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi; Hanazawa, Shigemasa; Takahashi, Kyoko] Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	ktaka@brs.nihon-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 26450165]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Japan Society for the Promotion of Science (KAKENHI 26450165 to K. T.).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Lee J. H., 2015, SCI REP, V5; Maudet C, 2014, FEBS LETT, V588, P4140, DOI 10.1016/j.febslet.2014.08.002; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Pruteanu M, 2013, AM J PHYSIOL-GASTR L, V305, pG740, DOI 10.1152/ajpgi.00316.2012; Pruteanu M, 2011, INFLAMM BOWEL DIS, V17, P1189, DOI 10.1002/ibd.21475; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi CZ, 2016, GUT, V65, P1470, DOI 10.1136/gutjnl-2014-308455; Singh N, 2012, INT J BIOL SCI, V8, P171, DOI 10.7150/ijbs.8.171; Smyth D, 2012, CELL MICROBIOL, V14, P1257, DOI 10.1111/j.1462-5822.2012.01796.x; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Sugi V., 2016, PLOS ONE, V11; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Zhang L, 2015, CELL BIOCHEM FUNCT, V33, P235, DOI 10.1002/cbf.3109; Zhang Y., 2015, BARRIERS, V3; Zhou QQ, 2015, GASTROENTEROLOGY, V148, P158, DOI 10.1053/j.gastro.2014.09.037; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	33	61	66	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15426	15433		10.1074/jbc.M117.788596	http://dx.doi.org/10.1074/jbc.M117.788596			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28760826	Green Published, hybrid			2022-12-28	WOS:000410809800022
J	Nickless, A; Cheruiyot, A; Flanagan, KC; Piwnica-Worms, D; Stewart, SA; You, ZS				Nickless, Andrew; Cheruiyot, Abigael; Flanagan, Kevin C.; Piwnica-Worms, David; Stewart, Sheila A.; You, Zhongsheng			p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; UNFOLDED PROTEIN RESPONSE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; SECRETORY PHENOTYPE; GENE-EXPRESSION; PATHWAY; KINASE; ATF3; NMD	Persistent DNA damage induces profound alterations in gene expression that, in turn, influence tissue homeostasis, tumorigenesis, and cancer treatment outcome. However, the underlying mechanism for gene expression reprogramming induced by persistent DNA damage remains poorly understood. Here, using a highly effective bioluminescence-based reporter system and other tools, we report that persistent DNA damage inhibits nonsense-mediated RNA decay (NMD), an RNA surveillance and gene-regulatory pathway, in noncycling cells. NMD suppression by persistent DNA damage required the activity of the p38 alpha MAPK. Activating transcription factor 3 (ATF3), anNMD target and a key stress-inducible transcription factor, was stabilized in a p38 alpha-and NMD-dependent manner following persistent DNA damage. Our results reveal a novel p38 alpha-dependent pathway that regulates NMD activity in response to persistent DNA damage, which, in turn, controls ATF3 expression in affected cells.	[Nickless, Andrew; Cheruiyot, Abigael; Flanagan, Kevin C.; Stewart, Sheila A.; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	You, ZS (corresponding author), Washington Univ, Sch Med, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	zyou@wustl.edu		You, Zhongsheng/0000-0002-9719-8791; Cheruiyot, Abigael/0000-0003-0612-6280	National Institutes of Health [R01GM098535]; American Cancer Society Research Scholar Grant [RSG-13-212-01-DMC]; Interdisciplinary Research Initiative Grant from the Children's Discovery Institute [MC-II-2012-215]; Siteman Investment Program Grant from the Siteman Cancer Center of Washington University [4036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Interdisciplinary Research Initiative Grant from the Children's Discovery Institute; Siteman Investment Program Grant from the Siteman Cancer Center of Washington University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant R01GM098535, American Cancer Society Research Scholar Grant RSG-13-212-01-DMC, Interdisciplinary Research Initiative Grant MC-II-2012-215 from the Children's Discovery Institute, and Siteman Investment Program Grant 4036 from the Siteman Cancer Center of Washington University.	Alimbetov D, 2016, BIOGERONTOLOGY, V17, P305, DOI 10.1007/s10522-015-9610-z; Alspach E, 2014, CANCER DISCOV, V4, P716, DOI 10.1158/2159-8290.CD-13-0743; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bent EH, 2016, GENE DEV, V30, P1811, DOI 10.1101/gad.284851.116; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Buganim Y, 2011, CARCINOGENESIS, V32, P1749, DOI 10.1093/carcin/bgr203; Burnette BL, 2009, PHARMACOLOGY, V84, P42, DOI 10.1159/000227286; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; Di Micco K, 2006, NATURE, V444, P638; Eom T, 2013, ELIFE, V2, DOI 10.7554/eLife.00178; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Guay J, 1997, J CELL SCI, V110, P357; Hai T, 1999, GENE EXPRESSION, V7, P321; Harada G, 2014, J BIOCHEM, V156, P283, DOI 10.1093/jb/mvu040; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Karam R, 2015, EMBO REP, V16, P599, DOI 10.15252/embr.201439696; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; kIerbig U., 2004, MOL CELL, V14, P501; Kim KH, 2015, CHEM RES TOXICOL, V28, P71, DOI 10.1021/tx500341z; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Liu MX, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117754; Long AA, 2010, J CELL SCI, V123, P3303, DOI 10.1242/jcs.069468; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Martin M, 2009, GENE CHROMOSOME CANC, V48, P745, DOI 10.1002/gcc.20679; Martin NT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Minieri V, 2015, J CELL MOL MED, V19, P734, DOI 10.1111/jcmm.12387; Morandell S, 2013, CELL REP, V5, P868, DOI 10.1016/j.celrep.2013.10.025; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Oren YS, 2014, EMBO MOL MED, V6, P685, DOI 10.1002/emmm.201303347; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Popp MW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7632; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossiello F, 2014, CURR OPIN GENET DEV, V26, P89, DOI 10.1016/j.gde.2014.06.009; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Soubeyrand S, 2010, MOL ONCOL, V4, P38, DOI 10.1016/j.molonc.2009.09.003; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yu Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0113-z	64	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15266	15276		10.1074/jbc.M117.787846	http://dx.doi.org/10.1074/jbc.M117.787846			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765281	Green Published, hybrid			2022-12-28	WOS:000410809800009
J	Astegno, A; Bonza, MC; Vallone, R; La Verde, V; D'Onofrio, M; Luoni, L; Molesini, B; Dominici, P				Astegno, Alessandra; Bonza, Maria Cristina; Vallone, Rosario; La Verde, Valentina; D'Onofrio, Mariapina; Luoni, Laura; Molesini, Barbara; Dominici, Paola			Arabidopsis calmodulin-like protein CML36 is a calcium (Ca2+) sensor that interacts with the plasma membrane Ca2+-ATPase isoform ACA8 and stimulates its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT GLUTAMATE-DECARBOXYLASE; ION-BINDING-PROPERTIES; N-TERMINUS; SACCHAROMYCES-CEREVISIAE; REFERENCE GENES; THALIANA; EXPRESSION; MECHANISM; NMR; MAGNESIUM	Calmodulin-like (CML) proteins are major EF-hand-containing, calcium (Ca2+)-binding proteins with crucial roles in plant development and in coordinating plant stress tolerance. Given their abundance in plants, the properties of Ca2+ sensors and identification of novel target proteins of CMLs deserve special attention. To this end, we recombinantly produced and biochemically characterized CML36 from Arabidopsis thaliana. We analyzed Ca2+ and Mg2+ binding to the individual EF-hands, observed metal-induced conformational changes, and identified a physiologically relevant target. CML36 possesses two high-affinity Ca2+/Mg2+ mixed binding sites and two low-affinity Ca2+-specific sites. Binding of Ca2+ induced an increase in the alpha-helical content and a conformational change that lead to the exposure of hydrophobic regions responsible for target protein recognition. Cation binding, either Ca2+ or Mg2+, stabilized the secondary and tertiary structures of CML36, guiding a large structural transition from a molten globule apo-state to a compact holoconformation. Importantly, through in vitro binding and activity assays, we showed that CML36 interacts directly with the regulative N terminus of the Arabidopsis plasma membrane Ca2+-ATPase isoform 8 (ACA8) and that this interaction stimulates ACA8 activity. Gene expression analysis revealed that CML36 and ACA8 are co-expressed mainly in inflorescences. Collectively, our results support a role for CML36 as a Ca2+ sensor that binds to and modulates ACA8, uncovering a possible involvement of the CML protein family in the modulation of plant-autoinhibited Ca2+ pumps.	[Astegno, Alessandra; Vallone, Rosario; La Verde, Valentina; D'Onofrio, Mariapina; Molesini, Barbara; Dominici, Paola] Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy; [Bonza, Maria Cristina; Luoni, Laura] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Verona; University of Milan	Astegno, A (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	alessandra.astegno@univr.it	Bonza, Maria Cristina/B-1351-2017	Bonza, Maria Cristina/0000-0001-7096-2967; Luoni, Laura/0000-0002-6485-5417; MOLESINI, Barbara/0000-0002-4324-4908; Astegno, Alessandra/0000-0002-7341-0970	Grant FUR from the University of Verona	Grant FUR from the University of Verona	This study was supported in part by Grant FUR2014 from the University of Verona (to A.A. and P.D.). The authors declare that they have no conflicts of interest with the contents of this article.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Astegno A, 2016, BBA-PROTEINS PROTEOM, V1864, P297, DOI 10.1016/j.bbapap.2015.12.003; Astegno A, 2015, BBA-PROTEINS PROTEOM, V1854, P1229, DOI 10.1016/j.bbapap.2015.01.001; Astegno A, 2014, NANOSCALE, V6, P15037, DOI 10.1039/c4nr04368e; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bonza MC, 2011, PLANT BIOLOGY, V13, P421, DOI 10.1111/j.1438-8677.2010.00405.x; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; Bonza MC, 2000, PLANT PHYSIOL, V123, P1495, DOI 10.1104/pp.123.4.1495; Bonza MC, 2004, PLANTA, V218, P814, DOI 10.1007/s00425-003-1160-y; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Cali T, 2017, BBA-MOL BASIS DIS, V1863, P165, DOI 10.1016/j.bbadis.2016.09.007; Cerana M, 2006, PLANT BIOLOGY, V8, P572, DOI 10.1055/s-2006-924111; Costa A, 2017, J EXP BOT, V68, P3215, DOI 10.1093/jxb/erx162; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dobney S, 2009, J BIOL CHEM, V284, P31647, DOI 10.1074/jbc.M109.056770; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; Favretto F, 2015, FEBS J, V282, P1271, DOI 10.1111/febs.13218; Frey NFD, 2012, PLANT PHYSIOL, V159, P798, DOI 10.1104/pp.111.192575; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GARRIGOS M, 1991, ANAL BIOCHEM, V194, P82, DOI 10.1016/0003-2697(91)90154-L; Giacometti S, 2012, J EXP BOT, V63, P1215, DOI 10.1093/jxb/err346; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2013, PLANT CELL, V25, P4512, DOI 10.1105/tpc.113.113183; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Gut H, 2009, J MOL BIOL, V392, P334, DOI 10.1016/j.jmb.2009.06.080; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luoni L, 2006, PHYSIOL PLANTARUM, V126, P175, DOI 10.1111/j.1399-3054.2006.00588.x; Luoni L, 2004, FEBS LETT, V574, P20, DOI 10.1016/j.febslet.2004.08.003; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Marino V, 2014, NANOSCALE, V6, P412, DOI 10.1039/c3nr04978g; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Permyakov E. A., 2010, CALCIUM BINDING PROT, P567; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Ranty B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00327; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schiott M, 2005, PHYSIOL PLANTARUM, V124, P278, DOI 10.1111/j.1399-3054.2005.00512.x; Sorensen BR, 1996, BIOPHYS J, V71, P3407, DOI 10.1016/S0006-3495(96)79535-8; Sorensen BR, 2001, BIOCHEMISTRY-US, V40, P896, DOI 10.1021/bi0023091; Steinhorst L, 2013, PLANT PHYSIOL, V163, P471, DOI 10.1104/pp.113.222950; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Vallone R, 2016, PROTEIN SCI, V25, P1461, DOI 10.1002/pro.2942; VANELDIK LJ, 1980, P NATL ACAD SCI-BIOL, V77, P1912, DOI 10.1073/pnas.77.4.1912; Waters BM, 2011, NEW PHYTOL, V190, P510, DOI 10.1111/j.1469-8137.2011.03724.x; Webb AAR, 1996, ADV BOT RES, V22, P45; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600	65	37	40	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15049	15061		10.1074/jbc.M117.787796	http://dx.doi.org/10.1074/jbc.M117.787796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726644	hybrid, Green Published			2022-12-28	WOS:000409902100027
J	Awad, AM; Venkataramanan, S; Nag, A; Galivanche, AR; Bradley, MC; Neves, LT; Douglass, S; Clarke, CF; Johnson, TL				Awad, Agape M.; Venkataramanan, Srivats; Nag, Anish; Galivanche, Anoop Raj; Bradley, Michelle C.; Neves, Lauren T.; Douglass, Stephen; Clarke, Catherine F.; Johnson, Tracy L.			Chromatin-remodeling SWI/SNF complex regulates coenzyme Q(6) synthesis and a metabolic shift to respiration in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SUCCINIC-DEHYDROGENASE; PROTEIN PHOSPHATASE; STRESS RESPONSES; Q BIOSYNTHESIS; MESSENGER-RNA; TRANSCRIPTION; DELETION; GENOME	Despite its relatively streamlined genome, there are many important examples of regulated RNA splicing in Saccharomyces cerevisiae. Here, we report a role for the chromatin remodeler SWI/SNF in respiration, partially via the regulation of splicing. We find that a nutrient-dependent decrease in Snf2 leads to an increase in splicing of the PTC7 transcript. The spliced PTC7 transcript encodes a mitochondrial phosphatase regulator of biosynthesis of coenzyme Q6 (ubiquinone or CoQ6) and a mitochondrial redox- active lipid essential for electron and proton transport in respiration. Increased splicing of PTC7 increases CoQ6 levels. The increase in PTC7 splicing occurs at least in part due to down-regulation of ribosomal protein gene expression, leading to the redistribution of spliceosomes from this abundant class of intron-containing RNAs to otherwise poorly spliced transcripts. In contrast, a protein encoded by the non-spliced isoform of PTC7 represses CoQ6 biosynthesis. Taken together, these findings uncover a link between Snf2 expression and the splicing of PTC7 and establish a previously unknown role for the SWI/SNF complex in the transition of yeast cells from fermentative to respiratory modes of metabolism.	[Awad, Agape M.; Nag, Anish; Bradley, Michelle C.; Clarke, Catherine F.] UCLA, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA; [Awad, Agape M.; Venkataramanan, Srivats; Nag, Anish; Bradley, Michelle C.; Neves, Lauren T.; Clarke, Catherine F.; Johnson, Tracy L.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA; [Venkataramanan, Srivats; Galivanche, Anoop Raj; Neves, Lauren T.; Douglass, Stephen; Johnson, Tracy L.] UCLA, Dept Mol Cell & Dev Biol, 610 Charles E Young Dr S, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), UCLA, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA.; Johnson, TL (corresponding author), UCLA, Dept Mol Cell & Dev Biol, 610 Charles E Young Dr S, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu; tljohnson@ucla.edu		Venkataramanan, Srivats/0000-0002-2507-401X; Galivanche, Anoop/0000-0003-3362-1930	National Science Foundation [MCB-1330803, 1518316]; NIGMS, National Institutes of Health [GM-085474]; Whitcome Pre-doctoral Fellowship in Molecular Biology; Ruth L. Kirschstein National Service [GM-007185]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085474, T32GM007185] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Whitcome Pre-doctoral Fellowship in Molecular Biology; Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants MCB-1330803 and 1518316, and by NIGMS, National Institutes of Health, Grant GM-085474; the Whitcome Pre-doctoral Fellowship in Molecular Biology (to S. V.); and Ruth L. Kirschstein National Service Award GM-007185 (to M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; [Anonymous], RNA, P1138; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; DE P, 1962, EXP CELL RES, V27, P172, DOI 10.1016/0014-4827(62)90061-7; DE P, 1962, EXPERIENTIA, V18, P562, DOI 10.1007/BF02172179; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826; Dutta A, 2017, CELL REP, V18, P2124, DOI 10.1016/j.celrep.2017.01.058; Dutta A, 2014, GENE DEV, V28, P2314, DOI 10.1101/gad.243584.114; Gabunilas J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005999; Gonzalez-Mariscal I, 2017, MICROB CELL, V4, P38, DOI 10.15698/mic2017.02.556; Gonzalez-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897; Grate L, 2002, METHOD ENZYMOL, V350, P380, DOI 10.1016/S0076-6879(02)50975-7; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; Hossain MA, 2016, MOL CELL, V62, P346, DOI 10.1016/j.molcel.2016.04.012; Hossain MA, 2011, NUCLEIC ACIDS RES, V39, P8612, DOI 10.1093/nar/gkr497; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Johnson TL, 2012, BBA-GENE REGUL MECH, V1819, P538, DOI 10.1016/j.bbagrm.2011.12.011; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; LIU J, 2017, SCI REP UK, V7; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall AN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003376; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin-Montalvo A, 2013, J BIOL CHEM, V288, P28126, DOI 10.1074/jbc.M113.474494; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; MCEWEN BS, 1963, J BIOL CHEM, V238, P2571; Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170; Munding EM, 2013, MOL CELL, V51, P338, DOI 10.1016/j.molcel.2013.06.012; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; NEIGEBORN L, 1984, GENETICS, V108, P845; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490; Sharmin D, 2014, YEAST, V31, P393, DOI 10.1002/yea.3032; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Venkataramanan S, 2017, NUCLEIC ACIDS RES, V45, P7708, DOI 10.1093/nar/gkx373; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	49	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14851	14866		10.1074/jbc.M117.798397	http://dx.doi.org/10.1074/jbc.M117.798397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739803	Green Published, hybrid			2022-12-28	WOS:000409902100013
J	Chouchani, ET; James, AM; Methner, C; Pell, VR; Prime, TA; Erickson, BK; Forkink, M; Lau, GY; Bright, TP; Menger, KE; Fearnley, IM; Krieg, T; Murphy, MP				Chouchani, Edward T.; James, Andrew M.; Methner, Carmen; Pell, Victoria R.; Prime, Tracy A.; Erickson, Brian K.; Forkink, Marleen; Lau, Gigi Y.; Bright, Thomas P.; Menger, Katja E.; Fearnley, Ian M.; Krieg, Thomas; Murphy, Michael P.			Identification and quantification of protein S-nitrosation by nitrite in the mouse heart during ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; OXIDATIVE STRESS; IN-VIVO; NITROSYLATION; OXIDE; CYSTEINE; NITRATE; SWITCH; PROTEOMICS; INJURY	Nitrate (NO3-) and nitrite (NO2-) are known to be cardioprotective and to alter energy metabolism in vivo. NO3- action results from its conversion to NO2- by salivary bacteria, but the mechanism(s) by which NO2- affects metabolism remains obscure. NO2- may act by S-nitrosating protein thiols, thereby altering protein activity. But how this occurs, and the functional importance of S-nitrosation sites across the mammalian proteome, remain largely uncharacterized. Here we analyzed protein thiols within mouse hearts in vivo using quantitative proteomics to determine S-nitrosation site occupancy. We extended the thiol-redox proteomic technique, isotope-coded affinity tag labeling, to quantify the extent of NO2--dependent S-nitrosation of proteins thiols in vivo. Using this approach, called SNOxICAT (S-nitrosothiol redox isotope-coded affinity tag), we found that exposure to NO2- under normoxic conditions or exposure to ischemia alone results in minimal S-nitrosation of protein thiols. However, exposure to NO2- in conjunction with ischemia led to extensive S-nitrosation of protein thiols across all cellular compartments. Several mitochondrial protein thiols exposed to the mitochondrial matrix were selectively S-nitrosated under these conditions, potentially contributing to the beneficial effects of NO2- on mitochondrial metabolism. The permeability of the mitochondrial inner membrane to HNO2, but not to NO2-, combined with the lack of S-nitrosation during anoxia alone or by NO2- during normoxia places constraints on how S-nitrosation occurs in vivo and on its mechanisms of cardioprotection and modulation of energy metabolism. Quantifying S-nitrosated protein thiols now allows determination of modified cysteines across the proteome and identification of those most likely responsible for the functional consequences of NO2- exposure.	[Chouchani, Edward T.; Erickson, Brian K.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02284 USA; [Chouchani, Edward T.; Erickson, Brian K.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [James, Andrew M.; Prime, Tracy A.; Forkink, Marleen; Lau, Gigi Y.; Bright, Thomas P.; Menger, Katja E.; Fearnley, Ian M.; Murphy, Michael P.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England; [Methner, Carmen; Pell, Victoria R.; Krieg, Thomas] Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chouchani, ET (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02284 USA.; Chouchani, ET (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; James, AM; Murphy, MP (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	EdwardT_Chouchani@dfci.harvard.edu; aj@mrc-mbu.cam.ac.uk; mpm@mrc-mbu.cam.ac.uk	Chouchani, Edward T./HCH-3775-2022; James, Andrew M/A-2639-2015; Murphy, Michael/C-2120-2009	James, Andrew M/0000-0002-0515-9649; Krieg, Thomas/0000-0002-5192-580X; Menger, Katja/0000-0002-6972-7326; Murphy, Michael/0000-0003-1115-9618	Medical Research Council UK [MC_U105663142]; Wellcome Trust Investigator Award [110159/Z/15/Z]; Medical Research Council [MC_U105663142, MR/P000320/1] Funding Source: researchfish; MRC [MR/P000320/1, MC_U105663142] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (MC_U105663142) and by Wellcome Trust Investigator Award 110159/Z/15/Z (to M. P. M). The authors declare that they have no conflicts of interest with the contents of this article.	Aagaard A, 2001, FEBS LETT, V494, P157, DOI 10.1016/S0014-5793(01)02299-2; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Cagney Gerard, 2003, Proteome Sci, V1, P5, DOI 10.1186/1477-5956-1-5; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Feelisch M, 2008, J BIOL CHEM, V283, P33927, DOI 10.1074/jbc.M806654200; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Knoefler D, 2012, MOL CELL, V47, P767, DOI 10.1016/j.molcel.2012.06.016; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kumar V, 2013, FREE RADICAL BIO MED, V58, P109, DOI 10.1016/j.freeradbiomed.2013.01.021; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Menger KE, 2015, CELL REP, V11, P1856, DOI [10.1016/j.celrep.2015.05.033, 10.1016/j.celrep.2015.10.048]; Methner C, 2014, EUR J HEART FAIL, V16, P712, DOI 10.1002/ejhf.100; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Murphy E, 2014, J MOL CELL CARDIOL, V73, P18, DOI 10.1016/j.yjmcc.2014.01.003; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Wang XD, 2006, J BIOL CHEM, V281, P26994, DOI 10.1074/jbc.M603953200; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012	42	29	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14486	14495		10.1074/jbc.M117.798744	http://dx.doi.org/10.1074/jbc.M117.798744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710281	Green Published, hybrid			2022-12-28	WOS:000408747500015
J	Feltham, RL; Moulin, M; Vince, JE; Mace, PD; Wong, WWL; Anderton, H; Day, CL; Vaux, DL; Silke, J				Feltham, Rebecca L.; Moulin, Maryline; Vince, James E.; Mace, Peter D.; Wong, Wendy Wei-Lynn; Anderton, Holly; Day, Catherine L.; Vaux, David L.; Silke, John			Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding (vol 285, pg 17525, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Vaux, David L/0000-0003-2703-1651; Feltham, Rebecca/0000-0001-8376-6869				Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635	1	2	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14310	14310		10.1074/jbc.A109.087635	http://dx.doi.org/10.1074/jbc.A109.087635			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28842477	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000408439800036
J	Johnson, KM; Phan, TTN; Albertolle, ME; Guengerich, FP				Johnson, Kevin M.; Phan, Thanh T. N.; Albertolle, Matthew E.; Guengerich, F. Peter			Human mitochondrial cytochrome P450 27C1 is localized in skin and preferentially desaturates trans-retinol to 3,4-dehydroretinol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN-CLEAVAGE; RATE-LIMITING STEPS; ADRENODOXIN REDUCTASE; HUMAN KERATINOCYTES; ELECTRON-TRANSFER; DRUG-METABOLISM; VITAMIN-A; SUBSTRATE; CHOLESTEROL; ENZYMES	Recently, zebrafish and human cytochrome P450 (P450) 27C1 enzymes have been shown to be retinoid 3,4-desaturases. The enzyme is unusual among mammalian P450s in that the predominant oxidation is a desaturation and in that hydroxylation represents only a minor pathway. We show by proteomic analysis that P450 27C1 is localized to human skin, with two proteins of different sizes present, one being a cleavage product of the full-length form. P450 27C1 oxidized all-trans-retinol to 3,4-dehydroretinol, 4-hydroxy (OH) retinol, and 3-OH retinol in a 100:3:2 ratio. Neither 3-OH nor 4-OH retinol was an intermediate in desaturation. No kinetic burst was observed in the steady state; neither the rate of substrate binding nor product release was rate-limiting. Ferric P450 27C1 reduction by adrenodoxin was 3-fold faster in the presence of the substrate and was similar to 5-fold faster than the overall turnover. Kinetic isotope effects of 1.5-2.3 (on k(cat)/K-m) were observed with 3,3-, 4,4-, and 3,3,4,4-deuterated retinol. Deuteration at C-4 produced a 4-fold increase in 3-hydroxylation due to metabolic switching, with no observable effect on 4-hydroxylation. Deuteration at C-3 produced a strong kinetic isotope effect for 3-hydroxylation but not 4-hydroxylation. Analysis of the products of deuterated retinol showed a lack of scrambling of a putative allylic radical at C-3 and C-4. We conclude that the most likely catalytic mechanism begins with abstraction of a hydrogen atom from C-4 (or possibly C-3) initiating the desaturation pathway, followed by a sequential abstraction of a hydrogen atom or proton-coupled electron transfer. Adrenodoxin reduction and hydrogen abstraction both contribute to rate limitation.	[Johnson, Kevin M.; Phan, Thanh T. N.; Albertolle, Matthew E.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Albertolle, Matthew E./0000-0003-4195-4006; , Thanh Thanh/0000-0002-2727-6133	National Institutes of Health [P30 CA068485]; NATIONAL CANCER INSTITUTE [T32CA009582, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the mass spectrometry and proteomic work was supported in part by National Institutes of Health Grant P30 CA068485 (Vanderbilt-Ingram Cancer Center Support Grant).	Acimovic J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28462; ANDERSSON E, 1994, BBA-MOL CELL RES, V1224, P349, DOI 10.1016/0167-4889(94)90267-4; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Arnqvist L, 2008, PLANTA, V227, P309, DOI 10.1007/s00425-007-0618-8; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Bell SG, 2012, CHEM-EUR J, V18, P16677, DOI 10.1002/chem.201202776; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Cooper HLR, 2012, J AM CHEM SOC, V134, P20365, DOI 10.1021/ja3059149; Daniels F., 1966, PHYS CHEM, P330; Distlerath L. M., 1987, MAMMALIAN CYTOCHROME, V1, P133; Du LP, 2004, TOXICOL APPL PHARM, V195, P278, DOI 10.1016/j.taap.2003.09.020; Enright JM, 2015, CURR BIOL, V25, P3048, DOI 10.1016/j.cub.2015.10.018; FASCO MJ, 1978, J MED CHEM, V21, P1054, DOI 10.1021/jm00208a009; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guan XM, 1998, CHEM-BIOL INTERACT, V110, P103, DOI 10.1016/S0009-2797(97)00145-2; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2013, J LABELLED COMPD RAD, V56, P428, DOI 10.1002/jlcr.3031; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P413, DOI 10.1021/tx00022a003; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; HUME R, 1984, EUR J BIOCHEM, V140, P583, DOI 10.1111/j.1432-1033.1984.tb08142.x; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; Ji L, 2015, CHEM-EUR J, V21, P9083, DOI 10.1002/chem.201500329; Johnson Kenneth A., 2003, P1; KATAGIRI M, 1977, BIOCHEM BIOPH RES CO, V77, P804, DOI 10.1016/S0006-291X(77)80049-1; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kramlinger VM, 2016, FEBS LETT, V590, P1304, DOI 10.1002/1873-3468.12167; Kumar D, 2004, J AM CHEM SOC, V126, P5072, DOI 10.1021/ja0318737; LAMBETH JD, 1980, J BIOL CHEM, V255, P4667; LAMBETH JD, 1979, J BIOL CHEM, V254, P7255; LAMBETH JD, 1977, J BIOL CHEM, V252, P2908; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MASSEY V, 1977, J BIOL CHEM, V252, P5612; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Nelson David R., 2009, Human Genomics, V4, P59; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Oesch F, 2007, DRUG METAB REV, V39, P659, DOI 10.1080/03602530701690366; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Palfey Bruce A., 2003, P203; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Popa C, 1999, BRIT J DERMATOL, V141, P460; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; RETTIE AE, 1988, J BIOL CHEM, V263, P13733; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; Rishavy MA, 2013, J BIOL CHEM, V288, P31556, DOI 10.1074/jbc.M113.497297; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Schiffler B, 2004, J BIOL CHEM, V279, P34269, DOI 10.1074/jbc.M402798200; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; SEYBERT DW, 1978, J BIOL CHEM, V253, P8355; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Skaggs BA, 1996, GENE, V169, P105, DOI 10.1016/0378-1119(95)00770-9; STEVENS VL, 1984, J BIOL CHEM, V259, P1174; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Swanson HI, 2004, CHEM-BIOL INTERACT, V149, P69, DOI 10.1016/j.cbi.2004.08.006; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tafrova JI, 2012, MOL CELL BIOCHEM, V364, P351, DOI 10.1007/s11010-012-1237-7; THOMAS PE, 1979, ARCH BIOCHEM BIOPHYS, V192, P524, DOI 10.1016/0003-9861(79)90122-X; TORMA H, 1994, J INVEST DERMATOL, V102, P49, DOI 10.1111/1523-1747.ep12371731; TORMA H, 1985, J INVEST DERMATOL, V85, P498, DOI 10.1111/1523-1747.ep12277290; Tuckey RC, 1997, EUR J BIOCHEM, V244, P835, DOI 10.1111/j.1432-1033.1997.00835.x; TUCKEY RC, 1982, J BIOL CHEM, V257, P9309; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VAHLQUIST A, 1982, J INVEST DERMATOL, V79, P94, DOI 10.1111/1523-1747.ep12500033; Vahlquist A, 1996, J INVEST DERMATOL, V106, P1070, DOI 10.1111/1523-1747.ep12339284; VAHLQUIST A, 1980, EXPERIENTIA, V36, P317, DOI 10.1007/BF01952299; Wang B, 2016, J AM CHEM SOC, V138, P2426, DOI 10.1021/jacs.5b13500; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; Whitehouse CJC, 2008, CHEM-EUR J, V14, P10905, DOI 10.1002/chem.200801927; Wu ZL, 2006, ARCH BIOCHEM BIOPHYS, V445, P138, DOI 10.1016/j.abb.2005.11.002; Yengi LG, 2003, ANAL BIOCHEM, V316, P103, DOI 10.1016/S0003-2697(03)00042-3; Yoshimoto FK, 2016, J AM CHEM SOC, V138, P12124, DOI 10.1021/jacs.6b04437; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200	95	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13672	13687		10.1074/jbc.M116.773937	http://dx.doi.org/10.1074/jbc.M116.773937			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28701464	hybrid, Green Published			2022-12-28	WOS:000407942400011
J	Gonzalez, E; Guengerich, FP				Gonzalez, Eric; Guengerich, F. Peter			Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED 17,20-LYASE DEFICIENCY; PROSTATE-CANCER; ORTERONEL TAK-700; 17-ALPHA-HYDROXYLASE-17,20-LYASE CYP17; MICROSOMAL CYTOCHROME-P-450; HUMAN P450C17; ACTIVE-SITE; B(5); INHIBITOR; ENZYMES	Cytochrome P450 (P450, CYP) 17A1 plays a critical role in steroid metabolism, catalyzing both the 17 alpha-hydroxylation of pregnenolone and progesterone and the subsequent 17 alpha,20-lyase reactions to form dehydroepiandrosterone (DHEA) and androstenedione (Andro), respectively, critical for generating glucocorticoids and androgens. Human P450 17A1 reaction rates examined are enhanced by the accessory protein cytochrome b(5) (b(5)), but the exact role of b(5) in P450 17A1-catalyzed reactions is unclear as are several details of these reactions. Here, we examined in detail the processivity of the 17 alpha-hydroxylation and lyase steps. b(5) did not enhance reaction rates by decreasing the k(off) rates of any of the steroids. Steroid binding to P450 17A1 was more complex than a simple two-state system. Pre-steady-state experiments indicated lag phases for Andro production from progesterone and for DHEA from pregnenolone, indicating a distributive character of the enzyme. However, we observed processivity in pregnenolone/DHEA pulse-chase experiments. (S)-Orteronel was three times more inhibitory toward the conversion of 17 alpha hydroxypregnenolone to DHEA than toward the 17 alpha-hydroxylation of pregnenolone. IC50 values for (S)-orteronel were identical for blocking DHEA formation from pregnenolone and for 17 alpha-hydroxylation, suggestive of processivity. Global kinetic modeling helped assign sets of rate constants for individual or groups of reactions, indicating that human P450 17A1 is an inherently distributive enzyme but that some processivity is present, i.e. some of the 17 alpha-OH pregnenolone formed from pregnenolone did not dissociate from P450 17A1 before conversion to DHEA. Our results also suggest multiple conformations of P450 17A1, as previously proposed on the basis of NMR spectroscopy and X-ray crystallography.	[Gonzalez, Eric; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 GM118122, R01 GM103937, T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, R01GM103937, R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.), R01 GM103937 (to F. P. G.), and T32 ES007028 (to E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Duggal R, 2016, BIOCHEM BIOPH RES CO, V477, P202, DOI 10.1016/j.bbrc.2016.06.043; ESTABROOK RW, 1971, BIOCHEM BIOPH RES CO, V42, P132, DOI 10.1016/0006-291X(71)90372-X; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Gan L, 2009, DRUG METAB DISPOS, V37, P90, DOI 10.1124/dmd.108.023424; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2017, CHEM RES TOXICOL, V30, P2, DOI 10.1021/acs.chemrestox.6b00226; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2013, J LABELLED COMPD RAD, V56, P428, DOI 10.1002/jlcr.3031; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; HAMAMOTO I, 1986, J BIOCHEM-TOKYO, V99, P1743, DOI 10.1093/oxfordjournals.jbchem.a135651; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hara T, 2013, J STEROID BIOCHEM, V134, P80, DOI 10.1016/j.jsbmb.2012.10.020; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Huggins C, 1940, J UROLOGY, V43, P705, DOI 10.1016/S0022-5347(17)71453-X; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; KOMINAMI S, 1992, J STEROID BIOCHEM, V42, P57, DOI 10.1016/0960-0760(92)90011-7; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUHNVELTEN WN, 1991, J BIOL CHEM, V266, P6291; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lee-Robichaud P, 1998, BIOCHEM J, V332, P293, DOI 10.1042/bj3320293; LEEROBICHAUD P, 1995, BIOCHEMISTRY-US, V34, P14104, DOI 10.1021/bi00043a015; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; McLaughlin LA, 2010, MOL PHARMACOL, V78, P269, DOI 10.1124/mol.110.064246; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; Njar VCO, 2015, J MED CHEM, V58, P2077, DOI 10.1021/jm501239f; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Rafferty SW, 2014, BIOORG MED CHEM LETT, V24, P2444, DOI 10.1016/j.bmcl.2014.04.024; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Soucy P, 2000, EUR J BIOCHEM, V267, P3243, DOI 10.1046/j.1432-1327.2000.01349.x; TAGASHIRA H, 1995, BIOCHEMISTRY-US, V34, P10939, DOI 10.1021/bi00034a028; Toren PJ, 2015, MOL CANCER THER, V14, P59, DOI 10.1158/1535-7163.MCT-14-0521; Turcu AF, 2015, J CLIN ENDOCR METAB, V100, P2283, DOI 10.1210/jc.2015-1023; Yadav R, 2017, MOL CELL ENDOCRINOL, V441, P68, DOI 10.1016/j.mce.2016.08.035; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YAMAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1125, P335; Yin LN, 2014, NAT REV UROL, V11, P32, DOI 10.1038/nrurol.2013.274; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	68	24	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13168	13185		10.1074/jbc.M117.794917	http://dx.doi.org/10.1074/jbc.M117.794917			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28684414	Green Published, hybrid			2022-12-28	WOS:000407465300008
J	Liu, JZ; Duan, JC; Ni, M; Liu, Z; Qiu, WL; Whitham, SA; Qian, WJ				Liu, Jian-Zhong; Duan, Jicheng; Ni, Min; Liu, Zhen; Qiu, Wen-Li; Whitham, Steven A.; Qian, Wei-Jun			S-Nitrosylation inhibits the kinase activity of tomato phosphoinositide-dependent kinase 1 (PDK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; nitric oxide; nitrosylation; phosphorylation; protein kinase; phosphoinositide-dependent kinase	APOPTOTIC CELL-DEATH; NITRIC-OXIDE; ASCORBATE PEROXIDASE; ARABIDOPSIS-THALIANA; PROTEIN; IDENTIFICATION; NITROSOTHIOLS; TOBACCO; COMPLEX; IMMUNITY	It is well known that the reactive oxygen species NO can trigger cell death in plants and other organisms, but the underlying molecular mechanisms are not well understood. Here we provide evidence that NO may trigger cell death in tomato (Solanum lycopersicum) by inhibiting the activity of phosphoinositide-dependent kinase 1 (SlPDK1), a conserved negative regulator of cell death in yeasts, mammals, and plants, via S-nitrosylation. Biotin-switch assays indicated that SlPDK1 is a target of S-nitrosylation. Moreover, the kinase activity of SlPDK1 was inhibited by S-nitrosoglutathione in a concentration-dependent manner, indicating that SlPDK1 activity is abrogated by S-nitrosylation. The S-nitrosoglutathione-induced inhibition was reversible in the presence of a reducing agent but additively enhanced by hydrogen peroxide (H2O2). Our LC-MS/MS analyses further indicated that SlPDK1 is primarily S-nitrosylated on a cysteine residue at position 128 (Cys(128)), and substitution of Cys(128) with serine completely abolished SlPDK1 kinase activity, suggesting that S-nitrosylation of Cys(128) is responsible for SlPDK1 inhibition. In summary, our results establish a potential link between NO-triggered cell death and inhibition of the kinase activity of tomato PDK1.	[Liu, Jian-Zhong; Ni, Min; Liu, Zhen] Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China; [Duan, Jicheng; Qian, Wei-Jun] Pacific Northwest Natl Lab, Div Biol Sci, Integrat Om, Richland, WA 99352 USA; [Qiu, Wen-Li; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Zhejiang Normal University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Iowa State University	Liu, JZ (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China.	jzliu@zjnu.cn	Qian, Wei-Jun/C-6167-2011; QIAN, Wei-Jun/AAC-1907-2021	QIAN, Wei-Jun/0000-0002-5393-2827; Liu, Jianzhong/0000-0001-7826-7045	Department of Energy [DE-AC05-76RL0 1830]	Department of Energy(United States Department of Energy (DOE))	We thank Prof. Gregory Martin and Dr. Timothy P Devarenne for providing the MBP-SlPDK1, MBP-Adi3, and MBP-Adi3<SUP>K337Q</SUP> constructs. We also thank Prof. Meihao Sun for providing technical support with protein purification. The mass spectrometry analyses were performed in the Environmental Molecular Sciences Laboratory, a Department of Energy national scientific user facility located at Pacific Northwest National Laboratory that is operated by the Battelle Memorial Institute for the Department of Energy under Contract DE-AC05-76RL0 1830.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Astier J, 2012, INT J MOL SCI, V13, P15193, DOI 10.3390/ijms131115193; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chen RQ, 2009, CELL RES, V19, P1377, DOI 10.1038/cr.2009.117; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Choudhary G, 2003, J PROTEOME RES, V2, P59, DOI 10.1021/pr025557n; de Pinto MC, 2013, PLANT PHYSIOL, V163, P1766, DOI 10.1104/pp.113.222703; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; Desai S, 2011, BBA-MOL CELL RES, V1813, P1190, DOI 10.1016/j.bbamcr.2011.03.007; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duan JC, 2017, MOL BIOSYST, V13, P816, DOI 10.1039/c6mb00861e; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Grennan AK, 2007, PLANT PHYSIOL, V144, P1237, DOI 10.1104/pp.104.900228; Han SJ, 2015, PLANT CELL, V27, P1316, DOI 10.1105/tpc.114.134692; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hu JL, 2015, PLANT PHYSIOL, V167, P1731, DOI 10.1104/pp.15.00026; Jaffrey S.R., 2001, SCI STKE, V2001, DOI [10.1126/stke.2001.86.pl1, DOI 10.1126/STKE.2001.86.PL1]; Jeon BW, 2002, J BIOCHEM, V131, P693, DOI 10.1093/oxfordjournals.jbchem.a003153; Keyster M, 2011, PLANT SIGNAL BEHAV, V6, P956, DOI 10.4161/psb.6.7.14879; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Li HL, 2013, ACTA BIOCH BIOPH SIN, V45, P153, DOI 10.1093/abbs/gms103; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu MA, 2010, ANAL CHEM, V82, P7160, DOI 10.1021/ac100569d; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu XM, 2005, J MASS SPECTROM, V40, P1140, DOI 10.1002/jms.885; Mannick JB, 2007, AMINO ACIDS, V32, P523, DOI 10.1007/s00726-006-0427-6; Mengel A, 2017, PLANT PHYSIOL, V173, P1434, DOI 10.1104/pp.16.01734; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sell S, 2008, METHOD ENZYMOL, V440, P283, DOI 10.1016/S0076-6879(07)00818-X; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Venigalla RKC, 2013, EMBO J, V32, P1008, DOI 10.1038/emboj.2013.40; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang PC, 2015, P NATL ACAD SCI USA, V112, P613, DOI 10.1073/pnas.1423481112; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang X, 2012, PROTEIN CELL, V3, P929, DOI 10.1007/s13238-012-2094-6; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	60	15	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19743	19751		10.1074/jbc.M117.803882	http://dx.doi.org/10.1074/jbc.M117.803882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972151	hybrid, Green Published			2022-12-28	WOS:000416911300019
J	Todaro, DR; Augustus-Wallace, AC; Klein, JM; Haas, AL				Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.			The mechanism of neural precursor cell expressed developmentally down-regulated 4-2 (Nedd4-2)/NEDD4L-catalyzed polyubiquitin chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; enzyme kinetics; enzyme mechanism; polyubiquitin chain; protein-protein interaction; ubiquitin; ubiquitylation (ubiquitination); linkage specificity; thiol exchange	UBIQUITIN-PROTEIN LIGASES; EPITHELIAL NA+ CHANNEL; C2 DOMAIN; CONJUGATING ENZYMES; BINDING DOMAINS; HECT DOMAIN; WW DOMAIN; NEDD4; DEGRADATION; SPECIFICITY	The mechanism of Nedd4-2 has been quantitatively explored for the first time using biochemically defined kinetic assays examining rates of I-125-polyubiquitin chain assembly as a functional readout. We demonstrate that Nedd4-2 exhibits broad specificity for E2 paralogs of the Ubc4/5 clade to assemble Lys(63)-linked polyubiquitin chains. Full-length Nedd4-2 catalyzes free I-125-polyubiquitin chain assembly by hyperbolic Michaelis-Menten kinetics with respect to Ubc5B approximate to ubiquitin thioester concentration (K-m = 44 +/- 6 nm; k(cat) = 0.020 +/- 0.007 s(-1)) and substrate inhibition above 0.5 m (K-i = 2.5 +/- 1.3 m) that tends to zero velocity, requiring ordered binding at two functionally distinct E2 approximate to ubiquitin-binding sites. The Ubc5BC85A product analog non-competitively inhibits Nedd4-2 (K-i = 2.0 +/- 0.5 m), consistent with the presence of the second E2-binding site. In contrast, the isosteric Ubc5BC85S-ubiquitin oxyester substrate analog exhibits competitive inhibition at the high-affinity Site 1 (K-i = 720 +/- 340 nm) and non-essential activation at the lower-affinity Site 2 (K-act = 750 +/- 260 nm). Additional studies utilizing Ubc5BF62A, defective in binding the canonical E2 site, demonstrate that the cryptic Site 1 is associated with thioester formation, whereas binding at the canonical site (Site 2) is associated with polyubiquitin chain elongation. Finally, previously described Ca2+-dependent C2 domain-mediated autoinhibition of Nedd4-2 is not observed under our reported experimental conditions. These studies collectively demonstrate that Nedd4-2 catalyzes polyubiquitin chain assembly by an ordered two-step mechanism requiring two dynamically linked E2 approximate to ubiquitin-binding sites analogous to that recently reported for E6AP, the founding member of the Hect ligase family.	[Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106392, R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034009 (to A. L. H.) and an appropriation from the Louisiana State University School of Medicine (New Orleans, LA). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Garrone NF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-26; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar B, 2010, J BIOL CHEM, V285, P41300, DOI 10.1074/jbc.M110.169136; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SEGAL IH, 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	70	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19521	19536		10.1074/jbc.M117.817882	http://dx.doi.org/10.1074/jbc.M117.817882			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972136	Green Published, hybrid			2022-12-28	WOS:000416226700030
J	Guzman, RE; Bungert-Plumke, S; Franzen, A; Fahlke, C				Guzman, Raul E.; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph			Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; protein sorting; protein-protein interaction; trafficking; transporter; ClC-3; ClC-4; chloride; proton exchanger; intracellular compartments; sorting signals	TRANSMEMBRANE CONDUCTANCE REGULATOR; MUSCLE CHLORIDE CHANNELS; ENDOPLASMIC-RETICULUM; FUNCTIONAL-CHARACTERIZATION; SUBUNIT STOICHIOMETRY; CYTOPLASMIC DOMAIN; LENTIVIRAL VECTORS; PLASMA-MEMBRANE; LIVING CELLS; PROTEIN	ClC-4 is an intracellular Cl-/H+ exchanger that is highly expressed in the brain and whose dysfunction has been linked to intellectual disability and epilepsy. Here we studied the subcellular localization of human ClC-4 in heterologous expression systems. ClC-4 is retained in the endoplasmic reticulum (ER) upon overexpression in HEK293T cells. Co-expression with distinct ClC-3 splice variants targets ClC-4 to late endosome/lysosomes (ClC-3a and ClC-3b) or recycling endosome (ClC-3c). When expressed in cultured astrocytes, ClC-4 sorted to endocytic compartments in WT cells but was retained in the ER in Clcn3(-/-) cells. To understand the virtual absence of ER-localized ClC-4 in WT astrocytes, we performed association studies by high-resolution clear native gel electrophoresis. Although other CLC channels and transporters form stable dimers, ClC-4 was mostly observed as monomer, with ClC-3-ClC-4 heterodimers being more stable than ClC-4 homodimers. We conclude that unique oligomerization properties of ClC-4 permit regulated targeting of ClC-4 to various endosomal compartment systems via expression of different ClC-3 splice variants.	[Guzman, Raul E.; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Guzman, RE; Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany.	r.guzman@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X				Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chadda R, 2016, ELIFE, V5, DOI 10.7554/eLife.17438; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Eggermont J, 1997, BIOCHEM J, V325, P269, DOI 10.1042/bj3250269; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Guzman RE, 2015, J BIOL CHEM, V290, P25851, DOI 10.1074/jbc.M115.668186; Guzman RE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00143; Guzman RE, 2013, ACS CHEM NEUROSCI, V4, P994, DOI 10.1021/cn400032z; Guzman RE, 2010, J NEUROSCI, V30, P10272, DOI 10.1523/JNEUROSCI.1551-10.2010; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; McMains E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017647; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mohammad-Panah R, 2002, J BIOL CHEM, V277, P566, DOI 10.1074/jbc.M106968200; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Palmer EE, 2018, MOL PSYCHIATR, V23, P222, DOI 10.1038/mp.2016.135; Parkerson KA, 2004, GLIA, V46, P419, DOI 10.1002/glia.10361; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Ronstedt K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15382; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; Schmieder S, 2001, BIOCHEM BIOPH RES CO, V286, P635, DOI 10.1006/bbrc.2001.5407; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Stolting G, 2015, J BIOL CHEM, V290, P30406, DOI 10.1074/jbc.M115.675827; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	57	14	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19055	19065		10.1074/jbc.M117.801951	http://dx.doi.org/10.1074/jbc.M117.801951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972156	hybrid, Green Published			2022-12-28	WOS:000415848000028
J	Mulero, MC; Huang, DB; Nguyen, HT; Wang, VYF; Li, YD; Biswas, T; Ghosh, G				Mulero, Maria Carmen; Huang, De-Bin; Thien Nguyen, H.; Wang, Vivien Ya-Fan; Li, Yidan; Biswas, Tapan; Ghosh, Gourisankar			DNA-binding affinity and transcriptional activity of the RelA homodimer of nuclear factor B are not correlated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; crystal structure; dimerization; DNA transcription; NF-kB transcription factor; E-selectin; RelA; kB site	NF-KAPPA-B; ACTIVATION; COMPLEXES; DIMERS; SITES; CRYSTALLIZATION; SUBUNIT	The nuclear factor B (NF-B) transcription factor family regulates genes involved in cell proliferation and inflammation. The promoters of these genes often contain NF-B-binding sites (B sites) arranged in tandem. How NF-B activates transcription through these multiple sites is incompletely understood. We report here an X-ray crystal structure of homodimers comprising the RelA DNA-binding domain containing the Rel homology region (RHR) in NF-B bound to an E-selectin promoter fragment with tandem B sites. This structure revealed that two dimers bind asymmetrically to the symmetrically arranged B sites at which multiple cognate contacts between one dimer to the corresponding DNA are broken. Because simultaneous RelA-RHR dimer binding to tandem sites in solution was anti-cooperative, we inferred that asymmetric RelA-RHR binding with fewer contacts likely indicates a dissociative binding mode. We found that both B sites are essential for reporter gene activation by full-length RelA homodimer, suggesting that dimers facilitate DNA binding to each other even though their stable co-occupation is not promoted. Promoter variants with altered spacing and orientation of tandem B sites displayed unexpected reporter activities that were not explained by the solution-binding pattern of RelA-RHR. Remarkably, full-length RelA bound all DNAs with a weaker affinity and specificity. Moreover, the transactivation domain played a negative role in DNA binding. These observations suggest that other nuclear factors influence full-length RelA binding to DNA by neutralizing the transactivation domain negative effect. We propose that DNA binding by NF-B dimers is highly complex and modulated by facilitated association-dissociation processes.	[Mulero, Maria Carmen; Huang, De-Bin; Thien Nguyen, H.; Wang, Vivien Ya-Fan; Li, Yidan; Biswas, Tapan; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Wang, Vivien Ya-Fan] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	University of California System; University of California San Diego; University of Macau	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [GM085490]; University of Macau [SRG2016-00084-FHS]; Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Macau; Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM085490 (to G. G.) and Start-up Research Grant SRG2016-00084-FHS from the University of Macau (to V. Y. F. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Biochemistry of Growth Regulation and Oncogenesis T32 Training Grant from the NCI, National Institutes of Health.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Choy MK, 2010, GENOME MED, V2, DOI 10.1186/gm158; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Huxford T, 2000, J BIOL CHEM, V275, P32800, DOI 10.1074/jbc.M006037200; JOACHIMIAK A, 1991, METHOD ENZYMOL, V208, P82; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Xing YJ, 2013, GENE, V526, P142, DOI 10.1016/j.gene.2013.05.001	26	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18821	18830		10.1074/jbc.M117.813980	http://dx.doi.org/10.1074/jbc.M117.813980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28935669	hybrid, Green Published			2022-12-28	WOS:000415848000008
J	Huffaker, TB; Lee, SH; Tang, WW; Wallace, JA; Alexander, M; Runtsch, MC; Larsen, DK; Thompson, J; Ramstead, AG; Voth, WP; Hu, RZ; Round, JL; Williams, MA; O'Connell, RM				Huffaker, Thomas B.; Lee, Soh-Hyun; Tang, William W.; Wallace, Jared A.; Alexander, Margaret; Runtsch, Marah C.; Larsen, Dane K.; Thompson, Jacob; Ramstead, Andrew G.; Voth, Warren P.; Hu, Ruozhen; Round, June L.; Williams, Matthew A.; O'Connell, Ryan M.			Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; leukocyte; microRNA (miRNA); tumor immunology; tumor microenvironment; T cell; miR-155	TUMOR-ASSOCIATED MACROPHAGES; UNTREATED MELANOMA; SUPPRESSOR-CELLS; MIR-155; CANCER; IPILIMUMAB; EXPRESSION; NIVOLUMAB; MICRORNAS; THERAPY	MicroRNA-155 (miR-155) regulates antitumor immune responses. However, its specific functions within distinct immune cell types have not been delineated in conditional KO mouse models. In this study, we investigated the role of miR-155 specifically within T cells during the immune response to syngeneic tumors. We found that miR-155 expression within T cells is required to limit syngeneic tumor growth and promote IFN production by T cells within the tumor microenvironment. Consequently, we found that miR-155 expression by T cells is necessary for proper tumor-associated macrophage expression of IFN-inducible genes. We also found that immune checkpoint-blocking (ICB) antibodies against programmed cell death protein 1/programmed death ligand 1 (PD-1/PD-L1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) restored antitumor immunity in miR-155 T cell-conditional KO mice. We noted that these ICB antibodies rescued the levels of IFN-expressing T cells, expression of multiple activation and effector genes expressed by tumor-infiltrating CD8(+) and CD4(+) T cells, and tumor-associated macrophage activation. Moreover, the ICB approach partially restored expression of several derepressed miR-155 targets in tumor-infiltrating, miR-155-deficient CD8(+) T cells, suggesting that miR-155 and ICB regulate overlapping pathways to promote antitumor immunity. Taken together, our findings highlight the multifaceted role of miR-155 in T cells, in which it promotes antitumor immunity. These results suggest that the augmentation of miR-155 expression could be used to improve anticancer immunotherapies.	[Huffaker, Thomas B.; Lee, Soh-Hyun; Tang, William W.; Wallace, Jared A.; Alexander, Margaret; Runtsch, Marah C.; Larsen, Dane K.; Thompson, Jacob; Ramstead, Andrew G.; Voth, Warren P.; Hu, Ruozhen; Round, June L.; Williams, Matthew A.; O'Connell, Ryan M.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	O'Connell, RM (corresponding author), Univ Utah, Sch Med, Dept Pathol, 15 N Med Dr E,JMRB4280, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu		Tang, William/0000-0001-7036-6460; Williams, Matthew/0000-0002-4721-4482; Thompson, Jacob/0000-0002-0952-5765; Larsen, Dane/0000-0002-9841-1443; Alexander, Margaret/0000-0003-2972-7521	American Cancer Society scholar award; NIA, National Institutes of Health Grant [RO1AG047956]; NCI, National Institutes of Health Grant [F30CA189731]; NATIONAL CANCER INSTITUTE [F30CA189731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047956] Funding Source: NIH RePORTER	American Cancer Society scholar award(American Cancer Society); NIA, National Institutes of Health Grant; NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided by an American Cancer Society scholar award (to R. M. O.); NIA, National Institutes of Health Grant RO1AG047956 (to R. M. O.); and NCI, National Institutes of Health Grant F30CA189731 (to T. B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen SQ, 2015, CANCER RES, V75, P519, DOI 10.1158/0008-5472.CAN-14-2331; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Hu RZ, 2013, J IMMUNOL, V190, P5972, DOI 10.4049/jimmunol.1300351; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Ji Y, 2015, P NATL ACAD SCI USA, V112, P476, DOI 10.1073/pnas.1422916112; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wang JF, 2015, INT J CANCER, V136, pE602, DOI 10.1002/ijc.29151; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yu F, 2013, MOL CANCER RES, V11, P923, DOI 10.1158/1541-7786.MCR-12-0686; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306	40	52	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18530	18541		10.1074/jbc.M117.808121	http://dx.doi.org/10.1074/jbc.M117.808121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28912267	Green Published, hybrid			2022-12-28	WOS:000414958100012
J	Yanda, MK; Liu, QN; Cebotaru, V; Guggino, WB; Cebotaru, L				Yanda, Murali K.; Liu, Qiangni; Cebotaru, Valeriu; Guggino, William B.; Cebotaru, Liudmila			Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; CELL-PROLIFERATION; EPITHELIAL-CELLS; TUMOR PROMOTER; GROWTH; TUBULIN; THAPSIGARGIN; CALMODULIN; TRANSPORT; CHANNELS	Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of multiple renal cysts, often leading to renal failure that cannot be prevented by a current treatment. Two proteins encoded by two genes are associated with ADPKD: PC1 (pkd1), primarily a signaling molecule, and PC2 (pkd2), a Ca2+ channel. Dysregulation of cAMP signaling is central to ADPKD, but the molecular mechanism is unresolved. Here, we studied the role of histone deacetylase 6 (HDAC6) in regulating cyst growth to test the possibility that inhibiting HDAC6 might help manage ADPKD. Chemical inhibition of HDAC6 reduced cyst growth in PC1-knock-out mice. In proximal tubule-derived, PC1-knock-out cells, adenylyl cyclase 6 and 3 (AC6 and-3) are both expressed. AC6 protein expression was higher in cells lacking PC1, compared with control cells containing PC1. Intracellular Ca2+ was higher in PC1knock-out cells than in control cells. HDAC inhibition caused a drop in intracellular Ca(2+)and increased ATP-simulated Ca2+ release. HDAC6 inhibition reduced the release of Ca(2+)from the endoplasmic reticulum induced by thapsigargin, an inhibitor of endoplasmic reticulum Ca2+-ATPase. HDAC6 inhibition and treatment of cells with the intracellular Ca2+ chelator 1,2-bis(2aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis(acetoxymethyl ester) reduced cAMP levels in PC1-knock-out cells. Finally, the calmodulin inhibitors W-7 and W-13 reduced cAMPlevels, andW-7reduced cyst growth, suggesting thatAC3 is involved in cyst growth regulated by HDAC6. We conclude that HDAC6 inhibition reduces cell growth primarily by reducing intracellular cAMP and Ca2+ levels. Our results provide potential therapeutic targets that may be useful as treatments for ADPKD.	[Yanda, Murali K.; Liu, Qiangni; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Cebotaru, L (corresponding author), Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Wood Basic Sci Bldg,Rm 414,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Yanda, Murali K/N-2324-2019	Yanda, Murali K/0000-0002-4913-470X	National Institutes of Health [P30 DK079310]; NIDDK [P30 DK090868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, P30DK090868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Debbie McClellan for editing the manuscript. We are grateful to S. Somlo for kindly providing the PH2 and PN18 cells though the George M. O'Brien Kidney Center at Yale University (supported by National Institutes of Health Grant P30 DK079310). These studies utilized resources provided by the NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center (Grant P30 DK090868).	Aalbers CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130612; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Chang MY, 2013, BRIT J CLIN PHARMACO, V76, P524, DOI 10.1111/bcp.12136; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; CONIGRAVE AD, 1995, CELL CALCIUM, V17, P111, DOI 10.1016/0143-4160(95)90080-2; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Li H, 2015, EUR J PHARMACOL, V750, P14, DOI 10.1016/j.ejphar.2014.12.026; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Liu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042408; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Mangolini Alessandra, 2016, World J Nephrol, V5, P76, DOI 10.5527/wjn.v5.i1.76; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Rees S, 2014, J AM SOC NEPHROL, V25, P232, DOI 10.1681/ASN.2013010077; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF701, DOI 10.1152/ajprenal.00656.2013; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Schwiebert EM, 2002, AM J PHYSIOL-RENAL, V282, pF763, DOI 10.1152/ajprenal.0337.2000; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Shen TS, 1997, AM J PHYSIOL-CELL PH, V273, pC323, DOI 10.1152/ajpcell.1997.273.1.C323; Silva M, 2017, CURR BIOL, V27, P968, DOI 10.1016/j.cub.2017.02.039; Simoes-Pires CA, 2017, EXPERT OPIN THER PAT, V27, P229, DOI 10.1080/13543776.2017.1282945; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Strait KA, 2010, AM J PHYSIOL-RENAL, V298, pF859, DOI 10.1152/ajprenal.00109.2009; Su Min, 2010, Sheng Li Ke Xue Jin Zhan, V41, P112; Terryn S, 2011, BBA-MOL BASIS DIS, V1812, P1314, DOI 10.1016/j.bbadis.2011.01.011; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres V E, 2007, Minerva Med, V98, P669; Torres VE, 2015, ANNU REV MED, V66, P195, DOI 10.1146/annurev-med-050913-022838; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Wilson PD, 1999, EXP NEPHROL, V7, P114; Woodward OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012305; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhou X, 2014, HUM MOL GENET, V23, P1644, DOI 10.1093/hmg/ddt556	55	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17897	17908		10.1074/jbc.M117.803775	http://dx.doi.org/10.1074/jbc.M117.803775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887310	Green Published, hybrid			2022-12-28	WOS:000414013000025
J	Gupta, P; Zhang, ZF; Sugiman-Marangos, SN; Tam, J; Raman, S; Julien, JP; Kroh, HK; Lacy, DB; Murgolo, N; Bekkari, K; Therien, AG; Hernandez, LD; Melnyk, RA				Gupta, Pulkit; Zhang, Zhifen; Sugiman-Marangos, Seiji N.; Tam, John; Raman, Swetha; Julien, Jean-Phillipe; Kroh, Heather K.; Lacy, D. Borden; Murgolo, Nicholas; Bekkari, Kavitha; Therien, Alex G.; Hernandez, Lorraine D.; Melnyk, Roman A.			Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS TPEL TOXIN; CRYSTAL-STRUCTURE; RHO-PROTEINS; MECHANISM; ANTIBODY; TRANSLOCATION; BEZLOTOXUMAB; ENTEROTOXIN; ACTOXUMAB; EPITOPES	Clostridium difficile is a major nosocomial pathogen that produces two exotoxins, TcdA and TcdB, with TcdB thought to be the primary determinant in human disease. TcdA and TcdB are large, multidomain proteins, each harboring a cytotoxic glucosyltransferase domain that is delivered into the cytosol from endosomes via a translocation domain after receptor-mediated endocytosis of toxins from the cell surface. Although there are currently no known host cell receptors for TcdA, three cell-surface receptors for TcdB have been identified: CSPG4, NECTIN3, and FZD1/2/7. The sites on TcdB that mediate binding to each receptor are not defined. Furthermore, it is not known whether the combined repetitive oligopeptide (CROP) domain is involved in or required for receptor binding. Here, in a screen designed to identify sites in TcdB that are essential for target cell intoxication, we identified a region at the junction of the translocation and the CROP domains that is implicated in CSPG4 binding. Using a series of C-terminal truncations, we show that the CSPG4-binding site on TcdB extends into the CROP domain, requiring three short repeats for binding and for full toxicity on CSPG4-expressing cells. Consistent with the location of the CSPG4-binding site on TcdB, we show that the anti-TcdB antibody bezlotoxumab, which binds partially within the first three short repeats, prevents CSPG4 binding to TcdB. In addition to establishing the binding region for CSPG4, this work ascribes for the first time a role in TcdB CROPs in receptor binding and further clarifies the relative roles of host receptors in TcdB pathogenesis.	[Gupta, Pulkit; Murgolo, Nicholas; Bekkari, Kavitha; Therien, Alex G.; Hernandez, Lorraine D.] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Zhang, Zhifen; Sugiman-Marangos, Seiji N.; Tam, John; Raman, Swetha; Julien, Jean-Phillipe; Melnyk, Roman A.] Hosp Sick Children, Mol Med, Toronto, ON M5G 0A4, Canada; [Zhang, Zhifen; Julien, Jean-Phillipe; Melnyk, Roman A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Kroh, Heather K.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA	Merck & Company; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Vanderbilt University; Vanderbilt University; Vanderbilt University	Melnyk, RA (corresponding author), Hosp Sick Children, 686 Bay St, Toronto, ON M5G 0A4, Canada.	roman.melnyk@sickkids.ca	Therien, Alex/AAS-8437-2021; Lacy, D. Borden/AFQ-2203-2022; Melnyk, Roman/GQA-9908-2022	Sugiman-Marangos, Seiji/0000-0002-8475-5456; Julien, Jean-Philippe/0000-0001-7602-3995; Lacy, Borden/0000-0003-2273-8121	Canadian Institutes of Health Research; Merck, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Merck, Inc.(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Canadian Institutes of Health Research and by Merck, Inc. P.G., N.M., K.B., A.G.T., and L.D.H. are employees of Merck, Inc.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Gerhard R, 2013, J MED MICROBIOL, V62, P1414, DOI 10.1099/jmm.0.057828-0; Guttenberg G, 2012, J BIOL CHEM, V287, P24929, DOI 10.1074/jbc.M112.347773; Haimes J., 2010, DEMONSTRATION DELTAD; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Manse JS, 2015, FEBS LETT, V589, P3945, DOI 10.1016/j.febslet.2015.11.017; Olling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017623; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Tam J, 2015, CHEM BIOL, V22, P175, DOI 10.1016/j.chembiol.2014.12.010; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wilcox M., 2015, IDWEEK 2015; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	35	35	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17290	17301		10.1074/jbc.M117.806687	http://dx.doi.org/10.1074/jbc.M117.806687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28842504	hybrid, Green Published			2022-12-28	WOS:000414009300012
J	Saadipour, K; MacLean, M; Pirkle, S; Ali, S; Lopez-Redondo, ML; Stokes, DL; Chao, MV				Saadipour, Khalil; MacLean, Michael; Pirkle, Sean; Ali, Solav; Lopez-Redondo, Maria-Luisa; Stokes, David L.; Chao, Moses V.			The transmembrane domain of the p75 neurotrophin receptor stimulates phosphorylation of the TrkB tyrosine kinase receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; ACTIVATION; PROTEIN; BRAIN; P75(NTR); BINDING	The function of protein products generated from intramembraneous cleavage by the gamma-secretase complex is not well defined. The gamma-secretase complex is responsible for the cleavage of several transmembrane proteins, most notably the amyloid precursor protein that results in A beta, a transmembrane (TM) peptide. Another protein that undergoes very similar gamma-secretase cleavage is the p75 neurotrophin receptor. However, the fate of the cleaved p75 TM domain is unknown. p75 neurotrophin receptor is highly expressed during early neuronal development and regulates survival and process formation of neurons. Here, we report that the p75 TM can stimulate the phosphorylation of TrkB (tyrosine kinase receptor B). In vitro phosphorylation experiments indicated that a peptide representing p75 TM increases TrkB phosphorylation in a dose-and time-dependent manner. Moreover, mutagenesis analyses revealed that a valine residue at position 264 in the rat p75 neurotrophin receptor is necessary for the ability of p75 TM to induce TrkB phosphorylation. Because this residue is just before the gamma-secretase cleavage site, we then investigated whether the p75(alpha gamma) peptide, which is a product of both alpha- and gamma-cleavage events, could also induce TrkB phosphorylation. Experiments using TM domains from other receptors, EGFR and FGFR1, failed to stimulate TrkB phosphorylation. Co-immunoprecipitation and biochemical fractionation data suggested that p75 TM stimulates TrkB phosphorylation at the cell membrane. Altogether, our results suggest that TrkB activation by p75(alpha gamma) peptide may be enhanced in situations where the levels of the p75 receptor are increased, such as during brain injury, Alzheimer's disease, and epilepsy.	[Saadipour, Khalil] NYU, Dept Cell Biol, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA; [Saadipour, Khalil] NYU, Dept Physiol & Neurosci, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA; [Saadipour, Khalil] NYU, Dept Psychiat, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Saadipour, K (corresponding author), NYU, Dept Cell Biol, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA.; Saadipour, K (corresponding author), NYU, Dept Physiol & Neurosci, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA.; Saadipour, K (corresponding author), NYU, Dept Psychiat, Langone Med Ctr, Skirball Inst Biomol Med, 550 1St Ave, New York, NY 10016 USA.	khalil.saadipour@nyumc.org		MacLean, Michael/0000-0001-9685-3400; Chao, Moses/0000-0002-6969-3744	National Institutes of Health [R01 AG025970]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS021072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 AG025970. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastasia A, 2015, J NEUROSCI, V35, P11911, DOI 10.1523/JNEUROSCI.0591-15.2015; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bothwell M, 2006, BRAIN BEHAV EVOLUT, V68, P124, DOI 10.1159/000094082; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deyev IE, 2013, J BIOL CHEM, V288, P33884, DOI 10.1074/jbc.M113.483172; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; JURETIC D, 1993, BIOPOLYMERS, V33, P255, DOI 10.1002/bip.360330208; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lee J, 2014, J BIOL CHEM, V289, P19769, DOI 10.1074/jbc.M114.578641; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Nadezhdin KD, 2016, J BIOL CHEM, V291, P12346, DOI 10.1074/jbc.M116.723585; Narisawa-Saito M, 2002, J BIOL CHEM, V277, P40901, DOI 10.1074/jbc.M202158200; Neumann S, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00105; Neves P, 2009, J PHARMACEUT BIOMED, V49, P276, DOI 10.1016/j.jpba.2008.11.026; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Parkhurst CN, 2010, J BIOL CHEM, V285, P5361, DOI 10.1074/jbc.M109.045054; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schecterson LC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.147pe50; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Simeonov P, 2013, BIOPHYS CHEM, V184, P37, DOI 10.1016/j.bpc.2013.08.003; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Uldry M, 2004, EMBO J, V23, P531, DOI 10.1038/sj.emboj.7600072; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Yano H, 2000, J NEUROSCI RES, V59, P356, DOI 10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G; Yao XQ, 2015, MOL PSYCHIATR, V20, P1301, DOI 10.1038/mp.2015.49; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	56	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16594	16604		10.1074/jbc.M117.788729	http://dx.doi.org/10.1074/jbc.M117.788729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28821608	Green Published, hybrid			2022-12-28	WOS:000412414800020
J	Choudhury, SR; Pandey, S				Choudhury, Swarup Roy; Pandey, Sona			Recently duplicated plant heterotrimeric G alpha proteins with subtle biochemical differences influence specific outcomes of signal-response coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; BETA-SUBUNIT; ARABIDOPSIS; DIVERSITY; GAMMA; ACID; POLYPLOIDY; RESISTANCE; COMPLEXES; INTERACTS	Heterotrimeric G-proteins, comprising G alpha, G beta, and G gamma subunits, regulate key signaling processes in eukaryotes. The G alpha subunit determines the status of signaling by switching between inactive GDP-bound and active GTP-bound forms. Unlike animal systems, in which multiple G alpha proteins with variable biochemical properties exist, plants have fewer, highly similar G alpha subunits that have resulted from recent genome duplications. These proteins exhibit subtle differences in their GTP-binding, GDP/GTP-exchange, and GTP-hydrolysis activities, but the extent to which these differences contribute to affect plant signaling and development remains unknown. To evaluate this, we expressed native and engineered G alpha proteins from soybean in an Arabidopsis G alpha-null background and studied their effects on modulating a range of developmental and hormonal signaling phenotypes. Our results indicated that inherent biochemical differences in these highly similar G alpha proteins are biologically relevant, and some proteins are more flexible than others in influencing the outcomes of specific signals. These observations suggest that alterations in the rate of the G-protein cycle itself may contribute to the specificity of response regulation in plants by affecting the duration of active signaling and/or by the formation of distinct protein-protein complexes. In species such as Arabidopsis having a single canonical G alpha, this rate could be affected by regulatory proteins in the presence of specific signals, whereas in plants with multiple G alpha proteins, an even more complex regulation may exist, which likely contributes to the specificity of signal-response coupling.	[Choudhury, Swarup Roy; Pandey, Sona] Donald Danforth Plant Sci Ctr, 975 North Warson Rd, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Pandey, S (corresponding author), Donald Danforth Plant Sci Ctr, 975 North Warson Rd, St Louis, MO 63132 USA.	spandey@danforthcenter.org	Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120	National Institute of Food and Agriculture/Agriculture and Food Research Initiative [AFRI-2015-67013-22964]; National Science Foundation [IOS-1557942]; Division Of Integrative Organismal Systems [1557942] Funding Source: National Science Foundation	National Institute of Food and Agriculture/Agriculture and Food Research Initiative; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute of Food and Agriculture/Agriculture and Food Research Initiative Grant AFRI-2015-67013-22964 and National Science Foundation Grant IOS-1557942 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Assmann Sarah M, 2004, Sci STKE, V2004, pre20; Bisht NC, 2011, NEW PHYTOL, V190, P35, DOI 10.1111/j.1469-8137.2010.03581.x; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chakravorty D, 2015, PLANT PHYSIOL, V169, P512, DOI 10.1104/pp.15.00251; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Choudhury SR, 2017, PLANT J, V90, P466, DOI 10.1111/tpj.13503; Choudhury SR, 2016, MOL PLANT, V9, P1093, DOI 10.1016/j.molp.2016.05.012; Choudhury SR, 2016, PLANT J, V86, P50, DOI 10.1111/tpj.13151; Choudhury SR, 2015, PLANT CELL, V27, P3260, DOI 10.1105/tpc.15.00517; Choudhury SR, 2014, BIOCHEM J, V461, P75, DOI 10.1042/BJ20131341; Choudhury SR, 2013, PLANT PHYSIOL, V162, P522, DOI 10.1104/pp.113.215400; Choudhury SR, 2012, J BIOL CHEM, V287, P17870, DOI 10.1074/jbc.M112.353219; Choudhury SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023361; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Delgado-Cerezo M, 2012, MOL PLANT, V5, P98, DOI 10.1093/mp/ssr082; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Guseman JM, 2015, DEVELOPMENT, V142, P905, DOI 10.1242/dev.117234; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Li SJ, 2012, NEW PHYTOL, V194, P690, DOI 10.1111/j.1469-8137.2012.04083.x; Liang XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13568; Maruta N, 2015, PLANT PHYSIOL, V167, P1004, DOI 10.1104/pp.114.255703; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.28; Paterson AH, 2005, GENETICA, V123, P191, DOI 10.1007/s10709-003-2742-0; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Renny-Byfield S, 2014, AM J BOT, V101, P1711, DOI 10.3732/ajb.1400119; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Salman-Minkov A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.115, 10.1038/NPLANTS.2016.115]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Thung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058503; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zhang LG, 2008, DEV BIOL, V324, P68, DOI 10.1016/j.ydbio.2008.09.008; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	62	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16188	16198		10.1074/jbc.M117.793380	http://dx.doi.org/10.1074/jbc.M117.793380			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28827312	Green Published, hybrid			2022-12-28	WOS:000412109400018
J	Yuan, X; Yao, PY; Jiang, JY; Zhang, Y; Su, ZQ; Yao, W; Wang, XY; Gui, P; Mullen, M; Henry, C; Ward, T; Wang, WW; Brako, L; Tian, RJ; Zhao, X; Wang, FS; Cao, XW; Wang, DM; Liu, X; Ding, X; Yao, XB				Yuan, Xiao; Yao, Phil Y.; Jiang, Jiying; Zhang, Yin; Su, Zeqi; Yao, Wendy; Wang, Xueying; Gui, Ping; Mullen, Mckay; Henry, Calmour; Ward, Tarsha; Wang, Wenwen; Brako, Larry; Tian, Ruijun; Zhao, Xuannv; Wang, Fengsong; Cao, Xinwang; Wang, Dongmei; Liu, Xing; Ding, Xia; Yao, Xuebiao			MST4 kinase phosphorylates ACAP4 protein to orchestrate apical membrane remodeling during gastric acid secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS-END; PARIETAL-CELLS; ERM PROTEINS; EZRIN; ACTIVATION; LOCALIZATION; AURORA; IDENTIFICATION; POLARIZATION; MIGRATION	Digestion in the stomach depends on acidification of the lumen. Histamine-elicited acid secretion is triggered by activation of the PKA cascade, which ultimately results in the insertion of gastric H, K-ATPases into the apical plasma membranes of parietal cells. Our recent study revealed the functional role of PKA-MST4-ezrin signaling axis in histamine-elicited acid secretion. However, it remains uncharacterized how the PKA-MST4-ezrin signaling axis operates the insertion of H, K-ATPases into the apical plasma membranes of gastric parietal cells. Here we show that MST4 phosphorylates ACAP4, an ARF6 GTPase-activating protein, at Thr(545). Histamine stimulation activates MST4 and promotes MST4 interaction with ACAP4. ACAP4 physically interacts with MST4 and is a cognate substrate of MST4 during parietal cell activation. The phosphorylation site of ACAP4 by MST4 was mapped to Thr(545) by mass spectrometric analyses. Importantly, phosphorylation of Thr(545) is essential for acid secretion in parietal cells because either suppression of ACAP4 or overexpression of non-phosphorylatable ACAP4 prevents the apical membrane reorganization and proton pump translocation elicited by histamine stimulation. In addition, persistent overexpression of MST4 phosphorylation-deficient ACAP4 results in inhibition of gastric acid secretion and blockage of tubulovesicle fusion to the apical membranes. Significantly, phosphorylation of Thr(545) enables ACAP4 to interact with ezrin. Given the location of Thr(545) between the GTPase-activating protein domain and the first ankyrin repeat, we reason that MST4 phosphorylation elicits a conformational change that enables ezrin-ACAP4 interaction. Taken together, these results define a novel molecular mechanism linking the PKA-MST4-ACAP4 signaling cascade to polarized acid secretion in gastric parietal cells.	[Yuan, Xiao; Jiang, Jiying; Zhang, Yin; Su, Zeqi; Wang, Xueying; Gui, Ping; Ward, Tarsha; Wang, Wenwen; Tian, Ruijun; Wang, Fengsong; Wang, Dongmei; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, BUCM USTC Collaborat Ctr Parietal Cell Res, CAS Ctr Excellence Mol Cell Sci, Hefei 230027, Anhui, Peoples R China; [Yao, Phil Y.; Zhang, Yin; Su, Zeqi; Zhao, Xuannv; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Yao, Phil Y.; Yao, Wendy; Mullen, Mckay; Henry, Calmour; Ward, Tarsha; Wang, Wenwen; Brako, Larry; Wang, Fengsong; Cao, Xinwang; Liu, Xing; Yao, Xuebiao] Keck Ctr Cellular Dynam, Morehouse Sch Med, Atlanta, GA 30310 USA; [Wang, Fengsong; Cao, Xinwang] Anhui Med Univ, Dept Biochem, Hefei 230027, Anhui, Peoples R China; [Tian, Ruijun] Southern Univ Sci & Technol, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine; Anhui Medical University; Southern University of Science & Technology	Liu, X; Yao, XB (corresponding author), Univ Sci & Technol China, BUCM USTC Collaborat Ctr Parietal Cell Res, CAS Ctr Excellence Mol Cell Sci, Hefei 230027, Anhui, Peoples R China.; Ding, X (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.; Liu, X; Yao, XB (corresponding author), Keck Ctr Cellular Dynam, Morehouse Sch Med, Atlanta, GA 30310 USA.	xing1017@ustc.edu.cn; dingx@bucm.edu.cn; xyao@msm.edu	Tian, Ruijun/J-3019-2014; Liu, Xing/H-2989-2018; Cao, Xinwang/W-2883-2019; Yao, Xuebiao/P-5771-2014; WANG, WENWEN/AAF-1080-2020	Liu, Xing/0000-0002-7480-5085; WANG, WENWEN/0000-0002-1545-4369; Tian, Ruijun/0000-0001-9521-5124; Gui, Ping/0000-0003-2049-3001; cao, xinwang/0000-0002-8052-7333	National Key Research and Development Program of China [2017YFA0503600, 2016YFA0100500]; Ministry of Education [IRT_17R102, 20113402130010]; Chinese Natural Science Foundation [31430054, 31621002, 81630080, 31501095, 31271518, 31501130]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB19000000]; National Institutes of Health [CA164133, DK115812, DK56292]; Central University [WK2070000066]; Morehouse School of Medicine; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115812, R01DK056292] Funding Source: NIH RePORTER	National Key Research and Development Program of China; Ministry of Education; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central University; Morehouse School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Key Research and Development Program of China Grants 2017YFA0503600 and 2016YFA0100500; Ministry of Education Grants IRT_17R102 and 20113402130010; Chinese Natural Science Foundation Grants 31430054, 31621002, 81630080, 31501095, 31271518, and 31501130; Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB19000000; National Institutes of Health Grants CA164133, DK115812, and DK56292; and Central University Grant WK2070000066. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Awarded a summer research fellowship of the Morehouse School of Medicine.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cao D, 2015, J BIOL CHEM, V290, P23766, DOI 10.1074/jbc.M115.673517; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Jiang H, 2015, J BIOL CHEM, V290, P28272, DOI 10.1074/jbc.M115.668855; Karvar S, 2002, J BIOL CHEM, V277, P50030, DOI 10.1074/jbc.M207694200; Karvar S, 2002, GASTROENTEROLOGY, V123, P281, DOI 10.1053/gast.2002.34217; Katsha A, 2013, GASTROENTEROLOGY, V145, P1312, DOI 10.1053/j.gastro.2013.08.050; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Lopez-Blanco JR, 2016, NUCLEIC ACIDS RES, V44, pW395, DOI 10.1093/nar/gkw395; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xiong WP, 2016, MOL CANCER THER, V15, P412, DOI 10.1158/1535-7163.MCT-15-0703; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yu HJ, 2014, J BIOL CHEM, V289, P33333, DOI 10.1074/jbc.M114.581280; Yu X, 2011, J BIOL CHEM, V286, P43735, DOI 10.1074/jbc.M111.278770; Zhao XN, 2013, P NATL ACAD SCI USA, V110, P11023, DOI 10.1073/pnas.1217727110; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	35	13	13	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16174	16187		10.1074/jbc.M117.808212	http://dx.doi.org/10.1074/jbc.M117.808212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28808054	Green Published, hybrid			2022-12-28	WOS:000412109400017
J	Pinker, F; Schelcher, C; Fernandez-Millan, P; Gobert, A; Birck, C; Thureau, A; Roblin, P; Giege, P; Sauter, C				Pinker, Franziska; Schelcher, Cedric; Fernandez-Millan, Pablo; Gobert, Anthony; Birck, Catherine; Thureau, Aurelien; Roblin, Pierre; Giege, Philippe; Sauter, Claude			Biophysical analysis of Arabidopsis protein-only RNase P alone and in complex with tRNA provides a refined model of tRNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						precursor tRNA (pre-tRNA); ribonuclease P (RNase P); RNA processing; small-angle X-ray scattering (SAXS); X-ray crystallography; PRORP; pentatricopeptide repeat (PPR); tRNA maturation	PENTATRICOPEPTIDE REPEAT PROTEINS; ANGLE SCATTERING DATA; RECOGNITION; PROGRAM; ULTRACENTRIFUGATION; MACROMOLECULES; MITOCHONDRIA; GENERATION; NUCLEUS; SUBUNIT	RNase P is a universal enzyme that removes 5 leader sequences from tRNA precursors. The enzyme is therefore essential for maturation of functional tRNAs and mRNA translation. RNase P represents a unique example of an enzyme that can occur either as ribonucleoprotein or as protein alone. The latter form of the enzyme, called protein-only RNase P (PRORP), is widespread in eukaryotes in which it can provide organellar or nuclear RNase P activities. Here, we have focused on Arabidopsis nuclear PRORP2 and its interaction with tRNA substrates. Affinity measurements helped assess the respective importance of individual pentatricopeptide repeat motifs in PRORP2 for RNA binding. We characterized the PRORP2 structure by X-ray crystallography and by small-angle X-ray scattering in solution as well as that of its complex with a tRNA precursor by small-angle X-ray scattering. Of note, our study reports the first structural data of a PRORP-tRNA complex. Combined with complementary biochemical and biophysical analyses, our structural data suggest that PRORP2 undergoes conformational changes to accommodate its substrate. In particular, the catalytic domain and the RNA-binding domain can move around a central hinge. Altogether, this work provides a refined model of the PRORP-tRNA complex that illustrates how protein-only RNase P enzymes specifically bind tRNA and highlights the contribution of protein dynamics to achieve this specific interaction.	[Pinker, Franziska; Fernandez-Millan, Pablo; Sauter, Claude] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire Architecture & Reactiv, UPR 9002, F-67000 Strasbourg, France; [Pinker, Franziska; Schelcher, Cedric; Gobert, Anthony; Giege, Philippe] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; [Birck, Catherine] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, UMR 7104, F-67404 Illkirch Graffenstaden, France; [Thureau, Aurelien; Roblin, Pierre] Synchrotron SOLEIL, F-91410 Lorme Des Merisiers, St Aubin, France; [Roblin, Pierre] Inst Natl Rech Agron Ctr Nantes, Unite Rech Biopolymeres Interact Assemblages URBI, UR 1268, 60 Rue Geraudiere, F-44316 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; SOLEIL Synchrotron; INRAE	Sauter, C (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire Architecture & Reactiv, UPR 9002, F-67000 Strasbourg, France.; Giege, P (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France.	philippe.giege@ibmp-cnrs.unistra.fr; c.sauter@ibmc-cnrs.unistra.fr	Fernández-Millán, Pablo/N-4930-2016	Fernández-Millán, Pablo/0000-0002-1887-8466; Gobert, Anthony/0000-0003-2626-8788; Schelcher, Cedric/0000-0003-0574-0975; sauter, claude/0000-0002-8766-287X; Giege, Philippe/0000-0003-2285-8190	French CNRS; University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant [ANR-11-BSV8-008-01/02]; LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir" [ANR-11-LABX-0057_MITOCROSS]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05]	French CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant(French National Research Agency (ANR)); LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir"(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the French CNRS, the University of Strasbourg, Agence Nationale de la Recherche (ANR) Blanc "PRO-RNase P" Research Grant ANR-11-BSV8-008-01/02 (to P. G. and Cl. S.), and the LabEx consortium "MitoCross" in the frame of the French National Program "Investissement d'Avenir" Grant ANR-11-LABX-0057_MITOCROSS. This work was also supported by the French Infrastructure for Integrated Structural Biology (FRISBI) (Grant ANR-10-INSB-05, which granted access to the resources of FRISBI and Instruct, a Landmark European Strategy Forum on Research Infrastructures project. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman S, 2007, MOL BIOSYST, V3, P604, DOI 10.1039/b707850c; Anantharaman Vivek, 2006, RNA Biol, V3, P18; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bonnard G, 2016, PLANT J, V87, P270, DOI 10.1111/tpj.13198; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brillante N, 2016, NUCLEIC ACIDS RES, V44, P2323, DOI 10.1093/nar/gkw080; Chen TH, 2016, NUCLEIC ACIDS RES, V44, P5344, DOI 10.1093/nar/gkw391; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evrard G, 2011, J APPL CRYSTALLOGR, V44, P1264, DOI 10.1107/S0021889811035758; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fujii S, 2016, PLANT J, V86, P504, DOI 10.1111/tpj.13185; Giege P, 2013, RNA BIOL, V10, P1417, DOI 10.4161/rna.26081; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hammani K, 2014, BIOCHIMIE, V100, P141, DOI 10.1016/j.biochi.2013.08.031; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Imai T, 2014, BIOCHEM BIOPH RES CO, V450, P1541, DOI 10.1016/j.bbrc.2014.07.030; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Karasik A, 2016, J MOL BIOL, V428, P26, DOI 10.1016/j.jmb.2015.11.025; Klipcan L, 2012, J MOL BIOL, V415, P527, DOI 10.1016/j.jmb.2011.11.029; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Lechner M, 2015, MOL BIOL EVOL, V32, P3186, DOI 10.1093/molbev/msv187; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Pavlova LV, 2012, CHEMBIOCHEM, V13, P2270, DOI 10.1002/cbic.201200434; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pinker F, 2015, ACTA CRYSTALLOGR F, V71, P1372, DOI 10.1107/S2053230X15017033; Pinker F, 2013, RNA BIOL, V10, P1457, DOI 10.4161/rna.25273; Placido A, 2010, NUCLEIC ACIDS RES, V38, P7711, DOI 10.1093/nar/gkq646; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Schelcher C, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030030; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Sherrer RL, 2011, NUCLEIC ACIDS RES, V39, P1034, DOI 10.1093/nar/gkq845; Sugita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108962; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286	55	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13904	13913		10.1074/jbc.M117.782078	http://dx.doi.org/10.1074/jbc.M117.782078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696260	Green Published, hybrid			2022-12-28	WOS:000408439800001
J	Trapasso, F; Pichiorri, F; Gaspari, M; Palumbo, T; Aqeilan, RI; Gaudio, E; Okumura, H; Iuliano, R; Di Leva, G; Fabbri, M; Birk, DE; Raso, C; Green-Church, K; Spagnoli, LG; Venuta, S; Huebner, K; Croce, CM				Trapasso, Francesco; Pichiorri, Flavia; Gaspari, Marco; Palumbo, Tiziana; Aqeilan, Rami I.; Gaudio, Eugenio; Okumura, Hiroshi; Iuliano, Rodolfo; Di Leva, Giampiero; Fabbri, Muller; Birk, David E.; Raso, Cinzia; Green-Church, Kari; Spagnoli, Luigi G.; Venuta, Salvatore; Huebner, Kay; Croce, Carlo M.			RETRACTION: Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. (Retraction of Vol 283, Pg 13736, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Aqeilan, Rami/AAT-7785-2020; Young, Richard A/F-6495-2012; Gaspari, Marco/C-2756-2009; Gaspari, Marco/ABE-1539-2020; Gaspari, Marco/HGB-2399-2022	Young, Richard A/0000-0001-8855-8647; Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; 	NCI NIH HHS [P30 CA016058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200	1	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14279	14279		10.1074/jbc.A117.709062	http://dx.doi.org/10.1074/jbc.A117.709062			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28842474	Green Published, hybrid			2022-12-28	WOS:000408439800031
J	He, Q; Wang, F; Gu, LC				He, Qing; Wang, Feng; Gu, Lichuan			Reply to Valadares and Woo: Mechanism of Rv2837c from Mycobacterium tuberculosis remains controversial	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Letter							PHOSPHODIESTERASE		[He, Qing; Wang, Feng; Gu, Lichuan] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China	Shandong University	Gu, LC (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lcgu@sdu.edu.cn						Dey RJ, 2017, NAT CHEM BIOL, V13, P210, DOI [10.1038/NCHEMBIO.2254, 10.1038/nchembio.2254]; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]; Valadares NF, 2017, J BIOL CHEM, V292, P13480, DOI 10.1074/jbc.L116.760678	4	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13481	13481		10.1074/jbc.L116.765933	http://dx.doi.org/10.1074/jbc.L116.765933			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28801353	Green Published, hybrid			2022-12-28	WOS:000407465300032
J	Anderson, EN; Wharton, KA				Anderson, Edward N.; Wharton, Kristi A.			Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); cell signaling; Drosophila; O-GlcNAcylation; protein processing; transforming growth factor (TGF-); Glass bottom boat (Gbb); prodomain; proprotein convertase	REGULATES SYNAPTIC GROWTH; DROSOPHILA-MELANOGASTER; TGF-BETA; TWISTED-GASTRULATION; II RECEPTOR; DECAPENTAPLEGIC GENE; ACTIVITY GRADIENT; ECDYSIS BEHAVIOR; PRODOMAIN LEADS; PRO-DOMAINS	The family of TGF- and bone morphogenetic protein (BMP) signaling proteins has numerous developmental and physiological roles. They are made as proprotein dimers and then cleaved by proprotein convertases to release the C-terminal domain as an active ligand dimer. Multiple proteolytic processing sites in Glass bottom boat (Gbb), the Drosophila BMP7 ortholog, can produce distinct ligand forms. Cleavage at the S1 or atypical S0 site in Gbb produces Gbb15, the conventional small BMP ligand, whereas NS site cleavage produces a larger Gbb38 ligand. We hypothesized that the Gbb prodomain is involved not only in regulating the production of specific ligands but also their signaling output. We found that blocking NS cleavage increased association of the full-length prodomain with Gbb15, resulting in a concomitant decrease in signaling activity. Moreover, NS cleavage was required in vivo for Gbb-Decapentaplegic (Dpp) heterodimer-mediated wing vein patterning but not for Gbb15-Dpp heterodimer activity in cell culture. Gbb NS cleavage was also required for viability through its regulation of pupal ecdysis in a type II receptor Wishful thinking (Wit)-dependent manner. In fact, Gbb38-mediated signaling exhibits a preference for Wit over the other type II receptor Punt. Finally, we discovered that Gbb38 is produced when processing at the S1/S0 site is blocked by O-linked glycosylation in third instar larvae. Our findings demonstrate that BMP prodomain cleavage ensures that the mature ligand is not inhibited by the prodomain. Furthermore, alternative processing of BMP proproteins produces ligands that signal through different receptors and exhibit specific developmental functions.	[Anderson, Edward N.; Wharton, Kristi A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Wharton, KA (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	kristi_wharton@brown.edu		Anderson, Edward/0000-0002-2468-0851	National Institutes of Health NIGMS [R01GM068118]; Brown University Emerging Area of New Science DEANS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068118] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537, P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brown University Emerging Area of New Science DEANS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health NIGMS Grant R01GM068118, and by a Brown University Emerging Area of New Science DEANS Award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Araujo H, 2011, GENESIS, V49, P698, DOI 10.1002/dvg.20778; Gorostiza EA, 2013, J NEUROSCI, V33, P687, DOI 10.1523/JNEUROSCI.3448-12.2013; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Beckwith EJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; CHADFIELD CG, 1985, DEV GENET, V5, P103; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P1; Fritsch C, 2012, J BIOL CHEM, V287, P5942, DOI 10.1074/jbc.M111.316745; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001; Haider SR, 2010, ANAL BIOANAL CHEM, V397, P655, DOI 10.1007/s00216-010-3588-9; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hwang JR, 2000, J BIOL CHEM, V275, P17886, DOI 10.1074/jbc.M000032200; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kuhfahl S, 2011, BIOCHEM BIOPH RES CO, V408, P300, DOI 10.1016/j.bbrc.2011.04.021; Kunnapuu J, 2014, DEV BIOL, V389, P149, DOI 10.1016/j.ydbio.2014.02.007; Lahr EC, 2012, J NEUROSCI, V32, P6819, DOI 10.1523/JNEUROSCI.5301-11.2012; Le VQ, 2012, DEV DYNAM, V241, P200, DOI 10.1002/dvdy.22779; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; Mace PD, 2006, BIOCHEM BIOPH RES CO, V351, P831, DOI 10.1016/j.bbrc.2006.10.109; Makanji Y, 2011, ENDOCRINOLOGY, V152, P3758, DOI 10.1210/en.2011-1052; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ohsawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133713; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Ray RP, 2001, DEVELOPMENT, V128, P3913; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Szuperak M, 2011, DEVELOPMENT, V138, P715, DOI 10.1242/dev.059477; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tilak A, 2014, DEVELOPMENT, V141, P3062, DOI 10.1242/dev.110130; Veverytsa L, 2012, P NATL ACAD SCI USA, V109, pE748, DOI 10.1073/pnas.1114710109; Veverytsa L, 2011, DEVELOPMENT, V138, P3147, DOI 10.1242/dev.064105; Vilmos P, 2005, EMBO REP, V6, P262, DOI 10.1038/sj.embor.7400347; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Wharton K, 1996, GENETICS, V142, P493; Wharton KA, 1999, GENETICS, V152, P629; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; Zhuang ZH, 2006, CELL SIGNAL, V18, P441, DOI 10.1016/j.cellsig.2005.05.013	88	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19160	19178		10.1074/jbc.M117.793513	http://dx.doi.org/10.1074/jbc.M117.793513			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28924042	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000416226700003
J	Pham, TL; He, JC; Kakazu, AH; Jun, B; Bazan, NG; Bazan, HEP				Thang Luong Pham; He, Jiucheng; Kakazu, Azucena H.; Jun, Bokkyoo; Bazan, Nicolas G.; Bazan, Haydee E. P.			Defining a mechanistic link between pigment epithelium-derived factor, docosahexaenoic acid, and corneal nerve regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose triglyceride lipase; brain-derived neurotrophic factor (BDNF); cornea; lipid signaling; phospholipase A; DHA; NGF; PEDF; Sema7A; neuropeptides	ADIPOSE TRIGLYCERIDE LIPASE; PEDF PLUS DHA; EXPERIMENTAL SURGERY; SENSORY NEURONS; GROWTH-FACTOR; SPINAL-CORD; DRY EYE; C-JUN; IDENTIFICATION; INFLAMMATION	The cornea is densely innervated to sustain the integrity of the ocular surface. Corneal nerve damage produced by aging, diabetes, refractive surgeries, and viral or bacterial infections impairs tear production, the blinking reflex, and epithelial wound healing, resulting in loss of transparency and vision. A combination of the known neuroprotective molecule, pigment epithelium-derived factor (PEDF) plus docosahexaenoic acid (DHA), has been shown to stimulate corneal nerve regeneration, but the mechanisms involved are unclear. Here, we sought to define the molecular events of this effect in an in vivo mouse injury model. We first confirmed that PEDF + DHA increased nerve regeneration in the mouse cornea. Treatment with PEDF activates the phospholipase A(2) activity of the PEDF-receptor (PEDF-R) leading to the release of DHA; this free DHA led to enhanced docosanoid synthesis and induction of bdnf, ngf, and the axon growth promoter semaphorin 7a (sema7a), and as a consequence, their products appeared in the mouse tears. Surprisingly, corneal injury and treatment with PEDF + DHA induced transcription of neuropeptide y (npy), small proline-rich protein 1a (sprr1a), and vasoactive intestinal peptide (vip) in the trigeminal ganglia (TG). The PEDF-R inhibitor, atglistatin, blocked all of these changes in the cornea and TG. In conclusion, we uncovered here an active cornea-TG axis, driven by PEDF-R activation, that fosters axon outgrowth in the cornea.	[Bazan, Haydee E. P.] Louisiana State Univ Hlth New Orleans, Sch Med, Dept Ophthalmol, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA; [Bazan, Haydee E. P.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, HEP (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Dept Ophthalmol, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.; Bazan, HEP (corresponding author), Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	hbazan1@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; PHAM, Thang/ABB-8181-2020	Bazan, Nicolas/0000-0002-9243-5444; PHAM, Thang/0000-0001-7600-7450	National Institutes of Health [R01 EY19465]; National Institutes of Health COBRE Phase III Grant [P30 GM103340]; NATIONAL EYE INSTITUTE [R01EY019465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE Phase III Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 EY19465 and National Institutes of Health COBRE Phase III Grant P30 GM103340. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763; BARLATI S, 1990, EXP EYE RES, V51, P1, DOI 10.1016/0014-4835(90)90162-N; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; BAZAN HEP, 1984, CURR EYE RES, V3, P1313, DOI 10.3109/02713688409007418; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Bilak MM, 2002, J NEUROSCI, V22, P9378; Campbell D, 2011, CORNEA, V30, P325, DOI 10.1097/ICO.0b013e3181eae239; Chang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053444; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Chaudhary S, 2012, CORNEA, V31, P1460, DOI 10.1097/ICO.0b013e318247b60e; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cortina MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P76, DOI 10.1001/archophthalmol.2011.287; Cortina MS, 2010, INVEST OPHTH VIS SCI, V51, P804, DOI 10.1167/iovs.09-3641; Cortina MS, 2013, INVEST OPHTH VIS SCI, V54, P4109, DOI 10.1167/iovs.13-12075; Crane AM, 2012, INVEST OPHTH VIS SCI, V53, P7122, DOI 10.1167/iovs.12-10448; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Eixarch H, 2013, TRENDS MOL MED, V19, P157, DOI 10.1016/j.molmed.2013.01.003; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Esquenazi S, 2005, INVEST OPHTH VIS SCI, V46, P3121, DOI 10.1167/iovs.05-0241; Ferrari G, 2014, INVEST OPHTH VIS SCI, V55, P6289, DOI 10.1167/iovs.14-13984; Finelli MJ, 2013, J NEUROSCI, V33, P19664, DOI 10.1523/JNEUROSCI.0589-13.2013; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; He JC, 2017, DIABETES, V66, P2511, DOI 10.2337/db17-0249; He JC, 2016, INVEST OPHTH VIS SCI, V57, P664, DOI 10.1167/iovs.15-18019; He JC, 2015, INVEST OPHTH VIS SCI, V56, P3505, DOI 10.1167/iovs.15-16755; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kymionis GD, 2007, J REFRACT SURG, V23, P937; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Lin Wei-Jye, 2013, Front Endocrinol (Lausanne), V4, P96, DOI 10.3389/fendo.2013.00096; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; MACLEAN DB, 1987, J NEUROCHEM, V48, P1794, DOI 10.1111/j.1471-4159.1987.tb05738.x; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Mulderry PK, 1996, EUR J NEUROSCI, V8, P2479, DOI 10.1111/j.1460-9568.1996.tb01542.x; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Subramanian P, 2013, J BIOL CHEM, V288, P23928, DOI 10.1074/jbc.M113.487884; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yamada A, 1999, J IMMUNOL, V162, P4094; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	55	37	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18486	18499		10.1074/jbc.M117.801472	http://dx.doi.org/10.1074/jbc.M117.801472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972155	Green Published, hybrid			2022-12-28	WOS:000414958100009
J	DeLigio, JT; Lin, G; Chalfant, CE; Park, MA				DeLigio, James T.; Lin, Grace; Chalfant, Charles E.; Park, Margaret A.			Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TRANSLATIONAL CONTROL; DEGRADATION; INHIBITION; ACTIVATION; EXPRESSION; ANOIKIS; GROWTH	The translational regulator cytosolic polyadenylation element-binding protein 2 (CPEB2) has two isoforms, CPEB2A and CPEB2B, derived by alternative splicing of RNA into a mature form that either includes or excludes exon 4. Previously, we reported that this splicing event is highly dysregulated in aggressive forms of breast cancers, which overexpress CPEB2B. The loss of CPEB2A with a concomitant increase in CPEB2B was also required for breast cancer cells to resist cell death because of detachment (anoikis resistance) and metastasize in vivo. To examine the mechanism by which CPEB2 isoforms mediate opposing effects on cancer-related phenotypes, we used next generation sequencing of triple negative breast cancer cells in which the isoforms were specifically down-regulated. Downregulation of the CPEB2B isoform inhibited pathways driving the epithelial-to-mesenchymal transition and hypoxic response, whereas down-regulation of the CPEB2A isoform did not have this effect. Examining key nodes of these pathways showed that CPEB2B induced the expression of regulatory DNA trans-factors (e.g. HIF1 alpha and TWIST1). Specifically, CPEB2B functioned as a translational activator of TWIST1 and HIF1 alpha. Functional studies showed that specific down-regulation of either HIF1 alpha or TWIST1 inhibited the ability of CPEB2B to induce the acquisition of anoikis resistance and drive metastasis. Overall, this study demonstrates that CPEB2 alternative splicing is a major regulator of key cellular pathways linked to anoikis resistance and metastasis.	[DeLigio, James T.; Lin, Grace; Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Canc Cell Signaling Program, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Hunter Holmes McGuire Vet Adm Med Ctr, Res Serv, Richmond, VA 23249 USA; [Chalfant, Charles E.] VCU Inst Mol Med, Richmond, VA 23298 USA; [Chalfant, Charles E.] VCU Johnson Ctr Crit Care & Pulm Res, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Chalfant, Charles E.; Park, Margaret A.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Chalfant, Charles E.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; H Lee Moffitt Cancer Center & Research Institute	Chalfant, CE; Park, MA (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	cechalfant@usf.edu; mapark@usf.edu			NCI, National Institutes of Health [P30 CA016059]; VCU Massey Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD087198] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA154314, P30CA016059, R01CA117950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VCU Massey Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Services and products in support of the research project were generated by the VCU Massey Cancer Center Shared Resources supported, in part, with funding from NCI, National Institutes of Health, Cancer Center Support Grant P30 CA016059.	Anderson TMR, 2016, CANCER RES, V76, P1653, DOI 10.1158/0008-5472.CAN-15-2510; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Dai XF, 2015, AM J CANCER RES, V5, P2929; Finlay J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/382745; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Granados-Principal S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0527-x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Haque R, 2012, CANCER EPIDEM BIOMAR, V21, P1848, DOI 10.1158/1055-9965.EPI-12-0474; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hsia TC, 2014, MOLECULES, V19, P19892, DOI 10.3390/molecules191219892; Johnson RM, 2015, J BIOL CHEM, V290, P25717, DOI 10.1074/jbc.M115.671206; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Mahara S, 2016, P NATL ACAD SCI USA, V113, pE3735, DOI 10.1073/pnas.1602079113; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Nairismagi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066070; Rhodes LV, 2015, ONCOTARGET, V6, P16638, DOI 10.18632/oncotarget.3184; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Shapiro BA, 2016, J BIOL CHEM, V291, P21669, DOI 10.1074/jbc.M116.737569; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Teo CSH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005927; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vu NT, 2016, CANCER RES, V76, P2977, DOI 10.1158/0008-5472.CAN-15-2512; Vu NT, 2013, J BIOL CHEM, V288, P8575, DOI 10.1074/jbc.M112.443333; Wang RH, 2016, BIOCHEM BIOPH RES CO, V470, P117, DOI 10.1016/j.bbrc.2016.01.005	28	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17909	17918		10.1074/jbc.M117.810127	http://dx.doi.org/10.1074/jbc.M117.810127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28904175	Green Published, hybrid			2022-12-28	WOS:000414013000026
J	Hara, K; Taharazako, S; Ikeda, M; Fujita, H; Mikami, Y; Kikuchi, S; Hishiki, A; Yokoyama, H; Ishikawa, Y; Kanno, S; Tanaka, K; Hashimoto, H				Hara, Kodai; Taharazako, Shota; Ikeda, Masanori; Fujita, Hiroki; Mikami, Yoshiko; Kikuchi, Sotaro; Hishiki, Asami; Yokoyama, Hideshi; Ishikawa, Yoshinobu; Kanno, Shin-ichiro; Tanaka, Kozo; Hashimoto, Hiroshi			Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ZETA; CRYSTAL-STRUCTURE; HUMAN REV7; COMPLEX; BINDING; MUTAGENESIS; INSIGHTS; GENE; ACTIVATION; INHIBITOR	Mitotic arrest deficient 2-like protein 2 (MAD2L2), also termed MAD2B or REV7, is involved in multiple cellular functions including translesion DNA synthesis (TLS), signal transduction, transcription, and mitotic events. MAD2L2 interacts with chromosome alignment-maintaining phosphoprotein (CAMP), a kinetochore-microtubule attachment protein in mitotic cells, presumably through a novel "WK" motif in CAMP. Structures of MAD2L2 in complex with binding regions of the TLS proteins REV3 and REV1 have revealed that MAD2L2 has two faces for protein-protein interactions that are regulated by its C-terminal region; however, the mechanisms underlying the MAD2L2-CAMP interaction and the mitotic role of MAD2L2 remain unknown. Here we have determined the structures of human MAD2L2 in complex with a CAMP fragment in two crystal forms. The overall structure of the MAD2L2-CAMP complex in both crystal forms was essentially similar to that of the MAD2L2-REV3 complex. However, the residue interactions between MAD2L2 and CAMP were strikingly different from those in the MAD2L2-REV3 complex. Furthermore, structure-based interaction analyses revealed an unprecedented mechanism involving CAMP's WK motif. Surprisingly, in one of the crystal forms, the MAD2L2-CAMP complex formed a dimeric structure in which the C-terminal region of MAD2L2 was swapped and adopted an immature structure. The structure provides direct evidence for the dynamic nature of MAD2L2 structure, which in turn may have implications for the protein-protein interaction mechanism and the multiple functions of this protein. This work is the first structural study of MAD2L2 aside from its role in TLS and might pave the way to clarify MAD2L2's function in mitosis.	[Hara, Kodai; Taharazako, Shota; Kikuchi, Sotaro; Hishiki, Asami; Ishikawa, Yoshinobu; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan; [Ikeda, Masanori; Fujita, Hiroki; Mikami, Yoshiko; Kanno, Shin-ichiro; Tanaka, Kozo] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Yokoyama, Hideshi] Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan	University of Shizuoka; Tohoku University; Tokyo University of Science	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019; Tanaka, Kozo/Y-6566-2018	hara, kodai/0000-0002-1586-6312; Tanaka, Kozo/0000-0001-6086-2858; Hashimoto, Hiroshi/0000-0003-1503-6789; Yokoyama, Hideshi/0000-0002-3137-2793	JSPS KAKENHI [25291017, 16H04755, 15K18491, 17K07314, 15H04368]; MEXT KAKENHI [25121728, 17H06014, 16H01296]; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [16H01296] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 25291017 and 16H04755, MEXT KAKENHI Grants 25121728 and 17H06014, The Takeda Science Foundation and Naito Foundation (to H. H.), JSPS KAKENHI Grants 15K18491 and 17K07314 (to K. H.), and JSPS KAKENHI Grant 15H04368, MEXT KAKENHI Grant 16H01296, and a grant from the Takeda Science Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhat A, 2015, CELL CYCLE, V14, P3929, DOI 10.1080/15384101.2015.1120922; Bluteau D, 2016, J CLIN INVEST, V126, P3580, DOI 10.1172/JCI88010; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Hanafusa T, 2010, GENES CELLS, V15, P281, DOI 10.1111/j.1365-2443.2009.01380.x; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Itoh G, 2011, EMBO J, V30, P130, DOI 10.1038/emboj.2010.276; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; LAWRENCE CW, 1985, MOL GEN GENET, V200, P86, DOI 10.1007/BF00383317; Listovsky T, 2013, J CELL BIOL, V203, P87, DOI 10.1083/jcb.201302060; Liu D, 2013, J MOL CELL BIOL, V5, P204, DOI 10.1093/jmcb/mjs061; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medendorp K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015128; Medendorp K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007020; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Tanaka AJ, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000661; Tomida J, 2015, NUCLEIC ACIDS RES, V43, P1000, DOI 10.1093/nar/gku1385; TORPEY LE, 1994, YEAST, V10, P1503, DOI 10.1002/yea.320101115; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Xie W, 2012, PROTEIN CELL, V3, P864, DOI 10.1007/s13238-012-2102-x; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	44	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17658	17667		10.1074/jbc.M117.804237	http://dx.doi.org/10.1074/jbc.M117.804237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887307	hybrid, Green Published			2022-12-28	WOS:000414013000008
J	Synowsky, SA; Shirran, SL; Cooke, FGM; Antoniou, AN; Botting, CH; Powis, SJ				Synowsky, Silvia A.; Shirran, Sally L.; Cooke, Fiona G. M.; Antoniou, Antony N.; Botting, Catherine H.; Powis, Simon J.			The major histocompatibility complex class I immunopeptidome of extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicles; immunology; major histocompatibility complex (MHC); mass spectrometry (MS); proteomics	NANOPARTICLE TRACKING ANALYSIS; MASS-SPECTROMETRY; EXOSOMES; CANCER; CELLS	Extracellular vesicles (EVs) are released by most cell types and have been associated with multiple immunomodulatory functions. MHC class I molecules have crucial roles in antigen presentation and in eliciting immune responses and are known to be incorporated into EVs. However, the MHC class I immunopeptidome of EVs has not been established. Here, using a small-scale immunoisolation of the antigen serotypes HLA-A*02:01 and HLA-B*27:05 expressed on the Epstein-Barr virus-transformed B cell line Jesthom and MS of the eluted peptides from both cells and EVs, we identified 516 peptides that bind either HLA-A*02:01 or HLA-B*27:05. Of importance, the predicted serotype-binding affinities and peptide-anchor motifs did not significantly differ between the peptide pools isolated from cells or EVs, indicating that during EV biogenesis, no obvious editing of the MHC class I immunopeptidome occurs. These results, for the first time, establish EVs as a source of MHC class I peptides that can be used for the study of the immunopeptidome and in the discovery of potential neoantigens for immunotherapies.	[Synowsky, Silvia A.; Shirran, Sally L.; Botting, Catherine H.] Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland; [Cooke, Fiona G. M.; Powis, Simon J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Antoniou, Antony N.] UCL, Adv Ctr Biochem Engn, London WC1E 7JE, England	University of St Andrews; University of St Andrews; University of London; University College London	Powis, SJ (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	sjp10@st-andrews.ac.uk		Shirran, Sally/0000-0003-3516-3507; Powis, Simon/0000-0003-4218-2984; Cooke, Fiona/0000-0002-7167-5481	Melville Trust for the Care and Cure of Cancer, Scotland, UK	Melville Trust for the Care and Cure of Cancer, Scotland, UK	This work was supported by the Melville Trust for the Care and Cure of Cancer, Scotland, UK. The authors declare that they have no conflicts of interest with the contents of this article.	Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; ARAKELYAN A, 2017, SCI REP UK, V7; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Caron E, 2015, MOL CELL PROTEOMICS, V14, P3105, DOI [10.1074/mcp.O115.052431, 10.1074/mcp.M115.052431]; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Lundberg V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36479; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Marino J, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8759; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; Syn NL, 2017, TRENDS BIOTECHNOL, V35, P665, DOI 10.1016/j.tibtech.2017.03.004; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Whiteside TL, 2017, CLIN EXP IMMUNOL, V189, P259, DOI 10.1111/cei.12974; Zheng Y, 2013, EXP CELL RES, V319, P1706, DOI 10.1016/j.yexcr.2012.10.006	22	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17084	17092		10.1074/jbc.M117.805895	http://dx.doi.org/10.1074/jbc.M117.805895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28860189	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000413140600027
J	Xiao, B; Goh, JY; Xiao, L; Xian, HX; Lim, KL; Liou, YC				Xiao, Bin; Goh, Jian-Yuan; Xiao, Lin; Xian, Hongxu; Lim, Kah-Leong; Liou, Yih-Cherng			Reactive oxygen species trigger Parkin/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; PINK1; UBIQUITIN; DEGRADATION; MUTATIONS; AUTOPHAGY; TRANSLOCATION; DISEASE; YEAST	Defective mitophagy linked to dysfunction in the proteins Parkin and PTEN-induced putative kinase 1 (PINK1) is implicated in the pathogenesis of Parkinson's disease. Although the mechanism by which Parkin mediates mitophagy in a PINK1-dependent manner is becoming clearer, the triggers for this mitophagy pathway remain elusive. Reactive oxygen species (ROS) have been suggested as such triggers, but this proposal remains controversial because ROS scavengers fail to retard mitophagy. Here we demonstrate that the role of ROS in mitophagy has been underappreciated as a result of the inefficiency of ROS scavengers to control ROS bursts after high-dose treatment with carbonyl cyanide m-chlorophenylhydrazone. Supporting this, combinatorial treatment with N-acetyl-L-cysteine and catalase substantially inhibited the ROS upsurge and PINK1-dependent Parkin translocation to mitochondria in response to carbonyl cyanide m-chlorophenylhydrazone treatment. In addition to the chemical mitophagy inducer, overexpression of voltage-dependent anion channel 1 (VDAC1) induced Parkin translocation to mitochondria, presumably by stimulating ROS generation. Similarly, combined N-acetyl-L-cysteine and catalase treatment also suppressed VDAC1-induced redistribution of Parkin. Alongside these observations, we also found that the elevated protein level of PINK1 was not necessary for Parkin translocation to mitochondria. Thus, our data suggest that ROS may act as a trigger for the induction of Parkin/PINK1-dependent mitophagy. In addition, our study casts doubt on the importance of protein quantity of PINK1 in the recruitment of Parkin to mitochondria.	[Xiao, Bin; Xiao, Lin; Xian, Hongxu; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Goh, Jian-Yuan; Liou, Yih-Cherng] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, 14 Sci Dr 4, Singapore 117543, Singapore; [Lim, Kah-Leong] Natl Neurosci Inst, Singapore 308433, Singapore; [Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Block MD9,2 Med Dr, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); National University of Singapore	Liou, YC (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Liou, YC (corresponding author), Natl Univ Singapore, Grad Sch Integrat Sci & Engn, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Xian, Hongxu/0000-0002-8610-2029; Xiao, Bin/0000-0003-2986-4980; Lim, Kah-Leong/0000-0002-5440-2588	Ministry of Education Tier 1 Grant [R-154-000-A15-114]; NMRC Singapore Grant [NMRC/CBRG/0067/2014]	Ministry of Education Tier 1 Grant; NMRC Singapore Grant(National Medical Research Council, Singapore)	This work was supported by Ministry of Education Tier 1 Grant R-154-000-A15-114) and NMRC Singapore Grant NMRC/CBRG/0067/2014 (to Y.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Berezhnov AV, 2016, J BIOL CHEM, V291, P8701, DOI 10.1074/jbc.M115.691774; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kanki T, 2010, AUTOPHAGY, V6, P278, DOI 10.4161/auto.6.2.10901; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018556; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee S, 2015, J BIOL CHEM, V290, P904, DOI 10.1074/jbc.M114.606798; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Padman BS, 2013, AUTOPHAGY, V9, P1862, DOI 10.4161/auto.26557; Pellegrino MW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0129-1; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Xiao B, 2017, BBA-MOL CELL RES, V1864, P1308, DOI 10.1016/j.bbamcr.2017.04.009; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	50	129	133	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16697	16708		10.1074/jbc.M117.787739	http://dx.doi.org/10.1074/jbc.M117.787739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28848050	hybrid, Green Published			2022-12-28	WOS:000412414800029
J	Zhang, N; Huang, HJ; Tan, BH; Wei, YL; Xiong, QQ; Yan, Y; Hou, LL; Wu, NN; Siwko, S; Cimarelli, A; Xu, JR; Han, HH; Qian, M; Liu, MY; Du, B				Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Siwko, Stefan; Cimarelli, Andrea; Xu, Jianrong; Han, Honghui; Qian, Min; Liu, Mingyao; Du, Bing			Leucine-rich repeat-containing G protein-coupled receptor 4 facilitates vesicular stomatitis virus infection by binding vesicular stomatitis virus glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL-RECEPTOR; HOST-CELLS; ENTRY; LGR4; MICE; INHIBITION; BULLET; HIV-1	Vesicular stomatitis virus (VSV) and rabies and Chandipura viruses belong to the Rhabdovirus family. VSV is a common laboratory virus to study viral evolution and host immune responses to viral infection, and recombinant VSV-based vectors have been widely used for viral oncolysis, vaccination, and gene therapy. Although the tropism of VSV is broad, and its envelope glycoprotein G is often used for pseudotyping other viruses, the host cellular components involved in VSV infection remain unclear. Here, we demonstrate that the host protein leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is essential for VSV and VSV-G pseudotyped lentivirus (VSVG-LV) to infect susceptible cells. Accordingly, Lgr4-deficient mice had dramatically decreased VSV levels in the olfactory bulb. Furthermore, Lgr4 knockdown in RAW 264.7 cells also significantly suppressed VSV infection, and Lgr4 overexpression in RAW 264.7 cells enhanced VSV infection. Interestingly, only VSV infection relied on Lgr4, whereas infections with Newcastle disease virus, influenza A virus (A/WSN/33), and herpes simplex virus were unaffected by Lgr4 status. Of note, assays of virus entry, cell ELISA, immunoprecipitation, and surface plasmon resonance indicated that VSV bound susceptible cells via the Lgr4 extracellular domain. Pretreating cells with an Lgr4 antibody, soluble LGR4 extracellular domain, or R-spondin 1 blocked VSV infection by competitively inhibiting VSV binding to Lgr4. Taken together, the identification of Lgr4 as a VSV-specific host factor provides important insights into understanding VSV entry and its pathogenesis and lays the foundation for VSV-based gene therapy and viral oncolytic therapeutics.	[Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Qian, Min; Liu, Mingyao; Du, Bing] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhang, Na; Huang, Hongjun; Tan, Binghe; Wei, Yinglei; Xiong, Qingqing; Yan, Yan; Hou, Lili; Wu, Nannan; Qian, Min; Liu, Mingyao; Du, Bing] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Cimarelli, Andrea] CIRI, F-69364 Lyon, France; [Cimarelli, Andrea] INSERM, U1111, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] Ecole Normale Super Lyon, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] CNRS, UMR5308, 46 Allee Italie, F-69364 Lyon, France; [Cimarelli, Andrea] Univ Lyon 1, UMS3444, BioSci Gerland US8, F-69364 Lyon, France; [Xu, Jianrong] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol, Sch Med, Shanghai 200025, Peoples R China; [Han, Honghui] Shanghai Bioray Labs Inc, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Shanghai Jiao Tong University	Liu, MY; Du, B (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Liu, MY; Du, B (corresponding author), East China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; bdu.ecnu@gmail.com		CIMARELLI, Andrea/0000-0003-0892-0488; Sweat, Yan/0000-0002-9903-8054; Siwko, Stefan/0000-0003-4260-2985	National Natural Science Foundation of China [31000398, 31570896, 81672811, 31770969]; Joint Research Institute for Science and Society (JoRISS) Grant [14JORISS01]; Science and Technology Commission of Shanghai Municipality Grant [15JC1401500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Institute for Science and Society (JoRISS) Grant; Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China Grants 31000398, 31570896, 81672811, and 31770969, Joint Research Institute for Science and Society (JoRISS) Grant 14JORISS01, and Science and Technology Commission of Shanghai Municipality Grant 15JC1401500. The authors declare that they have no conflicts of interest with the contents of this article.	Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Amirache F, 2014, BLOOD, V123, P1422, DOI 10.1182/blood-2013-11-540641; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen Y, 2007, AM J PHYSIOL-RENAL, V293, pF680, DOI 10.1152/ajprenal.00209.2007; Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; GILLIES S, 1980, VIROLOGY, V107, P497, DOI 10.1016/0042-6822(80)90316-5; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Kubo T, 2011, J ORTHOP RES, V29, P795, DOI 10.1002/jor.21307; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Muik A, 2011, J VIROL, V85, P5679, DOI 10.1128/JVI.02511-10; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Song QX, 2014, ACS NANO, V8, P2345, DOI 10.1021/nn4058215; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; SUPERTI F, 1987, J GEN VIROL, V68, P387, DOI 10.1099/0022-1317-68-2-387; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Yi Y, 2011, CURR GENE THER, V11, P218	41	14	14	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16527	16538		10.1074/jbc.M117.802090	http://dx.doi.org/10.1074/jbc.M117.802090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842478	Green Published, hybrid			2022-12-28	WOS:000412414800015
J	Zotter, A; Bauerle, F; Dey, D; Kiss, V; Schreiber, G				Zotter, Agnes; Baeuerle, Felix; Dey, Debabrata; Kiss, Vladimir; Schreiber, Gideon			Quantifying enzyme activity in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BETA-LACTAMASE; PROTEIN; VITRO; THERMODYNAMICS; ENVIRONMENTS; MECHANISM; CATALYSIS; KINETICS; PROGRESS	For over a century, enzymatic activity has been studied in vitro, assuming similar activity in the crowded cellular milieu. Here, we determined in real time the catalytic activity of TEM1-beta-lactamase inside living cells and compared the values to those obtained in vitro. We found the apparent in vivo catalytic efficiency, k(cat)/K-m, to be lower than in vitro, with significant cell-tocell variability. Surprisingly, the results show that inside the cell the apparent catalytic efficiency decreases, and Km increases with increasing enzyme concentration. To rationalize these findings, we measured enzyme and substrate diffusion rates in the cell and found the latter to be slower than expected. Simulations showed that for attenuated diffusion the substrate flux becomes rate-limiting, explaining why reaction rates in vivo can be independent on enzyme concentrations. The octanol/water partition of the substrate is 4.5, which is in the range of Food and Drug Administration-approved drugs. This suggests substrate-limited reaction rates to be common. These findings indicate that in vitro data cannot be simply extrapolated to the crowded in vivo environment.	[Zotter, Agnes; Baeuerle, Felix; Dey, Debabrata; Kiss, Vladimir; Schreiber, Gideon] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Baeuerle, Felix] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany	Weizmann Institute of Science; Max Planck Society	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il	DEY, DEBABRATA/AAR-5740-2021	DEY, DEBABRATA/0000-0003-3794-6476	Israel Science Foundation [1549/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1549/14. The authors declare that they have no conflicts of interest with the contents of this article.	Bauerle F, 2017, PROTEIN ENG DES SEL, V30, P151, DOI 10.1093/protein/gzw053; Barbieri L, 2016, NAT PROTOC, V11, P1101, DOI 10.1038/nprot.2016.061; BERG OG, 1990, BIOPOLYMERS, V30, P1027, DOI 10.1002/bip.360301104; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Davidi D, 2016, P NATL ACAD SCI USA, V113, P3401, DOI 10.1073/pnas.1514240113; Deichmann U, 2014, FEBS J, V281, P435, DOI 10.1111/febs.12598; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Frederick KK, 2015, CELL, V163, P620, DOI 10.1016/j.cell.2015.09.024; Garcia-Contreras R, 2012, FEBS J, V279, P4145, DOI 10.1111/febs.12007; Hooff GP, 2012, J PROTEOME RES, V11, P79, DOI 10.1021/pr200858r; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Marr C, 2016, CURR OPIN BIOTECH, V39, P207, DOI 10.1016/j.copbio.2016.04.015; MATAGNE A, 1995, BBA-PROTEIN STRUCT M, V1246, P109, DOI 10.1016/0167-4838(94)00177-I; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; MINTON AP, 1981, BIOCHEMISTRY-US, V20, P4821, DOI 10.1021/bi00520a003; Norris MGS, 2011, BIOCHEM BIOPH RES CO, V405, P388, DOI 10.1016/j.bbrc.2011.01.037; Page MI, 1999, CURR PHARM DESIGN, V5, P895; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Peleg Y, 2014, METHODS MOL BIOL, V1116, P73, DOI 10.1007/978-1-62703-764-8_6; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Phillip Y, 2012, P NATL ACAD SCI USA, V109, P1461, DOI 10.1073/pnas.1112171109; Rohwer JM, 1998, P NATL ACAD SCI USA, V95, P10547, DOI 10.1073/pnas.95.18.10547; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Sharp KA, 2015, P NATL ACAD SCI USA, V112, P7990, DOI 10.1073/pnas.1505396112; Shoemaker GK, 2005, ANAL CHEM, V77, P3132, DOI 10.1021/ac0481304; Smith AE, 2016, P NATL ACAD SCI USA, V113, P1725, DOI 10.1073/pnas.1518620113; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Yue SH, 2016, CURR OPIN CHEM BIOL, V33, P46, DOI 10.1016/j.cbpa.2016.05.016; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	35	40	41	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15838	15848		10.1074/jbc.M117.792119	http://dx.doi.org/10.1074/jbc.M117.792119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28784664	hybrid, Green Published			2022-12-28	WOS:000411512200021
J	Wang, Y; Chen, FQ; Zhao, M; Yang, Z; Li, J; Zhang, SQ; Zhang, WY; Ye, LH; Zhang, XD				Wang, Yuan; Chen, Fuquan; Zhao, Man; Yang, Zhe; Li, Jiong; Zhang, Shuqin; Zhang, Weiying; Ye, Lihong; Zhang, Xiaodong			The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOMA-CELLS; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; BREAST-CANCER; PROLIFERATION; PROTEIN; MIR-186; OVEREXPRESSION; TUMORIGENICITY; METASTASIS	The long noncoding RNA highly up-regulated in liver cancer (HULC) is aberrantly elevated in hepatocellular carcinoma (HCC), and this up-regulation is crucial for HCC pathogenesis. However, the underlying mechanism in HULC up-regulation is poorly understood. We hypothesized that HULC might modulate the oncogene high mobility group A2 (HMGA2) to promote hepatocarcinogenesis. Quantitative real-time PCR analysis showed that the expression levels of HULC were positively correlated with those of HMGA2 in clinical HCC tissues. Interestingly, we also observed that HULC could up-regulate HMGA2 in HCC cells. Mechanistically, we found that the microRNA-186 inhibited HMGA2 expression by targeting the 3'-untranslated region (3'-UTR) of HMGA2m RNA. Strikingly, HULC acted as a competing noncoding RNA to sequester miR-186 and thereby relieved miR-186-mediated HMGA2 repression. Functionally, HMGA2 knockdown decreased the HULC-enhanced growth of HCC cells both in vitro and in vivo. We conclude that the long noncoding RNA HULC increases HMGA2 expression by sequestering miR-186 post-transcriptionally and thereby promotes liver cancer growth, providing new insights into the mechanism by which HULC enhances hepatocarcinogenesis.	[Wang, Yuan; Chen, Fuquan; Zhao, Man; Yang, Zhe; Li, Jiong; Zhang, Shuqin; Zhang, Weiying] Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ye, Lihong; Zhang, Xiaodong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Ye, LH; Zhang, XD (corresponding author), Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022		National Basic Research Program of China 973 Program [2015CB553703, 2015CB553905]; National Natural Science Foundation of China [81272218, 81372186, 31670769, 31670771]; Project of Prevention and Treatment of Key Infectious Diseases Grant [2014ZX0002002-005]; Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant [2016YFC130340]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Prevention and Treatment of Key Infectious Diseases Grant; Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant	This work was supported by National Basic Research Program of China 973 Program Grants 2015CB553703 and 2015CB553905; National Natural Science Foundation of China Grants 81272218, 81372186, 31670769, and 31670771; Project of Prevention and Treatment of Key Infectious Diseases Grant 2014ZX0002002-005; and Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant 2016YFC130340. The authors declare that they have no conflicts of interest with the contents of this article.	Agostini A, 2016, ONCOTARGET, V7, P85058, DOI 10.18632/oncotarget.13187; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao CH, 2016, ONCOTARGET, V7, P79956, DOI 10.18632/oncotarget.13182; Cui M, 2015, NEOPLASIA, V17, P79, DOI 10.1016/j.neo.2014.11.004; Cui NI., 2015, CANC RES, V75; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hua X, 2016, AM J CANCER RES, V6, P1650; Kaur H, 2016, CANCER LETT, V377, P55, DOI 10.1016/j.canlet.2016.04.020; Khanduja JS, 2016, MOL CELL, V63, P7, DOI 10.1016/j.molcel.2016.06.011; Li C, 2015, CELL PHYSIOL BIOCHEM, V36, P423, DOI 10.1159/000430109; Li HL, 2013, CARCINOGENESIS, V34, P2145, DOI 10.1093/carcin/bgt158; Liu L, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.35; Liu YW, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0588-9; Lu ZP, 2016, ONCOTARGET, V7, P241, DOI 10.18632/oncotarget.6280; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Palumbo A, 2016, ONCOTARGET, V7, P25872, DOI 10.18632/oncotarget.8288; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ruan TY, 2016, ONCOL LETT, V11, P2941, DOI 10.3892/ol.2016.4312; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shi H, 2016, CANCER LETT, V382, P147, DOI 10.1016/j.canlet.2016.08.025; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang XC, 2011, CLIN CANCER RES, V17, P2570, DOI 10.1158/1078-0432.CCR-10-2542; Wang Y, 2016, BIOCHEM BIOPH RES CO, V480, P455, DOI 10.1016/j.bbrc.2016.10.070; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu I., 2016, CARCINOGENESIS, V37; Wu JJ, 2016, CANCER LETT, V376, P284, DOI 10.1016/j.canlet.2016.04.005; Wu JJ, 2013, J MOL MED, V91, P1155, DOI 10.1007/s00109-013-1055-8; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang X, 2015, CANCER LETT, V360, P119, DOI 10.1016/j.canlet.2015.02.035; You X, 2014, ONCOGENE, V33, P449, DOI 10.1038/onc.2012.618; You XN, 2013, CARCINOGENESIS, V34, P1644, DOI 10.1093/carcin/bgt089; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu X, 2017, J CELL MOL MED, V21, P410, DOI 10.1111/jcmm.12956; Yuan, 2014, CANCER CELL, V25, P666, DOI DOI 10.1016/J.CCR.2014.03.010; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang W, 2012, PLOS ONE, V7; Zhao XP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0777-0; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	50	104	107	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15395	15407		10.1074/jbc.M117.783738	http://dx.doi.org/10.1074/jbc.M117.783738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765279	Green Published, hybrid			2022-12-28	WOS:000410809800020
J	Peters, JM				Peters, Jeffrey M.			Flipping a citrate switch on liver cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; METABOLISM	Energy homeostasis and oncogenic signaling are critical determinants of the growth of human liver cancer cells, providing a strong rationale to elucidate the regulatory mechanisms for these systems. A new study reports that loss of solute carrier family 13 member 5, which transports citrate across cell membranes, halts liver cancer cell growth by altering both energy production and mammalian target of rapamycin signaling in human liver cancer cell lines and in both an in vitro and in vivo model of liver tumors, suggesting a new target for liver cancer chemoprevention and/or chemotherapy.	[Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA; [Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.; Peters, JM (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA.	jmp21@psu.edu		Peters, Jeffrey/0000-0003-2782-2998	National Institutes of Health [R01CA124533, R01CA141029]; NATIONAL CANCER INSTITUTE [R01CA141029, R01CA124533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants R01CA124533 and R01CA141029. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Bupathi M, 2015, MOL ONCOL, V9, P1501, DOI 10.1016/j.molonc.2015.06.005; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Cidon EU, 2017, WORLD J HEPATOL, V9, P797, DOI 10.4254/wjh.v9.i18.797; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Li ZH, 2017, J BIOL CHEM, V292, P13890, DOI 10.1074/jbc.M117.783860; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	9	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13902	13903		10.1074/jbc.H117.783860	http://dx.doi.org/10.1074/jbc.H117.783860			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28821606	hybrid, Green Published			2022-12-28	WOS:000407942400021
J	Wu, GR; Mu, TC; Gao, ZX; Wang, J; Sy, MS; Li, CY				Wu, Gui-Ru; Mu, Tian-Chen; Gao, Zhen-Xing; Wang, Jun; Sy, Man-Sun; Li, Chao-Yang			Prion protein is required for tumor necrosis factor (TNF)-triggered nuclear factor B (NF-B) signaling and cytokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); melanoma; NF-B (NF-B); prion; tumor necrosis factor (TNF); CYLD; NF-B signaling; PrP; TNF	CARCINOMA CELL-LINE; KAPPA-B; FACTOR-ALPHA; INFLAMMATORY RESPONSE; EPITHELIAL-CELLS; PRO-PRION; ACTIVATION; CANCER; BINDING; MICE	The expression of normal cellular prion protein (PrP) is required for the pathogenesis of prion diseases. However, the physiological functions of PrP remain ambiguous. Here, we identified PrP as being critical for tumor necrosis factor (TNF) -triggered signaling in a human melanoma cell line, M2, and a pancreatic ductal cell adenocarcinoma cell line, BxPC-3. In M2 cells, TNF up-regulates the expression of p-IB-kinase / (p-IKK/), p-p65, and p-JNK, but down-regulates the IB protein, all of which are downstream signaling intermediates in the TNF receptor signaling cascade. When PRNP is deleted in M2 cells, the effects of TNF are no longer detectable. More importantly, p-p65 and p-JNK responses are restored when PRNP is reintroduced into the PRNP null cells. TNF also activates NF-B and increases TNF production in wild-type M2 cells, but not in PrP-null M2 cells. Similar results are obtained in the BxPC-3 cells. Moreover, TNF activation of NF-B requires ubiquitination of receptor-interacting serine/threonine kinase 1 (RIP1) and TNF receptor-associated factor 2 (TRAF2). TNF treatment increases the binding between PrP and the deubiquitinase tumor suppressor cylindromatosis (CYLD), in these treated cells, binding of CYLD to RIP1 and TRAF2 is reduced. We conclude that PrP traps CYLD, preventing it from binding and deubiquitinating RIP1 and TRAF2. Our findings reveal that PrP enhances the responses to TNF, promoting proinflammatory cytokine production, which may contribute to inflammation and tumorigenesis.	[Wu, Gui-Ru; Gao, Zhen-Xing; Wang, Jun; Li, Chao-Yang] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Hubei, Peoples R China; [Wu, Gui-Ru] Univ Chinese Acad Sci, Beijing 100000, Peoples R China; [Mu, Tian-Chen] Wuhan Univ, Dept Life Sci, Wuhan 430010, Hubei, Peoples R China; [Sy, Man-Sun] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Chao-Yang] Wuhan Brain Hosp, 5 Huiji Rd, Wuhan 430010, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Case Western Reserve University	Li, CY (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Hubei, Peoples R China.	cyli@wh.iov.cn	Gao, Zhenxing/AAL-8244-2020	Mu, Tianchen/0000-0002-0271-0941; Li, Chaoyang/0000-0003-3582-4141; Gao, Zhenxing/0000-0002-2692-985X	Strategic Priority Research Program A of the Chinese Academy of Sciences [XDA12010309]; National Science Foundation of China [31670170]; Nature Science Foundation of Hubei Province [2015CFA087]; National Basic Research Priorities Program of China from the Ministry of Science and Technology of China [2013CB911102]	Strategic Priority Research Program A of the Chinese Academy of Sciences; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); National Basic Research Priorities Program of China from the Ministry of Science and Technology of China	This work was supported by Strategic Priority Research Program A of the Chinese Academy of Sciences Grant XDA12010309, National Science Foundation of China Grant 31670170, Nature Science Foundation of Hubei Province Grant 2015CFA087, and National Basic Research Priorities Program of China Grant 2013CB911102 from the Ministry of Science and Technology of China. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Besnier LS, 2015, MOL BIOL CELL, V26, P3313, DOI 10.1091/mbc.E14-11-1534; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brockes JP, 1999, CURR OPIN NEUROBIOL, V9, P571, DOI 10.1016/S0959-4388(99)00016-1; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campos LS, 2016, MOL CELL BIOL, V36, P320, DOI 10.1128/MCB.00554-15; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Dinarello CA, 2014, LANCET ONCOL, V15, P552, DOI 10.1016/S1470-2045(14)70164-0; Ding TJ, 2013, J MOL NEUROSCI, V51, P118, DOI 10.1007/s12031-013-9962-2; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao ZX, 2016, CELL SIGNAL, V28, P652, DOI 10.1016/j.cellsig.2016.03.010; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hachiya NS, 2005, NEUROSCI LETT, V374, P98, DOI 10.1016/j.neulet.2004.10.044; Haddon DJ, 2009, J INFECT DIS, V200, P827, DOI 10.1086/605022; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Li CY, 2007, BIOCHEM J, V406, P333, DOI 10.1042/BJ20061857; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu J, 2015, J MOL NEUROSCI, V55, P279, DOI 10.1007/s12031-014-0319-2; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mabbott NA, 1997, IMMUNOLOGY, V92, P161, DOI 10.1046/j.1365-2567.1997.00331.x; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; Martin GR, 2011, AM J PATHOL, V179, P2290, DOI 10.1016/j.ajpath.2011.07.025; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nasu-Nishimura Y, 2008, ARCH VIROL, V153, P1007, DOI 10.1007/s00705-008-0086-x; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; Petit CSV, 2012, GASTROENTEROLOGY, V143, P122, DOI 10.1053/j.gastro.2012.03.029; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Rybner C, 2002, J CELL BIOCHEM, V84, P408, DOI 10.1002/jcb.10017; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yang LH, 2016, J BIOL CHEM, V291, P6785, DOI 10.1074/jbc.A115.705830; Yang Liheng, 2014, Virologica Sinica, V29, P228, DOI 10.1007/s12250-014-3480-4; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhao YG, 2015, J BIOL CHEM, V290, P22076, DOI 10.1074/jbc.M115.658096; Zidi I, 2010, MED ONCOL, V27, P185, DOI 10.1007/s12032-009-9190-3	88	19	20	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18747	18759		10.1074/jbc.M117.787283	http://dx.doi.org/10.1074/jbc.M117.787283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900035	hybrid, Green Published			2022-12-28	WOS:000415848000002
J	Rajvanshi, PK; Arya, M; Rajasekharan, R				Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram			The stress-regulatory transcription factors Msn2 and Msn4 regulate fatty acid oxidation in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; lipotoxicity; peroxisome; stress response; transcription regulation; triacylglycerol; -oxidation; Msn2 and Msn4	PEROXISOMAL BETA-OXIDATION; KINASE-A ACTIVITY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; IN-VIVO; PROTEIN; GLUCOSE; SNF1; TOR	The transcription factors Msn2 and Msn4 (multicopy suppressor of SNF1 mutation proteins 2 and 4) bind the stress-response element in gene promoters in the yeast Saccharomyces cerevisiae. However, the roles of Msn2/4 in primary metabolic pathways such as fatty acid -oxidation are unclear. Here, in silico analysis revealed that the promoters of most genes involved in the biogenesis, function, and regulation of the peroxisome contain Msn2/4-binding sites. We also found that transcript levels of MSN2/MSN4 are increased in glucose-depletion conditions and that during growth in nonpreferred carbon sources, Msn2 is constantly localized to the nucleus in wild-type cells. Of note, the double mutant msn2msn4 exhibited a severe growth defect when grown with oleic acid as the sole carbon source and had reduced transcript levels of major -oxidation genes. ChIP indicated that Msn2 has increased occupancy on the promoters of -oxidation genes in glucose-depleted conditions, and in vivo reporter gene analysis indicated reduced expression of these genes in msn2msn4 cells. Moreover, mobility shift assays revealed that Msn4 binds -oxidation gene promoters. Immunofluorescence microscopy with anti-peroxisome membrane protein antibodies disclosed that the msn2msn4 strain had fewer peroxisomes than the wild type, and lipid analysis indicated that the msn2msn4 strain had increased triacylglycerol and steryl ester levels. Collectively, our data suggest that Msn2/Msn4 transcription factors activate expression of the genes involved in fatty acid oxidation. Because glucose sensing, signaling, and fatty acid -oxidation pathways are evolutionarily conserved throughout eukaryotes, the msn2msn4 strain could therefore be a good model system for further study of these critical processes.	[Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram] Cent Food Technol Res Inst, CSIR, Dept Lipid Sci, Lipid Ctr, Mysuru 570020, Karnataka, India; [Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram] Acad Sci & Innovat Res, CSIR, Cent Food Technol Res Inst, Mysuru 570020, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajasekharan, R (corresponding author), CSIR, Cent Food Technol Res Inst, Mysuru 570020, Karnataka, India.	ram@cftri.com	Rajvanshi, Praveen Kumar/ABH-1375-2021; Rajasekharan, Ram/R-2257-2019	Rajvanshi, Praveen Kumar/0000-0001-6831-002X; Ram, Rajasekharan/0000-0002-4114-0654; Rajasekharan, Ram/0000-0002-2124-6013	Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center); Council of Scientific and Industrial Research; J. C. Bose national fellowship	Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose national fellowship	This work was supported by the Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from the Council of Scientific and Industrial Research.; Recipient of the J. C. Bose national fellowship. To whom correspondence should be addressed: Central Food Technological Research Institute, Council of Scientific and Industrial Research, Mysuru 570020, Karnataka, India. Tel.: 91-821-2517760; Fax: 91-821-2516308; E-mail: ram@cftri.com.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Conway MK, 2012, G3-GENES GENOM GENET, V2, P1003, DOI 10.1534/g3.112.002808; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geisbrecht BV, 1998, J BIOL CHEM, V273, P33184, DOI 10.1074/jbc.273.50.33184; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Harmeyer KM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1347; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lefevre SD, 2013, AGING CELL, V12, P784, DOI 10.1111/acel.12113; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Norbeck J, 2000, YEAST, V16, P121, DOI 10.1002/(SICI)1097-0061(20000130)16:2<121::AID-YEA511>3.0.CO;2-A; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rani SH, 2013, MICROBIOL-SGM, V159, P155, DOI 10.1099/mic.0.063156-0; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; Seip J, 2013, APPL ENVIRON MICROB, V79, P7360, DOI 10.1128/AEM.02079-13; Skoneczny M, 1996, BIOCHIMIE, V78, P95, DOI 10.1016/0300-9084(96)82639-3; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Stewart-Ornstein J, 2013, CURR BIOL, V23, P2336, DOI 10.1016/j.cub.2013.09.043; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; Wierzbicki AS, 2002, J NEUROCHEM, V80, P727, DOI 10.1046/j.0022-3042.2002.00766.x; Yadav KK, 2016, FEBS LETT, V590, P3559, DOI 10.1002/1873-3468.12422; Yadav PK, 2016, J BIOL CHEM, V291, P18562, DOI 10.1074/jbc.M116.733378; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	49	18	19	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18628	18643		10.1074/jbc.M117.801704	http://dx.doi.org/10.1074/jbc.M117.801704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924051	Green Published, hybrid			2022-12-28	WOS:000414958100020
J	Rao, MV; Williams, DR; Cocklin, S; Loll, PJ				Rao, Maya V.; Williams, Dewight R.; Cocklin, Simon; Loll, Patrick J.			Interaction between the AAA(+) ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); conformational change; electron microscopy (EM); proteostasis; surface plasmon resonance (SPR); ataxin3; cofactor binding; multisystem proteinopathy 1 (MSP1); nucleotide regulation; p97; VCP	MACHADO-JOSEPH-DISEASE; VALOSIN-CONTAINING PROTEIN; CRYO-EM STRUCTURE; ENDOPLASMIC-RETICULUM STRESS; STRUCTURAL BASIS; PAGET-DISEASE; MOUSE MODEL; POLYGLUTAMINE DISEASE; UBIQUITIN CHAINS; VCP/P97	p97 is an essential ATPase associated with various cellular activities (AAA(+)) that functions as a segregase in diverse cellular processes, including the maintenance of proteostasis. p97 interacts with different cofactors that target it to distinct pathways; an important example is the deubiquitinase ataxin3, which collaborates with p97 in endoplasmic reticulum-associated degradation. However, the molecular details of this interaction have been unclear. Here, we characterized the binding of ataxin3 to p97, showing that ataxin3 binds with low-micromolar affinity to both wild-type p97 and mutants linked to degenerative disorders known as multisystem proteinopathy 1 (MSP1); we further showed that the stoichiometry of binding is one ataxin3 molecule per p97 hexamer. We mapped the binding determinants on each protein, demonstrating that ataxin3's p97/VCP-binding motif interacts with the inter-lobe cleft in the N-domain of p97. We also probed the nucleotide dependence of this interaction, confirming that ataxin3 and p97 associate in the presence of ATP and in the absence of nucleotide, but not in the presence of ADP. Our experiments suggest that an ADP-driven downward movement of the p97 N-terminal domain dislodges ataxin3 by inducing a steric clash between the D1-domain and ataxin3's C terminus. In contrast, MSP1 mutants of p97 bind ataxin3 irrespective of their nucleotide state, indicating a failure by these mutants to translate ADP binding into a movement of the N-terminal domain. Our model provides a mechanistic explanation for how nucleotides regulate the p97-ataxin3 interaction and why atypical cofactor binding is observed with MSP1 mutants.	[Rao, Maya V.; Cocklin, Simon; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 North 15th St, Philadelphia, PA 19102 USA; [Williams, Dewight R.] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci, Tempe, AZ 85287 USA	Drexel University; Arizona State University; Arizona State University-Tempe	Loll, PJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 North 15th St, Philadelphia, PA 19102 USA.	pjl28@drexel.edu			National Institutes of Health [R01 NS065140]; NCI Cancer Center Support Grant [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant R01 NS065140. Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility at Thomas Jefferson University, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann L, 2016, NAT STRUCT MOL BIOL, V23, P995, DOI 10.1038/nsmb.3296; Almeida B, 2015, BBA-MOL BASIS DIS, V1852, P1950, DOI 10.1016/j.bbadis.2015.06.010; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Bulfer SL, 2016, ACS CHEM BIOL, V11, P2112, DOI 10.1021/acschembio.6b00350; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Erzurumlu Y, 2013, INT J BIOCHEM CELL B, V45, P773, DOI 10.1016/j.biocel.2013.01.006; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Franz A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00073; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Hanzelmann P, 2016, STRUCTURE, V24, P140, DOI 10.1016/j.str.2015.10.027; Hanzelmann P, 2016, STRUCTURE, V24, P127, DOI 10.1016/j.str.2015.10.026; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim SJ, 2014, J BIOL CHEM, V289, P12264, DOI 10.1074/jbc.M113.523936; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kuhlbrodt K, 2011, NAT CELL BIOL, V13, P273, DOI 10.1038/ncb2200; Li XL, 2015, PROG NEUROBIOL, V132, P34, DOI 10.1016/j.pneurobio.2015.06.004; Liebl MP, 2016, AM J PHYSIOL-CELL PH, V311, pC166, DOI 10.1152/ajpcell.00074.2016; Lim JJ, 2016, BIOCHEM J, V473, P2863, DOI 10.1042/BCJ20160237; Liu S, 2013, BBA-PROTEINS PROTEOM, V1834, P2672, DOI 10.1016/j.bbapap.2013.09.021; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Locatelli-Hoops SC, 2013, BBA-PROTEINS PROTEOM, V1834, P2045, DOI 10.1016/j.bbapap.2013.06.003; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macedo-Ribeiro S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005834; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Onofre I, 2016, SCI REP-UK, V6, DOI 10.1038/srep28220; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Ramani B, 2015, HUM MOL GENET, V24, P1211, DOI 10.1093/hmg/ddu532; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigues AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018512; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Sutton JR, 2017, HUM MOL GENET, V26, P1419, DOI 10.1093/hmg/ddx039; Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2012, J STRUCT BIOL, V179, P83, DOI 10.1016/j.jsb.2012.04.024; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C., 2011, MUSCLE AGING INCLUSI, P206; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XH, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON NETWORKING, ARCHITECTURE AND STORAGE (NAS), P112, DOI 10.1109/NAS.2015.7255213; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	103	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18392	18407		10.1074/jbc.M117.806281	http://dx.doi.org/10.1074/jbc.M117.806281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939772	hybrid, Green Published			2022-12-28	WOS:000414958100002
J	Shibutani, S; Okazaki, H; Iwata, H				Shibutani, Shusaku; Okazaki, Hana; Iwata, Hiroyuki			Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; autophagy; dynamin; endocytosis; mammalian target of rapamycin (mTOR); mTORC1; mechanistic target of rapamycin (mTOR)	RAG GTPASES; AUTOPHAGY; PROTEINS; GROWTH; CANCER; SUFFICIENCY; INHIBITOR; RAGULATOR; DYNASORE; REQUIRES	The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of protein synthesis and potential target for modifying cellular metabolism in various conditions, including cancer and aging. mTORC1 activity is tightly regulated by the availability of extracellular amino acids, and previous studies have revealed that amino acids in the extracellular fluid are transported to the lysosomal lumen. There, amino acids induce recruitment of cytoplasmic mTORC1 to the lysosome by the Rag GTPases, followed by mTORC1 activation by the small GTPase Ras homolog enriched in brain (Rheb). However, how the extracellular amino acids reach the lysosomal lumen and activate mTORC1 remains unclear. Here, we show that amino acid uptake by dynamin-dependent endocytosis plays a critical role in mTORC1 activation. We found that mTORC1 is inactivated when endocytosis is inhibited by overexpression of a dominant-negative form of dynamin 2 or by pharmacological inhibition of dynamin or clathrin. Consistently, the recruitment of mTORC1 to the lysosome was suppressed by the dynamin inhibition. The activity and lysosomal recruitment of mTORC1 were rescued by increasing intracellular amino acids via cycloheximide exposure or by Rag overexpression, indicating that amino acid deprivation is the main cause of mTORC1 inactivation via the dynamin inhibition. We further show that endocytosis inhibition does not induce autophagy even though mTORC1 inactivation is known to strongly induce autophagy. These findings open new perspectives for the use of endocytosis inhibitors as potential agents that can effectively inhibit nutrient utilization and shut down the upstream signals that activate mTORC1.	[Shibutani, Shusaku; Okazaki, Hana; Iwata, Hiroyuki] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Hyg, 1677-1 Yoshida, Yamaguchi 7538515, Japan	Yamaguchi University	Shibutani, S; Iwata, H (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Hyg, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	shushibu@yamaguchi-u.ac.jp; hiwata@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [15K18530]; Funds for the Development of Human Resources in Science and Technology under MEXT through the Home for Innovative Researchers and Academic Knowledge Users (HIRAKU) consortium	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funds for the Development of Human Resources in Science and Technology under MEXT through the Home for Innovative Researchers and Academic Knowledge Users (HIRAKU) consortium	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 15K18530 and Funds for the Development of Human Resources in Science and Technology under MEXT through the Home for Innovative Researchers and Academic Knowledge Users (HIRAKU) consortium. The authors declare that they have no conflicts of interest with the contents of this article.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; CHAKRABARTI AC, 1994, AMINO ACIDS, V6, P213, DOI 10.1007/BF00813743; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dimitrakopoulou-Strauss A, 2003, J NUCL MED, V44, P556; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Groves AM, 2007, LANCET ONCOL, V8, P822, DOI 10.1016/S1470-2045(07)70274-7; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hemmings B. A., 2012, BIOL, V4; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lamming DW, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025924; Lamming DW, 2013, J CLIN INVEST, V123, P980, DOI 10.1172/JCI64099; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yoshida S, 2015, J CELL BIOL, V211, P159, DOI 10.1083/jcb.201504097; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18052	18061		10.1074/jbc.M117.776443	http://dx.doi.org/10.1074/jbc.M117.776443			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28808055	Green Published, hybrid			2022-12-28	WOS:000414458200006
J	Yu, CH; Yang, N; Bothe, J; Tonelli, M; Nokhrin, S; Dolgova, NV; Braiterman, L; Lutsenko, S; Dmitriev, OY				Yu, Corey H.; Yang, Nan; Bothe, Jameson; Tonelli, Marco; Nokhrin, Sergiy; Dolgova, Natalia V.; Braiterman, Lelita; Lutsenko, Svetlana; Dmitriev, Oleg Y.			The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; copper transport; membrane protein; membrane transport; nuclear magnetic resonance (NMR); protein dynamic; protein NMR	WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; BINDING DOMAIN; ATPASE ATP7B; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CANCER PATIENTS; MENKES-DISEASE; CISPLATIN; MECHANISM	The human transporter ATP7B delivers copper to the biosynthetic pathways and maintains copper homeostasis in the liver. Mutations in ATP7B cause the potentially fatal hepatoneurological disorder Wilson disease. The activity and intracellular localization of ATP7B are regulated by copper, but the molecular mechanism of this regulation is largely unknown. We show that the copper chaperone Atox1, which delivers copper to ATP7B, and the group of the first three metal-binding domains (MBD1-3) are central to the activity regulation of ATP7B. Atox1-Cu binding to ATP7B changes domain dynamics and interactions within the MBD1-3 group and activates ATP hydrolysis. To understand the mechanism linking Atox1-MBD interactions and enzyme activity, we have determined the MBD1-3 conformational space using small angle X-ray scattering and identified changes in MBD dynamics caused by apo-Atox1 and Atox1-Cu by solution NMR. The results show that copper transfer from Atox1 decreases domain interactions within the MBD1-3 group and increases the mobility of the individual domains. The N-terminal segment of MBD1-3 was found to interact with the nucleotide-binding domain of ATP7B, thus physically coupling the domains involved in copper binding and those involved in ATP hydrolysis. Taken together, the data suggest a regulatory mechanism in which Atox1-mediated copper transfer activates ATP7B by releasing inhibitory constraints through increased freedom of MBD1-3 motions.	[Yu, Corey H.; Nokhrin, Sergiy; Dolgova, Natalia V.; Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Yang, Nan; Braiterman, Lelita; Lutsenko, Svetlana] Johns Hopkins Med Univ, Dept Physiol, Baltimore, MD 21205 USA; [Bothe, Jameson; Tonelli, Marco] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA	University of Saskatchewan; Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; University of Wisconsin Madison	Dmitriev, OY (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca	Dolgova, Natalia V/J-7510-2018; Dolgova, Natalia/J-4859-2019; Dmitriev, Oleg/AAB-7830-2019	Dolgova, Natalia V/0000-0002-9951-6634; Dolgova, Natalia/0000-0002-9951-6634; 	Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [R01 DK071865, P41 GM103399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to O. Y. D.) and National Institutes of Health Grant R01 DK071865 (to S. L.). NMR data were collected at the Saskatchewan Structural Sciences Center and at the National Magnetic Resonance Facility at Madison (NMRFAM), which is supported by National Institutes of Health Grant P41 GM103399 and by the University of Wisconsin-Madison. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Bunce J, 2006, BBA-GEN SUBJECTS, V1760, P907, DOI 10.1016/j.bbagen.2006.02.005; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Dmitriev OY, 2011, BIOCHEM CELL BIOL, V89, P138, DOI [10.1139/O10-150, 10.1139/o10-150]; Dolgova NV, 2013, BIOCHEM J, V454, P147, DOI 10.1042/BJ20121656; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fatemi N, 2010, BIOCHEMISTRY-US, V49, P8468, DOI 10.1021/bi1008535; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hua HQ, 2011, BIOMETALS, V24, P445, DOI 10.1007/s10534-011-9438-1; Huang YP, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.580845; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kay KL, 2017, CHEM COMMUN, V53, P1397, DOI 10.1039/c6cc08966f; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; Li XP, 2014, TUMOR BIOL, V35, P8259, DOI 10.1007/s13277-014-2072-0; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Martinez-Balibrea E, 2009, INT J CANCER, V124, P2905, DOI 10.1002/ijc.24273; Mondol T, 2016, BIOCHEM BIOPH RES CO, V470, P663, DOI 10.1016/j.bbrc.2016.01.085; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Safaei R, 2009, J INORG BIOCHEM, V103, P333, DOI 10.1016/j.jinorgbio.2008.11.012; Sarkar B, 2000, J INORG BIOCHEM, V79, P187, DOI 10.1016/S0162-0134(99)00249-4; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sitsel O, 2015, BIOCHEMISTRY-US, V54, P5673, DOI 10.1021/acs.biochem.5b00512; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tsay MJ, 2004, BBA-MOL BASIS DIS, V1688, P78, DOI 10.1016/j.bbadis.2003.11.001; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Yang T, 2015, ONCOL LETT, V10, P2584, DOI 10.3892/ol.2015.3531; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Yu C. H., 2016, NMR STRUCTURE METALB; Yu CH, 2017, IUBMB LIFE, V69, P226, DOI 10.1002/iub.1611	58	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18169	18177		10.1074/jbc.M117.811752	http://dx.doi.org/10.1074/jbc.M117.811752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28900031	Green Published, hybrid			2022-12-28	WOS:000414458200015
J	Burel, S; Coyan, FC; Lorenzini, M; Meyer, MR; Lichti, CF; Brown, JH; Loussouarn, G; Charpentier, F; Nerbonne, JM; Townsend, RR; Maier, LS; Marionneau, C				Burel, Sophie; Coyan, Fabien C.; Lorenzini, Maxime; Meyer, Matthew R.; Lichti, Cheryl F.; Brown, Joan H.; Loussouarn, Gildas; Charpentier, Flavien; Nerbonne, Jeanne M.; Townsend, R. Reid; Maier, Lars S.; Marionneau, Celine			C-terminal phosphorylation of Na(V)1.5 impairs FGF13-dependent regulation of channel inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGOUS FACTOR; LATE SODIUM CURRENT; HEART-FAILURE; KINASE-II; MASS-SPECTROMETRY; NA+ CHANNELS; QUANTITATIVE-ANALYSIS; MEMBRANE-PROTEINS; STATISTICAL-MODEL; CRYSTAL-STRUCTURE	Voltage-gated Na+ (Na-V) channels are key regulators of myocardial excitability, and Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent alterations in Na(V)1.5 channel inactivation are emerging as a critical determinant of arrhythmias in heart failure. However, the global native phosphorylation pattern of Na(V)1.5 subunits associated with these arrhythmogenic disorders and the associated channel regulatory defects remain unknown. Here, we undertook phosphoproteomic analyses to identify and quantify in situ the phosphorylation sites in the Na(V)1.5 proteins purified from adult WT and failing CaMKII delta(c)-overexpressing (CaMKII delta(c)-Tg) mouse ventricles. Of 19 native Na(V)1.5 phosphorylation sites identified, two C-terminal phosphoserines at positions 1938 and 1989 showed increased phosphorylation in the CaMKII delta(c)-Tg compared with the WT ventricles. Wethen tested the hypothesis that phosphorylation at these two sites impairs fibroblast growth factor 13 (FGF13)-dependent regulation of Na(V)1.5 channel inactivation. Whole-cell voltage-clamp analyses in HEK293 cells demonstrated that FGF13 increases Na(V)1.5 channel availability and decreases late Na+ current, two effects that were abrogated with Na(V)1.5 mutants mimicking phosphorylation at both sites. Additional co-immunoprecipitation experiments revealed that FGF13 potentiates the binding of calmodulin to Na(V)1.5 and that phosphomimetic mutations at both sites decrease the interaction of FGF13 and, consequently, of calmodulin with Na(V)1.5. Together, we have identified two novel native phosphorylation sites in the C terminus of Na(V)1.5 that impair FGF13-dependent regulation of channel inactivation and may contribute to CaMKII delta(c)-dependent arrhythmogenic disorders in failing hearts.	[Burel, Sophie; Coyan, Fabien C.; Lorenzini, Maxime; Loussouarn, Gildas; Charpentier, Flavien; Marionneau, Celine] Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France; [Meyer, Matthew R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Nerbonne, Jeanne M.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Lichti, Cheryl F.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Brown, Joan H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Maier, Lars S.] Univ Hosp Regensburg, Univ Heart Ctr, Dept Internal Med 2, D-93042 Regensburg, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg	Marionneau, C (corresponding author), IRS Univ Nantes, CNRS UMR6291, INSERM UMR1087, Inst Thorax, 8 Quai Moncousu,BP 70721, F-44007 Nantes 1, France.	celine.marionneau@univ-nantes.fr	Loussouarn, Gildas/D-3590-2015; Maier, Lars/AAQ-8313-2021; Loussouarn, Gildas/ABH-6043-2020; Burel, Sophie/D-3583-2015; Charpentier, Flavien/D-3586-2015; Marionneau, Céline/D-4011-2015	Loussouarn, Gildas/0000-0001-8007-5931; Maier, Lars/0000-0001-9915-4429; Loussouarn, Gildas/0000-0001-8007-5931; Burel, Sophie/0000-0003-0557-3396; Charpentier, Flavien/0000-0002-5057-0998; Marionneau, Céline/0000-0003-0962-9756; Lichti, Cheryl/0000-0003-4099-4954	Agence Nationale de la Recherche [ANR-15-CE14-0006-01, ANR-12-BSV1-0013-01]; Marie Curie 7th Framework Program of the European Commission [PIRG06-GA-2009-256397]; Fondation d'Entreprise Genavie; National Institutes of Health [UL1 TR000448, P41 GM103422-35, R01 HL034161]; Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship [eOTP 1518DASS]; Deutsche Forschungsgemeinschaft [Ma 1982/5-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, R01HL034161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Marie Curie 7th Framework Program of the European Commission; Fondation d'Entreprise Genavie; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Agence Nationale de la Recherche Grants ANR-15-CE14-0006-01 (to C. M.) and ANR-12-BSV1-0013-01 (to F. C.), Marie Curie 7th Framework Program of the European Commission Grant PIRG06-GA-2009-256397 (to C. M.), the Fondation d'Entreprise Genavie (to C. M.), National Institutes of Health Grants UL1 TR000448 and P41 GM103422-35 (to R. R. T.) and R01 HL034161 (to J. M. N.), Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship eOTP 1518DASS (to S. B.), and the Deutsche Forschungsgemeinschaft Ma 1982/5-1 (to L. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 2015, CIRC RES, V116, P1971, DOI 10.1161/CIRCRESAHA.116.305017; Aiba T, 2013, CIRC-ARRHYTHMIA ELEC, V6, P546, DOI 10.1161/CIRCEP.113.000400; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Bosch MK, 2015, J NEUROSCI, V35, P6752, DOI 10.1523/JNEUROSCI.2663-14.2015; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Dybkova N, 2014, CARDIOVASC RES, V103, P168, DOI 10.1093/cvr/cvu120; Gabelli SB, 2016, CHANNELS, V10, P45, DOI 10.1080/19336950.2015.1075677; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Glynn P, 2015, CIRCULATION, V132, P567, DOI 10.1161/CIRCULATIONAHA.114.015218; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Herren AW, 2015, J PROTEOME RES, V14, P2298, DOI 10.1021/acs.jproteome.5b00107; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Maltsev VA, 2008, PROG BIOPHYS MOL BIO, V96, P421, DOI 10.1016/j.pbiomolbio.2007.07.010; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; Marionneau C, 2012, J PROTEOME RES, V11, P5994, DOI 10.1021/pr300702c; Michalski A, 2012, MOL CELL PROTEOMICS, V11, pO111, DOI DOI 10.1074/MCP.0111.013698; Musa H, 2015, P NATL ACAD SCI USA, V112, P12528, DOI 10.1073/pnas.1516430112; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Park DS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12966; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Taverner T, 2012, BIOINFORMATICS, V28, P2404, DOI 10.1093/bioinformatics/bts449; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; Wang XC, 2017, J MOL CELL CARDIOL, V104, P63, DOI 10.1016/j.yjmcc.2017.01.009; Yan HD, 2017, J GEN PHYSIOL, V149, P277, DOI 10.1085/jgp.201611721; Yang J, 2016, CHANNELS, V10, P410, DOI 10.1080/19336950.2016.1190055; Yu YQ, 2004, RAPID COMMUN MASS SP, V18, P711, DOI 10.1002/rcm.1374; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	45	18	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17431	17448		10.1074/jbc.M117.787788	http://dx.doi.org/10.1074/jbc.M117.787788			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882890	Green Published, hybrid			2022-12-28	WOS:000414009300024
J	Hettle, A; Fillo, A; Abe, K; Massel, P; Pluvinage, B; Langelaan, DN; Smith, SP; Boraston, AB				Hettle, Andrew; Fillo, Alexander; Abe, Kento; Massel, Patricia; Pluvinage, Benjamin; Langelaan, David N.; Smith, Steven P.; Boraston, Alisdair B.			Properties of a family 56 carbohydrate-binding module and its role in the recognition and hydrolysis of beta-1,3-glucan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycoside hydrolase; polysaccharide; protein structure; X-ray crystallography; curdlan; laminarin	SMALL-ANGLE SCATTERING; C-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; POLYSACCHARIDE RECOGNITION; LAMINARIN-BINDING; HIGHER-PLANTS; INSIGHTS; PROTEIN; MODEL; ENDO-1,3-BETA-GLUCANASE	BH0236 from Bacillus halodurans is a multimodular -1,3-glucanase comprising an N-terminal family 81 glycoside hydrolase catalytic module, an internal family 6 carbohydrate-binding module (CBM) that binds the nonreducing end of -1,3-glucan chains, and an uncharacterized C-terminal module classified into CBM family 56. Here, we determined that this latter CBM, BhCBM56, bound the soluble -1,3-glucan laminarin with a dissociation constant (K-d) of approximate to 26 m and displayed higher affinity for insoluble -1,3-glucans with K-d values of approximate to 2-10 m but lacked affinity for -1,3-glucooligosaccharides. The X-ray crystal structure of BhCBM56 and NMR-derived chemical shift mapping of the binding site revealed a -sandwich fold, with the face of one -sheet possessing the -1,3-glucan-binding surface. On the basis of the functional and structural properties of BhCBM56, we propose that it binds a quaternary polysaccharide structure, most likely the triple helix adopted by polymerized -1,3-glucans. Consistent with the BhCBM56 and BhCBM6/56 binding profiles, deletion of the CBM56 from BH0236 decreased activity of the enzyme on the insoluble -1,3-glucan curdlan but not on soluble laminarin; additional deletion of the CBM6 also did not affect laminarin degradation but further decreased curdlan hydrolysis. The pseudo-atomic solution structure of BH0236 determined by small-angle X-ray scattering revealed structural insights into the nature of avid binding by the BhCBM6/56 pair and how the orientation of the active site in the catalytic module factors into recognition and degradation of -1,3-glucans. Our findings reinforce the notion that catalytic modules and their cognate CBMs have complementary specificities, including targeting of polysaccharide quaternary structure.	[Hettle, Andrew; Fillo, Alexander; Abe, Kento; Massel, Patricia; Pluvinage, Benjamin; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Langelaan, David N.; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Langelaan, David N.] Dalhouise Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	University of Victoria; Queens University - Canada; Dalhousie University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Langelaan, David/AET-9707-2022	Langelaan, David/0000-0001-9592-3075; Smith, Steven/0000-0003-2710-4400; Boraston, Alisdair/0000-0001-6417-0592	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS (National Institutes of Health); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the beamline staff at the Stanford Synchrotron Research Laboratory BL11-1. SSRL is a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and NIGMS (National Institutes of Health).	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Barik S, 1997, Methods Mol Biol, V67, P173; BEATTIE A, 1961, BIOCHEM J, V79, P531, DOI 10.1042/bj0790531; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Futatsuyama H, 1999, BIOSCI BIOTECH BIOCH, V63, P1481, DOI 10.1271/bbb.63.1481; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Guinier A, 1955, J POLYM SCI, V1, P268; HOFFMANN GC, 1971, CARBOHYD RES, V20, P185, DOI 10.1016/S0008-6215(00)84962-9; Kanagawa M, 2011, J BIOL CHEM, V286, P29158, DOI 10.1074/jbc.M111.256701; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oda M, 2016, CARBOHYD RES, V431, P33, DOI 10.1016/j.carres.2016.05.008; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pluvinage B, 2017, STRUCTURE, V25, P1348, DOI 10.1016/j.str.2017.06.019; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Robb M, 2017, METHODS MOL BIOL, V1588, P215, DOI 10.1007/978-1-4939-6899-2_17; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamashiro T, 2012, GLYCOCONJUGATE J, V29, P77, DOI 10.1007/s10719-011-9366-x; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; Tung JY, 2008, BIOCHEM J, V416, P27, DOI 10.1042/BJ20080580; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto M, 1998, FEBS LETT, V433, P41, DOI 10.1016/S0014-5793(98)00881-3; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; 2009, CHEM BIOCH BIOL 1 3, P1	51	13	13	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16955	16968		10.1074/jbc.M117.806711	http://dx.doi.org/10.1074/jbc.M117.806711			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28827308	hybrid, Green Published			2022-12-28	WOS:000413140600016
J	Wang, MM; Tang, L; Liu, DH; Ying, QL; Ye, SD				Wang, Manman; Tang, Ling; Liu, Dahai; Ying, Qi-Long; Ye, Shoudong			The transcription factor Gbx2 induces expression of Kruppel-like factor 4 to maintain and induce naive pluripotency of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; differentiation; embryonic stem cell; Kruppel-like factor 4 (KLF4); reprogramming; Gbx2; self-renewal	LEUKEMIA INHIBITORY FACTOR; SELF-RENEWAL; SIGNALING PATHWAYS; STAT3 ACTIVATION; MOUSE EMBRYOS; GROUND-STATE; NANOG; DIFFERENTIATION; OCT4; GENE	The transcription factor Gbx2 (gastrulation brain homeobox 2) is a direct target of the LIF/STAT3 signaling pathway, maintains mouse embryonic stem cell (mESC) self-renewal, and facilitates mouse epiblast stem cell (mEpiSC) reprogramming to naive pluripotency. However, the mechanism by which Gbx2 mediates its effects on pluripotency remains unknown. Here, using an RNA-Seq approach, we identified Klf4 (Kruppel-like factor 4) as a direct target of Gbx2. Functional studies indicated that Klf4 mediates the self-renewal-promoting effects of Gbx2, because knockdown of Klf4 expression abrogated the ability of Gbx2 to maintain the undifferentiated state of mESCs. We also found that Gbx2 largely depends on Klf4 to reprogram mEpiSCs to a mESC-like state. In summary, our study has uncovered a mechanism by which Gbx2 maintains and induces naive pluripotency. These findings expand our understanding of the pluripotency control network and may inform the development of culture conditions for improved ESC maintenance and differentiation.	[Wang, Manman; Tang, Ling; Liu, Dahai; Ye, Shoudong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China; [Ying, Qi-Long] Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Anhui University; University of Southern California	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China [31501191, 31671535]; Anhui Province Grant [1508085SQC204]; Scientific Research Startup Fund of Anhui University [J01006068, J01006045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Province Grant; Scientific Research Startup Fund of Anhui University	This work was supported by Natural Science Foundation of China Grants 31501191 and 31671535, Anhui Province Grant 1508085SQC204, and Scientific Research Startup Fund of Anhui University Grants J01006068 and J01006045. The authors declare that they have no conflicts of interest with the contents of this article.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Huang GY, 2015, CELL MOL LIFE SCI, V72, P1741, DOI 10.1007/s00018-015-1833-2; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohtsuka S., 2015, JAK STAT, V4, DOI DOI 10.1080/21623996.2015; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Roeseler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047366; Russell R, 2015, STEM CELL REP, V5, P1155, DOI 10.1016/j.stemcr.2015.11.003; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ye SD, 2016, J CELL SCI, V129, P269, DOI 10.1242/jcs.177675; Ye SD, 2014, CURR OPIN GENET DEV, V28, P10, DOI 10.1016/j.gde.2014.08.002; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	43	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17121	17128		10.1074/jbc.M117.803254	http://dx.doi.org/10.1074/jbc.M117.803254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28848051	Green Published, hybrid			2022-12-28	WOS:000413140600031
J	Yanagisawa, S; Frasch, WD				Yanagisawa, Seiga; Frasch, Wayne D.			Protonation-dependent stepped rotation of the F-type ATP synthase c-ring observed by single-molecule measurements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; bioenergetics; F0F1-ATPase; proton transport; single-molecule biophysics	ESCHERICHIA-COLI; ALPHA-SUBUNIT; F-1-ATPASE; RESOLUTION; F1FO-ATPASE; F1-ATPASE; MOTORS; MUSCLE; F-1	The two opposed rotary molecular motors of the F0F1-ATP synthase work together to provide the majority of ATP in biological organisms. Rotation occurs in 120 degrees power strokes separated by dwells when F-1 synthesizes or hydrolyzes ATP. F-0 and F-1 complexes connect via a central rotor stalk and a peripheral stator stalk. A major unresolved question is the mechanism in which the interaction between subunit-a and rotating subunit-c-ring in the F-0 motor uses the flux of H+ across the membrane to induce clockwise rotation against the force of counterclockwise rotation driven by the F-1-ATPase. In single-molecule measurements of F0F1 embedded in lipid bilayer nanodiscs, we observed that the ability of the F-0 motor to form transient dwells increases with decreasing pH. Transient dwells can halt counterclockwise rotation powered by the F-1-ATPase in steps equivalent to the rotation of single c-subunits in the c-ring of F-0, and can push the common axle shared by the two motors clockwise by as much as one c-subunit. Because the F-0 proton half-channels that access the periplasm and the cytoplasm are exposed to the same pH, these data are consistent with the conclusion that the periplasmic half-channel is more easily protonated in a manner that halts ATPase-driven rotation by blocking ATPase-dependent proton pumping. The fit of transient dwell occurrence to the sum of three Gaussian curves suggests that the asymmetry of the three ATPase-dependent 120 degrees power strokes imposed by the relative positions of the central and peripheral stalks affects c-subunit stepping efficiency.	[Yanagisawa, Seiga; Frasch, Wayne D.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Frasch, WD (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	frasch@asu.edu			National Institutes of Health [R01 GM097510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health Grant R01 GM097510 (to W. D. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; ENGELBRECHT S, 1989, EUR J BIOCHEM, V181, P485, DOI 10.1111/j.1432-1033.1989.tb14750.x; Etzold C, 1997, EUR J BIOCHEM, V243, P336, DOI 10.1111/j.1432-1033.1997.0336a.x; Fillingame R. H., 2014, BIOCHIM BIOPHYS ACTA, V1837, P1062; FISCHER S, 1994, EUR J BIOCHEM, V225, P167, DOI 10.1111/j.1432-1033.1994.00167.x; Hornung T, 2011, METHODS MOL BIOL, V778, P273, DOI 10.1007/978-1-61779-261-8_18; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598, DOI 10.1152/ajpcell.1992.263.3.C598; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LIGHTOWLERS RN, 1987, BIOCHIM BIOPHYS ACTA, V894, P399, DOI 10.1016/0005-2728(87)90118-6; Martin J, 2015, J BIOL CHEM, V290, P10717, DOI 10.1074/jbc.M115.646430; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sobti M, 2016, ELIFE, V5, DOI 10.7554/eLife.21598; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; VIK SB, 1988, J BIOL CHEM, V263, P6599; WILKEMOUNTS S, 1994, ARCH BIOCHEM BIOPHYS, V309, P363, DOI 10.1006/abbi.1994.1125	29	12	11	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17093	17100		10.1074/jbc.M117.799940	http://dx.doi.org/10.1074/jbc.M117.799940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842481	hybrid, Green Published			2022-12-28	WOS:000413140600028
J	Citterio, CE; Veluswanny, B; Morgan, SJ; Galton, VA; Banga, JP; Atkins, S; Morishita, Y; Neumann, S; Latif, R; Gershengorn, MC; Smith, TJ; Arvan, P				Citterio, Cintia E.; Veluswanny, Balaji; Morgan, Sarah J.; Galton, Valerie A.; Banga, J. Paul; Atkins, Stephen; Morishita, Yoshiaki; Neumann, Susanne; Latif, Rauf; Gershengorn, Marvin C.; Smith, Terry J.; Arvan, Peter			De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN CONTROLS; IODINATION SITES; GRAVES-DISEASE; THYROGLOBULIN; THYROXINE; IODINE; CELLS; MANAGEMENT; TERMINUS; BIOLOGY	The thyroid gland secretes primarily tetraiodothyronine (T-4), and some triiodothyronine (T-3). Under normal physiological circumstances, only one-fifth of circulating T-3 is directly released by the thyroid, but in states of hyperactivation of thyroid-stimulating hormone receptors (TSHRs), patients develop a syndrome of relative T-3 toxicosis. Thyroidal T-4 production results from iodination of thyroglobulin (TG) at residues Tyr(5) and Tyr(130), whereas thyroidal T-3 production may originate in several different ways. In this study, the data demonstrate that within the carboxyl-terminal portion of mouse TG, T-3 is formed de novo independently of deiodination from T-4. We found that upon iodination in vitro, de novo T-3 formation in TG was decreased in mice lacking TSHRs. Conversely, de novo T-3 that can be formed upon iodination of TG secreted from PCCL3 (rat thyrocyte) cells was augmented from cells previously exposed to increased TSH, a TSHR agonist, a cAMP analog, or a TSHR-stimulating antibody. We present data suggesting that TSH-stimulated TG phosphorylation contributes to enhanced de novo T-3 formation. These effects were reversed within a few days after removal of the hyperstimulating conditions. Indeed, direct exposure of PCCL3 cells to human serum from two patients with Graves' disease, but not control sera, led to secretion of TG with an increased intrinsic ability to form T-3 upon in vitro iodination. Furthermore, TG secreted from human thyrocyte cultures hyperstimulated with TSH also showed an increased intrinsic ability to form T-3. Our data support the hypothesis that TG processing in the secretory pathway of TSHR-hyperstimulated thyrocytes alters the structure of the iodination substrate in a way that enhances de novo T-3 formation, contributing to the relative T-3 toxicosis of Graves' disease.	[Citterio, Cintia E.; Veluswanny, Balaji; Morishita, Yoshiaki; Smith, Terry J.; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Citterio, Cintia E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol Catedra Genet, C1113AAD, Buenos Aires, DF, Argentina; [Citterio, Cintia E.] Univ Buenos Aires, Inst Inmunol Genet & Metab INIGEM, CONICET, C1120AAR, Buenos Aires, DF, Argentina; [Morgan, Sarah J.; Neumann, Susanne; Gershengorn, Marvin C.] NIDDK, NIH, LERB, Bethesda, MD 20892 USA; [Galton, Valerie A.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Banga, J. Paul] Univ Duisburg Essen, Dept Mol Ophthalmol, D-45147 Essen, Germany; [Atkins, Stephen; Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Latif, Rauf] Icahn Sch Med Mt Sinai, Thyroid Res Unit, James J Peters Vet Affairs Med Ctr, New York, NY 10468 USA	University of Michigan System; University of Michigan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Dartmouth College; University of Duisburg Essen; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai	Arvan, P (corresponding author), Brehm Tower,Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Morishita, Yoshiaki/AAX-6552-2021; Smith, Terry/ABG-1360-2020; Neumann, Susanne/GPK-6035-2022; latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020; Citterio, Cintia E./AAI-4888-2021; Morishita, Yoshiaki/GWQ-6726-2022	Morishita, Yoshiaki/0000-0003-4733-7981; Latif, Rauf/0000-0002-4226-3728; Citterio, Cintia E./0000-0002-3547-5458; Smith, Terry/0000-0002-6279-9685	National Institutes of Health [R01 DK40344]; NATIONAL EYE INSTITUTE [R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI110557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011006, R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK40344 (to P. A.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Bernal J, 2017, J ENDOCRINOL, V232, pR83, DOI 10.1530/JOE-16-0424; Bianco AC, 2005, THYROID, V15, P777, DOI 10.1089/thy.2005.15.777; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; Burch HB, 2015, JAMA-J AM MED ASSOC, V314, P2544, DOI 10.1001/jama.2015.16535; Calza L, 2015, COMPR PHYSIOL, V5, P1405, DOI 10.1002/cphy.c140035; Cetrangolo GP, 2014, BIOCHEM BIOPH RES CO, V450, P488, DOI 10.1016/j.bbrc.2014.05.144; Chanoine J. P., 1993, J CLIN INVEST, V91, P2709; CONSIGLIO E, 1987, J BIOL CHEM, V262, P10304; Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; DESRUISSEAU S, 1994, ENDOCRINOLOGY, V134, P1676, DOI 10.1210/en.134.4.1676; Desruisseau S, 1996, MOL CELL ENDOCRINOL, V122, P223, DOI 10.1016/0303-7207(96)03880-4; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; DIJESO B, 1992, J BIOL CHEM, V267, P1938; Dunn JT, 2001, THYROID, V11, P407, DOI 10.1089/105072501300176363; DUNN JT, 1987, J BIOL CHEM, V262, P16948; FASSLER CA, 1988, J BIOL CHEM, V263, P17366; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gilbert JA, 2006, J IMMUNOL, V176, P5084, DOI 10.4049/jimmunol.176.8.5084; GROLLMAN EF, 1993, J BIOL CHEM, V268, P3604; HAEBERLI A, 1981, ENDOCRINOLOGY, V109, P523, DOI 10.1210/endo-109-2-523; Holzer G, 2016, J BIOL CHEM, V291, P16553, DOI 10.1074/jbc.M116.719047; IZUMI M, 1977, J CLIN INVEST, V59, P1105, DOI 10.1172/JCI108734; KASAGI K, 1987, ACTA ENDOCRINOL-COP, V115, P30, DOI 10.1530/acta.0.1150030; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Koibuchi Noriyuki, 2012, Nihon Rinsho, V70, P1844; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; LAMAS L, 1986, ENDOCRINOLOGY, V118, P2131, DOI 10.1210/endo-118-5-2131; LARSEN PR, 1975, J CLIN ENDOCR METAB, V41, P1098, DOI 10.1210/jcem-41-6-1098; Latif R, 2015, THYROID, V25, P51, DOI 10.1089/thy.2014.0119; LAURBERG P, 1984, METABOLISM, V33, P379, DOI 10.1016/0026-0495(84)90203-8; LEONARDI A, 1994, BIOCHEM BIOPH RES CO, V202, P38, DOI 10.1006/bbrc.1994.1890; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Morgan SJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00168; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Nlend MC, 1999, EUR J ENDOCRINOL, V141, P61, DOI 10.1530/eje.0.1410061; Palmero CY, 2013, MOL CELL ENDOCRINOL, V376, P12, DOI 10.1016/j.mce.2013.05.020; Prummel MF, 1998, THYROID, V8, P545, DOI 10.1089/thy.1998.8.545; SCHIMMEL M, 1977, ANN INTERN MED, V87, P760, DOI 10.7326/0003-4819-87-6-760; Sellitti DF, 2014, THYROID, V24, P625, DOI 10.1089/thy.2013.0344; Smith TJ, 2016, NEW ENGL J MED, V375, P1552, DOI 10.1056/NEJMra1510030; STERLING K, 1970, J AMER MED ASSOC, V213, P571, DOI 10.1001/jama.213.4.571; Suban D, 2012, BIOCHIMIE, V94, P719, DOI 10.1016/j.biochi.2011.10.018; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Targovnik HM, 2011, HORM RES PAEDIAT, V75, P311, DOI 10.1159/000324882; Taurog AM, 2000, WERNER INGBARS THYRO, P61; Woeber KA, 2006, THYROID, V16, P687, DOI 10.1089/thy.2006.16.687; Xavier ACW, 2016, ARCH ENDOCRIN METAB, V60, P66, DOI 10.1590/2359-3997000000103; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	54	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15434	15444		10.1074/jbc.M117.784447	http://dx.doi.org/10.1074/jbc.M117.784447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28743746	Green Published, hybrid			2022-12-28	WOS:000410809800023
J	Kim, IH; Pham, V; Jablonka, W; Goodman, WG; Ribeiro, JMC; Andersen, JF				Kim, Il Hwan; Van Pham; Jablonka, Willy; Goodman, Walter G.; Ribeiro, Jose M. C.; Andersen, John F.			A mosquito hemolymph odorant-binding protein family member specifically binds juvenile hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; ANOPHELES-DARLINGI; AEDES-AEGYPTI; MECHANISM; EVOLUTION; GENES; TOOLS	Juvenile hormone (JH) is a key regulator of insect development and reproduction. In adult mosquitoes, it is essential for maturation of the ovary and normal male reproductive behavior, but how JH distribution and activity is regulated after secretion is unclear. Here, we report a new type of specific JH-binding protein, given the name mosquito juvenile hormone-binding protein (mJHBP), which circulates in the hemolymph of pupal and adult Aedes aegypti males and females. mJHBP is a member of the odorant-binding protein (OBP) family, and orthologs are present in the genomes of Aedes, Culex, and Anopheles mosquito species. Using isothermal titration calorimetry, we show that mJHBP specifically binds JH II and JH III but not eicosanoids or JH derivatives. mJHBP was crystallized in the presence of JH III and found to have a double OBP domain structure reminiscent of salivary "long" D7 proteins of mosquitoes. We observed that a single JH III molecule is contained in the N-terminal domain binding pocket that is closed in an apparent conformational change by a C-terminal domain-derived alpha-helix. The electron density for the ligand indicated a high occupancy of the natural 10R enantiomer of JH III. Of note, mJHBP is structurally unrelated to hemolymph JHBP from lepidopteran insects. A low level of expression of mJHBP in Ae. aegypti larvae suggests that it is primarily active during the adult stage where it could potentially influence the effects of JH on egg development, mating behavior, feeding, or other processes.	[Kim, Il Hwan; Van Pham; Jablonka, Willy; Ribeiro, Jose M. C.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Goodman, Walter G.; Andersen, John F.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison	Andersen, JF (corresponding author), 2E32B Twinbrook,3 Bldg,12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	john.andersen@nih.gov		KIM, IL-HWAN/0000-0002-3279-0823	intramural research program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	intramural research program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alva V, 2016, BBA-MOL CELL BIOL L, V1861, P913, DOI 10.1016/j.bbalip.2016.01.016; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Benoit JB, 2017, ELIFE, V6, DOI [10.7554/elife.19535, 10.7554/eLife.19535]; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cusson M, 1997, ANAL BIOCHEM, V249, P83, DOI 10.1006/abio.1997.2144; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOODMAN W, 1978, P NATL ACAD SCI USA, V75, P185, DOI 10.1073/pnas.75.1.185; GOODMAN W, 1978, GEN COMP ENDOCR, V35, P27, DOI 10.1016/0016-6480(78)90165-X; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; MACK SR, 1979, J INVERTEBR PATHOL, V34, P105, DOI 10.1016/0022-2011(79)90088-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramirez JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8403; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Stanley David, 2011, Front Endocrinol (Lausanne), V2, P105, DOI 10.3389/fendo.2011.00105; Suzuki R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00133; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; Wei D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16845; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4	38	31	34	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15329	15339		10.1074/jbc.M117.802009	http://dx.doi.org/10.1074/jbc.M117.802009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28751377	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000410809800015
J	Sample, A; Zhao, BZ; Qiang, L; He, YY				Sample, Ashley; Zhao, Baozhong; Qiang, Lei; He, Yu-Ying			Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; CYCLOOXYGENASE-2 EXPRESSION; CARCINOMA-CELLS; HAIRLESS MICE; AUTOPHAGY; TUMORIGENESIS; TFEB; P62/SQSTM1; ACTIVATION; INHIBITION	Skin cancer is the most common cancer, and exposure to ultraviolet (UV) radiation, namely UVA and UVB, is the major risk factor for skin cancer development. UVAis significantly less effective in causing direct DNA damage than UVB, but UVA has been shown to increase skin cancer risk. The mechanism by which UVA contributes to skin cancer remains unclear. Here, using RNA-Seq, we show that UVA induces autophagy and lysosomal gene expression, including the autophagy receptor and substrate p62. We found that UVA activates transcription factor EB (TFEB), a known regulator of autophagy and lysosomal gene expression, which, in turn, induces p62 transcription. Next, we identified a novel relationship between p62 and cyclooxygenase-2 (COX-2), a prostaglandin synthase critical for skin cancer development. COX-2 expression was up-regulated by UVA-induced p62, suggesting that p62 plays a role in UVA-induced skin cancer. Moreover, we found that p62 stabilizes COX-2 protein through the p62 ubiquitin-associated domain and that p62 regulates prostaglandin E-2 production in vitro. In a syngeneic squamous cell carcinoma mouse model, p62 knockdown inhibited tumor growth and metastasis. Furthermore, p62-deficient tumors exhibited reduced immune cell infiltration and increased cell differentiation. Because prostaglandin E-2 is known to promote pro-tumorigenic immune cell infiltration, increase proliferation, and inhibit keratinocyte differentiation in vivo, this work suggests that UVA-induced p62 acts through COX-2 to promote skin tumor growth and progression. These findings expand our understanding of UVA-induced skin tumorigenesis and tumor progression and suggest that targeting p62 can help prevent or treat UVA-associated skin cancer.	[Sample, Ashley; Zhao, Baozhong; Qiang, Lei; He, Yu-Ying] Univ Chicago, Dept Med, Sect Dermatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Sample, Ashley; He, Yu-Ying] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Qiang, Lei] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing 210008, Jiangsu, Peoples R China	University of Chicago; University of Chicago; China Pharmaceutical University	He, YY (corresponding author), Univ Chicago, Dept Med, Sect Dermatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012	Qiang, Lei/0000-0002-7164-3164	NIEHS, National Institutes of Health (NIH) [ES024373, ES016936]; American Cancer Society [RSG-13-078-01]; NCI, NIH [P30 CA014599]; NIH (CTSA) [UL1 TR000430]; University of Chicago; NATIONAL CANCER INSTITUTE [T32CA009594, P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024373, P30ES027792, R01ES016936] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health (NIH); American Cancer Society(American Cancer Society); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health (NIH), Grants ES024373 and ES016936 (to Y. Y. H.), American Cancer Society Grant RSG-13-078-01 (to Y. Y. H.), NCI, NIH, Grant P30 CA014599 (University of Chicago Cancer Research Center), NIH Clinical and Translational Science Award (CTSA) UL1 TR000430, and the University of Chicago Friends of Dermatology Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Bachelor MA, 2002, ONCOGENE, V21, P7092, DOI 10.1038/sj.onc.1205855; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Ellis RA, 2014, J INVEST DERMATOL, V134, P1476, DOI 10.1038/jid.2013.497; Elmets CA, 2010, JNCI-J NATL CANCER I, V102, P1835, DOI 10.1093/jnci/djq442; Higashi Y, 2000, INT J CANCER, V86, P667, DOI 10.1002/(SICI)1097-0215(20000601)86:5<667::AID-IJC10>3.3.CO;2-P; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; KELFKENS G, 1991, CARCINOGENESIS, V12, P1377, DOI 10.1093/carcin/12.8.1377; Klein K, 2016, INT J ONCOL, V49, P164, DOI 10.3892/ijo.2016.3505; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Singh B, 2005, INT J ONCOL, V26, P1393; STERENBORG HJCM, 1990, PHOTOCHEM PHOTOBIOL, V51, P325, DOI 10.1111/j.1751-1097.1990.tb01718.x; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tiano HF, 2002, CANCER RES, V62, P3395; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VANWEELDEN H, 1988, ARCH DERMATOL RES, V280, P300, DOI 10.1007/BF00440604; White AL, 2004, PHOTOCHEM PHOTOBIOL, V80, P340, DOI 10.1562/2003-12-31-RA-040.1; Wischermann K, 2008, ONCOGENE, V27, P4269, DOI 10.1038/onc.2008.70; Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang MF, 2012, J CLIN ONCOL, V30, P1588, DOI 10.1200/JCO.2011.39.3652; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26	51	18	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14786	14795		10.1074/jbc.M117.786160	http://dx.doi.org/10.1074/jbc.M117.786160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724634	Green Published, hybrid			2022-12-28	WOS:000409902100007
J	Huang, X; Liu, BX; Wei, YD; Beyea, R; Yan, H; Olson, ST				Huang, Xin; Liu, Baoxin; Wei, Yidong; Beyea, Ryan; Yan, Han; Olson, Steven T.			Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FACTOR PATHWAY INHIBITOR; OXIDIZED PHOSPHOLIPIDS; KINETIC CHARACTERIZATION; Z DEFICIENCY; FACTOR XA; SERPIN; ACTIVATION; DISEASE; HYDROPEROXIDES	Lipid oxidation due to oxidative stress plays an important role in the pathogenesis of inflammatory and thrombotic cardiovascular diseases. Several findings suggest that lipid peroxidation can alter the function of coagulation proteins and contribute to a hypercoagulable state, but the molecular mechanisms are unclear. Here, we report that oxidized phospholipids suppress the anticoagulant function of the serpin, protein Z-dependent protease inhibitor (ZPI), a specific inhibitor of membrane-associated factor Xa (FXa) that requires protein Z (PZ), phospholipid, and calcium as cofactors. We found that this suppression arises from a diminished ability of the oxidized membrane to function as a cofactor to promote ZPI inhibition of membrane-bound FXa, due fully or in part to the susceptibility of the bound ZPI-PZ complex to oxidative inactivation. Surprisingly, free ZPI was also susceptible to inactivation by oxidized membrane vesicles in the absence of calcium. Oxidized vesicles containing both phosphatidylserine and polyunsaturated fatty acids were required to promote inactivation of the ZPI-PZ complex or free ZPI, indicating that binding of the PZ-complexed or free ZPI to peroxide-modified phospholipid vesicles mediates the inactivation. Heparin protected the ZPI-PZ complex and free ZPI from inactivation, suggesting that blocking the heparin-binding site on ZPI interferes with ZPI binding to lipid or to PZ. This was confirmed by direct lipid-binding experiments. Native PAGE indicated that oxidization induced dissociation of the ZPI-PZ complex and increased the negative charge of ZPI. We conclude that compromised ZPI anticoagulant function could contribute to thrombus initiation and growth in oxidative stress-induced cardiovascular diseases.	[Huang, Xin; Beyea, Ryan; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Huang, Xin; Liu, Baoxin; Wei, Yidong; Beyea, Ryan; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Liu, Baoxin; Wei, Yidong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China; [Yan, Han] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurol, Shanghai 200072, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tongji University; Tongji University	Wei, YD (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.; Huang, X; Olson, ST (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, 801 S Paulina St, Chicago, IL 60612 USA.	xinhuang@uic.edu; ywei@tongji.edu.cn; stolson@uic.edu		Huang, Xin/0000-0002-4730-9318	American Heart Association Scientist Development [SDG48880022]; National Institutes of Health [R37 HL39888]; International Exchange Program for Graduate Student, Shanghai Tongji University Grants [2015020040, 2015020041]; National Natural Science Foundation of China [30800466, 81270193]; MOST Summer Undergraduate Program, University of Illinois College of Dentistry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Exchange Program for Graduate Student, Shanghai Tongji University Grants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST Summer Undergraduate Program, University of Illinois College of Dentistry; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Scientist Development Grant SDG48880022 (to X. H.), National Institutes of Health Grant R37 HL39888 (to S. T. O.), International Exchange Program for Graduate Student, Shanghai Tongji University Grants 2015020040 (to B. L.) and 2015020041 (to H. Y.), National Natural Science Foundation of China Grants 30800466 and 81270193 (to Y. W.), and the MOST Summer Undergraduate Program, University of Illinois College of Dentistry (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Becatti M, 2014, ARTERIOSCL THROM VAS, V34, P1355, DOI 10.1161/ATVBAHA.114.303785; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLOK J, 1968, RADIAT RES, V34, P689, DOI 10.2307/3572513; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; DECRISTOFARO R, 1991, J PROTEIN CHEM, V10, P455, DOI 10.1007/BF01025473; Ellulu MS, 2016, INFLAMMOPHARMACOLOGY, V24, P1, DOI 10.1007/s10787-015-0255-y; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; HICKS M, 1979, ANAL BIOCHEM, V99, P249, DOI 10.1016/S0003-2697(79)80003-2; Hiraishi S, 2002, BIOCHEM BIOPH RES CO, V298, P468, DOI 10.1016/S0006-291X(02)02508-1; Horie S, 2002, THROMB HAEMOSTASIS, V87, P80; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2012, BLOOD, V120, P1726, DOI 10.1182/blood-2012-03-419598; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; JAIN SK, 1985, J CLIN INVEST, V76, P281, DOI 10.1172/JCI111958; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Patel RP, 1997, BIOCHEM J, V322, P425, DOI 10.1042/bj3220425; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; Safa O, 2001, J BIOL CHEM, V276, P1829, DOI 10.1074/jbc.M005931200; Salomon RG, 2012, CIRC RES, V111, P930, DOI 10.1161/CIRCRESAHA.112.275388; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; VOSSEN RCRM, 1993, LIPIDS, V28, P857, DOI 10.1007/BF02536243; VOSSEN RCRM, 1991, BIOCHIM BIOPHYS ACTA, V1083, P243, DOI 10.1016/0005-2760(91)90078-V; Weinstein EA, 2000, J BIOL CHEM, V275, P22925, DOI 10.1074/jbc.M002438200; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	41	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14625	14635		10.1074/jbc.M117.793901	http://dx.doi.org/10.1074/jbc.M117.793901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28717005	Green Published, hybrid			2022-12-28	WOS:000408747500027
J	Elam, WA; Cao, WX; Kang, H; Huehn, A; Hocky, GM; Prochniewicz, E; Schramm, AC; Negron, K; Garcia, J; Bonello, TT; Gunning, PW; Thomas, DD; Voth, GA; Sindelar, CV; De La Cruz, EM				Elam, W. Austin; Cao, Wenxiang; Kang, Hyeran; Huehn, Andrew; Hocky, Glen M.; Prochniewicz, Ewa; Schramm, Anthony C.; Negron, Karina; Garcia, Jean; Bonello, Teresa T.; Gunning, Peter W.; Thomas, David D.; Voth, Gregory A.; Sindelar, Charles V.; De La Cruz, Enrique M.			Phosphomimetic S3D cofilin binds but only weakly severs actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; cooperativity; molecular dynamics; spectroscopy	F-ACTIN; DEPOLYMERIZING FACTOR; MOLECULAR-DYNAMICS; KINETIC-ANALYSIS; NONCOOPERATIVE BINDING; ADF/COFILIN FAMILY; CIRCULAR-DICHROISM; PHALLOIDIN BINDING; PH SENSITIVITY; LINKED CHANGES	Many biological processes, including cell division, growth, and motility, rely on rapid remodeling of the actin cytoskeleton and on actin filament severing by the regulatory protein cofilin. Phosphorylation of vertebrate cofilin at Ser-3 regulates both actin binding and severing. Substitution of serine with aspartate at position 3 (S3D) is widely used to mimic cofilin phosphorylation in cells and in vitro. The S3D substitution weakens cofilin binding to filaments, and it is presumed that subsequent reduction in cofilin occupancy inhibits filament severing, but this hypothesis has remained untested. Here, using time-resolved phosphorescence anisotropy, electron cryomicroscopy, and all-atom molecular dynamics simulations, we show that S3D cofilin indeed binds filaments with lower affinity, but also with a higher cooperativity than wild-type cofilin, and severs actin weakly across a broad range of occupancies. We found that three factors contribute to the severing deficiency of S3D cofilin. First, the high cooperativity of S3D cofilin generates fewer boundaries between bare and decorated actin segments where severing occurs preferentially. Second, S3D cofilin only weakly alters filament bending and twisting dynamics and therefore does not introduce the mechanical discontinuities required for efficient filament severing at boundaries. Third, Ser-3 modification (i.e. substitution with Asp or phosphorylation) undocks and repositions the cofilin N terminus away from the filament axis, which compromises S3D cofilin's ability to weaken longitudinal filament subunit interactions. Collectively, our results demonstrate that, in addition to inhibiting actin binding, Ser-3 modification favors formation of a cofilin-binding mode that is unable to sufficiently alter filament mechanical properties and promote severing.	[Elam, W. Austin; Cao, Wenxiang; Kang, Hyeran; Huehn, Andrew; Schramm, Anthony C.; Negron, Karina; Garcia, Jean; Sindelar, Charles V.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hocky, Glen M.; Voth, Gregory A.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Prochniewicz, Ewa; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Bonello, Teresa T.; Gunning, Peter W.] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Elam, W. Austin] C4 Therapeut, 675 W Kendall St, Cambridge, MA 02142 USA; [Kang, Hyeran] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32826 USA; [Negron, Karina] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Garcia, Jean] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Program, Baltimore, MD 21205 USA	Yale University; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of New South Wales Sydney; State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins University	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu	Gunning, Peter W/E-9058-2010; Hocky, Glen/E-9412-2012	Gunning, Peter/0000-0003-0833-3128; Thomas, David D./0000-0002-8822-2040; Negron, Karina/0000-0002-5376-7657; Hocky, Glen/0000-0002-5637-0698; Kang, Ellen/0000-0003-2785-3479	National Institutes of Health R01 Grants [GM097348, GM110533001, AR032961]; American Cancer Society [IRG5801255]; Department of Defense Army Research Office through MURI Grant [W911NF1410403]; American Heart Association Postdoctoral Fellowship; Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health) [F32 GM11345-01]; National Science Foundation [DBI-1156585]; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; NHMRC [APP1004188]; Kids Cancer Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032961, R37AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348, T32GM008283, R01GM110530, F32GM113415] Funding Source: NIH RePORTER	National Institutes of Health R01 Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense Army Research Office through MURI Grant; American Heart Association Postdoctoral Fellowship(American Heart Association); Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health); National Science Foundation(National Science Foundation (NSF)); Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Kids Cancer Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM097348 (to E. M. D. L. C.), GM110533001 (to C. V. S.), and AR032961 (to D. D. T.); American Cancer Society Grant IRG5801255 (to C. V. S.); and the Department of Defense Army Research Office through MURI Grant W911NF1410403 (on which G. A. V. and E. M. D. L. C. are co-investigators). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Heart Association Postdoctoral Fellowship. Present address: C4 Therapeutics, 675 W. Kendall St., Cambridge, MA 02142.; Supported by a Ruth L. Kirschstein National Research Service Award (NIGMS, National Institutes of Health, Grant F32 GM11345-01).; Supported by the National Science Foundation, Grant DBI-1156585, and by the Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences.; Supported by NHMRC Grant APP1004188 and the Kids Cancer Network.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; ALLISON SA, 1979, CHEM PHYS, V41, P35, DOI 10.1016/0301-0104(79)80131-7; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bonello TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19816; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graham JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094766; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Hocky GM, 2016, J PHYS CHEM B, V120, P4558, DOI 10.1021/acs.jpcb.6b02741; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Kang HR, 2014, P NATL ACAD SCI USA, V111, P17821, DOI 10.1073/pnas.1413397111; Kang H, 2013, BIOPHYS J, V105, P2621, DOI 10.1016/j.bpj.2013.10.032; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; Lakowicz J., 1983, PRINCIPLES FLUORESCE, p[98, 353]; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mayhood TW, 2005, ANAL BIOCHEM, V345, P187, DOI 10.1016/j.ab.2005.07.032; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pope BJ, 2000, J MOL BIOL, V298, P649, DOI 10.1006/jmbi.2000.3688; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Prochniewicz E, 1999, BIOCHEMISTRY-US, V38, P14860, DOI 10.1021/bi991343g; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; SCHURR JM, 1984, CHEM PHYS, V84, P71, DOI 10.1016/0301-0104(84)80007-5; Shukla VK, 2015, BIOCHEM J, V465, P63, DOI 10.1042/BJ20140923; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Vitriol EA, 2013, MOL BIOL CELL, V24, P2238, DOI 10.1091/mbc.E13-03-0156; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Yehl J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44506; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	76	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19565	19579		10.1074/jbc.M117.808378	http://dx.doi.org/10.1074/jbc.M117.808378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28939776	hybrid, Green Published			2022-12-28	WOS:000416911300003
J	Garg, H; Loughlin, PC; Willows, RD; Chen, M				Garg, Harsh; Loughlin, Patrick C.; Willows, Robert D.; Chen, Min			The C2(1)-formyl group in chlorophyll f originates from molecular oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; chlorophyll; cyanobacteria; isotopic tracer; mass spectrometry (MS); photosynthetic pigment; chlorophyll f; deuterated molecules	RHODOBACTER-SPHAEROIDES; DEUTERIUM; DEGRADATION; DERIVATION; WATER; BACTERIOCHLOROPHYLL; CYANOBACTERIUM; METABOLISM; CONVERSION; O-18(2)	Chlorophylls (Chls) are the most important cofactors for capturing solar energy to drive photosynthetic reactions. Five spectral types of Chls have been identified to date, with Chl f having the most red-shifted absorption maximum because of a C2(1)-formyl group substitution of Chl f. However, the biochemical provenance of this formyl group is unknown. Here, we used a stable isotope labeling technique (O-18 and H-2) to determine the origin of the C2(1)-formyl group of Chl f and to verify whether Chl f is synthesized from Chl a in the cyanobacterial species Halomicronema hongdechloris. In the presence of either (H2O)-O-18 or O-18(2), the origin of oxygen atoms in the newly synthesized chlorophylls was investigated. The pigments were isolated with HPLC, followed by MS analysis. We found that the oxygen atom of the C2(1)-formyl group originates from molecular oxygen and not from H2O. Moreover, we examined the kinetics of the labeling of Chl a and Chl f from H. hongdechloris grown in 50% D2O-seawater medium under different light conditions. When cells were shifted from white light D2O-seawater medium to far-red light H2O-seawater medium, the observed deuteration in Chl f indicated that Chl(ide) a is the precursor of Chl f. Taken together, our results advance our understanding of the biosynthesis pathway of the chlorophylls and the formation of the formyl group in Chl f.	[Garg, Harsh; Loughlin, Patrick C.; Chen, Min] Univ Sydney, Australian Res Council Ctr Excellence Translat Ph, Sydney, NSW 2006, Australia; [Garg, Harsh; Loughlin, Patrick C.; Chen, Min] Univ Sydney, Sch Life & Environm Sci, A12 Macleay Bldg, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Macquarie University	Chen, M (corresponding author), Univ Sydney, Sch Life & Environm Sci, A12 Macleay Bldg, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Willows, Robert/C-1537-2010	Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Australian Research Council [CE140100015]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Grant CE140100015. The authors declare that they have no conflicts of interest with the contents of this article.	Akutsu S., 2011, PHOTOMED PHOTOBIOL, V33, P35; Berry D, 2015, P NATL ACAD SCI USA, V112, pE194, DOI 10.1073/pnas.1420406112; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Chen M, 2012, FEBS LETT, V586, P3249, DOI 10.1016/j.febslet.2012.06.045; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; CHORNEY W, 1960, BIOCHIM BIOPHYS ACTA, V37, P280, DOI 10.1016/0006-3002(60)90235-3; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Egorova-Zachernyuk T, 2008, MAGN RESON CHEM, V46, P1074, DOI 10.1002/mrc.2295; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; Garvey CJ, 2013, INT J MOL SCI, V14, P8148, DOI 10.3390/ijms14048148; GRANICK S., 1965, P67; Ho MY, 2016, SCIENCE, V353, DOI 10.1126/science.aaf9178; Hochuli M, 2000, J BIOMOL NMR, V17, P33, DOI 10.1023/A:1008329124672; Hollingshead S, 2017, BIOCHEM J, V474, P667, DOI 10.1042/BCJ20161002; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Kasumov T., 2015, RECENT ADV PROTEOMIC; KATZ JJ, 1964, J AM CHEM SOC, V86, P4220, DOI 10.1021/ja01073a080; KELLER MD, 1987, J PHYCOL, V23, P633; Krautler B, 2011, ANGEW CHEM INT EDIT, V50, P2439, DOI 10.1002/anie.201007339; LESTER W, 1960, ANN NY ACAD SCI, V84, P667, DOI 10.1111/j.1749-6632.1960.tb39099.x; Li YQ, 2016, BBA-BIOENERGETICS, V1857, P107, DOI 10.1016/j.bbabio.2015.10.009; Li YQ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00067; Loughlin PC, 2014, SCI REP-UK, V4, DOI 10.1038/srep06069; Lu M., 2013, AFR J MICROBIOL RES, V7, P604; Mosin O., 2015, J HLTH MED NURSING, V11, P2422; Mosin O. V., 2014, EUR J MOL BIOTECHNOL, V3, P11; Mosin OV, 2012, WATER CHEM ECOLOGY, V3, P83; PENGELLY WL, 1983, PLANT PHYSIOL, V73, P445, DOI 10.1104/pp.73.2.445; PORRA RJ, 1994, EUR J BIOCHEM, V219, P671, DOI 10.1111/j.1432-1033.1994.tb19983.x; Porra RJ, 2000, PHOTOSYNTH RES, V66, P159, DOI 10.1023/A:1010631505071; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Schliep M, 2010, J BIOL CHEM, V285, P28450, DOI 10.1074/jbc.M110.146753; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tcherkez G, 2009, PLANT PHYSIOL, V151, P620, DOI 10.1104/pp.109.142976; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; WILLOWS RD, 1994, AUST J PLANT PHYSIOL, V21, P327, DOI 10.1071/PP9940327; Willows RD, 2013, ORG LETT, V15, P1588, DOI 10.1021/ol400327j	41	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19279	19289		10.1074/jbc.M117.814756	http://dx.doi.org/10.1074/jbc.M117.814756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972142	Green Published, hybrid			2022-12-28	WOS:000416226700011
J	Gonzalez, D; Luyten, A; Bartholdy, B; Zhou, QL; Kardosova, M; Ebralidze, A; Swanson, KD; Radomska, HS; Zhang, P; Kobayashi, SS; Welner, RS; Levantini, E; Steidl, U; Chong, G; Collombet, S; Choi, MH; Friedman, AD; Scott, LM; Alberich-Jorda, M; Tenen, DG				Gonzalez, David; Luyten, Annouck; Bartholdy, Boris; Zhou, Qiling; Kardosova, Miroslava; Ebralidze, Alex; Swanson, Kenneth D.; Radomska, Hanna S.; Zhang, Pu; Kobayashi, Susumu S.; Welner, Robert S.; Levantini, Elena; Steidl, Ulrich; Chong, Gilbert; Collombet, Samuel; Choi, Min Hee; Friedman, Alan D.; Scott, Linda M.; Alberich-Jorda, Meritxell; Tenen, Daniel G.			ZNF143 protein is an important regulator of the myeloid transcription factor C/EBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT-enhancer-binding protein (C; EBP); gene regulation; hematopoiesis; promoter; transcription factor; C; EBPalpha; ZNF143	SELENOCYSTEINE TRANSFER-RNA; TISSUE-SPECIFIC EXPRESSION; LUCIFERASE REPORTER GENE; DNA-BINDING PROTEINS; TUMOR-SUPPRESSOR; ZINC-FINGER; STEM-CELLS; ALPHA; LEUKEMIA; PROMOTER	The transcription factor C/EBP is essential for myeloid differentiation and is frequently dysregulated in acute myeloid leukemia. Although studied extensively, the precise regulation of its gene by upstream factors has remained largely elusive. Here, we investigated its transcriptional activation during myeloid differentiation. We identified an evolutionarily conserved octameric sequence, CCCAGCAG, approximate to 100 bases upstream of the CEBPA transcription start site, and demonstrated through mutational analysis that this sequence is crucial for C/EBP expression. This sequence is present in the genes encoding C/EBP in humans, rodents, chickens, and frogs and is also present in the promoters of other C/EBP family members. We identified that ZNF143, the human homolog of the Xenopus transcriptional activator STAF, specifically binds to this 8-bp sequence to activate C/EBP expression in myeloid cells through a mechanism that is distinct from that observed in liver cells and adipocytes. Altogether, our data suggest that ZNF143 plays an important role in the expression of C/EBP in myeloid cells.	[Gonzalez, David; Luyten, Annouck; Zhou, Qiling; Chong, Gilbert; Collombet, Samuel; Choi, Min Hee; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Gonzalez, David; Bartholdy, Boris; Ebralidze, Alex; Radomska, Hanna S.; Zhang, Pu; Kobayashi, Susumu S.; Welner, Robert S.; Levantini, Elena; Steidl, Ulrich; Tenen, Daniel G.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kardosova, Miroslava; Alberich-Jorda, Meritxell] ASCR, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic; [Kardosova, Miroslava; Alberich-Jorda, Meritxell] Charles Univ Prague, Childhood Leukaemia Invest Prague, Univ Hosp Motol, Fac Med 2, Prague 15006, Czech Republic; [Swanson, Kenneth D.; Radomska, Hanna S.; Kobayashi, Susumu S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Welner, Robert S.] Univ Alabama Birmingham, Hematol Oncol Dept, Birmingham, AL 35294 USA; [Levantini, Elena] CNR, Inst Biomed Technol, I-56124 Pisa, Italy; [Friedman, Alan D.] Johns Hopkins Univ, Baltimore, MD 21231 USA; [Scott, Linda M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Radomska, Hanna S.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Dept Med Oncol, New York, NY 10461 USA	National University of Singapore; Harvard University; Harvard Medical School; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Motol University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Johns Hopkins University; University of Queensland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yeshiva University; Yeshiva University	Alberich-Jorda, M (corresponding author), ASCR, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic.; Tenen, DG (corresponding author), Natl Univ Singapore, Canc Sci Inst, Ctr Translat Med, 14 Med Dr 12-01, Singapore 11759, Singapore.	alberich@img.cas.cz; daniel.tenen@nus.edu.sg	Scott, Linda/D-9777-2012; collombet, Samuel/AAS-8227-2021; levantini, elena/AAK-7201-2021; Zhou, Qiling/AAB-2493-2021; Levantini, Elena/AGY-0242-2022; Jorda, Meritxell Alberich/G-3137-2014	Scott, Linda/0000-0003-0334-1479; levantini, elena/0000-0003-4612-3105; Jorda, Meritxell Alberich/0000-0002-8093-641X	Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; National Institutes of Health [HL131477, CA66996, R21CA178301, R01CA169259]; IMG AS CR [RVO 68378050]; German Research Foundation (DFG) [BA 3771/1-1]; American Cancer Society [RSG-13-047-01]; Harvard Stem Cell Institute [DP-0110-12-00]; NATIONAL CANCER INSTITUTE [R21CA178301, P01CA066996, R01CA169259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131477] Funding Source: NIH RePORTER	Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centers of Excellence initiative(Ministry of Education, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMG AS CR; German Research Foundation (DFG)(German Research Foundation (DFG)); American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (to D. G. T.) and by the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative; National Institutes of Health Grants HL131477 and CA66996 (to D. G. T.); institutional funding from the IMG AS CR (RVO 68378050) (to M. A.-J.); and German Research Foundation (DFG) Grant BA 3771/1-1 (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R21CA178301 and R01CA169259, American Cancer Society Grant RSG-13-047-01, and Harvard Stem Cell Institute Grant DP-0110-12-00.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Grossman CE, 2004, J BIOL CHEM, V279, P12190, DOI 10.1074/jbc.M307039200; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150809; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Halbig KM, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-3; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Iwama A, 1999, MOL CELL BIOL, V19, P3940; Izumi H, 2010, CANCER SCI, V101, P2538, DOI 10.1111/j.1349-7006.2010.01725.x; Khanna-Gupta A, 2000, BLOOD, V95, P3734; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LopezRodriguez C, 1995, EUR J IMMUNOL, V25, P3496, DOI 10.1002/eji.1830251243; Maxam A M, 1980, Methods Enzymol, V65, P499; Mead PE, 1998, P NATL ACAD SCI USA, V95, P11251, DOI 10.1073/pnas.95.19.11251; Myslinski E, 1998, J BIOL CHEM, V273, P21998, DOI 10.1074/jbc.273.34.21998; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ngondo-Mbongo RP, 2013, NUCLEIC ACIDS RES, V41, P4000, DOI 10.1093/nar/gkt088; Niebuhr B, 2009, LEUKEMIA, V23, P978, DOI 10.1038/leu.2008.332; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OGAWA M, 1993, BLOOD, V81, P2844; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; PAHL HL, 1991, EXP HEMATOL, V19, P1038; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schaub M, 2000, NUCLEIC ACIDS RES, V28, P2114, DOI 10.1093/nar/28.10.2114; Schaub M, 1999, J BIOL CHEM, V274, P25042, DOI 10.1074/jbc.274.35.25042; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SCHUSTER C, 1995, EMBO J, V14, P3777, DOI 10.1002/j.1460-2075.1995.tb00047.x; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; WILLIAMS M, 1992, NUCLEIC ACIDS RES, V20, P4935, DOI 10.1093/nar/20.18.4935; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023; Yuan CC, 2007, MOL CELL BIOL, V27, P8729, DOI 10.1128/MCB.00846-07; ZARET KS, 1990, MOL CELL BIOL, V10, P4582, DOI 10.1128/MCB.10.9.4582; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zheng G, 2004, J BIOL CHEM, V279, P42410, DOI 10.1074/jbc.M407287200	61	12	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18924	18936		10.1074/jbc.M117.811109	http://dx.doi.org/10.1074/jbc.M117.811109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900037	hybrid, Green Published			2022-12-28	WOS:000415848000017
J	Lin, Y; Currie, SL; Rosen, MK				Lin, Yuan; Currie, Simon L.; Rosen, Michael K.			Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; fused in sarcoma (FUS); intrinsically disordered protein; posttranslational modification (PTM); Src homology 3 domain (SH3 domain); RNA granules; liquid-liquid phase separation; multivalency	2ND VIRIAL-COEFFICIENT; ELASTIN-LIKE POLYPEPTIDE; RNA-BINDING PROTEINS; INVERSE TEMPERATURE TRANSITION; LOW-COMPLEXITY DOMAINS; CELL-FREE FORMATION; ACID SIDE-CHAINS; ANTIBODY SOLUTIONS; STRESS GRANULES; LIQUID DROPLETS	Liquid-liquid phase separation (LLPS) is thought to contribute to the establishment of many biomolecular condensates, eukaryotic cell structures that concentrate diverse macromolecules but lack a bounding membrane. RNA granules control RNA metabolism and comprise a large class of condensates that are enriched in RNA-binding proteins and RNA molecules. Many RNA granule proteins are composed of both modular domains and intrinsically disordered regions (IDRs) having low amino acid sequence complexity. Phase separation of these molecules likely plays an important role in the generation and stability of RNA granules. To understand how folded domains and IDRs can cooperate to modulate LLPS, we generated a series of engineered proteins. These were based on fusions of an IDR derived from the RNA granule protein FUS (fused in sarcoma) to a multivalent poly-Src homology 3 (SH3) domain protein that phase-separates when mixed with a poly-proline-rich-motif (polyPRM) ligand. We found that the wild-type IDR promotes LLPS of the polySH3-polyPRM system, decreasing the phase separation threshold concentration by 8-fold. Systematic mutation of tyrosine residues in Gly/Ser-Tyr-Gly/Ser motifs of the IDR reduced this effect, depending on the number but not on the position of these substitutions. Mutating all tyrosines to non-aromatic residues or phosphorylating the IDR raised the phase separation threshold above that of the unmodified polySH3-polyPRM pair. These results show that low-complexity IDRs can modulate LLPS both positively and negatively, depending on the degree of aromaticity and phosphorylation status. Our findings provide plausible mechanisms by which these sequences could alter RNA granule properties on evolutionary and cellular timescales.	[Lin, Yuan; Currie, Simon L.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Lin, Yuan; Currie, Simon L.; Rosen, Michael K.] Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu		Currie, Simon/0000-0001-5083-1484	Howard Hughes Medical Institute; Welch Foundation [I-1544]; National Institutes of Health [R01-056322]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Howard Hughes Medical Institute, the Welch Foundation (I-1544), and National Institutes of Health Grant R01-056322. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auton M, 2007, METHOD ENZYMOL, V428, P397, DOI 10.1016/S0076-6879(07)28023-1; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chow CK, 2016, MOL PHARMACEUT, V13, P915, DOI 10.1021/acs.molpharmaceut.5b00817; Christensen T, 2013, BIOMACROMOLECULES, V14, P1514, DOI 10.1021/bm400167h; Condon JE, 2017, SOFT MATTER, V13, P2907, DOI 10.1039/c6sm02874h; Connolly BD, 2012, BIOPHYS J, V103, P69, DOI 10.1016/j.bpj.2012.04.047; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Fasman G. D., 1976, HDB BIOCH MOL BIOL, V1, P115; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; Haas C, 1999, J PHYS CHEM B, V103, P2808, DOI 10.1021/jp984035l; Halfmann R, 2016, CURR OPIN STRUC BIOL, V38, P18, DOI 10.1016/j.sbi.2016.05.002; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; HARDING SE, 1985, BIOCHEM J, V231, P543, DOI 10.1042/bj2310543; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; Kato M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023598; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lazaridis T., 2013, HYDROPHOBIC EFFECT, DOI [10.1002/9780470015902.a0002974.pub2, DOI 10.1002/9780470015902.A0002974.PUB2]; Lee CD, 2015, CELL REP, V11, P1638, DOI 10.1016/j.celrep.2015.05.014; Lehermayr C, 2011, J PHARM SCI-US, V100, P2551, DOI 10.1002/jps.22506; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Luo TZ, 2015, J AM CHEM SOC, V137, P15362, DOI 10.1021/jacs.5b09941; Mehta CM, 2012, BIOTECHNOL PROGR, V28, P163, DOI 10.1002/btpr.724; Meyer DE, 2001, BIOTECHNOL PROGR, V17, P720, DOI 10.1021/bp010049o; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neal BL, 1998, BIOPHYS J, V75, P2469, DOI 10.1016/S0006-3495(98)77691-X; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Rant AS, 2015, MOL PHARMACEUT, V12, P3261, DOI 10.1021/acs.molpharmaceut.5b00256; Raut AS, 2015, J PHARM SCI-US, V104, P1263, DOI 10.1002/jps.24326; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ringer AL, 2006, J PHYS CHEM A, V110, P10822, DOI 10.1021/jp0627401; Ruppert S, 2001, BIOTECHNOL PROGR, V17, P182, DOI 10.1021/bp0001314; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Saluja A, 2010, BIOPHYS J, V99, P2657, DOI 10.1016/j.bpj.2010.08.020; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Scherer M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004512; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sinnokrot MO, 2004, J AM CHEM SOC, V126, P7690, DOI 10.1021/ja049434a; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Trabbic-Carlson K, 2004, PROTEIN ENG DES SEL, V17, P57, DOI 10.1093/protein/gzh006; URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O; URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057; Urry DW, 1995, CIBA F SYMP, V192, P4; URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411; Vliegenthart GA, 2000, J CHEM PHYS, V112, P5364, DOI 10.1063/1.481106; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Waugh David S, 2016, Postepy Biochem, V62, P377; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wills PR, 2015, ANAL BIOCHEM, V490, P55, DOI 10.1016/j.ab.2015.08.020; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yadav S, 2010, J PHARM SCI-US, V99, P1152, DOI 10.1002/jps.21898; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	98	178	182	12	85	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19110	19120		10.1074/jbc.M117.800466	http://dx.doi.org/10.1074/jbc.M117.800466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924037	hybrid, Green Published			2022-12-28	WOS:000415848000033
J	Lu, T; Wang, XL; Chai, Q; Sun, XJ; Sieck, GC; Katusic, ZS; Lee, HC				Lu, Tong; Wang, Xiao-Li; Chai, Qiang; Sun, Xiaojing; Sieck, Garry C.; Katusic, Zvonimir S.; Lee, Hon-Chi			Role of the endothelial caveolae microdomain in shear stress-mediated coronary vasorelaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; endothelial cell; ion channel; patch clamp; potassium channel; shear stress; transient receptor potential channels; TRP channels; TRPV4 channels; SK channel	CHANNEL ACTIVATION; DEPENDENT DILATION; SMALL-CONDUCTANCE; DOWN-REGULATION; CA2+ SIGNALS; K+-CHANNELS; BK CHANNELS; PROSTACYCLIN; CALCIUM; MECHANOTRANSDUCTION	In this study, we determined the role of caveolae and the ionic mechanisms that mediate shear stress-mediated vasodilation (SSD). We found that both TRPV4 and SK channels are targeted to caveolae in freshly isolated bovine coronary endothelial cells (BCECs) and that TRPV4 and KCa2.3 (SK3) channels are co-immunoprecipitated by anti-caveolin-1 antibodies. Acute exposure of BCECs seeded in a capillary tube to 10 dynes/cm(2) of shear stress (SS) resulted in activation of TRPV4 and SK currents. However, after incubation with HC067047 (TRPV4 inhibitor), SK currents could no longer be activated by SS, suggesting SK channel activation by SS was mediated through TRPV4. SK currents in BCECs were also activated by isoproterenol or by GSK1016790A (TRPV4 activator). In addition, preincubation of isolated coronary arterioles with apamin (SK inhibitor) resulted in a significant diminution of SSD whereas preincubation with HC067047 produced vasoconstriction by SS. Exposure of BCECs to SS (15 dynes/cm(2) 16 h) enhanced the production of nitric oxide and prostacyclin (PGI(2)) and facilitated the translocation of TRPV4 to the caveolae. Inhibition of TRPV4 abolished the SS-mediated intracellular Ca2+ ([Ca2+](i)) increase in BCECs. These results indicate a dynamic interaction in the vascular endothelium among caveolae TRPV4 and SK3 channels. This caveolae-TRPV4-SK3 channel complex underlies the molecular and ionic mechanisms that modulate SSD in the coronary circulation.	[Lu, Tong; Wang, Xiao-Li; Chai, Qiang; Sun, Xiaojing; Lee, Hon-Chi] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Sieck, Garry C.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Katusic, Zvonimir S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Chai, Qiang] Shandong Acad Med Sci, Inst Basic Med, Dept Physiol, Jinan 250062, Shandong, Peoples R China	Mayo Clinic; Mayo Clinic; Mayo Clinic; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Lee, HC (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	Lee.honchi@mayo.edu	Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643; sieck, gary/0000-0003-3040-9424	American Diabetes Association [1-12-BS-119, 1-16-IBS-195]; National Institutes of Health [HL-74180, HL-080118]; Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award; National Natural Science Foundation of China [81470489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080118, R56HL074180, R01HL074180] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Diabetes Association Grants 1-12-BS-119 and 1-16-IBS-195, National Institutes of Health Grants HL-74180 and HL-080118, Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award, and National Natural Science Foundation of China Grant 81470489. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Busse R, 2003, TRENDS PHARMACOL SCI, V24, P24, DOI 10.1016/S0165-6147(02)00005-6; Chai Q, 2015, PFLUG ARCH EUR J PHY, V467, P329, DOI 10.1007/s00424-014-1526-y; Chai Q, 2013, CARDIOVASC RES, V100, P151, DOI 10.1093/cvr/cvt157; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Flockerzi V., 2014, HDB EXPT PHARM, V1, pv; Frank PG, 2006, J CLIN INVEST, V116, P1222, DOI 10.1172/JCI28509; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Gluais P, 2005, BRIT J PHARMACOL, V144, P477, DOI 10.1038/sj.bjp.0706003; Goedicke-Fritz S, 2015, EUR J CELL BIOL, V94, P391, DOI 10.1016/j.ejcb.2015.06.002; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Makino A, 2008, AM J PHYSIOL-CELL PH, V295, pC221, DOI 10.1152/ajpcell.00433.2007; Malek Adel M., 1995, Methods in Cell Science, V17, P165, DOI 10.1007/BF00996123; Matsumoto T, 2012, PHARMACOL RES, V65, P537, DOI 10.1016/j.phrs.2012.02.004; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Merkus D, 2006, AM J PHYSIOL-HEART C, V291, pH2075, DOI 10.1152/ajpheart.01109.2005; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Oriji GK, 1999, PROSTAG LEUKOTR ESS, V61, P45, DOI 10.1054/plef.1999.0072; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rosa AO, 2009, BBA-MOL CELL BIOL L, V1791, P697, DOI 10.1016/j.bbalip.2009.03.009; Sandow SL, 2012, ADV EXP MED BIOL, V740, P811, DOI 10.1007/978-94-007-2888-2_36; Santhanam AVR, 2007, CIRC RES, V100, P1379, DOI 10.1161/01.RES.0000265848.55035.5d; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Sullivan MN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005659; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Yi F, 2015, J BIOL CHEM, V290, P7016, DOI 10.1074/jbc.M114.607952; Yi F, 2014, J BIOL CHEM, V289, P10853, DOI 10.1074/jbc.M113.520940; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1	48	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19013	19023		10.1074/jbc.M117.786152	http://dx.doi.org/10.1074/jbc.M117.786152			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924052	Green Published, hybrid			2022-12-28	WOS:000415848000024
J	Hasegawa, Y; Takahashi, M; Ariki, S; Saito, A; Uehara, Y; Takamiya, R; Kuronuma, K; Chiba, H; Sakuma, Y; Takahashi, H; Kuroki, Y				Hasegawa, Yoshihiro; Takahashi, Motoko; Ariki, Shigeru; Saito, Atsushi; Uehara, Yasuaki; Takamiya, Rina; Kuronuma, Koji; Chiba, Hirofumi; Sakuma, Yuji; Takahashi, Hiroki; Kuroki, Yoshio			Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collectin; epidermal growth factor receptor (EGFR); lung cancer; oligomerization; pulmonary surfactant	LUNG-CANCER PROGRESSION; PULMONARY SURFACTANT; INTERSTITIAL PNEUMONIA; CELLULAR-RESPONSE; INNATE IMMUNITY; BINDING LECTIN; COLLECTINS; OLIGOMERIZATION; APOPROTEINS; MACROPHAGES	We recently reported that the lectin surfactant protein D (SP-D) suppresses epidermal growth factor receptor (EGFR) signaling by interfering with ligand binding to EGFR through an interaction between the carbohydrate-recognition domain (CRD) of SP-D and N-glycans of EGFR. Here, we report that surfactant protein A (SP-A) also suppresses EGF signaling in A549 human lung adenocarcinoma cells and in CHOK1 cells stably expressing human EGFR and that SP-A inhibits the proliferation and motility of the A549 cells. Results with I-125-EGF indicated that SP-A interferes with EGF binding to EGFR, and a ligand blot analysis suggested that SP-A binds EGFR in A549 cells. We also found that SP-A directly binds the recombinant extracellular domain of EGFR (soluble EGFR or sEGFR), and this binding, unlike that of SP-D, was not blocked by EDTA, excess mannose, or peptide:N-glycosidase F treatment. We prepared a collagenase-resistant fragment (CRF) of SP-A, consisting of CRD plus the neck domain of SP-A, and observed that CRF directly binds sEGFR but does not suppress EGF-induced phosphorylation of EGFR in or proliferation of A549 cells. These results indicated that SP-A binds EGFR and down-regulates EGF signaling by inhibiting ligand binding to EGFR as well as SP-D. However, unlike for SP-D, SP-A lectin activity and EGFR N-glycans were not involved in the interaction between SP-A and EGFR. Furthermore, our results suggested that oligomerization of SP-A is necessary to suppress the effects of SP-A on EGF signaling.	[Hasegawa, Yoshihiro; Takahashi, Motoko; Ariki, Shigeru; Saito, Atsushi; Uehara, Yasuaki; Takamiya, Rina; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Res Inst Frontier Med, Sapporo, Hokkaido 0608556, Japan; [Hasegawa, Yoshihiro; Saito, Atsushi; Uehara, Yasuaki; Kuronuma, Koji; Chiba, Hirofumi; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Resp Med & Allergol, Res Inst Frontier Med, Sapporo, Hokkaido 0608556, Japan; [Sakuma, Yuji] Sapporo Med Univ, Sch Med, Dept Mol Med, Res Inst Frontier Med, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Hasegawa, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.; Hasegawa, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Resp Med, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.; Hasegawa, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Allergol, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	y-hasegawa@sapmed.ac.jp	Sakuma, Yuji/HGC-0692-2022; Saito, Atsushi/M-7382-2018; Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Sakuma, Yuji/0000-0003-2298-1359; Saito, Atsushi/0000-0003-3430-884X; Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142; Takamiya, Rina/0000-0002-5947-488X; Uehara, Yasuaki/0000-0002-6439-2715	Japan Society for the Promotion of Science [26860611, 16K19461]; Northern Advancement Center for Science and Technology Grant [H26 T-1-35]; Ito Foundation Grant [H26-23]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Northern Advancement Center for Science and Technology Grant; Ito Foundation Grant	This work was supported in part by Grants-in-aid for Scientific Research from Japan Society for the Promotion of Science 26860611 and 16K19461, Northern Advancement Center for Science and Technology Grant H26 T-1-35, and Ito Foundation Grant H26-23. The authors declare that they have no conflicts of interest with the contents of this article.	Ariki S, 2011, J IMMUNOL, V187, P2586, DOI 10.4049/jimmunol.1100024; Bejarano PA, 1996, MODERN PATHOL, V9, P445; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; De Masson A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1127493; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Griese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051050; Hasegawa Y, 2015, ONCOGENE, V34, P838, DOI [10.1038/onc.2014.20, 10.1038/onc.2015.266]; Ishii T, 2012, COPD, V9, P409, DOI 10.3109/15412555.2012.676110; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; KUROKI Y, 1985, BIOCHIM BIOPHYS ACTA, V836, P201; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Ledford JG, 2015, J IMMUNOL, V194, P6123, DOI 10.4049/jimmunol.1500104; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Mitsuhashi A, 2013, AM J PATHOL, V182, P1843, DOI 10.1016/j.ajpath.2013.01.030; MIZUTANI Y, 1988, CANCER, V61, P532, DOI 10.1002/1097-0142(19880201)61:3<532::AID-CNCR2820610319>3.0.CO;2-8; Nathan N, 2016, HUM MOL GENET, V25, P1457, DOI 10.1093/hmg/ddw014; NICHOLSON AG, 1995, HISTOPATHOLOGY, V27, P57, DOI 10.1111/j.1365-2559.1995.tb00291.x; NOMORI H, 1994, VIRCHOWS ARCH, V424, P517; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Saito A, 2012, J BIOL CHEM, V287, P15034, DOI 10.1074/jbc.M111.308056; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Takahashi M, 2013, J BIOL CHEM, V288, P32910, DOI 10.1074/jbc.M113.491902; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Tsutsumida H, 2004, HISTOPATHOLOGY, V44, P147, DOI 10.1111/j.1365-2559.2004.01797.x; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; Umeda Y., 2017, ONCOGENE, V2017, P253, DOI DOI 10.1038/0NC.2017.253; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	39	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18565	18576		10.1074/jbc.M117.800771	http://dx.doi.org/10.1074/jbc.M117.800771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972165	Green Published, hybrid			2022-12-28	WOS:000414958100015
J	Majdoul, S; Cosette, J; Seye, AK; Bernard, E; Frin, S; Holic, N; Chazal, N; Briant, L; Espert, L; Galy, A; Fenard, D				Majdoul, Saliha; Cosette, Jeremie; Seye, Ababacar K.; Bernard, Eric; Frin, Sophie; Holic, Nathalie; Chazal, Nathalie; Briant, Laurence; Espert, Lucile; Galy, Anne; Fenard, David			Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; Beclin1 (BECN1); gene therapy; hematopoietic stem cells; lentivirus; virus entry	HEMATOPOIETIC STEM-CELLS; RETROVIRAL GENE-TRANSFER; HIV-1 REPLICATION; MAMMALIAN-CELLS; AUTOPHAGY; TRANSDUCTION; INFECTION; PROTEINS; IDENTIFICATION; PATHOGENESIS	Autophagy-related proteins such as Beclin-1 are involved in an array of complex processes, including antiviral responses, and may also modulate the efficiency of gene therapy viral vectors. The Tat-Beclin-1 (TB1) peptide has been reported as an autophagy-inducing factor inhibiting the replication of pathogens such as HIV, type 1 (HIV-1). However, autophagy-related proteins are also essential for the early steps of HIV-1 infection. Therefore, we examined the effects of the Beclin-1 evolutionarily conserved domain in TB1 on viral transduction and autophagy in single-round HIV infection or with nonreplicative HIV-1-derived lentiviral vectors. TB1 enhanced transduction with various pseudotypes but without inducing the autophagy process. TB1 augmented the transduction of human CD34+ hematopoietic stem/progenitor cells while maintaining their capacity to engraft in vivo into humanized mice. TB1 was as effective as other transduction additives and functioned by enhancing the adhesion and fusion of viral particles with target cells but not their aggregation. We also found that the N-terminal L1 loop was critical for TB1 transduction-enhancing activity. Interestingly, the Tat-Beclin-2 (TB2) peptide, derived from the human Beclin-2 protein, was even more potent than TB1 in promoting viral transduction and infection. Taken together, our findings suggest that the TB1 and TB2 peptides enhance the viral entry step. Tat-Beclin peptides therefore represent a new family of viral transduction enhancers for potential use in gene therapy.	[Majdoul, Saliha; Seye, Ababacar K.; Frin, Sophie; Holic, Nathalie; Galy, Anne; Fenard, David] Univ Evry, EPHE, INSERM, Genethon,Integrare Res Unit,UMR S951, F-91000 Evry, France; [Cosette, Jeremie] Genethon, F-91000 Evry, France; [Bernard, Eric; Chazal, Nathalie; Briant, Laurence; Espert, Lucile] Univ Montpellier, CNRS, Infect Dis Res Inst Montpellier, IRIM Ex CPBS UMR 9004, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Galy, A (corresponding author), Genethon, UMR S951, 1bis Rue Int, F-91000 Evry, France.; Fenard, D (corresponding author), TxCell SA, Allee Nertiere, F-06560 Valbonne, France.	galy@genethon.fr; david.fenard@txcell.com	Chazal, Nathalie/AAH-2937-2021; Briant, Laurence/AAB-9281-2021; Holic, Nathalie/U-8979-2018; Fenard, David/D-9533-2011; Espert, Lucile/ABF-5614-2021; Galy, Anne HM/J-4439-2013	Chazal, Nathalie/0000-0002-1528-9607; Holic, Nathalie/0000-0001-9869-1388; Fenard, David/0000-0003-0242-386X; Galy, Anne HM/0000-0002-0153-4392; Briant, Laurence/0000-0002-1995-3501	Association Francaise contre les Myopathies (AFM/Telethon)	Association Francaise contre les Myopathies (AFM/Telethon)(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (AFM/Telethon). The authors declare that they have no conflicts of interest with the contents of this article.	Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Eberle HB, 2002, J CELL SCI, V115, P827; Eekels JJM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-69; Fenard D, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.17; Fenard D, 2013, J VIROL METHODS, V189, P375, DOI 10.1016/j.jviromet.2013.02.005; Frecha C, 2008, CURR GENE THER, V8, P449, DOI 10.2174/156652308786848003; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Holic N, 2016, METHODS MOL BIOL, V1448, P41, DOI 10.1007/978-1-4939-3753-0_3; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Ingrao D, 2014, HUM GENE THER METHOD, V25, P48, DOI 10.1089/hgtb.2013.090; Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Killian MS, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-16; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Liang M, 2009, J VIROL, V83, P13026, DOI 10.1128/JVI.01530-09; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Majdoul S, 2016, J BIOL CHEM, V291, P2161, DOI 10.1074/jbc.M115.675033; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275; Merten OW, 2011, HUM GENE THER, V22, P343, DOI 10.1089/hum.2010.060; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pirooz S, 2014, AUTOPHAGY, V10, P1355, DOI 10.4161/auto.29075; Pirooz SD, 2014, P NATL ACAD SCI USA, V111, P2716, DOI 10.1073/pnas.1320629111; Salvador B, 2009, VIROLOGY, V393, P33, DOI 10.1016/j.virol.2009.07.013; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Timberlake N, 2016, MOL THER, V24, pS2, DOI 10.1016/S1525-0016(16)32813-1; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]	38	5	5	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18672	18681		10.1074/jbc.M117.800813	http://dx.doi.org/10.1074/jbc.M117.800813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28928217	Green Published, hybrid			2022-12-28	WOS:000414958100023
J	Gil, J; Ramirez-Torres, A; Chiappe, D; Luna-Penaloza, J; Fernandez-Reyes, FC; Arcos-Encarnacion, B; Contreras, S; Encarnacion-Guevara, S				Gil, Jeovanis; Ramirez-Torres, Alberto; Chiappe, Diego; Luna-Penaloza, Juan; Fernandez-Reyes, Francis C.; Arcos-Encarnacion, Bolivar; Contreras, Sandra; Encarnacion-Guevara, Sergio			Lysine acetylation stoichiometry and proteomics analyses reveal pathways regulated by sirtuin 1 in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cancer; histone deacetylase inhibitor (HDAC inhibitor) (HDI); sirtuin 1 (SIRT1); stoichiometry	IN-VIVO; IDENTIFICATION; COMPLEXES; PEPTIDES; PROTEINS; CANCER; ROLES	Lysine acetylation is a widespread posttranslational modification affecting many biological pathways. Recent studies indicate that acetylated lysine residues mainly exhibit low acetylation occupancy, but challenges in sample preparation and analysis make it difficult to confidently assign these numbers, limiting understanding of their biological significance. Here, we tested three common sample preparation methods to determine their suitability for assessing acetylation stoichiometry in three human cell lines, identifying the acetylation occupancy in more than 1,300 proteins from each cell line. The stoichiometric analysis in combination with quantitative proteomics also enabled us to explore their functional roles. We found that higher abundance of the deacetylase sirtuin 1 (SIRT1) correlated with lower acetylation occupancy and lower levels of ribosomal proteins, including those involved in ribosome biogenesis and rRNA processing. Treatment with the SIRT1 inhibitor EX-527 confirmed SIRT1's role in the regulation of pre-rRNA synthesis and processing. Specifically, proteins involved in pre-rRNA transcription, including subunits of the polymerase I and SL1 complexes and the RNA polymerase I-specific transcription initiation factor RRN3, were up-regulated after SIRT1 inhibition. Moreover, many protein effectors and regulators of pre-rRNA processing needed for rRNA maturation were also up-regulated after EX-527 treatment with the outcome that pre-rRNA and 28S rRNA levels also increased. More generally, we found that SIRT1 inhibition down-regulates metabolic pathways, including glycolysis and pyruvate metabolism. Together, these results provide the largest data set thus far of lysine acetylation stoichiometry (available via ProteomeXchange with identifier PXD005903) and set the stage for further biological investigations of this central posttranslational modification.	[Gil, Jeovanis; Ramirez-Torres, Alberto; Luna-Penaloza, Juan; Arcos-Encarnacion, Bolivar; Contreras, Sandra; Encarnacion-Guevara, Sergio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Func Procariotes, Ave Univ S-N, Cuernavaca 62210, Morelos, Mexico; [Gil, Jeovanis] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Doctorado Ciencias Biomed, Ave Univ S-N, Cuernavaca 62210, Morelos, Mexico; [Chiappe, Diego] Ecole Polytech Fed Lausanne, Prote Core Facil, CH-1015 Lausanne, Switzerland; [Fernandez-Reyes, Francis C.] Univ Autonoma Estado Morelos, Ctr Invest Ciencia, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca 62210, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universidad Autonoma del Estado de Morelos	Encarnacion-Guevara, S (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Func Procariotes, Ave Univ S-N, Cuernavaca 62210, Morelos, Mexico.	encarnac@ccg.unam.mx	Valdes, Jeovanis Gil/AAH-9840-2020; Valdes, Jeovanis Gil/G-6390-2016	Valdes, Jeovanis Gil/0000-0003-3601-3893; Valdes, Jeovanis Gil/0000-0003-3601-3893; Arcos, Bolivar/0000-0002-8031-6392	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [220790]; Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica [IN-206113, IN-213216]; CONACyT Fellowship [343827]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT Fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by Consejo Nacional de Ciencia y Tecnologia (CONACyT) Grant 220790 and Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica Grants IN-206113 and IN-213216. The authors declare that they have no conflicts of interest with the contents of this article.; This work was submitted to fulfill the requirements for a doctorate of philosophy at Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico. Recipient of CONACyT Fellowship 343827.	Ali M, 2012, J MOL BIOL, V424, P328, DOI 10.1016/j.jmb.2012.10.004; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Betancourt L, 2005, J PROTEOME RES, V4, P491, DOI 10.1021/pr049794x; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Chakraborty A, 2002, J CHROMATOGR A, V949, P173, DOI 10.1016/S0021-9673(02)00047-X; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Gil J, 2017, J PROTEOMICS, V150, P297, DOI 10.1016/j.jprot.2016.10.003; Gil J, 2009, HUM VACCINES, V5, P347, DOI 10.4161/hv.5.5.7367; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji JY, 2000, J CHROMATOGR B, V745, P197, DOI 10.1016/S0378-4347(00)00192-4; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lin Y, 2008, ANAL BIOCHEM, V377, P259, DOI 10.1016/j.ab.2008.03.009; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Sanchez A, 2007, RAPID COMMUN MASS SP, V21, P2237, DOI 10.1002/rcm.3079; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Simmons GE, 2015, INT J MOL SCI, V16, P950, DOI 10.3390/ijms16010950; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Voit R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005246; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Zhou T, 2016, J PROTEOME RES, V15, P1103, DOI 10.1021/acs.jproteome.5b01097; Zink LM, 2016, CURR OPIN GENET DEV, V37, P82, DOI 10.1016/j.gde.2015.12.002	34	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18129	18144		10.1074/jbc.M117.784546	http://dx.doi.org/10.1074/jbc.M117.784546			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28893905	Green Published, hybrid			2022-12-28	WOS:000414458200012
J	Sarwar, S; Ali, A; Pal, M; Chakrabarti, P				Sarwar, Shamila; Ali, Asif; Pal, Mahadeb; Chakrabarti, Pinak			Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholera toxin; ganglioside; infectious disease; microbiology; Vibrio cholerae; ELISA; HT-29 cells; ZnO nanoparticles	VIBRIO-CHOLERAE; ANTIBACTERIAL AGENTS; GOLD NANOPARTICLES; MOLECULE; DIARRHEA; COLONIZATION; ANTIBIOTICS; RESISTANCE; INHIBITOR; VIRULENCE	Vibrio cholerae causes cholera and is the leading cause of diarrhea in developing countries, highlighting the need for the development of new treatment strategies to combat this disease agent. While exploring the possibility of using zinc oxide (ZnO) nanoparticles (NPs) in cholera treatment, we previously found that ZnO NPs reduce fluid accumulation in mouse ileum induced by the cholera toxin (CT) protein. To uncover the mechanism of action of ZnO NPs on CT activity, here we used classical (O395) and El Tor (C6706) V. cholerae biotypes in growth and biochemical assays. We found that a ZnO NP concentration of 10 g/ml did not affect the growth rates of these two strains, nor did we observe that ZnO NPs reduce the expression levels of CT mRNA and protein. It was observed that ZnO NPs form a complex with CT, appear to disrupt the CT secondary structure, and block its interaction with the GM1 ganglioside receptor in the outer leaflet of the plasma membrane in intestinal (HT-29) cells and thereby reduce CT uptake into the cells. In the range of 2.5-10 g/ml, ZnO NPs exhibited no cytotoxicity on kidney (HEK293) and HT-29 cells. We conclude that ZnO NPs prevent the first step in the translocation of cholera toxin into intestinal epithelial cells without exerting measurable toxic effects on HEK293 and HT-29 cells.	[Sarwar, Shamila; Chakrabarti, Pinak] P1 12 CIT Scheme VIIM, Bose Inst, Dept Biochem, Kolkata, India; [Ali, Asif; Pal, Mahadeb] P1 12 CIT Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Sarwar, S; Chakrabarti, P (corresponding author), P1 12 CIT Scheme VIIM, Bose Inst, Dept Biochem, Kolkata, India.	shamilabmb@gmail.com; pinak@jcbose.ac.in			Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Science and Technology, India, and the Council of Scientific and Industrial Research, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from the Council of Scientific and Industrial Research (CSIR), India.	Akanda AS, 2013, AM J TROP MED HYG, V89, P950, DOI 10.4269/ajtmh.12-0492; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI [10.1586/eri.11.121, 10.1586/ERI.11.121]; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P433; Azman AS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004230; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Benitez JA, 2016, TOXICON, V115, P55, DOI 10.1016/j.toxicon.2016.03.003; CHARANIA Z, 1991, J MICROBIOL METH, V14, P171, DOI 10.1016/0167-7012(91)90020-Q; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Chatterjee T, 2017, BBA-GEN SUBJECTS, V1861, P977, DOI 10.1016/j.bbagen.2017.02.007; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Duggan C, 2004, JAMA-J AM MED ASSOC, V291, P2628, DOI 10.1001/jama.291.21.2628; Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Kolodziejczak-Radzimska A, 2014, MATERIALS, V7, P2833, DOI 10.3390/ma7042833; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lam SJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.162, 10.1038/nmicrobiol.2016.162]; Lockridge O, 2008, J BIOL CHEM, V283, P22582, DOI 10.1074/jbc.M802555200; Mahamud AS, 2012, J INFECT DEV COUNTR, V6, P234, DOI 10.3855/jidc.1966; Mandal J, 2012, J HEALTH POPUL NUTR, V30, P12; Mocz Gabor, 2013, Methods Mol Biol, V1008, P169, DOI 10.1007/978-1-62703-398-5_7; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Negi R, 2015, ACTA PAEDIATR, V104, pe367, DOI 10.1111/apa.12645; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; OHTOMO N, 1976, J INFECT DIS, V133, pS31, DOI 10.1093/infdis/133.Supplement_1.S31; Pang B, 2007, J BACTERIOL, V189, P4837, DOI 10.1128/JB.01959-06; Pariwat P, 2008, J PHARMACOL EXP THER, V324, P798, DOI 10.1124/jpet.107.129288; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Rudramurthy GR, 2016, MOLECULES, V21, DOI 10.3390/molecules21070836; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sarwar S, 2016, NANOMED-NANOTECHNOL, V12, P1499, DOI 10.1016/j.nano.2016.02.006; Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; SHEARS P, 1991, EPIDEMIOL INFECT, V107, P241, DOI 10.1017/S0950268800048895; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Smallman-Raynor MR, 2004, INFECT DIS CLIN N AM, V18, P341, DOI 10.1016/j.idc.2004.01.009; Spagnuolo AM, 2011, J THEOR BIOL, V289, P247, DOI 10.1016/j.jtbi.2011.08.028; Wadhwa N, 2011, J PEDIATR GASTR NUTR, V53, P161, DOI 10.1097/MPG.0b013e318213ca55; Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843	44	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18303	18311		10.1074/jbc.M117.793240	http://dx.doi.org/10.1074/jbc.M117.793240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882894	hybrid, Green Published			2022-12-28	WOS:000414458200027
J	Lin, YH; Qiu, DC; Chang, WH; Yeh, YQ; Jeng, US; Liu, FT; Huang, JR				Lin, Yu-Hao; Qiu, De-Chen; Chang, Wen-Han; Yeh, Yi-Qi; Jeng, U-Ser; Liu, Fu-Tong; Huang, Jie-rong			The intrinsically disordered N-terminal domain of galectin-3 dynamically mediates multisite self-association of the protein through fuzzy interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMER-DIMER EQUILIBRIUM; CARBOHYDRATE-RECOGNITION DOMAIN; RESIDUAL DIPOLAR COUPLINGS; N-15 NMR RELAXATION; BACKBONE DYNAMICS; PHASE-TRANSITION; STAPHYLOCOCCAL NUCLEASE; UNFOLDED PROTEINS; BINDING PROTEINS; ANIMAL LECTIN	Galectins are a family of lectins that bind beta-galactosides through their conserved carbohydrate recognition domain (CRD) and can induce aggregation with glycoproteins or glycolipids on the cell surface and thereby regulate cell activation, migration, adhesion, and signaling. Galectin-3 has an intrinsically disordered N-terminal domain and a canonical CRD. Unlike the other 14 known galectins in mammalian cells, which have dimeric or tandem-repeated CRDs enabling multivalency for various functions, galectin-3 is monomeric, and its functional multivalency therefore is somewhat of a mystery. Here, we used NMR spectroscopy, mutagenesis, small-angle X-ray scattering, and computational modeling to study the selfassociation- related multivalency of galectin-3 at the residuespecific level. We show that the disordered N-terminal domain (residues similar to 20-100) interacts with itself and with a part of the CRD not involved in carbohydrate recognition (beta-strands 7-9; residues similar to 200-220), forming a fuzzy complex via inter-and intramolecular interactions, mainly through hydrophobicity. These fuzzy interactions are characteristic of intrinsically disordered proteins to achieve liquid-liquid phase separation, and we demonstrated that galectin-3 can also undergo liquid-liquid phase separation. We propose that galectin-3 may achieve multivalency through this multisite self-association mechanism facilitated by fuzzy interactions.	[Lin, Yu-Hao; Qiu, De-Chen; Chang, Wen-Han; Huang, Jie-rong] Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan; [Huang, Jie-rong] Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan; [Yeh, Yi-Qi; Jeng, U-Ser] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Jeng, U-Ser] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; Academia Sinica - Taiwan	Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan.	jierongh@ym.edu.tw	Huang, Jie-rong/O-3661-2019; Liu, FU-TONG/A-5749-2019	Huang, Jie-rong/0000-0003-3674-2228; Liu, FU-TONG/0000-0002-3354-1001	Ministry of Science and Technology of Taiwan [104-2113-M-010-001-MY2, 106-2113-M-010-005-MY2, 106-2321-B-001-042]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grants 104-2113-M-010-001-MY2 and 106-2113-M-010-005-MY2 (to J. H.) and 106-2321-B-001-042 (to F.-T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abyzov A, 2016, J AM CHEM SOC, V138, P6240, DOI 10.1021/jacs.6b02424; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Bae SH, 2009, J AM CHEM SOC, V131, P6814, DOI 10.1021/ja809687r; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen TC, 2016, PROTEIN PEPTIDE LETT, V23, P967, DOI 10.2174/0929866523666160920100045; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Goddard T. D., 2005, SPARKY 3; Gong HC, 1999, CANCER RES, V59, P6239; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Halimi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111836; HSU DK, 1992, J BIOL CHEM, V267, P14167; Huang JR, 2012, BIOCHEM SOC T, V40, P989, DOI 10.1042/BST20120187; Ippel H, 2016, GLYCOBIOLOGY, V26, P888, DOI 10.1093/glycob/cww021; Ippel H, 2015, BIOMOL NMR ASSIGN, V9, P59, DOI 10.1007/s12104-014-9545-3; Jensen MR, 2008, PROTEINS, V73, P161, DOI 10.1002/prot.22039; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Korchuganov DS, 2001, J AM CHEM SOC, V123, P2068, DOI 10.1021/ja0025447; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MEHUL B, 1994, J BIOL CHEM, V269, P18250; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Parigi G, 2014, J AM CHEM SOC, V136, P16201, DOI 10.1021/ja506820r; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pfuhl M, 1999, J BIOMOL NMR, V14, P307, DOI 10.1023/A:1008319917267; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rezaei-Ghaleh N, 2015, BIOINFORMATICS, V31, P1319, DOI 10.1093/bioinformatics/btu824; Rezaei-Ghaleh N, 2013, ANGEW CHEM INT EDIT, V52, P11410, DOI 10.1002/anie.201305094; ROFF CF, 1983, J BIOL CHEM, V258, P657; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Taylor J. R., 1997, INTRO ERROR ANAL; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yeh YQ, 2017, J PHYS CHEM LETT, V8, P470, DOI 10.1021/acs.jpclett.6b02722; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	79	33	34	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17845	17856		10.1074/jbc.M117.802793	http://dx.doi.org/10.1074/jbc.M117.802793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893908	Green Published, hybrid			2022-12-28	WOS:000414013000021
J	Malhotra, N; Karthikeyan, S; Chakraborti, PK				Malhotra, Neha; Karthikeyan, Subramanian; Chakraborti, Pradip K.			Phosphorylation of mycobacterial phosphodiesterase by eukaryotic-type Ser/Thr kinase controls its two distinct and mutually exclusive functionalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PROTEIN-KINASE; CAMP; TUBERCULOSIS; ACTIVATION; PKNA; IDENTIFICATION; BIOSYNTHESIS; MECHANISMS; PATHWAY	Phosphorylation-mediated negative feedback regulation of cAMP levels by phosphodiesterase is well-established in eukaryotic cells. However, such a mechanism remains unexplored in prokaryotes. We report here the involvement of eukaryotic-type Ser/Thr kinases, particularly PknA in trans-phosphorylating phosphodiesterase from Mycobacterium tuberculosis (mPDE), that resulted in decreased enzyme turnover rate compared with its unphosphorylated counterpart. To elucidate the role of mPDE phosphorylation in hydrolyzing cellular cAMP, we utilized a phosphodiesterase knock-out Escherichia coli strain, Delta cpdA, where interference of endogenous eukaryotic-type Ser/Thr kinases could be excluded. Interestingly, the mPDE-complemented Delta cpdA strain showed enhanced cAMP levels in the presence of PknA, and this effect was antagonized by PknA-K42N, a kinase-dead variant. Structural analysis of mPDE revealed that four Ser/Thr residues (Ser-20, Thr-22, Thr-182, and Thr-240) were close to the active site, indicating their possible role in phosphorylation-mediated alteration in enzymatic activity. Mutation of these residues one at a time to alanine or a combination of all four (mPDE-4A) affected catalytic activity of mPDE. Moreover, mPDE-4A protein in kinase assays exhibited reduction in its phosphorylation compared with mPDE. In consonance, phosphoproteins obtained after co-expression of PknA with mPDE/S20A/T240A/4A displayed decreased phospho-signal intensities in immunoblotting with anti-phosphoserine/ phosphothreonine antibodies. Furthermore, unlike mPDE, phospho-ablated mPDE-T309A protein exhibited impaired cell wall localization in Mycobacterium smegmatis, whereas mPDE-4A behaved similarly as wild type. Taken together, our findings establish mutually exclusive dual functionality of mPDE upon PknA-mediated phosphorylation, where Ser-20/Thr-240 influence enzyme activity and Thr-309 endorses its cell wall localization.	[Malhotra, Neha; Karthikeyan, Subramanian; Chakraborti, Pradip K.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chakraborti, PK (corresponding author), Jamia Hamdarad Hamdard Univ, Dept Biotechnol, Sch Chem & Life Sci, New Delhi 110062, India.	pradip@imtech.res.in		Malhotra, Neha/0000-0002-5545-7986	Council of Scientific and Industrial Research (CSIR) [BSC-104]; Department of Science and Technology (JC Bose National Fellowship), New Delhi, India [SR/S2/JCB-87/2012]; CSIR, New Delhi, India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (JC Bose National Fellowship), New Delhi, India; CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by research grants from network project (BSC-104) of the Council of Scientific and Industrial Research (CSIR) and the Department of Science and Technology (JC Bose National Fellowship to P. K. C., SR/S2/JCB-87/2012, Science and Engineering Research Board), New Delhi, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Senior Research Fellowship from CSIR, New Delhi, India.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Dar HH, 2010, BIOCHEM J, V430, P539, DOI 10.1042/BJ20100026; Dave JA, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-30; DeLano WL, 2011, PYMOL MOL GRAPHICS S; Dhiman RK, 2004, J LIPID RES, V45, P1140, DOI 10.1194/jlr.M400047-JLR200; Dong HL, 2015, BREAST CANCER RES TR, V152, P17, DOI 10.1007/s10549-015-3445-9; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gerbaud Pascale, 2016, Biologie Aujourd hui, V210, P139, DOI 10.1051/jbio/2016017; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Malhotra N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00123; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Midha M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036094; Oberholzer M, 2015, MBIO, V6, DOI 10.1128/mBio.01954-14; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PERLMAN RL, 1969, NATURE, V223, P810, DOI 10.1038/223810a0; Plattner F, 2015, NAT NEUROSCI, V18, P1094, DOI 10.1038/nn.4066; Prisic S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0006-2013; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Wang L, 2000, J BIOL CHEM, V275, P7224, DOI 10.1074/jbc.275.10.7224; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Yang W, 2001, PROTEIN EXPRES PURIF, V22, P472, DOI 10.1006/prep.2001.1453; Zaveri A, 2013, CURR SCI INDIA, V105, P666; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	42	1	1	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17362	17374		10.1074/jbc.M117.784124	http://dx.doi.org/10.1074/jbc.M117.784124			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28855253	Green Published, hybrid			2022-12-28	WOS:000414009300018
J	Kumar, H; Singh, J; Kumari, P; Udgaonkar, JB				Kumar, Harish; Singh, Jogender; Kumari, Pratibha; Udgaonkar, Jayant B.			Modulation of the extent of structural heterogeneity in -synuclein fibrils by the small molecule thioflavin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); atomic force microscopy (AFM); hydrogen exchange mass spectrometry; neurodegenerative disease; toxicity; fibril heterogeneity; thioflavin T	HUMAN ALPHA-SYNUCLEIN; BETA-AMYLOID FIBRILS; SOLID-STATE NMR; MOUSE PRION PROTEIN; C-TERMINAL REGION; MASS-SPECTROMETRY; PARKINSONS-DISEASE; BINDING MODES; CONFORMATIONAL HETEROGENEITY; SECONDARY STRUCTURE	The transition of intrinsically disordered, monomeric -synuclein into -sheet-rich oligomers and fibrils is associated with multiple neurodegenerative diseases. Fibrillar aggregates possessing distinct structures that differ in toxicity have been observed in different pathological phenotypes. Understanding the mechanism of the formation of various fibril polymorphs with differing cytotoxic effects is essential for determining how the aggregation reaction could be modulated to favor nontoxic fibrils over toxic fibrils. In this study, two morphologically different -synuclein fibrils, one helical and the other ribbon-like, are shown to form together. Surprisingly, a widely used small molecule for probing aggregation reactions, thioflavin T (ThT), was found to tune the structural heterogeneity found in the fibrils. The ribbon-like fibrils formed in the presence of ThT were found to have a longer structural core than the helical fibrils formed in the absence of ThT. The ribbon-like fibrils are also more toxic to cells. By facilitating the formation of ribbon-like fibrils over helical fibrils, ThT reduced the extent of fibril polymorphism. This study highlights the role of a small molecule such as ThT in selectively favoring the formation of a specific type of fibril by binding to aggregates formed early on one of multiple pathways, thereby altering the structural core and external morphology of the fibrils formed.	[Kumar, Harish; Singh, Jogender; Kumari, Pratibha; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India; [Singh, Jogender] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kumari, Pratibha] Swiss Fed Inst Technol, Phys Chem Lab, Honggerberg Campus, CH-8093 Zurich, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	jayant@ncbs.res.in		Kumari, Pratibha/0000-0002-6696-9514; Singh, Jogender/0000-0002-7947-0405	Tata Institute of Fundamental Research; Department of Biotechnology, Ministry of Science and Technology, Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was funded by the Tata Institute of Fundamental Research and the Department of Biotechnology, Ministry of Science and Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; D'Amico M, 2012, J PHYS CHEM LETT, V3, P1596, DOI 10.1021/jz300412v; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fandrich M., 2013, AMYLOID FIBRILS PREF, P321; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gurry T, 2013, J AM CHEM SOC, V135, P3865, DOI 10.1021/ja310518p; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ivancic VA, 2016, CHEMPHYSCHEM, V17, P2461, DOI 10.1002/cphc.201600246; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jameson LP, 2012, ACS CHEM NEUROSCI, V3, P807, DOI 10.1021/cn300076x; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumar S, 2007, J MOL BIOL, V367, P1186, DOI 10.1016/j.jmb.2007.01.039; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Lam HT, 2016, BIOCHEMISTRY-US, V55, P675, DOI 10.1021/acs.biochem.5b01168; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li S, 2016, ACTA PHYS-CHIM SIN, V32, P1391, DOI 10.3866/PKU.WHXB201603221; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Losasso V, 2011, BIOCHEMISTRY-US, V50, P6994, DOI 10.1021/bi2007564; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mao XB, 2011, ACS CHEM NEUROSCI, V2, P281, DOI 10.1021/cn200006h; Marshall KE, 2014, PRION, V8, P192, DOI 10.4161/pri.28860; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mirecka EA, 2014, ANGEW CHEM INT EDIT, V53, P4227, DOI 10.1002/anie.201309001; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Okazaki H, 2013, FEBS LETT, V587, P3709, DOI 10.1016/j.febslet.2013.09.039; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rodriguez-Rodriguez C, 2010, CHEM COMMUN, V46, P1156, DOI 10.1039/b912396b; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; Singh J, 2015, BIOCHEMISTRY-US, V54, P4431, DOI 10.1021/acs.biochem.5b00605; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wu KP, 2010, J AM CHEM SOC, V132, P5546, DOI 10.1021/ja9105495; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	91	20	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16891	16903		10.1074/jbc.M117.795617	http://dx.doi.org/10.1074/jbc.M117.795617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28760825	Green Published, hybrid			2022-12-28	WOS:000413140600011
J	Bassi, R; Burgoyne, JR; DeNicola, GF; Rudyk, O; DeSantis, V; Charles, RL; Eaton, P; Marber, MS				Bassi, Rekha; Burgoyne, Joseph R.; DeNicola, Gian F.; Rudyk, Olena; DeSantis, Vittorio; Charles, Rebecca L.; Eaton, Philip; Marber, Michael S.			Redox-dependent dimerization of p38 alpha mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MAP KINASE; HYDROGEN-PEROXIDE; SIMULATED ISCHEMIA; OXIDATIVE STRESS; CELL-SURVIVAL; MURINE MODEL; FATTY-ACIDS; P38 MAPK; REPERFUSION	The kinase p38 alpha MAPK (p38 alpha) plays a pivotal role in many biological processes. p38 alpha is activated by canonical upstream kinases that phosphorylate the activation region. The purpose of our study was to determine whether such activation may depend on redox-sensing cysteines within p38 alpha. p38 alpha was activated and formed a disulfide-bound heterodimer with MAP2K3 (MKK3) in rat cardiomyocytes and isolated hearts exposed to H2O2. This disulfide heterodimer was sensitive to reduction by mercaptoethanol and was enhanced by the thioredoxin-reductase inhibitor auranofin. We predicted that Cys-119 or Cys-162 of p38 alpha, close to the known MKK3 docking domain, were relevant for these redox characteristics. The C119S mutation decreased whereas the C162S mutation increased the dimer formation, suggesting that these two Cys residues act as vicinal thiols, consistent with C119S/C162S being incapable of sensing H2O2. Similarly, disulfide heterodimer formation was abolished in H9C2 cells expressing both MKK3 and p38 alpha C119S/C162S and subjected to simulated ischemia and reperfusion. However, the p38 alpha C119S/C162S mutants did not exhibit appreciable alteration in activating dual phosphorylation. In contrast, the anti-inflammatory agent 10-nitro-oleic acid (NO2-OA), a component of the Mediterranean diet, reduced p38 alpha activation and covalently modified Cys-119/Cys-162, probably obstructing MKK3 access. Moreover, NO2-OA reduced the dephosphorylation of p38 alpha by hematopoietic tyrosine phosphatase (HePTP). Furthermore, steric obstruction of Cys-119/Cys-162 by NO2-OA pretreatment in Langendorff-perfused murine hearts prevented the p38-MKK3 disulfide dimer formation and attenuated H2O2-induced contractile dysfunction. Our findings suggest that cysteine residues within p38 alpha act as redox sensors that can dynamically regulate the association between p38 and MKK3.	[Bassi, Rekha; Burgoyne, Joseph R.; DeNicola, Gian F.; Rudyk, Olena; DeSantis, Vittorio; Charles, Rebecca L.; Eaton, Philip; Marber, Michael S.] Kings Coll London British Heart Fdn Ctr Excellenc, St Thomas Hosp, Dept Cardiol, Rayne Inst, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Marber, MS (corresponding author), KCL, Rayne Inst, Cardiovasc Div, St Thomas Hosp Campus, London SE1 7EH, England.	mike.marber@kcl.ac.uk	marber, michael/AAW-7916-2021; Rudyk, Olena/AAY-3789-2020; Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Charles, Rebecca/0000-0003-4115-6135; Rudyk, Olena/0000-0001-9422-9233; Burgoyne, Joseph/0000-0001-7325-7382; Marber, Michael/0000-0002-3463-7128	British Heart Foundation [SP/14/2/30922]; Medical Research Council [MR/J007501/1]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Department of Health via Clinical Research Facilities awards; King's College London; King's College Hospital NHS Foundation Trust; MRC [MR/P023150/1, G0600785, G0700320, G1000458, MR/K003232/1, MR/L009684/1, MR/J007501/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/17/44/33064, PG/10/98/28655, PG/13/13/30018, RG/12/12/29872, FS/11/45/28859, PG/15/26/31373, FS/14/57/31138, FS/14/29/30896, FS/14/1/30551] Funding Source: researchfish; Medical Research Council [MR/P023150/1, MR/L009684/1, MR/K003232/1, G0600785, G1000458, G0700320] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Health via Clinical Research Facilities awards; King's College London(General Electric); King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grant SP/14/2/30922 and Medical Research Council Grant MR/J007501/1. This work was also supported by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy and St. Thomas NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Bukhtiyarova M, 2004, PROTEIN EXPRES PURIF, V37, P154, DOI 10.1016/j.pep.2004.05.017; Burgoyne JR, 2011, BIOCHEM SOC T, V39, P1260, DOI 10.1042/BST0391260; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diao YR, 2010, P NATL ACAD SCI USA, V107, P20974, DOI 10.1073/pnas.1007225107; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Engelbrecht A-M, 2004, BASIC RES CARDIOL, V99, P338, DOI 10.1007/s00395-004-0478-3; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Klinke A, 2014, AM J RESP CELL MOL, V51, P155, DOI 10.1165/rcmb.2013-0063OC; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Matsumoto Y, 2000, MOL CELL BIOCHEM, V204, P97, DOI 10.1023/A:1007042611127; Meldrum DR, 1998, SURGERY, V124, P291, DOI 10.1067/msy.1998.90570; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; Patel SB, 2004, BBA-PROTEINS PROTEOM, V1696, P67, DOI 10.1016/j.bbapap.2003.09.009; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; SHATTOCK MJ, 1982, PHARMACOLOGY, V24, P118, DOI 10.1159/000137585; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zimmer KM, 1997, MOL CELL BIOCHEM, V176, P171, DOI 10.1023/A:1006812003834	40	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16161	16173		10.1074/jbc.M117.785410	http://dx.doi.org/10.1074/jbc.M117.785410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28739872	hybrid, Green Published			2022-12-28	WOS:000412109400016
J	Hamadani, KM; Howe, J; Jensen, MK; Wu, P; Cate, JHD; Marqusee, S				Hamadani, Kambiz M.; Howe, Jesse; Jensen, Madeleine K.; Wu, Peng; Cate, Jamie H. D.; Marqusee, Susan			An in vitro tag-and-modify protein sample generation method for single-molecule fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZIDE-ALKYNE CYCLOADDITION; NONCANONICAL AMINO-ACIDS; CLICK CHEMISTRY; GENETIC-CODE; PURIFIED COMPONENTS; POLYPEPTIDE-CHAIN; FRET MEASUREMENTS; ESCHERICHIA-COLI; T4 LYSOZYME; DE-NOVO	Biomolecular systems exhibit many dynamic and biologically relevant properties, such as conformational fluctuations, multistep catalysis, transient interactions, folding, and allosteric structural transitions. These properties are challenging to detect and engineer using standard ensemble-based techniques. To address this drawback, single-molecule methods offer a way to access conformational distributions, transient states, and asynchronous dynamics inaccessible to these standard techniques. Fluorescence-based single-molecule approaches are parallelizable and compatible with multiplexed detection; to date, however, they have remained limited to serial screens of small protein libraries. This stems from the current absence of methods for generating either individual dual-labeled protein samples at high throughputs or protein libraries compatible with multiplexed screening platforms. Here, we demonstrate that by combining purified and reconstituted in vitro translation, quantitative unnatural amino acid incorporation via AUG codon reassignment, and copper-catalyzed azidealkyne cycloaddition, we can overcome these challenges for target proteins that are, or can be, methionine-depleted. We present an in vitro parallelizable approach that does not require laborious target-specific purification to generate dual-labeled proteins and ribosome-nascent chain libraries suitable for single-molecule FRET-based conformational phenotyping. We demonstrate the power of this approach by tracking the effects of mutations, C-terminal extensions, and ribosomal tethering on the structure and stability of three protein model systems: barnase, spectrin, and T4 lysozyme. Importantly, dual-labeled ribosome-nascent chain libraries enable single-molecule co-localization of genotypes with phenotypes, are well suited for multiplexed single-molecule screening of protein libraries, and should enable the in vitro directed evolution of proteins with designer single-molecule conformational phenotypes of interest.	[Hamadani, Kambiz M.; Cate, Jamie H. D.; Marqusee, Susan] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Jensen, Madeleine K.; Cate, Jamie H. D.; Marqusee, Susan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hamadani, Kambiz M.; Howe, Jesse] Calif State Univ, Dept Chem & Biochem, San Marcos, CA 92096 USA; [Wu, Peng] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; California State University System; California State University San Marcos; Scripps Research Institute	Hamadani, KM; Cate, JHD; Marqusee, S (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Cate, JHD; Marqusee, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Hamadani, KM (corresponding author), Calif State Univ, Dept Chem & Biochem, San Marcos, CA 92096 USA.	khamadani@csusm.edu; jcate@lbl.gov; marqusee@berkeley.edu	Hamadani, Kambiz/AAM-4138-2020	Hamadani, Kambiz/0000-0002-2768-3361	National Institutes of Health (NIH) [GM50945]; NIH [GM65050]; CSUPERB New Investigator [20132014_522]; CSUSM Summer Scholar's Program award; National Science Foundation Graduate Research Fellowship [DGE 1106400]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050945, R01GM065050, T32GM007232] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSUPERB New Investigator; CSUSM Summer Scholar's Program award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant GM50945 (to S. M.), NIH Grant GM65050 (to J. H. D. C.), a CSUPERB New Investigator Grant 20132014_522 (to K. M. H.), the CSUSM Summer Scholar's Program award (to J. H.), and a National Science Foundation Graduate Research Fellowship Grant DGE 1106400 (to M. K. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Instit utes of Health.	Albayrak C, 2014, ACS SYNTH BIOL, V3, P353, DOI 10.1021/sb400116x; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Back JW, 2005, ANGEW CHEM INT EDIT, V44, P7946, DOI 10.1002/anie.200502431; Batey S, 2006, BIOPHYS J, V90, P2120, DOI 10.1529/biophysj.105.072710; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Best RB, 2015, BIOPHYS J, V108, P2721, DOI 10.1016/j.bpj.2015.04.038; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Borgia A, 2016, J AM CHEM SOC, V138, P11714, DOI 10.1021/jacs.6b05917; Brustad EM, 2008, J AM CHEM SOC, V130, P17664, DOI 10.1021/ja807430h; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; del Amo DS, 2010, J AM CHEM SOC, V132, P16893, DOI 10.1021/ja106553e; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Gu LC, 2014, NATURE, V515, P554, DOI 10.1038/nature13761; Ha T, 2014, NAT METHODS, V11, P1015, DOI 10.1038/nmeth.3107; Hamadani KM, 2008, BIOPHYS J, V95, P352, DOI 10.1529/biophysj.107.127431; Hein JE, 2010, CHEM SOC REV, V39, P1302, DOI 10.1039/b904091a; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Horiya S, 2014, J AM CHEM SOC, V136, P5407, DOI 10.1021/ja500678v; Ingargiola A, 2013, PROC SPIE, V8590, DOI 10.1117/12.2003704; Iwane Y, 2016, NAT CHEM, V8, P317, DOI [10.1038/NCHEM.2446, 10.1038/nchem.2446]; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Jiang H, 2014, BIOCONJUGATE CHEM, V25, P698, DOI 10.1021/bc400502d; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kempe D, 2015, J PHYS CHEM B, V119, P4668, DOI 10.1021/acs.jpcb.5b02170; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kim S, 2011, NAT METHODS, V8, P242, DOI 10.1038/NMETH.1569; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lemke EA, 2011, METHODS MOL BIOL, V751, P3, DOI 10.1007/978-1-61779-151-2_1; Lerner E, 2013, ANAL BIOANAL CHEM, V405, P5983, DOI 10.1007/s00216-013-7002-2; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; McKay CS, 2014, CHEM BIOL, V21, P1075, DOI 10.1016/j.chembiol.2014.09.002; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; Nettels D., 2011, SINGLE MOL FRET PROT, V146, DOI [10.1002/9781118131374.ch2, DOI 10.1002/9781118131374.CH2]; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Paredes E, 2011, CHEMBIOCHEM, V12, P125, DOI 10.1002/cbic.201000466; Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Ratner V, 2002, BIOCONJUGATE CHEM, V13, P1163, DOI 10.1021/bc025537b; Riedel C, 2015, NATURE, V517, P227, DOI 10.1038/nature14043; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Samelson AJ, 2016, P NATL ACAD SCI USA, V113, P13402, DOI 10.1073/pnas.1610272113; Scott KA, 2004, J MOL BIOL, V344, P207, DOI 10.1016/j.jmb.2004.09.023; Shi XH, 2012, NAT METHODS, V9, P499, DOI [10.1038/NMETH.1954, 10.1038/nmeth.1954]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740; Terasaka N, 2015, INT J MOL SCI, V16, P6513, DOI 10.3390/ijms16036513; Tyagi S, 2014, NAT METHODS, V11, P297, DOI 10.1038/nmeth.2809; Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang A, 2008, CHEMBIOCHEM, V9, P324, DOI 10.1002/cbic.200700379; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang W, 2011, CHEM-ASIAN J, V6, P2796, DOI 10.1002/asia.201100385; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Worrell BT, 2013, SCIENCE, V340, P457, DOI 10.1126/science.1229506; Wu B, 2012, CHEMBIOCHEM, V13, P1405, DOI 10.1002/cbic.201200281; Xiao H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023945; Yang MY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5981; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112	79	3	3	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15636	15648		10.1074/jbc.M117.791723	http://dx.doi.org/10.1074/jbc.M117.791723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28754692	hybrid, Green Published			2022-12-28	WOS:000411512200005
J	Johnson, NB; Deck, KM; Nizzi, CP; Eisenstein, RS				Johnson, Nathan B.; Deck, Kathryn M.; Nizzi, Christopher P.; Eisenstein, Richard S.			A synergistic role of IRP1 and FBXL5 proteins in coordinating iron metabolism during cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; ELEMENT-BINDING-PROTEIN; REGULATORY PROTEIN-1; SULFUR CLUSTER; RNA-BINDING; DEPENDENT DEGRADATION; CYTOSOLIC ACONITASE; IN-VIVO; HOMEOSTASIS; BIOGENESIS	Iron-regulatory protein 1 (IRP1) belongs to a family of RNAbinding proteins that modulate metazoan iron metabolism. Multiple mechanisms are employed to control the action of IRP1 in dictating changes in the uptake and metabolic fate of iron. Inactivation of IRP1 RNA binding by iron primarily involves insertion of a [4Fe-4S] cluster by the cytosolic ironsulfur cluster assembly (CIA) system, converting it into cytosolic aconitase (c-acon), but can also involve iron-mediated degradation of IRP1 by the E3 ligase FBXL5 that also targets IRP2. How CIA and FBXL5 collaborate to maintain cellular iron homeostasis through IRP1 and other pathways is poorly understood. Because impaired Fe-S cluster biogenesis associates with human disease, we determined the importance of FBXL5 for regulating IRP1 when CIA is impaired. Suppression of FBXL5 expression coupled with induction of an IRP1 mutant (IRPI3C>3S) that cannot insert the Fe-S cluster, or along with knockdown of the CIA factors NUBP2 or FAM96A, reduced cell viability. Iron supplementation reversed this growth defect and was associated with FBXL5-dependent polyubiquitination of IRP1. Phosphorylation of IRP1 at Ser-138 increased when CIA was inhibited and was required for iron rescue. Impaired CIA activity, as noted by reduced c-acon activity, was associated with enhanced FBXL5 expression and a concomitant reduction in IRP1 and IRP2 protein level and RNA-binding activity. Conversely, expression of either IRP induced FBXL5 protein level, demonstrating a negative feedback loop limiting excessive accumulation of ironresponse element RNA-binding activity, whose disruption reduces cell growth. We conclude that a regulatory circuit involving FBXL5 and CIA acts through both IRPs to control iron metabolism and promote optimal cell growth.	[Johnson, Nathan B.; Deck, Kathryn M.; Nizzi, Christopher P.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eisenstein, RS (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eisenste@nutrisci.wisc.edu			National Institutes of Health [RO1 DK66600]; United States Department of Agriculture Hatch Project [WIS01667]; Iron Metabolism Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Hatch Project; Iron Metabolism Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK66600, United States Department of Agriculture Hatch Project WIS01667, and the Iron Metabolism Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Deck KM, 2009, J BIOL CHEM, V284, P12701, DOI 10.1074/jbc.M807717200; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; GOESSLING LS, 1992, SCIENCE, V256, P670, DOI 10.1126/science.1316633; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Ma CL, 2004, J BIOL CHEM, V279, P1533, DOI 10.1074/jbc.M310866200; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Martelli A, 2015, CELL METAB, V21, P311, DOI 10.1016/j.cmet.2015.01.010; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Roy CN, 2002, J CELL PHYSIOL, V190, P218, DOI 10.1002/JCP.10056; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201731; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Unden G, 2013, DALTON T, V42, P3082, DOI 10.1039/c2dt32089d; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vinas-Castells R, 2014, NUCLEIC ACIDS RES, V42, P1079, DOI 10.1093/nar/gkt935; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	47	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15976	15989		10.1074/jbc.M117.785741	http://dx.doi.org/10.1074/jbc.M117.785741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768766	hybrid, Green Published			2022-12-28	WOS:000411512200034
J	Luo, WJ; Tan, P; Rodriguez, M; He, L; Tan, KR; Zeng, L; Siwko, S; Liu, MY				Luo, Weijia; Tan, Peng; Rodriguez, Melissa; He, Lian; Tan, Kunrong; Zeng, Li; Siwko, Stefan; Liu, Mingyao			Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; TUMOR-GROWTH; EXPRESSION; GPR48; CELLS; SNAIL; GENE; KNOCKOUT; ANDROGEN; MARKER	Prostate cancer is a highly penetrant disease among men in industrialized societies, but the factors regulating the transition from indolent to aggressive and metastatic cancer remain poorly understood. We found that men with prostate cancers expressing high levels of the G protein-coupled receptor LGR4 had a significantly shorter recurrence-free survival compared with patients with cancers having low LGR4 expression. LGR4 expression was elevated in human prostate cancer cell lines with metastatic potential. We therefore generated a novel transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model to investigate the role of Lgr4 in prostate cancer development and metastasis in vivo. TRAMP Lgr4(-/-) mice exhibited an initial delay in prostate intraepithelial neoplasia formation, but the frequency of tumor formation was equivalent between TRAMP and TRAMP Lgr4(-/-) mice by 12 weeks. The loss of Lgr4 significantly improved TRAMP mouse survival and dramatically reduced the occurrence of lung metastases. LGR4 knockdown impaired the migration, invasion, and colony formation of DU145 cells and reversed epithelial-mesenchymal transition (EMT), as demonstrated by up-regulation of E-cadherin and decreased expression of the EMT transcription factors ZEB, Twist, and Snail. Overexpression of LGR4 in LNCaP cells had the opposite effects. Orthotopic injection of DU145 cells stably expressing shRNA targeting LGR4 resulted in decreased xenograft tumor size, reduced tumor EMT marker expression, and impaired metastasis, in accord with our findings in TRAMP Lgr4(-/-) mice. In conclusion, we propose that Lgr4 is a key protein necessary for prostate cancer EMT and metastasis.	[Luo, Weijia; Tan, Peng; Rodriguez, Melissa; He, Lian; Tan, Kunrong; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Translat Canc Res, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Tan, Peng; Zeng, Li; Liu, Mingyao] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Tan, Peng; Zeng, Li; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; East China Normal University; East China Normal University	Liu, MY (corresponding author), Alkek Rm 526,2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Tan, Peng/ABD-8190-2020; Tan, Peng/HGD-6812-2022; Tan, Peng/P-3825-2015	Tan, Peng/0000-0002-7005-1896; Tan, Peng/0000-0001-6992-9000; Luo, Weijia/0000-0002-4261-5084; He, Lian/0000-0002-8842-235X; Siwko, Stefan/0000-0003-4260-2985	National Basic Research Program of China Grant [2012CB910402]; National Natural Science Foundation of China Grant [81330049]; Department of Defense Grant [PC093061]; Cancer Prevention and Research Institute of Texas Grant [RP160235]; NCI, National Institutes of Health Grant [R01CA106479]; Department of Defense [PC424681, PC094495]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER	National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Department of Defense Grant(United States Department of Defense); Cancer Prevention and Research Institute of Texas Grant; NCI, National Institutes of Health Grant; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Basic Research Program of China Grant 2012CB910402, National Natural Science Foundation of China Grant 81330049, Department of Defense Grant PC093061 (to M. L.), Cancer Prevention and Research Institute of Texas Grant RP160235 (subaward to M. L.), and NCI, National Institutes of Health Grant R01CA106479 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Department of Defense predoctoral research award PC424681.; Supported by Department of Defense predoctoral research award PC094495.	Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cervantes-Arias A, 2013, VET COMP ONCOL, V11, P169, DOI 10.1111/j.1476-5829.2011.00313.x; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Drake JM, 2010, J BIOL CHEM, V285, P33940, DOI 10.1074/jbc.M110.136044; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Heeboll S, 2009, APMIS, V117, P196, DOI 10.1111/j.1600-0463.2008.00007.x; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Hurwitz A. A., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.1m2005s45, DOI 10.1002/0471142735.1M2005S45]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin Y, 2013, P NATL ACAD SCI USA, V110, pE2572, DOI 10.1073/pnas.1304318110; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Khamis ZI, 2012, MED RES REV, V32, P1026, DOI 10.1002/med.20232; Lang SH, 2009, J PATHOL, V217, P299, DOI 10.1002/path.2478; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lucarelli G, 2013, J UROLOGY, V190, P2271, DOI 10.1016/j.juro.2013.05.004; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Russell Pamela J, 2003, Methods Mol Med, V81, P21; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Steffen JS, 2012, VIRCHOWS ARCH, V461, P355, DOI 10.1007/s00428-012-1292-1; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Wen YC, 2014, CLIN CHIM ACTA, V431, P169, DOI 10.1016/j.cca.2014.01.036; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Whiteland H, 2013, EXP MOL PATHOL, V95, P220, DOI 10.1016/j.yexmp.2013.07.010; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816; Zhang L, 2016, EXPERT REV GASTROENT, V10, P595, DOI 10.1586/17474124.2016.1140036; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	58	19	20	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15525	15537		10.1074/jbc.M116.771931	http://dx.doi.org/10.1074/jbc.M116.771931			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768769	hybrid, Green Published			2022-12-28	WOS:000410809800031
J	Sinha, I; Kumar, S; Poonia, P; Sawhney, S; Natarajan, K				Sinha, Ishani; Kumar, Shambhu; Poonia, Poonam; Sawhney, Sonal; Natarajan, Krishnamurthy			Functional specialization of two paralogous TAF12 variants by their selective association with SAGA and TFIID transcriptional regulatory complexes.(vol 292,pg 6047,yr 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Kumar, Shambhu] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Kumar, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi 110067, India.		Kumar, Shambhu/O-7598-2017; Kumar, Shambhu/K-1260-2019	Kumar, Shambhu/0000-0003-0567-3346; Kumar, Shambhu/0000-0003-1225-1790				SINHA I, 2017, FUNCTIONAL SPCIALIZA, V292, P6047	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15587	15587		10.1074/jbc.A116.768549	http://dx.doi.org/10.1074/jbc.A116.768549			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28916565	Green Published, hybrid			2022-12-28	WOS:000410809800036
J	Vaamonde-Garcia, C; Courties, A; Pigenet, A; Laiguillon, MC; Sautet, A; Houard, X; Kerdine-Romer, S; Meijide, R; Berenbaum, F; Sellam, J				Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Sautet, Alain; Houard, Xavier; Kerdine-Romer, Saadia; Meijide, Rosa; Berenbaum, Francis; Sellam, Jeremie			The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; ARTICULAR CHONDROCYTES; KNEE OSTEOARTHRITIS; UP-REGULATION; NRF2; CARTILAGE; INDUCTION; ARTHRITIS; PATHWAY	Epidemiological findings support the hypothesis that type 2 diabetes mellitus (T2DM) is a risk factor for osteoarthritis (OA). Moreover, OA cartilage from patients with T2DM exhibits a greater response to inflammatory stress, but the molecular mechanism is unclear. To investigate whether the antioxidant defense system participates in this response, we examined here the expression of nuclear factor-erythroid 2-related factor (Nrf2), a master antioxidant transcription factor, and of heme oxygenase-1 (HO-1), one of its main target genes, in OA cartilage from T2DM and non-T2DM patients as well as in murine chondrocytes exposed to high glucose (HG). Ex vivo experiments indicated that Nrf-2 and HO-1 expression is reduced in T2DM versus non-T2DM OA cartilage (0.57-fold Nrf-2 and 0.34-fold HO-1), and prostaglandin E-2 (PGE(2)) release was increased in samples with low HO-1 expression. HG-exposed, IL-1 beta-stimulated chondrocytes had lower Nrf-2 levels in vitro, particularly in the nuclear fraction, than chondrocytes exposed to normal glucose (NG). Accordingly, HO-1 levels were also decreased (0.49-fold) in these cells. The HO-1 inducer cobalt protoporphyrin IX more efficiently attenuated PGE(2) and IL-6 release in HG+IL-1 beta-treated cells than in NG+IL-1 beta-treated cells. Greater reductions in HO-1 expression and increase in PGE(2)/IL-6 production were observed in HG+IL-1 beta-stimulated chondrocytes from Nrf-2(-/-) mice than in chondrocytes from wild-type mice. We conclude that the Nrf-2/HO-1 axis is a critical pathway in the hyperglucidic-mediated dysregulation of chondrocytes. Impairments in this antioxidant system may explain the greater inflammatory responsiveness of OA cartilage from T2DM patients and may inform treatments of such patients.	[Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Sautet, Alain; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] St Antoine Med Fac, INSERM, UMR S938, F-75012 Paris, France; [Vaamonde-Garcia, Carlos; Courties, Alice; Pigenet, Audrey; Laiguillon, Marie-Charlotte; Houard, Xavier; Berenbaum, Francis; Sellam, Jeremie] St Antoine Hosp, Inflammat Immunopathol Biotherapy Dept DHU i2B, F-75012 Paris, France; [Vaamonde-Garcia, Carlos; Meijide, Rosa] Univ A Coruna, Dept Med, Tissue Engn & Cellular Therapy Grp, La Coruna 15006, Spain; [Courties, Alice; Berenbaum, Francis; Sellam, Jeremie] St Antoine Hosp, AP HP, Dept Rheumatol, F-75012 Paris, France; [Sautet, Alain] St Antoine Hosp, AP HP, Dept Orthoped Surg, F-75012 Paris, France; [Kerdine-Romer, Saadia] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR 996, F-92296 Chatenay Malabry, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade da Coruna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Berenbaum, F (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.; Berenbaum, F (corresponding author), St Antoine Med Fac, INSERM, UMR S938, F-75012 Paris, France.; Berenbaum, F (corresponding author), St Antoine Hosp, Inflammat Immunopathol Biotherapy Dept DHU i2B, F-75012 Paris, France.; Berenbaum, F (corresponding author), St Antoine Hosp, AP HP, Dept Rheumatol, F-75012 Paris, France.	francis.berenbaum@aphp.fr	Berenbaum, Francis/AAO-5690-2020; Meijide-Failde, Rosa/H-3446-2016; Kerdine-Römer, Saadia/AAT-9855-2020; Vaamonde-García, Carlos/AAA-4488-2019	Berenbaum, Francis/0000-0001-8252-7815; Meijide-Failde, Rosa/0000-0001-8516-9419; Vaamonde-Garcia, Carlos/0000-0001-8658-5502; Kerdine-Romer, Saadia/0000-0003-3313-952X	French State Transimmunom Funds [ANR-11-IDEX-0004-02]; Fondation Arthritis Jacques Courtin	French State Transimmunom Funds; Fondation Arthritis Jacques Courtin	This work was supported by the French State Transimmunom Funds managed by the ANR within the Investissements d'Avenir Program (ANR-11-IDEX-0004-02) and Fondation Arthritis Jacques Courtin. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Berenbaum F, 2014, JOINT BONE SPINE, V81, P284, DOI 10.1016/j.jbspin.2014.04.001; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Bitar MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE1119, DOI 10.1152/ajpendo.00047.2011; Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596; Cai DW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0774-3; Chang SH, 2002, J BIOL CHEM, V277, P1933, DOI 10.1074/jbc.M108921200; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Clerigues V, 2013, CLIN SCI, V125, P99, DOI 10.1042/CS20120491; Clerigues V, 2012, BIOCHEM PHARMACOL, V83, P395, DOI 10.1016/j.bcp.2011.11.024; Courties A, 2015, OSTEOARTHR CARTILAGE, V23, P1955, DOI 10.1016/j.joca.2015.05.016; Davidson RK, 2013, ARTHRITIS RHEUM-US, V65, P3130, DOI 10.1002/art.38133; Denzer I, 2016, PHARMACOL RES, V103, P80, DOI 10.1016/j.phrs.2015.11.019; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Guillen MI, 2008, J PATHOL, V214, P515, DOI 10.1002/path.2313; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; HART DJ, 1995, J RHEUMATOL, V22, P1118; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Hui W, 2016, ANN RHEUM DIS, V75, P449, DOI 10.1136/annrheumdis-2014-206295; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kim HA, 2005, ARTHRITIS RES THER, V7, pR526, DOI 10.1186/ar1705; Kim HA, 2012, RHEUMATOLOGY, V51, P1006, DOI 10.1093/rheumatology/ker525; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Laiguillon MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4467; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Li J, 2014, J DIABETES COMPLICAT, V28, P662, DOI 10.1016/j.jdiacomp.2014.06.008; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Mawatari T, 2013, J ORTHOP RES, V31, P1943, DOI 10.1002/jor.22394; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; Mishra M, 2014, FREE RADICAL BIO MED, V75, P129, DOI 10.1016/j.freeradbiomed.2014.07.001; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P874, DOI 10.1002/art.38310; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Nowak WN, 2014, J DIABETES INVEST, V5, P99, DOI 10.1111/jdi.12131; O'Connell MA, 2015, BIOCHEM SOC T, V43, P687, DOI 10.1042/BST20150069; Ochiai S, 2008, J ORTHOP RES, V26, P894, DOI 10.1002/jor.20579; Ozen M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00084; Rousset F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066478; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schneider KS, 2013, ADV NUTR, V4, P62, DOI 10.3945/an.112.003103; Seo HA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/184598; Soares MP, 2015, BIOCHEM SOC T, V43, P663, DOI 10.1042/BST20150054; Takada T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0792-1; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Wang X, 2015, OSTEOARTHR CARTILAGE, V23, P22, DOI 10.1016/j.joca.2014.10.002; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	62	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14505	14515		10.1074/jbc.M117.802157	http://dx.doi.org/10.1074/jbc.M117.802157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684418	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000408747500017
J	Gangula, NR; Maddika, S				Gangula, Narmadha Reddy; Maddika, Subbareddy			Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E3 ubiquitin ligase; kinetochore; mitosis; phosphatase; PHLPP1; RNF41; SGT1	MICROTUBULE INTERFACE; DEGRADATION; GROWTH; AKT; PHOSPHORYLATION; DIMERIZATION; APOPTOSIS; COMPLEX; POLO	Kinetochores link chromosomes to spindle microtubules and are essential for accurate chromosome segregation during cell division. Kinetochores assemble at the centromeric region of chromosomes as a multiprotein complex. However, the molecular mechanisms of kinetochore assembly have not yet been fully elucidated. In this study, we identified pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) as a regulatory phosphatase that facilitates proper kinetochore assembly. We found that PHLPP1 interacted with the essential outer-kinetochore protein SGT1 and stabilized its protein levels. Loss of PHLPP1 from cells led to SGT1 degradation and thereby caused defective kinetochore assembly. We also found that the ring finger protein 41 (RNF41) as an E3 ligase ubiquitinated and degraded SGT1 in a phosphorylation-dependent manner. PHLPP1 dephosphorylated SGT1 at four conserved residues (Ser-17, Ser-249, Ser-289, and Thr-233) and thereby prevented SGT1 from associating with RNF41, in turn, countering SGT1 degradation. Importantly, depletion of RNF41 or expression of a non-phosphorylatable SGT1 mutant rescued the kinetochore defects caused by the loss of PHLPP1. Taken together, our results suggest that PHLPP1 plays an important role in the assembly of kinetochores by counteracting RNF41-mediated SGT1 degradation.	[Gangula, Narmadha Reddy; Maddika, Subbareddy] Ctr DNA Fingerprinting & Diagnost, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Maddika, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India.	msreddy@cdfd.org.in			Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship [IA/S/16/2/502729]; INSPIRE Program of Department of Science and Technology (DST), India; Centre for DNA Fingerprinting and Diagnostics core funds; Department of Biotechnology's Senior IYBA Award [BT/01/IYBA/2009]	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship; INSPIRE Program of Department of Science and Technology (DST), India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics core funds; Department of Biotechnology's Senior IYBA Award	This work was supported in part by Wellcome Trust/Department of Biotechnology (DBT) India Alliance Grant Senior Fellowship IA/S/16/2/502729 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a senior research fellowship from the INSPIRE Program of Department of Science and Technology (DST), India, as well as salary support from Centre for DNA Fingerprinting and Diagnostics core funds. This work was submitted in partial fulfillment of the requirements for a Ph. D. at Manipal University.; Recipient of Department of Biotechnology's Senior IYBA Award BT/01/IYBA/2009. To whom correspondence should be addressed. Tel.: 91-4024749353; Fax: 91-40-24749448; E-mail: msreddy@cdfd.org.in.	Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Gangula NR, 2013, J BIOL CHEM, V288, P34545, DOI 10.1074/jbc.M113.503383; Gao GL, 2013, MOL BIOL REP, V40, P2947, DOI 10.1007/s11033-012-2363-8; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gascoigne KE, 2013, J CELL BIOL, V201, P23, DOI 10.1083/jcb.201301006; Godek KM, 2015, NAT REV MOL CELL BIO, V16, P57, DOI 10.1038/nrm3916; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu XS, 2012, MOL CELL BIOL, V32, P4053, DOI 10.1128/MCB.00516-12; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Nagpal H, 2016, CHROMOSOMA, V125, P645, DOI 10.1007/s00412-016-0608-3; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	26	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13947	13958		10.1074/jbc.M117.782896	http://dx.doi.org/10.1074/jbc.M117.782896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696259	Green Published, hybrid			2022-12-28	WOS:000408439800005
J	Jett, KA; Leary, SC				Jett, Kimberly A.; Leary, Scot C.			Building the Cu-A site of cytochrome c oxidase: A complicated, redox-dependent process driven by a surprisingly large complement of accessory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INNER MEMBRANE-PROTEIN; HUMAN SCO1; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; ASSEMBLY FACTOR; SUBUNIT-II; COPPER-METABOLISM; TERMINAL TAIL; MUTATION; YEAST	Cytochrome c oxidase (COX) was initially purified more than 70 years ago. A tremendous amount of insight into its structure and function has since been gleaned from biochemical, biophysical, genetic, and molecular studies. As a result, we now appreciate that COX relies on its redox-active metal centers (heme a and a(3), Cu-A and Cu-B) to reduce oxygen and pump protons in a reaction essential for most eukaryotic life. Questions persist, however, about how individual structural subunits are assembled into a functional holoenzyme. Here, we focus on what is known and what remains to be learned about the accessory proteins that facilitate Cu-A site maturation.	[Jett, Kimberly A.; Leary, Scot C.] Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,Rm 4D10,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Leary, SC (corresponding author), Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,Rm 4D10,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.leary@usask.ca						Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Bode M, 2015, MOL BIOL CELL, V26, P2385, DOI 10.1091/mbc.E14-11-1526; BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bourens M, 2017, J BIOL CHEM, V292, P7774, DOI 10.1074/jbc.M117.778514; Bourens M, 2017, EMBO REP, V18, P477, DOI 10.15252/embr.201643103; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Cobine PA, 2006, J BIOL CHEM, V281, P12270, DOI 10.1074/jbc.M600496200; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Coenen MJH, 2005, J INHERIT METAB DIS, V28, P1091, DOI 10.1007/s10545-005-4483-y; Dela Cruz R, 2016, MICROB CELL, V3, P275, DOI 10.15698/mic2016.07.511; Doss S, 2014, J NEUROL, V261, P207, DOI 10.1007/s00415-013-7177-7; Elliott LE, 2012, GENETICS, V190, P559, DOI 10.1534/genetics.111.135665; Fiumera HL, 2007, MOL CELL BIOL, V27, P4664, DOI 10.1128/MCB.01955-06; Fiumera HL, 2009, GENETICS, V182, P519, DOI 10.1534/genetics.109.101196; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Ghosh A, 2016, HUM MOL GENET, V25, P660, DOI 10.1093/hmg/ddv503; Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Horvath R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005; Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; Kojer K, 2015, MOL BIOL CELL, V26, P195, DOI 10.1091/mbc.E14-10-1422; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Lorenzi I., 2016, MOL CELL BIOL; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012; Papadopoulou LC, 1999, NAT GENET, V23, P333; Punter FA, 2003, J BIOL CHEM, V278, P30875, DOI 10.1074/jbc.M302358200; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Rigby K, 2008, J BIOL CHEM, V283, P15015, DOI 10.1074/jbc.M710072200; Sacconi S, 2009, J HUM GENET, V54, P419, DOI 10.1038/jhg.2009.36; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Sinkler CA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1534056; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; SPENO H, 1995, J BIOL CHEM, V270, P25363, DOI 10.1074/jbc.270.43.25363; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Timon-Gomez A., 2017, SEMIN CELL DEV BIOL; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Vidoni S, 2017, CELL REP, V18, P1727, DOI 10.1016/j.celrep.2017.01.044; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012	89	26	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4644	4652		10.1074/jbc.R117.816132	http://dx.doi.org/10.1074/jbc.R117.816132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	28972150	hybrid, Green Published			2022-12-28	WOS:000428848300007
J	Zaidi, H; Hoffman, EA; Shetty, SJ; Bekiranov, S; Auble, DT				Zaidi, Hussain; Hoffman, Elizabeth A.; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.			Second-generation method for analysis of chromatin binding with formaldehyde-cross-linking kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); chromatin structure; nucleic acid chemistry; protein cross-linking; protein dynamic; transcription factor; formaldehyde chemistry	RNA-POLYMERASE-II; GENERAL INITIATION-FACTORS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; HUMAN GENOME; AMINO-ACIDS; DNA; PROTEIN; DYNAMICS; IDENTIFICATION	Formaldehyde-cross-linking underpins many of the most commonly used experimental approaches in the chromatin field, especially in capturing site-specific protein-DNA interactions. Extending such assays to assess the stability and binding kinetics of protein-DNA interactions is more challenging, requiring absolute measurements with a relatively high degree of physical precision. We previously described an experimental framework called the cross-linking kinetics (CLK) assay, which uses time-dependent formaldehyde-cross-linking data to extract kinetic parameters of chromatin binding. Many aspects of formaldehyde behavior in cells are unknown or undocumented, however, and could potentially affect CLK data analyses. Here, we report biochemical results that better define the properties of formaldehyde-cross-linking in budding yeast cells. These results have the potential to inform interpretations of standard chromatin assays, including chromatin immunoprecipitation. Moreover, the chemical complexity we uncovered resulted in the development of an improved method for measuring binding kinetics with the CLK approach. Optimum conditions included an increased formaldehyde concentration and more robust glycine-quench conditions. Notably, we observed that formaldehyde-cross-linking rates can vary dramatically for different protein-DNA interactions in vivo. Some interactions were cross-linked much faster than the in vivo macromolecular interactions, making them suitable for kinetic analysis. For other interactions, we found the cross-linking reaction occurred on the same time scale or slower than binding dynamics; for these interactions, it was sometimes possible to compute the in vivo equilibrium-binding constant but not binding on- and off-rates. This improved method yields more accurate in vivo binding kinetics estimates on the minute time scale.	[Zaidi, Hussain] Univ Virginia, Sch Med Res Comp, Charlottesville, VA 22908 USA; [Hoffman, Elizabeth A.; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Bekiranov, S; Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	sb3de@virginia.edu; auble@virginia.edu			National Institutes of Health [R01 GM55763, R21 GM110380]; NCI Cancer Training Grant [T32 CA009109-38]; Wagner Fellowship; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R21GM110380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Training Grant; Wagner Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM55763 (to D. T. A.), Grant R21 GM110380 (to S. B. and D. T. A.), and NCI Cancer Training Grant T32 CA009109-38 and a Wagner Fellowship (to E. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Cramer P, 2014, CELL, V159, P985, DOI 10.1016/j.cell.2014.10.047; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gavrilov A, 2015, BRIEF FUNCT GENOMICS, V14, P163, DOI 10.1093/bfgp/elu037; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Horn AE, 2016, NUCLEIC ACIDS RES, V44, P7132, DOI 10.1093/nar/gkw321; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; Kawashima Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-4; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Luse DS, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27050; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1281, DOI 10.1021/bi00677a029; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Ravarani CNJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10417; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shi SR, 2013, PROTEOM CLIN APPL, V7, P264, DOI 10.1002/prca.201200031; SIKORSKI RS, 1989, GENETICS, V122, P19; SIOMIN YA, 1973, BIOCHIM BIOPHYS ACTA, V331, P27, DOI 10.1016/0005-2787(73)90415-2; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Toth J, 2000, Nucleic Acids Res, V28, pe4, DOI 10.1093/nar/28.2.e4; Viswanathan R, 2014, METHODS, V70, P97, DOI 10.1016/j.ymeth.2014.10.029; Wal M, 2012, METHOD ENZYMOL, V513, P233, DOI 10.1016/B978-0-12-391938-0.00010-0; Wolfram Research Inc, 2016, MATH VERS 10 6; Wu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026217; Zaidi HA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39631; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6	48	6	6	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19338	19355		10.1074/jbc.M117.796441	http://dx.doi.org/10.1074/jbc.M117.796441			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972159	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000416226700016
J	Kim, S; Yang, XK; Li, QJ; Wu, M; Costyn, L; Beharry, Z; Bartlett, MG; Cai, HJ				Kim, Sungjin; Yang, Xiangkun; Li, Qianjin; Wu, Meng; Costyn, Leah; Beharry, Zanna; Bartlett, Michael G.; Cai, Houjian			Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diet; fatty acid; prostate cancer; protein myristoylation; Src	PROTEIN N-MYRISTOYLATION; FAMILY KINASES; CANCER; METABOLISM; ACTIVATION; ACIDS; N-MYRISTOYLTRANSFERASE-1; MYRISTYLATION; MEN	Exogenous fatty acids provide substrates for energy production and biogenesis of the cytoplasmic membrane, but they also enhance cellular signaling during cancer cell proliferation. However, it remains controversial whether dietary fatty acids are correlated with tumor progression. In this study, we demonstrate that increased Src kinase activity is associated with high-fat diet-accelerated progression of prostate tumors and that Src kinases mediate this pathological process. Moreover, in the in vivo prostate regeneration assay, host SCID mice carrying Src(Y529F)-transduced regeneration tissues were fed a low-fat diet or a high-fat diet and treated with vehicle or dasatinib. The high-fat diet not only accelerated Src-induced prostate tumorigenesis in mice but also compromised the inhibitory effect of the anticancer drug dasatinib on Src kinase oncogenic potential in vivo. We further show that myristoylation of Src kinase is essential to facilitate Src-induced and high-fat diet-accelerated tumor progression. Mechanistically, metabolism of exogenous myristic acid increased the biosynthesis of myristoyl CoA and myristoylated Src and promoted Src kinase-mediated oncogenic signaling in human cells. Of the fatty acids tested, only exogenous myristic acid contributed to increased intracellular myristoyl CoA levels. Our results suggest that targeting Src kinase myristoylation, which is required for Src kinase association at the cellular membrane, blocks dietary fat-accelerated tumorigenesis in vivo. Our findings uncover the molecular basis of how the metabolism of myristic acid stimulates high-fat diet-mediated prostate tumor progression.	[Kim, Sungjin; Yang, Xiangkun; Li, Qianjin; Wu, Meng; Costyn, Leah; Bartlett, Michael G.; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA	University System of Georgia; University of Georgia; State University System of Florida; Florida Gulf Coast University	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu	Cai, Houjian/AAJ-1290-2020; Yang, Xiangkun/I-6141-2019; Wu, Meng/N-9345-2014	Wu, Meng/0000-0001-8436-2209; Bartlett, Michael/0000-0003-0626-3234	National Institutes of Health Grant [R01CA172495]; Department of Defense [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA172495 and Department of Defense Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Araujo JC, 2013, LANCET ONCOL, V14, P1307, DOI 10.1016/S1470-2045(13)70479-0; BAGRODIA S, 1993, MOL CELL BIOL, V13, P1464, DOI 10.1128/MCB.13.3.1464; Bullen JW, 2004, AM J PHYSIOL-ENDOC M, V287, pE662, DOI 10.1152/ajpendo.00114.2004; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Crowe FL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju240; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Epstein MM, 2012, AM J EPIDEMIOL, V176, P240, DOI 10.1093/aje/kwr520; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FELSTED RL, 1995, J NATL CANCER I, V87, P1571, DOI 10.1093/jnci/87.21.1571; French KJ, 2004, J PHARMACOL EXP THER, V309, P340, DOI 10.1124/jpet.103.061572; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Higuchi T, 2012, J PHYSIOL SCI, V62, P45, DOI 10.1007/s12576-011-0184-5; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Kovacs M, 2014, J EXP MED, V211, P1993, DOI 10.1084/jem.20132496; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Liu ST, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00416; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mollinedo Faustino, 2015, Adv Biol Regul, V57, P130, DOI 10.1016/j.jbior.2014.10.003; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Strom SS, 2008, INT J CANCER, V122, P2581, DOI 10.1002/ijc.23414; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yang XK, 2017, ANAL CHEM, V89, P813, DOI 10.1021/acs.analchem.6b03623; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	38	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18422	18433		10.1074/jbc.M117.798827	http://dx.doi.org/10.1074/jbc.M117.798827			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939770	Green Published, hybrid			2022-12-28	WOS:000414958100004
J	Ahn, KW; Root, MJ				Ahn, Koree W.; Root, Michael J.			Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL MEMBRANE-FUSION; CCR5 DENSITY LEVELS; CD4 T-CELLS; ENVELOPE GLYCOPROTEIN; SMALL-MOLECULE; IN-VITRO; MONOCLONAL-ANTIBODIES; POTENT INHIBITORS; HELICAL DOMAIN	The homotrimeric HIV-1 envelope glycoprotein (Env) undergoes receptor-triggered structural changes that mediate viral entry through membrane fusion. This process is inhibited by chemokine receptor antagonists (CoRAs) that block Envreceptor interactions and by fusion inhibitors (FIs) that disrupt Env conformational transitions. Synergy between CoRAs and FIs has been attributed to a CoRA-dependent decrease in the rate of viral membrane fusion that extends the lifetime of the intermediate state targeted by FIs. Here, we demonstrated that the magnitude of CoRA/FI synergy unexpectedly depends on FI-binding affinity and the stoichiometry of chemokine receptor binding to trimeric Env. For C-peptide FIs (clinically represented by enfuvirtide), synergy waned as binding strength decreased until inhibitor combinations behaved additively. Curiously, this affinity dependence on synergy was absent for 5-Helix-type FIs. We linked this complex behavior to the CoRA dependence of Env deactivation following FI binding. For both FI classes, reducing chemokine receptor levels on target cells or eliminating competent chemokine receptor-binding sites on Env trimers resulted in a loss of synergistic activity. These data imply that the stoichiometry required for CoRA/FI synergy exceeds that required for HIV-1 entry. Our analysis suggests two distinct roles for chemokine receptor binding, one to trigger formation of the FI-sensitive intermediate state and another to facilitate subsequent conformational transitions. Together, our results could explain the wide variety of previously reported activities for CoRA/FI combinations. These findings also have implications for the combined use of CoRAs and FIs in antiviral therapies and point to a multifaceted role for chemokine receptor binding in promoting HIV-1 entry.	[Ahn, Koree W.; Root, Michael J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University	Root, MJ (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,Rm 802, Philadelphia, PA 19107 USA.	michael.root@jefferson.edu			National Institutes of Health NCI Cancer Center Support Grant [P30 CA056036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066682] Funding Source: NIH RePORTER	National Institutes of Health NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. D. Kabat for cell lines JC.10 and JC.53; Dr. M. Kay for D-peptide PIE12 trimer; Drs. M. Khasnis and K. Halkidis for helpful discussions; Drs. J. Benovic, P. Wedegaertner, C. Scott, and members of the Root laboratory for critical evaluation of the manuscript. Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Shared Resource at Thomas Jefferson University, which is supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA056036.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Biswas P, 2007, EXPERT OPIN PHARMACO, V8, P923, DOI 10.1517/14656566.8.7.923; Bjorndal A, 1997, J VIROL, V71, P7478; Breitinger HG, 2012, TOXICITY AND DRUG TESTING, P143; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gupta RK, 2007, INT J STD AIDS, V18, P630, DOI 10.1258/095646207781568493; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heredia A, 2007, ANTIMICROB AGENTS CH, V51, P2489, DOI 10.1128/AAC.01602-06; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Ji C, 2007, MOL PHARMACOL, V72, P18, DOI 10.1124/mol.107.035055; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Ketas TJ, 2012, VIROLOGY, V422, P22, DOI 10.1016/j.virol.2011.09.019; Khasnis MD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006098; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-55; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Murga JD, 2006, ANTIMICROB AGENTS CH, V50, P3289, DOI 10.1128/AAC.00699-06; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Platt EJ, 2005, J VIROL, V79, P4357, DOI 10.1128/JVI.79.7.4357-4368.2005; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Ray N, 2007, J VIROL, V81, P3240, DOI 10.1128/JVI.02413-06; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Root MJ, 2003, P NATL ACAD SCI USA, V100, P5016, DOI 10.1073/pnas.0936926100; Shaheen F, 2004, CURR OPIN INFECT DIS, V17, P7, DOI 10.1097/00001432-200402000-00003; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tremblay CL, 2002, ANTIMICROB AGENTS CH, V46, P1336, DOI 10.1128/AAC.46.5.1336-1339.2002; Tremblay CL, 2000, J ACQ IMMUN DEF SYND, V25, P99, DOI 10.1097/00126334-200010010-00001; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083	71	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16498	16510		10.1074/jbc.M117.791731	http://dx.doi.org/10.1074/jbc.M117.791731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28696261	Green Published, hybrid			2022-12-28	WOS:000412414800008
J	Barta, ML; Shearer, JP; Arizmendi, O; Tremblay, JM; Mehzabeen, N; Zheng, Q; Battaile, KP; Lovell, S; Tzipori, S; Picking, WD; Shoemaker, CB; Picking, WL				Barta, Michael L.; Shearer, Jonathan P.; Arizmendi, Olivia; Tremblay, Jacqueline M.; Mehzabeen, Nurjahan; Zheng, Qi; Battaile, Kevin P.; Lovell, Scott; Tzipori, Saul; Picking, William D.; Shoemaker, Charles B.; Picking, Wendy L.			Single-domain antibodies pinpoint potential targets within Shigella invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM NEEDLE; PROTEIN SECRETION; IPAD; FLEXNERI; MODEL; NANOBODIES; CHALLENGE; PATHOGENS; APPARATUS; FEATURES	Numerous Gram-negative pathogens infect eukaryotes and use the type III secretion system (T3SS) to deliver effector proteins into host cells. One important T3SS feature is an extracellular needle with an associated tip complex responsible for assembly of a pore-forming translocon in the host cell membrane. Shigella spp. cause shigellosis, also called bacillary dysentery, and invade colonic epithelial cells via the T3SS. The tip complex of Shigella flexneri contains invasion plasmid antigen D (IpaD), which initially regulates secretion and provides a physical platform for the translocon pore. The tip complex represents a promising therapeutic target for many important T3SS-containing pathogens. Here, in an effort to further elucidate its function, we created a panel of single-VH domain antibodies (VHHs) that recognize distinct epitopes within IpaD. These VHHs recognized the in situ tip complex and modulated the infectious properties of Shigella. Moreover, structural elucidation of several IpaD-VHH complexes provided critical insights into tip complex formation and function. Of note, one VHH heterodimer could reduce Shigella hemolytic activity by >80%. Our observations along with previous findings support the hypothesis that the hydrophobic translocator (IpaB in Shigella) likely binds to a region within the tip protein that is structurally conserved across all T3SS-possessing pathogens, suggesting potential therapeutic avenues for managing infections by these pathogens.	[Barta, Michael L.; Arizmendi, Olivia; Zheng, Qi; Picking, William D.; Picking, Wendy L.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA; [Shearer, Jonathan P.; Tremblay, Jacqueline M.; Tzipori, Saul; Shoemaker, Charles B.] Tufts Clin & Translat Sci Inst, Dept Infect Dis & Global Hlth, North Grafton, MA 02111 USA; [Mehzabeen, Nurjahan; Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, IMCA CAT, Argonne, IL 60439 USA	University of Kansas; University of Kansas; Hauptman Woodward Medical Research Institute	Picking, WL (corresponding author), Univ Kansas, 2030 Becker Dr, Lawrence, KS 66047 USA.	wendy.picking@ku.edu		Arizmendi, Olivia/0000-0002-7182-0255; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [P30 GM110761]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the University of Kansas Protein Structure Laboratory was supported by National Institutes of Health P30 GM110761 (NIGMS). Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barta ML, 2012, PROTEINS, V80, P935, DOI 10.1002/prot.23251; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; de Marco A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0320-7; De Tavernier E, 2016, J BIOL CHEM, V291, P15243, DOI 10.1074/jbc.M115.684241; DeLano W.L, PYMOL MOL GRAPHICS S; Dickenson NE, 2013, BIOCHEMISTRY-US, V52, P8790, DOI 10.1021/bi400755f; Dickenson NE, 2011, BIOCHEMISTRY-US, V50, P172, DOI 10.1021/bi101365f; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epler CR, 2012, J MOL BIOL, V420, P29, DOI 10.1016/j.jmb.2012.03.025; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu J, 2009, MICROBES INFECT, V11, P835, DOI 10.1016/j.micinf.2009.04.024; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaur K, 2016, CHEMBIOCHEM, V17, P745, DOI 10.1002/cbic.201500556; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuhn P, 2016, PROTEOM CLIN APPL, V10, P922, DOI 10.1002/prca.201600002; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rossmann FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118405; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Sawa T, 2014, MICROBIOL IMMUNOL, V58, P267, DOI 10.1111/1348-0421.12147; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Vrentas CE, 2016, J BIOL CHEM, V291, P21596, DOI 10.1074/jbc.M116.749184; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	59	10	11	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16677	16687		10.1074/jbc.M117.802231	http://dx.doi.org/10.1074/jbc.M117.802231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28842484	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000412414800027
J	Latham, JA; Barr, I; Klinman, JP				Latham, John A.; Barr, Ian; Klinman, Judith P.			At the confluence of ribosomally synthesized peptide modification and radical S-adenosylmethionine (SAM) enzymology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THIOETHER BOND FORMATION; PYRROLOQUINOLINE QUINONE; POSTTRANSLATIONAL MODIFICATION; CROSS-LINK; STREPTOCOCCUS-THERMOPHILUS; STRUCTURE INFORMATION; 4FE-4S CLUSTERS; ENZYME; BIOSYNTHESIS; PROTEIN	Radical S-adenosylmethionine (RS) enzymology has emerged as a major biochemical strategy for the homolytic cleavage of unactivated C-H bonds. At the same time, the post-translational modification of ribosomally synthesized peptides is a rapidly expanding area of investigation. We discuss the functional cross-section of these two disciplines, highlighting the recently uncovered importance of protein-protein interactions, especially between the peptide substrate and its chaperone, which functions either as a stand-alone protein or as an N-terminal fusion to the respective RS enzyme. The need for further work on this class of enzymes is emphasized, given the poorly understood roles performed by multiple, auxiliary iron-sulfur clusters and the paucity of protein X-ray structural data.	[Latham, John A.] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Barr, Ian; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of Denver; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Klinman, JP (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	klinman@berkeley.edu		Barr, Ian/0000-0003-1805-1415; Latham, John/0000-0002-3034-1768	National Institutes of Health [GM118117-02, GM124002-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118117, R01GM124002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118117-02 (to J. P. K.) and GM124002-01 (to J. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benjdia A., 2016, CHEM; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2017, J BIOL CHEM, V292, P10835, DOI 10.1074/jbc.M117.783464; Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Booker SJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1151, DOI 10.1016/j.bbapap.2012.07.006; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P4131, DOI 10.1021/acs.biochem.6b00598; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Evans RL, 2017, BIOCHEMISTRY-US, V56, P2735, DOI 10.1021/acs.biochem.7b00247; Evans RL, 2016, BIOMOL NMR ASSIGN, V10, P385, DOI 10.1007/s12104-016-9705-8; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Grove TL, 2017, J AM CHEM SOC, V139, P11734, DOI 10.1021/jacs.7b01283; Haft DH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41074; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hover BM, 2015, P NATL ACAD SCI USA, V112, P6347, DOI 10.1073/pnas.1500697112; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khaliullin B, 2017, J BIOL CHEM, V292, P13022, DOI 10.1074/jbc.M117.795682; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; Koehnke J, 2015, NAT CHEM BIOL, V11, P558, DOI 10.1038/nchembio.1841; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Lilla EA, 2016, NAT CHEM BIOL, V12, P905, DOI [10.1038/NCHEMBIO.2187, 10.1038/nchembio.2187]; Maiocco SJ, 2015, J AM CHEM SOC, V137, P8664, DOI 10.1021/jacs.5b03384; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Wecksler SR, 2010, CHEM COMMUN, V46, P7031, DOI 10.1039/c0cc00968g; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032	49	12	14	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16397	16405		10.1074/jbc.R117.797399	http://dx.doi.org/10.1074/jbc.R117.797399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28830931	Green Published, hybrid			2022-12-28	WOS:000412414800001
J	Bu, QX; Li, ZQ; Zhang, JY; Xu, F; Liu, JM; Liu, HL				Bu, Qixin; Li, Zhiqiang; Zhang, Junying; Xu, Fei; Liu, Jianmei; Liu, Heli			The crystal structure of full-length Sizzled from Xenopus laevis yields insights into Wnt-antagonistic function of secreted Frizzled-related proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK REGULATOR; SFRP2; INHIBITION; SYSTEM; GROWTH; BINDS; MECHANISMS; SUFFICIENT; ACTIVATE; PATHWAY	The Wnt-signaling pathway is crucial to cell proliferation, differentiation, and migration. The secreted Frizzled-related proteins (sFRPs) represent the largest family of secreted Wnt inhibitors. However, their function in antagonizing Wnt signaling has remained somewhat controversial. Here, we report the crystal structure of Sizzled from Xenopus laevis, the first full-length structure of an sFRP. Tethered by an inter-domain disulfide bond and a linker, the N-terminal cysteine-rich domain (CRD) and the C-terminal netrin-like domain (NTR) of Sizzled are arranged in a tandem fashion, with the NTR domain occluding the groove of CRD for Wnt accessibility. A Dual-Luciferase assay demonstrated that removing the NTR domain and replacing the CRD groove residues His-116 and His-118 with aromatic residues may significantly enhance antagonistic function of Sizzled in inhibiting Wnt3A signaling. Sizzled is a monomer in solution, and Sizzled CRD exhibited different packing in the crystal, suggesting that sFRPs do not have a conserved CRD dimerization mode. Distinct from the canonical NTR domain, the Sizzled NTR adopts a novel alpha/beta folding with two perpendicular helices facing the central mixed beta-sheet. The subgroup of human sFRP1/2/5 and Sizzled should have a similar NTR domain that features a highly positively charged region, opposite the NTR-CRD interface, suggesting that the NTR domain in human sFRPs, at least sFRP1/2/5, is unlikely to bind to Wnt but is likely involved in biphasic Wnt signaling modulation. In summary, the Sizzled structure provides the first insights into how the CRD and the NTR domains relate to each other for modulating Wnt-antagonistic function of sFRPs.	[Bu, Qixin; Li, Zhiqiang; Zhang, Junying; Xu, Fei; Liu, Jianmei; Liu, Heli] Peking Univ, Hlth Sci Ctr, State Key Lab Nat & Biomimet Drugs, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Bu, Qixin; Li, Zhiqiang; Zhang, Junying; Xu, Fei; Liu, Jianmei; Liu, Heli] Peking Univ, Hlth Sci Ctr, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Zhang, Junying] Rehabil Hosp, Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China	Peking University; Peking University	Liu, HL (corresponding author), Peking Univ, Hlth Sci Ctr, State Key Lab Nat & Biomimet Drugs, 38 Xueyuan Rd, Beijing 100191, Peoples R China.; Liu, HL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	liuheli@hsc.pku.edu.cn			China "Thousand Talents Program"; National Natural Science Foundation of China [81322047, 81673525]	China "Thousand Talents Program"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China "Thousand Talents Program" and National Natural Science Foundation of China Grants 81322047 and 81673525 (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Bijakowski C, 2012, J BIOL CHEM, V287, P33581, DOI 10.1074/jbc.M112.380816; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; Brinkmann EM, 2016, J BIOL CHEM, V291, P13730, DOI 10.1074/jbc.M116.733766; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dennis S, 1999, J CELL SCI, V112, P3815; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Driehuis E, 2017, BRIT J PHARMACOL, V174, P4547, DOI 10.1111/bph.13758; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huet J, 2013, ACTA CRYSTALLOGR D, V69, P2017, DOI 10.1107/S0907444913018015; Janda CY, 2015, BIOCHEM SOC T, V43, P211, DOI 10.1042/BST20140249; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Kwack MH, 2016, EXP DERMATOL, V25, P813, DOI 10.1111/exd.12993; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; Lee CS, 2000, DEVELOPMENT, V127, P109; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Liang WGG, 2016, P NATL ACAD SCI USA, V113, P5000, DOI 10.1073/pnas.1523981113; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Liu Q, 2015, CURR OPIN STRUC BIOL, V34, P99, DOI 10.1016/j.sbi.2015.08.003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Longman D, 2012, ONCOL RES, V20, P1, DOI 10.3727/096504012X13425470196010; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Salic AN, 1997, DEVELOPMENT, V124, P4739; Sarma GN, 2006, ACTA CRYSTALLOGR D, V62, P707, DOI 10.1107/S0907444906014946; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wishart DS, 2001, MOL BIOTECHNOL, V19, P59, DOI 10.1385/MB:19:1:059; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	69	8	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16055	16069		10.1074/jbc.M117.791756	http://dx.doi.org/10.1074/jbc.M117.791756			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28808056	hybrid, Green Published			2022-12-28	WOS:000412109400007
J	Jank, T; Belyi, Y; Wirth, C; Rospert, S; Hu, ZH; Dengjel, J; Tzivelekidis, T; Andersen, GR; Hunte, C; Schlosser, A; Aktories, K				Jank, Thomas; Belyi, Yury; Wirth, Christophe; Rospert, Sabine; Hu, Zehan; Dengjel, Joern; Tzivelekidis, Tina; Andersen, Gregers Rom; Hunte, Carola; Schlosser, Andreas; Aktories, Klaus			Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS ELONGATION-FACTOR-1-ALPHA; STRUCTURAL BASIS; TRANSFER-RNA; NUCLEOTIDE EXCHANGE; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; SHUTTLE VECTORS; TRANSLATION; COMPLEX; EEF1A	Ribosomal translation factors are fundamental for protein synthesis and highly conserved in all kingdoms of life. The essential eukaryotic elongation factor 1A (eEF1A) delivers aminoacyl tRNAs to the A-site of the translating 80S ribosome. Several studies have revealed that eEF1A is posttranslationally modified. Using MS analysis, site-directed mutagenesis, and X-ray structural data analysis of Saccharomyces cerevisiae eEF1A, we identified a posttranslational modification in which the alpha amino group of mono-L-glutamine is covalently linked to the side chain of glutamate 45 in eEF1A. The MS analysis suggested that all eEF1A molecules are modified by this glutaminylation and that this posttranslational modification occurs at all stages of yeast growth. The mutational studies revealed that this glutaminylation is not essential for the normal functions of eEF1A in S. cerevisiae. However, eEF1A glutaminylation slightly reduced growth under antibiotic-induced translational stress conditions. Moreover, we identified the same posttranslational modification in eEF1A from Schizosaccharomyces pombe but not in various other eukaryotic organisms tested despite strict conservation of the Glu(45) residue among these organisms. We therefore conclude that eEF1A glutaminylation is a yeast-specific posttranslational modification that appears to influence protein translation.	[Jank, Thomas; Tzivelekidis, Tina; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Fac Med, D-79104 Freiburg, Germany; [Belyi, Yury] Gamaleya Res Ctr, Moscow 123098, Russia; [Belyi, Yury] Bioclinicum, Moscow 123098, Russia; [Wirth, Christophe; Rospert, Sabine; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Fac Med, D-79104 Freiburg, Germany; [Rospert, Sabine; Hunte, Carola; Aktories, Klaus] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Freiburg, Dept Dermatol, Fac Med, D-79106 Freiburg, Germany; [Hu, Zehan; Dengjel, Joern; Aktories, Klaus] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79104 Freiburg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Andersen, Gregers Rom] Aarhus Univ, Dept Mol Biol & Genet, Ctr Struct Biol, DK-8000 Aarhus, Denmark; [Schlosser, Andreas] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Tzivelekidis, Tina] Roche Diagnost GmbH, D-68305 Mannheim, Germany	University of Freiburg; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Fribourg; Aarhus University; University of Wurzburg; Roche Holding	Jank, T; Aktories, K (corresponding author), Albert Ludwigs Univ Freiburg, Med Fak, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	thomas.jank@pharmakol.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Jank, Thomas/R-9627-2017; Hu, Zehan/AAZ-8321-2021; Aktories, Klaus/CAJ-5682-2022; Hunte, Carola/E-4071-2015; Dengjel, Joern/AAI-3682-2020	Aktories, Klaus/0000-0002-5397-0436; Hunte, Carola/0000-0002-0826-3986; Wirth, Christophe/0000-0001-8864-6508; Hu, Zehan/0000-0001-6182-4781; Andersen, Gregers Rom/0000-0001-6292-3319; Dengjel, Joern/0000-0002-9453-4614; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft Collaborative Research Center [746]; Deutsche Forschungsgemeinschaft [AK6/22-1]; Excellence Initiative of the German Federal and State Governments BIOSS [294]	Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments BIOSS	This work was supported by the Deutsche Forschungsgemeinschaft Collaborative Research Center 746 (to T. J., K. A., S. R., and C. H.), Deutsche Forschungsgemeinschaft AK6/22-1 (to K. A.), and the Excellence Initiative of the German Federal and State Governments (cluster of excellence 294) BIOSS (to K. A. and C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2012, J BIOL CHEM, V287, P26029, DOI 10.1074/jbc.M112.372672; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crepin T, 2014, NUCLEIC ACIDS RES, V42, P12939, DOI 10.1093/nar/gku974; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh R. A., 2001, INT TABLES CRYSTALLO, VF, P382; Freist W, 1997, BIOL CHEM, V378, P1103; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P9319, DOI 10.1093/nar/gks660; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mittal N, 2013, MOL BIOCHEM PARASIT, V187, P21, DOI 10.1016/j.molbiopara.2012.11.001; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Pedersen L, 2001, ACTA CRYSTALLOGR D, V57, P159, DOI 10.1107/S0907444900015559; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Traugh J A, 2001, Prog Mol Subcell Biol, V26, P33; Tzivelekidis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029525; Vitagliano L, 2004, BIOCHEMISTRY-US, V43, P6630, DOI 10.1021/bi0363331; Vitagliano L, 2001, EMBO J, V20, P5305, DOI 10.1093/emboj/20.19.5305; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16014	16023		10.1074/jbc.M117.801035	http://dx.doi.org/10.1074/jbc.M117.801035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28801462	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000412109400003
J	Matsumura, R; Akashi, M				Matsumura, Ritsuko; Akashi, Makoto			Multiple circadian transcriptional elements cooperatively regulate cell-autonomous transcriptional oscillation of Period3, a mammalian clock gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOCK-BMAL1; EXPRESSION; BINDING; MPER3; TIME; MOP3; SCN; WEB	Cell-autonomous oscillation in clock gene expression drives circadian rhythms. The development of comprehensive analytical techniques, such as bioinformatics and ChIP-sequencing, has enabled the genome-wide identification of potential circadian transcriptional elements that regulate the transcriptional oscillation of clock genes. However, detailed analyses using traditional biochemical and molecular-biological approaches, such as binding and reporter assays, are still necessary to determine whether these potential circadian transcriptional elements are actually functional and how significantly they contribute to driving transcriptional oscillation. Here, we focused on the molecular mechanism of transcriptional oscillations in the mammalian clock gene Period3 (Per3). The PER3 protein is essential for robust peripheral clocks and is a key component in circadian output processes. We found three E box-like elements located upstream of human Per3 transcription start sites that additively contributed to cell-autonomous transcriptional oscillation. However, we also found that Per3 is still expressed in a circadian manner when all three E box-like elements are functionally impaired. We noted that Per3 transcription was activated by the synergistic actions of two D box-like elements and the three E box-like elements, leading to a drastic increase in circadian amplitude. Interestingly, circadian expression of Per3 was completely disrupted only when all five transcriptional elements were functionally impaired. These results indicate that three E box-like and two D box-like elements cooperatively and redundantly regulate cell-autonomous transcriptional oscillation of Per3.	[Matsumura, Ritsuko; Akashi, Makoto] Yamaguchi Univ, Res Inst Time Studies, 1677-1 Yoshida, Yamaguchi 7538511, Japan	Yamaguchi University	Akashi, M (corresponding author), Yamaguchi Univ, Res Inst Time Studies, 1677-1 Yoshida, Yamaguchi 7538511, Japan.	akashima@yamaguchi-u.ac.jp	Matsumura, Ritsuko/AAS-7122-2020		KAKENHI; Grants-in-Aid for Scientific Research [15J40101] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (KAKENHI). The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2014, CELL REP, V7, P1056, DOI 10.1016/j.celrep.2014.03.072; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chiou YY, 2016, P NATL ACAD SCI USA, V113, pE6072, DOI 10.1073/pnas.1612917113; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Matsumura R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04032; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rosbash M, 1998, CELL, V93, P917, DOI 10.1016/S0092-8674(00)81197-6; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tokuda IT, 2017, MOL BIOL CELL, V28, P2333, DOI 10.1091/mbc.E17-02-0129; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhang LY, 2016, P NATL ACAD SCI USA, V113, pE1536, DOI 10.1073/pnas.1600039113; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16081	16092		10.1074/jbc.M117.806836	http://dx.doi.org/10.1074/jbc.M117.806836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821614	Green Published, hybrid			2022-12-28	WOS:000412109400009
J	Niehaus, TD; Elbadawi-Sidhu, M; de Crecy-Lagard, V; Fiehn, O; Hanson, AD				Niehaus, Thomas D.; Elbadawi-Sidhu, Mona; de Crecy-Lagard, Valerie; Fiehn, Oliver; Hanson, Andrew D.			Discovery of a widespread prokaryotic 5-oxoprolinase that was hiding in plain sight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL CYCLE; ALCALIGENES-FAECALIS N-38A; ATP-HYDROLYZING ACTIVITY; COMPLETE GENOME SEQUENCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; AMINO-ACIDS; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ALLOPHANATE HYDROLASE	5-Oxoproline (OP) is well-known as an enzymatic intermediate in the eukaryotic gamma-glutamyl cycle, but it is also an unavoidable damage product formed spontaneously from glutamine and other sources. Eukaryotes metabolize OP via an ATP-dependent 5-oxoprolinase; most prokaryotes lack homologs of this enzyme (and the gamma-glutamyl cycle) but are predicted to have some way to dispose of OP if its spontaneous formation in vivo is significant. Comparative analysis of prokaryotic genomes showed that the gene encoding pyroglutamyl peptidase, which removes N-terminal OP residues, clusters in diverse genomes with genes specifying homologs of a fungal lactamase (renamed prokaryotic 5-oxoprolinase A, pxpA) and homologs of allophanate hydrolase subunits (renamed pxpB and pxpC). Inactivation of Bacillus subtilis pxpA, pxpB, or pxpC genes slowed growth, caused OP accumulation in cells and medium, and prevented use of OP as a nitrogen source. Assays of cell lysates showed that ATP-dependent 5-oxoprolinase activity disappeared when pxpA, pxpB, or pxpC was inactivated. 5-Oxoprolinase activity could be reconstituted in vitro by mixing recombinant B. subtilis PxpA, PxpB, and PxpC proteins. In addition, overexpressing Escherichia coli pxpABC genes in E. coli increased 5-oxoprolinase activity in lysates >= 1700-fold. This work shows that OP is a major universal metabolite damage product and that OP disposal systems are common in all domains of life. Furthermore, it illustrates how easily metabolite damage and damage-control systems can be overlooked, even for central metabolites in model organisms.	[Niehaus, Thomas D.; Hanson, Andrew D.] Univ Florida, Hort Sci Dept, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA; [Elbadawi-Sidhu, Mona; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [de Crecy-Lagard, Valerie] Univ Florida, Microbiol & Cell Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of California System; University of California Davis; State University System of Florida; University of Florida	Niehaus, TD; Hanson, AD (corresponding author), Univ Florida, Hort Sci Dept, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA.	tomniehaus@ufl.edu; adha@ufl.edu	de Crecy-Lagard, Valerie/AAN-8995-2020	Niehaus, Thomas/0000-0002-3575-8001	National Science Foundation [MCB-1153413]; C. V. Griffin, Sr. Foundation; Direct For Biological Sciences [1611711] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1611846] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); C. V. Griffin, Sr. Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant number MCB-1153413 and by an endowment from the C. V. Griffin, Sr. Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	AWADE A, 1992, FEBS LETT, V305, P67, DOI 10.1016/0014-5793(92)80656-2; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrillo DR, 2010, BIOL CHEM, V391, P1419, DOI 10.1515/BC.2010.130; Golubev A G, 1996, Biokhimiia, V61, P2018; Golubev A, 2017, J BIOL CHEM, V292, P6029, DOI 10.1074/jbc.R116.751164; Gray MW, 2017, MOL BIOL CELL, V28, P1285, DOI 10.1091/mbc.E16-07-0509; GRIFFITH OW, 1978, P NATL ACAD SCI USA, V75, P5405, DOI 10.1073/pnas.75.11.5405; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Harwood C. R., 1990, MOL BIOL METHODS BAC, P27; Jacques DA, 2011, ACTA CRYSTALLOGR D, V67, P105, DOI 10.1107/S0907444910051127; Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Juttukonda LJ, 2016, MBIO, V7, DOI 10.1128/mBio.01475-16; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Kumar A, 2010, FEMS YEAST RES, V10, P394, DOI 10.1111/j.1567-1364.2010.00619.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; LI LY, 1988, J BIOL CHEM, V263, P6495; Lin Y, 2016, PROTEIN SCI, V25, P1812, DOI 10.1002/pro.2990; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MAZELIS M, 1978, PLANT PHYSIOL, V62, P798, DOI 10.1104/pp.62.5.798; MEISTER A, 1973, SCIENCE, V180, P33, DOI 10.1126/science.180.4081.33; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Nishimura A, 1999, APPL ENVIRON MICROB, V65, P712; Nishimura A, 2000, APPL ENVIRON MICROB, V66, P3201, DOI 10.1128/AEM.66.8.3201-3205.2000; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Ouzounis CA, 2006, RES MICROBIOL, V157, P57, DOI 10.1016/j.resmic.2005.06.015; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park CB, 2001, APPL ENVIRON MICROB, V67, P3650, DOI 10.1128/AEM.67.8.3650-3654.2001; Paulose B, 2013, PLANT CELL, V25, P4580, DOI 10.1105/tpc.113.111815; Pederzolli CD, 2007, METAB BRAIN DIS, V22, P51, DOI 10.1007/s11011-006-9041-2; PEDROTTI EL, 1994, SCI HORTIC-AMSTERDAM, V57, P89, DOI 10.1016/0304-4238(94)90037-X; Peracchi A, 2017, P NATL ACAD SCI USA, V114, pE3233, DOI 10.1073/pnas.1613736114; Ristoff E, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-16; Sass JO, 2016, MOL GENET METAB, V119, P44, DOI 10.1016/j.ymgme.2016.07.008; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; SEDDON AP, 1984, J BIOL CHEM, V259, P8091; SEDDON AP, 1986, J BIOL CHEM, V261, P1538; Silva AR, 2001, NEUROCHEM RES, V26, P1277, DOI 10.1023/A:1014289232039; TRITSCH GL, 1962, EXP CELL RES, V28, P360, DOI 10.1016/0014-4827(62)90290-2; VANDERWERF P, 1971, P NATL ACAD SCI USA, V68, P2982; VANDERWERF P, 1974, BIOCHEM BIOPH RES CO, V56, P90, DOI 10.1016/S0006-291X(74)80319-0; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; Yu ACS, 2014, APPL MICROBIOL BIOT, V98, P855, DOI 10.1007/s00253-013-5377-9; Zhang Y, 2011, FEMS MICROBIOL LETT, V317, P75, DOI 10.1111/j.1574-6968.2011.02213.x	51	26	32	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16360	16367		10.1074/jbc.M117.805028	http://dx.doi.org/10.1074/jbc.M117.805028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28830929	hybrid, Green Published			2022-12-28	WOS:000412109400033
J	Gebre, ST; Cameron, SA; Li, L; Babu, YS; Schramm, VL				Gebre, Sara T.; Cameron, Scott A.; Li, Lei; Babu, Y. S.; Schramm, Vern L.			Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDENCE TIME; IMMUCILLIN-H; CONFORMATIONAL DYNAMICS; BINDING	Purine nucleoside phosphorylase (PNP) is part of the human purine salvage pathway. Its deficiency triggers apoptosis of activated T-cells, making it a target for T-cell proliferative disorders. Transition-state analogues of PNP bind with picomolar (pM) dissociation constants. Tight-binding PNP inhibitors show exceptionally long lifetimes on the target enzyme. We solve the mechanism of the target residence time by comparing functional off-rates in vitro and in vivo. We report in vitro PNPinhibitor dissociation rates (t(1/2)) from 3 to 31 min for seven Immucillins with dissociation constants of 115 to 6 pM. Treatment of human erythrocytes with DADMe-Immucillin-H (DADMe-ImmH, 22 pM) causes complete inhibition of PNP. Loss of [C-14] DADMe-ImmH from erythrocytes during multiple washes is slow and biphasic, resulting from inhibitor release and rebinding toPNPcatalytic sites. The slow phase gave a t(1/2) of 84 h. Loss of [C-14] DADMe-ImmH from erythrocytes in the presence of excess unlabeled DADMe-ImmH increased to a t(1/2) of 1.6 h by preventing rebinding. Thus, in human erythrocytes, rebinding of DADMe-ImmH is 50-fold more likely than diffusional loss of the inhibitor from the erythrocyte. Humans treated with a single oral dose of DADMe-ImmH in phase 1 clinical trials exhibit regain of PNP activity with a t(1/2) of 59 days, corresponding to the erythropoiesis rate in humans. Thus, the PNP catalytic site recapture of DADMe-ImmH is highly favored in vivo. We conclude that transition-state analogues with picomolar dissociation constants exhibit long lifetimes on their targets in vivo because the probability of the target enzyme recapturing inhibitor molecules is greater than diffusional loss to the extracellular space.	[Gebre, Sara T.; Cameron, Scott A.; Li, Lei; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Babu, Y. S.] BioCryst Pharmaceut Inc, Birmingham, AL 35244 USA; [Cameron, Scott A.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt 5010, New Zealand; [Li, Lei] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Victoria University Wellington; Harvard University; Brigham & Women's Hospital	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu		Cameron, Scott/0000-0003-2669-8622	National Institutes of Health [R01 GM041916]; PREP (Postbaccalaureate Research Education Program) [R25 GM104547]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM104547, R01GM041916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PREP (Postbaccalaureate Research Education Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM041916 and PREP (Postbaccalaureate Research Education Program) Grant R25 GM104547. The Albert Einstein College of Medicine and Victoria University of Wellington own patents for the Immucillins as purine nucleoside phosphorylase inhibitors. BioCryst Pharmaceuticals is a licensee of these patents and distributes license fees and royalties to the licensors.	Bantia S, 2001, INT IMMUNOPHARMACOL, V1, P1199, DOI 10.1016/S1567-5769(01)00056-X; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cramer J, 2017, ACS CHEM BIOL, V12, P225, DOI 10.1021/acschembio.6b00979; Edwards AA, 2010, BIOCHEMISTRY-US, V49, P2058, DOI 10.1021/bi902041j; Edwards AA, 2009, BIOCHEMISTRY-US, V48, P5226, DOI 10.1021/bi9005896; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Evans GB, 2001, J ORG CHEM, V66, P5723, DOI 10.1021/jo0155613; Firestone RS, 2017, ACS CHEM BIOL, V12, P464, DOI 10.1021/acschembio.6b00885; Hirschi JS, 2010, J PHYS CHEM B, V114, P16263, DOI 10.1021/jp108056s; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; Hothersall JD, 2016, DRUG DISCOV TODAY, V21, P90, DOI 10.1016/j.drudis.2015.07.015; Huang M, 2008, LEUKEMIA RES, V32, P1268, DOI 10.1016/j.leukres.2007.12.015; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURKIN AS, 2010, DRUG DESIGN STRUCTUR, P215; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Sattui SE, 2016, THER ADV MUSCULOSKEL, V8, P145, DOI 10.1177/1759720X16646703; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Spagnuolo LA, 2017, J AM CHEM SOC, V139, P3417, DOI 10.1021/jacs.6b11148; Taylor EA, 2007, J AM CHEM SOC, V129, P6984, DOI 10.1021/ja071087s; Vauquelin G, 2015, EXPERT OPIN DRUG DIS, V10, P1085, DOI 10.1517/17460441.2015.1067196	29	13	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15907	15915		10.1074/jbc.M117.801779	http://dx.doi.org/10.1074/jbc.M117.801779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794158	hybrid, Green Published			2022-12-28	WOS:000411512200027
J	Takeuchi, H; Yu, HJ; Hao, HL; Takeuchi, M; Ito, A; Li, HL; Haltiwanger, RS				Takeuchi, Hideyuki; Yu, Hongjun; Hao, Huilin; Takeuchi, Megumi; Ito, Atsuko; Li, Huilin; Haltiwanger, Robert S.			O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; DOWLING-DEGOS DISEASE; LIGAND-BINDING REGION; PROTEIN O-FUCOSYL-TRANSFERASE-1; DROSOPHILA NOTCH; QUALITY-CONTROL; MODIFIES NOTCH; LINKED FUCOSE; MOUSE NOTCH1; EGF MODULES	Glycosylation in the endoplasmic reticulum (ER) is closely associated with protein folding and quality control. We recently described a non-canonical ER quality control mechanism for folding of thrombospondin type 1 repeats by protein O-fucosyl-transferase 2 (POFUT2). Epidermal growth factor-like (EGF) repeats are also small cysteine-rich protein motifs that can be O-glycosylated by several ER-localized enzymes, including protein O-glucosyltransferase 1 (POGLUT1) and POFUT1. Both POGLUT1 and POFUT1 modify the Notch receptor on multiple EGF repeats and are essential for full Notch function. The fact that POGLUT1 and POFUT1 can distinguish between folded and unfolded EGF repeats raised the possibility that they participate in a quality control pathway for folding of EGF repeats in proteins such as Notch. Here, we demonstrate that cell-surface expression of endogenous Notch1 in HEK293T cells is dependent on the presence of POGLUT1 and POFUT1 in an additive manner. In vitro unfolding assays reveal that addition of O-glucose or O-fucose stabilizes a single EGF repeat and that addition of both O-glucose and O-fucose enhances stability in an additive manner. Finally, we solved the crystal structure of a single EGF repeat covalently modified by a full O-glucose trisaccharide at 2.2 angstrom resolution. The structure reveals that the glycan fills up a surface groove of the EGF with multiple contacts with the protein, providing a chemical basis for the stabilizing effects of the glycans. Taken together, this work suggests that O-fucose and O-glucose glycans cooperatively stabilize individual EGF repeats through intramolecular interactions, thereby regulating Notch trafficking in cells.	[Takeuchi, Hideyuki; Hao, Huilin; Takeuchi, Megumi; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Yu, Hongjun; Li, Huilin] Van Andel Res Inst, CryoEM Struct Biol Lab, Grand Rapids, MI 49503 USA; [Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Takeuchi, Hideyuki] Nagoya Univ, Sch Med, Dept Mol Biochem, Nagoya, Aichi 4668550, Japan	University System of Georgia; University of Georgia; Van Andel Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nagoya University	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhalti@uga.edu	Takeuchi, Hideyuki/AAZ-9210-2020	Yu, Hongjun/0000-0002-1483-2962; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [GM061126, AG029979]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants GM061126 (to R.S.H.) and AG029979 (to H.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams JC, 2000, DEV DYNAM, V218, P280; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berger RP, 2016, STEM CELLS, V34, P1742, DOI 10.1002/stem.2379; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Haltom AR, 2015, GLYCOBIOLOGY, V25, P1027, DOI 10.1093/glycob/cwv052; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Harvey BM, 2016, J BIOL CHEM, V291, P16348, DOI 10.1074/jbc.M116.732537; Hayakawa S, 2016, BIOCHEMISTRY-US, V55, P776, DOI 10.1021/acs.biochem.5b01284; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Lee TV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006723; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Li M, 2013, AM J HUM GENET, V92, P895, DOI 10.1016/j.ajhg.2013.04.022; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Matsumoto K, 2016, J BIOL CHEM, V291, P13743, DOI 10.1074/jbc.M115.710483; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yu HJ, 2016, NAT CHEM BIOL, V12, P735, DOI 10.1038/nchembio.2135	50	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15964	15973		10.1074/jbc.M117.800102	http://dx.doi.org/10.1074/jbc.M117.800102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28729422	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000411512200032
J	Pontarollo, G; Acquasaliente, L; Peterle, D; Frasson, R; Artusi, I; De Filippis, V				Pontarollo, Giulia; Acquasaliente, Laura; Peterle, Daniele; Frasson, Roberta; Artusi, Ilaria; De Filippis, Vincenzo			Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREEXISTING CONFORMATIONAL EQUILIBRIUM; NONCODED AMINO-ACIDS; STRUCTURAL BASIS; BINDING PROTEIN; ALPHA-THROMBIN; ACTIVE-SITE; MECHANISM; ZYMOGEN; METALLOPROTEASE; SPECIFICITY	Blood coagulation is a finely regulated physiological process culminating with the factor Xa (FXa)-mediated conversion of the prothrombin (ProT) zymogen to active alpha-thrombin (alpha T). In the prothrombinase complex on the platelet surface, FXa cleaves ProT at Arg-271, generating the inactive precursor prethrombin- 2 (Pre2), which is further attacked at Arg-320-Ile-321 to yield mature alpha T. Whereas the mechanism of physiological ProT activation has been elucidated in great detail, little is known about the role of bacterial proteases, possibly released in the bloodstream during infection, in inducing blood coagulation by direct proteolytic ProT activation. This knowledge gap is particularly concerning, as bacterial infections are frequently complicated by severe coagulopathies. Here, we show that addition of subtilisin (50 nM to 2 mu M), a serine protease secreted by the non-pathogenic bacterium Bacillus subtilis, induces plasma clotting by proteolytically converting ProT into active sigma Pre2, a nicked Pre2 derivative with a single cleaved Ala-470-Asn-471 bond. Notably, we found that this non-canonical cleavage at Ala-470-Asn-471 is instrumental for the onset of catalysis in sigma Pre2, which was, however, reduced about 100-200-fold compared with alpha T. Of note, sigma Pre2 could generate fibrin clots from fibrinogen, either in solution or in blood plasma, and could aggregate human platelets, either isolated or in whole blood. Our findings demonstrate that alternative cleavage of ProT by proteases, even by those secreted by non-virulent bacteria such as B. subtilis, can shift the delicate procoagulant-anticoagulant equilibrium toward thrombosis.	[Pontarollo, Giulia; Acquasaliente, Laura; Peterle, Daniele; Frasson, Roberta; Artusi, Ilaria; De Filippis, Vincenzo] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy	University of Padua	De Filippis, V (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.	vincenzo.defilippis@unipd.it	Acquasaliente, Laura/AAE-2793-2021	Acquasaliente, Laura/0000-0001-6495-0871; Peterle, Daniele/0000-0002-9960-1054; Artusi, Ilaria/0000-0002-8827-449X	Grant PRAT from the University of Padua	Grant PRAT from the University of Padua	This work was supported in part by Grant PRAT-2015 from the University of Padua (to V. D. F.). Part of this work will be presented at ISTH-2017 conference, July 8-13, 2017, Berlin, Germany. Communication. OC 42.5. The authors declare that they have no conflicts of interest with the contents of this article.	Acquasaliente L, 2016, BIOCHEM J, V473, P4629, DOI 10.1042/BCJ20160603; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arcone R, 2009, BBA-PROTEINS PROTEOM, V1794, P602, DOI 10.1016/j.bbapap.2008.12.006; BODE W, 1992, PROTEIN SCI, V1, P426; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Chang AK, 2005, J BACTERIOL, V187, P6909, DOI 10.1128/JB.187.20.6909-6916.2005; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; De Cristofaro R, 2003, BIOCHEM J, V373, P593, DOI 10.1042/BJ20030167; De Filippis V, 1999, PROTEIN SCI, V8, P2213; De Filippis V, 2005, BIOCHEM J, V390, P485, DOI 10.1042/BJ20050252; De Filippis V, 2002, BIOCHEMISTRY-US, V41, P13556, DOI 10.1021/bi0203482; De Filippis V, 1998, BIOCHEMISTRY-US, V37, P13507, DOI 10.1021/bi980717n; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Imamura T, 2001, J BIOL CHEM, V276, P18984, DOI 10.1074/jbc.M006760200; Jiang LG, 2013, BIOCHEM J, V449, P161, DOI 10.1042/BJ20121132; KETTNER C, 1981, METHOD ENZYMOL, V80, P826; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Komiyama T, 1996, PROTEIN SCI, V5, P874; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lechtenberg BC, 2014, J MOL BIOL, V426, P881, DOI 10.1016/j.jmb.2013.11.027; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Li W, 2010, J BIOL CHEM, V285, P38621, DOI 10.1074/jbc.M110.144964; Liu CL, 2007, BIOCHEM BIOPH RES CO, V358, P356, DOI 10.1016/j.bbrc.2007.04.133; Loeb L, 1904, J MED RES, V10, P407; Loof TG, 2015, MICROBIOL-SGM, V161, P621, DOI 10.1099/mic.0.000019; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; MANN KG, 1992, SEMIN HEMATOL, V29, P213; Menkin V, 1938, PHYSIOL REV, V18, P366, DOI 10.1152/physrev.1938.18.3.366; MORITA T, 1981, METHOD ENZYMOL, V80, P303; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NG AS, 1993, METHOD ENZYMOL, V222, P341; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Oggioni MR, 1998, J CLIN MICROBIOL, V36, P325, DOI 10.1128/JCM.36.1.325-326.1998; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; ORTHNER CL, 1993, THROMB HAEMOSTASIS, V69, P441; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Pozzi N, 2013, J THROMB HAEMOST, V11, P1093, DOI 10.1111/jth.12238; Pozzi N, 2016, J BIOL CHEM, V291, P18107, DOI 10.1074/jbc.M116.738310; Pozzi N, 2016, BIOCHEMISTRY-US, V55, P3984, DOI 10.1021/acs.biochem.6b00385; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Roberts HR, 2006, SEMIN THROMB HEMOST, V32, P32, DOI 10.1055/s-2006-939552; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Siezen RJ, 2007, PROTEINS, V67, P681, DOI 10.1002/prot.21290; SMITH EL, 1968, J BIOL CHEM, V243, P2184; Sokolov AV, 2015, FREE RADICAL BIO MED, V86, P279, DOI 10.1016/j.freeradbiomed.2015.05.016; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Valotteau C, 2017, ACS NANO, V11, P2160, DOI 10.1021/acsnano.6b08404; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALKER B, 1985, BIOCHEM J, V230, P645, DOI 10.1042/bj2300645; WEGRZYNOWICZ Z, 1980, J CLIN MICROBIOL, V12, P138, DOI 10.1128/JCM.12.2.138-139.1980; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Whelihan MF, 2012, BLOOD, V120, P3837, DOI 10.1182/blood-2012-05-427856	76	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15161	15179		10.1074/jbc.M117.795245	http://dx.doi.org/10.1074/jbc.M117.795245			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28684417	hybrid, Green Published			2022-12-28	WOS:000410809800001
J	Roy, D; Farabaugh, KT; Wu, J; Charrier, A; Smas, C; Hatzoglou, M; Thirumurugan, K; Buchner, DA				Roy, Debasish; Farabaugh, Kenneth T.; Wu, Jing; Charrier, Alyssa; Smas, Cynthia; Hatzoglou, Maria; Thirumurugan, Kavitha; Buchner, David A.			Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor gamma (PPAR gamma) during adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; LEUCINE-ZIPPER; GENOME-WIDE; TNF-ALPHA; LIPOLYSIS; CELLS; BINDING; OBESITY	The breakdown of stored fat deposits into its components is a highly regulated process that maintains plasma levels of free fatty acids to supply energy to cells. Insulin-mediated transcription of Atgl, the enzyme that mediates the rate-limiting step in lipolysis, is a key point of this regulation. Under conditions such as obesity or insulin resistance, Atgl transcription is often misregulated, which can contribute to overall disease progression. The mechanisms by which Atgl is induced during adipogenesis are not fully understood. Weutilized computational approaches to identify putative transcriptional regulatory elements in Atgl and then tested the effect of these elements and the transcription factors that bind to them in cultured preadipocytes and mature adipocytes. Here we report that Atgl is down-regulated by the basal transcription factor Sp1 in preadipocytes and that the magnitude of down-regulation depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPAR gamma). In mature adipocytes, when PPAR gamma is abundant, PPAR gamma abrogated transcriptional repression by Sp1 at the Atgl promoter and up-regulated Atgl mRNA expression. Targeting the PPAR gamma Sp1 interaction could be a potential therapeutic strategy to restore insulin sensitivity by modulating Atgl levels in adipocytes.	[Roy, Debasish; Thirumurugan, Kavitha] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Farabaugh, Kenneth T.; Wu, Jing; Charrier, Alyssa; Hatzoglou, Maria; Buchner, David A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Smas, Cynthia] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43614 USA	Vellore Institute of Technology; Case Western Reserve University; University System of Ohio; University of Toledo	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, 2109 Adelbert Rd, Cleveland, OH 44106 USA.; Thirumurugan, K (corresponding author), VIT Univ, Ctr Biomed Res, Sch Biosci & Technol, 213B, Vellore 632014, Tamil Nadu, India.	mxh8@case.edu; m.kavitha@vit.ac.in		Thirumurugan, Kavitha/0000-0002-4673-4099; Buchner, David/0000-0003-3920-4871; Roy, Debasish/0000-0001-7516-8615	National Institutes of Health [R01DK53307, R37DK060596, R03DK099533]; American Diabetes Association; United StatesIndia Educational Foundation; Fulbright Commission; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099533, R37DK060596, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); United StatesIndia Educational Foundation; Fulbright Commission; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK53307 and R37DK060596 (to M. H.) and R03DK099533 (to D. B.), an American Diabetes Association postdoctoral fellowship (to A. C.), and the United StatesIndia Educational Foundation and the Fulbright Commission (Fulbright-Nehru Doctoral Research fellowship) (to D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; BURNS TW, 1968, J LAB CLIN MED, V72, P813; BURNS TW, 1979, DIABETES, V28, P957, DOI 10.2337/diabetes.28.11.957; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Canaff L, 2008, J BIOL CHEM, V283, P13586, DOI 10.1074/jbc.M708087200; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; FAIN JN, 1966, ENDOCRINOLOGY, V78, P773, DOI 10.1210/endo-78-4-773; Glass CK, 2000, GENE DEV, V14, P121; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; Lei N, 2002, BIOL REPROD, V66, P675, DOI 10.1095/biolreprod66.3.675; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Opitz OG, 2000, CANCER RES, V60, P2825; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pan XL, 2001, ENDOCRINOLOGY, V142, P1635, DOI 10.1210/en.142.4.1635; Parisi F, 2007, NUCLEIC ACIDS RES, V35, P1098, DOI 10.1093/nar/gkl1157; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	52	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14827	14835		10.1074/jbc.M117.783043	http://dx.doi.org/10.1074/jbc.M117.783043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726642	Green Published, hybrid			2022-12-28	WOS:000409902100011
J	Roche, JV; Survery, S; Kreida, S; Nesverova, V; Ampah-Korsah, H; Gourdon, M; Deen, PMT; Tornroth-Horsefield, S				Roche, Jennifer Virginia; Survery, Sabeen; Kreida, Stefan; Nesverova, Veronika; Ampah-Korsah, Henry; Gourdon, Maria; Deen, Peter M. T.; Tornroth-Horsefield, Susanna			Phosphorylation of human aquaporin 2 (AQP2) allosterically controls its interaction with the lysosomal trafficking protein LIP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER CHANNEL AQUAPORIN-2; COLLECTING DUCT; SITES; VASOPRESSIN; TRANSPORT; CELLS; ENDOCYTOSIS; UBIQUITINATION; IDENTIFICATION; DOMAIN	The interaction between the renal water channel aquaporin-2 (AQP2) and the lysosomal trafficking regulator-interacting protein LIP5 targets AQP2 to multivesicular bodies and facilitates lysosomal degradation. This interaction is part of a process that controls AQP2 apical membrane abundance in a vasopressin-dependent manner, allowing for urine volume adjustment. Vasopressin regulates phosphorylation at four sites within the AQP2 C terminus (Ser(256), Ser(261), Ser(264), and Thr(269)), of which Ser(256) is crucial and sufficient for AQP2 translocation from storage vesicles to the apical membrane. However, whether AQP2 phosphorylation modulates AQP2-LIP5 complex affinity is unknown. Here we used far-Western blot analysis and microscale thermophoresis to show that the AQP2 binds LIP5 in a phosphorylation-dependent manner. We constructed five phospho-mimicking mutants (S256E, S261E, S264E, T269E, and S256E/T269E) and a C-terminal truncation mutant (Delta P242) that lacked all phosphorylation sites but retained a previously suggested LIP5-binding site. CD spectroscopy indicated that wild-type AQP2 and the phospho-mimicking mutants had similar overall structure but displayed differences in melting temperatures possibly arising from C-terminal conformational changes. Non-phosphorylated AQP2 bound LIP5 with the highest affinity, whereas AQP2-Delta P242 had 20-fold lower affinity as determined by microscale thermophoresis. AQP2-S256E, S261E, T269E, and S256E/T269E all had reduced affinity. This effect was most prominent for AQP2-S256E, which fits well with its role in apical membrane targeting. AQP2-S264E had affinity similar to non-phosphorylated AQP2, possibly indicating a role in exosome excretion. Our data suggest that AQP2 phosphorylation allosterically controls its interaction with LIP5, illustrating how altered affinities to interacting proteins form the basis for regulation of AQP2 trafficking by post-translational modifications.	[Roche, Jennifer Virginia; Survery, Sabeen; Kreida, Stefan; Nesverova, Veronika; Ampah-Korsah, Henry; Gourdon, Maria; Tornroth-Horsefield, Susanna] Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden; [Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 GA Nijmegen, Netherlands	Lund University; Radboud University Nijmegen	Tornroth-Horsefield, S (corresponding author), Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden.	susanna.horsefield@biochemistry.lu.se	Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014	Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; Tornroth-Horsefield, Susanna/0000-0002-9435-8243; Kreida, Stefan/0000-0003-1593-8360	Vetenskapsradet Grants [2010-5208, 20122849]; Craafordska stiftelsen Grant [20140711]	Vetenskapsradet Grants; Craafordska stiftelsen Grant	This work was supported by Vetenskapsradet Grants 2010-5208 and 20122849 and Craafordska stiftelsen Grant 20140711 to (S. T.-H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ampah-Korsah H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00862; Arthur J, 2015, AM J PHYSIOL-RENAL, V309, pF673, DOI 10.1152/ajprenal.00152.2015; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Frick A, 2014, P NATL ACAD SCI USA, V111, P6305, DOI 10.1073/pnas.1321406111; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Guo EZ, 2015, J BIOL CHEM, V290, P8396, DOI 10.1074/jbc.M114.607903; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Katsura T, 1997, Am J Physiol, V272, pF817; Kinoshita E, 2012, PROTEOMICS, V12, P932, DOI 10.1002/pmic.201100639; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Moeller HB, 2016, J BIOL CHEM, V291, P2469, DOI 10.1074/jbc.M115.691121; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Park EJ, 2013, AM J PHYSIOL-RENAL, V304, pF958, DOI 10.1152/ajprenal.00469.2012; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; van Balkom BWM, 2009, J AM SOC NEPHROL, V20, P990, DOI 10.1681/ASN.2008060648; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Vild CJ, 2015, J BIOL CHEM, V290, P7291, DOI 10.1074/jbc.M114.616730; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Zwang NA, 2009, J PROTEOME RES, V8, P1540, DOI 10.1021/pr800894p	37	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14636	14648		10.1074/jbc.M117.788364	http://dx.doi.org/10.1074/jbc.M117.788364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28710278	Green Published, hybrid			2022-12-28	WOS:000408747500028
J	van Gils, MJ; Sanders, RW				van Gils, Marit J.; Sanders, Rogier W.			Opposites attract in bispecific antibody engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Bispecific antibodies show great promise as intrinsic combination therapies, but often suffer from poor physiochemical properties, many times related to poor heterodimerization. De Nardis et al. identify specific electrostatic interactions that facilitate efficient heterodimerization, resulting in bispecific antibodies with physiochemical properties very similar to those of naturally occurring antibodies. This provides a new platform for the treatment of an array of diseases from cancer and autoimmune diseases to infectious diseases.	[van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	van Gils, MJ; Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.; Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	m.j.vangils@amc.uva.nl; r.w.sanders@amc.uva.nl	van Gils, Marit J./H-4791-2019	van Gils, Marit J./0000-0003-3422-8161				De Nardis C, 2017, J BIOL CHEM, V292, P14706, DOI 10.1074/jbc.M117.793497; Fan GW, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0227-0; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Ha JH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00394; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Liu HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00038; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Wec AZ, 2016, SCIENCE, V354, P350, DOI 10.1126/science.aag3267	8	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14718	14719		10.1074/jbc.H117.793497	http://dx.doi.org/10.1074/jbc.H117.793497			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28864715	Green Published, hybrid			2022-12-28	WOS:000408747500036
J	Liu, Y; Chen, YL; Zhang, JL; Liu, YL; Zhang, YJ; Su, ZG				Liu, Yin; Chen, Yulong; Zhang, Jinlong; Liu, Yulan; Zhang, Yanjie; Su, Zhiguang			Retinoic acid receptor-related orphan receptor stimulates adipose tissue inflammation by modulating endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipose tissue; endoplasmic reticulum stress (ER stress); inflammation; obesity; ROR	UNFOLDED PROTEIN RESPONSE; INDUCED LUNG INFLAMMATION; ROR-ALPHA; GENE-EXPRESSION; OBESITY; ACTIVATION; INSULIN; DISEASE; ER	Adipose tissue inflammation has been linked to metabolic diseases such as obesity and type 2 diabetes. However, the molecules that mediate inflammation in adipose tissue have not been addressed. Although retinoic acid receptor-related orphan receptor (ROR) is known to be involved in the regulation of inflammatory response in some tissues, its role is largely unknown in adipose tissue. Conversely, it is known that endoplasmic reticulum (ER) stress and unfolding protein response (UPR) signaling affect the inflammatory response in obese adipose tissue, but whether ROR regulates these processes remains unknown. In this study, we investigate the link between ROR and adipose tissue inflammation. We showed that the inflammatory response in macrophages or 3T3-L1 adipocytes stimulated by lipopolysaccharide, as well as adipose tissue in obese mice, markedly increased the expression of ROR. Adenovirus-mediated overexpression of ROR or treatment with the ROR-specific agonist SR1078 enhanced the expression of inflammatory cytokines and increased the number of infiltrated macrophages into adipose tissue. Furthermore, SR1078 up-regulated the mRNA expression of ER stress response genes and enhanced phosphorylations of two of the three mediators of major UPR signaling pathways, PERK and IRE1. Finally, we found that alleviation of ER stress using a chemical chaperone followed by the suppression of ROR induced inflammation in adipose tissue. Our data suggest that ROR-induced ER stress response potentially contributes to the adipose tissue inflammation that can be mitigated by treatment with chemical chaperones. The relationships established here between ROR expression, inflammation, and UPR signaling may have implications for therapeutic targeting of obesity-related metabolic diseases.	[Liu, Yin; Chen, Yulong; Zhang, Jinlong; Liu, Yulan; Zhang, Yanjie; Su, Zhiguang] Sichuan Univ, West China Hosp, Mol Med Res Ctr, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China	Sichuan University	Su, ZG (corresponding author), Sichuan Univ, West China Hosp, Mol Med Res Ctr, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.	zhiguang.su@scu.edu.cn	Su, Zhiguang/AFS-0022-2022; zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [31071108]; Sichuan Province Science and Technology Support Program Grant [2015SZ0140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Support Program Grant	This work was supported by National Natural Science Foundation of China Grant 31071108 and Sichuan Province Science and Technology Support Program Grant 2015SZ0140. The authors declare that they have no conflicts of interest with the contents of this article.	Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Ghosh AK, 2015, J GERONTOL A-BIOL, V70, P1320, DOI 10.1093/gerona/glu186; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Jetten Anton M, 2013, Front Endocrinol (Lausanne), V4, P1, DOI 10.3389/fendo.2013.00001; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kuang JY, 2014, FEBS LETT, V588, P1071, DOI 10.1016/j.febslet.2014.02.029; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Liu YL, 2017, MOL CELL BIOCHEM, V426, P47, DOI 10.1007/s11010-016-2879-7; Lu M., 2013, BIO-PROTOCOL, V3, pe976, DOI DOI 10.21769/BI0PR0T0C.976; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagliassotti MJ, 2016, METABOLISM, V65, P1238, DOI 10.1016/j.metabol.2016.05.002; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Solt LA, 2012, TRENDS ENDOCRIN MET, V23, P619, DOI 10.1016/j.tem.2012.05.012; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Wang YJ, 2010, ACS CHEM BIOL, V5, P1029, DOI 10.1021/cb100223d; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Zenri F, 2012, J STEROID BIOCHEM, V128, P21, DOI 10.1016/j.jsbmb.2011.10.001	35	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13959	13969		10.1074/jbc.M117.782391	http://dx.doi.org/10.1074/jbc.M117.782391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28698385	Green Published, hybrid			2022-12-28	WOS:000408439800006
J	Knoot, CJ; Ungerer, J; Wangikar, PP; Pakrasi, HB				Knoot, Cory J.; Ungerer, Justin; Wangikar, Pramod P.; Pakrasi, Himadri B.			Cyanobacteria: Promising biocatalysts for sustainable chemical production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						biofuel; cyanobacteria; metabolic engineering; natural product; photosynthesis	HETEROLOGOUS EXPRESSION HOST; FATTY-ACID PRODUCTION; SYNECHOCOCCUS-ELONGATUS; PHOTOSYNTHETIC PRODUCTION; CARBON-DIOXIDE; ENGINEERED CYANOBACTERIUM; HYDROCARBONS PRODUCTION; ISOPROPANOL PRODUCTION; MARINE CYANOBACTERIA; SYNTHETIC PATHWAY	Cyanobacteria are photosynthetic prokaryotes showing great promise as biocatalysts for the direct conversion of CO2 into fuels, chemicals, and other value-added products. Introduction of just a few heterologous genes can endow cyanobacteria with the ability to transform specific central metabolites into many end products. Recent engineering efforts have centered around harnessing the potential of these microbial biofactories for sustainable production of chemicals conventionally produced from fossil fuels. Here, we present an overview of the unique chemistry that cyanobacteria have been co-opted to perform. We highlight key lessons learned from these engineering efforts and discuss advantages and disadvantages of various approaches.	[Knoot, Cory J.; Ungerer, Justin; Pakrasi, Himadri B.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Washington University (WUSTL); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pakrasi@wustl.edu		Pakrasi, Himadri/0000-0001-8240-2123	Indo-U.S. Science and Technology Forum for Indo-U.S. Advanced Bioenergy Consortium (IUABC); Washington University; Office of Science, Department of Energy-Biological and Environmental Research	Indo-U.S. Science and Technology Forum for Indo-U.S. Advanced Bioenergy Consortium (IUABC); Washington University; Office of Science, Department of Energy-Biological and Environmental Research	This work was supported by Indo-U.S. Science and Technology Forum for Indo-U.S. Advanced Bioenergy Consortium (IUABC) (to H. B. P. and P. P. W.), Washington University (to H. B. P.), and the Office of Science, Department of Energy-Biological and Environmental Research (to H. B. P.). This is the fourth article in the Thematic Minireview series "Green biological chemistry." The authors declare that they have no conflicts of interest with the contents of this article.	Aikawa S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-88; Anastas P. T., 1998, GREEN CHEM THEORY PR; Anfelt J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0355-9; Angermayr SA, 2012, APPL ENVIRON MICROB, V78, P7098, DOI 10.1128/AEM.01587-12; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; BLUMWALD E, 1983, PLANT PHYSIOL, V73, P377, DOI 10.1104/pp.73.2.377; Branco Dos Santos Filipe, 2014, Front Bioeng Biotechnol, V2, P36, DOI 10.3389/fbioe.2014.00036; Bullerjahn GS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00359; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Chi ZY, 2011, TRENDS BIOTECHNOL, V29, P537, DOI 10.1016/j.tibtech.2011.06.006; Chwa JW, 2016, PLANT BIOTECHNOL J, V14, P1768, DOI 10.1111/pbi.12536; Davies Fiona K, 2014, Front Bioeng Biotechnol, V2, P21, DOI 10.3389/fbioe.2014.00021; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Dittmann E, 2015, TRENDS MICROBIOL, V23, P642, DOI 10.1016/j.tim.2015.07.008; Ducat DC, 2012, CURR OPIN CHEM BIOL, V16, P337, DOI 10.1016/j.cbpa.2012.05.002; Ducat DC, 2012, APPL ENVIRON MICROB, V78, P2660, DOI 10.1128/AEM.07901-11; Englund E, 2015, ACS SYNTH BIOL, V4, P1270, DOI 10.1021/acssynbio.5b00070; Englund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090270; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Formighieri C, 2015, METAB ENG, V32, P116, DOI 10.1016/j.ymben.2015.09.010; Gao X, 2016, ENERG ENVIRON SCI, V9, P1400, DOI 10.1039/c5ee03102h; Gimpel JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01376; Halfmann C, 2014, APPL MICROBIOL BIOT, V98, P9869, DOI 10.1007/s00253-014-6118-4; Hamilton TL, 2016, ENVIRON MICROBIOL, V18, P325, DOI 10.1111/1462-2920.13118; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; Hendry JI, 2017, BIOTECHNOL BIOENG, V114, P2298, DOI 10.1002/bit.26350; Hendry JI, 2016, BIORESOURCE TECHNOL, V213, P190, DOI 10.1016/j.biortech.2016.02.128; Hirokawa Y, 2017, METAB ENG, V39, P192, DOI 10.1016/j.ymben.2016.12.001; Hirokawa Y, 2016, METAB ENG, V34, P97, DOI 10.1016/j.ymben.2015.12.008; Hirokawa Y, 2015, J BIOSCI BIOENG, V119, P585, DOI 10.1016/j.jbiosc.2014.10.005; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Jacobsen JH, 2014, METAB ENG, V21, P60, DOI 10.1016/j.ymben.2013.11.004; Jazmin LJ, 2017, METAB ENG, V42, P9, DOI 10.1016/j.ymben.2017.05.001; Jimenez-Diaz L, 2017, MICROB BIOTECHNOL, V10, P103, DOI 10.1111/1751-7915.12423; Jones AC, 2012, FEBS J, V279, P1243, DOI 10.1111/j.1742-4658.2012.08517.x; Kaczmarzyk D, 2010, PLANT PHYSIOL, V152, P1598, DOI 10.1104/pp.109.148007; Kageyama H, 2015, CURR MICROBIOL, V71, P115, DOI 10.1007/s00284-015-0833-7; Kaiser BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058307; Kehr JC, 2011, BEILSTEIN J ORG CHEM, V7, P1622, DOI 10.3762/bjoc.7.191; Kopka J, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0741-0; Kusakabe T, 2013, METAB ENG, V20, P101, DOI 10.1016/j.ymben.2013.09.007; Lan EI, 2016, METAB ENG, V38, P483, DOI 10.1016/j.ymben.2016.10.014; Lan EI, 2015, METAB ENG, V31, P163, DOI 10.1016/j.ymben.2015.08.002; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lan EI, 2011, METAB ENG, V13, P353, DOI 10.1016/j.ymben.2011.04.004; Lassen LM, 2014, ACS SYNTH BIOL, V3, P1, DOI 10.1021/sb400136f; Lassen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102184; Leonard E, 2009, NAT CHEM BIOL, V5, P292, DOI 10.1038/nchembio.160; Li H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-4; Li XQ, 2014, PHOTOSYNTH RES, V120, P301, DOI 10.1007/s11120-014-9987-6; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6905, DOI 10.1073/pnas.1103016108; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Markou G, 2011, APPL ENERG, V88, P3389, DOI 10.1016/j.apenergy.2010.12.042; McNeely K, 2010, APPL ENVIRON MICROB, V76, P5032, DOI 10.1128/AEM.00862-10; Melis A, 2013, CURR OPIN CHEM BIOL, V17, P453, DOI 10.1016/j.cbpa.2013.03.010; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Niederholtmeyer H, 2010, APPL ENVIRON MICROB, V76, P3462, DOI 10.1128/AEM.00202-10; Oliver JWK, 2015, METAB ENG, V29, P106, DOI 10.1016/j.ymben.2015.03.006; Oliver JWK, 2013, P NATL ACAD SCI USA, V110, P1249, DOI 10.1073/pnas.1213024110; Pate R, 2011, APPL ENERG, V88, P3377, DOI 10.1016/j.apenergy.2011.04.023; Reinsvold RE, 2011, J PLANT PHYSIOL, V168, P848, DOI 10.1016/j.jplph.2010.11.006; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Ruffing Anne M, 2014, Front Bioeng Biotechnol, V2, P17, DOI 10.3389/fbioe.2014.00017; Ruffing AM, 2013, J APPL PHYCOL, V25, P1495, DOI 10.1007/s10811-013-9993-7; Ruffing AM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-113; Ruffing AM, 2012, BIOTECHNOL BIOENG, V109, P2190, DOI 10.1002/bit.24509; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sharma NK, 2014, CYANOBACTERIA: AN ECONOMIC PERSPECTIVE, P167; Shen CR, 2012, ENERG ENVIRON SCI, V5, P9574, DOI 10.1039/c2ee23148d; Song K, 2016, APPL MICROBIOL BIOT, V100, P7865, DOI 10.1007/s00253-016-7510-z; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Steinhauser D, 2012, TRENDS PLANT SCI, V17, P503, DOI 10.1016/j.tplants.2012.05.005; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tiruveedula GSS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178565; Trauger JW, 2000, P NATL ACAD SCI USA, V97, P3112, DOI 10.1073/pnas.040560597; Ungerer J, 2012, ENERG ENVIRON SCI, V5, P8998, DOI 10.1039/c2ee22555g; Videau P, 2016, ACS SYNTH BIOL, V5, P978, DOI 10.1021/acssynbio.6b00038; Wang B, 2013, METAB ENG, V16, P68, DOI 10.1016/j.ymben.2013.01.001; Wang WH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-69; Wang X, 2016, P NATL ACAD SCI USA, V113, P14225, DOI 10.1073/pnas.1613340113; Wang Y, 2015, GREEN CHEM, V17, P3100, DOI 10.1039/c5gc00129c; Wang YP, 2016, METAB ENG, V34, P60, DOI 10.1016/j.ymben.2015.10.008; Whitton BA, 2002, ECOLOGY CYANOBACTERI, P1, DOI DOI 10.1007/0-306-46855-7_1; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wlodarczyk A, 2016, METAB ENG, V33, P1, DOI 10.1016/j.ymben.2015.10.009; Xiong W, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.53; Xue Y, 2014, J APPL PHYCOL, V26, P219, DOI 10.1007/s10811-013-0113-5; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858; Zhou J, 2012, METAB ENG, V14, P394, DOI 10.1016/j.ymben.2012.03.005; Ziemert N, 2008, ANGEW CHEM INT EDIT, V47, P7756, DOI 10.1002/anie.200802730	100	113	113	8	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5044	5052		10.1074/jbc.R117.815886	http://dx.doi.org/10.1074/jbc.R117.815886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	28972147	Green Published, hybrid			2022-12-28	WOS:000429409300010
J	Padilla-Benavides, T; Nasipak, BT; Paskavitz, AL; Haokip, DT; Schnabl, JM; Nickerson, JA; Imbalzano, AN				Padilla-Benavides, Teresita; Nasipak, Brian T.; Paskavitz, Amanda L.; Haokip, Dominic T.; Schnabl, Jake M.; Nickerson, Jeffrey A.; Imbalzano, Anthony N.			Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; chromatin regulation; chromatin remodeling; phosphorylation; transcription; Brg1; SWI; SNF subunits; casein kinase 2; myoblast	CHROMATIN REMODELING COMPLEXES; SATELLITE CELLS; NUCLEAR SUBSTRUCTURE; SELF-RENEWAL; PROTEIN; PAX7; CK2; SUBUNIT; BRG1; COMPONENTS	Transcriptional regulation is modulated in part by chromatin-remodeling enzymes that control gene accessibility by altering chromatin compaction or nucleosome positioning. Brahma-related gene 1 (Brg1), a catalytic subunit of the mammalian SWI/SNF chromatin-remodeling enzymes, is required for both myoblast proliferation and differentiation, and the control of Brg1 phosphorylation by calcineurin, PKC1, and p38 regulates the transition to differentiation. However, we hypothesized that Brg1 activity might be regulated by additional kinases. Here, we report that Brg1 is also a target of casein kinase 2 (CK2), a serine/threonine kinase, in proliferating myoblasts. We found that CK2 interacts with Brg1, and mutation of putative phosphorylation sites to non-phosphorylatable (Ser to Ala, SA) or phosphomimetic residues (Ser to Glu, SE) reduced Brg1 phosphorylation by CK2. Although BRG1-deleted myoblasts that ectopically express the SA-Brg1 mutant proliferated similarly to the parental cells or cells ectopically expressing wild-type (WT) Brg1, ectopic expression of the SE-Brg1 mutant reduced proliferation and increased cell death, similar to observations from cells lacking Brg1. Moreover, pharmacological inhibition of CK2 increased myoblast proliferation. Furthermore, the Pax7 promoter, which controls expression of a key transcription factor required for myoblast proliferation, was in an inaccessible chromatin state in the SE-Brg1 mutant, suggesting that hyperphosphorylated Brg1 cannot remodel chromatin. WT-, SA-, and SE-Brg1 exhibited distinct differences in interacting with and affecting expression of the SWI/SNF subunits Baf155 and Baf170 and displayed differential sub-nuclear localization. Our results indicate that CK2-mediated phosphorylation of Brg1 regulates myoblast proliferation and provides insight into one mechanism by which composition of the mammalian SWI/SNF enzyme complex is regulated.	[Padilla-Benavides, Teresita; Nasipak, Brian T.; Paskavitz, Amanda L.; Haokip, Dominic T.; Schnabl, Jake M.; Imbalzano, Anthony N.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, 364 Plantat St, Worcester, MA 01605 USA; [Nickerson, Jeffrey A.] Univ Massachusetts, Dept Pediat, Med Sch, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, 364 Plantat St, Worcester, MA 01605 USA.	anthony.imbalzano@umassmed.edu	Padilla-Benavides, Teresita/K-1968-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822	National Institutes of Health [GM56244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM56244. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bouazoune K, 2005, J BIOL CHEM, V280, P41912, DOI 10.1074/jbc.M507084200; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cui HH, 2016, NUCLEIC ACIDS RES, V44, P2538, DOI 10.1093/nar/gkv1244; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dobson JR, 2017, J CELL PHYSIOL, V232, P1295, DOI 10.1002/jcp.25596; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Fawcett DW., 1966, ATLAS FINE STRUCTURE, P112; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289; Gonzalez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154919; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kimura A, 2014, J PROTEOME RES, V13, P4959, DOI 10.1021/pr500470h; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Kwon SJ, 2015, ONCOGENE, V34, P351, DOI 10.1038/onc.2013.556; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ P, 1993, J BIOL CHEM, V268, P2733; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; Mansouri A, 1996, DEVELOPMENT, V122, P831; Hernandez-Hernandez JM, 2013, NUCLEIC ACIDS RES, V41, P5704, DOI 10.1093/nar/gkt285; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825; Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nasipak BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8441; Nickerson JA, 2009, RNA BIOL, V6, P25, DOI 10.4161/rna.6.1.7563; Ohkawa Y, 2012, METHODS MOL BIOL, V798, P531, DOI 10.1007/978-1-61779-343-1_32; Olguin HC, 2011, BIOL RES, V44, P323, DOI /S0716-97602011000400002; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Padilla-Benavides T, 2015, J CELL PHYSIOL, V230, P2990, DOI 10.1002/jcp.25031; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PEPPERKOK R, 1991, EXP CELL RES, V197, P245, DOI 10.1016/0014-4827(91)90429-X; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quaresma AJC, 2013, MOL BIOL CELL, V24, P1208, DOI 10.1091/mbc.E12-06-0450; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sambasivan Ramkumar, 2015, Results Probl Cell Differ, V56, P191, DOI 10.1007/978-3-662-44608-9_9; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seldin DC, 2008, MOL CELL BIOCHEM, V316, P141, DOI 10.1007/s11010-008-9811-8; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Tripodi F, 2013, EUKARYOT CELL, V12, P1271, DOI 10.1128/EC.00117-13; Tyagi M, 2016, NUCLEUS-PHILA, V7, P388, DOI 10.1080/19491034.2016.1211217; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang YH, 2013, MOL CELL, V49, P283, DOI 10.1016/j.molcel.2012.10.028; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	81	17	17	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18592	18607		10.1074/jbc.M117.799676	http://dx.doi.org/10.1074/jbc.M117.799676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939766	hybrid, Green Published			2022-12-28	WOS:000414958100017
J	Malecki, J; Jakobsson, ME; Ho, AYY; Moen, A; Rustan, AC; Falnes, PO				Malecki, Jedrzej; Jakobsson, Magnus E.; Ho, Angela Y. Y.; Moen, Anders; Rustan, Arild C.; Falnes, Pal O.			Uncovering human METTL12 as a mitochondrial methyltransferase that modulates citrate synthase activity through metabolite-sensitive lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; MESSENGER-RNA TRANSLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE METHYLATION; BETA-SUBUNIT; ALPHA EEF1A; ETF-BETA; PROTEIN; SEQUENCE; IDENTIFICATION	Lysine methylation is an important and much-studied post-translational modification of nuclear and cytosolic proteins but is present also in mitochondria. However, the responsible mitochondrial lysine-specific methyltransferases (KMTs) remain largely elusive. Here, we investigated METTL12, a mitochondrial human S-adenosylmethionine (AdoMet)-dependent methyltransferase and found it to methylate a single protein in mitochondrial extracts, identified as citrate synthase (CS). Using several in vitro and in vivo approaches, we demonstrated that METTL12 methylates CS on Lys-395, which is localized in the CS active site. Interestingly, the METTL12-mediated methylation inhibited CS activity and was blocked by the CS substrate oxaloacetate. Moreover, METTL12 was strongly inhibited by the reaction product S-adenosylhomocysteine (AdoHcy). In summary, we have uncovered a novel human mitochondrial KMT that introduces a methyl modification into a metabolic enzyme and whose activity can be modulated by metabolic cues. Based on the established naming nomenclature for similar enzymes, we suggest that METTL12 be renamed CS-KMT (gene name CSKMT).	[Malecki, Jedrzej; Jakobsson, Magnus E.; Ho, Angela Y. Y.; Moen, Anders; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Rustan, Arild C.] Univ Oslo, Fac Math & Nat Sci, Sch Pharm, N-0316 Oslo, Norway; [Jakobsson, Magnus E.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Prote Program,Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of Oslo; University of Oslo; Novo Nordisk Foundation; University of Copenhagen	Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Rustan, Arild C./0000-0003-0963-5363; Malecki, Jedrzej/0000-0003-0825-7962; Falnes, Pal/0000-0001-8114-6025	Research Council of Norway [FRIMEDBIO-240009]; Norwegian Cancer Society [107744-PR-2007-0132]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Research Council of Norway (FRIMEDBIO-240009] and the Norwegian Cancer Society (107744-PR-2007-0132). The authors declare that they have no conflicts of interest with the contents of this article.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; BEECKMANS S, 1984, INT J BIOCHEM, V16, P341, DOI 10.1016/0020-711X(84)90131-9; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; EVANS CT, 1988, BIOCHEM BIOPH RES CO, V157, P1231, DOI 10.1016/S0006-291X(88)81006-4; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11464; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; LANOUE KF, 1972, J BIOL CHEM, V247, P667; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2016, J BIOL CHEM, V291, P9581, DOI 10.1074/jbc.M115.709261; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mentch SJ, 2016, ANN NY ACAD SCI, V1363, P91, DOI 10.1111/nyas.12956; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97	43	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17950	17962		10.1074/jbc.M117.808451	http://dx.doi.org/10.1074/jbc.M117.808451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887308	Green Published, hybrid			2022-12-28	WOS:000414013000030
J	Roy, K; Jerman, S; Jozsef, L; McNamara, T; Onyekaba, G; Sun, ZX; Marin, EP				Roy, Kasturi; Jerman, Stephanie; Jozsef, Levente; McNamara, Thomas; Onyekaba, Ginikanwa; Sun, Zhaoxia; Marin, Ethan P.			Palmitoylation of the ciliary GTPase ARL13b is necessary for its stability and its role in cilia formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; MEMBRANE LOCALIZATION; TRANSPORT; ACYLATION; PDE6D; NPHP3; SITE; FORM	Primary cilia are hairlike extensions of the plasma membrane of most mammalian cells that serve specialized signaling functions. To traffic properly to cilia, multiple cilia proteins rely on palmitoylation, the post-translational attachment of a saturated 16-carbon lipid. However, details regarding the mechanism of how palmitoylation affects cilia protein localization and function are unknown. Herein, we investigated the protein ADP-ribosylation factor-like GTPase 13b (ARL13b) as a model palmitoylated ciliary protein. Using biochemical, cellular, and in vivo studies, we found that ARL13b palmitoylation occurs in vivo in mouse kidneys and that it is required for trafficking to and function within cilia. Myristoylation, a 14-carbon lipid, is shown to largely substitute for palmitoylation with regard to cilia localization of ARL13b, but not with regard to its function within cilia. The functional importance of palmitoylation results in part from a dramatic increase in ARL13b stability, which is not observed with myristoylation. Additional results show that blockade of depalmitoylation slows the degradation of ARL13b that occurs during cilia resorption, raising the possibility that the sensitivity of ARL13b stability to palmitoylation may be exploited by the cell to accelerate degradation of ARL13b by depalmitoylating it. Together, the results show that palmitoylation plays a unique and critical role in controlling the localization, stability, abundance, and thus function of ARL13b. Pharmacological manipulation of protein palmitoylation may be a strategy to alter cilia function.	[Roy, Kasturi; Jozsef, Levente; McNamara, Thomas; Onyekaba, Ginikanwa; Marin, Ethan P.] Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, New Haven, CT 06520 USA; [Jerman, Stephanie; Sun, Zhaoxia] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Marin, EP (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, New Haven, CT 06520 USA.	ethan.marin@yale.edu	Roy, Kasturi/I-2244-2019	Roy, Kasturi/0000-0003-2504-3114	National Institutes of Health [R01HL125885, K08 HL103831]; PKD Foundation [213G16A]; American Society of Nephrology; Pilot and Feasibility Award from the Yale Polycystic Kidney Disease Program [P30 DK090744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103831, R01HL125885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; American Society of Nephrology; Pilot and Feasibility Award from the Yale Polycystic Kidney Disease Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01HL125885 and PKD Foundation Grant 213G16A (to Z. S.), by an American Society of Nephrology Gottschalk Award and National Institutes of Health Grant K08 HL103831, and by Pilot and Feasibility Award P30 DK090744 from the Yale Polycystic Kidney Disease Program (to E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003977; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Dallavilla T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004774; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Li YY, 2016, J AM SOC NEPHROL, V27, P3628, DOI 10.1681/ASN.2015091004; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Nakata K, 2012, CYTOSKELETON, V69, P221, DOI 10.1002/cm.21014; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; Prodromou NV, 2012, J CELL SCI, V125, P4297, DOI 10.1242/jcs.100545; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Westerfield M., 2000, ZEBRAFISH BOOK AGUID; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111	41	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17703	17717		10.1074/jbc.M117.792937	http://dx.doi.org/10.1074/jbc.M117.792937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28848045	Green Published, hybrid			2022-12-28	WOS:000414013000011
J	Dong, SL; Baranwal, S; Garcia, A; Serrano-Gomez, SJ; Eastlack, S; Iwakuma, T; Mercante, D; Mauvais-Jarvis, F; Alahari, SK				Dong, Shengli; Baranwal, Somesh; Garcia, Anapatricia; Serrano-Gomez, Silvia J.; Eastlack, Steven; Iwakuma, Tomoo; Mercante, Donald; Mauvais-Jarvis, Franck; Alahari, Suresh K.			Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); calorimetry; cell metabolism; cell migration; glucose; obesity	RICH REPEAT PROTEINS; GLUCOSE-METABOLISM; BINDING PROTEIN; CELL-MIGRATION; BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FATTY-ACID; IQGAP1	Nischarin (Nisch) is a key protein functioning as a molecular scaffold and thereby hosting interactions with several protein partners. To explore the physiological importance of Nisch, here we generated Nisch loss-of-function mutant mice and analyzed their metabolic phenotype. Nisch-mutant embryos exhibited delayed development, characterized by small size and attenuated weight gain. We uncovered the reason for this phenotype by showing that Nisch binds to and inhibits the activity of AMP-activated protein kinase (AMPK), which regulates energy homeostasis by suppressing anabolic and activating catabolic processes. The Nisch mutations enhanced AMPK activation and inhibited mechanistic target of rapamycin signaling in mouse embryonic fibroblasts as well as in muscle and liver tissues of mutant mice. Nisch-mutant mice also exhibited increased rates of glucose oxidation with increased energy expenditure, despite reduced overall food intake. Moreover, the Nisch-mutant mice had reduced expression of liver markers of gluconeogenesis associated with increased glucose tolerance. As a result, these mice displayed decreased growth and body weight. Taken together, our results indicate that Nisch is an important AMPK inhibitor and a critical regulator of energy homeostasis, including lipid and glucose metabolism.	[Dong, Shengli; Baranwal, Somesh; Serrano-Gomez, Silvia J.; Eastlack, Steven; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Mercante, Donald] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat, New Orleans, LA 70112 USA; [Baranwal, Somesh] Cent Univ Punjab, Ctr Biochem & Microbial Sci, City Campus Mansa Rd, Bathinda 151001, India; [Garcia, Anapatricia] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Bogota 11001000, Colombia; [Iwakuma, Tomoo] Univ Kansas, Dept Canc Biol, Med Ctr, Kansas City, KS 66160 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Div Endocrinol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Central University of Punjab; Emory University; Pontificia Universidad Javeriana; University of Kansas; University of Kansas Medical Center; Tulane University	Alahari, SK (corresponding author), Louisiana Sch Med, Biochem, CSRB 406, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health [R01 DK074970, DK107444]; NATIONAL CANCER INSTITUTE [R01CA174735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107444, R01DK074970] Funding Source: NIH RePORTER	Louisiana State University School of Medicine; Fred G. Brazda Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Louisiana State University School of Medicine and the Fred G. Brazda Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R01 DK074970 and DK107444.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Chawla B, 2017, J BIOL CHEM, V292, P3273, DOI 10.1074/jbc.M116.752642; Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kohan AB, 2009, BIOCHEM BIOPH RES CO, V388, P117, DOI 10.1016/j.bbrc.2009.07.130; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liangpunsakul S, 2013, J INVEST MED, V61, P270, DOI 10.2310/JIM.0b013e31827c2795; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marini C, 2013, CELL CYCLE, V12, P3490, DOI 10.4161/cc.26461; Maziveyi M, 2015, CANCER RES, V75, P4252, DOI 10.1158/0008-5472.CAN-15-1395; Meng XY, 2016, J BIOL CHEM, V291, P10625, DOI 10.1074/jbc.M116.713768; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Piletz JE, 2000, DNA CELL BIOL, V19, P319, DOI 10.1089/10445490050043290; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36561; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; Zhang L, 2013, CNS NEUROSCI THER, V19, P978, DOI 10.1111/cns.12192; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	54	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16833	16846		10.1074/jbc.M117.784256	http://dx.doi.org/10.1074/jbc.M117.784256			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842496	Green Published, hybrid			2022-12-28	WOS:000413140600006
J	Khan, MZ; Bhaskar, A; Upadhyay, S; Kumari, P; Rajmani, RS; Jain, P; Singh, A; Kumar, D; Bhavesh, NS; Nandicoori, VK				Khan, Mehak Zahoor; Bhaskar, Ashima; Upadhyay, Sandeep; Kumari, Pooja; Rajmani, Raju S.; Jain, Preeti; Singh, Amit; Kumar, Dhiraj; Bhavesh, Neel Sarovar; Nandicoori, Vinay Kumar			Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency-like conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; HYPOXIC RESPONSE; METABOLISM; GROWTH; GENE; EXPRESSION; HOMEOSTASIS; PERSISTENCE; ADAPTATION; STARVATION	Protein kinase G (PknG), a thioredoxin-fold-containing eukaryotic-like serine/threonine protein kinase, is a virulence factor in Mycobacterium tuberculosis, required for inhibition of phagolysosomal fusion. Here, we unraveled novel functional facets of PknG during latency-like conditions. We found that PknG mediates persistence under stressful conditions like hypoxia and abets drug tolerance. PknG mutant displayed minimal growth in nutrient-limited conditions, suggesting its role in modulating cellular metabolism. Intracellular metabolic profiling revealed that PknG is necessary for efficient metabolic adaptation during hypoxia. Notably, the PknG mutant exhibited a reductive shift in mycothiol redox potential and compromised stress response. Exposure to antibiotics and hypoxic environment resulted in higher oxidative shift in mycothiol redox potential of PknG mutant compared with the wild type. Persistence during latency-like conditions required kinase activity and thioredoxin motifs of PknG and is mediated through phosphorylation of a central metabolic regulator GarA. Finally, using a guinea pig model of infection, we assessed the in vivo role of PknG in manifestation of disease pathology and established a role for PknG in the formation of stable granuloma, hallmark structures of latent tuberculosis. Taken together, PknG-mediated GarA phosphorylation is important for maintenance of both mycobacterial physiology and redox poise, an axis that is dispensable for survival under normoxic conditions but is critical for non-replicating persistence of mycobacteria. In conclusion, we propose that PknG probably acts as a modulator of latency-associated signals.	[Khan, Mehak Zahoor; Bhaskar, Ashima; Upadhyay, Sandeep; Jain, Preeti; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Kumari, Pooja; Kumar, Dhiraj; Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Rajmani, Raju S.; Singh, Amit] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Upadhyay, Sandeep] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Institute of Science (IISC) - Bangalore; Washington University (WUSTL)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in	Upadhyay, Sandeep/ABF-5956-2020; Upadhyay, Sandeep/X-5218-2019; Kumari, Pooja/HHZ-7577-2022; Bhavesh, Neel Sarovar/F-3127-2015	Upadhyay, Sandeep/0000-0001-5958-5419; Kumari, Pooja/0000-0002-9486-6723; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Khan, Mehak Zahoor/0000-0002-2780-4119; BHASKAR, ASHIMA/0000-0002-7367-874X; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank Prof. Av-Gay for the kind gift of M. tuberculosis PknG knock-out. We thank Dr. Divya Tiwari for generation of the GarA mutants. We thank the Tuberculosis Aerosol Challenge Facility (DBT-TACF) staff at the International Centre for Genetic Engineering and Biotechnology (New Delhi, India) for kind help. We thank the Central Flow Cytometry Facility at the National Institute of Immunology (NII) and <INF>T</INF>. Khaling for support in managing the facility. We thank the Department of Biotechnology, Government of India for providing financial support for the High Field NMR spectrometer at the ICGEB, New Delhi. We thank Dr. Savita Lochab and Saba Naz for critical reading of the manuscript.	Alnimr AM, 2015, BRAZ J MICROBIOL, V46, P641, DOI 10.1590/S1517-838246320140507; Anand A, 2015, MOL CELL, V60, P637, DOI 10.1016/j.molcel.2015.10.016; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cossu A, 2013, MICROB PATHOGENESIS, V65, P89, DOI 10.1016/j.micpath.2013.10.004; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Keller R., 2004, COMPUTER AIDED RESON, V1; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; MCDERMOTT W, 1959, PUBLIC HEALTH REP, V74, P485, DOI 10.2307/4590490; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Richard-Greenblatt M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0005-2015; Rieck B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006399; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Ventura M, 2013, MOL MICROBIOL, V90, P356, DOI 10.1111/mmi.12368; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123327; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WAYNE LG, 1976, AM REV RESPIR DIS, V114, P807; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1967, J BACTERIOL, V93, P1374, DOI 10.1128/JB.93.4.1374-1381.1967; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wolff KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004839; Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09	50	64	67	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16093	16108		10.1074/jbc.M117.797563	http://dx.doi.org/10.1074/jbc.M117.797563			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28821621	Green Published, hybrid			2022-12-28	WOS:000412109400010
J	Dias, AF; Rodrigues, TA; Pedrosa, AG; Barros-Barbosa, A; Francisco, T; Azevedo, JE				Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.			The peroxisomal matrix protein translocon is a large cavity-forming protein assembly into which PEX5 protein enters to release its cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL RECEPTOR; II SECRETION SYSTEM; HUMAN PTS1 RECEPTOR; IMPORT RECEPTOR; CYCLING RECEPTOR; MEMBRANE-PROTEIN; CONSERVED CYSTEINE; DOCKING PROTEIN; AAA PEROXINS; MACHINERY	A remarkable property of the machinery for import of peroxisomal matrix proteins is that it can accept already folded proteins as substrates. This import involves binding of newly synthesized proteins by cytosolic peroxisomal biogenesis factor 5 (PEX5) followed by insertion of the PEX5-cargo complex into the peroxisomal membrane at the docking/translocation module (DTM). However, how these processes occur remains largely unknown. Here, we used truncated PEX5 molecules to probe the DTM architecture. We found that the DTM can accommodate a larger number of truncated PEX5 molecules comprising amino acid residues 1-197 than full-length PEX5 molecules. A shorter PEX5 version (PEX5(1-125)) still interacted correctly with the DTM; however, this species was largely accessible to exogenously added proteinase K, suggesting that this protease can access the DTM occupied by a small PEX5 protein. Interestingly, the PEX5(1-125)-DTM interaction was inhibited by a polypeptide comprising PEX5 residues 138-639. Apparently, the DTM can recruit soluble PEX5 through interactions with different PEX5 domains, suggesting that the PEX5-DTM interactions are to some degree fuzzy. Finally, we found that the interaction between PEX5 and PEX14, a major DTM component, is stable at pH 11.5. Thus, there is no reason to assume that the hitherto intriguing resistance of DTM-bound PEX5 to alkaline extraction reflects its direct contact with the peroxisomal lipid bilayer. Collectively, these results suggest that the DTM is best described as a large cavity-forming protein assembly into which cytosolic PEX5 can enter to release its cargo.	[Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Azevedo, Jorge E.] Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Azevedo, JE (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Azevedo, JE (corresponding author), Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	jazevedo@ibmc.up.pt	Barros-Barbosa, AR/L-1321-2014; Francisco, Tânia/AAK-9920-2020; Azevedo, Jorge E/A-4113-2008; Rodrigues, Tony/K-1141-2014	Barros-Barbosa, AR/0000-0003-4484-4427; Francisco, Tânia/0000-0003-3571-5164; Azevedo, Jorge E/0000-0001-7714-5302; Dias, Ana Filipa/0000-0002-6667-1961; Rodrigues, Tony/0000-0003-2311-8258; Pedrosa, Ana G/0000-0001-8887-2046	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, PTDC/BEX-BCM/2311/2014]; Portuguese funds through Norte Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" [NORTE-01-0145-FEDER-000008]; Fundacao para a Ciencia e a Tecnologia; Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional; Fundo Social Europeu; FEDER funds through the COMPETE POCI, Portugal	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; Portuguese funds through Norte Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S"; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional; Fundo Social Europeu; FEDER funds through the COMPETE POCI, Portugal	This work was supported in part by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020 and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (Grant POCI-01-0145-FEDER-007274) and "The molecular mechanisms of peroxisome biogenesis" (Grant PTDC/BEX-BCM/2311/2014) and through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" (Grant NORTE-01-0145-FEDER-000008). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Fundacao para a Ciencia e a Tecnologia, Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional, and Fundo Social Europeu.r Supported by FEDER funds through the COMPETE 2020-POCI, Portugal 2020.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Baker A, 2016, BIOCHEM SOC T, V44, P783, DOI 10.1042/BST20160036; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; CARTER P, 1989, PROTEINS, V6, P240, DOI 10.1002/prot.340060306; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dias AF, 2016, BBA-MOL CELL RES, V1863, P814, DOI 10.1016/j.bbamcr.2015.09.025; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Francisco T, 2017, METHODS MOL BIOL, V1595, P27, DOI 10.1007/978-1-4939-6937-1_3; Francisco T, 2014, BIOCHIMIE, V98, P29, DOI 10.1016/j.biochi.2013.08.003; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Freitas MO, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140236; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2016, BBA-MOL CELL RES, V1863, P821, DOI 10.1016/j.bbamcr.2015.10.013; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2016, BBA-MOL CELL RES, V1863, P838, DOI 10.1016/j.bbamcr.2015.09.010; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rodrigues TA, 2016, NAT PROTOC, V11, P2454, DOI 10.1038/nprot.2016.147; Rodrigues TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11806; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Urquhart AJ, 2000, J BIOL CHEM, V275, P4127, DOI 10.1074/jbc.275.6.4127; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	87	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15287	15300		10.1074/jbc.M117.805044	http://dx.doi.org/10.1074/jbc.M117.805044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765278	Green Published, hybrid			2022-12-28	WOS:000410809800011
J	Bouillet, S; Genest, O; Mejean, V; Iobbi-Nivol, C				Bouillet, Sophie; Genest, Olivier; Mejean, Vincent; Iobbi-Nivol, Chantal			Protection of the general stress response sigma(S) factor by the CrsR regulator allows a rapid and efficient adaptation of Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FACTOR SPOIIAB; COMPLEX; RSSB	To cope with environmental stresses, bacteria have evolved various strategies, including the general stress response (GSR). GSR is governed by an alternative transcriptional sigma factor named sigma(S) ( RpoS) that associates withRNApolymerase and controls the expression of numerous genes. Previously, we have reported that posttranslational regulation of sigma(S) in the aquatic bacterium Shewanella oneidensis involves the CrsR-CrsA partner- switching regulatory system, but the exact mechanism by which CrsR and CrsA control sigma(S) activity is not completely unveiled. Here, using a translational gene fusion, we show that CrsR sequesters and protects sigma(S) during the exponential growth phase and thus enables rapid gene activation by sigma(S) as soon as the cells enter early stationary phase. Wefurther demonstrate by an in vitro approach that this protection is mediated by the anti-sigma domain of CrsR. Structure-based alignments of CsrR orthologs and other anti-sigma factors identified a CsrR-specific region characteristic of a new family of anti-sigma factors. Wefound that CrsR is conserved in many aquatic proteobacteria, and most of the time it is associated with CrsA. In conclusion, our results suggest that CsrR-mediated protection of sigma(S) during exponential growth enables rapid adaptation of S. oneidensis to changing and stressful growth conditions, and this ability is probably widespread among aquatic proteobacteria.	[Bouillet, Sophie; Genest, Olivier; Mejean, Vincent; Iobbi-Nivol, Chantal] Aix Marseille Univ, CNRS, BIP UMR7281, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Iobbi-Nivol, C (corresponding author), CNRS, BIP IMM, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@imm.cnrs.fr	Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Mejean, Vincent/0000-0001-6533-5846	CNRS; Aix-Marseille Universite (AMU); Ministere de l'Enseignement Superieur et de la Recherche fellowship; AMU	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite (AMU); Ministere de l'Enseignement Superieur et de la Recherche fellowship; AMU	This work was supported in part by the CNRS and Aix-Marseille Universite (AMU). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Ministere de l'Enseignement Superieur et de la Recherche fellowship and AMU.	Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Bordi C, 2003, J BACTERIOL, V185, P2042, DOI 10.1128/JB.185.6.2042-2045.2003; Bouillet S, 2016, J BIOL CHEM, V291, P26151, DOI 10.1074/jbc.M116.751933; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fiebig A, 2015, ANNU REV GENET, V49, P603, DOI 10.1146/annurev-genet-112414-054813; Francez-Charlot A, 2015, TRENDS MICROBIOL, V23, P164, DOI 10.1016/j.tim.2014.12.006; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Herrou J, 2015, MBIO, V6, DOI 10.1128/mBio.00910-15; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanehisa M., 2000, POST GENOME INFORM; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lemaire ON, 2016, RES MICROBIOL, V167, P630, DOI 10.1016/j.resmic.2016.05.004; Mao XM, 2014, FEBS LETT, V588, P608, DOI 10.1016/j.febslet.2013.12.029; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Vallenet D, 2017, NUCLEIC ACIDS RES, V45, pD517, DOI 10.1093/nar/gkw1101	32	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14921	14928		10.1074/jbc.M117.781443	http://dx.doi.org/10.1074/jbc.M117.781443			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729423	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000409902100017
J	Aziz, Q; Li, YW; Anderson, N; Ojake, L; Tsisanova, E; Tinker, A				Aziz, Qadeer; Li, Yiwen; Anderson, Naomi; Ojake, Leona; Tsisanova, Elena; Tinker, Andrew			Molecular and functional characterization of the endothelial ATP-sensitive potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERIAL SMOOTH-MUSCLE; PROTEIN-KINASE-A; CORONARY-ARTERY; K+ CHANNEL; ADENOSINE; ACTIVATION; CELLS; SUBUNIT; KIR6.1; FLOW	ATP-sensitive potassium (K-ATP) channels are widely expressed in the cardiovascular system, where they regulate a range of biological activities by linking cellular metabolism with membrane excitability. K-ATP channels in vascular smooth muscle have a well-defined role in regulating vascular tone. K-ATP channels are also thought to be expressed in vascular endothelial cells, but their presence and function in this context are less clear. As a result, we aimed to investigate the molecular composition and physiological role of endothelial K-ATP channels. We first generated mice with an endothelial specific deletion of the channel subunit Kir6.1 (eKO) using cre-loxP technology. Data from qRT-PCR, patch clamp, ex vivo coronary perfusion Langendorff heart experiments, and endothelial cell Ca2+ imaging comparing eKO and wild-type mice show that Kir6.1-containing K-ATP channels are indeed present in vascular endothelium. An increase in intracellular [Ca2+], which is central to changes in endothelial function such as mediator release, at least partly contributes to the endothelium-dependent vasorelaxation induced by the K-ATP channel opener pinacidil. The absence of Kir6.1 did not elevate basal coronary perfusion pressure in eKO mice. However, vasorelaxation was impaired during hypoxia in the coronary circulation, and this resulted in greater cardiac injury during ischemia-reperfusion. The response to adenosine receptor stimulation was impaired in eKO mice in single cells in patch clamp recordings and in the intact coronary circulation. Our data support the existence of an endothelial K-ATP channel that contains Kir6.1, is involved in vascular reactivity in the coronary circulation, and has a protective role in ischemia reperfusion.	[Aziz, Qadeer; Li, Yiwen; Anderson, Naomi; Ojake, Leona; Tsisanova, Elena; Tinker, Andrew] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Heart Ctr, Charterhouse Sq, London EC1M 6BQ, England	University of London; Queen Mary University London	Tinker, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Heart Ctr, Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Tsisanova, Elena/P-5553-2018	Tsisanova, Elena/0000-0003-3927-7894; Aziz, Qadeer/0000-0002-7636-6813; Aziz, Qasim/0000-0002-2718-2065	British Heart Foundation [RG/15/15/31742]; British Heart Foundation [PG/17/59/33139] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grant RG/15/15/31742 and was facilitated by the National Institute for Health Research Biomedical Research Centre at Barts. The authors declare that they have no conflicts of interest with the contents of this article.	Aziz Q, 2015, CHANNELS, V9, P3, DOI 10.1080/19336950.2015.1004289; Aziz Q, 2014, HYPERTENSION, V64, P523, DOI 10.1161/HYPERTENSIONAHA.114.03116; Aziz Q, 2012, J BIOL CHEM, V287, P6196, DOI 10.1074/jbc.M111.243923; Bell RM, 2011, J MOL CELL CARDIOL, V50, P940, DOI 10.1016/j.yjmcc.2011.02.018; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cheng K. T., 2016, VASCULAR ION CHANNEL; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; DART C, 1993, J PHYSIOL-LONDON, V471, P767, DOI 10.1113/jphysiol.1993.sp019927; Edwards DH, 2008, ARTERIOSCL THROM VAS, V28, P1774, DOI 10.1161/ATVBAHA.108.172692; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Fedorov VV, 2011, J MOL CELL CARDIOL, V51, P215, DOI 10.1016/j.yjmcc.2011.04.016; Gao S, 2009, CARDIOVASC RES, V83, P444, DOI 10.1093/cvr/cvp099; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Katnik C, 1997, AM J PHYSIOL-HEART C, V272, pH2507, DOI 10.1152/ajpheart.1997.272.5.H2507; KATNIK C, 1995, J PHYSIOL-LONDON, V485, P595, DOI 10.1113/jphysiol.1995.sp020755; Kleppisch T, 1995, P NATL ACAD SCI USA, V92, P12441, DOI 10.1073/pnas.92.26.12441; KUO L, 1995, AM J PHYSIOL-HEART C, V269, pH541, DOI 10.1152/ajpheart.1995.269.2.H541; Langheinrich U, 1998, PFLUG ARCH EUR J PHY, V435, P435, DOI 10.1007/s004240050536; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Malester B, 2007, FASEB J, V21, P2162, DOI 10.1096/fj.06-7821com; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Pagliaro P, 2000, CARDIOVASC RES, V45, P1001, DOI 10.1016/S0008-6363(99)00414-9; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; QUAYLE JM, 1994, J PHYSIOL-LONDON, V475, P9, DOI 10.1113/jphysiol.1994.sp020045; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; RANDALL MD, 1995, BRIT J PHARMACOL, V116, P3068, DOI 10.1111/j.1476-5381.1995.tb15965.x; Rossello X, 2016, J CARDIOVASC PHARM T, V21, P286, DOI 10.1177/1074248415604462; Schnitzler MMY, 2000, J PHYSIOL-LONDON, V525, P307, DOI 10.1111/j.1469-7793.2000.t01-1-00307.x; Seino S, 2004, J PHYSIOL-LONDON, V554, P295, DOI 10.1113/jphysiol.2003.047175; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; Wang H, 2007, CARDIOVASC RES, V73, P497, DOI 10.1016/j.cardiores.2006.10.007; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022	40	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17587	17597		10.1074/jbc.M117.810325	http://dx.doi.org/10.1074/jbc.M117.810325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893911	hybrid, Green Published			2022-12-28	WOS:000414013000002
J	Rohrbeck, A; Holtje, M; Adolf, A; Oms, E; Hagemann, S; Ahnert-Hilger, G; Just, I				Rohrbeck, Astrid; Hoeltje, Markus; Adolf, Andrej; Oms, Elisabeth; Hagemann, Sandra; Ahnert-Hilger, Gudrun; Just, Ingo			The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; MICROVASCULAR ENDOTHELIAL-CELLS; JAPANESE ENCEPHALITIS-VIRUS; FILAMENT PROTEIN VIMENTIN; DISINTEGRIN-LIKE DOMAIN; CLOSTRIDIUM-BOTULINUM; STAPHYLOCOCCUS-AUREUS; CYTOPLASMIC TAIL; EPITHELIAL-CELLS; RGD MOTIF	The Rho ADP-ribosylating C3 exoenzyme (C3bot) is a bacterial protein toxin devoid of a cell-binding or-translocation domain. Nevertheless, C3 can efficiently enter intact cells, including neurons, but the mechanism of C3 binding and uptake is not yet understood. Previously, we identified the intermediate filament vimentin as an extracellular membranous interaction partner of C3. However, uptake of C3 into cells still occurs (although reduced) in the absence of vimentin, indicating involvement of an additional host cell receptor. C3 harbors an Arg-Gly-Asp (RGD) motif, which is the major integrin-binding site, present in a variety of integrin ligands. To check whether the RGD motif of C3 is involved in binding to cells, we performed a competition assay with C3 and RGD peptide or with a monoclonal antibody binding to beta 1-integrin subunit and binding assays in different cell lines, primary neurons, and synaptosomes with C3-RGD mutants. Here, we report that preincubation of cells with the GRGDNP peptide strongly reduced C3 binding to cells. Moreover, mutation of the RGD motif reduced C3 binding to intact cells and also to recombinant vimentin. Anti-integrin antibodies also lowered the C3 binding to cells. Our results indicate that the RGD motif of C3 is at least one essential C3 motif for binding to host cells and that integrin is an additional receptor for C3 besides vimentin.	[Rohrbeck, Astrid; Oms, Elisabeth; Hagemann, Sandra; Just, Ingo] Hannover Med Sch, Inst Toxicol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Hoeltje, Markus; Adolf, Andrej; Ahnert-Hilger, Gudrun] Charite, Inst Integrat Neuroanat, D-10115 Berlin, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohrbeck, A (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	rohrbeck.astrid@mh-hannover.de		Holtje, Markus/0000-0003-3193-4140	Deutsche Forschungsgemeinschaft (DFG) [JU 231/7-1, RO 5129/2-1, AH 67/10-1, HO 3249/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants JU 231/7-1 (to I. J.), RO 5129/2-1 (to A. R.), AH 67/10-1 (to G. A. H.), and HO 3249/5-1 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolf A, 2016, J NEUROCHEM, V139, P234, DOI 10.1111/jnc.13739; Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Becher A, 1999, J NEUROSCI, V19, P1922; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Eckes B, 2000, J CELL SCI, V113, P2455; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Gianni T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003806; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gilles C, 1999, J CELL SCI, V112, P4615; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Homan SM, 1998, J CELL SCI, V111, P2717; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; JUST I, 1992, J BIOL CHEM, V267, P10274; Khan TA, 2016, BIOCHEMISTRY-US, V55, P2078, DOI 10.1021/acs.biochem.5b01243; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kim J, 2016, J CELL SCI, V129, P2030, DOI 10.1242/jcs.180315; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lutschg V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1391; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mak TN, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020018; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pall T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029305; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; PONCZ M, 1990, BLOOD, V75, P1282; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rohrbeck A, 2016, TOXINS, V8, DOI 10.3390/toxins8040100; Rohrbeck A, 2015, TOXINS, V7, P380, DOI 10.3390/toxins7020380; Rohrbeck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101071; Rotsch J, 2012, N-S ARCH PHARMACOL, V385, P883, DOI 10.1007/s00210-012-0764-9; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Walker LR, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-015-0066-2; Walker LR, 2014, J GEN VIROL, V95, P1770, DOI 10.1099/vir.0.066829-0; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Yang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38372; Yu YTC, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0234-7; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	95	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17668	17680		10.1074/jbc.M117.798231	http://dx.doi.org/10.1074/jbc.M117.798231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882889	Green Published, hybrid			2022-12-28	WOS:000414013000009
J	Chouchani, ET; Kazak, L; Spiegelman, BM				Chouchani, Edward T.; Kazak, Lawrence; Spiegelman, Bruce M.			Mitochondrial reactive oxygen species and adipose tissue thermogenesis: Bridging physiology and mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						adipocyte; adipose tissue; adipose tissue metabolism; mitochondria; reactive oxygen species (ROS); thermogenesis	DIET-INDUCED OBESITY; BROWN-FAT MITOCHONDRIA; INSULIN SENSITIVITY; UNCOUPLING PROTEINS; ENERGY-EXPENDITURE; OXIDATIVE-PHOSPHORYLATION; ISOCITRATE DEHYDROGENASE; PROTON CONDUCTANCE; DIVERGENT ROLES; MICE LACKING	Brown and beige adipose tissues can catabolize stored energy to generate heat, relying on the principal effector of thermogenesis: uncoupling protein 1 (UCP1). This unique capability could be leveraged as a therapy for metabolic disease. Numerous animal and cellular models have now demonstrated that mitochondrial reactive oxygen species (ROS) signal to support adipocyte thermogenic identity and function. Herein, we contextualize these findings within the established principles of redox signaling and mechanistic studies of UCP1 function. We provide a framework for understanding the role of mitochondrial ROS signaling in thermogenesis together with testable hypotheses for understanding mechanisms and developing therapies.	[Chouchani, Edward T.; Kazak, Lawrence; Spiegelman, Bruce M.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Chouchani, Edward T.; Kazak, Lawrence; Spiegelman, Bruce M.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.; Spiegelman, BM (corresponding author), Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Chouchani, Edward T./HCH-3775-2022		National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK31405. This is the second article in the Thematic Minireview Series "Redox metabolism and signaling." B. M. S. is a consultant to Calico LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Barbato DL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13091; Bertholet AM, 2017, BIOCHIMIE, V134, P28, DOI 10.1016/j.biochi.2016.10.013; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; DEQUIROGA GB, 1991, BIOCHEM J, V277, P289, DOI 10.1042/bj2770289; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; Heppner DE, 2017, ARCH BIOCHEM BIOPHYS, V616, P40, DOI 10.1016/j.abb.2017.01.008; HITTELMAN KJ, 1969, EUR J BIOCHEM, V11, P183, DOI 10.1111/j.1432-1033.1969.tb00759.x; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Lee SJ, 2016, FREE RADICAL BIO MED, V99, P179, DOI 10.1016/j.freeradbiomed.2016.08.011; Lob HE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87094; LOCKE RM, 1982, EUR J BIOCHEM, V129, P373, DOI 10.1111/j.1432-1033.1982.tb07060.x; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Malingriaux EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077786; Martinez-Acedo P, 2014, J MASS SPECTROM, V49, P257, DOI 10.1002/jms.3336; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Nicholls DG, 2017, BIOCHIMIE, V134, P9, DOI 10.1016/j.biochi.2016.09.003; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; RAFAEL J, 1969, H-S Z PHYSIOL CHEM, V350, P1121, DOI 10.1515/bchm2.1969.350.2.1121; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Rhee SG, 2016, FREE RADICAL BIO MED, V99, P120, DOI 10.1016/j.freeradbiomed.2016.07.029; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Ro SH, 2014, P NATL ACAD SCI USA, V111, P7849, DOI 10.1073/pnas.1401787111; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Sanchez-Alavez Manuel, 2014, Temperature (Austin), V1, P227; Sanchez-Alavez Manuel, 2013, Front Endocrinol (Lausanne), V4, P44, DOI 10.3389/fendo.2013.00044; Schneider K, 2016, J BIOL CHEM, V291, P7754, DOI 10.1074/jbc.M115.673756; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shannon DA, 2015, CURR OPIN CHEM BIOL, V24, P18, DOI 10.1016/j.cbpa.2014.10.021; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Stier A, 2014, J EXP BIOL, V217, P624, DOI 10.1242/jeb.092700; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yang J, 2016, MOL CELL PROTEOMICS, V15, P1, DOI 10.1074/mcp.O115.056051	58	58	58	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16810	16816		10.1074/jbc.R117.789628	http://dx.doi.org/10.1074/jbc.R117.789628			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842500	Green Published, hybrid			2022-12-28	WOS:000413140600003
J	Ning, YJ; Feng, K; Min, YQ; Deng, F; Hu, ZH; Wang, HL				Ning, Yun-Jia; Feng, Kuan; Min, Yuan-Qin; Deng, Fei; Hu, Zhihong; Wang, Hualin			Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOCYTOPENIA SYNDROME VIRUS; NF-KAPPA-B; SEVERE FEVER; RIG-I; ADAPTER PROTEIN; BUNYAVIRIDAE PHLEBOVIRUS; NONSTRUCTURAL PROTEIN; UNITED-STATES; IKK-EPSILON; INNATE	Heartland virus (HRTV) is a pathogenic phlebovirus related to the severe fever with thrombocytopenia syndrome virus (SFTSV), another phlebovirus causing life-threatening disease in humans. Previous findings have suggested that SFTSV can antagonize the host interferon (IFN) system via viral nonstructural protein (NSs)-mediated sequestration of antiviral signaling proteins into NSs-induced inclusion bodies. However, whether and how HRTV counteracts the host innate immunity is unknown. Here, we report that HRTV NSs (HNSs) also antagonizes IFN and cytokine induction and bolsters viral replication, although no noticeable inclusion body formation was observed in HNSs-expressing cells. Furthermore, HNSs inhibited the virus-triggered activation of IFN-beta promoter by specifically targeting the IFN-stimulated response element but not the NF-kappa B response element. Consistently, HNSs blocked the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3, an IFN-stimulated response element-activating transcription factor). Reporter gene assays next showed that HNSs blockades the antiviral signaling mediated by RIG-I-like receptors likely at the level of TANK-binding kinase 1 (TBK1). Indeed, HNSs strongly interacts with TBK1 as indicated by confocal microscopy and pulldown analyses, and we also noted that the scaffold dimerization domain of TBK1 is required for the TBK1-HNSs interaction. Finally, pulldown assays demonstrated that HNSs expression dose-dependently diminishes a TBK1-IRF3 interaction, further explaining the mechanism for HNSs function. Collectively, these data suggest that HNSs, an antagonist of host innate immunity, interacts with TBK1 and thereby hinders the association of TBK1 with its substrate IRF3, thus blocking IRF3 activation and transcriptional induction of the cellular antiviral responses.	[Ning, Yun-Jia; Feng, Kuan; Min, Yuan-Qin; Deng, Fei; Hu, Zhihong; Wang, Hualin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Feng, Kuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.	h.wang@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928	National Natural Science Foundation of China [31621061, 31600144]; strategic priority research program of the Chinese Academy of Sciences [XDPB0301]; National Basic Research Program (973 Program) of China [2013CB911101]; Science and Technology Basic Work Program [2013FY113500]; National Key Research and Development Program of China [2016YFC1200400, 2016YFE0113500]; European Union's Horizon 2020 project European Virus Archive goes global (EVAg) [653316]; Hubei Provincial Natural Science Foundation of China [2016CFB124]; "One-Three-Five" Research Program of Wuhan Institute of Virology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); strategic priority research program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Science and Technology Basic Work Program; National Key Research and Development Program of China; European Union's Horizon 2020 project European Virus Archive goes global (EVAg); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "One-Three-Five" Research Program of Wuhan Institute of Virology	This work was supported by the National Natural Science Foundation of China (31621061 and 31600144), the strategic priority research program of the Chinese Academy of Sciences (XDPB0301), the National Basic Research Program (973 Program) of China (2013CB911101), the Science and Technology Basic Work Program (2013FY113500), the National Key Research and Development Program of China (2016YFC1200400 and 2016YFE0113500), European Union's Horizon 2020 project European Virus Archive goes global (EVAg, Grant 653316), the Hubei Provincial Natural Science Foundation of China (2016CFB124), and the "One-Three-Five" Research Program of Wuhan Institute of Virology. The authors declare that they have no conflicts of interest with the contents of this article.	Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472; Bosco-Lauth AM, 2015, AM J TROP MED HYG, V92, P1163, DOI 10.4269/ajtmh.14-0702; Chen H, 2013, J MOL CELL BIOL, V5, P111, DOI 10.1093/jmcb/mjt006; Denic S, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/204056; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fill MMA, 2017, CLIN INFECT DIS, V64, P510, DOI 10.1093/cid/ciw766; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gowen BB, 2017, J VIROL, V91, DOI 10.1128/JVI.01942-16; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DY, 2015, CURR OPIN VIROL, V12, P26, DOI 10.1016/j.coviro.2015.02.005; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuno K, 2015, J VIROL, V89, P594, DOI 10.1128/JVI.02704-14; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muehlenbachs A, 2014, CLIN INFECT DIS, V59, P845, DOI 10.1093/cid/ciu434; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P270; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Ran Y, 2016, J MOL CELL BIOL, V8, P31, DOI 10.1093/jmcb/mjv068; Riemersma KK, 2015, EMERG INFECT DIS, V21, P1830, DOI 10.3201/eid2110.150380; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wang YY, 2012, CELL HOST MICROBE, V12, P129, DOI 10.1016/j.chom.2012.07.006; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wu XD, 2014, FASEB J, V28, P2504, DOI 10.1096/fj.13-243857; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	54	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16722	16733		10.1074/jbc.M117.805127	http://dx.doi.org/10.1074/jbc.M117.805127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28848048	Green Published, hybrid			2022-12-28	WOS:000412414800031
J	Amireddy, N; Puttapaka, SN; Vinnakota, RL; Ravuri, HG; Thonda, S; Kalivendi, SV				Amireddy, Niharika; Puttapaka, Srinivas N.; Vinnakota, Ravali L.; Ravuri, Halley G.; Thonda, Swaroop; Kalivendi, Shasi V.			The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED ANTIOXIDANT MITOQ; DISEASE; DYSFUNCTION; PINK1; 2,4-DINITROPHENOL; NEUROPROTECTION; DEGENERATION; INHIBITION; PROTEINS; THERAPY	Mitochondria play a primary role in the pathophysiology of Parkinson's disease (PD), and small molecules that counteract the initial stages of disease may offer therapeutic benefit. In this regard, we have examined whether the off- target effects of the Food and Drug Administration (FDA)-approved anti-helminth drug nitazoxanide (NTZ) on mitochondrial respiration could possess any therapeutic potential for PD. Results indicate that MPP+ - induced loss in oxygen consumption rate (OCR) and ATP production by mitochondria were ameliorated byNTZin real time by virtue of its mild uncoupling effect. Pretreatment of cells with NTZ mitigated MPP+ - induced loss in mitochondrial OCR and reactive oxygen species (ROS). Similarly, addition of NTZ to cells pretreated with MPP+ could reverse block in mitochondrialOCRand reactive oxygen species induced by MPP+ in real time. The observed effects of NTZ were found to be transient and reversible as removal of NTZ from incubation medium restored the mitochondrial respiration tothatofcontrols. Apoptosisinducedby MPP+ wasamelioratedby NTZ in a dose-dependent manner. In vivo results demonstrated that oral administration of NTZ (50 mg/kg) in an acute MPTP mouse model of PD conferred significant protection against the loss of tyrosine hydroxylase (TH)-positive neurons of substantia nigra. Based on the above observationswebelieve that repurposing of NTZ for PD may offer therapeutic benefit.	[Amireddy, Niharika; Puttapaka, Srinivas N.; Vinnakota, Ravali L.; Thonda, Swaroop; Kalivendi, Shasi V.] Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Telangana State, India; [Ravuri, Halley G.] Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Pharmacol & Toxicol, Uppal Rd, Hyderabad 500007, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Telangana State, India.	kalivendi@iict.res.in	Ravuri, Halley/AAD-2517-2021					Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Carvalho C, 2015, EXPERT REV NEUROTHER, V15, P867, DOI 10.1586/14737175.2015.1058160; Cole GM, 2003, NEURON, V37, P889, DOI 10.1016/S0896-6273(03)00160-0; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; Di Santo N, 2014, MUTAT RES-FUND MOL M, V768, P16, DOI 10.1016/j.mrfmmm.2014.05.005; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gassen M, 1999, J NEURAL TRANSM-SUPP, P193; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kalivendi SV, 2010, FREE RADICAL BIO MED, V48, P377, DOI 10.1016/j.freeradbiomed.2009.10.045; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kieburtz K, 2006, NEUROLOGY, V66, pS50, DOI 10.1212/WNL.66.10_suppl_4.S50; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Lam KKY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002691; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MIZUNO Y, 1987, BIOCHEM BIOPH RES CO, V143, P294, DOI 10.1016/0006-291X(87)90664-4; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Norris EH, 2005, ANTIOXID REDOX SIGN, V7, P673; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1; Requejo-Aguilar R, 2016, FREE RADICAL BIO MED, V100, P123, DOI 10.1016/j.freeradbiomed.2016.04.012; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Sahdeo S, 2014, MITOCHONDRION, V17, P116, DOI 10.1016/j.mito.2014.07.002; Schapira A. H., 2011, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011/159160; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Torok N, 2016, EXPERT OPIN INV DRUG, V25, P1281, DOI 10.1080/13543784.2016.1237501; TREVOR AJ, 1987, J NEURAL TRANSM, P73; White Clinton A Jr, 2004, Expert Rev Anti Infect Ther, V2, P43; Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802	43	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15731	15743		10.1074/jbc.M117.791863	http://dx.doi.org/10.1074/jbc.M117.791863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28798236	Green Published, hybrid			2022-12-28	WOS:000411512200013
J	Jin, HL; Xie, QP; Guo, XR; Xu, JH; Wang, A; Li, JX; Zhu, JL; Wu, XR; Huang, HS; Huang, CS				Jin, Honglei; Xie, Qipeng; Guo, Xirui; Xu, Jiheng; Wang, Annette; Li, Jingxia; Zhu, Junlan; Wu, Xue-Ru; Huang, Haishan; Huang, Chuanshu			p63 alpha protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION CONTRIBUTES; LAMELLIPODIA FORMATION; TUMOR PROGRESSION; P63 EXPRESSION; CELL-MIGRATION; METASTASIS; WAVE3; SURVIVAL; GENE; ACTIVATION	Bladder cancer (BC) is the sixth most common cancer in the United States and is the number one cause of death among patients with urinary system malignancies. This makes the identification of invasive regulator(s)/effector(s) as the potential therapeutic targets for managing BC a high priority. p63 is a member of the p53 family of tumor suppressor genes/proteins, plays a role in the differentiation of epithelial tissues, and is believed to function as a tumor suppressor. However, it remains unclear whether and how p63 functions in BC cell invasion after tumorigenesis. Here, we show that p63 alpha protein levels were much higher in mouse high-invasive BC tissues than in normal tissues. Our results also revealed that p63 alpha is crucial for heat shock protein 70 (Hsp70) expression and subsequently increases the ability of BC invasion. Mechanistic experiments demonstrated that p63 alpha can transcriptionally up-regulate Hsp70 expression, thereby promoting BC cell invasion via the Hsp70/Wasf3/Wave3/MMP-9 axis. Wefurther show that E2F transcription factor 1 (E2F1) mediates p63 alpha overexpressioninduced Hsp70 transcription. We also found that p63 alpha overexpression activates E2F1 transcription, which appears to be stimulated by p63 alpha together with E2F1. Collectively, our results demonstrate that p63 alpha is a positive regulator of BC cell invasion after tumorigenesis, providing significant insights into the biological function of p63 alpha in BC and supporting the notion that p63 alpha might be a potential target for invasive BC therapy.	[Jin, Honglei; Guo, Xirui; Xu, Jiheng; Wang, Annette; Li, Jingxia; Zhu, Junlan; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA; [Jin, Honglei; Xie, Qipeng; Huang, Haishan] Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst Manha, New York, NY 10010 USA	New York University; Wenzhou Medical University; New York University; New York University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.; Huang, HS (corresponding author), Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China.	haishan_333@163.com; chuanshu.huang@nyumc.org	Xu, Jiheng/AAV-5732-2020	Xu, Jiheng/0000-0002-3538-3174; Wu, Xue-Ru/0000-0001-6058-6291; Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health [CA112557, CA165980]; NCI [CA177665]; NIEHS [ES000260]; Natural Science Foundation of China [NSFC81773391, NSFC81702530, NSFC81372946, NSFC81601849]; Key Project of Science and Technology Innovation Team of Zhejiang Province [2013TD10]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology Innovation Team of Zhejiang Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557, CA165980, and CA177665 (NCI) and ES000260 (NIEHS). This work was also supported by the Natural Science Foundation of China (NSFC81773391, NSFC81702530, NSFC81372946, and NSFC81601849) and the Key Project of Science and Technology Innovation Team of Zhejiang Province (2013TD10). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; [Anonymous], 2017, J BIOL CHEM, V292, P15952; Armstrong SR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122041; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Candi E, 2014, HUM MUTAT, V35, P702, DOI 10.1002/humu.22523; Canoz Ozlem, 2002, Pathology & Oncology Research, V8, P262; Cowan NC, 2010, CURR OPIN UROL, V20, P409, DOI 10.1097/MOU.0b013e32833cbcb9; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fang Y, 2013, MOL CANCER THER, V12, P1492, DOI 10.1158/1535-7163.MCT-12-0922; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Giacobbe A, 2013, CELL CYCLE, V12, P1395, DOI 10.4161/cc.24478; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Jin HL, 2015, ONCOTARGET, V6, P522, DOI 10.18632/oncotarget.2680; Juhasz K, 2014, CANCERS, V6, P42, DOI 10.3390/cancers6010042; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MURPHY WM, 1984, CANCER, V53, P1555, DOI 10.1002/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G; Park BJ, 2000, CANCER RES, V60, P3370; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wu GJ, 2003, CANCER RES, V63, P2351; Xie QP, 2016, ONCOTARGET, V7, P16636, DOI 10.18632/oncotarget.7674; Xu JW, 2016, ONCOTARGET, V7, P34112, DOI 10.18632/oncotarget.8746; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu Y, 2014, ONCOGENE, V33, P996, DOI 10.1038/onc.2013.8; Zhang DY, 2015, J BIOL CHEM, V290, P4784, DOI 10.1074/jbc.M114.598219; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	61	19	19	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15952	15963		10.1074/jbc.M117.792010	http://dx.doi.org/10.1074/jbc.M117.792010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794159	Green Published, hybrid			2022-12-28	WOS:000411512200031
J	Oda, T; Hirabayashi, H; Shikauchi, G; Takamura, R; Hiraga, K; Minami, H; Hashimoto, H; Yamamoto, M; Wakabayashi, K; Shimizu, T; Sato, M				Oda, Takashi; Hirabayashi, Hirokazu; Shikauchi, Gen; Takamura, Ryouma; Hiraga, Kiyoshi; Minami, Hiroshi; Hashimoto, Hiroshi; Yamamoto, Masafumi; Wakabayashi, Keiji; Shimizu, Toshiyuki; Sato, Mamoru			Structural basis of autoinhibition and activation of the DNA-targeting ADP-ribosyltransferase pierisin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING PROTEIN; MOSQUITOCIDAL TOXIN; BACILLUS-SPHAERICUS; RIBOSYLATING TOXIN; STRUCTURE VALIDATION; MOLECULAR-CLONING; PURIFICATION; RECOGNITION; FAMILY; MONO(ADP-RIBOSYL)ATION	ADP-ribosyltransferases transfer the ADP-ribose moiety of beta NAD(+) to an acceptor molecule, usually a protein that modulates the function of the acceptor. Pierisin-1 is an ADP-ribosyltransferase from the cabbage butterfly Pieris rapae and is composed of N-terminal catalytic and C-terminal ricin B-like domains. Curiously, it ADP-ribosylates the DNA duplex, resulting in apoptosis of various cancer cells, which has raised interest in pierisin-1 as an anti-cancer agent. However, both the structure and the mechanism of DNA ADP-ribosylation are unclear. Here, we report the crystal structures of the N-terminal catalytic domain of pierisin-1, its complex with beta NAD(+), and the catalytic domain with the linker connecting it to the ricin B-like domains. We found that the catalytic domain possesses a defined, positively charged region on the molecular surface but that its overall structure is otherwise similar to those of proteintargeting ADP-ribosyltransferases. Electrophoretic mobility shift assays and site-directed mutagenesis indicated that pierisin- 1 binds double-stranded but not single-stranded DNA and that Lys(122), Lys(123), and Lys(124), which are found in a loop, and Arg(181) and Arg(187), located in a basic cleft near the loop, are required for DNA binding. Furthermore, the structure of the catalytic domain with the linker revealed an autoinhibitory mechanism in which the linker occupies and blocks both the beta NAD(+) - and DNA-binding sites, suggesting that proteolytic cleavage to remove the linker is necessary for enzyme catalysis. Our study provides a structural basis for the DNA-acceptor specificity of pierisin-1 and reveals that a self-regulatory mechanism is required for its activity.	[Oda, Takashi; Hirabayashi, Hirokazu; Shikauchi, Gen; Takamura, Ryouma; Hiraga, Kiyoshi; Minami, Hiroshi; Hashimoto, Hiroshi; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan; [Yamamoto, Masafumi] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Yokohama City University; University of Shizuoka; University of Shizuoka; University of Tokyo	Sato, M (corresponding author), Yokohama City Univ, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	msato@tsurumi.yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Carpusca I, 2006, MOL MICROBIOL, V62, P621, DOI 10.1111/j.1365-2958.2006.05401.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kanazawa T, 2001, P NATL ACAD SCI USA, V98, P2226, DOI 10.1073/pnas.051628898; Kono T, 1999, CANCER LETT, V137, P75, DOI 10.1016/S0304-3835(98)00346-2; Koyama K, 1996, JPN J CANCER RES, V87, P1259, DOI 10.1111/j.1349-7006.1996.tb03141.x; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Matsumoto Y, 2008, P NATL ACAD SCI USA, V105, P2516, DOI 10.1073/pnas.0712221105; Matsushima-Hibiya Y, 2000, EUR J BIOCHEM, V267, P5742, DOI 10.1046/j.1432-1327.2000.01640.x; Matsushima-Hibiya Y, 2003, J BIOL CHEM, V278, P9972, DOI 10.1074/jbc.M212114200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2006, P NATL ACAD SCI USA, V103, P13652, DOI 10.1073/pnas.0606140103; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Orth JHC, 2011, TOXICON, V57, P199, DOI 10.1016/j.toxicon.2010.11.011; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinert DJ, 2006, J MOL BIOL, V357, P1226, DOI 10.1016/j.jmb.2006.01.025; Schirmer J, 2002, J BIOL CHEM, V277, P11941, DOI 10.1074/jbc.M108463200; Schirmer J, 2002, APPL ENVIRON MICROB, V68, P4894, DOI 10.1128/AEM.68.10.4894-4899.2002; Subbarayan S, 2016, INT J BIOL MACROMOL, V87, P16, DOI 10.1016/j.ijbiomac.2016.01.072; Takamura-Enya T, 2004, BIOCHEM BIOPH RES CO, V323, P579, DOI 10.1016/j.bbrc.2004.08.132; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; THANABALU T, 1992, J BACTERIOL, V174, P5051, DOI 10.1128/JB.174.15.5051-5056.1992; Treiber N, 2008, J MOL BIOL, V381, P150, DOI 10.1016/j.jmb.2008.05.067; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watanabe M, 1999, P NATL ACAD SCI USA, V96, P10608, DOI 10.1073/pnas.96.19.10608; Watanabe M, 1998, JPN J CANCER RES, V89, P556, DOI 10.1111/j.1349-7006.1998.tb03297.x; Watanabe M, 2004, COMP BIOCHEM PHYS A, V139, P125, DOI 10.1016/j.cbpb.2004.07.010; Watanabe M, 2004, J BIOCHEM, V135, P471, DOI 10.1093/jb/mvh062; Yamamoto M, 2009, COMP BIOCHEM PHYS B, V154, P326, DOI 10.1016/j.cbpb.2009.07.007	41	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15445	15455		10.1074/jbc.M117.776641	http://dx.doi.org/10.1074/jbc.M117.776641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765284	Green Published, hybrid			2022-12-28	WOS:000410809800024
J	Miranda, MZ; Bialik, JF; Speight, P; Dan, QH; Yeung, T; Szaszi, K; Pedersen, SF; Kapus, A				Miranda, Maria Zena; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Yeung, Tony; Szaszi, Katalin; Pedersen, Stine F.; Kapus, Andras			TGF-beta 1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; YES-ASSOCIATED PROTEIN; SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; TGF-BETA; MYOFIBROBLAST TRANSITION; STEM-CELLS; HIPPO PATHWAY; OSTEOGENIC DIFFERENTIATION	Hippo pathway transcriptional coactivators TAZ and YAP and the TGF-beta 1 (TGF beta) effector Smad3 regulate a common set of genes, can physically interact, and exhibit multilevel crosstalk regulating cell fate-determining and fibrogenic pathways. However, a key aspect of this cross-talk, TGF beta-mediated regulation of TAZ or YAP expression, remains uncharacterized. Here, we show that TGF beta induces robust TAZ but not YAP protein expression in both mesenchymal and epithelial cells. TAZ levels, and to a lesser extent YAP levels, also increased during experimental kidney fibrosis. Pharmacological or genetic inhibition of Smad3 did not prevent the TGF beta-induced TAZ up-regulation, indicating that this canonical pathway is dispensable. In contrast, inhibition of p38 MAPK, its downstream effector MK2 (e.g. by the clinically approved antifibrotic pirferidone), or Akt suppressed the TGF beta-inducedTAZexpression. Moreover, TGF beta elevated TAZmRNAin a p38-dependent manner. Myocardin-related transcription factor (MRTF) was a central mediator of this effect, as MRTF silencing/inhibition abolished the TGF beta-induced TAZ expression. MRTF overexpression drove the TAZ promoter in a CC(A/T-rich) 6GG (CArG) box-dependent manner and induced TAZ protein expression. TGF beta did not act by promoting nuclear MRTF translocation; instead, it triggered p38-and MK2-mediated, Nox4-promoted MRTF phosphorylation and activation. Functionally, higher TAZ levels increased TAZ/TEAD-dependent transcription and primed cells for enhancedTAZactivity upon a second stimulus (i. e. sphingosine 1-phosphate) that induced nuclear TAZ translocation. In conclusion, our results uncover an important aspect of the cross-talk between TGF beta and Hippo signaling, showing that TGF beta induces TAZ via a Smad3-independent, p38-and MRTF-mediated and yet MRTF translocation-independent mechanism.	[Miranda, Maria Zena; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Yeung, Tony; Szaszi, Katalin; Kapus, Andras] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1T8N, Canada; [Szaszi, Katalin; Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B 1T8N, Canada; [Miranda, Maria Zena; Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON M5B 1T8N, Canada; [Bialik, Janne Folke; Pedersen, Stine F.] Univ Copenhagen, Dept Cell & Dev Biol, DK-2100 Copenhagen, Denmark	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Copenhagen	Kapus, A (corresponding author), Keenan Res Ctr Biomed Sci, Rm 621,209 Victoria St, Toronto, ON M5B 1T8, Canada.	kapusa@smh.ca	Pedersen, Stine Falsig/O-1133-2019	Pedersen, Stine Falsig/0000-0002-3044-7714; Yeung, Tony/0000-0002-1970-5751; Kapus, Andras/0000-0002-6610-9530	Canadian Institutes of Health Research (CIHR) [MOP-106625, MOP-130463]; Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN227-908-13, RGPIN 327407]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-106625 and MOP-130463 (to A. K.), the Kidney Foundation of Canada (to A. K. and K. S.), and Natural Sciences and Engineering Research Council of Canada (NSERC) Grants RGPIN227-908-13 (to A. K.) and RGPIN 327407 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdalla M, 2013, J BIOL CHEM, V288, P33483, DOI 10.1074/jbc.M113.504290; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Bertero T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18277; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bian HJ, 2016, MOL METAB, V5, P970, DOI 10.1016/j.molmet.2016.08.012; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Goettsch C, 2009, BIOCHEM BIOPH RES CO, V380, P355, DOI 10.1016/j.bbrc.2009.01.107; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hayashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10627; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Jorgenson AJ, 2017, AM J PHYSIOL-CELL PH, V312, pC277, DOI 10.1152/ajpcell.00205.2016; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Lee M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153199; Liu CY, 2016, ONCOTARGET, V7, P13706, DOI 10.18632/oncotarget.7333; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2011, CELLS TISSUES ORGANS, V193, P41, DOI 10.1159/000320180; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mourey RJ, 2010, J PHARMACOL EXP THER, V333, P797, DOI 10.1124/jpet.110.166173; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Onwuegbusi BA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000177; Panayiotou R, 2016, ELIFE, V5, DOI 10.7554/eLife.15460; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rogliani P, 2016, PULM PHARMACOL THER, V40, P95, DOI 10.1016/j.pupt.2016.07.009; Ronkina N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31219; Rozycki M, 2016, J BIOL CHEM, V291, P227, DOI 10.1074/jbc.M115.674606; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Sousa AM, 2007, J CELL BIOCHEM, V100, P1581, DOI 10.1002/jcb.21154; Speight P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11642; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Xiang LS, 2014, ONCOTARGET, V5, P12509, DOI 10.18632/oncotarget.2997; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Xue P, 2013, BIOCHEM BIOPH RES CO, V433, P226, DOI 10.1016/j.bbrc.2013.02.088; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	88	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14902	14920		10.1074/jbc.M117.780502	http://dx.doi.org/10.1074/jbc.M117.780502			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739802	Green Published, hybrid			2022-12-28	WOS:000409902100016
J	Yin, N; Lepp, A; Ji, YS; Mortensen, M; Hou, SW; Qi, XM; Myers, CR; Chen, G				Yin, Ning; Lepp, Adrienne; Ji, Yongsheng; Mortensen, Matthew; Hou, Songwang; Qi, Xiao-Mei; Myers, Charles R.; Chen, Guan			The K-Ras effector p38 gamma MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ESTROGEN-RECEPTOR ER; BREAST-CANCER; THERAPEUTIC TARGET; COLON-CANCER; TUMOR-SUPPRESSOR; STRESS-RESPONSE; P38-GAMMA MAPK; GROWTH; ACTIVATION	Mutations in K-Ras and epidermal growth factor receptor (EGFR) are mutually exclusive, but it is not known how K-Ras activation inactivates EGFR, leading to resistance of cancer cells to anti-EGFR therapy. Here, we report that the K-Ras effector p38 gamma MAPK confers intrinsic resistance to small molecular tyrosine kinase inhibitors (TKIs) by concurrently stimulating EGFR gene transcription and protein dephosphorylation. We found that p38 gamma increases EGFR transcription by c-Jun-mediated promoter binding and stimulates EGFR dephosphorylation via activation of protein-tyrosine phosphatase H1 (PTPH1). Silencing the p38 gamma/c-Jun/PTPH1 signaling network increased sensitivities to TKIs in K-Ras mutant cells in which EGFR knockdown inhibited growth. Similar results were obtained with the p38 gamma-specific pharmacological inhibitor pirfenidone. These results indicate that in K-Ras mutant cancers, EGFR activity is regulated by the p38 gamma/c-Jun/PTPH1 signaling network, whose disruption may be a novel strategy to restore the sensitivity to TKIs.	[Yin, Ning; Lepp, Adrienne; Ji, Yongsheng; Mortensen, Matthew; Hou, Songwang; Qi, Xiao-Mei; Myers, Charles R.; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Chen, Guan] Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA	Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.; Chen, G (corresponding author), Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA.	gchen@mcw.edu	Ji, Yongsheng/AAB-7772-2020; Yin, Ning/AAA-7617-2020	Mortensen, Matthew/0000-0002-0629-6856	Department of Veterans Affairs Merit Review Grant [1I01BX002883]; Department of Defense Grant [BC141898]; Cancer Center of the Medical College of Wisconsin; Veterans Affairs [I01BX002883] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Department of Defense Grant(United States Department of Defense); Cancer Center of the Medical College of Wisconsin; Veterans Affairs(US Department of Veterans Affairs)	This study was supported by Department of Veterans Affairs Merit Review Grant 1I01BX002883, Department of Defense Grant BC141898, and the Cancer Center of the Medical College of Wisconsin (to G.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Ashktorab H, 2007, AM J GASTROENTEROL, V102, P2135, DOI 10.1111/j.1572-0241.2007.01400.x; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dolloff NG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001384; Frank D, 2012, J GASTROINTEST ONCOL, V3, P90, DOI 10.3978/j.issn.2078-6891.2011.049; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Grana TM, 2003, CANCER RES, V63, P7807; Hou S., 2010, UCSD NAT MOL, P1038; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hou SW, 2012, J BIOL CHEM, V287, P27895, DOI 10.1074/jbc.M111.335794; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Ma S, 2015, ONCOTARGET, V6, P13320, DOI 10.18632/oncotarget.3645; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2015, STEM CELLS, V33, P2738, DOI 10.1002/stem.2068; Qi XM, 2014, ONCOTARGET, V5, P4269, DOI 10.18632/oncotarget.2001; Qi XM, 2012, J BIOL CHEM, V287, P14681, DOI 10.1074/jbc.M112.349357; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Sabio G, 2010, J CELL SCI, V123, P2596, DOI 10.1242/jcs.066514; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segovia-Mendoza M, 2015, AM J CANCER RES, V5, P2531; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Suresh PS, 2014, MOL CANCER THER, V13, P230, DOI 10.1158/1535-7163.MCT-13-0610; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; van Houdt WJ, 2010, NEOPLASIA, V12, P443, DOI 10.1593/neo.92088; Wang F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-65; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yin N, 2016, ONCOGENE, V35, P1039, DOI 10.1038/onc.2015.158; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	55	6	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15070	15079		10.1074/jbc.M117.779488	http://dx.doi.org/10.1074/jbc.M117.779488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739874	Green Published, hybrid			2022-12-28	WOS:000409902100029
J	Dagnell, M; Pace, PE; Cheng, Q; Frijhoff, J; Ostman, A; Arner, ESJ; Hampton, MB; Winterbourn, CC				Dagnell, Markus; Pace, Paul E.; Cheng, Qing; Frijhoff, Jeroen; Ostman, Arne; Arner, Elias S. J.; Hampton, Mark B.; Winterbourn, Christine C.			Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H2O2 exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE INACTIVATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; OXIDIZED PTP1B; PEROXIREDOXIN; STATE; NITROSYLATION; INHIBITION; ACTIVATION; REGULATOR	Regulation of growth factor signaling involves reversible inactivation of protein tyrosine phosphatases (PTPs) through the oxidation and reduction of their active site cysteine. However, there is limited mechanistic understanding of these redox events and their co-ordination in the presence of cellular antioxidant networks. Here we investigated interactions between PTP1B and the peroxiredoxin 2 (Prx2)/thioredoxin 1 (Trx1)/thioredoxin reductase 1 (TrxR1) network. We found that Prx2 becomes oxidized in PDGF-treated fibroblasts, but only when TrxR1 has first been inhibited. Using purified proteins, we also found that PTP1B is relatively insensitive to inactivation by H2O2 but found no evidence for a relay mechanism in which Prx2 or Trx1 facilitates PTP1B oxidation. Instead, these proteins prevented PTP1B inactivation by H2O2. Intriguingly, we discovered that TrxR1/NADPH directly protects PTP1B from inactivation when present during the H2O2 exposure. This protection was dependent on the concentration of TrxR1 and independent of Trx1 and Prx2. The protection was blocked by auranofin and required an intact selenocysteine residue in TrxR1. This activity likely involves reduction of the sulfenic acid intermediate form of PTP1B by TrxR1 and is therefore distinct from the previously described reactivation of end-point oxidized PTP1B, which requires both Trx1 and TrxR1. The ability of TrxR1 to directly reduce an oxidized phosphatase is a novel activity that can help explain previously observed increases in PTP1B oxidation and PDGF receptor phosphorylation in TrxR1 knockout cells. The activity of TrxR1 is therefore of potential relevance for understanding the mechanisms of redox regulation of growth factor signaling pathways.	[Dagnell, Markus; Pace, Paul E.; Hampton, Mark B.; Winterbourn, Christine C.] Univ Otago, Dept Pathol, Ctr Free Radical Res, Christchurch 8041, New Zealand; [Dagnell, Markus; Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Frijhoff, Jeroen] Maastricht Univ, Fac Hlth Med & Life Sci, Cardiovasc Res Inst, NL-6229 ER Maastricht, Netherlands; [Ostman, Arne] Karolinska Inst, Dept Oncol & Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden	University of Otago; Karolinska Institutet; Maastricht University; Karolinska Institutet	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, Ctr Free Radical Res, Christchurch 8041, New Zealand.	christine.winterbourn@otago.ac.nz	Pace, Paul E/A-3104-2012; Arnér, Elias/K-6737-2019; Hampton, Mark B/A-8490-2008	Pace, Paul E/0000-0003-1855-5760; Arnér, Elias/0000-0002-4807-6114; Hampton, Mark B/0000-0002-7349-3729; Dagnell, Markus/0000-0002-5925-6794	Swedish Research Council [537-2014-360]; Swedish Society of Medicine; Health Research Council of New Zealand	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by Swedish Research Council Grant 537-2014-360, The Swedish Society of Medicine, and the Health Research Council of New Zealand. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; CHARBONNEAU H, 1989, P NATL ACAD SCI USA, V86, P5252, DOI 10.1073/pnas.86.14.5252; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Dagnell M, 2013, P NATL ACAD SCI USA, V110, P13398, DOI 10.1073/pnas.1302891110; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Frijhoff J, 2014, ANTIOXID REDOX SIGN, V20, P1994, DOI 10.1089/ars.2013.5643; Frijhoff J, 2014, FREE RADICAL BIO MED, V68, P268, DOI 10.1016/j.freeradbiomed.2013.12.022; Garcia FJ, 2014, EUR J MED CHEM, V88, P28, DOI 10.1016/j.ejmech.2014.06.040; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; HOPPE E, 1994, EUR J BIOCHEM, V223, P1069, DOI 10.1111/j.1432-1033.1994.tb19085.x; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jayavelu AK, 2016, LEUKEMIA, V30, P473, DOI 10.1038/leu.2015.234; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nourooz-Zadeh J, 1999, METHOD ENZYMOL, V300, P58; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Parsonage D, 2016, J STRUCT BIOL, V194, P180, DOI 10.1016/j.jsb.2016.02.015; Parsons ZD, 2013, BIOCHEMISTRY-US, V52, P6412, DOI 10.1021/bi400451m; PENG X, 2014, CELL DEATH DIS, V5; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schwertassek U, 2014, FEBS J, V281, P3545, DOI 10.1111/febs.12898; Sivaramakrishnan S, 2010, BIOORG MED CHEM LETT, V20, P444, DOI 10.1016/j.bmcl.2009.12.001; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Travasso RDM, 2017, REDOX BIOL, V12, P233, DOI 10.1016/j.redox.2017.01.003; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang J, 2016, J AM CHEM SOC, V138, P10413, DOI 10.1021/jacs.6b06009; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; XU J, 2015, CELL DEATH DIS, V6; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	56	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14371	14380		10.1074/jbc.M117.793745	http://dx.doi.org/10.1074/jbc.M117.793745			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28684416	Green Published, hybrid			2022-12-28	WOS:000408747500006
J	Perez-Leal, O; Barrero, CA; Merali, S				Perez-Leal, Oscar; Barrero, Carlos Alberto; Merali, Salim			Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; molecular pharmacology; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); oxidative stress; translation control	TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE KINASE; WISTAR ALBINO RATS; OXIDATIVE STRESS; EPITHELIAL-CELLS; MAMMALIAN-CELLS; KEAP1; APIGENIN; DISEASE; PATHWAY	Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the master regulator of the antioxidant response, and its function is tightly regulated at the transcriptional, translational, and post-translational levels. It is well-known that Nrf2 is regulated at the protein level by proteasomal degradation via Kelch-like ECH-associated protein 1 (Keap1), but how Nrf2 is regulated at the translational level is less clear. Here, we show that pharmacological stimulation increases Nrf2 levels by overcoming basal translational repression. We developed a novel reporter assay that enabled identification of natural compounds that induce Nrf2 translation by a mechanism independent of Keap1-mediated degradation. Apigenin, resveratrol, and piceatannol all induced Nrf2 translation. More importantly, the pharmacologically induced Nrf2 overcomes Keap1 regulation, translocates to the nucleus, and activates the antioxidant response. We conclude that translational regulation controls physiological levels of Nrf2, and this can be modulated by apigenin, resveratrol, and piceatannol. Also, targeting this mechanism with novel compounds could provide new insights into prevention and treatment of multiple diseases in which oxidative stress plays a significant role.	[Perez-Leal, Oscar; Barrero, Carlos Alberto; Merali, Salim] Temple Univ, Sch Pharm, Moulder Ctr Drug Discovery Res, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Perez-Leal, O; Merali, S (corresponding author), Temple Univ, Sch Pharm, 3307 N Broad St, Philadelphia, PA 19140 USA.	operez@temple.edu; smerali@temple.edu		Barrero, Carlos/0000-0001-5779-6642; Perez-Leal, Oscar/0000-0002-5641-0311	National Institutes of Health [R01AI064017, R03AG051095, R03DK105267-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK105267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG051095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R01AI064017, R03AG051095, and R03DK105267-01. The authors declare that they have a conflict of interest due to a patent application generated with partial data from this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716; Chen C, 2005, TRENDS PHARMACOL SCI, V26, P318, DOI 10.1016/j.tips.2005.04.004; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Huang CS, 2013, ARCH TOXICOL, V87, P167, DOI 10.1007/s00204-012-0913-4; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jennings P, 2013, ARCH TOXICOL, V87, P49, DOI 10.1007/s00204-012-0919-y; Jeyabal PVS, 2005, MOL CARCINOGEN, V44, P11, DOI 10.1002/mc.20115; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kanazawa K, 2006, ARCH BIOCHEM BIOPHYS, V455, P197, DOI 10.1016/j.abb.2006.09.003; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Lee SC, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00122-16; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Li WG, 2010, NUCLEIC ACIDS RES, V38, P778, DOI 10.1093/nar/gkp1048; Lin FM, 2015, HEPATOLOGY, V62, P505, DOI 10.1002/hep.27832; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017; Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Paredes-Gonzalez X, 2014, AAPS J, V16, P727, DOI 10.1208/s12248-014-9613-8; Park EK, 2008, J ENVIRON SCI HEAL B, V43, P71, DOI 10.1080/03601230701735110; Perez-Leal O, 2013, BIOCHEM BIOPH RES CO, V437, P134, DOI 10.1016/j.bbrc.2013.06.052; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Qin S, 2016, MOL NUTR FOOD RES, V60, P1731, DOI 10.1002/mnfr.201501017; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Singh B, 2013, CARCINOGENESIS, V34, P1165, DOI 10.1093/carcin/bgt026; Singh JPV, 2004, PHYTOMEDICINE, V11, P309, DOI 10.1078/0944711041495254; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tong X, 2009, MOL CARCINOGEN, V48, P118, DOI 10.1002/mc.20460; Tong X, 2012, MOL CARCINOGEN, V51, P268, DOI 10.1002/mc.20793; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Vucicevic L, 2011, AUTOPHAGY, V7, P40, DOI 10.4161/auto.7.1.13883; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	74	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14108	14121		10.1074/jbc.M116.770925	http://dx.doi.org/10.1074/jbc.M116.770925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28684421	Green Published, hybrid			2022-12-28	WOS:000408439800017
J	Zhao, T; Ding, XC; Yan, C; Du, H				Zhao, Ting; Ding, Xinchun; Yan, Cong; Du, Hong			Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; endothelial cell; lysosome; tumor metastasis; tumor microenvironment; Rab7 GTPase; lysosomal acid lipase	CANCER-CELL PROLIFERATION; SUPPRESSOR-CELLS; LAL(-/-) MICE; MTOR PATHWAY; ANGIOGENESIS; DISEASE; PROGRESSION; METABOLISM; ACTIVATION; PROMOTES	Tumors depend on their microenvironment for sustained growth, invasion, and metastasis. In this environment, endothelial cells (ECs) are an important stromal cell type interacting with malignant cells to facilitate tumor angiogenesis and cancer cell extravasation. Of note, lysosomal acid lipase (LAL) deficiency facilitates melanoma growth and metastasis. ECs from LAL-deficient (lal(-/-)) mice possess enhanced proliferation, migration, and permeability of inflammatory cells by activating the mammalian target of rapamycin (mTOR) pathway. Here we report that lal(-/-) ECs facilitated in vivo tumor angiogenesis, growth, and metastasis, largely by stimulating tumor cell proliferation, migration, adhesion, and transendothelial migration via increased expression of IL-6 and monocyte chemoattractant protein 1 (MCP-1). This prompted us to look for lysosomal proteins that are involved in lal(-/-) EC dysfunctions. We found that lal(-/-) ECs displayed increased expression of Rab7, a late endosome/lysosome-associated small GTPase. Moreover, Rab7 and mTOR were co-increased and co-localized to lysosomes and physically interacted in lal(-/-) ECs. Rab7 inhibition reversed lal(-/-) EC dysfunctions, including decreasing their enhanced migration and permeability of tumor-stimulatory myeloid cells, and suppressed EC-mediated stimulation of in vitro tumor cell transmigration, proliferation, and migration and in vivo tumor growth and metastasis. Finally, Rab7 inhibition reduced overproduction of reactive oxygen species and increased IL-6 and MCP-1 secretion in lal(-/-) ECs. Our results indicate that metabolic reprogramming resulting from LAL deficiency enhances the ability of ECs to stimulate tumor cell proliferation and metastasis through stimulation of lysosome-anchored Rab7 activity.	[Zhao, Ting; Ding, Xinchun; Yan, Cong; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, 975 W Walnut St,IB424G, Indianapolis, IN 46202 USA; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis	Yan, C; Du, H (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, 975 W Walnut St,IB424G, Indianapolis, IN 46202 USA.	coyan@iupui.edu; hongdu@iupui.edu			National Institutes of Health [HL087001, CA138759, CA152099]; NATIONAL CANCER INSTITUTE [R01CA152099, R01CA138759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL087001 (to H. D.) and CA138759 and CA152099 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso-Curbelo D, 2014, CANCER CELL, V26, P61, DOI 10.1016/j.ccr.2014.04.030; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Ding XC, 2017, ONCOTARGET, V8, P30123, DOI 10.18632/oncotarget.16280; Ding XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121001; Ding XC, 2014, AM J PATHOL, V184, P397, DOI 10.1016/j.ajpath.2013.10.015; Farhan MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135245; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Grabowski G., 2014, ONLINE METABOLIC MOL; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Lee E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05853; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mulligan JK, 2010, J IMMUNOTHER, V33, P126, DOI 10.1097/CJI.0b013e3181b91c9c; Numrich J, 2014, BIOL CHEM, V395, P327, DOI 10.1515/hsz-2013-0258; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Reymond N, 2012, METHODS MOL BIOL, V827, P123, DOI 10.1007/978-1-61779-442-1_9; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yadav A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141602; Yan C, 2014, WORLD J IMMUNOL, V27, P42; Yan CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035076; Young MR, 2012, CANCER IMMUNOL IMMUN, V61, P1609, DOI 10.1007/s00262-012-1335-0; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032; Zhao T, 2015, ONCOGENE, V34, P1938, DOI 10.1038/onc.2014.143; Zhao T, 2016, ONCOTARGET, V7, P61121, DOI 10.18632/oncotarget.11244; Zhao T, 2016, ONCOTARGET, V7, P1529, DOI 10.18632/oncotarget.6414; Zhao T, 2014, J IMMUNOL, V193, P1942, DOI 10.4049/jimmunol.1301941; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	11	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19198	19208		10.1074/jbc.M116.773093	http://dx.doi.org/10.1074/jbc.M116.773093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28924047	hybrid, Green Published			2022-12-28	WOS:000416226700005
J	Opalko, HE; Moseley, JB				Opalko, Hannah E.; Moseley, James B.			Dynamic regulation of Cdr1 kinase localization and phosphorylation during osmotic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; mitosis; protein kinase; protein phosphorylation; Schizosaccharomyces pombe; yeast; Cdr1; Wee1; osmotic stress	ACTIVATED PROTEIN-KINASE; NIM1/CDR1 MITOTIC INDUCER; REQUIRES P38 KINASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; MAP KINASE; HYPERTONIC STRESS; FAMILY KINASE; CHECKPOINT	Environmental conditions modulate cell cycle progression in many cell types. A key component of the eukaryotic cell cycle is the protein kinase Wee1, which inhibits the cyclin-dependent kinase Cdk1 in yeast through human cells. In the fission yeast Schizosaccharomyces pombe, the protein kinase Cdr1 is a mitotic inducer that promotes mitotic entry by phosphorylating and inhibiting Wee1. Cdr1 and Wee1 both localize to punctate structures, termed nodes, on the medial cortex, but it has been unknown whether node localization can be altered by physiological signals. Here we investigated how environmental conditions regulate Cdr1 signaling for cell division. Osmotic stress induced hyperphosphorylation of the mitotic inducer Cdr1 for several hours, and cells delayed division for the same time period. This stress-induced hyperphosphorylation required both Cdr1 autophosphorylation and the stress-activated protein kinase Sty1. During osmotic stress, Cdr1 exited cortical nodes and localized in the cytoplasm. Using a series of truncation mutants, we mapped a C-terminal domain that is necessary and sufficient for Cdr1 node localization and found that Sty1 directly phosphorylates this domain in vitro. Sty1 was not required for Cdr1 exit from nodes, indicating the existence of additional regulatory signals. Both Cdr1 phosphorylation and node localization returned to basal levels when cells adapted to osmotic conditions and resumed cell cycle progression. In summary, we identified a mechanism that prevents Cdr1 colocalization with its inhibitory target Wee1 during osmotic stress. Dynamic regulation of protein localization to cortical nodes might represent a strategy to modulate entry into mitosis under differing environmental conditions.	[Opalko, Hannah E.; Moseley, James B.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA	Dartmouth College	Moseley, JB (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.	james.b.moseley@dartmouth.edu		opalko, hannah/0000-0002-5629-789X	National Institutes of Health [R01 GM099774]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099774 (to J. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Degols G, 1996, MOL CELL BIOL, V16, P2870; Deng L, 2013, MOL BIOL CELL, V24, P1872, DOI 10.1091/mbc.E13-02-0104; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Greenfield E. A., 2014, ANTIBODIES LAB MANUA; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kelkar M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9445; King K, 2013, MOL BIOL CELL, V24, P914, DOI 10.1091/mbc.E12-11-0812; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Aviles S, 2008, MOL BIOL CELL, V19, P1670, DOI 10.1091/mbc.E07-07-0639; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mutavchiev DR, 2016, CURR BIOL, V26, P2921, DOI 10.1016/j.cub.2016.08.048; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Pan KZ, 2014, ELIFE, V3, DOI 10.7554/eLife.02040; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Wu L, 1997, EMBO J, V16, P1342, DOI 10.1093/emboj/16.6.1342; YOUNG PG, 1987, J CELL SCI, V88, P295; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	41	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18457	18468		10.1074/jbc.M117.793034	http://dx.doi.org/10.1074/jbc.M117.793034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924043	hybrid, Green Published			2022-12-28	WOS:000414958100007
J	Nakhleh, J; Christophides, GK; Osta, MA				Nakhleh, Johnny; Christophides, George K.; Osta, Mike A.			The serine protease homolog CLIPA14 modulates the intensity of the immune response in the mosquito Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host defense; host-pathogen interaction; immunology; malaria; plasmodium; clip domain serine protease; melanization; mosquito immunity	PROPHENOLOXIDASE PROPO ACTIVATION; PATTERN-RECOGNITION PROTEIN; TENEBRIO-MOLITOR LARVAE; MASQUERADE-LIKE PROTEIN; COMPLEMENT-LIKE PROTEIN; MANDUCA-SEXTA; PACIFASTACUS-LENIUSCULUS; DROSOPHILA-MELANOGASTER; SYSTEMIC INFECTIONS; PLASMODIUM	Clip domain serine protease homologs (SPHs) are positive and negative regulators of Anopheles gambiae immune responses mediated by the complement-like protein TEP1 against Plasmodium malaria parasites and other microbial infections. We have previously reported that the SPH CLIPA2 is a negative regulator of the TEP1-mediated response by showing that CLIPA2 knockdown (kd) enhances mosquito resistance to infections with fungi, bacteria, and Plasmodium parasites. Here, we identify another SPH, CLIPA14, as a novel regulator of mosquito immunity. We found that CLIPA14 is a hemolymph protein that is rapidly cleaved following a systemic infection. CLIPA14 kd mosquitoes elicited a potent melanization response against Plasmodium berghei ookinetes and exhibited significantly increased resistance to Plasmodium infections as well as to systemic and oral bacterial infections. The activity of the enzyme phenoloxidase, which initiates melanin biosynthesis, dramatically increased in the hemolymph of CLIPA14 kd mosquitoes in response to systemic bacterial infections. Ookinete melanization and hemolymph phenoloxidase activity were further increased after cosilencing CLIPA14 and CLIPA2, suggesting that these two SPHs act in concert to control the melanization response. Interestingly, CLIPA14 RNAi phenotypes and its infection-induced cleavage were abolished in a TEP1 loss-of-function background. Our results suggest that a complex network of SPHs functions downstream of TEP1 to regulate the melanization reaction.	[Nakhleh, Johnny; Osta, Mike A.] Amer Univ Beirut, Dept Biol, Bliss St, Beirut 11072020, Lebanon; [Christophides, George K.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	American University of Beirut; Imperial College London	Osta, MA (corresponding author), Amer Univ Beirut, Dept Biol, Bliss St, Beirut 11072020, Lebanon.	mo07@aub.edu.lb		Christophides, George/0000-0002-3323-1687	American University of Beirut University Research Board; K. A. Shair Award; Lebanese National Council for Scientific Research; Wellcome Trust [093587/Z/10/Z, 107983/Z/15/Z]	American University of Beirut University Research Board; K. A. Shair Award; Lebanese National Council for Scientific Research; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the American University of Beirut University Research Board, K. A. Shair Award, and Lebanese National Council for Scientific Research (to M. A. O. and J. N.). The work at Imperial College London was supported by Wellcome Trust Project Grant 093587/Z/10/Z and Senior Investigator Award 107983/Z/15/Z (to G. K. C.). The authors declare that they have no conflicts of interest with the contents of this article.	An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Jearaphunt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121073; Kamareddine L, 2016, J INNATE IMMUN, V8, P314, DOI 10.1159/000443883; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Sutthangkul J, 2015, J BIOL CHEM, V290, P6470, DOI 10.1074/jbc.M114.605568; Takahashi D, 2015, P NATL ACAD SCI USA, V112, P13856, DOI 10.1073/pnas.1517236112; Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007; Volohonsky G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006113; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2014, INSECT BIOCHEM MOLEC, V50, P82, DOI 10.1016/j.ibmb.2014.04.005; Yassine H, 2014, J INNATE IMMUN, V6, P806, DOI 10.1159/000363296; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	53	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18217	18226		10.1074/jbc.M117.797787	http://dx.doi.org/10.1074/jbc.M117.797787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28928218	Green Published, hybrid			2022-12-28	WOS:000414458200019
J	Xu, YJ; Meng, XX; Hou, X; Sun, JF; Kong, XH; Sun, YQ; Liu, ZY; Ma, YY; Niu, Y; Song, YB; Cui, Y; Zhao, MY; Zhang, JH				Xu, Yijia; Meng, Xiangxue; Hou, Xue; Sun, Jianfang; Kong, Xiaohua; Sun, Yuqi; Liu, Zeyu; Ma, Yuanyuan; Niu, Ye; Song, Yongbo; Cui, Yong; Zhao, Mingyi; Zhang, Jinghai			A mutant of the Buthus martensii Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNa(v)1.4 and hNa(v)1.5 channels while retaining analgesic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; pain; peptides; sodium channel; toxicity; AGAP; Trp38; hNav1; 4; hNav1; 5	MYOCARDIAL-INFARCTION; SODIUM-CHANNELS; SENSORY NEURONS; ESCHERICHIA-COLI; VENOM; EXPRESSION; PAIN; NA(V)1.7; RAT; PURIFICATION	Scorpion toxins can kill other animals by inducing paralysis and arrhythmia, which limits the potential applications of these agents in the clinical management of diseases. Antitumor-analgesic peptide (AGAP), purified from Buthus martensii Karsch, has been proved to possess analgesic and antitumor activities. Trp(38), a conserved aromatic residue of AGAP, might play an important role in mediating AGAP activities according to the sequence and homology-modeling analyses. Therefore, an AGAP mutant, W38G, was generated, and effects of both AGAP and the mutant W38G were examined by whole-cell patch clamp techniques on the sodium channels hNa(v)1.4 and hNa(v)1.5, which were closely associated with the biotoxicity of skeletal and cardiac muscles, respectively. The data showed that both W38G and AGAP inhibited the peak currents of hNa(v)1.4 and hNa(v)1.5; however, W38G induced a much weaker inhibition of both channels than AGAP. Accordingly, W38G exhibited much less toxic effect on both skeletal and cardiac muscles than AGAP in vivo. The analgesic activity of W38G and AGAP were verified in vivo as well, and W38G retained analgesic activity similar to AGAP. Inhibition to both Na(v)1.7 and Na(v)1.8 was involved in the analgesic mechanism of AGAP and W38G. These findings indicated that Trp(38) was a key amino acid involved in the biotoxicity of AGAP, and the AGAP mutant W38G might be a safer alternative for clinical application because it retains the analgesic efficacy with less toxicity to skeletal and cardiac muscles.	[Xu, Yijia; Meng, Xiangxue; Hou, Xue; Kong, Xiaohua; Sun, Yuqi; Liu, Zeyu; Ma, Yuanyuan; Niu, Ye; Song, Yongbo; Zhao, Mingyi] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut Sci, Shenyang 110016, Liaoning, Peoples R China; [Sun, Jianfang] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110004, Liaoning, Peoples R China; [Cui, Yong; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Med Devices, Shenyang 110016, Liaoning, Peoples R China	Shenyang Pharmaceutical University; Northeastern University - China; Shenyang Pharmaceutical University	Zhao, MY (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut Sci, Shenyang 110016, Liaoning, Peoples R China.; Zhang, JH (corresponding author), Shenyang Pharmaceut Univ, Sch Med Devices, Shenyang 110016, Liaoning, Peoples R China.	zmy_dl@126.com; zhangjinghai@syphu.edu.cn			National Key Scientific Project for New Drug Discovery and Development of China [2014ZX09101044-001]; National Natural Science Foundation of China [81202855]; Natural Science Foundation of Liaoning Province [2015020726, 2015020743]; Career Development Support Program of Shenyang Pharmaceutical University for Young and Middle-aged Teachers Grant [13]	National Key Scientific Project for New Drug Discovery and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Career Development Support Program of Shenyang Pharmaceutical University for Young and Middle-aged Teachers Grant	This work was supported by National Key Scientific Project for New Drug Discovery and Development of China Grant 2014ZX09101044-001, National Natural Science Foundation of China Grant 81202855, Natural Science Foundation of Liaoning Province Grants 2015020726 and 2015020743, and Career Development Support Program of Shenyang Pharmaceutical University for Young and Middle-aged Teachers Grant 13. The authors declare that they have no conflicts of interest with the contents of this article.	Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anger T, 2001, J MED CHEM, V44, P115, DOI 10.1021/jm000155h; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Cao P, 2010, BIOTECHNOL PROGR, V26, P1240, DOI 10.1002/btpr.433; Cao ZY, 2004, J PEPT RES, V64, P33, DOI 10.1111/j.1399-3011.2004.00164.x; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chai ZF, 2006, BIOCHEM J, V399, P445, DOI 10.1042/BJ20060035; Chen J, 2006, PEPTIDES, V27, P2182, DOI 10.1016/j.peptides.2006.03.026; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cui Y, 2010, PEPTIDES, V31, P995, DOI 10.1016/j.peptides.2010.03.017; [邓艳萍 Deng Yanping], 2002, [中国药学杂志, Chinese Pharmaceutical Journal], V37, P459; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Du J, 2013, BIOTECHNOL LETT, V35, P861, DOI 10.1007/s10529-013-1167-9; GALEN RS, 1975, HUM PATHOL, V6, P141, DOI 10.1016/S0046-8177(75)80175-4; Galeotti N, 1999, BRIT J PHARMACOL, V126, P1653, DOI 10.1038/sj.bjp.0702467; He XH, 2003, CHINESE MED J-PEKING, V116, P1898; Henderson A. R., 1986, TIETZ TXB CLIN CHEM, P356; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kahlig KM, 2010, BRIT J PHARMACOL, V161, P1414, DOI 10.1111/j.1476-5381.2010.00976.x; King JH, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00154; Lewandrowski Kent, 2002, Am J Clin Pathol, V118 Suppl, pS93; Lin SG, 2017, PROTEIN PEPTIDE LETT, V24, P235, DOI 10.2174/0929866524666170117142404; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Mao QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078239; Marquez MF, 2012, HEART RHYTHM, V9, P1995, DOI 10.1016/j.hrthm.2012.08.027; Meng XX, 2017, INT J BIOL MACROMOL, V99, P105, DOI 10.1016/j.ijbiomac.2017.01.020; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Possani L. D., 1984, HDB NATURAL TOXINS, V2, P513; Quintero-Hernandez V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117188; ROARK SF, 1976, CIRCULATION, V53, P965, DOI 10.1161/01.CIR.53.6.965; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Santibanez-Lopez CE, 2015, TOXICON, V107, P317, DOI 10.1016/j.toxicon.2015.06.029; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Thomas-Tran R, 2016, P NATL ACAD SCI USA, V113, P5856, DOI 10.1073/pnas.1603486113; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Zaharieva IT, 2016, BRAIN, V139, P674, DOI 10.1093/brain/awv352; Zhang XG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00227; Zhao R, 2008, BRIT J PHARMACOL, V154, P1116, DOI 10.1038/bjp.2008.156; Zhou X. H., 1984, PROGR BIOCH BIOPHYS, V56, P20, DOI DOI 10.3390/TOXINS12050326; Zhu HY, 2016, BEHAV BRAIN RES, V308, P166, DOI 10.1016/j.bbr.2016.04.036; Zlotkin E., 1978, ARTHROPOD VENOMS, P317	47	19	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18270	18280		10.1074/jbc.M117.792697	http://dx.doi.org/10.1074/jbc.M117.792697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924048	hybrid, Green Published			2022-12-28	WOS:000414458200024
J	Li, ZG; Liu, JH; Li, J; Kong, YF; Sandusky, G; Rao, X; Liu, YL; Wan, J; Liu, XQ				Li, Zhiguo; Liu, Jinghui; Li, Jie; Kong, Yifan; Sandusky, George; Rao, Xi; Liu, Yunlong; Wan, Jun; Liu, Xiaoqi			Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PHOSPHORYLATION; INHIBITION; APOPTOSIS; P53; GEMCITABINE; EFFICACY; PROTEIN; ARREST; G2	Polo-like kinase 1 (Plk1), a serine/threonine protein kinase normally expressed in mitosis, is frequently up-regulated in multiple types of human tumors regardless of the cell cycle stage. However, the causal relationship between Plk1 up-regulation and tumorigenesis is incompletely investigated. To this end, using a conditional expression system, here we generated Plk1 transgenic mouse lines to examine the role of Plk1 in tumorigenesis. Plk1 overexpression in mouse embryonic fibroblasts prepared from the transgenic mice led to aberrant mitosis followed by aneuploidy and apoptosis. Surprisingly, Plk1 overexpression had no apparent phenotypes in the mice. Given that no malignant tumor formation was observed even after a long period of Plk1 overexpression, we reasoned that additional factors are required for tumorigenesis in Plk1-overexpressing mice. Because Plk1 can directly participate in the regulation of theDNAdamage response (DDR) pathway, we challenged Plk1-overexpressing mice with ionizing radiation (IR) and found that Plk1-overexpressing mice are much more sensitive to IR than their wild-type littermates. Analysis of tumor development in the Plk1-overexpressing mice indicated a marked decrease in the time required for tumor emergence after IR. At the molecular level, Plk1 overexpression led to reduced phosphorylation of the serine/threonine kinases ATM and Chk2 and of histone H2AX after IR treatment both in vivo and in vitro. Furthermore, RNA-Seq analysis suggested that Plk1 elevation decreases the expression of several DDR genes. We conclude that Plk1 overexpression may contribute to tumor formation by both inducing chromosomal instability and suppressing the DDR pathway.	[Li, Zhiguo; Liu, Jinghui; Li, Jie; Kong, Yifan; Liu, Xiaoqi] Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA; [Sandusky, George] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Rao, Xi; Liu, Yunlong; Wan, Jun] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562	Walther Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA196634, R01CA196835, P30CA023168, R01CA157429] Funding Source: NIH RePORTER	Walther Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The RNA-Seq analysis was performed by the Collaborative Core for Cancer Bioinformatics shared by Indiana University Simon Cancer Center and Purdue University Center for Cancer Research with the support from the Walther Cancer Foundation.	Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hou XZ, 2013, PROSTATE, V73, P1352, DOI 10.1002/pros.22683; Hyun SY, 2014, BMB REP, V47, P249, DOI 10.5483/BMBRep.2014.47.5.061; Johnson LN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002234; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lee K., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.4046/TRD.2015.78.4.360; Li J, 2016, CELL CYCLE, V15, P711, DOI 10.1080/15384101.2016.1148838; Li ZN, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0415-1; Li ZG, 2017, CANCER RES, V77, P3169, DOI 10.1158/0008-5472.CAN-16-2787; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodel F, 2010, AM J PATHOL, V177, P918, DOI 10.2353/ajpath.2010.100040; Scharow A, 2016, CHEMBIOCHEM, V17, P759, DOI 10.1002/cbic.201500535; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shao C, 2015, J BIOL CHEM, V290, P2024, DOI 10.1074/jbc.M114.596817; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Strebhardt K, 2015, EXPERT OPIN DRUG DIS, V10, P1, DOI 10.1517/17460441.2015.962510; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; SUNKEL CE, 1988, J CELL SCI, V89, P25; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhang Z, 2014, CANCER RES, V74, P6635, DOI 10.1158/0008-5472.CAN-14-1916	40	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17461	17472		10.1074/jbc.M117.810960	http://dx.doi.org/10.1074/jbc.M117.810960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28900036	hybrid, Green Published			2022-12-28	WOS:000414009300026
J	Mills, CA; Suzuki, A; Arceci, A; Mo, JY; Duncan, A; Salmon, ED; Emanuele, MJ				Mills, Christine A.; Suzuki, Aussie; Arceci, Anthony; Mo, Jin Yao; Duncan, Alex; Salmon, Edward D.; Emanuele, Michael J.			Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDZONE FORMATION; TOPOISOMERASE-II; RANGAP1; SUMOYLATION; RANBP2; MICROTUBULES; KINETOCHORES; CONJUGATION; TARGETS; PRC1	The mitotic spindle is composed of dynamic microtubules and associated proteins that together direct chromosome movement during mitosis. The spindle plays a vital role in accurate chromosome segregation fidelity and is a therapeutic target in cancer. Nevertheless, the molecular mechanisms by which many spindle-associated proteins function remains unknown. The nucleolar and spindle-associated protein NUSAP1 is a microtubule-binding protein implicated in spindle stability and chromosome segregation. We show here that NUSAP1 localizes to dynamic spindle microtubules in a unique chromosome-centric pattern, in the vicinity of overlapping microtubules, during metaphase and anaphase of mitosis. Mass spectrometry-based analysis of endogenous NUSAP1 interacting proteins uncovered a cell cycle-regulated interaction between the RanBP2-RanGAP1-UBC9 SUMO E3 ligase complex and NUSAP1. Like NUSAP1 depletion, RanBP2 depletion impaired the response of cells to the microtubule poison Taxol. NUSAP1 contains a conserved SAP domain (SAF-A/B, Acinus, and PIAS). SAP domains are common among many other SUMO E3s, and are implicated in substrate recognition and ligase activity. We speculate that NUSAP1 contributes to accurate chromosome segregation by acting as a co-factor for RanBP2-RanGAP1-UBC9 during cell division.	[Mills, Christine A.; Arceci, Anthony; Duncan, Alex; Emanuele, Michael J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mills, Christine A.; Emanuele, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Suzuki, Aussie; Salmon, Edward D.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Arceci, Anthony; Emanuele, Michael J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Mo, Jin Yao; Duncan, Alex] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Mo, Jin Yao; Duncan, Alex] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Emanuele, MJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Emanuele, MJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Emanuele, MJ (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	emanuele@email.unc.edu	Suzuki, Aussie/ABF-4170-2021; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Suzuki, Aussie/0000-0001-7390-5116	Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120309, T32GM007040] Funding Source: NIH RePORTER	Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks to the Emanuele laboratory for critical feedback throughout this study. This work was done in part at the University of North Carolina Flow Cytometry and Proteomics Core Facilities, supported in part by Cancer Center Core Support Grant P30 CA016086 to the Lineberger Cancer Center.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Chou HY, 2011, CELL CYCLE, V10, P4083, DOI 10.4161/cc.10.23.18200; Choudhury R, 2016, CELL REP, V16, P3359, DOI 10.1016/j.celrep.2016.08.058; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Harlow E., 1999, USING ANTIBODIES LAB; Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kellogg EH, 2016, P NATL ACAD SCI USA, V113, P9430, DOI 10.1073/pnas.1609903113; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Okamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142252; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Suzuki A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9161; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Vanden Bosch A, 2010, J CELL SCI, V123, P3244, DOI 10.1242/jcs.063875; Verbakel W, 2011, BIOCHEM BIOPH RES CO, V411, P732, DOI 10.1016/j.bbrc.2011.07.015; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	48	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17178	17189		10.1074/jbc.M117.796045	http://dx.doi.org/10.1074/jbc.M117.796045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28900032	hybrid, Green Published			2022-12-28	WOS:000414009300003
J	Kumar, R; Nurse, P; Bahng, S; Lee, CM; Marians, KJ				Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Lee, Chong M.; Marians, Kenneth J.			The MukB-topoisomerase IV interaction is required for proper chromosome compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA structure; DNA topoisomerase; DNA topology; nucleic acid enzymology	ESCHERICHIA-COLI CHROMOSOME; GREEN FLUORESCENT PROTEIN; DNA-REPLICATION; CONDENSIN MUKB; IN-VIVO; SEGREGATION; ORGANIZATION; COMPLEX; CELLS; TRANSCRIPTION	The bacterial condensin MukB and the cellular decatenating enzyme topoisomerase IV interact. This interaction stimulates intramolecular reactions catalyzed by topoisomerase IV, supercoiled DNA relaxation, and DNA knotting but not intermolecular reactions such as decatenation of linked DNAs. We have demonstrated previously that MukB condenses DNA by sequestering negative supercoils and stabilizing topologically isolated loops in the DNA. We show here that the MukB-topoisomerase IV interaction stabilizes MukB on DNA, increasing the extent of DNA condensation without increasing the amount of MukB bound to the DNA. This effect does not require the catalytic activity of topoisomerase IV. Cells carrying a mukB mutant allele that encodes a protein that does not interact with topoisomerase IV exhibit severe nucleoid decompaction leading to chromosome segregation defects. These findings suggest that the MukB-topoisomerase IV complex may provide a scaffold for DNA condensation.	[Kumar, Rupesh; Nurse, Pearl; Bahng, Soon; Lee, Chong M.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health Cancer Center Core Support Grant from NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Memorial Sloan Kettering Cancer Center was recipient of National Institutes of Health Cancer Center Core Support Grant P30CA008748 from NCI.	ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Bakshi S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00636; Corcoran CP, 2010, J BACTERIOL, V192, P4790, DOI 10.1128/JB.00531-10; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; El Sayyed H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006025; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Helgesen E, 2016, J BACTERIOL, V198, P1305, DOI 10.1128/JB.00919-15; HIRAGA S, 1989, J BACTERIOL, V171, P1496, DOI 10.1128/jb.171.3.1496-1505.1989; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO J, 1992, J BIOL CHEM, V267, P25676; Kumar R, 2017, J BIOL CHEM, V292, P16904, DOI 10.1074/jbc.M117.803312; Lee C, 2013, J BIOL CHEM, V288, P31503, DOI 10.1074/jbc.M113.494237; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Murphy LD, 1997, J STRUCT BIOL, V119, P321, DOI 10.1006/jsbi.1997.3883; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Ohsumi K, 2001, MOL MICROBIOL, V40, P835, DOI 10.1046/j.1365-2958.2001.02447.x; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; PENG H, 1993, J BIOL CHEM, V268, P24481; Peng H., 1995, THESIS; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Pong H, 1999, METH MOL B, V94, P163; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Vos SM, 2013, EMBO J, V32, P2950, DOI 10.1038/emboj.2013.218; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034	46	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16921	16932		10.1074/jbc.M117.803346	http://dx.doi.org/10.1074/jbc.M117.803346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842485	Green Published, hybrid			2022-12-28	WOS:000413140600013
J	Schaenzer, AJ; Wlodarchak, N; Drewry, DH; Zuercher, WJ; Rose, WE; Striker, R; Sauer, JD				Schaenzer, Adam J.; Wlodarchak, Nathan; Drewry, David H.; Zuercher, William J.; Rose, Warren E.; Striker, Rob; Sauer, John-Demian			A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; bacterial protein kinase; bacterial signal transduction; drug discovery; drug screening; Listeria monocytogenes; PASTA Kinase; aminofurazans; -lactams	RESISTANT STAPHYLOCOCCUS-AUREUS; SERINE/THREONINE KINASE; SER/THR KINASE; ANTIBIOTIC-RESISTANCE; B PKNB; PHOSPHORYLATION; VIRULENCE; WALL; STK1; SUSCEPTIBILITY	Bacterial signaling systems such as protein kinases and quorum sensing have become increasingly attractive targets for the development of novel antimicrobial agents in a time of rising antibiotic resistance. The family of bacterial Penicillin-binding-protein And Serine/Threonine kinase-Associated (PASTA) kinases is of particular interest due to the role of these kinases in regulating resistance to -lactam antibiotics. As such, small-molecule kinase inhibitors that target PASTA kinases may prove beneficial as treatments adjunctive to -lactam therapy. Despite this interest, only limited progress has been made in identifying functional inhibitors of the PASTA kinases that have both activity against the intact microbe and high kinase specificity. Here, we report the results of a small-molecule screen that identified GSK690693, an imidazopyridine aminofurazan-type kinase inhibitor that increases the sensitivity of the intracellular pathogen Listeria monocytogenes to various -lactams by inhibiting the PASTA kinase PrkA. GSK690693 potently inhibited PrkA kinase activity biochemically and exhibited significant selectivity for PrkA relative to the Staphylococcus aureus PASTA kinase Stk1. Furthermore, other imidazopyridine aminofurazans could effectively inhibit PrkA and potentiate -lactam antibiotic activity to varying degrees. The presence of the 2-methyl-3-butyn-2-ol (alkynol) moiety was important for both biochemical and antimicrobial activity. Finally, mutagenesis studies demonstrated residues in the back pocket of the active site are important for GSK690693 selectivity. These data suggest that targeted screens can successfully identify PASTA kinase inhibitors with both biochemical and antimicrobial specificity. Moreover, the imidazopyridine aminofurazans represent a family of PASTA kinase inhibitors that have the potential to be optimized for selective PASTA kinase inhibition.	[Schaenzer, Adam J.; Wlodarchak, Nathan; Striker, Rob; Sauer, John-Demian] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Schaenzer, Adam J.; Wlodarchak, Nathan; Rose, Warren E.; Striker, Rob] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Drewry, David H.; Zuercher, William J.] UNC, SGC UNC, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Rose, Warren E.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; [Striker, Rob] WS Middleton Mem Vet Hosp, Dept Mol & Cell Biol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Sauer, JD (corresponding author), 1550 Linden Dr,Rm 4203, Madison, WI 53706 USA.	sauer3@wisc.edu	Wlodarchak, Nathan/GXH-3756-2022; Sauer, John-Demian/AAV-8538-2020	Sauer, John-Demian/0000-0001-9367-794X; Striker, Rob/0000-0002-0454-895X	National Institutes of Health from Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences [UL1TR000427]; NIAID, National Institutes of Health [AI121704]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust [106169/ZZ14/Z]; Hartwell Foundation; Wisconsin Partnership Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	National Institutes of Health from Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Hartwell Foundation; Wisconsin Partnership Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant UL1TR000427 from the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences and Grant AI121704 from the NIAID, National Institutes of Health. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766, Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust Grant 106169/ZZ14/Z. N. W., R. S., and J. D. S. are inventors on U. S. Patent number 9,540,369 for the Use of Kinase Inhibitors to Increase the Susceptibility of Gram-positive Bacteria to beta-lactam Antibiotics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Hartwell Foundation.; Supported by the Wisconsin Partnership Program. To whom correspondence should be addressed: 1550 Linden Dr., Rm. 4203, Madison WI 53706. Tel.: 608-263-1529; Fax: 608-262-8418; E-mail: sauer3@wisc.edu.	Aberg E, 2012, BIOL CHEM, V393, P1121, DOI 10.1515/hsz-2012-0248; [Anonymous], 2013, SYBYL X VERISON 2 1; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Boudreau MA, 2015, ACS INFECT DIS, V1, P454, DOI 10.1021/acsinfecdis.5b00086; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Canova MJ, 2014, BIOCHEM BIOPH RES CO, V447, P165, DOI 10.1016/j.bbrc.2014.03.128; Chapman TM, 2012, BIOORG MED CHEM LETT, V22, P3349, DOI 10.1016/j.bmcl.2012.02.107; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cheung A, 2012, J INFECT DIS, V205, P1625, DOI 10.1093/infdis/jis255; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Foulquier E, 2014, J BIOL CHEM, V289, P23662, DOI 10.1074/jbc.M114.562496; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Fridman M, 2013, BIOCHEMISTRY-US, V52, P7975, DOI 10.1021/bi401177n; Frieden T., 2013, ANTIBIOTIC RESISTANC; Hall CL, 2013, ANTIMICROB AGENTS CH, V57, P6179, DOI 10.1128/AAC.01472-13; HANCOCK IC, 1976, FEBS LETT, V69, P75, DOI 10.1016/0014-5793(76)80657-6; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Kant S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05314-z; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Kurosu M, 2010, DRUG DEVELOP RES, V71, P168, DOI 10.1002/ddr.20362; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Liu QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019811; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Lougheed KEA, 2011, TUBERCULOSIS, V91, P277, DOI 10.1016/j.tube.2011.03.005; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Norman RA, 2012, TRENDS PHARMACOL SCI, V33, P273, DOI 10.1016/j.tips.2012.03.005; O'Neill J., 2014, REV ANTIMICROBIAL RE; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Pensinger DA, 2018, TRENDS MICROBIOL, V26, P56, DOI 10.1016/j.tim.2017.06.010; Pensinger DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006001; Pensinger DA, 2014, ANTIMICROB AGENTS CH, V58, P4486, DOI 10.1128/AAC.02396-14; Projan SJ, 2004, CLIN MICROBIOL INFEC, V10, P18, DOI 10.1111/j.1465-0691.2004.1006.x; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Shah I. M., 2008, CELL, V29, P997; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Vornhagen J, 2015, PATHOGENS, V4, P708, DOI 10.3390/pathogens4040708; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Xu JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44908; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	66	20	22	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17037	17045		10.1074/jbc.M117.808600	http://dx.doi.org/10.1074/jbc.M117.808600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28821610	Green Published, hybrid			2022-12-28	WOS:000413140600023
J	Tomita, H; Katsuyama, Y; Minami, H; Ohnishi, Y				Tomita, Hiroya; Katsuyama, Yohei; Minami, Hiromichi; Ohnishi, Yasuo			Identification and characterization of a bacterial cytochrome P450 monooxygenase catalyzing the 3-nitration of tyrosine in rufomycin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-OXYGENASE AURF; AMINO-ACID; NONRIBOSOMAL PEPTIDE; PSEUDOMONAS-PUTIDA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PYRROLOMYCIN-A; STREPTOMYCES; GENE; CHLORAMPHENICOL	Rufomycin is a circular heptapeptide with anti-mycobacterial activity and is produced by Streptomyces atratus ATCC 14046. Its structure contains three non-proteinogenic amino acids, N-dimethylallyltryptophan, trans-2-crotylglycine, and 3-nitrotyrosine (3NTyr). Although the rufomycin structure was already reported in the 1960s, its biosynthesis, including 3NTyr generation, remains unclear. To elucidate the rufomycin biosynthetic pathway, we assembled a draft genome sequence of S. atratus and identified the rufomycin biosynthetic gene cluster (ruf cluster), consisting of 20 ORFs (rufA-rufT). We found a putative heptamodular nonribosomal peptide synthetase encoded by rufT, a putative tryptophan N-dimethylallyltransferase encoded by rufP, and a putative trimodular type I polyketide synthase encoded by rufEF. Moreover, the ruf cluster contains an apparent operon harboring putative cytochrome P450 (rufO) and nitric oxide synthase (rufN) genes. A similar operon, txtDE, is responsible for the formation of 4-nitrotryptophan in thaxtomin biosynthesis; the cytochrome P450 TxtE catalyzes the 4-nitration of Trp. Therefore, we hypothesized that RufO should catalyze the Tyr 3-nitration. Disruption of rufO abolished rufomycin production by S. atratus, which was restored when 3NTyr was added to the culture medium of the disruptant. Recombinant RufO protein exhibited Tyr 3-nitration activity both in vitro and in vivo. Spectroscopic analysis further revealed that RufO recognizes Tyr as the substrate with a dissociation constant of similar to 0.1 mu M. These results indicate that RufO is an unprecedented cytochrome P450 that catalyzes Tyr nitration. Taken together with the results of an in silico analysis of the ruf cluster, we propose a rufomycin biosynthetic pathway in S. atratus.	[Tomita, Hiroya; Katsuyama, Yohei; Ohnishi, Yasuo] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1,Yayoi, Tokyo 1138657, Japan; [Tomita, Hiroya; Katsuyama, Yohei; Ohnishi, Yasuo] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, 7,Gobancho, Tokyo 1020076, Japan; [Minami, Hiromichi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, 1-308,Suematsu, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Ishikawa Prefecture University	Katsuyama, Y; Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1,Yayoi, Tokyo 1138657, Japan.	aykatsu@mail.ecc.u-tokyo.ac.jp; ayasuo@mail.ecc.u-tokyo.ac.jp	Tomita, Hiroya/GQY-9725-2022	Tomita, Hiroya/0000-0001-7967-921X; Katsuyama, Yohei/0000-0003-4905-5320; Ohnishi, Yasuo/0000-0001-7633-9236	CREST; JST, Japan [JPMJCR13B3]; Japan Society for the Promotion of Science (JSPS); Amano Enzyme Inc., Japan;  [17J06071]	CREST(Core Research for Evolutional Science and Technology (CREST)); JST, Japan(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Amano Enzyme Inc., Japan; 	This work was supported in part by CREST, JST, Grant JPMJCR13B3, Japan; the Japan Society for the Promotion of Science (JSPS) A3 Foresight Program; Grant-in-Aid for JSPS Research Fellow 17J06071; and Amano Enzyme Inc., Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Bushley KE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003496; CARY LW, 1971, FEBS LETT, V17, P145, DOI 10.1016/0014-5793(71)80584-7; Chanco E, 2014, BIOORGAN MED CHEM, V22, P5569, DOI 10.1016/j.bmc.2014.06.002; Chang FC, 1998, CURR MICROBIOL, V36, P125, DOI 10.1007/PL00006755; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Dodani SC, 2016, NAT CHEM, V8, P419, DOI [10.1038/nchem.2474, 10.1038/NCHEM.2474]; Dodani SC, 2014, CHEMBIOCHEM, V15, P2259, DOI 10.1002/cbic.201402241; EZAKI N, 1981, J ANTIBIOT, V34, P1363, DOI 10.7164/antibiotics.34.1363; EZAKI N, 1983, J ANTIBIOT, V36, P1263, DOI 10.7164/antibiotics.36.1263; FUJINO M, 1964, CHEM PHARM BULL, V12, P1390; Gober JG, 2017, ACS CHEM BIOL, V12, P1726, DOI 10.1021/acschembio.7b00358; He J, 2004, J AM CHEM SOC, V126, P3694, DOI 10.1021/ja039328t; Higashide E., 1968, J AGR CHEM SOC JPN, V42, P394; Hudson GA, 2015, J AM CHEM SOC, V137, P16012, DOI 10.1021/jacs.5b10194; KANEDA M, 1981, J ANTIBIOT, V34, P1366, DOI 10.7164/antibiotics.34.1366; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Knoot CJ, 2016, J BIOL INORG CHEM, V21, P589, DOI 10.1007/s00775-016-1363-x; KOGA H, 1989, J BIOCHEM-TOKYO, V106, P831, DOI 10.1093/oxfordjournals.jbchem.a122939; KOYAMA M, 1983, J ANTIBIOT, V36, P1483, DOI 10.7164/antibiotics.36.1483; KOYAMA M, 1981, J ANTIBIOT, V34, P1569, DOI 10.7164/antibiotics.34.1569; Kudo F, 2016, CHEMBIOCHEM, V17, P233, DOI 10.1002/cbic.201500533; KUNZ DA, 1981, J BACTERIOL, V148, P72, DOI 10.1128/JB.148.1.72-82.1981; Lambooy P. K., 2000, PCT Int Appl., Patent No. [WO2000078798 A1, 2000078798, WO 2000078798 Al 20001228]; Lee JK, 2005, J BIOL CHEM, V280, P36719, DOI 10.1074/jbc.M505334200; Lu HG, 2012, TETRAHEDRON, V68, P7651, DOI 10.1016/j.tet.2012.06.036; Molnar I, 2005, APPL ENVIRON MICROB, V71, P6977, DOI 10.1128/AEM.71.11.6977-6985.2005; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; OFFENZELLER M, 1993, J BIOL CHEM, V268, P26127; OMURA T, 1964, J BIOL CHEM, V239, P2379; Paranthaman S, 2003, APPL ENVIRON MICROB, V69, P84, DOI 10.1128/AEM.69.1.84-91.2003; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Payton M, 2001, MICROBIOL-SGM, V147, P1137, DOI 10.1099/00221287-147-5-1137; Ratnayake AS, 2008, J NAT PROD, V71, P1923, DOI 10.1021/np800401h; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Renner MK, 1999, J AM CHEM SOC, V121, P11273, DOI 10.1021/ja992482o; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Sugai Y, 2016, NAT CHEM BIOL, V12, P73, DOI [10.1038/NCHEMBIO.1991, 10.1038/nchembio.1991]; TAKITA T, 1964, J ANTIBIOT, V17, P129; TAKITA T, 1964, J ANTIBIOT, V17, P90; TAKITA T, 1962, J ANTIBIOT, V15, P46; TAKITA T, 1964, J ANTIBIOT, V17, P264; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042; Yu FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056597; Zenno S, 1996, J BACTERIOL, V178, P4508, DOI 10.1128/jb.178.15.4508-4514.1996; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06; Zhao B, 2008, J BIOL CHEM, V283, P8183, DOI 10.1074/jbc.M710421200; Zuo R, 2017, SCI REP, V7	54	32	32	5	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15859	15869		10.1074/jbc.M117.791269	http://dx.doi.org/10.1074/jbc.M117.791269			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28774961	Green Published, hybrid			2022-12-28	WOS:000411512200023
J	Bugge, M; Bergstrom, B; Eide, OK; Solli, H; Kjonstad, IF; Stenvik, J; Espevik, T; Nilsen, NJ				Bugge, Marit; Bergstrom, Bjarte; Eide, Oda K.; Solli, Helene; Kjonstad, Ingrid F.; Stenvik, Jorgen; Espevik, Terje; Nilsen, Nadra J.			Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; COLON-CANCER PROGRESSION; IFN-BETA PRODUCTION; COLORECTAL-CANCER; IN-VIVO; GENE-TRANSCRIPTION; TLR3	Toll-like receptors (TLRs) are innate immune receptors for sensing microbial molecules and damage-associated molecular patterns released from host cells. Double-strandedRNAand the synthetic analog polyinosinic:polycytidylic acid (poly(I:C)) bind and activate TLR3. This stimulation leads to recruitment of the adaptor molecule TRIF (Toll/IL-1 resistance (TIR) domaincontaining adapter-inducing interferon beta) and activation of the transcription factors nuclear factor kappa B (NF-kappa B) and interferon regulatory factor 3 (IRF-3), classically inducing IFN beta production. Here we report that, unlike non-metastatic intestinal epithelial cells (IECs), metastatic IECs express TLR3 and that TLR3 promotes invasiveness of these cells. In response to poly(I:C) addition, the metastatic IECs also induced the chemokine CXCL10 in a TLR3-, TRIF-, and IRF3-dependent manner but failed to produce IFN beta. This was in contrast to healthy and non-metastatic IECs, which did not respond to poly(I:C) stimulation. Endolysosomal acidification and the endosomal transporter protein UNC93B1 was required for poly(I:C)-induced CXCL10 production. However, TLR3-induced CXCL10 was triggered by immobilized poly(I:C), was only modestly affected by inhibition of endocytosis, and could be blocked with an anti-TLR3 antibody, indicating that TLR3 can still signal from the cell surface of these cells. Furthermore, plasma membrane fractions from metastatic IECs contained both full-length and cleaved TLR3, demonstrating surface expression of both forms of TLR3. Our results imply that metastatic IECs express surface TLR3, allowing it to sense extracellular stimuli that trigger chemokine responses and promote invasiveness in these cells. We conclude that altered TLR3 expression and localization may have implications for cancer progression.	[Bugge, Marit; Bergstrom, Bjarte; Eide, Oda K.; Solli, Helene; Kjonstad, Ingrid F.; Stenvik, Jorgen; Espevik, Terje; Nilsen, Nadra J.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, Prinsesse Kristinas Gt 1, N-7489 Trondheim, Norway; [Bugge, Marit; Nilsen, Nadra J.] St Olavs Univ Hosp, Clin Med, N-7030 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Nilsen, NJ (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, Prinsesse Kristinas Gt 1, N-7489 Trondheim, Norway.	nadra.nilsen@ntnu.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Nilsen, Nadra J./G-5592-2017	Nilsen, Nadra J./0000-0003-0407-1060; Fadum Kjonstad, Ingrid/0000-0001-5306-3492	Norwegian Cancer Society [47069308]; liaison committee; Norwegian University of Science and Technology [90064601, 90071001]; Research Council of Norway through its Centres of Excellence funding scheme [223255/F50]; Cancer Fund, St. Olav's Hospital, Trondheim, Norway	Norwegian Cancer Society(Norwegian Cancer Society); liaison committee; Norwegian University of Science and Technology; Research Council of Norway through its Centres of Excellence funding scheme; Cancer Fund, St. Olav's Hospital, Trondheim, Norway	This work was funded by Norwegian Cancer Society Project 47069308 and the liaison committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (Projects 90064601 (to N. J. N.) and 90071001 (to M. B.)). This work was also partly funded by the Research Council of Norway through its Centres of Excellence funding scheme (Project 223255/F50) and by the Cancer Fund, St. Olav's Hospital, Trondheim, Norway.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Bai M, 2016, MOL CLIN ONCOL, V4, P23, DOI 10.3892/mco.2015.665; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cheng GH, 1998, J INTERF CYTOK RES, V18, P987, DOI 10.1089/jir.1998.18.987; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Coward WR, 2010, MOL CELL BIOL, V30, P2874, DOI 10.1128/MCB.01527-09; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Dimberg J, 2014, BIOMED REP, V2, P340, DOI 10.3892/br.2014.255; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Flatmark K., 2014, EUR J CANCER, V40, P1593; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Goh F. G., 2010, BLOOD, V116, P5580; Gurtler C, 2014, J IMMUNOL, V192, P4821, DOI 10.4049/jimmunol.1302980; Guilbaud N, 2001, CLIN CANCER RES, V7, P2573; Hewitt RE, 2000, J PATHOL, V192, P446; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Hirata Y, 2007, J IMMUNOL, V179, P5425, DOI 10.4049/jimmunol.179.8.5425; Hoffman RW, 2004, ARTHRITIS RHEUM-US, V50, P2891, DOI 10.1002/art.20428; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Killeen SD, 2009, BRIT J CANCER, V100, P1589, DOI 10.1038/sj.bjc.6604942; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li DW, 2013, CLIN CANCER RES, V19, P62, DOI 10.1158/1078-0432.CCR-12-1588; Liang XH, 2008, ORAL ONCOL, V44, P1172, DOI 10.1016/j.oraloncology.2008.03.004; Lin RT, 1999, MOL CELL BIOL, V19, P959; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luddy KA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00429; Malik N, 2015, BIOCHEM J, V468, P363, DOI 10.1042/BJ20141523; Matijevic T, 2011, CLIN EXP METASTAS, V28, P701, DOI 10.1007/s10585-011-9402-z; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Nagi RS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00161; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ostvik AE, 2013, INFLAMM BOWEL DIS, V19, P265, DOI 10.1002/ibd.23034; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Pohar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092391; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Pollheimer MJ, 2010, HUM PATHOL, V41, P1749, DOI 10.1016/j.humpath.2010.04.018; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Shah V, 1994, In Vivo, V8, P321; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Song CW, 2006, CANC DRUG DISC DEV, P21, DOI 10.1007/978-1-59745-035-5_2; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toiyama Y, 2012, INT J ONCOL, V40, P560, DOI 10.3892/ijo.2011.1247; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087	86	26	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15408	15425		10.1074/jbc.M117.784090	http://dx.doi.org/10.1074/jbc.M117.784090			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28717003	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000410809800021
J	Carmon, KS; Gong, X; Yi, J; Wu, L; Thomas, A; Moore, CM; Masuho, I; Timson, DJ; Martemyanov, KA; Liu, QJY				Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Moore, Catherine M.; Masuho, Ikuo; Timson, David J.; Martemyanov, Kirill A.; Liu, Qingyun J.			LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; WNT RECEPTORS; E3 LIGASE; MEMBRANE; BINDING; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION; ENDOCYTOSIS; RECOGNITION	Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a bona fide marker of adult stem cells in several epithelial tissues, most notably in the intestinal crypts, and is highly up-regulated in many colorectal, hepatocellular, and ovarian cancers. LGR5 activation by R-spondin (RSPO) ligands potentiates Wnt/beta-catenin signaling in vitro; however, deletion of LGR5 in stem cells has little or no effect on Wnt/beta-catenin signaling or cell proliferation in vivo. Remarkably, modulation of LGR5 expression has a major impact on the actin cytoskeletal structure and cell adhesion in the absence of RSPO stimulation, but the molecular mechanism is unclear. Here, we show that LGR5 interacts with IQ motif-containing GTPase-activating protein 1 (IQGAP1), an effector of Rac1/CDC42 GTPases, in the regulation of actin cytoskeleton dynamics and cell-cell adhesion. Specifically, LGR5 decreased levels of IQGAP1 phosphorylation at Ser-1441/1443, leading to increased binding of Rac1 to IQGAP1 and thus higher levels of cortical F-actin and enhanced cell-cell adhesion. LGR5 ablation in colon cancer cells and crypt stem cells resulted in loss of cortical F-actin, reduced cell-cell adhesion, and disrupted localization of adhesion-associated proteins. No evidence of LGR5 coupling to any of the four major subtypes of heterotrimeric G proteins was found. These findings suggest that LGR5 primarily functions via the IQGAP1-Rac1 pathway to strengthen cell-cell adhesion in normal adult crypt stem cells and colon cancer cells.	[Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA; [Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Yi, Jing] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Moore, Catherine M.; Timson, David J.] Queens Univ Belfast, Med Biol Ctr, Sch Biol Sci, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Timson, David J.] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg,Lewes Rd, Brighton BN2 4GJ, E Sussex, England; [Moore, Catherine M.] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, Cranmer Terrace, London SW17 0RE, England	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Queens University Belfast; Scripps Research Institute; University of Brighton; St Georges University London	Liu, QJY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA.	Qingyun.liu@uth.tmc.edu	Moore, Catherine M/AAS-9688-2021	Moore, Catherine M/0000-0001-6678-6999; Carmon, Kendra/0000-0002-3244-6096; Timson, David/0000-0002-0985-8818	Cancer Prevention and Research Institute of Texas [RP100678]; National Institutes of Health [R01GM102485, MH105482]; Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; Biotechnology and Biological Sciences Research Council UK [BB/D000394/1]; Action Cancer, Northern Ireland, UK [PG2 2005]; BBSRC [BB/D000394/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D000394/1] Funding Source: researchfish	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Action Cancer, Northern Ireland, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Prevention and Research Institute of Texas Grant RP100678, National Institutes of Health Grant R01GM102485, the Texas Emerging Technology Fund, and the Janice D. Gordon endowment for bowel cancer research (to Q.J.L.); Biotechnology and Biological Sciences Research Council UK Grant BB/D000394/1 and Action Cancer, Northern Ireland, UK Grant PG2 2005 (to D.J.T.); and National Institutes of Health Grant MH105482 (to K.A.M.). Q.J.L. is a co-founder of Wntrix. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Brieher WM, 2013, CURR OPIN CELL BIOL, V25, P39, DOI 10.1016/j.ceb.2012.10.010; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Elliott Sarah F, 2012, World J Biol Chem, V3, P53, DOI 10.4331/wjbc.v3.i3.53; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glatt S, 2008, INT J CANCER, V122, P2008, DOI 10.1002/ijc.23349; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Gong X, 2016, MOL CANCER THER, V15, P1580, DOI 10.1158/1535-7163.MCT-16-0114; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kwon MS, 2013, MOL CELLS, V36, P267, DOI 10.1007/s10059-013-0173-z; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Snyder JC, 2017, J BIOL CHEM, V292, P7208, DOI 10.1074/jbc.M116.756635; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Zebisch M, 2015, PROG BIOPHYS MOL BIO, V118, P112, DOI 10.1016/j.pbiomolbio.2015.04.006; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	58	40	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14989	15001		10.1074/jbc.M117.786798	http://dx.doi.org/10.1074/jbc.M117.786798			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739799	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000409902100022
J	Brown, LM; Hanna, DT; Khaw, SL; Ekert, PG				Brown, Lauren M.; Hanna, Diane T.; Khaw, Seong L.; Ekert, Paul G.			Dysregulation of BCL-2 family proteins by leukemia fusion genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; CELL-DEATH; EXPRESSION PATTERNS; CANCER DEVELOPMENT; SOMATIC MUTATIONS; BH3 DOMAINS; IN-VITRO; C-MYC; SURVIVAL	The genomic lesions that characterize acute lymphoblastic leukemia in childhood include recurrent translocations that result in the expression of fusion proteins that typically involve genes encoding tyrosine kinases, cytokine receptors, and transcription factors. These genetic rearrangements confer phenotypic hallmarks of malignant transformation, including unrestricted proliferation and a relative resistance to apoptosis. In this Minireview, we discuss the molecular mechanisms that link these fusions to the control of cell death. We examine how these fusion genes dysregulate the BCL-2 family of proteins, preventing activation of the apoptotic effectors, BAX and BAK, and promoting cell survival.	[Brown, Lauren M.; Khaw, Seong L.; Ekert, Paul G.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Brown, Lauren M.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Hanna, Diane T.; Khaw, Seong L.; Ekert, Paul G.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Hanna, Diane T.; Khaw, Seong L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute	Ekert, PG (corresponding author), Murdoch Childrens Res Inst, Canc Res Grp, Flemington Rd, Parkville, Vic 3052, Australia.	paul.ekert@mcri.edu.au	Ekert, Paul/Q-1842-2015; Brown, Lauren/AAP-6972-2021	Ekert, Paul/0000-0002-2976-8617; Brown, Lauren/0000-0002-4322-8203				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adamson PC, 2015, CA-CANCER J CLIN, V65, P212, DOI 10.3322/caac.21273; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Andersson AK, 2011, BLOOD, V118, P33, DOI 10.1182/blood.V118.21.69.69; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Bachmann PS, 2005, BLOOD, V105, P2519, DOI 10.1182/blood-2004-05-2023; Benito JM, 2015, CELL REP, V13, P2715, DOI 10.1016/j.celrep.2015.12.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brumatti G, 2013, ONCOTARGET, V4, P1933, DOI 10.18632/oncotarget.1306; Cambier N, 1998, ONCOGENE, V16, P335, DOI 10.1038/sj.onc.1201490; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; Chase A, 2013, HAEMATOLOGICA, V98, P404, DOI 10.3324/haematol.2012.067959; Chen CW, 2015, EXP HEMATOL, V43, P673, DOI 10.1016/j.exphem.2015.05.012; Chessells JM, 2002, LEUKEMIA, V16, P776, DOI 10.1038/sj.leu.2402468; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cuesta-Dominguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032451; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Dreyer ZE, 2015, PEDIATR BLOOD CANCER, V62, P419, DOI 10.1002/pbc.25322; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Ferrao PT, 2003, BLOOD, V102, P4499, DOI 10.1182/blood-2003-01-0083; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; FUKUHARA S, 1978, INT J CANCER, V22, P14, DOI 10.1002/ijc.2910220105; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guo JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/861907; Hanna D., 2016, TRANSL CANC RES, P1428; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Jain N, 2017, BLOOD, V129, P572, DOI 10.1182/blood-2016-07-726588; Jayanthan A, 2011, PEDIATR BLOOD CANCER, V56, P353, DOI 10.1002/pbc.22760; Jones L, 2016, LEUKEMIA, V30, P2133, DOI 10.1038/leu.2016.192; Kersey JH, 1998, LEUKEMIA, V12, P1561, DOI 10.1038/sj.leu.2401148; Khaw SL, 2016, BLOOD, V128, P1382, DOI 10.1182/blood-2016-03-707414; Korfi K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.70; Koss B, 2013, BLOOD, V122, P1587, DOI 10.1182/blood-2012-06-440230; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Leonard JT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5309; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lock R, 2008, PEDIATR BLOOD CANCER, V50, P1181, DOI 10.1002/pbc.21433; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mangolini M, 2013, BLOOD, V122, P542, DOI 10.1182/blood-2012-11-465252; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Muntean AG, 2009, AM J PATHOL, V175, P1353, DOI 10.2353/ajpath.2009.081142; Okuda K, 1996, ONCOGENE, V13, P1147; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P318, DOI 10.1038/nrd3432; Richmond J, 2016, CANCER RES, V76, P4579, DOI 10.1158/0008-5472.CAN-16-0523; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Roberts KG, 2017, J CLIN ONCOL, V35, P394, DOI 10.1200/JCO.2016.69.0073; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; Rubert J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-24; Rubnitz JE, 2008, J CLIN ONCOL, V26, P2186, DOI 10.1200/JCO.2007.14.3552; Scherr M, 2014, LEUKEMIA, V28, P554, DOI 10.1038/leu.2013.361; Schinner D, 2015, BLOOD, V125, P1282, DOI 10.1182/blood-2014-04-570960; Stam RW, 2010, BLOOD, V115, P1018, DOI 10.1182/blood-2009-02-205963; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Suryani S, 2015, MOL CANCER THER, V14, P364, DOI 10.1158/1535-7163.MCT-14-0647; Szenajch J, 2010, BBA-REV CANCER, V1806, P82, DOI 10.1016/j.bbcan.2010.04.002; Torrano V, 2011, BLOOD, V118, P4910, DOI 10.1182/blood-2011-05-354266; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Waibel M, 2013, CELL REP, V5, P1047, DOI 10.1016/j.celrep.2013.10.038; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zaliova M, 2011, LEUKEMIA, V25, P313, DOI 10.1038/leu.2010.277; Zeuner A, 2009, BLOOD, V113, P1522, DOI 10.1182/blood-2008-03-143321	100	22	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14325	14333		10.1074/jbc.R117.799056	http://dx.doi.org/10.1074/jbc.R117.799056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28717011	Green Published, hybrid			2022-12-28	WOS:000408747500002
J	Motl, N; Skiba, MA; Kabil, O; Smith, JL; Banerjee, R				Motl, Nicole; Skiba, Meredith A.; Kabil, Omer; Smith, Janet L.; Banerjee, Ruma			Structural and biochemical analyses indicate that a bacterial persulfide dioxygenase-rhodanese fusion protein functions in sulfur assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; hydrogen sulfide; iron; sulfur; X-ray crystallography	HYDROGEN-SULFIDE; CRYSTAL-STRUCTURE; H2S; SULFURTRANSFERASE; ETHE1; MUTATIONS; ELECTROSTATICS; IDENTIFICATION; BIOSYNTHESIS; THIOSULFATE	Hydrogen sulfide (H2S) is a signaling molecule that is toxic at elevated concentrations. In eukaryotes, it is cleared via a mitochondrial sulfide oxidation pathway, which comprises sulfide quinone oxidoreductase, persulfide dioxygenase (PDO), rhodanese, and sulfite oxidase and converts H2S to thiosulfate and sulfate. Natural fusions between the non-heme iron containing PDO and rhodanese, a thiol sulfurtransferase, exist in some bacteria. However, little is known about the role of the PDO-rhodanese fusion (PRF) proteins in sulfur metabolism. Herein, we report the kinetic properties and the crystal structure of a PRF from the Gram-negative endophytic bacterium Burkholderia phytofirmans. The crystal structures of wild-type PRF and a sulfurtransferase-inactivated C314S mutant with and without glutathione were determined at 1.8, 2.4, and 2.7 angstrom resolution, respectively. We found that the two active sites are distant and do not show evidence of direct communication. The B. phytofirmans PRF exhibited robust PDO activity and preferentially catalyzed sulfur transfer in the direction of thiosulfate to sulfite and glutathione persulfide; sulfur transfer in the reverse direction was detectable only under limited turnover conditions. Together with the kinetic data, our bioinformatics analysis reveals that B. phytofirmans PRF is poised to metabolize thiosulfate to sulfite in a sulfur assimilation pathway rather than in sulfide stress response as seen, for example, with the Staphylococcus aureus PRF or sulfide oxidation and disposal as observed with the homologous mammalian proteins.	[Motl, Nicole; Skiba, Meredith A.; Kabil, Omer; Smith, Janet L.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Skiba, Meredith A.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [GM112455]; NIGMS Training Grant [T32GM008353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM112455 (to R. B.) and NIGMS Training Grant T32GM008353 (to N. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; Barton LL, 2014, METAL IONS LIFE SCI, V14, P237, DOI 10.1007/978-94-017-9269-1_10; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; CHAUNCEY TR, 1987, METHOD ENZYMOL, V143, P350; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Czyzewski BK, 2012, NATURE, V483, P494, DOI 10.1038/nature10881; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Higgins KA, 2015, BIOCHEMISTRY-US, V54, P2385, DOI 10.1021/acs.biochem.5b00056; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Iwanicka-Nowicka R, 2007, J BACTERIOL, V189, P1675, DOI 10.1128/JB.00592-06; JARABAK R, 1974, BIOCHEMISTRY-US, V13, P3233, DOI 10.1021/bi00713a006; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Lochowska A, 2011, J BACTERIOL, V193, P1843, DOI 10.1128/JB.00483-10; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luebke JL, 2014, MOL MICROBIOL, V94, P1343, DOI 10.1111/mmi.12835; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Motl N, 2013, HYDROGEN SULFIDE ITS, P1; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Sattler SA, 2015, J BIOL CHEM, V290, P18914, DOI 10.1074/jbc.M115.652537; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shen J, 2016, BIOCHEMISTRY-US, V55, P6524, DOI 10.1021/acs.biochem.6b00714; Shen JC, 2015, BIOCHEMISTRY-US, V54, P4542, DOI 10.1021/acs.biochem.5b00584; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	52	16	18	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14026	14038		10.1074/jbc.M117.790170	http://dx.doi.org/10.1074/jbc.M117.790170			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28684420	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000408439800011
J	Azakir, BA; Di Fulvio, S; Kinter, J; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Kinter, Jochen; Sinnreich, Michael			RETRACTION: Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells. (Retraction of Vol 287, Pg 10344, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Sinnreich, Michael/0000-0002-9835-1276				Azakir BA, 2012, J BIOL CHEM, V287, P10344, DOI 10.1074/jbc.M111.329078	1	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12542	12542		10.1074/jbc.A111.329078	http://dx.doi.org/10.1074/jbc.A111.329078			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28754767	Green Published, hybrid			2022-12-28	WOS:000406636900018
J	Jinnelov, A; Ali, L; Tinti, M; Guether, MLS; Ferguson, MAJ				Jinnelov, Anders; Ali, Liaqat; Tinti, Michele; Guether, Maria Lucia S.; Ferguson, Michael A. J.			Single-subunit oligosaccharyltransferases of Trypanosoma brucei display different and predictable peptide acceptor specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein biosynthesis; N-linked glycosylation; oligosaccharyltransferase; parasitology; Trypanosoma brucei; STT3; glycoproteomics; machine learning	VARIANT SURFACE GLYCOPROTEIN; LIFE-CYCLE STAGES; ASPARAGINE-LINKED OLIGOSACCHARIDES; N-GLYCOSYLATION; STRUCTURAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; ANTIGENIC VARIATION; MEMBRANE ANCHOR; PROTEIN; REVEALS	Trypanosoma brucei causes African trypanosomiasis and contains three full-length oligosaccharyltransferase (OST) genes; two of which, TbSTT3A and TbSTT3B, are expressed in the bloodstream form of the parasite. These OSTs have different peptide acceptor and lipid-linked oligosaccharide donor specificities, and trypanosomes do not follow many of the canonical rules developed for other eukaryotic N-glycosylation pathways, raising questions as to the basic architecture and detailed function of trypanosome OSTs. Here, we show by blue-native gel electrophoresis and stable isotope labeling in cell culture proteomics that the TbSTT3A and TbSTT3B proteins associate with each other in large complexes that contain no other detectable protein subunits. We probed the peptide acceptor specificities of the OSTs in vivo using a transgenic glycoprotein reporter system and performed glycoproteomics on endogenous parasite glycoproteins using sequential endoglycosidase H and peptide:N-glycosidase-F digestions. This allowed us to assess the relative occupancies of numerous N-glycosylation sites by endoglycosidase H-resistant N-glycans originating from Man(5)GlcNAc(2)-PP-dolichol transferred by TbSTT3A, and endoglycosidase H-sensitive N-glycans originating from Man(9)GlcNAc(2)-PP-dolichol transferred by TbSTT3B. Using machine learning, we assessed the features that best define TbSTT3A and TbSTT3B substrates in vivo and built an algorithm to predict the types of N-glycan most likely to predominate at all the putative N-glycosylation sites in the parasite proteome. Finally, molecular modeling was used to suggest why TbSTT3A has a distinct preference for sequons containing and/or flanked by acidic amino acid residues. Together, these studies provide insights into how a highly divergent eukaryote has re-wired protein N-glycosylation to provide protein sequence-specific N-glycan modifications. Data are available via ProteomeXchange with identifiers PXD007236, PXD007267, and PXD007268.	[Jinnelov, Anders; Ali, Liaqat; Tinti, Michele; Guether, Maria Lucia S.; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee DD1 5EH, Scotland	University of Dundee	Ferguson, MAJ (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk		Tinti, Michele/0000-0002-0051-017X; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [101842/Z13/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Wellcome Trust Investigator Award 101842/Z13/Z (to M. A. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Allison H, 2014, MICROB CELL, V1, P325, DOI 10.15698/mic2014.10.170; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; Bandini G, 2012, MOL MICROBIOL, V85, P513, DOI 10.1111/j.1365-2958.2012.08124.x; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Boehm CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006063; Brandes N, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw133; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Castillo-Acosta VM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005851; Castillo-Acosta VM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003612; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Choi BK, 2012, APPL MICROBIOL BIOT, V95, P671, DOI 10.1007/s00253-012-4067-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damerow M, 2016, J BIOL CHEM, V291, P13834, DOI 10.1074/jbc.M116.733246; Damerow M, 2014, J BIOL CHEM, V289, P9328, DOI 10.1074/jbc.M114.555029; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; Engstler M, 2005, J CELL SCI, V118, P2105, DOI 10.1242/jcs.02327; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guther MLS, 2009, EUKARYOT CELL, V8, P1407, DOI 10.1128/EC.00178-09; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Jackson AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002121; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kalb LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31212; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lingnau A, 1999, J CELL SCI, V112, P3061; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Maishman L, 2016, NUCLEIC ACIDS RES, V44, P10554, DOI 10.1093/nar/gkw751; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Nagamune K, 2003, P NATL ACAD SCI USA, V100, P10682, DOI 10.1073/pnas.1833260100; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poljak K, 2017, J BIOL CHEM, V292, P20342, DOI 10.1074/jbc.M117.811133; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Schwede A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005259; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Tiengwe C, 2016, CELL MICROBIOL, V18, P1673, DOI 10.1111/cmi.12605; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Yan AX, 2005, P NATL ACAD SCI USA, V102, P7121, DOI 10.1073/pnas.0502669102; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	74	10	11	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20328	20341		10.1074/jbc.M117.810945	http://dx.doi.org/10.1074/jbc.M117.810945			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28928222	Green Published, hybrid			2022-12-28	WOS:000417696400035
J	Heier, C; Kien, B; Huang, FF; Eichmann, TO; Xie, H; Zechner, R; Chang, PA				Heier, Christoph; Kien, Benedikt; Huang, Feifei; Eichmann, Thomas O.; Xie, Hao; Zechner, Rudolf; Chang, Ping-An			The phospholipase PNPLA7 functions as a lysophosphatidylcholine hydrolase and interacts with lipid droplets through its catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); lipid droplet; lysophospholipid; phospholipase; phospholipid metabolism; protein domain	NEUROPATHY TARGET ESTERASE; PROTEIN; MUTATIONS; MEMBRANE; PHOSPHATIDYLCHOLINE; IDENTIFICATION; LIPASE; PURIFICATION; EXPRESSION; DISEASE	Mammalian patatin-like phospholipase domain-containing proteins (PNPLAs) are lipid-metabolizing enzymes with essential roles in energy metabolism, skin barrier development, and brain function. A detailed annotation of enzymatic activities and structure-function relationships remains an important prerequisite to understand PNPLA functions in (patho-)physiology, for example, in disorders such as neutral lipid storage disease, non-alcoholic fatty liver disease, and neurodegenerative syndromes. In this study, we characterized the structural features controlling the subcellular localization and enzymatic activity of PNPLA7, a poorly annotated phospholipase linked to insulin signaling and energy metabolism. We show that PNPLA7 is an endoplasmic reticulum (ER) transmembrane protein that specifically promotes hydrolysis of lysophosphatidylcholine in mammalian cells. We found that transmembrane and regulatory domains in the PNPLA7 N-terminal region cooperate to regulate ER targeting but are dispensable for substrate hydrolysis. Enzymatic activity is instead mediated by the C-terminal domain, which maintains full catalytic competence even in the absence of N-terminal regions. Upon elevated fatty acid flux, the catalytic domain targets cellular lipid droplets and promotes interactions of PNPLA7 with these organelles in response to increased cAMP levels. We conclude that PNPLA7 acts as an ER-anchored lysophosphatidylcholine hydrolase that is composed of specific functional domains mediating catalytic activity, subcellular positioning, and interactions with cellular organelles. Our study provides critical structural insights into an evolutionarily conserved class of phospholipid-metabolizing enzymes.	[Heier, Christoph; Kien, Benedikt; Eichmann, Thomas O.; Xie, Hao; Zechner, Rudolf; Chang, Ping-An] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Zechner, Rudolf] BioTechMed Graz, A-8010 Graz, Austria; [Huang, Feifei; Chang, Ping-An] Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing 400065, Peoples R China	University of Graz; Chongqing University of Posts & Telecommunications	Chang, PA (corresponding author), Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing 400065, Peoples R China.	changpingan@aliyun.com		Eichmann, Thomas O./0000-0002-8521-2795; Kien, Benedikt/0000-0002-3083-2479; Heier, Christoph/0000-0001-6858-408X	Austrian Science Fund (FWF) [SFB LIPOTOX F30]; Wittgenstein Award [Z136]; Foundation Leducq Transatlantic Network on Triglycerides [12CVD04]; European Union [340896]; European Research Council LipoCheX; National Natural Science Foundation in China [31271523]; Natural Science Foundation Project of Chongqing Science and Technology Commission [2014jcyjA10033, cstc2016jcyjA0572]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Wittgenstein Award(Austrian Science Fund (FWF)); Foundation Leducq Transatlantic Network on Triglycerides; European Union(European Commission); European Research Council LipoCheX; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing)	This work was supported by Austrian Science Fund (FWF) Grant SFB LIPOTOX F30 and Wittgenstein Award Z136, Foundation Leducq Transatlantic Network on Triglycerides Grant 12CVD04, European Union's Seventh Framework Program Grant FP/2007-2013/ERC under Grant Agreement 340896, European Research Council LipoCheX, National Natural Science Foundation in China Grant 31271523, and Natural Science Foundation Project of Chongqing Science and Technology Commission Grants 2014jcyjA10033 and cstc2016jcyjA0572. The authors declare that they have no conflicts of interest with the contents of this article.	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Brasaemle Dawn L, 2016, Curr Protoc Cell Biol, V72, DOI 10.1002/cpcb.10; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furse S, 2015, MOL MEMBR BIOL, V32, P117, DOI 10.3109/09687688.2015.1066894; Glynn P, 2005, BBA-MOL CELL BIOL L, V1736, P87, DOI 10.1016/j.bbalip.2005.08.002; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Heier C, 2015, J BIOL CHEM, V290, P26141, DOI 10.1074/jbc.M115.671842; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSON MK, 1969, BIOCHEM J, V114, P711, DOI 10.1042/bj1140711; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kmoch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6614; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Li Y, 2003, J BIOL CHEM, V278, P8820, DOI 10.1074/jbc.M210743200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lush MJ, 1998, BIOCHEM J, V332, P1; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Papadopoulos C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005149; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Read DJ, 2009, J NEUROSCI, V29, P11594, DOI 10.1523/JNEUROSCI.3007-09.2009; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato S, 2010, FEBS LETT, V584, P4389, DOI 10.1016/j.febslet.2010.09.047; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Song Y, 2013, DIS MODEL MECH, V6, P404, DOI 10.1242/dmm.009688; Synofzik M, 2014, BRAIN, V137, P69, DOI 10.1093/brain/awt326; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	11	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19087	19098		10.1074/jbc.M117.792978	http://dx.doi.org/10.1074/jbc.M117.792978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28887301	Green Published, hybrid			2022-12-28	WOS:000415848000031
J	Zhang, G; Vilim, FS; Liu, DD; Romanova, EV; Yu, K; Yuan, WD; Xiao, H; Hummon, AB; Chen, TT; Alexeeva, V; Yin, SY; Chen, SA; Cropper, EC; Sweedler, JV; Weiss, KR; Jing, J				Zhang, Guo; Vilim, Ferdinand S.; Liu, Dan-Dan; Romanova, Elena V.; Yu, Ke; Yuan, Wang-Ding; Xiao, Hui; Hummon, Amanda B.; Chen, Ting-Ting; Alexeeva, Vera; Yin, Si-Yuan; Chen, Song-An; Cropper, Elizabeth C.; Sweedler, Jonathan V.; Weiss, Klaudiusz R.; Jing, Jian			Discovery of leucokinin-like neuropeptides that modulate a specific parameter of feeding motor programs in the molluscan model, Aplysia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); neurobiology; neuropeptide; neuroscience; neurotransmitter; Aplysia; Leucokinin; arthropods; feeding; neuromodulation	PROTEIN-COUPLED RECEPTOR; REPRESENTATIONAL DIFFERENCE ANALYSIS; ACID-CONTAINING NEUROPEPTIDE; LEUCOPHAEA-MADERAE; FUNCTIONAL-CHARACTERIZATION; DISTINGUISHES INGESTION; DROSOPHILA-MELANOGASTER; SYNAPTIC CONNECTIONS; MALPIGHIAN TUBULES; MYOTROPIC PEPTIDE	A better understanding of neuromodulation in a behavioral system requires identification of active modulatory transmitters. Here, we used identifiable neurons in a neurobiological model system, the mollusc Aplysia, to study neuropeptides, a diverse class of neuromodulators. We took advantage of two types of feeding neurons, B48 and B1/B2, in the Aplysia buccal ganglion that might contain different neuropeptides. We performed a representational difference analysis (RDA) by subtraction of mRNAs in B48 versus mRNAs in B1/B2. The RDA identified an unusually long (2025 amino acids) peptide precursor encoding Aplysia leucokinin-like peptides (ALKs; e.g. ALK-1 and ALK-2). Northern blot analysis revealed that, compared with other ganglia (e.g. the pedal-pleural ganglion), ALK mRNA is predominantly present in the buccal ganglion, which controls feeding behavior. We then used in situ hybridization and immunohistochemistry to localize ALKs to specific neurons, including B48. MALDI-TOF MS on single buccal neurons revealed expression of 40 ALK precursor-derived peptides. Among these, ALK-1 and ALK-2 are active in the feeding network; they shortened the radula protraction phase of feeding motor programs triggered by a command-like neuron. We also found that this effect may be mediated by the ALK-stimulated enhancement of activity of an interneuron, which has previously been shown to terminate protraction. We conclude that our multipronged approach is effective for determining the structure and defining the diverse functions of leucokinin-like peptides. Notably, the ALK precursor is the first verified nonarthropod precursor for leucokinin-like peptides with a novel, marked modulatory effect on a specific parameter (protraction duration) of feeding motor programs.	[Zhang, Guo; Liu, Dan-Dan; Yu, Ke; Yuan, Wang-Ding; Xiao, Hui; Chen, Ting-Ting; Yin, Si-Yuan; Chen, Song-An; Jing, Jian] Nanjing Univ, State Key Lab Pharmaceut Biotechnol,Sch Life Sci, Collaborat Innovat Ctr Chem Life Sci,Adv Inst Lif, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Vilim, Ferdinand S.; Alexeeva, Vera; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Vilim, Ferdinand S.; Alexeeva, Vera; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Romanova, Elena V.; Hummon, Amanda B.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Romanova, Elena V.; Hummon, Amanda B.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Hummon, Amanda B.] Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA	Nanjing University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame	Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	jingj01@live.com	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Romanova, Elena/0000-0002-2040-3312; Jing, Jian/0000-0003-1422-143X	National Natural Science Foundation of China [31671097, 31371104, J1103512, J1210026]; NINDS, National Institutes of Health [RO1 NS066587, RO1 NS070583, RO1 NS031609]; NIDA, National Institutes of Health [P30 DA018310]; National Science Foundation [CHE 16-067915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066587, R01NS070583, R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Division Of Chemistry [1606791] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Natural Science Foundation of China Grants 31671097, 31371104, J1103512, and J1210026; NINDS, National Institutes of Health, Grants RO1 NS066587, RO1 NS070583, and RO1 NS031609; NIDA, National Institutes of Health, Grant P30 DA018310; and National Science Foundation Grant CHE 16-067915. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and other funding agencies.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; BLACKBURN MB, 1995, J INSECT PHYSIOL, V41, P723, DOI 10.1016/0022-1910(95)00005-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH PJ, 1991, J NEUROSCI, V11, P618; CHURCH PJ, 1994, J NEUROPHYSIOL, V72, P1794, DOI 10.1152/jn.1994.72.4.1794; CLOTTENS FL, 1993, REGUL PEPTIDES, V49, P145, DOI 10.1016/0167-0115(93)90436-C; COAST GM, 1990, J INSECT PHYSIOL, V36, P481, DOI 10.1016/0022-1910(90)90098-Z; Comi TJ, 2017, J AM CHEM SOC, V139, P3920, DOI 10.1021/jacs.6b12822; Cox KJA, 1997, J NEUROSCI, V17, P1197; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; CROPPER EC, 1987, P NATL ACAD SCI USA, V84, P3486, DOI 10.1073/pnas.84.10.3486; CROPPER EC, 1990, P NATL ACAD SCI USA, V87, P933, DOI 10.1073/pnas.87.3.933; Cropper EC, 2014, CURR OPIN NEUROBIOL, V29, P33, DOI 10.1016/j.conb.2014.04.011; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Evans CG, 2003, J NEUROSCI, V23, P2920; Evans CG, 1996, J NEUROPHYSIOL, V76, P1267, DOI 10.1152/jn.1996.76.2.1267; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; HAYES TK, 1989, LIFE SCI, V44, P1259, DOI 10.1016/0024-3205(89)90362-7; Holman G.M., 1990, P195; HOLMAN GM, 1983, COMP BIOCHEM PHYS C, V76, P39, DOI 10.1016/0742-8413(83)90041-5; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V84, P271, DOI 10.1016/0742-8413(86)90093-9; HOLMAN GM, 1987, COMP BIOCHEM PHYS C, V88, P31, DOI 10.1016/0742-8413(87)90043-0; HOLMAN GM, 1987, COMP BIOCHEM PHYS C, V88, P27, DOI 10.1016/0742-8413(87)90042-9; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2017, NETWORK FUNCTIONS AND PLASTICITY: PERSPECTIVES FROM STUDYING NEURONAL ELECTRICAL COUPLING IN MICROCIRCUITS, P79, DOI 10.1016/B978-0-12-803471-2.00005-9; Jing J, 2004, J NEUROSCI, V24, P6315, DOI 10.1523/JNEUROSCI.0965-04.2004; Jing J, 2003, J NEUROSCI, V23, P5283; Jing J, 2002, J NEUROSCI, V22, P6228; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2009, ENCY NEUROSCIENCE, P1149; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2015, J NEUROSCI, V35, P9137, DOI 10.1523/JNEUROSCI.0180-15.2015; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; Li LJ, 1998, PEPTIDES, V19, P1425, DOI 10.1016/S0196-9781(98)00094-1; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Livnat I, 2016, ANAL CHEM, V88, P11868, DOI 10.1021/acs.analchem.6b03658; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MORTON DW, 1993, J COMP PHYSIOL A, V173, P519; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nielsen H, 1996, PROTEINS, V24, P165, DOI 10.1002/(SICI)1097-0134(199602)24:2<165::AID-PROT4>3.0.CO;2-I; Nusbaum MP, 2012, CURR OPIN NEUROBIOL, V22, P592, DOI 10.1016/j.conb.2012.01.003; Perrins R, 1998, J NEUROSCI, V18, P3977; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Radford JHC, 2004, J EXP BIOL, V207, P4573, DOI 10.1242/jeb.01317; Romanova EV, 2014, NEUROPSYCHOPHARMACOL, V39, P50, DOI 10.1038/npp.2013.145; Romanova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048764; ROSEN SC, 1991, J NEUROSCI, V11, P3630; Sasaki K, 2013, J NEUROSCI, V33, P93, DOI 10.1523/JNEUROSCI.3841-12.2013; Sasaki K, 2007, J NEUROPHYSIOL, V98, P3796, DOI 10.1152/jn.00965.2007; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; SCHOOFS L, 1992, REGUL PEPTIDES, V37, P49, DOI 10.1016/0167-0115(92)90063-Z; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Southey Bruce R, 2008, Front Neuroinform, V2, P7, DOI 10.3389/neuro.11.007.2008; Strand FL, 1999, NEUROPEPTIDES REGULA; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Terhzaz S, 1999, J EXP BIOL, V202, P3667; VEENSTRA JA, 1994, BIOCHEM BIOPH RES CO, V202, P715, DOI 10.1006/bbrc.1994.1989; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; Vilim FS, 2001, PEPTIDES, V22, P2027, DOI 10.1016/S0196-9781(01)00561-7; Wu JS, 2007, J NEUROSCI, V27, P10818, DOI 10.1523/JNEUROSCI.1806-07.2007; Wu JS, 2014, J NEUROSCI, V34, P6510, DOI 10.1523/JNEUROSCI.5094-13.2014; Yang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147335; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514	89	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18775	18789		10.1074/jbc.M117.795450	http://dx.doi.org/10.1074/jbc.M117.795450			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924050	Green Published, hybrid			2022-12-28	WOS:000415848000004
J	Bourdin, B; Briot, J; Tetreault, MP; Sauve, R; Parent, L				Bourdin, Benoite; Briot, Julie; Tetreault, Marie-Philippe; Sauve, Remy; Parent, Lucie			Negatively charged residues in the first extracellular loop of the L-type Ca(V)1.2 channel anchor the interaction with the Ca-V alpha 2 delta 1 auxiliary subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNELS; CA2+ INFLUX; ALPHA(2)DELTA SUBUNITS; SURFACE EXPRESSION; VOLTAGE SENSORS; BETA-SUBUNITS; DOMAIN; HYPERTROPHY; ARRHYTHMIA; SITE	Voltage-gated L-type Ca(V)1.2 channels in cardiomyocytes exist as heteromeric complexes. Co-expression of Ca-V alpha 2 delta 1 with Ca-V beta/Ca-V alpha 1 proteins reconstitutes the functional properties of native L-type currents, but the interacting domains at the Ca(V)1.2/ Ca-V alpha 2 delta 1 interface are unknown. Here, a homology- based model of Ca(V)1.2 identified protein interfaces between the extracellular domain of Ca-V alpha 2 delta 1 and the extracellular loops of the Ca-V alpha 1 protein in repeats I (IS1S2 and IS5S6), II (IIS5S6), and III (IIIS5S6). Insertion of a 9-residue hemagglutinin epitope in IS1S2, but not in IS5S6 or in IIS5S6, prevented the co-immunoprecipitation of CaV1.2 with Ca-V alpha 2 delta 1. IS1S2 contains a cluster of three conserved negatively charged residues Glu-179, Asp-180, and Asp-181 that could contribute to non-bonded interactions with Ca-V alpha 2 delta 1. Substitutions of CaV1.2 Asp-181 impaired the co-immunoprecipitation of Ca-V beta/Ca(V)1.2 with Ca-V alpha 2 delta 1 and the Ca-V alpha 2 delta 1-dependent shift in voltage-dependent activation gating. In contrast, single substitutions in Ca(V)1.2 in neighboring positions in the same loop (179, 180, and 182-184) did not significantly alter the functional up-regulation of Ca(V)1.2 whole-cell currents. However, a negatively charged residue at position 180 was necessary to convey the Ca-V alpha 2 delta 1-mediated shift in the activation gating. We also found a more modest contribution from the positively charged Arg-1119 in the extracellular pore region in repeat III of Ca(V)1.2. We conclude that Ca(V)1.2 Asp-181 anchors the physical interaction that facilitates the Ca-V alpha 2 delta 1-mediated functional modulation of Ca(V)1.2 currents. By stabilizing the first extracellular loop of Ca(V)1.2, Ca-V alpha 2 delta 1 may up-regulate currents by promoting conformations of the voltage sensor that are associated with the channel's open state.	[Briot, Julie; Sauve, Remy; Parent, Lucie] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H3C 3J7, Canada; [Bourdin, Benoite; Briot, Julie; Tetreault, Marie-Philippe; Parent, Lucie] Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca		Parent, Lucie/0000-0002-7932-4264; Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant-in-aid G-15-0009329 from the Canadian Heart and Stroke Foundation (to L.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bannister JP, 2012, HYPERTENSION, V60, P1006, DOI 10.1161/HYPERTENSIONAHA.112.199661; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Briot J., 2016, BIOCH MOL BIOL J, V2, P3, DOI [10.21767/2471-8084.100025, DOI 10.21767/2471-8084.100025]; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gonzalez Carlos, 2012, Biophys Rev, V4, P1, DOI 10.1007/s12551-011-0061-8; Hille B., 1992, IONIC CHANNELS EXCIT; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lugenbiel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116395; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Pantazis A, 2014, P NATL ACAD SCI USA, V111, P18381, DOI 10.1073/pnas.1411127112; Parent L., 1997, J MEMBRANE BIOL, V160, p1E; Paxman JJ, 2017, METHODS MOL BIOL, V1549, P209, DOI 10.1007/978-1-4939-6740-7_16; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Savalli N, 2016, J GEN PHYSIOL, V148, P147, DOI 10.1085/jgp.201611586; Segura E, 2017, J BIOL CHEM, V292, P11109, DOI 10.1074/jbc.M117.784355; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tuluc P, 2016, STRUCTURE, V24, P261, DOI 10.1016/j.str.2015.11.011; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Voigt A., 2016, NEUROPHOTONICS, V3; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	57	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17236	17249		10.1074/jbc.M117.806893	http://dx.doi.org/10.1074/jbc.M117.806893			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28864774	Green Published, hybrid			2022-12-28	WOS:000414009300008
J	Lyons, A; Coleman, M; Riis, S; Favre, C; O'Flanagan, CH; Zhdanov, AV; Papkovsky, DB; Hursting, SD; O'Connor, R				Lyons, Amy; Coleman, Michael; Riis, Sarah; Favre, Cedric; O'Flanagan, Ciara H.; Zhdanov, Alexander V.; Papkovsky, Dmitri B.; Hursting, Stephen D.; O'Connor, Rosemary			Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer therapy; cell metabolism; cell signaling; cell surface receptor; drug resistance; insulin-like growth factor (IGF); mitochondria; mitophagy	PYRIMIDINE NUCLEOTIDE CARRIER; BREAST-CANCER; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; HYPOXIA; AUTOPHAGY; THERAPY; KINASE; ALPHA; BNIP3	Mitochondrial activity and metabolic reprogramming influence the phenotype of cancer cells and resistance to targeted therapy. We previously established that an insulin-like growth factor 1 (IGF-1)-inducible mitochondrial UTP carrier (PNC1/SLC25A33) promotes cell growth. This prompted us to investigate whether IGF signaling is essential for mitochondrial maintenance in cancer cells and whether this contributes to therapy resistance. Here we show that IGF-1 stimulates mitochondrial biogenesis in a range of cell lines. In MCF-7 and ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor coactivator 1 (PGC-1) and PGC-1-related coactivator (PRC). Suppression of PGC-1 and PRC with siRNA reverses the effects of IGF-1 and disrupts mitochondrial morphology and membrane potential. IGF-1 also induced expression of the redox regulator nuclear factor-erythroid-derived 2-like 2 (NFE2L2 alias NRF-2). Of note, MCF-7 cells with acquired resistance to an IGF-1 receptor (IGF-1R) tyrosine kinase inhibitor exhibited reduced expression of PGC-1, PRC, and mitochondrial biogenesis. Interestingly, these cells exhibited mitochondrial dysfunction, indicated by reactive oxygen species expression, reduced expression of the mitophagy mediators BNIP3 and BNIP3L, and impaired mitophagy. In agreement with this, IGF-1 robustly induced BNIP3 accumulation in mitochondria. Other active receptor tyrosine kinases could not compensate for reduced IGF-1R activity in mitochondrial protection, and MCF-7 cells with suppressed IGF-1R activity became highly dependent on glycolysis for survival. We conclude that IGF-1 signaling is essential for sustaining cancer cell viability by stimulating both mitochondrial biogenesis and turnover through BNIP3 induction. This core mitochondrial protective signal is likely to strongly influence responses to therapy and the phenotypic evolution of cancer.	[Lyons, Amy; Coleman, Michael; Riis, Sarah; Favre, Cedric; O'Connor, Rosemary] Univ Coll Cork, Sch Biochem & Cell Biol, Cell Biol Lab, Cork T12 YT20, Ireland; [Zhdanov, Alexander V.; Papkovsky, Dmitri B.] Univ Coll Cork, Sch Biochem & Cell Biol, Biophys & Bioanal Lab, Cork T12 YT20, Ireland; [O'Flanagan, Ciara H.; Hursting, Stephen D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Nutr Biochem, Chapel Hill, NC 27599 USA	University College Cork; University College Cork; University of North Carolina; University of North Carolina Chapel Hill	O'Connor, R (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cell Biol Lab, Cork T12 YT20, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014; Coleman, Michael/AAM-4725-2021	O'Connor, Rosemary/0000-0002-0687-3422; Coleman, Michael/0000-0002-6914-848X; Zhdanov, Alexander/0000-0001-5787-2035	Science Foundation Ireland PI Awards [11/PI/1139, 06/IN.1/B107]; Health Research Board; Higher Education Authority of Ireland Ph.D. Program in Molecular Cell Biology; Ph.D. Studentship from Irish Cancer Society; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Science Foundation Ireland PI Awards(Science Foundation Ireland); Health Research Board; Higher Education Authority of Ireland Ph.D. Program in Molecular Cell Biology; Ph.D. Studentship from Irish Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Science Foundation Ireland PI Awards 11/PI/1139 and 06/IN.1/B107; the Health Research Board; the Higher Education Authority of Ireland Ph.D. Program in Molecular Cell Biology (to A. L.); and a Ph.D. Studentship from the Irish Cancer Society (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldelli S, 2013, BBA-GEN SUBJECTS, V1830, P4137, DOI 10.1016/j.bbagen.2013.04.006; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Caino MC, 2016, CLIN CANCER RES, V22, P540, DOI 10.1158/1078-0432.CCR-15-0460; Cao HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31072; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; de Mas IM, 2014, FUTURE MED CHEM, V6, P1791, DOI 10.4155/FMC.14.119; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gopal YNV, 2014, CANCER RES, V74, P7037, DOI 10.1158/0008-5472.CAN-14-1392; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li L, 2016, ONCOTARGET, V7, P34442, DOI 10.18632/oncotarget.9120; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; O'Flanagan CH, 2016, ONCOTARGET, V7, P56826, DOI 10.18632/oncotarget.10862; Palikaras K, 2015, CELL DEATH DIFFER, V22, P1399, DOI 10.1038/cdd.2015.86; Palikaras K, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1056332; Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Raimundo N, 2014, TRENDS MOL MED, V20, P282, DOI 10.1016/j.molmed.2014.01.005; Sadaba MC, 2016, BBA-MOL BASIS DIS, V1862, P1267, DOI 10.1016/j.bbadis.2016.03.010; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wu Y, 2015, BREAST CANCER RES TR, V151, P529, DOI 10.1007/s10549-015-3386-3; Xia LM, 2009, J CELL BIOCHEM, V106, P247, DOI 10.1002/jcb.21996; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772; Zhang P, 2009, GRAEF ARCH CLIN EXP, V247, P633, DOI 10.1007/s00417-008-1031-0; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	49	67	68	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16983	16998		10.1074/jbc.M117.792838	http://dx.doi.org/10.1074/jbc.M117.792838			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28821609	Green Published, hybrid			2022-12-28	WOS:000413140600019
J	McNally, JR; O'Brien, PJ				McNally, Justin R.; O'Brien, Patrick J.			Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELL VIABILITY; ZINC-FINGER; POLY(ADP-RIBOSE) POLYMERASE; EMBRYONIC LETHALITY; PROTEIN XRCC1; BINDING; GENE; RECOMBINATION; MUTATIONS; LIGATION	Humans have three genes encoding DNA ligases with conserved structural features and activities, but they also have notable differences. The LIG3 gene encodes a ubiquitous isoform in all tissues (LIG3 alpha) and a germ line-specific splicing isoform (LIG3 beta) that differs in the C-terminal domain. Both isoforms are found in the nucleus and the mitochondria. Here, we determined the kinetics and thermodynamics of single-stranded break ligation by LIG3 alpha and LIG3 alpha and compared this framework to that of LIG1, the nuclear replicative ligase. The kinetic parameters of the LIG3 isoforms are nearly identical under all tested conditions, indicating that the BRCA1 C terminal (BRCT) domain specific to LIG3 alpha does not alter ligation kinetics. Although LIG3 is only 22% identical to LIG1 across their conserved domains, the two enzymes had very similar maximal ligation rates. Comparison of the rate and equilibrium constants for LIG3 and LIG1 nevertheless revealed important differences. The LIG3 isoforms were seven times more efficient than LIG1 at ligating nicked DNA under optimal conditions, mainly because of their lower K-m value for the DNA substrate. This could explain why LIG3 is less prone to abortive ligation than LIG1. Surprisingly, the affinity of LIG3 for Mg2+ was ten times weaker than that of LIG1, suggesting that Mg2+ availability regulates DNA ligation in vivo, because Mg2+ levels are higher in the mitochondria than in the nucleus. The biochemical differences between the LIG3 isoforms and LIG1 identified here will guide the understanding of both unique and overlapping biological roles of these critical enzymes.	[McNally, Justin R.; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Michigan Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu		McNally, Justin/0000-0003-2694-2410	National Cancer Institute [P30CA046592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Jurkiw for the gift of the purified Delta 232 LIG1 and members of the O'Brien laboratory for helpful discussions. The University of Michigan Comprehensive Cancer Center is supported by National Cancer Institute Grant P30CA046592.	Arakawa H, 2012, NUCLEIC ACIDS RES, V40, P2599, DOI 10.1093/nar/gkr1024; Badie S, 2015, EMBO J, V34, P828, DOI 10.15252/embj.201570610; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bentley DJ, 2002, J CELL SCI, V115, P1551; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Gunther T, 2006, MAGNESIUM RES, V19, P225; Han L, 2014, CELL REP, V7, P316, DOI 10.1016/j.celrep.2014.03.024; Jones RE, 2014, CELL REP, V8, P1063, DOI 10.1016/j.celrep.2014.07.007; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lu GQ, 2016, P NATL ACAD SCI USA, V113, P1256, DOI 10.1073/pnas.1521597113; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Masani S, 2016, P NATL ACAD SCI USA, V113, P1261, DOI 10.1073/pnas.1521630113; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Newman EA, 2015, MOL CANCER RES, V13, P470, DOI 10.1158/1541-7786.MCR-14-0337; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Perez-Jannotti RM, 2001, J BIOL CHEM, V276, P48978, DOI 10.1074/jbc.M107177200; PETRINI JHJ, 1995, MOL CELL BIOL, V15, P4303; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Taylor RM, 1998, NUCLEIC ACIDS RES, V26, P4804, DOI 10.1093/nar/26.21.4804; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061; Wiest N. E., 2013, TRANSL CANC RES, V2, P1219	48	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15870	15879		10.1074/jbc.M117.804625	http://dx.doi.org/10.1074/jbc.M117.804625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28751376	Green Published, hybrid			2022-12-28	WOS:000411512200024
J	Siddiqui, SS; Springer, SA; Verhagen, A; Sundaramurthy, V; Alisson-Silva, F; Jiang, WP; Ghosh, P; Varki, A				Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Jiang, Weiping; Ghosh, Pradipta; Varki, Ajit			The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; PHYLOGENETIC ANALYSIS; TARGETING SIGNAL-1; COMMON VARIANTS; RARE VARIANTS; 2 ISOFORMS; RECEPTOR; EXPRESSION; RISK; PEROXISOMES	The immunomodulatory receptor Siglec-3/CD33 influences risk for late-onset Alzheimer's disease (LOAD), an apparently human-specific post-reproductive disease. CD33 generates two splice variants: a full-length CD33M transcript produced primarily by the "LOAD-risk" allele and a shorter CD33m isoform lacking the sialic acid-binding domain produced primarily from the "LOAD-protective" allele. An SNP that modulates CD33 splicing to favor CD33m is associated with enhanced microglial activity. Individuals expressing more protective isoform accumulate less brain beta-amyloid and have a lower LOAD risk. How the CD33m isoform increases beta-amyloid clearance remains unknown. We report that the protection by the CD33m isoform may not be conferred by what it does but, rather, from what it cannot do. Analysis of blood neutrophils and monocytes and a microglial cell line revealed that unlike CD33M, the CD33m isoform does not localize to cell surfaces; instead, it accumulates in peroxisomes. Cell stimulation and activation did not mobilize CD33m to the surface. Thus, the CD33m isoform may neither interact directly with amyloid plaques nor engage in cell-surface signaling. Rather, production and localization of CD33m in peroxisomes is a way of diminishing the amount of CD33M and enhancing beta-amyloid clearance. We confirmed intracellular localization by generating a CD33m-specific monoclonal antibody. Of note, CD33 is the only Siglec with a peroxisome-targeting sequence, and this motif emerged by convergent evolution in toothed whales, the only other mammals with a prolonged post-reproductive lifespan. The CD33 allele that protects post-reproductive individuals from LOAD may have evolved by adaptive loss-of-function, an example of the less-is-more hypothesis.	[Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Varki, Ajit] Univ Calif San Diego, CARTA, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Varki, Ajit] Univ Calif San Diego, GRTC, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Alisson-Silva, Frederico; Ghosh, Pradipta; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Alisson-Silva, Frederico; Ghosh, Pradipta; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Jiang, Weiping] BioLegend Inc, San Diego, CA 92121 USA; [Sundaramurthy, Venkatasubrannaniam] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Alisson-Silva, Frederico] CAPES, Program Sci Borders Ciencias Sem Fronteiras, BR-70040031 Brasilia, DF, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Varki, A (corresponding author), Univ Calif San Diego, GRTC, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	da Silva, Frederico/AAY-4758-2021; da Silva, Frederico/X-7822-2018	da Silva, Frederico/0000-0001-6717-2518; da Silva, Frederico/0000-0001-6717-2518; Sundaramurthy, Venkatasubramaniam/0000-0002-9245-1604; Siddiqui, Shoib/0000-0002-7028-290X	National Institutes of Health [R01GM32373, P01HL107150, CA160911, DK099226]; Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia, Brazil; NATIONAL CANCER INSTITUTE [R01CA160911, R01CA100768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia, Brazil; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM32373 and P01HL107150 (to A.V.) and CA160911 and DK099226 (to P.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia 70040-031, Brazil.	AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Brinkman-Vand der Linden ECM, 2003, MOL CELL BIOL, V23, P4199, DOI 10.1128/MCB.23.12.4199-4206.2003; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Finch CE, 2015, NEUROBIOL AGING, V36, P553, DOI 10.1016/j.neurobiolaging.2014.10.025; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mohan KVK, 2003, BIOINFORMATICS, V19, P10, DOI 10.1093/bioinformatics/19.1.10; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; O'SHEA JJ, 1985, J IMMUNOL, V134, P2580; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Paul SP, 2000, BLOOD, V96, P483; Perez-Oliva AB, 2011, GLYCOBIOLOGY, V21, P757, DOI 10.1093/glycob/cwq220; Porcellotti S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/967203; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; Rivas MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12342; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schwarz F, 2016, P NATL ACAD SCI USA, V113, P74, DOI 10.1073/pnas.1517951112; Schwarz F, 2015, ADV EXP MED BIOL, V842, P1, DOI 10.1007/978-3-319-11280-0_1; Siddiqui S, 2017, J BIOL CHEM, V292, P1029, DOI 10.1074/jbc.M116.738351; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Springer S. A., 2016, SEPARATING SPANDRELS, P309; Springer SA, 2016, P NATL ACAD SCI USA, V113, pE1591, DOI 10.1073/pnas.1601419113; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terlecky Stanley R, 2012, World J Biol Chem, V3, P93, DOI 10.4331/wjbc.v3.i5.93; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Walke DG, 2015, NEUROBIOL AGING, V36, P571, DOI 10.1016/j.neurobiolaging.2014.09.023; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; WEIGEL PH, 1983, J BIOL CHEM, V258, P5095; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	67	41	41	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15312	15320		10.1074/jbc.M117.799346	http://dx.doi.org/10.1074/jbc.M117.799346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747436	Green Published, hybrid			2022-12-28	WOS:000410809800013
J	Gyongyosi, N; Szoke, A; Ella, K; Kaldi, K				Gyongyosi, Norbert; Szoke, Anita; Ella, Krisztina; Kaldi, Krisztina			The small G protein RAS2 is involved in the metabolic compensation of the circadian clock in the circadian model Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT SIGNAL-TRANSDUCTION; GATED CALCIUM-CHANNELS; SUPRACHIASMATIC NUCLEUS; SACCHAROMYCES-CEREVISIAE; FREQUENCY DETERMINES; TRANSCRIPTION FACTOR; REGULATED GENES; WHITE COLLAR-1; FEEDBACK LOOPS; KINASE	Accumulating evidence from both experimental and clinical investigations indicates a tight interaction between metabolism and circadian timekeeping; however, knowledge of the underlying mechanism is still incomplete. Metabolic compensation allows circadian oscillators to run with a constant speed at different substrate levels and, therefore, is a substantial criterion of a robust rhythm in a changing environment. Because previous data have suggested a central role of RAS2-mediated signaling in the adaptation of yeast to different nutritional environments, we examined the involvement of RAS2 in the metabolic regulation of the clock in the circadian model organism Neurospora crassa. We show that, in a ras2-deficient strain, the period is longer than in the control. Moreover, unlike in the WT, in Delta ras2, operation of the circadian clock was affected by glucose; compared with starvation conditions, the period was longer and the oscillation of expression of the frequency (frq) gene was dampened. In constant darkness, the delayed phosphorylation of the FRQ protein and the long-lasting accumulation of FRQ in the nucleus were in accordance with the longer period and the less robust rhythm in the mutant. Although glucose did not affect the subcellular distribution of FRQ in the WT, highly elevated FRQ levels were detected in the nucleus in Delta ras2. RAS2 interacted with the RAS-binding domain of the adenylate cyclase in vitro, and the cAMP analogue 8-bromo-cyclic AMP partially rescued the circadian phenotype in vivo. We therefore propose that RAS2 acts via a cAMP-dependent pathway and exerts significant metabolic control on the Neurospora circadian clock.	[Gyongyosi, Norbert; Szoke, Anita; Ella, Krisztina; Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary	Semmelweis University	Kaldi, K (corresponding author), Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary.	kaldi.krisztina@med.semmelweis-univ.hu	Káldi, Krisztina/X-4080-2019; Ella, Krisztina/N-8552-2017	Ella, Krisztina/0000-0003-4961-5615; Kaldi, Krisztina/0000-0002-5724-0182; Szoke, Andrei/0000-0003-2973-7981	EMBO-HHMI; National Research, Development and Innovation Office, NKFIH [K115953]	EMBO-HHMI(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); National Research, Development and Innovation Office, NKFIH	This work was supported by an EMBO-HHMI startup grant (to K. K.) and the National Research, Development and Innovation Office, NKFIH (K115953). The authors declare that they have no conflicts of interest with the contents of this article.	Adhvaryu K, 2016, J BIOL RHYTHM, V31, P258, DOI 10.1177/0748730416639717; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BOS JL, 1989, CANCER RES, V49, P4682; Bouchard-Cannon P, 2012, CHRONOBIOL INT, V29, P965, DOI 10.3109/07420528.2012.707264; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cha J, 2013, EMBO REP, V14, P923, DOI 10.1038/embor.2013.131; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Cheng HYM, 2006, J NEUROSCI, V26, P12984, DOI 10.1523/JNEUROSCI.4253-06.2006; Cheng HYM, 2006, SEMIN CELL DEV BIOL, V17, P345, DOI 10.1016/j.semcdb.2006.03.006; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Dettmann A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004762; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Emerson JM, 2015, P NATL ACAD SCI USA, V112, P15707, DOI 10.1073/pnas.1521918112; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gai KX, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006732; Gerstner JR, 2006, NEUROSCIENCE, V139, P1435, DOI 10.1016/j.neuroscience.2006.01.020; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Gyongyosi N, 2014, ANTIOXID REDOX SIGN, V20, P3007, DOI 10.1089/ars.2013.5558; Gyongyosi N, 2013, FREE RADICAL BIO MED, V58, P134, DOI 10.1016/j.freeradbiomed.2012.12.016; Hayashi Y, 2001, FEBS LETT, V491, P71, DOI 10.1016/S0014-5793(01)02153-6; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Huang CCY, 2012, J CELL BIOCHEM, V113, P911, DOI 10.1002/jcb.23419; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Hurley JM, 2016, FUNGAL GENET BIOL, V90, P39, DOI 10.1016/j.fgb.2015.10.002; Johnson C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004183; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kanauchi A, 1997, MOL GEN GENET, V254, P427, DOI 10.1007/s004380050435; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Koletar MM, 2011, CHRONOBIOL INT, V28, P553, DOI 10.3109/07420528.2011.592235; Kozma-Bognar L, 2008, CHEMBIOCHEM, V9, P2565, DOI 10.1002/cbic.200800385; Larrondo LF, 2015, SCIENCE, V347, DOI 10.1126/science.1257277; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Relogio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004338; Sancar G, 2012, GENE DEV, V26, P2435, DOI 10.1101/gad.199547.112; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Serchov T, 2016, MOL NEUROBIOL, V53, P1843, DOI 10.1007/s12035-015-9135-0; Shi M, 2013, ACTA BIOCH BIOPH SIN, V45, P61, DOI 10.1093/abbs/gms110; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Tsuchiya Y, 2013, P JPN ACAD B-PHYS, V89, P59, DOI 10.2183/pjab.89.59; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Weeks G, 2003, CELL SIGNAL, V15, P901, DOI 10.1016/S0898-6568(03)00073-1; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097	80	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14929	14939		10.1074/jbc.M117.804922	http://dx.doi.org/10.1074/jbc.M117.804922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729421	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000409902100018
J	Lei, X; Seldin, MM; Little, HC; Choy, N; Klonisch, T; Wong, GW				Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Klonisch, Thomas; Wong, G. William			C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; C1Q/TNF FAMILY-MEMBERS; NECROSIS-FACTOR-ALPHA; HEPATIC STEATOSIS; LIPID HOMEOSTASIS; SKELETAL-MUSCLE; FOOD-INTAKE; TNF-ALPHA; EXPRESSION; GLUCOSE	Obesity is associated with chronic low-grade inflammation, and metabolic regulators linking obesity to inflammation have therefore received much attention. Secreted C1q/TNF-related proteins (CTRPs) are one such group of regulators that regulate glucose and fat metabolism in peripheral tissues and modulate inflammation in adipose tissue. We have previously shown that expression of CTRP6 is up-regulated in leptin-deficient mice and, conversely, down-regulated by the anti-diabetic drug rosiglitazone. Here, we provide evidence for a novel role of CTRP6 in modulating both inflammation and insulin sensitivity. We found that in obese and diabetic humans and mouse models, CTRP6 expression was markedly up-regulated in adipose tissue and that stromal vascular cells, such as macrophages, are a major CTRP6 source. Overexpressing mouse or human CTRP6 impaired glucose disposal in peripheral tissues in response to glucose and insulin challenge in wild-type mice. Conversely, Ctrp6 gene deletion improved insulin action and increased metabolic rate and energy expenditure in diet-induced obese mice. Mechanistically, CTRP6 regulates local inflammation and glucose metabolism by targeting macrophages and adipocytes, respectively. In cultured macrophages, recombinant CTRP6 dose-dependently up-regulated the expression and production of TNF-alpha. Conversely, CTRP6 deficiency reduced circulating inflammatory cytokines and pro-inflammatory macrophages in adipose tissue. CTRP6-overexpressing mice or CTRP6-treated adipocytes had reduced insulin-stimulated Akt phosphorylation and glucose uptake. In contrast, loss of CTRP6 enhanced insulin-stimulated Akt activation in adipose tissue. Together, these results establish CTRP6 as a novel metabolic/immune regulator linking obesity to adipose tissue inflammation and insulin resistance.	[Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lei, Xia; Seldin, Marcus M.; Little, Hannah C.; Choy, Nicholas; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Klonisch, Thomas] Univ Manitoba, Dept Human Anat & Cell Sci, Fac Med, Winnipeg, MB, Canada	Johns Hopkins University; Johns Hopkins University; University of Manitoba	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Klonisch, Thomas/W-9923-2019	Klonisch, Thomas/0000-0003-0448-6741; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [POST17070119]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant DK084171 (to G. W. W.) and American Heart Association post-doctoral fellowship POST17070119 (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fan RH, 2016, BIOCHEM BIOPH RES CO, V475, P356, DOI 10.1016/j.bbrc.2016.05.013; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kim MJ, 2010, MOL CELLS, V30, P59, DOI 10.1007/s10059-010-0088-x; Lee W, 2010, FEBS LETT, V584, P968, DOI 10.1016/j.febslet.2010.01.040; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu W, 2015, AUTOM ELECT POWER SY, V39, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	42	53	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14836	14850		10.1074/jbc.M116.766808	http://dx.doi.org/10.1074/jbc.M116.766808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28726640	Green Published, hybrid			2022-12-28	WOS:000409902100012
J	Yuan, LS; Mao, Y; Mao, Y; Luo, W; Wu, WW; Xu, H; Wang, XL; Shen, YH				Yuan, Liangshuai; Mao, Yun; Mao, Yun; Luo, Wei; Wu, Weiwei; Xu, Hao; Wang, Xing Li; Shen, Ying H.			Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; CYCLIC GMP-AMP; DIABETIC FOOT; I INTERFERON; REGENERATION; DISEASE; DYSFUNCTION; MEMBRANE; PROTEIN; CELLS	Impaired angiogenesis and wound healing carry significant morbidity and mortality in diabetic patients. Metabolic stress from hyperglycemia and elevated free fatty acids have been shown to inhibit endothelial angiogenesis. However, the underlying mechanisms remain poorly understood. In this study, we show that dysregulation of the Hippo-Yes-associated protein (YAP) pathway, an important signaling mechanism in regulating tissue repair and regeneration, underlies palmitic acid (PA)induced inhibition of endothelial angiogenesis. PA inhibited endothelial cell proliferation, migration, and tube formation, which were associated with increased expression of mammalian Ste20-like kinases 1 (MST1), YAP phosphorylation/ inactivation, and nuclear exclusion. Overexpression of YAP or knockdown of MST1 prevented PA-induced inhibition of angiogenesis. When searching upstream signaling mechanisms, we found that PA dysregulated the Hippo-YAP pathway by inducing mitochondrial damage. PA treatment induced mitochondrial DNA (mtDNA) release to cytosol, and activated cytosolic DNA sensor cGAS-STING-IRF3 signaling. Activated IRF3 bound to the MST1 gene promoter and induced MST1 expression, leading to MST1 up-regulation, YAP inactivation, and angiogenesis inhibition. Thus, mitochondrial damage and cytosolic DNA sensor cGAS-STING-IRF3 signaling are critically involved in PA-induced Hippo-YAP dysregulation and angiogenesis suppression. This mechanism may have implication in impairment of angiogenesis and wound healing in diabetes.	[Yuan, Liangshuai; Mao, Yun; Mao, Yun; Luo, Wei; Wu, Weiwei; Xu, Hao; Wang, Xing Li] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Shandong Univ, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Mao, Yun; Mao, Yun; Wang, Xing Li; Shen, Ying H.] Texas Heart Inst, Dept Surg, Houston, TX 77030 USA	Shandong University; Shandong University; Baylor College of Medicine; Texas Heart Institute	Wang, XL (corresponding author), Qilu Hosp, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Shen, YH (corresponding author), Baylor Coll Med, BM390,One Baylor Plaza, Houston, TX 77030 USA.	xingliwang@sdu.edu.cn; hyshen@bcm.edu	shen, ying/HHS-5635-2022		973 National Basic Research Program of China [2014CB542401]; National Institutes of Health [1R01HL131980-01]; American Heart Association [15GRNT23040007]; Shandong University National Qianren Scholar Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL143359, R01HL131980] Funding Source: NIH RePORTER	973 National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Shandong University National Qianren Scholar Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 973 National Basic Research Program of China Grant 2014CB542401 (to X.L.W.), National Institutes of Health Grant 1R01HL131980-01 (to Y.H.S.), American Heart Association Grant 15GRNT23040007 (to Y.H.S.), and the Shandong University National Qianren Scholar Fund (to X.L.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bowie A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002919; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Dunn LL, 2014, DIABETES, V63, P675, DOI 10.2337/db13-0417; Elbediwy A, 2016, BIOESSAYS, V38, P644, DOI 10.1002/bies.201600037; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He L, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0882-1; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kurz ARM, 2016, J CLIN INVEST, V126, P4125, DOI 10.1172/JCI87043; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/atvbaha.117.309017, 10.1161/ATVBAHA.117.309017]; Margolis DJ, 2011, DIABETES CARE, V34, P2363, DOI 10.2337/dc11-0807; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; Mehra VC, 2014, AM J PATHOL, V184, P1562, DOI 10.1016/j.ajpath.2014.01.009; Meng FS, 2016, GENE DEV, V30, P1086, DOI 10.1101/gad.277533.116; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moya IM, 2016, CURR OPIN CELL BIOL, V43, P62, DOI 10.1016/j.ceb.2016.08.004; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pi XC, 2014, ARTERIOSCL THROM VAS, V34, P2023, DOI 10.1161/ATVBAHA.114.303733; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qi WW, 2015, DIABETES, V64, P1407, DOI 10.2337/db14-1111; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Singh A, 2016, CELL REP, V15, P1384, DOI 10.1016/j.celrep.2016.04.027; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Vono R, 2016, DIABETES, V65, P3691, DOI 10.2337/db16-0248; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wu JQ, 2017, STEM CELL RES, V21, P74, DOI 10.1016/j.scr.2017.04.001; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu W., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0132499; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang J, 2015, ARTERIOSCL THROM VAS, V35, P163, DOI 10.1161/ATVBAHA.114.304705; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou Q, 2015, CIRC RES, V116, P1431, DOI 10.1161/CIRCRESAHA.116.303311	60	60	66	6	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15002	15015		10.1074/jbc.M117.804005	http://dx.doi.org/10.1074/jbc.M117.804005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28698384	Green Published, hybrid			2022-12-28	WOS:000409902100023
J	Kries, H; Kellner, F; Kamileen, MO; O'Connor, SE				Kries, Hajo; Kellner, Franziska; Kamileen, Mohamed Omar; O'Connor, Sarah E.			Inverted stereocontrol of iridoid synthase in snapdragon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APHID SEX-PHEROMONE; ANTIRRHINUM-MAJUS; BIOSYNTHESIS; CHEMOTAXONOMY; ACTIVATION; OLEUROPEIN; GLYCOSIDES; CULTURES	The natural product class of iridoids, found in various species of flowering plants, harbors astonishing chemical complexity. The discovery of iridoid biosynthetic genes in the medicinal plant Catharanthus roseus has provided insight into the biosynthetic origins of this class of natural product. However, not all iridoids share the exact five-to six-bicyclic ring scaffold of the Catharanthus iridoids. For instance, iridoids in the ornamental flower snapdragon (Antirrhinum majus, Plantaginaceae family) are derived from the C7 epimer of this scaffold. Here we have cloned and characterized the iridoid synthase enzyme from A. majus (AmISY), the enzyme that is responsible for converting 8-oxogeranial into the bicyclic iridoid scaffold in a two-step reduction-cyclization sequence. Chiral analysis of the reaction products reveals that AmISY reduces C7 to generate the opposite stereoconfiguration in comparison with the Catharanthus homologue CrISY. The catalytic activity of AmISY thus explains the biosynthesis of 7-epi-iridoids in Antirrhinum and related genera. However, although the stereoselectivity of the reduction step catalyzed by AmISY is clear, in both AmISY and CrISY, the cyclization step produces a diastereomeric mixture. Although the reduction of 8-oxogeranial is clearly enzymatically catalyzed, the cyclization step appears to be subject to less stringent enzyme control.	[Kries, Hajo; Kellner, Franziska; Kamileen, Mohamed Omar; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Kellner, Franziska] LeafSystems, Norwich NR4 7UH, Norfolk, England; [Kries, Hajo] Leibniz Inst Nat Prod Res & Infect Biol eV, Hans Knoll Inst, D-07745 Jena, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Hans Knoll Institute (HKI)	O'Connor, SE (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.oconnor@jic.ac.uk	O'Connor, Sarah Ellen/X-2893-2019	Kries, Hajo/0000-0002-4919-2811; Kamileen, Mohamed Omar/0000-0002-1346-1055; Kellner, Franziska/0000-0002-3424-6776	National Science Foundation Plant Genome Research Program Grant [IOS-1444499]; Biotechnological and Biological Sciences Research Council [BB/L014130/1]; Swiss National Science Foundation early postdoctoral mobility fellowship; Marie-Sklodowska-Curie postdoctoral fellowship [H2020-MSCA-IF-2014]; BBSRC [BB/L014130/1, BB/N007905/1, BBS/E/J/000CA512, BBS/E/J/000PR9790] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA512, BBS/E/J/000PR9790, BB/N007905/1, BB/L014130/1] Funding Source: researchfish	National Science Foundation Plant Genome Research Program Grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation early postdoctoral mobility fellowship; Marie-Sklodowska-Curie postdoctoral fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Science Foundation Plant Genome Research Program Grant IOS-1444499 (to S. E. O.), Biotechnological and Biological Sciences Research Council Grant BB/L014130/1, Swiss National Science Foundation early postdoctoral mobility fellowship (to H. K.), and a Marie-Sklodowska-Curie postdoctoral fellowship H2020-MSCA-IF-2014 (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alagna F, 2016, J BIOL CHEM, V291, P5542, DOI 10.1074/jbc.M115.701276; Beninger CW, 2007, J CHEM ECOL, V33, P731, DOI 10.1007/s10886-007-9253-x; Beninger CW, 2009, J CHEM ECOL, V35, P1363, DOI 10.1007/s10886-009-9715-4; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; BREINHOLT J, 1992, PHYTOCHEMISTRY, V31, P795, DOI 10.1016/0031-9422(92)80017-9; Burse A., 2017, Z NATURFORSCH, DOI 10.1515/znc-2017-0015; DAMTOFT S, 1993, PHYTOCHEMISTRY, V33, P1087, DOI 10.1016/0031-9422(93)85027-O; DAMTOFT S, 1994, PHYTOCHEMISTRY, V35, P1187, DOI 10.1016/S0031-9422(00)94819-2; DAMTOFT S, 1995, PHYTOCHEMISTRY, V39, P549, DOI 10.1016/0031-9422(95)00086-M; Damtoft S., 1983, BIOCHEM SOC T, V11, P593, DOI 10.1042/bst0110593; Dawson GW, 1996, BIOORGAN MED CHEM, V4, P351, DOI 10.1016/0968-0896(96)00012-0; DAWSON GW, 1989, PURE APPL CHEM, V61, P555, DOI 10.1351/pac198961030555; de la Fuente Marie-Ann, 1995, Chemoecology, V5-6, P13; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; FODERARO TA, 1992, PHYTOCHEMISTRY, V31, P4191, DOI 10.1016/0031-9422(92)80441-G; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Jensen SR, 2002, PHYTOCHEMISTRY, V60, P213, DOI 10.1016/S0031-9422(02)00102-4; Keller MA, 2015, CURR OPIN BIOTECH, V34, P153, DOI 10.1016/j.copbio.2014.12.020; Kim BM, 2011, HORTIC ENVIRON BIOTE, V52, P176, DOI 10.1007/s13580-011-0172-y; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Kries H, 2016, NAT CHEM BIOL, V12, P6, DOI 10.1038/nchembio.1955; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Munkert J, 2015, MOL PLANT, V8, P136, DOI 10.1016/j.molp.2014.11.005; MURAI F, 1982, PLANTA MED, V46, P45, DOI 10.1055/s-2007-970017; Preston JC, 2010, PLANT J, V62, P704, DOI 10.1111/j.1365-313X.2010.04184.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tantillo DJ, 2017, ANGEW CHEM INT EDIT, V56, P10040, DOI 10.1002/anie.201702363; Taskova RM, 2006, PHYTOCHEMISTRY, V67, P286, DOI 10.1016/j.phytochem.2005.11.011; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; UESATO S, 1986, TETRAHEDRON LETT, V27, P2893, DOI 10.1016/S0040-4039(00)84672-9; UESATO S, 1986, PHYTOCHEMISTRY, V25, P2309, DOI 10.1016/S0031-9422(00)81686-6; Viljoen A, 2012, CURR MED CHEM, V19, P2104; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winberg JO, 1999, J MOL BIOL, V294, P601, DOI 10.1006/jmbi.1999.3235	35	18	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14659	14667		10.1074/jbc.M117.800979	http://dx.doi.org/10.1074/jbc.M117.800979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28701463	Green Published, hybrid			2022-12-28	WOS:000408747500030
J	Kroh, HK; Chandrasekaran, R; Rosenthal, K; Woods, R; Jin, XF; Ohi, MD; Nyborg, AC; Rainey, GJ; Warrener, P; Spiller, BW; Lacy, DB				Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Ohi, Melanie D.; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul; Spiller, Benjamin W.; Lacy, D. Borden			Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INFECTION; PROTECTION; BEZLOTOXUMAB; RECOGNITION; SOFTWARE; SYSTEM; DOMAIN; VISUALIZATION; MECHANISM	Clostridium difficile is a clinically significant pathogen that causes mild-to-severe (and often recurrent) colon infections. Disease symptoms stem from the activities of two large, multidomain toxins known as TcdA and TcdB. The toxins can bind, enter, and perturb host cell function through a multistep mechanism of receptor binding, endocytosis, pore formation, autoproteolysis, and glucosyltransferase-mediated modification of host substrates. Monoclonal antibodies that neutralize toxin activity provide a survival benefit in preclinical animal models and prevent recurrent infections in human clinical trials. However, the molecular mechanisms involved in these neutralizing activities are unclear. To this end, we performed structural studies on a neutralizing monoclonal antibody, PA50, a humanized mAb with both potent and broad-spectrum neutralizing activity, in complex with TcdA. Electron microscopy imaging and multiangle light-scattering analysis revealed that PA50 binds multiple sites on the TcdA C-terminal combined repetitive oligopeptides (CROPs) domain. A crystal structure of two PA50 Fabs bound to a segment of the TcdA CROPs helped define a conserved epitope that is distinct from previously identified carbohydrate-binding sites. Binding of TcdA to the host cell surface was directly blocked by either PA50 mAb or Fab and suggested that receptor blockade is the mechanism by which PA50 neutralizes TcdA. These findings highlight the importance of the CROPsCterminus in cell-surface binding and a role for neutralizing antibodies in defining structural features critical to a pathogen's mechanism of action. We conclude that PA50 protects host cells by blocking the binding of TcdA to cell surfaces.	[Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Spiller, Benjamin W.; Lacy, D. Borden] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul] MedImmune LLC, Gaithersburg, MD 20878 USA; [Ohi, Melanie D.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Lacy, D. Borden] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Rainey, G. Jonah] MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA	Vanderbilt University; AstraZeneca; Medimmune; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, A5301 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.; Lacy, DB (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, A5301 Med Ctr North,161 21st Ave South, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu; borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Ohi, Melanie/0000-0003-1750-4793; Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [S10 RR026915]; Vanderbilt Structural Electron Microscopy Facility - Vanderbilt Center for Structural Biology; DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108778, R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Structural Electron Microscopy Facility - Vanderbilt Center for Structural Biology; DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	A portion of the experiments described here used the Vanderbilt robotic crystallization facility, which was supported by National Institutes of Health Grant S10 RR026915, and the Vanderbilt Structural Electron Microscopy Facility, which is supported in part by the Vanderbilt Center for Structural Biology. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chandrasekaran R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006070; Chapman BC, 2016, J TRAUMA ACUTE CARE, V81, P756, DOI 10.1097/TA.0000000000001195; Chen SY, 2015, TOXINS, V7, P5254, DOI 10.3390/toxins7124874; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Hernandez LD, 2015, ANTIMICROB AGENTS CH, V59, P1052, DOI 10.1128/AAC.04433-14; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Huang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135045; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Martin J, 2016, CURR OPIN INFECT DIS, V29, P546, DOI 10.1097/QCO.0000000000000320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGlone SM, 2012, CLIN MICROBIOL INFEC, V18, P282, DOI 10.1111/j.1469-0691.2011.03571.x; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rao K, 2015, INFECT DIS CLIN N AM, V29, P109, DOI 10.1016/j.idc.2014.11.009; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Teneberg S, 1996, GLYCOBIOLOGY, V6, P599, DOI 10.1093/glycob/6.6.599; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Waterman D. G., 2013, CCP4 NEWSLETTER PROT, V49, P16; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang ZY, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw078; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Youngster I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0680-9	57	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14401	14412		10.1074/jbc.M117.781112	http://dx.doi.org/10.1074/jbc.M117.781112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FF2SQ	28705932	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000408747500009
J	Sharma, AK; Rohrer, B				Sharma, Ashish K.; Rohrer, Baerbel			RETRACTION: Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line (Retraction of Vol 279, Pg 35564, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction															NEI NIH HHS [R01 EY013520] Funding Source: Medline; RRD VA [I01 RX000444] Funding Source: Medline; BLRD VA [I01 BX003050] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013520] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003050] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); RRD VA; BLRD VA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)		Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200	1	3	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13186	13186		10.1074/jbc.A117.401037	http://dx.doi.org/10.1074/jbc.A117.401037			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28801351	Green Published, hybrid			2022-12-28	WOS:000407465300009
J	Taylor, AA				Taylor, Alexandra A.			Side by side: The work of Elizabeth and James Miller	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Taylor, Alexandra A.] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Taylor, AA (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	alexandraataylor@gmail.com							0	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					12008	12009		10.1074/jbc.O117.000003	http://dx.doi.org/10.1074/jbc.O117.000003			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28710341	hybrid, Green Published			2022-12-28	WOS:000405485600036
J	Nogal, B; Bowman, CA; Ward, AB				Nogal, Bartek; Bowman, Charles A.; Ward, Andrew B.			Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron microscopy (EM); glycoprotein; human immunodeficiency virus (HIV); kinetics; protein-protein interaction; broadly neutralizing antibodies; single-particle analysis	BROADLY NEUTRALIZING ANTIBODIES; HIV-1 ENVELOPE GLYCOPROTEIN; CRYO-EM STRUCTURE; TREATMENT INTERRUPTION; CD4 BINDING; TRIMER; 3BNC117; SYSTEM; IMAGES; VRC01	Several biophysical approaches are available to study protein-protein interactions. Most approaches are conducted in bulk solution, and are therefore limited to an average measurement of the ensemble of molecular interactions. Here, we show how single-particle EM can enrich our understanding of protein-protein interactions at the single-molecule level and potentially capture states that are unobservable with ensemble methods because they are below the limit of detection or not conducted on an appropriate time scale. Using the HIV-1 envelope glycoprotein (Env) and its interaction with receptor CD4-binding site neutralizing antibodies as a model system, we both corroborate ensemble kinetics-derived parameters and demonstrate how time-course EM can further dissect stoichiometric states of complexes that are not readily observable with other methods. Visualization of the kinetics and stoichiometry of Env-antibody complexes demonstrated the applicability of our approach to qualitatively and semi-quantitatively differentiate two highly similar neutralizing antibodies. Furthermore, implementation of machine-learning techniques for sorting class averages of these complexes into discrete subclasses of particles helped reduce human bias. Our data provide proof of concept that single-particle EM can be used to generate a visual kinetic profile that should be amenable to studying many other protein-protein interactions, is relatively simple and complementary to well-established biophysical approaches. Moreover, our method provides critical insights into broadly neutralizing antibody recognition of Env, which may inform vaccine immunogen design and immunotherapeutic development.	[Nogal, Bartek; Bowman, Charles A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Ward, AB (corresponding author), 10550 North Torrey Pines Rd,Mail Code TRY-21, La Jolla, CA 92037 USA.	andrew@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769	Bill and Melinda Gates Foundation [OPP1115782]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Bill and Melinda Gates Foundation Grant OPP1115782. The authors declare that they have no conflicts of interest with the contents of this article.	Balla-Jhagjhoorsingh SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068863; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chen B, 2015, STRUCTURE, V23, P1097, DOI 10.1016/j.str.2015.04.007; Ciompi F, 2015, IEEE T MED IMAGING, V34, P962, DOI 10.1109/TMI.2014.2371821; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Gray GE, 2016, CURR OPIN VIROL, V17, P104, DOI 10.1016/j.coviro.2016.02.010; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee J.S., 2015, NAT COMMUN, V6; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rich R. L., 2011, LABEL FREE TECHNOLOG; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Stephenson KE, 2016, CURR HIV-AIDS REP, V13, P31, DOI 10.1007/s11904-016-0299-7; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19400	19410		10.1074/jbc.M117.808352	http://dx.doi.org/10.1074/jbc.M117.808352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972148	hybrid, Green Published			2022-12-28	WOS:000416226700021
J	Sieber, J; Wieder, N; Ostrosky-Frid, M; Dvela-Levitt, M; Aygun, O; Udeshi, ND; Carr, SA; Greka, A				Sieber, Jonas; Wieder, Nicolas; Ostrosky-Frid, Mauricio; Dvela-Levitt, Moran; Aygun, Ozan; Udeshi, Namrata D.; Carr, Steven A.; Greka, Anna			Lysine trimethylation regulates 78-kDa glucose-regulated protein proteostasis during endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; endoplasmic reticulum stress (ER stress); GRP78; protein degradation; proteomics; unfolded protein response (UPR); BIP; HSPA5; METTL21A; lysine trimethylation	PODOCYTES; PHOSPHORYLATION; METHYLATION; ENRICHMENT; CHAPERONE; BIP	The up-regulation of chaperones such as the 78-kDa glucose-regulated protein (GRP78, also referred to as BiP or HSPA5) is part of the adaptive cellular response to endoplasmic reticulum (ER) stress. GRP78 is widely used as a marker of the unfolded protein response, associated with sustained ER stress. Here we report the discovery of a proteostatic mechanism involving GRP78 trimethylation in the context of ER stress. Using mass spectrometry-based proteomics, we identified two GRP78 fractions, one homeostatic and one induced by ER stress. ER stress leads to de novo biosynthesis of non-trimethylated GRP78, whereas homeostatic, METTL21A-dependent lysine 585-trimethylated GRP78 is reduced. This proteostatic mechanism, dependent on the posttranslational modification of GRP78, allows cells to differentially regulate specific protein abundance during cellular stress.	[Sieber, Jonas; Wieder, Nicolas; Dvela-Levitt, Moran; Greka, Anna] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sieber, Jonas; Wieder, Nicolas; Dvela-Levitt, Moran; Aygun, Ozan; Udeshi, Namrata D.; Carr, Steven A.; Greka, Anna] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ostrosky-Frid, Mauricio] Univ Nacl Autonoma Mexico, Plan Combined Studies Med PECEM, Fac Med, Mexico City 04510, DF, Mexico	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidad Nacional Autonoma de Mexico	Greka, A (corresponding author), Harvard Med Sch, Harvard Inst Med, Brigham & Womens Hosp, 4 Blackfan Circle, Boston, MA USA.	agreka@bwh.harvard.edu	Carr, Steven A./AAH-8366-2019; Ostrosky-Frid, Mauricio/U-5227-2017	Sieber, Jonas/0000-0002-4325-4444; Ostrosky-Frid, Mauricio/0000-0002-0672-1074; Wieder, Nicolas/0000-0001-5683-2891	Swiss National Science Foundation [PBBSP3-144160, P300P3-151739]; Deutsche Forschungsgesellschaft [WI 4612/1-1]; Broad-ISF postdoctoral fellowship; National Institutes of Health [DK099465, DK095045]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Broad-ISF postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by Swiss National Science Foundation Fellowships PBBSP3-144160 and P300P3-151739.; Supported by Deutsche Forschungsgesellschaft Fellowship WI 4612/1-1.; Supported by a Broad-ISF postdoctoral fellowship.; Supported by National Institutes of Health Grants DK099465 and DK095045. To whom correspondence should be addressed: Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA02115. Tel.:617-525-5939; Fax:617-525-5965; E-mail: agreka@bwh.harvard.edu or agreka@broadinstitute.org.	Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buvall L, 2017, J AM SOC NEPHROL, V28, P837, DOI 10.1681/ASN.2016040414; Buvall L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3863; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sieber J, 2013, AM J PATHOL, V183, P735, DOI 10.1016/j.ajpath.2013.05.023; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1	26	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18878	18885		10.1074/jbc.M117.797084	http://dx.doi.org/10.1074/jbc.M117.797084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28912266	hybrid, Green Published			2022-12-28	WOS:000415848000013
J	Shedlovskiy, D; Zinskie, JA; Gardner, E; Pestov, DG; Shcherbik, N				Shedlovskiy, Daniel; Zinskie, Jessica A.; Gardner, Ethan; Pestov, Dimitri G.; Shcherbik, Natalia			Endonucleolytic cleavage in the expansion segment 7 of 25S rRNA is an early marker of low-level oxidative stress in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); oxidative stress; reactive oxygen species (ROS); redox signaling; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); ribosome; RNA degradation; RNA structure; Saccharomyces cerevisiae; stress response	UNFOLDED PROTEIN RESPONSE; EUKARYOTIC 80S RIBOSOME; OXIDIZED MESSENGER-RNA; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; REGULATES APOPTOSIS; THIOL PEROXIDASE; QUALITY-CONTROL	The ability to detect and respond to oxidative stress is crucial to the survival of living organisms. In cells, sensing of increased levels of reactive oxygen species (ROS) activates many defensive mechanisms that limit or repair damage to cell components. The ROS-signaling responses necessary for cell survival under oxidative stress conditions remain incompletely understood, especially for the translational machinery. Here, we found that drug treatments or a genetic deficiency in the thioredoxin system that increase levels of endogenous hydrogen peroxide in the yeast Saccharomyces cerevisiae promote site-specific endonucleolytic cleavage in 25S ribosomal RNA (rRNA) adjacent to the c loop of the expansion segment 7 (ES7), a putative regulatory region located on the surface of the 60S ribosomal subunit. Our data also show that ES7c is cleaved at early stages of the gene expression program that enables cells to successfully counteract oxidative stress and is not a prerequisite or consequence of apoptosis. Moreover, the 60S subunits containing ES7c-cleaved rRNA cofractionate with intact subunits in sucrose gradients and repopulate polysomes after a short starvation-induced translational block, indicating their active role in translation. These results demonstrate that ES7c cleavage in rRNA is an early and sensitive marker of increased ROS levels in yeast cells and suggest that changes in ribosomes may be involved in the adaptive response to oxidative stress.	[Shedlovskiy, Daniel; Zinskie, Jessica A.; Gardner, Ethan; Pestov, Dimitri G.; Shcherbik, Natalia] Rowan Univ, Dept Cell Biol & Neurosci, Stratford, NJ 08084 USA; [Gardner, Ethan] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University	Shcherbik, N (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	shcherna@rowan.edu		Pestov, Dimitri/0000-0002-1425-9879	National Institutes of Health [R01GM114308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114308 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; AMROLIA P, 1989, J APPL TOXICOL, V9, P113, DOI 10.1002/jat.2550090208; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doronina VA, 2015, MOL MICROBIOL, V96, P163, DOI 10.1111/mmi.12930; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Gu C, 2014, FEBS LETT, V588, P4287, DOI 10.1016/j.febslet.2014.09.038; Held KD, 1996, RADIAT RES, V145, P542, DOI 10.2307/3579272; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jin CY, 2014, MOL BIOL CELL, V25, P1396, DOI 10.1091/mbc.E13-09-0550; Kachur AV, 1997, RADIAT RES, V147, P409, DOI 10.2307/3579496; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; Lee JY, 2017, J MICROBIOL BIOTECHN, V27, P633, DOI 10.4014/jmb.1610.10045; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Ludovico P, 2014, FEMS YEAST RES, V14, P33, DOI 10.1111/1567-1364.12070; Luidalepp H, 2016, J MOL BIOL, V428, P2237, DOI 10.1016/j.jmb.2016.01.033; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mansour FH, 2013, ANAL BIOCHEM, V441, P18, DOI 10.1016/j.ab.2013.06.008; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Mirzaei H, 2006, J PROTEOME RES, V5, P3249, DOI 10.1021/pr060337l; MISRA HP, 1974, J BIOL CHEM, V249, P2151; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; Nagano T, 2015, J BIOCHEM, V158, P165, DOI 10.1093/jb/mvv026; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nilsen Timothy W, 2015, Cold Spring Harb Protoc, V2015, P314, DOI 10.1101/pdb.prot081026; Nilsson J, 2007, J MOL BIOL, V369, P429, DOI 10.1016/j.jmb.2007.03.035; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Ramos LMG, 2016, J MOL BIOL, V428, P4048, DOI 10.1016/j.jmb.2016.08.008; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Satheeshkumar K, 2011, CHEM-EUR J, V17, P4849, DOI 10.1002/chem.201003417; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shcherbik N, 2016, NUCLEIC ACIDS RES, V44, P6840, DOI 10.1093/nar/gkw566; Shedlovskiy D., 2017, RNA BIOL IN PRESS; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Sideri TC, 2011, J BIOL CHEM, V286, P38924, DOI 10.1074/jbc.M111.272419; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Simms CL, 2014, CELL REP, V9, P1256, DOI 10.1016/j.celrep.2014.10.042; Strich R, 2015, GENETICS, V200, P1003, DOI 10.1534/genetics.115.179150; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	83	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18469	18485		10.1074/jbc.M117.800003	http://dx.doi.org/10.1074/jbc.M117.800003			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28939771	Green Published, hybrid			2022-12-28	WOS:000414958100008
J	Chen, Z; Gui, B; Zhang, Y; Xie, GJ; Li, WJ; Liu, SM; Xu, BS; Wu, CY; He, L; Yang, JG; Yi, X; Yang, XH; Sun, LY; Liang, J; Shang, YF				Chen, Zhe; Gui, Bin; Zhang, Yu; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Wu, Chongyang; He, Lin; Yang, Jianguo; Yi, Xia; Yang, Xiaohan; Sun, Luyang; Liang, Jing; Shang, Yongfeng			Identification of a 35S U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complex intermediate in spliceosome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; ribonuclear protein (RNP); RNA helicase; RNA splicing; spliceosome; Cajal body; snRNP assembly; tri-snRNP	PRE-MESSENGER-RNA; G-PATCH PROTEIN; COMPENSATORY BASE CHANGE; ZINC-FINGER PROTEINS; DEAH BOX ATPASE; CAJAL BODIES; RIBOSOME BIOGENESIS; ELECTRON CRYOMICROSCOPY; BREAST CARCINOGENESIS; CATALYTIC ACTIVATION	The de novo assembly and post-splicing reassembly of the U4/U6.U5 tri-snRNP remain to be investigated. We report here that ZIP, a protein containing a CCCH-type zinc finger and a G-patch domain, as characterized by us previously, regulates pre-mRNA splicing independent of RNA binding. We found that ZIP physically associates with the U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP). Remarkably, the ZIP-containing tri-snRNP, which has a sedimentation coefficient of approximate to 35S, is a tri-snRNP that has not been described previously. We also found that the 35S tri-snRNP contains hPrp24, indicative of a state in which the U4/U6 di-snRNP is integrating with the U5 snRNP. We found that the 35S tri-snRNP is enriched in the Cajal body, indicating that it is an assembly intermediate during 25S tri-snRNP maturation. We showed that the 35S tri-snRNP also contains hPrp43, in which ATPase/RNA helicase activities are stimulated by ZIP. Our study identified, for the first time, a tri-snRNP intermediate, shedding new light on the de novo assembly and recycling of the U4/U6.U5 tri-snRNP.	[Chen, Zhe; Gui, Bin; Zhang, Yu; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Wu, Chongyang; He, Lin; Yang, Jianguo; Yi, Xia; Yang, Xiaohan; Sun, Luyang; Liang, Jing; Shang, Yongfeng] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr,Key Lab Carcinogenesis & Translat Re, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Shang, Yongfeng] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China	Peking University; Tianjin Medical University; Capital Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157	National Natural Science Foundation of China [91219201, 81530073, 81730079]; Ministry of Science and Technology of China [2016YFC1302304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 91219201, 81530073, and 81730079 from the National Natural Science Foundation of China (to Y. S.) and Grant 2016YFC1302304 from the Ministry of Science and Technology of China (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; BACH M, 1989, P NATL ACAD SCI USA, V86, P6038, DOI 10.1073/pnas.86.16.6038; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; BINDEREIF A, 1987, EMBO J, V6, P2415, DOI 10.1002/j.1460-2075.1987.tb02520.x; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Christian H, 2014, NUCLEIC ACIDS RES, V42, P1162, DOI 10.1093/nar/gkt985; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Didychuk AL, 2016, NUCLEIC ACIDS RES, V44, P1398, DOI 10.1093/nar/gkv1374; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Fouraux MA, 2002, RNA, V8, P1428, DOI 10.1017/S1355838202021076; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Klingauf M, 2006, MOL BIOL CELL, V17, P4972, DOI 10.1091/mbc.E06-06-0513; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; KRAMER A, 1984, CELL, V38, P299, DOI 10.1016/0092-8674(84)90551-8; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Niu ZY, 2012, FEBS LETT, V586, P977, DOI 10.1016/j.febslet.2012.02.052; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Novotny I, 2011, MOL BIOL CELL, V22, P513, DOI 10.1091/mbc.E10-07-0560; Novotny I, 2015, CELL REP, V10, P429, DOI 10.1016/j.celrep.2014.12.030; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Robert-Paganin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/931857; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Silverman EJ, 2004, MOL CELL BIOL, V24, P10101, DOI 10.1128/MCB.24.23.10101-10110.2004; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Tanaka N, 2006, BIOCHEMISTRY-US, V45, P6510, DOI 10.1021/bi052656g; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Theuser M, 2016, P NATL ACAD SCI USA, V113, P7798, DOI 10.1073/pnas.1524616113; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Tsai RT, 2005, GENE DEV, V19, P2991, DOI 10.1101/gad.1377405; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	85	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18113	18128		10.1074/jbc.M117.797357	http://dx.doi.org/10.1074/jbc.M117.797357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28878014	hybrid, Green Published			2022-12-28	WOS:000414458200011
J	Boopathy, GTK; Kulkarni, M; Ho, SY; Boey, A; Chua, EWM; Barathi, VA; Carney, TJ; Wang, XM; Hong, WJ				Boopathy, Gandhi T. K.; Kulkarni, Madhura; Ho, Sze Yuan; Boey, Adrian; Chua, Edmond Wei Min; Barathi, Veluchamy A.; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin			Cavin-2 regulates the activity and stability of endothelial nitric-oxide synthase (eNOS) in angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-INDUCED RETINOPATHY; PATHOLOGICAL ANGIOGENESIS; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; IN-VIVO; CAVEOLAE; MICROPARTICLES; MEMBRANE; CELLS; ACTIVATION	Angiogenesis is a highly regulated process for formation of new blood vessels from pre-existing ones. Angiogenesis is dysregulated in various pathologies, including age-related macular degeneration, arthritis, and cancer. Inhibiting pathological angiogenesis therefore represents a promising therapeutic strategy for treating these disorders, highlighting the need to study angiogenesis in more detail. To this end, identifying the genes essential for blood vessel formation and elucidating their function are crucial for a complete understanding of angiogenesis. Here, focusing on potential candidate genes for angiogenesis, we performed a morpholino-based genetic screen in zebrafish and identified Cavin-2, a membrane-bound phosphatidylserine-binding protein and critical organizer of caveolae (small microdomains in the plasma membrane), as a regulator of angiogenesis. Using endothelial cells, we show that Cavin-2 is required for in vitro angiogenesis and also for endothelial cell proliferation, migration, and invasion. We noted a high level of Cavin-2 expression in the neovascular tufts in the mouse model of oxygen-induced retinopathy, suggesting a role for Cavin-2 in pathogenic angiogenesis. Interestingly, we also found that Cavin-2 regulates the production of nitric oxide (NO) in endothelial cells by controlling the stability and activity of the endothelial nitric-oxide synthase (eNOS) and that Cavin-2 knockdown cells produce much less NO than WT cells. Also, mass spectrometry, flow cytometry, and electron microscopy analyses indicated that Cavin-2 is secreted in endothelial microparticles (EMPs) and is required for EMP biogenesis. Taken together, our results indicate that in addition to its function in caveolae biogenesis, Cavin-2 plays a critical role in endothelial cell maintenance and function by regulating eNOS activity.	[Boopathy, Gandhi T. K.; Boey, Adrian; Chua, Edmond Wei Min; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin] ASTAR, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore; [Kulkarni, Madhura; Ho, Sze Yuan; Carney, Tom J.; Wang, Xiaomeng] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Barathi, Veluchamy A.; Wang, Xiaomeng] SERI, 20 Coll Rd, Singapore 169856, Singapore; [Barathi, Veluchamy A.] Duke NUS Grad Med Sch, Ophthalmol & Visual Sci Acad Clin Program, 8 Coll Rd, Singapore 169857, Singapore; [Barathi, Veluchamy A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Boopathy, Gandhi T. K.; Barathi, Veluchamy A.; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin] SERI IMCB, SERI IMCB Programme Retinal Angiogen Dis SIPRAD, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Boopathy, GTK; Hong, WJ (corresponding author), ASTAR, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore.	gandhibtk@imcb.a-star.edu.sg; mcbhwj@imcb.a-star.edu.sg	Wang, Xiaomeng/F-9504-2015; Carney, Tom J/H-4389-2011; Boey, Adrian/AAC-4239-2022; Carney, Tom James/ACF-9214-2022	Carney, Tom J/0000-0003-2371-1924; Carney, Tom James/0000-0003-2371-1924; T. K. Boopathy, Gandhi/0000-0002-1821-9540; Wang, Xiaomeng/0000-0002-1036-2764; Boey, Adrian/0000-0003-2835-6159	Agency for Science, Technology and Research (A*STAR); SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD)	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD)	This work was supported by Agency for Science, Technology and Research (A*STAR) funds (to W. H.) and the SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baguley B., 2001, ANTICANCER DRUG DEV; Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Brown LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013905; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; COHEN RA, 1995, PROG CARDIOVASC DIS, V38, P105, DOI 10.1016/S0033-0620(05)80002-7; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Curtis AM, 2013, VASC MED, V18, P204, DOI 10.1177/1358863X13499773; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; FLAVAHAN NA, 1992, CIRCULATION, V85, P1927, DOI 10.1161/01.CIR.85.5.1927; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mineo C, 2012, ADV EXP MED BIOL, V729, P51, DOI 10.1007/978-1-4614-1222-9_4; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Razani B, 2001, J BIOL CHEM, V276, P38121; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	64	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17760	17776		10.1074/jbc.M117.794743	http://dx.doi.org/10.1074/jbc.M117.794743			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28912276	hybrid, Green Published			2022-12-28	WOS:000414013000015
J	Sathiyamoorthy, K; Vijayalakshmi, J; Tirupati, B; Fan, LX; Saper, MA				Sathiyamoorthy, Karthik; Vijayalakshmi, J.; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A.			Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL-MODE ANALYSIS; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; WALL SYNTHESIS; PROTEINS; DYNAMICS; SCATTERING; STIMULATE; MOTIONS; FITNESS	In many Gram-negative bacteria, the peptidoglycan synthase PBP1A requires the outer membrane lipoprotein LpoA for constructing a functional peptidoglycan required for bacterial viability. Previously, we have shown that the C-terminal domain of Haemophilus influenzae LpoA (HiLpoA) has a highly conserved, putative substrate-binding cleft between two alpha/beta lobes. Here, we report a 2.0 angstrom resolution crystal structure of the HiLpoA N-terminal domain. Two subdomains contain tetratricopeptide-like motifs that form a concave groove, but their relative orientation differs by similar to 45 degrees from that observed in an NMR structure of the Escherichia coli LpoA N domain. We also determined three 2.0-2.8 angstrom resolution crystal structures containing four independent full-length HiLpoA molecules. In contrast to an elongated model previously suggested for E. coli LpoA, each HiLpoA formed a U-shaped structure with a different C-domain orientation. This resulted from both N-domain twisting and rotation of the C domain (up to 30 degrees) at the end of the relatively immobile interdomain linker. Moreover, a previously predicted hinge between the lobes of the LpoA C domain exhibited variations of up to 12 degrees. Small-angle X-ray scattering data revealed excellent agreement with a model calculated by normal mode analysis from one of the full-length HiLpoA molecules but even better agreement with an ensemble of this molecule and two of the partially extended normal mode analysis-predicted models. The different LpoA structures helped explain how an outer membrane-anchored LpoA can either withdraw from or extend toward the inner membrane-bound PBP1A through peptidoglycan gaps and hence regulate the synthesis of peptidoglycan necessary for bacterial viability.	[Sathiyamoorthy, Karthik; Vijayalakshmi, J.; Tirupati, Bhramara; Saper, Mark A.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Saper, Mark A.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA; [Fan, Lixin] Leidos Biomed Res Inc, Small Angle Xray Scattering Core Facil, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Sathiyamoorthy, Karthik] Stanford Univ, Dept Struct Biol, Palo Alto, CA 94305 USA; [Tirupati, Bhramara] Adv Bion, Valencia, CA 91355 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Saper, MA (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	saper@umich.edu	Sathiyamoorthy, Karthik/K-6190-2015	Sathiyamoorthy, Karthik/0000-0002-5736-8709	DOE Office of Science [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; E. I. DuPont de Nemours Co.; Dow Chemical Company; State of Illinois; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099984] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; E. I. DuPont de Nemours Co.; Dow Chemical Company; State of Illinois; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Brian Akerley for support from the beginning of this project and for reading the manuscript. We thank Mykola Murskyj for help with cloning and members of the Saper laboratory for advice. For the SAXS experiments, we acknowledge use of the SAXS Core facility of the Center for Cancer Research, NCI/National Institutes of Health, and thank Dr. Xiaobing Zuo for expert support. We thank the outstanding synchrotron support staff at LSCAT and DND-CAT. We also benefitted from discussions with Tobias Dorr, Matthew Larson, Kathleen Wisser, Erik R. P. Zuiderweg, and Charles Brooks III. We also thank Ilan Rosenshine and Susan Buchanan for hosting M. A. S. in their laboratories. We thank the software authors for writing and sharing the software necessary for this project. Jerry Brown provided expert editing. This research used resources of the Advanced Photon Source (APS), a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (ANL) under Contract DE-AC02-06CH11357. The SAXS beamline 12-ID-B at APS was allocated under the PUP-24152 agreement between NCI/National Institutes of Health and ANL. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The LpoA-N data were measured at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of APS. DND-CAT was supported by E. I. DuPont de Nemours & Co., The Dow Chemical Company, and the State of Illinois.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Azari F, 2013, J BACTERIOL, V195, P1680, DOI 10.1128/JB.02149-12; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Dorr T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004433; Dorr T, 2014, INFECT IMMUN, V82, P2115, DOI 10.1128/IAI.00012-14; Doruker P, 2002, J COMPUT CHEM, V23, P119, DOI 10.1002/jcc.1160; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Gray AN, 2015, ELIFE, V4, DOI 10.7554/eLife.07118; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jean NL, 2014, STRUCTURE, V22, P1047, DOI 10.1016/j.str.2014.04.017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King DT, 2014, J BIOL CHEM, V289, P19245, DOI 10.1074/jbc.M114.565879; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; Lee TK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13170; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Lupoli TJ, 2014, J AM CHEM SOC, V136, P52, DOI 10.1021/ja410813j; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Parashar V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001512; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sambrook J., 1989, MOL CLONING LAB MANU; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tama F, 2003, PROTEIN PEPTIDE LETT, V10, P119, DOI 10.2174/0929866033479077; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Troshin PV, 2011, BIOINFORMATICS, V27, P2001, DOI 10.1093/bioinformatics/btr304; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Turner RD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2503; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vijayalakshmi J, 2008, PROTEINS, V73, P204, DOI 10.1002/prot.22033; Wong SM, 2013, P NATL ACAD SCI USA, V110, P15413, DOI 10.1073/pnas.1311217110; Wong SM, 2003, GENE, V316, P177, DOI 10.1016/S0378-1119(03)00762-5; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839; Zouhir S, 2013, NUCLEIC ACIDS RES, V41, P7920, DOI 10.1093/nar/gkt546	64	10	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17626	17642		10.1074/jbc.M117.804997	http://dx.doi.org/10.1074/jbc.M117.804997			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887305	Green Published, hybrid			2022-12-28	WOS:000414013000006
J	Scannevin, RH; Alexander, R; Haarlander, TM; Burke, SL; Singer, M; Huo, CF; Zhang, YM; Maguire, D; Spurlino, J; Deckman, I; Carroll, KI; Lewandowski, F; Devine, E; Dzordzorme, K; Tounge, B; Milligan, C; Bayoumy, S; Williams, R; Schalk-Hihi, C; Leonard, K; Jackson, P; Todd, M; Kuo, LC; Rhodes, KJ				Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.			Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROSARCOMA CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MATRIX METALLOPROTEINASE-3 STROMELYSIN; BRAIN-BARRIER DISRUPTION; MONOCLONAL-ANTIBODIES; FOCAL ISCHEMIA; IV COLLAGENASE; GELATINASE-B; SPINAL-CORD; EXPRESSION	Aberrant activation of matrix metalloproteinases (MMPs) is a common feature of pathological cascades observed in diverse disorders, such as cancer, fibrosis, immune dysregulation, and neurodegenerative diseases. MMP-9, in particular, is highly dynamically regulated in several pathological processes. Development of MMP inhibitors has therefore been an attractive strategy for therapeutic intervention. However, a long history of failed clinical trials has demonstrated that broad-spectrum MMP inhibitors have limited clinical utility, which has spurred the development of inhibitors selective for individual MMPs. Attaining selectivity has been technically challenging because of sequence and structural conservation across the various MMPs. Here, through a biochemical and structural screening paradigm, we have identified JNJ0966, a highly selective compound that inhibited activation of MMP-9 zymogen and subsequent generation of catalytically active enzyme. JNJ0966 had no effect on MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14 catalytic activity and did not inhibit activation of the highly related MMP-2 zymogen. The molecular basis for this activity was characterized as an interaction of JNJ0966 with a structural pocket in proximity to the MMP-9 zymogen cleavage site near Arg-106, which is distinct from the catalytic domain. JNJ0966 was efficacious in reducing disease severity in a mouse experimental autoimmune encephalomyelitis model, demonstrating the viability of this therapeutic approach. This discovery reveals an unprecedented pharmacological approach to MMP inhibition, providing an opportunity to improve selectivity of future clinical drug candidates. Targeting zymogen activation in this manner may also allow for pharmaceutical exploration of other enzymes previously viewed as intractable drug targets.	[Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.] Janssen Res & Dev LLC, Spring House, PA 19477 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Scannevin, RH (corresponding author), Yuman Therapeut, 790 Mem Dr, Cambridge, MA 02139 USA.	rscannevin@yumanity.com		Spurlino, John/0000-0003-1308-2570; Scannevin, Robert/0000-0002-5749-2785	companies of the Industrial Macromolecular Crystallography Association; University of Chicago; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	companies of the Industrial Macromolecular Crystallography Association; University of Chicago(University of Chicago); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We sincerely thank H. Moore Arnold for thoughtful assistance in reviewing and editing the manuscript. Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the University of Chicago. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; BU CH, 1995, J BIOL CHEM, V270, P18563, DOI 10.1074/jbc.270.31.18563; Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Duncan ME, 1998, EUR J BIOCHEM, V258, P37, DOI 10.1046/j.1432-1327.1998.2580037.x; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fabre B, 2014, CHEMBIOCHEM, V15, P399, DOI 10.1002/cbic.201300698; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gege C, 2012, J MED CHEM, V55, P709, DOI 10.1021/jm201152u; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; GOLUB LM, 1995, J CLIN PERIODONTOL, V22, P100; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; King J, 2003, ANTICANCER RES, V23, P639; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Lijnen HR, 1998, BLOOD, V91, P2045, DOI 10.1182/blood.V91.6.2045.2045_2045_2053; Lindberg RLP, 2001, BRAIN, V124, P1743, DOI 10.1093/brain/124.9.1743; Maquoi E, 2002, EXP CELL RES, V275, P110, DOI 10.1006/excr.2002.5489; Zapico JM, 2015, ORG BIOMOL CHEM, V13, P142, DOI 10.1039/c4ob01516a; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park BC, 2007, EUR J PHARMACOL, V567, P193, DOI 10.1016/j.ejphar.2007.04.014; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Schnute ME, 2010, BIOORG MED CHEM LETT, V20, P576, DOI 10.1016/j.bmcl.2009.11.081; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Shibayama M, 1997, ACT NEUR S, V70, P220; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/neu.2004.21.1706; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Udi Y, 2013, J MOL BIOL, V425, P2330, DOI 10.1016/j.jmb.2013.04.009; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xu XP, 2007, BIOCHEM J, V406, P147, DOI 10.1042/BJ20070591; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhao Y, 2008, BIOCHEM BIOPH RES CO, V369, P1215, DOI 10.1016/j.bbrc.2008.03.038	59	70	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17963	17974		10.1074/jbc.M117.806075	http://dx.doi.org/10.1074/jbc.M117.806075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28860188	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000414013000031
J	Tsuboi, M; Taniuchi, K; Shimizu, T; Saito, M; Saibara, T				Tsuboi, Makiko; Taniuchi, Keisuke; Shimizu, Takahiro; Saito, Motoaki; Saibara, Toshiji			The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; ACTIN REORGANIZATION; DNA-BINDING; HOMEODOMAIN PROTEIN; EPITHELIAL-CELLS; BREAST-CANCER; GROWTH-FACTOR; K-RAS; METASTASIS; MIGRATION	HOX genes encode transcription factors that function as sequence-specific transcription factors that are involved in cellular proliferation, differentiation, and death. The aim of this study was to investigate the role of a HOX family protein, HOXB7, in the motility and invasiveness of pancreatic cancer cells. We previously identified a HOXB7 transcript that is one of a number of transcripts that are preferentially translated in membrane protrusions in pancreatic cancer cells. Immunocytochemistry showed that HOXB7 was localized to the cell protrusions of migrating pancreatic cancer cells. Knockdown of HOXB7 by transfection with HOXB7-specific siRNA decreased these protrusions and inhibited the motility and invasiveness of the cells. Transfection of a HOXB7-rescue construct into the HOXB7-knockdown cells restored peripheral actin structures in cell protrusions and abrogated the HOXB7 knockdown-induced decrease in cell protrusions. It is generally accepted that the Rho family of GTPases regulate the organization of actin filaments and contribute to the formation of cell protrusions. The levels of the active Rho GTPases were not influenced by HOXB7 in the cells; however, HOXB7 knockdown decreased the level of phosphorylated ERK1/2. This inactivation of ERK1/2 decreased cell protrusions, thereby inhibiting the invasiveness of pancreatic cancer cells. Further investigation showed that HOXB7/ERK1/2 signaling selectively stimulated JNK and HSP27 phosphorylation and thereby increased the motility and invasiveness of pancreatic cancer cells. These results suggested that HOXB7 stimulates ERK1/2 phosphorylation and provided evidence that HOXB7, besides its role in transcriptional regulation, also promotes cell motility and invasiveness.	[Tsuboi, Makiko; Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi 7838505, Japan; [Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Oko Cho, Nankoku, Kochi 7838505, Japan; [Shimizu, Takahiro; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan	Kochi University; Kochi University; Kochi University	Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Oko Cho, Nankoku, Kochi 7838505, Japan.	ktaniuchi@kochi-u.ac.jp			 [24591013];  [15K14396]	; 	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) 24591013 and 15K14396. The authors declare that they have no conflicts of interest with the contents of this article.	Ahrendt SA, 2002, ONCOLOGY-NY, V16, P725; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Baumgart M, 2005, CELL ONCOL, V27, P3; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 2001, CANCER RES, V61, P6532; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen HX, 2008, CANCER RES, V68, P3637, DOI 10.1158/0008-5472.CAN-07-2926; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; How C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067846; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Kaltschmidt JA, 2002, NAT CELL BIOL, V4, P937, DOI 10.1038/ncb882; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ridley AJ, 2001, J CELL SCI, V114, P2713; Robitaille H, 2010, J INVEST DERMATOL, V130, P74, DOI 10.1038/jid.2009.185; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Taniuchi K, 2012, NEOPLASIA, V14, P440, DOI 10.1593/neo.12352; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yip-Schneider MT, 1999, INT J ONCOL, V15, P271; Yip-Schneider MT, 2003, PANCREAS, V27, P337, DOI 10.1097/00006676-200311000-00012; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-61	49	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17681	17702		10.1074/jbc.M116.772780	http://dx.doi.org/10.1074/jbc.M116.772780			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28912272	hybrid, Green Published			2022-12-28	WOS:000414013000010
J	Zimmermann, K; Eells, R; Heinrich, F; Rintoul, S; Josey, B; Shekhar, P; Losche, M; Stern, LJ				Zimmermann, Kerstin; Eells, Rebecca; Heinrich, Frank; Rintoul, Stefanie; Josey, Brian; Shekhar, Prabhanshu; Losche, Mathias; Stern, Lawrence J.			The cytosolic domain of T-cell receptor zeta associates with membranes in a dynamic equilibrium and deeply penetrates the bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCR-CD3 COMPLEX; TRANSMEMBRANE DIMER; LIPID MEMBRANES; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; SUBUNIT CONTAINS; BINDING MOTIF; IN-VITRO; CHAIN; PHOSPHORYLATION	Interactions between lipid bilayers and the membrane-proximal regions of membrane-associated proteins play important roles in regulating membrane protein structure and function. The T-cell antigen receptor is an assembly of eight single-pass membrane-spanning subunits on the surface of T lymphocytes that initiates cytosolic signaling cascades upon binding antigens presented by MHC-family proteins on antigen-presenting cells. Its zeta-subunit contains multiple cytosolic immunoreceptor tyrosine-based activation motifs involved in signal transduction, and this subunit by itself is sufficient to couple extracellular stimuli to intracellular signaling events. Interactions of the cytosolic domain of zeta (zeta(cyt)) with acidic lipids have been implicated in the initiation and regulation of transmembrane signaling. zeta(cyt) is unstructured in solution. Interaction with acidic phospholipids induces structure, but its disposition when bound to lipid bilayers is controversial. Here, using surface plasmon resonance and neutron reflection, we characterized the interaction of zeta(cyt) with planar lipid bilayers containing mixtures of acidic and neutral lipids. We observed two binding modes of zeta(cyt) to the bilayers in dynamic equilibrium: one in which zeta(cyt) is peripherally associated with lipid headgroups and one in which it penetrates deeply into the bilayer. Such an equilibrium between the peripherally bound and embedded forms of zeta(cyt) apparently controls accessibility of the immunoreceptor tyrosine-based activation signal transduction pathway. Our results reconcile conflicting findings of the zeta structure reported in previous studies and provide a framework for understanding how lipid interactions regulate motifs to tyrosine kinases and may regulate the T-cell antigen receptor biological activities for this cell-surface receptor system.	[Zimmermann, Kerstin; Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA; [Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Eells, Rebecca; Heinrich, Frank; Rintoul, Stefanie; Josey, Brian; Shekhar, Prabhanshu; Losche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Losche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Losche, Mathias] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Rintoul, Stefanie] Harvard Sch Business, Boston, MA 02163 USA; [Shekhar, Prabhanshu] Intel Corp, Beaverton, OR 97007 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Carnegie Mellon University; Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA; Harvard University; Intel Corporation	Stern, LJ (corresponding author), Univ Massachusetts, Med Sch, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	Lawrence.Stern@umassmed.edu	Heinrich, Frank/A-5339-2010; Lösche, Mathias/J-2986-2013	Heinrich, Frank/0000-0002-8579-553X; Lösche, Mathias/0000-0001-6666-916X	 [S10RR027897]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038996, R01AI038996, R37AI038996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101647] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael J. Eck (Harvard Medical School) for recombinant baculovirus and appreciate the help from Lara Strittmatter and Gregory M. Hendricks (University of Massachusetts Medical School, Electron Microscopy Facility, Project S10RR027897).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; ANKNER JF, 1992, P SOC PHOTO-OPT INS, V1738, P260, DOI 10.1117/12.130637; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BenTal N, 1997, BIOPHYS J, V73, P1717, DOI 10.1016/S0006-3495(97)78203-1; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Bridgeman JS, 2014, CLIN EXP IMMUNOL, V175, P258, DOI 10.1111/cei.12216; Budvytyte R, 2013, LANGMUIR, V29, P8645, DOI 10.1021/la401132c; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DeFord-Watts LM, 2009, J IMMUNOL, V183, P1055, DOI 10.4049/jimmunol.0900404; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duchardt E, 2007, CHEMBIOCHEM, V8, P820, DOI 10.1002/cbic.200600413; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Elisabeth Gasteiger, 2005, PROTEIN IDENTIFICATI; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; Frigault MJ, 2016, INT IMMUNOL, V28, P355, DOI 10.1093/intimm/dxw018; Furlan G, 2014, J BIOL CHEM, V289, P28514, DOI 10.1074/jbc.M114.574319; Gagnon E, 2010, CELL, V142, P669, DOI 10.1016/j.cell.2010.08.019; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Heinrich F, 2014, BBA-BIOMEMBRANES, V1838, P2341, DOI 10.1016/j.bbamem.2014.03.007; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laczko I, 1998, BIOCHEM BIOPH RES CO, V242, P474, DOI 10.1006/bbrc.1997.7989; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MacCallum JL, 2011, BIOPHYS J, V101, P110, DOI 10.1016/j.bpj.2011.05.038; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Petruk AA, 2013, BBA-BIOMEMBRANES, V1828, P2637, DOI 10.1016/j.bbamem.2013.07.019; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sharma S, 2014, BBA-BIOMEMBRANES, V1838, P739, DOI 10.1016/j.bbamem.2013.12.001; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Sigalov AB, 2009, BIOCHEM BIOPH RES CO, V389, P388, DOI 10.1016/j.bbrc.2009.09.002; Sun GQ, 1997, BIOCHEMISTRY-US, V36, P2139, DOI 10.1021/bi962291n; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Szymczak AL, 2005, J IMMUNOL, V174, P4153, DOI 10.4049/jimmunol.174.7.4153; TRASATTI S, 1991, PURE APPL CHEM, V63, P711, DOI 10.1351/pac199163050711; Vanderah DJ, 2003, LANGMUIR, V19, P2612, DOI 10.1021/la026990e; Weissenhorn W, 1996, EUR J BIOCHEM, V238, P440, DOI 10.1111/j.1432-1033.1996.0440z.x; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	60	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17746	17759		10.1074/jbc.M117.794370	http://dx.doi.org/10.1074/jbc.M117.794370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893902	hybrid, Green Published			2022-12-28	WOS:000414013000014
J	Algamal, M; Ahmed, R; Jafari, N; Ahsan, B; Ortega, J; Melacini, G				Algamal, Moustafa; Ahmed, Rashik; Jafari, Naeimeh; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe			Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid beta(A beta) peptides in the monomer and protofibril states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; A-BETA-PEPTIDE; ALZHEIMERS-DISEASE; THERAPEUTIC ALBUMIN; NMR-SPECTROSCOPY; STRUCTURAL BASIS; PLASMA-EXCHANGE; OLIGOMERS; BINDING; A-BETA(1-40)	Self-association of amyloid beta (A beta) peptides is a hallmark of Alzheimer's disease and serves as a general prototype for amyloid formation. A key endogenous inhibitor of A beta self-association is human serum albumin (HSA), which binds similar to 90% of plasma A beta. However, the exact molecular mechanism by which HSA binds A beta monomers and protofibrils is not fully understood. Here, using dark-state exchange saturation transfer NMR and relaxation experiments complemented by morphological characterization, we mapped the HSA-A beta interactions at atomic resolution by examining the effects ofHSAonA beta monomers and soluble high-molecular weight oligomeric protofibrils. We found that HSA binds both monomeric and protofibrillar A beta, but the affinity of HSA for A beta monomers is lower than for A beta protofibrils (K-d values are submillimolar rather than micromolar) yet physiologically relevant because of the similar to 0.6-0.7 mM plasma HSA concentration. In both A beta-protofibrils and monomers, HSA targets key A beta self-recognition sites spanning the beta strands found in cross-beta protofibril structures, leading to a net switch from direct to tethered contacts between the monomeric A beta and the protofibril surface. These HSAA beta interactions are isoform-specific, because the HSA affinity of A beta monomers is lower for A beta (1-42) than for A beta (1-40). In addition, the HSA-induced perturbations of the monomer/protofibrils pseudo-equilibrium extend to the C-terminal residues in the A beta (1-42) isoform but not in A beta (1-40). These results provide an unprecedented view of how albumin interacts with A beta and illustrate the potential of dark-state exchange saturation transfer NMR in mapping the interactions between amyloid-inhibitory proteins and amyloidogenic peptides.	[Algamal, Moustafa; Jafari, Naeimeh; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Ahmed, Rashik; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Ahmed, Rashik/AAZ-2325-2020; Ortega, Joaquin/AAS-1322-2020	Ahmed, Rashik/0000-0003-2001-9684; Algamal, Moustafa/0000-0002-6215-0122	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04514]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant RGPIN-2014-04514 from the Natural Sciences and Engineering Research Council of Canada (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Algamal M, 2013, BIOPHYS J, V105, P1700, DOI 10.1016/j.bpj.2013.08.025; Anaya F, 2010, REV NEUROLOGIA, V50, pS5; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Boada M, 2016, NEUROLOGIA, V31, P473, DOI 10.1016/j.nrl.2014.02.003; Boada M, 2009, DRUG NEWS PERSPECT, V22, P325, DOI 10.1358/dnp.2009.22.6.1395256; Boada-Rovira M, 2010, REV NEUROLOGIA, V50, pS9; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Bouvignies G, 2012, J PHYS CHEM B, V116, P14311, DOI 10.1021/jp311109u; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Costa M, 2012, J ALZHEIMERS DIS, V29, P159, DOI 10.3233/JAD-2012-111139; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Ezra A, 2016, J ALZHEIMERS DIS, V50, P175, DOI 10.3233/JAD-150694; Fawzi NL, 2012, NAT PROTOC, V7, P1523, DOI 10.1038/nprot.2012.077; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Kotler SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11811; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Llewellyn DJ, 2010, CURR ALZHEIMER RES, V7, P91, DOI 10.2174/156720510790274392; Long D, 2013, ANGEW CHEM INT EDIT, V52, P10771, DOI 10.1002/anie.201305434; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Milojevic J., 2012, THESIS; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2014, J ALZHEIMERS DIS, V38, P753, DOI 10.3233/JAD-131169; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Naldi M, 2012, ACS CHEM NEUROSCI, V3, P952, DOI 10.1021/cn3000982; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Raditsis AV, 2013, BIOPHYS J, V105, P473, DOI 10.1016/j.bpj.2013.03.065; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Roche J, 2016, J BIOMOL NMR, V64, P1, DOI 10.1007/s10858-015-0004-y; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Suzuki Y, 2013, BIOCHEMISTRY-US, V52, P1903, DOI 10.1021/bi400027y; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Wang CG, 2016, RSC ADV, V6, P71165, DOI 10.1039/c6ra14590f; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	47	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17158	17168		10.1074/jbc.M117.792853	http://dx.doi.org/10.1074/jbc.M117.792853			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28798235	Green Published, hybrid			2022-12-28	WOS:000414009300001
J	Otrusinova, O; Demo, G; Padrta, P; Jasenakova, Z; Pekarova, B; Gelova, Z; Szmitkowska, A; Kaderavek, P; Jansen, S; Zachrdla, M; Klumpler, T; Marek, J; Hritz, J; Janda, L; Iwai, H; Wimmerova, M; Hejatko, J; Zidek, L				Otrusinova, Olga; Demo, Gabriel; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Klumpler, Tomas; Marek, Jaromir; Hritz, Jozef; Janda, Lubomir; Iwai, Hideo; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas			Conformational dynamics are a key factor in signaling mediated by the receiver domain of a sensor histidine kinase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MODEL-FREE APPROACH; X-RAY ANALYSIS; PROTEIN CHEY; MACROMOLECULAR CRYSTALLOGRAPHY; RELAXATION EXPERIMENT; CRYSTAL-STRUCTURES; ETHYLENE RECEPTOR; STRUCTURAL BASIS; NMR	Multistep phosphorelay (MSP) cascades mediate responses to a wide spectrum of stimuli, including plant hormonal signaling, but several aspects of MSP await elucidation. Here, we provide first insight into the key step of MSP- mediated phosphotransfer in a eukaryotic system, the phosphorylation of the receiver domain of the histidine kinase CYTOKININ-INDEPENDENT 1 (CKI1(RD)) from Arabidopsis thaliana. We observed that the crystal structures of free, Mg2+-bound, and beryllofluoridated CKI1(RD) (a stable analogue of the labile phosphorylated form) were identical and similar to the active state of receiver domains of bacterial response regulators. However, the three CKI1(RD) variants exhibited different conformational dynamics in solution. NMR studies revealed that Mg2+ binding and beryllofluoridation alter the conformational equilibrium of the beta 3-beta 3 loop close to the phosphorylation site. Mutations that perturbed the conformational behavior of the beta 3-beta 3 loop while keeping the active- site aspartate intact resulted in suppression of CKI1 function. Mechanistically, homology modeling indicated that the beta 3 beta 3 loop directly interacts with the ATP- binding site of the CKI1 histidine kinase domain. The functional relevance of the conformational dynamics observed in the beta 3-beta 3 loop of CKI1(RD) was supported by a comparison with another A. thaliana histidine kinase, ETR1. In contrast to the highly dynamic beta 3- beta 3 loop of CKI1(RD), the corresponding loop of the ETR1 receiver domain (ETR1(RD)) exhibited little conformational exchange and adopted a different orientation in crystals. Biochem-ical data indicated that ETR1(RD) is involved in phosphorylation-independent signaling, implying a direct link between conformational behavior and the ability of eukaryotic receiver domains to participate in MSP.	[Otrusinova, Olga; Demo, Gabriel; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Klumpler, Tomas; Marek, Jaromir; Hritz, Jozef; Janda, Lubomir; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Otrusinova, Olga; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Janda, Lubomir; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Iwai, Hideo] Univ Helsinki, Inst Biotechnol, Viikinkaari 1,POB 65, Helsinki 00014, Finland; [Demo, Gabriel] Univ Massachusetts, RNA Therapeut Inst, Sch Med, 368 Plantat St, Worcester, MA 01605 USA; [Kaderavek, Pavel] Ecole Normale Super, Dept Chim, 24 Rue Lhomond, F-75005 Paris, France	Masaryk University Brno; Masaryk University Brno; University of Helsinki; University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Zidek, L (corresponding author), Masaryk Univ, Cent European Inst Technol, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.; Zidek, L (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.	lzidek@chemi.muni.cz	Kadeřávek, Pavel/D-7670-2012; Wimmerova, Michaela/A-4114-2010; Hejatko, Jan/AAN-1182-2021; Zidek, Lukas/AAB-6109-2020; Gelová, Zuzana/ABG-5834-2020; Hejatko, Jan/H-4296-2014; Zidek, Lukas/D-7112-2012; Marek, Jaromír/AAU-7603-2021; Iwaï, Hideo/A-6416-2009; Demo, Gabriel/D-7261-2012; Hritz, Jozef/J-6887-2015; Padrta, Petr/AAA-7945-2019; Jansen, Severine/Q-6364-2019; Pekárová, Blanka/E-3560-2012	Wimmerova, Michaela/0000-0002-7108-4198; Zidek, Lukas/0000-0002-8013-0336; Hejatko, Jan/0000-0002-2622-6046; Zidek, Lukas/0000-0002-8013-0336; Marek, Jaromír/0000-0002-6242-7638; Iwaï, Hideo/0000-0001-7376-5264; Demo, Gabriel/0000-0002-5472-9249; Hritz, Jozef/0000-0002-4512-9241; Janda, Lubomir/0000-0002-5406-4208; Gelova, Zuzana/0000-0003-4783-1752	MEYS CR [LM2015043]	MEYS CR	We thank Helmholtz-Zentrum Berlin and EMBL/DESY, operating the DORIS synchrotron, for providing access to their synchrotron data-collection facilities and the allocation of synchrotron radiation beam time, and Dr. Vladimir Rogov of the J.W. Goethe University at Frankfurt for helpful suggestions. CIISB research infrastructure project LM2015043 funded by MEYS CR is gratefully acknowledged for the financial support of the measurements at the Josef Dadok National NMR Centre, CEITEC-Masaryk University.	Banerjee R, 2015, J PHYS CHEM B, V119, P6591, DOI 10.1021/acs.jpcb.5b02582; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Degtjarik O, 2013, ACTA CRYSTALLOGR F, V69, P158, DOI 10.1107/S174430911205186X; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Grantz AA, 1998, ACTA CRYSTALLOGR D, V54, P690, DOI 10.1107/S0907444997015023; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; HALLE B, 1981, J AM CHEM SOC, V103, P500, DOI 10.1021/ja00393a004; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hung YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160598; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Khalili M, 2008, J PHYS CHEM B, V112, P2456, DOI 10.1021/jp076628e; Klumpler T, 2009, ACTA CRYSTALLOGR F, V65, P478, DOI 10.1107/S1744309109012032; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Long D, 2008, J AM CHEM SOC, V130, P2432, DOI 10.1021/ja710477h; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Ma L, 2007, J AM CHEM SOC, V129, P10261, DOI 10.1021/ja073059f; McDonald LR, 2013, J MOL BIOL, V425, P2372, DOI 10.1016/j.jmb.2013.04.029; McDonald LR, 2012, STRUCTURE, V20, P1363, DOI 10.1016/j.str.2012.05.008; Morin S, 2014, BIOINFORMATICS, V30, P2219, DOI 10.1093/bioinformatics/btu166; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Otten R, 2010, J AM CHEM SOC, V132, P17004, DOI 10.1021/ja107410x; Park SY, 2004, P NATL ACAD SCI USA, V101, P11646, DOI 10.1073/pnas.0401038101; Pekarova B, 2016, MOL PLANT, V9, P71, DOI 10.1016/j.molp.2015.11.008; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Podgornaia AI, 2013, STRUCTURE, V21, P1636, DOI 10.1016/j.str.2013.07.005; Pontiggia F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8284; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Sheftic SR, 2012, BIOCHEMISTRY-US, V51, P6932, DOI 10.1021/bi300922z; Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Usher KC, 1998, PROTEIN SCI, V7, P403; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanatta DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8283; Vicha J, 2016, PROTEINS, V84, P686, DOI 10.1002/prot.25019; Villali J, 2014, J MOL BIOL, V426, P1554, DOI 10.1016/j.jmb.2013.12.027; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VOLZ K, 1991, J BIOL CHEM, V266, P15511; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Welch M, 1998, NAT STRUCT BIOL, V5, P25, DOI 10.1038/nsb0198-25; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045	79	4	4	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17525	17540		10.1074/jbc.M117.790212	http://dx.doi.org/10.1074/jbc.M117.790212			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860196	Green Published, hybrid			2022-12-28	WOS:000414009300032
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series: Redox metabolism and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						cancer; hypoxia; metabolism; reactive oxygen species (ROS); redox signaling; stress		Life on oxygen predisposes cells to reactive oxygen species (ROS) generation by electron slippage in the electron transfer chain. Aerobic metabolism also generates superoxide (O.) and hydrogen peroxide (H2O2) as bona fide products in reactions involving 1- or 2-electron reduction of O-2. Although often viewed as dangerous, ROS are now recognized as important messengers in redox signaling pathways. A delicate balance between needed versus excessive ROS production distinguishes health from an array of disease states. A collection of provocative reviews in this thematic series discusses the relative importance of mitochondrial sites for ROS production, ROS signaling-mediated regulation of cellular stress responses and thermogenesis, and how O-2 deficiency leads to metabolic reprograming in cancer.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, HL58984, GM112455]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK45776, HL58984, and GM112455 (to R. B.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Chouchani ET, 2017, J BIOL CHEM, V292, P16810, DOI 10.1074/jbc.R117.789628; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Xie H, 2017, J BIOL CHEM, V292, P16825, DOI 10.1074/jbc.R117.799973	4	2	2	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16802	16803		10.1074/jbc.R117.814160	http://dx.doi.org/10.1074/jbc.R117.814160			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28842492	Green Published, hybrid			2022-12-28	WOS:000413140600001
J	Mishra, J; Das, JK; Kumar, N				Mishra, Jayshree; Das, Jugal Kishore; Kumar, Narendra			Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through beta-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; TYROSINE PHOSPHORYLATION; N-CADHERIN; SRC FAMILY; COMPLEX; IDENTIFICATION; PROTEIN; SWITCH; PREDISPOSITION; EXPRESSION	Compromise in adherens junctions (AJs) is associated with several chronic inflammatory diseases. We reported previously that Janus kinase 3, a non-receptor tyrosine kinase, plays a crucial role in AJ formation through its interaction with beta-catenin. In this report, we characterize the structural determinants responsible for Jak3 interactions with beta-catenin and determine the functional implications of previously unknown tyrosine residues on beta-catenin phosphorylated by Jak3. We demonstrate that Jak3 autophosphorylation was the rate-limiting step during Jak3 trans-phosphorylation of beta-catenin, where Jak3 directly phosphorylated three tyrosine residues, viz. Tyr(30), Tyr(64), and Tyr(86) in the N-terminal domain (NTD) of beta-catenin. However, prior phosphorylation of beta-catenin at Tyr(654) was essential for further phosphorylation of beta-catenin by Jak3. Interaction studies indicated that phosphorylated Jak3 bound to phosphorylated beta-catenin with a dissociation constant of 0.28 beta M, and although both the kinase and FERM(Band 4.1, ezrin, radixin, and moesin) domains of Jak3 interacted with beta-catenin, the NTD domain of beta-catenin facilitated its interactions with Jak3. Physiologically, Jak3-mediated phosphorylation of beta-catenin suppressed EGF-mediated epithelial-mesenchymal transition and facilitated epithelial barrier functions by AJ localization of phosphorylated beta-catenin through its interactions with beta-catenin. Moreover, loss of Jak3-mediated phosphorylation sites in beta-catenin abrogated its AJ localization and compromised epithelial barrier functions. Thus, we not only characterize Jak3 interaction with beta-catenin but also demonstrate the mechanism of molecular interplay between AJ dynamics and EMT by Jak3-mediated NTD phosphorylation of beta-catenin.	[Mishra, Jayshree; Das, Jugal Kishore; Kumar, Narendra] Texas A&M Hlth Sci Ctr, ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mishra, J; Kumar, N (corresponding author), Texas A&M HSC, ILR Coll Pharm, 1010 W Ave B,MSC 131, Kingsville, TX 78363 USA.	mishra@pharmacy.tamhsc.edu; nkumar@tamhsc.edu	Das, Jugal/GLU-4420-2022; MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	National Institutes of Health [DK081661, GM109528]; Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM109528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK081661 (to N. K.) and GM109528 (to N. K. and J. M.). The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABERLE H, 1994, J CELL SCI, V107, P3655; Alves CH, 2014, PROG RETIN EYE RES, V40, P35, DOI 10.1016/j.preteyeres.2014.01.001; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chen CY, 2017, DEV NEUROBIOL, V77, P61, DOI 10.1002/dneu.22411; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coopman P, 2016, CELL MOL LIFE SCI, V73, P3535, DOI 10.1007/s00018-016-2260-8; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Govaere O, 2017, ONCOGENE, V36, P6605, DOI 10.1038/onc.2017.260; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kajiguchi T, 2012, EUR J HAEMATOL, V88, P314, DOI 10.1111/j.1600-0609.2011.01738.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klinke DJ, 2015, MOL BIOL CELL, V26, P4135, DOI 10.1091/mbc.E15-02-0083; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kumar N., 2015, U.S. Patent, Patent No. [US20150344934A1, 20150344934]; Kumar N., 2016, U. S. Patent, Patent No. [US20160223545 A1, 20160223545]; Kumar N., 2012, J IMMUNODEFIC DISORD, V1; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Libusova L, 2010, DEVELOPMENT, V137, P2297, DOI 10.1242/dev.048488; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; McCrea PD, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.3; Mehta S, 2015, CELL TISSUE RES, V360, P749, DOI 10.1007/s00441-014-1994-6; Mishra J, 2015, J BIOL CHEM, V290, P29301, DOI 10.1074/jbc.M115.670331; Mishra J, 2014, J BIOL CHEM, V289, P15951, DOI 10.1074/jbc.C113.527523; Mishra J, 2013, J BIOL CHEM, V288, P31795, DOI 10.1074/jbc.M113.504126; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Mishra J, 2013, PROG BRAIN RES, V207, P351, DOI 10.1016/B978-0-444-63327-9.00013-8; Mukherjee N, 2016, BBA-MOL BASIS DIS, V1862, P1472, DOI 10.1016/j.bbadis.2016.05.009; Padmanabhan A, 2015, CURR OPIN CELL BIOL, V36, P32, DOI 10.1016/j.ceb.2015.06.008; Safford MG, 1997, EXP HEMATOL, V25, P374; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Tacchelly-Benites O, 2013, BIOESSAYS, V35, P1063, DOI 10.1002/bies.201300101; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; Valizadeh A, 1997, AM J PATHOL, V150, P1977; Veracini L, 2015, ONCOTARGET, V6, P7570, DOI 10.18632/oncotarget.3071; Xi Y, 2013, ONCOGENE, V32, P5048, DOI 10.1038/onc.2012.530; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yu YM, 2004, IMMUNOL RES, V29, P55, DOI 10.1385/IR:29:1-3:055	49	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16406	16419		10.1074/jbc.M117.811802	http://dx.doi.org/10.1074/jbc.M117.811802			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28821617	hybrid, Green Published			2022-12-28	WOS:000412414800002
J	Pilipczuk, J; Zalewska-Piatek, B; Bruzdziak, P; Czub, J; Wieczor, M; Olszewski, M; Wanarska, M; Nowicki, B; Augustin-Nowacka, D; Piatek, R				Pilipczuk, Justyna; Zalewska-Piatek, Beata; Bruzdziak, Piotr; Czub, Jacek; Wieczor, Milosz; Olszewski, Marcin; Wanarska, Marta; Nowicki, Bogdan; Augustin-Nowacka, Danuta; Piatek, Rafal			Role of the disulfide bond in stabilizing and folding of the fimbrial protein DraE from uropathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE CAF1M; YERSINIA-PESTIS; ADHESINS; COMPLEX; BIOGENESIS; RESOLUTION; PATHOGENS; SUBFAMILY; SUBUNIT; STRAINS	Dr fimbriae are homopolymeric adhesive organelles of uropathogenic Escherichia coli composed of DraE subunits, responsible for the attachment to host cells. These structures are characterized by enormously high stability resulting from the structural properties of an Ig-like fold of DraE. One feature of DraE and other fimbrial subunits that makes them peculiar among Ig-like domain-containing proteins is a conserved disulfide bond that joins their A and B strands. Here, we investigated how this disulfide bond affects the stability and folding/unfolding pathway of DraE. We found that the disulfide bond stabilizes self-complemented DraE (DraE-sc) by similar to 50 kJ mol(-1) in an exclusively thermodynamic manner, i.e. by lowering the free energy of the native state and with almost no effect on the free energy of the transition state. This finding was confirmed by experimentally determined folding and unfolding rate constants of DraE-sc and a disulfide bond-lacking DraE-sc variant. Although the folding of both proteins exhibited similar kinetics, the unfolding rate constant changed upon deletion of the disulfide bond by 10 orders of magnitude, from similar to 10(-17) s(-1) to 10(-7) s(-1). Molecular simulations revealed that unfolding of the disulfide bond-lacking variant is initiated by strands A or G and that disulfide bond-mediated joining of strand A to the core strand B cooperatively stabilizes the whole protein. We also show that the disulfide bond in DraE is recognized by the DraB chaperone, indicating a mechanism that precludes the incorporation of less stable, non-oxidized DraE forms into the fimbriae.	[Pilipczuk, Justyna; Zalewska-Piatek, Beata; Olszewski, Marcin; Wanarska, Marta; Piatek, Rafal] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Ul Narutowicza 11-12, PL-80233 Gdansk, Poland; [Bruzdziak, Piotr; Czub, Jacek; Wieczor, Milosz] Gdansk Univ Technol, Dept Phys Chem, Gdansk, Poland; [Nowicki, Bogdan] Nowicki Inst Womens Hlth Res, Brentwood, TN 37027 USA; [Augustin-Nowacka, Danuta] Univ Gdansk, Fac Chem, PL-80308 Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; University of Gdansk	Piatek, R (corresponding author), Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Ul Narutowicza 11-12, PL-80233 Gdansk, Poland.	rafpiate@pg.gda.pl	Olszewski, Marcin/HFZ-9682-2022; Wieczór, Miłosz/O-6562-2019; Bruździak, Piotr/G-1029-2018	Olszewski, Marcin/0000-0002-5116-2793; Wieczór, Miłosz/0000-0003-4990-8629; Bruździak, Piotr/0000-0002-6445-0743; Piatek, Rafal/0000-0003-3808-6906; Zalewska-Piatek, Beata/0000-0003-1654-1218; Czub, Jacek/0000-0003-3639-6935; Wanarska, Marta/0000-0001-5343-4302	Ministry of Science and Higher Education "Iuventus Plus" Grant [IP2011 041371]; Polish National Science Centre [2014/13/B/NZ6/00257]; PL-Grid infrastructure	Ministry of Science and Higher Education "Iuventus Plus" Grant; Polish National Science Centre; PL-Grid infrastructure	This work was supported by Ministry of Science and Higher Education "Iuventus Plus" Grant IP2011 041371 (to R. P.) and by Polish National Science Centre Grant 2014/13/B/NZ6/00257 (to R. P.). This work was also supported in part by PL-Grid infrastructure. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Anderson KL, 2004, MOL CELL, V15, P647, DOI 10.1016/j.molcel.2004.08.003; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Carnoy C, 1997, MOL MICROBIOL, V23, P365, DOI 10.1046/j.1365-2958.1997.2231590.x; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Cota E, 2006, MOL MICROBIOL, V62, P356, DOI 10.1111/j.1365-2958.2006.05375.x; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; Giese C, 2016, ANGEW CHEM INT EDIT, V55, P9350, DOI 10.1002/anie.201603652; Hamill SJ, 2000, J MOL BIOL, V297, P165, DOI 10.1006/jmbi.2000.3517; Hamill SJ, 1998, BIOCHEMISTRY-US, V37, P8071, DOI 10.1021/bi9801659; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; Korotkova N, 2006, J BIOL CHEM, V281, P29120, DOI 10.1074/jbc.M605681200; NOWICKI B, 1988, NEW ENGL J MED, V319, P1289; Pettigrew D, 2004, J BIOL CHEM, V279, P46851, DOI 10.1074/jbc.M409284200; Piatek R, 2005, INFECT IMMUN, V73, P135, DOI 10.1128/IAI.73.1.135-145.2005; Piatek R, 2010, BIOCHEMISTRY-US, V49, P1460, DOI 10.1021/bi901896b; Piatek R, 2009, BIOCHEMISTRY-US, V48, P11807, DOI 10.1021/bi900920k; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Puorger C, 2011, J MOL BIOL, V412, P520, DOI 10.1016/j.jmb.2011.07.044; Roccatano D, 2003, BIOPHYS J, V84, P1876, DOI 10.1016/S0006-3495(03)74995-9; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Zalewska B, 2003, INFECT IMMUN, V71, P5505, DOI 10.1128/IAI.71.10.5505-5513.2003; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08; Zav'yalov V, 2010, FEMS MICROBIOL REV, V34, P317, DOI 10.1111/j.1574-6976.2009.00201.x; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zavialvo AV, 2005, BIOCHEM J, V389, P685, DOI 10.1042/BJ20050426; ZAVYALOV VP, 1995, FEMS IMMUNOL MED MIC, V11, P19, DOI 10.1016/0928-8244(94)00098-E; ZavYalov VP, 1997, BIOCHEM J, V324, P571, DOI 10.1042/bj3240571	32	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16136	16149		10.1074/jbc.M117.785477	http://dx.doi.org/10.1074/jbc.M117.785477			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28739804	hybrid, Green Published			2022-12-28	WOS:000412109400014
J	Aarnio-Peterson, M; Zhao, P; Yu, SH; Christian, C; Flanagan-Steet, H; Wells, L; Steet, R				Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard			Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; ALZHEIMERS AMYLOID-BETA; MUCOLIPIDOSIS-II; GAMMA-SUBUNIT; REVERSIBLE OXIDATION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; SKIN FIBROBLASTS; DISEASE	Acid hydrolases utilize a carbohydrate-dependent mechanism for lysosomal targeting. These hydrolases acquire a mannose 6-phosphate tag by the action of the GlcNAc-1-phospho-transferase enzyme, allowing them to bind receptors and traffic to endosomes. Loss of GlcNAc-1-phosphotransferase results in hydrolase hypersecretion and profound lysosomal storage. Little, however, is known about how these cellular phenotypes affect the trafficking, activity, and localization of surface glycoproteins. To address this question, we profiled the abundance of surface glycoproteins in WT and CRISPR-mediated GNPTAB(-/-) HeLa cells and identified changes in numerous glycoproteins, including the uptake receptor LRP1 and multiple receptor tyrosine kinases. Decreased cell surface LRP1 in GNPTAB(-/-) cells corresponded with a reduction in its steady-state level and less amyloid-beta-40 (A beta 40) peptide uptake. GNPTAB(-/-) cells displayed elevated activation of several kinases including Met receptor. We found increased Met phosphorylation within both the kinase and the docking domains and observed that lower concentrations of pervanadate were needed to cause an increase in phospho-Met in GNPTAB(-/-) cells. Together, these data suggested a decrease in the activity of the receptor and non-receptor protein-tyrosine phosphatases that down-regulate Met phosphorylation. GNPTAB(-/-) cells exhibited elevated levels of reactive oxygen species, known to inactivate cell surface and cytosolic phosphatases by oxidation of active site cysteine residues. Consistent with this mode of action, peroxide treatment of parental HeLa cells elevated phospho-Met levels whereas antioxidant treatment of GNPTAB(-/-) cells reduced phospho-Met levels. Collectively, these findings identify new mechanisms whereby impaired lysosomal targeting can impact the activity and recycling of receptors.	[Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu		Zhao, Peng/0000-0002-9296-5293; Wells, Lance/0000-0003-4956-5363; Yu, Seok-Ho/0000-0002-8372-1094	National Institutes of Health [GM086524, GM107012]; Yash Gandhi Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM086524 and GM107012 and the Yash Gandhi Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Boivin B, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975633; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Clavijo-Cornejo D, 2013, BIOCHIMIE, V95, P1177, DOI 10.1016/j.biochi.2013.01.005; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Dittmer F, 1999, J CELL SCI, V112, P1591; Flanagan-Steet H, 2016, J BONE MINER RES, V31, P535, DOI 10.1002/jbmr.2722; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Gomez-Quiroz LE, 2016, TOXICOLOGY, V361, P39, DOI 10.1016/j.tox.2016.07.004; Gujdar A, 2004, CELL SIGNAL, V16, P505, DOI 10.1016/j.cellsig.2003.09.009; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Markmann S, 2015, TRAFFIC, V16, P743, DOI 10.1111/tra.12284; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mbua NE, 2013, P NATL ACAD SCI USA, V110, P10207, DOI 10.1073/pnas.1221105110; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Otomo T, 2009, MOL GENET METAB, V98, P393, DOI 10.1016/j.ymgme.2009.07.002; Owen JB, 2010, FREE RADICAL BIO MED, V49, P1798, DOI 10.1016/j.freeradbiomed.2010.09.013; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Stewart F, 1996, Rev Reprod, V1, P144, DOI 10.1530/ror.0.0010144; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Sun TT, 2016, J AM CHEM SOC, V138, P11575, DOI 10.1021/jacs.6b04049; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tseng WL, 2017, CELL TRANSPLANT, V26, P513, DOI 10.3727/096368916X694265; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yu SH, 2016, J BIOL CHEM, V291, P3982, DOI 10.1074/jbc.M115.700369; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	57	0	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15094	15104		10.1074/jbc.M117.790139	http://dx.doi.org/10.1074/jbc.M117.790139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28724630	hybrid, Green Published			2022-12-28	WOS:000409902100031
J	English, CA; Sherman, W; Meng, WL; Gierasch, LM				English, Charles A.; Sherman, Woody; Meng, Wenli; Gierasch, Lila M.			The Hsp70 interdomain linker is a dynamic switch that enables allosteric communication between two structured domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ALPHA-SYNUCLEIN AGGREGATION; MOLECULAR CHAPERONE DNAK; CONFORMATIONAL-CHANGES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; PK(A) VALUES; AMINO-ACIDS; ATPASE; NUCLEOTIDE	Hsp70 molecular chaperones play key roles in cellular protein homeostasis by binding to exposed hydrophobic regions of incompletely folded or aggregated proteins. This crucial Hsp70 function relies on allosteric communication between two well-structured domains: an N-terminal nucleotide-binding domain (NBD) and a C-terminal substrate-binding domain (SBD), which are tethered by an interdomain linker. ATP or ADP binding to the NBD alters the substrate-binding affinity of the SBD, triggering functionally essential cycles of substrate binding and release. The interdomain linker is a well-structured participant in the interdomain interface in ATP-bound Hsp70s. By contrast, in the ADP-bound state, exemplified by the Escherichia coli Hsp70 DnaK, the interdomain linker is flexible. Hsp70 interdomain linker sequences are highly conserved; moreover, mutations in this region compromise interdomain allostery. To better understand the role of this region in Hsp70 allostery, we used molecular dynamics simulations to explore the conformational landscape of the interdomain linker in ADP-bound DnaK and supported our simulations by strategic experimental data. We found that while the interdomain linker samples many conformations, it behaves as three relatively ordered segments connected by hinges. As a consequence, the distances and orientations between the NBD and SBD are limited. Additionally, the C-terminal region of the linker forms previously unreported, transient interactions with the SBD, and the predominant linker-docking site is available in only one allosteric state, that with high affinity for substrate. This preferential binding implicates the interdomain linker as a dynamic allosteric switch. The linker-binding site on the SBD is a potential target for small molecule modulators of the Hsp70 allosteric cycle.	[English, Charles A.; Sherman, Woody; Meng, Wenli; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Sherman, Woody; Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Sherman, Woody] Schrodinger Inc, Cambridge, MA 02142 USA; [Sherman, Woody] Silicon Therapeut, 300 A St, Boston, MA 02210 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Sherman, Woody/AAF-6952-2020	Sherman, Woody/0000-0001-9079-1376	University of Massachusetts (Amherst, MA); Schrodinger Inc.; NIGMS, National Institutes of Health [5R01GM027616-37, 1R35GM118161-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118161, R01GM027616] Funding Source: NIH RePORTER	University of Massachusetts (Amherst, MA); Schrodinger Inc.; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Massachusetts (Amherst, MA) and Schrodinger Inc. through an Academic-Industry Fellowship as well as NIGMS, National Institutes of Health, Grants 5R01GM027616-37 and 1R35GM118161-01 (to L.M.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eastman P, 2013, J CHEM THEORY COMPUT, V9, P461, DOI 10.1021/ct300857j; Eastman P, 2010, COMPUT SCI ENG, V12, P34, DOI 10.1109/MCSE.2010.27; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gierasch L. M., 2016, STRUCTURE ACTION MOL, P1; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; Kathuria SV, 2016, PROTEIN SCI, V25, P662, DOI 10.1002/pro.2860; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Penkler D, 2017, J CHEM INF MODEL, V57, P1359, DOI 10.1021/acs.jcim.6b00775; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Stetz G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005299; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Torrance GM, 2009, J MOL BIOL, V385, P1076, DOI 10.1016/j.jmb.2008.11.007; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	54	41	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14765	14774		10.1074/jbc.M117.789313	http://dx.doi.org/10.1074/jbc.M117.789313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28754691	Green Published, hybrid			2022-12-28	WOS:000409902100005
J	Gerodimos, CA; Chang, HHY; Watanabe, G; Lieber, MR				Gerodimos, Christina A.; Chang, Howard H. Y.; Watanabe, Go; Lieber, Michael R.			Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; DNA recombination; DNA repair; DNA-dependent serine; threonine protein kinase (DNA-PK); endonuclease; nucleic acid enzymology; NHEJ; V(D)J recombination; double strand DNA breaks; nonhomologous DNA end joining	DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; STRANDED-DNA; NUCLEASE ARTEMIS; JOINT FORMATION; DEFICIENT MICE; BREAK REPAIR; DAMAGE; PKCS; KU	In humans, nonhomologous DNA end-joining (NHEJ) is the major pathway by which DNA double-strand breaks are repaired. Recognition of each broken DNA end by the DNA repair protein Ku is the first step in NHEJ, followed by the iterative binding of nucleases, DNA polymerases, and the XRCC4-DNA ligase IV (X4-LIV) complex in an order influenced by the configuration of the two DNA ends at the break site. The endonuclease Artemis improves joining efficiency by functioning in a complex with DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) that carries out endonucleolytic cleavage of 5 and 3 overhangs. Previously, we observed that X4-LIV alone can stimulate Artemis activity on 3 overhangs, but this DNA-PKcs-independent endonuclease activity of Artemis awaited confirmation. Here, using in vitro nuclease and ligation assays, we find that stimulation of Artemis nuclease activity by X4-LIV and the efficiency of blunt-end ligation are determined by structural configurations at the DNA end. Specifically, X4-LIV stimulated Artemis to cut near the end of 3 overhangs without the involvement of other NHEJ proteins. Of note, this ligase complex is not able to stimulate Artemis activity at hairpins or at 5 overhangs. We also found that X4-LIV and DNA-PKcs interfere with one another with respect to stimulating Artemis activity at 3 overhangs, favoring the view that these NHEJ proteins are sequentially rather than concurrently recruited to DNA ends. These data suggest specific functional and positional relationships among these components that explain genetic and molecular features of NHEJ and V(D)J recombination within cells.	[Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci,Sect Mol & Computat Biol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	lieber@usc.edu		Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA196671, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to M. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang HHY, 2016, J BIOL CHEM, V291, P24377, DOI 10.1074/jbc.M116.752329; Chang HHY, 2015, J BIOL CHEM, V290, P24036, DOI 10.1074/jbc.M115.680900; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; GRIFFITH AJ, 1992, J BIOL CHEM, V267, P331; Gu JF, 2008, GENE DEV, V22, P411, DOI 10.1101/gad.1646608; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Kulesza P, 1998, NUCLEIC ACIDS RES, V26, P3944, DOI 10.1093/nar/26.17.3944; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LIEBER MR, 1988, P NATL ACAD SCI USA, V85, P8588, DOI 10.1073/pnas.85.22.8588; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Niewolik D, 2017, J BIOL CHEM, V292, P3351, DOI 10.1074/jbc.M116.770461; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Reid DA, 2017, NUCLEIC ACIDS RES, V45, P1872, DOI 10.1093/nar/gkw1221; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Santivasi WL, 2014, ANTIOXID REDOX SIGN, V21, P251, DOI 10.1089/ars.2013.5668; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Touvrey C, 2008, MOL IMMUNOL, V45, P3383, DOI 10.1016/j.molimm.2008.04.004; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908	36	21	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13914	13924		10.1074/jbc.M117.798850	http://dx.doi.org/10.1074/jbc.M117.798850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28696258	hybrid, Green Published			2022-12-28	WOS:000408439800002
J	Zhou, M; Wang, M; Xue, L; Lin, Z; He, QF; Shi, WW; Chen, YR; Jin, XF; Li, HY; Jiang, PP; Guan, MX				Zhou, Mi; Wang, Meng; Xue, Ling; Lin, Zhi; He, Qiufen; Shi, Wenwen; Chen, Yaru; Jin, Xiaofen; Li, Haiying; Jiang, Pingping; Guan, Min-Xin			A hypertension-associated mitochondrial DNA mutation alters the tertiary interaction and function of tRNA(Leu(UUR))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypertension; mitochondrial disease; mitochondrial DNA (mtDNA); mitochondrial membrane potential; mitochondrial metabolism; mitochondrial respiratory chain complex; mutant; pathogenesis; RNA structure; transfer RNA (tRNA)	TRANSFER-RNA MUTATIONS; MATERNALLY INHERITED HYPERTENSION; OXIDATIVE STRESS; BLOOD-PRESSURE; MTDNA; GENE; AMINOACYLATION; HEALTH; DEFICIENCY; METABOLISM	Several mitochondrial tRNA mutations have been associated with hypertension, but their pathophysiology remains poorly understood. In this report, we identified a novel homoplasmic 3253TC mutation in the mitochondrial tRNA(Leu(UUR)) gene in a Han Chinese family with maternally inherited hypertension. The m.3253TC mutation affected a highly conserved uridine at position 22 at the D-stem of tRNA(Leu(UUR)), introducing a G-C base pairing (G13-C22) at the D-stem and a tertiary base pairing (C22-G46) between the D-stem and the variable loop. We therefore hypothesized that the m.3253TC mutation altered both the structure and function of tRNA(Leu(UUR)). Using cytoplasmic hybrid (cybrid) cell lines derived from this Chinese family, we demonstrated that the m.3253TC mutation perturbed the conformation and stability of tRNA(Leu(UUR)), as suggested by faster electrophoretic mobility of mutated tRNA relative to the wild-type molecule. Northern blot analysis revealed an approximate to 45% decrease in the steady-state level of tRNA(Leu(UUR)) in the mutant cell lines carrying the m.3253TC mutation, as compared with control cell lines. Moreover, an approximate to 35% reduction in aminoacylation efficiency of tRNA(Leu(UUR)) was observed in the m.3253TC mutant cells. These alterations in tRNA(Leu(UUR)) metabolism impaired mitochondrial translation, especially for those polypeptides with a high proportion of Leu(UUR) codons, such as ND6. Furthermore, we demonstrated that the m.3253TC mutation decreased the activities of mitochondrial complexes I and V, markedly diminished mitochondrial ATP levels and membrane potential, and increased the production of reactive oxygen species in the cells. In conclusion, our findings may provide new insights into the pathophysiology of maternally inherited hypertension.	[Zhou, Mi; Wang, Meng; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Mi; Wang, Meng; He, Qiufen; Jin, Xiaofen; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Xue, Ling; Lin, Zhi; Shi, Wenwen; Chen, Yaru] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Wenzhou 325600, Zhejiang, Peoples R China; [Li, Haiying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325600, Zhejiang, Peoples R China; [Guan, Min-Xin] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University	Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		He, Qiufen/0000-0002-1175-1913; JIANG, PINGPING/0000-0002-4975-4861; Guan, Min-Xin/0000-0001-5067-6736	National Basic Research Priorities Program of China [2014CB541704]; National Natural Science Foundation of China [81600326, 31371270, 31401070, 81500611]; Postdoctoral Science Foundation of China [2016M591987]; Fundamental Research Funds for the Central Universities Grant [2017QNA7026]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities Grant(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541704 (to M. X. G.); National Natural Science Foundation of China Grants 81600326 (to M. Z.), 31371270 (to P. J.), 31401070 (to L. X.), and 81500611 (to M. W.); Postdoctoral Science Foundation of China Grant 2016M591987 (to M. Z.); and Fundamental Research Funds for the Central Universities Grant 2017QNA7026 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804; Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677; HAVLIK RJ, 1982, HYPERTENSION, V4, P121; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu CY, 2012, HYPERTENSION, V60, P949, DOI 10.1161/HYPERTENSIONAHA.112.196519; Liu YJ, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/6903524; Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Marian AJ, 2011, CIRC RES, V108, P784, DOI 10.1161/CIRCRESAHA.111.242768; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Moser Marvin, 1999, J Clin Hypertens (Greenwich), V1, P48; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Watson B, 2001, AM J KIDNEY DIS, V38, P529, DOI 10.1053/ajkd.2001.26848; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801	69	20	22	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					13934	13946		10.1074/jbc.M117.787028	http://dx.doi.org/10.1074/jbc.M117.787028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28679533	hybrid, Green Published			2022-12-28	WOS:000408439800004
J	Xie, Q; Wang, ZA				Xie, Qing; Wang, Zhu A.			Transcriptional regulation of the Nkx3.1 gene in prostate luminal stem cell specification and cancer initiation via its 3 ' genomic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ANDROGEN RECEPTOR; MOUSE PROSTATE; HOMEOBOX GENE; DNA-DAMAGE; PTEN LOSS; EXPRESSION; MODEL; CASTRATION; ADENOCARCINOMA	NK3 homeobox 1 (Nkx3.1), a transcription factor expressed in the prostate epithelium, is crucial for maintaining prostate cell fate and suppressing tumor initiation. Nkx3.1 isubiquitously expressed in luminal cells of hormonally intact prostate but, upon androgen deprivation, exclusively labels a type of luminal stem cells named castration-resistant Nkx3.1-expressing cells (CARNs). During prostate cancer initiation, Nkx3.1 expression is frequently lost in both humans and mouse models. Therefore, investigating how Nkx3.1 expression is regulated in vivo is important for understanding the mechanisms of prostate stem cell specification and cancer initiation. Here, using a transgenic mouse line with destabilized GFP, we identified an 11-kb genomic region 3' of the Nkx3.1 transcription start site to be responsible for alterations in Nkx3.1 expression patterns under various physiological conditions. We found that androgen cell-autonomously activates Nkx3.1 expression through androgen receptor (AR) binding to the 11-kb region in both normal luminal cells and CARNs and discovered new androgen response elements in the Nkx3.1 3' UTR. In contrast, we foundthat, in Pten(-/-) prostatetumors, loss of Nkx3.1 expression is mediated at the transcriptional level through the 11-kb region despite functional AR in the nucleus. Importantly, the GFP reporter specifically labeled CARNs in the regressed prostate only in the presence of cell-autonomous AR, supporting a facultative model for CARN specification.	[Xie, Qing; Wang, Zhu A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St,Mailstop MCDB, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Wang, ZA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St,Mailstop MCDB, Santa Cruz, CA 95064 USA.	zwang36@ucsc.edu		Wang, Zhu/0000-0002-8855-8951	UCSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116872] Funding Source: NIH RePORTER	UCSC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank UCSC for a special research grant enabling generation of the Nkx3.1(11)-d2EGFP mice.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bethel CR, 2007, PROSTATE, V67, P1740, DOI 10.1002/pros.20579; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2015, CANCER RES, V75, P2686, DOI 10.1158/0008-5472.CAN-14-3387; Bowen C, 2010, CANCER RES, V70, P3089, DOI 10.1158/0008-5472.CAN-09-3138; Cai BW, 2013, CELL REP, V4, P516, DOI 10.1016/j.celrep.2013.06.039; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang LW, 2005, DEV BIOL, V278, P396, DOI 10.1016/j.ydbio.2004.11.020; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kojima Chinatsu, 2010, Gene Expr, V15, P89; Kruithof-de Julio M, 2013, DEV DYNAM, V242, P1160, DOI 10.1002/dvdy.24008; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nodouzi V, 2015, INT BRAZ J UROL, V41, P898, DOI 10.1590/S1677-5538.IBJU.2014.0036; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thomas MA, 2006, J CELL BIOCHEM, V99, P1409, DOI 10.1002/jcb.21020; Thomas MA, 2010, BIOCHEM J, V425, P575, DOI 10.1042/BJ20091109; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xie Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14284; Yoo YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12943; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhang HL, 2016, PROSTATE, V76, P402, DOI 10.1002/pros.23131	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13521	13530		10.1074/jbc.M117.788315	http://dx.doi.org/10.1074/jbc.M117.788315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28679531	Green Published, hybrid			2022-12-28	WOS:000407942400032
J	Murakami, A; Matsuda, M; Harada, Y; Hirata, M				Murakami, Ayako; Matsuda, Miho; Harada, Yui; Hirata, Masato			Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; INS(1,4,5)P-3 BINDING-PROTEIN; ORTHODONTIC TOOTH MOVEMENT; NECROSIS-FACTOR RECEPTOR; GENE-EXPRESSION; EXPERIMENTAL-MODEL; GABA(A) RECEPTORS; NFATC1; CELLS; MICE	Phospholipase C-related, but catalytically inactive protein (PRIP) was previously identified as a novel inositol 1,4,5-trisphosphate-binding protein with a domain organization similar to that of phospholipase C-delta but lacking phospholipase activity. We recently showed that PRIP gene knock-out (KO) in mice increases bone formation and concomitantly decreases bone resorption, resulting in increased bone mineral density and trabecular bone volume. However, the role of PRIP in osteoclastogenesis has not yet been fully elucidated. Here, we investigated the effects of PRIP on bone remodeling by investigating dynamic tooth movement in mice fitted with orthodontic devices. Morphological analysis indicated that the extent of tooth movement was smaller in the PRIP-KO mice than in wild-type mice. Histological analysis revealed fewer osteoclasts on the bone-resorption side in maxillary bones of PRIP-KO mice, and osteoclast formation assays and flow cytometry indicated lower osteoclast differentiation in bone marrow cells isolated from these mice. The expression of genes implicated in bone resorption was lower in differentiated PRIP-KO cells, and genes involved in osteoclast differentiation, such as the transcription factor NFATc1, exhibited lower expression in immature PRIP-KO cells initiated by M-CSF. Moreover, calcineurin expression and activity were also lower in the PRIP-KO cells. The PRIP-KO cells also displayed fewer M-CSF-induced changes in intracellular Ca2+ and exhibited reduced nuclear localization of NFATc1. Up-regulation of intracellular Ca2+ restored osteoclastogenesis of the PRIP-KO cells. These results indicate that PRIP deficiency impairs osteoclast differentiation, particularly at the early stages, and that PRIP stimulates osteoclast differentiation through calcium-calcineurin-NFATc1 signaling via regulating intracellular Ca2+.	[Murakami, Ayako; Matsuda, Miho; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Harada, Yui] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 8128582, Japan; [Hirata, Masato] Fukuoka Dent Coll, Fukuoka 8140175, Japan	Kyushu University; Kyushu University; Fukuoka Dental College (FDC)	Matsuda, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	natural@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24229009, 24592804]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (KAKENHI nos. 24229009 (to M. H.) and 24592804 (to M. M.)) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andrade I, 2007, J DENT RES, V86, P1089, DOI 10.1177/154405910708601113; Andrade I, 2009, J DENT RES, V88, P1037, DOI 10.1177/0022034509346230; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crotti T. N., 2008, J CELL; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Inaba T, 1996, MOL CELL BIOL, V16, P2264; Inoue M, 1998, MOL ENDOCRINOL, V12, P1955, DOI 10.1210/me.12.12.1955; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kotani M, 2015, J CELL BIOCHEM, V116, P2814, DOI 10.1002/jcb.25228; Long Courtney L, 2012, Bonekey Rep, V1; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pavlin D, 2000, ORTHODONTICALLY STRE, V3, P55; Ren YJ, 2007, J PERIODONTOL, V78, P453, DOI 10.1902/jop.2007.060261; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; SHINAR DM, 1993, J BONE MINER RES, V8, P403; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Soysa Niroshani Surangika, 2012, J Med Dent Sci, V59, P65; STOREY E, 1973, AM J ORTHOD DENTOFAC, V63, P292, DOI 10.1016/0002-9416(73)90353-9; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugiyama Goro, 2013, Advances in Biological Regulation, V53, P331, DOI 10.1016/j.jbior.2013.07.001; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Toyoda H, 2015, PFLUG ARCH EUR J PHY, V467, P267, DOI 10.1007/s00424-014-1511-5; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; Verna C, 2004, EUR J ORTHODONT, V26, P459, DOI 10.1093/ejo/26.5.459; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimatsu M, 2006, J BONE MINER METAB, V24, P20, DOI 10.1007/s00774-005-0641-4; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhu HJ, 1996, J CELL BIOCHEM, V61, P420; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	60	20	23	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7994	8006		10.1074/jbc.M117.784777	http://dx.doi.org/10.1074/jbc.M117.784777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28341745	Green Published, hybrid			2022-12-28	WOS:000401154100025
